Citrus Sinensis ID: 043278
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 752 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LW83 | 850 | G-type lectin S-receptor- | yes | no | 0.964 | 0.852 | 0.445 | 1e-176 | |
| O64793 | 818 | G-type lectin S-receptor- | no | no | 0.954 | 0.877 | 0.438 | 1e-169 | |
| Q9SXB8 | 842 | G-type lectin S-receptor- | no | no | 0.948 | 0.846 | 0.403 | 1e-150 | |
| O81906 | 849 | G-type lectin S-receptor- | no | no | 0.958 | 0.849 | 0.386 | 1e-149 | |
| Q9SXB4 | 820 | G-type lectin S-receptor- | no | no | 0.930 | 0.853 | 0.388 | 1e-139 | |
| Q9ZR08 | 852 | G-type lectin S-receptor- | no | no | 0.912 | 0.805 | 0.382 | 1e-139 | |
| Q9SY89 | 842 | Putative G-type lectin S- | no | no | 0.948 | 0.846 | 0.388 | 1e-138 | |
| Q9S972 | 847 | Receptor-like serine/thre | no | no | 0.954 | 0.847 | 0.374 | 1e-137 | |
| O81905 | 850 | Receptor-like serine/thre | no | no | 0.964 | 0.852 | 0.375 | 1e-137 | |
| Q39086 | 843 | Receptor-like serine/thre | no | no | 0.932 | 0.831 | 0.378 | 1e-136 |
| >sp|Q9LW83|CE101_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase CES101 OS=Arabidopsis thaliana GN=CES101 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 617 bits (1592), Expect = e-176, Method: Compositional matrix adjust.
Identities = 373/837 (44%), Positives = 495/837 (59%), Gaps = 112/837 (13%)
Query: 3 LVSAFGNFKLGFFSPASSTTTERYLGIWHDTAPDTLGWYFRPFLPRYQTDEPIWIANRNT 62
LVSAF FKL FF+ +S+ YLGIW++ + +WIANRN
Sbjct: 39 LVSAFNIFKLKFFNFENSSNW--YLGIWYNN---------------FYLSGAVWIANRNN 81
Query: 63 PILDQSGVLTIDSIDGNLKILHNGGNPIAVSSVEGASNNTSATLLQSGNLVLREMDTDGT 122
P+L +SG LT+DS+ G L+IL + + +SS E + NT+ LL SGNL L+EMD+DG+
Sbjct: 82 PVLGRSGSLTVDSL-GRLRILRGASSLLELSSTE-TTGNTTLKLLDSGNLQLQEMDSDGS 139
Query: 123 IKRVLWQSFDYPTDTLLPGMKLGINLQTGHQWFLQSWLDYSSPAQGSFTLGIEPNATNQL 182
+KR LWQSFDYPTDTLLPGMKLG N++TG +W L SWL + PA GSF G++ N TN+L
Sbjct: 140 MKRTLWQSFDYPTDTLLPGMKLGFNVKTGKRWELTSWLGDTLPASGSFVFGMDDNITNRL 199
Query: 183 IIRWRRETIYWTSGLLLNGNFNFSR--SWNLSFSYTSNEQEKYFEYSLNEGVTSSVF--L 238
I W +YW SGL G F+ + + FS+ S E E YF YS +E +F +
Sbjct: 200 TILWL-GNVYWASGLWFKGGFSLEKLNTNGFIFSFVSTESEHYFMYSGDENYGGPLFPRI 258
Query: 239 RIDPEGALSD-------SRGSFAPCTYG-----GCWNQLPRPIC----RKGTGPEN---- 278
RID +G+L +P +G GC+ Q R ++ TG +
Sbjct: 259 RIDQQGSLQKINLDGVKKHVHCSPSVFGEELEYGCYQQNFRNCVPARYKEVTGSWDCSPF 318
Query: 279 ----------------------FQSKVGLISEHGFKFKE-SDNMSSTDCRANCFYNCSCI 315
F+ V +E+GF F E +SS DC C NCSC+
Sbjct: 319 GFGYTYTRKTYDLSYCSRFGYTFRETVSPSAENGFVFNEIGRRLSSYDCYVKCLQNCSCV 378
Query: 316 AFATGTSEYTDKQAYCEIWSEGTEFTEIASNNSREIFILAIKEEKWWRS-LTIAIGVVLG 374
A+A+ + T CEIW+ AS++ R I+I IK K + L + + L
Sbjct: 379 AYASTNGDGTG----CEIWNTDPTNENSASHHPRTIYI-RIKGSKLAATWLVVVASLFLI 433
Query: 375 IPLLCYLCYVTWRKLKAK------DNVSLLPTYG-----KRKSPEK-----DQSI----- 413
IP+ + Y+ RK K K +++ ++ + KR S + DQ +
Sbjct: 434 IPVTWLIIYLVLRKFKIKGTNFVSESLKMISSQSCSLTNKRLSTLRVGSTIDQEMLLLEL 493
Query: 414 ---------------SHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEVA 458
++EL+IF F+++A A + FS NKLGEGGFGPVYKG+L D +EVA
Sbjct: 494 GIERRRRGKRSARNNNNELQIFSFESVAFATDYFSDANKLGEGGFGPVYKGRLIDGEEVA 553
Query: 459 IKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLF 518
IKRLS +SGQG+VEFKNE LIAKLQHTNLV+LLGC + +E++L+YE+MPNKSLD+FLF
Sbjct: 554 IKRLSLASGQGLVEFKNEAMLIAKLQHTNLVKLLGCCVEKDEKMLIYEYMPNKSLDYFLF 613
Query: 519 NSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGM 578
+ RK VL+W+ RF I+EGI QGLLYLHKYSRL+VIHRD+KA NILLD+ MNPKISDFGM
Sbjct: 614 DPLRKIVLDWKLRFRIMEGIIQGLLYLHKYSRLKVIHRDIKAGNILLDEDMNPKISDFGM 673
Query: 579 ARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHH 638
ARIF ES+ANTKR+ GT+GYMSPEY G+ S K+DVFSFGVL+LEI+ G+KN++ HH
Sbjct: 674 ARIFGAQESKANTKRVAGTFGYMSPEYFREGLFSAKSDVFSFGVLMLEIICGRKNNSFHH 733
Query: 639 -PDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSAN-EVMRCIHVGLLCVQDQAMDRPTM 696
+ PLNLI + W L + + E+IDPSL N +V+RC+ V LLCVQ A DRP+M
Sbjct: 734 DSEGPLNLIVHVWNLFKENRVREVIDPSLGDSAVENPQVLRCVQVALLCVQQNADDRPSM 793
Query: 697 PEVVCMLQNE-TMPLPPPKQPAFFINANADDQVPEVPDNEVAKFSTNDVTMTTMEAR 752
+VV M+ + L PK+PAF+ EV E+ S N VT+T MEAR
Sbjct: 794 LDVVSMIYGDGNNALSLPKEPAFYDGPPRSSPEMEVEPPEMENVSANRVTITVMEAR 850
|
Promotes the expression of genes involved in photosynthesis at least in dedifferentiated calli. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O64793|Y1675_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g67520 OS=Arabidopsis thaliana GN=At1g67520 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 594 bits (1531), Expect = e-169, Method: Compositional matrix adjust.
Identities = 356/812 (43%), Positives = 474/812 (58%), Gaps = 94/812 (11%)
Query: 3 LVSAFGNFKLGFFSPASSTTTERYLGIWHDTAPDTLGWYFRPFLPRYQTDEPIWIANRNT 62
LVSAF FKL FF+ +S YLGIW + +L D P+WIANRN
Sbjct: 39 LVSAFKIFKLKFFNFKNSENL--YLGIWFNNL----------YLNTDSQDRPVWIANRNN 86
Query: 63 PILDQSGVLTIDSIDGNLKILHNGGNPIAVSSVEGASNNTSATLLQSGNLVLREMDTDGT 122
PI D+SG LT+DS+ G LKIL + +SS+E + NT+ LL SGNL L+EMD DG+
Sbjct: 87 PISDRSGSLTVDSL-GRLKILRGASTMLELSSIE-TTRNTTLQLLDSGNLQLQEMDADGS 144
Query: 123 IKRVLWQSFDYPTDTLLPGMKLGINLQTGHQWFLQSWLDYSSPAQGSFTLGIEPNATNQL 182
+KRVLWQSFDYPTDTLLPGMKLG + +T +W L SWL + PA GSF G++ N TN L
Sbjct: 145 MKRVLWQSFDYPTDTLLPGMKLGFDGKTRKRWELTSWLGDTLPASGSFVFGMDTNITNVL 204
Query: 183 IIRWRRETIYWTSGLLLNGNFNFSR--SWNLSFSYTSNEQEKYFEYSLNEGVTSSVF--L 238
I WR +YW+SGL G F+ FS+ S + +YF YS ++ + F +
Sbjct: 205 TILWR-GNMYWSSGLWNKGRFSEEELNECGFLFSFVSTKSGQYFMYSGDQDDARTFFPTI 263
Query: 239 RIDPEGALSDSR---------GSFAPCTYGGCWNQLPRPICRKGTGPENFQSKVGLISEH 289
ID +G L + C G + + G +F+ V + +
Sbjct: 264 MIDEQGILRREQMHRQRNRQNYRNRNCLAAG------YVVRDEPYGFTSFRVTVSSSASN 317
Query: 290 GFKFKESDNMSSTDCRANCFYNCSCIAFATGTSEYTDKQAYCEIWSEGTEFTEIASNNSR 349
GF S SS DC A C N SC+A+A+ + T CEIW+ AS++ R
Sbjct: 318 GFVL--SGTFSSVDCSAICLQNSSCLAYASTEPDGTG----CEIWNTYPTNKGSASHSPR 371
Query: 350 EIFILAIKEEKWWRSLTIAIGVVLGIPLLCYLCYVTWRKLKAK----------------- 392
I+I + +K + + L P++ ++ Y+ RK K
Sbjct: 372 TIYIRGNENKKVAAWHIVVATLFLMTPIIWFIIYLVLRKFNVKGRNCIRITHKTVLVSMV 431
Query: 393 ----------------------DNVSLLPTYGKRKS---PEKDQSISHELKIFDFQTIAA 427
D LL G +S ++ ++EL+IF F+++ +
Sbjct: 432 FLLTMIGFIRRRILSLRFGSTIDQEMLLRELGIDRSCIHKRNERKSNNELQIFSFESVVS 491
Query: 428 AANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTN 487
A ++FS NKLGEGGFGPVYKGKL + +EVAIKRLS +SGQG+VEFKNE LIAKLQHTN
Sbjct: 492 ATDDFSDENKLGEGGFGPVYKGKLLNGEEVAIKRLSLASGQGLVEFKNEAILIAKLQHTN 551
Query: 488 LVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHK 547
LV++LGC + +E++L+YE+M NKSLD+FLF+ RKNVL+W RF I+EGI QGLLYLHK
Sbjct: 552 LVQVLGCCIEKDEKMLIYEYMQNKSLDYFLFDPLRKNVLDWTLRFRIMEGIIQGLLYLHK 611
Query: 548 YSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM 607
YSRL+VIHRD+KASNILLD+ MNPKISDFG+ARIF E+ ANTKR+ GT+GYMSPEY
Sbjct: 612 YSRLKVIHRDIKASNILLDEDMNPKISDFGLARIFGAEETRANTKRVAGTFGYMSPEYFR 671
Query: 608 SGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHP-DRPLNLIGYAWQLLSDGKGLELIDPSL 666
G+ S K+DVFSFGVL+LEI+ G+KN++ HH + PLNLI + W L + K E+ID SL
Sbjct: 672 EGLFSAKSDVFSFGVLMLEIICGRKNNSFHHDLEGPLNLIVHVWNLFKENKIREVIDLSL 731
Query: 667 -EQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE-TMPLPPPKQPAFFINANA 724
+ +V+RC+ V LLCVQ+ A DRP+M +VV M+ E L PK+PAF+
Sbjct: 732 RDSALDYPQVLRCVQVALLCVQENAEDRPSMLDVVSMIYGEGNNALSLPKEPAFYDGPRR 791
Query: 725 D----DQVPEVPDNEVAKFSTNDVTMTTMEAR 752
P+ P+N A +T+T +EAR
Sbjct: 792 SFPEMKVEPQEPENVSAS-----ITITVLEAR 818
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB8|Y1133_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330 OS=Arabidopsis thaliana GN=At1g11330 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 531 bits (1369), Expect = e-150, Method: Compositional matrix adjust.
Identities = 336/833 (40%), Positives = 460/833 (55%), Gaps = 120/833 (14%)
Query: 3 LVSAFGNFKLGFFSPASSTTTERYLGIWHDTAPDTLGWYFRPFLPRYQTDEPIWIANRNT 62
L+ G F+ GFF+P +STT RY+GIW++ P QT +W+AN+++
Sbjct: 47 LLCKSGIFRFGFFTPVNSTTRLRYVGIWYEKIP-------------IQT--VVWVANKDS 91
Query: 63 PILDQSGVLTIDSIDGNLKILHNGGNPIAVS---SVEGASNNTSATLLQSGNLVLREMDT 119
PI D SGV++I DGNL + +G N + S SV A N T L+ SGNL+L++
Sbjct: 92 PINDTSGVISIYQ-DGNLAVT-DGRNRLVWSTNVSVPVAPNATWVQLMDSGNLMLQDNRN 149
Query: 120 DGTIKRVLWQSFDYPTDTLLPGMKLGINLQTGHQWFLQSWLDYSSPAQGSFTLGIEPNAT 179
+G I LW+SF +P D+ +P M LG + +TG L SW + P+ G++T GI P
Sbjct: 150 NGEI---LWESFKHPYDSFMPRMTLGTDGRTGGNLKLTSWTSHDDPSTGNYTAGIAPFTF 206
Query: 180 NQLIIRWRRETIYWTSG----------------LLLNG-NFNFSRSWNLSFSYTSNEQEK 222
+L+I W+ W SG L L+G N N +S SY ++
Sbjct: 207 PELLI-WKNNVPTWRSGPWNGQVFIGLPNMDSLLFLDGFNLNSDNQGTISMSYANDS--- 262
Query: 223 YFEYSLN---EGV-------TSSVFLRIDPEGALSDSR-----GSFAPCTYGGCWNQLPR 267
F Y N EG+ TS RI + +D G F C G + P
Sbjct: 263 -FMYHFNLDPEGIIYQKDWSTSMRTWRIGVKFPYTDCDAYGRCGRFGSCHAG----ENPP 317
Query: 268 PICRKGTGPEN------------FQSKVGLISEH--------------GF----KFK--- 294
C KG P+N K L E GF K K
Sbjct: 318 CKCVKGFVPKNNTEWNGGNWSNGCMRKAPLQCERQRNVSNGGGGGKADGFLKLQKMKVPI 377
Query: 295 --ESDNMSSTDCRANCFYNCSCIAFATGTSEYTDKQAYCEIWSEGTEFTEIASNNSREIF 352
E S C C NCSC A+A D+ C +WS + + ++F
Sbjct: 378 SAERSEASEQVCPKVCLDNCSCTAYAY------DRGIGCMLWSGDLVDMQSFLGSGIDLF 431
Query: 353 I-LAIKEEKWWRSLTIAIGV-VLGIPLLCYLCYV-TWRKLK-----AKDNVSLLPTYGKR 404
I +A E K +L + I V+G+ L+ +C + RK K AKD + L
Sbjct: 432 IRVAHSELKTHSNLAVMIAAPVIGVMLIAAVCVLLACRKYKKRPAPAKDRSAELMFKRME 491
Query: 405 KSPEKDQSISHELKI-----FDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEVAI 459
++S S+++K+ F+FQ +A + ++FS NKLG+GGFGPVYKGKL + QE+A+
Sbjct: 492 ALTSDNESASNQIKLKELPLFEFQVLATSTDSFSLRNKLGQGGFGPVYKGKLPEGQEIAV 551
Query: 460 KRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFN 519
KRLSR SGQG+ E NEV +I+KLQH NLV+LLGC + GEER+LVYE+MP KSLD +LF+
Sbjct: 552 KRLSRKSGQGLEELMNEVVVISKLQHRNLVKLLGCCIEGEERMLVYEYMPKKSLDAYLFD 611
Query: 520 SGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMA 579
++ +L+W+ RF I+EGI +GLLYLH+ SRL++IHRDLKASNILLD+ +NPKISDFG+A
Sbjct: 612 PMKQKILDWKTRFNIMEGICRGLLYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLA 671
Query: 580 RIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHP 639
RIF NE EANT+R+VGTYGYMSPEYAM G S K+DVFS GV+ LEI+SG++N + H
Sbjct: 672 RIFRANEDEANTRRVVGTYGYMSPEYAMEGFFSEKSDVFSLGVIFLEIISGRRNSSSHKE 731
Query: 640 DRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEV 699
+ LNL+ YAW+L +DG+ L DP++ C E+ +C+H+GLLCVQ+ A DRP + V
Sbjct: 732 ENNLNLLAYAWKLWNDGEAASLADPAVFDKCFEKEIEKCVHIGLLCVQEVANDRPNVSNV 791
Query: 700 VCMLQNETMPLPPPKQPAFFINANADDQVPEVPDNEVAKFSTNDVTMTTMEAR 752
+ ML E M L PKQPAF + A + E D K S NDV++T + R
Sbjct: 792 IWMLTTENMSLADPKQPAFIVRRGASEA--ESSDQSSQKVSINDVSLTAVTGR 842
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 528 bits (1360), Expect = e-149, Method: Compositional matrix adjust.
Identities = 323/835 (38%), Positives = 454/835 (54%), Gaps = 114/835 (13%)
Query: 3 LVSAFGNFKLGFFSPASSTTTERYLGIWHDTAPDTLGWYFRPFLPRYQTDEPIWIANRNT 62
LVS F+LGFFSP SST R+LGIW+ D +W+ANR T
Sbjct: 44 LVSPQKTFELGFFSPGSST--HRFLGIWYGNIED---------------KAVVWVANRAT 86
Query: 63 PILDQSGVLTIDSIDGNLKILHNGGNPIAVSSVEGAS---NNTSATLLQSGNLVLREMDT 119
PI DQSGVL I S DGNL +L + S++E ++ NN ++ +GN VL E DT
Sbjct: 87 PISDQSGVLMI-SNDGNLVLLDGKNITVWSSNIESSTTNNNNRVVSIHDTGNFVLSETDT 145
Query: 120 DGTIKRVLWQSFDYPTDTLLPGMKLGINLQTGHQWFLQSWLDYSSPAQGSFTLGIEPNAT 179
D R +W+SF++PTDT LP M++ +N QTG SW + P+ G+++LG++P+
Sbjct: 146 D----RPIWESFNHPTDTFLPQMRVRVNPQTGDNHAFVSWRSETDPSPGNYSLGVDPSGA 201
Query: 180 NQLIIRWRRETIYWTSG--------------LLLNGNFNFSRS------WNLSFSYTSNE 219
++++ +T W SG LL N + F S ++ F+Y ++
Sbjct: 202 PEIVLWEGNKTRKWRSGQWNSAIFTGIPNMSLLTNYLYGFKLSSPPDETGSVYFTYVPSD 261
Query: 220 QEKYFEYSL-----------NEGVTSSVFLRIDPEG-----------ALSDSRGS--FAP 255
+ + NE + + +P+ + D +GS
Sbjct: 262 PSVLLRFKVLYNGTEEELRWNETLKKWTKFQSEPDSECDQYNRCGKFGICDMKGSNGICS 321
Query: 256 CTYG-----------GCWNQLPRPICRKGTGPENFQSKVGLISEHGFKFKESDNMSSTDC 304
C +G GC + P R + E+ + + F+ E + + DC
Sbjct: 322 CIHGYEQVSVGNWSRGCRRRTPLKCERNISVGEDEFLTLKSVKLPDFEIPEHNLVDPEDC 381
Query: 305 RANCFYNCSCIAFATGTSEYTDKQAYCEIWSEG-TEFTEIASNNSREIFILAIKEEKWWR 363
R C NCSC A++ C IW++ + + + S LA E R
Sbjct: 382 RERCLRNCSCNAYSLVGG------IGCMIWNQDLVDLQQFEAGGSSLHIRLADSEVGENR 435
Query: 364 SLTIAI--GVVLGIPLLCYLCYVTWRKLKAKD---------NVSLLPTYGKRKSPEKDQS 412
IA+ V++G+ L+ + WR + KD + + KS E +
Sbjct: 436 KTKIAVIVAVLVGVILIGIFALLLWRFKRKKDVSGAYCGKNTDTSVVVADLTKSKETTSA 495
Query: 413 IS--------------HELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEVA 458
S EL +F IA A N+F N+LG GGFGPVYKG L D +E+A
Sbjct: 496 FSGSVDIMIEGKAVNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIA 555
Query: 459 IKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLF 518
+KRLS SGQG+ EFKNE+ LIAKLQH NLVRLLGC GEE++LVYE+MPNKSLDFFLF
Sbjct: 556 VKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLF 615
Query: 519 NSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGM 578
+ ++ +++W+ RF IIEGI++GLLYLH+ SRLR+IHRDLK SN+LLD +MNPKISDFGM
Sbjct: 616 DETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGM 675
Query: 579 ARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHH 638
ARIF N++EANT R+VGTYGYMSPEYAM G+ S+K+DV+SFGVL+LEIVSG++N +
Sbjct: 676 ARIFGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRS 735
Query: 639 PDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPE 698
+ +LIGYAW L + G+ EL+DP + CS E +RCIHV +LCVQD A +RP M
Sbjct: 736 SEHG-SLIGYAWYLYTHGRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMAS 794
Query: 699 VVCMLQNETMPLPPPKQPAFF-INANADDQVPEVPDNEVAKFSTNDVTMTTMEAR 752
V+ ML+++T L P+QP F N+ D + ++ S+N++T T + R
Sbjct: 795 VLLMLESDTATLAAPRQPTFTSTRRNSIDVNFALDSSQQYIVSSNEITSTVVLGR 849
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB4|Y1130_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11300 OS=Arabidopsis thaliana GN=At1g11300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 497 bits (1279), Expect = e-139, Method: Compositional matrix adjust.
Identities = 322/829 (38%), Positives = 444/829 (53%), Gaps = 129/829 (15%)
Query: 3 LVSAFGNFKLGFFSPASSTTTERYLGIWHDTAPDTLGWYFRPFLPRYQTDEPIWIANRNT 62
+VS+F F+ GFFSP +ST+ RY GIW+++ IW+AN++
Sbjct: 42 IVSSFRTFRFGFFSPVNSTS--RYAGIWYNSV---------------SVQTVIWVANKDK 84
Query: 63 PILDQSGVLTIDSIDGNLKILHNGGNPIAVS---SVEGASNNTSATLLQSGNLVLREMDT 119
PI D SGV+++ S DGNL ++ +G + S S + ++N+T A LL SGNLVL+E +
Sbjct: 85 PINDSSGVISV-SQDGNL-VVTDGQRRVLWSTNVSTQASANSTVAELLDSGNLVLKEASS 142
Query: 120 DGTIKRVLWQSFDYPTDTLLPGMKLGINLQTGH-QWFLQSWLDYSSPAQGSFTLGIEPNA 178
D LW+SF YPTD+ LP M +G N + G + SW S P+ GS+T + A
Sbjct: 143 DA----YLWESFKYPTDSWLPNMLVGTNARIGGGNVTITSWKSPSDPSPGSYTAALVLAA 198
Query: 179 TNQLII--RWRRETIYWTSG----LLLNG-------------NFNFSRSWNLSFSYTSNE 219
+L I + W SG + NG N + +++ SY ++
Sbjct: 199 YPELFIMNNNNNNSTVWRSGPWNGQMFNGLPDVYAGVFLYRFIVNDDTNGSVTMSYANDS 258
Query: 220 QEKYFEYSLNEGVTS----------SVFLRIDPEGALSDSR--GSFAPCT---------- 257
+YF V +V L++ P + R G FA C
Sbjct: 259 TLRYFYMDYRGSVIRRDWSETRRNWTVGLQV-PATECDNYRRCGEFATCNPRKNPLCSCI 317
Query: 258 ----------------YGGCWNQLPRPICRKGTGPENFQSKVGLISEHGFK---FKESDN 298
GGC ++P R+ N S G + K F
Sbjct: 318 RGFRPRNLIEWNNGNWSGGCTRRVPLQCERQ----NNNGSADGFLRLRRMKLPDFARRSE 373
Query: 299 MSSTDCRANCFYNCSCIAFATGTSEYTDKQAYCEIWSEGTEFTEIASNNSREIFI-LAIK 357
S +C C CSCIA A G C IW+ ++ S + +++I LA
Sbjct: 374 ASEPECLRTCLQTCSCIAAAHGLG------YGCMIWNGSLVDSQELSASGLDLYIRLAHS 427
Query: 358 EEKWWRSLTIAIGVVL-GIPLLCYLCYVTWRKLKAKDNVSLLPTYGKRKSPEKDQSISH- 415
E K I IG +L G + C + R++ K K+K + +Q
Sbjct: 428 EIKTKDKRPILIGTILAGGIFVVAACVLLARRIVMKKR-------AKKKGRDAEQIFERV 480
Query: 416 ------------ELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLS 463
EL +F+FQ +AAA NNFS NKLG+GGFGPVYKGKL + QE+A+KRLS
Sbjct: 481 EALAGGNKGKLKELPLFEFQVLAAATNNFSLRNKLGQGGFGPVYKGKLQEGQEIAVKRLS 540
Query: 464 RSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRK 523
R+SGQG+ E NEV +I+KLQH NLV+LLGC + GEER+LVYEFMP KSLD++LF+S R
Sbjct: 541 RASGQGLEELVNEVVVISKLQHRNLVKLLGCCIAGEERMLVYEFMPKKSLDYYLFDSRRA 600
Query: 524 NVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFE 583
+L+W+ RF II GI +GLLYLH+ SRLR+IHRDLKASNILLD+ + PKISDFG+ARIF
Sbjct: 601 KLLDWKTRFNIINGICRGLLYLHRDSRLRIIHRDLKASNILLDENLIPKISDFGLARIFP 660
Query: 584 VNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPL 643
NE EANT+R+VGTYGYM+PEYAM G+ S K+DVFS GV++LEI+SG++N
Sbjct: 661 GNEDEANTRRVVGTYGYMAPEYAMGGLFSEKSDVFSLGVILLEIISGRRNSNS------- 713
Query: 644 NLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCML 703
L+ Y W + ++G+ L+DP + E+ +CIH+GLLCVQ+ A DRP++ V ML
Sbjct: 714 TLLAYVWSIWNEGEINSLVDPEIFDLLFEKEIHKCIHIGLLCVQEAANDRPSVSTVCSML 773
Query: 704 QNETMPLPPPKQPAFFINANADDQVPEVPDNEVAKFSTNDVTMTTMEAR 752
+E +P PKQPAF N + E +N K S N+VT+T + R
Sbjct: 774 SSEIADIPEPKQPAFISRNNVPE--AESSENSDLKDSINNVTITDVTGR 820
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZR08|Y4230_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g03230 OS=Arabidopsis thaliana GN=At4g03230 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 495 bits (1275), Expect = e-139, Method: Compositional matrix adjust.
Identities = 310/810 (38%), Positives = 441/810 (54%), Gaps = 124/810 (15%)
Query: 3 LVSAFGNFKLGFFSPASSTTTERYLGIW-HDTAPDTLGWYFRPFLPRYQTDEPIWIANRN 61
LVSA F+LGFF+P S+ RYLGIW ++ P T+ +W+ANR
Sbjct: 44 LVSAGQRFELGFFTPNGSSDERRYLGIWFYNLHPLTV----------------VWVANRE 87
Query: 62 TPILDQSGVLTIDSIDGNLKILHNGGNPIAVSSVEGASNNTS--ATLLQSGNLVLREMDT 119
+P+LD+S + TI S DGNL+++ + G + V+ +S + L+ +GNLVL +
Sbjct: 88 SPVLDRSCIFTI-SKDGNLEVIDSKGRVYWDTGVKPSSVSAERMVKLMDNGNLVLI---S 143
Query: 120 DGTIKRVLWQSFDYPTDTLLPGMKLGINLQTGHQWFLQSWLDYSSPAQGSFTLGIEPNAT 179
DG V+WQSF PTDT LPGM++ N+ L SW ++ P+ G+FT ++
Sbjct: 144 DGNEANVVWQSFQNPTDTFLPGMRMDENMT------LSSWRSFNDPSHGNFTFQMDQEED 197
Query: 180 NQLIIRWRRETIYWTSGLLLNGNF---------------NFSRS---------------- 208
Q II W+R YW SG+ +G F NF+ +
Sbjct: 198 KQFII-WKRSMRYWKSGI--SGKFIGSDEMPYAISYFLSNFTETVTVHNASVPPLFTSLY 254
Query: 209 WNLSFSYTSNEQEKYFEYSLNEGVTSSVFLRIDPEGALSDSRGSFAPCTY---------- 258
N F+ +S+ Q +YF E + ++ E ++ ++ G+F C
Sbjct: 255 TNTRFTMSSSGQAQYFRLD-GERFWAQIWAEPRDECSVYNACGNFGSCNSKNEEMCKCLP 313
Query: 259 ----------------GGCWNQLPRPICRKGTGPENFQSKVGLISEHGFKFKESDNMSST 302
GGC ++ R + G + + ++ E G + D +
Sbjct: 314 GFRPNFLEKWVKGDFSGGC-SRESRICGKDGVVVGDMFLNLSVV-EVGSPDSQFDAHNEK 371
Query: 303 DCRANCFYNCSCIAFATGTSEYTDKQAYCEIWSEGTEFTEIASNNSREIFI-LAIK---- 357
+CRA C NC C A++ + C IW E + SR +FI +A+
Sbjct: 372 ECRAECLNNCQCQAYSYEEVDILQSNTKCWIWLEDLNNLKEGYLGSRNVFIRVAVPDIGS 431
Query: 358 ----------EEKWWRSLTIAI---GVVLGIPLLCYLCYVTWRKLKAKDNVSLLP----- 399
E K L I + + + L YV ++ K + +P
Sbjct: 432 HVERGRGRYGEAKTPVVLIIVVTFTSAAILVVLSSTASYVFLQRRKVNKELGSIPRGVHL 491
Query: 400 TYGKRKSPE--------KDQSISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKL 451
+R E +D S ++ F+ +TI A +NFS NKLG+GGFGPVYKG
Sbjct: 492 CDSERHIKELIESGRFKQDDSQGIDVPSFELETILYATSNFSNANKLGQGGFGPVYKGMF 551
Query: 452 ADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNK 511
+QE+A+KRLSR SGQG+ EFKNEV LIAKLQH NLVRLLG + GEE+LL+YE+MP+K
Sbjct: 552 PGDQEIAVKRLSRCSGQGLEEFKNEVVLIAKLQHRNLVRLLGYCVAGEEKLLLYEYMPHK 611
Query: 512 SLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNP 571
SLDFF+F+ L+W+ R II GI++GLLYLH+ SRLR+IHRDLK SNILLD++MNP
Sbjct: 612 SLDFFIFDRKLCQRLDWKMRCNIILGIARGLLYLHQDSRLRIIHRDLKTSNILLDEEMNP 671
Query: 572 KISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
KISDFG+ARIF +E+ ANT R+VGTYGYMSPEYA+ G+ S K+DVFSFGV+V+E +SG+
Sbjct: 672 KISDFGLARIFGGSETSANTNRVVGTYGYMSPEYALEGLFSFKSDVFSFGVVVIETISGK 731
Query: 632 KNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAM 691
+N H P++ L+L+G+AW L +G+EL+D +L++ C ++C++VGLLCVQ+
Sbjct: 732 RNTGFHEPEKSLSLLGHAWDLWKAERGIELLDQALQESCETEGFLKCLNVGLLCVQEDPN 791
Query: 692 DRPTMPEVVCML-QNETMPLPPPKQPAFFI 720
DRPTM VV ML +E LP PKQPAF +
Sbjct: 792 DRPTMSNVVFMLGSSEAATLPTPKQPAFVL 821
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SY89|Y1661_ARATH Putative G-type lectin S-receptor-like serine/threonine-protein kinase At1g61610 OS=Arabidopsis thaliana GN=At1g61610 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 494 bits (1271), Expect = e-138, Method: Compositional matrix adjust.
Identities = 325/836 (38%), Positives = 448/836 (53%), Gaps = 123/836 (14%)
Query: 3 LVSAFGNFKLGFFSPASSTTTERYLGIWH-DTAPDTLGWYFRPFLPRYQTDEPIWIANRN 61
L+S +F+LGFF+P +ST RY+GIW+ + P T+ +W+ANR
Sbjct: 44 LISEDESFELGFFTPKNSTL--RYVGIWYKNIEPQTV----------------VWVANRE 85
Query: 62 TPILDQSGVLTIDSIDGNLKILHNGGNPIAVSSVEGASNNTSATLLQSGNLVLREMDTDG 121
P+LD G L I + DGNL I++ I ++VE SNNT A L ++G+LVL +D
Sbjct: 86 KPLLDHKGALKI-ADDGNLVIVNGQNETIWSTNVEPESNNTVAVLFKTGDLVLC---SDS 141
Query: 122 TIKRVLWQSFDYPTDTLLPGMKLGINLQTGHQWFLQSWLDYSSPAQGSFTLGIEPNATNQ 181
++ W+SF+ PTDT LPGM++ +N G W S P+ G +++GI+P +
Sbjct: 142 DRRKWYWESFNNPTDTFLPGMRVRVNPSLGENRAFIPWKSESDPSPGKYSMGIDPVGALE 201
Query: 182 LIIRWRRETIYWTSG----LLLNGNFNFSRSWNLSFSYT-----SNEQEKYFEYSLNEGV 232
++I W E W SG + G + R N + + + YF Y ++
Sbjct: 202 IVI-WEGEKRKWRSGPWNSAIFTGIPDMLRFTNYIYGFKLSSPPDRDGSVYFTYVASD-- 258
Query: 233 TSSVFLR--IDPEGALSDSR-------------------------GSFAPCT-------- 257
SS FLR I P+G R G+++ C
Sbjct: 259 -SSDFLRFWIRPDGVEEQFRWNKDIRNWNLLQWKPSTECEKYNRCGNYSVCDDSKEFDSG 317
Query: 258 ---------------------YGGCWNQLPRPICRKG--TGPENFQSKVGLISEHGFKFK 294
GGC ++P C + G E+ + + I F
Sbjct: 318 KCSCIDGFEPVHQDQWNNRDFSGGCQRRVPLN-CNQSLVAGQEDGFTVLKGIKVPDFGSV 376
Query: 295 ESDNMSSTDCRANCFYNCSCIAFATGTSEYTDKQAYCEIWSEGTEFTEIASNNSREIFIL 354
N S T C+ C +CSC A+A C IW+ E I I
Sbjct: 377 VLHNNSET-CKDVCARDCSCKAYALVVG------IGCMIWTRDLIDMEHFERGGNSINIR 429
Query: 355 AIKEE----KWWRSLTIAIGVVLGIPLLCYLCYVTWR---KLKA----KDNVSLLPTYGK 403
+ K +L I + V+G LL ++ W+ LKA K ++++
Sbjct: 430 LAGSKLGGGKENSTLWIIVFSVIGAFLLGLCIWILWKFKKSLKAFLWKKKDITVSDIIEN 489
Query: 404 R---KSPEK----DQSISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQE 456
R SP K DQ + +L IF F ++A+A +F+ NKLG+GGFG VYKG ++ +E
Sbjct: 490 RDYSSSPIKVLVGDQVDTPDLPIFSFDSVASATGDFAEENKLGQGGFGTVYKGNFSEGRE 549
Query: 457 VAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF 516
+A+KRLS S QG+ EFKNE+ LIAKLQH NLVRLLGC + E++L+YE+MPNKSLD F
Sbjct: 550 IAVKRLSGKSKQGLEEFKNEILLIAKLQHRNLVRLLGCCIEDNEKMLLYEYMPNKSLDRF 609
Query: 517 LFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDF 576
LF+ ++ L+W KR+ +I GI++GLLYLH+ SRL++IHRDLKASNILLD +MNPKISDF
Sbjct: 610 LFDESKQGSLDWRKRWEVIGGIARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKISDF 669
Query: 577 GMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTR 636
GMARIF + ANT R+VGTYGYM+PEYAM GI S K+DV+SFGVL+LEIVSG+KN +
Sbjct: 670 GMARIFNYRQDHANTIRVVGTYGYMAPEYAMEGIFSEKSDVYSFGVLILEIVSGRKNVSF 729
Query: 637 HHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTM 696
D +LIGYAW L S GK E+IDP ++ E MRCIHVG+LC QD + RP M
Sbjct: 730 RGTDHG-SLIGYAWHLWSQGKTKEMIDPIVKDTRDVTEAMRCIHVGMLCTQDSVIHRPNM 788
Query: 697 PEVVCMLQNETMPLPPPKQPAFFINANADDQVPEVPDNEVAKFSTNDVTMTTMEAR 752
V+ ML+++T LPPP+QP F N+ D ++VA S NDVT TT+ R
Sbjct: 789 GSVLLMLESQTSQLPPPRQPTFHSFLNSGDIELNFDGHDVA--SVNDVTFTTIVGR 842
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 490 bits (1261), Expect = e-137, Method: Compositional matrix adjust.
Identities = 308/822 (37%), Positives = 445/822 (54%), Gaps = 104/822 (12%)
Query: 10 FKLGFFSPASSTTTERYLGIWHDTAPDTLGWYFRPFLPRYQTDEPIWIANRNTPILDQSG 69
F+LGFF+P SS+ YLGIW+ P R + +W+ANR+ P+ +G
Sbjct: 51 FELGFFNPDSSS--RWYLGIWYKIIP------IRTY---------VWVANRDNPLSSSNG 93
Query: 70 VLTIDSIDGNLKILHNGGNPIAVSSVEGASNNT--SATLLQSGNLVLREMDTDGTIKRVL 127
L I D NL I P+ +++ G + +A LL GN VLR+ + L
Sbjct: 94 TLKIS--DNNLVIFDQSDRPVWSTNITGGDVRSPVAAELLDYGNFVLRD-SKNNKPSGFL 150
Query: 128 WQSFDYPTDTLLPGMKLG-INLQTGHQWFLQSWLDYSSPAQGSFTLGIEPNATNQLIIRW 186
WQSFD+PTDTLL MK+G N G L+SW P+ G F+ + + + I +
Sbjct: 151 WQSFDFPTDTLLSDMKMGWDNKSGGFNRILRSWKTTDDPSSGDFSTKLRTSGFPEFYI-Y 209
Query: 187 RRETIYWTSGLLLNGNFNFSRSWN----LSFSYTSNEQEKYFEYSLNEGVTSSVFLRIDP 242
+E+I + SG L F+ + S+T N Q+ + Y +N+ S+ L +
Sbjct: 210 NKESITYRSGPWLGNRFSSVPGMKPVDYIDNSFTENNQQVVYSYRVNKTNIYSI-LSLSS 268
Query: 243 EGAL-------------------SDSRGSFAPC-TYGGC-WNQLPRPICRKGTGPENFQS 281
G L D ++ C YG C N P C KG P N Q+
Sbjct: 269 TGLLQRLTWMEAAQSWKQLWYSPKDLCDNYKECGNYGYCDANTSPICNCIKGFEPMNEQA 328
Query: 282 -------------KVGLISEHGF----KFKESDNMSST--------DCRANCFYNCSCIA 316
K+ GF K + D ++ +C C C+C A
Sbjct: 329 ALRDDSVGCVRKTKLSCDGRDGFVRLKKMRLPDTTETSVDKGIGLKECEERCLKGCNCTA 388
Query: 317 FATGTSEYTDKQAYCEIWSEGTEFTEIASNNSREIFILAIK---EEKWWRSLTIAIGVVL 373
FA ++ + + C IWS G + +++++ E+K +S I IG +
Sbjct: 389 FAN--TDIRNGGSGCVIWSGGLFDIRNYAKGGQDLYVRVAAGDLEDKRIKSKKI-IGSSI 445
Query: 374 GIPLLCYLCYVTWRKLKAKDNVSL-------------------LPTYGKRKSPEKDQSIS 414
G+ +L L ++ + K K S+ L + + +++++
Sbjct: 446 GVSILLLLSFIIFHFWKRKQKRSITIQTPIVDLVRSQDSLMNELVKASRSYTSKENKTDY 505
Query: 415 HELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFK 474
EL + +++ +A A NNFST NKLG+GGFG VYKG L D +E+A+KRLS+ S QG EF
Sbjct: 506 LELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSKMSSQGTDEFM 565
Query: 475 NEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFII 534
NEVRLIAKLQH NLVRLLGC + E++L+YE++ N SLD LF+ R + LNW+KRF I
Sbjct: 566 NEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDI 625
Query: 535 IEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594
I GI++GLLYLH+ SR R+IHRDLKASN+LLD M PKISDFGMARIF E+EANT+R+
Sbjct: 626 INGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRV 685
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLS 654
VGTYGYMSPEYAM GI S+K+DVFSFGVL+LEI+SG++N ++ +R LNL+G+ W+
Sbjct: 686 VGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWK 745
Query: 655 DGKGLELIDP----SLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETMPL 710
+GK LE++DP +L +E++RCI +GLLCVQ++A DRP M V+ ML +ET +
Sbjct: 746 EGKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSETTAI 805
Query: 711 PPPKQPAFFINANADDQVPEVPDNEVAKFSTNDVTMTTMEAR 752
P PK+P F + ++ + + + N VT++ ++AR
Sbjct: 806 PQPKRPGFCVGRSSLEVDSSSSTQRDDECTVNQVTLSVIDAR 847
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 488 bits (1257), Expect = e-137, Method: Compositional matrix adjust.
Identities = 312/830 (37%), Positives = 450/830 (54%), Gaps = 105/830 (12%)
Query: 3 LVSAFGNFKLGFFSPASSTTTERYLGIWHDTAPDTLGWYFRPFLPRYQTDEPIWIANRNT 62
+VS F+LGFF P + YLGIW+ R + +W+ANR+T
Sbjct: 46 IVSPGNVFELGFFKPG--LDSRWYLGIWYKAISK------RTY---------VWVANRDT 88
Query: 63 PILDQSGVLTIDSIDGNLKILHNGGNPIAVSSVEGASNNTS--ATLLQSGNLVLREMDTD 120
P+ G L I D NL +L P+ +++ G + A LL +GN VLR+ +
Sbjct: 89 PLSSSIGTLKIS--DSNLVVLDQSDTPVWSTNLTGGDVRSPLVAELLDNGNFVLRD-SKN 145
Query: 121 GTIKRVLWQSFDYPTDTLLPGMKLGINLQTGHQWFLQSWLDYSSPAQGSFTLGIEPNATN 180
VLWQSFD+PTDTLLP MKLG + +TG F++SW P+ G F+ +E
Sbjct: 146 SAPDGVLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKLETEGFP 205
Query: 181 QLIIRWRRETIYWTSG----LLLNGNFNFSRSWNLSFSYTSNEQEKYFEYSLNEGVTSSV 236
++ + W RE+ + SG + +G + F++T++++E + + + + S
Sbjct: 206 EIFL-WNRESRMYRSGPWNGIRFSGVPEMQPFEYMVFNFTTSKEEVTYSFRITKSDVYSR 264
Query: 237 FLRIDPEGAL-------------------SDSRGSFAPC-TYGGC-WNQLPRPICRKGTG 275
L I G L D + C YG C N P C KG
Sbjct: 265 -LSISSSGLLQRFTWIETAQNWNQFWYAPKDQCDEYKECGVYGYCDSNTSPVCNCIKGFK 323
Query: 276 PENFQS-----------KVGLIS---EHGF----KFKESDNMSST--------DCRANCF 309
P N Q + L+S GF K K D +++ +C C
Sbjct: 324 PRNPQVWGLRDGSDGCVRKTLLSCGGGDGFVRLKKMKLPDTTTASVDRGIGVKECEQKCL 383
Query: 310 YNCSCIAFATGTSEYTDKQAYCEIWSEGTEFTEIASNNSREIFI-LAIK--EEKWWRSLT 366
+C+C AFA ++ + C W+ + +++++ LA E+K RS
Sbjct: 384 RDCNCTAFAN--TDIRGSGSGCVTWTGELFDIRNYAKGGQDLYVRLAATDLEDKRNRSAK 441
Query: 367 IAIGVVLGIPLLCYLCYVTWRKLKAKDNVSLL--------------------PTYGKRKS 406
I IG +G+ +L L ++ + K K S+L +R
Sbjct: 442 I-IGSSIGVSVLLLLSFIIFFLWKRKQKRSILIETPIVDHQLRSRDLLMNEVVISSRRHI 500
Query: 407 PEKDQSISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSS 466
++ + EL + +F+ +A A NNFS NKLG+GGFG VYKGKL D QE+A+KRLS++S
Sbjct: 501 SRENNTDDLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMAVKRLSKTS 560
Query: 467 GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVL 526
QG EFKNEV+LIA+LQH NLVRLL C + E++L+YE++ N SLD LF+ R + L
Sbjct: 561 VQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSKL 620
Query: 527 NWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586
NW+ RF II GI++GLLYLH+ SR R+IHRDLKASNILLD M PKISDFGMARIF +E
Sbjct: 621 NWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRDE 680
Query: 587 SEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLI 646
+EANT+++VGTYGYMSPEYAM GI S+K+DVFSFGVL+LEI+S ++N ++ DR LNL+
Sbjct: 681 TEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDRDLNLL 740
Query: 647 GYAWQLLSDGKGLELIDPSLEQPCSA---NEVMRCIHVGLLCVQDQAMDRPTMPEVVCML 703
G W+ +GKGLE+IDP + S +E++RCI +GLLCVQ++A DRPTM V+ ML
Sbjct: 741 GCVWRNWKEGKGLEIIDPIITDSSSTFRQHEILRCIQIGLLCVQERAEDRPTMSLVILML 800
Query: 704 QNETMPLPPPKQPAFFI-NANADDQVPEVPDNEVAKFSTNDVTMTTMEAR 752
+E+ +P PK P + + + D + ++ N +T++ ++AR
Sbjct: 801 GSESTTIPQPKAPGYCLERSLLDTDSSSSKQRDDESWTVNQITVSVLDAR 850
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 486 bits (1250), Expect = e-136, Method: Compositional matrix adjust.
Identities = 316/835 (37%), Positives = 448/835 (53%), Gaps = 134/835 (16%)
Query: 10 FKLGFFSPASSTTTERYLGIWHDTAPDTLGWYFRPFLPRYQTDEPIWIANRNTPILDQSG 69
F+LGFF+PASS+ YLGIW+ P R + +W+ANR+ P+ +G
Sbjct: 51 FELGFFNPASSS--RWYLGIWYKIIP------IRTY---------VWVANRDNPLSSSNG 93
Query: 70 VLTIDSIDGNLKILHNGGNPIAVSSVEGASNNT--SATLLQSGNLVLREMDTDGTIKRVL 127
L I NL I P+ +++ G + +A LL +GN +LR+ + R+L
Sbjct: 94 TLKISG--NNLVIFDQSDRPVWSTNITGGDVRSPVAAELLDNGNFLLRDSNN-----RLL 146
Query: 128 WQSFDYPTDTLLPGMKLGINLQTGHQWFLQSWLDYSSPAQGSFTLGIEPNATNQLIIRWR 187
WQSFD+PTDTLL MKLG + +TG L+SW P+ G F+ +E + + I
Sbjct: 147 WQSFDFPTDTLLAEMKLGWDQKTGFNRILRSWKTTDDPSSGEFSTKLETSEFPEFYI-CS 205
Query: 188 RETIYWTSGLLLNG-----------------NFNFSRSWNLSFSYTSNEQEKYFEYSLN- 229
+E+I + SG NG NF S+ +++SY N+ Y LN
Sbjct: 206 KESILYRSG-PWNGMRFSSVPGTIQVDYMVYNFTASKE-EVTYSYRINKTNLYSRLYLNS 263
Query: 230 ----------EGVTSSVFLRIDPEGALSDSR--GSFAPCTYGGCWNQLPRPICRKGTGPE 277
E S L P+ + + G+F C N LP C KG P
Sbjct: 264 AGLLQRLTWFETTQSWKQLWYSPKDLCDNYKVCGNFGYCDS----NSLPNCYCIKGFKPV 319
Query: 278 NFQ--------------SKVGLISEHGF----KFKESDNMSS--------TDCRANCFYN 311
N Q +++ GF + K D ++ C+ C +
Sbjct: 320 NEQAWDLRDGSAGCMRKTRLSCDGRDGFTRLKRMKLPDTTATIVDREIGLKVCKERCLED 379
Query: 312 CSCIAFATGTSEYTDKQAYCEIWSEGTEFTEIASNNSREIFI---LAIKEEKWWRSLTIA 368
C+C AFA ++ + + C IW+ + +++++ A E+K ++ I
Sbjct: 380 CNCTAFA--NADIRNGGSGCVIWTREILDMRNYAKGGQDLYVRLAAAELEDKRIKNEKI- 436
Query: 369 IGVVLGIPLLCYLCYVTWRKLKAKDNVSLLPTYGKRKSPEKDQSISHELKIFDF------ 422
IG +G+ +L L +V + K K S+ ++P DQ S + I D
Sbjct: 437 IGSSIGVSILLLLSFVIFHFWKRKQKRSITI-----QTPNVDQVRSQDSLINDVVVSRRG 491
Query: 423 ------------------QTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSR 464
+ +A A NNFS NKLG+GGFG VYKG+L D +E+A+KRLS+
Sbjct: 492 YTSKEKKSEYLELPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAVKRLSK 551
Query: 465 SSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKN 524
S QG EF NEVRLIAKLQH NLVRLLGC + E++L+YE++ N SLD LF+ R +
Sbjct: 552 MSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSS 611
Query: 525 VLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
LNW+KRF II GI++GLLYLH+ SR R+IHRDLKASN+LLD M PKISDFGMARIF
Sbjct: 612 NLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGR 671
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLN 644
E+EANT+R+VGTYGYMSPEYAM GI S+K+DVFSFGVL+LEI+SG++N ++ +R LN
Sbjct: 672 EETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLN 731
Query: 645 LIGYAWQLLSDGKGLELIDP----SLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVV 700
L+G+ W+ +G LE++DP SL +E++RCI +GLLCVQ++A DRP M V+
Sbjct: 732 LLGFVWRHWKEGNELEIVDPINIDSLSSKFPTHEILRCIQIGLLCVQERAEDRPVMSSVM 791
Query: 701 CMLQNETMPLPPPKQPAFFINAN---ADDQVPEVPDNEVAKFSTNDVTMTTMEAR 752
ML +ET +P PK+P F I + AD D+E + N +T++ ++AR
Sbjct: 792 VMLGSETTAIPQPKRPGFCIGRSPLEADSSSSTQRDDEC---TVNQITLSVIDAR 843
|
Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 752 | ||||||
| 255550026 | 795 | Serine/threonine-protein kinase PBS1, pu | 0.954 | 0.903 | 0.519 | 0.0 | |
| 255550034 | 789 | receptor protein kinase, putative [Ricin | 0.966 | 0.921 | 0.504 | 0.0 | |
| 359482600 | 789 | PREDICTED: G-type lectin S-receptor-like | 0.952 | 0.907 | 0.514 | 0.0 | |
| 359480375 | 757 | PREDICTED: G-type lectin S-receptor-like | 0.871 | 0.865 | 0.504 | 0.0 | |
| 359480377 | 751 | PREDICTED: G-type lectin S-receptor-like | 0.916 | 0.917 | 0.491 | 0.0 | |
| 225463860 | 795 | PREDICTED: G-type lectin S-receptor-like | 0.905 | 0.856 | 0.502 | 0.0 | |
| 147780889 | 906 | hypothetical protein VITISV_034502 [Viti | 0.880 | 0.730 | 0.483 | 1e-178 | |
| 397134747 | 852 | S domain subfamily receptor-like kinase | 0.974 | 0.860 | 0.445 | 1e-176 | |
| 9294449 | 805 | receptor kinase 1 [Arabidopsis thaliana] | 0.946 | 0.884 | 0.455 | 1e-174 | |
| 15233263 | 850 | lectin receptor kinase CES101 [Arabidops | 0.964 | 0.852 | 0.445 | 1e-174 |
| >gi|255550026|ref|XP_002516064.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] gi|223544969|gb|EEF46484.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 756 bits (1953), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 408/785 (51%), Positives = 519/785 (66%), Gaps = 67/785 (8%)
Query: 3 LVSAFGNFKLGFFSPASS-TTTERYLGIWHDTAPDTLGWYFRPFLPRYQTDEPIWIANRN 61
LVSA G FKL F + S +++ YLGIW++ + P+W+ANR+
Sbjct: 43 LVSADGMFKLKFGTVGESGESSDSYLGIWYNYIEEKF---------------PVWVANRD 87
Query: 62 TPILDQSGVLTIDSIDGNLKILHNGGNPIAVSSVEGASNNTSATLLQSGNLVLREMDTDG 121
TPI SG+LT+DS GNLKIL + G I + SV+ A N ATL +GN +LRE++++G
Sbjct: 88 TPIFGNSGILTVDS-QGNLKILRDKGRSIVLYSVQKAIYNAIATLEDTGNFILRELNSNG 146
Query: 122 TIKRVLWQSFDYPTDTLLPGMKLGINLQTGHQWFLQSWLDYSSPAQGSFTLGIEPNATNQ 181
+IK+VLWQSFDYPTDT LPGMKLGINL+TG QW + SW + SPA+G+F LG +P++ NQ
Sbjct: 147 SIKQVLWQSFDYPTDTFLPGMKLGINLKTGQQWSVISWRSFESPARGTFVLGTDPDSKNQ 206
Query: 182 LIIRWRRETIYWTSG-----LLLNGNFNFSRSWNLSFSYTSNEQEKYFEYSLNEGVTSSV 236
L+I WR+ IYW SG L G +F+ +N FSY S+E E YF YS+N+ +
Sbjct: 207 LVI-WRQGHIYWASGSWVGQFSLLGGLSFNVLYN--FSYFSDENESYFIYSINKANSIFP 263
Query: 237 FLRIDPEGALS--------------DSRGSFAPCTYGGCWNQLPRPICRKGTGPENFQSK 282
L I+ EG L S +P GC Q P CR + F+ +
Sbjct: 264 RLTINAEGVLIGFLKYDYHEEVKCITSYDYMSPTV--GCLEQ-NLPNCRSPSDAFLFKPR 320
Query: 283 VGLISEHGFKFKESDNMSSTDCRANCFYNCSCIAFATGTSEYTDKQAYCEIWSEGTEFTE 342
G + GFK+ +S+N++ DC+ NC NCSCIA+A+ + T CEIW F
Sbjct: 321 TGYMYSDGFKYSDSENLTMIDCKLNCLKNCSCIAYASKNEDGTG----CEIWRSARSFIG 376
Query: 343 IASNNSREIFILAIKEEKWWRSLTIAIGVVLGIPLLCYLCYVTWRKL------------- 389
+S++SR+I+I + KWW +TI +G + IP LC Y W+K
Sbjct: 377 SSSDDSRKIYIFD-EVNKWWLPVTITLGGIFLIPALCAFLYAIWKKCSRTGNGKTNLKNL 435
Query: 390 --KAKDNVSLLPTYGKRKSPEKDQSISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVY 447
+ + N L TY ++ + + EL IF F+ IA A F NKLGEGGFGPVY
Sbjct: 436 WNELEGNALSLTTYDTLRTQKNEWD---ELHIFCFEIIAIATKYFKPENKLGEGGFGPVY 492
Query: 448 KGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507
KGKL D QE+AIKRLSRSSGQG+VEFKNE LIAKLQHTNLV+LLG + GEER+LVYE+
Sbjct: 493 KGKLLDGQEIAIKRLSRSSGQGLVEFKNEAILIAKLQHTNLVKLLGFCVDGEERILVYEY 552
Query: 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDD 567
MP KSLD +LF+S +K+ L+W+KRF II+GI+QGLLYLHKYSRL+VIHRDLKASNILLDD
Sbjct: 553 MPKKSLDIYLFDSHKKSELDWKKRFKIIDGITQGLLYLHKYSRLKVIHRDLKASNILLDD 612
Query: 568 KMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEI 627
+MNPKISDFGMARIF + ESEANT RIVGTYGYMSPEYAM+G+VS KTDVFSFGVL+LEI
Sbjct: 613 EMNPKISDFGMARIFGLKESEANTNRIVGTYGYMSPEYAMNGVVSTKTDVFSFGVLLLEI 672
Query: 628 VSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQ 687
+SG+KN + H+ + P+NLIGYAW L D +GLELIDP L++ N+V+RCIH+GLLCVQ
Sbjct: 673 ISGRKNTSFHYSECPINLIGYAWLLWKDNRGLELIDPKLDEFLPQNQVLRCIHIGLLCVQ 732
Query: 688 DQAMDRPTMPEVVCMLQNETMPLPPPKQPAFFINANADDQVPEVPDNEVAKFSTNDVTMT 747
D A DRPT+ +VV ML NET+ L PKQPAFF+NA Q P P N K S N V+++
Sbjct: 733 DHAADRPTVFDVVSMLSNETILLATPKQPAFFVNAVV--QEPGEPRNRSDKCSINLVSIS 790
Query: 748 TMEAR 752
MEAR
Sbjct: 791 VMEAR 795
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255550034|ref|XP_002516068.1| receptor protein kinase, putative [Ricinus communis] gi|223544973|gb|EEF46488.1| receptor protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 703 bits (1814), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 389/771 (50%), Positives = 500/771 (64%), Gaps = 44/771 (5%)
Query: 3 LVSAFGNFKLGFFSPASSTTTERYLGIWHDTAPDTLGWYFRPFLPRYQ-TDEPIWIANRN 61
LVSA G F L FF + + YLGIW++ + + + ++ + + +W+ANRN
Sbjct: 42 LVSASGIFLLRFFR-----SDKHYLGIWYNMTDE------QESINEFELSSKVVWVANRN 90
Query: 62 TPILDQSGVLTIDSIDGNLKILH-NGGNPIAVSSVEGASNNT--SATLLQSGNLVLREMD 118
PI+D+SG+LTI DGNLKI + +GG+ I+++SV+ + NNT +ATLL SGNLVLRE+
Sbjct: 91 NPIVDKSGILTIGR-DGNLKISYGSGGDNISLTSVQKSGNNTNITATLLDSGNLVLRELY 149
Query: 119 TDGTIKRVLWQSFDYPTDTLLPGMKLGINLQTGHQWFLQSWLDYSSPAQGSFTLGIEPNA 178
T+ + R+LWQSFDYPT L PGMK+GINLQTGH W L SW++ SPA GSFT G++ N
Sbjct: 150 TNRSASRLLWQSFDYPTHALFPGMKIGINLQTGHSWSLTSWINTQSPAIGSFTFGMDRNG 209
Query: 179 TNQLIIRWRRETIYWTSGLLLNGNFNF----SRSWNLSFSYTSNEQEKYFEYSLNEGVTS 234
NQLII W + +YW SG ++G F F S F Y SNE E YF Y+ +E
Sbjct: 210 MNQLIIWWAGD-VYWISGNWVDGGFKFWHMLSAQEGYHFRYFSNENETYFTYNASENAKY 268
Query: 235 SVFLRIDPEG-------ALSDSRGSFAPCTYGGCWNQLPRPICRKGTGPENFQSKVGLIS 287
L I+ G L R + GC RPIC K F+ + +S
Sbjct: 269 FPMLWINDFGLSSSFARPLISCRSQYDYMNTIGCVQS--RPICPKKA--TEFEYETAAVS 324
Query: 288 EHGFKFKESDNMSSTDCRANCFYNCSCIAFATGTSEYTDKQAYCEIWSEGTEFTEIASNN 347
FKF ESD++S DC C NCSC+A++ T+E CEIWS+ T + +
Sbjct: 325 GDSFKFNESDHLSLDDCLEKCLRNCSCVAYSP-TNEIDGTG--CEIWSKVTIESSADGRH 381
Query: 348 SREIFILAIKEEKWWRSLTIAIGVVLGIPLLCYLCYVTWRKLKAK----DNVSLLPTYG- 402
R +F+L +E+KW L IA L I LL + CY+ WRK K D LL G
Sbjct: 382 WRPVFVLKSEEKKWVWWLVIAAAGSLIITLLLFSCYLLWRKFKEAKTDTDKEMLLHELGM 441
Query: 403 -KRKSPEKDQSISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKR 461
+P + SHEL+ F F+T+A+A NNF++TNKLG+GG+GPVYKGKL D QEVA+KR
Sbjct: 442 DANYTPNTHEKSSHELQFFKFETVASATNNFASTNKLGQGGYGPVYKGKLPDGQEVAMKR 501
Query: 462 LSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSG 521
LS +S QG VEF NE+++IAKLQH NLVRL+GC + EE++L+YE+MPNKSLD FLF+
Sbjct: 502 LSTNSRQGSVEFGNEIKVIAKLQHNNLVRLVGCCIEKEEKILIYEYMPNKSLDLFLFDPI 561
Query: 522 RKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARI 581
KNVL+W KRF IIEGI QGLLYLHKYSRL++IHRDLKA NILLD KMNPKISDFGMARI
Sbjct: 562 DKNVLDWRKRFNIIEGIIQGLLYLHKYSRLKIIHRDLKAGNILLDSKMNPKISDFGMARI 621
Query: 582 FEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDR 641
F E++ANT +VGTYGYMSPEYAM GI S K+DVFSFGVL+LEIVSG+KN++ + D
Sbjct: 622 FGSEETKANTNTVVGTYGYMSPEYAMEGIFSTKSDVFSFGVLLLEIVSGKKNNSFQYSDG 681
Query: 642 PLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVC 701
PL+LI YAW L + + LEL DP + P EV+RCIH+GLLCVQ+ MDRP+M +V
Sbjct: 682 PLSLIAYAWNLWIEERVLELTDPIIGDP-DQTEVLRCIHIGLLCVQENPMDRPSMLDVTS 740
Query: 702 MLQNETMPLPPPKQPAFFINANADDQVPEVPDNEVAKFSTNDVTMTTMEAR 752
M+ NE LP P QPAF+ N Q E+ + + S N V+++ MEAR
Sbjct: 741 MIYNEANQLPSPNQPAFYYRKNF--QYTEILEQKQDCLSQNGVSISEMEAR 789
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359482600|ref|XP_003632790.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase CES101-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 699 bits (1803), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 402/782 (51%), Positives = 496/782 (63%), Gaps = 66/782 (8%)
Query: 3 LVSAFGNFKLGFFSPASSTTTERYLGIWHDTAPDTLGWYFRPFLPRYQTDEPIWIANRNT 62
LVSA F LGFF+ SS RYLGIW+ + F R +W+ANRN
Sbjct: 42 LVSANYAFTLGFFTQGSSDN--RYLGIWYTS-----------FEVR-----RVWVANRND 83
Query: 63 PILDQSGVLTIDSIDGNLKILHNGGNPIAVSSVEGASNNTSATLLQSGNLVLREMDTDGT 122
P+ D SG L ID LKI +NGG IAVS+ ++NTSA L +GN +LRE +DGT
Sbjct: 84 PVPDTSGNLMIDHA-WKLKITYNGGF-IAVSNYSQIASNTSAILQDNGNFILREHMSDGT 141
Query: 123 IKRVLWQSFDYPTDTLLPGMKLGINLQTGHQWFLQSWLDYSSPAQGSFTLGIEPNATNQL 182
RVLWQSFDYPTDTLLPGMKLGINL+TGHQW L SWL PA G F+ G + +QL
Sbjct: 142 T-RVLWQSFDYPTDTLLPGMKLGINLRTGHQWSLTSWLTNQIPATGYFSFGADFRNNSQL 200
Query: 183 IIRWRRETIYWTSGLLLNGNFNFSR---------SWN--LSFSYTSNEQEKYFEYSLNEG 231
I WR + IYWTSG NGN +F WN F Y SN++E YF + NE
Sbjct: 201 ITWWRGK-IYWTSGFWHNGNLSFDNLRASLPQKDHWNDGYGFRYMSNKKEMYFSFHPNES 259
Query: 232 VTSSVFLRIDPEGALSDSRGSFAPCT----YGGCWNQLPRPICRKGTGPENFQSKVGLIS 287
V + + + P G L ++ C GC + P CR + G +
Sbjct: 260 VFFPMLVLL-PSGVLKSLLRTYVHCESHIERQGC-VKPDLPKCRNPASQRFQYTDGGYVV 317
Query: 288 EHGFKFKESDNMSSTDCRANCFYNCSCIAFATGTSEYTDKQAYCEIWSEGTEFTEIASNN 347
GF F DN +S DC C+ NCSC+AF+ +E C IWS + +
Sbjct: 318 SEGFMF--DDNATSVDCHFRCWNNCSCVAFSLHLAE-----TRCVIWSR-IQPRKYFVGE 369
Query: 348 SREIFILAIKE---EKWWRSLTIAIGVVLGIPLLCYLCYVTWRKLKA----KDNVSLLPT 400
S++I++L + + WW L A G + I L LC + W+KLK K LL
Sbjct: 370 SQQIYVLQTDKAARKMWWIWLVTAAGGAVIILLASSLCCLGWKKLKLQEENKRQQELLFE 429
Query: 401 YGKRKSP---------EKDQSISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKL 451
G P EK ++EL++F FQ++AAA NNFS NKLGEGGFGPVYKGKL
Sbjct: 430 LGAITKPFTKHNSKKHEKVGKKTNELQLFSFQSLAAATNNFSIENKLGEGGFGPVYKGKL 489
Query: 452 ADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNK 511
D QE+AIKRLS+SS QG+VEFKNE+ LIAKLQH NLV+LLGC + EE++L+YE++PNK
Sbjct: 490 LDGQEIAIKRLSKSSRQGLVEFKNEIALIAKLQHDNLVKLLGCCIKEEEKILIYEYLPNK 549
Query: 512 SLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNP 571
SLDFF+F+ +KN+LNW+KR+ IIEGI+QGLLYLHK+SRLRVIHRDLKASNILLD++MNP
Sbjct: 550 SLDFFIFDPSKKNLLNWKKRYNIIEGITQGLLYLHKFSRLRVIHRDLKASNILLDNEMNP 609
Query: 572 KISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
KISDFGMARIF +E EANT R+VGTYGYMSPEY M GI S K+DVFSFGVL+LEIVS +
Sbjct: 610 KISDFGMARIFGQDECEANTNRVVGTYGYMSPEYVMQGIFSTKSDVFSFGVLLLEIVSSK 669
Query: 632 KNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSL-EQPCSANEVMRCIHVGLLCVQDQA 690
KNH+ +H +RPLNLIGYAW+L +GK LEL+D +L + P S N V RCIHVGLLCVQ+
Sbjct: 670 KNHSNYHYERPLNLIGYAWELWKEGKELELMDQTLCDGPSSNNVVKRCIHVGLLCVQENP 729
Query: 691 MDRPTMPEVVCMLQNETMPLPPPKQPAFFINANADDQVPEVPDNEVAKFSTNDVTMTTME 750
DRPTM +VV ML NE+M L PKQPAFFI +Q E+P S N V+++ ME
Sbjct: 730 KDRPTMSDVVLMLANESMQLSIPKQPAFFI--RGIEQELEIPKRNSENCSLNIVSISVME 787
Query: 751 AR 752
AR
Sbjct: 788 AR 789
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359480375|ref|XP_002268267.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g67520-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 647 bits (1669), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 374/742 (50%), Positives = 468/742 (63%), Gaps = 87/742 (11%)
Query: 2 LLVSAFGNFKLGFFSPASSTTTERYLGIWHDTAPDTLGWYFRPFLPRYQTDE---PIWIA 58
LLVSA G F LGFFS S + YLGIW Y TD+ +W+A
Sbjct: 47 LLVSAKGTFTLGFFSLESGS----YLGIW------------------YTTDDYHKKVWVA 84
Query: 59 NRNTPILDQSGVLTIDSIDGNLKILHNGGNPIAVSSVEGASNNTSATLLQSGNLVLREMD 118
NR+ I LT+D+ DG L I H+GG+PI ++S + A N+T ATLL SGN VL+E +
Sbjct: 85 NRDKAISGTDANLTLDA-DGKLMITHSGGDPIVLNSNQAARNST-ATLLDSGNFVLKEFN 142
Query: 119 TDGTIKRVLWQSFDYPTDTLLPGMKLGINLQTGHQWFLQSWLDYSSPAQGSFTLGIEPNA 178
+DG++K LW+SFD PTDTLLPGMKLGINL+TG W L SW+ PA G+FTL E N
Sbjct: 143 SDGSVKEKLWESFDNPTDTLLPGMKLGINLKTGRNWSLASWISEQVPAPGTFTL--EWNG 200
Query: 179 TNQLIIRWRRETIYWTSGLLLNGNFNFSRSWNLS---------FSYTSNEQEKYFEYSLN 229
T QL+++ RR YW+SG L + +F F +W +S F+ SN E YF YS+
Sbjct: 201 T-QLVMK-RRGGTYWSSGTLKDRSFEFI-TWLMSPDTFNNIYSFNSVSNANEIYFSYSVP 257
Query: 230 EGVTSSVFLRIDPEGALSD-SRGSFAP---CT----YGGCWNQLPRPICRKGTGPENFQS 281
+GV S L EG L D SR F C Y GC Q P P CR T + F
Sbjct: 258 DGVVSEWVLT--SEGGLFDTSRPVFVLDDLCDRYEEYPGCAVQNP-PTCR--TRKDGFMK 312
Query: 282 KVGLISEHGFKFKESDNMSSTDCRANCFYNCSCIAFATGTSEYTDKQAYCEIWSEGTEFT 341
+ LIS KE+ ++ +DC+A C+ NCSC A+ S YT+ C WS T+F
Sbjct: 313 QSVLISGSPSSIKENSSLGLSDCQAICWNNCSCTAY---NSIYTNGTG-CRFWS--TKFA 366
Query: 342 EIASN--NSREIFILAIKEEKWWRSLTIAIGVVLGIPLLCYLCYVTWRKLKAKDNVSLLP 399
+ + N E+++L+ R + A + L
Sbjct: 367 QALKDDANQEELYVLSSSRVTGEREMEEAALLELATS----------------------D 404
Query: 400 TYGKRKSPEKD-QSISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEVA 458
++G K E D + +H+LK+F F +I AA NNFS NKLGEGGFGPVYKGKL + QE+A
Sbjct: 405 SFGDSKDDEHDGKRGAHDLKLFSFDSIVAATNNFSPENKLGEGGFGPVYKGKLLEGQEIA 464
Query: 459 IKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLF 518
+KRLSR S QG+VEFKNE+RLI KLQH NLVRLLGC + GEE++L+YEFMPNKSLDFFLF
Sbjct: 465 VKRLSRGSSQGLVEFKNEIRLIVKLQHMNLVRLLGCCIKGEEKMLIYEFMPNKSLDFFLF 524
Query: 519 NSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGM 578
+ R+ +L+W++R IIEGI+QGLLYLHKYSRLR+IHRDLKASNILLD +NPKISDFGM
Sbjct: 525 DPARRKILDWKRRHNIIEGIAQGLLYLHKYSRLRIIHRDLKASNILLDHDLNPKISDFGM 584
Query: 579 ARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHH 638
AR F N SEANT RIVGTYGYM PEYAM GI S+K+DV+SFGVL+LEIVSG+KN + HH
Sbjct: 585 ARTFGRNASEANTNRIVGTYGYMPPEYAMEGIFSVKSDVYSFGVLLLEIVSGRKNKSFHH 644
Query: 639 PDR--PLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTM 696
+NL YAW L +G LEL+DP LE S +++RCIH+ LLCVQ++A DRPTM
Sbjct: 645 NHGAFAINLAVYAWDLWKEGTSLELVDPMLEDSYSTTQMLRCIHIALLCVQERAADRPTM 704
Query: 697 PEVVCMLQNETMPLPPPKQPAF 718
V+ ML NET+PLP P PAF
Sbjct: 705 SAVISMLTNETVPLPNPNLPAF 726
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359480377|ref|XP_003632441.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase CES101-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 647 bits (1668), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 377/767 (49%), Positives = 487/767 (63%), Gaps = 78/767 (10%)
Query: 2 LLVSAFGNFKLGFFSPASSTTTERYLGIWHDTAPDTLGWYFRPFLPRYQTDEPIWIANRN 61
LLVSA G F LGFFS S + YLGIW+ T +++ +W+ANR+
Sbjct: 47 LLVSAKGTFTLGFFSLQSGS----YLGIWNTTD---------------HSNKKVWVANRD 87
Query: 62 TPILDQSGVLTIDSIDGNLKILHNGGNPIAVSSVEGASNNTSATLLQSGNLVLREMDTDG 121
I LT+D+ DG L I H+ G+PI ++S + A N+T ATLL SGN VL+E ++DG
Sbjct: 88 KAISGTDANLTLDA-DGKLMITHSEGDPIVLNSNQVARNST-ATLLDSGNFVLKEFNSDG 145
Query: 122 TIKRVLWQSFDYPTDTLLPGMKLGINLQTGHQWFLQSWLDYSSPAQGSFTLGIEPNATNQ 181
++K LW+SFD PTDTLLPGMKLGINL+TG W L SW+ PA G+FTL E N T Q
Sbjct: 146 SVKEKLWESFDNPTDTLLPGMKLGINLKTGRNWSLASWISEQVPAPGTFTL--EWNGT-Q 202
Query: 182 LIIRWRRETIYWTSGLLLNGNFNFSRSWN--LSFSYTSNEQEKYFEYSLNEGVTSSVFLR 239
L+++ RR YW+SG L + +F F N SF+ SN E YF YS+ EGV S L
Sbjct: 203 LVMK-RRGGTYWSSGTLKDRSFEFIPLLNNIYSFNSVSNANEIYFSYSVPEGVGSDWVLT 261
Query: 240 IDPEGALSDSRGSF----APCT----YGGCWNQLPRPICRKGTGPENFQSKVGLISEHGF 291
EG L D+ S C Y GC Q P P CR T + F + LIS
Sbjct: 262 --SEGGLFDTNRSVFMQDDQCDRDKEYPGCAVQNP-PTCR--TRKDGFVKESVLISGSPS 316
Query: 292 KFKESDNMSSTDCRANCFYNCSCIAFATGTSEYTDKQAYCEIWSEGTEFTEIASN--NSR 349
KE+ ++ DC+A C+ NCSC A+ S +T+ C WS T+F + + N
Sbjct: 317 SIKENSSLGLGDCQAICWNNCSCTAY---NSIHTNGTG-CRFWS--TKFAQAYKDDGNQE 370
Query: 350 EIFILAIKEEKWWRSLTIAIGVVLGIPLLCYLCYVTWRKLKAKDNVSLLPTYGKRKSPEK 409
E ++L+ R + A+ +P L A N ++ K E
Sbjct: 371 ERYVLSSSRVTGEREMEEAM-----LPEL------------ATSN-----SFSDSKDVEH 408
Query: 410 DQSI-SHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQ 468
D + +H+LK+F F +I AA N FS+ NKLGEGGFGPVYKGKL + E+A+KRLSR S Q
Sbjct: 409 DGTRGAHDLKLFSFDSIVAATNYFSSENKLGEGGFGPVYKGKLLEGHEIAVKRLSRGSSQ 468
Query: 469 GIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNW 528
G+VEFKNE+RLIAKLQH NLVRLLGC + GEE++L+YEFMPNKSLDFFLF+ R+ +L+W
Sbjct: 469 GLVEFKNEIRLIAKLQHMNLVRLLGCCIQGEEKMLIYEFMPNKSLDFFLFDPDRRKILDW 528
Query: 529 EKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE 588
++R IIEG++QGLLYLHKYSRLR+IHRDLK SNILLD +NPKISDFGMARIF N SE
Sbjct: 529 KRRHNIIEGVAQGLLYLHKYSRLRIIHRDLKVSNILLDHDLNPKISDFGMARIFGRNASE 588
Query: 589 ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDR--PLNLI 646
ANT RIVGTYGYM+PEYAM GI S+K+DV+SFGVL+LEIVSG+KN + HH +NL
Sbjct: 589 ANTNRIVGTYGYMAPEYAMEGIFSVKSDVYSFGVLLLEIVSGRKNKSFHHNHGAFAINLA 648
Query: 647 GYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706
GYAW+L +G LEL+DP LE S +++RCIH+ LLCVQ+ A DRPTM +V+ ML NE
Sbjct: 649 GYAWELWKEGTSLELVDPMLEDSYSTTQMLRCIHIALLCVQESAADRPTMSDVISMLTNE 708
Query: 707 TMPLPPPKQPAFFINANADDQVPEVPDNEVAKFSTN-DVTMTTMEAR 752
++ LP P P+F +A +V E+ N+ S++ +VT++ ME R
Sbjct: 709 SVSLPDPNLPSF----SAHHKVSELDSNKSGPESSSVNVTISEMEGR 751
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225463860|ref|XP_002268342.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g67520-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 645 bits (1663), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 379/754 (50%), Positives = 480/754 (63%), Gaps = 73/754 (9%)
Query: 2 LLVSAFGNFKLGFFSPASSTTTERYLGIWHDTAPDTLGWYFRPFLPRYQTDEPIWIANRN 61
LLVSA G F LGFFS S + YLGIW+ T + +W+ANR+
Sbjct: 47 LLVSAKGTFTLGFFSLESGS----YLGIWYTTD---------------DYHKKVWVANRD 87
Query: 62 TPILDQSGVLTIDSIDGNLKILHNGGNPIAVSSVEGASNNTSATLLQSGNLVLREMDTDG 121
I LT+D+ DG L I H+GG+PI ++S + A N+T ATLL SGN VL E ++DG
Sbjct: 88 KAISGTDANLTLDA-DGKLMITHSGGDPIVLNSNQAARNST-ATLLDSGNFVLEEFNSDG 145
Query: 122 TIKRVLWQSFDYPTDTLLPGMKLGINLQTGHQWFLQSWLDYSSPAQGSFTLGIEPNATNQ 181
++K LW SFD PTDTLLPGMKLGINL+TG W L SW+ PA G+FTL E N T Q
Sbjct: 146 SLKEKLWASFDNPTDTLLPGMKLGINLKTGRNWSLASWISEQVPAPGTFTL--EWNGT-Q 202
Query: 182 LIIRWRRETIYWTSGLLLNGNFNF------SRSWN--LSFSYTSNEQEKYFEYSLNEGVT 233
L+++ RR YW+SG L + +F F S ++N SF+ SN E YF YS+ EGV
Sbjct: 203 LVMK-RRGGTYWSSGTLKDRSFEFIPWLMSSDTFNNIYSFNSVSNANEIYFSYSVPEGVV 261
Query: 234 SSVFLRIDPEGALSD-SRGSFA---PCT----YGGCWNQLPRPICRKGTGPENFQSKVGL 285
S L EG L D SR F C Y GC Q P P CR + + F + L
Sbjct: 262 SDWVLT--SEGGLFDTSRPVFVLDDQCARYEEYPGCAVQNP-PTCR--SRKDGFMKQSVL 316
Query: 286 ISEHGFKFKESDNMSSTDCRANCFYNCSCIAFATGTSEYTDKQAYCEIWSEGTEFTEIAS 345
IS KE ++ DC+A C+ +CSC A+ S YT+ C WS T+F +
Sbjct: 317 ISGSPSSIKEKSSLGLRDCKALCWNDCSCTAY---NSLYTNGTG-CRFWS--TKFAQALK 370
Query: 346 N--NSREIFILA---IKEEKWWRSLTIAIGVVLGIPLLCYL-----CYVTWRKLKAK--- 392
+ N E+++L+ + WW + IA V++ + +L L Y + RK + +
Sbjct: 371 DDANQEELYVLSSSRVTGSSWWIWVIIAGVVLVVLLVLVVLLLTGSLYYSRRKFRGEREM 430
Query: 393 DNVSLLP-----TYGKRKSPEKD-QSISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPV 446
+ +LL ++ K E D + +H+LK+F F +I AA NNFS+ NKLGEGGFG V
Sbjct: 431 EEAALLELTTSNSFSDSKDVEHDGKRGAHDLKLFSFDSIVAATNNFSSENKLGEGGFGQV 490
Query: 447 YKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYE 506
YKGKL + QE+A+KRLSR S QG+VEFKNE+RLI KLQH NLVRLLGC + GEE++L+YE
Sbjct: 491 YKGKLPEGQEIAVKRLSRGSSQGLVEFKNEIRLIVKLQHMNLVRLLGCCIKGEEKMLIYE 550
Query: 507 FMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLD 566
FMPNKSLDFFLF+ R+ +L+W++R IIEGI+QGLLYLHKYSRLR+IHRDLKASNILLD
Sbjct: 551 FMPNKSLDFFLFDPARRKILDWKRRHNIIEGIAQGLLYLHKYSRLRIIHRDLKASNILLD 610
Query: 567 DKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLE 626
+NPKISDFGMAR F N SEANT RIVGTYGYM PEYAM GI S+K+DV+SFGVL+LE
Sbjct: 611 HDLNPKISDFGMARTFGRNASEANTNRIVGTYGYMPPEYAMEGIFSVKSDVYSFGVLLLE 670
Query: 627 IVSGQKNHTRHHPDR--PLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLL 684
IVSG+KN + HH +NL YAW L +G LEL+DP LE S +++RCIH+ LL
Sbjct: 671 IVSGRKNKSFHHNHGAFAINLAVYAWDLWKEGTSLELVDPMLEDSYSTTQMLRCIHIALL 730
Query: 685 CVQDQAMDRPTMPEVVCMLQNETMPLPPPKQPAF 718
CVQ+ A DRPTM V+ ML NET+PLP P PAF
Sbjct: 731 CVQESAADRPTMSAVISMLTNETVPLPNPNLPAF 764
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147780889|emb|CAN61711.1| hypothetical protein VITISV_034502 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 630 bits (1625), Expect = e-178, Method: Compositional matrix adjust.
Identities = 371/767 (48%), Positives = 470/767 (61%), Gaps = 105/767 (13%)
Query: 2 LLVSAFGNFKLGFFSPASSTTTERYLGIWHDTAPDTLGWYFRPFLPRYQTDEPIWIANRN 61
LLVSA G F LGFFS S + YLGIW E +W+ANR+
Sbjct: 132 LLVSAKGTFTLGFFSLESGS----YLGIWFTIDAQ---------------KEKVWVANRD 172
Query: 62 TPILDQSGVLTIDSIDGNLKILHNGGNPIAVSSVEGASNNTSATLLQSGNLVLREMDTDG 121
PI LT+D+ DG L I+H+GG+PI ++S + A N+T ATLL SGN VL E ++D
Sbjct: 173 KPISGTDANLTLDA-DGKLMIMHSGGDPIVLNSNQAARNST-ATLLDSGNFVLEEFNSDR 230
Query: 122 TIKRVLWQSFDYPTDTLLPGMKLGINLQTGHQWFLQSWLDYSSPAQGSFTLGIEPNATNQ 181
++K LW+SFD PTDTLLPGMKLGINL+TG W L SW++ PA G+FTL E N T Q
Sbjct: 231 SVKEKLWESFDNPTDTLLPGMKLGINLKTGQNWSLASWINEQVPAPGTFTL--EWNGT-Q 287
Query: 182 LIIRWRRETIYWTSGLLLNGNFNFSRSWNLS-------FSYTSNEQEKYFEYSLNEGVTS 234
+++ RR YW+SG L N +F F + F+ +NE E YF YS+ +GV S
Sbjct: 288 FVMK-RRGGTYWSSGTLKNRSFEFIPWLSFDTCNNIYCFNSVANENEIYFSYSVPDGVVS 346
Query: 235 SVFLRIDPEGALSDS-RGSFAP---C----TYGGCWNQLPRPICRKGTGPENFQSKVGLI 286
L + G LSD+ R F C Y GC Q P P CR T + F + I
Sbjct: 347 EWAL--NSRGGLSDTNRPLFVTDDVCDGLEEYPGCAVQNP-PTCR--TRKDGFMKQSVHI 401
Query: 287 SEHGFKFKESDNMSSTDCRANCFYNCSCIAFATGTSEYTDKQAYCEIWSEGTEFTEIASN 346
SE KE ++ +DC+A C+ NCSC A T YT+ C W GT+FT+ +
Sbjct: 402 SESPSSIKEDSSLGPSDCQAICWNNCSCTACNT---IYTNGTG-CRFW--GTKFTQAYAG 455
Query: 347 --NSREIFILAIKEEKWWRSLTIAIGVVLGIPLLCYLCYVTWRKLKAKDNVSLLPTYGKR 404
N +++L+ R + A+ L A N ++
Sbjct: 456 DANQEALYVLSSSRVTGERKMEEAMLHEL-----------------ATSN-----SFSDS 493
Query: 405 KSPEKDQSISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSR 464
K + D +H+LK+F F +I AA+NNFS+ NKLGEGGFGPVYKGKL + QE+A+KRLSR
Sbjct: 494 KDVDHDGKRAHDLKLFSFDSIVAASNNFSSENKLGEGGFGPVYKGKLPEGQEIAVKRLSR 553
Query: 465 SSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKN 524
SGQG+VEFKNE+RLIA+LQH NLVRLLGC + GEE++L+YEFMPNKSLDFFLF+ R+
Sbjct: 554 GSGQGLVEFKNEIRLIARLQHMNLVRLLGCCIXGEEKMLIYEFMPNKSLDFFLFDPARRK 613
Query: 525 VLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
+L+W++R IIEGI+QGLLYLHKYSRLR+IHRDLKASNILLD +NPKISDFGMAR F
Sbjct: 614 ILDWKRRHNIIEGIAQGLLYLHKYSRLRIIHRDLKASNILLDHDLNPKISDFGMARTFGR 673
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPL- 643
N SEANT RIVGTYGYM PEYAM GI S+K+DV+SFGVL+LEIVSG+KN + +H D L
Sbjct: 674 NASEANTNRIVGTYGYMPPEYAMEGIFSVKSDVYSFGVLLLEIVSGRKNKSFYHNDGALT 733
Query: 644 -NLIGY----------------------------AWQLLSDGKGLELIDPSLEQPCSANE 674
NL GY AW+L +G L+L+DP LE S+ +
Sbjct: 734 INLAGYVNLLNLIFVSTLLSTTPGVSFQNFHTNLAWELWKEGTSLQLVDPMLEVFHSSTQ 793
Query: 675 VMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETMPLPPPKQPAFFIN 721
++R IH+ LLCVQ+ A DRPTM V+ ML NET+PLP P PAF I+
Sbjct: 794 MLRWIHIALLCVQESAADRPTMSAVISMLTNETVPLPNPNLPAFSIH 840
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|397134747|gb|AFO11038.1| S domain subfamily receptor-like kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 624 bits (1609), Expect = e-176, Method: Compositional matrix adjust.
Identities = 370/831 (44%), Positives = 488/831 (58%), Gaps = 98/831 (11%)
Query: 3 LVSAFGNFKLGFFSPASSTTTERYLGIWHDTAPDTLGWYFRPFLPRYQ--TDEPIWIANR 60
LVS F FK+ FF+ +S+ YLGIW++ +Y +Y D+ +WIANR
Sbjct: 39 LVSTFNIFKVKFFNFENSSNW--YLGIWYNN------FYLSGGNKKYGDIKDKAVWIANR 90
Query: 61 NTPILDQSGVLTIDSIDGNLKILHNGGNPIAVSSVEGASNNTSATLLQSGNLVLREMDTD 120
N P+L +SG LT+DS+ G L+IL + + +SS E + NT+ LL SGNL L+EMD+D
Sbjct: 91 NNPVLGRSGSLTVDSL-GRLRILRGASSLLELSSTE-TTGNTTLKLLDSGNLQLQEMDSD 148
Query: 121 GTIKRVLWQSFDYPTDTLLPGMKLGINLQTGHQWFLQSWLDYSSPAQGSFTLGIEPNATN 180
G++ R+LWQSFDYPTDTLLPGMKLG N++ G +W L SWL + PA GS G++ N TN
Sbjct: 149 GSMMRILWQSFDYPTDTLLPGMKLGFNVKNGKRWELTSWLGDTLPASGSLVFGMDANITN 208
Query: 181 QLIIRWRRETIYWTSGLLLNGNFNFSR--SWNLSFSYTSNEQEKYFEYSLNEGVTSSVF- 237
+L I WR +YW SGL G F+ + FS+ S E E YF YS ++ + F
Sbjct: 209 RLTILWR-GNMYWASGLWFKGGFSLEELNDYGFLFSFISTESEHYFMYSGDQKYAGTFFP 267
Query: 238 -LRIDPEGAL--------------------SDS-----RGSFAPCTYGGCWNQLPRPICR 271
+ ID +G L DS R + C + GC +P
Sbjct: 268 AIMIDQQGILRIYRLDRERLYVHCSPFTLDEDSNFNCYRRNSRDCLHAGC--IVPERQNE 325
Query: 272 KGTGPENFQSKVGLISEHGFKFKESDN-MSSTDCRANCFYNCSCIAFATGTSEYTDKQAY 330
G F+ V S +GF E+ SS DCRA C N SC+A+A+ + T
Sbjct: 326 SFYGFRFFRETVSAFSSNGFVLNETGGRFSSADCRAICMQNASCLAYASTNLDGTG---- 381
Query: 331 CEIWSEGTEFTEIASNNSREI------FILAIKEEKWWRSLTIAIGVVLGIPLLCYLCYV 384
CEIW+ + + R I F++ + EK L + + L IP+ ++ Y+
Sbjct: 382 CEIWNTYPTDKRSSPQSPRTIYIRVKGFVVNHENEKAATWLVVVASLFLMIPVTWFIIYL 441
Query: 385 TWRKLKAKDNV-----------SLLPT---YGKRKSPEK------DQSI----------- 413
RK K K + ++P + +R+ P DQ +
Sbjct: 442 VLRKFKVKVTIIFRGMFYFLWGKVIPQMIGFIRRRLPTLRVGSTIDQEMLLRELGIDRRR 501
Query: 414 ---------SHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSR 464
++EL+IF F+++A A + FS NKLGEGGFGPVYKG L D +EVAIKRLS
Sbjct: 502 RGKRSARKNNNELQIFSFESVALATDYFSDANKLGEGGFGPVYKGSLIDGEEVAIKRLSL 561
Query: 465 SSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKN 524
+SGQG+VEFKNE LIAKLQHTNLV+LLGC + +E++L+YE+MPNKSLD+FLF+ RKN
Sbjct: 562 ASGQGLVEFKNEAMLIAKLQHTNLVQLLGCCIEKDEKMLIYEYMPNKSLDYFLFDPLRKN 621
Query: 525 VLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
VL+W RF I+EGI QGLLYLHKYSRL+VIHRD+KASNILLD+ MNPKISDFGMARIF
Sbjct: 622 VLDWTLRFRIMEGIIQGLLYLHKYSRLKVIHRDIKASNILLDEDMNPKISDFGMARIFGA 681
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHH-PDRPL 643
ES+ANTKR+ GT+GYMSPEY G+ S K+DVFSFGVL+LEI+ G+KN++ HH + PL
Sbjct: 682 QESKANTKRVAGTFGYMSPEYFREGLFSTKSDVFSFGVLMLEIICGRKNNSFHHDSEGPL 741
Query: 644 NLIGYAWQLLSDGKGLELIDPSLEQPCSAN-EVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702
NLI + W L + E+IDPSL N +V+RC+ V LLCVQ A DRP+M VV M
Sbjct: 742 NLIVHVWNLFKENHVREVIDPSLGDSAVENPQVLRCVQVALLCVQQNADDRPSMLHVVSM 801
Query: 703 LQNE-TMPLPPPKQPAFFINANADDQVPEVPDNEVAKFSTNDVTMTTMEAR 752
+ + L PK+PAF+ Q EV E+ S N VT+T MEAR
Sbjct: 802 IYGDGNNALSLPKEPAFYDGPRRSLQEMEVEPPELENVSANRVTITVMEAR 852
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|9294449|dbj|BAB02668.1| receptor kinase 1 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 618 bits (1594), Expect = e-174, Method: Compositional matrix adjust.
Identities = 367/805 (45%), Positives = 482/805 (59%), Gaps = 93/805 (11%)
Query: 3 LVSAFGNFKLGFFSPASSTTTERYLGIWHDTAPDTLGWYFRPFLPRYQ--TDEPIWIANR 60
LVSAF FKL FF+ +S+ YLGIW++ +Y +Y D+ +WIANR
Sbjct: 39 LVSAFNIFKLKFFNFENSSNW--YLGIWYNN------FYLSGGNKKYGDIKDKAVWIANR 90
Query: 61 NTPILDQSGVLTIDSIDGNLKILHNGGNPIAVSSVEGASNNTSATLLQSGNLVLREMDTD 120
N P+L +SG LT+DS+ G L+IL + + +SS E + NT+ LL SGNL L+EMD+D
Sbjct: 91 NNPVLGRSGSLTVDSL-GRLRILRGASSLLELSSTE-TTGNTTLKLLDSGNLQLQEMDSD 148
Query: 121 GTIKRVLWQSFDYPTDTLLPGMKLGINLQTGHQWFLQSWLDYSSPAQGSFTLGIEPNATN 180
G++KR LWQSFDYPTDTLLPGMKLG N++TG +W L SWL + PA GSF G++ N TN
Sbjct: 149 GSMKRTLWQSFDYPTDTLLPGMKLGFNVKTGKRWELTSWLGDTLPASGSFVFGMDDNITN 208
Query: 181 QLIIRWRRETIYWTSGLLLNGNFNFSR--SWNLSFSYTSNEQEKYFEYSLNEGVTSSVF- 237
+L I W +YW SGL G F+ + + FS+ S E E YF YS +E +F
Sbjct: 209 RLTILWL-GNVYWASGLWFKGGFSLEKLNTNGFIFSFVSTESEHYFMYSGDENYGGPLFP 267
Query: 238 -LRIDPEGALSD-------SRGSFAPCTYG-----GCWNQLPRPIC----RKGTGPEN-- 278
+RID +G+L +P +G GC+ Q R ++ TG +
Sbjct: 268 RIRIDQQGSLQKINLDGVKKHVHCSPSVFGEELEYGCYQQNFRNCVPARYKEVTGSWDCS 327
Query: 279 ------------------------FQSKVGLISEHGFKFKE-SDNMSSTDCRANCFYNCS 313
F+ V +E+GF F E +SS DC C NCS
Sbjct: 328 PFGFGYTYTRKTYDLSYCSRFGYTFRETVSPSAENGFVFNEIGRRLSSYDCYVKCLQNCS 387
Query: 314 CIAFATGTSEYTDKQAYCEIWSEGTEFTEIASNNSREIFILAIKEEKWWRSLTIAIGVVL 373
C+A+A+ + + +G E K W L + + L
Sbjct: 388 CVAYASTNGDGV-------VVDQGNE-----------------KAATW---LVVVASLFL 420
Query: 374 GIPLLCYLCYVTWRKLKAKDNVSLLPTYGKRKSPEKDQSI---SHELKIFDFQTIAAAAN 430
IP+ + Y+ RK K KD LL G + +S ++EL+IF F+++A A +
Sbjct: 421 IIPVTWLIIYLVLRKFKIKDQEMLLLELGIERRRRGKRSARNNNNELQIFSFESVAFATD 480
Query: 431 NFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVR 490
FS NKLGEGGFGPVYKG+L D +EVAIKRLS +SGQG+VEFKNE LIAKLQHTNLV+
Sbjct: 481 YFSDANKLGEGGFGPVYKGRLIDGEEVAIKRLSLASGQGLVEFKNEAMLIAKLQHTNLVK 540
Query: 491 LLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSR 550
LLGC + +E++L+YE+MPNKSLD+FLF+ RK VL+W+ RF I+EGI QGLLYLHKYSR
Sbjct: 541 LLGCCVEKDEKMLIYEYMPNKSLDYFLFDPLRKIVLDWKLRFRIMEGIIQGLLYLHKYSR 600
Query: 551 LRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGI 610
L+VIHRD+KA NILLD+ MNPKISDFGMARIF ES+ANTKR+ GT+GYMSPEY G+
Sbjct: 601 LKVIHRDIKAGNILLDEDMNPKISDFGMARIFGAQESKANTKRVAGTFGYMSPEYFREGL 660
Query: 611 VSIKTDVFSFGVLVLEIVSGQKNHTRHH-PDRPLNLIGYAWQLLSDGKGLELIDPSLEQP 669
S K+DVFSFGVL+LEI+ G+KN++ HH + PLNLI + W L + + E+IDPSL
Sbjct: 661 FSAKSDVFSFGVLMLEIICGRKNNSFHHDSEGPLNLIVHVWNLFKENRVREVIDPSLGDS 720
Query: 670 CSAN-EVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE-TMPLPPPKQPAFFINANADDQ 727
N +V+RC+ V LLCVQ A DRP+M +VV M+ + L PK+PAF+
Sbjct: 721 AVENPQVLRCVQVALLCVQQNADDRPSMLDVVSMIYGDGNNALSLPKEPAFYDGPPRSSP 780
Query: 728 VPEVPDNEVAKFSTNDVTMTTMEAR 752
EV E+ S N VT+T MEAR
Sbjct: 781 EMEVEPPEMENVSANRVTITVMEAR 805
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15233263|ref|NP_188224.1| lectin receptor kinase CES101 [Arabidopsis thaliana] gi|313118276|sp|Q9LW83.2|CE101_ARATH RecName: Full=G-type lectin S-receptor-like serine/threonine-protein kinase CES101; AltName: Full=Protein CALLUS EXPRESSION OF RBCS 101; Flags: Precursor gi|332642243|gb|AEE75764.1| lectin receptor kinase CES101 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 617 bits (1592), Expect = e-174, Method: Compositional matrix adjust.
Identities = 373/837 (44%), Positives = 495/837 (59%), Gaps = 112/837 (13%)
Query: 3 LVSAFGNFKLGFFSPASSTTTERYLGIWHDTAPDTLGWYFRPFLPRYQTDEPIWIANRNT 62
LVSAF FKL FF+ +S+ YLGIW++ + +WIANRN
Sbjct: 39 LVSAFNIFKLKFFNFENSSNW--YLGIWYNN---------------FYLSGAVWIANRNN 81
Query: 63 PILDQSGVLTIDSIDGNLKILHNGGNPIAVSSVEGASNNTSATLLQSGNLVLREMDTDGT 122
P+L +SG LT+DS+ G L+IL + + +SS E + NT+ LL SGNL L+EMD+DG+
Sbjct: 82 PVLGRSGSLTVDSL-GRLRILRGASSLLELSSTE-TTGNTTLKLLDSGNLQLQEMDSDGS 139
Query: 123 IKRVLWQSFDYPTDTLLPGMKLGINLQTGHQWFLQSWLDYSSPAQGSFTLGIEPNATNQL 182
+KR LWQSFDYPTDTLLPGMKLG N++TG +W L SWL + PA GSF G++ N TN+L
Sbjct: 140 MKRTLWQSFDYPTDTLLPGMKLGFNVKTGKRWELTSWLGDTLPASGSFVFGMDDNITNRL 199
Query: 183 IIRWRRETIYWTSGLLLNGNFNFSR--SWNLSFSYTSNEQEKYFEYSLNEGVTSSVF--L 238
I W +YW SGL G F+ + + FS+ S E E YF YS +E +F +
Sbjct: 200 TILWL-GNVYWASGLWFKGGFSLEKLNTNGFIFSFVSTESEHYFMYSGDENYGGPLFPRI 258
Query: 239 RIDPEGALSD-------SRGSFAPCTYG-----GCWNQLPRPIC----RKGTGPEN---- 278
RID +G+L +P +G GC+ Q R ++ TG +
Sbjct: 259 RIDQQGSLQKINLDGVKKHVHCSPSVFGEELEYGCYQQNFRNCVPARYKEVTGSWDCSPF 318
Query: 279 ----------------------FQSKVGLISEHGFKFKE-SDNMSSTDCRANCFYNCSCI 315
F+ V +E+GF F E +SS DC C NCSC+
Sbjct: 319 GFGYTYTRKTYDLSYCSRFGYTFRETVSPSAENGFVFNEIGRRLSSYDCYVKCLQNCSCV 378
Query: 316 AFATGTSEYTDKQAYCEIWSEGTEFTEIASNNSREIFILAIKEEKWWRS-LTIAIGVVLG 374
A+A+ + T CEIW+ AS++ R I+I IK K + L + + L
Sbjct: 379 AYASTNGDGTG----CEIWNTDPTNENSASHHPRTIYI-RIKGSKLAATWLVVVASLFLI 433
Query: 375 IPLLCYLCYVTWRKLKAK------DNVSLLPTYG-----KRKSPEK-----DQSI----- 413
IP+ + Y+ RK K K +++ ++ + KR S + DQ +
Sbjct: 434 IPVTWLIIYLVLRKFKIKGTNFVSESLKMISSQSCSLTNKRLSTLRVGSTIDQEMLLLEL 493
Query: 414 ---------------SHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEVA 458
++EL+IF F+++A A + FS NKLGEGGFGPVYKG+L D +EVA
Sbjct: 494 GIERRRRGKRSARNNNNELQIFSFESVAFATDYFSDANKLGEGGFGPVYKGRLIDGEEVA 553
Query: 459 IKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLF 518
IKRLS +SGQG+VEFKNE LIAKLQHTNLV+LLGC + +E++L+YE+MPNKSLD+FLF
Sbjct: 554 IKRLSLASGQGLVEFKNEAMLIAKLQHTNLVKLLGCCVEKDEKMLIYEYMPNKSLDYFLF 613
Query: 519 NSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGM 578
+ RK VL+W+ RF I+EGI QGLLYLHKYSRL+VIHRD+KA NILLD+ MNPKISDFGM
Sbjct: 614 DPLRKIVLDWKLRFRIMEGIIQGLLYLHKYSRLKVIHRDIKAGNILLDEDMNPKISDFGM 673
Query: 579 ARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHH 638
ARIF ES+ANTKR+ GT+GYMSPEY G+ S K+DVFSFGVL+LEI+ G+KN++ HH
Sbjct: 674 ARIFGAQESKANTKRVAGTFGYMSPEYFREGLFSAKSDVFSFGVLMLEIICGRKNNSFHH 733
Query: 639 -PDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSAN-EVMRCIHVGLLCVQDQAMDRPTM 696
+ PLNLI + W L + + E+IDPSL N +V+RC+ V LLCVQ A DRP+M
Sbjct: 734 DSEGPLNLIVHVWNLFKENRVREVIDPSLGDSAVENPQVLRCVQVALLCVQQNADDRPSM 793
Query: 697 PEVVCMLQNE-TMPLPPPKQPAFFINANADDQVPEVPDNEVAKFSTNDVTMTTMEAR 752
+VV M+ + L PK+PAF+ EV E+ S N VT+T MEAR
Sbjct: 794 LDVVSMIYGDGNNALSLPKEPAFYDGPPRSSPEMEVEPPEMENVSANRVTITVMEAR 850
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 752 | ||||||
| TAIR|locus:2093397 | 850 | CES101 "CALLUS EXPRESSION OF R | 0.465 | 0.411 | 0.583 | 1.6e-176 | |
| TAIR|locus:2200908 | 842 | AT1G61610 [Arabidopsis thalian | 0.642 | 0.573 | 0.464 | 2.4e-138 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.446 | 0.395 | 0.573 | 5e-138 | |
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.482 | 0.427 | 0.518 | 8.2e-132 | |
| TAIR|locus:2131694 | 815 | AT4G27300 [Arabidopsis thalian | 0.625 | 0.576 | 0.449 | 8.7e-132 | |
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.480 | 0.426 | 0.521 | 1.3e-129 | |
| TAIR|locus:2200151 | 830 | SD1-13 "S-domain-1 13" [Arabid | 0.643 | 0.583 | 0.440 | 2.4e-127 | |
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.468 | 0.449 | 0.534 | 1.7e-126 | |
| TAIR|locus:2197744 | 807 | AT1G61420 [Arabidopsis thalian | 0.626 | 0.583 | 0.432 | 1.5e-123 | |
| UNIPROTKB|O49974 | 848 | KIK1 "Serine/threonine-protein | 0.635 | 0.563 | 0.442 | 4.5e-122 |
| TAIR|locus:2093397 CES101 "CALLUS EXPRESSION OF RBCS 101" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1042 (371.9 bits), Expect = 1.6e-176, Sum P(4) = 1.6e-176
Identities = 206/353 (58%), Positives = 261/353 (73%)
Query: 403 KRKSPEKDQSISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRL 462
+R+ ++ ++EL+IF F+++A A + FS NKLGEGGFGPVYKG+L D +EVAIKRL
Sbjct: 498 RRRGKRSARNNNNELQIFSFESVAFATDYFSDANKLGEGGFGPVYKGRLIDGEEVAIKRL 557
Query: 463 SRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGR 522
S +SGQG+VEFKNE LIAKLQHTNLV+LLGC + +E++L+YE+MPNKSLD+FLF+ R
Sbjct: 558 SLASGQGLVEFKNEAMLIAKLQHTNLVKLLGCCVEKDEKMLIYEYMPNKSLDYFLFDPLR 617
Query: 523 KNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIF 582
K VL+W+ RF I+EGI QGLLYLHKYSRL+VIHRD+KA NILLD+ MNPKISDFGMARIF
Sbjct: 618 KIVLDWKLRFRIMEGIIQGLLYLHKYSRLKVIHRDIKAGNILLDEDMNPKISDFGMARIF 677
Query: 583 EVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDR- 641
ES+ANTKR+ GT+GYMSPEY G+ S K+DVFSFGVL+LEI+ G+KN++ HH
Sbjct: 678 GAQESKANTKRVAGTFGYMSPEYFREGLFSAKSDVFSFGVLMLEIICGRKNNSFHHDSEG 737
Query: 642 PLNLIGYAWQLLSDGKGLELIDPSLEQPCSAN-EVMRCIHVGLLCVQDQAMDRPTMPEVV 700
PLNLI + W L + + E+IDPSL N +V+RC+ V LLCVQ A DRP+M +VV
Sbjct: 738 PLNLIVHVWNLFKENRVREVIDPSLGDSAVENPQVLRCVQVALLCVQQNADDRPSMLDVV 797
Query: 701 CMLQNE-TMPLPPPKQPAFFINANADDQVPEVPDNEVAKFSTNDVTMTTMEAR 752
M+ + L PK+PAF+ EV E+ S N VT+T MEAR
Sbjct: 798 SMIYGDGNNALSLPKEPAFYDGPPRSSPEMEVEPPEMENVSANRVTITVMEAR 850
|
|
| TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1030 (367.6 bits), Expect = 2.4e-138, Sum P(3) = 2.4e-138
Identities = 239/514 (46%), Positives = 315/514 (61%)
Query: 259 GGCWNQLPRPICRKG--TGPENFQSKVGLISEHGFKFKESDNMSSTDCRANCFYNCSCIA 316
GGC ++P C + G E+ + + I F N S T C+ C +CSC A
Sbjct: 340 GGCQRRVPLN-CNQSLVAGQEDGFTVLKGIKVPDFGSVVLHNNSET-CKDVCARDCSCKA 397
Query: 317 FAT----GTSEYTDKQAYCEIWSEGTEFTEIASNNSREIFILAIKEEKWWRSLTIAIGVV 372
+A G +T E + G I S+ + KE +L I + V
Sbjct: 398 YALVVGIGCMIWTRDLIDMEHFERGGNSINIRLAGSK---LGGGKENS---TLWIIVFSV 451
Query: 373 LGIPLLCYLCYVTWR---KLKA-----KD-NVS-LLPTYGKRKSPEK----DQSISHELK 418
+G LL ++ W+ LKA KD VS ++ SP K DQ + +L
Sbjct: 452 IGAFLLGLCIWILWKFKKSLKAFLWKKKDITVSDIIENRDYSSSPIKVLVGDQVDTPDLP 511
Query: 419 IFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVR 478
IF F ++A+A +F+ NKLG+GGFG VYKG ++ +E+A+KRLS S QG+ EFKNE+
Sbjct: 512 IFSFDSVASATGDFAEENKLGQGGFGTVYKGNFSEGREIAVKRLSGKSKQGLEEFKNEIL 571
Query: 479 LIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGI 538
LIAKLQH NLVRLLGC + E++L+YE+MPNKSLD FLF+ ++ L+W KR+ +I GI
Sbjct: 572 LIAKLQHRNLVRLLGCCIEDNEKMLLYEYMPNKSLDRFLFDESKQGSLDWRKRWEVIGGI 631
Query: 539 SQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTY 598
++GLLYLH+ SRL++IHRDLKASNILLD +MNPKISDFGMARIF + ANT R+VGTY
Sbjct: 632 ARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKISDFGMARIFNYRQDHANTIRVVGTY 691
Query: 599 GYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKG 658
GYM+PEYAM GI S K+DV+SFGVL+LEIVSG+KN + D +LIGYAW L S GK
Sbjct: 692 GYMAPEYAMEGIFSEKSDVYSFGVLILEIVSGRKNVSFRGTDHG-SLIGYAWHLWSQGKT 750
Query: 659 LELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETMPLPPPKQPAF 718
E+IDP ++ E MRCIHVG+LC QD + RP M V+ ML+++T LPPP+QP F
Sbjct: 751 KEMIDPIVKDTRDVTEAMRCIHVGMLCTQDSVIHRPNMGSVLLMLESQTSQLPPPRQPTF 810
Query: 719 FINANADDQVPEVPDNEVAKFSTNDVTMTTMEAR 752
N+ D ++VA S NDVT TT+ R
Sbjct: 811 HSFLNSGDIELNFDGHDVA--SVNDVTFTTIVGR 842
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1011 (360.9 bits), Expect = 5.0e-138, Sum P(3) = 5.0e-138
Identities = 194/338 (57%), Positives = 251/338 (74%)
Query: 416 ELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKN 475
EL +F IA A N+F N+LG GGFGPVYKG L D +E+A+KRLS SGQG+ EFKN
Sbjct: 513 ELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVDEFKN 572
Query: 476 EVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIII 535
E+ LIAKLQH NLVRLLGC GEE++LVYE+MPNKSLDFFLF+ ++ +++W+ RF II
Sbjct: 573 EIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRFSII 632
Query: 536 EGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIV 595
EGI++GLLYLH+ SRLR+IHRDLK SN+LLD +MNPKISDFGMARIF N++EANT R+V
Sbjct: 633 EGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTVRVV 692
Query: 596 GTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSD 655
GTYGYMSPEYAM G+ S+K+DV+SFGVL+LEIVSG++N + + +LIGYAW L +
Sbjct: 693 GTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSEHG-SLIGYAWYLYTH 751
Query: 656 GKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETMPLPPPKQ 715
G+ EL+DP + CS E +RCIHV +LCVQD A +RP M V+ ML+++T L P+Q
Sbjct: 752 GRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMASVLLMLESDTATLAAPRQ 811
Query: 716 PAFF-INANADDQVPEVPDNEVAKFSTNDVTMTTMEAR 752
P F N+ D + ++ S+N++T T + R
Sbjct: 812 PTFTSTRRNSIDVNFALDSSQQYIVSSNEITSTVVLGR 849
|
|
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 979 (349.7 bits), Expect = 8.2e-132, Sum P(3) = 8.2e-132
Identities = 193/372 (51%), Positives = 266/372 (71%)
Query: 388 KLKAKDNVSLLPTYGKRKSPEKDQSISH-ELKIFDFQTIAAAANNFSTTNKLGEGGFGPV 446
+L+++D + R+ ++ + EL + +F+ +A A NNFS NKLG+GGFG V
Sbjct: 481 QLRSRDLLMNEVVISSRRHISRENNTDDLELPLMEFEEVAMATNNFSNANKLGQGGFGIV 540
Query: 447 YKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYE 506
YKGKL D QE+A+KRLS++S QG EFKNEV+LIA+LQH NLVRLL C + E++L+YE
Sbjct: 541 YKGKLLDGQEMAVKRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYE 600
Query: 507 FMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLD 566
++ N SLD LF+ R + LNW+ RF II GI++GLLYLH+ SR R+IHRDLKASNILLD
Sbjct: 601 YLENLSLDSHLFDKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLD 660
Query: 567 DKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLE 626
M PKISDFGMARIF +E+EANT+++VGTYGYMSPEYAM GI S+K+DVFSFGVL+LE
Sbjct: 661 KYMTPKISDFGMARIFGRDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLE 720
Query: 627 IVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSA---NEVMRCIHVGL 683
I+S ++N ++ DR LNL+G W+ +GKGLE+IDP + S +E++RCI +GL
Sbjct: 721 IISSKRNKGFYNSDRDLNLLGCVWRNWKEGKGLEIIDPIITDSSSTFRQHEILRCIQIGL 780
Query: 684 LCVQDQAMDRPTMPEVVCMLQNETMPLPPPKQPAFFINAN---ADDQVPEVPDNEVAKFS 740
LCVQ++A DRPTM V+ ML +E+ +P PK P + + + D + D+E ++
Sbjct: 781 LCVQERAEDRPTMSLVILMLGSESTTIPQPKAPGYCLERSLLDTDSSSSKQRDDE--SWT 838
Query: 741 TNDVTMTTMEAR 752
N +T++ ++AR
Sbjct: 839 VNQITVSVLDAR 850
|
|
| TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1044 (372.6 bits), Expect = 8.7e-132, Sum P(2) = 8.7e-132
Identities = 226/503 (44%), Positives = 328/503 (65%)
Query: 260 GCWNQLPRPICRKGTGPENFQSKVGL-ISEHGFKFKESDN-MSSTDCRANCFYNCSCIAF 317
GC +++P C K + F GL + + + + ++ N M+ DC+ C NCSC A+
Sbjct: 336 GCVHEIPTN-CEK---KDAFVKFPGLKLPDTSWSWYDAKNEMTLEDCKIKCSSNCSCTAY 391
Query: 318 ATGTSEYTDKQAYCEIW-SEGTEFTEIASNNSREIFI---LAIKEEKWWRSLTIAIGVVL 373
A ++ + C +W + + E +S ++++I A E K + + +G V+
Sbjct: 392 AN--TDIREGGKGCLLWFGDLVDMREYSSFG-QDVYIRMGFAKIEFKGREVVGMVVGSVV 448
Query: 374 GIPLLCYLCYVTWRKLKAKDNVSLLPTY-GK--RKSPEKDQSISHELKIFDFQTIAAAAN 430
I ++ + + +RK ++ Y G+ RK E++ +L IFD +TI+ A +
Sbjct: 449 AIAVVLVVVFACFRK-------KIMKRYRGENFRKGIEEEDL---DLPIFDRKTISIATD 498
Query: 431 NFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVR 490
+FS N LG GGFGPVYKGKL D QE+A+KRLS +SGQG+ EFKNEV+LIAKLQH NLVR
Sbjct: 499 DFSYVNFLGRGGFGPVYKGKLEDGQEIAVKRLSANSGQGVEEFKNEVKLIAKLQHRNLVR 558
Query: 491 LLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSR 550
LLGC + GEE +L+YE+MPNKSLDFF+F+ R L+W+KR II G+++G+LYLH+ SR
Sbjct: 559 LLGCCIQGEECMLIYEYMPNKSLDFFIFDERRSTELDWKKRMNIINGVARGILYLHQDSR 618
Query: 551 LRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGI 610
LR+IHRDLKA N+LLD+ MNPKISDFG+A+ F ++SE++T R+VGTYGYM PEYA+ G
Sbjct: 619 LRIIHRDLKAGNVLLDNDMNPKISDFGLAKSFGGDQSESSTNRVVGTYGYMPPEYAIDGH 678
Query: 611 VSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPS-LEQP 669
S+K+DVFSFGVLVLEI++G+ N H D LNL+G+ W++ + + +E+ + LE+
Sbjct: 679 FSVKSDVFSFGVLVLEIITGKTNRGFRHADHDLNLLGHVWKMWVEDREIEVPEEEWLEET 738
Query: 670 CSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETMPLPPPKQPAFFINANADDQVP 729
EV+RCIHV LLCVQ + DRPTM VV M +++ LP P QP FF N N VP
Sbjct: 739 SVIPEVLRCIHVALLCVQQKPEDRPTMASVVLMFGSDSS-LPHPTQPGFFTNRN----VP 793
Query: 730 EVPDNEVAKFSTNDVTMTTMEAR 752
++ + ++ S N+V++T ++ R
Sbjct: 794 DI-SSSLSLRSQNEVSITMLQGR 815
|
|
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 977 (349.0 bits), Expect = 1.3e-129, Sum P(3) = 1.3e-129
Identities = 194/372 (52%), Positives = 264/372 (70%)
Query: 389 LKAKDNVSLLPTYGKRKSPEKDQSISH-ELKIFDFQTIAAAANNFSTTNKLGEGGFGPVY 447
++++D++ R K+ + EL + +++ +A A NNFST NKLG+GGFG VY
Sbjct: 479 VRSQDSLMNELVKASRSYTSKENKTDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIVY 538
Query: 448 KGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507
KG L D +E+A+KRLS+ S QG EF NEVRLIAKLQH NLVRLLGC + E++L+YE+
Sbjct: 539 KGMLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEY 598
Query: 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDD 567
+ N SLD LF+ R + LNW+KRF II GI++GLLYLH+ SR R+IHRDLKASN+LLD
Sbjct: 599 LENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDK 658
Query: 568 KMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEI 627
M PKISDFGMARIF E+EANT+R+VGTYGYMSPEYAM GI S+K+DVFSFGVL+LEI
Sbjct: 659 NMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEI 718
Query: 628 VSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDP----SLEQPCSANEVMRCIHVGL 683
+SG++N ++ +R LNL+G+ W+ +GK LE++DP +L +E++RCI +GL
Sbjct: 719 ISGKRNKGFYNSNRDLNLLGFVWRHWKEGKELEIVDPINIDALSSEFPTHEILRCIQIGL 778
Query: 684 LCVQDQAMDRPTMPEVVCMLQNETMPLPPPKQPAFFINANA---DDQVPEVPDNEVAKFS 740
LCVQ++A DRP M V+ ML +ET +P PK+P F + ++ D D+E +
Sbjct: 779 LCVQERAEDRPVMSSVMVMLGSETTAIPQPKRPGFCVGRSSLEVDSSSSTQRDDEC---T 835
Query: 741 TNDVTMTTMEAR 752
N VT++ ++AR
Sbjct: 836 VNQVTLSVIDAR 847
|
|
| TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1034 (369.0 bits), Expect = 2.4e-127, Sum P(2) = 2.4e-127
Identities = 224/509 (44%), Positives = 315/509 (61%)
Query: 260 GCWNQLPRPICRKGTGPENFQSKVGLISEHGFKFKESDNMSST---DCRANCFYNCSCIA 316
GC + P C + + G + K + S DC +C NCSC A
Sbjct: 331 GCVRKAPLQ-CESRDNNDGSRKSDGFVRVQKMKVPHNPQRSGANEQDCPESCLKNCSCTA 389
Query: 317 FATGTSEYTDKQAYCEIWSEGTEFTEIASNNSREIFI-LAIKE--EKWWRSLTIAIGVVL 373
++ D+ C +WS + S +I LA E ++ RS+ I + +++
Sbjct: 390 YSF------DRGIGCLLWSGNLMDMQEFSGTGVVFYIRLADSEFKKRTNRSIVITVTLLV 443
Query: 374 GIPLLC-YLCYVTWRKLKAKD---NVSLLPTYGKRKSPEK------DQSISHELKIFDFQ 423
G L + W+ K ++ N LL + S +Q EL +F+FQ
Sbjct: 444 GAFLFAGTVVLALWKIAKHREKNRNTRLLNERMEALSSNDVGAILVNQYKLKELPLFEFQ 503
Query: 424 TIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKL 483
+A A NNFS TNKLG+GGFG VYKG+L + ++A+KRLSR+SGQG+ EF NEV +I+KL
Sbjct: 504 VLAVATNNFSITNKLGQGGFGAVYKGRLQEGLDIAVKRLSRTSGQGVEEFVNEVVVISKL 563
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLL 543
QH NLVRLLG + GEER+LVYEFMP LD +LF+ ++ +L+W+ RF II+GI +GL+
Sbjct: 564 QHRNLVRLLGFCIEGEERMLVYEFMPENCLDAYLFDPVKQRLLDWKTRFNIIDGICRGLM 623
Query: 544 YLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSP 603
YLH+ SRL++IHRDLKASNILLD+ +NPKISDFG+ARIF+ NE E +T R+VGTYGYM+P
Sbjct: 624 YLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFQGNEDEVSTVRVVGTYGYMAP 683
Query: 604 EYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELID 663
EYAM G+ S K+DVFS GV++LEIVSG++N + ++ + NL YAW+L + G+ + L+D
Sbjct: 684 EYAMGGLFSEKSDVFSLGVILLEIVSGRRNSSFYNDGQNPNLSAYAWKLWNTGEDIALVD 743
Query: 664 PSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETMPLPPPKQPAFFINAN 723
P + + C NE+ RC+HVGLLCVQD A DRP++ V+ ML +E LP PKQPAF I
Sbjct: 744 PVIFEECFENEIRRCVHVGLLCVQDHANDRPSVATVIWMLSSENSNLPEPKQPAF-IPRR 802
Query: 724 ADDQVPEVPDNEVAKFSTNDVTMTTMEAR 752
+V ++ + S N+V++T + R
Sbjct: 803 GTSEVESSGQSD-PRASINNVSLTKITGR 830
|
|
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 948 (338.8 bits), Expect = 1.7e-126, Sum P(2) = 1.7e-126
Identities = 192/359 (53%), Positives = 246/359 (68%)
Query: 391 AKDNVSLLPTYGKRKSPEKDQSISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGK 450
A + L R S K + EL D T++ A + FS NKLG+GGFGPVYKG
Sbjct: 424 ASSEIETLQRESSRVSSRKQEEEDLELPFLDLDTVSEATSGFSAGNKLGQGGFGPVYKGT 483
Query: 451 LADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPN 510
LA QEVA+KRLSR+S QG+ EFKNE++LIAKLQH NLV++LG + EER+L+YE+ PN
Sbjct: 484 LACGQEVAVKRLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVDEEERMLIYEYQPN 543
Query: 511 KSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMN 570
KSLD F+F+ R+ L+W KR II+GI++G+LYLH+ SRLR+IHRDLKASN+LLD MN
Sbjct: 544 KSLDSFIFDKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLKASNVLLDSDMN 603
Query: 571 PKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
KISDFG+AR +E+EANT R+VGTYGYMSPEY + G S+K+DVFSFGVLVLEIVSG
Sbjct: 604 AKISDFGLARTLGGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSDVFSFGVLVLEIVSG 663
Query: 631 QKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCS-ANEVMRCIHVGLLCVQDQ 689
++N + + LNL+G+AW+ + K E+ID ++ + C+ +EV+R IH+GLLCVQ
Sbjct: 664 RRNRGFRNEEHKLNLLGHAWRQFLEDKAYEIIDEAVNESCTDISEVLRVIHIGLLCVQQD 723
Query: 690 AMDRPTMPEVVCMLQNETMPLPPPKQPAFFINANA--DDQVP---EVPDNEVAKFSTND 743
DRP M VV ML +E M L P+QP FF N D V E+P N S D
Sbjct: 724 PKDRPNMSVVVLMLSSE-MLLLDPRQPGFFNERNLLFSDTVSINLEIPSNNFQTMSVID 781
|
|
| TAIR|locus:2197744 AT1G61420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 987 (352.5 bits), Expect = 1.5e-123, Sum P(2) = 1.5e-123
Identities = 211/488 (43%), Positives = 303/488 (62%)
Query: 259 GGCWNQLPRPICRKGTGP-ENFQSKVGLISEHGFKFKESDNMSSTDCRANCFYNCSCIAF 317
GGC + TG N V I F ++ + ++ +C+ +C +NCSC+AF
Sbjct: 323 GGCVRRTELYCQGNSTGKYANVFHPVARIKPPDF-YEFASFVNVEECQKSCLHNCSCLAF 381
Query: 318 ATGTSEYTDKQAYCEIWSE----GTEFTEIASNNSREIFILAIKEEKWWRSLTIAIGVVL 373
A Y D C +W++ +F+E S + + K +++T +I +
Sbjct: 382 A-----YIDGIG-CLMWNQDLMDAVQFSEGGELLSIRLARSELGGNKRKKAITASIVSLS 435
Query: 374 GIPLLCYLCYVTWR-KLKAKDNVSLLPTYGKRKSPEKDQSISHELKIFDFQTIAAAANNF 432
+ ++ ++ + WR ++K +++ + ++ K Q + L FD TI A NNF
Sbjct: 436 LVVIIAFVAFCFWRYRVKHNADITTDASQVSWRNDLKPQDVPG-LDFFDMHTIQTATNNF 494
Query: 433 STTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLL 492
S +NKLG+GGFGPVYKGKL D +E+A+KRLS SSGQG EF NE+ LI+KLQH NLVR+L
Sbjct: 495 SISNKLGQGGFGPVYKGKLQDGKEIAVKRLSSSSGQGKEEFMNEIVLISKLQHKNLVRIL 554
Query: 493 GCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLR 552
GC + GEE+LL+YEFM N SLD FLF+S ++ ++W KR II+GI++G+ YLH+ S L+
Sbjct: 555 GCCIEGEEKLLIYEFMLNNSLDTFLFDSRKRLEIDWPKRLDIIQGIARGIHYLHRDSHLK 614
Query: 553 VIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVS 612
VIHRDLK SNILLD+KMNPKISDFG+AR+++ E + NT+R+VGT GYM+PEYA +G+ S
Sbjct: 615 VIHRDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDNTRRVVGTLGYMAPEYAWTGMFS 674
Query: 613 IKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSA 672
K+D++SFGVL+LEI+SG+K + LI YAW+ D G++L+D + C
Sbjct: 675 EKSDIYSFGVLMLEIISGEKISRFSYGKEEKTLIAYAWESWCDTGGIDLLDKDVADSCRP 734
Query: 673 NEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETMPLPPPKQPAFFINANADDQVPE-- 730
EV RC+ +GLLCVQ Q DRP E++ ML T LPPP+QP F ++ D E
Sbjct: 735 LEVERCVQIGLLCVQHQPADRPNTLELLSMLTT-TSDLPPPEQPTFVVHRRDDKSSSEDL 793
Query: 731 VPDNEVAK 738
+ NE+ K
Sbjct: 794 ITVNEMTK 801
|
|
| UNIPROTKB|O49974 KIK1 "Serine/threonine-protein kinase" [Zea mays (taxid:4577)] | Back alignment and assigned GO terms |
|---|
Score = 1003 (358.1 bits), Expect = 4.5e-122, Sum P(2) = 4.5e-122
Identities = 230/520 (44%), Positives = 309/520 (59%)
Query: 260 GCWNQLPRPICRKGTGPENFQSKVGLISEHGFKFKESDNMSSTDCRANCFYNCSCIAFA- 318
GC P C + F +G I F + S CR C NCSC A+
Sbjct: 344 GCIRSPPLG-CETNQSGDGFLP-MGNIKWPDFSYWVSTVGDEPGCRTVCLNNCSCGAYVY 401
Query: 319 TGTS-------EYTDKQ-----AYC-EIWSEGTEFT------EIASNNSREI-FILAIKE 358
T T+ E D AY + +E +IA+ S + F+LA
Sbjct: 402 TATTGCLAWGNELIDMHELQTGAYTLNLKLPASELRGHHPIWKIATIISAIVLFVLAACL 461
Query: 359 EKWWRSLTIAIGVVLGIPLLCYLCYVTWRK----LKAKDNVSLLP-TYGKRKSPEKDQSI 413
WW+ V G +WR +++ N ++L + R + +
Sbjct: 462 LLWWKHGRNIKDAVHG----------SWRSRHSSTQSQQNSAMLDISQSIRFDDDVEDGK 511
Query: 414 SHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEF 473
SHELK++ I A +NFS +NKLGEGGFGPVY G L +EVA+KRL R+SGQG+ EF
Sbjct: 512 SHELKVYSLDRIRTATSNFSDSNKLGEGGFGPVYMGTLPGGEEVAVKRLCRNSGQGLEEF 571
Query: 474 KNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFI 533
KNEV LIAKLQH NLVRLLGC + EE++LVYE+MPNKSLD FLFN ++ +L+W+KRF
Sbjct: 572 KNEVILIAKLQHRNLVRLLGCCIPREEKILVYEYMPNKSLDAFLFNPEKQRLLDWKKRFD 631
Query: 534 IIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKR 593
IIEGI++GLLYLH+ SRLRV+HRDLKASNILLD M PKISDFGMAR+F ++++ NT R
Sbjct: 632 IIEGIARGLLYLHRDSRLRVVHRDLKASNILLDADMKPKISDFGMARMFGGDQNQFNTNR 691
Query: 594 IVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLL 653
+VGT+GYMSPEYAM GI S+K+DV+ FGVL+LEI++G++ + H + LN+ GYAW+
Sbjct: 692 VVGTFGYMSPEYAMEGIFSVKSDVYGFGVLILEIITGKRAVSFHCHEDSLNIAGYAWRQW 751
Query: 654 SDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETMPLPPP 713
++ ELIDP + CS +V+RCIH+ LLCVQD A +RP +P V+ ML N++ LP P
Sbjct: 752 NEDNAAELIDPVIRASCSVRQVLRCIHIALLCVQDHADERPDIPTVILMLSNDSSSLPNP 811
Query: 714 KQPAFFINANADDQVPEVPDNEVAK-FSTNDVTMTTMEAR 752
+ P + ++ +E + S VTMT + R
Sbjct: 812 RPPTLMLRGR---EIESSKSSEKDRSHSIGTVTMTQLHGR 848
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9LW83 | CE101_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.4456 | 0.9640 | 0.8529 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00034405001 | SubName- Full=Chromosome chr9 scaffold_7, whole genome shotgun sequence; (770 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 752 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-50 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-49 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-49 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-48 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-46 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-46 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-45 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-36 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-34 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-33 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-32 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 9e-32 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 9e-31 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-30 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-30 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-30 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-30 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-29 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-29 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 4e-29 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-29 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 8e-29 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-28 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-28 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-28 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-27 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-26 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-26 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 6e-26 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-26 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 8e-26 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-25 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-25 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-25 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-24 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-24 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-24 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-24 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-24 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 7e-24 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 9e-24 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-23 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-23 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-23 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-23 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 3e-23 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-22 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-22 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-22 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-22 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 2e-22 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-22 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-22 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-22 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-22 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-22 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-22 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-22 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 9e-22 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 9e-22 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-21 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-21 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-21 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-21 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-21 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-21 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-21 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-21 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-21 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 8e-21 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-20 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-20 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-20 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-20 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-20 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-20 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-20 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-20 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-20 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-20 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-20 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-20 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-20 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-20 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-20 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-20 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 7e-20 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 7e-20 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 9e-20 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-19 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-19 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-19 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-19 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-19 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-19 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-19 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-19 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-19 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 8e-19 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-18 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-18 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-18 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-18 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-18 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-18 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-18 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-18 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-18 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-18 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-18 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 5e-18 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 8e-18 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-17 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-17 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-17 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-17 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-17 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-17 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-17 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-17 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-17 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-17 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 6e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-17 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 6e-17 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 8e-17 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 8e-17 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 9e-17 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-16 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-16 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-16 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-16 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-16 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-16 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-16 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-16 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-16 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-16 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-16 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-16 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 7e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 8e-16 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 9e-16 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 9e-16 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-15 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-15 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-15 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-15 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-15 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-15 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-15 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-15 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-15 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-15 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-15 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-15 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-15 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-15 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-15 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-15 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-15 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-15 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 9e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 9e-15 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-14 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-14 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-14 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-14 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-14 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-14 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-14 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-14 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-14 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 7e-14 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 7e-14 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 8e-14 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-13 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-13 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-13 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-13 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-13 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-12 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-12 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-12 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 7e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 8e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 9e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 9e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-11 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-11 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-11 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-11 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-11 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 8e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 9e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-10 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-10 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-10 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-10 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-10 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-10 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-10 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 5e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 8e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 9e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 9e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-09 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 5e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 8e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 9e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 9e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 9e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-08 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-08 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 6e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-07 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-07 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-07 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-07 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 3e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 7e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-06 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 6e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 6e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 7e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 8e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 9e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 1e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-05 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 7e-05 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 5e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 6e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 7e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 0.001 | |
| pfam08276 | 66 | pfam08276, PAN_2, PAN-like domain | 0.001 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 0.003 | |
| smart00605 | 94 | smart00605, CW, CW domain | 0.004 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 175 bits (447), Expect = 4e-50
Identities = 92/281 (32%), Positives = 133/281 (47%), Gaps = 43/281 (15%)
Query: 437 KLGEGGFGPVYKGKL-----ADEQEVAIKRL-SRSSGQGIVEFKNEVRLIAKLQHTNLVR 490
KLGEG FG VYKGKL + EVA+K L +S Q I EF E R++ KL H N+V+
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 491 LLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSR 550
LLG E +V E+M L +L + L+ I++G+ YL
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE---S 120
Query: 551 LRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT---YGYMSPEYAM 607
IHRDL A N L+ + + KISDFG++R + + + R G +M+PE
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYRKRGGKLPIRWMAPESLK 176
Query: 608 SGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666
G + K+DV+SFGVL+ EI + G++ +P + + L +G L
Sbjct: 177 EGKFTSKSDVWSFGVLLWEIFTLGEQP----YPGMSNEEV---LEYLKNGY-------RL 222
Query: 667 EQP--CSAN--EVMRCIHVGLLCVQDQAMDRPTMPEVVCML 703
QP C ++M C + DRPT E+V +L
Sbjct: 223 PQPPNCPPELYDLMLQ------CWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 174 bits (444), Expect = 1e-49
Identities = 93/281 (33%), Positives = 136/281 (48%), Gaps = 42/281 (14%)
Query: 437 KLGEGGFGPVYKGKLAD-----EQEVAIKRL-SRSSGQGIVEFKNEVRLIAKLQHTNLVR 490
KLGEG FG VYKG L E EVA+K L +S Q I EF E R++ KL H N+V+
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 491 LLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSR 550
LLG E ++V E+MP L +L + R L+ I++G+ YL
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRKN-RPKELSLSDLLSFALQIARGMEYLE---S 121
Query: 551 LRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT---YGYMSPEYAM 607
IHRDL A N L+ + + KISDFG++R + + + ++ G +M+PE
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYKVKGGKLPIRWMAPESLK 177
Query: 608 SGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666
G + K+DV+SFGVL+ EI + G++ P ++ + L G L
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFTLGEE------PYPGMSNA-EVLEYLKKGY-------RL 223
Query: 667 EQP--CSAN--EVMRCIHVGLLCVQDQAMDRPTMPEVVCML 703
+P C ++M L C + DRPT E+V +L
Sbjct: 224 PKPPNCPPELYKLM------LQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 5e-49
Identities = 70/194 (36%), Positives = 106/194 (54%), Gaps = 11/194 (5%)
Query: 438 LGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAKLQHTNLVRLLGCS 495
LGEGGFG VY + ++VAIK + + ++E E+ ++ KL H N+V+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 496 LHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIH 555
LV E+ SL L + L+ ++ I+ I +GL YLH +IH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKE--NEGKLSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 556 RDLKASNILLD-DKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMS-GIVSI 613
RDLK NILLD D K++DFG++++ ++S T IVGT YM+PE + G S
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSE 173
Query: 614 KTDVFSFGVLVLEI 627
K+D++S GV++ E+
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 2e-48
Identities = 94/292 (32%), Positives = 134/292 (45%), Gaps = 53/292 (18%)
Query: 436 NKLGEGGFGPVYKGKL----ADEQEVAIKRLSRS-SGQGIVEFKNEVRLIAKLQHTNLVR 490
KLGEG FG VYKGKL EVA+K L S + +F E R++ KL H N+VR
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 491 LLGCSLHGEERLLVYEFMPNKSLDFFL------FNSGRKNVLNWEKRFIIIEGISQGLLY 544
LLG E LV E+M L +L F S K+ L+ + I++G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 545 LHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR-IFEVNESEANTKRIVGTYGYMSP 603
L + +HRDL A N L+ + + KISDFG++R +++ + T + +M+P
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAP 176
Query: 604 EYAMSGIVSIKTDVFSFGVLVLEIVS-------GQKNHTRHHPDRPLNLIGYAWQLLSDG 656
E GI + K+DV+SFGVL+ EI + G N ++ + L G
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE---------EVL----EYLRKG 223
Query: 657 KGLELIDPSLEQP--CSAN--EVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ 704
L +P C E+M C Q DRPT E+V L+
Sbjct: 224 Y-------RLPKPEYCPDELYELMLS------CWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 1e-46
Identities = 73/200 (36%), Positives = 105/200 (52%), Gaps = 14/200 (7%)
Query: 437 KLGEGGFGPVYKGK-LADEQEVAIKRL---SRSSGQGIVEFKNEVRLIAKLQHTNLVRLL 492
KLG G FG VYK K + VA+K L S S + + E+R++ +L H N+VRL+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQ-TARREIRILRRLSHPNIVRLI 64
Query: 493 GCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLR 552
+ LV E+ L +L G L+ ++ I I +GL YLH
Sbjct: 65 DAFEDKDHLYLVMEYCEGGDLFDYLSRGGP---LSEDEAKKIALQILRGLEYLH---SNG 118
Query: 553 VIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGI-V 611
+IHRDLK NILLD+ KI+DFG+A+ + S T VGT YM+PE + G
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT--FVGTPWYMAPEVLLGGNGY 176
Query: 612 SIKTDVFSFGVLVLEIVSGQ 631
K DV+S GV++ E+++G+
Sbjct: 177 GPKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 164 bits (419), Expect = 3e-46
Identities = 94/281 (33%), Positives = 132/281 (46%), Gaps = 42/281 (14%)
Query: 437 KLGEGGFGPVYKGKL-----ADEQEVAIKRLSRSSG-QGIVEFKNEVRLIAKLQHTNLVR 490
KLGEG FG VYKG L E +VA+K L + + EF E ++ KL H N+VR
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 491 LLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSR 550
LLG GE +V E+MP L FL G K L + + I++G+ YL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEK--LTLKDLLQMALQIAKGMEYLE---S 120
Query: 551 LRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG---YMSPEYAM 607
+HRDL A N L+ + + KISDFG++R ++ E + KR G +M+PE
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSR--DIYEDDYYRKR-GGGKLPIKWMAPESLK 177
Query: 608 SGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666
G + K+DV+SFGVL+ EI + G++ +P + L + L
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGEQ----PYPGMSNEEV--LELLEDGYR--------L 223
Query: 667 EQP--CSAN--EVMRCIHVGLLCVQDQAMDRPTMPEVVCML 703
+P C E+M L C DRPT E+V L
Sbjct: 224 PRPENCPDELYELM------LQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 3e-45
Identities = 68/203 (33%), Positives = 104/203 (51%), Gaps = 13/203 (6%)
Query: 432 FSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAKLQHTNLV 489
+ KLGEG FG VY + + VAIK + + + E E++++ KL+H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLN-WEKRFIIIEGISQGLLYLHKY 548
RL ++ LV E+ L L GR L+ E RF + + I L YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGR---LSEDEARFYLRQ-ILSALEYLHS- 115
Query: 549 SRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMS 608
++HRDLK NILLD+ + K++DFG+AR + E VGT YM+PE +
Sbjct: 116 --KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGE---KLTTFVGTPEYMAPEVLLG 170
Query: 609 GIVSIKTDVFSFGVLVLEIVSGQ 631
D++S GV++ E+++G+
Sbjct: 171 KGYGKAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 66/217 (30%), Positives = 105/217 (48%), Gaps = 9/217 (4%)
Query: 432 FSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVR 490
F K+G+GGFG VYK + +EVAIK + S + + NE++++ K +H N+V+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 491 LLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSR 550
G L +E +V EF SL L L + + + + +GL YLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLL--KSTNQTLTESQIAYVCKELLKGLEYLHSN-- 117
Query: 551 LRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGI 610
+IHRD+KA+NILL K+ DFG++ +VGT +M+PE
Sbjct: 118 -GIIHRDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNTMVGTPYWMAPEVINGKP 173
Query: 611 VSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIG 647
K D++S G+ +E+ G+ ++ P + L I
Sbjct: 174 YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIA 210
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 64/226 (28%), Positives = 106/226 (46%), Gaps = 26/226 (11%)
Query: 436 NKLGEGGFGPVYKGKLADE-QEVAIK--RLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLL 492
LG G FG VY D + +A+K LS S + + + E+R+++ LQH N+VR
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 493 GCSLHGEER-LLVY-EFMPNKSLDFFLFNSGR---KNVLNWEKRFIIIEGISQGLLYLHK 547
G E+ L ++ E++ SL L G+ + + ++ I +GL YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQ------ILEGLAYLH- 118
Query: 548 YSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM 607
++HRD+K +NIL+D K++DFG A+ E+ T + GT +M+PE
Sbjct: 119 --SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 608 SGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLL 653
D++S G V+E+ +G+ P + +G L
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGK---------PPWSELGNPMAAL 213
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 75/277 (27%), Positives = 131/277 (47%), Gaps = 21/277 (7%)
Query: 436 NKLGEGGFGPVYKGKLADEQ-----EVAIKRLSRSSG-QGIVEFKNEVRLIAKLQHTNLV 489
+LGEG FG V + +VA+K L+ S Q +F+ E+ ++ L H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 490 RLLGCS--LHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHK 547
+ G G L+ E++P+ SL +L ++ +N ++ + I +G+ YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLGS 127
Query: 548 YSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE----ANTKRIVGTYGYMSP 603
R IHRDL A NIL++ + KISDFG+A++ + E + + Y +P
Sbjct: 128 ---QRYIHRDLAARNILVESEDLVKISDFGLAKV--LPEDKDYYYVKEPGESPIFWY-AP 181
Query: 604 EYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELID 663
E + S +DV+SFGV + E+ + + ++ P L +IG A + + LEL+
Sbjct: 182 ECLRTSKFSSASDVWSFGVTLYELFT-YGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240
Query: 664 PSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVV 700
P + + LC + + DRP+ +++
Sbjct: 241 EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLI 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 7e-32
Identities = 70/196 (35%), Positives = 101/196 (51%), Gaps = 12/196 (6%)
Query: 437 KLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSL 496
KLG G FG V+ G +VA+K L + F E +++ KL+H LV+L
Sbjct: 13 KLGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS 71
Query: 497 HGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHR 556
E +V E+M SL FL SG L + + I++G+ YL IHR
Sbjct: 72 EEEPIYIVTEYMSKGSLLDFL-KSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHR 127
Query: 557 DLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT---YGYMSPEYAMSGIVSI 613
DL A NIL+ + + KI+DFG+AR+ E +E A G + +PE A G +I
Sbjct: 128 DLAARNILVGENLVCKIADFGLARLIEDDEYTARE----GAKFPIKWTAPEAANYGRFTI 183
Query: 614 KTDVFSFGVLVLEIVS 629
K+DV+SFG+L+ EIV+
Sbjct: 184 KSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 9e-32
Identities = 65/205 (31%), Positives = 106/205 (51%), Gaps = 13/205 (6%)
Query: 431 NFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRS--SGQGIVEFKNEVRLIAKLQHTN 487
N+ + +G G FG VYKG L VAIK++S + + E+ L+ L+H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 488 LVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHK 547
+V+ +G + ++ E+ N SL + G + + + QGL YLH+
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGP---FPESLVAVYVYQVLQGLAYLHE 117
Query: 548 YSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPE-YA 606
VIHRD+KA+NIL K++DFG+A ++N+ + +VGT +M+PE
Sbjct: 118 QG---VIHRDIKAANILTTKDGVVKLADFGVAT--KLNDVSKDDASVVGTPYWMAPEVIE 172
Query: 607 MSGIVSIKTDVFSFGVLVLEIVSGQ 631
MSG S +D++S G V+E+++G
Sbjct: 173 MSG-ASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 9e-31
Identities = 85/283 (30%), Positives = 136/283 (48%), Gaps = 55/283 (19%)
Query: 438 LGEGGFGPVYKGKLADEQE-----VAIKRLSRSSG-QGIVEFKNEVRLIAKLQHTNLVRL 491
LG G FG VYKG E E VAIK L + + E +E ++A + H ++VRL
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 492 LGCSLHGEERLLVYEFMPNKSLDFFLFNS----GRKNVLNWEKRFIIIEGISQGLLYLHK 547
LG L + L+ + MP L ++ N G + +LNW + I++G+ YL +
Sbjct: 75 LGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLEE 127
Query: 548 YSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM 607
R++HRDL A N+L+ + KI+DFG+A++ +V+E E + + +M+ E +
Sbjct: 128 K---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL 184
Query: 608 SGIVSIKTDVFSFGVLVLEIVS-GQKNH----TRHHPDRPLNLIGYAWQLLSDGKGLELI 662
I + K+DV+S+GV V E+++ G K + PD LL G+
Sbjct: 185 HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPD-----------LLEKGE----- 228
Query: 663 DPSLEQP--CSANEVM---RCIHVGLLCVQDQAMDRPTMPEVV 700
L QP C+ + M +C + D RPT E++
Sbjct: 229 --RLPQPPICTIDVYMVLVKCWMI------DAES-RPTFKELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 124 bits (311), Expect = 1e-30
Identities = 82/326 (25%), Positives = 133/326 (40%), Gaps = 22/326 (6%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSR---SSGQGIVEFKNEVRLIAKLQHT- 486
++ KLGEG FG VY + D + VA+K L++ S + + F E++++A L H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 487 NLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLH 546
N+V+L LV E++ SL+ L GRK L+ + I+ I L YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 547 KYSRLRVIHRDLKASNILLD-DKMNPKISDFGMARIFEVNESEAN----TKRIVGTYGYM 601
+IHRD+K NILLD D K+ DFG+A++ S ++ VGT GYM
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 602 SPEYAMSGI---VSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKG 658
+PE + S +D++S G+ + E+++G + +L
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLK--IILELPTP 233
Query: 659 LELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM-LQNETMPLPPPKQPA 717
S P ++ + LL +R + + L
Sbjct: 234 SLASPLSPSNPELISKAASDLLKKLLAK--DPKNRLSSSSDLSHDLLAHLKLKESDLSDL 291
Query: 718 FFINANADDQVPEVPDNEVAKFSTND 743
+ +A ++ P E S N
Sbjct: 292 LKPDDSAPLRLSLPPSLEALISSLNS 317
|
Length = 384 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 73/239 (30%), Positives = 113/239 (47%), Gaps = 33/239 (13%)
Query: 421 DFQTIAAAANNFSTTNKLGEGGFGPVYKGK-LADEQEVAIK--RLSRSSGQGIVEFKNEV 477
D + + K+GEG G VYK A +EVAIK RL + + + I+ NE+
Sbjct: 10 DIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII---NEI 66
Query: 478 RLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEG 537
++ +H N+V L G+E +V E+M SL +++ + E
Sbjct: 67 LIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSL---------TDIITQ-NFVRMNEP 116
Query: 538 --------ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEA 589
+ QGL YLH VIHRD+K+ NILL + K++DFG F ++
Sbjct: 117 QIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFG----FAAQLTKE 169
Query: 590 NTKR--IVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLI 646
+KR +VGT +M+PE K D++S G++ +E+ G+ + R P R L LI
Sbjct: 170 KSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLI 228
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 68/199 (34%), Positives = 109/199 (54%), Gaps = 8/199 (4%)
Query: 432 FSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRL 491
F+ KLG G FG V++G + VAIK L +F+ EV+ + +L+H +L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 492 LG-CSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSR 550
CS+ GE ++ E M SL FL S VL + +++G+ YL +
Sbjct: 68 FAVCSV-GEPVYIITELMEKGSLLAFL-RSPEGQVLPVASLIDMACQVAEGMAYLEEQ-- 123
Query: 551 LRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGI 610
IHRDL A NIL+ + + K++DFG+AR+ + + ++ K+I Y + +PE A G
Sbjct: 124 -NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGT 180
Query: 611 VSIKTDVFSFGVLVLEIVS 629
S K+DV+SFG+L+ E+ +
Sbjct: 181 FSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 4e-30
Identities = 56/213 (26%), Positives = 101/213 (47%), Gaps = 33/213 (15%)
Query: 436 NKLGEGGFGPVYKGK-LADEQEVAIKR--LSRSSGQGIVEFKNEVRLIAKLQHTNLVRLL 492
++G+G FG VY + +D + +K LS S + + NEV+++ KL H N+++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 493 GCSLHGEERLLVYEFMPNKSLDFFLFNSGRKN-------VLNWEKRFIIIEGISQGLLYL 545
+ +V E+ L + ++ +L+W F+ + L YL
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDW---FV---QLCLALKYL 119
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPE- 604
H SR +++HRD+K NI L K+ DFG++++ A T +VGT Y+SPE
Sbjct: 120 H--SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYYLSPEL 174
Query: 605 -----YAMSGIVSIKTDVFSFGVLVLEIVSGQK 632
Y + K+D++S G ++ E+ + +
Sbjct: 175 CQNKPY------NYKSDIWSLGCVLYELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 67/204 (32%), Positives = 103/204 (50%), Gaps = 24/204 (11%)
Query: 438 LGEGGFGPVYKGKLADEQEV-AIKRLSRSSGQGIVEFK------NEVRLIAKLQHTNLVR 490
LG+G FG V + D ++ A+K L + I++ K E +++++ H +V+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKK---IIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 491 LLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEK--RFIIIEGISQGLLYLHK 547
L + EE+L LV E+ P L L GR + E+ RF E I L YLH
Sbjct: 58 LH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFS----EERARFYAAE-IVLALEYLH- 110
Query: 548 YSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM 607
L +I+RDLK NILLD + K++DFG+A+ S NT GT Y++PE +
Sbjct: 111 --SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVLL 166
Query: 608 SGIVSIKTDVFSFGVLVLEIVSGQ 631
D +S GVL+ E+++G+
Sbjct: 167 GKGYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 65/192 (33%), Positives = 102/192 (53%), Gaps = 11/192 (5%)
Query: 438 LGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLH 497
+G+G FG V G Q+VA+K L S F E ++ L+H NLV+LLG L
Sbjct: 14 IGKGEFGDVMLGDYRG-QKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 498 GEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRD 557
G +V E+M SL +L + GR V+ ++ + +G+ YL + +HRD
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGRA-VITLAQQLGFALDVCEGMEYLEEK---NFVHRD 127
Query: 558 LKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDV 617
L A N+L+ + + K+SDFG+A+ E ++ + + K V + +PE S K+DV
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAK--EASQGQDSGKLPV---KWTAPEALREKKFSTKSDV 182
Query: 618 FSFGVLVLEIVS 629
+SFG+L+ EI S
Sbjct: 183 WSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 4e-29
Identities = 48/113 (42%), Positives = 61/113 (53%), Gaps = 7/113 (6%)
Query: 54 PIWIANRNTPILDQSGVLTIDSIDGNLKILHNGGNPIAVSSVEGASNNTSATLLQSGNLV 113
+W+ANR P+ D S L + S DGNL + G + S+ G + A L GNLV
Sbjct: 4 VVWVANRLNPLTDSSYTLILQS-DGNLVLYDGNGRVVWSSNTSGKGSGCVAVLQDDGNLV 62
Query: 114 LREMDTDGTIKRVLWQSFDYPTDTLLPGMKLGINLQTGHQWFLQSWLDYSSPA 166
L D G +VLWQSFD+PTDTLLPG K G N+ G L SW + P+
Sbjct: 63 LY--DNSG---KVLWQSFDHPTDTLLPGQKDG-NVVIGGSRRLTSWKSNTDPS 109
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 6e-29
Identities = 75/272 (27%), Positives = 127/272 (46%), Gaps = 27/272 (9%)
Query: 437 KLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSL 496
KLG G FG V++G + VA+K L + +F E +++ KL+H L++L
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 497 HGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHR 556
E +V E M SL +L + L + + ++ G+ YL + IHR
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRA-LKLPQLIDMAAQVASGMAYLEAQN---YIHR 127
Query: 557 DLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT---YGYMSPEYAMSGIVSI 613
DL A N+L+ + K++DFG+AR+ + + EA G + +PE A+ SI
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDIYEARE----GAKFPIKWTAPEAALYNRFSI 183
Query: 614 KTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSAN 673
K+DV+SFG+L+ EIV+ + R + Y +++ + L+ +D PC
Sbjct: 184 KSDVWSFGILLTEIVT----YGR---------MPYPG--MTNAEVLQQVDQGYRMPCPPG 228
Query: 674 EVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
+ L C ++ DRPT + L++
Sbjct: 229 CPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 8e-29
Identities = 73/201 (36%), Positives = 104/201 (51%), Gaps = 9/201 (4%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLV 489
KLG G FG V+ G +VAIK L + S F E L+ +LQH LV
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLV 64
Query: 490 RLLGCSLHGEERLLVYEFMPNKSL-DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
RL + E ++ E+M N SL DF G K L K + I++G+ ++
Sbjct: 65 RLYAV-VTQEPIYIITEYMENGSLVDFLKTPEGIK--LTINKLIDMAAQIAEGMAFIE-- 119
Query: 549 SRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMS 608
R IHRDL+A+NIL+ + + KI+DFG+AR+ E NE A + +PE
Sbjct: 120 -RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKF-PIKWTAPEAINY 177
Query: 609 GIVSIKTDVFSFGVLVLEIVS 629
G +IK+DV+SFG+L+ EIV+
Sbjct: 178 GTFTIKSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 70/213 (32%), Positives = 109/213 (51%), Gaps = 25/213 (11%)
Query: 438 LGEGGFGPVYKGKLADE------QEVAIKRLSRS-SGQGIVEFKNEVRLIAKLQHTNLVR 490
LGEG FG VYKG+L VAIK L + + EF+ E L++ LQH N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 491 LLGCSLHGEERLLVYEFMPNKSLDFFL----------FNSGRKNVLN--WEKRFI-IIEG 537
LLG + +++E++ + L FL SG + V + F+ I
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 538 ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR-IFEVNESEANTKRIVG 596
I+ G+ YL S +HRDL A N L+ + + KISDFG++R I+ + +K ++
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 597 TYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+M PE + G + ++D++SFGV++ EI S
Sbjct: 190 VR-WMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 85/294 (28%), Positives = 143/294 (48%), Gaps = 49/294 (16%)
Query: 429 ANNFSTTNKLGEGGFGPVYKG--KLADEQE--VAIKRL-SRSSGQGIVEFKNEVRLIAKL 483
+ + +G G FG V +G KL ++E VAIK L + SS + ++F E ++ +
Sbjct: 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQF 62
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKN--VLNWEKRFIIIEGISQG 541
H N++RL G +++ E+M N SLD FL R+N + ++ GI+ G
Sbjct: 63 DHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFL----RENDGKFTVGQLVGMLRGIASG 118
Query: 542 LLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTK--RIVGTYG 599
+ YL S + +HRDL A NIL++ + K+SDFG++R E +E+ TK +I
Sbjct: 119 MKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKI--PIR 173
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQL------- 652
+ +PE + +DV+SFG+++ E++S + +RP Y W +
Sbjct: 174 WTAPEAIAYRKFTSASDVWSFGIVMWEVMS--------YGERP-----Y-WDMSNQDVIK 219
Query: 653 -LSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
+ DG L P ++ P + ++M L C Q +RPT ++V L
Sbjct: 220 AVEDGYRLP---PPMDCPSALYQLM------LDCWQKDRNERPTFSQIVSTLDK 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 66/231 (28%), Positives = 106/231 (45%), Gaps = 26/231 (11%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQE-VAIKRLSRSSGQGIVEFK----NEVRLIAKLQ 484
++ LG+G G VYK + + A+K++ G EF+ E++ + +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIH---VDGDEEFRKQLLRELKTLRSCE 57
Query: 485 HTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFI--IIEGISQGL 542
+V+ G E +V E+M SL L K V + + I I +GL
Sbjct: 58 SPYVVKCYGAFYKEGEISIVLEYMDGGSLADLL-----KKVGKIPEPVLAYIARQILKGL 112
Query: 543 LYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMS 602
YLH + +IHRD+K SN+L++ K KI+DFG++++ E + NT VGT YMS
Sbjct: 113 DYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT--FVGTVTYMS 168
Query: 603 PEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLL 653
PE S D++S G+ +LE G P P + ++L+
Sbjct: 169 PERIQGESYSYAADIWSLGLTLLECALG------KFPFLPPGQPSF-FELM 212
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 83/296 (28%), Positives = 132/296 (44%), Gaps = 60/296 (20%)
Query: 438 LGEGGFGPVYKGKLAD------EQEVAIKRLS-RSSGQGIVEFKNEVRLIAKLQHTNLVR 490
LG+G FG VY+G E VAIK ++ +S + +EF NE ++ + ++VR
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 491 LLGCSLHGEERLLVYEFMPNKSLDFFL--------FNSG-----RKNVLNWEKRFIIIEG 537
LLG G+ L+V E M L +L N G + + E
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQM-----AAE- 127
Query: 538 ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR-IFEVNESEANTKRIVG 596
I+ G+ YL + +HRDL A N ++ + + KI DFGM R I+E + K ++
Sbjct: 128 IADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLP 184
Query: 597 TYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-------GQKNHTRHHPDRPLNLIGYA 649
+M+PE G+ + K+DV+SFGV++ E+ + G N + L +
Sbjct: 185 VR-WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN------EEVLKFVI-- 235
Query: 650 WQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
DG L+L + + E+MR +C Q RPT E+V L++
Sbjct: 236 -----DGGHLDLPE-NCPDKLL--ELMR------MCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 88/298 (29%), Positives = 126/298 (42%), Gaps = 52/298 (17%)
Query: 431 NFSTTNKLGEGGFGPVYKGKL------ADEQEVAIKRL-SRSSGQGIVEFKNEVRLIAKL 483
+ + LG G FG VY+G A E +VA+K L S Q +F E +++K
Sbjct: 7 SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF 66
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLF----NSGRKNVLNWEKRFIIIEGIS 539
H N+VRL+G S R ++ E M L FL R + L + ++
Sbjct: 67 NHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVA 126
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNP----KISDFGMARIFEVNESEANTK--R 593
+G YL + IHRD+ A N LL K P KI+DFGMAR ++ + K R
Sbjct: 127 KGCKYLEEN---HFIHRDIAARNCLLTCK-GPGRVAKIADFGMAR--DIYRASYYRKGGR 180
Query: 594 IVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGY----- 648
+ +M PE + GI + KTDV+SFGVL+ EI S L + Y
Sbjct: 181 AMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS-------------LGYMPYPGRTN 227
Query: 649 --AWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ 704
+ ++ G L DP P +M C Q DRP ++ +Q
Sbjct: 228 QEVMEFVTGGGRL---DPPKGCPGPVYRIMT------DCWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 77/294 (26%), Positives = 128/294 (43%), Gaps = 52/294 (17%)
Query: 438 LGEGGFGPVYKGKLA------DEQEVAIKRLSRSSGQGIVE-FKNEVRLIAKLQHTNLVR 490
LGEG FG V+ G+ D++ VA+K L ++ + F+ E L+ QH N+V+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 491 LLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNV-----------LNWEKRFIIIEGIS 539
G G+ ++V+E+M + L+ FL + G L + I I+
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT-- 597
G++YL + +HRDL N L+ + KI DFGM+R + R+ G
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTD----YYRVGGHTM 185
Query: 598 --YGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSD 655
+M PE M + ++DV+SFGV++ EI + K +P W LS+
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGK--------QP-------WYGLSN 230
Query: 656 GKGLELIDPS--LEQP--CSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
+ +E I L++P C + + L C + R + ++ LQ
Sbjct: 231 EEVIECITQGRLLQRPRTCPSE----VYDIMLGCWKRDPQQRINIKDIHERLQK 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 6e-26
Identities = 63/217 (29%), Positives = 106/217 (48%), Gaps = 12/217 (5%)
Query: 432 FSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVR 490
F KLGEG +G VYK Q VAIK + + + E E+ ++ + +V+
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVK 62
Query: 491 LLGCSLHGEERLLVYEFMPNKS-LDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
G + +V E+ S D + K L E+ I+ +GL YLH
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSD--IMKITNK-TLTEEEIAAILYQTLKGLEYLHS-- 117
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSG 609
+ IHRD+KA NILL+++ K++DFG++ ++ NT ++GT +M+PE
Sbjct: 118 -NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGTPFWMAPEVIQEI 174
Query: 610 IVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLI 646
+ K D++S G+ +E+ G+ ++ HP R + +I
Sbjct: 175 GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI 211
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 6e-26
Identities = 71/211 (33%), Positives = 95/211 (45%), Gaps = 28/211 (13%)
Query: 436 NKLGEGGFGPVYKGKL----ADEQEVAIKRLSRS-SGQGIVEFKNEVRLIAKLQHTNLVR 490
+LG G FG V KG E EVA+K L + G EF E ++A+L H +VR
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 491 LLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQ---GLLYLHK 547
L+G GE +LV E P L +L V + + E Q G+ YL
Sbjct: 61 LIGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSD------LKELAHQVAMGMAYLES 113
Query: 548 YSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG-----YMS 602
+HRDL A N+LL ++ KISDFGM+R T G + +
Sbjct: 114 ---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT----TAGRWPLKWYA 166
Query: 603 PEYAMSGIVSIKTDVFSFGVLVLEIVS-GQK 632
PE G S K+DV+S+GV + E S G K
Sbjct: 167 PECINYGKFSSKSDVWSYGVTLWEAFSYGAK 197
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 8e-26
Identities = 68/228 (29%), Positives = 104/228 (45%), Gaps = 35/228 (15%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSSGQGIVEFK-----NEVRLIAKL 483
++F +GEG F V K +E AIK L + Q I E K E ++ +L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKR--QLIKEKKVKYVKIEKEVLTRL 58
Query: 484 -QHTNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQG 541
H +++L + EE L V E+ PN L ++ G + RF E I
Sbjct: 59 NGHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKC--TRFYAAE-ILLA 114
Query: 542 LLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIF---------------EVNE 586
L YLH +IHRDLK NILLD M+ KI+DFG A++ ++
Sbjct: 115 LEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171
Query: 587 SEANTKR---IVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
E N +R VGT Y+SPE +D+++ G ++ ++++G+
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 83/261 (31%), Positives = 131/261 (50%), Gaps = 25/261 (9%)
Query: 437 KLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSL 496
KLG G FG V+ G + +VA+K L + + F E L+ LQH LVRL
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 497 HGEERLLVYEFMPNKSL-DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIH 555
E ++ E+M SL DF + G K +L K I++G+ Y+ + + IH
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIERKN---YIH 126
Query: 556 RDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKT 615
RDL+A+N+L+ + + KI+DFG+AR+ E NE A + +PE G +IK+
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSFTIKS 185
Query: 616 DVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQ-PCSANE 674
DV+SFG+L+ EIV+ K +P + + A Q +G + P +E P +
Sbjct: 186 DVWSFGILLYEIVTYGK---IPYPGMSNSDVMSALQ-----RGYRM--PRMENCPDELYD 235
Query: 675 VMRCIHVGLLCVQDQAMDRPT 695
+M+ C +++A +RPT
Sbjct: 236 IMK------TCWKEKAEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 65/215 (30%), Positives = 108/215 (50%), Gaps = 34/215 (15%)
Query: 432 FSTTNKLGEGGFGPVYKGK-LADEQEVAIKRL-SRSSGQGIVEFKN---EVRLIAKLQHT 486
+ KLGEG +G VYK + + VA+K++ + +GI E+ L+ +L+H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGI--PSTALREISLLKELKHP 58
Query: 487 NLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFI--IIEGISQGLL 543
N+V+LL +H E +L LV+E+ + L +L N K + ++ G++
Sbjct: 59 NIVKLL-DVIHTERKLYLVFEYC-DMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLA---- 112
Query: 544 YLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSP 603
Y H S R++HRDLK NIL++ K++DFG+AR F + T +V T Y +P
Sbjct: 113 YCH--SH-RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TYTHEVV-TLWYRAP 167
Query: 604 E-------YAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
E Y S D++S G + E+++G+
Sbjct: 168 EILLGSKHY------STAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 69/212 (32%), Positives = 112/212 (52%), Gaps = 15/212 (7%)
Query: 431 NFSTTNKLGEGGFGPVYKG-KLADEQEVAIKR--LSRSSGQGIVEFKNEVRLIAKLQHTN 487
+F NK+G+G FG V+K + AD++ A+K+ LS+ + + E +E R++AKL +
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 488 LVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHK 547
++R L + +V E+ N L L R L ++ + I GL +LH
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLL-KMQRGRPLPEDQVWRFFIQILLGLAHLHS 119
Query: 548 YSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM 607
+++HRD+K+ N+ LD N KI D G+A++ N + ANT IVGT Y+SPE
Sbjct: 120 K---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPELCE 174
Query: 608 SGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHP 639
+ K+DV++ GV++ E +G HP
Sbjct: 175 DKPYNEKSDVWALGVVLYECCTG------KHP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 98/315 (31%), Positives = 148/315 (46%), Gaps = 63/315 (20%)
Query: 438 LGEGGFGPVYKGKLADEQE-----VAIKRLSRSSG-QGIVEFKNEVRLIAKLQHTNLVRL 491
LG G FG VYKG E E VAIK L+ ++G + VEF +E ++A + H +LVRL
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 492 LGCSLHGEERLLVYEFMPNKSLDFFLF----NSGRKNVLNWEKRFIIIEGISQGLLYLHK 547
LG L +L V + MP+ L ++ N G + +LNW + I++G++YL +
Sbjct: 75 LGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 127
Query: 548 YSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM 607
R++HRDL A N+L+ + KI+DFG+AR+ E +E E N +M+ E
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184
Query: 608 SGIVSIKTDVFSFGVLVLEIVS-GQKNH----TRHHPDRPLNLIGYAWQLLSDGKGLELI 662
+ ++DV+S+GV + E+++ G K + TR PD LL G+
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPD-----------LLEKGE----- 228
Query: 663 DPSLEQP--CSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ--------------NE 706
L QP C+ + M V + C A RP E+ ++
Sbjct: 229 --RLPQPPICTIDVYM----VMVKCWMIDADSRPKFKELAAEFSRMARDPQRYLVIQGDD 282
Query: 707 TMPLPPPKQPAFFIN 721
M LP P FF N
Sbjct: 283 RMKLPSPNDSKFFQN 297
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 79/273 (28%), Positives = 123/273 (45%), Gaps = 29/273 (10%)
Query: 437 KLGEGGFGPVYKGKLADEQEVAIK--RLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGC 494
K+G+G FG VYKG L EVA+K R + +F E ++ + H N+V+L+G
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKR-KFLQEAEILKQYDHPNIVKLIGV 60
Query: 495 SLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVI 554
+ + +V E +P SL FL +KN L +K + + G+ YL S+ I
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFL--RKKKNRLTVKKLLQMSLDAAAGMEYLE--SK-NCI 115
Query: 555 HRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIK 614
HRDL A N L+ + KISDFGM+R E + + +PE G + +
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSE 175
Query: 615 TDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPC---S 671
+DV+S+G+L+ E S D P + +S+ + E I+ P
Sbjct: 176 SDVWSYGILLWETFSLG--------DTP-------YPGMSNQQTRERIESGYRMPAPQLC 220
Query: 672 ANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ 704
E+ R + L C +RP+ E+ LQ
Sbjct: 221 PEEIYRLM---LQCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-24
Identities = 70/216 (32%), Positives = 110/216 (50%), Gaps = 27/216 (12%)
Query: 438 LGEGGFGPVYKGKLAD-------EQEVAIKRLSR-SSGQGIVEFKNEVRLIAKLQHTNLV 489
LG G FG VY+G D VA+K L + ++ Q EF E L++ H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKN-----VLNWEKRFIIIEGISQGLLY 544
+LLG L E + ++ E M L +L R +L ++ I +++G +Y
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYL-RDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 545 LHKYSRLRVIHRDLKASNILLDDKMNP-----KISDFGMARIFEVNESEANTKRIVGTYG 599
L ++ IHRDL A N L+ +K KI DFG+AR ++ +S+ K G
Sbjct: 122 LE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR--DIYKSDYYRKEGEGLLP 176
Query: 600 --YMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQK 632
+M+PE + G + ++DV+SFGVL+ EI++ GQ+
Sbjct: 177 VRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQ 212
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 65/195 (33%), Positives = 99/195 (50%), Gaps = 11/195 (5%)
Query: 437 KLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSL 496
++G G FG V+ G ++++VAIK + R +F E +++ KL H LV+L G
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 497 HGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHR 556
LV+EFM + L +L ++ + E + + +G+ YL + VIHR
Sbjct: 70 ERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHR 124
Query: 557 DLKASNILLDDKMNPKISDFGMARIFEVNE--SEANTKRIVGTYGYMSPEYAMSGIVSIK 614
DL A N L+ + K+SDFGM R ++ S TK V + SPE S K
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPV---KWSSPEVFSFSKYSSK 181
Query: 615 TDVFSFGVLVLEIVS 629
+DV+SFGVL+ E+ S
Sbjct: 182 SDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 71/218 (32%), Positives = 115/218 (52%), Gaps = 30/218 (13%)
Query: 438 LGEGGFGPVYKGKLADEQEV-AIKRLSRSSGQG---------IVEFKNEVRLIAKLQHTN 487
+G G FG VY G A E+ A+K++ S + E+ L+ +LQH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 488 LVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFI--IIEGISQGLLYL 545
+V+ LG SL + + E++P S+ L N G +E+ + + I +GL YL
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYG-----AFEETLVRNFVRQILKGLNYL 122
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVN--ESEANTKR--IVGTYGYM 601
H +R +IHRD+K +NIL+D+K KISDFG+++ E N ++ N R + G+ +M
Sbjct: 123 H--NR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179
Query: 602 SPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHP 639
+PE + K D++S G LV+E+++G+ HP
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGK------HP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 69/198 (34%), Positives = 97/198 (48%), Gaps = 13/198 (6%)
Query: 438 LGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLG-CSL 496
LG G FG V+ GK + +VAIK + R +F E +++ KL H NLV+L G C+
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 497 HGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHR 556
+ V E+M N L +L RK L E + + + + YL IHR
Sbjct: 71 QRPIFI-VTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHR 124
Query: 557 DLKASNILLDDKMNPKISDFGMARIFEVNE--SEANTKRIVGTYGYMSPEYAMSGIVSIK 614
DL A N L+ + K+SDFG+AR ++ S TK V + PE S K
Sbjct: 125 DLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPV---KWAPPEVFDYSRFSSK 181
Query: 615 TDVFSFGVLVLEIVSGQK 632
+DV+SFGVL+ E+ S K
Sbjct: 182 SDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 9e-24
Identities = 65/224 (29%), Positives = 114/224 (50%), Gaps = 19/224 (8%)
Query: 432 FSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIV-EFKNEVRLIAKLQHT--- 486
+ +G G +G VY+GK + + VA+K ++ + V + + EV L+++L+ +
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 487 NLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFI--IIEGISQGLLY 544
N+ + G L G ++ E+ S+ L +G +++I II + L Y
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAEGGSVRT-LMKAGP-----IAEKYISVIIREVLVALKY 116
Query: 545 LHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPE 604
+HK VIHRD+KA+NIL+ + N K+ DFG+A + N S+ +T VGT +M+PE
Sbjct: 117 IHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST--FVGTPYWMAPE 171
Query: 605 YAMSGIV-SIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIG 647
G K D++S G+ + E+ +G ++ R + LI
Sbjct: 172 VITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIP 215
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 86/276 (31%), Positives = 134/276 (48%), Gaps = 36/276 (13%)
Query: 437 KLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAKLQHTNLVRLLGCS 495
KLG+G FG V+ G +VAIK L G + E F E +++ KL+H LV L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLK--PGTMMPEAFLQEAQIMKKLRHDKLVPLYAV- 69
Query: 496 LHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIH 555
+ E +V EFM SL FL G L + + I+ G+ Y+ R+ IH
Sbjct: 70 VSEEPIYIVTEFMGKGSLLDFL-KEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIH 125
Query: 556 RDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKT 615
RDL+A+NIL+ D + KI+DFG+AR+ E NE A + +PE A+ G +IK+
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 184
Query: 616 DVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPC----- 670
DV+SFG+L+ E+V+ + + + + + LE ++ PC
Sbjct: 185 DVWSFGILLTELVTKGR---------------VPYPGMVNREVLEQVERGYRMPCPQGCP 229
Query: 671 -SANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
S +E+M+ LC + +RPT + L++
Sbjct: 230 ESLHELMK------LCWKKDPDERPTFEYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 66/218 (30%), Positives = 109/218 (50%), Gaps = 13/218 (5%)
Query: 432 FSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLS-RSSGQGIVEFKNEVRLIAKLQHTNLV 489
F+ +G+G FG VYK Q VAIK + + I + + E++ +++ + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 490 RLLGCSLHGEERLLVYEFMPNKS-LDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
+ G L G + ++ E+ S LD L G+ L+ I+ + GL YLH+
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSCLD--LLKPGK---LDETYIAFILREVLLGLEYLHEE 117
Query: 549 SRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMS 608
IHRD+KA+NILL ++ + K++DFG++ S+ NT VGT +M+PE
Sbjct: 118 ---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT--FVGTPFWMAPEVIKQ 172
Query: 609 GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLI 646
K D++S G+ +E+ G+ + HP R L LI
Sbjct: 173 SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLI 210
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 64/204 (31%), Positives = 104/204 (50%), Gaps = 22/204 (10%)
Query: 438 LGEGGFGPVY------KGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRL 491
LG G FG VY G +EV++ ++ + + + + E+ L++KLQH N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 492 LGCSLHGEERLLVY-EFMPNKSLDFFL--FNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
LG E+ L ++ E +P SL L + S + V+ R I++ GL YLH
Sbjct: 68 LGTERE-EDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL-----GLEYLH-- 119
Query: 549 SRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMS 608
R +HRD+K +NIL+D K++DFGMA+ + K G+ +M+PE
Sbjct: 120 DR-NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF---SFAKSFKGSPYWMAPEVIAQ 175
Query: 609 -GIVSIKTDVFSFGVLVLEIVSGQ 631
G + D++S G VLE+ +G+
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-23
Identities = 67/193 (34%), Positives = 103/193 (53%), Gaps = 7/193 (3%)
Query: 437 KLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSL 496
KLG G FG V+ G +VA+K L + F E +++ KL+H LV+L +
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQLYAV-V 70
Query: 497 HGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHR 556
E +V E+M SL FL G L + ++ G+ Y+ R+ IHR
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFL-KDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHR 126
Query: 557 DLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTD 616
DL+++NIL+ D + KI+DFG+AR+ E NE A + +PE A+ G +IK+D
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSD 185
Query: 617 VFSFGVLVLEIVS 629
V+SFG+L+ E+V+
Sbjct: 186 VWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 3e-23
Identities = 44/132 (33%), Positives = 57/132 (43%), Gaps = 25/132 (18%)
Query: 3 LVSAFGNFKLGFFSPASSTTTERYLGIWHDTAPDTLGWYFRPFLPRYQTDEPIWIANRNT 62
LVS+ F+LGFF + Y I + + T +W+ANR+
Sbjct: 10 LVSSGSLFELGFFKLIMQS--RDYNLILYKGSSRT----------------VVWVANRDN 51
Query: 63 PILDQSGVLTIDSIDGNLKILHNGGNPIAVSSVEGASNNTSATLLQSGNLVLREMDTDGT 122
P S LT+ S DGNL I G + S+ + N LL GNLVL + D
Sbjct: 52 P-SGSSCTLTLQS-DGNLVIYDGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYDSD---- 105
Query: 123 IKRVLWQSFDYP 134
LWQSFDYP
Sbjct: 106 -GNFLWQSFDYP 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 1e-22
Identities = 85/293 (29%), Positives = 122/293 (41%), Gaps = 65/293 (22%)
Query: 437 KLGEGGFGPVYKGK----LADEQEVAIKRLSRSSGQGIV-EFKNEVRLIAKLQHTNLVRL 491
KLG+G FG V +G+ VA+K L I+ +F E ++ L H NL+RL
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 492 LGCSLHGEERLLVYEFMPNKSL---------DFFLFNSGRKNVLNWEKRFIIIEGISQGL 542
G L ++V E P SL FL ++ + ++ I+ G+
Sbjct: 62 YGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLIST----LCDYA------VQIANGM 110
Query: 543 LYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE----SEANTKRIVGTY 598
YL S+ R IHRDL A NILL KI DFG+ R NE E + K +
Sbjct: 111 RYLE--SK-RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV---PF 164
Query: 599 GYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGK 657
+ +PE + S +DV+ FGV + E+ + G++ W LS +
Sbjct: 165 AWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEE----------------PWAGLSGSQ 208
Query: 658 GLELIDPS---LEQP--CSAN--EVMRCIHVGLLCVQDQAMDRPTMPEVVCML 703
L+ ID LE+P C + VM L C DRPT + L
Sbjct: 209 ILKKIDKEGERLERPEACPQDIYNVM------LQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 1e-22
Identities = 58/204 (28%), Positives = 99/204 (48%), Gaps = 12/204 (5%)
Query: 432 FSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKN--EVRLIAKLQHTNL 488
+ K+GEG +G VYK + + VAIK++ + E++L+ +L H N+
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
++LL H + LV+EFM D + R+ L + + QGL + H +
Sbjct: 61 IKLLDVFRHKGDLYLVFEFM---DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH 117
Query: 549 SRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM- 607
++HRDLK N+L++ + K++DFG+AR F T +V T Y +PE +
Sbjct: 118 ---GILHRDLKPENLLINTEGVLKLADFGLARSFGS-PVRPYTHYVV-TRWYRAPELLLG 172
Query: 608 SGIVSIKTDVFSFGVLVLEIVSGQ 631
S D++S G + E++S +
Sbjct: 173 DKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 2e-22
Identities = 67/194 (34%), Positives = 102/194 (52%), Gaps = 9/194 (4%)
Query: 437 KLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSL 496
KLG G FG V+ +VA+K + S + F E ++ LQH LV+L +
Sbjct: 13 KLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKL-HAVV 70
Query: 497 HGEERLLVYEFMPNKSL-DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIH 555
E ++ EFM SL DF + G K L K I++G+ ++ + + IH
Sbjct: 71 TKEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRN---YIH 125
Query: 556 RDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKT 615
RDL+A+NIL+ + KI+DFG+AR+ E NE A + +PE G +IK+
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSFTIKS 184
Query: 616 DVFSFGVLVLEIVS 629
DV+SFG+L++EIV+
Sbjct: 185 DVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 2e-22
Identities = 79/269 (29%), Positives = 130/269 (48%), Gaps = 22/269 (8%)
Query: 437 KLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSL 496
KLG+G FG V+ G VAIK L + F E +++ KL+H LV+L +
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 70
Query: 497 HGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHR 556
E +V E+M SL FL K L + + I+ G+ Y+ R+ +HR
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 126
Query: 557 DLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTD 616
DL+A+NIL+ + + K++DFG+AR+ E NE A + +PE A+ G +IK+D
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSD 185
Query: 617 VFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVM 676
V+SFG+L+ E+ + + +R + L +G + P E P S +++M
Sbjct: 186 VWSFGILLTELTTKGRVPYPGMVNREV--------LDQVERGYRMPCPP-ECPESLHDLM 236
Query: 677 RCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
C + + +RPT + L++
Sbjct: 237 ------CQCWRKEPEERPTFEYLQAFLED 259
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 2e-22
Identities = 44/131 (33%), Positives = 61/131 (46%), Gaps = 26/131 (19%)
Query: 3 LVSAFGNFKLGFFSPASSTTTERYLGIWHDTAPDTLGWYFRPFLPRYQTDEPIWIANRNT 62
LVS F+LGFF+ Y I + ++ T +W+ANR+
Sbjct: 10 LVSGNSLFELGFFTLIMQ---NDYNLILYKSSSRT----------------VVWVANRDN 50
Query: 63 PILDQSGVLTIDSIDGNLKILHNGGNPIAVSSVEGASNNTSATLLQSGNLVLREMDTDGT 122
P+ D S LT+ S DGNL + G + S+ GA+ N LL GNLV+ + D +
Sbjct: 51 PVSD-SCTLTLQS-DGNLVLYDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYDSDGN-- 106
Query: 123 IKRVLWQSFDY 133
LWQSFDY
Sbjct: 107 ---FLWQSFDY 114
|
Length = 114 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 2e-22
Identities = 60/201 (29%), Positives = 99/201 (49%), Gaps = 17/201 (8%)
Query: 438 LGEGGFGPVY------KGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRL 491
LG+GGFG V GK+ +++ KRL + G+ + NE +++ K+ + +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMA--LNEKKILEKV-SSRFIVS 57
Query: 492 LGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSR 550
L + ++ L LV M L + ++N G F + I GL +LH +
Sbjct: 58 LAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQ-IICGLEHLH---Q 113
Query: 551 LRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGI 610
R+++RDLK N+LLDD N +ISD G+A E+ + R GT GYM+PE +
Sbjct: 114 RRIVYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGR-AGTPGYMAPEVLQGEV 170
Query: 611 VSIKTDVFSFGVLVLEIVSGQ 631
D F+ G + E+++G+
Sbjct: 171 YDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 96.9 bits (241), Expect = 3e-22
Identities = 76/276 (27%), Positives = 135/276 (48%), Gaps = 32/276 (11%)
Query: 438 LGEGGFGPVYKGKLA----DEQEVAIKRL-SRSSGQGIVEFKNEVRLIAKLQHTNLVRLL 492
+G G FG V +G+L E VAIK L S + + +F +E ++ + H N++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 493 GCSLHGEERLLVYEFMPNKSLDFFL-FNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRL 551
G +++ EFM N +LD FL N G+ V+ + ++ GI+ G+ YL S +
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVI---QLVGMLRGIAAGMKYL---SEM 125
Query: 552 RVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVG---TYGYMSPEYAMS 608
+HRDL A NIL++ + K+SDFG++R E + S+ +G + +PE
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185
Query: 609 GIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLE 667
+ +DV+S+G+++ E++S G++ + +N I ++L P ++
Sbjct: 186 RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRL----------PPPMD 235
Query: 668 QPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCML 703
P + +++M L C Q RP ++V L
Sbjct: 236 CPTALHQLM------LDCWQKDRNARPKFGQIVSTL 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 3e-22
Identities = 62/210 (29%), Positives = 98/210 (46%), Gaps = 22/210 (10%)
Query: 436 NKLGEGGFGPVYKGK-LADEQEVAIKRLSRSS-----GQGIVEFKNEVRLIAKLQHTNLV 489
+G+G FG V K + +D + + K + + Q +V +EV ++ +L+H N+V
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLV---SEVNILRELKHPNIV 62
Query: 490 RLLGCSLHGEERLLVY---EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLH 546
R + +Y E+ L + +K E+ FI ++Q LL L+
Sbjct: 63 RYYD-RIIDRSNQTLYIVMEYCEGGDLAQLIQKC-KKERKYIEEEFIW-RILTQLLLALY 119
Query: 547 -----KYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYM 601
V+HRDLK +NI LD N K+ DFG+A+I + S A T VGT YM
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVGTPYYM 177
Query: 602 SPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
SPE K+D++S G L+ E+ +
Sbjct: 178 SPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 4e-22
Identities = 74/245 (30%), Positives = 112/245 (45%), Gaps = 26/245 (10%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADEQEV-AIKRLSRSSGQGIVEFK------NEVRLIAKL 483
+F +G+G FG V + D +++ A+K +++ Q VE NE R++ +L
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNK---QKCVEKGSVRNVLNERRILQEL 57
Query: 484 QHTNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEK-RFIIIEGISQG 541
H LV L S EE + LV + + L + L +K + E+ +F I E I
Sbjct: 58 NHPFLVNLWY-SFQDEENMYLVVDLLLGGDLRYHL---SQKVKFSEEQVKFWICE-IVLA 112
Query: 542 LLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYM 601
L YLH +IHRD+K NILLD++ + I+DF +A + T GT GYM
Sbjct: 113 LEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGYM 166
Query: 602 SPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ---KNHTRHHPDRPLNLIGYAWQLLSDGKG 658
+PE S+ D +S GV E + G+ + H+R D+ A L
Sbjct: 167 APEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWS 226
Query: 659 LELID 663
E ID
Sbjct: 227 TEAID 231
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 5e-22
Identities = 75/226 (33%), Positives = 113/226 (50%), Gaps = 34/226 (15%)
Query: 431 NFSTT---NKLGEGGFGPVYKGKL------ADEQEVAIKRLS-RSSGQGIVEFKNEVRLI 480
N ST +LGE FG VYKG L Q VAIK L ++ G EFK+E +
Sbjct: 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMR 62
Query: 481 AKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLF-------------NSGRKNVLN 527
++LQH N+V LLG + +++ + + L FL + K+ L
Sbjct: 63 SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLE 122
Query: 528 WEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES 587
I+ I+ G+ +L S V+H+DL N+L+ DK+N KISD G+ R EV
Sbjct: 123 PADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFR--EV--Y 175
Query: 588 EANTKRIVGT----YGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
A+ +++G +MSPE M G SI +D++S+GV++ E+ S
Sbjct: 176 AADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 5e-22
Identities = 79/282 (28%), Positives = 129/282 (45%), Gaps = 29/282 (10%)
Query: 438 LGEGGFGPV----YKGKLADEQE-VAIKRLSRSSGQGIVE-FKNEVRLIAKLQHTNLVRL 491
LGEG FG V Y E VA+K L R GQ +K E+ ++ L H N+V+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 492 LGCSLHGEER--LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
GC + L+ E++P SL +L K+ LN + + + I +G+ YLH
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYL----PKHKLNLAQLLLFAQQICEGMAYLHSQ- 126
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMAR-------IFEVNESEANTKRIVGTYGYMS 602
IHRDL A N+LLD+ KI DFG+A+ + V E + + +
Sbjct: 127 --HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS------PVFWYA 178
Query: 603 PEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELI 662
E S +DV+SFGV + E+++ + + P + +IG ++ + +EL+
Sbjct: 179 VECLKENKFSYASDVWSFGVTLYELLT-HCDSKQSPPKKFEEMIGPKQGQMTVVRLIELL 237
Query: 663 DPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ 704
+ + PC N + C + +A RPT ++ +L+
Sbjct: 238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILK 279
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 7e-22
Identities = 66/206 (32%), Positives = 106/206 (51%), Gaps = 15/206 (7%)
Query: 431 NFSTTNKLGEGGFGPVYKGK-LADEQEVAIKR--LSRSSGQGIVEFKNEVRLIAKLQHTN 487
+F KLG+G +G VYK K L+D Q A+K L S + + NE+R++A + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 488 LVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEK---RFIIIEGISQGLLY 544
++ L G + +V E+ P L + +K L E+ R I + +GL
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFI--QLLRGLQA 118
Query: 545 LHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPE 604
LH+ +++HRDLK++NILL KI D G++++ + N K +GT YM+PE
Sbjct: 119 LHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM----AKTQIGTPHYMAPE 171
Query: 605 YAMSGIVSIKTDVFSFGVLVLEIVSG 630
S K+D++S G L+ E+ +
Sbjct: 172 VWKGRPYSYKSDIWSLGCLLYEMATF 197
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 9e-22
Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 33/211 (15%)
Query: 436 NKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSG-QGI-VEFKNEVRLIAKLQHTNLVRLL 492
++GEG +G VYK + + VA+K++ + +G + E++L+ KL+H N+VRL
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 493 GCSLHGEER---LLVYEFMPNKSLDFFLFNSG---RKNVLNWEKRFII--IEGISQ---- 540
+ + + +V+E+M + D +G V +F I+ +
Sbjct: 65 -EIVTSKGKGSIYMVFEYMDH---DL----TGLLDSPEV-----KFTESQIKCYMKQLLE 111
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGY 600
GL YLH ++HRD+K SNIL+++ K++DFG+AR + S T R++ T Y
Sbjct: 112 GLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWY 167
Query: 601 MSPEYAM-SGIVSIKTDVFSFGVLVLEIVSG 630
PE + + + D++S G ++ E+ G
Sbjct: 168 RPPELLLGATRYGPEVDMWSVGCILAELFLG 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 9e-22
Identities = 80/292 (27%), Positives = 140/292 (47%), Gaps = 48/292 (16%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGKLA----DEQEVAIKRLSRS-SGQGIVEFKNEVRLIAKL 483
A+ +G G FG V G+L E VAIK L + + +F +E ++ +
Sbjct: 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQF 62
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIE------G 537
H N++ L G + ++V E+M N SLD FL RK+ + +F +I+ G
Sbjct: 63 DHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFL----RKH----DGQFTVIQLVGMLRG 114
Query: 538 ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT 597
I+ G+ YL S + +HRDL A NIL++ + K+SDFG++R+ E + A T R
Sbjct: 115 IASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR---- 167
Query: 598 YG------YMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQ 651
G + +PE + +DV+S+G+++ E++S + +RP +
Sbjct: 168 -GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS--------YGERPYWEMSNQDV 218
Query: 652 LLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCML 703
+ + +G L P ++ P + +++M L C Q +RP ++V +L
Sbjct: 219 IKAIEEGYRLPAP-MDCPAALHQLM------LDCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 1e-21
Identities = 82/295 (27%), Positives = 132/295 (44%), Gaps = 56/295 (18%)
Query: 438 LGEGGFGPVYKGK------LADEQEVAIKRLSRSSGQGIVEFK---NEVRLIAKLQHTNL 488
LGEG FG V K A VA+K L ++ E + +E L+ ++ H ++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASS--SELRDLLSEFNLLKQVNHPHV 65
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNS-----------GRKNV----------LN 527
++L G LL+ E+ SL FL S G +N L
Sbjct: 66 IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125
Query: 528 WEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES 587
IS+G+ YL + ++++HRDL A N+L+ + KISDFG++R +V E
Sbjct: 126 MGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSR--DVYEE 180
Query: 588 EANTKRIVG--TYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLN 644
++ KR G +M+ E I + ++DV+SFGVL+ EIV+ G + P+R
Sbjct: 181 DSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER--- 237
Query: 645 LIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEV 699
+ LL G +E+P + +E M + L C + + RPT ++
Sbjct: 238 ----LFNLLKTGY-------RMERPENCSEEMYNLM--LTCWKQEPDKRPTFADI 279
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 62/217 (28%), Positives = 109/217 (50%), Gaps = 11/217 (5%)
Query: 436 NKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGC 494
++G G +G VYK + +A + VAIK + G + E+ ++ + +H N+V G
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 495 SLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVI 554
L ++ +V E+ SL ++ R + + ++ E + +GL YLH+ I
Sbjct: 69 YLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAYVCRETL-KGLAYLHE---TGKI 123
Query: 555 HRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYA---MSGIV 611
HRD+K +NILL + + K++DFG++ ++ + A K +GT +M+PE A G
Sbjct: 124 HRDIKGANILLTEDGDVKLADFGVSA--QLTATIAKRKSFIGTPYWMAPEVAAVERKGGY 181
Query: 612 SIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGY 648
K D+++ G+ +E+ Q HP R L LI
Sbjct: 182 DGKCDIWALGITAIELAELQPPMFDLHPMRALFLISK 218
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 2e-21
Identities = 86/291 (29%), Positives = 137/291 (47%), Gaps = 40/291 (13%)
Query: 437 KLGEGGFGPVYKGKLAD------EQEVAIKRLSRS-SGQGIVEFKNEVRLIAKLQHTNLV 489
+LG+G FG VY+G D E VA+K ++ S S + +EF NE ++ ++V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWE-------KRFIIIEG-ISQG 541
RLLG G+ L+V E M + L +L S R N + I + I+ G
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYL-RSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131
Query: 542 LLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR-IFEVNESEANTKRIVGTYGY 600
+ YL+ + +HRDL A N ++ KI DFGM R I+E + K ++
Sbjct: 132 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW- 187
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLE 660
M+PE G+ + +D++SFGV++ EI S L +Q LS+ + L+
Sbjct: 188 MAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQVLK 232
Query: 661 LI--DPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETMP 709
+ L+QP + E R + +C Q RPT E+V +L+++ P
Sbjct: 233 FVMDGGYLDQPDNCPE--RVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHP 281
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 2e-21
Identities = 79/272 (29%), Positives = 127/272 (46%), Gaps = 32/272 (11%)
Query: 437 KLGEGGFGPVYKGKLADEQEVAIKRLS-RSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCS 495
+GEG FG V +G+ Q+VA+K + + Q F E ++ KL H NLVRLLG
Sbjct: 13 IIGEGEFGAVLQGEYTG-QKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVI 68
Query: 496 LHGEERLLVYEFMPNKSLDFFLFNSGRKNV-LNWEKRFIIIEGISQGLLYLHKYSRLRVI 554
LH +V E M +L FL GR V + +F + +++G+ YL +++
Sbjct: 69 LH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSL--DVAEGMEYLESK---KLV 122
Query: 555 HRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIK 614
HRDL A NIL+ + K+SDFG+AR V + ++ + +PE S K
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLAR---VGSMGVDNSKL--PVKWTAPEALKHKKFSSK 177
Query: 615 TDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSANE 674
+DV+S+GVL+ E+ S + +P L + + KG + +P P
Sbjct: 178 SDVWSYGVLLWEVFSYGR---APYPKMSLKEVKECVE-----KGYRM-EPPEGCPADVYV 228
Query: 675 VMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706
+M C + + RP+ ++ L+ E
Sbjct: 229 LMTS------CWETEPKKRPSFHKLREKLEKE 254
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 2e-21
Identities = 68/216 (31%), Positives = 107/216 (49%), Gaps = 36/216 (16%)
Query: 431 NFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLS-RSSGQGIVEFK-NEVRLIAKLQHTN 487
+++ K+GEG +G VYKG+ Q VA+K++ S +G+ E+ L+ +LQH N
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60
Query: 488 LVRLLGCSLHGEERL-LVYEFM------------PNKSLDFFLFNSGRKNVLNWEKRFII 534
+V L L E RL L++EF+ + +D L S +L
Sbjct: 61 IVCLQDV-LMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQIL-------- 111
Query: 535 IEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594
QG+L+ H RV+HRDLK N+L+D+K K++DFG+AR F + T +
Sbjct: 112 -----QGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI-PVRVYTHEV 162
Query: 595 VGTYGYMSPEYAM-SGIVSIKTDVFSFGVLVLEIVS 629
V T Y +PE + S S D++S G + E+ +
Sbjct: 163 V-TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 3e-21
Identities = 58/209 (27%), Positives = 99/209 (47%), Gaps = 20/209 (9%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKN---EVRLIAKLQH 485
++ +LG G G V K + +A+K + + K E+ ++ K
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE--AIQKQILRELDILHKCNS 58
Query: 486 TNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFI---IIEGISQGL 542
+V G + + + E+M SLD L K V I I + +GL
Sbjct: 59 PYIVGFYGAFYNNGDISICMEYMDGGSLDKIL-----KEVQGRIPERILGKIAVAVLKGL 113
Query: 543 LYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMS 602
YLH + ++IHRD+K SNIL++ + K+ DFG++ ++ S A T VGT YM+
Sbjct: 114 TYLH--EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSG--QLVNSLAKT--FVGTSSYMA 167
Query: 603 PEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
PE S+K+D++S G+ ++E+ +G+
Sbjct: 168 PERIQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 3e-21
Identities = 68/220 (30%), Positives = 116/220 (52%), Gaps = 17/220 (7%)
Query: 432 FSTTNKLGEGGFGPVYKGKLADEQEV-AIKRLSRSSGQGIVE-FKNEVRLIAKLQHTNLV 489
F+ ++G+G FG VYKG +EV AIK + + +E + E+ ++++ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 490 RLLGCSLHGEERLLVYEFMPNKS-LDFFLFNSGRKNVLNWEKRFI--IIEGISQGLLYLH 546
R G L G + ++ E++ S LD L G E+ +I I+ I +GL YLH
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALD--LLKPG-----PLEETYIATILREILKGLDYLH 118
Query: 547 KYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYA 606
R IHRD+KA+N+LL ++ + K++DFG+A ++ +++ VGT +M+PE
Sbjct: 119 SE---RKIHRDIKAANVLLSEQGDVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEVI 173
Query: 607 MSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLI 646
K D++S G+ +E+ G+ ++ HP R L LI
Sbjct: 174 KQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI 213
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 3e-21
Identities = 80/288 (27%), Positives = 128/288 (44%), Gaps = 40/288 (13%)
Query: 437 KLGEGGFGPVYKGK---LADEQE---VAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVR 490
+LGEG FG V+ + L EQ+ VA+K L +S +F+ E L+ LQH ++VR
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 491 LLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRK------------NVLNWEKRFIIIEGI 538
G G L+V+E+M + L+ FL + G L + I I
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 539 SQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTY 598
+ G++YL + L +HRDL N L+ + KI DFGM+R + R +
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 599 GYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKG 658
+M PE + + ++D++SFGV++ EI + K W LS+ +
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQ---------------PWYQLSNTEA 233
Query: 659 LELIDP--SLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ 704
+E I LE+P + + I G C Q + R + ++ LQ
Sbjct: 234 IECITQGRELERPRTCPPEVYAIMQG--CWQREPQQRMVIKDIHSRLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 54/171 (31%), Positives = 89/171 (52%), Gaps = 10/171 (5%)
Query: 437 KLGEGGFGPVYKGK-LADEQEVAIKRL-SRSSGQGI-VEFKNEVRLIAKLQHTNLVRLLG 493
++GEG G V+K K + VA+K++ R GI + E++ + QH +V+LL
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 494 CSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRV 553
HG +LV E+MP+ L L + R K ++ + + +G+ Y+H +
Sbjct: 67 VFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRM--LLKGVAYMHA---NGI 120
Query: 554 IHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPE 604
+HRDLK +N+L+ KI+DFG+AR+F E + + V T Y +PE
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 8e-21
Identities = 71/203 (34%), Positives = 104/203 (51%), Gaps = 19/203 (9%)
Query: 432 FSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKN---EVRLIAKLQHTN 487
F+ ++G G FG VY + + + VAIK++S S Q ++++ EVR + +L+H N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 488 LVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHK 547
+ GC L LV E+ + D + K L + I G QGL YLH
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHS 133
Query: 548 YSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPE--Y 605
+ R IHRD+KA NILL + K++DFG A + S AN+ VGT +M+PE
Sbjct: 134 HER---IHRDIKAGNILLTEPGTVKLADFGSASLV----SPANS--FVGTPYWMAPEVIL 184
Query: 606 AM-SGIVSIKTDVFSFGVLVLEI 627
AM G K DV+S G+ +E+
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 1e-20
Identities = 64/209 (30%), Positives = 101/209 (48%), Gaps = 17/209 (8%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADE-QEVAIKR-----LSRSSGQGIVEFKNEVRLIAKL 483
N+ LG+G FG VY D +E+A+K+ S + + + + E++L+ L
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSG--RKNVLNWEKRFIIIEGISQG 541
QH +V+ GC E + E+MP S+ L G + V R I+ +G
Sbjct: 62 QHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL-----EG 116
Query: 542 LLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMA-RIFEVNESEANTKRIVGTYGY 600
+ YLH ++HRD+K +NIL D N K+ DFG + R+ + S K + GT +
Sbjct: 117 VEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYW 173
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
MSPE K DV+S G V+E+++
Sbjct: 174 MSPEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 1e-20
Identities = 64/207 (30%), Positives = 106/207 (51%), Gaps = 19/207 (9%)
Query: 431 NFSTTNKLGEGGFGPVY--KGKLADEQEVAIK-----RLSRSSGQGIVEFKNEVRLIAKL 483
+ +G G FG V+ + K AD++ V IK ++++ +NE +++ L
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRK-ADQKLVIIKQIPVEQMTKDERLAA---QNECQVLKLL 56
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLL 543
H N++ L + ++V E+ P +L ++ R N L E I+ Q LL
Sbjct: 57 SHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYI--QKRCNSLLDEDT--ILHFFVQILL 112
Query: 544 YLHKYSRLRVIHRDLKASNILLDD-KMNPKISDFGMARIFEVNESEANTKRIVGTYGYMS 602
LH ++HRDLK NILLD KM KI DFG+++I ++S+A T +VGT Y+S
Sbjct: 113 ALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL-SSKSKAYT--VVGTPCYIS 169
Query: 603 PEYAMSGIVSIKTDVFSFGVLVLEIVS 629
PE + K+D+++ G ++ E+ S
Sbjct: 170 PELCEGKPYNQKSDIWALGCVLYELAS 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-20
Identities = 80/294 (27%), Positives = 135/294 (45%), Gaps = 38/294 (12%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK---LADEQE---VAIKRLSRSSGQGIVEFKNEVRLIAKL 483
+N +LGEG FG V+ + L EQ+ VA+K L +S +F E L+ L
Sbjct: 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 64
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWE----------KRFI 533
QH ++V+ G + G+ ++V+E+M + L+ FL G VL E +
Sbjct: 65 QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124
Query: 534 IIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKR 593
I + I+ G++YL + +HRDL N L+ + + KI DFGM+R +
Sbjct: 125 IAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGH 181
Query: 594 IVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLL 653
+ +M PE M + ++DV+S GV++ EI + K W L
Sbjct: 182 TMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ---------------PWYQL 226
Query: 654 SDGKGLELIDPS--LEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
S+ + +E I L++P + + + + +G C Q + R + E+ +LQN
Sbjct: 227 SNNEVIECITQGRVLQRPRTCPKEVYDLMLG--CWQREPHMRLNIKEIHSLLQN 278
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 2e-20
Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 12/206 (5%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEV-AIKRLSRSSGQGIV-EFKNEVRLIAKLQHTN 487
++LGEG G V K +L + + A+K ++ + + E+ + +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 488 LVRLLGCSL--HGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFI-IIEGISQGLLY 544
+V+ G L + E+ SLD ++ EK I E + +GL Y
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120
Query: 545 LHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPE 604
LH SR ++IHRD+K SNILL K K+ DFG++ E+ S A T GT YM+PE
Sbjct: 121 LH--SR-KIIHRDIKPSNILLTRKGQVKLCDFGVSG--ELVNSLAGT--FTGTSFYMAPE 173
Query: 605 YAMSGIVSIKTDVFSFGVLVLEIVSG 630
SI +DV+S G+ +LE+
Sbjct: 174 RIQGKPYSITSDVWSLGLTLLEVAQN 199
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 2e-20
Identities = 62/211 (29%), Positives = 112/211 (53%), Gaps = 25/211 (11%)
Query: 438 LGEGGFGPVYKGKLADEQEV-AIKRL---SRSSG------QGIVE-FKNEVRLIAKLQHT 486
+G+G +G VY E+ A+K++ + +G + +V+ ++E+ + L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 487 NLVRLLGCSLHGEERLLVY-EFMPNKSLDFFLFNSGRKNVLNWEKRFI--IIEGISQGLL 543
N+V+ LG EE L ++ E++P S+ L GR +E++ + E + +GL
Sbjct: 69 NIVQYLGFE-TTEEYLSIFLEYVPGGSIGSCLRTYGR-----FEEQLVRFFTEQVLEGLA 122
Query: 544 YLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSP 603
YLH ++HRDLKA N+L+D KISDFG+++ + + G+ +M+P
Sbjct: 123 YLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAP 179
Query: 604 E--YAMSGIVSIKTDVFSFGVLVLEIVSGQK 632
E ++ S S K D++S G +VLE+ +G++
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-20
Identities = 73/275 (26%), Positives = 132/275 (48%), Gaps = 30/275 (10%)
Query: 438 LGEGGFGPVYKGKLA----DEQEVAIKRLSRS-SGQGIVEFKNEVRLIAKLQHTNLVRLL 492
+G G FG V++G L E VAIK L + + +F +E ++ + H N++RL
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 493 GCSLHGEERLLVYEFMPNKSLDFFLF-NSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRL 551
G + +++ E+M N +LD +L + G + + ++ GI+ G+ YL S +
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSY---QLVGMLRGIAAGMKYL---SDM 126
Query: 552 RVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG--YMSPEYAMSG 609
+HRDL A NIL++ + K+SDFG++R+ E ++ E G + +PE
Sbjct: 127 NYVHRDLAARNILVNSNLECKVSDFGLSRVLE-DDPEGTYTTSGGKIPIRWTAPEAIAYR 185
Query: 610 IVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQP 669
+ +DV+SFG+++ E++S +RP + + + G L P ++ P
Sbjct: 186 KFTSASDVWSFGIVMWEVMS--------FGERPYWDMSNHEVMKAINDGFRLPAP-MDCP 236
Query: 670 CSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ 704
+ ++M L C Q RP ++V +L
Sbjct: 237 SAVYQLM------LQCWQQDRARRPRFVDIVNLLD 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 2e-20
Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 23/212 (10%)
Query: 438 LGEGGFGPVYKGKLADE----QEVAIK--RLSRSSGQGIVEFKNEVRLIAKLQHTNLVRL 491
LGEG FG V +G+L+ + +VA+K +L + I EF +E + H N+++L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 492 LGCSLHGEER------LLVYEFMPNKSLDFFLFNS---GRKNVLNWEKRFIIIEGISQGL 542
+G +++ FM + L FL S G L + + I+ G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 543 LYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR-IFEVNESEANTKRIVGT-YGY 600
YL S IHRDL A N +L + M ++DFG+++ I+ + RI +
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIY--SGDYYRQGRIAKMPVKW 181
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQ 631
++ E + + K+DV++FGV + EI + GQ
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEIATRGQ 213
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 92.5 bits (229), Expect = 3e-20
Identities = 68/203 (33%), Positives = 104/203 (51%), Gaps = 19/203 (9%)
Query: 432 FSTTNKLGEGGFGPVYKGKLADEQEV-AIKRLSRSSGQGIVEFKN---EVRLIAKLQHTN 487
F+ ++G G FG VY + EV AIK++S S Q ++++ EV+ + +++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 488 LVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHK 547
+ GC L LV E+ + D + K L + I G QGL YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHS 143
Query: 548 YSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM 607
++ +IHRD+KA NILL + K++DFG A I S AN+ VGT +M+PE +
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSASIA----SPANS--FVGTPYWMAPEVIL 194
Query: 608 S---GIVSIKTDVFSFGVLVLEI 627
+ G K DV+S G+ +E+
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 3e-20
Identities = 62/205 (30%), Positives = 106/205 (51%), Gaps = 14/205 (6%)
Query: 436 NKLGEGGFGPVYKGKLADEQEV-AIK--RLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLL 492
NK+G G FG VY D E+ A+K R+ + + I E +E++++ L+H NLV+
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 493 GCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLR 552
G +H E+ + E+ +L+ L + GR + + + + + +GL YLH +
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEH-GRILDEHVIRVYTL--QLLEGLAYLHSH---G 119
Query: 553 VIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANT--KRIVGTYGYMSPEYAMSGI 610
++HRD+K +NI LD K+ DFG A + N + + + GT YM+PE G
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK 179
Query: 611 VSIK---TDVFSFGVLVLEIVSGQK 632
D++S G +VLE+ +G++
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 3e-20
Identities = 72/218 (33%), Positives = 114/218 (52%), Gaps = 21/218 (9%)
Query: 428 AANNFSTTNKLGEGGFGPVY----KGKLADEQE--VAIKRLSRS-SGQGIVEFKNEVRLI 480
A + + +LG+G FG VY KG + DE E VAIK ++ + S + +EF NE ++
Sbjct: 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63
Query: 481 AKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWE-------KRFI 533
+ ++VRLLG G+ L++ E M L +L S R + N K+ I
Sbjct: 64 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVQAPPSLKKMI 122
Query: 534 IIEG-ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR-IFEVNESEANT 591
+ G I+ G+ YL+ + +HRDL A N ++ + KI DFGM R I+E +
Sbjct: 123 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 179
Query: 592 KRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
K ++ +MSPE G+ + +DV+SFGV++ EI +
Sbjct: 180 KGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 4e-20
Identities = 66/198 (33%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 437 KLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSL 496
+LG G FG V+ GK + +VAIK + +F E +++ KL H LV+L G
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 497 HGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHR 556
+ +V EFM N L +L R+ L+ + + + + +G+ YL + S IHR
Sbjct: 70 QQKPLYIVTEFMENGCLLNYL--RQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHR 124
Query: 557 DLKASNILLDDKMNPKISDFGMARIFEVNE--SEANTKRIVGTYGYMSPEYAMSGIVSIK 614
DL A N L+ K+SDFGM R +E S + K V + PE S K
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPV---KWSPPEVFNFSKYSSK 181
Query: 615 TDVFSFGVLVLEIVSGQK 632
+DV+SFGVL+ E+ + K
Sbjct: 182 SDVWSFGVLMWEVFTEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 4e-20
Identities = 79/294 (26%), Positives = 126/294 (42%), Gaps = 43/294 (14%)
Query: 431 NFSTTNKLGEGGFGPVYKGKL------ADEQEVAIKRLSRSSGQGI-VEFKNEVRLIAKL 483
N LG G FG V+ K E V +K L ++ + + EF+ E+ + KL
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNV------LNWEKRFIIIEG 537
H N+VRLLG E ++ E+ L FL + K+ L+ +++ +
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 538 ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE----ANTKR 593
I+ G+ +L S R +HRDL A N L+ + K+S +++ +V SE N
Sbjct: 126 IALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSK--DVYNSEYYKLRNALI 180
Query: 594 IVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQL 652
+ +++PE S K+DV+SFGVL+ E+ + G+ + LN +
Sbjct: 181 PLR---WLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQ----- 232
Query: 653 LSDGKGLELIDPSLEQPCSANEVM-RCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
LEL P P ++M RC V DRP+ E+V L
Sbjct: 233 ---AGKLELPVPE-GCPSRLYKLMTRCWAVN-------PKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 4e-20
Identities = 64/232 (27%), Positives = 109/232 (46%), Gaps = 41/232 (17%)
Query: 430 NNFSTTNKLGEGGFGPVYK----GKLADEQE--VAIKRLSR-SSGQGIVEFKNEVRLIAK 482
NN +G+G FG V++ G L E VA+K L +S +F+ E L+A+
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64
Query: 483 LQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFL-------------------FNSGRK 523
H N+V+LLG G+ L++E+M L+ FL
Sbjct: 65 FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 524 NVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR--- 580
L+ ++ I + ++ G+ YL S + +HRDL N L+ + M KI+DFG++R
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181
Query: 581 ---IFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
++ +E++A R +M PE + ++DV+++GV++ EI S
Sbjct: 182 SADYYKASENDAIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 4e-20
Identities = 62/197 (31%), Positives = 100/197 (50%), Gaps = 11/197 (5%)
Query: 436 NKLGEGGFGPVYKGKLAD-EQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGC 494
+KLG G +G VY+G VA+K L + + EF E ++ +++H NLV+LLG
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 495 SLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVI 554
++ EFM +L +L R+ +N + IS + YL K + I
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN---FI 126
Query: 555 HRDLKASNILLDDKMNPKISDFGMARIF--EVNESEANTKRIVGTYGYMSPEYAMSGIVS 612
HRDL A N L+ + K++DFG++R+ + + A K + + +PE S
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFS 183
Query: 613 IKTDVFSFGVLVLEIVS 629
IK+DV++FGVL+ EI +
Sbjct: 184 IKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 5e-20
Identities = 63/194 (32%), Positives = 101/194 (52%), Gaps = 9/194 (4%)
Query: 438 LGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGI-VEFKNEVRLIAKLQHTNLVRLLGCSL 496
LG+G FG V+KG L D+ VA+K Q + ++F +E R++ + H N+V+L+G
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 497 HGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHR 556
+ +V E +P DF F +K+ L ++ + G+ YL + IHR
Sbjct: 63 QRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117
Query: 557 DLKASNILLDDKMNPKISDFGMARIFEVN-ESEANTKRIVGTYGYMSPEYAMSGIVSIKT 615
DL A N L+ + KISDFGM+R + S + K+I + +PE G S ++
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI--PIKWTAPEALNYGRYSSES 175
Query: 616 DVFSFGVLVLEIVS 629
DV+S+G+L+ E S
Sbjct: 176 DVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 6e-20
Identities = 64/202 (31%), Positives = 105/202 (51%), Gaps = 17/202 (8%)
Query: 438 LGEGGFGPVYKGK---LADE--QEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLL 492
LG+G FG V + L D + VA+K+L S+ + + +F+ E+ ++ LQH N+V+
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 493 G-CSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSR 550
G C G L LV E++P SL +L + L+ K + I +G+ YL
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYL---GS 126
Query: 551 LRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVG---TYGYMSPEYAM 607
R +HRDL NIL++ + KI DFG+ ++ ++ E R G + Y +PE
Sbjct: 127 KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK-EYYKVREPGESPIFWY-APESLT 184
Query: 608 SGIVSIKTDVFSFGVLVLEIVS 629
S+ +DV+SFGV++ E+ +
Sbjct: 185 ESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 90.6 bits (224), Expect = 6e-20
Identities = 73/273 (26%), Positives = 133/273 (48%), Gaps = 19/273 (6%)
Query: 410 DQSISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQ 468
D+ I +L+ +I ++ K+G+G G V+ +A QEVAIK+++
Sbjct: 1 DEEIMEKLRTI--VSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP 58
Query: 469 GIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNW 528
NE+ ++ +L++ N+V L L G+E +V E++ SL + + ++
Sbjct: 59 KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDE 114
Query: 529 EKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE 588
+ + Q L +LH +VIHRD+K+ N+LL + K++DFG +S+
Sbjct: 115 AQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK 171
Query: 589 ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGY 648
+T +VGT +M+PE K D++S G++ +E+V G+ + +P R L LI
Sbjct: 172 RST--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA- 228
Query: 649 AWQLLSDGKGLELIDPSLEQPCSANEVMRCIHV 681
++G EL +P P + + RC+ +
Sbjct: 229 -----TNGTP-ELQNPEKLSPIFRDFLNRCLEM 255
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 7e-20
Identities = 64/216 (29%), Positives = 110/216 (50%), Gaps = 10/216 (4%)
Query: 432 FSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVR 490
++ K+G+G G VY +A QEVAIK+++ NE+ ++ + +H N+V
Sbjct: 21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVN 80
Query: 491 LLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSR 550
L L G+E +V E++ SL + + ++ + + Q L +LH
Sbjct: 81 YLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN-- 134
Query: 551 LRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGI 610
+VIHRD+K+ NILL + K++DFG +S+ +T +VGT +M+PE
Sbjct: 135 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKA 191
Query: 611 VSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLI 646
K D++S G++ +E+V G+ + +P R L LI
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI 227
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 7e-20
Identities = 69/203 (33%), Positives = 105/203 (51%), Gaps = 19/203 (9%)
Query: 432 FSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKN---EVRLIAKLQHTN 487
FS ++G G FG VY + + + + VAIK++S S Q ++++ EVR + KL+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 488 LVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHK 547
++ GC L LV E+ + D + K L + + G QGL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 548 YSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM 607
++ +IHRD+KA NILL + K+ DFG A I + AN VGT +M+PE +
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM----APANX--FVGTPYWMAPEVIL 184
Query: 608 S---GIVSIKTDVFSFGVLVLEI 627
+ G K DV+S G+ +E+
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 9e-20
Identities = 80/270 (29%), Positives = 127/270 (47%), Gaps = 26/270 (9%)
Query: 437 KLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSL 496
+LG G FG V GK + +VAIK + S EF E +++ KL H LV+L G
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 497 HGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHR 556
+V E+M N L +L G++ + + + + +G+ YL + IHR
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKR--FQPSQLLEMCKDVCEGMAYLESK---QFIHR 124
Query: 557 DLKASNILLDDKMNPKISDFGMARIFEVNE--SEANTKRIVGTYGYMSPEYAMSGIVSIK 614
DL A N L+DD+ K+SDFG++R +E S +K V + PE + S K
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPV---RWSPPEVLLYSKFSSK 181
Query: 615 TDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSANE 674
+DV++FGVL+ E+ S K P + + +GL L P L A+E
Sbjct: 182 SDVWAFGVLMWEVYSLGK--------MPYERFNNSETVEKVSQGLRLYRPHL-----ASE 228
Query: 675 VMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ 704
+ I C ++A +RPT +++ ++
Sbjct: 229 KVYAIMYS--CWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-19
Identities = 61/218 (27%), Positives = 114/218 (52%), Gaps = 13/218 (5%)
Query: 432 FSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAKLQHTNLV 489
F+ ++G+G FG V+KG +Q VAIK + + +E + E+ ++++ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 490 RLLGCSLHGEERLLVYEFMPNKS-LDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
+ G L G + ++ E++ S LD R + + +++ I +GL YLH
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLL-----RAGPFDEFQIATMLKEILKGLDYLHSE 120
Query: 549 SRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMS 608
+ IHRD+KA+N+LL ++ + K++DFG+A ++ +++ VGT +M+PE
Sbjct: 121 KK---IHRDIKAANVLLSEQGDVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEVIQQ 175
Query: 609 GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLI 646
K D++S G+ +E+ G+ ++ HP R L LI
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI 213
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 1e-19
Identities = 60/202 (29%), Positives = 99/202 (49%), Gaps = 12/202 (5%)
Query: 436 NKLGEGGFGPVYKGKLADEQE-VAIKRLSRSSGQGIVEF-KNEVRLIAKLQHTNLVRLLG 493
+G G VY E VAIKR+ Q V+ + EV+ +++ H N+V+
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 494 CSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFI--IIEGISQGLLYLHKYSRL 551
+ G+E LV ++ SL + +S + L ++ I +++ + +GL YLH +
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGL--DEAIIATVLKEVLKGLEYLHSNGQ- 123
Query: 552 RVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKR--IVGTYGYMSPEYAMSG 609
IHRD+KA NILL + + KI+DFG++ R VGT +M+PE
Sbjct: 124 --IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQV 181
Query: 610 I-VSIKTDVFSFGVLVLEIVSG 630
K D++SFG+ +E+ +G
Sbjct: 182 HGYDFKADIWSFGITAIELATG 203
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-19
Identities = 68/214 (31%), Positives = 107/214 (50%), Gaps = 25/214 (11%)
Query: 437 KLGEGGFGPVYKGKL-----ADEQEVAIKRLSR-SSGQGIVEFKNEVRLIAKLQHTNLVR 490
+LGE FG +YKG L Q VAIK L ++ Q EF+ E L+A+L H N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 491 LLGCSLHGEERLLVYEFMPNKSLDFFLF--------------NSGRKNVLNWEKRFIIIE 536
LLG + +++E++ L FL + K+ L+ I
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR-IFEVNESEANTKRIV 595
I+ G+ YL + +H+DL A NIL+ ++++ KISD G++R I+ + K ++
Sbjct: 132 QIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 596 GTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+M PE M G S +D++SFGV++ EI S
Sbjct: 189 PIR-WMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 65/203 (32%), Positives = 103/203 (50%), Gaps = 18/203 (8%)
Query: 438 LGEGGFGPVY------KGKLADEQEVAIKRLSRSSG-QGIVEFKNEVRLIAKLQHTNLVR 490
LG+GGFG V GKL +++ KRL + G +G + E R++AK+ H+ +
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMV---EKRILAKV-HSRFIV 56
Query: 491 LLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEG-ISQGLLYLHKY 548
L + + L LV M L + ++N +N E R I GL +LH+
Sbjct: 57 SLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR 116
Query: 549 SRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMS 608
R+I+RDLK N+LLD+ N +ISD G+A E+ + ++ TK GT G+M+PE
Sbjct: 117 ---RIIYRDLKPENVLLDNDGNVRISDLGLA--VELKDGQSKTKGYAGTPGFMAPELLQG 171
Query: 609 GIVSIKTDVFSFGVLVLEIVSGQ 631
D F+ GV + E+++ +
Sbjct: 172 EEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 4e-19
Identities = 69/204 (33%), Positives = 108/204 (52%), Gaps = 27/204 (13%)
Query: 437 KLGEGGFGPVYKGK-LADEQEVAIKRLS-RSSGQGIVEFK-NEVRLIAKLQHTNLVRLLG 493
K+GEG +G VYK + + VA+K++ + +G+ E+ L+ +L H N+VRLL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 494 CSLHGEERL-LVYEFMPNKSLDFFL---FNSGRKNVLNWE--KRFI--IIEGISQGLLYL 545
+H E +L LV+EF LD L +S L+ K ++ +++GI+ Y
Sbjct: 66 V-VHSENKLYLVFEF-----LDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIA----YC 115
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEY 605
H S RV+HRDLK N+L+D + K++DFG+AR F V T +V T Y +PE
Sbjct: 116 H--SH-RVLHRDLKPQNLLIDREGALKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEI 170
Query: 606 AMSG-IVSIKTDVFSFGVLVLEIV 628
+ S D++S G + E+V
Sbjct: 171 LLGSRQYSTPVDIWSIGCIFAEMV 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 5e-19
Identities = 62/218 (28%), Positives = 110/218 (50%), Gaps = 13/218 (5%)
Query: 432 FSTTNKLGEGGFGPVYKGKLADEQEV-AIKRLSRSSGQGIVE-FKNEVRLIAKLQHTNLV 489
F+ K+G+G FG V+KG Q+V AIK + + +E + E+ ++++ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 490 RLLGCSLHGEERLLVYEFMPNKS-LDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
+ G L + ++ E++ S LD L+ + I+ I +GL YLH
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLL-----EPGPLDETQIATILREILKGLDYLHSE 120
Query: 549 SRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMS 608
+ IHRD+KA+N+LL + K++DFG+A ++ +++ VGT +M+PE
Sbjct: 121 KK---IHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEVIKQ 175
Query: 609 GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLI 646
K D++S G+ +E+ G+ H+ HP + L LI
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLI 213
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 5e-19
Identities = 67/203 (33%), Positives = 102/203 (50%), Gaps = 19/203 (9%)
Query: 432 FSTTNKLGEGGFGPVYKGKLADEQE-VAIKRLSRSSGQGIVEFKN---EVRLIAKLQHTN 487
F +++G G FG VY + E VA+K++S S Q ++++ EV+ + +L+H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 488 LVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHK 547
+ GC L LV E+ + D + K L + I G QGL YLH
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCLGSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHS 139
Query: 548 YSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM 607
++ IHRD+KA NILL + K++DFG A S AN+ VGT +M+PE +
Sbjct: 140 HNM---IHRDIKAGNILLTEPGQVKLADFGSASK----SSPANS--FVGTPYWMAPEVIL 190
Query: 608 S---GIVSIKTDVFSFGVLVLEI 627
+ G K DV+S G+ +E+
Sbjct: 191 AMDEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 5e-19
Identities = 60/217 (27%), Positives = 107/217 (49%), Gaps = 25/217 (11%)
Query: 438 LGEGGFGPVYK------GKLADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAKLQHTNLVR 490
LG G F Y+ G L ++V R + S + +VE + E+RL+A+L H +++R
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 491 LLGCSLHGEERLLVYEFMPNKSLDFFLFNSG--RKNVLNWEKRFIIIEGISQGLLYLHKY 548
+LG + L E+M S+ L G ++ V+ + E + +GL YLH+
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVII---NY--TEQLLRGLSYLHEN 122
Query: 549 SRLRVIHRDLKASNILLDDK-MNPKISDFGMARIFEVNESEAN--TKRIVGTYGYMSPEY 605
++IHRD+K +N+L+D +I+DFG A + A +++GT +M+PE
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV 179
Query: 606 AMSGIVSIKTDVFSFGVLVLEIVSGQ-----KNHTRH 637
DV+S G +++E+ + + + H+ H
Sbjct: 180 LRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH 216
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 6e-19
Identities = 63/206 (30%), Positives = 105/206 (50%), Gaps = 18/206 (8%)
Query: 438 LGEGGFGPV------YKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRL 491
LG+GGFG V GK+ +++ KRL + SG+ + + E+ + K+ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI--LEKVNSPFIVNL 58
Query: 492 LGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRL 551
LV M L + ++N G + L E+ I+ G+L+LH +
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERG-LEMERVIHYSAQITCGILHLHS---M 114
Query: 552 RVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIV 611
+++RD+K N+LLDD+ N ++SD G+A E+ + + T+R GT GYM+PE
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQR-AGTNGYMAPEILKEEPY 171
Query: 612 SIKTDVFSFGVLVLEIVSGQ---KNH 634
S D F+ G + E+V+G+ K+H
Sbjct: 172 SYPVDWFAMGCSIYEMVAGRTPFKDH 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 8e-19
Identities = 64/207 (30%), Positives = 103/207 (49%), Gaps = 16/207 (7%)
Query: 437 KLGEGGFGPVYKGKLADEQ----EVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLL 492
K+GEG G V +A E+ +VA+K + Q NEV ++ QH N+V +
Sbjct: 28 KIGEGSTGIVC---IAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMY 84
Query: 493 GCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLR 552
L GEE ++ EF+ +L + + LN E+ + E + Q L YLH
Sbjct: 85 KSYLVGEELWVLMEFLQGGALT----DIVSQTRLNEEQIATVCESVLQALCYLHSQG--- 137
Query: 553 VIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVS 612
VIHRD+K+ +ILL K+SDFG ++++ K +VGT +M+PE
Sbjct: 138 VIHRDIKSDSILLTLDGRVKLSDFGFCA--QISKDVPKRKSLVGTPYWMAPEVISRTPYG 195
Query: 613 IKTDVFSFGVLVLEIVSGQKNHTRHHP 639
+ D++S G++V+E+V G+ + P
Sbjct: 196 TEVDIWSLGIMVIEMVDGEPPYFSDSP 222
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-18
Identities = 83/278 (29%), Positives = 132/278 (47%), Gaps = 45/278 (16%)
Query: 438 LGEGGFGPVYKGKLADEQE-----VAIKRL-SRSSGQGIVEFKNEVRLIAKLQHTNLVRL 491
LG G FG VYKG + E VAIK L +S + E +E ++A + + RL
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 492 LGCSLHGEERLLVYEFMPNKSL-DFFLFNSGR---KNVLNWEKRFIIIEGISQGLLYLHK 547
LG L +L V + MP L D+ N R +++LNW + I++G+ YL +
Sbjct: 75 LGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYLEE 127
Query: 548 YSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM 607
+R++HRDL A N+L+ + KI+DFG+AR+ +++E+E + +M+ E +
Sbjct: 128 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184
Query: 608 SGIVSIKTDVFSFGVLVLEIVS-GQKNH----TRHHPDRPLNLIGYAWQLLSDGKGLELI 662
+ ++DV+S+GV V E+++ G K + R PD LL G+
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPD-----------LLEKGE----- 228
Query: 663 DPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVV 700
L QP + I V C + RP E+V
Sbjct: 229 --RLPQPPICTIDVYMIMVK--CWMIDSECRPRFRELV 262
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 54/183 (29%), Positives = 89/183 (48%), Gaps = 30/183 (16%)
Query: 436 NKLGEGGFGPVYKGK-LADEQEVAIKRL---SRSSGQGIVEFK--NEVRLIAKLQHTNLV 489
KLGEG + VYK + + VAIK++ R + + F E++L+ +L+H N++
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 490 RLLGCSLHGEERLLVYEFMP--------NKSLDFFLFNSGRKNVLNWEKRFIIIEGISQG 541
LL H LV+EFM +KS+ ++ ++ +G
Sbjct: 66 GLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVL-----TPADIKSYMLM------TLRG 114
Query: 542 LLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYM 601
L YLH ++HRDLK +N+L+ K++DFG+AR F + + T ++V T Y
Sbjct: 115 LEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSF-GSPNRKMTHQVV-TRWYR 169
Query: 602 SPE 604
+PE
Sbjct: 170 APE 172
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 2e-18
Identities = 69/206 (33%), Positives = 111/206 (53%), Gaps = 17/206 (8%)
Query: 431 NFSTTNKLGEGGFGPVYKGK-LADEQEVAIK--RLSRSSGQGIVEFK-NEVRLIAKLQHT 486
NF K+GEG +G VYK + + VA+K RL + +G+ E+ L+ +L H
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHP 59
Query: 487 NLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNV-LNWEKRFIIIEGISQGLLY 544
N+V+LL +H E +L LV+EF+ ++ L F+ S + L K ++ + QGL +
Sbjct: 60 NIVKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLF--QLLQGLAF 115
Query: 545 LHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPE 604
H + RV+HRDLK N+L++ + K++DFG+AR F V T +V T Y +PE
Sbjct: 116 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPE 170
Query: 605 YAM-SGIVSIKTDVFSFGVLVLEIVS 629
+ S D++S G + E+V+
Sbjct: 171 ILLGCKYYSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 60/203 (29%), Positives = 100/203 (49%), Gaps = 12/203 (5%)
Query: 431 NFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLV 489
K+GEG G V + ++VA+K++ Q NEV ++ QH N+V
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIV 79
Query: 490 RLLGCSLHGEERLLVYEFMPNKSL-DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
+ L G+E +V EF+ +L D + R +N E+ + + + L +LH
Sbjct: 80 EMYSSYLVGDELWVVMEFLEGGALTD--IVTHTR---MNEEQIATVCLAVLKALSFLHAQ 134
Query: 549 SRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMS 608
VIHRD+K+ +ILL K+SDFG +V++ K +VGT +M+PE
Sbjct: 135 ---GVIHRDIKSDSILLTSDGRVKLSDFGFCA--QVSKEVPRRKSLVGTPYWMAPEVISR 189
Query: 609 GIVSIKTDVFSFGVLVLEIVSGQ 631
+ D++S G++V+E+V G+
Sbjct: 190 LPYGTEVDIWSLGIMVIEMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 64/206 (31%), Positives = 98/206 (47%), Gaps = 15/206 (7%)
Query: 438 LGEGGFGPV------YKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRL 491
LG+GGFG V GK+ +++ KR+ + G+ + NE R++ K+ +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKRILEKVNSRFVVSL 65
Query: 492 LGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRL 551
+ LV M L F ++N G F E + GL L R
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAE-LCCGLEDLQ---RE 121
Query: 552 RVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIV 611
R+++RDLK NILLDD+ + +ISD G+A ++ E E R VGT GYM+PE +
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLA--VQIPEGETVRGR-VGTVGYMAPEVINNEKY 178
Query: 612 SIKTDVFSFGVLVLEIVSGQKNHTRH 637
+ D + G L+ E++ GQ +
Sbjct: 179 TFSPDWWGLGCLIYEMIQGQSPFRKR 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 2e-18
Identities = 65/197 (32%), Positives = 99/197 (50%), Gaps = 11/197 (5%)
Query: 437 KLGEGGFGPVYKGKL-ADEQEVAIKRLSRSSGQGI-VEFKNEVRLIAKLQHTNLVRLLGC 494
++G G FG V+ G+L AD VA+K + + +F E R++ + H N+VRL+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 495 SLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVI 554
+ +V E + FL G + L ++ ++E + G+ YL I
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFLRTEGPR--LKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 555 HRDLKASNILLDDKMNPKISDFGMARIFE--VNESEANTKRIVGTYGYMSPEYAMSGIVS 612
HRDL A N L+ +K KISDFGM+R E V S K+I + +PE G S
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI--PVKWTAPEALNYGRYS 174
Query: 613 IKTDVFSFGVLVLEIVS 629
++DV+SFG+L+ E S
Sbjct: 175 SESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 3e-18
Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 40/202 (19%)
Query: 430 NNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRL---SRSSGQGIVEFKNEVRLIAKLQH 485
++ KLGEG FG VYK ++ + VA+K++ + G I + E++++ KL+H
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKLKH 66
Query: 486 TNLVRLLGCSL-----HGEERLLVYEFMPNKSLDF--FLFN-------SGRKNVLNWEKR 531
N+V L+ ++ +R VY P D L N S K
Sbjct: 67 PNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKC------- 119
Query: 532 FIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVN------ 585
+ + +G+ YLH+ ++HRD+KA+NIL+D++ KI+DFG+AR ++
Sbjct: 120 --YMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKG 174
Query: 586 ---ESEANTKRIVGTYGYMSPE 604
+V T Y PE
Sbjct: 175 GGGGGTRKYTNLVVTRWYRPPE 196
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 3e-18
Identities = 66/239 (27%), Positives = 118/239 (49%), Gaps = 12/239 (5%)
Query: 410 DQSISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQ 468
D+ I +L+ ++ ++ K+G+G G VY +A QEVAIK+++
Sbjct: 1 DEEILEKLR--SIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP 58
Query: 469 GIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNW 528
NE+ ++ + ++ N+V L L G+E +V E++ SL + + ++
Sbjct: 59 KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDE 114
Query: 529 EKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE 588
+ + Q L +LH +VIHRD+K+ NILL + K++DFG +S+
Sbjct: 115 GQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171
Query: 589 ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIG 647
+T +VGT +M+PE K D++S G++ +E+V G+ + +P R L LI
Sbjct: 172 RST--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA 228
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 4e-18
Identities = 60/217 (27%), Positives = 105/217 (48%), Gaps = 17/217 (7%)
Query: 435 TNKLGEGGFGPVYKGKLADE-QEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLG 493
+LG+G FG VYK + + A K + S + + +F E+ ++++ +H N+V L
Sbjct: 10 IGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYE 69
Query: 494 CSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRV 553
+ + ++ EF +LD + R L + + + + L +LH + +V
Sbjct: 70 AYFYENKLWILIEFCDGGALDSIMLELER--GLTEPQIRYVCRQMLEALNFLHSH---KV 124
Query: 554 IHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKR--IVGTYGYMSPEYAM---- 607
IHRDLKA NILL + K++DFG++ N+S KR +GT +M+PE
Sbjct: 125 IHRDLKAGNILLTLDGDVKLADFGVS---AKNKSTLQ-KRDTFIGTPYWMAPEVVACETF 180
Query: 608 -SGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPL 643
K D++S G+ ++E+ + H +P R L
Sbjct: 181 KDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL 217
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 4e-18
Identities = 67/206 (32%), Positives = 113/206 (54%), Gaps = 15/206 (7%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADEQE-VAIKRLSRSSGQGIVEFK-NEVRLIAKLQHTNL 488
NF KLGEG + VYKG+ E VA+K + + +G E+ L+ +L+H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 489 VRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVL--NWEKRFIIIEGISQGLLYL 545
VRL +H E +L LV+E+M +K L ++ G + L N K F + +G+ +
Sbjct: 61 VRLHDV-IHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFT--YQLLKGIAFC 116
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEY 605
H+ RV+HRDLK N+L++ + K++DFG+AR F + + + + V T Y +P+
Sbjct: 117 HEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNE--VVTLWYRAPDV 171
Query: 606 AM-SGIVSIKTDVFSFGVLVLEIVSG 630
+ S S D++S G ++ E+++G
Sbjct: 172 LLGSRTYSTSIDIWSVGCIMAEMITG 197
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 4e-18
Identities = 65/200 (32%), Positives = 98/200 (49%), Gaps = 15/200 (7%)
Query: 438 LGEGGFGPV------YKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRL 491
LG+GGFG V GK+ +++ KR+ + G+ + NE +++ K+ +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNSRFVVSL 65
Query: 492 LGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRL 551
+ LV M L F ++N G F E I+ GL LH R
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAE-ITCGLEDLH---RE 121
Query: 552 RVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIV 611
R+++RDLK NILLDD + +ISD G+A E+ E E R VGT GYM+PE +
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLA--VEIPEGETIRGR-VGTVGYMAPEVVKNERY 178
Query: 612 SIKTDVFSFGVLVLEIVSGQ 631
+ D + G L+ E++ G+
Sbjct: 179 TFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 5e-18
Identities = 63/208 (30%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTN- 487
+ T + LG G G V K K V K++ + V K +R + +
Sbjct: 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVR-KQILRELQIMHECRS 62
Query: 488 --LVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSG--RKNVLNWEKRFIIIEGISQGLL 543
+V G L+ + EFM SLD G +L I + +GL
Sbjct: 63 PYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLT 117
Query: 544 YLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSP 603
YL Y+ R++HRD+K SNIL++ + K+ DFG++ E+ S A+T VGT YMSP
Sbjct: 118 YL--YNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSG--ELINSIADT--FVGTSTYMSP 171
Query: 604 EYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
E G ++K+DV+S G+ ++E+ G+
Sbjct: 172 ERIQGGKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 5e-18
Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 22/212 (10%)
Query: 437 KLGEGGFGPVYKGK------LADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVR 490
+LGEG FG V+ + D+ VA+K L + +F+ E L+ LQH ++V+
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 491 LLGCSLHGEERLLVYEFMPNKSLDFFLFNSG-------------RKNVLNWEKRFIIIEG 537
G G+ ++V+E+M + L+ FL G K L + I
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 538 ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT 597
I+ G++YL + +HRDL N L+ + KI DFGM+R + +
Sbjct: 132 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188
Query: 598 YGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+M PE M + ++DV+SFGV++ EI +
Sbjct: 189 IRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 84.4 bits (208), Expect = 8e-18
Identities = 62/239 (25%), Positives = 117/239 (48%), Gaps = 12/239 (5%)
Query: 410 DQSISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQ 468
D+ I +L+ ++ ++ K+G+G G VY +A QEVAI++++
Sbjct: 2 DEEILEKLR--SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP 59
Query: 469 GIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNW 528
NE+ ++ + ++ N+V L L G+E +V E++ SL + + ++
Sbjct: 60 KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDE 115
Query: 529 EKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE 588
+ + Q L +LH +VIHRD+K+ NILL + K++DFG ++ +
Sbjct: 116 GQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQ 170
Query: 589 ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIG 647
+ +VGT +M+PE K D++S G++ +E++ G+ + +P R L LI
Sbjct: 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA 229
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 67/210 (31%), Positives = 106/210 (50%), Gaps = 19/210 (9%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADE-QEVAIKRL-----SRSSGQGIVEFKNEVRLIAKLQ 484
N+ LG G FG VY AD +E+A+K++ S+ + + + + E++L+ L+
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 485 HTNLVRLLGCSLHGEERLL--VYEFMPNKSLDFFL--FNSGRKNVLNWEKRFIIIEGISQ 540
H +V+ GC EE+ L E+MP S+ L + + +NV R I+ Q
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQIL-----Q 117
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMA-RIFEVNESEANTKRIVGTYG 599
G+ YLH ++HRD+K +NIL D N K+ DFG + RI + S K + GT
Sbjct: 118 GVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPY 174
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+MSPE K DV+S V+E+++
Sbjct: 175 WMSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 62/219 (28%), Positives = 107/219 (48%), Gaps = 25/219 (11%)
Query: 437 KLGEGGFGPVYKGKLADEQEVAI-KRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCS 495
+LG+G FG VYK K + +A K + S + + ++ E+ ++A H +V+LLG
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 496 LHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIH 555
+ ++ EF P ++D + R L + +I + + L YLH +++IH
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVICRQMLEALQYLHS---MKIIH 133
Query: 556 RDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI------VGTYGYMSPEYAMSG 609
RDLKA N+LL + K++DFG+ S N K + +GT +M+PE M
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGV--------SAKNVKTLQRRDSFIGTPYWMAPEVVMCE 185
Query: 610 IVS-----IKTDVFSFGVLVLEIVSGQKNHTRHHPDRPL 643
+ K D++S G+ ++E+ + H +P R L
Sbjct: 186 TMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL 224
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 1e-17
Identities = 65/208 (31%), Positives = 109/208 (52%), Gaps = 20/208 (9%)
Query: 432 FSTTNKLGEGGFGPVYKGKLADEQE-----VAIKRLSR-SSGQGIVEFKNEVRLIAKLQH 485
F LG G FG VYKG E E VAIK L +S + E +E ++A + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 486 TNLVRLLGCSLHGEERLLVYEFMPNKSL-DFFLFNS---GRKNVLNWEKRFIIIEGISQG 541
++ RLLG L +L + + MP L D+ + G + +LNW + I++G
Sbjct: 69 PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 121
Query: 542 LLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYM 601
+ YL + R++HRDL A N+L+ + KI+DFG+A++ +E E + + +M
Sbjct: 122 MNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWM 178
Query: 602 SPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+ E + I + ++DV+S+GV V E+++
Sbjct: 179 ALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 66/239 (27%), Positives = 98/239 (41%), Gaps = 32/239 (13%)
Query: 428 AANNFSTTNKLGEGGFGPVYKGKLADE-QEVAIKRLSRSSGQGIVEFKNEVRLIAKL-QH 485
F +GEG +G VYK + Q VAIK + E K E ++ K H
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD-IIEDEEEEIKEEYNILRKYSNH 62
Query: 486 TNLVRLLGCSL------HGEERLLVYEFMPNKSL-DFFLFNSGRKNVLNWEKRF------ 532
N+ G + + ++ LV E S+ D K + KR
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV------KGLRKKGKRLKEEWIA 116
Query: 533 IIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTK 592
I+ +GL YLH+ +VIHRD+K NILL K+ DFG++ + NT
Sbjct: 117 YILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT- 172
Query: 593 RIVGTYGYMSPE-----YAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLI 646
+GT +M+PE ++DV+S G+ +E+ G+ HP R L I
Sbjct: 173 -FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKI 230
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 61/213 (28%), Positives = 100/213 (46%), Gaps = 30/213 (14%)
Query: 432 FSTTNKLGEGGFGPVYKGKLADEQE-VAIKRLSRSSGQGIVEFKN--------EVRLIAK 482
+ +LG+G FG VY + + E VAIK++ + +F + EV+ + K
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKK-------KFYSWEECMNLREVKSLRK 53
Query: 483 LQ-HTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQG 541
L H N+V+L +E V+E+M +L + L + + II I QG
Sbjct: 54 LNEHPNIVKLKEVFRENDELYFVFEYM-EGNL-YQLMKDRKGKPFSESVIRSIIYQILQG 111
Query: 542 LLYLHK--YSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
L ++HK + HRDLK N+L+ KI+DFG+AR E+ T V T
Sbjct: 112 LAHIHKHGF-----FHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTD-YVSTRW 163
Query: 600 YMSPEYAM-SGIVSIKTDVFSFGVLVLEIVSGQ 631
Y +PE + S S D+++ G ++ E+ + +
Sbjct: 164 YRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 72/259 (27%), Positives = 120/259 (46%), Gaps = 34/259 (13%)
Query: 437 KLGEGGFGPV------YKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVR 490
K+GEG G V GKL VA+K++ Q NEV ++ QH N+V
Sbjct: 27 KIGEGSTGIVCIATVKSSGKL-----VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 81
Query: 491 LLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSR 550
+ L G+E +V EF+ +L + ++ +N E+ + + + L LH
Sbjct: 82 MYNSYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLKALSVLHAQG- 136
Query: 551 LRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGI 610
VIHRD+K+ +ILL K+SDFG +V++ K +VGT +M+PE
Sbjct: 137 --VIHRDIKSDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKSLVGTPYWMAPELISRLP 192
Query: 611 VSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLE--- 667
+ D++S G++V+E+V G+ + P + + +I L K L + PSL+
Sbjct: 193 YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD--NLPPKLKNLHKVSPSLKGFL 250
Query: 668 ---------QPCSANEVMR 677
Q +A E+++
Sbjct: 251 DRLLVRDPAQRATAAELLK 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 58/213 (27%), Positives = 101/213 (47%), Gaps = 22/213 (10%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKN---------EVRL 479
NF K+G+G F VYK L D + VA+K++ I E + E+ L
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQ------IFEMMDAKARQDCLKEIDL 55
Query: 480 IAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKR-FIIIEGI 538
+ +L H N+++ L + E +V E L + + ++ L E+ + +
Sbjct: 56 LKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL 115
Query: 539 SQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTY 598
L ++H S+ R++HRD+K +N+ + K+ D G+ R F + A++ VGT
Sbjct: 116 CSALEHMH--SK-RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL--VGTP 170
Query: 599 GYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
YMSPE + K+D++S G L+ E+ + Q
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 64/201 (31%), Positives = 99/201 (49%), Gaps = 17/201 (8%)
Query: 438 LGEGGFGPV------YKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRL 491
LG+GGFG V GK+ +++ KR+ + G+ + NE +++ K+ +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA--LNEKQILEKVNSRFVVSL 65
Query: 492 LGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRL 551
+ LV M L F +++ G F E I GL LH +
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAE-ICCGLEDLH---QE 121
Query: 552 RVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANT-KRIVGTYGYMSPEYAMSGI 610
R+++RDLK NILLDD + +ISD G+A V+ E T K VGT GYM+PE +
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLA----VHVPEGQTIKGRVGTVGYMAPEVVKNER 177
Query: 611 VSIKTDVFSFGVLVLEIVSGQ 631
+ D ++ G L+ E+++GQ
Sbjct: 178 YTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 4e-17
Identities = 67/202 (33%), Positives = 109/202 (53%), Gaps = 17/202 (8%)
Query: 436 NKLGEGGFGPVYKG--KLADEQEVAIK--RLSRSSGQGIVEFKNEVRLIAKLQHTNLVRL 491
+KLGEG + VYKG KL D VA+K RL G + EV L+ L+H N+V L
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTL 69
Query: 492 LGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSR 550
+H E+ L LV+E++ +K L +L + G N +N + + + +GL Y H R
Sbjct: 70 HDI-IHTEKSLTLVFEYL-DKDLKQYLDDCG--NSINMHNVKLFLFQLLRGLNYCH---R 122
Query: 551 LRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM-SG 609
+V+HRDLK N+L++++ K++DFG+AR + + + V T Y P+ + S
Sbjct: 123 RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNE--VVTLWYRPPDILLGST 180
Query: 610 IVSIKTDVFSFGVLVLEIVSGQ 631
S + D++ G + E+ +G+
Sbjct: 181 DYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 4e-17
Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 21/204 (10%)
Query: 438 LGEGGFGPVYKGKLADEQ-EVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSL 496
LG+G +G VY + Q +AIK + + + E+ L + L+H N+V+ LG
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 497 HGEERLLVYEFMPNKSLDFFLFN-----SGRKNVLNWEKRFIIIEGISQGLLYLHKYSRL 551
+ E +P SL L + + + + + I+ +GL YLH
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL-----EGLKYLHD---N 127
Query: 552 RVIHRDLKASNILLDDKMNP-KISDFGMA-RIFEVNESEANTKRIVGTYGYMSPEYAMSG 609
+++HRD+K N+L++ KISDFG + R+ +N T+ GT YM+PE G
Sbjct: 128 QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC---TETFTGTLQYMAPEVIDKG 184
Query: 610 I--VSIKTDVFSFGVLVLEIVSGQ 631
D++S G ++E+ +G+
Sbjct: 185 PRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 5e-17
Identities = 62/201 (30%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 441 GGFGPVYKG-KLADEQEVAIKRLSRSSGQG---IVEFKNEVRLIAKLQHTNLVRLLGCSL 496
G +G V+ K + AIK + ++ + + E ++++ Q +V+L S
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-YSF 62
Query: 497 HGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIH 555
G++ L LV E++P L L N G L+ + I I I L YLH +IH
Sbjct: 63 QGKKNLYLVMEYLPGGDLASLLENVG---SLDEDVARIYIAEIVLALEYLHSNG---IIH 116
Query: 556 RDLKASNILLDDKMNPKISDFG------MARIFEVNESEANTKRIVGTYGYMSPEYAMSG 609
RDLK NIL+D + K++DFG + R +N+ E KRIVGT Y++PE +
Sbjct: 117 RDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQ 176
Query: 610 IVSIKTDVFSFGVLVLEIVSG 630
S D +S G ++ E + G
Sbjct: 177 GHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 5e-17
Identities = 66/202 (32%), Positives = 107/202 (52%), Gaps = 16/202 (7%)
Query: 438 LGEGGFGPVY------KGKLADEQEVAIKRLS-RSSGQGIVEFKNEVRLIAKLQHTNLVR 490
LGEG FG V +G EQ VA+K L S G I + K E+ ++ L H N+V+
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQ-VAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 491 LLG-CSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
G C+ G + L+ EF+P+ SL +L KN +N +++ I +G+ YL
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLKQQLKYAVQICKGMDYLG-- 126
Query: 549 SRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT-YGYMSPEYAM 607
SR + +HRDL A N+L++ + KI DFG+ + E ++ K + + + +PE +
Sbjct: 127 SR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185
Query: 608 SGIVSIKTDVFSFGVLVLEIVS 629
I +DV+SFGV + E+++
Sbjct: 186 QSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 6e-17
Identities = 83/277 (29%), Positives = 128/277 (46%), Gaps = 40/277 (14%)
Query: 438 LGEGGFGPVYKGKLAD----EQEVAIKRLSRSSGQGIVE-FKNEVRLIAKLQHTNLVRLL 492
+G+G FG VY G L D + A+K L+R + VE F E ++ H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 493 GCSLHGE-ERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEG--ISQGLLYLHKYS 549
G L E L+V +M + L F+ + N + +I G +++G+ YL +
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETH----NPTVKDLIGFGLQVAKGMEYL---A 115
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMAR-IFEVN-ESEANTKRIVGTYGYMSPEYAM 607
+ +HRDL A N +LD+ K++DFG+AR I++ S N +M+ E
Sbjct: 116 SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175
Query: 608 SGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRP----LNLIGYAWQLLSDGKGLELID 663
+ + K+DV+SFGVL+ E++ TR P P ++ Y Q G L+
Sbjct: 176 TQKFTTKSDVWSFGVLLWELM------TRGAPPYPDVDSFDITVYLLQ------GRRLLQ 223
Query: 664 PSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVV 700
P P EVM L C + RPT E+V
Sbjct: 224 PEY-CPDPLYEVM------LSCWHPKPEMRPTFSELV 253
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 6e-17
Identities = 62/198 (31%), Positives = 104/198 (52%), Gaps = 23/198 (11%)
Query: 438 LGEGGFGPV----YKGKLADEQEVAIKRLSR-SSGQGIVEFKNEVRLIAKLQHTNLVRLL 492
+G+G FG V Y+G +VA+K + ++ Q F E ++ +L+H+NLV+LL
Sbjct: 14 IGKGEFGDVMLGDYRGN-----KVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLL 65
Query: 493 GCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRL 551
G + + L +V E+M SL +L + GR +VL + + + + YL +
Sbjct: 66 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEANN-- 122
Query: 552 RVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIV 611
+HRDL A N+L+ + K+SDFG+ + E + ++ K V + +PE
Sbjct: 123 -FVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLPV---KWTAPEALREKKF 176
Query: 612 SIKTDVFSFGVLVLEIVS 629
S K+DV+SFG+L+ EI S
Sbjct: 177 STKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 6e-17
Identities = 53/203 (26%), Positives = 91/203 (44%), Gaps = 25/203 (12%)
Query: 438 LGEGGFGPVYKGKLADEQEV-AIKRLSRSSGQGIVE------FKNEVRLIAKLQHTNLVR 490
LG GGFG V K+ + A+K + + IVE +E ++ + H +V+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRH---IVETGQQEHIFSEKEILEECNHPFIVK 57
Query: 491 LLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVL--NWEKRFIIIEGISQGLLYLHK 547
L + ++ + ++ E+ L + R L + RF I + YLH
Sbjct: 58 LY-RTFKDKKYIYMLMEYCLGGEL----WTILRDRGLFDEYTARFYI-ACVVLAFEYLH- 110
Query: 548 YSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM 607
+I+RDLK N+LLD K+ DFG A+ + + T GT Y++PE +
Sbjct: 111 --NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIIL 165
Query: 608 SGIVSIKTDVFSFGVLVLEIVSG 630
+ D +S G+L+ E+++G
Sbjct: 166 NKGYDFSVDYWSLGILLYELLTG 188
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 8e-17
Identities = 65/230 (28%), Positives = 105/230 (45%), Gaps = 18/230 (7%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKL-QHTN 487
A F +G G +G VYKG+ ++A ++ +G E K E+ ++ K H N
Sbjct: 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRN 64
Query: 488 LVRLLGCSLH------GEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQG 541
+ G + ++ LV EF S+ + N+ + N L E I I +G
Sbjct: 65 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRG 123
Query: 542 LLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYM 601
L +LH++ +VIHRD+K N+LL + K+ DFG++ + NT +GT +M
Sbjct: 124 LSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWM 178
Query: 602 SPEYAM-----SGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLI 646
+PE K+D++S G+ +E+ G HP R L LI
Sbjct: 179 APEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI 228
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 8e-17
Identities = 64/203 (31%), Positives = 106/203 (52%), Gaps = 14/203 (6%)
Query: 437 KLGEGGFGPVYKG--KLADEQ-EVAIKRLSRSSGQGIV-EFKNEVRLIAKLQHTNLVRLL 492
+LG G FG V KG K+ +Q +VAIK L + + + E E ++ +L + +VR++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 493 GCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLR 552
G E +LV E L+ FL SG+K+ + ++ +S G+ YL +
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKN--- 115
Query: 553 VIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTY--GYMSPEYAMSGI 610
+HRDL A N+LL ++ KISDFG+++ ++S R G + + +PE
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY-KARSAGKWPLKWYAPECINFRK 174
Query: 611 VSIKTDVFSFGVLVLEIVS-GQK 632
S ++DV+S+G+ + E S GQK
Sbjct: 175 FSSRSDVWSYGITMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 9e-17
Identities = 61/220 (27%), Positives = 109/220 (49%), Gaps = 12/220 (5%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADEQEVA-IKRLSRSSGQGIVEFKNEVRLIAKLQHTNLV 489
+F ++G G +G VYK + + E+A IK + G+ + E+ ++ +H+N+V
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIV 69
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
G L ++ + EF SL +G + + ++ E + QGL YLH
Sbjct: 70 AYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSES--QIAYVSRETL-QGLYYLHSKG 126
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM-- 607
+ +HRD+K +NILL D + K++DFG++ ++ + A K +GT +M+PE A
Sbjct: 127 K---MHRDIKGANILLTDNGHVKLADFGVSA--QITATIAKRKSFIGTPYWMAPEVAAVE 181
Query: 608 -SGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLI 646
G + D+++ G+ +E+ Q HP R L L+
Sbjct: 182 RKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM 221
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 1e-16
Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 25/210 (11%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQE-VAIKRLSRSSGQGIVEFKNEVRLIAK----LQ 484
+F ++G+GG+G V+ K D E VA+KR+ +S ++ NEVR + L
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKS----LLFKLNEVRHVLTERDILT 56
Query: 485 HTN---LVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVL-NWEKRFIIIEGISQ 540
T LV+LL E L E++P L N G VL RF + E +
Sbjct: 57 TTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLG---VLSEDHARFYMAEMF-E 112
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGY 600
+ LH L IHRDLK N L+D + K++DFG+++ + AN+ +VG+ Y
Sbjct: 113 AVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGI---VTYANS--VVGSPDY 164
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
M+PE D +S G ++ E + G
Sbjct: 165 MAPEVLRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 2e-16
Identities = 67/212 (31%), Positives = 107/212 (50%), Gaps = 28/212 (13%)
Query: 431 NFSTTNKLGEGGFGPVY--KGKLADEQEVAIKR--LSRSSGQGIVEFKNEVRLIAKLQHT 486
+ K+GEG FG +Y K K +D + IK L++ + K EV L+AK++H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 487 NLVRLLGCSLHGEERL-LVYEFMPNKSL-------DFFLFNSGRKNVLNWEKRFIIIEGI 538
N+V S RL +V E+ L LF+ + +L+W F+ I
Sbjct: 60 NIVTFFA-SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQ--ILSW---FV---QI 110
Query: 539 SQGLLYLHKYSRLRVIHRDLKASNILLD-DKMNPKISDFGMARIFEVNESEANTKRIVGT 597
S GL ++H +++HRD+K+ NI L + M K+ DFG+AR +N+S VGT
Sbjct: 111 SLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELAYTCVGT 165
Query: 598 YGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
Y+SPE + + KTD++S G ++ E+ +
Sbjct: 166 PYYLSPEICQNRPYNNKTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 64/220 (29%), Positives = 109/220 (49%), Gaps = 28/220 (12%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADE---QEVAIKRLSRSSGQGI-VEFKNEVRLIAKL-Q 484
N+ + +GEG FG V K ++ + + AIKR+ + + +F E+ ++ KL
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66
Query: 485 HTNLVRLLGCSLHGEERLLVYEFMPNKSL-DF------------FLFNSGRKNVLNWEKR 531
H N++ LLG H L E+ P+ +L DF F + + L+ ++
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 532 FIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANT 591
+++G+ YL S+ + IHRDL A NIL+ + KI+DFG++R E
Sbjct: 127 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYV 178
Query: 592 KRIVGTYG--YMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
K+ +G +M+ E + + +DV+S+GVL+ EIVS
Sbjct: 179 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-16
Identities = 61/221 (27%), Positives = 110/221 (49%), Gaps = 12/221 (5%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVA-IKRLSRSSGQGIVEFKNEVRLIAKLQHTNL 488
+++ ++G G +G VYK + E+A +K + G + E+ ++ + +H N+
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNI 68
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
V G L E+ + E+ SL +G + L + ++ E + QGL YLH
Sbjct: 69 VAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSEL--QIAYVCRETL-QGLAYLHSK 125
Query: 549 SRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM- 607
++ HRD+K +NILL D + K++DFG+A ++ + A K +GT +M+PE A
Sbjct: 126 GKM---HRDIKGANILLTDNGDVKLADFGVAA--KITATIAKRKSFIGTPYWMAPEVAAV 180
Query: 608 --SGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLI 646
+G + D+++ G+ +E+ Q HP R L L+
Sbjct: 181 EKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM 221
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 56/206 (27%), Positives = 90/206 (43%), Gaps = 11/206 (5%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQE-VAIKRLSRSSGQGIVEFK--NEVRLIAKLQHT 486
N + +GEG +G V K + E VAIK+ S V+ EV+++ +L+H
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 487 NLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLH 546
N+V L LV+E++ L+ L + I + Q + Y H
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYVERTLLELL---EASPGGLPPDAVRSYIWQLLQAIAYCH 117
Query: 547 KYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYA 606
+IHRD+K NIL+ + K+ DFG AR + T V T Y +PE
Sbjct: 118 ---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD-YVATRWYRAPELL 173
Query: 607 MSGIVSIK-TDVFSFGVLVLEIVSGQ 631
+ K DV++ G ++ E++ G+
Sbjct: 174 VGDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 438 LGEGGFGPVY------KGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRL 491
LG+G FG VY G+ ++V S + + + + E++L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 492 LGC-SLHGEERLLVY-EFMPNKSLDFFL--FNSGRKNVLNWEKRFIIIEGISQGLLYLHK 547
GC E+ L ++ E+MP S+ L + + ++V R I+ +G+ YLH
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQIL-----EGMSYLHS 124
Query: 548 YSRLRVIHRDLKASNILLDDKMNPKISDFGMA-RIFEVNESEANTKRIVGTYGYMSPEYA 606
++HRD+K +NIL D N K+ DFG + R+ + S + + GT +MSPE
Sbjct: 125 N---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVI 181
Query: 607 MSGIVSIKTDVFSFGVLVLEIVS 629
K DV+S G V+E+++
Sbjct: 182 SGEGYGRKADVWSLGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 80/304 (26%), Positives = 126/304 (41%), Gaps = 46/304 (15%)
Query: 433 STTNKLGEGGFGPVY----------------KGKLADEQE-VAIKRLSRS-SGQGIVEFK 474
+ KLGEG FG V+ + AD VA+K L S +F
Sbjct: 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67
Query: 475 NEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNS-GRKNVLNWEKRFI 533
EV+++++L N+ RLLG ++ E+M N L+ FL + L + +
Sbjct: 68 KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127
Query: 534 -------IIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586
+ I+ G+ YL L +HRDL N L+ KI+DFGM+R N
Sbjct: 128 SFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSR----NL 180
Query: 587 SEANTKRIVGT----YGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDR 641
++ R+ G +M+ E + G + K+DV++FGV + EI++ ++ H D+
Sbjct: 181 YSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240
Query: 642 PLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVC 701
+I A D + P E+M L C + DRPT E+
Sbjct: 241 --QVIENAGHFFRDDGRQIYLPRPPNCPKDIYELM------LECWRRDEEDRPTFREIHL 292
Query: 702 MLQN 705
LQ
Sbjct: 293 FLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 65/213 (30%), Positives = 98/213 (46%), Gaps = 31/213 (14%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEV-AIKRLSRSSGQGIVEFK------NEVRLIAK 482
++F LG G FG V + + A+K LS+ IV+ K NE R++
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSK---AKIVKLKQVEHVLNEKRILQS 57
Query: 483 LQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGL 542
++H LV L G LV E++P L L SGR RF + + L
Sbjct: 58 IRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFP--EPVARFYAAQ-VVLAL 114
Query: 543 LYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMS 602
YLH L +++RDLK N+LLD KI+DFG A+ + T + GT Y++
Sbjct: 115 EYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRV-----KGRTYTLCGTPEYLA 166
Query: 603 PEYAMSGIVSIK-----TDVFSFGVLVLEIVSG 630
PE I+ K D ++ G+L+ E+++G
Sbjct: 167 PE-----IILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 3e-16
Identities = 65/206 (31%), Positives = 97/206 (47%), Gaps = 15/206 (7%)
Query: 432 FSTTNKLGEGGFGPV------YKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQH 485
F LG+GGFG V GK+ + + KR+ + G+ + NE +++ K+
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMA--LNEKQILEKVNS 59
Query: 486 TNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYL 545
+V L + LV M L F ++N G F E I GL L
Sbjct: 60 QFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAE-ILCGLEDL 118
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEY 605
H R ++RDLK NILLDD + +ISD G+A ++ E E+ R VGT GYM+PE
Sbjct: 119 H---RENTVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGR-VGTVGYMAPEV 172
Query: 606 AMSGIVSIKTDVFSFGVLVLEIVSGQ 631
+ ++ D + G L+ E++ GQ
Sbjct: 173 LNNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 65/203 (32%), Positives = 102/203 (50%), Gaps = 19/203 (9%)
Query: 438 LGEGGFGPVYKGKLADE-QEVAIKRL-----SRSSGQGIVEFKNEVRLIAKLQHTNLVRL 491
LG+G FG VY AD +E+A+K++ S + + + + E++L+ L H +V+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 492 LGCSLHGEERLL--VYEFMPNKSLDFFLFNSG--RKNVLNWEKRFIIIEGISQGLLYLHK 547
GC ER L E MP S+ L + G +NV R I+ +G+ YLH
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQIL-----EGVSYLHS 124
Query: 548 YSRLRVIHRDLKASNILLDDKMNPKISDFGMA-RIFEVNESEANTKRIVGTYGYMSPEYA 606
++HRD+K +NIL D N K+ DFG + R+ + S K + GT +MSPE
Sbjct: 125 N---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181
Query: 607 MSGIVSIKTDVFSFGVLVLEIVS 629
K D++S G V+E+++
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 3e-16
Identities = 64/221 (28%), Positives = 106/221 (47%), Gaps = 34/221 (15%)
Query: 437 KLGEGGFGPV----------YKGKLADEQE-----VAIKRL-SRSSGQGIVEFKNEVRLI 480
KLGEG FG V + G+ A E + VA+K L + + +F E++++
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 481 AKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGIS- 539
++L++ N++RLLG + + ++ E+M N L+ FL S R+ E F I
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFL--SQRE----IESTFTHANNIPS 125
Query: 540 ---QGLLYLH-------KY-SRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE 588
LLY+ KY + L +HRDL N L+ + KI+DFGM+R +
Sbjct: 126 VSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY 185
Query: 589 ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
R V +M+ E + G + +DV++FGV + E+ +
Sbjct: 186 RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 60/207 (28%), Positives = 103/207 (49%), Gaps = 16/207 (7%)
Query: 437 KLGEGGFGPVYKGKLADEQ----EVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLL 492
K+GEG G V +A E+ +VA+K++ Q NEV ++ H N+V +
Sbjct: 29 KIGEGSTGIVC---IATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMY 85
Query: 493 GCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLR 552
L G+E +V EF+ +L + ++ +N E+ + + + L YLH
Sbjct: 86 NSYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIATVCLSVLRALSYLHNQG--- 138
Query: 553 VIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVS 612
VIHRD+K+ +ILL K+SDFG +V++ K +VGT +M+PE
Sbjct: 139 VIHRDIKSDSILLTSDGRIKLSDFGFCA--QVSKEVPKRKSLVGTPYWMAPEVISRLPYG 196
Query: 613 IKTDVFSFGVLVLEIVSGQKNHTRHHP 639
+ D++S G++V+E++ G+ + P
Sbjct: 197 TEVDIWSLGIMVIEMIDGEPPYFNEPP 223
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 3e-16
Identities = 52/170 (30%), Positives = 81/170 (47%), Gaps = 35/170 (20%)
Query: 476 EVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFI-- 533
E+ ++ + H N+V+ H E ++ EFM SL+ G +++F+
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLE------GTHI---ADEQFLAD 172
Query: 534 IIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKR 593
+ I G+ YLH R ++HRD+K SN+L++ N KI+DFG++RI N+
Sbjct: 173 VARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS- 228
Query: 594 IVGTYGYMSPEYAMSGIVSIKT------------DVFSFGVLVLEIVSGQ 631
VGT YMSPE I T D++S GV +LE G+
Sbjct: 229 -VGTIAYMSPE-------RINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 3e-16
Identities = 66/211 (31%), Positives = 111/211 (52%), Gaps = 28/211 (13%)
Query: 432 FSTTNKLGEGGFGPVYKGKLADEQE-VAIKRLS-RSSGQGIVEFK-NEVRLIAKLQHTNL 488
+ K+GEG +G VYK + E +A+K++ +G+ E+ L+ ++QH N+
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
Query: 489 VRLLGCSLHGEERL-LVYEFMP---NKSLDFFLFNSGRKNVLNWEKRFIIIEG----ISQ 540
VRL +H E+RL LV+E++ K +D + ++ K +I+ I +
Sbjct: 64 VRLQDV-VHSEKRLYLVFEYLDLDLKKHMD---------SSPDFAKNPRLIKTYLYQILR 113
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDKMNP-KISDFGMARIFEVNESEANTKRIVGTYG 599
G+ Y H + RV+HRDLK N+L+D + N K++DFG+AR F + T +V T
Sbjct: 114 GIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI-PVRTFTHEVV-TLW 168
Query: 600 YMSPEYAM-SGIVSIKTDVFSFGVLVLEIVS 629
Y +PE + S S D++S G + E+V+
Sbjct: 169 YRAPEILLGSRHYSTPVDIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 65/201 (32%), Positives = 108/201 (53%), Gaps = 15/201 (7%)
Query: 436 NKLGEGGFGPVYKGKLA-DEQEVAIK--RLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLL 492
KLGEG + V+KG+ E VA+K RL G + EV L+ L+H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLH 70
Query: 493 GCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRL 551
+H ++ L LV+E++ +K L ++ + G N+++ I + I +GL Y H R
Sbjct: 71 DI-VHTDKSLTLVFEYL-DKDLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCH---RR 123
Query: 552 RVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM-SGI 610
+V+HRDLK N+L++++ K++DFG+AR V + + V T Y P+ + S
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNE--VVTLWYRPPDVLLGSSE 181
Query: 611 VSIKTDVFSFGVLVLEIVSGQ 631
S + D++ G + E+ SG+
Sbjct: 182 YSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 5e-16
Identities = 79/286 (27%), Positives = 132/286 (46%), Gaps = 32/286 (11%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK---LADEQ---EVAIKRLSRSSGQGIVE-FKNEVRLIAK 482
NN S LG G FG V + L+ +VA+K L ++ E +E+++++
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 483 L-QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQG 541
L H N+V LLG G L++ E+ L FL R++ L E +++G
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFL-RRKRESFLTLEDLLSFSYQVAKG 153
Query: 542 LLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR-IFEVNE--SEANTKRIVGTY 598
+ +L + IHRDL A N+LL KI DFG+AR I + + N + V
Sbjct: 154 MAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPV--- 207
Query: 599 GYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKG 658
+M+PE + + + ++DV+S+G+L+ EI S N +P P++ Y +L+ +G
Sbjct: 208 KWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSN---PYPGMPVDSKFY--KLIKEGY- 261
Query: 659 LELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ 704
+ QP A + I C + RPT ++V ++
Sbjct: 262 ------RMAQPEHAPAEIYDIMKT--CWDADPLKRPTFKQIVQLIG 299
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 7e-16
Identities = 55/215 (25%), Positives = 99/215 (46%), Gaps = 28/215 (13%)
Query: 438 LGEGGFGPVYKG------KLADEQEVAIKRL-SRSSGQGIVEFKNEVRLIAKL-QHTNLV 489
LGEG FG V K + VA+K L ++ + + + +E+ ++ + +H N++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEG------------ 537
LLG +V E+ + +L FL E
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 538 -ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVG 596
+++G+ +L + + IHRDL A N+L+ + KI+DFG+AR +++ + K G
Sbjct: 140 QVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLAR--DIHHIDYYRKTTNG 194
Query: 597 --TYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+M+PE + + ++DV+SFGVL+ EI +
Sbjct: 195 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 8e-16
Identities = 57/180 (31%), Positives = 97/180 (53%), Gaps = 19/180 (10%)
Query: 436 NKLGEGGFGPVYKGK-LADEQEVAIKRLS-RSSGQGIVEFK-NEVRLIAKLQ---HTNLV 489
++GEG +G VYK + L + VA+K++ S +GI E+ L+ +L+ H N+V
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 490 RLL----GCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLY 544
RLL G E +L LV+E + ++ L +L + + + ++ + + +G+ +
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQ-LLRGVDF 122
Query: 545 LHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPE 604
LH + R++HRDLK NIL+ KI+DFG+ARI+ E + +V T Y +PE
Sbjct: 123 LHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYS-FEMALTS--VVVTLWYRAPE 176
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 9e-16
Identities = 66/274 (24%), Positives = 117/274 (42%), Gaps = 35/274 (12%)
Query: 438 LGEGGFGP--VYKGKLADEQEVAIKR--LSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLG 493
LG+G FG +Y+ + D+ V K L+R S + + NE+ +++ LQH N++
Sbjct: 8 LGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 494 CSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRV 553
+ L+ E+ +L + + + E + I + Y+HK +
Sbjct: 67 HFMDDNTLLIEMEYANGGTL-YDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---I 122
Query: 554 IHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSI 613
+HRD+K NI L K+ DFG+++I S A T +VGT YMSPE +
Sbjct: 123 LHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPELCQGVKYNF 180
Query: 614 KTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNL----IGYAWQLLSDGKGLELIDPSLEQP 669
K+D+++ G ++ E+++ ++ PLNL + + + ELI
Sbjct: 181 KSDIWALGCVLYELLTLKRTFD---ATNPLNLVVKIVQGNYTPVVSVYSSELI------- 230
Query: 670 CSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCML 703
++ +Q RPT EV+
Sbjct: 231 ----SLVHS------LLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 9e-16
Identities = 58/187 (31%), Positives = 98/187 (52%), Gaps = 22/187 (11%)
Query: 432 FSTTNKLGEGGFGPVYKGKLADEQE-VAIKRL---SRSSGQGIVEFKNEVRLIAKLQHTN 487
F ++GEG +G VYK + D E VA+K++ + G I + E++++ +L H N
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQLNHRN 67
Query: 488 LVRLLGCSLHGEERL----------LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEG 537
+V L ++ L LV+E+M + + L SG + + + ++
Sbjct: 68 IVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMG--LLESGLVH-FSEDHIKSFMKQ 124
Query: 538 ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT 597
+ +GL Y HK + L HRD+K SNILL++K K++DFG+AR++ ES T +++ T
Sbjct: 125 LLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI-T 180
Query: 598 YGYMSPE 604
Y PE
Sbjct: 181 LWYRPPE 187
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 1e-15
Identities = 69/204 (33%), Positives = 99/204 (48%), Gaps = 23/204 (11%)
Query: 438 LGEGGFGPVYKGKLADEQEV-AIKRLSRSSGQGIVEFKNEVR--------LIAKLQHTNL 488
LG+G FG V +L E AIK L + +V ++V L +H L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKD----VVLEDDDVECTMVERRVLALAWEHPFL 58
Query: 489 VRLLGCSLHGEERLL-VYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHK 547
L C+ +E L V E++ L F + +SGR + RF E I GL +LHK
Sbjct: 59 THLF-CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDE--ARARFYAAEIIC-GLQFLHK 114
Query: 548 YSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM 607
+I+RDLK N+LLD + KI+DFGM + E +A+T GT Y++PE
Sbjct: 115 KG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST--FCGTPDYIAPEILK 169
Query: 608 SGIVSIKTDVFSFGVLVLEIVSGQ 631
+ D +SFGVL+ E++ GQ
Sbjct: 170 GQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 62/198 (31%), Positives = 96/198 (48%), Gaps = 13/198 (6%)
Query: 437 KLGEGGFGPVY--KGKLADEQEVAIKRLSR-SSGQ----GIVEFKNEVRLIAKLQHTNLV 489
+LG+G FG VY K K A +E +K L G+ V+ E +L++KL H +V
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEE-RLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
+ L + ++ E+ + LD L E + + E Q LL +H
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQ--VCEWFIQLLLGVHYMH 123
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSG 609
+ R++HRDLKA NI L + + KI DFG++R+ + A T GT YMSPE
Sbjct: 124 QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FTGTPYYMSPEALKHQ 180
Query: 610 IVSIKTDVFSFGVLVLEI 627
K+D++S G ++ E+
Sbjct: 181 GYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 19/215 (8%)
Query: 431 NFSTTNKLGEGGFGPVYK-------GKLADEQEV-----AIKRLSRSSGQGIVEFKNEVR 478
++ LG G FG VYK L +E+ A + R + I + +EV
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 479 LIAK-LQHTNLVRLLGCSLHGEERLLVYEFMPNKSL-DFFLFNSGRKNVLNWEKRFIIIE 536
+I + L+H N+VR L + +V + + L + F +K E+ + I
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVG 596
+ L YLHK R ++HRDL +NI+L + I+DFG+A+ + E+ +VG
Sbjct: 121 QMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSVVG 175
Query: 597 TYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
T Y PE + K DV++FG ++ ++ + Q
Sbjct: 176 TILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQ 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 49/152 (32%), Positives = 84/152 (55%), Gaps = 11/152 (7%)
Query: 437 KLGEGGFGPVYKGKLADEQE-VAIKRLS-RSSGQGIVEFK-NEVRLIAKLQHTNLVRLLG 493
K+GEG +G V+K K + E VA+KR+ +G+ E+ L+ +L+H N+VRL
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 494 CSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLR 552
LH +++L LV+E+ ++ L + + K F+ + +GL + H +
Sbjct: 67 V-LHSDKKLTLVFEYC-DQDLKKYFDSCNGDIDPEIVKSFMF--QLLKGLAFCHSH---N 119
Query: 553 VIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
V+HRDLK N+L++ K++DFG+AR F +
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLARAFGI 151
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 78/285 (27%), Positives = 128/285 (44%), Gaps = 46/285 (16%)
Query: 440 EGGFGPVYKGKLAD-----EQEVAIKRLSRSSGQGIVE-FKNEVRLIAKLQHTNLVRLLG 493
EG FG ++ G L D E+EV +K + + + V E L+ L H N++ +L
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75
Query: 494 -CSLHGEERLLVYEFMPNKSLDFFLFN---SGRKNVLNWEKRFIIIEG--ISQGLLYLHK 547
C GE ++Y +M +L FL N + ++ I+ G+ YLHK
Sbjct: 76 VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK 135
Query: 548 YSRLRVIHRDLKASNILLDDKMNPKISDFGMAR-IF--EVNESEANTKRIVGTYGYMSPE 604
VIH+D+ A N ++D+++ KI+D ++R +F + + N R V +M+ E
Sbjct: 136 R---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPV---KWMALE 189
Query: 605 YAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELID 663
++ S +DV+SFGVL+ E+++ GQ T + P + Y L DG
Sbjct: 190 SLVNKEYSSASDVWSFGVLLWELMTLGQ---TPYVEIDPFEMAAY----LKDGY------ 236
Query: 664 PSLEQPCSAN----EVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ 704
L QP + VM C C +RP+ ++V L
Sbjct: 237 -RLAQPINCPDELFAVMAC------CWALDPEERPSFSQLVQCLT 274
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 1e-15
Identities = 86/291 (29%), Positives = 131/291 (45%), Gaps = 45/291 (15%)
Query: 438 LGEGGFGPVYKGKLADEQE-----VAIKRL-SRSSGQGIVEFKNEVRLIAKLQHTNLVRL 491
LG G FG V+KG E + VAIK + RS Q E + + + L H +VRL
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 492 LG-CSLHGEERLLVYEFMPNKSL-DFFLFNSGRKN---VLNWEKRFIIIEGISQGLLYLH 546
LG C G LV + P SL D + + +LNW + I++G+ YL
Sbjct: 75 LGICP--GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ------IAKGMYYLE 126
Query: 547 KYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYA 606
++ R++HR+L A NILL +I+DFG+A + ++ + +M+ E
Sbjct: 127 EH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183
Query: 607 MSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPS 665
+ G + ++DV+S+GV V E++S G + + P +L+ KG L P
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL---------EKGERLAQP- 233
Query: 666 LEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE--TMPLPPPK 714
Q C+ + M V + C RPT E L NE M PP+
Sbjct: 234 --QICTIDVYM----VMVKCWMIDENVRPTFKE----LANEFTRMARDPPR 274
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 63/216 (29%), Positives = 105/216 (48%), Gaps = 21/216 (9%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKR-LSRSSGQGIVEFK-NEVRLIAKLQHT 486
+ + K+GEG +G VYK + + VA+K+ +GI E+ L+ L +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 487 N-LVRLLGCSLHGEERL------LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFI--IIEG 537
+VRLL H EE+ LV+E++ + L F+ ++GR + I +
Sbjct: 61 IYIVRLL-DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118
Query: 538 ISQGLLYLHKYSRLRVIHRDLKASNILLD-DKMNPKISDFGMARIFEVNESEANTKRIVG 596
+ +G+ + HK+ V+HRDLK N+L+D K KI+D G+ R F + ++ T IV
Sbjct: 119 LLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI-PVKSYTHEIV- 173
Query: 597 TYGYMSPEYAMSGI-VSIKTDVFSFGVLVLEIVSGQ 631
T Y +PE + S D++S G + E+ Q
Sbjct: 174 TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQ 209
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 24/213 (11%)
Query: 431 NFSTTNKLGEGGFGPVYKGK-LADEQEVAIKR------LSRSSGQGIVEFKNEVRLIAKL 483
NF K+G G F VY+ L D + VA+K+ + + Q V+ E+ L+ +L
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVK---EIDLLKQL 59
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLL 543
H N+++ L + E +V E L + ++ KR I + + +
Sbjct: 60 NHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQ------KRLIPERTVWKYFV 113
Query: 544 YL-----HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTY 598
L H +SR RV+HRD+K +N+ + K+ D G+ R F + A++ +VGT
Sbjct: 114 QLCSAVEHMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTP 170
Query: 599 GYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
YMSPE + K+D++S G L+ E+ + Q
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 64/208 (30%), Positives = 101/208 (48%), Gaps = 30/208 (14%)
Query: 437 KLGEGGFGPVYKGKLADE-QEVAIKRLSRSSGQGIVEFK---NEVRLIAKLQHTNLVRLL 492
K+GEG +G V+K + + Q VAIK+ S +++ K E+R++ +L+H NLV L+
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIK-KIALREIRMLKQLKHPNLVNLI 66
Query: 493 GC-----SLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFI--IIEGISQGLLYL 545
LH LV+E+ D + N KN + I II Q + +
Sbjct: 67 EVFRRKRKLH-----LVFEY-----CDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFC 116
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEY 605
HK++ IHRD+K NIL+ + K+ DFG ARI + + V T Y +PE
Sbjct: 117 HKHN---CIHRDVKPENILITKQGQIKLCDFGFARI--LTGPGDDYTDYVATRWYRAPEL 171
Query: 606 AMSGIVSIKT--DVFSFGVLVLEIVSGQ 631
+ G DV++ G + E+++GQ
Sbjct: 172 -LVGDTQYGPPVDVWAIGCVFAELLTGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 64/212 (30%), Positives = 101/212 (47%), Gaps = 28/212 (13%)
Query: 438 LGEGGFGPVYKG---KLADEQEVAIKRLSR-SSGQGIVEFKNEVRLIAKL-QHTNLVRLL 492
+GEG FG V + K + AIK L +S +F E+ ++ KL H N++ LL
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 493 GCSLHGEERLLVYEFMPNKSLDFFLFNS-------------GRKNVLNWEKRFIIIEGIS 539
G + + E+ P +L FL S G + L ++ ++
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
G+ YL S + IHRDL A N+L+ + + KI+DFG++R E K+ +G
Sbjct: 130 TGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR-----GEEVYVKKTMGRLP 181
Query: 600 --YMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+M+ E + + K+DV+SFGVL+ EIVS
Sbjct: 182 VRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 56/184 (30%), Positives = 97/184 (52%), Gaps = 23/184 (12%)
Query: 436 NKLGEGGFGPVYKGKLADEQE-VAIKRL---SRSSGQGIVEFKNEVRLIAKLQHTNLVRL 491
K+G+G FG V+K + ++ VA+K++ + G I + E++++ L+H N+V L
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNL 76
Query: 492 LG-CSLHGEER-------LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLL 543
+ C LV+EF + L L N K L+ K+ +++ + GL
Sbjct: 77 IEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKK--VMKMLLNGLY 133
Query: 544 YLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEAN---TKRIVGTYGY 600
Y+H R +++HRD+KA+NIL+ K++DFG+AR F ++++ T R+V T Y
Sbjct: 134 YIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV-TLWY 189
Query: 601 MSPE 604
PE
Sbjct: 190 RPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 65/201 (32%), Positives = 107/201 (53%), Gaps = 15/201 (7%)
Query: 436 NKLGEGGFGPVYKGKLA-DEQEVAIK--RLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLL 492
+KLGEG + V+KG+ E VA+K RL G + EV L+ L+H N+V L
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLH 69
Query: 493 GCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRL 551
+H E L LV+E++ + L +L N G N+++ I + + +GL Y HK
Sbjct: 70 DI-IHTERCLTLVFEYLDS-DLKQYLDNCG--NLMSMHNVKIFMFQLLRGLSYCHKR--- 122
Query: 552 RVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM-SGI 610
+++HRDLK N+L+++K K++DFG+AR V + + V T Y P+ + S
Sbjct: 123 KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNE--VVTLWYRPPDVLLGSTE 180
Query: 611 VSIKTDVFSFGVLVLEIVSGQ 631
S D++ G ++ E+ +G+
Sbjct: 181 YSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 3e-15
Identities = 79/298 (26%), Positives = 132/298 (44%), Gaps = 44/298 (14%)
Query: 437 KLGEGGFGPVY----KG--KLADEQ-----------EVAIKRLSRSSGQGIV-EFKNEVR 478
KLGEG FG V+ +G K D+ VA+K L + + +F E++
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 479 LIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVL-NWEKRFI---- 533
++++L+ N++RLL + + ++ E+M N L+ FL + + I
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 534 ---IIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEAN 590
+ I+ G+ YL S L +HRDL N L+ KI+DFGM+R +
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188
Query: 591 TKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLN---LIG 647
R V +MS E + G + +DV++FGV + EI+ + P L+ +I
Sbjct: 189 QGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEIL----TLCKEQPYSQLSDEQVIE 244
Query: 648 YAWQLLSD-GKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ 704
+ D G+ + L P+L P S ++M L C + A +RP+ E+ L
Sbjct: 245 NTGEFFRDQGRQVYLPKPAL-CPDSLYKLM------LSCWRRNAKERPSFQEIHATLL 295
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 3e-15
Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 20/208 (9%)
Query: 436 NKLGEGGFGPVYKGKLADEQEVAIKRLS-RSSGQGIVE-----FKNEVRLIAKLQHTNLV 489
LG+G +G VY G Q +A+K++ +S E + EV L+ L+H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFL--FNSGRKNVLNWEKRFIIIEGISQGLLYLHK 547
+ LG L + EF+P S+ L F + V + I+ G+ YLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQIL-----DGVAYLHN 120
Query: 548 YSRLRVIHRDLKASNILLDDKMNPKISDFGMAR---IFEVNESEANT-KRIVGTYGYMSP 603
V+HRD+K +N++L K+ DFG AR ++ + +N K + GT +M+P
Sbjct: 121 NC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177
Query: 604 EYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
E K+D++S G V E+ +G+
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-15
Identities = 61/219 (27%), Positives = 105/219 (47%), Gaps = 25/219 (11%)
Query: 437 KLGEGGFGPVYKGKLADEQEVAI-KRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCS 495
+LG+G FG VYK + + +A K + S + + ++ E+ ++A H N+V+LL
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 496 LHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIH 555
+ ++ EF ++D + R L + ++ + + L YLH+ ++IH
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLELERP--LTEPQIRVVCKQTLEALNYLHEN---KIIH 126
Query: 556 RDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI------VGTYGYMSPEYAMSG 609
RDLKA NIL + K++DFG+ S NT+ I +GT +M+PE M
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGV--------SAKNTRTIQRRDSFIGTPYWMAPEVVMCE 178
Query: 610 I-----VSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPL 643
K DV+S G+ ++E+ + H +P R L
Sbjct: 179 TSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVL 217
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 4e-15
Identities = 60/199 (30%), Positives = 85/199 (42%), Gaps = 53/199 (26%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADEQE-VAIK--RLSRSSGQGIVEFKNEVRLIAKLQHTN 487
F N++GEG +G VY+ + E VA+K R+ + E+ L+ L+H N
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67
Query: 488 LVRLL----GCSLHGEERLLVYEF-----------MPN-------KSLDFFLFNSGRKNV 525
+V L G L + LV E+ MP K L L
Sbjct: 68 IVELKEVVVGKHL--DSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLL------- 118
Query: 526 LNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVN 585
+GL YLH +IHRDLK SN+LL DK KI+DFG+AR +
Sbjct: 119 --------------RGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYG-L 160
Query: 586 ESEANTKRIVGTYGYMSPE 604
++ T ++V T Y +PE
Sbjct: 161 PAKPMTPKVV-TLWYRAPE 178
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 4e-15
Identities = 73/284 (25%), Positives = 125/284 (44%), Gaps = 36/284 (12%)
Query: 438 LGEGGFGPVYKGKLADEQ---EVAIK--RLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLL 492
LGEG FG V +G+L + +VA+K +++ + + +F +E + + H N++RL+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 493 GCSLHGEER------LLVYEFMPNKSLDFFLFNSGRKNV---LNWEKRFIIIEGISQGLL 543
G L E +++ FM + L FL S + L + + I+ G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 544 YLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT-YGYMS 602
YL S IHRDL A N +L++ MN ++DFG+++ N RI +++
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKI-YNGDYYRQGRIAKMPVKWIA 182
Query: 603 PEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELI 662
E + + K+DV+SFGV + EI TR P + L G
Sbjct: 183 IESLADRVYTTKSDVWSFGVTMWEIA------TRGQTPYPGVENSEIYDYLRQGN----- 231
Query: 663 DPSLEQPCSANEVMRCIHVGLL-CVQDQAMDRPTMPEVVCMLQN 705
L+QP + + ++ + C DRP+ + C L+
Sbjct: 232 --RLKQPP---DCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 6e-15
Identities = 57/205 (27%), Positives = 99/205 (48%), Gaps = 17/205 (8%)
Query: 431 NFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRS---SGQGIVEFKNEVRLIAKLQHT 486
+ +G G FG V+ + E A+K ++ + NE R++ ++ H
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61
Query: 487 NLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYL 545
++RL + H + L ++ E++P L +L NSGR + N F E + L YL
Sbjct: 62 FIIRLF-WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFS--NSTGLFYASEIVC-ALEYL 117
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEY 605
H +++RDLK NILLD + + K++DFG A+ + T + GT Y++PE
Sbjct: 118 HS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGTPEYLAPEV 169
Query: 606 AMSGIVSIKTDVFSFGVLVLEIVSG 630
S + D ++ G+L+ E++ G
Sbjct: 170 IQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 6e-15
Identities = 84/358 (23%), Positives = 163/358 (45%), Gaps = 38/358 (10%)
Query: 356 IKEEKWWRSLTIAIGVVLGIPLLCYLCYVTWRKLKAKDNVSLLPTYGKRKSPEKDQSISH 415
K WW +T +G L + L+ + ++ ++N+ L K E +
Sbjct: 623 RKTPSWWFYITCTLGAFLVLALVAFGFVF----IRGRNNLEL-------KRVENEDGT-W 670
Query: 416 ELKIFDFQ-----TIAAAANNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQG 469
EL+ FD + TI ++ N + G G YKGK + + + +K ++ +
Sbjct: 671 ELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-- 728
Query: 470 IVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWE 529
I +E+ + KLQH N+V+L+G + L++E++ K+L L N L+WE
Sbjct: 729 IPS--SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWE 780
Query: 530 KRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEA 589
+R I GI++ L +LH V+ +L I++D K P + + + +
Sbjct: 781 RRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD---- 835
Query: 590 NTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYA 649
I + Y++PE + ++ K+D++ FG++++E+++G K+ +++ +A
Sbjct: 836 TKCFI--SSAYVAPETRETKDITEKSDIYGFGLILIELLTG-KSPADAEFGVHGSIVEWA 892
Query: 650 WQLLSDGKGLELIDPSLEQPCSAN--EVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
SD IDPS+ S N E++ +++ L C RP +V+ L++
Sbjct: 893 RYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLES 950
|
Length = 968 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 9e-15
Identities = 68/212 (32%), Positives = 104/212 (49%), Gaps = 24/212 (11%)
Query: 437 KLGEGGFGPVYKG---KLADEQEVAIKRLSRSSGQGIV--EFKNEVRLIAKLQHTNLVRL 491
+LG G FG V KG E+ VA+K L + + E E ++ +L + +VR+
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 492 LGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFI-IIEGISQGLLYLHKYSR 550
+G E +LV E L+ FL +KN EK ++ +S G+ YL + +
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFL----QKNKHVTEKNITELVHQVSMGMKYLEETN- 115
Query: 551 LRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG-----YMSPEY 605
+HRDL A N+LL + KISDFG+++ +E+ K T+G + +PE
Sbjct: 116 --FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK----THGKWPVKWYAPEC 169
Query: 606 AMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTR 636
S K+DV+SFGVL+ E S GQK +
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKG 201
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 9e-15
Identities = 64/238 (26%), Positives = 106/238 (44%), Gaps = 18/238 (7%)
Query: 421 DFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLI 480
D + A F +G G +G VYKG+ ++A ++ + E K E+ ++
Sbjct: 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINML 66
Query: 481 AKL-QHTNLVRLLGCSL------HGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFI 533
K H N+ G + H ++ LV EF S+ + N+ + N L +
Sbjct: 67 KKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAY 125
Query: 534 IIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKR 593
I I +GL +LH + +VIHRD+K N+LL + K+ DFG++ + NT
Sbjct: 126 ICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-- 180
Query: 594 IVGTYGYMSPEYAM-----SGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLI 646
+GT +M+PE ++D++S G+ +E+ G HP R L LI
Sbjct: 181 FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLI 238
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 59/227 (25%), Positives = 105/227 (46%), Gaps = 37/227 (16%)
Query: 437 KLGEGGFGPVYKGKLADEQE-----------------VAIKRL-SRSSGQGIVEFKNEVR 478
KLGEG FG V+ ++ + Q+ VA+K L ++ +F EV+
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 479 LIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFL----------------FNSGR 522
++++L+ N++RLLG + + ++ E+M N L+ FL +
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 523 KNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIF 582
+++ + I+ G+ YL S L +HRDL N L+ + + KI+DFGM+R
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188
Query: 583 EVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+ R V +M+ E + G + +DV++FGV + EI+
Sbjct: 189 YAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 70/219 (31%), Positives = 106/219 (48%), Gaps = 26/219 (11%)
Query: 438 LGEGGFGPVYKGKLADEQEV-AIKRLSRSS---GQGIVEFKNEVRLIAKLQHTNLVRLLG 493
+G GGFG VY + AD ++ A+K L + QG NE R++ L T +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE-RIMLSLVSTGDCPFIV 60
Query: 494 C---SLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
C + H ++L + + M L + L G + E RF E I GL ++H +
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFS--EKEMRFYATE-IILGLEHMH--N 115
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSG 609
R V++RDLK +NILLD+ + +ISD G+A F + A+ VGT+GYM+PE G
Sbjct: 116 RF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEVLQKG 170
Query: 610 IV-SIKTDVFSFGVLVLEIVSG------QKNHTRHHPDR 641
D FS G ++ +++ G K +H DR
Sbjct: 171 TAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR 209
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 1e-14
Identities = 49/204 (24%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 426 AAAANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQH 485
A+ ++ L G G V+ + + + ++ + I E L+ + H
Sbjct: 62 VVASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLI-----EAMLLQNVNH 116
Query: 486 TNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYL 545
+++R+ + G +V +P+ S D + + + R L ++ II + I +GL YL
Sbjct: 117 PSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYL 173
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEY 605
H R+IHRD+K NI ++D I D G A+ F V + GT +PE
Sbjct: 174 HAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQ-FPVVAP--AFLGLAGTVETNAPEV 227
Query: 606 AMSGIVSIKTDVFSFGVLVLEIVS 629
+ K D++S G+++ E+++
Sbjct: 228 LARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 14/207 (6%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADE-QEVAIKRLSRSSGQGIVE--FKNEVRLIAKLQHT 486
+ +GEG +G V K K + Q VAIK+ S +V+ E+R++ +L+H
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60
Query: 487 NLVRLLGCSLHGEERLLVYEFMPNKSLD-FFLFNSGRKNVLNWEKRFIIIEGISQGLLYL 545
NLV L+ + LV+EF+ + LD + +G + F I+ GI +
Sbjct: 61 NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIE----FC 116
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEY 605
H ++ +IHRD+K NIL+ K+ DFG AR E T V T Y +PE
Sbjct: 117 HSHN---IIHRDIKPENILVSQSGVVKLCDFGFAR-TLAAPGEVYTD-YVATRWYRAPEL 171
Query: 606 AMSGIVSIK-TDVFSFGVLVLEIVSGQ 631
+ + D+++ G LV E+++G+
Sbjct: 172 LVGDTKYGRAVDIWAVGCLVTEMLTGE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 61/212 (28%), Positives = 99/212 (46%), Gaps = 39/212 (18%)
Query: 438 LGEGGFGPVYKGKLAD-EQEVAIKRLSRSSGQGIVEFKN---EVRLIAKLQHTNLVRLLG 493
+G G +G V ++VAIK+LSR Q + K E+RL+ + H N++ LL
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMDHENVIGLLD 81
Query: 494 CSLHGEERLLVYEFMPNKSLDFF-------------LFNSGRKNVLNWEKRFIIIEGISQ 540
F P SL+ F L N + L+ + ++ I +
Sbjct: 82 V------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILR 129
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGY 600
GL Y+H +IHRDLK SNI +++ KI DFG+AR + E V T Y
Sbjct: 130 GLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARH---TDDEMTG--YVATRWY 181
Query: 601 MSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
+PE ++ + +T D++S G ++ E+++G+
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 3e-14
Identities = 63/203 (31%), Positives = 100/203 (49%), Gaps = 21/203 (10%)
Query: 438 LGEGGFGPVYKGKLADEQE-VAIKRLSRSSGQGIVEFKNEV-------RLIAKLQHTNLV 489
LG+G FG V +L + E A+K L + +V ++V R++A +
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKD----VVLIDDDVECTMVEKRVLALAWENPFL 58
Query: 490 RLLGCSLHGEERLL-VYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
L C+ +E L V EF+ L F + + GR ++ + F E I GL +LH
Sbjct: 59 THLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDL--YRATFYAAE-IVCGLQFLHSK 115
Query: 549 SRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMS 608
+I+RDLK N++LD + KI+DFGM + ++ A+T GT Y++PE
Sbjct: 116 G---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST--FCGTPDYIAPEILQG 170
Query: 609 GIVSIKTDVFSFGVLVLEIVSGQ 631
+ D +SFGVL+ E++ GQ
Sbjct: 171 LKYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 3e-14
Identities = 64/212 (30%), Positives = 105/212 (49%), Gaps = 28/212 (13%)
Query: 438 LGEGGFGPVYKGKLADE---QEVAIKRLSR-SSGQGIVEFKNEVRLIAKL-QHTNLVRLL 492
+GEG FG V K ++ + + AIKR+ +S +F E+ ++ KL H N++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 493 GCSLHGEERLLVYEFMPNKSLDFFLFNS-------------GRKNVLNWEKRFIIIEGIS 539
G H L E+ P+ +L FL S + L+ ++ ++
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
+G+ YL S+ + IHRDL A NIL+ + KI+DFG++R E K+ +G
Sbjct: 123 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGRLP 174
Query: 600 --YMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+M+ E + + +DV+S+GVL+ EIVS
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 4e-14
Identities = 55/201 (27%), Positives = 90/201 (44%), Gaps = 18/201 (8%)
Query: 437 KLGEGGFGPVYKG----KLADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAKLQHTNLVRL 491
+GEG FG VY+G ++ VA+K + + E F E ++ + H ++V+L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 492 LG-CSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSR 550
+G + +V E P L +L K L+ + +S L YL
Sbjct: 73 IGVIT--ENPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLES--- 125
Query: 551 LRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTY--GYMSPEYAMS 608
R +HRD+ A N+L+ K+ DFG++R E E+ K G +M+PE
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL---EDESYYKASKGKLPIKWMAPESINF 182
Query: 609 GIVSIKTDVFSFGVLVLEIVS 629
+ +DV+ FGV + EI+
Sbjct: 183 RRFTSASDVWMFGVCMWEILM 203
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 5e-14
Identities = 74/243 (30%), Positives = 114/243 (46%), Gaps = 32/243 (13%)
Query: 438 LGEGGFGPVYKGKLADEQEV-AIKRLSRSS---GQGIVEFKNEVRLIAKLQHTNLVRLLG 493
+G GGFG VY + AD ++ A+K L + QG NE R++ L T +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE-RIMLSLVSTGDCPFIV 60
Query: 494 C---SLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
C + H ++L + + M L + L G + E RF E I GL ++H +
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS--EAEMRFYAAE-IILGLEHMH--N 115
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSG 609
R V++RDLK +NILLD+ + +ISD G+A F + A+ VGT+GYM+PE G
Sbjct: 116 RF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEVLQKG 170
Query: 610 IV-SIKTDVFSFGVLVLEIVSGQ------KNHTRHHPDRPLNLIGYAW------QLLSDG 656
+ D FS G ++ +++ G K +H DR + +L S
Sbjct: 171 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLL 230
Query: 657 KGL 659
+GL
Sbjct: 231 EGL 233
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 5e-14
Identities = 57/210 (27%), Positives = 99/210 (47%), Gaps = 18/210 (8%)
Query: 431 NFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLS---RSSGQGIVEFKNEVRLIAKLQHT 486
NF K+G G F VY+ L D VA+K++ + + E+ L+ +L H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 487 NLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYL- 545
N+++ + E +V E L + + + +KR I + + + + L
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKK------QKRLIPEKTVWKYFVQLC 116
Query: 546 ----HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYM 601
H +SR RV+HRD+K +N+ + K+ D G+ R F + A++ +VGT YM
Sbjct: 117 SALEHMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 173
Query: 602 SPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
SPE + K+D++S G L+ E+ + Q
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQ 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 6e-14
Identities = 50/189 (26%), Positives = 89/189 (47%), Gaps = 18/189 (9%)
Query: 455 QEVAIKRLSRSSGQG---IVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLL-VYEFMPN 510
EVAIK L + + F+ E L A+L H N+V LL L V+E++P
Sbjct: 4 HEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPG 63
Query: 511 KSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILL---DD 567
++L L G L + ++ + L H ++HRDLK NI++
Sbjct: 64 RTLREVLAADG---ALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTGV 117
Query: 568 KMNPKISDFGMARIF----EVNESEAN-TKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGV 622
+ + K+ DFG+ + + + + T ++GT Y +PE V+ +D++++G+
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGL 177
Query: 623 LVLEIVSGQ 631
+ LE ++GQ
Sbjct: 178 IFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 7e-14
Identities = 63/201 (31%), Positives = 102/201 (50%), Gaps = 19/201 (9%)
Query: 438 LGEGGFGPVYKG--KLADEQE--VAIKRLSRS-SGQGIVEFKNEVRLIAKLQHTNLVRLL 492
LG G FG + +G KL ++E VAI L S + F E + + H+N+VRL
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 493 GCSLHGEERLLVYEFMPNKSLDFFLFNSGRKN--VLNWEKRFIIIEGISQGLLYLHKYSR 550
G G ++V E+M N +LD FL RK+ L + ++ G++ G+ YL S
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFL----RKHEGQLVAGQLMGMLPGLASGMKYL---SE 125
Query: 551 LRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEA--NTKRIVGTYGYMSPEYAMS 608
+ +H+ L A +L++ + KIS F R+ E ++SEA T + +PE
Sbjct: 126 MGYVHKGLAAHKVLVNSDLVCKISGFR--RLQE-DKSEAIYTTMSGKSPVLWAAPEAIQY 182
Query: 609 GIVSIKTDVFSFGVLVLEIVS 629
S +DV+SFG+++ E++S
Sbjct: 183 HHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 7e-14
Identities = 64/209 (30%), Positives = 107/209 (51%), Gaps = 15/209 (7%)
Query: 428 AANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFK--NEVRLIAKLQ 484
AA ++ KLGEG + VYKG + Q VA+K +S + +G V F E L+ L+
Sbjct: 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG-VPFTAIREASLLKGLK 61
Query: 485 HTNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLL 543
H N+V LL +H +E L V+E+M + + + G + N R + + + +GL
Sbjct: 62 HANIV-LLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYN--VRLFMFQ-LLRGLA 117
Query: 544 YLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSP 603
Y+H ++HRDLK N+L+ K++DFG+AR + S+ + +V T Y P
Sbjct: 118 YIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSI-PSQTYSSEVV-TLWYRPP 172
Query: 604 EYAMSGI-VSIKTDVFSFGVLVLEIVSGQ 631
+ + S D++ G + +E++ GQ
Sbjct: 173 DVLLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 8e-14
Identities = 63/206 (30%), Positives = 102/206 (49%), Gaps = 27/206 (13%)
Query: 437 KLGEGGFGPVYKGK-LADEQEVAIK--RLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLG 493
KLGEG + VYKG+ Q VA+K RL G + E L+ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIV-TLH 69
Query: 494 CSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLR 552
+H ++ L LV+E++ + L ++ + G L+ + + + +GL Y H+ R
Sbjct: 70 DIIHTKKTLTLVFEYL-DTDLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQR---R 123
Query: 553 VIHRDLKASNILLDDKMNPKISDFGMARIFEV------NESEANTKRIVGTYGYMSPEYA 606
V+HRDLK N+L+ ++ K++DFG+AR V NE V T Y P+
Sbjct: 124 VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNE--------VVTLWYRPPDVL 175
Query: 607 M-SGIVSIKTDVFSFGVLVLEIVSGQ 631
+ S S D++ G + E+ +G+
Sbjct: 176 LGSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 1e-13
Identities = 57/210 (27%), Positives = 109/210 (51%), Gaps = 22/210 (10%)
Query: 431 NFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLS-RSSGQGI-VEFKNEVRLIAKLQHTN 487
+ N++ EG +G VY+ + + VA+K+L +G + E+ ++ KLQH N
Sbjct: 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPN 65
Query: 488 LVRL----LGCSLHGEERLLVYEFMPN--KSLDFFLFNSGRKNVLNWEKRFIIIEGISQG 541
+V + +G +L + +V E++ + KSL + ++ L E + ++++ +S G
Sbjct: 66 IVTVKEVVVGSNLD--KIYMVMEYVEHDLKSL----METMKQPFLQSEVKCLMLQLLS-G 118
Query: 542 LLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYM 601
+ +LH ++HRDLK SN+LL+++ KI DFG+AR + ++V T Y
Sbjct: 119 VAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK--PYTQLVVTLWYR 173
Query: 602 SPEYAMS-GIVSIKTDVFSFGVLVLEIVSG 630
+PE + S D++S G + E+++
Sbjct: 174 APELLLGAKEYSTAIDMWSVGCIFAELLTK 203
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 64/205 (31%), Positives = 107/205 (52%), Gaps = 26/205 (12%)
Query: 438 LGEGGFGPVY---KGKLADEQEV-AIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRL 491
LG+G FG V+ K D ++ A+K L +++ + V K E ++A++ H +V+L
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 492 LGCSLHGEERLLVYEFMPNKSLDFF----LFNSGRKNVLNWEK--RFIIIEGISQGLLYL 545
+ E +L + LDF LF K V+ E+ +F + E ++ L +L
Sbjct: 64 -HYAFQTEGKLYLI-------LDFLRGGDLFTRLSKEVMFTEEDVKFYLAE-LALALDHL 114
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEY 605
H L +I+RDLK NILLD++ + K++DFG+++ E + E GT YM+PE
Sbjct: 115 H---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEV 169
Query: 606 AMSGIVSIKTDVFSFGVLVLEIVSG 630
+ D +SFGVL+ E+++G
Sbjct: 170 VNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 64/233 (27%), Positives = 106/233 (45%), Gaps = 53/233 (22%)
Query: 432 FSTTNKLGEGGFGPVYKGKLADE----QEVAIKRLSRS--SGQGIVEFKNEVRLIAKLQH 485
F+ LG+G FG V + +L E Q+VA+K L S I EF E + + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 486 TNLVRLLGCSLHGEER------LLVYEFMPNKSLDFFL---------FNSGRKNVLNWEK 530
N+++L+G SL + +++ FM + L FL F + ++
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLV---- 116
Query: 531 RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEAN 590
RF+I I+ G+ YL S IHRDL A N +L++ M ++DFG+++
Sbjct: 117 RFMI--DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSK---------- 161
Query: 591 TKRIVGTY-----------GYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQ 631
K G Y +++ E + + +DV++FGV + EI++ GQ
Sbjct: 162 -KIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQ 213
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (177), Expect = 2e-13
Identities = 66/240 (27%), Positives = 105/240 (43%), Gaps = 53/240 (22%)
Query: 435 TNKLGEGGFGPVYKGKLADEQE-VAIKRLSRSSGQGIVEFKN---------EVRLIAKLQ 484
+G G +G V VAIK++S F + E++L+ L+
Sbjct: 5 LKPIGSGAYGVVCSAVDKRTGRKVAIKKISN-------VFDDLIDAKRILREIKLLRHLR 57
Query: 485 HTNLVRLLGC----SLHGEERL-LVYEFMP---NKSLDFFLFNSGRKNVLNWEK-RFIII 535
H N++ LL S + +V E M +K + S + L + ++ +
Sbjct: 58 HENIIGLLDILRPPSPEDFNDVYIVTELMETDLHK-----VIKSPQP--LTDDHIQYFLY 110
Query: 536 EGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEAN--TKR 593
+ I +GL YLH VIHRDLK SNIL++ + KI DFG+AR + +E E T+
Sbjct: 111 Q-ILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEY 166
Query: 594 IVGTYGYMSPEYAMSGI---VSIKTDVFSFGVLVLEIVSG----QKNHTRHHPDRPLNLI 646
+V T Y +PE +S +I D++S G + E+++ LNLI
Sbjct: 167 VV-TRWYRAPELLLSSSRYTKAI--DIWSVGCIFAELLTRKPLFPGRDYIDQ----LNLI 219
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 3e-13
Identities = 64/226 (28%), Positives = 106/226 (46%), Gaps = 29/226 (12%)
Query: 422 FQTIAAAANNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKN--EVR 478
F T+ N + +G G FG V + Q VAIK++ + ++ + E++
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61
Query: 479 LIAKLQHTNLVRLLGCSLHGEERL-LVYEFMPNKSLDFF-LFNSGRKNVLNWEKRFI--I 534
L+ L+H N++ L + E + V E + D L S EK+FI
Sbjct: 62 LLKHLRHENIISLSDIFISPLEDIYFVTELL---GTDLHRLLTSRP-----LEKQFIQYF 113
Query: 535 IEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594
+ I +GL Y+H V+HRDLK SNIL+++ + KI DFG+ARI +
Sbjct: 114 LYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI-----QDPQMTGY 165
Query: 595 VGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQ-----KNH 634
V T Y +PE ++ ++ D++S G + E++ G+ K+H
Sbjct: 166 VSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH 211
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 57/203 (28%), Positives = 105/203 (51%), Gaps = 20/203 (9%)
Query: 437 KLGEGGFGPVYKGKLADE--QEVAIKRLS-RSSGQGI-VEFKNEVRLIAKLQ---HTNLV 489
++GEG +G V+K + + VA+KR+ ++ +G+ + EV ++ L+ H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 490 RLLG-CSLHGEER----LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLY 544
RL C++ +R LV+E + ++ L +L V + ++ + + +GL +
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQ-LLRGLDF 125
Query: 545 LHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPE 604
LH + RV+HRDLK NIL+ K++DFG+ARI+ + +V T Y +PE
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYRAPE 179
Query: 605 YAMSGIVSIKTDVFSFGVLVLEI 627
+ + D++S G + E+
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 4e-13
Identities = 64/207 (30%), Positives = 105/207 (50%), Gaps = 15/207 (7%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIK--RLSRSSGQGIVEFKNEVRLIAKLQH 485
A+++ KLGEG + VYKGK + + VA+K RL G + E L+ L+H
Sbjct: 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKH 62
Query: 486 TNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLY 544
N+V LL +H +E L LV+E++ D + L+ E + + + +GL Y
Sbjct: 63 ANIV-LLHDIIHTKETLTLVFEYV---HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSY 118
Query: 545 LHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPE 604
+H+ ++HRDLK N+L+ D K++DFG+AR V S + +V T Y P+
Sbjct: 119 IHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSV-PSHTYSNEVV-TLWYRPPD 173
Query: 605 YAM-SGIVSIKTDVFSFGVLVLEIVSG 630
+ S S D++ G + +E++ G
Sbjct: 174 VLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 57/230 (24%), Positives = 96/230 (41%), Gaps = 47/230 (20%)
Query: 436 NKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKN--------------EVRLI 480
LGEG +G V K + VAIK++ V E++++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 481 AKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRF------II 534
+++H N++ L+ + G+ LV + M S K V++ + R I
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIM----------ASDLKKVVDRKIRLTESQVKCI 124
Query: 535 IEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIF------------ 582
+ I GL LHK+ +HRDL +NI ++ K KI+DFG+AR +
Sbjct: 125 LLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKD 181
Query: 583 EVNESEANTKRIVGTYGYMSPEYAM-SGIVSIKTDVFSFGVLVLEIVSGQ 631
E + V T Y +PE M + D++S G + E+++G+
Sbjct: 182 ETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 5e-13
Identities = 65/211 (30%), Positives = 97/211 (45%), Gaps = 34/211 (16%)
Query: 438 LGEGGFGPVYKGKLAD-EQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHT-------NLV 489
+G G FG V K +A+KR+ RS V+ K + RL+ L +V
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRI-RS----TVDEKEQKRLLMDLDVVMRSSDCPYIV 66
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFI---IIEGIS----QGL 542
+ G + + E M + SLD F K V K I I+ I+ + L
Sbjct: 67 KFYGALFREGDCWICMELM-DISLDKFY-----KYVYEVLKSVIPEEILGKIAVATVKAL 120
Query: 543 LYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMS 602
YL + L++IHRD+K SNILLD N K+ DFG++ +S A T R G YM+
Sbjct: 121 NYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV--DSIAKT-RDAGCRPYMA 175
Query: 603 PEYAMSGIVS---IKTDVFSFGVLVLEIVSG 630
PE +++DV+S G+ + E+ +G
Sbjct: 176 PERIDPSARDGYDVRSDVWSLGITLYEVATG 206
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-12
Identities = 63/230 (27%), Positives = 110/230 (47%), Gaps = 45/230 (19%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPV---YKGKLADEQEVAIKRLSRSSGQGIVEFKN---E 476
+TI + + +G G +G V + K VA+K+LSR Q I+ K E
Sbjct: 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTG--LRVAVKKLSRPF-QSIIHAKRTYRE 66
Query: 477 VRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNVLNW 528
+RL+ ++H N++ LL F P +SL+ F L + N++
Sbjct: 67 LRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKC 114
Query: 529 EK------RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIF 582
+K +F+I + I +GL Y+H +IHRDLK SN+ +++ KI DFG+AR
Sbjct: 115 QKLTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-- 168
Query: 583 EVNESEANTKRIVGTYGYMSPEYAMSGI-VSIKTDVFSFGVLVLEIVSGQ 631
++ V T Y +PE ++ + + D++S G ++ E+++G+
Sbjct: 169 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 63/202 (31%), Positives = 97/202 (48%), Gaps = 19/202 (9%)
Query: 438 LGEGGFGPVYKGKLADEQEV-AIKRLSRSSGQGIVEFKN------EVRLIAKLQHTNLVR 490
LG+G FG V +L EV AIK L + I++ + E R++A +
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDV---ILQDDDVDCTMTEKRILALAAKHPFLT 59
Query: 491 LLGCSLHGEERLL-VYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
L C ++RL V E++ L F RK RF E ++ L++LH++
Sbjct: 60 ALHCCFQTKDRLFFVMEYVNGGDL-MFQIQRSRKFDEP-RSRFYAAE-VTLALMFLHRHG 116
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSG 609
VI+RDLK NILLD + + K++DFGM + E + T GT Y++PE
Sbjct: 117 ---VIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAPEILQEL 171
Query: 610 IVSIKTDVFSFGVLVLEIVSGQ 631
D ++ GVL+ E+++GQ
Sbjct: 172 EYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 61/212 (28%), Positives = 97/212 (45%), Gaps = 36/212 (16%)
Query: 438 LGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHT-------NLV 489
LG G +G V K + + +A+KR+ R++ V + + RL+ L + V
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRI-RAT----VNSQEQKRLLMDLDISMRSVDCPYTV 63
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRF------IIIEGISQGLL 543
G + + E M + SLD F K V + I I + L
Sbjct: 64 TFYGALFREGDVWICMEVM-DTSLDKFY-----KKVYDKGLTIPEDILGKIAVSIVKALE 117
Query: 544 YLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSP 603
YLH S+L VIHRD+K SN+L++ K+ DFG++ + +S A T G YM+P
Sbjct: 118 YLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGISG--YLVDSVAKTIDA-GCKPYMAP 172
Query: 604 E-----YAMSGIVSIKTDVFSFGVLVLEIVSG 630
E G +K+DV+S G+ ++E+ +G
Sbjct: 173 ERINPELNQKGY-DVKSDVWSLGITMIELATG 203
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 55/205 (26%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 432 FSTTNKLGEGGFGP--VYKGKLADEQ----EVAIKRLSRSSGQGIVEFKNEVRLIAKLQH 485
+ K+GEG FG + K K +Q E+ I ++S + E + EV +++ ++H
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKERE---ESRKEVAVLSNMKH 58
Query: 486 TNLVRLLGCSLHGEERLLVYEFMPN-KSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLY 544
N+V+ EE +Y M + D + + ++ VL E + I++ Q L
Sbjct: 59 PNIVQY---QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQ--ILDWFVQICLA 113
Query: 545 LHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPE 604
L +++HRD+K+ NI L K+ DFG+AR+ A T +GT Y+SPE
Sbjct: 114 LKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART--CIGTPYYLSPE 171
Query: 605 YAMSGIVSIKTDVFSFGVLVLEIVS 629
+ + K+D+++ G ++ E+ +
Sbjct: 172 ICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 67/238 (28%), Positives = 100/238 (42%), Gaps = 47/238 (19%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEV-AIKRLSRS----SGQGIVEFKNEVRLIAKLQ 484
++F +G G FG V+ + D +V A+K L +S Q I + E R I L
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQ-IAHVRAE-RDI--LA 56
Query: 485 HTN---LVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQ 540
+ +V+L S EE L LV E+MP L L RF I E +
Sbjct: 57 DADSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDV--FPEETARFYIAELV-- 111
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMA--------RIFEVNESEANTK 592
L L +L IHRD+K NIL+D + K++DFG+ R + +N+S
Sbjct: 112 --LALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLF 169
Query: 593 R-------------------IVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
R VGT Y++PE ++ D +S GV++ E++ G
Sbjct: 170 RDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGF 227
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 55/190 (28%), Positives = 88/190 (46%), Gaps = 33/190 (17%)
Query: 437 KLGEGGFGPVYKGKL---ADEQEVAIKRL--SRSSGQGIVEFK-NEVRLIAKLQHTNLVR 490
+G G +G VYK K D +E AIK+ + GI + E+ L+ +L+H N+V
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66
Query: 491 LLGCSLHGEERL--LVYEFMPNKSLDFFLFNSGRKNV---------LNWEKRFIIIEGIS 539
L+ L ++ L++++ + F+ K V L W+ I
Sbjct: 67 LVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ--------IL 118
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILL----DDKMNPKISDFGMARIF-EVNESEANTKRI 594
G+ YLH V+HRDLK +NIL+ ++ KI D G+AR+F + A+ +
Sbjct: 119 NGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPV 175
Query: 595 VGTYGYMSPE 604
V T Y +PE
Sbjct: 176 VVTIWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 4e-12
Identities = 60/230 (26%), Positives = 112/230 (48%), Gaps = 45/230 (19%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPV---YKGKLADEQEVAIKRLSRSSGQGIVEFKN---E 476
+T+ + +G G +G V Y +L Q+VA+K+LSR Q ++ + E
Sbjct: 8 KTVWEVPERYQNLTPVGSGAYGSVCSAYDTRL--RQKVAVKKLSRPF-QSLIHARRTYRE 64
Query: 477 VRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF--------LFNSGRKNVLNW 528
+RL+ ++H N++ LL F P S++ F L + N++
Sbjct: 65 LRLLKHMKHENVIGLLDV------------FTPATSIENFNEVYLVTNLMGADLNNIVKC 112
Query: 529 EK------RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIF 582
+K +F+I + + +GL Y+H +IHRDLK SN+ +++ +I DFG+AR
Sbjct: 113 QKLSDEHVQFLIYQ-LLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR-- 166
Query: 583 EVNESEANTKRIVGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
+++ V T Y +PE ++ + +T D++S G ++ E++ G+
Sbjct: 167 ---QADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 4e-12
Identities = 65/203 (32%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 438 LGEGGFGPVYKGKLADEQEV-AIKRLSRSSGQGIVE------FKNEVRLIAKL-QHTNLV 489
LG+G FG V +L E+ A+K L + I++ E R++A +H L
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDV---ILQDDDVECTMTEKRVLALAGKHPFLT 59
Query: 490 RLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
+L C ++RL V E++ L F + SGR + RF E I GL +LH+
Sbjct: 60 QLHSC-FQTKDRLFFVMEYVNGGDLMFHIQRSGRFD--EPRARFYAAE-IVLGLQFLHER 115
Query: 549 SRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMS 608
+I+RDLK N+LLD + + KI+DFGM + E T GT Y++PE
Sbjct: 116 G---IIYRDLKLDNVLLDSEGHIKIADFGMCK--EGILGGVTTSTFCGTPDYIAPEILSY 170
Query: 609 GIVSIKTDVFSFGVLVLEIVSGQ 631
D ++ GVL+ E+++GQ
Sbjct: 171 QPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 5e-12
Identities = 43/127 (33%), Positives = 74/127 (58%), Gaps = 13/127 (10%)
Query: 506 EFMPNKSLDFFLFNSGR--KNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNI 563
E M SLD L +GR +N+L I + +GL YL + + +++HRD+K SNI
Sbjct: 79 EHMDGGSLDQVLKKAGRIPENILG-----KISIAVLRGLTYLRE--KHKIMHRDVKPSNI 131
Query: 564 LLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVL 623
L++ + K+ DFG++ ++ +S AN+ VGT YMSPE ++++D++S G+
Sbjct: 132 LVNSRGEIKLCDFGVSG--QLIDSMANS--FVGTRSYMSPERLQGTHYTVQSDIWSLGLS 187
Query: 624 VLEIVSG 630
++E+ G
Sbjct: 188 LVEMAIG 194
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 67.2 bits (165), Expect = 6e-12
Identities = 62/190 (32%), Positives = 97/190 (51%), Gaps = 41/190 (21%)
Query: 436 NKLGEGGFGPVYKGKLADEQE-VAIKRLSRSSGQGIVEFKN---------EVRLIAKL-Q 484
KLG+G +G V+K +E VA+K++ + F+N E+ + +L
Sbjct: 13 QKLGKGAYGIVWKAIDRRTKEVVALKKIFDA-------FRNATDAQRTFREIMFLQELGD 65
Query: 485 HTNLVRLLGCSLHGEER----LLVYEFMPNKSLDFFLFNSGRKNVL-NWEKRFIIIEGIS 539
H N+V+LL ++ E LV+E+M + L R N+L + KR+I+ + +
Sbjct: 66 HPNIVKLL--NVIKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKRYIMYQ-LL 117
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI----- 594
+ L Y+H S VIHRDLK SNILL+ K++DFG+AR ++E E N +
Sbjct: 118 KALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLAR--SLSELEENPENPVLTDY 172
Query: 595 VGTYGYMSPE 604
V T Y +PE
Sbjct: 173 VATRWYRAPE 182
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 7e-12
Identities = 57/218 (26%), Positives = 103/218 (47%), Gaps = 22/218 (10%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFK--NEVRL 479
+T+ +++ ++G G +G V ++VAIK+LSR I + E+ L
Sbjct: 8 KTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTL 67
Query: 480 IAKLQHTNLVRLL-----GCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFII 534
+ +QH N++ LL S + Y MP D + L+ +K +
Sbjct: 68 LKHMQHENVIGLLDVFTSAVSGDEFQDF--YLVMPYMQTDL---QKIMGHPLSEDKVQYL 122
Query: 535 IEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594
+ + GL Y+H +IHRDLK N+ +++ KI DFG+AR ++A
Sbjct: 123 VYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGY 174
Query: 595 VGTYGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
V T Y +PE ++ + +T D++S G ++ E+++G+
Sbjct: 175 VVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 8e-12
Identities = 62/204 (30%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 438 LGEGGFGPVYKGKL-ADEQEVAIKRLSRSSGQGIVEFKNEVR--------LIAKLQHTNL 488
LG+G FG V+ +L Q AIK L + +V ++V L +H L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKD----VVLMDDDVECTMVEKRVLSLAWEHPFL 58
Query: 489 VRLLGCSLHGEERLL-VYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHK 547
L C+ +E L V E++ L F + + + + + I GL +LH
Sbjct: 59 THLY-CTFQTKENLFFVMEYLNGGDLMFHIQSCHK---FDLPRATFYAAEIICGLQFLHS 114
Query: 548 YSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM 607
+++RDLK NILLD + KI+DFGM + E +A T GT Y++PE +
Sbjct: 115 KG---IVYRDLKLDNILLDTDGHIKIADFGMCK--ENMLGDAKTCTFCGTPDYIAPEILL 169
Query: 608 SGIVSIKTDVFSFGVLVLEIVSGQ 631
+ D +SFGVL+ E++ GQ
Sbjct: 170 GQKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 9e-12
Identities = 64/246 (26%), Positives = 106/246 (43%), Gaps = 46/246 (18%)
Query: 437 KLGEGGFGPVYKG-KLADEQEVAIKRLSRS-SGQGIVE--FKNEVRLIAKLQHTNLVRLL 492
+G+GG G VY + VA+K++ S +++ F E ++ A L H +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 493 GCSLHGEERLLVYEFMP---NKSLDFFLFNSGRKNVLNWE-------KRFI-IIEGISQG 541
G+ VY MP +L L + +K L+ E F+ I I
Sbjct: 69 SICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT 125
Query: 542 LLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE-----ANTK---- 592
+ Y+H S+ V+HRDLK NILL I D+G A ++ E + + +
Sbjct: 126 IEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182
Query: 593 -------RIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS---------GQKNHTR 636
+IVGT YM+PE + S TD+++ GV++ ++++ G+K R
Sbjct: 183 SSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYR 242
Query: 637 HHPDRP 642
P
Sbjct: 243 DVILSP 248
|
Length = 932 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 9e-12
Identities = 45/136 (33%), Positives = 70/136 (51%), Gaps = 21/136 (15%)
Query: 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILL 565
EFM SLD ++ ++VL I + +GL YL L+++HRD+K SN+L+
Sbjct: 79 EFMDGGSLD--VYRKIPEHVLGR-----IAVAVVKGLTYLWS---LKILHRDVKPSNMLV 128
Query: 566 DDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVL 625
+ + K+ DFG++ ++ S A T VGT YM+PE I +DV+S G+ +
Sbjct: 129 NTRGQVKLCDFGVST--QLVNSIAKT--YVGTNAYMAPERISGEQYGIHSDVWSLGISFM 184
Query: 626 EIVSG-------QKNH 634
E+ G QKN
Sbjct: 185 ELALGRFPYPQIQKNQ 200
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 27/213 (12%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADEQEV-AIKRLSRSSGQGIVEFKN--------EVRLIA 481
+F+ LG+G FG V + E+ AIK L + V ++ E R++A
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKD-----VIIQDDDVECTMVEKRVLA 55
Query: 482 KLQHTNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQ 540
+ L +RL V E++ L + + G+ F E I+
Sbjct: 56 LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGK--FKEPHAVFYAAE-IAI 112
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR--IFEVNESEANTKRIVGTY 598
GL +LH +I+RDLK N++LD + + KI+DFGM + IF T+ GT
Sbjct: 113 GLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG----GKTTRTFCGTP 165
Query: 599 GYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
Y++PE D ++FGVL+ E+++GQ
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 84/313 (26%), Positives = 140/313 (44%), Gaps = 52/313 (16%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVR--LIAKLQHTN 487
++F ++LG G G V+K + ++L +E K +R +I +LQ +
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIH------LEIKPAIRNQIIRELQVLH 58
Query: 488 ------LVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGR--KNVLNWEKRFIIIEGIS 539
+V G E + E M SLD L +GR + +L +I
Sbjct: 59 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI----- 113
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
+GL YL + + +++HRD+K SNIL++ + K+ DFG++ ++ +S AN+ VGT
Sbjct: 114 KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANS--FVGTRS 167
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGL 659
YMSPE S+++D++S G+ ++E+ G+ +P P D K L
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR------YPIPP-----------PDAKEL 210
Query: 660 ELI-DPSLEQPCSANEVMRCIHVGLLCVQDQAMD-RPTMP--EVVCMLQNETMPLPPPKQ 715
EL+ +E + +E + D RP M E++ + NE PPPK
Sbjct: 211 ELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNE----PPPKL 266
Query: 716 PAFFINANADDQV 728
P+ A D V
Sbjct: 267 PSGVFGAEFQDFV 279
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 35/84 (41%), Positives = 51/84 (60%), Gaps = 9/84 (10%)
Query: 553 VIHRDLKASNILLDDKMNPKISDFGMA-RIFEVNESEANTKRIVGTYGYMSPEY----AM 607
VIHRD+K SNILLD N K+ DFG++ R+ +S+A T R G YM+PE
Sbjct: 136 VIHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKAKT-RSAGCAAYMAPERIDPPDP 191
Query: 608 SGIVSIKTDVFSFGVLVLEIVSGQ 631
+ I+ DV+S G+ ++E+ +GQ
Sbjct: 192 NPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 436 NKLGEGGFGPVYKGK-LADEQEVAIKRLSR--SSGQGIVEFKNEVRLIAKLQ-HTNLVRL 491
K+GEG F V K + + AIK + + S + + E++ + +L H N++RL
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL-REIQALRRLSPHPNILRL 63
Query: 492 LGC---SLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHK 547
+ G RL LV+E M ++ + GRK L ++ + + + L ++H
Sbjct: 64 IEVLFDRKTG--RLALVFELM---DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH- 117
Query: 548 YSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM 607
R + HRD+K NIL+ D K++DFG R + T+ I T Y +PE +
Sbjct: 118 --RNGIFHRDIKPENILIKDD-ILKLADFGSCR--GIYSKPPYTEYI-STRWYRAPECLL 171
Query: 608 -SGIVSIKTDVFSFGVLVLEIVS 629
G K D+++ G + EI+S
Sbjct: 172 TDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 61/202 (30%), Positives = 99/202 (49%), Gaps = 22/202 (10%)
Query: 438 LGEGGFGPVYKGK-LADEQEVAIKRLS--RSSGQGIVEFKNEVRLIAKLQHTNLVRLLGC 494
+G+G +G V + D ++ IK+L+ +S + + E +L+++L+H N+V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE- 66
Query: 495 SLHGEERLL--VYEFMPNKSLDFFLFNSGRK-----NVLNWEKRFIIIEGISQGLLYLHK 547
S GE+ LL V F L L K V+ W F+ I+ L YLH+
Sbjct: 67 SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEW---FV---QIAMALQYLHE 120
Query: 548 YSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM 607
++HRDLK N+ L K+ D G+AR+ E A+T ++GT YMSPE
Sbjct: 121 K---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGTPYYMSPELFS 175
Query: 608 SGIVSIKTDVFSFGVLVLEIVS 629
+ + K+DV++ G V E+ +
Sbjct: 176 NKPYNYKSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 63/208 (30%), Positives = 99/208 (47%), Gaps = 23/208 (11%)
Query: 431 NFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSSGQGIVEFKN------EVRLIAKL 483
+F LG G FG V K + AIK L + + I++ K E ++ +L
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKK---REILKMKQVQHVAQEKSILMEL 75
Query: 484 QHTNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGL 542
H +V ++ CS E R+ + EF+ L L +GR N +F E +
Sbjct: 76 SHPFIVNMM-CSFQDENRVYFLLEFVVGGELFTHLRKAGR--FPNDVAKFYHAE-LVLAF 131
Query: 543 LYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMS 602
YLH +I+RDLK N+LLD+K + K++DFG A+ +V + T + GT Y++
Sbjct: 132 EYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK--KVPD---RTFTLCGTPEYLA 183
Query: 603 PEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
PE S D ++ GVL+ E ++G
Sbjct: 184 PEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 3e-11
Identities = 56/200 (28%), Positives = 89/200 (44%), Gaps = 48/200 (24%)
Query: 454 EQEVAIKRLSRSSGQGIVEFKN---------EVRLIAKLQHTNLVRLLGCSLHGEERLLV 504
Q VAIK+LSR F+N E+ L+ + H N++ LL
Sbjct: 41 GQNVAIKKLSRP-------FQNVTHAKRAYRELVLMKLVNHKNIIGLLNV---------- 83
Query: 505 YEFMPNKSLDFF--------LFNSGRKNVLNWE---KR--FIIIEGISQGLLYLHKYSRL 551
F P KSL+ F L ++ V+ + +R +++ + + G+ +LH
Sbjct: 84 --FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLC-GIKHLHSAG-- 138
Query: 552 RVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIV 611
+IHRDLK SNI++ KI DFG+AR S T +V Y Y +PE +
Sbjct: 139 -IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRY-YRAPEVILGMGY 194
Query: 612 SIKTDVFSFGVLVLEIVSGQ 631
D++S G ++ E++ G
Sbjct: 195 KENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 56/200 (28%), Positives = 92/200 (46%), Gaps = 27/200 (13%)
Query: 441 GGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKNEV------RLIAKLQHT--NLVRL 491
G FG VY K + AIK L +S + KN+V R I +Q + +L
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSD----MIAKNQVTNVKAERAIMMIQGESPYVAKL 62
Query: 492 LGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRL 551
+ LV E++ + G +W K++I + G+ LH+
Sbjct: 63 YYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLP-EDWAKQYI--AEVVLGVEDLHQRG-- 117
Query: 552 RVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIV 611
+IHRD+K N+L+D + K++DFG++R N K+ VGT Y++PE + G+
Sbjct: 118 -IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN------KKFVGTPDYLAPETIL-GVG 169
Query: 612 SIK-TDVFSFGVLVLEIVSG 630
K +D +S G ++ E + G
Sbjct: 170 DDKMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 4e-11
Identities = 64/239 (26%), Positives = 114/239 (47%), Gaps = 30/239 (12%)
Query: 437 KLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGI-VEFKNEVRLIAKLQHTNLVRLLGCS 495
K+G G +G VYK K D ++ L + G GI + E+ L+ +L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 496 L-HGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLY-----LHKY 548
L H + ++ L++++ + F+ K +K + G+ + LLY +H
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPVQLPRGMVKSLLYQILDGIHYL 124
Query: 549 SRLRVIHRDLKASNILL----DDKMNPKISDFGMARIFEVN-ESEANTKRIVGTYGYMSP 603
V+HRDLK +NIL+ ++ KI+D G AR+F + A+ +V T+ Y +P
Sbjct: 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 604 EYAMSGIVSIKT-DVFSFGVLVLEIVSGQK-NHTR----------HHP--DRPLNLIGY 648
E + K D+++ G + E+++ + H R HH DR N++G+
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGF 243
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 4e-11
Identities = 60/201 (29%), Positives = 91/201 (45%), Gaps = 17/201 (8%)
Query: 438 LGEGGFGPVYKGKLADEQEV-AIKRLSRSS--GQGIVEFKNEVRLIAKL--QHTNLVRLL 492
LG+G FG V +L + + A+K L + VE + I L H L +L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 493 GCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLR 552
C + V EF+ L F + S R + RF E I+ L++LH
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD--EARARFYAAE-ITSALMFLHDKG--- 116
Query: 553 VIHRDLKASNILLDDKMNPKISDFGMAR--IFEVNESEANTKRIVGTYGYMSPEYAMSGI 610
+I+RDLK N+LLD + + K++DFGM + IF T GT Y++PE +
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN----GKTTSTFCGTPDYIAPEILQEML 172
Query: 611 VSIKTDVFSFGVLVLEIVSGQ 631
D ++ GVL+ E++ G
Sbjct: 173 YGPSVDWWAMGVLLYEMLCGH 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 10/205 (4%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQE-VAIKRLSRSSGQGIVEFKN--EVRLIAKLQHT 486
N F +GEG +G V K + + +E VAIK+ S V+ E++++ L+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 487 NLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLH 546
N+V L + LV+E++ L+ L V + R I + I + + + H
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSYIYQLI-KAIHWCH 117
Query: 547 KYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYA 606
K ++HRD+K N+L+ K+ DFG AR S AN V T Y SPE
Sbjct: 118 KND---IVHRDIKPENLLISHNDVLKLCDFGFARNLS-EGSNANYTEYVATRWYRSPELL 173
Query: 607 MSGIVSIKTDVFSFGVLVLEIVSGQ 631
+ D++S G ++ E+ GQ
Sbjct: 174 LGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 5e-11
Identities = 55/202 (27%), Positives = 96/202 (47%), Gaps = 19/202 (9%)
Query: 437 KLGEGGFGPVYKGKLADE-QEVAIKRLSRSSGQGIVEFKN--EVRLIAKLQ---HTNLVR 490
++G G +G VYK + VA+K + + + + EV L+ +L+ H N+VR
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 491 LLG-CSLHGEER----LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYL 545
L+ C+ +R LV+E + ++ L +L L E ++ +GL +L
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPG-LPAETIKDLMRQFLRGLDFL 124
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEY 605
H ++HRDLK NIL+ K++DFG+ARI+ + +V T Y +PE
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA---LTPVVVTLWYRAPEV 178
Query: 606 AMSGIVSIKTDVFSFGVLVLEI 627
+ + D++S G + E+
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 5e-11
Identities = 56/213 (26%), Positives = 106/213 (49%), Gaps = 28/213 (13%)
Query: 438 LGEGGFGPVYKGKLAD-EQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRL---LG 493
LG G G V+ +D ++ VA+K++ + Q + E+++I +L H N+V++ LG
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 494 CSLHGEERLL-----------VYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGL 542
S + V E+M + L N + L+ E + + + +GL
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLSEEHARLFMYQLLRGL 127
Query: 543 LYLHKYSRLRVIHRDLKASNILLD-DKMNPKISDFGMARIFEVNESEAN--TKRIVGTYG 599
Y+H + V+HRDLK +N+ ++ + + KI DFG+ARI + + S ++ +V +
Sbjct: 128 KYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW- 183
Query: 600 YMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
Y SP +S K D+++ G + E+++G+
Sbjct: 184 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 8e-11
Identities = 48/141 (34%), Positives = 71/141 (50%), Gaps = 16/141 (11%)
Query: 538 ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT 597
I +GL YLH ++HRD+K N+L++ KI DFG+AR+ E +ES+ T+ +V
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168
Query: 598 YGYMSPEYAM-SGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDG 656
Y Y +PE M S + D++S G + E++ + P + L+LI LL
Sbjct: 169 Y-YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLI---TDLLG-- 222
Query: 657 KGLELIDPSLEQPCSANEVMR 677
PSLE SA E R
Sbjct: 223 ------TPSLEAMRSACEGAR 237
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 9e-11
Identities = 38/104 (36%), Positives = 55/104 (52%), Gaps = 7/104 (6%)
Query: 529 EKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE 588
E R I E I L +LH+ L +I+RD+K NILLD + + ++DFG+++ F E E
Sbjct: 106 EVRVYIAE-IVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE 161
Query: 589 ANTKRIVGTYGYMSPEYAMSGIV--SIKTDVFSFGVLVLEIVSG 630
GT YM+PE G D +S GVL E+++G
Sbjct: 162 -RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 57/217 (26%), Positives = 104/217 (47%), Gaps = 30/217 (13%)
Query: 438 LGEGGFGPVY--------KGKLADEQEVAIKRLS-RSSGQGIVEFKNEVRLIAKL-QHTN 487
LGEG FG V K K + VA+K L ++ + + + +E+ ++ + +H N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 488 LVRLLGCSLHGEERLLVYEFMPNKSLDFFL-----------FNSGR--KNVLNWEKRFII 534
++ LLG ++ E+ +L +L ++ R + ++
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 535 IEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594
+++G+ YL + + IHRDL A N+L+ + KI+DFG+AR +VN + K
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DVNNIDYYKKTT 197
Query: 595 VGTY--GYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
G +M+PE + + ++DV+SFGVL+ EI +
Sbjct: 198 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 68/283 (24%), Positives = 118/283 (41%), Gaps = 39/283 (13%)
Query: 436 NKLGEGGFGPVYKGK---LADEQEVAIKRLSRSSG-QGIVEFKNEVRLIAKLQHTNLVRL 491
+++G G FG V G+ + V +K L S+ + F EV+ +L H N+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 492 LGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFI--IIEGISQGLLYLHKYS 549
LG + LLV EF P L +L ++ +K + + ++ GLL+LH
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH--- 117
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMAR------IFEVNESEANTKRIVGTYGYMSP 603
+ IH DL N L ++ KI D+G+A + + A R +++P
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR------WLAP 171
Query: 604 EYAMSGIVSIKT-------DVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDG 656
E + +++S GV + E+ + + +PD L+ Q++ +
Sbjct: 172 ELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT---AADQPYPD--LSDEQVLKQVVRE- 225
Query: 657 KGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEV 699
+ ++L P L+ S R V C D RPT EV
Sbjct: 226 QDIKLPKPQLDLKYSD----RWYEVMQFCWLDPE-TRPTAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 57/217 (26%), Positives = 105/217 (48%), Gaps = 30/217 (13%)
Query: 438 LGEGGFGPVY--------KGKLADEQEVAIKRLSR-SSGQGIVEFKNEVRLIAKL-QHTN 487
LGEG FG V K K VA+K L ++ + + + +E+ ++ + +H N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 488 LVRLLGCSLHGEERLLVYEFMPNKSLDFFL-----------FNSGR--KNVLNWEKRFII 534
++ LLG ++ E+ +L +L F++ + + L ++
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 535 IEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594
+++G+ YL + + IHRDL A N+L+ + KI+DFG+AR +V+ + K
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLAR--DVHNIDYYKKTT 194
Query: 595 VGTY--GYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
G +M+PE + + ++DV+SFGVL+ EI +
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 62/212 (29%), Positives = 102/212 (48%), Gaps = 30/212 (14%)
Query: 438 LGEGGFGP--VYKGKLADEQEVAIK--RLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLG 493
+GEG FG + + +D Q+ A+K RL +SS + + + E L+AK++H N+V
Sbjct: 8 VGEGSFGRALLVQHVNSD-QKYAMKEIRLPKSS-SAVEDSRKEAVLLAKMKHPNIVAFKE 65
Query: 494 CSLHGEERL-LVYEFMPNKSL-DFFLFNSGR----KNVLNWEKRFIIIEGISQGLLYLHK 547
S + L +V E+ L G+ +L W F+ + G+ ++H+
Sbjct: 66 -SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW---FV---QMCLGVQHIHE 118
Query: 548 YSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM 607
RV+HRD+K+ NI L K+ DFG AR+ + A T VGT Y+ PE
Sbjct: 119 K---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPEIWE 173
Query: 608 SGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHP 639
+ + K+D++S G ++ E+ T HP
Sbjct: 174 NMPYNNKSDIWSLGCILYELC------TLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 58/212 (27%), Positives = 106/212 (50%), Gaps = 23/212 (10%)
Query: 437 KLGEGGFGPVYKGKL---ADEQEVAIKRLSRSSGQGI-VEFKNEVRLIAKLQHTNLVRLL 492
K+G G +G VYK K DE+E A+K++ G GI + E+ L+ +L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQI---EGTGISMSACREIALLRELKHPNVIALQ 64
Query: 493 GCSLHGEER--LLVYEFMPNK---SLDFFLFNSGRKNVLNWEKRFI--IIEGISQGLLYL 545
L +R L++++ + + F + K + + + ++ I G+ YL
Sbjct: 65 KVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL 124
Query: 546 HKYSRLRVIHRDLKASNILL----DDKMNPKISDFGMARIFEVN-ESEANTKRIVGTYGY 600
H V+HRDLK +NIL+ ++ KI+D G AR+F + A+ +V T+ Y
Sbjct: 125 HAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181
Query: 601 MSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
+PE + K D+++ G + E+++ +
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 60/212 (28%), Positives = 89/212 (41%), Gaps = 41/212 (19%)
Query: 438 LGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKNEVR--------LIAKLQHTNL 488
+G+G FG V K AD + A+K L + + + K E + L+ ++H L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKA----ILKKKEQKHIMAERNVLLKNVKHPFL 58
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFL--FNSGR--------KNVLNWEKRFIIIEGI 538
V LH Y F L F L N G ++ RF E I
Sbjct: 59 V-----GLH-------YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAE-I 105
Query: 539 SQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTY 598
+ L YLH L +I+RDLK NILLD + + ++DFG+ + E E T GT
Sbjct: 106 ASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTP 160
Query: 599 GYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
Y++PE D + G ++ E++ G
Sbjct: 161 EYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 57/216 (26%), Positives = 105/216 (48%), Gaps = 28/216 (12%)
Query: 438 LGEGGFGPVY--------KGKLADEQEVAIKRL-SRSSGQGIVEFKNEVRLIAKL-QHTN 487
LGEG FG V K K +VA+K L S ++ + + + +E+ ++ + +H N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 488 LVRLLGCSLHGEERLLVYEFMPNKSLDFFL-----------FNSGRKNVLNWEKRFII-- 534
++ LLG ++ E+ +L +L +N + + ++
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 535 IEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR-IFEVNESEANTKR 593
+++G+ YL + + IHRDL A N+L+ + KI+DFG+AR I ++ + T
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 594 IVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+ +M+PE I + ++DV+SFGVL+ EI +
Sbjct: 203 RLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 4e-10
Identities = 61/233 (26%), Positives = 107/233 (45%), Gaps = 33/233 (14%)
Query: 431 NFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFK-NEVRLIAKLQHTNL 488
+ + +GEG +G V +VAIK++S Q + E++++ + +H N+
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENI 65
Query: 489 VRLLG-------CSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQG 541
+ +L S + + +V E M L+ + L+ + + I +G
Sbjct: 66 IGILDIIRPPSFESFN--DVYIVQELMETD-----LYKLIKTQHLSNDHIQYFLYQILRG 118
Query: 542 LLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI---VGTY 598
L Y+H + V+HRDLK SN+LL+ + KI DFG+ARI + +T + V T
Sbjct: 119 LKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI--ADPEHDHTGFLTEYVATR 173
Query: 599 GYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQK----NHTRHHPDRPLNLI 646
Y +PE ++ K D++S G ++ E++S + H LNLI
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ----LNLI 222
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 4e-10
Identities = 63/218 (28%), Positives = 111/218 (50%), Gaps = 32/218 (14%)
Query: 438 LGEGGFGPVYK----GKLADEQE----VAIKRLS-RSSGQGIVEFKNEVRLIAKL-QHTN 487
LGEG FG V + G + VA+K L ++ + + + +E+ L+ + +H N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 488 LVRLLG-CSLHGEERLLVYEFMPNKSLDFFL-----------FNSGR--KNVLNWEKRFI 533
++ LLG C+ G ++V E+ +L FL F+ + + L+++
Sbjct: 80 IINLLGVCTQEGPLYVIV-EYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVS 138
Query: 534 IIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKR 593
+++G+ YL SR R IHRDL A N+L+ + KI+DFG+AR V++ + K
Sbjct: 139 CAYQVARGMEYLE--SR-RCIHRDLAARNVLVTEDNVMKIADFGLAR--GVHDIDYYKKT 193
Query: 594 IVGTY--GYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
G +M+PE + + ++DV+SFG+L+ EI +
Sbjct: 194 SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 5e-10
Identities = 62/233 (26%), Positives = 104/233 (44%), Gaps = 36/233 (15%)
Query: 438 LGEGGFGPVYKGKLAD--------EQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLV 489
LG+G F ++KG + + EV +K L +S F ++++L H +LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
G + G+E ++V E++ SLD +L + ++W+ +E Q LH
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWK-----LEVAKQLAWALHFLE 117
Query: 550 RLRVIHRDLKASNILL----DDKM-NP---KISDFGMARIFEVNESEANTKRIVGTYGYM 601
+ H ++ A N+LL D K NP K+SD G++ V E +RI ++
Sbjct: 118 DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS--ITVLPKEILLERI----PWV 171
Query: 602 SPE-YAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLL 653
PE +S+ D +SFG + EI SG D+PL+ + +L
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSGG--------DKPLSALDSQKKLQ 216
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 8e-10
Identities = 33/83 (39%), Positives = 48/83 (57%), Gaps = 10/83 (12%)
Query: 552 RVIHRDLKASNILLDDKMNPKISDFGMAR-IFE----VNESEANTKRIVGTYGYMSPEYA 606
+ IHRDL A NILL + KI DFG+AR I++ V + +A +M+PE
Sbjct: 193 KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP-----LKWMAPESI 247
Query: 607 MSGIVSIKTDVFSFGVLVLEIVS 629
+ + ++DV+SFGVL+ EI S
Sbjct: 248 FDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 9e-10
Identities = 39/107 (36%), Positives = 56/107 (52%), Gaps = 3/107 (2%)
Query: 523 KNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIF 582
K VL E +++G+ +L SR + IHRDL A NILL + KI DFG+AR
Sbjct: 173 KKVLTLEDLICYSFQVAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDI 229
Query: 583 EVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
+ +M+PE + +I++DV+SFGVL+ EI S
Sbjct: 230 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 9e-10
Identities = 34/94 (36%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 538 ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT 597
IS GL +LH+ +I+RDLK N++LD + + KI+DFGM + E T+ GT
Sbjct: 110 ISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGT 164
Query: 598 YGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
Y++PE D +++GVL+ E+++GQ
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 74/285 (25%), Positives = 125/285 (43%), Gaps = 37/285 (12%)
Query: 437 KLGEGGFGPVYKGKL---ADEQEVAIKRLSRSSG-QGIVEFKNEVRLIAKLQHTNLVRLL 492
++G G FG V G++ +V +K L S+ Q ++F E + LQH+NL++ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 493 GCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFI--IIEGISQGLLYLHKYSR 550
G LLV EF P L +L + + ++ + + + I+ GLL+LHK +
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120
Query: 551 LRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEY---AM 607
IH DL N LL + KI D+G++ + ++ +++PE
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 608 SGIV----SIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLS---DGKGLE 660
++ + +++V+S GV + E+ RH D Q+L+ + L+
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE---------QVLTYTVREQQLK 229
Query: 661 LIDPSLEQPCSAN--EVMRCIHVGLLCVQDQAMDRPTMPEVVCML 703
L P L+ P S EVM+ L Q RP+ EV +L
Sbjct: 230 LPKPRLKLPLSDRWYEVMQ--FCWL-----QPEQRPSAEEVHLLL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 1e-09
Identities = 56/198 (28%), Positives = 99/198 (50%), Gaps = 25/198 (12%)
Query: 442 GFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEER 501
G +GK E+ +A KR+ ++ + ++ +NE+ + +L H N++++ E
Sbjct: 181 GVNSTNQGKPKCERLIA-KRV-KAGSRAAIQLENEILALGRLNHENILKI--------EE 230
Query: 502 LLVYE---FMPNKSLDFFLFNSGRKNVLNWEKRFI------IIEGISQGLLYLHKYSRLR 552
+L E +M + DF L++ +W+ R + I++ + + Y+H +
Sbjct: 231 ILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---K 287
Query: 553 VIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPE-YAMSGIV 611
+IHRD+K NI L+ + DFG A FE E EA VGT SPE A G
Sbjct: 288 LIHRDIKLENIFLNCDGKIVLGDFGTAMPFE-KEREAFDYGWVGTVATNSPEILAGDGYC 346
Query: 612 SIKTDVFSFGVLVLEIVS 629
I TD++S G+++L+++S
Sbjct: 347 EI-TDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 58/208 (27%), Positives = 92/208 (44%), Gaps = 22/208 (10%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADEQ--EVAIKRLSRSS---GQGIVEFKNEVRLIAKLQH 485
+F+ LG G FG V +E VAIKR +S + + +E +++ + H
Sbjct: 31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINH 90
Query: 486 TNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGI---SQGL 542
V L G LV EF+ +FF F L KRF G +Q +
Sbjct: 91 PFCVNLYGSFKDESYLYLVLEFVIGG--EFFTF-------LRRNKRFPNDVGCFYAAQIV 141
Query: 543 LYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMS 602
L L +++RDLK N+LLD K++DFG A++ + T + GT Y++
Sbjct: 142 LIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV-----DTRTYTLCGTPEYIA 196
Query: 603 PEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
PE ++ D ++ G+ + EI+ G
Sbjct: 197 PEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 58/210 (27%), Positives = 104/210 (49%), Gaps = 23/210 (10%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVR--LIAKLQHTN 487
++F ++LG G G V K + + ++L +E K +R +I +LQ +
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIH------LEIKPAIRNQIIRELQVLH 58
Query: 488 ------LVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQG 541
+V G E + E M SLD L + R + E + + +G
Sbjct: 59 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR---IPEEILGKVSIAVLRG 115
Query: 542 LLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYM 601
L YL + + +++HRD+K SNIL++ + K+ DFG++ ++ +S AN+ VGT YM
Sbjct: 116 LAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANS--FVGTRSYM 169
Query: 602 SPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
SPE S+++D++S G+ ++E+ G+
Sbjct: 170 SPERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 71/260 (27%), Positives = 101/260 (38%), Gaps = 48/260 (18%)
Query: 387 RKLKAKDNVSLLPTYGKRKSPEKDQSISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPV 446
RK K DN + R ++ +K DF I +G G FG V
Sbjct: 16 RKNKNIDN------FLSRYEKAAEKITKLRMKAEDFDVIKV----------IGRGAFGEV 59
Query: 447 YKGKLADEQEV-AIKRLS------RSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGE 499
+ ++V A+K LS RS F E R I ++ + L + +
Sbjct: 60 QLVRHKSSKQVYAMKLLSKFEMIKRSD----SAFFWEERDIMAHANSEWIVQLHYAFQDD 115
Query: 500 ERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDL 558
+ L +V E+MP D S W RF E + L +H IHRD+
Sbjct: 116 KYLYMVMEYMPGG--DLVNLMSNYDIPEKW-ARFYTAE-VVLALDAIHSMG---FIHRDV 168
Query: 559 KASNILLDDKMNPKISDFG----MARIFEVNESEANTKRIVGTYGYMSPEYAMS----GI 610
K N+LLD + K++DFG M V A VGT Y+SPE S G
Sbjct: 169 KPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTA-----VGTPDYISPEVLKSQGGDGY 223
Query: 611 VSIKTDVFSFGVLVLEIVSG 630
+ D +S GV + E++ G
Sbjct: 224 YGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 55/202 (27%), Positives = 95/202 (47%), Gaps = 16/202 (7%)
Query: 438 LGEGGFGPVYKGKLADEQE----VAIKRLSRS----SGQGIVEFKNEVRLIAKLQHTNLV 489
LG+GG+G V++ + + A+K L ++ + + K E ++ ++H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
L+ G + L+ E++ L L G + F + E IS L +LH+
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLEREGI--FMEDTACFYLSE-ISLALEHLHQ-- 118
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSG 609
+I+RDLK NILLD + + K++DFG+ + E T GT YM+PE M
Sbjct: 119 -QGIIYRDLKPENILLDAQGHVKLTDFGLCK--ESIHEGTVTHTFCGTIEYMAPEILMRS 175
Query: 610 IVSIKTDVFSFGVLVLEIVSGQ 631
D +S G L+ ++++G
Sbjct: 176 GHGKAVDWWSLGALMYDMLTGA 197
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 2e-09
Identities = 32/90 (35%), Positives = 51/90 (56%)
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
Q LL +H +IHRD+K++NILL K+ DFG ++++ S+ + GT
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY 210
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
Y++PE S K D+FS GVL+ E+++
Sbjct: 211 YVAPEIWRRKPYSKKADMFSLGVLLYELLT 240
|
Length = 496 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 56/212 (26%), Positives = 103/212 (48%), Gaps = 39/212 (18%)
Query: 438 LGEGGFGPV-YKGKLADEQEVAIKRLSRSSGQGIVEFK--NEVRLIAKLQHTNLVRLLGC 494
+G G +G V +VAIK+L R + + E+RL+ ++H N++ LL
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 495 SLHGEERLLVYEFMPNKSLD----FFL----FNSGRKNVLNWEK------RFIIIEGISQ 540
F P+ SLD F+L + ++ EK +F++ + + +
Sbjct: 83 ------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQ-MLK 129
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGY 600
GL Y+H +IHRDLK N+ +++ KI DFG+AR ++++ V T Y
Sbjct: 130 GLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYVVTRWY 181
Query: 601 MSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
+PE ++ + +T D++S G ++ E+++G+
Sbjct: 182 RAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 35/94 (37%), Positives = 53/94 (56%), Gaps = 5/94 (5%)
Query: 538 ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT 597
I+ GL +LH +I+RDLK N++LD + + KI+DFGM + E TK GT
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGT 164
Query: 598 YGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
Y++PE D ++FGVL+ E+++GQ
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 55/198 (27%), Positives = 97/198 (48%), Gaps = 14/198 (7%)
Query: 438 LGEGGFGPVYKGKLADEQEV-AIKRLSRS---SGQGIVEFKNEVRLIAKLQHTNLVRLLG 493
+G+G FG V + + D Q + A+K + ++ S + E ++A++ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL-K 59
Query: 494 CSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLR 552
S E+L LV F+ L L GR ++ RF ++ L L +
Sbjct: 60 FSFQSPEKLYLVLAFINGGELFHHLQREGRFDL--SRARFYT----AELLCALENLHKFN 113
Query: 553 VIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVS 612
VI+RDLK NILLD + + + DFG+ ++ ++ + NT GT Y++PE + +
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT--FCGTPEYLAPELLLGHGYT 171
Query: 613 IKTDVFSFGVLVLEIVSG 630
D ++ GVL+ E+++G
Sbjct: 172 KAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 59/186 (31%), Positives = 87/186 (46%), Gaps = 28/186 (15%)
Query: 457 VAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF 516
VA+K+LSR F+N+ AK + LV LL C H L+ F P KSL+ F
Sbjct: 49 VAVKKLSRP-------FQNQTH--AKRAYRELV-LLKCVNHKNIISLLNVFTPQKSLEEF 98
Query: 517 --------LFNSGRKNV----LNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNIL 564
L ++ V L+ E+ ++ + G+ +LH +IHRDLK SNI+
Sbjct: 99 QDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIV 155
Query: 565 LDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLV 624
+ KI DFG+AR N T +V Y Y +PE + D++S G ++
Sbjct: 156 VKSDCTLKILDFGLARTACTN--FMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIM 212
Query: 625 LEIVSG 630
E+V G
Sbjct: 213 GELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 72/258 (27%), Positives = 118/258 (45%), Gaps = 28/258 (10%)
Query: 438 LGEGGFGPVYKGK-LADEQEVAIKRLSRS---SGQGIVEFKNEVRLIAKLQHTNLVRLLG 493
LG+G FG V + A + A+K L + + + E R++ +H L L
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL-K 61
Query: 494 CSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEK-RFIIIEGISQGLLYLHKYSRL 551
S ++RL V E++ L F L R+ V + ++ RF E +S L YLH
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHL---SRERVFSEDRTRFYGAEIVS-ALDYLHSG--- 114
Query: 552 RVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIV 611
++++RDLK N++LD + KI+DFG+ + E A K GT Y++PE
Sbjct: 115 KIVYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVLEDNDY 172
Query: 612 SIKTDVFSFGVLVLEIVSGQ-----KNHTRHHPDRPLNLIGYAWQLLSDGK----GLELI 662
D + GV++ E++ G+ ++H + + I + L +D K GL +
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIK 232
Query: 663 DPSLE---QPCSANEVMR 677
DP+ P A E+MR
Sbjct: 233 DPNKRLGGGPDDAKEIMR 250
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 35/100 (35%), Positives = 58/100 (58%), Gaps = 11/100 (11%)
Query: 538 ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES----EANTKR 593
++QG+ +L + IHRD+ A N+LL D KI DFG+AR N+S + N +
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIM-NDSNYVVKGNARL 276
Query: 594 IVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKN 633
V +M+PE + ++++DV+S+G+L+ EI S K+
Sbjct: 277 PV---KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS 313
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 65/237 (27%), Positives = 106/237 (44%), Gaps = 19/237 (8%)
Query: 404 RKSPEKDQSISHELKIF-DFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEV-AIKR 461
RK+ D ++ KI + + A ++ +G G FG V + Q+V A+K
Sbjct: 16 RKNKNIDNFLNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKL 75
Query: 462 LSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLF 518
LS+ + F E R I ++ V L C+ ++ L +V E+MP L +
Sbjct: 76 LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMS 135
Query: 519 NSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGM 578
N W K + ++ +L L + +IHRD+K N+LLD + K++DFG
Sbjct: 136 NYDVPE--KWAKFYT-----AEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGT 188
Query: 579 A-RIFEVNESEANTKRIVGTYGYMSPEYAMS----GIVSIKTDVFSFGVLVLEIVSG 630
++ E +T VGT Y+SPE S G + D +S GV + E++ G
Sbjct: 189 CMKMDETGMVRCDTA--VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 59/190 (31%), Positives = 89/190 (46%), Gaps = 28/190 (14%)
Query: 454 EQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSL 513
E+ VAIK+LSR F+N+ AK + LV L+ C H L+ F P KSL
Sbjct: 49 ERNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSL 98
Query: 514 DFF--------LFNSGRKNV----LNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKAS 561
+ F L ++ V L+ E+ ++ + G+ +LH +IHRDLK S
Sbjct: 99 EEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPS 155
Query: 562 NILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFG 621
NI++ KI DFG+AR S T +V Y Y +PE + D++S G
Sbjct: 156 NIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVG 212
Query: 622 VLVLEIVSGQ 631
++ E++ G
Sbjct: 213 CIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 8e-09
Identities = 67/213 (31%), Positives = 98/213 (46%), Gaps = 40/213 (18%)
Query: 438 LGEGGFGPVYKGKLADEQEV-AIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVR-LLGCS 495
+G+G FG VY+ + D + + A+K LS+ IV K EV HT R +L +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKE---IVA-KKEV------AHTIGERNILVRT 50
Query: 496 LHGE---------------ERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKR--FIIIEGI 538
L E + LV ++M L + L GR + E R F I E +
Sbjct: 51 LLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFS----EDRAKFYIAELV 106
Query: 539 SQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTY 598
L +LHKY +++RDLK NILLD + + DFG+++ + NT GT
Sbjct: 107 -LALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT--FCGTT 160
Query: 599 GYMSPEYAMSGIVSIK-TDVFSFGVLVLEIVSG 630
Y++PE + K D +S GVLV E+ G
Sbjct: 161 EYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 9e-09
Identities = 59/220 (26%), Positives = 105/220 (47%), Gaps = 37/220 (16%)
Query: 431 NFSTTNKLGEGGFGPVY---------KGKLADEQEVAIKRLSRSS----GQGIVEFKNEV 477
NF LG G +G V+ GKL A+K L +++ + + + E
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKL-----YAMKVLQKAALVQKAKTVEHTRTER 55
Query: 478 RLIAKLQHTNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIE 536
++ ++ + + L + E +L L+ +++ + L+ R N E RF E
Sbjct: 56 NVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ--RDNFSEDEVRFYSGE 113
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVG 596
I L +LHK L +++RD+K NILLD + + ++DFG+++ F ++E + T G
Sbjct: 114 -IILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEF-LSEEKERTYSFCG 168
Query: 597 TYGYMSPEYAMSGIVSIKT------DVFSFGVLVLEIVSG 630
T YM+PE I+ K D +S G+L+ E+++G
Sbjct: 169 TIEYMAPE-----IIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 9e-09
Identities = 66/242 (27%), Positives = 102/242 (42%), Gaps = 33/242 (13%)
Query: 422 FQTIAAAANNFSTTNKLGEGGFGPVYK-GKLADEQEVAIKRLSRSSGQGIVEFKNEVRLI 480
+++ + + +G+G +G VYK D A+K L S E + E ++
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNIL 72
Query: 481 AKL-QHTNLVRLLGC-----SLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRF-- 532
L H N+V+ G L G + LV E S+ + K +L +R
Sbjct: 73 QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV-----KGLLICGQRLDE 127
Query: 533 ----IIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE 588
I+ G GL +LH R+IHRD+K +NILL + K+ DFG++
Sbjct: 128 AMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR 184
Query: 589 ANTKRIVGTYGYMSPE-------YAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDR 641
NT VGT +M+PE Y S + DV+S G+ +E+ G HP +
Sbjct: 185 RNTS--VGTPFWMAPEVIACEQQYDYS--YDARCDVWSLGITAIELGDGDPPLFDMHPVK 240
Query: 642 PL 643
L
Sbjct: 241 TL 242
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 9e-09
Identities = 58/215 (26%), Positives = 100/215 (46%), Gaps = 22/215 (10%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEV----AIKRLSRSS--GQGIVEFKNEVRLIAKL 483
+F + +G G FG V ++ E+ A+K + +S Q V F E R I +
Sbjct: 1 KDFDVKSLVGRGHFGEV---QVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSI 57
Query: 484 QHTNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGL 542
++ + L + ++ L LV E+ P L L N +F + E +
Sbjct: 58 SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDL-LSLLNRYEDQFDEDMAQFYLAELV---- 112
Query: 543 LYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMS 602
L +H ++ +HRD+K N+L+D + K++DFG A N+ N+K VGT Y++
Sbjct: 113 LAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM-VNSKLPVGTPDYIA 171
Query: 603 PEY--AMSG----IVSIKTDVFSFGVLVLEIVSGQ 631
PE M+G ++ D +S GV+ E++ G+
Sbjct: 172 PEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 65/261 (24%), Positives = 112/261 (42%), Gaps = 43/261 (16%)
Query: 438 LGEGGFGPVYKGKLAD-----------EQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHT 486
LG+G F +YKG L E V +K L S + + F L+++L H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVL-GSDHRDSLAFFETASLMSQLSHK 61
Query: 487 NLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLH 546
+LV+L G + +E ++V E++ LD FL L+W + + + ++ L YL
Sbjct: 62 HLVKLYGVCV-RDENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLE 118
Query: 547 KYSRLRVIHRDLKASNILL----DDKMNP---KISDFGMARIFEVNESEANTKRIVGTYG 599
+++H ++ NIL+ ++ K+SD G+ V E +RI
Sbjct: 119 D---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI--TVLSREERVERI----P 169
Query: 600 YMSPEYAMSGIVS--IKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGK 657
+++PE +G S I D +SFG +LEI S + PL+ + + +
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGE--------EPLSTLSSSEKERFYQD 221
Query: 658 GLELIDPSLEQPCSANEVMRC 678
L P + AN + +C
Sbjct: 222 QHRL--PMPDCAELANLINQC 240
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 51/168 (30%), Positives = 78/168 (46%), Gaps = 17/168 (10%)
Query: 538 ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT 597
+++G+ +L SR + IHRDL A NILL + KI DFG+AR +
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 598 YGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGK 657
+M+PE + + ++DV+SFGVL+ EI S + P + + Q L DG
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGAS-----PYPGVQINEEFCQRLKDGT 294
Query: 658 GLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
+ P P E+ R + L C Q +RPT +V +L +
Sbjct: 295 RMRA--PENATP----EIYRIM---LACWQGDPKERPTFSALVEILGD 333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 52/165 (31%), Positives = 79/165 (47%), Gaps = 21/165 (12%)
Query: 485 HTNLVRLLGCSLHGEERLL-VYEFMPNKSLDFFLFNSGRKNVLNWEK-RFIIIEGISQGL 542
H LV L C E RL V E++ L +F+ R+ L E RF E IS L
Sbjct: 55 HPFLVGLHSC-FQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAE-ISLAL 109
Query: 543 LYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMS 602
YLH+ +I+RDLK N+LLD + + K++D+GM + E T GT Y++
Sbjct: 110 NYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIA 164
Query: 603 PEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIG 647
PE D ++ GVL+ E+++G+ P +++G
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRS---------PFDIVG 200
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 57/216 (26%), Positives = 99/216 (45%), Gaps = 28/216 (12%)
Query: 431 NFSTTNKLGEGGFGPVY---------KGKLADEQEVAIKRLSRSS----GQGIVEFKNEV 477
NF LG G +G V+ GKL A+K L +++ + + E
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKL-----YAMKVLKKATIVQKAKTTEHTRTER 55
Query: 478 RLIAKLQHTNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIE 536
+++ ++ + + L + + +L L+ +++ L F S R+ E + E
Sbjct: 56 QVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGEL--FTHLSQRERFKEQEVQIYSGE 113
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVG 596
I L +LHK L +I+RD+K NILLD + ++DFG+++ F +E E G
Sbjct: 114 -IVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCG 168
Query: 597 TYGYMSPEYAMSGIV--SIKTDVFSFGVLVLEIVSG 630
T YM+P+ G D +S GVL+ E+++G
Sbjct: 169 TIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 57/226 (25%), Positives = 96/226 (42%), Gaps = 64/226 (28%)
Query: 438 LGEGGFGPVYKGKLADEQE-VAIKRLSRSSGQGIVEFKN---------EVRLIAKLQHTN 487
+G G +G V K ++ E VAIK+++ + F N E++L+ L H N
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANA-------FDNRIDAKRTLREIKLLRHLDHEN 65
Query: 488 LVRLLGCSLHGEER-----LLVYEFM---------PNKSL-----DFFLFNSGRKNVLNW 528
++ + +VYE M +++L +FL+
Sbjct: 66 VIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQ--------- 116
Query: 529 EKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE 588
+ +GL Y+H + V+HRDLK SN+LL+ + KI DFG+AR +E
Sbjct: 117 ---------LLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART--TSEKG 162
Query: 589 ANTKRIVGTYGYMSPEYAMSG---IVSIKTDVFSFGVLVLEIVSGQ 631
V T Y +PE ++ +I DV+S G + E++ +
Sbjct: 163 DFMTEYVVTRWYRAPELLLNCSEYTTAI--DVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 3e-08
Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 19/201 (9%)
Query: 438 LGEGGFGPVYKGKL-ADEQEVAIKRLSRSSGQGIVEFKNEVRLIAK-------LQHTNLV 489
+G+G FG V K +D A+K L + + I++ K + ++A+ L+H LV
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKT---ILKKKEQNHIMAERNVLLKNLKHPFLV 59
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
L E+ V +++ L F L + L RF E ++ + YLH
Sbjct: 60 GLHYSFQTAEKLYFVLDYVNGGELFFHL--QRERCFLEPRARFYAAE-VASAIGYLHS-- 114
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSG 609
L +I+RDLK NILLD + + ++DFG+ + E E E T GT Y++PE
Sbjct: 115 -LNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRKE 171
Query: 610 IVSIKTDVFSFGVLVLEIVSG 630
D + G ++ E++ G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 3e-08
Identities = 41/152 (26%), Positives = 65/152 (42%), Gaps = 7/152 (4%)
Query: 476 EVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIII 535
E+ ++ + H ++ L+ +V MP D F + R L E+ I
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMV---MPKYKCDLFTYVD-RSGPLPLEQAITIQ 191
Query: 536 EGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIV 595
+ + L YLH +IHRD+K NI LD+ N + DFG A + +
Sbjct: 192 RRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWS 248
Query: 596 GTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEI 627
GT SPE KTD++S G+++ E+
Sbjct: 249 GTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 51/207 (24%), Positives = 94/207 (45%), Gaps = 22/207 (10%)
Query: 436 NKLGEGGFGPVYK------GKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLV 489
++LG+G +G VYK G +E+ ++ L S I+ E+ ++ K +V
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIM---ELDILHKAVSPYIV 62
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
G + E+M SLD + + I + +GL +L +
Sbjct: 63 DFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE-- 120
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSG 609
+IHRD+K +N+L++ K+ DFG++ + ++ N +G YM+PE SG
Sbjct: 121 EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN----IGCQSYMAPERIKSG 176
Query: 610 ------IVSIKTDVFSFGVLVLEIVSG 630
++++DV+S G+ +LE+ G
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALG 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 63/204 (30%), Positives = 97/204 (47%), Gaps = 23/204 (11%)
Query: 438 LGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKNEV-------RLIAKLQHTNLV 489
LG+G FG V K A + A+K L + ++ K+EV R++ +H L
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKE----VIVAKDEVAHTLTENRVLQNSRHPFLT 58
Query: 490 RLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEK-RFIIIEGISQGLLYLHK 547
L S +RL V E+ L F L R+ V + ++ RF E +S L YLH
Sbjct: 59 AL-KYSFQTHDRLCFVMEYANGGELFFHL---SRERVFSEDRARFYGAEIVS-ALDYLH- 112
Query: 548 YSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM 607
S V++RDLK N++LD + KI+DFG+ + E + A K GT Y++PE
Sbjct: 113 -SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLE 169
Query: 608 SGIVSIKTDVFSFGVLVLEIVSGQ 631
D + GV++ E++ G+
Sbjct: 170 DNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 50/149 (33%), Positives = 74/149 (49%), Gaps = 12/149 (8%)
Query: 485 HTNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEK-RFIIIEGISQGL 542
H LV L C E RL V EF+ L +F+ R+ L E RF E IS L
Sbjct: 55 HPFLVGLHSC-FQTESRLFFVIEFVSGGDL---MFHMQRQRKLPEEHARFYSAE-ISLAL 109
Query: 543 LYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMS 602
+LH+ +I+RDLK N+LLD + + K++D+GM + E T GT Y++
Sbjct: 110 NFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYIA 164
Query: 603 PEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
PE D ++ GVL+ E+++G+
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 4e-08
Identities = 58/187 (31%), Positives = 88/187 (47%), Gaps = 28/187 (14%)
Query: 454 EQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSL 513
++ VAIK+LSR F+N+ AK + LV L+ C H L+ F P KSL
Sbjct: 42 DRNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKCVNHKNIISLLNVFTPQKSL 91
Query: 514 DFF--------LFNSGRKNV----LNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKAS 561
+ F L ++ V L+ E+ ++ + G+ +LH +IHRDLK S
Sbjct: 92 EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPS 148
Query: 562 NILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFG 621
NI++ KI DFG+AR S T +V Y Y +PE + D++S G
Sbjct: 149 NIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVG 205
Query: 622 VLVLEIV 628
++ E+V
Sbjct: 206 CIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 6e-08
Identities = 61/246 (24%), Positives = 102/246 (41%), Gaps = 56/246 (22%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEV-AIKRLSRSSGQGIVEFKNEV------RLIAK 482
++F + +G G FG V + D + A+K+L +S ++E K +V R I
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSE---MLE-KEQVAHVRAERDILA 56
Query: 483 LQHTNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEK-RFIIIEGISQ 540
V L S E L L+ E++P + L +K+ E+ RF I E I
Sbjct: 57 EADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLM---KKDTFTEEETRFYIAETI-- 111
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFE----------VNESEAN 590
L + +L IHRD+K N+LLD K + K+SDFG+ + ++ + +
Sbjct: 112 --LAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPS 169
Query: 591 TKR--------------------------IVGTYGYMSPEYAMSGIVSIKTDVFSFGVLV 624
VGT Y++PE + + + D +S GV++
Sbjct: 170 NFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIM 229
Query: 625 LEIVSG 630
E++ G
Sbjct: 230 YEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 20/214 (9%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLA---DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQH-- 485
+ +LG+G +G V + A +E+ VAIK+++ + I+ K +R + L+H
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKIL-AKRALRELKLLRHFR 59
Query: 486 -----TNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQ 540
T L + L +YE + L + SG+ + + + I + I
Sbjct: 60 GHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQII-RSGQP-LTDAHFQSFIYQ-ILC 116
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVN--ESEANTKRIVGTY 598
GL Y+H + V+HRDLK N+L++ KI DFG+AR F N E+ V T
Sbjct: 117 GLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR 173
Query: 599 GYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
Y +PE +S K DV+S G ++ E++ +
Sbjct: 174 WYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 61/241 (25%), Positives = 102/241 (42%), Gaps = 31/241 (12%)
Query: 422 FQTIAAAANNFSTTNKLGEGGFGPVYK-GKLADEQEVAIKRLSRSSGQGIVEFKNEVRLI 480
F + ++ + +G+G +G V+K + + A+K L E + E ++
Sbjct: 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNIL 68
Query: 481 AKLQ-HTNLVRLLGC-----SLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKR--- 531
L H N+V+ G +G++ LV E S+ + K L +R
Sbjct: 69 KALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLV-----KGFLKRGERMEE 123
Query: 532 ----FIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES 587
+I+ E + GL +LH + IHRD+K +NILL + K+ DFG++
Sbjct: 124 PIIAYILHEAL-MGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL 179
Query: 588 EANTKRIVGTYGYMSPEY-----AMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRP 642
NT VGT +M+PE + + DV+S G+ +E+ G HP R
Sbjct: 180 RRNTS--VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA 237
Query: 643 L 643
L
Sbjct: 238 L 238
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 55/205 (26%), Positives = 87/205 (42%), Gaps = 24/205 (11%)
Query: 438 LGEGGFGPVYKGKLADEQEV-AIKRLSRSSGQGIVE------FKNEVRL---IAKLQHTN 487
LG G FG V + E+ AIK L + I+ E R+ +H
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKK---GDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 488 LVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEG-ISQGLLYLH 546
LV L C + V E+ L + +V + E R + + GL YLH
Sbjct: 64 LVNLFACFQTEDHVCFVMEYAAGGDLMMHI----HTDVFS-EPRAVFYAACVVLGLQYLH 118
Query: 547 KYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYA 606
+ ++++RDLK N+LLD + KI+DFG+ + E T GT +++PE
Sbjct: 119 EN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK--EGMGFGDRTSTFCGTPEFLAPEVL 173
Query: 607 MSGIVSIKTDVFSFGVLVLEIVSGQ 631
+ D + GVL+ E++ G+
Sbjct: 174 TETSYTRAVDWWGLGVLIYEMLVGE 198
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 27/213 (12%)
Query: 438 LGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEV-------RLIAKLQHTNLVR 490
LG+G FG V L E+ + + ++ K+EV R++ +H L
Sbjct: 3 LGKGTFGKVI---LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 59
Query: 491 LLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEK-RFIIIEGISQGLLYLHKY 548
L + +RL V E+ L F L R+ V E+ RF E +S L YLH
Sbjct: 60 L-KYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVS-ALEYLHSR 114
Query: 549 SRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMS 608
V++RD+K N++LD + KI+DFG+ + E A K GT Y++PE
Sbjct: 115 D---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLED 169
Query: 609 GIVSIKTDVFSFGVLVLEIVSGQ-----KNHTR 636
D + GV++ E++ G+ ++H R
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 202
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 49/213 (23%), Positives = 97/213 (45%), Gaps = 27/213 (12%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADE----QEVAIKRLSRSSGQGIVEFKN--EVRLIAKLQ 484
+ +G G +G V A + ++VAIK++ + + + E++++ +
Sbjct: 6 RYKPIENIGSGAYGVVCS---AIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFK 62
Query: 485 HTNLVRLLGCSL----HGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQ 540
H N++ + ++ +V + M + D + + R+ + + + +
Sbjct: 63 HDNIIAIRDILRPPGADFKDVYVVMDLMES---DLHHIIHSDQPLTEEHIRYFLYQ-LLR 118
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI----VG 596
GL Y+H + VIHRDLK SN+L+++ +I DFGMAR ++ S K V
Sbjct: 119 GLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR--GLSSSPTEHKYFMTEYVA 173
Query: 597 TYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIV 628
T Y +PE +S + D++S G + E++
Sbjct: 174 TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 45/158 (28%), Positives = 80/158 (50%), Gaps = 24/158 (15%)
Query: 554 IHRDLKASNILLDDKMNPKISDFGMARIFEVNES----EANTKRIVGTYGYMSPEYAMSG 609
IHRDL A NILL KI DFG+AR N+S + N + V +M+PE +
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLARDIR-NDSNYVVKGNARLPV---KWMAPESIFNC 291
Query: 610 IVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQ 668
+ + ++DV+S+G+L+ EI S G + +P P++ Y +++ + G ++ P
Sbjct: 292 VYTFESDVWSYGILLWEIFSLG----SSPYPGMPVDSKFY--KMIKE--GYRMLSPEC-A 342
Query: 669 PCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706
P ++M+ C + RPT ++V +++ +
Sbjct: 343 PSEMYDIMKS------CWDADPLKRPTFKQIVQLIEQQ 374
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 57/202 (28%), Positives = 94/202 (46%), Gaps = 21/202 (10%)
Query: 438 LGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKNEVR-------LIAKLQHTNLV 489
+G+G FG V + A+E+ A+K L + + I++ K E L+ ++H LV
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQK---KAILKKKEEKHIMSERNVLLKNVKHPFLV 59
Query: 490 RLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
L S ++L V +++ L + L + L RF E I+ L YLH
Sbjct: 60 GL-HFSFQTADKLYFVLDYINGGELFYHL--QRERCFLEPRARFYAAE-IASALGYLHS- 114
Query: 549 SRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMS 608
L +++RDLK NILLD + + ++DFG+ + E E T GT Y++PE
Sbjct: 115 --LNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHK 170
Query: 609 GIVSIKTDVFSFGVLVLEIVSG 630
D + G ++ E++ G
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.0 bits (129), Expect = 2e-07
Identities = 66/243 (27%), Positives = 108/243 (44%), Gaps = 56/243 (23%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQE------VAIKRL-SRSSGQGIVEFKNEVRLIAK 482
N + K+G G FG V+ K QE ++ + L R Q ++E V ++ +
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIE----VNVMRE 68
Query: 483 LQHTNLVRLLGCSLH--GEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIE---- 536
L+H N+VR + L+ ++ ++ EF L +N+ K F IE
Sbjct: 69 LKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLS--------RNIQKCYKMFGKIEEHAI 120
Query: 537 -GISQGLLYLHKYSR--------LRVIHRDLKASNILLD-------------DKMN---- 570
I++ LL+ Y RV+HRDLK NI L + +N
Sbjct: 121 VDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPI 180
Query: 571 PKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSI--KTDVFSFGVLVLEIV 628
KI DFG+++ + ES A++ VGT Y SPE + S K+D+++ G ++ E+
Sbjct: 181 AKIGDFGLSKNIGI-ESMAHS--CVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237
Query: 629 SGQ 631
SG+
Sbjct: 238 SGK 240
|
Length = 1021 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 60/204 (29%), Positives = 94/204 (46%), Gaps = 24/204 (11%)
Query: 438 LGEGGFGPVYKGKLADEQEV-AIKRLSRSSGQGIVEFKNEV-------RLIAKLQHTNLV 489
LG+G FG V + + A+K L + ++ K+EV R++ +H L
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKE----VIIAKDEVAHTLTESRVLQNTRHPFLT 58
Query: 490 RLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEK-RFIIIEGISQGLLYLHK 547
L S +RL V E+ L F L R+ V + ++ RF E +S L YLH
Sbjct: 59 AL-KYSFQTHDRLCFVMEYANGGELFFHL---SRERVFSEDRARFYGAEIVS-ALGYLH- 112
Query: 548 YSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM 607
V++RDLK N++LD + KI+DFG+ + E A K GT Y++PE
Sbjct: 113 --SCDVVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLE 168
Query: 608 SGIVSIKTDVFSFGVLVLEIVSGQ 631
D + GV++ E++ G+
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 3e-07
Identities = 35/147 (23%), Positives = 62/147 (42%), Gaps = 15/147 (10%)
Query: 437 KLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLV--RLLGC 494
L G VY L + E + +++ S +G + EV ++ L L ++L
Sbjct: 5 LLKGGLTNRVYL--LGTKDEDYVLKINPSREKGAD-REREVAILQLLARKGLPVPKVLAS 61
Query: 495 SLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVI 554
L+ E++ ++LD ++ E++ I E +++ L LH+ L +
Sbjct: 62 GESDGWSYLLMEWIEGETLD----------EVSEEEKEDIAEQLAELLAKLHQLPLLVLC 111
Query: 555 HRDLKASNILLDDKMNPKISDFGMARI 581
H DL NIL+DD I D+ A
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 40/177 (22%), Positives = 79/177 (44%), Gaps = 14/177 (7%)
Query: 455 QEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLD 514
+ V IK R G E ++ + H ++++L G + + L+ +P D
Sbjct: 118 EHVVIKAGQR---GGTA---TEAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTD 168
Query: 515 FFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKIS 574
+ + + ++N+ + I + + + YLH+ R+IHRD+KA NI ++ + +
Sbjct: 169 LYCYLAAKRNIAICDI-LAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLG 224
Query: 575 DFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
DFG A F V+ + GT +PE D++S G+++ E+ +
Sbjct: 225 DFGAA-CFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 7e-07
Identities = 45/145 (31%), Positives = 69/145 (47%), Gaps = 10/145 (6%)
Query: 488 LVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEK-RFIIIEGISQGLLYLH 546
LV L C LV E++ L +F+ R+ L E RF E I L +LH
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAE-ICIALNFLH 113
Query: 547 KYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYA 606
+ +I+RDLK N+LLD + K++D+GM + E T GT Y++PE
Sbjct: 114 ERG---IIYRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEIL 168
Query: 607 MSGIVSIKTDVFSFGVLVLEIVSGQ 631
D ++ GVL+ E+++G+
Sbjct: 169 RGEEYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 1e-06
Identities = 46/210 (21%), Positives = 83/210 (39%), Gaps = 28/210 (13%)
Query: 438 LGEGGFGPVYKGKLADEQEVAIKR--LSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCS 495
+ + K K + VA+K+ L S + + + E+ +LQH N++ +
Sbjct: 10 FEDLMIVHLAKHKPTNTL-VAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68
Query: 496 LHGEERLLVYEFMPNKSLDFFL---FNSGRKNVLNWEKRFI--IIEGISQGLLYLHKYSR 550
+ E +V M S + L F G + I I++ + L Y+H
Sbjct: 69 IVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELA------IAFILKDVLNALDYIHS--- 119
Query: 551 LRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEAN------TKRIVGTYGYMSPE 604
IHR +KAS+ILL +S + + + K V ++SPE
Sbjct: 120 KGFIHRSVKASHILLSGDGKVVLSGLRYSVSM-IKHGKRQRVVHDFPKSSVKNLPWLSPE 178
Query: 605 Y---AMSGIVSIKTDVFSFGVLVLEIVSGQ 631
+ G + K+D++S G+ E+ +G
Sbjct: 179 VLQQNLQG-YNEKSDIYSVGITACELANGH 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 53/238 (22%), Positives = 100/238 (42%), Gaps = 43/238 (18%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSG----QGIVEFKNEVRLIAKLQH 485
++F + +G G FG V + D + ++ R + + + + E ++ +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 486 TNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYL 545
+V++ L+ EF+P + L +K+ L+ E I ++ +L +
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM---KKDTLSEEATQFYI---AETVLAI 114
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR-IFEVNESE---------------- 588
+L IHRD+K N+LLD K + K+SDFG+ + + + +E
Sbjct: 115 DAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174
Query: 589 -ANTKR---------------IVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
N+KR VGT Y++PE M + D +S GV++ E++ G
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 4e-06
Identities = 55/200 (27%), Positives = 89/200 (44%), Gaps = 17/200 (8%)
Query: 438 LGEGGFGPVYKGKLA-DEQEVAIKRL------SRSSGQGIVEFKNEVRLIAKLQHTNLVR 490
+G+G FG V K D + A+K L +R + I+ +N L+ ++H LV
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNV--LLKNVKHPFLVG 60
Query: 491 LLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSR 550
L E+ V +F+ L F L ++ RF E I+ L YLH
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHL--QRERSFPEPRARFYAAE-IASALGYLHS--- 114
Query: 551 LRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGI 610
+ +++RDLK NILLD + + ++DFG+ + E T GT Y++PE
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPEVIRKQP 172
Query: 611 VSIKTDVFSFGVLVLEIVSG 630
D + G ++ E++ G
Sbjct: 173 YDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 5e-06
Identities = 26/76 (34%), Positives = 41/76 (53%)
Query: 554 IHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSI 613
+HRDL A N+LL KI DFG+AR + + + +M+PE + +
Sbjct: 259 VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTT 318
Query: 614 KTDVFSFGVLVLEIVS 629
+DV+S+G+L+ EI S
Sbjct: 319 LSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 6e-06
Identities = 57/238 (23%), Positives = 99/238 (41%), Gaps = 45/238 (18%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSG----QGIVEFKNEVRLIAKLQHT 486
+F + +G G FG V + D V ++ R + + + + E ++ +
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 487 NLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEK-RFIIIEGISQGLLYL 545
+V++ L+ EF+P + L +K+ L E+ +F I E + L +
Sbjct: 62 WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM---KKDTLTEEETQFYIAETV----LAI 114
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFE----------VNES-------- 587
+L IHRD+K N+LLD K + K+SDFG+ + +N S
Sbjct: 115 DSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQ 174
Query: 588 EANTKR---------------IVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
N+KR VGT Y++PE M + D +S GV++ E++ G
Sbjct: 175 NMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 6e-06
Identities = 43/163 (26%), Positives = 70/163 (42%), Gaps = 22/163 (13%)
Query: 430 NNFSTTNKLGEGGFGPV-YKGKLADEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKLQH 485
+F T +G+G FG V K + A+K L +S + K E ++A+
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 486 TNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWE------KRFIIIEGIS 539
+V L + L+ EF+P L L + ++ RF + E +
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTML--------IKYDTFSEDVTRFYMAECV- 111
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIF 582
L + +L IHRD+K NIL+D + K+SDFG++ F
Sbjct: 112 ---LAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 7e-06
Identities = 34/107 (31%), Positives = 55/107 (51%), Gaps = 12/107 (11%)
Query: 531 RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMA-RIFEVNESEA 589
RF + E + L + +L +HRD+K N+LLD + +++DFG R+ ++
Sbjct: 105 RFYLAEMV----LAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS 160
Query: 590 NTKRIVGTYGYMSPEY--AM---SGIVSIKTDVFSFGVLVLEIVSGQ 631
N VGT Y+SPE AM G + D +S GV + E++ G+
Sbjct: 161 NVA--VGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 8e-06
Identities = 61/228 (26%), Positives = 104/228 (45%), Gaps = 25/228 (10%)
Query: 416 ELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQE-VAIKRLSRSSGQGIVEFK 474
E K+ D + ++ N +G G FG VY+ D E VAIK++ + ++K
Sbjct: 52 EEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYK 106
Query: 475 NEVRLIAK-LQHTNLVRL-----LGCSLHGEERL---LVYEFMPNKSLDFFLFNSGRKNV 525
N LI K L H N++ L C E+ + +V EF+P + + +
Sbjct: 107 NRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHA 166
Query: 526 LNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNP-KISDFGMARIFEV 584
L + + + L Y+H S+ + HRDLK N+L+D + K+ DFG A+ +
Sbjct: 167 LPLFLVKLYSYQLCRALAYIH--SKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAK--NL 221
Query: 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKT--DVFSFGVLVLEIVSG 630
+ + I + Y +PE M G + T D++S G ++ E++ G
Sbjct: 222 LAGQRSVSYICSRF-YRAPEL-MLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (114), Expect = 9e-06
Identities = 34/119 (28%), Positives = 53/119 (44%), Gaps = 31/119 (26%)
Query: 529 EKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNP-KISDFGMARIFEVNES 587
E + II + + + L LHK+ +IH D+K N+L D + + D+G+ +I
Sbjct: 110 EVKKIIRQ-LVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKI------ 159
Query: 588 EANTKRIV-GTYGYMSPE------YAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHP 639
T GT Y SPE Y +S D ++ GVL E+++G HP
Sbjct: 160 -IGTPSCYDGTLDYFSPEKIKGHNYDVS------FDWWAVGVLTYELLTG------KHP 205
|
Length = 267 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 28/91 (30%), Positives = 49/91 (53%), Gaps = 3/91 (3%)
Query: 554 IHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSI 613
+HRDL A N+L+ + KI DFG+AR + + + +M+PE + + +
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTT 320
Query: 614 KTDVFSFGVLVLEIVSGQKNHTRHHPDRPLN 644
+DV+SFG+L+ EI + +P+ P+N
Sbjct: 321 LSDVWSFGILLWEIFTLGGT---PYPELPMN 348
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 47/169 (27%), Positives = 76/169 (44%), Gaps = 19/169 (11%)
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
Q +L L + +++HRDLK++NI L K+ DFG ++ + + S GT
Sbjct: 177 QIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPY 236
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGL 659
Y++PE S K D++S GV++ E++ T H P + + Q+L GK
Sbjct: 237 YLAPELWERKRYSKKADMWSLGVILYELL------TLHRPFKGPSQREIMQQVLY-GK-- 287
Query: 660 ELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETM 708
DP PC + M+ + LL RPT + +L E +
Sbjct: 288 --YDPF---PCPVSSGMKALLDPLL--SKNPALRPTTQQ---LLHTEFL 326
|
Length = 478 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 45/176 (25%), Positives = 70/176 (39%), Gaps = 32/176 (18%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADEQEVAIKR--LSRSSGQGIVEFKNEVRL-------IA 481
+F KLGEG FG VYK L ++Q + L +++ G VE R+ A
Sbjct: 133 DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCA 192
Query: 482 KLQHTNLVRL---------LGCSLHGEERLLVYEFMPNKSLDF----FLFNSGRKNVLNW 528
+ L + L GE L + M +K + +L +
Sbjct: 193 DFVYGFLEPVSSKKEDEYWLVWRYEGESTL--ADLMQSKEFPYNVEPYLLGKVQDLPKGL 250
Query: 529 EKRFIIIEGISQGLLY----LHKYSRLRVIHRDLKASNILLDDKMNP-KISDFGMA 579
E+ II+ I + +L+ LH ++HRD+K NI+ + KI D G A
Sbjct: 251 ERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 48/182 (26%), Positives = 85/182 (46%), Gaps = 19/182 (10%)
Query: 454 EQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSL 513
E V +K L S + F L++++ H +L + G + G E ++V EF+ + L
Sbjct: 44 ELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL 103
Query: 514 DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNIL-----LDDK 568
D L + + W + + + ++ L YL + ++H ++ A NIL L +
Sbjct: 104 DVCLRKEKGRVPVAW--KITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEG 158
Query: 569 MNP--KISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGI-VSIKTDVFSFGVLVL 625
+P K+SD G++ F E +RI +++PE G +S D +SFG +L
Sbjct: 159 TSPFIKLSDPGVS--FTALSREERVERI----PWIAPECVPGGNSLSTAADKWSFGTTLL 212
Query: 626 EI 627
EI
Sbjct: 213 EI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 59/210 (28%), Positives = 89/210 (42%), Gaps = 16/210 (7%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGKLADEQEV-AIKRLSRSS--GQGIVEFKNEVRLIAKLQH 485
A ++ +G G FG V + ++V A+K LS+ + F E R I +
Sbjct: 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 101
Query: 486 TNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLY 544
+ V L + + L +V E+MP L + N +V RF E + L
Sbjct: 102 SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVV----LA 154
Query: 545 LHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPE 604
L + IHRD+K N+LLD + K++DFG E VGT Y+SPE
Sbjct: 155 LDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN-KEGMVRCDTAVGTPDYISPE 213
Query: 605 YAMS----GIVSIKTDVFSFGVLVLEIVSG 630
S G + D +S GV + E++ G
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 35/103 (33%), Positives = 55/103 (53%), Gaps = 14/103 (13%)
Query: 538 ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFG----MARIFEVNESEANTKR 593
I++ +L +H +L +HRD+K N+LLD + +++DFG M + V S A
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVA---- 163
Query: 594 IVGTYGYMSPEY--AMS---GIVSIKTDVFSFGVLVLEIVSGQ 631
VGT Y+SPE AM G + D +S GV + E++ G+
Sbjct: 164 -VGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 54/222 (24%), Positives = 97/222 (43%), Gaps = 31/222 (13%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLAD-EQEVAIKRLSRSSGQGIVEFKNEV------RLIAK 482
+F T + G +G VY + + Q A+K++++ Q ++ +N++ R I
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINK---QNLI-LRNQIQQVFVERDILT 56
Query: 483 LQHTNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQG 541
V + CS + L +V E++ L N G V R E +
Sbjct: 57 FAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVD--MARMYFAETV-LA 113
Query: 542 LLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARI-------------FEVNESE 588
L YLH Y ++HRDLK N+L+ + K++DFG+++I E + E
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 589 ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
K++ GT Y++PE + D ++ G+++ E + G
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 60/250 (24%), Positives = 112/250 (44%), Gaps = 27/250 (10%)
Query: 437 KLGEGGFGPVYKGKLADEQEVA---IKRLSRSSG-QGIVEFKNEVRLIAKLQHTNLVRLL 492
++G G FG V ++ + VA +K L ++ + EF + LQH N+++ L
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 493 GCSLHGEERLLVYEFMPNKSLDFFLFNSG--RKNVLNWEKRFIIIEGISQGLLYLHKYSR 550
G + LLV+E+ L +L R+N + + E I+ G+ ++HK++
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACE-IAAGVTHMHKHNF 120
Query: 551 LRVIHRDLKASNILLDDKMNPKISDFGMARI-FEVNESEANTKRIVGTYGYMSPEYAMS- 608
L H DL N L + K+ D+G+ ++ + E + V +++PE
Sbjct: 121 L---HSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCV-PLRWLAPELVGEF 176
Query: 609 --GIVSIK----TDVFSFGVLVLEIVSGQKNHTRHHPDRP-LNLIGYAWQLLSDGKGLEL 661
G+++ + ++V++ GV + E+ H DR LN ++ D + ++L
Sbjct: 177 HGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLN------HVIKD-QQVKL 229
Query: 662 IDPSLEQPCS 671
P LE P S
Sbjct: 230 FKPQLELPYS 239
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 3e-05
Identities = 57/222 (25%), Positives = 91/222 (40%), Gaps = 52/222 (23%)
Query: 438 LGEGGFGPVYKGK-LADEQEVAIKRLSR-----SSGQGIVEFKNEVRLIAKLQHTNLVRL 491
+G+G +G V ++VAIK+++ S I+ E++L+ L+H ++V +
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILR---EIKLLRLLRHPDIVEI 64
Query: 492 LGCSLHGEER-----LLVYEFM---------PNKSL-----DFFLFNSGRKNVLNWEKRF 532
L R +V+E M N L FFL+ R
Sbjct: 65 KHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLR---------- 114
Query: 533 IIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARI-FEVNESEANT 591
L Y+H + V HRDLK NIL + KI DFG+AR+ F +
Sbjct: 115 --------ALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 163
Query: 592 KRIVGTYGYMSPEYAMS--GIVSIKTDVFSFGVLVLEIVSGQ 631
V T Y +PE S + D++S G + E+++G+
Sbjct: 164 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 7e-05
Identities = 14/58 (24%), Positives = 24/58 (41%), Gaps = 5/58 (8%)
Query: 296 SDNMSSTDCRANCFYNCSCIAFATGTSEYTDKQAYCEIWSEGTEFTEIASNNSREIFI 353
+S +CR C NCSC A+A Y + C +W+ S+ +++
Sbjct: 29 ITAISLEECREACLSNCSCTAYA-----YNNGSGGCLLWNGLLNNLRSLSSGGGTLYL 81
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 44/195 (22%), Positives = 89/195 (45%), Gaps = 22/195 (11%)
Query: 446 VYKGKLADEQEVAIKRL---SRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERL 502
+YKG ++ EV I+ + I +NE++ + ++ N++++ G + + L
Sbjct: 36 IYKGIFNNK-EVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 503 ----LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDL 558
L+ E+ L L K+ L+++ + + +GL L+KY+ +++L
Sbjct: 95 PRLSLILEYCTRGYLREVLDKE--KD-LSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNL 149
Query: 559 KASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVS---IKT 615
+ + L+ + KI G+ +I K V Y S + ++ I S IK
Sbjct: 150 TSVSFLVTENYKLKIICHGLEKILSSPPF----KN-VNFMVYFSYKM-LNDIFSEYTIKD 203
Query: 616 DVFSFGVLVLEIVSG 630
D++S GV++ EI +G
Sbjct: 204 DIYSLGVVLWEIFTG 218
|
Length = 283 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 39/156 (25%), Positives = 69/156 (44%), Gaps = 14/156 (8%)
Query: 475 NEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFII 534
+E RL+ +L H ++ LL + G LV +P D + + R L +
Sbjct: 209 HEARLLRRLSHPAVLALLDVRVVGGLTCLV---LPKYRSDLYTYLGARLRPLGLAQ---- 261
Query: 535 IEGISQGLL----YLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEAN 590
+ +++ LL Y+H +IHRD+K N+L++ + + DFG A + S
Sbjct: 262 VTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318
Query: 591 TKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLE 626
I GT +PE + D++S G+++ E
Sbjct: 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 5e-04
Identities = 55/211 (26%), Positives = 92/211 (43%), Gaps = 32/211 (15%)
Query: 438 LGEGGFGPVYKGKLAD-----------EQE--VAIKRLSRSSGQGIVEFKNEVRLIAKLQ 484
LG G +Y G L E+E V +K L S + F ++ ++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 485 HTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLY 544
H ++V L G + E ++V EF+ LD F+ + +VL +F + + ++ L Y
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSY 120
Query: 545 LHKYSRLRVIHRDLKASNILL-----DDKMNP--KISDFGMARIFEVNESEANTKRIVGT 597
L ++H ++ NILL D + P K+SD G+ V + +RI
Sbjct: 121 LEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP--ITVLSRQECVERI--- 172
Query: 598 YGYMSPEYAM-SGIVSIKTDVFSFGVLVLEI 627
+++PE S +SI D +SFG + EI
Sbjct: 173 -PWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 6e-04
Identities = 59/231 (25%), Positives = 90/231 (38%), Gaps = 47/231 (20%)
Query: 437 KLGEGGFGPVYKGKLADEQEV-AIKRLSRSSGQGIVEFKN---EVRLIAKLQHTNLVRLL 492
LG+G G V+ +L ++ A+K L + + K E ++A L H L L
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67
Query: 493 GCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEK-RFIIIEGISQGLLYLHKYSR 550
S E L LV ++ P L F L L+ E RF E + L YLH
Sbjct: 68 -ASFQTETYLCLVMDYCPGGEL-FRLLQRQPGKCLSEEVARFYAAE-VLLALEYLHL--- 121
Query: 551 LRVIHRDLKASNILLDDKMNPKISDF----------------------GMARIFEVNE-- 586
L +++RDLK NILL + + +SDF + +E
Sbjct: 122 LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETF 181
Query: 587 ---SEANTKRIVGTYGYMSPE----YAMSGIVSIKTDVFSFGVLVLEIVSG 630
+ VGT Y++PE V D ++ G+L+ E++ G
Sbjct: 182 SEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV----DWWTLGILLYEMLYG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 7e-04
Identities = 16/40 (40%), Positives = 30/40 (75%), Gaps = 3/40 (7%)
Query: 542 LLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARI 581
L YLH++ +IHRDLK N+L+ ++ + K++DFG++++
Sbjct: 117 LDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 27/100 (27%), Positives = 53/100 (53%), Gaps = 8/100 (8%)
Query: 538 ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMA-RIFEVNESEANTKRIVG 596
+++ ++ + +L +HRD+K NIL+D + +++DFG ++ E + + VG
Sbjct: 108 LAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME--DGTVQSSVAVG 165
Query: 597 TYGYMSPEYAMS-----GIVSIKTDVFSFGVLVLEIVSGQ 631
T Y+SPE + G + D +S GV + E++ G+
Sbjct: 166 TPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain | Back alignment and domain information |
|---|
Score = 37.3 bits (87), Expect = 0.001
Identities = 13/39 (33%), Positives = 18/39 (46%), Gaps = 7/39 (17%)
Query: 298 NMSSTDCRANCFYNCSCIAFATGTSEYTDKQAY--CEIW 334
++ +C C NCSC A+A Y D + C IW
Sbjct: 26 SIGLKECEQRCLSNCSCTAYA-----YADIRGGSGCLIW 59
|
Length = 66 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.003
Identities = 55/247 (22%), Positives = 97/247 (39%), Gaps = 55/247 (22%)
Query: 432 FSTTNKLGEGGFGPVYKGKLADEQEV-AIKRLSRSS---GQGIVEFKNEVRLIAKLQHTN 487
F +G G FG V + D + A+K L ++ K E ++A+ +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 488 LVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWE-KRFIIIEGISQGLLYL 545
+V+L S ++ L V +++P + L R + + RF I E ++ + +
Sbjct: 63 VVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLI---RLGIFEEDLARFYIAE-LTCAIESV 117
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFE---------------------V 584
HK + IHRD+K NIL+D + K++DFG+ F
Sbjct: 118 HK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPS 174
Query: 585 NESEANTKR--------------------IVGTYGYMSPEYAMSGIVSIKTDVFSFGVLV 624
E + +VGT Y++PE + + D +S GV++
Sbjct: 175 EEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234
Query: 625 LEIVSGQ 631
E++ GQ
Sbjct: 235 YEMLVGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|214742 smart00605, CW, CW domain | Back alignment and domain information |
|---|
Score = 37.0 bits (86), Expect = 0.004
Identities = 13/60 (21%), Positives = 25/60 (41%), Gaps = 7/60 (11%)
Query: 298 NMSSTDCRANCFYNCSCIAFATGTSEYTDKQAYCEIWSEGTEFTEIASNNSREIFILAIK 357
+S +C C+ + +C+ Y + C ++S GT T + +S +A K
Sbjct: 21 TLSWDECIQKCYEDSNCVLA------YGNSSETCYLFSYGTVLT-VKKLSSSSGKKVAFK 73
|
Length = 94 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 752 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.98 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.98 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.98 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.98 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.98 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.98 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.98 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.98 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.98 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.98 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.98 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.88 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.86 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.85 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.83 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.81 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.8 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.8 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.77 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.75 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.75 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.72 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.71 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.68 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.68 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.67 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.66 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.66 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.65 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.61 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.58 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.56 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.54 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.54 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.49 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.39 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.38 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.26 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.19 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.17 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.12 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.09 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.09 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.07 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.06 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.06 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.98 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 98.88 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 98.81 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.8 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.77 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.73 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.68 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.62 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.56 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.46 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.45 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 98.44 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.35 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.32 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.32 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.2 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.12 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.04 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.03 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.01 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 97.99 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.98 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.97 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 97.89 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.84 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.75 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.7 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.69 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.66 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.63 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.61 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.6 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.41 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.38 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.26 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.21 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.13 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.12 | |
| PF11883 | 48 | DUF3403: Domain of unknown function (DUF3403); Int | 97.03 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 96.91 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.88 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.79 | |
| PLN02236 | 344 | choline kinase | 96.72 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.69 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.67 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.43 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 96.41 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.39 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.84 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.81 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.79 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.75 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-56 Score=473.31 Aligned_cols=289 Identities=45% Similarity=0.773 Sum_probs=258.9
Q ss_pred ccccccHHHHHHHhcCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeee
Q 043278 416 ELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCS 495 (752)
Q Consensus 416 ~~~~~~~~~i~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 495 (752)
..+.|++.++..+|++|+..+.||+|+||.||+|.+++|+.||||++.....+...+|.+|+.++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 57789999999999999999999999999999999999999999988776543256699999999999999999999999
Q ss_pred eeCC-eeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceec
Q 043278 496 LHGE-ERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKIS 574 (752)
Q Consensus 496 ~~~~-~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~ 574 (752)
.+++ +++||||||++|+|+++|+..... .|+|.+|++||.++|+||+|||+.+.++||||||||+|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9999 599999999999999999876544 79999999999999999999999998899999999999999999999999
Q ss_pred ccccceeecccccccccccc-cccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHh
Q 043278 575 DFGMARIFEVNESEANTKRI-VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLL 653 (752)
Q Consensus 575 DFgla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 653 (752)
|||+|+...... ...... .||.+|+|||++..+..+.|+|||||||+|+||++|+++.+...+.....+..|++..+
T Consensus 220 DFGLa~~~~~~~--~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 220 DFGLAKLGPEGD--TSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred CccCcccCCccc--cceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 999997543211 111112 79999999999999999999999999999999999999988776666667899999999
Q ss_pred hCCCcccccCCCCC-CCCCH-HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCC
Q 043278 654 SDGKGLELIDPSLE-QPCSA-NEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNET 707 (752)
Q Consensus 654 ~~~~~~~~~d~~l~-~~~~~-~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~ 707 (752)
.+++..+++|+.+. ...+. +++.++.+++.+|++.+|.+||+|.||+++|+...
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 99999999999987 55554 78999999999999999999999999999996654
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=387.69 Aligned_cols=253 Identities=31% Similarity=0.494 Sum_probs=210.0
Q ss_pred cCCeeecCCcccEEEEEecCCceeEEEEcccCCccc--HHHHHHHHHHHHhcCCCCcceeeeeeeeCC-eeEEEEeeCCC
Q 043278 434 TTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQG--IVEFKNEVRLIAKLQHTNLVRLLGCSLHGE-ERLLVYEFMPN 510 (752)
Q Consensus 434 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~E~~~~ 510 (752)
..+.||+|+||+||+|.+.+...||||++....... .++|.+|+.+|.+++|||||+++|.|.+.. ..+||||||++
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 345699999999999999766669999997653222 568999999999999999999999999888 79999999999
Q ss_pred CCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCC-Cceecccccceeeccccccc
Q 043278 511 KSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKM-NPKISDFGMARIFEVNESEA 589 (752)
Q Consensus 511 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~-~~kl~DFgla~~~~~~~~~~ 589 (752)
|+|..+++.. ....+++..++.++.|||+||.|||+... ||||||||+||||+.++ ++||+|||+++...... .
T Consensus 125 GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~ 199 (362)
T KOG0192|consen 125 GSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--T 199 (362)
T ss_pred CcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc--c
Confidence 9999999764 45679999999999999999999999874 99999999999999997 99999999998755332 2
Q ss_pred ccccccccCCccChhhhc--cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCC
Q 043278 590 NTKRIVGTYGYMSPEYAM--SGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLE 667 (752)
Q Consensus 590 ~~~~~~gt~~y~aPE~~~--~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 667 (752)
......||+.|||||++. ...|+.|+||||||++||||+||+.||..... ...+......+....+
T Consensus 200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~~~~v~~~~~Rp~~------ 267 (362)
T KOG0192|consen 200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQVASAVVVGGLRPPI------ 267 (362)
T ss_pred cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcCCCCCC------
Confidence 223368999999999999 66999999999999999999999999987764 1122222323322222
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 668 QPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 668 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
+......+..++.+||+.||..||++.|++.+|+.+
T Consensus 268 ---p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~ 303 (362)
T KOG0192|consen 268 ---PKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESI 303 (362)
T ss_pred ---CccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence 112445677888899999999999999999999865
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=381.74 Aligned_cols=252 Identities=31% Similarity=0.448 Sum_probs=213.0
Q ss_pred cCCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCCCCCH
Q 043278 434 TTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSL 513 (752)
Q Consensus 434 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 513 (752)
..+.||+|.||.|+.|.++....||+|.++... ...++|.+|+++|.+|+|+|||+++|+|..++..+||||||+.|+|
T Consensus 210 l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsL 288 (468)
T KOG0197|consen 210 LIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSL 288 (468)
T ss_pred HHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcH
Confidence 347899999999999999888899999998753 3456889999999999999999999999998899999999999999
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccccccccc
Q 043278 514 DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKR 593 (752)
Q Consensus 514 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~ 593 (752)
.++|.. ..+..+...+.+.++.|||.||+||++++ +|||||.++||||+++..+||+|||||+....+..... ..
T Consensus 289 l~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~-~~ 363 (468)
T KOG0197|consen 289 LDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTAS-EG 363 (468)
T ss_pred HHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceeec-CC
Confidence 999976 34567999999999999999999999998 99999999999999999999999999996554433222 22
Q ss_pred ccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCCCCH
Q 043278 594 IVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSA 672 (752)
Q Consensus 594 ~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 672 (752)
..-+..|.|||.+..+.++.|||||||||+||||+| |+.|+..... ....+.+..|.. -+.+.
T Consensus 364 ~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn-------~ev~~~le~GyR---------lp~P~ 427 (468)
T KOG0197|consen 364 GKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN-------EEVLELLERGYR---------LPRPE 427 (468)
T ss_pred CCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH-------HHHHHHHhccCc---------CCCCC
Confidence 344678999999999999999999999999999999 7777766652 223344444433 33344
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCC
Q 043278 673 NEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNET 707 (752)
Q Consensus 673 ~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~ 707 (752)
..+..+.+|+..||+.+|++|||++.+...|+...
T Consensus 428 ~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 428 GCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred CCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 45567888999999999999999999999998763
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-44 Score=358.34 Aligned_cols=250 Identities=26% Similarity=0.352 Sum_probs=204.8
Q ss_pred CcCCeeecCCcccEEEEEec-CCceeEEEEcccC-CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCC-eeEEEEeeCC
Q 043278 433 STTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRS-SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGE-ERLLVYEFMP 509 (752)
Q Consensus 433 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~E~~~ 509 (752)
+..+.||+|..|+|||++++ +++.+|+|.+... .....+++.+|++++.+.+||+||.++|.|.... ...|+||||+
T Consensus 82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMD 161 (364)
T KOG0581|consen 82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMD 161 (364)
T ss_pred hhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcC
Confidence 34579999999999999986 5778999999544 3445678899999999999999999999999988 5999999999
Q ss_pred CCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCcEeecCCCCCcEEecCCCCceecccccceeecccccc
Q 043278 510 NKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHK-YSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE 588 (752)
Q Consensus 510 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 588 (752)
+|+|+.++... +.+++...-+|+.+|++||.|||+ .+ ||||||||+||||+..|.+||+|||.++.+-..
T Consensus 162 gGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--- 232 (364)
T KOG0581|consen 162 GGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--- 232 (364)
T ss_pred CCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence 99999999654 458999999999999999999996 55 999999999999999999999999999865433
Q ss_pred cccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCC
Q 043278 589 ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQ 668 (752)
Q Consensus 589 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 668 (752)
......||..|||||.+.+..|+.++||||||+.++|+++|+.|+....+... ....... .+..+.. |.+..
T Consensus 233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~-~~~~Ll~-~Iv~~pp-----P~lP~ 304 (364)
T KOG0581|consen 233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYL-DIFELLC-AIVDEPP-----PRLPE 304 (364)
T ss_pred -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCC-CHHHHHH-HHhcCCC-----CCCCc
Confidence 34568999999999999999999999999999999999999999987622111 1111111 1112211 12211
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 669 PCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 669 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
. ....++..++-.|+++||.+||+++|++++
T Consensus 305 ~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 305 G---EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred c---cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1 244567889999999999999999999876
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=372.83 Aligned_cols=248 Identities=24% Similarity=0.388 Sum_probs=211.8
Q ss_pred cCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccC---CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRS---SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 505 (752)
..|...+.||+|||+.||+++. ..|+.||+|++.+. .....+...+|+++.++|+|||||+++++|++.++.+||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5788899999999999999997 78999999999874 2334567889999999999999999999999999999999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccc
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVN 585 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~ 585 (752)
|+|++++|.+++. +++.+++.++..+++||+.||.|||+++ |||||||..|+||+++.++||+|||||..+..+
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999998884 5667999999999999999999999998 999999999999999999999999999987654
Q ss_pred ccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCC
Q 043278 586 ESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPS 665 (752)
Q Consensus 586 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 665 (752)
.. .....+||+.|.|||++.....+..+||||+|||||-|+.|++||+...-.+.. ..++..+ ..-
T Consensus 172 ~E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety-------~~Ik~~~---Y~~-- 237 (592)
T KOG0575|consen 172 GE--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETY-------NKIKLNE---YSM-- 237 (592)
T ss_pred cc--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHH-------HHHHhcC---ccc--
Confidence 33 334589999999999999999999999999999999999999999887633322 2222111 111
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 666 LEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 666 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
+........+|+..+|+.||.+|||+++|+..
T Consensus 238 -----P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 238 -----PSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred -----ccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 11233346678889999999999999999875
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=354.72 Aligned_cols=203 Identities=29% Similarity=0.516 Sum_probs=181.2
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccC--CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEE
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRS--SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 505 (752)
..+|...+.||.|+||+||+|++. ++.+||||.+.+. .....+-+..|+.+|++++|||||++++++..++..+|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 357888889999999999999975 5789999999876 4556667889999999999999999999999999999999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCC------CCceecccccc
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDK------MNPKISDFGMA 579 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~------~~~kl~DFgla 579 (752)
|||.+|+|..|+... +.+++..+..++.|||.||++||+++ ||||||||+||||+.. -.+||+|||+|
T Consensus 89 EyC~gGDLs~yi~~~---~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRR---GRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 999999999999654 35999999999999999999999998 9999999999999764 56899999999
Q ss_pred eeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCC
Q 043278 580 RIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPD 640 (752)
Q Consensus 580 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~ 640 (752)
+.+.... .....+|++.|||||++..+.|+.|+|+||+|+|||++++|+.||......
T Consensus 163 R~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~ 220 (429)
T KOG0595|consen 163 RFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPK 220 (429)
T ss_pred hhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHH
Confidence 9877433 233579999999999999999999999999999999999999999866543
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=391.78 Aligned_cols=260 Identities=30% Similarity=0.461 Sum_probs=220.9
Q ss_pred cCCCcCCeeecCCcccEEEEEec------CCceeEEEEcccCCcc-cHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA------DEQEVAIKRLSRSSGQ-GIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERL 502 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 502 (752)
.+....+.||+|.||+||+|+.. +.+.||||.++..... .+.+|++|++++..++|||||+|+|.|.+++..+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 34455689999999999999853 3456999999987655 7889999999999999999999999999999999
Q ss_pred EEEeeCCCCCHhHHHhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCc
Q 043278 503 LVYEFMPNKSLDFFLFNSGR-----------KNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNP 571 (752)
Q Consensus 503 lv~E~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~ 571 (752)
||+|||..|+|.+||..... +..|+..+.+.||.|||.||+||-++. +|||||.++|+||.++..+
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEE
Confidence 99999999999999974311 234889999999999999999999988 9999999999999999999
Q ss_pred eecccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHH
Q 043278 572 KISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAW 650 (752)
Q Consensus 572 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~ 650 (752)
||+||||++.....+.......-.-+.+|||||.|+.+.||.+||||||||||||+++ |+-|+.....+ .+.
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~-------EVI 715 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ-------EVI 715 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH-------HHH
Confidence 9999999997765554444434455789999999999999999999999999999999 88888766533 344
Q ss_pred HHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCC
Q 043278 651 QLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETM 708 (752)
Q Consensus 651 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~~ 708 (752)
+.++.|++.+ .+...+.++..|++.||+.+|.+||+++||-..|+....
T Consensus 716 e~i~~g~lL~---------~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 716 ECIRAGQLLS---------CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred HHHHcCCccc---------CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 5666666543 344455678899999999999999999999999988654
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=354.74 Aligned_cols=253 Identities=23% Similarity=0.332 Sum_probs=205.7
Q ss_pred hcCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCCcc-------cHHHHHHHHHHHHhcCCCCcceeeeeeeeCCe
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSSGQ-------GIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEE 500 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 500 (752)
.+.|.+.+.||+|+||.|-+|.- ++|+.||||++.+.... ......+|+++|++++|||||++.+++...+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 35678889999999999999975 57999999999764211 22335799999999999999999999999999
Q ss_pred eEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCC---CCceecccc
Q 043278 501 RLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDK---MNPKISDFG 577 (752)
Q Consensus 501 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~---~~~kl~DFg 577 (752)
.+||||||++|.|.+.+... +.+.+.....++.|++.|+.|||+++ |+||||||+||||..+ ..+||+|||
T Consensus 251 ~YmVlE~v~GGeLfd~vv~n---k~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVAN---KYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred eEEEEEEecCccHHHHHHhc---cccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccc
Confidence 99999999999999998653 34777778889999999999999999 9999999999999655 789999999
Q ss_pred cceeecccccccccccccccCCccChhhhccCC---CCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhh
Q 043278 578 MARIFEVNESEANTKRIVGTYGYMSPEYAMSGI---VSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLS 654 (752)
Q Consensus 578 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 654 (752)
+|+..+. .......+||+.|.|||++..+. +..|+|+||+|||||-+++|.+||.....+.. + .+.+.
T Consensus 325 lAK~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s--l----~eQI~ 395 (475)
T KOG0615|consen 325 LAKVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS--L----KEQIL 395 (475)
T ss_pred hhhcccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc--H----HHHHh
Confidence 9998662 22345689999999999998653 33488999999999999999999987764431 1 22333
Q ss_pred CCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 655 DGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 655 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.|+... ......+..++..+++.++|..||++|||+.|++++
T Consensus 396 ~G~y~f------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 396 KGRYAF------GPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred cCcccc------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 333221 112334556678899999999999999999999875
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=338.81 Aligned_cols=258 Identities=25% Similarity=0.378 Sum_probs=208.8
Q ss_pred CCCcCCeeecCCcccEEEEE-ecCCceeEEEEcccC--CcccHHHHHHHHHHHHhcCCCCcceeee-eeeeCCe-eEEEE
Q 043278 431 NFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRS--SGQGIVEFKNEVRLIAKLQHTNLVRLLG-CSLHGEE-RLLVY 505 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~-~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~~lv~ 505 (752)
.|.+.++||.|.||+|||++ +.+|..+|.|.+.-. +.+.......|+.+|++|+|||||++++ .+.+++. ..|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 45667899999999999997 578999999998743 3445567889999999999999999999 5555555 78999
Q ss_pred eeCCCCCHhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcC-CCcEeecCCCCCcEEecCCCCceecccccceeec
Q 043278 506 EFMPNKSLDFFLFNS-GRKNVLNWEKRFIIIEGISQGLLYLHKYS-RLRVIHRDLKASNILLDDKMNPKISDFGMARIFE 583 (752)
Q Consensus 506 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~ 583 (752)
|||..|+|..++.+. ..++.++++.+++++.|+++||..+|+.- +..|+||||||.||+|+++|.+||+||||++++.
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 999999999998764 34567999999999999999999999832 1249999999999999999999999999999876
Q ss_pred ccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccC
Q 043278 584 VNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELID 663 (752)
Q Consensus 584 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 663 (752)
..... ....+|||.||+||.+.+..|+.|+||||+||++|||+.-++||.++. +... .+.+..++...+.+
T Consensus 180 s~~tf--A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n------~~~L-~~KI~qgd~~~~p~ 250 (375)
T KOG0591|consen 180 SKTTF--AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN------LLSL-CKKIEQGDYPPLPD 250 (375)
T ss_pred chhHH--HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc------HHHH-HHHHHcCCCCCCcH
Confidence 54433 335799999999999999999999999999999999999999998773 2222 33444443322211
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 043278 664 PSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705 (752)
Q Consensus 664 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~ 705 (752)
......+..|+..|+..||+.||+.-.+++.++.
T Consensus 251 --------~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 251 --------EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred --------HHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 2334556778889999999999986555555544
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=379.44 Aligned_cols=257 Identities=26% Similarity=0.437 Sum_probs=219.5
Q ss_pred cCCCcCCeeecCCcccEEEEEecC----CceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLAD----EQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLV 504 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 504 (752)
....+.++||.|.||.|++|+++- ...||||.|+... +....+|..|+.+|.+++||||++|.|+.......+||
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 345667899999999999999752 4569999998764 44567899999999999999999999999999999999
Q ss_pred EeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecc
Q 043278 505 YEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~ 584 (752)
+|||+||+|+.||.... ..+++.+..-+.++||.||.||.+.+ +|||||.++|||++.+..+|++||||++.+.+
T Consensus 709 TEyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred hhhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeeccc
Confidence 99999999999997654 44999999999999999999999988 99999999999999999999999999998765
Q ss_pred cccccccccccc--cCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccc
Q 043278 585 NESEANTKRIVG--TYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLEL 661 (752)
Q Consensus 585 ~~~~~~~~~~~g--t~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 661 (752)
+... ......| +.+|.|||.+....+|.++||||||+|+||.++ |++|+-....++ +...
T Consensus 784 d~~~-~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd----------------VIka 846 (996)
T KOG0196|consen 784 DPEA-AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD----------------VIKA 846 (996)
T ss_pred CCCc-cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH----------------HHHH
Confidence 5422 2222223 578999999999999999999999999999998 999986665332 1222
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCC
Q 043278 662 IDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETM 708 (752)
Q Consensus 662 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~~ 708 (752)
++..++-+.+++.+..|.+|+++|||+|-.+||++.+|+.+|.++..
T Consensus 847 Ie~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 847 IEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred HHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 34445556778888899999999999999999999999999988754
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=335.31 Aligned_cols=242 Identities=23% Similarity=0.342 Sum_probs=199.6
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC---cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEE
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLV 504 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 504 (752)
.++|++.+.||+|+||+||.++.. .++.+|+|++++.. ....+..+.|..+|.+++||.||+++-.|++.+..+||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 468999999999999999999865 57889999998763 23456788999999999999999999999999999999
Q ss_pred EeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecc
Q 043278 505 YEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~ 584 (752)
+||+.||.|..+|.+. ..+++..+.-++..|+.||.|||+.+ ||||||||+|||||++|+++|+||||++..-.
T Consensus 104 ld~~~GGeLf~hL~~e---g~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQRE---GRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHHHhc---CCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 9999999999999643 34888988899999999999999999 99999999999999999999999999985332
Q ss_pred cccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCC
Q 043278 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDP 664 (752)
Q Consensus 585 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 664 (752)
. ...+..++||+.|||||++.+..|+..+|.||+|+++|||++|.+||...+... .. +.+..++... .
T Consensus 178 ~--~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~------~~-~~I~~~k~~~--~- 245 (357)
T KOG0598|consen 178 D--GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK------MY-DKILKGKLPL--P- 245 (357)
T ss_pred C--CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH------HH-HHHhcCcCCC--C-
Confidence 2 233445899999999999999999999999999999999999999998776322 22 2222222110 0
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 043278 665 SLEQPCSANEVMRCIHVGLLCVQDQAMDRP 694 (752)
Q Consensus 665 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP 694 (752)
+.-...+..+++...++.||++|-
T Consensus 246 ------p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 246 ------PGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred ------CccCCHHHHHHHHHHhccCHHHhc
Confidence 111122455677788999999995
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=353.42 Aligned_cols=265 Identities=26% Similarity=0.443 Sum_probs=212.4
Q ss_pred HHHHHHhcCCCcCCeeecCCcccEEEEEecCCceeEEEEcccC--CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCe
Q 043278 423 QTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRS--SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEE 500 (752)
Q Consensus 423 ~~i~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 500 (752)
++.....+.+.+.+.||+|.||+||+|++.+ .||||.+... ..+..+.|++|+..+++-+|.||+-+.|+|.....
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 4444455667778999999999999999865 4999999765 34466789999999999999999999999998877
Q ss_pred eEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccce
Q 043278 501 RLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR 580 (752)
Q Consensus 501 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~ 580 (752)
.||+.+|++.+|+.+|+..+ ..+...+.+.||+|||+||.|||.++ |||||||..||+|.+++++||+||||+.
T Consensus 463 -AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred -eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEeccccee
Confidence 99999999999999998654 45899999999999999999999998 9999999999999999999999999997
Q ss_pred eecccccccccccccccCCccChhhhcc---CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCC
Q 043278 581 IFEVNESEANTKRIVGTYGYMSPEYAMS---GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGK 657 (752)
Q Consensus 581 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 657 (752)
.-..-..........|...|||||++.. .+|+..+||||||+|+|||++|..|+.....+..+.++ |+
T Consensus 537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmV---------Gr 607 (678)
T KOG0193|consen 537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMV---------GR 607 (678)
T ss_pred eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEe---------cc
Confidence 6543322233334567788999999864 57999999999999999999999999844433322221 11
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCC
Q 043278 658 GLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNET 707 (752)
Q Consensus 658 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~ 707 (752)
-.-..|.... ......++.+|+..||..++++||.+.+|+.+|+.+.
T Consensus 608 G~l~pd~s~~---~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~ 654 (678)
T KOG0193|consen 608 GYLMPDLSKI---RSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELL 654 (678)
T ss_pred cccCccchhh---hccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhh
Confidence 1111121111 1123345677888999999999999999999998764
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=324.69 Aligned_cols=265 Identities=24% Similarity=0.312 Sum_probs=209.9
Q ss_pred cCCCcCCeeecCCcccEEEEEecC-CceeEEEEcccCCc-ccH-HHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEe
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLAD-EQEVAIKRLSRSSG-QGI-VEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYE 506 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~-~~~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 506 (752)
+.|+...++|+|+||.|||++.++ |+.||||++....+ ... +-.++|+++|++++|+|+|.++.+|......+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 356777899999999999999764 89999999976643 222 346899999999999999999999999999999999
Q ss_pred eCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccc
Q 043278 507 FMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586 (752)
Q Consensus 507 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~ 586 (752)
||+..-|+++-.. ...++.+...+++.|+++|+.|+|+++ +|||||||+||||+.++.+||+|||+|+.+....
T Consensus 82 ~~dhTvL~eLe~~---p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 82 YCDHTVLHELERY---PNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPG 155 (396)
T ss_pred ecchHHHHHHHhc---cCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence 9998777666532 345889999999999999999999998 9999999999999999999999999999876421
Q ss_pred cccccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHH--------HHHhhCC-
Q 043278 587 SEANTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYA--------WQLLSDG- 656 (752)
Q Consensus 587 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~--------~~~~~~~- 656 (752)
..-+..+.|.+|+|||.+.+ .+|...+|||++||++.||++|.+.|.+....+...++... .+.....
T Consensus 156 --d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 156 --DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred --chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 22234678999999999887 79999999999999999999999999988765554444322 2222222
Q ss_pred CcccccCCCCCCCCCHH-----HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 657 KGLELIDPSLEQPCSAN-----EVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 657 ~~~~~~d~~l~~~~~~~-----~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
-...+.-|......+.+ ....+++++..|++.||.+|++-+|++.+
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 12222223222222221 23467889999999999999999888754
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=339.89 Aligned_cols=267 Identities=24% Similarity=0.305 Sum_probs=205.4
Q ss_pred hcCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeeeC--CeeEE
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHG--EERLL 503 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 503 (752)
.+.|+.+++||+|+||.||+|+. .+|+.||+|++.... .....-..+|+.+|++|+||||++|.+...+. ...+|
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 34566678999999999999984 679999999997654 33344557999999999999999999998776 68999
Q ss_pred EEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeec
Q 043278 504 VYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFE 583 (752)
Q Consensus 504 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~ 583 (752)
|+|||++ +|.-++.. ..-.++..++..++.||+.||+|+|+.+ |.|||||.+|||||++|.+||+|||||+++.
T Consensus 196 VFeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence 9999986 56566533 2335899999999999999999999999 9999999999999999999999999999887
Q ss_pred ccccccccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHH-----HhhCCC
Q 043278 584 VNESEANTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQ-----LLSDGK 657 (752)
Q Consensus 584 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~-----~~~~~~ 657 (752)
.......+. .+-|..|+|||.+.+ ..|+.++|+||.||||.||+.|++.+++..+.+..+.|-.... .|...+
T Consensus 270 ~~~~~~~T~-rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 270 PSGSAPYTS-RVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred CCCCccccc-ceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence 665555444 566999999999987 5799999999999999999999999998876554444332111 111111
Q ss_pred cc--cccCCCCCCCC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 658 GL--ELIDPSLEQPC-----SANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 658 ~~--~~~d~~l~~~~-----~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
+. ..+.+...... ........++|+-.+|..||.+|.|+.++++.
T Consensus 349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 11 11111111000 11112345677888999999999999998764
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=337.11 Aligned_cols=257 Identities=26% Similarity=0.388 Sum_probs=204.2
Q ss_pred cCCCcCCeeecCCcccEEEEEecC-CceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCC--eeEEEEe
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLAD-EQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGE--ERLLVYE 506 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~E 506 (752)
.++...+.||+|+||+||++...+ |...|||.+........+.+.+|+.+|.+++|||||+.+|.....+ .+.+.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 356667899999999999998754 8899999987764444667899999999999999999999855444 6899999
Q ss_pred eCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecC-CCCceecccccceeecc-
Q 043278 507 FMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDD-KMNPKISDFGMARIFEV- 584 (752)
Q Consensus 507 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~-~~~~kl~DFgla~~~~~- 584 (752)
|+++|+|.+++...+. .|++..+..++.||++||+|||+++ ||||||||+||||+. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 9999999999976543 5999999999999999999999998 999999999999999 79999999999987653
Q ss_pred cccccccccccccCCccChhhhccCC-CCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccC
Q 043278 585 NESEANTKRIVGTYGYMSPEYAMSGI-VSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELID 663 (752)
Q Consensus 585 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 663 (752)
...........||+.|||||++..+. ...++|||||||++.||+||++||... .....+..........
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~----- 241 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSL----- 241 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCC-----
Confidence 11122233578999999999999643 345999999999999999999999764 1111222222222211
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 043278 664 PSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705 (752)
Q Consensus 664 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~ 705 (752)
| ..+........+++..|++.+|++|||+.+++++.--
T Consensus 242 P----~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 242 P----EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred C----CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 1 1222233456788899999999999999999998643
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=352.41 Aligned_cols=261 Identities=27% Similarity=0.398 Sum_probs=205.3
Q ss_pred hcCCCcCCeeecCCcccEEEEEe------cCCceeEEEEcccCCc-ccHHHHHHHHHHHHhc-CCCCcceeeeeeeeCC-
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKL------ADEQEVAIKRLSRSSG-QGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGE- 499 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~- 499 (752)
.++|.+.++||+|+||.||+|.. ..++.||||++..... .....+.+|+.++.++ +||||++++++|...+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 46788899999999999999974 2346799999975432 2345689999999999 8999999999887644
Q ss_pred eeEEEEeeCCCCCHhHHHhhcCC---------------------------------------------------------
Q 043278 500 ERLLVYEFMPNKSLDFFLFNSGR--------------------------------------------------------- 522 (752)
Q Consensus 500 ~~~lv~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 522 (752)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 57899999999999999864321
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccccccccccccCCc
Q 043278 523 --KNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGY 600 (752)
Q Consensus 523 --~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y 600 (752)
...+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...............++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 234888999999999999999999988 999999999999999999999999999865433222222334567889
Q ss_pred cChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHH
Q 043278 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCI 679 (752)
Q Consensus 601 ~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 679 (752)
+|||++.+..++.++||||||++||||++ |+.||....... .....+..+..... +......+.
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~------~~~~~~~~~~~~~~---------~~~~~~~l~ 307 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE------EFCQRLKDGTRMRA---------PENATPEIY 307 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH------HHHHHHhcCCCCCC---------CCCCCHHHH
Confidence 99999999999999999999999999997 999987654221 11222222221111 111224577
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHhhcCC
Q 043278 680 HVGLLCVQDQAMDRPTMPEVVCMLQNET 707 (752)
Q Consensus 680 ~l~~~Cl~~dp~~RPt~~ev~~~L~~~~ 707 (752)
+++.+||+.||.+|||+.|++++|+.+.
T Consensus 308 ~li~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 308 RIMLACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 8999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=346.26 Aligned_cols=251 Identities=29% Similarity=0.419 Sum_probs=211.3
Q ss_pred hcCCCcCCeeecCCcccEEEEE-ecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEee
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
...|..-++||+|+.|.||.+. ...++.||||++........+-+.+|+.+|+..+|+|||+++..+..+++.++||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 3456777899999999999997 456889999999766555555678999999999999999999999999999999999
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccc
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES 587 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~ 587 (752)
|++|+|.+.+. ...+++.++..|++++++||+|||.++ |+|||||.+||||+.+|.+||+|||++..+.....
T Consensus 352 m~ggsLTDvVt----~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 352 MEGGSLTDVVT----KTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred cCCCchhhhhh----cccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 99999999883 345999999999999999999999999 99999999999999999999999999987665443
Q ss_pred ccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCC
Q 043278 588 EANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLE 667 (752)
Q Consensus 588 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 667 (752)
.....+||+.|||||++....|.+|+||||||++++||+-|++||-.+.+-+...++. .....++-.
T Consensus 425 --KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa-------~ng~P~lk~---- 491 (550)
T KOG0578|consen 425 --KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-------TNGTPKLKN---- 491 (550)
T ss_pred --ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHh-------hcCCCCcCC----
Confidence 3345799999999999999999999999999999999999999998866554443332 222222212
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 668 QPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 668 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
+......+.+++.+||+.|+++||++.|++++
T Consensus 492 ---~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 492 ---PEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred ---ccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 22233456778889999999999999999885
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=342.85 Aligned_cols=265 Identities=24% Similarity=0.389 Sum_probs=216.8
Q ss_pred hcCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCCc-ccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEee
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSG-QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
.....+.++||+|.||.|.++....+..||||+++.... ....+|.+|+++|.+++||||++++|.|..++..++|+||
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 345667799999999999999998889999999987643 3458899999999999999999999999999999999999
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccc
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES 587 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~ 587 (752)
|++|+|..|+....... +.-+....|+.||+.||+||.+.. +|||||.++|+|++.++++||+|||+++-+.....
T Consensus 617 mEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred HhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCc
Confidence 99999999997653322 556677789999999999999987 99999999999999999999999999998776666
Q ss_pred ccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh--CCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCC
Q 043278 588 EANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS--GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPS 665 (752)
Q Consensus 588 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt--G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 665 (752)
.....+.+-+.+|||||.+..+++|.++|||+||+.+||+++ .+.|+.....+ ..+......+..+.....
T Consensus 693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e---~vven~~~~~~~~~~~~~---- 765 (807)
T KOG1094|consen 693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE---QVVENAGEFFRDQGRQVV---- 765 (807)
T ss_pred eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH---HHHHhhhhhcCCCCccee----
Confidence 555555677889999999999999999999999999999876 55666544322 122222333333222211
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 666 LEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 666 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
...+.-....+.+++++||..+..+||+++++...|+..
T Consensus 766 --l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 766 --LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred --ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 122333455678999999999999999999999998764
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=372.72 Aligned_cols=258 Identities=32% Similarity=0.476 Sum_probs=213.7
Q ss_pred cCCCcCCeeecCCcccEEEEEecC--Cc----eeEEEEcccC-CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLAD--EQ----EVAIKRLSRS-SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERL 502 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~--~~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 502 (752)
.+.+..+.||+|.||.||.|...+ +. .||||.+++. +.+...+|.+|..+|++++|||||+++|+|.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 445667899999999999998653 33 4999999876 4566778999999999999999999999999999999
Q ss_pred EEEeeCCCCCHhHHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceeccccc
Q 043278 503 LVYEFMPNKSLDFFLFNSG----RKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGM 578 (752)
Q Consensus 503 lv~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgl 578 (752)
|++|||++|+|..||.+.+ ....|+..+.+.++.|||+|+.|||+++ +|||||..+|+||++...+||+||||
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccch
Confidence 9999999999999998752 2456999999999999999999999998 99999999999999999999999999
Q ss_pred ceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCC
Q 043278 579 ARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGK 657 (752)
Q Consensus 579 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 657 (752)
|+.+...+.........-+..|||||.+.++.+|.|+|||||||+|||++| |..|+......+-. ...+..|
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~------~~~~~gg- 921 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVL------LDVLEGG- 921 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHH------HHHHhCC-
Confidence 996655444333333344578999999999999999999999999999999 88888777643221 1122333
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 658 GLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 658 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
.+ + .+......+.+++.+||+.+|++||++..+++.++.+
T Consensus 922 --RL-~------~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i 961 (1025)
T KOG1095|consen 922 --RL-D------PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAI 961 (1025)
T ss_pred --cc-C------CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhh
Confidence 11 1 1334455678999999999999999999999988765
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=341.36 Aligned_cols=264 Identities=25% Similarity=0.305 Sum_probs=207.5
Q ss_pred HhcCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCCcccHHH--HHHHHHHHHhcC-CCCcceeeeeeeeCC-eeE
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSSGQGIVE--FKNEVRLIAKLQ-HTNLVRLLGCSLHGE-ERL 502 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~--~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~ 502 (752)
..++|...++||.|+||.||+|+- ..+..||||++++.... .++ -.+|+..|.+++ ||||+++...+.+.+ ..+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 346788889999999999999984 56889999999876443 333 368999999998 999999999998888 899
Q ss_pred EEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceee
Q 043278 503 LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIF 582 (752)
Q Consensus 503 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~ 582 (752)
+|||||+ .+|.+++.+. +..+++..+..|+.||++||+|+|.+| +.|||+||+|||+..+..+||+|||+||-.
T Consensus 87 fVfE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 87 FVFEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eeHHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccc
Confidence 9999997 4677777554 668999999999999999999999999 999999999999999999999999999965
Q ss_pred cccccccccccccccCCccChhhhc-cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHh-----hCC
Q 043278 583 EVNESEANTKRIVGTYGYMSPEYAM-SGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLL-----SDG 656 (752)
Q Consensus 583 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~-----~~~ 656 (752)
.... .-+..+.|..|+|||++. .+.|+.+.|+|++|||++||.+-++.|.+..+.+....+-...... .+|
T Consensus 161 ~Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg 237 (538)
T KOG0661|consen 161 RSKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG 237 (538)
T ss_pred ccCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH
Confidence 4322 223478899999999875 5889999999999999999999999998877554333222111100 000
Q ss_pred ---------CcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 657 ---------KGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 657 ---------~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
+........+..-.+. ...++++++.+|++-||.+|||++|.+++
T Consensus 238 ~~La~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 238 YNLASAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 0000101111111111 44678889999999999999999999987
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=309.45 Aligned_cols=265 Identities=24% Similarity=0.323 Sum_probs=206.4
Q ss_pred cCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCCcc--cHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEe
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSSGQ--GIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYE 506 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 506 (752)
.+|...++||+|.||.||+|+. ..|+.||||+++..... -.....+|++.|++++|+||+.++++|-+.+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 3567778999999999999985 56999999999765322 13456899999999999999999999999999999999
Q ss_pred eCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccc
Q 043278 507 FMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586 (752)
Q Consensus 507 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~ 586 (752)
||+ .+|+..+.+ +...++..++..++.++++||+|||++. |+||||||.|+|++++|.+||+|||+|+.++...
T Consensus 82 fm~-tdLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMP-TDLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred ecc-ccHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 997 578888754 4457999999999999999999999998 9999999999999999999999999999887543
Q ss_pred cccccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcc---ccc
Q 043278 587 SEANTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGL---ELI 662 (752)
Q Consensus 587 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~---~~~ 662 (752)
.... ..+-|..|+|||.+.+ ..|+..+|+||.|||+.||+-|.+-|.+...-+....+-.+.....+.... ++.
T Consensus 156 ~~~~--~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lp 233 (318)
T KOG0659|consen 156 RIQT--HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLP 233 (318)
T ss_pred cccc--cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccc
Confidence 2222 2367899999998886 579999999999999999999999888776443333222221111111111 111
Q ss_pred ---------CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 043278 663 ---------DPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCML 703 (752)
Q Consensus 663 ---------d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L 703 (752)
.+.+.. .-.......++++..++..||.+|+|++|.+++=
T Consensus 234 dY~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~ 282 (318)
T KOG0659|consen 234 DYVKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKHP 282 (318)
T ss_pred cHHHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcch
Confidence 111111 1122334558899999999999999999998863
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=324.78 Aligned_cols=263 Identities=24% Similarity=0.350 Sum_probs=209.2
Q ss_pred hcCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEe
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYE 506 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 506 (752)
.+.|++.+.||.|..++||+|+. +.++.||||++.-.. ....+.+.+|+..+..++||||++++..|..++..++||+
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 46788899999999999999984 567999999996542 2336889999999999999999999999999999999999
Q ss_pred eCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccc
Q 043278 507 FMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586 (752)
Q Consensus 507 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~ 586 (752)
||.+|++.+++...- ...+++..+..|.+++++||.|||+++ .||||||+.||||+++|.+||+|||.+..+....
T Consensus 105 fMa~GS~ldIik~~~-~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYY-PDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhcCCcHHHHHHHHc-cccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 999999999887643 344899999999999999999999999 9999999999999999999999999876654332
Q ss_pred ccc-cc-ccccccCCccChhhhcc--CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCccccc
Q 043278 587 SEA-NT-KRIVGTYGYMSPEYAMS--GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELI 662 (752)
Q Consensus 587 ~~~-~~-~~~~gt~~y~aPE~~~~--~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 662 (752)
.+. .. ....||+.|||||++.. ..|+.|+||||||+...||.+|+.||....+-..+ ...+ .+....+.
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL------l~tL-qn~pp~~~ 253 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL------LLTL-QNDPPTLL 253 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH------HHHh-cCCCCCcc
Confidence 211 11 45789999999999654 46999999999999999999999999887753221 1111 11111111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 663 DPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 663 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
-..+..+.....-..+.+++..|++.||.+|||++++++.
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 1111112222223366788899999999999999999876
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=345.67 Aligned_cols=257 Identities=32% Similarity=0.440 Sum_probs=206.6
Q ss_pred CCCcCCeeecCCcccEEEEEecC--C--ce-eEEEEcccC---CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeE
Q 043278 431 NFSTTNKLGEGGFGPVYKGKLAD--E--QE-VAIKRLSRS---SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERL 502 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~~~--~--~~-vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 502 (752)
+....++||+|+||.||+|++.. + .. ||||..+.. ......+|++|+++|++++|||||+++|++......+
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ 237 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM 237 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence 33445899999999999998753 2 23 899998852 3556778999999999999999999999999999999
Q ss_pred EEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceee
Q 043278 503 LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIF 582 (752)
Q Consensus 503 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~ 582 (752)
||||+|++|+|+++|..... .++..+++.++.+.|.||+|||+.+ +|||||.++|+|+..++.+||+||||++..
T Consensus 238 ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRAG 312 (474)
T ss_pred EEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccCC
Confidence 99999999999999965433 5999999999999999999999998 999999999999999999999999998753
Q ss_pred cccccccccc-cccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCccc
Q 043278 583 EVNESEANTK-RIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLE 660 (752)
Q Consensus 583 ~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 660 (752)
. ...... ...-+..|+|||.+..+.|+.|+|||||||++||+++ |..|+...... .........+-...
T Consensus 313 ~---~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~------~v~~kI~~~~~r~~ 383 (474)
T KOG0194|consen 313 S---QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY------EVKAKIVKNGYRMP 383 (474)
T ss_pred c---ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH------HHHHHHHhcCccCC
Confidence 2 111111 1234678999999999999999999999999999999 88888766532 11122223332222
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCCCC
Q 043278 661 LIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETMPL 710 (752)
Q Consensus 661 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~~~~ 710 (752)
. +......+..++.+|++.+|++||||.++.+.|+.+....
T Consensus 384 ~---------~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~ 424 (474)
T KOG0194|consen 384 I---------PSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK 424 (474)
T ss_pred C---------CCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence 2 1233344556777999999999999999999998875533
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=334.35 Aligned_cols=264 Identities=24% Similarity=0.386 Sum_probs=203.5
Q ss_pred cCCCcCCeeecCCcccEEEEEecC-----------------CceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCccee
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLAD-----------------EQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRL 491 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~-----------------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l 491 (752)
++|.+.++||+|+||.||++..++ +..||+|.+.... .....+|.+|+.++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 578888999999999999997532 2369999987643 3345678999999999999999999
Q ss_pred eeeeeeCCeeEEEEeeCCCCCHhHHHhhcC----------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEee
Q 043278 492 LGCSLHGEERLLVYEFMPNKSLDFFLFNSG----------------RKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIH 555 (752)
Q Consensus 492 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH 555 (752)
++++.+.+..++||||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 999999999999999999999999885421 1234788999999999999999999988 999
Q ss_pred cCCCCCcEEecCCCCceecccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhC--CCC
Q 043278 556 RDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG--QKN 633 (752)
Q Consensus 556 ~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG--~~p 633 (752)
|||||+|||++.++.+||+|||+++.+.............++..|+|||++....++.++||||||+++|||+++ ..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 999999999999999999999999865433322223334567889999999999999999999999999999974 455
Q ss_pred CCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 043278 634 HTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705 (752)
Q Consensus 634 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~ 705 (752)
+...... ..+................. .+......+.+++.+||+.+|++||||.||.+.|++
T Consensus 242 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELTDE---QVIENAGEFFRDQGRQVYLF------RPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCCHH---HHHHHHHHHhhhcccccccc------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 6543321 12222222222111110000 011223457889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=324.82 Aligned_cols=268 Identities=26% Similarity=0.398 Sum_probs=206.9
Q ss_pred CcCCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHh--cCCCCcceeeeeeeeCC----eeEEEEe
Q 043278 433 STTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAK--LQHTNLVRLLGCSLHGE----ERLLVYE 506 (752)
Q Consensus 433 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~~lv~E 506 (752)
...+.||+|.||.||||++.+ +.||||++... ....|++|-++... ++|+||+++++.-..+. +++||+|
T Consensus 213 ~l~eli~~Grfg~V~KaqL~~-~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~ 288 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQLDN-RLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE 288 (534)
T ss_pred hhHHHhhcCccceeehhhccC-ceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence 345789999999999999955 89999999654 44567888877776 48999999999877665 8899999
Q ss_pred eCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc------CCCcEeecCCCCCcEEecCCCCceecccccce
Q 043278 507 FMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY------SRLRVIHRDLKASNILLDDKMNPKISDFGMAR 580 (752)
Q Consensus 507 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~------~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~ 580 (752)
|.+.|+|.++| +...++|....+|+..+++||+|||+. .+++|+|||||++||||.+++++.|+|||||.
T Consensus 289 fh~kGsL~dyL----~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl 364 (534)
T KOG3653|consen 289 FHPKGSLCDYL----KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL 364 (534)
T ss_pred eccCCcHHHHH----HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence 99999999999 445699999999999999999999974 45689999999999999999999999999999
Q ss_pred eecccccccccccccccCCccChhhhccCC-CC-----ccchhHHHHHHHHHHHhCCCCCCC--CC----CCC----Ccc
Q 043278 581 IFEVNESEANTKRIVGTYGYMSPEYAMSGI-VS-----IKTDVFSFGVLVLEIVSGQKNHTR--HH----PDR----PLN 644 (752)
Q Consensus 581 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~t-----~k~DV~S~G~vl~elltG~~p~~~--~~----~~~----~~~ 644 (752)
.+........+...+||.+|||||++.+.. +. .+.||||+|.|||||++...-+.. .. +.+ ..-
T Consensus 365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP 444 (534)
T KOG3653|consen 365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP 444 (534)
T ss_pred EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence 988766666666689999999999997742 33 368999999999999997654431 11 110 001
Q ss_pred hHHHHHHHh-hCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCCCCCC
Q 043278 645 LIGYAWQLL-SDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETMPLPP 712 (752)
Q Consensus 645 l~~~~~~~~-~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~~~~~~ 712 (752)
..+..+..+ ++.....+.+. .... ..+..+++.+..||..||+.|-|+.=|-+++..+.+..+.
T Consensus 445 t~e~mq~~VV~kK~RP~~p~~-W~~h---~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 445 TLEEMQELVVRKKQRPKIPDA-WRKH---AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred CHHHHHHHHHhhccCCCChhh-hhcC---ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 112222222 22222222222 2122 4455677888999999999999999999999887664443
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=335.93 Aligned_cols=253 Identities=25% Similarity=0.332 Sum_probs=207.8
Q ss_pred HhcCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCC---cccHHHHHHHHHHHHhc-CCCCcceeeeeeeeCCeeE
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGEERL 502 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 502 (752)
..++|...+.||+|+|++|++|+. +.++++|||++.+.. ....+-...|-..|.+| .||.|++|+-.|.+....+
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 346888899999999999999985 468999999997652 22334467888899999 8999999999999999999
Q ss_pred EEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceee
Q 043278 503 LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIF 582 (752)
Q Consensus 503 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~ 582 (752)
+|+||+++|+|-++|.+. +.+++..+..++.+|+.||+|||+.+ ||||||||+|||||+++++||+|||.|+.+
T Consensus 151 FvLe~A~nGdll~~i~K~---Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKY---GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred EEEEecCCCcHHHHHHHh---CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccC
Confidence 999999999999999654 45899999999999999999999999 999999999999999999999999999988
Q ss_pred cccccc---------cc--cccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHH
Q 043278 583 EVNESE---------AN--TKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQ 651 (752)
Q Consensus 583 ~~~~~~---------~~--~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~ 651 (752)
...... .. ...++||..|.+||++.+...+..+|+|+|||+||.|+.|++||....+.-.. .+
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliF------qk 298 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIF------QK 298 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHH------HH
Confidence 643221 11 14589999999999999999999999999999999999999999876632111 11
Q ss_pred HhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 043278 652 LLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCML 703 (752)
Q Consensus 652 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L 703 (752)
.+. ++ ..++....+.+.+|+.+.|..||.+|+|.+|+-++.
T Consensus 299 I~~-------l~----y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 299 IQA-------LD----YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred HHH-------hc----ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 111 11 112222224566788889999999999999998873
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=306.04 Aligned_cols=265 Identities=25% Similarity=0.296 Sum_probs=217.0
Q ss_pred HhcCCCcCCeeecCCcccEEEEE-ecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCC-----ee
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGE-----ER 501 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~ 501 (752)
..++|.+.+.||+|||+-||+++ +.++..+|+|++.....++.+..++|++..++++|||++++++++..+. +.
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 45789999999999999999998 5678899999999888788888999999999999999999999876443 48
Q ss_pred EEEEeeCCCCCHhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccce
Q 043278 502 LLVYEFMPNKSLDFFLFNSG-RKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR 580 (752)
Q Consensus 502 ~lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~ 580 (752)
+|+++|...|+|.+.+.... +...+++.+.+.|+.+|++||++||+.. ++++||||||.|||+.+.+.++|.|||.++
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence 99999999999999887644 3457999999999999999999999986 579999999999999999999999999987
Q ss_pred eecccc---cc----cccccccccCCccChhhhc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHH
Q 043278 581 IFEVNE---SE----ANTKRIVGTYGYMSPEYAM---SGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAW 650 (752)
Q Consensus 581 ~~~~~~---~~----~~~~~~~gt~~y~aPE~~~---~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~ 650 (752)
...-.- .. ........|..|+|||.+. +..+++++|||||||+||+|+.|..||+..........
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla----- 252 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA----- 252 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE-----
Confidence 643110 00 0112245688999999874 45789999999999999999999999987654332210
Q ss_pred HHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 651 QLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 651 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
..+..+.+..+......+.+.+++.+|+|.||.+||++.|++..++.+
T Consensus 253 --------LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 253 --------LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred --------EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 122233333333444667789999999999999999999999998765
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=338.08 Aligned_cols=242 Identities=26% Similarity=0.394 Sum_probs=201.0
Q ss_pred CCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCCCCCHh
Q 043278 435 TNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLD 514 (752)
Q Consensus 435 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~ 514 (752)
.+-||+|+.|.||+|+++ ++.||||+++... ..+++-|++|+|+||+.+.|+|.....+|||||||+.|-|.
T Consensus 129 LeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~ 200 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY 200 (904)
T ss_pred hhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence 478999999999999994 5679999885432 35788999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccccccccc
Q 043278 515 FFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594 (752)
Q Consensus 515 ~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~ 594 (752)
..|.. ...++......+..+||.||.|||.+. |||||||.-||||..+..+||+|||-++..... .+...+
T Consensus 201 ~VLka---~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSF 271 (904)
T KOG4721|consen 201 EVLKA---GRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSF 271 (904)
T ss_pred HHHhc---cCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhh
Confidence 99953 445888899999999999999999988 999999999999999999999999998854432 223358
Q ss_pred cccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCCCCHHH
Q 043278 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSANE 674 (752)
Q Consensus 595 ~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 674 (752)
.||..|||||++...+.++|+||||||||||||+||+.|+...+..... +.-| ...|.-+.+...
T Consensus 272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII---------wGVG------sNsL~LpvPstc 336 (904)
T KOG4721|consen 272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII---------WGVG------SNSLHLPVPSTC 336 (904)
T ss_pred hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE---------Eecc------CCcccccCcccC
Confidence 9999999999999999999999999999999999999999766532211 1111 011222333444
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCC
Q 043278 675 VMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETM 708 (752)
Q Consensus 675 ~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~~ 708 (752)
..-+.-|+.+||+..|..||++.+++.+|+-...
T Consensus 337 P~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~p 370 (904)
T KOG4721|consen 337 PDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASP 370 (904)
T ss_pred chHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCH
Confidence 5556678889999999999999999999976543
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=345.82 Aligned_cols=258 Identities=26% Similarity=0.402 Sum_probs=203.9
Q ss_pred cCCCcCCeeecCCcccEEEEEe------cCCceeEEEEcccCC-cccHHHHHHHHHHHHhc-CCCCcceeeeeeeeCCee
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKL------ADEQEVAIKRLSRSS-GQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGEER 501 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 501 (752)
++|++.++||+|+||.||+++. +.+..||||+++... ......+.+|+.++..+ +||||++++++|..++..
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 4688889999999999999963 235689999997543 23445688999999999 899999999999999999
Q ss_pred EEEEeeCCCCCHhHHHhhcCC-----------------------------------------------------------
Q 043278 502 LLVYEFMPNKSLDFFLFNSGR----------------------------------------------------------- 522 (752)
Q Consensus 502 ~lv~E~~~~gsL~~~l~~~~~----------------------------------------------------------- 522 (752)
++||||+++|+|..++.....
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 999999999999998864321
Q ss_pred -------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccccc
Q 043278 523 -------------KNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEA 589 (752)
Q Consensus 523 -------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 589 (752)
...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.........
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 124788999999999999999999988 9999999999999999999999999998654332222
Q ss_pred ccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCC
Q 043278 590 NTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQ 668 (752)
Q Consensus 590 ~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 668 (752)
......++..|+|||++.+..++.++||||||+++|||++ |..||....... ...+.+..+.... .+.
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~------~~~~~~~~~~~~~--~~~--- 340 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS------KFYKMIKEGYRML--SPE--- 340 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH------HHHHHHHhCccCC--CCC---
Confidence 2222345678999999999999999999999999999998 888876543221 1122233222111 111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 043278 669 PCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705 (752)
Q Consensus 669 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~ 705 (752)
....++.+|+.+|++.||++||||.||+++|+.
T Consensus 341 ----~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 341 ----CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred ----CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 112357789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=328.78 Aligned_cols=245 Identities=19% Similarity=0.303 Sum_probs=197.6
Q ss_pred CCeeecCCcccEEEEEecCCceeEEEEcccCCccc---HHHHHHHHHHHHhcCCCCcceeeeeeee----CCeeEEEEee
Q 043278 435 TNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQG---IVEFKNEVRLIAKLQHTNLVRLLGCSLH----GEERLLVYEF 507 (752)
Q Consensus 435 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~E~ 507 (752)
...||+|++|.||+|.. +|+.||||+++...... .+.|.+|+.++.+++||||+++++++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 36899999999999998 68899999997654333 4678899999999999999999999876 3467899999
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEeecCCCCCcEEecCCCCceecccccceeecccc
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY-SRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~ 586 (752)
+++|+|.+++... ..+++...+.++.+++.||.|||+. + ++||||||+|||+++++.+||+|||+++.+....
T Consensus 104 ~~~g~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~ 177 (283)
T PHA02988 104 CTRGYLREVLDKE---KDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP 177 (283)
T ss_pred CCCCcHHHHHhhC---CCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence 9999999998543 4589999999999999999999984 5 7899999999999999999999999998643221
Q ss_pred cccccccccccCCccChhhhcc--CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCC
Q 043278 587 SEANTKRIVGTYGYMSPEYAMS--GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDP 664 (752)
Q Consensus 587 ~~~~~~~~~gt~~y~aPE~~~~--~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 664 (752)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||...... .+ .......+.. +
T Consensus 178 -----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~---~~---~~~i~~~~~~-----~ 241 (283)
T PHA02988 178 -----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK---EI---YDLIINKNNS-----L 241 (283)
T ss_pred -----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH---HH---HHHHHhcCCC-----C
Confidence 12457889999999976 68999999999999999999999999755321 11 1111111111 1
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 665 SLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 665 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
.+ +......+.+++.+||+.||++|||++|+++.|+..
T Consensus 242 ~~----~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 242 KL----PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred CC----CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 11 112234577899999999999999999999999865
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=344.99 Aligned_cols=259 Identities=26% Similarity=0.417 Sum_probs=203.8
Q ss_pred cCCCcCCeeecCCcccEEEEEe------cCCceeEEEEcccCC-cccHHHHHHHHHHHHhc-CCCCcceeeeeeeeCCee
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKL------ADEQEVAIKRLSRSS-GQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGEER 501 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 501 (752)
++|.+.+.||+|+||.||+++. .++..||||++.... ......+.+|+.+++.+ +|+||++++++|......
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 5788889999999999999874 234579999997543 22345688999999999 899999999999999999
Q ss_pred EEEEeeCCCCCHhHHHhhcCC-----------------------------------------------------------
Q 043278 502 LLVYEFMPNKSLDFFLFNSGR----------------------------------------------------------- 522 (752)
Q Consensus 502 ~lv~E~~~~gsL~~~l~~~~~----------------------------------------------------------- 522 (752)
++||||+++|+|.+++.....
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 999999999999998854211
Q ss_pred --------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccccccccc
Q 043278 523 --------KNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594 (752)
Q Consensus 523 --------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~ 594 (752)
...+++.+++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..............
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 124788999999999999999999988 999999999999999999999999999865433222222223
Q ss_pred cccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCCCCHH
Q 043278 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSAN 673 (752)
Q Consensus 595 ~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 673 (752)
.++..|+|||++.+..++.++||||||+++|||++ |+.||........ .......+... ..+ ..
T Consensus 275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~------~~~~~~~~~~~--~~~-------~~ 339 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK------FYKMVKRGYQM--SRP-------DF 339 (374)
T ss_pred CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH------HHHHHHcccCc--cCC-------CC
Confidence 45678999999999999999999999999999997 9999876543211 11122221110 011 11
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 674 EVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 674 ~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
....+.+++.+||+.||.+|||+.+|+++|+++
T Consensus 340 ~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 340 APPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 124577889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=377.81 Aligned_cols=262 Identities=24% Similarity=0.426 Sum_probs=213.6
Q ss_pred hcCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEee
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
...|...+.||+|+||.||+|+. .++..||||++...... ..+|++.+++++|||||+++++|.+++..++||||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 45677888999999999999987 57889999998754322 23568899999999999999999999999999999
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccc
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES 587 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~ 587 (752)
+++|+|.+++. .++|..+..++.||++||+|||+.+.++|+||||||+||+++.++.+++. ||.+.....
T Consensus 765 ~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~--- 834 (968)
T PLN00113 765 IEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT--- 834 (968)
T ss_pred CCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc---
Confidence 99999999984 28999999999999999999997766679999999999999999988875 665543211
Q ss_pred ccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCC
Q 043278 588 EANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLE 667 (752)
Q Consensus 588 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 667 (752)
.....++..|+|||++.+..++.|+|||||||++|||++|+.|+..... .......|+............+|+.+.
T Consensus 835 ---~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (968)
T PLN00113 835 ---DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSIR 910 (968)
T ss_pred ---CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCcccc
Confidence 1123578899999999999999999999999999999999999854332 233455565555444445556666653
Q ss_pred C--CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCC
Q 043278 668 Q--PCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETM 708 (752)
Q Consensus 668 ~--~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~~ 708 (752)
. ....++..++.+++.+|++.+|++||||.||+++|+....
T Consensus 911 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 911 GDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred CCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 3 3455677788999999999999999999999999987643
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=332.06 Aligned_cols=251 Identities=25% Similarity=0.348 Sum_probs=205.0
Q ss_pred HhcCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccC----Cc-ccHHHHHHHHHHHHhcC-CCCcceeeeeeeeCCe
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRS----SG-QGIVEFKNEVRLIAKLQ-HTNLVRLLGCSLHGEE 500 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 500 (752)
..++|.+.+.||+|+||+|+.|.. ..+..||+|.+.+. .. .....+.+|+.++++++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 457889999999999999999975 46799999977664 11 23455678999999998 9999999999999999
Q ss_pred eEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCC-CCceecccccc
Q 043278 501 RLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDK-MNPKISDFGMA 579 (752)
Q Consensus 501 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~-~~~kl~DFgla 579 (752)
.++||||+.+|+|.+++.. ...+.+..+..+++|++.|++|+|+.+ |+||||||+|||++.+ +++||+|||++
T Consensus 95 ~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 9999999999999999965 345888999999999999999999998 9999999999999999 99999999999
Q ss_pred eeecccccccccccccccCCccChhhhccCC-CC-ccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCC
Q 043278 580 RIFEVNESEANTKRIVGTYGYMSPEYAMSGI-VS-IKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGK 657 (752)
Q Consensus 580 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~t-~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 657 (752)
.... .........+|++.|+|||++.+.. |+ .++||||+||+||.|++|+.||...... .. ...+..+.
T Consensus 169 ~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~------~l-~~ki~~~~ 239 (370)
T KOG0583|consen 169 AISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP------NL-YRKIRKGE 239 (370)
T ss_pred cccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH------HH-HHHHhcCC
Confidence 9764 1223344579999999999999977 76 7899999999999999999999874311 11 12222222
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 658 GLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 658 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.. -|.. . . ...+..++.+|++.||.+|+|+.|+++.
T Consensus 240 ~~---~p~~---~--~-S~~~~~Li~~mL~~~P~~R~t~~~i~~h 275 (370)
T KOG0583|consen 240 FK---IPSY---L--L-SPEARSLIEKMLVPDPSTRITLLEILEH 275 (370)
T ss_pred cc---CCCC---c--C-CHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence 11 1111 0 0 3457788999999999999999999843
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=326.53 Aligned_cols=257 Identities=28% Similarity=0.476 Sum_probs=206.8
Q ss_pred cCCCcCCeeecCCcccEEEEEecCC------ceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLADE------QEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERL 502 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~~------~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 502 (752)
++|++.+.||+|+||.||+|..... ..||+|.+.... .....+|.+|+.++.+++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 3677789999999999999986432 579999987543 233456899999999999999999999999988999
Q ss_pred EEEeeCCCCCHhHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCC
Q 043278 503 LVYEFMPNKSLDFFLFNSGR-------------KNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKM 569 (752)
Q Consensus 503 lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~ 569 (752)
++|||+++++|.+++..... ...+++...+.++.|++.||+|||+.+ ++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999865321 145889999999999999999999988 99999999999999999
Q ss_pred CceecccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHH
Q 043278 570 NPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGY 648 (752)
Q Consensus 570 ~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~ 648 (752)
.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||......+
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~------- 234 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE------- 234 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------
Confidence 999999999986543322222333456788999999999999999999999999999998 999987644221
Q ss_pred HHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 043278 649 AWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705 (752)
Q Consensus 649 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~ 705 (752)
....+..+.... .+.....++.+|+.+||+.||.+||++.||+++|+.
T Consensus 235 ~~~~i~~~~~~~---------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 235 VIEMIRSRQLLP---------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHcCCcCC---------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 122222222111 122334567889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=329.23 Aligned_cols=247 Identities=27% Similarity=0.400 Sum_probs=206.0
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccC--CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEe
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRS--SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYE 506 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 506 (752)
++|.+.+.||+|.||.||||+-+ +.+.||+|.+.+. .....+.+.+|++++++++|||||.++++|+...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46777889999999999999854 5788999998765 33455678999999999999999999999999999999999
Q ss_pred eCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccc
Q 043278 507 FMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586 (752)
Q Consensus 507 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~ 586 (752)
|+.+ +|..+|.+. ..|+++.+..|+.++..||.|||++. |+|||+||+||||+.++++|++|||+|+.+..+.
T Consensus 82 ~a~g-~L~~il~~d---~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQD---GKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hhhh-hHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 9987 999999654 44999999999999999999999998 9999999999999999999999999999765432
Q ss_pred cccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCC
Q 043278 587 SEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666 (752)
Q Consensus 587 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 666 (752)
.....+.||+.|||||...+++|+..+|.||+||||||+++|++||.... ........+.+ +.
T Consensus 155 --~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------i~~Lv~~I~~d--------~v- 217 (808)
T KOG0597|consen 155 --SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------ITQLVKSILKD--------PV- 217 (808)
T ss_pred --eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------HHHHHHHHhcC--------CC-
Confidence 22345789999999999999999999999999999999999999996543 11122222221 11
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 667 EQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 667 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
..+......+..++.-.+++||..|.|..+++.+
T Consensus 218 --~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 218 --KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred --CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 1122444567778888999999999999998876
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=324.42 Aligned_cols=249 Identities=28% Similarity=0.425 Sum_probs=208.7
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEee
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
..|+..+.||+|.||.||+|... .++.||+|++.-.. .....+.++|+.+|.+++++||.++++.+..+...+++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 45666789999999999999864 57889999997653 33456788999999999999999999999999999999999
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccc
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES 587 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~ 587 (752)
|.+|++.+.+.. ...+.+....-++++++.||.|||.++ .+|||||+.|||+.++|.+|++|||.+..+.....
T Consensus 93 ~~gGsv~~lL~~---~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLLKS---GNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhhcc---CCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 999999998842 333577777889999999999999998 99999999999999999999999999987765544
Q ss_pred ccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCC
Q 043278 588 EANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLE 667 (752)
Q Consensus 588 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 667 (752)
.. ..++||+.|||||++....|+.|+||||||++.+||++|.+|+...++-+-..++ ..-..|.+.
T Consensus 167 rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI------------pk~~PP~L~ 232 (467)
T KOG0201|consen 167 RR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI------------PKSAPPRLD 232 (467)
T ss_pred cc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec------------cCCCCCccc
Confidence 43 5689999999999999889999999999999999999999999988874433322 111233343
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 668 QPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 668 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
..+ ...+.+++..|+..||+.||++.+++++
T Consensus 233 ~~~----S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 233 GDF----SPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ccc----CHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 332 2346778889999999999999999875
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=320.41 Aligned_cols=256 Identities=28% Similarity=0.432 Sum_probs=207.0
Q ss_pred hcCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeC
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFM 508 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 508 (752)
.++|++.+.||+|++|.||+|...+++.||+|.++... ....++.+|+.++++++|+||+++++++...+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 35688889999999999999998788889999986543 34567899999999999999999999999999999999999
Q ss_pred CCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccc
Q 043278 509 PNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE 588 (752)
Q Consensus 509 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 588 (752)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||+++........
T Consensus 84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 9999999986543 345899999999999999999999988 999999999999999999999999999876522111
Q ss_pred cccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCC
Q 043278 589 ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLE 667 (752)
Q Consensus 589 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 667 (752)
.......+..|+|||++.+..++.++||||||++++||++ |+.|+...... .....+..+...
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------~~~~~~~~~~~~-------- 223 (261)
T cd05068 160 -AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA-------EVLQQVDQGYRM-------- 223 (261)
T ss_pred -ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHHcCCCC--------
Confidence 1111223458999999999999999999999999999999 88888654311 111122111110
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 668 QPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 668 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
+.+......+.+++.+|++.+|.+||++.++++.||++
T Consensus 224 -~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 224 -PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred -CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 11112235678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=322.75 Aligned_cols=255 Identities=25% Similarity=0.373 Sum_probs=203.0
Q ss_pred cCCCcCCeeecCCcccEEEEEec----CCceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA----DEQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLV 504 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 504 (752)
++|++.+.||+|+||.||+|.+. .+..||+|.++... ......+.+|+..+.+++||||+++++++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 56788899999999999999753 35689999987653 23345788999999999999999999999999999999
Q ss_pred EeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecc
Q 043278 505 YEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~ 584 (752)
|||+++|+|..++... ...+++..++.++.||+.||+|||+.+ ++||||||+|||++.++.+|++|||.+.....
T Consensus 85 ~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 85 TEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 9999999999998643 235899999999999999999999988 99999999999999999999999998764322
Q ss_pred cccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccccC
Q 043278 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELID 663 (752)
Q Consensus 585 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 663 (752)
... .......++..|+|||.+.+..++.++||||||+++||+++ |+.||....... ..+.+.++...
T Consensus 160 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~-------~~~~~~~~~~~---- 227 (266)
T cd05064 160 EAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD-------VIKAVEDGFRL---- 227 (266)
T ss_pred cch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHHCCCCC----
Confidence 111 11112344678999999999999999999999999999875 999987554221 11222222111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 664 PSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 664 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
+.+......+.+++..||+.+|.+||++.|+++.|++.
T Consensus 228 -----~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 228 -----PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -----CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 11122334577899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=301.79 Aligned_cols=236 Identities=26% Similarity=0.350 Sum_probs=195.9
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCcc---cHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQ---GIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 505 (752)
.+|+..+.||.|+||.|.+++.+ +|..+|+|++.+...- ..+...+|..+|+.+.||.++++++.+.+....+|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 46777899999999999999975 4788999999876432 3344678999999999999999999999999999999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccc
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVN 585 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~ 585 (752)
||+++|.|..++... ..++.+.+.-+|.||+.||+|||+.+ |++|||||+|||||.+|.+||+|||+|+....
T Consensus 124 eyv~GGElFS~Lrk~---~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~- 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKS---GRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG- 196 (355)
T ss_pred eccCCccHHHHHHhc---CCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC-
Confidence 999999999999654 34899999999999999999999998 99999999999999999999999999986542
Q ss_pred ccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCC
Q 043278 586 ESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPS 665 (752)
Q Consensus 586 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 665 (752)
.+-..+||+.|+|||+++...+..++|.|+|||++|||+.|.+||....+.. ..+.+-++++.
T Consensus 197 ----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~-------iY~KI~~~~v~------ 259 (355)
T KOG0616|consen 197 ----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ-------IYEKILEGKVK------ 259 (355)
T ss_pred ----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH-------HHHHHHhCccc------
Confidence 2456899999999999999999999999999999999999999998776521 12233333221
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCC
Q 043278 666 LEQPCSANEVMRCIHVGLLCVQDQAMDR 693 (752)
Q Consensus 666 l~~~~~~~~~~~l~~l~~~Cl~~dp~~R 693 (752)
.+......+.+|+...++.|-.+|
T Consensus 260 ----fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 260 ----FPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ----CCcccCHHHHHHHHHHHhhhhHhh
Confidence 111122234566667788888877
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=321.91 Aligned_cols=250 Identities=33% Similarity=0.506 Sum_probs=194.4
Q ss_pred cCCeeecCCcccEEEEEec-----CCceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEee
Q 043278 434 TTNKLGEGGFGPVYKGKLA-----DEQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 434 ~~~~LG~G~fg~Vy~~~~~-----~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
..+.||.|.||.||+|.+. .+..|+||.++... .+..++|.+|++.+.+++||||++++|++.+.+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3478999999999999886 25679999996543 33467899999999999999999999999988889999999
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccc
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES 587 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~ 587 (752)
+++|+|.+++... ....+++..+..|+.||++||.|||+.+ ++|+||+++||++++++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 9999999999765 2346899999999999999999999988 99999999999999999999999999987633222
Q ss_pred ccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCC
Q 043278 588 EANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666 (752)
Q Consensus 588 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 666 (752)
............|+|||.+....++.++||||||+++|||++ |+.|+..... ......+.++.....
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~-------~~~~~~~~~~~~~~~----- 226 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN-------EEIIEKLKQGQRLPI----- 226 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH-------HHHHHHHHTTEETTS-----
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc-------cccccccccccccee-----
Confidence 222333456778999999999999999999999999999999 6777654421 111223333332221
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 043278 667 EQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCML 703 (752)
Q Consensus 667 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L 703 (752)
+......+.+++..||+.+|++||||.++++.|
T Consensus 227 ----~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 227 ----PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ----BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ----ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 111234577899999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=325.69 Aligned_cols=256 Identities=21% Similarity=0.273 Sum_probs=206.2
Q ss_pred HHhcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC---cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeE
Q 043278 427 AAANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERL 502 (752)
Q Consensus 427 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 502 (752)
...++|++.+.||+|+||.||+++-+ .|..+|+|++++.. .......+.|-.+|...+++.||+|+-.|.+.+..+
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 35678999999999999999999865 58999999998764 334456788999999999999999999999999999
Q ss_pred EEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceee
Q 043278 503 LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIF 582 (752)
Q Consensus 503 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~ 582 (752)
|||||+|||++..+|.. ...|++..+..++.+.+-|++.||+.+ +|||||||+|+|||..|++||+||||+.-+
T Consensus 218 LiMEylPGGD~mTLL~~---~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMR---KDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred EEEEecCCccHHHHHHh---cCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchh
Confidence 99999999999999854 456999999999999999999999999 999999999999999999999999998543
Q ss_pred ccc--------------------c-ccc------------------------ccccccccCCccChhhhccCCCCccchh
Q 043278 583 EVN--------------------E-SEA------------------------NTKRIVGTYGYMSPEYAMSGIVSIKTDV 617 (752)
Q Consensus 583 ~~~--------------------~-~~~------------------------~~~~~~gt~~y~aPE~~~~~~~t~k~DV 617 (752)
... . ... .....+|||.|||||++.+..|+..+|.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw 371 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW 371 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence 210 0 000 0012479999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCC--
Q 043278 618 FSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPT-- 695 (752)
Q Consensus 618 ~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-- 695 (752)
||||||+||||.|-+||..+.+......+......+... ...+...+..+||.+|+. ||++|--
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP-------------~~~~~s~eA~DLI~rll~-d~~~RLG~~ 437 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFP-------------EEVDLSDEAKDLITRLLC-DPENRLGSK 437 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCC-------------CcCcccHHHHHHHHHHhc-CHHHhcCcc
Confidence 999999999999999999988765433222222222211 111112566788888988 9999975
Q ss_pred -HHHHHHH
Q 043278 696 -MPEVVCM 702 (752)
Q Consensus 696 -~~ev~~~ 702 (752)
++||-++
T Consensus 438 G~~EIK~H 445 (550)
T KOG0605|consen 438 GAEEIKKH 445 (550)
T ss_pred cHHHHhcC
Confidence 5565544
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=323.85 Aligned_cols=251 Identities=25% Similarity=0.353 Sum_probs=200.5
Q ss_pred CCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCC---cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEee
Q 043278 432 FSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 432 ~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
|+..+.||+|+||.||++.. .+++.||+|.+.... ......+.+|+.++.+++|+||+++++++.+++..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 66778999999999999986 468999999986542 22334678999999999999999999999999999999999
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccc
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES 587 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~ 587 (752)
+++|+|..++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 82 ~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05631 82 MNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE- 156 (285)
T ss_pred cCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence 99999988875432 235899999999999999999999988 9999999999999999999999999998653221
Q ss_pred ccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCC
Q 043278 588 EANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLE 667 (752)
Q Consensus 588 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 667 (752)
......|+..|+|||++.+..++.++|||||||++|||++|+.||.......... ..........
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~---~~~~~~~~~~---------- 221 (285)
T cd05631 157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKRE---EVDRRVKEDQ---------- 221 (285)
T ss_pred --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHH---HHHHHhhccc----------
Confidence 1223568999999999999999999999999999999999999998655322111 1111111110
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 043278 668 QPCSANEVMRCIHVGLLCVQDQAMDRPT-----MPEVVCM 702 (752)
Q Consensus 668 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-----~~ev~~~ 702 (752)
...+......+.+|+.+||+.||.+||+ ++|++++
T Consensus 222 ~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 0111122345678899999999999997 7888774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=330.05 Aligned_cols=255 Identities=27% Similarity=0.419 Sum_probs=201.6
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCc----eeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQ----EVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLL 503 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 503 (752)
.+|+..+.||+|+||.||+|++. +++ .||+|.++... .....++.+|+.+++.++|+||++++|+|... ...+
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46888899999999999999864 333 38999987543 33456789999999999999999999998764 5779
Q ss_pred EEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeec
Q 043278 504 VYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFE 583 (752)
Q Consensus 504 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~ 583 (752)
++||+++|+|.+++... ...+++...+.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 99999999999998653 235889999999999999999999988 9999999999999999999999999998765
Q ss_pred ccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCccccc
Q 043278 584 VNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELI 662 (752)
Q Consensus 584 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 662 (752)
............++..|+|||++.+..++.++||||||+++|||++ |+.|+...... ........+....
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~-------~~~~~~~~~~~~~-- 231 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-------EISSILEKGERLP-- 231 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHhCCCCCC--
Confidence 4332222222334678999999999999999999999999999998 99988654311 1112222221111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 663 DPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 663 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
.+ ......+.+++.+||+.+|.+||++.+++..|...
T Consensus 232 ~~-------~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~ 268 (316)
T cd05108 232 QP-------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 268 (316)
T ss_pred CC-------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11 11123567899999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=322.87 Aligned_cols=260 Identities=27% Similarity=0.427 Sum_probs=210.3
Q ss_pred cCCCcCCeeecCCcccEEEEEec------CCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA------DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLL 503 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 503 (752)
++|.+.+.||+|+||.||+++.. ++..+++|.+..........+.+|+.++.+++|+||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45777889999999999999742 345699999877665556778999999999999999999999999999999
Q ss_pred EEeeCCCCCHhHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCC
Q 043278 504 VYEFMPNKSLDFFLFNSG-------------RKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMN 570 (752)
Q Consensus 504 v~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~ 570 (752)
||||+++++|.+++.... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999986532 1235899999999999999999999998 999999999999999999
Q ss_pred ceecccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHH
Q 043278 571 PKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYA 649 (752)
Q Consensus 571 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~ 649 (752)
+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |+.|+....... .
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~ 234 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-------V 234 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------H
Confidence 99999999976543322222233456788999999999999999999999999999999 999886554211 1
Q ss_pred HHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCC
Q 043278 650 WQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETM 708 (752)
Q Consensus 650 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~~ 708 (752)
.+....+..... .......+.+++.+|++.+|++|||+.+|+++|+.+..
T Consensus 235 ~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 235 IECITQGRVLER---------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HHHHhCCCCCCC---------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 222233322211 11123457789999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=323.63 Aligned_cols=259 Identities=26% Similarity=0.431 Sum_probs=204.1
Q ss_pred HhcCCCcCCeeecCCcccEEEEEec------CCceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCe
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGKLA------DEQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEE 500 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 500 (752)
.+++|++.+.||+|+||.||+|... .+..||+|++.... .....++.+|+.++..++|+||+++++++.++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4578999999999999999998753 24679999986542 2334568899999999999999999999999999
Q ss_pred eEEEEeeCCCCCHhHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCcee
Q 043278 501 RLLVYEFMPNKSLDFFLFNSGR-------KNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKI 573 (752)
Q Consensus 501 ~~lv~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl 573 (752)
.++||||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 9999999999999999865321 234678899999999999999999987 999999999999999999999
Q ss_pred cccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHH
Q 043278 574 SDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQL 652 (752)
Q Consensus 574 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 652 (752)
+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+...... .....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~-------~~~~~ 233 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE-------QVLRF 233 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHH
Confidence 99999876543322222222345778999999999999999999999999999999 67887654321 11112
Q ss_pred hhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 043278 653 LSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705 (752)
Q Consensus 653 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~ 705 (752)
...+..... +......+.+++.+|++.+|++|||+.|++++|++
T Consensus 234 ~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 234 VMEGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHcCCcCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 222221111 11122457789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=321.97 Aligned_cols=257 Identities=30% Similarity=0.461 Sum_probs=210.6
Q ss_pred HhcCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEee
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
...+|+..++||.|+||.||+|...+++.+++|.+.........++.+|+.++..++|+||+++++++...+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 34568888999999999999999888999999999877665667889999999999999999999999999999999999
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccc
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES 587 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~ 587 (752)
+++++|.+++.... ...+++..+..++.||+.||.|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 84 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 84 MEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred cccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 99999999996543 345899999999999999999999988 99999999999999999999999999976543221
Q ss_pred ccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCC
Q 043278 588 EANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666 (752)
Q Consensus 588 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 666 (752)
.. ....++..|+|||.+....++.++||||||+++++|++ |+.|+....... .. .....+..
T Consensus 160 ~~--~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~---~~----~~~~~~~~-------- 222 (261)
T cd05148 160 LS--SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE---VY----DQITAGYR-------- 222 (261)
T ss_pred cc--cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH---HH----HHHHhCCc--------
Confidence 11 12345678999999999999999999999999999998 888886544211 11 11111111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 667 EQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 667 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
.+.+......+.+++.+|++.+|.+|||+.++++.|+++
T Consensus 223 -~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 223 -MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred -CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 111122334577899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=323.47 Aligned_cols=256 Identities=26% Similarity=0.444 Sum_probs=206.1
Q ss_pred cCCCcCCeeecCCcccEEEEEecC------CceeEEEEcccCCcc-cHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLAD------EQEVAIKRLSRSSGQ-GIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERL 502 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 502 (752)
++|.+.+.||+|+||.||+|...+ ++.||+|.++..... ....+.+|++++.+++|+||+++++++..++..+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 457778999999999999998643 468999999765443 4568999999999999999999999999999999
Q ss_pred EEEeeCCCCCHhHHHhhcC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCc
Q 043278 503 LVYEFMPNKSLDFFLFNSG-----------RKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNP 571 (752)
Q Consensus 503 lv~E~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~ 571 (752)
+||||+++++|.+++.... ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999986532 2345889999999999999999999988 9999999999999999999
Q ss_pred eecccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHH
Q 043278 572 KISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAW 650 (752)
Q Consensus 572 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~ 650 (752)
||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |+.||....... ..
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~-------~~ 234 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE-------VI 234 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HH
Confidence 9999999986543322222223445778999999999999999999999999999998 999986544221 11
Q ss_pred HHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 043278 651 QLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ 704 (752)
Q Consensus 651 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~ 704 (752)
.....+..... +......+.+++.+||+.||++||++.||++.|+
T Consensus 235 ~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 235 ECITQGRLLQR---------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHHcCCcCCC---------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 12222221111 1112345778999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=338.19 Aligned_cols=261 Identities=22% Similarity=0.342 Sum_probs=206.1
Q ss_pred hcCCCcCCeeecCCcccEEEEEecC------CceeEEEEcccCCc-ccHHHHHHHHHHHHhcC-CCCcceeeeeeeeCCe
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLAD------EQEVAIKRLSRSSG-QGIVEFKNEVRLIAKLQ-HTNLVRLLGCSLHGEE 500 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 500 (752)
.++|.+.+.||+|+||.||+|+... +..||||++..... .....+.+|+.++.++. ||||+++++++.+.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 4678888999999999999998532 34699999975433 33457899999999996 9999999999999999
Q ss_pred eEEEEeeCCCCCHhHHHhhcCC----------------------------------------------------------
Q 043278 501 RLLVYEFMPNKSLDFFLFNSGR---------------------------------------------------------- 522 (752)
Q Consensus 501 ~~lv~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 522 (752)
.+|||||+++|+|.+++.....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 9999999999999998865311
Q ss_pred -----------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecC
Q 043278 523 -----------------------------------KNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDD 567 (752)
Q Consensus 523 -----------------------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~ 567 (752)
...+++..++.++.||+.||+|||+.+ |+|+||||+|||+++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence 124788889999999999999999988 999999999999999
Q ss_pred CCCceecccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchH
Q 043278 568 KMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLI 646 (752)
Q Consensus 568 ~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~ 646 (752)
++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+.......
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~----- 347 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS----- 347 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH-----
Confidence 99999999999986543322222233456788999999999999999999999999999997 888886543211
Q ss_pred HHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCC
Q 043278 647 GYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNET 707 (752)
Q Consensus 647 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~ 707 (752)
........+.... .+......+.+++.+||+.+|++|||+.+|+++|+.+.
T Consensus 348 -~~~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 348 -TFYNKIKSGYRMA---------KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred -HHHHHHhcCCCCC---------CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 1111222221111 11122346778999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=319.39 Aligned_cols=254 Identities=30% Similarity=0.460 Sum_probs=206.2
Q ss_pred cCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCC
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMP 509 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 509 (752)
++|++.++||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.++++++|+||+++++++..++..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 5788889999999999999998888899999986543 345678999999999999999999999999999999999999
Q ss_pred CCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccccc
Q 043278 510 NKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEA 589 (752)
Q Consensus 510 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 589 (752)
+++|.+++... ....+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++........
T Consensus 85 ~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~- 159 (261)
T cd05072 85 KGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT- 159 (261)
T ss_pred CCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee-
Confidence 99999988653 2345889999999999999999999987 999999999999999999999999999875432211
Q ss_pred ccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCC
Q 043278 590 NTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQ 668 (752)
Q Consensus 590 ~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 668 (752)
......++..|+|||++....++.++||||||+++|||++ |+.||....... ....+..+... +.
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-------~~~~~~~~~~~----~~--- 225 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD-------VMSALQRGYRM----PR--- 225 (261)
T ss_pred ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH-------HHHHHHcCCCC----CC---
Confidence 1122345678999999999999999999999999999998 898886543211 11112221111 11
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 043278 669 PCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705 (752)
Q Consensus 669 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~ 705 (752)
.......+.+++.+|++.+|++||+++++++.|++
T Consensus 226 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 226 --MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred --CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11122457789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=319.45 Aligned_cols=256 Identities=29% Similarity=0.451 Sum_probs=205.2
Q ss_pred cCCCcCCeeecCCcccEEEEEecC----CceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLAD----EQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLV 504 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 504 (752)
++|++.+.||+|+||.||+|.+.. ...||+|.++... .....+|.+|+.++.+++|+||+++++++..++..+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 568888999999999999998742 3579999987543 33445788999999999999999999999999999999
Q ss_pred EeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecc
Q 043278 505 YEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~ 584 (752)
|||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+|+||||+|||+++++.+||+|||+++....
T Consensus 84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 84 TEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 99999999999986532 36899999999999999999999988 99999999999999999999999999987652
Q ss_pred cccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccccC
Q 043278 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELID 663 (752)
Q Consensus 585 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 663 (752)
...........++..|+|||.+.+..++.++||||||++++||++ |..|+...... ........+....
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~-------~~~~~~~~~~~~~--- 228 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ-------DVIKAVEDGYRLP--- 228 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH-------HHHHHHHcCCCCC---
Confidence 222222222344678999999999999999999999999999998 98888543311 1112222211110
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 664 PSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 664 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
.+......+.+++.+|++.+|++||++.||+++|+.+
T Consensus 229 ------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 229 ------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1112234577899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=317.68 Aligned_cols=252 Identities=29% Similarity=0.424 Sum_probs=203.0
Q ss_pred cCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCC
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMP 509 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 509 (752)
+.|.+.+.||+|+||.||+++..++..+|+|.+... .....++.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 356777899999999999999988889999988644 3345678999999999999999999999999999999999999
Q ss_pred CCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccccc
Q 043278 510 NKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEA 589 (752)
Q Consensus 510 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 589 (752)
+|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||+++........
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05114 83 NGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT- 156 (256)
T ss_pred CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence 999999886432 35899999999999999999999988 999999999999999999999999999865322211
Q ss_pred ccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCC
Q 043278 590 NTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQ 668 (752)
Q Consensus 590 ~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 668 (752)
......++..|+|||++....++.++||||||+++|||++ |+.||......+ . ...+..+... ..+.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~------~-~~~i~~~~~~--~~~~--- 224 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE------V-VEMISRGFRL--YRPK--- 224 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH------H-HHHHHCCCCC--CCCC---
Confidence 1112334568999999998899999999999999999999 888886544211 1 1122222111 1111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 043278 669 PCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ 704 (752)
Q Consensus 669 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~ 704 (752)
.....+.+++.+|++.+|.+||++.|+++.|.
T Consensus 225 ----~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 225 ----LASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred ----CCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 12245788999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=343.86 Aligned_cols=258 Identities=22% Similarity=0.297 Sum_probs=213.3
Q ss_pred HhcCCCcCCeeecCCcccEEEEEecCC-ceeEEEEcccCCcccHHHHHHHHHHHHhcC-CCCcceeeee-eee------C
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGKLADE-QEVAIKRLSRSSGQGIVEFKNEVRLIAKLQ-HTNLVRLLGC-SLH------G 498 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~-~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~------~ 498 (752)
...++++.+.|.+|||+.||+++...+ .++|+|++-..+........+|+++|++|+ |+|||.+++. ... .
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 345667789999999999999998765 999999998888888999999999999996 9999999993 221 1
Q ss_pred CeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceeccccc
Q 043278 499 EERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGM 578 (752)
Q Consensus 499 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgl 578 (752)
-+.+|.||||++|.|-+++....... |++.++++|+.++++|+++||... ++|||||||-+||||..+++.||||||.
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccc
Confidence 36789999999999999997654443 999999999999999999999975 7899999999999999999999999999
Q ss_pred ceeeccccccccc-------ccccccCCccChhhhc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHH
Q 043278 579 ARIFEVNESEANT-------KRIVGTYGYMSPEYAM---SGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGY 648 (752)
Q Consensus 579 a~~~~~~~~~~~~-------~~~~gt~~y~aPE~~~---~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~ 648 (752)
|.-.......... -...-|+.|+|||++. +..+++|+|||+|||+||-|+....||+.....
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l-------- 264 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL-------- 264 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce--------
Confidence 8743222110000 0123589999999874 678999999999999999999999999876422
Q ss_pred HHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 649 AWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 649 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
.+++.....+.......++.+||..||+.||.+||++-+|++.+-.+
T Consensus 265 -----------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l 311 (738)
T KOG1989|consen 265 -----------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFEL 311 (738)
T ss_pred -----------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHH
Confidence 34444555555567788899999999999999999999999887654
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=327.40 Aligned_cols=245 Identities=24% Similarity=0.303 Sum_probs=200.1
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC---cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 505 (752)
++|.+.+.||+|+||.||+++.. +++.||+|.+.... ......+.+|+.++.+++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 46788899999999999999875 57899999986532 233456889999999999999999999999999999999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccc
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVN 585 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~ 585 (752)
||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKA---GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 999999999988643 35788999999999999999999988 999999999999999999999999999865322
Q ss_pred ccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCC
Q 043278 586 ESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPS 665 (752)
Q Consensus 586 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 665 (752)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||...... ...+.+..+... + +
T Consensus 172 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-------~~~~~i~~~~~~-~--p- 235 (329)
T PTZ00263 172 -----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF-------RIYEKILAGRLK-F--P- 235 (329)
T ss_pred -----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH-------HHHHHHhcCCcC-C--C-
Confidence 12357899999999999999999999999999999999999999654321 111222222110 0 1
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 043278 666 LEQPCSANEVMRCIHVGLLCVQDQAMDRPT-----MPEVVCM 702 (752)
Q Consensus 666 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-----~~ev~~~ 702 (752)
. ....++.+++.+||+.||.+||+ +++++.+
T Consensus 236 --~----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 236 --N----WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred --C----CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1 11234678899999999999997 6777755
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=329.65 Aligned_cols=248 Identities=25% Similarity=0.319 Sum_probs=207.2
Q ss_pred cCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCC---cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 505 (752)
+-|++.+.||.|+-|.|-+|+. ..|+.+|||++.+.. ......+.+|+.+|+.+.|||++++++++++..+.++|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 4577789999999999999986 579999999997652 223345789999999999999999999999999999999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccc
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVN 585 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~ 585 (752)
||+++|-|.+++.. ++.+++.++.+++.||+.|+.|+|..+ |+||||||+|+|||..+++||+|||+|.+...+
T Consensus 92 Eyv~gGELFdylv~---kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 92 EYVPGGELFDYLVR---KGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EecCCchhHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 99999999999854 456999999999999999999999998 999999999999999999999999999864332
Q ss_pred ccccccccccccCCccChhhhccCCCC-ccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCC
Q 043278 586 ESEANTKRIVGTYGYMSPEYAMSGIVS-IKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDP 664 (752)
Q Consensus 586 ~~~~~~~~~~gt~~y~aPE~~~~~~~t-~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 664 (752)
. ....-+|.++|++||++.+.+|. .++||||+|||||.|++|+.||+.+. +......+..|...
T Consensus 166 k---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN-------ir~LLlKV~~G~f~----- 230 (786)
T KOG0588|consen 166 K---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN-------IRVLLLKVQRGVFE----- 230 (786)
T ss_pred c---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc-------HHHHHHHHHcCccc-----
Confidence 2 23346999999999999999886 68999999999999999999998443 23333444444321
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 043278 665 SLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCML 703 (752)
Q Consensus 665 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L 703 (752)
.+.....++.+|+.+|+..||..|.|++||+++-
T Consensus 231 -----MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 231 -----MPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred -----CCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 1122233566788899999999999999999973
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=322.00 Aligned_cols=257 Identities=30% Similarity=0.442 Sum_probs=203.4
Q ss_pred cCCCcCCeeecCCcccEEEEEe-----cCCceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKL-----ADEQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLL 503 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 503 (752)
..|++.+.||+|+||.||+|.. ..+..+++|.+.... .+...++.+|+.++++++|+||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 3567778999999999999974 245789999997543 3344678899999999999999999999999999999
Q ss_pred EEeeCCCCCHhHHHhhcC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCC
Q 043278 504 VYEFMPNKSLDFFLFNSG--------------RKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKM 569 (752)
Q Consensus 504 v~E~~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~ 569 (752)
||||+++++|.+++.... ....+++.+.+.++.|++.||+|||+.+ ++|+||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 999999999999985321 1235789999999999999999999988 99999999999999999
Q ss_pred CceecccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHH
Q 043278 570 NPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGY 648 (752)
Q Consensus 570 ~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~ 648 (752)
.+||+|||+++...............++..|+|||++.+..++.++||||||++++||++ |..||...... .
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~-------~ 234 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ-------E 234 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-------H
Confidence 999999999986543332222233445678999999998899999999999999999999 88888654311 1
Q ss_pred HHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 043278 649 AWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705 (752)
Q Consensus 649 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~ 705 (752)
..+....+.... .+.....++.+++.+|++.+|++||++.+|.++|..
T Consensus 235 ~~~~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 235 VIEMVRKRQLLP---------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHcCCcCC---------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 112222222111 111122457788999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=323.52 Aligned_cols=260 Identities=28% Similarity=0.451 Sum_probs=208.7
Q ss_pred cCCCcCCeeecCCcccEEEEEec------CCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA------DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLL 503 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 503 (752)
.+|.+.+.||+|+||.||++... ++..+|+|.+..........+.+|+.++.+++|+||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 46788899999999999999742 245689999877665566779999999999999999999999999999999
Q ss_pred EEeeCCCCCHhHHHhhcC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCcee
Q 043278 504 VYEFMPNKSLDFFLFNSG----------RKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKI 573 (752)
Q Consensus 504 v~E~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl 573 (752)
||||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999999986432 2235899999999999999999999988 999999999999999999999
Q ss_pred cccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHH
Q 043278 574 SDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQL 652 (752)
Q Consensus 574 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 652 (752)
+|||+++...............++..|+|||++.+..++.++||||||++++||++ |+.||....... ....
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-------~~~~ 234 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-------VIEC 234 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHH
Confidence 99999986543322222223445778999999999999999999999999999998 888886544211 1122
Q ss_pred hhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCC
Q 043278 653 LSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETM 708 (752)
Q Consensus 653 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~~ 708 (752)
...+..... ... ....+.+++.+|++.+|.+|||+.||++.|+.+..
T Consensus 235 i~~~~~~~~-----~~~----~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 235 ITQGRVLQR-----PRT----CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred HHcCCcCCC-----CCC----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 222222111 111 22357889999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=333.29 Aligned_cols=253 Identities=23% Similarity=0.336 Sum_probs=203.0
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC---cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 505 (752)
++|++.++||+|+||.||+|+.. +++.||||+++... ......+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888899999999999999975 47899999987542 223456789999999999999999999999999999999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccc
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVN 585 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~ 585 (752)
||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 99999999999854 235889999999999999999999988 99999999999999999999999999975432
Q ss_pred ccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCC
Q 043278 586 ESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPS 665 (752)
Q Consensus 586 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 665 (752)
......|++.|+|||++.+..++.++|||||||++|||++|+.||......+.. ..+.... ..+..+.
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-------~~i~~~~-~~~~~~~ 221 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETW-------ENLKYWK-ETLQRPV 221 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHH-------HHHHhcc-ccccCCC
Confidence 223467899999999999999999999999999999999999999765432111 1111100 0000111
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 666 LEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 666 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
... ........+.+++.+|++.+|.+||++.|++++
T Consensus 222 ~~~-~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 222 YDD-PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCc-cccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 100 001223456788889999999999999999976
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=328.05 Aligned_cols=200 Identities=25% Similarity=0.336 Sum_probs=174.4
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEee
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
++|++.+.||+|+||.||+++.. ++..+|+|.+.... .....++.+|++++.+++|+||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence 67888999999999999999875 57889999887542 23345789999999999999999999999999999999999
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccc
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES 587 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~ 587 (752)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||++......
T Consensus 85 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 157 (331)
T cd06649 85 MDGGSLDQVLKEA---KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (331)
T ss_pred CCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence 9999999998543 34889999999999999999999853 3999999999999999999999999998755322
Q ss_pred ccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 043278 588 EANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHH 638 (752)
Q Consensus 588 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~ 638 (752)
......|+..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 158 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~ 206 (331)
T cd06649 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPD 206 (331)
T ss_pred --ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1233568999999999999999999999999999999999999996543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=320.08 Aligned_cols=257 Identities=28% Similarity=0.416 Sum_probs=201.2
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCc----eeEEEEcccCCc-ccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQ----EVAIKRLSRSSG-QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLL 503 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~----~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 503 (752)
++|.+.+.||+|+||.||+|... +++ .+++|.+..... ....++..|+..+.+++|+||+++++++. +...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 46677799999999999999864 344 478888754432 23456788888999999999999999875 455788
Q ss_pred EEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeec
Q 043278 504 VYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFE 583 (752)
Q Consensus 504 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~ 583 (752)
++||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ ++|+||||+|||+++++.+||+|||+++...
T Consensus 86 i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 99999999999998643 345899999999999999999999988 9999999999999999999999999998764
Q ss_pred ccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCccccc
Q 043278 584 VNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELI 662 (752)
Q Consensus 584 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 662 (752)
............++..|+|||.+.+..++.++||||||+++|||++ |+.|+....+.. ....+..+....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~-- 231 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE-------VPDLLEKGERLA-- 231 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHCCCcCC--
Confidence 3332222334556788999999999999999999999999999998 998887654221 112222222111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCC
Q 043278 663 DPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETM 708 (752)
Q Consensus 663 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~~ 708 (752)
.+.. . ...+.+++.+|++.+|++|||+.|+++.|+....
T Consensus 232 ~~~~---~----~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 232 QPQI---C----TIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CCCC---C----CHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 1111 1 2345678889999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=331.00 Aligned_cols=261 Identities=26% Similarity=0.397 Sum_probs=204.6
Q ss_pred hcCCCcCCeeecCCcccEEEEEec------CCceeEEEEcccCCc-ccHHHHHHHHHHHHhc-CCCCcceeeeeeee-CC
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA------DEQEVAIKRLSRSSG-QGIVEFKNEVRLIAKL-QHTNLVRLLGCSLH-GE 499 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~ 499 (752)
.++|++.+.||+|+||.||+|... .++.||+|++..... .....+.+|+.++.++ +|+||++++++|.. +.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 357888999999999999999642 246899999875432 2345678899999999 89999999998764 45
Q ss_pred eeEEEEeeCCCCCHhHHHhhcCC---------------------------------------------------------
Q 043278 500 ERLLVYEFMPNKSLDFFLFNSGR--------------------------------------------------------- 522 (752)
Q Consensus 500 ~~~lv~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 522 (752)
..+++|||+++++|..++.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 67899999999999998854221
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccccccccccccCCcc
Q 043278 523 -KNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYM 601 (752)
Q Consensus 523 -~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~ 601 (752)
...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.............++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 136899999999999999999999988 9999999999999999999999999998764333222233345677899
Q ss_pred ChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHH
Q 043278 602 SPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIH 680 (752)
Q Consensus 602 aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 680 (752)
|||++.+..++.++|||||||+|+||++ |+.||......+ .....+..+..... +......+.+
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~~~~~---------~~~~~~~~~~ 307 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE------EFCRRLKEGTRMRA---------PEYATPEIYS 307 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH------HHHHHHhccCCCCC---------CccCCHHHHH
Confidence 9999999999999999999999999998 999986543221 11122222211110 1122345788
Q ss_pred HHHHcccCCCCCCCCHHHHHHHhhcCC
Q 043278 681 VGLLCVQDQAMDRPTMPEVVCMLQNET 707 (752)
Q Consensus 681 l~~~Cl~~dp~~RPt~~ev~~~L~~~~ 707 (752)
++.+|++.+|++||++.||+++|+.+.
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~~ 334 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDLL 334 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=320.45 Aligned_cols=265 Identities=24% Similarity=0.294 Sum_probs=201.5
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEe
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYE 506 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 506 (752)
++|++.+.||+|+||.||+++.. +++.||+|++.... ......+.+|+.++.+++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46888999999999999999975 57889999987542 2334567899999999999999999999999999999999
Q ss_pred eCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccc
Q 043278 507 FMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586 (752)
Q Consensus 507 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~ 586 (752)
|++++++..+.. ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 999988765542 2345899999999999999999999988 9999999999999999999999999998654322
Q ss_pred cccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHH--------HHH-hhCCC
Q 043278 587 SEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYA--------WQL-LSDGK 657 (752)
Q Consensus 587 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~--------~~~-~~~~~ 657 (752)
. .......|++.|+|||++.+..++.++|||||||++|||++|+.||...........+... ... .....
T Consensus 155 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 155 N-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred c-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 1 1122356899999999999989999999999999999999999999765432111111000 000 00101
Q ss_pred cccccCCCCCCCCC------HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 043278 658 GLELIDPSLEQPCS------ANEVMRCIHVGLLCVQDQAMDRPTMPEVVC 701 (752)
Q Consensus 658 ~~~~~d~~l~~~~~------~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~ 701 (752)
......+....... ......+.+++.+|++.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11111111111000 012245788999999999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=322.06 Aligned_cols=245 Identities=23% Similarity=0.304 Sum_probs=199.7
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC---cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 505 (752)
++|++.+.||+|+||.||++... +++.||+|++.... ......+.+|+.++.+++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36788899999999999999875 58899999986432 223456789999999999999999999999999999999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccc
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVN 585 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~ 585 (752)
||+++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRNS---GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 999999999988543 35889999999999999999999988 999999999999999999999999999865321
Q ss_pred ccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCC
Q 043278 586 ESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPS 665 (752)
Q Consensus 586 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 665 (752)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||....... . .+.+..+.. .
T Consensus 155 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~------~-~~~i~~~~~------~ 216 (291)
T cd05612 155 -----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG------I-YEKILAGKL------E 216 (291)
T ss_pred -----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------H-HHHHHhCCc------C
Confidence 223568999999999999999999999999999999999999997654211 1 111112111 0
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 043278 666 LEQPCSANEVMRCIHVGLLCVQDQAMDRPT-----MPEVVCM 702 (752)
Q Consensus 666 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-----~~ev~~~ 702 (752)
+ +......+.+++.+|++.||.+||+ ++|++++
T Consensus 217 ~----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 217 F----PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred C----CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 1 1111235678899999999999995 8888765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=309.97 Aligned_cols=246 Identities=24% Similarity=0.376 Sum_probs=207.4
Q ss_pred cCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCC---cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 505 (752)
.+|++.++||+|.||.|-++.. ..|+.||||.+++.. .++...+.+|+++|..|+||||+.++.+|+..+..+|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 4677778999999999999975 679999999998763 445556789999999999999999999999999999999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccc
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVN 585 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~ 585 (752)
||..+|.|.+++.. +..|++.++..+++||..|+.|+|.+. ++|||||.+|||||.++++||+||||+.++...
T Consensus 133 EYaS~GeLYDYiSe---r~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 133 EYASGGELYDYISE---RGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EecCCccHHHHHHH---hccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 99999999999964 445999999999999999999999988 999999999999999999999999999876543
Q ss_pred ccccccccccccCCccChhhhccCCCC-ccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCC
Q 043278 586 ESEANTKRIVGTYGYMSPEYAMSGIVS-IKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDP 664 (752)
Q Consensus 586 ~~~~~~~~~~gt~~y~aPE~~~~~~~t-~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 664 (752)
. ....++|.+-|.+||++.+.+|. +.+|-||||++||-|+.|..||++.+-. ...+.+..|...+ |
T Consensus 207 k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk-------~lvrQIs~GaYrE---P 273 (668)
T KOG0611|consen 207 K---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK-------RLVRQISRGAYRE---P 273 (668)
T ss_pred c---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH-------HHHHHhhcccccC---C
Confidence 3 23358999999999999999886 7899999999999999999999877622 1223333333222 2
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 665 SLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 665 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
. ......-|+.||+..+|++|.|+.+|..+
T Consensus 274 ~--------~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 274 E--------TPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred C--------CCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 1 11124457889999999999999999887
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=321.31 Aligned_cols=258 Identities=28% Similarity=0.415 Sum_probs=203.8
Q ss_pred CCCcCCeeecCCcccEEEEEec------CCceeEEEEcccCCc-ccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEE
Q 043278 431 NFSTTNKLGEGGFGPVYKGKLA------DEQEVAIKRLSRSSG-QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLL 503 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 503 (752)
+|.+.+.||+|+||.||+|+.. ....+++|.+..... ....++.+|+.++..++||||+++++.+..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4677899999999999999753 235689998875532 334578899999999999999999999999999999
Q ss_pred EEeeCCCCCHhHHHhhcC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCc
Q 043278 504 VYEFMPNKSLDFFLFNSG---------------------RKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASN 562 (752)
Q Consensus 504 v~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~N 562 (752)
++||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999885421 1235889999999999999999999988 9999999999
Q ss_pred EEecCCCCceecccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCC
Q 043278 563 ILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDR 641 (752)
Q Consensus 563 Ill~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~ 641 (752)
||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |+.|+....+.
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~- 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE- 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence 9999999999999999986543322222223345678999999999999999999999999999998 98888654321
Q ss_pred CcchHHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCC
Q 043278 642 PLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNET 707 (752)
Q Consensus 642 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~ 707 (752)
..+.....+... ..+......+.+++.+|++.+|++||++.|+++.|+.+.
T Consensus 237 ------~~~~~~~~~~~~---------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 237 ------RLFNLLKTGYRM---------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred ------HHHHHHhCCCCC---------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 112222221111 111122345778999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=315.89 Aligned_cols=255 Identities=27% Similarity=0.398 Sum_probs=204.5
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeC
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFM 508 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 508 (752)
..|...++||+|++|.||+|... .++.||+|.+... .....++.+|++++.+++|+||+++++++..++..+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 35777889999999999999865 4788999998754 334567899999999999999999999999999999999999
Q ss_pred CCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccc
Q 043278 509 PNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE 588 (752)
Q Consensus 509 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 588 (752)
++++|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 85 TYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 9999999985432 345899999999999999999999988 999999999999999999999999999865432211
Q ss_pred cccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCC
Q 043278 589 ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLE 667 (752)
Q Consensus 589 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 667 (752)
......++..|+|||.+.+..++.++||||||+++|||++ |..|+...... .....+..+.. +.
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-------~~~~~~~~~~~-----~~-- 225 (263)
T cd05052 161 -AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-------QVYELLEKGYR-----ME-- 225 (263)
T ss_pred -ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHHCCCC-----CC--
Confidence 1112234568999999999999999999999999999998 88888654321 11122222111 11
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 668 QPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 668 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
.+......+.+++.+|++.+|++|||+.+++++|+.+
T Consensus 226 --~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 226 --RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred --CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 1111234577899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=329.32 Aligned_cols=243 Identities=23% Similarity=0.359 Sum_probs=202.1
Q ss_pred HhcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC---cccHHHHHHHHHHHHhc-CCCCcceeeeeeeeCCeeE
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGEERL 502 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 502 (752)
.-++|...++||+|.||+|+++.++ +++.+|||.+++.. ....+..+.|.+++... +||.+++++.+|...++.+
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 4468999999999999999999876 47789999998863 44566778888888887 5999999999999999999
Q ss_pred EEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceee
Q 043278 503 LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIF 582 (752)
Q Consensus 503 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~ 582 (752)
+||||+.+|++..+. ....+++..+.-++..|+.||.|||+++ ||+||||.+|||||.+|++||+||||++..
T Consensus 446 fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred EEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccccc
Confidence 999999999943333 3356999999999999999999999999 999999999999999999999999999852
Q ss_pred cccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCccccc
Q 043278 583 EVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELI 662 (752)
Q Consensus 583 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 662 (752)
- .....+.+++||+.|||||++.+..|+..+|.|||||+||||+.|+.||.++++++.... .+.+
T Consensus 519 m--~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~Fds------I~~d------- 583 (694)
T KOG0694|consen 519 M--GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDS------IVND------- 583 (694)
T ss_pred C--CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH------HhcC-------
Confidence 2 123356679999999999999999999999999999999999999999998875543221 1111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 043278 663 DPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTM 696 (752)
Q Consensus 663 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~ 696 (752)
|+ .++.-...+.+.|+.+.+..+|++|--+
T Consensus 584 ~~----~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 584 EV----RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CC----CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 11 1233344556788889999999999866
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=318.44 Aligned_cols=257 Identities=31% Similarity=0.455 Sum_probs=202.1
Q ss_pred hcCCCcCCeeecCCcccEEEEEecC------CceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCee
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLAD------EQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEER 501 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 501 (752)
+++|.+.+.||+|++|.||+|...+ +..|++|.+.... ......|.+|+.++++++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4678889999999999999998753 4678999886543 33445689999999999999999999999998899
Q ss_pred EEEEeeCCCCCHhHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCC---Cceec
Q 043278 502 LLVYEFMPNKSLDFFLFNSGR----KNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKM---NPKIS 574 (752)
Q Consensus 502 ~lv~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~---~~kl~ 574 (752)
++||||+++++|.+++..... ...+++..++.++.||+.||+|||+.+ ++|+||||+||+++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 999999999999999865432 235899999999999999999999988 99999999999998754 58999
Q ss_pred ccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHh
Q 043278 575 DFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLL 653 (752)
Q Consensus 575 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 653 (752)
|||+++................+..|+|||++.+..++.++|||||||++|||++ |+.||....... . ....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~---~----~~~~ 234 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE---V----MEFV 234 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---H----HHHH
Confidence 9999986533222111222233568999999999999999999999999999997 888887544221 1 1111
Q ss_pred hCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 043278 654 SDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ 704 (752)
Q Consensus 654 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~ 704 (752)
....... .+......+.+++.+|++.+|++||++.+|++.|+
T Consensus 235 ~~~~~~~---------~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 235 TGGGRLD---------PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HcCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1111111 11122345778999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=314.22 Aligned_cols=256 Identities=25% Similarity=0.365 Sum_probs=204.0
Q ss_pred HHhcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCc--------------ccHHHHHHHHHHHHhcCCCCccee
Q 043278 427 AAANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSG--------------QGIVEFKNEVRLIAKLQHTNLVRL 491 (752)
Q Consensus 427 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~l 491 (752)
..-++|++.+.||+|.||.|-+|+.. +++.||||++.+... ...+...+|+.+|++++|+|||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34578999999999999999999864 688999999976421 123468899999999999999999
Q ss_pred eeeeeeC--CeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCC
Q 043278 492 LGCSLHG--EERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKM 569 (752)
Q Consensus 492 ~~~~~~~--~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~ 569 (752)
+.+..+. +..+||+|||..|.+... ......|+..++++++.++..||+|||.++ ||||||||+|+||+++|
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~---p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWC---PPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccC---CCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCC
Confidence 9997654 578999999998877432 233334999999999999999999999999 99999999999999999
Q ss_pred Cceecccccceeecccc---cccccccccccCCccChhhhccCC----CCccchhHHHHHHHHHHHhCCCCCCCCCCCCC
Q 043278 570 NPKISDFGMARIFEVNE---SEANTKRIVGTYGYMSPEYAMSGI----VSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRP 642 (752)
Q Consensus 570 ~~kl~DFgla~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~----~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~ 642 (752)
++||+|||.+..+.... .........||+.|+|||...++. .+.+.||||+||+||.|+.|+-||-.+...
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~-- 325 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL-- 325 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH--
Confidence 99999999998763321 122223478999999999987732 457899999999999999999999766522
Q ss_pred cchHHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 043278 643 LNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCML 703 (752)
Q Consensus 643 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L 703 (752)
....+ ++...+..+...+.-+++.+|+.++|++||+.|.+..+|..+.
T Consensus 326 ----~l~~K---------Ivn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 326 ----ELFDK---------IVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred ----HHHHH---------HhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 11111 2222333343445667788899999999999999999998775
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=342.98 Aligned_cols=252 Identities=19% Similarity=0.196 Sum_probs=203.1
Q ss_pred CCCcCCeeecCCcccEEEEEec-C-CceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeC
Q 043278 431 NFSTTNKLGEGGFGPVYKGKLA-D-EQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFM 508 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~~-~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 508 (752)
.|.+.+.||+|+||.||++... + ++.||+|.+..........+.+|+.++..++||||+++++++..++..+|||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4778899999999999999753 3 5778889876555445566788999999999999999999999999999999999
Q ss_pred CCCCHhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccc
Q 043278 509 PNKSLDFFLFNS-GRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES 587 (752)
Q Consensus 509 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~ 587 (752)
++|+|..++... .....+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999888643 23446889999999999999999999988 99999999999999999999999999987654332
Q ss_pred ccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCC
Q 043278 588 EANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLE 667 (752)
Q Consensus 588 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 667 (752)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... .....+....
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~------~~~-~~~~~~~~~~------- 290 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR------EIM-QQVLYGKYDP------- 290 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHH-HHHHhCCCCC-------
Confidence 22334567999999999999999999999999999999999999998654311 111 1111121111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 043278 668 QPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVC 701 (752)
Q Consensus 668 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~ 701 (752)
.+......+.+++.+||+.+|++||++.+++.
T Consensus 291 --~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 291 --FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred --CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 01112245778899999999999999999865
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=313.55 Aligned_cols=252 Identities=29% Similarity=0.438 Sum_probs=202.7
Q ss_pred cCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCC
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMP 509 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 509 (752)
++|.+.+.||+|+||.||+++..++..+|+|.+.... ....++.+|+.++.+++||||+++++++.+.+..+++|||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4567788999999999999998777789999987543 345678999999999999999999999998889999999999
Q ss_pred CCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccccc
Q 043278 510 NKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEA 589 (752)
Q Consensus 510 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 589 (752)
+++|.+++.... ..+++..++.++.||+.||+|||+.+ ++|+||||+||++++++.+||+|||+++........
T Consensus 83 ~~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05113 83 NGCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT- 156 (256)
T ss_pred CCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCcee-
Confidence 999999886532 25899999999999999999999988 999999999999999999999999999865433211
Q ss_pred ccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCC
Q 043278 590 NTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQ 668 (752)
Q Consensus 590 ~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 668 (752)
......++..|+|||.+....++.++||||||+++|||++ |+.|+...... . .......+.... .+
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~------~-~~~~~~~~~~~~--~~---- 223 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS------E-TVEKVSQGLRLY--RP---- 223 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH------H-HHHHHhcCCCCC--CC----
Confidence 1112345678999999998889999999999999999999 88888644321 1 111122221111 01
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 043278 669 PCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ 704 (752)
Q Consensus 669 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~ 704 (752)
......+.+++.+||+.+|.+||++.++++.|+
T Consensus 224 ---~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 224 ---HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ---CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 112356788999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=320.41 Aligned_cols=262 Identities=24% Similarity=0.354 Sum_probs=198.6
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEee
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
++|.+.++||+|+||.||+|... +++.||+|+++... ......+.+|+.++++++|+||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46888899999999999999865 57899999986543 22345678999999999999999999999999999999999
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccc
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES 587 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~ 587 (752)
+++ +|..++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 85 ~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 85 LDS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred CCc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 985 888877543 235789999999999999999999988 99999999999999999999999999976432211
Q ss_pred ccccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhC-----------
Q 043278 588 EANTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSD----------- 655 (752)
Q Consensus 588 ~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~----------- 655 (752)
......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||......+.... .......
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07871 159 --TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHL---IFRLLGTPTEETWPGITS 233 (288)
T ss_pred --cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHhCCCChHHhhcccc
Confidence 1223467899999998875 5689999999999999999999999976543221111 1111100
Q ss_pred -CCcccccCCCCCCCC----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 656 -GKGLELIDPSLEQPC----SANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 656 -~~~~~~~d~~l~~~~----~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
........+...... .......+.+++.+|++.||.+|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 234 NEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred chhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000011111110000 00112356789999999999999999999863
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=315.51 Aligned_cols=256 Identities=25% Similarity=0.420 Sum_probs=201.4
Q ss_pred CCcCCeeecCCcccEEEEEecC----CceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCe-----
Q 043278 432 FSTTNKLGEGGFGPVYKGKLAD----EQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEE----- 500 (752)
Q Consensus 432 ~~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 500 (752)
|.+.+.||+|+||.||+|.... +..||+|+++... .....++.+|++.+..++|+||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567899999999999998643 3679999987542 2334578999999999999999999998876554
Q ss_pred -eEEEEeeCCCCCHhHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceeccc
Q 043278 501 -RLLVYEFMPNKSLDFFLFNSG---RKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDF 576 (752)
Q Consensus 501 -~~lv~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DF 576 (752)
.++++||+++++|..++.... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 789999999999999886532 2346899999999999999999999988 999999999999999999999999
Q ss_pred ccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhC
Q 043278 577 GMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSD 655 (752)
Q Consensus 577 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 655 (752)
|+++...............++..|+|||.+....++.++||||||+++|||++ |..|+...... .. ......
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---~~----~~~~~~ 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---EI----YDYLRH 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---HH----HHHHHc
Confidence 99987643332222222334678999999988999999999999999999999 88888654321 11 112222
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 656 GKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 656 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
+..... +......+.+++.+|++.||.+|||+.||++.|+.+
T Consensus 231 ~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 GNRLKQ---------PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCCCC---------CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 221111 112334678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=312.75 Aligned_cols=248 Identities=28% Similarity=0.407 Sum_probs=195.8
Q ss_pred CeeecCCcccEEEEEec-CCceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCCCCCH
Q 043278 436 NKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSL 513 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 513 (752)
+.||+|+||.||+|+.. +++.+|+|.+.... ......+.+|++++++++|+||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 47999999999999874 68889999886543 33456789999999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccccccccc
Q 043278 514 DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKR 593 (752)
Q Consensus 514 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~ 593 (752)
.+++... ...+++..++.++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||++..............
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRTE--GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 9998542 345899999999999999999999988 99999999999999999999999999875432211111111
Q ss_pred ccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCCCCH
Q 043278 594 IVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSA 672 (752)
Q Consensus 594 ~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 672 (752)
...+..|+|||.+.++.++.++||||||+++|||++ |..|+....... ........... ..+.
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-------~~~~~~~~~~~---------~~~~ 219 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-------TREAIEQGVRL---------PCPE 219 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-------HHHHHHcCCCC---------CCcc
Confidence 223457999999999999999999999999999998 888775443211 11111111100 1111
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 043278 673 NEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ 704 (752)
Q Consensus 673 ~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~ 704 (752)
.....+.+++.+|++.+|++|||+.||+++|+
T Consensus 220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 22346778999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=324.83 Aligned_cols=242 Identities=22% Similarity=0.277 Sum_probs=195.3
Q ss_pred CeeecCCcccEEEEEec-CCceeEEEEcccCC---cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCCCC
Q 043278 436 NKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNK 511 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 511 (752)
+.||+|+||.||+++.. +++.||+|+++... ......+.+|+.++.+++||||+++++++..++..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999864 68899999987542 223456788999999999999999999999999999999999999
Q ss_pred CHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccccccc
Q 043278 512 SLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANT 591 (752)
Q Consensus 512 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~ 591 (752)
+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~ 152 (323)
T cd05571 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATM 152 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCcc
Confidence 99888854 345899999999999999999999998 999999999999999999999999998753211 1122
Q ss_pred ccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCCCC
Q 043278 592 KRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCS 671 (752)
Q Consensus 592 ~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 671 (752)
....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .......+.. .+ +
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-------~~~~~~~~~~------~~----p 215 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-------LFELILMEEI------RF----P 215 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH-------HHHHHHcCCC------CC----C
Confidence 34678999999999999999999999999999999999999996543211 1111111111 11 1
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 043278 672 ANEVMRCIHVGLLCVQDQAMDRP-----TMPEVVCM 702 (752)
Q Consensus 672 ~~~~~~l~~l~~~Cl~~dp~~RP-----t~~ev~~~ 702 (752)
......+.+++.+|++.||++|| ++.+++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 12234567888999999999999 79998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=319.88 Aligned_cols=255 Identities=29% Similarity=0.412 Sum_probs=201.7
Q ss_pred CCcCCeeecCCcccEEEEEecC------CceeEEEEcccCCcc-cHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEE
Q 043278 432 FSTTNKLGEGGFGPVYKGKLAD------EQEVAIKRLSRSSGQ-GIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLV 504 (752)
Q Consensus 432 ~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 504 (752)
|.+.++||+|+||.||+|+..+ ++.||+|++...... ....+.+|+.++.+++|+||+++++++.+.+..+++
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~ 86 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI 86 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence 5556899999999999998632 467999999755332 245688999999999999999999999999999999
Q ss_pred EeeCCCCCHhHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCc
Q 043278 505 YEFMPNKSLDFFLFNSG-------------RKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNP 571 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~ 571 (752)
+||+++++|..++.... .+..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05091 87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNV 163 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCce
Confidence 99999999999985321 1235888999999999999999999988 9999999999999999999
Q ss_pred eecccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHH
Q 043278 572 KISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAW 650 (752)
Q Consensus 572 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~ 650 (752)
||+|||+++...............+++.|+|||.+..+.++.++||||||+++|||++ |..|+...... ...
T Consensus 164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-------~~~ 236 (283)
T cd05091 164 KISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ-------DVI 236 (283)
T ss_pred EecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH-------HHH
Confidence 9999999886543322222233455789999999998899999999999999999998 77777654321 112
Q ss_pred HHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 043278 651 QLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705 (752)
Q Consensus 651 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~ 705 (752)
..+..+..... +......+.+++..|++.+|.+||++.+|++.|+.
T Consensus 237 ~~i~~~~~~~~---------~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 237 EMIRNRQVLPC---------PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHcCCcCCC---------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 22223222111 11223447789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=317.38 Aligned_cols=257 Identities=27% Similarity=0.442 Sum_probs=204.3
Q ss_pred cCCCcCCeeecCCcccEEEEEec------CCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA------DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLL 503 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 503 (752)
++|...++||+|+||.||++... ++..+|+|.+..........+.+|++++..++|+||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46677899999999999999642 356799999887666666789999999999999999999999999999999
Q ss_pred EEeeCCCCCHhHHHhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCc
Q 043278 504 VYEFMPNKSLDFFLFNSGR------------KNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNP 571 (752)
Q Consensus 504 v~E~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~ 571 (752)
+|||+++++|.+++..... ...+++..++.++.||+.||+|||+.+ ++|+||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999865321 135889999999999999999999988 9999999999999999999
Q ss_pred eecccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHH
Q 043278 572 KISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAW 650 (752)
Q Consensus 572 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~ 650 (752)
||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ . .
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------~-~ 234 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE------A-I 234 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH------H-H
Confidence 9999999976543322222223345678999999999999999999999999999998 888875443211 1 1
Q ss_pred HHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 043278 651 QLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705 (752)
Q Consensus 651 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~ 705 (752)
.....+.... . +......+.+++.+||+.||.+||++.||++.|+.
T Consensus 235 ~~~~~~~~~~--~-------~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 235 ECITQGRELE--R-------PRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHHcCccCC--C-------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 1111211111 0 11122346789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=328.00 Aligned_cols=260 Identities=17% Similarity=0.165 Sum_probs=195.4
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEee
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
.++|++.+.||+|+||.||++... .++.||+|.... ..+.+|++++++++||||+++++++..+...++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 357999999999999999999864 578899997542 3467899999999999999999999999999999999
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccc
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES 587 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~ 587 (752)
+. ++|..++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 165 ~~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~- 236 (391)
T PHA03212 165 YK-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN- 236 (391)
T ss_pred CC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc-
Confidence 86 678777743 235889999999999999999999988 9999999999999999999999999997533211
Q ss_pred ccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCc----chHHHHHHHhhCCC------
Q 043278 588 EANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPL----NLIGYAWQLLSDGK------ 657 (752)
Q Consensus 588 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~----~l~~~~~~~~~~~~------ 657 (752)
........||+.|+|||++.+..++.++|||||||++|||++|+.|+......... ..+...........
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 11122357899999999999999999999999999999999999876543221100 00111110000000
Q ss_pred ----cc---------cccCCCCCC--CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 658 ----GL---------ELIDPSLEQ--PCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 658 ----~~---------~~~d~~l~~--~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.. ....+.... .........+.+++.+||+.||.+|||++|+++.
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00 000000000 0001223467789999999999999999999864
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=317.32 Aligned_cols=264 Identities=23% Similarity=0.335 Sum_probs=197.4
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCc-ccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEe
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSG-QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYE 506 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 506 (752)
.++|.+.++||+|+||.||+|+.. +++.||||++..... .....+.+|+.++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 467889999999999999999875 688999999875432 233457889999999999999999999999999999999
Q ss_pred eCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccc
Q 043278 507 FMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586 (752)
Q Consensus 507 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~ 586 (752)
|++ ++|.+++... ...++...+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 996 5676666432 345889999999999999999999998 9999999999999999999999999997543221
Q ss_pred cccccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCc------c
Q 043278 587 SEANTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKG------L 659 (752)
Q Consensus 587 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~------~ 659 (752)
.......+++.|+|||++.+ ..++.++||||+||++|||++|+.||....... .........+..... .
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd07869 158 --HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ--DQLERIFLVLGTPNEDTWPGVH 233 (303)
T ss_pred --ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhCCCChhhccchh
Confidence 11223567899999999875 468899999999999999999999997643211 111111111100000 0
Q ss_pred c--ccCCC-CC--CCCCH-------HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 660 E--LIDPS-LE--QPCSA-------NEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 660 ~--~~d~~-l~--~~~~~-------~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
. -.++. .. .+... .....+.+++..|++.||++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 0 00000 00 00000 012346688999999999999999999863
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=318.20 Aligned_cols=267 Identities=27% Similarity=0.407 Sum_probs=201.2
Q ss_pred CCcCCeeecCCcccEEEEEe-----cCCceeEEEEcccCCc-ccHHHHHHHHHHHHhcCCCCcceeeeeeeeC--CeeEE
Q 043278 432 FSTTNKLGEGGFGPVYKGKL-----ADEQEVAIKRLSRSSG-QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHG--EERLL 503 (752)
Q Consensus 432 ~~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 503 (752)
|...+.||+|+||+||++.. .+++.||+|.+..... .....+.+|++++++++|+||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37789999999999988653 3577899999876532 3456788999999999999999999988653 35789
Q ss_pred EEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeec
Q 043278 504 VYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFE 583 (752)
Q Consensus 504 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~ 583 (752)
+|||+++++|.+++.. ..+++..++.++.|+++||+|||+.+ |+|+||||+|||+++++.+||+|||+++...
T Consensus 86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence 9999999999999853 34899999999999999999999988 9999999999999999999999999998654
Q ss_pred ccccc-cccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCccccc
Q 043278 584 VNESE-ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELI 662 (752)
Q Consensus 584 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 662 (752)
..... .......++..|+|||.+.+..++.++||||||++++||++|+.|+........ ................+++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccccchhhhhhhh
Confidence 32211 111223456679999999989999999999999999999999998765432100 0000000000000111111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 663 DPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 663 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
+.....+.+......+.+++.+|++.+|++|||+++|+++|+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 11111122223345678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=314.58 Aligned_cols=255 Identities=26% Similarity=0.427 Sum_probs=198.4
Q ss_pred CcCCeeecCCcccEEEEEecCCc---eeEEEEcccC--CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeC------Cee
Q 043278 433 STTNKLGEGGFGPVYKGKLADEQ---EVAIKRLSRS--SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHG------EER 501 (752)
Q Consensus 433 ~~~~~LG~G~fg~Vy~~~~~~~~---~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~ 501 (752)
.+.++||+|+||.||+|+..... .+|+|.++.. .......+.+|+.++..++|+||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 45689999999999999875532 5899988654 233456788999999999999999999987532 246
Q ss_pred EEEEeeCCCCCHhHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceeccccc
Q 043278 502 LLVYEFMPNKSLDFFLFNSG---RKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGM 578 (752)
Q Consensus 502 ~lv~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgl 578 (752)
+++|||+++|+|..++.... ....+++.....++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence 89999999999998875322 2345899999999999999999999987 99999999999999999999999999
Q ss_pred ceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCC
Q 043278 579 ARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGK 657 (752)
Q Consensus 579 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 657 (752)
++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... ........+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-------~~~~~~~~~~ 231 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS-------EIYDYLRQGN 231 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHHcCC
Confidence 987543322112222345678999999999999999999999999999999 78888653321 1122233332
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 658 GLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 658 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
.... +......+.+++.+|++.+|.+|||+.|+++.|+.+
T Consensus 232 ~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 232 RLKQ---------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 2111 111223467899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=311.65 Aligned_cols=251 Identities=28% Similarity=0.393 Sum_probs=201.0
Q ss_pred CCCcCCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCCC
Q 043278 431 NFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPN 510 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 510 (752)
+|++.+.||+|+||.||++...++..+|+|.+.... ....++.+|+.++.+++|+||+++++++...+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 467778999999999999998777789999986543 2445788999999999999999999999999999999999999
Q ss_pred CCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccccc
Q 043278 511 KSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEAN 590 (752)
Q Consensus 511 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~ 590 (752)
++|.+++.... ..+++..++.++.||+.||+|||+.+ ++||||||+||++++++.+||+|||+++.........
T Consensus 84 ~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~- 157 (256)
T cd05059 84 GCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS- 157 (256)
T ss_pred CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccc-
Confidence 99999986432 35899999999999999999999988 9999999999999999999999999998654322111
Q ss_pred cccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCC
Q 043278 591 TKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQP 669 (752)
Q Consensus 591 ~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 669 (752)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ . ......+... .
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~----~~~~~~~~~~---------~ 221 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---V----VESVSAGYRL---------Y 221 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---H----HHHHHcCCcC---------C
Confidence 111223457999999999999999999999999999999 788886543221 1 1112111110 0
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 043278 670 CSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ 704 (752)
Q Consensus 670 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~ 704 (752)
.+......+.+++.+|++.+|++||||.|+++.|.
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 222 RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 11112346778999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=318.94 Aligned_cols=263 Identities=23% Similarity=0.397 Sum_probs=201.3
Q ss_pred cCCCcCCeeecCCcccEEEEEec-----CCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeee--CCeeE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-----DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLH--GEERL 502 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-----~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~ 502 (752)
.+|++.+.||+|+||.||++..+ +++.||+|++..........+.+|++++.+++|+||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46788899999999999999742 477899999987666666788999999999999999999998754 34678
Q ss_pred EEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceee
Q 043278 503 LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIF 582 (752)
Q Consensus 503 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~ 582 (752)
+||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||+++..
T Consensus 84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 999999999999998543 235899999999999999999999988 999999999999999999999999999876
Q ss_pred ccccccc-ccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCC--------C-cchHHHHHHH
Q 043278 583 EVNESEA-NTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDR--------P-LNLIGYAWQL 652 (752)
Q Consensus 583 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~--------~-~~l~~~~~~~ 652 (752)
....... ......++..|+|||.+.+..++.++||||||++++||++|..+.......- . ..........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL 238 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence 4322111 1111223456999999999999999999999999999999877653321100 0 0000011111
Q ss_pred hhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 653 LSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 653 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
+..+. ..+........+.+++.+||+.+|++||||.||++.|+.+
T Consensus 239 ~~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 239 LKNNG---------RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HhcCC---------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 11111 0111112234577899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=299.50 Aligned_cols=265 Identities=22% Similarity=0.261 Sum_probs=199.4
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCccc--HHHHHHHHHHHHhcCCCCcceeeeeeee--CCeeEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQG--IVEFKNEVRLIAKLQHTNLVRLLGCSLH--GEERLLV 504 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv 504 (752)
+.|+..++|++|+||.||+|+.+ +++.||+|+++...... -..-.+|+.+|.+.+|||||.+-.+..- -+..+||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 45777899999999999999875 57889999997653221 1123789999999999999999887653 3478999
Q ss_pred EeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecc
Q 043278 505 YEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~ 584 (752)
||||+. +|...+.... +.+...++.-++.|+++|++|||++. |+||||||+|+|++..|.+||+|||+|+.++.
T Consensus 156 Me~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred HHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcC
Confidence 999975 7878876544 45888999999999999999999998 99999999999999999999999999997764
Q ss_pred cccccccccccccCCccChhhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccC
Q 043278 585 NESEANTKRIVGTYGYMSPEYAMSG-IVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELID 663 (752)
Q Consensus 585 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 663 (752)
... ..+..+-|..|+|||.+.+. .|+...|+||+|||+.||+++++.|.+..+-+....+-.......+.....+-.
T Consensus 230 p~k--~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~ 307 (419)
T KOG0663|consen 230 PLK--PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSE 307 (419)
T ss_pred Ccc--cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccc
Confidence 422 12345679999999999874 699999999999999999999999988875544333321111111111111111
Q ss_pred CC--------------CCCCCCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 664 PS--------------LEQPCSAN-EVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 664 ~~--------------l~~~~~~~-~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.. +...+... ..+.-.+|+...+..||.+|-|++|.++.
T Consensus 308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 00 00111111 12345677788899999999999998875
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=321.02 Aligned_cols=260 Identities=26% Similarity=0.395 Sum_probs=206.3
Q ss_pred HhcCCCcCCeeecCCcccEEEEEecC------CceeEEEEcccCC-cccHHHHHHHHHHHHhc-CCCCcceeeeeeeeCC
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGKLAD------EQEVAIKRLSRSS-GQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGE 499 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 499 (752)
..++|+..+.||+|+||.||++...+ ...+|+|.+.... .....++.+|+.++.++ +|+||+++++++..+.
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 34578888999999999999998642 3579999987542 23345688999999999 8999999999999999
Q ss_pred eeEEEEeeCCCCCHhHHHhhc-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEec
Q 043278 500 ERLLVYEFMPNKSLDFFLFNS-------------GRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLD 566 (752)
Q Consensus 500 ~~~lv~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~ 566 (752)
..+++|||+++|+|..++... .....+++..++.++.|++.||+|||+.+ |+|+||||+|||++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence 999999999999999998642 22346899999999999999999999987 99999999999999
Q ss_pred CCCCceecccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcch
Q 043278 567 DKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNL 645 (752)
Q Consensus 567 ~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l 645 (752)
+++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |..|+......
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----- 241 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE----- 241 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH-----
Confidence 999999999999987654332222222345678999999999999999999999999999998 88887644311
Q ss_pred HHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 646 IGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 646 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
.....+..+.... .+......+.+++.+|++.+|++||||.|+++.|+++
T Consensus 242 --~~~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 242 --ELFKLLKEGYRME---------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred --HHHHHHHcCCcCC---------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 1122222221111 1112234677899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=317.54 Aligned_cols=261 Identities=26% Similarity=0.377 Sum_probs=207.6
Q ss_pred HhcCCCcCCeeecCCcccEEEEEecC-----CceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeee-CCe
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGKLAD-----EQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLH-GEE 500 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~ 500 (752)
..++|.+.+.||+|+||.||+|...+ +..|++|++.... ......+.+|+.++.+++|+||+++++++.+ +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 35678888999999999999998765 6789999987543 3345668899999999999999999998766 467
Q ss_pred eEEEEeeCCCCCHhHHHhhcCCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecc
Q 043278 501 RLLVYEFMPNKSLDFFLFNSGRK-----NVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISD 575 (752)
Q Consensus 501 ~~lv~E~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~D 575 (752)
.++++||+++++|..++...... ..+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998654322 56899999999999999999999987 99999999999999999999999
Q ss_pred cccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhh
Q 043278 576 FGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLS 654 (752)
Q Consensus 576 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~ 654 (752)
||+++.+.............++..|+|||++.+..++.++||||||+++||+++ |+.||....+. .. ...+.
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~-~~~~~ 233 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF------EM-AAYLK 233 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH------HH-HHHHH
Confidence 999986543322222223345678999999999899999999999999999999 99998654321 11 12222
Q ss_pred CCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCC
Q 043278 655 DGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNET 707 (752)
Q Consensus 655 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~ 707 (752)
.+... . ........+.+++.+|++.+|++|||+.||++.|+.+.
T Consensus 234 ~~~~~-----~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 234 DGYRL-----A----QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred cCCCC-----C----CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 22110 0 01112245778999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=315.74 Aligned_cols=263 Identities=23% Similarity=0.368 Sum_probs=200.8
Q ss_pred cCCCcCCeeecCCcccEEEEEecC---------------CceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeee
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLAD---------------EQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLG 493 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~---------------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~ 493 (752)
++|++.+.||+|+||.||++...+ ...||+|.+.... ......|.+|++++.+++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578888999999999999987532 1248999987542 334457899999999999999999999
Q ss_pred eeeeCCeeEEEEeeCCCCCHhHHHhhcCC---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEE
Q 043278 494 CSLHGEERLLVYEFMPNKSLDFFLFNSGR---------KNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNIL 564 (752)
Q Consensus 494 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIl 564 (752)
++...+..++||||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++|+||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 99999999999999999999999854321 124788999999999999999999988 999999999999
Q ss_pred ecCCCCceecccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh--CCCCCCCCCCCCC
Q 043278 565 LDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS--GQKNHTRHHPDRP 642 (752)
Q Consensus 565 l~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt--G~~p~~~~~~~~~ 642 (752)
+++++.+||+|||++................++..|+|||++..+.++.++||||||++++||++ +..||.......
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~- 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ- 240 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH-
Confidence 99999999999999976543322222223445678999999999999999999999999999998 445554433211
Q ss_pred cchHHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 043278 643 LNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ 704 (752)
Q Consensus 643 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~ 704 (752)
.+....+............ .+......+.+|+.+|++.+|++||||.+|++.|+
T Consensus 241 --~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 --VIENTGEFFRNQGRQIYLS------QTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred --HHHHHHHhhhhccccccCC------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 1111111111111100000 01112346889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=339.69 Aligned_cols=259 Identities=19% Similarity=0.241 Sum_probs=205.7
Q ss_pred HHHHhcCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccC--CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCC--
Q 043278 425 IAAAANNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRS--SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGE-- 499 (752)
Q Consensus 425 i~~~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-- 499 (752)
+....++|.+.+.||+|+||+||+++. .+++.||||++... .......+.+|+..+..++|+|++++...+...+
T Consensus 27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 344567999999999999999999985 46899999998654 2334556789999999999999999988765432
Q ss_pred ------eeEEEEeeCCCCCHhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCce
Q 043278 500 ------ERLLVYEFMPNKSLDFFLFNSG-RKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPK 572 (752)
Q Consensus 500 ------~~~lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~k 572 (752)
..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+||||+.++.+|
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vk 183 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVK 183 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEE
Confidence 3579999999999999886532 3356899999999999999999999988 99999999999999999999
Q ss_pred ecccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHH
Q 043278 573 ISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQL 652 (752)
Q Consensus 573 l~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~ 652 (752)
|+|||+++.+.............||+.|+|||++.+..++.++||||||+++|||++|+.||...... .. ...
T Consensus 184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~------~~-~~~ 256 (496)
T PTZ00283 184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME------EV-MHK 256 (496)
T ss_pred EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH------HH-HHH
Confidence 99999998765433333334567999999999999999999999999999999999999999654311 11 111
Q ss_pred hhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 653 LSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 653 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
...+.... .+......+.+++.+||+.+|.+||++.+++++
T Consensus 257 ~~~~~~~~---------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 257 TLAGRYDP---------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HhcCCCCC---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 11221111 111223457788999999999999999999875
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=317.92 Aligned_cols=261 Identities=23% Similarity=0.325 Sum_probs=193.6
Q ss_pred cCCCcCCeeecCCcccEEEEEec--CCceeEEEEcccCCc--ccHHHHHHHHHHHHhc---CCCCcceeeeeee-----e
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA--DEQEVAIKRLSRSSG--QGIVEFKNEVRLIAKL---QHTNLVRLLGCSL-----H 497 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~-----~ 497 (752)
++|.+.+.||+|+||.||+++.. +++.||+|++..... .....+.+|+.++..+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888899999999999999863 467899998865422 2234566777777665 6999999999885 2
Q ss_pred CCeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccc
Q 043278 498 GEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFG 577 (752)
Q Consensus 498 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg 577 (752)
....++||||++ ++|..++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 346899999997 68888875432 335899999999999999999999988 9999999999999999999999999
Q ss_pred cceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCC-
Q 043278 578 MARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDG- 656 (752)
Q Consensus 578 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~- 656 (752)
+++..... .......|++.|+|||.+.+..++.++||||||+++|||++|++||......+. +..........
T Consensus 156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~---~~~i~~~~~~~~ 229 (290)
T cd07862 156 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---LGKILDVIGLPG 229 (290)
T ss_pred ceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH---HHHHHHHhCCCC
Confidence 99865432 222345689999999999999999999999999999999999999976543221 11111111000
Q ss_pred --Ccc---cccCCCC--CCCCCH-----HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 043278 657 --KGL---ELIDPSL--EQPCSA-----NEVMRCIHVGLLCVQDQAMDRPTMPEVVC 701 (752)
Q Consensus 657 --~~~---~~~d~~l--~~~~~~-----~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~ 701 (752)
... .+....+ ....+. .....+.+++.+|++.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000 0000000 000011 12234568999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=310.90 Aligned_cols=254 Identities=28% Similarity=0.448 Sum_probs=203.2
Q ss_pred cCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCC
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMP 509 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 509 (752)
++|.+.++||+|+||.||+|+..++..||+|++.... ....++.+|+.++.+++|+||+++++++. ....++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 5688899999999999999998777789999997533 34567899999999999999999999875 456789999999
Q ss_pred CCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccccc
Q 043278 510 NKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEA 589 (752)
Q Consensus 510 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 589 (752)
+++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++........
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~- 158 (262)
T cd05071 84 KGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT- 158 (262)
T ss_pred CCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc-
Confidence 99999998643 2345789999999999999999999988 999999999999999999999999999865433211
Q ss_pred ccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCC
Q 043278 590 NTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQ 668 (752)
Q Consensus 590 ~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 668 (752)
......++..|+|||+..+..++.++||||||+++|||++ |+.||....... . ......+.. .
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~---~----~~~~~~~~~---------~ 222 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---V----LDQVERGYR---------M 222 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH---H----HHHHhcCCC---------C
Confidence 1122345678999999999999999999999999999999 777876543211 1 111111110 0
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 669 PCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 669 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
..+.+....+.+++.+|++.+|++||++.++++.|+..
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 11223345678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=304.08 Aligned_cols=268 Identities=25% Similarity=0.314 Sum_probs=204.3
Q ss_pred HhcCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccC--CcccHHHHHHHHHHHHhcCCCCcceeeeeeee-----CC
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRS--SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLH-----GE 499 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~ 499 (752)
....|...+.||+|+||.|..+.. .+|+.||||++.+. .....++..+|+++|+.++|+||+.+++.+.. -+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 445666678999999999999986 46899999999843 44456677899999999999999999998765 34
Q ss_pred eeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccc
Q 043278 500 ERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMA 579 (752)
Q Consensus 500 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla 579 (752)
..++|+|+| ..+|...+.. ...|+..+...++.||++||.|+|+.+ |+||||||+|+|++.+...||+|||+|
T Consensus 100 DvYiV~elM-etDL~~iik~---~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKS---QQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred eeEEehhHH-hhHHHHHHHc---CccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccce
Confidence 679999999 5678777743 334999999999999999999999998 999999999999999999999999999
Q ss_pred eeecccccccccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHH--------
Q 043278 580 RIFEVNESEANTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAW-------- 650 (752)
Q Consensus 580 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~-------- 650 (752)
+...........+..+.|..|+|||.+.. ..||.+.||||.|||+.||++|++.|.+.+......++....
T Consensus 173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l 252 (359)
T KOG0660|consen 173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDL 252 (359)
T ss_pred eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHH
Confidence 98754322223345778999999998765 689999999999999999999999999887554433332111
Q ss_pred HHhhCCCcccccCCCC-CCCCCH-----HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 651 QLLSDGKGLELIDPSL-EQPCSA-----NEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 651 ~~~~~~~~~~~~d~~l-~~~~~~-----~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
..+...+....+.... ....+. ..-...++|+.+||..||.+|+|++|.+++
T Consensus 253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 253 QKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 1111111111111000 000111 112356778889999999999999999886
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=323.10 Aligned_cols=201 Identities=24% Similarity=0.342 Sum_probs=173.9
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEe
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYE 506 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 506 (752)
.++|++.++||+|+||.||++... ++..+|+|.+.... ......+.+|++++.+++|+||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 368899999999999999999876 57889999887542 2334568899999999999999999999999999999999
Q ss_pred eCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccc
Q 043278 507 FMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586 (752)
Q Consensus 507 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~ 586 (752)
|+++++|.+++... ..+++..+..++.|++.||.|||+.+ +|+|+||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~- 157 (333)
T cd06650 84 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (333)
T ss_pred cCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence 99999999998543 34889999999999999999999753 3999999999999999999999999998754321
Q ss_pred cccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 043278 587 SEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHH 638 (752)
Q Consensus 587 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~ 638 (752)
......|+..|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 206 (333)
T cd06650 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD 206 (333)
T ss_pred ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc
Confidence 1223568899999999999899999999999999999999999987543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=290.57 Aligned_cols=248 Identities=26% Similarity=0.373 Sum_probs=207.2
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccC---CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRS---SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 505 (752)
++|++.+.||+|-||.||.|+.+ ++-.||+|++.+. ..+...++.+|+++-..|+||||++++++|.+....+|++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 67889999999999999999865 4678999999765 2345567899999999999999999999999999999999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccc
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVN 585 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~ 585 (752)
||.+.|.|...|... ....++......++.|+|.||.|+|..+ +|||||||+|+|++..+..||+|||.+..-.
T Consensus 102 Eya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-- 175 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP-- 175 (281)
T ss_pred EecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence 999999999999743 3345888889999999999999999988 9999999999999999999999999987533
Q ss_pred ccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCC
Q 043278 586 ESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPS 665 (752)
Q Consensus 586 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 665 (752)
.......+||..|.|||+..+...+.++|+|++|++.||++.|.+||+.....+.. +.+.. .++.+|
T Consensus 176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etY-------krI~k---~~~~~p- 242 (281)
T KOG0580|consen 176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETY-------KRIRK---VDLKFP- 242 (281)
T ss_pred --CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHH-------HHHHH---ccccCC-
Confidence 22334589999999999999999999999999999999999999999876622211 11111 112222
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 666 LEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 666 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
......+.+++.+|+..+|.+|.+..||+..
T Consensus 243 ------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 243 ------STISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ------cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 2233456788999999999999999999864
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=309.83 Aligned_cols=261 Identities=25% Similarity=0.325 Sum_probs=197.6
Q ss_pred CCCcCCeeecCCcccEEEEEecC-CceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCC-----eeEEE
Q 043278 431 NFSTTNKLGEGGFGPVYKGKLAD-EQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGE-----ERLLV 504 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv 504 (752)
.|...+.+|.|+||.||+|++.. ++.||||+........ .+|+++|+++.|||||+++-+|.... ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k----nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK----NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC----cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 45556899999999999999754 6899999986554321 47999999999999999999876432 33589
Q ss_pred EeeCCCCCHhHHHhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCC-CCceecccccceee
Q 043278 505 YEFMPNKSLDFFLFN-SGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDK-MNPKISDFGMARIF 582 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~-~~~kl~DFgla~~~ 582 (752)
|||||. +|...+.+ ...+..++...+.-+..||.+||+|||+.+ |+||||||+|+|+|.+ |.+||+|||.|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999985 67677654 223455788888889999999999999987 9999999999999976 99999999999987
Q ss_pred cccccccccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhC------
Q 043278 583 EVNESEANTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSD------ 655 (752)
Q Consensus 583 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~------ 655 (752)
-.++.. .....+..|+|||.+.+ ..|+.+.||||.|||+.||+.|++.|.+++.......+-........
T Consensus 177 ~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 177 VKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred ccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 654432 24567889999999987 57999999999999999999999999997755443333222111100
Q ss_pred -CCcccccCCCCCCC-----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 656 -GKGLELIDPSLEQP-----CSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 656 -~~~~~~~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
....+.-.|.+... .......+.++++.++++.+|.+|.++.|++.+
T Consensus 254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 01112222222211 222334567889999999999999999999875
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=317.42 Aligned_cols=261 Identities=27% Similarity=0.443 Sum_probs=204.8
Q ss_pred HhcCCCcCCeeecCCcccEEEEEec------CCceeEEEEcccCCc-ccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCe
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGKLA------DEQEVAIKRLSRSSG-QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEE 500 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 500 (752)
..++|++.+.||+|+||.||+|... .+..||+|.+..... .....+.+|+.+++.++|+||+++++++.+.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4578899999999999999999753 245799998865432 233467899999999999999999999999999
Q ss_pred eEEEEeeCCCCCHhHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCcee
Q 043278 501 RLLVYEFMPNKSLDFFLFNSGR-------KNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKI 573 (752)
Q Consensus 501 ~~lv~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl 573 (752)
.++||||+++|+|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999965321 234677888999999999999999988 999999999999999999999
Q ss_pred cccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHH
Q 043278 574 SDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQL 652 (752)
Q Consensus 574 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 652 (752)
+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |+.|+...... .....
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~-------~~~~~ 233 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE-------QVLKF 233 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHH
Confidence 99999986543222222222345678999999999999999999999999999999 67787643321 11122
Q ss_pred hhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCC
Q 043278 653 LSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNET 707 (752)
Q Consensus 653 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~ 707 (752)
...+..... +......+.+++.+|++.+|.+|||+.++++.|++..
T Consensus 234 ~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 234 VMDGGYLDQ---------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HHcCCCCCC---------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 222211111 1112346788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=311.23 Aligned_cols=257 Identities=28% Similarity=0.453 Sum_probs=205.4
Q ss_pred cCCCcCCeeecCCcccEEEEEecC------CceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLAD------EQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERL 502 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 502 (752)
++|.+.+.||+|+||.||+|...+ +..||+|.+.... ......+.+|+.++..++|+||+++++++..+...+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL 85 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence 577888999999999999998643 3679999986543 233457889999999999999999999999999999
Q ss_pred EEEeeCCCCCHhHHHhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecc
Q 043278 503 LVYEFMPNKSLDFFLFNSG-------RKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISD 575 (752)
Q Consensus 503 lv~E~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~D 575 (752)
+||||+++++|..++.... ....+++..++.++.||+.||.|||+.+ ++||||||+|||++.++.+||+|
T Consensus 86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEECC
Confidence 9999999999999986532 1234789999999999999999999988 99999999999999999999999
Q ss_pred cccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhh
Q 043278 576 FGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLS 654 (752)
Q Consensus 576 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~ 654 (752)
||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+....... ......
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~~~~~~ 235 (277)
T cd05032 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE-------VLKFVI 235 (277)
T ss_pred cccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH-------HHHHHh
Confidence 999986543332222233456789999999998899999999999999999998 888886543211 112222
Q ss_pred CCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 043278 655 DGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705 (752)
Q Consensus 655 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~ 705 (752)
.+...... ......+.+++.+|++.+|++|||+.|+++.|+.
T Consensus 236 ~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 236 DGGHLDLP---------ENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred cCCCCCCC---------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 22211111 1123467789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=309.77 Aligned_cols=253 Identities=29% Similarity=0.486 Sum_probs=202.7
Q ss_pred cCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCC
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMP 509 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 509 (752)
++|++.++||+|+||.||++...++..+|+|.+..... ...++.+|+.++++++|+|++++++++. .+..+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 46788899999999999999988888899999875433 4567899999999999999999999875 456789999999
Q ss_pred CCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccccc
Q 043278 510 NKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEA 589 (752)
Q Consensus 510 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 589 (752)
+++|.+++.... ...+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++..+......
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~- 158 (260)
T cd05070 84 KGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT- 158 (260)
T ss_pred CCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc-
Confidence 999999986532 345899999999999999999999988 999999999999999999999999999875432211
Q ss_pred ccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCC
Q 043278 590 NTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQ 668 (752)
Q Consensus 590 ~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 668 (752)
......++..|+|||.+....++.++||||||++++||++ |+.||...... . ....+..+...
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~------~-~~~~~~~~~~~--------- 222 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR------E-VLEQVERGYRM--------- 222 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH------H-HHHHHHcCCCC---------
Confidence 1112334568999999988899999999999999999999 88888654311 1 11112111111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 043278 669 PCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705 (752)
Q Consensus 669 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~ 705 (752)
+.+......+.+++.+|++.+|.+|||+.++.+.|+.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1112223457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=320.53 Aligned_cols=240 Identities=21% Similarity=0.285 Sum_probs=192.0
Q ss_pred eecCCcccEEEEEec-CCceeEEEEcccC---CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCCCCCH
Q 043278 438 LGEGGFGPVYKGKLA-DEQEVAIKRLSRS---SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSL 513 (752)
Q Consensus 438 LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 513 (752)
||+|+||.||+++.. +++.||+|++... .......+.+|+.++.+++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999875 5788999998653 233445678999999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccccccccc
Q 043278 514 DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKR 593 (752)
Q Consensus 514 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~ 593 (752)
..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 152 (312)
T cd05585 81 FHHLQRE---GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNT 152 (312)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccc
Confidence 9988543 35899999999999999999999988 9999999999999999999999999997532221 12234
Q ss_pred ccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCCCCHH
Q 043278 594 IVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSAN 673 (752)
Q Consensus 594 ~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 673 (752)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........ +.. .+ +..
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~------~~~~~~~~-~~~------~~----~~~ 215 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN------EMYRKILQ-EPL------RF----PDG 215 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH------HHHHHHHc-CCC------CC----CCc
Confidence 67899999999999999999999999999999999999999754311 11111111 110 01 111
Q ss_pred HHHHHHHHHHHcccCCCCCCCCH---HHHHHH
Q 043278 674 EVMRCIHVGLLCVQDQAMDRPTM---PEVVCM 702 (752)
Q Consensus 674 ~~~~l~~l~~~Cl~~dp~~RPt~---~ev~~~ 702 (752)
....+.+++.+||+.||.+||++ .|++.+
T Consensus 216 ~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 216 FDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 22356788899999999999864 555443
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=314.46 Aligned_cols=264 Identities=27% Similarity=0.388 Sum_probs=204.9
Q ss_pred cCCCcCCeeecCCcccEEEEEecC-----------------CceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCccee
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLAD-----------------EQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRL 491 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~-----------------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l 491 (752)
++|++.+.||+|+||.||++...+ +..||+|.+.... .....++.+|++++.+++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 578888999999999999987643 2458999987553 2345678899999999999999999
Q ss_pred eeeeeeCCeeEEEEeeCCCCCHhHHHhhcC--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcE
Q 043278 492 LGCSLHGEERLLVYEFMPNKSLDFFLFNSG--------RKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNI 563 (752)
Q Consensus 492 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NI 563 (752)
++++..+...++++||+++++|..++.... ....+++..++.++.|++.||+|||+.+ ++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~Ni 161 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhce
Confidence 999999999999999999999999986543 1235899999999999999999999988 99999999999
Q ss_pred EecCCCCceecccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh--CCCCCCCCCCCC
Q 043278 564 LLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS--GQKNHTRHHPDR 641 (752)
Q Consensus 564 ll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt--G~~p~~~~~~~~ 641 (752)
++++++.++|+|||+++...............++..|+|||.+....++.++||||||+++|||++ +..|+.....
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~-- 239 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD-- 239 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh--
Confidence 999999999999999986543332222334456788999999998899999999999999999998 5566643321
Q ss_pred CcchHHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 043278 642 PLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705 (752)
Q Consensus 642 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~ 705 (752)
..................... .+.....++.+++.+|++.||.+|||+.||++.|+.
T Consensus 240 -~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 240 -QQVIENAGHFFRDDGRQIYLP------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred -HHHHHHHHhccccccccccCC------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 111222222211111111111 111222467889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=309.55 Aligned_cols=246 Identities=29% Similarity=0.394 Sum_probs=195.5
Q ss_pred eeecCCcccEEEEEe---cCCceeEEEEcccCCc--ccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCCCC
Q 043278 437 KLGEGGFGPVYKGKL---ADEQEVAIKRLSRSSG--QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNK 511 (752)
Q Consensus 437 ~LG~G~fg~Vy~~~~---~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 511 (752)
+||+|+||.||+|.+ .+++.+|+|+++.... ...+++.+|+.++..++|+||+++++++. ++..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 699999999999965 3568899999865432 23567899999999999999999999875 45678999999999
Q ss_pred CHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccccc-
Q 043278 512 SLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEAN- 590 (752)
Q Consensus 512 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~- 590 (752)
+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..........
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQKN---KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 999998543 35899999999999999999999988 99999999999999999999999999987643322111
Q ss_pred cccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCC
Q 043278 591 TKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQP 669 (752)
Q Consensus 591 ~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 669 (752)
.....++..|+|||.+....++.++||||||+++|||++ |+.||...... .....+..+.... .
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------~~~~~i~~~~~~~-----~--- 219 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN-------EVTQMIESGERME-----C--- 219 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHCCCCCC-----C---
Confidence 112234578999999988889999999999999999998 99998654321 1122222222111 1
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 043278 670 CSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705 (752)
Q Consensus 670 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~ 705 (752)
+......+.+++.+|++.||++||++.+|+++|++
T Consensus 220 -~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 220 -PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred -CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 11223457789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=330.01 Aligned_cols=260 Identities=22% Similarity=0.367 Sum_probs=204.0
Q ss_pred hcCCCcCCeeecCCcccEEEEEec------CCceeEEEEcccCCcc-cHHHHHHHHHHHHhcC-CCCcceeeeeeeeCCe
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA------DEQEVAIKRLSRSSGQ-GIVEFKNEVRLIAKLQ-HTNLVRLLGCSLHGEE 500 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 500 (752)
.++|.+.++||+|+||.||+|++. .++.||||+++..... ....+.+|++++.++. |+||+++++++...+.
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 346777899999999999999853 2457999999765332 2346889999999997 9999999999999999
Q ss_pred eEEEEeeCCCCCHhHHHhhcCC----------------------------------------------------------
Q 043278 501 RLLVYEFMPNKSLDFFLFNSGR---------------------------------------------------------- 522 (752)
Q Consensus 501 ~~lv~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 522 (752)
.++||||+++|+|.++++....
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 9999999999999999865321
Q ss_pred -------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEe
Q 043278 523 -------------------------------------KNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILL 565 (752)
Q Consensus 523 -------------------------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll 565 (752)
...+++...+.++.||+.||+|||+.+ ++||||||+|||+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEE
Confidence 124778889999999999999999987 9999999999999
Q ss_pred cCCCCceecccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcc
Q 043278 566 DDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLN 644 (752)
Q Consensus 566 ~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~ 644 (752)
++++.+||+|||+++...............++..|+|||.+....++.++||||||++++||++ |+.|+......+
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~--- 349 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE--- 349 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH---
Confidence 9999999999999986533222122223456788999999999899999999999999999998 888876543211
Q ss_pred hHHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 645 LIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 645 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
.....+..+.... . +......+.+++..||+.+|.+||+++||++.|+.+
T Consensus 350 ---~~~~~~~~~~~~~--~-------p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 350 ---QFYNAIKRGYRMA--K-------PAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred ---HHHHHHHcCCCCC--C-------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1112222221111 1 111234577888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=323.16 Aligned_cols=245 Identities=24% Similarity=0.320 Sum_probs=199.5
Q ss_pred cCCCcCCeeecCCcccEEEEEecC--CceeEEEEcccCC---cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLAD--EQEVAIKRLSRSS---GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLV 504 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~--~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 504 (752)
++|.+.+.||+|+||.||+|.... +..||+|++.... ......+.+|+.++..++||||+++++++.+++..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 468888999999999999998643 3689999986432 23345678999999999999999999999999999999
Q ss_pred EeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecc
Q 043278 505 YEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~ 584 (752)
|||+++|+|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 110 ~Ey~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRN---KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 9999999999998543 35889999999999999999999998 99999999999999999999999999986532
Q ss_pred cccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCC
Q 043278 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDP 664 (752)
Q Consensus 585 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 664 (752)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||....+. ...+.+..+.. . +.
T Consensus 184 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-------~~~~~i~~~~~-~-~p- 248 (340)
T PTZ00426 184 R-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL-------LIYQKILEGII-Y-FP- 248 (340)
T ss_pred C-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH-------HHHHHHhcCCC-C-CC-
Confidence 1 22457899999999999989999999999999999999999999765421 11112222211 0 11
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 043278 665 SLEQPCSANEVMRCIHVGLLCVQDQAMDRP-----TMPEVVCM 702 (752)
Q Consensus 665 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~ev~~~ 702 (752)
.. ....+.+++.+|++.||.+|+ +++|++++
T Consensus 249 ---~~----~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 249 ---KF----LDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ---CC----CCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 11 123456788899999999995 89998876
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=326.22 Aligned_cols=247 Identities=25% Similarity=0.345 Sum_probs=191.9
Q ss_pred CCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCc-ccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeC
Q 043278 431 NFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSG-QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFM 508 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 508 (752)
+|+..++||+|+||.||+++.. +++.||||++..... .....+.+|+++++.++|+||+++++++.+++..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 3455689999999999999865 688999999865432 33467899999999999999999999999999999999999
Q ss_pred CCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccc
Q 043278 509 PNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE 588 (752)
Q Consensus 509 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 588 (752)
++++|.... .+.+..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.....
T Consensus 155 ~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~- 223 (353)
T PLN00034 155 DGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD- 223 (353)
T ss_pred CCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc-
Confidence 999985432 3567778899999999999999988 99999999999999999999999999986543221
Q ss_pred cccccccccCCccChhhhcc-----CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccC
Q 043278 589 ANTKRIVGTYGYMSPEYAMS-----GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELID 663 (752)
Q Consensus 589 ~~~~~~~gt~~y~aPE~~~~-----~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 663 (752)
......|+..|+|||++.. ...+.++|||||||++|||++|+.||..........+ ... ......
T Consensus 224 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~---~~~-~~~~~~----- 293 (353)
T PLN00034 224 -PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASL---MCA-ICMSQP----- 293 (353)
T ss_pred -cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHH---HHH-HhccCC-----
Confidence 1223578999999998743 3345699999999999999999999974332211111 111 101100
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 664 PSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 664 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
+. ........+.+++.+||+.||++|||+.|++++
T Consensus 294 ~~----~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 294 PE----APATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CC----CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01 111223457789999999999999999999986
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=312.50 Aligned_cols=258 Identities=26% Similarity=0.438 Sum_probs=204.3
Q ss_pred hcCCCcCCeeecCCcccEEEEEec------CCceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCee
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA------DEQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEER 501 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 501 (752)
.++|+..+.||+|+||.||++... ++..||+|.+.... .....++.+|+.++.+++|+||+++++++.++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 357888899999999999999863 45789999987543 23456789999999999999999999999999999
Q ss_pred EEEEeeCCCCCHhHHHhhcC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCc
Q 043278 502 LLVYEFMPNKSLDFFLFNSG-------------------RKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASN 562 (752)
Q Consensus 502 ~lv~E~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~N 562 (752)
+++|||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999986421 1234788999999999999999999988 9999999999
Q ss_pred EEecCCCCceecccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCC
Q 043278 563 ILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDR 641 (752)
Q Consensus 563 Ill~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~ 641 (752)
||+++++.+||+|||+++................+..|+|||.+.+..++.++||||||+++|||++ |..|+......
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~- 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE- 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence 9999999999999999886543322111222334667999999998999999999999999999998 77777543311
Q ss_pred CcchHHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 043278 642 PLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705 (752)
Q Consensus 642 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~ 705 (752)
........+..... +.....++.+++.+|++.+|.+|||+.|+++.|+.
T Consensus 240 ------~~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 ------EVIYYVRDGNVLSC---------PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ------HHHHHHhcCCCCCC---------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 11122223322111 11223567889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=321.66 Aligned_cols=251 Identities=22% Similarity=0.318 Sum_probs=210.7
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccC--CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCe-eEEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRS--SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEE-RLLVY 505 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv~ 505 (752)
++|...+++|+|+||.++..+.+ +++.+++|.+.-. .........+|+.++++++|||||.+.+.+.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 46778899999999999999864 5678999988644 33344467899999999999999999999999887 99999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccc
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVN 585 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~ 585 (752)
+|+++|+|.+.+.+.+ ...++++.++.++.|++.|+.|||++. |.|||||+.||+++.+..+||.|||+|+.+...
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999997654 467899999999999999999999887 999999999999999999999999999987755
Q ss_pred ccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCC
Q 043278 586 ESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPS 665 (752)
Q Consensus 586 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 665 (752)
.. ......||+.||.||.+.+.+|..|+|||||||++|||++-+++|...+... ...+.... .
T Consensus 160 ~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~------Li~ki~~~-----~---- 222 (426)
T KOG0589|consen 160 DS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE------LILKINRG-----L---- 222 (426)
T ss_pred hh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH------HHHHHhhc-----c----
Confidence 42 3345899999999999999999999999999999999999999997765332 22222111 1
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 666 LEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 666 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
..+.+......+..++..|++.+|..||++.+++.+
T Consensus 223 -~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 223 -YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 123344455667788899999999999999999886
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=323.30 Aligned_cols=242 Identities=21% Similarity=0.278 Sum_probs=195.1
Q ss_pred CeeecCCcccEEEEEec-CCceeEEEEcccCC---cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCCCC
Q 043278 436 NKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNK 511 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 511 (752)
+.||+|+||.||+++.. +++.||+|++.... ......+.+|+.+++.++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999864 58899999997542 234456788999999999999999999999999999999999999
Q ss_pred CHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccccccc
Q 043278 512 SLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANT 591 (752)
Q Consensus 512 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~ 591 (752)
+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~ 152 (328)
T cd05593 81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATM 152 (328)
T ss_pred CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc--cccc
Confidence 99888754 235899999999999999999999988 999999999999999999999999998753221 1122
Q ss_pred ccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCCCC
Q 043278 592 KRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCS 671 (752)
Q Consensus 592 ~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 671 (752)
....||+.|+|||++.+..++.++|||||||++|||++|+.||....... . ......+. ..+ +
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~------~-~~~~~~~~------~~~----p 215 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK------L-FELILMED------IKF----P 215 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH------H-HHHhccCC------ccC----C
Confidence 34578999999999999999999999999999999999999997543211 1 11111111 011 1
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 043278 672 ANEVMRCIHVGLLCVQDQAMDRP-----TMPEVVCM 702 (752)
Q Consensus 672 ~~~~~~l~~l~~~Cl~~dp~~RP-----t~~ev~~~ 702 (752)
......+.+++.+|++.||.+|| ++.|++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 216 RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 11223567888999999999997 89998865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=312.92 Aligned_cols=257 Identities=27% Similarity=0.401 Sum_probs=201.8
Q ss_pred cCCCcCCeeecCCcccEEEEEe-cCCc----eeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKL-ADEQ----EVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLL 503 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 503 (752)
++|...++||+|+||.||+|+. .+++ .||+|.++... .....++.+|+.++..++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 5678889999999999999985 3444 48999987543 3345678899999999999999999999875 45789
Q ss_pred EEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeec
Q 043278 504 VYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFE 583 (752)
Q Consensus 504 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~ 583 (752)
++||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 86 ~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 86 VTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecc
Confidence 99999999999998643 345899999999999999999999988 9999999999999999999999999998765
Q ss_pred ccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCccccc
Q 043278 584 VNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELI 662 (752)
Q Consensus 584 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 662 (752)
............++..|+|||.+.+..++.++||||||+++|||++ |..|+...... .+ ...+..+.....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~----~~~~~~~~~~~~- 232 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR---EI----PDLLEKGERLPQ- 232 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HH----HHHHHCCCcCCC-
Confidence 3322211222334678999999999999999999999999999998 88888654321 11 112222211111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCC
Q 043278 663 DPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETM 708 (752)
Q Consensus 663 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~~ 708 (752)
+......+.+++..|++.||++||++.|+++.|+....
T Consensus 233 --------~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 233 --------PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred --------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 11123356789999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=317.95 Aligned_cols=254 Identities=25% Similarity=0.401 Sum_probs=209.9
Q ss_pred hcCCCcCCeeecCCcccEEEEEec---CCc--eeEEEEcccC-CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeE
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA---DEQ--EVAIKRLSRS-SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERL 502 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~---~~~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 502 (752)
.+.....++||+|.||.||+|... .|+ .||||..+.. .....+.|..|..+|++++||||++++|.|.+ ...+
T Consensus 388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~W 466 (974)
T KOG4257|consen 388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMW 466 (974)
T ss_pred hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-ccee
Confidence 344556689999999999999853 233 4899998874 44556789999999999999999999999976 5789
Q ss_pred EEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceee
Q 043278 503 LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIF 582 (752)
Q Consensus 503 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~ 582 (752)
||||.++.|.|..+|... +..|+......++.||+.+|+|||+.. +|||||..+|||+...-.+||+|||+++.+
T Consensus 467 ivmEL~~~GELr~yLq~n--k~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQN--KDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYL 541 (974)
T ss_pred EEEecccchhHHHHHHhc--cccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhc
Confidence 999999999999999764 345889999999999999999999987 999999999999999999999999999988
Q ss_pred cccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccc
Q 043278 583 EVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLEL 661 (752)
Q Consensus 583 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 661 (752)
........+ ...-+..|||||-+.-..+|.++|||.|||.+|||++ |.+||++....+-. ..
T Consensus 542 ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI----------------~~ 604 (974)
T KOG4257|consen 542 EDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI----------------GH 604 (974)
T ss_pred cccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE----------------EE
Confidence 765544333 3445778999999999999999999999999999988 99999876643322 11
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 043278 662 IDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705 (752)
Q Consensus 662 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~ 705 (752)
++..-+-+.+...+..+..|+.+||+.+|.+||++.|+...|+.
T Consensus 605 iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsd 648 (974)
T KOG4257|consen 605 IENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSD 648 (974)
T ss_pred ecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHH
Confidence 22222234455566678899999999999999999999887754
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=310.70 Aligned_cols=256 Identities=26% Similarity=0.439 Sum_probs=203.3
Q ss_pred cCCCcCCeeecCCcccEEEEEecC-C---ceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLAD-E---QEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLV 504 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~-~---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 504 (752)
++|+..+.||+|+||.||+|+... + ..+|+|.+.... .....++.+|++++.+++|+|++++.+++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 467788999999999999998753 3 369999987553 33456789999999999999999999999999999999
Q ss_pred EeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecc
Q 043278 505 YEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~ 584 (752)
|||+++++|..++... ...+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++.....
T Consensus 85 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 85 TEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 9999999999998543 245899999999999999999999988 99999999999999999999999999986543
Q ss_pred ccccccc-ccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCccccc
Q 043278 585 NESEANT-KRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELI 662 (752)
Q Consensus 585 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 662 (752)
....... .....+..|+|||++....++.++||||||+++|||++ |+.|+...... .....+..+..
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~-------~~~~~i~~~~~---- 228 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH-------EVMKAINDGFR---- 228 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH-------HHHHHHhcCCC----
Confidence 2211111 11223457999999998899999999999999999998 99998654321 11122222111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 663 DPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 663 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
.+...+....+.+++.+|++.+|++||+|.+|++.|+++
T Consensus 229 -----~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 229 -----LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 011112234678999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=319.97 Aligned_cols=242 Identities=23% Similarity=0.280 Sum_probs=194.0
Q ss_pred CeeecCCcccEEEEEec-CCceeEEEEcccCC---cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCCCC
Q 043278 436 NKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNK 511 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 511 (752)
+.||+|+||.||+++.. +|+.||+|.+.... ......+.+|+.++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 47999999999999864 68899999987542 223456778999999999999999999999999999999999999
Q ss_pred CHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccccccc
Q 043278 512 SLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANT 591 (752)
Q Consensus 512 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~ 591 (752)
+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~ 152 (323)
T cd05595 81 ELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATM 152 (323)
T ss_pred cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccc
Confidence 998887543 35899999999999999999999988 9999999999999999999999999987532211 112
Q ss_pred ccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCCCC
Q 043278 592 KRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCS 671 (752)
Q Consensus 592 ~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 671 (752)
....|++.|+|||++.+..++.++|||||||++|||++|+.||....... . ......+.. .+ +
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~------~-~~~~~~~~~------~~----p 215 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER------L-FELILMEEI------RF----P 215 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH------H-HHHHhcCCC------CC----C
Confidence 23568999999999999999999999999999999999999997544221 1 111111110 11 1
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 043278 672 ANEVMRCIHVGLLCVQDQAMDRP-----TMPEVVCM 702 (752)
Q Consensus 672 ~~~~~~l~~l~~~Cl~~dp~~RP-----t~~ev~~~ 702 (752)
......+.+++.+|++.||.+|| ++.+++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 11223566888899999999998 88888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=308.20 Aligned_cols=259 Identities=22% Similarity=0.356 Sum_probs=207.0
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC---cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 505 (752)
++|++.+.||+|+||.||+|+.. +++.||||.+.... ......+.+|+++++.++||||+++++++.+.+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 47888899999999999999864 68899999876432 233456889999999999999999999999999999999
Q ss_pred eeCCCCCHhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecc
Q 043278 506 EFMPNKSLDFFLFNSG-RKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~ 584 (752)
||+++++|..++.... ....++...+..++.||++||+|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999998875432 3455889999999999999999999988 99999999999999999999999999987543
Q ss_pred cccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCC
Q 043278 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDP 664 (752)
Q Consensus 585 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 664 (752)
... ......++..|+|||.+.+..++.++|+||||+++|||++|+.|+...... ..... ..+.......
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~----~~~~~-~~~~~~~~~~---- 227 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LFSLC-QKIEQCDYPP---- 227 (267)
T ss_pred hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc----HHHHH-HHHhcCCCCC----
Confidence 221 112346788999999999888999999999999999999999998654321 11111 1222111111
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 665 SLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 665 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
. ........+.+++.+||+.+|.+||++.||++.|+.+
T Consensus 228 -~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 228 -L---PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred -C---ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 1 1112335678899999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=318.10 Aligned_cols=259 Identities=24% Similarity=0.376 Sum_probs=205.3
Q ss_pred hcCCCcCCeeecCCcccEEEEEec--------CCceeEEEEcccCC-cccHHHHHHHHHHHHhc-CCCCcceeeeeeeeC
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA--------DEQEVAIKRLSRSS-GQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHG 498 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 498 (752)
..+|.+.+.||+|+||.||+++.. ++..||+|.+.... .....++.+|+.++..+ +|+||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 467788899999999999999741 23479999887542 33456789999999999 899999999999999
Q ss_pred CeeEEEEeeCCCCCHhHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEe
Q 043278 499 EERLLVYEFMPNKSLDFFLFNSGR-------------KNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILL 565 (752)
Q Consensus 499 ~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll 565 (752)
...++||||+++++|.+++..... ...+++.+++.++.||+.||.|||+.+ ++||||||+|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 999999999999999999875321 235889999999999999999999988 9999999999999
Q ss_pred cCCCCceecccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcc
Q 043278 566 DDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLN 644 (752)
Q Consensus 566 ~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~ 644 (752)
++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+.....
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----- 245 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV----- 245 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH-----
Confidence 9999999999999987654332222333445678999999999899999999999999999998 7777754331
Q ss_pred hHHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 645 LIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 645 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
......+..+..... +......+.+++.+|++.+|.+||||.||++.|+.+
T Consensus 246 --~~~~~~~~~~~~~~~---------~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~ 296 (304)
T cd05101 246 --EELFKLLKEGHRMDK---------PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI 296 (304)
T ss_pred --HHHHHHHHcCCcCCC---------CCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHH
Confidence 111222222221111 112234577889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=319.29 Aligned_cols=259 Identities=25% Similarity=0.372 Sum_probs=203.7
Q ss_pred hcCCCcCCeeecCCcccEEEEEec--------CCceeEEEEcccCC-cccHHHHHHHHHHHHhc-CCCCcceeeeeeeeC
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA--------DEQEVAIKRLSRSS-GQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHG 498 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 498 (752)
.++|.+.+.||+|+||.||+++.. ....+|+|.+.... .....++.+|+.++.++ +|+||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 357888999999999999999752 23469999997542 23445688899999999 799999999999999
Q ss_pred CeeEEEEeeCCCCCHhHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEe
Q 043278 499 EERLLVYEFMPNKSLDFFLFNSGR-------------KNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILL 565 (752)
Q Consensus 499 ~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll 565 (752)
+..++||||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++||||||+|||+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 999999999999999999965321 235899999999999999999999987 9999999999999
Q ss_pred cCCCCceecccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcc
Q 043278 566 DDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLN 644 (752)
Q Consensus 566 ~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~ 644 (752)
+.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |+.|+.....
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~----- 248 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV----- 248 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH-----
Confidence 9999999999999876543221111222234568999999999999999999999999999998 8888754331
Q ss_pred hHHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 645 LIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 645 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
......+..+...+ .+......+.+++.+|++.+|.+||||.||++.|+.+
T Consensus 249 --~~~~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~ 299 (307)
T cd05098 249 --EELFKLLKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299 (307)
T ss_pred --HHHHHHHHcCCCCC---------CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 11112222222111 1112234677889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=311.72 Aligned_cols=252 Identities=25% Similarity=0.337 Sum_probs=200.8
Q ss_pred CCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC---cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEe
Q 043278 431 NFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYE 506 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 506 (752)
+|+..++||+|+||+||++... +++.||+|++.... ......+.+|+.++.+++|+||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 3677899999999999999864 58899999986542 2223457789999999999999999999999999999999
Q ss_pred eCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccc
Q 043278 507 FMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586 (752)
Q Consensus 507 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~ 586 (752)
|+++|+|..++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||+++......
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 999999998886432 345899999999999999999999988 9999999999999999999999999998653222
Q ss_pred cccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCC
Q 043278 587 SEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666 (752)
Q Consensus 587 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 666 (752)
......|+..|+|||++.+..++.++||||+|+++|||++|+.||......... ......+....
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~--------- 221 (285)
T cd05605 157 ---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR---EEVERRVKEDQ--------- 221 (285)
T ss_pred ---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH---HHHHHHhhhcc---------
Confidence 112346889999999999999999999999999999999999999765422111 11111111110
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 043278 667 EQPCSANEVMRCIHVGLLCVQDQAMDRP-----TMPEVVCM 702 (752)
Q Consensus 667 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~ev~~~ 702 (752)
...+......+.+++..|++.||.+|| ++.+++++
T Consensus 222 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 222 -EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred -cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 011122334567899999999999999 88888665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=314.10 Aligned_cols=241 Identities=26% Similarity=0.354 Sum_probs=189.1
Q ss_pred CeeecCCcccEEEEEec-CCceeEEEEcccCC---cccHHHHHHHHHHHHh-cCCCCcceeeeeeeeCCeeEEEEeeCCC
Q 043278 436 NKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS---GQGIVEFKNEVRLIAK-LQHTNLVRLLGCSLHGEERLLVYEFMPN 510 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~E~~~~ 510 (752)
+.||+|+||.||+|+.. +++.||+|.++... ......+..|..++.. .+||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999875 47789999987532 2233445666666665 4899999999999999999999999999
Q ss_pred CCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccccc
Q 043278 511 KSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEAN 590 (752)
Q Consensus 511 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~ 590 (752)
|+|..++... ..++...+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~ 152 (316)
T cd05592 81 GDLMFHIQSS---GRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK 152 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence 9999888543 35899999999999999999999988 9999999999999999999999999998543222 22
Q ss_pred cccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCCC
Q 043278 591 TKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPC 670 (752)
Q Consensus 591 ~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 670 (752)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... . ...+.... +.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~------~-~~~i~~~~------~~~---- 215 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE------L-FDSILNDR------PHF---- 215 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH------H-HHHHHcCC------CCC----
Confidence 234678999999999999999999999999999999999999997654211 1 11111110 111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 043278 671 SANEVMRCIHVGLLCVQDQAMDRPTMP-EVVC 701 (752)
Q Consensus 671 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~-ev~~ 701 (752)
+......+.+++.+|++.+|.+||++. ++++
T Consensus 216 ~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 216 PRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 111223456788899999999999875 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=316.02 Aligned_cols=256 Identities=27% Similarity=0.396 Sum_probs=200.2
Q ss_pred cCCCcCCeeecCCcccEEEEEecC-Cc--eeEEEEcccC-CcccHHHHHHHHHHHHhc-CCCCcceeeeeeeeCCeeEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLAD-EQ--EVAIKRLSRS-SGQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGEERLLV 504 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 504 (752)
++|++.+.||+|+||.||+|...+ +. .+++|.++.. .......+.+|+.++.++ +||||+++++++......+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 467888999999999999998754 32 4788888743 233456789999999999 799999999999998999999
Q ss_pred EeeCCCCCHhHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCc
Q 043278 505 YEFMPNKSLDFFLFNSG-------------RKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNP 571 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~ 571 (752)
+||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999986532 1235889999999999999999999987 9999999999999999999
Q ss_pred eecccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHH
Q 043278 572 KISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAW 650 (752)
Q Consensus 572 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~ 650 (752)
||+|||++...... ........+..|+|||++....++.++||||||+++|||++ |+.||....... ..
T Consensus 159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~-------~~ 228 (297)
T cd05089 159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE-------LY 228 (297)
T ss_pred EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HH
Confidence 99999998642211 11111223557999999999899999999999999999998 999986554211 11
Q ss_pred HHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCC
Q 043278 651 QLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNET 707 (752)
Q Consensus 651 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~ 707 (752)
.....+.. +.. +......+.+++.+|++.+|.+|||+.++++.|+...
T Consensus 229 ~~~~~~~~-----~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 276 (297)
T cd05089 229 EKLPQGYR-----MEK----PRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML 276 (297)
T ss_pred HHHhcCCC-----CCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11211111 111 1112245678999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=325.46 Aligned_cols=265 Identities=23% Similarity=0.330 Sum_probs=195.0
Q ss_pred CCCcCCeeecCCcccEEEEEec-CCceeEEEEcccC--CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeC-----CeeE
Q 043278 431 NFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRS--SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHG-----EERL 502 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~ 502 (752)
+|++.++||+|+||.||+|+.. +++.||||++... ......++.+|+.++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4778899999999999999864 6889999998743 223345688999999999999999999987543 2479
Q ss_pred EEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceee
Q 043278 503 LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIF 582 (752)
Q Consensus 503 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~ 582 (752)
+||||++ ++|..++.. ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999996 688887743 235899999999999999999999998 999999999999999999999999999864
Q ss_pred ccccc-ccccccccccCCccChhhhcc--CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHH--------HHH
Q 043278 583 EVNES-EANTKRIVGTYGYMSPEYAMS--GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGY--------AWQ 651 (752)
Q Consensus 583 ~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~--------~~~ 651 (752)
..... ........|++.|+|||++.+ ..++.++|||||||++|||++|+.||...........+.. ...
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 32221 112234578999999999876 6789999999999999999999999976542111100000 000
Q ss_pred HhhCCCcccc---cCCCCCCCCC---HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 652 LLSDGKGLEL---IDPSLEQPCS---ANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 652 ~~~~~~~~~~---~d~~l~~~~~---~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.+........ +.+....... ......+.+++.+|++.||++|||++|++++
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000000000 0000000000 0112346789999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=310.95 Aligned_cols=264 Identities=25% Similarity=0.392 Sum_probs=202.1
Q ss_pred cCCCcCCeeecCCcccEEEEEec-----------------CCceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCccee
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-----------------DEQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRL 491 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-----------------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l 491 (752)
++|++.++||+|+||.||++... +...+|+|++.... .....++.+|+.++.+++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 56888999999999999998532 23468999987543 3345678999999999999999999
Q ss_pred eeeeeeCCeeEEEEeeCCCCCHhHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcE
Q 043278 492 LGCSLHGEERLLVYEFMPNKSLDFFLFNSGR--------KNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNI 563 (752)
Q Consensus 492 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NI 563 (752)
++++..++..+++|||+++++|..++..... ...+++..+..++.|++.||+|||+.+ ++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 9999999999999999999999999865321 234788899999999999999999988 99999999999
Q ss_pred EecCCCCceecccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh--CCCCCCCCCCCC
Q 043278 564 LLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS--GQKNHTRHHPDR 641 (752)
Q Consensus 564 ll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt--G~~p~~~~~~~~ 641 (752)
|++.++.++|+|||+++.+.............++..|+|||....+.++.++||||||+++|||++ |..|+......+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999986543322222222344678999999988899999999999999999998 666775433221
Q ss_pred CcchHHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 043278 642 PLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705 (752)
Q Consensus 642 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~ 705 (752)
.+............... .+ .+......+.+++.+|++.||++||+|.||++.|+.
T Consensus 242 ---~~~~~~~~~~~~~~~~~-~~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 242 ---VIENTGEFFRDQGRQVY-LP-----KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred ---HHHHHHHHHhhcccccc-CC-----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11111111111111111 11 011122567789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=324.88 Aligned_cols=253 Identities=24% Similarity=0.340 Sum_probs=202.7
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC---cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 505 (752)
++|.+.+.||+|+||.||+++.. +++.||||++.... ......+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46888899999999999999875 68899999987542 234556889999999999999999999999999999999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccc
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVN 585 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~ 585 (752)
||+++++|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999998653 45899999999999999999999988 999999999999999999999999999865432
Q ss_pred c---------------------------cccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 043278 586 E---------------------------SEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHH 638 (752)
Q Consensus 586 ~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~ 638 (752)
. .........||+.|+|||++.+..++.++|||||||+||||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 0011223568999999999999999999999999999999999999997654
Q ss_pred CCCCcchHHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCC-HHHHHHH
Q 043278 639 PDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPT-MPEVVCM 702 (752)
Q Consensus 639 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-~~ev~~~ 702 (752)
... ............. -+. .......+.+++..|++ +|.+||+ +.|++++
T Consensus 235 ~~~------~~~~i~~~~~~~~--~p~-----~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 LQE------TYNKIINWKESLR--FPP-----DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHH------HHHHHhccCCccc--CCC-----CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 211 1111111000000 010 11123456678889997 9999999 9999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=305.12 Aligned_cols=254 Identities=27% Similarity=0.366 Sum_probs=193.1
Q ss_pred CeeecCCcccEEEEEecC---CceeEEEEcccCCc-ccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCCCC
Q 043278 436 NKLGEGGFGPVYKGKLAD---EQEVAIKRLSRSSG-QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNK 511 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~~---~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 511 (752)
+.||+|+||.||+|...+ +..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 369999999999998643 35799998875532 33457889999999999999999999999988999999999999
Q ss_pred CHhHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccccc
Q 043278 512 SLDFFLFNSGR--KNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEA 589 (752)
Q Consensus 512 sL~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 589 (752)
+|.+++..... ....++..+..++.|++.||+|||+.+ ++|+||||+||+++.++++||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999865322 234677888899999999999999988 9999999999999999999999999997543322222
Q ss_pred ccccccccCCccChhhhccC-------CCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccc
Q 043278 590 NTKRIVGTYGYMSPEYAMSG-------IVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLEL 661 (752)
Q Consensus 590 ~~~~~~gt~~y~aPE~~~~~-------~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 661 (752)
......++..|+|||++... .++.++||||||+++|||++ |+.||......+. . .....+.....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~---~----~~~~~~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV---L----TYTVREQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH---H----HHHhhcccCCC
Confidence 22234567889999988642 35889999999999999996 9999865432211 1 11111122222
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 043278 662 IDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ 704 (752)
Q Consensus 662 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~ 704 (752)
.++.+.... ...+.+++..|+ .+|++|||++||+..|+
T Consensus 231 ~~~~~~~~~----~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLKLPL----SDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccCCCC----ChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 333322221 223566778898 58999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=307.94 Aligned_cols=254 Identities=31% Similarity=0.454 Sum_probs=204.1
Q ss_pred hcCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeC
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFM 508 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 508 (752)
.+.|.+.++||+|+||.||+|..++++.||+|.+.... ....++.+|+.++++++|+|++++++++. .+..+++|||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 35788889999999999999998889999999987543 34567899999999999999999999874 45789999999
Q ss_pred CCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccc
Q 043278 509 PNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE 588 (752)
Q Consensus 509 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 588 (752)
++++|.+++.... ...+++.++..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++.........
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 83 ENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 9999999886533 346899999999999999999999988 999999999999999999999999999865422211
Q ss_pred cccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCC
Q 043278 589 ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLE 667 (752)
Q Consensus 589 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 667 (752)
......++..|+|||++....++.++||||||++++||++ |+.||...... . ....+..+....
T Consensus 159 -~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~----~~~~~~~~~~~~------- 223 (260)
T cd05067 159 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP---E----VIQNLERGYRMP------- 223 (260)
T ss_pred -cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH---H----HHHHHHcCCCCC-------
Confidence 1122345678999999999999999999999999999999 99998654311 1 111122211111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 043278 668 QPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705 (752)
Q Consensus 668 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~ 705 (752)
.+......+.+++.+|++.+|++|||++++++.|+.
T Consensus 224 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 224 --RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred --CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 111123457889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=322.17 Aligned_cols=254 Identities=28% Similarity=0.417 Sum_probs=211.3
Q ss_pred CCCcCCeeecCCcccEEEEEecC-CceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCC
Q 043278 431 NFSTTNKLGEGGFGPVYKGKLAD-EQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMP 509 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 509 (752)
+.....+||.|.||.||.|.++. .-.||||.++... -..++|.+|..+|+.++|||+|+|+|+|..+..++||+|||.
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~ 346 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMC 346 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEeccc
Confidence 44566899999999999999865 5679999997654 457899999999999999999999999999999999999999
Q ss_pred CCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccccc
Q 043278 510 NKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEA 589 (752)
Q Consensus 510 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 589 (752)
+|+|-++|.+..+ ..++-...+.++.||+.||+||...+ +|||||..+|+|+.++..+||+||||++++..+....
T Consensus 347 yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTA 422 (1157)
T KOG4278|consen 347 YGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTA 422 (1157)
T ss_pred CccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCceec
Confidence 9999999987644 45777888999999999999999988 9999999999999999999999999999986543222
Q ss_pred ccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCC
Q 043278 590 NTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQ 668 (752)
Q Consensus 590 ~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 668 (752)
.....-+..|.|||-+....++.|+|||+|||+||||.| |-.|+.+.+ .......+..+ .+.
T Consensus 423 -HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid-------lSqVY~LLEkg---------yRM 485 (1157)
T KOG4278|consen 423 -HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID-------LSQVYGLLEKG---------YRM 485 (1157)
T ss_pred -ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc-------HHHHHHHHhcc---------ccc
Confidence 112234678999999999999999999999999999999 666765544 22233344333 333
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 669 PCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 669 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
..+.....++.+|++.||+-.|.+||++.|+-+.+|.+
T Consensus 486 ~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm 523 (1157)
T KOG4278|consen 486 DGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM 523 (1157)
T ss_pred cCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence 34445566788999999999999999999999888764
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=316.41 Aligned_cols=259 Identities=26% Similarity=0.405 Sum_probs=204.8
Q ss_pred hcCCCcCCeeecCCcccEEEEEec------CCceeEEEEcccCCc-ccHHHHHHHHHHHHhc-CCCCcceeeeeeeeCCe
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA------DEQEVAIKRLSRSSG-QGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGEE 500 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 500 (752)
.++|...+.||+|+||.||++... .+..||||.++.... .....+.+|+.+++++ +|+||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 357888999999999999999742 345799999876532 3345688999999999 89999999999999999
Q ss_pred eEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccce
Q 043278 501 RLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR 580 (752)
Q Consensus 501 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~ 580 (752)
.+++|||+++++|.+++.... ...+++.++..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||+++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence 999999999999999986432 234899999999999999999999988 9999999999999999999999999998
Q ss_pred eecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcc
Q 043278 581 IFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGL 659 (752)
Q Consensus 581 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 659 (752)
...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+....... ........+...
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~------~~~~~~~~~~~~ 263 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS------KFYKLIKEGYRM 263 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH------HHHHHHHcCCcC
Confidence 6543322112223345778999999999999999999999999999998 998886543211 111122222111
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 660 ELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 660 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
. .+......+.+++.+|++.+|++|||+.|+++.|+..
T Consensus 264 ~---------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 264 A---------QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred C---------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 0 0111224577899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=325.73 Aligned_cols=203 Identities=24% Similarity=0.362 Sum_probs=174.5
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC---cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 505 (752)
++|+..+.||+|+||+||++... .++.||+|++.... ......+.+|+.++.+++|+||+++++.+.++...++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46888899999999999999864 57899999986532 223456788999999999999999999999999999999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccc
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVN 585 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~ 585 (752)
||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMKK---DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 999999999998643 45899999999999999999999988 999999999999999999999999998754321
Q ss_pred cc---------------------------------ccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCC
Q 043278 586 ES---------------------------------EANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQK 632 (752)
Q Consensus 586 ~~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~ 632 (752)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 10 000123579999999999999999999999999999999999999
Q ss_pred CCCCCC
Q 043278 633 NHTRHH 638 (752)
Q Consensus 633 p~~~~~ 638 (752)
||....
T Consensus 235 Pf~~~~ 240 (363)
T cd05628 235 PFCSET 240 (363)
T ss_pred CCCCCC
Confidence 997654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=328.50 Aligned_cols=253 Identities=22% Similarity=0.341 Sum_probs=195.1
Q ss_pred CCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC---cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEe
Q 043278 431 NFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYE 506 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 506 (752)
.|+..+.||+|+||+||+|+.. +++.||||++.... ......+.+|+.++.+++|+||+++++++.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5778899999999999999864 57899999996542 2334568899999999999999999999999999999999
Q ss_pred eCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccc
Q 043278 507 FMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586 (752)
Q Consensus 507 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~ 586 (752)
|+++|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++++||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIRM---EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 99999999988543 35888999999999999999999988 9999999999999999999999999986432110
Q ss_pred c---------------------------------------------ccccccccccCCccChhhhccCCCCccchhHHHH
Q 043278 587 S---------------------------------------------EANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFG 621 (752)
Q Consensus 587 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G 621 (752)
. ........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0 0001235789999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHH--cccCCCCCCCCHHHH
Q 043278 622 VLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLL--CVQDQAMDRPTMPEV 699 (752)
Q Consensus 622 ~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~--Cl~~dp~~RPt~~ev 699 (752)
|++|||++|+.||....... .............+ .+. ...+ ..+.+++.+ |+..++..||++.|+
T Consensus 236 ~il~elltG~~Pf~~~~~~~------~~~~i~~~~~~~~~-~~~--~~~s----~~~~dli~~ll~~~~~~~~R~~~~~~ 302 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTE------TQLKVINWENTLHI-PPQ--VKLS----PEAVDLITKLCCSAEERLGRNGADDI 302 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHH------HHHHHHccccccCC-CCC--CCCC----HHHHHHHHHHccCcccccCCCCHHHH
Confidence 99999999999997654221 11111111111111 000 0112 234455544 667777789999999
Q ss_pred HHH
Q 043278 700 VCM 702 (752)
Q Consensus 700 ~~~ 702 (752)
+++
T Consensus 303 l~h 305 (381)
T cd05626 303 KAH 305 (381)
T ss_pred hcC
Confidence 886
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=320.90 Aligned_cols=252 Identities=21% Similarity=0.292 Sum_probs=197.4
Q ss_pred CCCcCCeeecCCcccEEEEEe----cCCceeEEEEcccCC----cccHHHHHHHHHHHHhc-CCCCcceeeeeeeeCCee
Q 043278 431 NFSTTNKLGEGGFGPVYKGKL----ADEQEVAIKRLSRSS----GQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGEER 501 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 501 (752)
+|++.++||+|+||.||+++. ..++.||+|++.+.. ......+.+|+.++.++ +|+||+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 477889999999999999875 357889999986532 22345678899999999 589999999999999999
Q ss_pred EEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceeccccccee
Q 043278 502 LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARI 581 (752)
Q Consensus 502 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~ 581 (752)
++||||+++|+|..++.. +..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 999999999999998854 345899999999999999999999988 99999999999999999999999999986
Q ss_pred ecccccccccccccccCCccChhhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCccc
Q 043278 582 FEVNESEANTKRIVGTYGYMSPEYAMSG-IVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLE 660 (752)
Q Consensus 582 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 660 (752)
...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.......... ........
T Consensus 155 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~---~~~~~~~~----- 225 (332)
T cd05614 155 FLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS---EVSRRILK----- 225 (332)
T ss_pred ccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH---HHHHHHhc-----
Confidence 433222 122345789999999999865 48899999999999999999999997554322211 11111111
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 043278 661 LIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRP-----TMPEVVCM 702 (752)
Q Consensus 661 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~ev~~~ 702 (752)
.++.+.. .....+.+++.+|++.||++|| ++++++++
T Consensus 226 -~~~~~~~----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 226 -CDPPFPS----FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred -CCCCCCC----CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 1111111 1223466788999999999999 67788765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=304.81 Aligned_cols=247 Identities=28% Similarity=0.399 Sum_probs=198.2
Q ss_pred CeeecCCcccEEEEEecCCceeEEEEcccCCc-ccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCCCCCHh
Q 043278 436 NKLGEGGFGPVYKGKLADEQEVAIKRLSRSSG-QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLD 514 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~ 514 (752)
+.||+|+||.||+|...+++.+|+|.+..... .....+.+|+.++.+++|+||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 47999999999999988889999999876543 23346889999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccccccccc
Q 043278 515 FFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594 (752)
Q Consensus 515 ~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~ 594 (752)
.++... ...+++..+..++.|++.+|.|||+.+ ++|+||||+||+++.++.+||+|||++......... .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~ 154 (250)
T cd05085 81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLK 154 (250)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCC
Confidence 988543 235889999999999999999999988 999999999999999999999999999754322211 11122
Q ss_pred cccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCCCCHH
Q 043278 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSAN 673 (752)
Q Consensus 595 ~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 673 (752)
.++..|+|||++....++.++||||||+++||+++ |..||...... ........+.... .+..
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~-------~~~~~~~~~~~~~---------~~~~ 218 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ-------QAREQVEKGYRMS---------CPQK 218 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH-------HHHHHHHcCCCCC---------CCCC
Confidence 34567999999999999999999999999999998 88888654321 1111222221111 1112
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 043278 674 EVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ 704 (752)
Q Consensus 674 ~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~ 704 (752)
....+.+++.+|++.+|++||++.|+++.|.
T Consensus 219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 2356788999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=315.54 Aligned_cols=245 Identities=22% Similarity=0.321 Sum_probs=192.3
Q ss_pred CCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC---cccHHHHHHHHHHH---HhcCCCCcceeeeeeeeCCeeEEE
Q 043278 432 FSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS---GQGIVEFKNEVRLI---AKLQHTNLVRLLGCSLHGEERLLV 504 (752)
Q Consensus 432 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv 504 (752)
|.+.+.||+|+||.||++... +++.||||+++... ......+.+|++++ ..++||||+++++++..++..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 556789999999999999865 58899999997542 22334566666655 466899999999999999999999
Q ss_pred EeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecc
Q 043278 505 YEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~ 584 (752)
|||+++++|..++. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 99999999988773 245899999999999999999999988 99999999999999999999999999874321
Q ss_pred cccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCC
Q 043278 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDP 664 (752)
Q Consensus 585 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 664 (752)
. ........|++.|+|||.+.+..++.++|||||||++|||++|+.||....... . ...+..+..
T Consensus 154 ~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~------~-~~~i~~~~~------ 218 (324)
T cd05589 154 F--GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE------V-FDSIVNDEV------ 218 (324)
T ss_pred C--CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH------H-HHHHHhCCC------
Confidence 1 112234678999999999999999999999999999999999999997654211 1 111111111
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 043278 665 SLEQPCSANEVMRCIHVGLLCVQDQAMDRP-----TMPEVVCM 702 (752)
Q Consensus 665 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~ev~~~ 702 (752)
.. +......+.+++.+|++.||.+|| ++.++++.
T Consensus 219 ~~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 219 RY----PRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred CC----CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 01 111224467889999999999999 56666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=317.65 Aligned_cols=242 Identities=24% Similarity=0.339 Sum_probs=193.9
Q ss_pred CeeecCCcccEEEEEe----cCCceeEEEEcccCC----cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEee
Q 043278 436 NKLGEGGFGPVYKGKL----ADEQEVAIKRLSRSS----GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
+.||+|+||.||+++. ..++.||+|.++... ......+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6899999999999975 357889999987532 22344578899999999999999999999999999999999
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccc
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES 587 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~ 587 (752)
+++++|..++... ..+.+..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (323)
T cd05584 82 LSGGELFMHLERE---GIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG- 154 (323)
T ss_pred CCCchHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-
Confidence 9999999888543 35788889999999999999999988 9999999999999999999999999987533221
Q ss_pred ccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCC
Q 043278 588 EANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLE 667 (752)
Q Consensus 588 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 667 (752)
.......|++.|+|||++.+..++.++||||||+++|||++|+.||...... .. ...+..+.. . +
T Consensus 155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~------~~-~~~~~~~~~-~-----~- 219 (323)
T cd05584 155 -TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK------KT-IDKILKGKL-N-----L- 219 (323)
T ss_pred -CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH------HH-HHHHHcCCC-C-----C-
Confidence 1223357899999999999989999999999999999999999999765421 11 111111111 0 1
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 043278 668 QPCSANEVMRCIHVGLLCVQDQAMDRP-----TMPEVVCM 702 (752)
Q Consensus 668 ~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~ev~~~ 702 (752)
+......+.+++.+|++.+|++|| ++.++++.
T Consensus 220 ---~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 220 ---PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred ---CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 111123567889999999999999 78888764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=323.16 Aligned_cols=261 Identities=28% Similarity=0.411 Sum_probs=202.1
Q ss_pred hcCCCcCCeeecCCcccEEEEEe------cCCceeEEEEcccCCc-ccHHHHHHHHHHHHhc-CCCCcceeeeeeee-CC
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKL------ADEQEVAIKRLSRSSG-QGIVEFKNEVRLIAKL-QHTNLVRLLGCSLH-GE 499 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~ 499 (752)
.++|.+.+.||+|+||.||+|.. ..++.||||+++.... .....+.+|+.++.++ +|+||+++++++.. +.
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 35788899999999999999973 3467899999976432 2345688999999999 78999999998765 44
Q ss_pred eeEEEEeeCCCCCHhHHHhhcCC---------------------------------------------------------
Q 043278 500 ERLLVYEFMPNKSLDFFLFNSGR--------------------------------------------------------- 522 (752)
Q Consensus 500 ~~~lv~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 522 (752)
..+++|||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 67899999999999998864211
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccccccccccc
Q 043278 523 -------KNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIV 595 (752)
Q Consensus 523 -------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~ 595 (752)
...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...............
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 124788899999999999999999988 9999999999999999999999999998654332222222334
Q ss_pred ccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCCCCHHH
Q 043278 596 GTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSANE 674 (752)
Q Consensus 596 gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 674 (752)
++..|+|||.+.+..++.++||||||+++|||++ |..|+....... .....+..+..... +. . .
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~~~~~~~~~--~~---~----~ 307 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEGTRMRA--PD---Y----T 307 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH------HHHHHHhccCCCCC--CC---C----C
Confidence 5678999999999999999999999999999997 888886543211 11122222221111 11 1 1
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCC
Q 043278 675 VMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNET 707 (752)
Q Consensus 675 ~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~ 707 (752)
...+.+++.+|++.+|.+|||+.||+++|+.+.
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 235778999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=318.15 Aligned_cols=259 Identities=25% Similarity=0.381 Sum_probs=204.1
Q ss_pred cCCCcCCeeecCCcccEEEEEecC--------CceeEEEEcccCC-cccHHHHHHHHHHHHhc-CCCCcceeeeeeeeCC
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLAD--------EQEVAIKRLSRSS-GQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGE 499 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 499 (752)
.+|.+.+.||+|+||.||+++... ...||+|.+.... .....++.+|+.++.++ +|+||+++++++.+++
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 468888999999999999997421 2368999887542 33456789999999999 8999999999999999
Q ss_pred eeEEEEeeCCCCCHhHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEec
Q 043278 500 ERLLVYEFMPNKSLDFFLFNSG-------------RKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLD 566 (752)
Q Consensus 500 ~~~lv~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~ 566 (752)
..++++||+++|+|.+++.... ....+++..++.++.||+.||+|||+.+ ++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 9999999999999999986532 1235889999999999999999999988 99999999999999
Q ss_pred CCCCceecccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcch
Q 043278 567 DKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNL 645 (752)
Q Consensus 567 ~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l 645 (752)
+++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+......
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----- 243 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE----- 243 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH-----
Confidence 999999999999986543322222222334567999999999999999999999999999998 78887654311
Q ss_pred HHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCC
Q 043278 646 IGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNET 707 (752)
Q Consensus 646 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~ 707 (752)
.....+..+..... +......+.+++.+|++.+|++||||.|+++.|+...
T Consensus 244 --~~~~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 244 --ELFKLLKEGHRMDK---------PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred --HHHHHHHcCCCCCC---------CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 11222222211111 1122345778999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=305.69 Aligned_cols=253 Identities=31% Similarity=0.471 Sum_probs=202.1
Q ss_pred cCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCC
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMP 509 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 509 (752)
++|.+.+.||+|++|.||++...++..+|+|.+.... .....+.+|+.++++++|+|++++++++. .+..+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 4678889999999999999998777789999886543 34567899999999999999999999875 456889999999
Q ss_pred CCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccccc
Q 043278 510 NKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEA 589 (752)
Q Consensus 510 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 589 (752)
+++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||+++........
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~- 158 (260)
T cd05069 84 KGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT- 158 (260)
T ss_pred CCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc-
Confidence 99999998653 2345889999999999999999999988 999999999999999999999999999875432211
Q ss_pred ccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCC
Q 043278 590 NTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQ 668 (752)
Q Consensus 590 ~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 668 (752)
......++..|+|||...+..++.++||||||+++|||++ |+.|+....... .......+...
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~--------- 222 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE-------VLEQVERGYRM--------- 222 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCC---------
Confidence 1112345678999999999999999999999999999999 888886543211 11112111110
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 043278 669 PCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705 (752)
Q Consensus 669 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~ 705 (752)
..+......+.+++.+|++.+|++||++++|++.|+.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1112233567789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=317.69 Aligned_cols=249 Identities=22% Similarity=0.305 Sum_probs=195.5
Q ss_pred CeeecCCcccEEEEEec-CCceeEEEEcccCC---cccHHHHHHHHHHHHhc-CCCCcceeeeeeeeCCeeEEEEeeCCC
Q 043278 436 NKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGEERLLVYEFMPN 510 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 510 (752)
+.||+|+||.||+++.. +++.||+|+++... ......+..|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 47999999999999875 57899999997542 23345678899999888 799999999999999999999999999
Q ss_pred CCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccccc
Q 043278 511 KSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEAN 590 (752)
Q Consensus 511 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~ 590 (752)
|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~ 152 (329)
T cd05588 81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDT 152 (329)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC--CCc
Confidence 9998887543 45899999999999999999999998 999999999999999999999999998742211 112
Q ss_pred cccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCC--CcchHHHHHHHhhCCCcccccCCCCCC
Q 043278 591 TKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDR--PLNLIGYAWQLLSDGKGLELIDPSLEQ 668 (752)
Q Consensus 591 ~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~d~~l~~ 668 (752)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......+..+....+.. .+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~~-- 224 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI------RI-- 224 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC------CC--
Confidence 234678999999999999999999999999999999999999997433221 11112222222222211 11
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCC------HHHHHHH
Q 043278 669 PCSANEVMRCIHVGLLCVQDQAMDRPT------MPEVVCM 702 (752)
Q Consensus 669 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt------~~ev~~~ 702 (752)
+......+.+++.+|++.||.+||+ +.+++++
T Consensus 225 --p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 225 --PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred --CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 1112235678899999999999997 6777654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=310.15 Aligned_cols=255 Identities=25% Similarity=0.419 Sum_probs=200.9
Q ss_pred CCCcCCeeecCCcccEEEEEecC-C---ceeEEEEcccC-CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEE
Q 043278 431 NFSTTNKLGEGGFGPVYKGKLAD-E---QEVAIKRLSRS-SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~~~-~---~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 505 (752)
.|++.+.||+|+||.||+|.... + ..||||.+... ......+|..|+.++++++||||+++++++.++...++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 46678999999999999998753 3 35999998765 2334567999999999999999999999999999999999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccc
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVN 585 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~ 585 (752)
||+++++|..++... ...+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++......
T Consensus 85 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 85 EFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred ecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccC
Confidence 999999999988543 345899999999999999999999988 999999999999999999999999998865433
Q ss_pred ccccc-ccccc--ccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccc
Q 043278 586 ESEAN-TKRIV--GTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLEL 661 (752)
Q Consensus 586 ~~~~~-~~~~~--gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 661 (752)
..... ..... .+..|+|||++....++.++||||||+++|||++ |+.||....... ..........
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~-------~~~~i~~~~~--- 229 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-------VINAIEQDYR--- 229 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH-------HHHHHHcCCc---
Confidence 22111 11111 2457999999999999999999999999999887 999886544211 1111111110
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 662 IDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 662 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
.+.+.+....+.+++.+|++.+|.+||+|.+|+.+|+..
T Consensus 230 ------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 230 ------LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 011112234567899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=306.72 Aligned_cols=255 Identities=25% Similarity=0.395 Sum_probs=202.3
Q ss_pred hcCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEee
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
.++|++.+.||+|+||.||+|+. .+++.||+|++..........+.+|+.++.+++|+||+++++++..++..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35788899999999999999986 46788999999766555566788999999999999999999999999999999999
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccc
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES 587 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~ 587 (752)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||++..+.....
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 88 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 999999998854 235899999999999999999999987 99999999999999999999999999986542211
Q ss_pred ccccccccccCCccChhhhc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCC
Q 043278 588 EANTKRIVGTYGYMSPEYAM---SGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDP 664 (752)
Q Consensus 588 ~~~~~~~~gt~~y~aPE~~~---~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 664 (752)
......++..|+|||.+. ...++.++||||||++++||++|+.|+....+...... +.... +..+
T Consensus 162 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~-------~~~~~---~~~~ 229 (267)
T cd06646 162 --KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL-------MSKSN---FQPP 229 (267)
T ss_pred --ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhee-------eecCC---CCCC
Confidence 112346788999999874 34578899999999999999999999865432211100 00000 0111
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 043278 665 SLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCML 703 (752)
Q Consensus 665 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L 703 (752)
.... .......+.+++.+|++.+|++|||++++++.|
T Consensus 230 ~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 230 KLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 1111 112234677899999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=317.46 Aligned_cols=249 Identities=22% Similarity=0.319 Sum_probs=194.0
Q ss_pred CeeecCCcccEEEEEec-CCceeEEEEcccCC---cccHHHHHHHHHHHHhc-CCCCcceeeeeeeeCCeeEEEEeeCCC
Q 043278 436 NKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGEERLLVYEFMPN 510 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 510 (752)
+.||+|+||.||+++.. +++.+|+|+++... ......+.+|+.++.++ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999875 57889999997642 23345577888888776 899999999999999999999999999
Q ss_pred CCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccccc
Q 043278 511 KSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEAN 590 (752)
Q Consensus 511 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~ 590 (752)
|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~ 152 (329)
T cd05618 81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DT 152 (329)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Cc
Confidence 9998887543 35899999999999999999999988 9999999999999999999999999987532211 12
Q ss_pred cccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCC--cchHHHHHHHhhCCCcccccCCCCCC
Q 043278 591 TKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRP--LNLIGYAWQLLSDGKGLELIDPSLEQ 668 (752)
Q Consensus 591 ~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~--~~l~~~~~~~~~~~~~~~~~d~~l~~ 668 (752)
.....||..|+|||++.+..++.++||||||+++|||++|+.||........ .....+..+....... . +
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-~-----~-- 224 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-R-----I-- 224 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC-C-----C--
Confidence 2346789999999999999999999999999999999999999964322211 1112222222222111 1 1
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCC------HHHHHHH
Q 043278 669 PCSANEVMRCIHVGLLCVQDQAMDRPT------MPEVVCM 702 (752)
Q Consensus 669 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt------~~ev~~~ 702 (752)
+......+.+++.+|++.||.+||+ +.+++++
T Consensus 225 --p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 225 --PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred --CCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 1122345678899999999999998 4666554
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=305.72 Aligned_cols=259 Identities=22% Similarity=0.352 Sum_probs=208.3
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccC---CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRS---SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 505 (752)
++|++.+.||+|+||.||+|... +++.||+|.++.. .......+.+|++++++++|+|++++++++.+++..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888999999999999999976 7899999988643 2233567899999999999999999999999999999999
Q ss_pred eeCCCCCHhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecc
Q 043278 506 EFMPNKSLDFFLFNSG-RKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~ 584 (752)
||+++++|..++.... ....+++.++..++.++++||.|||+.+ ++|+||+|+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999886532 3445899999999999999999999988 99999999999999999999999999886543
Q ss_pred cccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCC
Q 043278 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDP 664 (752)
Q Consensus 585 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 664 (752)
.... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+..... ..... ......+......
T Consensus 159 ~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~-~~~~~~~~~~~~~-- 229 (267)
T cd08224 159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSL-CKKIEKCDYPPLP-- 229 (267)
T ss_pred CCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHHH-HhhhhcCCCCCCC--
Confidence 2211 1234678899999999998999999999999999999999999865431 11111 1111111111110
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 665 SLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 665 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
.......+.+++.+|++.+|.+|||+.+|+++|+.+
T Consensus 230 ------~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 230 ------ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred ------hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 112334577899999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=307.30 Aligned_cols=259 Identities=22% Similarity=0.355 Sum_probs=206.3
Q ss_pred cCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCC---cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 505 (752)
++|++.+.||+|+||.||+++. .+++.++||.+.... .....++.+|+.++..++|+||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 3577788999999999999985 478899999876532 223457889999999999999999999999999999999
Q ss_pred eeCCCCCHhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecc
Q 043278 506 EFMPNKSLDFFLFNS-GRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584 (752)
Q Consensus 506 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~ 584 (752)
||+++++|.+++... .....+++..++.++.||++||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999988642 23456899999999999999999999988 99999999999999999999999999876543
Q ss_pred cccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCC
Q 043278 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDP 664 (752)
Q Consensus 585 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 664 (752)
... ......++..|+|||++.+..++.++||||||+++|||++|..|+....... ... .+..... ..+
T Consensus 159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~-~~~~~~~-----~~~ 226 (267)
T cd08229 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----YSL-CKKIEQC-----DYP 226 (267)
T ss_pred CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH----HHH-hhhhhcC-----CCC
Confidence 221 1123467889999999999999999999999999999999999986543211 111 1111111 111
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 665 SLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 665 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
.+. .......+.+++.+|++.+|.+||||.+|+++++..
T Consensus 227 ~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 227 PLP---SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred CCC---cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 111 112334577888999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=323.05 Aligned_cols=253 Identities=20% Similarity=0.287 Sum_probs=200.3
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC---cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 505 (752)
++|.+.+.||+|+||+||+++.. +++.||+|+++... ......+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888899999999999999864 58899999987542 234456889999999999999999999999999999999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccc
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVN 585 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~ 585 (752)
||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999998653 245899999999999999999999988 999999999999999999999999999876433
Q ss_pred ccccccccccccCCccChhhhc------cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcc
Q 043278 586 ESEANTKRIVGTYGYMSPEYAM------SGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGL 659 (752)
Q Consensus 586 ~~~~~~~~~~gt~~y~aPE~~~------~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 659 (752)
... ......||+.|+|||++. ...++.++|||||||++|||++|+.||...... ......+......
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~~i~~~~~~~ 228 (330)
T cd05601 156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA------KTYNNIMNFQRFL 228 (330)
T ss_pred Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH------HHHHHHHcCCCcc
Confidence 221 222356899999999987 456889999999999999999999999755421 1111222111111
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 660 ELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 660 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
... ........+.+++..|++ +|.+|||+.+++++
T Consensus 229 ~~~-------~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 229 KFP-------EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred CCC-------CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 111 111122346677788997 99999999999865
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=301.84 Aligned_cols=250 Identities=35% Similarity=0.479 Sum_probs=204.3
Q ss_pred CeeecCCcccEEEEEecC----CceeEEEEcccCCccc-HHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCCC
Q 043278 436 NKLGEGGFGPVYKGKLAD----EQEVAIKRLSRSSGQG-IVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPN 510 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 510 (752)
+.||+|+||.||++.... +..+++|.+....... ...+.+|++.+..++|+|++++++++..+...++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999998754 7789999998764433 67889999999999999999999999999999999999999
Q ss_pred CCHhHHHhhcCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecc
Q 043278 511 KSLDFFLFNSGR------KNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584 (752)
Q Consensus 511 gsL~~~l~~~~~------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~ 584 (752)
++|.+++..... ...+++..+..++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999866421 356999999999999999999999988 99999999999999999999999999987654
Q ss_pred cccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccccC
Q 043278 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELID 663 (752)
Q Consensus 585 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 663 (752)
...........++..|+|||.+....++.++||||||++++||++ |+.|+...... .....+..+....
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~~~~~~~~~--- 227 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE-------EVLEYLRKGYRLP--- 227 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHHcCCCCC---
Confidence 432222334567889999999998899999999999999999999 58888765321 1122222221111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 043278 664 PSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ 704 (752)
Q Consensus 664 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~ 704 (752)
.+......+.+++.+|++.+|.+|||+.|+++.|+
T Consensus 228 ------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 228 ------KPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ------CCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11112346778999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=328.25 Aligned_cols=254 Identities=23% Similarity=0.295 Sum_probs=200.5
Q ss_pred HhcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccC---CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEE
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRS---SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLL 503 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 503 (752)
..++|++.+.||+|+||.||+++.. +++.||+|++... .......+.+|+.+++.++||||+++++++.+++..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3568889999999999999999875 5789999998643 22234457889999999999999999999999999999
Q ss_pred EEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeec
Q 043278 504 VYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFE 583 (752)
Q Consensus 504 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~ 583 (752)
||||+++|+|..++.. ..++...+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 121 v~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999998843 24788889999999999999999988 9999999999999999999999999998654
Q ss_pred ccccccccccccccCCccChhhhccC----CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcc
Q 043278 584 VNESEANTKRIVGTYGYMSPEYAMSG----IVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGL 659 (752)
Q Consensus 584 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 659 (752)
.... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .............
T Consensus 194 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~~~~~~ 266 (370)
T cd05596 194 ANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMDHKNSL 266 (370)
T ss_pred CCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH------HHHHHHHcCCCcC
Confidence 3221 112345789999999998653 4889999999999999999999999765421 1111222111111
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 043278 660 ELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMD--RPTMPEVVCM 702 (752)
Q Consensus 660 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~--RPt~~ev~~~ 702 (752)
.+ +........+.+++..|++.+|.+ |||+.|++++
T Consensus 267 ~~-------~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 267 TF-------PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CC-------CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 11 111112345677888999999987 9999999876
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=327.19 Aligned_cols=253 Identities=22% Similarity=0.317 Sum_probs=197.9
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC---cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 505 (752)
++|++.+.||+|+||.||+++.. +++.||||++.... ......+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46888899999999999999875 58899999997532 233456788999999999999999999999999999999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccc
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVN 585 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~ 585 (752)
||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~~g~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMKK---DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 999999999998643 35899999999999999999999998 999999999999999999999999998764321
Q ss_pred cccc------------------------------------ccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh
Q 043278 586 ESEA------------------------------------NTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629 (752)
Q Consensus 586 ~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt 629 (752)
.... ......||+.|+|||++....++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 1000 0112468999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCC---HHHHHHH
Q 043278 630 GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPT---MPEVVCM 702 (752)
Q Consensus 630 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt---~~ev~~~ 702 (752)
|+.||....... .............+ + ........+.+++.+|+. +|.+|++ +.|++++
T Consensus 235 G~~Pf~~~~~~~------~~~~i~~~~~~~~~--~-----~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 235 GYPPFCSDNPQE------TYRKIINWKETLQF--P-----DEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCCCHHH------HHHHHHcCCCccCC--C-----CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 999997654211 11111111111111 1 011112345567778886 8999998 8888775
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=306.17 Aligned_cols=255 Identities=30% Similarity=0.443 Sum_probs=205.8
Q ss_pred hcCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeC
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFM 508 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 508 (752)
.++|.+.++||+|+||.||++..++++.+|||.+.... ....++.+|+.++++++|+||+++++++..+...++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 46788899999999999999998888899999987543 34567899999999999999999999999888999999999
Q ss_pred CCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccc
Q 043278 509 PNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE 588 (752)
Q Consensus 509 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 588 (752)
++++|.+++.... ...+++..+..++.|++.||.|||+++ ++|+||||+||++++++.+||+|||+++.+......
T Consensus 84 ~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (261)
T cd05034 84 SKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT 159 (261)
T ss_pred CCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence 9999999986532 245899999999999999999999988 999999999999999999999999999876432111
Q ss_pred cccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCC
Q 043278 589 ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLE 667 (752)
Q Consensus 589 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 667 (752)
.......+..|+|||.+.+..++.++||||||++++||++ |+.||...... . .......+.. .
T Consensus 160 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~----~~~~~~~~~~-----~--- 223 (261)
T cd05034 160 -AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR---E----VLEQVERGYR-----M--- 223 (261)
T ss_pred -hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---H----HHHHHHcCCC-----C---
Confidence 1112234568999999999999999999999999999999 99888654311 1 1111111110 0
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 043278 668 QPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705 (752)
Q Consensus 668 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~ 705 (752)
+.+......+.+++.+|++.+|.+||+++++++.|+.
T Consensus 224 -~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 224 -PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0011113457789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=305.91 Aligned_cols=248 Identities=27% Similarity=0.400 Sum_probs=195.1
Q ss_pred eeecCCcccEEEEEec---CCceeEEEEcccCCc-ccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCCCCC
Q 043278 437 KLGEGGFGPVYKGKLA---DEQEVAIKRLSRSSG-QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKS 512 (752)
Q Consensus 437 ~LG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gs 512 (752)
.||+|+||.||+|.+. .+..||+|++..... ....++.+|+.++++++|+||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999763 345699999876533 23456899999999999999999999885 457899999999999
Q ss_pred HhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccccc-c
Q 043278 513 LDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEAN-T 591 (752)
Q Consensus 513 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~-~ 591 (752)
|.+++... ...+++..++.++.||+.||+|||+.+ ++|+||||+|||++.++.+||+|||+++.......... .
T Consensus 81 L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSGK--KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 99988542 345899999999999999999999988 99999999999999999999999999986543322111 1
Q ss_pred ccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCCC
Q 043278 592 KRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPC 670 (752)
Q Consensus 592 ~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 670 (752)
....++..|+|||.+....++.++||||||+++||+++ |+.||...... .....+..+.... .
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~~~~~~~~---------~ 219 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP-------EVMSFIEQGKRLD---------C 219 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH-------HHHHHHHCCCCCC---------C
Confidence 11233578999999988889999999999999999996 99998755321 1122222222111 1
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 671 SANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 671 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
+......+.+++.+||+.+|++||++.+|++.|+..
T Consensus 220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 112234667899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=309.15 Aligned_cols=247 Identities=24% Similarity=0.294 Sum_probs=195.1
Q ss_pred eecCCcccEEEEEec-CCceeEEEEcccCCc---ccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCCCCCH
Q 043278 438 LGEGGFGPVYKGKLA-DEQEVAIKRLSRSSG---QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSL 513 (752)
Q Consensus 438 LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 513 (752)
||+|+||+||++... +++.+|+|.+..... .....+..|+.++++++|+||+++.+++..++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999864 678999999865422 2335677899999999999999999999999999999999999999
Q ss_pred hHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccccccc
Q 043278 514 DFFLFNSG-RKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTK 592 (752)
Q Consensus 514 ~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~ 592 (752)
..++.... ....+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++..+..... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 88875432 3456899999999999999999999988 99999999999999999999999999976543221 122
Q ss_pred cccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCCCCH
Q 043278 593 RIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSA 672 (752)
Q Consensus 593 ~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 672 (752)
...|++.|+|||++.+..++.++||||||+++|||++|+.||......... . ........ ... ..+.
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~--~-~~~~~~~~--------~~~--~~~~ 222 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--K-ELKQRILN--------DSV--TYPD 222 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH--H-HHHHhhcc--------cCC--CCcc
Confidence 357899999999999999999999999999999999999999765422111 0 01111111 000 1111
Q ss_pred HHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 043278 673 NEVMRCIHVGLLCVQDQAMDRP-----TMPEVVCM 702 (752)
Q Consensus 673 ~~~~~l~~l~~~Cl~~dp~~RP-----t~~ev~~~ 702 (752)
.....+.+++.+|++.||++|| ++++++++
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 2334567888999999999999 67777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=325.37 Aligned_cols=253 Identities=22% Similarity=0.299 Sum_probs=195.3
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC---cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 505 (752)
++|.+.++||+|+||.||+++.. +++.||||++.... ......+.+|++++.+++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46888899999999999999864 68899999986532 233456789999999999999999999999999999999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccc
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVN 585 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~ 585 (752)
||+++|+|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIKY---DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 999999999988543 45889999999999999999999998 999999999999999999999999999643211
Q ss_pred ccc---------------------------------------------cccccccccCCccChhhhccCCCCccchhHHH
Q 043278 586 ESE---------------------------------------------ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSF 620 (752)
Q Consensus 586 ~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~ 620 (752)
... .......||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 000 00012468999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCC---CCHH
Q 043278 621 GVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDR---PTMP 697 (752)
Q Consensus 621 G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~R---Pt~~ 697 (752)
||++|||++|+.||........ ............+ +. .......+.+++.+|++ +|.+| |++.
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~------~~~i~~~~~~~~~--p~-----~~~~s~~~~dli~~lL~-~~~~r~~r~~~~ 300 (377)
T cd05629 235 GAIMFECLIGWPPFCSENSHET------YRKIINWRETLYF--PD-----DIHLSVEAEDLIRRLIT-NAENRLGRGGAH 300 (377)
T ss_pred chhhhhhhcCCCCCCCCCHHHH------HHHHHccCCccCC--CC-----CCCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence 9999999999999976542111 1111111111111 10 11112345677778887 66654 6999
Q ss_pred HHHHH
Q 043278 698 EVVCM 702 (752)
Q Consensus 698 ev~~~ 702 (752)
|++++
T Consensus 301 ~~l~h 305 (377)
T cd05629 301 EIKSH 305 (377)
T ss_pred HHhcC
Confidence 98886
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=325.92 Aligned_cols=255 Identities=22% Similarity=0.283 Sum_probs=198.8
Q ss_pred HHhcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccC---CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeE
Q 043278 427 AAANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRS---SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERL 502 (752)
Q Consensus 427 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 502 (752)
...++|++.+.||+|+||.||+++.. +++.+|+|.+.+. .......+.+|+.+++.++||||+++++++.+++..+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 34578999999999999999999875 4788999998642 2223445789999999999999999999999999999
Q ss_pred EEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceee
Q 043278 503 LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIF 582 (752)
Q Consensus 503 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~ 582 (752)
+||||+++|+|..++.. ..++...+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 120 lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 120 MVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred EEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceec
Confidence 99999999999998843 24788999999999999999999988 999999999999999999999999999875
Q ss_pred cccccccccccccccCCccChhhhccC----CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCc
Q 043278 583 EVNESEANTKRIVGTYGYMSPEYAMSG----IVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKG 658 (752)
Q Consensus 583 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 658 (752)
..... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||...... ............
T Consensus 193 ~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~------~~~~~i~~~~~~ 265 (370)
T cd05621 193 DETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV------GTYSKIMDHKNS 265 (370)
T ss_pred ccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCcc
Confidence 42221 112346789999999998754 3789999999999999999999999765421 111122211111
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 043278 659 LELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMD--RPTMPEVVCM 702 (752)
Q Consensus 659 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~--RPt~~ev~~~ 702 (752)
.. .+........+.+++..|++.++.+ ||++.|++++
T Consensus 266 ~~-------~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 266 LN-------FPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred cC-------CCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 11 1111122334566777888765543 8999999887
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=302.94 Aligned_cols=254 Identities=24% Similarity=0.348 Sum_probs=189.7
Q ss_pred CeeecCCcccEEEEEecC---CceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCCCC
Q 043278 436 NKLGEGGFGPVYKGKLAD---EQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNK 511 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~~---~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 511 (752)
+.||+|+||.||+|...+ ...+++|.+.... ......+.+|+..++.++|+||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997543 3468888876543 233456889999999999999999999999999999999999999
Q ss_pred CHhHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccccc
Q 043278 512 SLDFFLFNSGR--KNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEA 589 (752)
Q Consensus 512 sL~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 589 (752)
+|.+++..... ....++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999865432 233567888999999999999999988 9999999999999999999999999987533222111
Q ss_pred ccccccccCCccChhhhcc-------CCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccc
Q 043278 590 NTKRIVGTYGYMSPEYAMS-------GIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLEL 661 (752)
Q Consensus 590 ~~~~~~gt~~y~aPE~~~~-------~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 661 (752)
......++..|+|||++.. ..++.++||||||+++|||++ |..|+....... ........ ....+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~~~~~~-~~~~~ 230 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ------VLKQVVRE-QDIKL 230 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH------HHHHHhhc-cCccC
Confidence 1222345678999998743 457889999999999999999 777776443211 11111221 22222
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 043278 662 IDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ 704 (752)
Q Consensus 662 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~ 704 (752)
.++.+... ....+.+++..|+ .||++|||++||++.|.
T Consensus 231 ~~~~~~~~----~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQLDLK----YSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCccccc----CCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 33332222 2234456777787 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=303.46 Aligned_cols=248 Identities=29% Similarity=0.411 Sum_probs=198.9
Q ss_pred CeeecCCcccEEEEEecCCceeEEEEcccCCcc-cHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCCCCCHh
Q 043278 436 NKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQ-GIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLD 514 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~ 514 (752)
++||+|+||.||++...+++.|++|.+...... ....+.+|++++++++|+||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 479999999999999877999999998765433 4567899999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccccccccc
Q 043278 515 FFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594 (752)
Q Consensus 515 ~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~ 594 (752)
+++... ...+++..++.++.+++.+|+|||+++ ++||||||+|||++.++.+||+|||+++..............
T Consensus 81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 998543 235789999999999999999999988 999999999999999999999999999865422211111122
Q ss_pred cccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCCCCHH
Q 043278 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSAN 673 (752)
Q Consensus 595 ~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 673 (752)
..+..|+|||.+.++.++.++|+||||++++||++ |..|+....... ....+..+. . ...+..
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~-------~~~~~~~~~--~-------~~~~~~ 219 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ-------TRERIESGY--R-------MPAPQL 219 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH-------HHHHHhcCC--C-------CCCCcc
Confidence 33567999999998999999999999999999999 777776544211 111111111 0 011112
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 043278 674 EVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ 704 (752)
Q Consensus 674 ~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~ 704 (752)
....+.+++.+|++.+|.+|||+.||++.|+
T Consensus 220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 2346788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=305.00 Aligned_cols=250 Identities=28% Similarity=0.415 Sum_probs=204.1
Q ss_pred hcCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeC
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFM 508 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 508 (752)
.++|++.+.||+|+||.||++... ++.||+|.+..... ...++.+|+.++.+++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 357788899999999999999874 78899999976644 5678899999999999999999999999889999999999
Q ss_pred CCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccc
Q 043278 509 PNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE 588 (752)
Q Consensus 509 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 588 (752)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.......
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 83 AKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 9999999986533 235899999999999999999999988 99999999999999999999999999986532211
Q ss_pred cccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCC
Q 043278 589 ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLE 667 (752)
Q Consensus 589 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 667 (752)
....+..|+|||++....++.++||||||++++||++ |+.|+...... ........+.....
T Consensus 158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~~~~~~~~~~------ 220 (256)
T cd05039 158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-------DVVPHVEKGYRMEA------ 220 (256)
T ss_pred ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHhcCCCCCC------
Confidence 2234568999999998899999999999999999998 88888644311 11112222111111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 043278 668 QPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705 (752)
Q Consensus 668 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~ 705 (752)
+......+.+++.+|++.+|.+|||+.|++++|+.
T Consensus 221 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 221 ---PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred ---ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 11123467789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=310.88 Aligned_cols=251 Identities=25% Similarity=0.395 Sum_probs=203.9
Q ss_pred hcCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEee
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
..+|+..+.||+|+||.||+|.. .+++.|++|.+..........+.+|+.+++.++|+|++++++.+..+...++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 35788889999999999999985 46889999999776555567789999999999999999999999999999999999
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccc
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES 587 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~ 587 (752)
+++++|.+++.. ..+++.++..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred cCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 999999998843 34789999999999999999999988 99999999999999999999999999876432221
Q ss_pred ccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCC
Q 043278 588 EANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLE 667 (752)
Q Consensus 588 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 667 (752)
......+++.|+|||.+.+..++.++||||||+++|||++|+.||....+.... ......+. +.+
T Consensus 172 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~------~~~~~~~~------~~~- 236 (296)
T cd06654 172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL------YLIATNGT------PEL- 236 (296)
T ss_pred --ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH------HHHhcCCC------CCC-
Confidence 112346788999999999988999999999999999999999999765432111 11111110 011
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 668 QPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 668 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
..+......+.+++.+|++.+|++|||+.|+++.
T Consensus 237 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 237 -QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred -CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 1112233457789999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=315.12 Aligned_cols=259 Identities=25% Similarity=0.389 Sum_probs=203.6
Q ss_pred cCCCcCCeeecCCcccEEEEEec--------CCceeEEEEcccCC-cccHHHHHHHHHHHHhc-CCCCcceeeeeeeeCC
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA--------DEQEVAIKRLSRSS-GQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGE 499 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 499 (752)
++|.+.++||+|+||.||+++.. ....+|+|.++... .....++.+|+.++.++ +|+||+++++++.+..
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 57788899999999999999742 24568999887542 23456788999999999 6999999999999988
Q ss_pred eeEEEEeeCCCCCHhHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEec
Q 043278 500 ERLLVYEFMPNKSLDFFLFNSG-------------RKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLD 566 (752)
Q Consensus 500 ~~~lv~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~ 566 (752)
..+++|||+++|+|..++.... ....+++.++..++.||+.||.|||+.+ ++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEc
Confidence 9999999999999999986532 1245899999999999999999999988 99999999999999
Q ss_pred CCCCceecccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcch
Q 043278 567 DKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNL 645 (752)
Q Consensus 567 ~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l 645 (752)
+++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~----- 243 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE----- 243 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH-----
Confidence 999999999999986543222222222234567999999999999999999999999999999 88887544321
Q ss_pred HHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCC
Q 043278 646 IGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNET 707 (752)
Q Consensus 646 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~ 707 (752)
........+..... +......+.+++.+|++.+|++|||+.|+++.|+...
T Consensus 244 --~~~~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 244 --ELFKLLREGHRMDK---------PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred --HHHHHHHcCCCCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 11222222221111 1112235668999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=322.90 Aligned_cols=262 Identities=23% Similarity=0.323 Sum_probs=196.9
Q ss_pred CCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCC-----eeE
Q 043278 431 NFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGE-----ERL 502 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 502 (752)
+|+..+.||+|+||.||++.. .+++.||||++.... .....++.+|++++..++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 467789999999999999986 468999999986542 234457889999999999999999999998776 789
Q ss_pred EEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceee
Q 043278 503 LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIF 582 (752)
Q Consensus 503 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~ 582 (752)
+|+||+. ++|...+.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS---PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999997 567666643 345899999999999999999999998 999999999999999999999999999865
Q ss_pred cccccccccccccccCCccChhhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHH-------------
Q 043278 583 EVNESEANTKRIVGTYGYMSPEYAMSG-IVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGY------------- 648 (752)
Q Consensus 583 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~------------- 648 (752)
...... ......++..|+|||.+.+. .++.++|||||||+++||++|+.||....+......+..
T Consensus 154 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 232 (372)
T cd07853 154 EPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA 232 (372)
T ss_pred ccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 432221 12234678899999998874 589999999999999999999999976553221111100
Q ss_pred ---HHHHh-hCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 649 ---AWQLL-SDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 649 ---~~~~~-~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
....+ ........... + ..........+.+++.+|++.||++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 233 CEGARAHILRGPHKPPSLPV-L-YTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hHHHHHHHHhCCCCCCchHH-h-cccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00000 00000000000 0 00111123457789999999999999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=314.28 Aligned_cols=255 Identities=29% Similarity=0.446 Sum_probs=199.5
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCc--eeEEEEcccCC-cccHHHHHHHHHHHHhc-CCCCcceeeeeeeeCCeeEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQ--EVAIKRLSRSS-GQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGEERLLV 504 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~--~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 504 (752)
++|++.+.||+|+||.||+|... ++. .+++|.++... .....++.+|++++.++ +|+||+++++++.+++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 56788899999999999999864 343 46888776432 33455788999999999 899999999999999999999
Q ss_pred EeeCCCCCHhHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCc
Q 043278 505 YEFMPNKSLDFFLFNSG-------------RKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNP 571 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~ 571 (752)
|||+++++|..++.... ....+++..++.++.||+.||+|||+.+ ++||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 99999999999986532 1235889999999999999999999988 9999999999999999999
Q ss_pred eecccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHH
Q 043278 572 KISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAW 650 (752)
Q Consensus 572 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~ 650 (752)
||+|||+++..... .......++..|+|||++....++.++||||||++++||++ |..||......+ . .
T Consensus 164 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~----~ 233 (303)
T cd05088 164 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---L----Y 233 (303)
T ss_pred EeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH---H----H
Confidence 99999998632211 11111234567999999988889999999999999999998 999986543211 1 1
Q ss_pred HHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 651 QLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 651 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
.....+...+ .+......+.+++.+|++.+|++||++.+++++|+..
T Consensus 234 ~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 234 EKLPQGYRLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred HHHhcCCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1111111010 0111223567899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=315.38 Aligned_cols=249 Identities=22% Similarity=0.313 Sum_probs=196.4
Q ss_pred CeeecCCcccEEEEEec-CCceeEEEEcccCC---cccHHHHHHHHHHHHhc-CCCCcceeeeeeeeCCeeEEEEeeCCC
Q 043278 436 NKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGEERLLVYEFMPN 510 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 510 (752)
+.||+|+||.||+++.. +++.+|+|+++... ......+.+|+.++.++ +|+||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999875 57889999997642 22345578899999888 699999999999999999999999999
Q ss_pred CCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccccc
Q 043278 511 KSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEAN 590 (752)
Q Consensus 511 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~ 590 (752)
|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (327)
T cd05617 81 GDLMFHMQRQ---RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DT 152 (327)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Cc
Confidence 9998887543 35899999999999999999999988 9999999999999999999999999987532111 12
Q ss_pred cccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCCC
Q 043278 591 TKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPC 670 (752)
Q Consensus 591 ~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 670 (752)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||................+....... . +
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~-----~---- 222 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI-R-----I---- 222 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC-C-----C----
Confidence 23467899999999999999999999999999999999999999765443333333333333322211 0 1
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCH------HHHHHH
Q 043278 671 SANEVMRCIHVGLLCVQDQAMDRPTM------PEVVCM 702 (752)
Q Consensus 671 ~~~~~~~l~~l~~~Cl~~dp~~RPt~------~ev~~~ 702 (752)
+......+.+++.+|++.||.+||++ .++.++
T Consensus 223 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 223 PRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 11122346788899999999999985 466554
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=303.85 Aligned_cols=250 Identities=27% Similarity=0.360 Sum_probs=203.3
Q ss_pred CCCcCCeeecCCcccEEEEEec-CCceeEEEEcccC--CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEee
Q 043278 431 NFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRS--SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
+|+..+.||+|++|.||+++.. +++.|++|.+... ......++.+|++++++++|+|++++++++.+++..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 3667789999999999999875 5788999988643 334566788999999999999999999999999999999999
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccc
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES 587 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~ 587 (752)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||+++.......
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 9999999998654 2346899999999999999999999987 99999999999999999999999999986543322
Q ss_pred ccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCC
Q 043278 588 EANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLE 667 (752)
Q Consensus 588 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 667 (752)
. .....++..|+|||++.+..++.++|+||||++++||++|+.||...... ........+....
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~------- 220 (256)
T cd08529 157 F--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG-------ALILKIIRGVFPP------- 220 (256)
T ss_pred h--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHcCCCCC-------
Confidence 1 22346788999999999999999999999999999999999998655411 1111111211111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 668 QPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 668 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.+......+.+++.+|++.+|++||++.++++.
T Consensus 221 --~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 221 --VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred --CccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 111233457889999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=323.45 Aligned_cols=262 Identities=19% Similarity=0.234 Sum_probs=196.0
Q ss_pred hcCCCcCCeeecCCcccEEEEEecC-CceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEee
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLAD-EQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
..+|.+.+.||+|+||.||++.... ++.||||.... ..+.+|++++++++|+|||++++++..++..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4578999999999999999998754 78899996432 2457899999999999999999999999999999999
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccc
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES 587 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~ 587 (752)
+. ++|..++... ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.......
T Consensus 242 ~~-~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 242 YR-SDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred cC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 95 6887777542 235999999999999999999999988 99999999999999999999999999987643322
Q ss_pred ccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCC-CCcchHHHHHHHhhCCCcc--cc---
Q 043278 588 EANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPD-RPLNLIGYAWQLLSDGKGL--EL--- 661 (752)
Q Consensus 588 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~-~~~~l~~~~~~~~~~~~~~--~~--- 661 (752)
........||..|+|||++.+..++.++|||||||+||||++|..++...... ..........+.+...... ++
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 22223457899999999999999999999999999999999988654332211 1010111111111111100 00
Q ss_pred ----------------cCCCCCCCCC---HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 662 ----------------IDPSLEQPCS---ANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 662 ----------------~d~~l~~~~~---~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
..+....... ......+.+|+.+||+.||.+|||+.|++++
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0000000000 0111246679999999999999999999875
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=314.47 Aligned_cols=242 Identities=23% Similarity=0.358 Sum_probs=192.6
Q ss_pred CeeecCCcccEEEEEec-CCceeEEEEcccC---CcccHHHHHHHHHHHHhc-CCCCcceeeeeeeeCCeeEEEEeeCCC
Q 043278 436 NKLGEGGFGPVYKGKLA-DEQEVAIKRLSRS---SGQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGEERLLVYEFMPN 510 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 510 (752)
+.||+|+||.||+++.. +++.||||++... .......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999875 5788999998753 223445677888888876 799999999999999999999999999
Q ss_pred CCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccccc
Q 043278 511 KSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEAN 590 (752)
Q Consensus 511 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~ 590 (752)
|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~~---~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~ 152 (320)
T cd05590 81 GDLMFHIQKS---RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KT 152 (320)
T ss_pred chHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cc
Confidence 9999888543 35899999999999999999999988 9999999999999999999999999987532221 12
Q ss_pred cccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCCC
Q 043278 591 TKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPC 670 (752)
Q Consensus 591 ~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 670 (752)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||....... ..+.+..+.. ..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-------~~~~i~~~~~---~~~------ 216 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD-------LFEAILNDEV---VYP------ 216 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH-------HHHHHhcCCC---CCC------
Confidence 234578999999999999999999999999999999999999997654211 1112212111 011
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCH------HHHHHH
Q 043278 671 SANEVMRCIHVGLLCVQDQAMDRPTM------PEVVCM 702 (752)
Q Consensus 671 ~~~~~~~l~~l~~~Cl~~dp~~RPt~------~ev~~~ 702 (752)
......+.+++.+|++.||.+||++ ++++++
T Consensus 217 -~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 217 -TWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred -CCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 1122356788899999999999998 555543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=305.96 Aligned_cols=250 Identities=23% Similarity=0.338 Sum_probs=197.9
Q ss_pred CCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccC-CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeC
Q 043278 431 NFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRS-SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFM 508 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 508 (752)
+|+..+.||+|+||.||++.. .+++.||+|.+... ......++.+|++++.+++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 567788999999999999986 46788999998654 2334457889999999999999999999999999999999999
Q ss_pred CCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccc
Q 043278 509 PNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE 588 (752)
Q Consensus 509 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 588 (752)
++++|..+. .+++..+..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||++......
T Consensus 82 ~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--- 148 (279)
T cd06619 82 DGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--- 148 (279)
T ss_pred CCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc---
Confidence 999996553 3678889999999999999999988 999999999999999999999999999765322
Q ss_pred cccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCC
Q 043278 589 ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQ 668 (752)
Q Consensus 589 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 668 (752)
......++..|+|||++.+..++.++||||||+++|||++|+.||................+....... +.+..
T Consensus 149 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~ 222 (279)
T cd06619 149 -IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP-----PVLPV 222 (279)
T ss_pred -cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCC-----CCCCC
Confidence 122357889999999999999999999999999999999999998754322211111111111111111 11101
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 669 PCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 669 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
......+.+++.+|++.+|++||+++|+++.
T Consensus 223 ---~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 223 ---GQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred ---CcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 1122356788999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=299.17 Aligned_cols=263 Identities=24% Similarity=0.326 Sum_probs=201.3
Q ss_pred CCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCCcc--cHHHHHHHHHHHHhcCCCC-cceeeeeeeeCC------e
Q 043278 431 NFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSSGQ--GIVEFKNEVRLIAKLQHTN-LVRLLGCSLHGE------E 500 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~------~ 500 (752)
.|...++||+|+||+||+|+. .+|+.||+|++.-...+ .-....+|+.++.+++|+| ||++++++...+ .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 344457899999999999985 46889999999765432 2233579999999999999 999999998877 7
Q ss_pred eEEEEeeCCCCCHhHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccc
Q 043278 501 RLLVYEFMPNKSLDFFLFNSGRK-NVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMA 579 (752)
Q Consensus 501 ~~lv~E~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla 579 (752)
.++|+||++ .+|..++...... ..++...+..++.||++||+|||+++ |+||||||+||||++.|.+||+|||+|
T Consensus 92 l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 92 LYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred EEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccchH
Confidence 789999995 5888888665432 45777889999999999999999998 999999999999999999999999999
Q ss_pred eeecccccccccccccccCCccChhhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCC--
Q 043278 580 RIFEVNESEANTKRIVGTYGYMSPEYAMSG-IVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDG-- 656 (752)
Q Consensus 580 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~-- 656 (752)
+...-... .....+.|..|+|||++.+. .|+...|+||+||++.||++++..|......+ +.....+.+...
T Consensus 168 ra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~---ql~~If~~lGtP~e 242 (323)
T KOG0594|consen 168 RAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEID---QLFRIFRLLGTPNE 242 (323)
T ss_pred HHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHH---HHHHHHHHcCCCCc
Confidence 96542221 12346789999999999886 79999999999999999999999998877532 223333333221
Q ss_pred -Ccc---cccCCC-----CCCCCCHHH-----HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 657 -KGL---ELIDPS-----LEQPCSANE-----VMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 657 -~~~---~~~d~~-----l~~~~~~~~-----~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
... .+.+-. ...+.+... .....+++.+|++.+|.+|.|++..+++
T Consensus 243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 111 111111 000000000 1356789999999999999999999987
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=321.16 Aligned_cols=262 Identities=25% Similarity=0.304 Sum_probs=204.8
Q ss_pred cCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCCcccHHHHHHHHHHHHhcC-C-----CCcceeeeeeeeCCeeE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQ-H-----TNLVRLLGCSLHGEERL 502 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~ 502 (752)
.+|++.+.||+|+||.|-++.. ..++.||||++++.. .-..+...|+.+|..++ | -|+|+++++|...++.|
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 3889999999999999999975 458999999998764 34456688999999997 4 38999999999999999
Q ss_pred EEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCC--CCceecccccce
Q 043278 503 LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDK--MNPKISDFGMAR 580 (752)
Q Consensus 503 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~--~~~kl~DFgla~ 580 (752)
||+|.+. .+|.+++...+. ..++...+..|+.||+.||.+||+.+ |||+||||+||||.+. ..+||+|||.++
T Consensus 265 iVfELL~-~NLYellK~n~f-~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 265 IVFELLS-TNLYELLKNNKF-RGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSC 339 (586)
T ss_pred eeehhhh-hhHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccccc
Confidence 9999985 589999976544 34999999999999999999999988 9999999999999653 369999999999
Q ss_pred eecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHH-----HHh--
Q 043278 581 IFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAW-----QLL-- 653 (752)
Q Consensus 581 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~-----~~~-- 653 (752)
+....-. ....+..|+|||++.+.+|+.+.|+||||||+.||++|.+.|.++.+.+....+.... ..+
T Consensus 340 ~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~ 414 (586)
T KOG0667|consen 340 FESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDT 414 (586)
T ss_pred ccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 7543221 4677889999999999999999999999999999999999998887654332222111 000
Q ss_pred --------hC-CCc--------------------------ccccCC----CCCCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 043278 654 --------SD-GKG--------------------------LELIDP----SLEQPCSANEVMRCIHVGLLCVQDQAMDRP 694 (752)
Q Consensus 654 --------~~-~~~--------------------------~~~~d~----~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP 694 (752)
.. ... .+..-| .+.......+-..+++++.+|++.||.+|+
T Consensus 415 ~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~ 494 (586)
T KOG0667|consen 415 AKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI 494 (586)
T ss_pred ccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcC
Confidence 00 000 000001 000111223345678999999999999999
Q ss_pred CHHHHHHH
Q 043278 695 TMPEVVCM 702 (752)
Q Consensus 695 t~~ev~~~ 702 (752)
|..|.+++
T Consensus 495 tp~qal~H 502 (586)
T KOG0667|consen 495 TPAQALNH 502 (586)
T ss_pred CHHHHhcC
Confidence 99999887
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=306.78 Aligned_cols=256 Identities=27% Similarity=0.450 Sum_probs=202.5
Q ss_pred cCCCcCCeeecCCcccEEEEEec-C---CceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-D---EQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLV 504 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~---~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 504 (752)
.+|.+.+.||+|+||.||+|+.. . +..+|+|.++... ......+.+|+.++.+++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46778899999999999999863 2 3369999987543 23345789999999999999999999999999999999
Q ss_pred EeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecc
Q 043278 505 YEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~ 584 (752)
|||+++++|.+++... ...+++.+++.++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||++.....
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 9999999999998643 235899999999999999999999988 99999999999999999999999999987643
Q ss_pred cccccc-cccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCccccc
Q 043278 585 NESEAN-TKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELI 662 (752)
Q Consensus 585 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 662 (752)
...... .....++..|+|||++.+..++.++||||||++++|+++ |+.||......+ . .....++...
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~----~~~~~~~~~~--- 228 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---V----IKAIEEGYRL--- 228 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---H----HHHHhCCCcC---
Confidence 322111 111223568999999999899999999999999999887 999986554221 1 1112221110
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 663 DPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 663 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
+.+......+.+++.+|++.+|.+||+|.++++.|+..
T Consensus 229 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 229 ------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 11112234567899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=316.00 Aligned_cols=238 Identities=24% Similarity=0.295 Sum_probs=190.8
Q ss_pred CeeecCCcccEEEEEe----cCCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCC
Q 043278 436 NKLGEGGFGPVYKGKL----ADEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMP 509 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~----~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 509 (752)
+.||+|+||.||+++. ..|+.+|+|++.... ......+.+|++++.+++||||+++++++..++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6899999999999874 357899999987542 2234456789999999999999999999999999999999999
Q ss_pred CCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccccc
Q 043278 510 NKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEA 589 (752)
Q Consensus 510 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 589 (752)
+|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...... .
T Consensus 82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~ 153 (318)
T cd05582 82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--K 153 (318)
T ss_pred CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--C
Confidence 9999998854 345899999999999999999999988 9999999999999999999999999987543221 1
Q ss_pred ccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCC
Q 043278 590 NTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQP 669 (752)
Q Consensus 590 ~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 669 (752)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... ... ........ .+
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~------~~~-~~i~~~~~------~~--- 217 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK------ETM-TMILKAKL------GM--- 217 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH------HHH-HHHHcCCC------CC---
Confidence 223467899999999999988999999999999999999999999754421 111 11111111 01
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 043278 670 CSANEVMRCIHVGLLCVQDQAMDRPTMPE 698 (752)
Q Consensus 670 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~e 698 (752)
+......+.+++.+|++.||.+||++.+
T Consensus 218 -p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 218 -PQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred -CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 1111234667889999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=314.81 Aligned_cols=242 Identities=24% Similarity=0.340 Sum_probs=193.3
Q ss_pred CeeecCCcccEEEEEec-CCceeEEEEcccCC---cccHHHHHHHHHHHHhc-CCCCcceeeeeeeeCCeeEEEEeeCCC
Q 043278 436 NKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGEERLLVYEFMPN 510 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 510 (752)
+.||+|+||.||+|+.. .++.||+|++.... ......+..|.+++..+ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999875 47899999987542 23345577888888866 899999999999999999999999999
Q ss_pred CCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccccc
Q 043278 511 KSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEAN 590 (752)
Q Consensus 511 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~ 590 (752)
++|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (321)
T cd05591 81 GDLMFQIQRS---RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VT 152 (321)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--cc
Confidence 9998888543 35889999999999999999999998 9999999999999999999999999987533221 12
Q ss_pred cccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCCC
Q 043278 591 TKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPC 670 (752)
Q Consensus 591 ~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 670 (752)
.....|++.|+|||++.+..++.++||||||+++|||++|+.||....... . ......+.. ..+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~------~-~~~i~~~~~---~~p~----- 217 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD------L-FESILHDDV---LYPV----- 217 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH------H-HHHHHcCCC---CCCC-----
Confidence 234578999999999999999999999999999999999999997654221 1 111111111 0111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCC-------CHHHHHHH
Q 043278 671 SANEVMRCIHVGLLCVQDQAMDRP-------TMPEVVCM 702 (752)
Q Consensus 671 ~~~~~~~l~~l~~~Cl~~dp~~RP-------t~~ev~~~ 702 (752)
.....+.+++..|++.||++|| ++.+++++
T Consensus 218 --~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 218 --WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred --CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 1123567888999999999999 88888765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=322.33 Aligned_cols=262 Identities=19% Similarity=0.241 Sum_probs=200.0
Q ss_pred hcCCCcCCeeecCCcccEEEEEec---CCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEE
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA---DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 505 (752)
..+|.+.+.||+|+||.||++... .+..||+|.+... ..+.+|++++.+++|+||+++++++......+++|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 357999999999999999999753 3567999988643 23468999999999999999999999999999999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccc
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVN 585 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~ 585 (752)
|++. ++|..++. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 166 e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9986 57777773 3346899999999999999999999988 999999999999999999999999999865543
Q ss_pred ccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCc-------
Q 043278 586 ESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKG------- 658 (752)
Q Consensus 586 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~------- 658 (752)
..........||+.|+|||++....++.++|||||||++|||++|+.||...........+....+.+.....
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 3333333467899999999999999999999999999999999999999776543322111111111111000
Q ss_pred ----------ccccCCCCCCCC---CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 659 ----------LELIDPSLEQPC---SANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 659 ----------~~~~d~~l~~~~---~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.....+....+. .......+.+++.+|++.||++|||+.|++.+
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000000 00112356678899999999999999999886
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=321.35 Aligned_cols=242 Identities=22% Similarity=0.274 Sum_probs=193.6
Q ss_pred CeeecCCcccEEEEEec-CCceeEEEEcccCC---cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCCCC
Q 043278 436 NKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNK 511 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 511 (752)
+.||+|+||.||++... +++.||+|.+.... ......+.+|++++..++|+||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999864 68899999987542 223456788999999999999999999999999999999999999
Q ss_pred CHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCcEeecCCCCCcEEecCCCCceecccccceeecccccccc
Q 043278 512 SLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHK-YSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEAN 590 (752)
Q Consensus 512 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~ 590 (752)
+|..++.. ...+++..+..++.||+.||+|||+ .+ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (325)
T cd05594 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--AT 152 (325)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cc
Confidence 99888753 2358999999999999999999997 56 9999999999999999999999999987532221 11
Q ss_pred cccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCCC
Q 043278 591 TKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPC 670 (752)
Q Consensus 591 ~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 670 (752)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .......+.. .+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~-------~~~~i~~~~~------~~p~-- 217 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-------LFELILMEEI------RFPR-- 217 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH-------HHHHHhcCCC------CCCC--
Confidence 223568999999999999999999999999999999999999996544211 1111111110 1111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 043278 671 SANEVMRCIHVGLLCVQDQAMDRP-----TMPEVVCM 702 (752)
Q Consensus 671 ~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~ev~~~ 702 (752)
.....+.+++.+|++.||++|+ ++.+++++
T Consensus 218 --~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 218 --TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred --CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 1223467788899999999996 89999865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=327.05 Aligned_cols=202 Identities=24% Similarity=0.389 Sum_probs=172.3
Q ss_pred CCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC---cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEe
Q 043278 431 NFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYE 506 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 506 (752)
.|+..++||+|+||.||+|+.. +++.||+|++.... ......+.+|+.++++++|+||+++++.+.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5788899999999999999864 57889999986542 2234567899999999999999999999999999999999
Q ss_pred eCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccc
Q 043278 507 FMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586 (752)
Q Consensus 507 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~ 586 (752)
|+++|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIRM---GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 99999999988543 35888999999999999999999988 9999999999999999999999999975332100
Q ss_pred c---------------------------------------------ccccccccccCCccChhhhccCCCCccchhHHHH
Q 043278 587 S---------------------------------------------EANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFG 621 (752)
Q Consensus 587 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G 621 (752)
. ........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0 0001234689999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCC
Q 043278 622 VLVLEIVSGQKNHTRHH 638 (752)
Q Consensus 622 ~vl~elltG~~p~~~~~ 638 (752)
|++|||++|+.||....
T Consensus 236 vil~elltG~~Pf~~~~ 252 (382)
T cd05625 236 VILYEMLVGQPPFLAQT 252 (382)
T ss_pred HHHHHHHhCCCCCCCCC
Confidence 99999999999997654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=306.39 Aligned_cols=249 Identities=29% Similarity=0.439 Sum_probs=194.7
Q ss_pred CeeecCCcccEEEEEecC-Cc--eeEEEEcccCC-cccHHHHHHHHHHHHhc-CCCCcceeeeeeeeCCeeEEEEeeCCC
Q 043278 436 NKLGEGGFGPVYKGKLAD-EQ--EVAIKRLSRSS-GQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGEERLLVYEFMPN 510 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~~-~~--~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 510 (752)
+.||+|+||.||+|++.+ +. .+++|.++... ......+.+|++++.++ +||||+++++++...+..+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 369999999999998754 33 47888887532 33456788999999999 899999999999999999999999999
Q ss_pred CCHhHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccc
Q 043278 511 KSLDFFLFNSG-------------RKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFG 577 (752)
Q Consensus 511 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg 577 (752)
++|.+++.... ....+++..++.++.|++.||+|||+.+ ++|+||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999986532 1234889999999999999999999987 9999999999999999999999999
Q ss_pred cceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCC
Q 043278 578 MARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDG 656 (752)
Q Consensus 578 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 656 (752)
++...... ........+..|+|||++....++.++||||||++++||++ |+.||....... .......+
T Consensus 158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~-------~~~~~~~~ 227 (270)
T cd05047 158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LYEKLPQG 227 (270)
T ss_pred Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH-------HHHHHhCC
Confidence 98632111 11111233567999999998899999999999999999997 999986543211 11112221
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 657 KGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 657 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
...+ . +......+.+++.+|++.+|.+|||+.|+++.|+.+
T Consensus 228 ~~~~-----~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 228 YRLE-----K----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred CCCC-----C----CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 1111 1 111223567899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=317.62 Aligned_cols=247 Identities=23% Similarity=0.338 Sum_probs=194.8
Q ss_pred CCCcCCeeecCCcccEEEEEec-CCceeEEEEcccC---CcccHHHHHHHHHHHHhcCCC-CcceeeeeeeeCCeeEEEE
Q 043278 431 NFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRS---SGQGIVEFKNEVRLIAKLQHT-NLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~ 505 (752)
+|++.+.||+|+||.||+|+.. .++.||||++... .......+..|.+++..++|+ +|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4777899999999999999875 4678999998753 223445678899999999765 5888999999999999999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccc
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVN 585 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~ 585 (752)
||+++|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQV---GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 999999999888543 34889999999999999999999988 999999999999999999999999998743211
Q ss_pred ccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCC
Q 043278 586 ESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPS 665 (752)
Q Consensus 586 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 665 (752)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... + ........ ..
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~----~~~i~~~~------~~ 219 (324)
T cd05587 155 G--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---L----FQSIMEHN------VS 219 (324)
T ss_pred C--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---H----HHHHHcCC------CC
Confidence 1 12234578999999999999999999999999999999999999997554211 1 11111111 01
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHHH
Q 043278 666 LEQPCSANEVMRCIHVGLLCVQDQAMDRPTM-----PEVVCM 702 (752)
Q Consensus 666 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~-----~ev~~~ 702 (752)
+ +......+.+++.+|++.||.+||+. .++.++
T Consensus 220 ~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 220 Y----PKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred C----CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1 11122356788899999999999976 566543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=317.98 Aligned_cols=246 Identities=26% Similarity=0.423 Sum_probs=203.0
Q ss_pred CeeecCCcccEEEEEecCC-ceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCCCCCHh
Q 043278 436 NKLGEGGFGPVYKGKLADE-QEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLD 514 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~~~-~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~ 514 (752)
-+||+|.||+||.|+..+. ..+|||.+.....+...-+.+|+.+-++++|.|||+++|++.++...-|.||.+|+|+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 3799999999999997654 469999998887777778899999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEec-CCCCceecccccceeeccccccccc
Q 043278 515 FFLFNSGRKNVL--NWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLD-DKMNPKISDFGMARIFEVNESEANT 591 (752)
Q Consensus 515 ~~l~~~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~-~~~~~kl~DFgla~~~~~~~~~~~~ 591 (752)
.+|.. +-++| ++.+.--+..||++||.|||++. |||||||-+|||++ -.|.+||+|||-++.+.. -.+.+
T Consensus 661 sLLrs--kWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~T 733 (1226)
T KOG4279|consen 661 SLLRS--KWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCT 733 (1226)
T ss_pred HHHHh--ccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc--CCccc
Confidence 99854 22344 67777788999999999999998 99999999999995 688999999998875432 23445
Q ss_pred ccccccCCccChhhhccCC--CCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCC
Q 043278 592 KRIVGTYGYMSPEYAMSGI--VSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQP 669 (752)
Q Consensus 592 ~~~~gt~~y~aPE~~~~~~--~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 669 (752)
..+.||..|||||++..++ |..++|||||||.+.||.||++||........ .+.+-|- -.+. .+
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA--------AMFkVGm--yKvH----P~ 799 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA--------AMFKVGM--YKVH----PP 799 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH--------hhhhhcc--eecC----CC
Confidence 5688999999999998764 88999999999999999999999976542211 1111111 1112 23
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 670 CSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 670 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.+.+...++..++++|+..+|.+||+++++++.
T Consensus 800 iPeelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 800 IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred CcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 466667788899999999999999999999864
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=338.57 Aligned_cols=260 Identities=22% Similarity=0.300 Sum_probs=202.8
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCc---ccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSG---QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 505 (752)
++|.+.++||+|+||.||+|... .++.||+|++..... ....++.+|++++.+++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57888999999999999999865 588999999875422 23457899999999999999999999999999999999
Q ss_pred eeCCCCCHhHHHhhcC--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccc
Q 043278 506 EFMPNKSLDFFLFNSG--------RKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFG 577 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg 577 (752)
||+++++|.+++.... ....+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999886421 1234667888999999999999999988 9999999999999999999999999
Q ss_pred cceeecccccc----------------cccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCC
Q 043278 578 MARIFEVNESE----------------ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDR 641 (752)
Q Consensus 578 la~~~~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~ 641 (752)
+++........ .......||+.|+|||.+.+..++.++|||||||+++||++|+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 99876211100 01123568999999999999999999999999999999999999997643211
Q ss_pred CcchHHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHhhcC
Q 043278 642 PLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRP-TMPEVVCMLQNE 706 (752)
Q Consensus 642 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-t~~ev~~~L~~~ 706 (752)
.. .. ... .++... ....+....+.+++.+|++.||++|| +++++++.|+..
T Consensus 239 i~----~~-~~i--------~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 239 IS----YR-DVI--------LSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred hh----hh-hhc--------cChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 10 00 000 011000 00012234567889999999999996 677788877664
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=309.42 Aligned_cols=240 Identities=24% Similarity=0.331 Sum_probs=190.0
Q ss_pred CeeecCCcccEEEEEec-CCceeEEEEcccCC---cccHHHHHHHHHHHHhc-CCCCcceeeeeeeeCCeeEEEEeeCCC
Q 043278 436 NKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGEERLLVYEFMPN 510 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 510 (752)
+.||+|+||.||+++.. +++.||+|.++... ......+..|..++... +|+||+++++++.+++..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999875 57889999987542 22344567777777754 899999999999999999999999999
Q ss_pred CCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccccc
Q 043278 511 KSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEAN 590 (752)
Q Consensus 511 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~ 590 (752)
|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~i~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~ 152 (316)
T cd05620 81 GDLMFHIQDK---GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DNR 152 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC--CCc
Confidence 9999888542 35889999999999999999999988 999999999999999999999999998743211 112
Q ss_pred cccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCCC
Q 043278 591 TKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPC 670 (752)
Q Consensus 591 ~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 670 (752)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||...... ...+....+. +.+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~-------~~~~~~~~~~------~~~~~~- 218 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED-------ELFESIRVDT------PHYPRW- 218 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCC------CCCCCC-
Confidence 23467899999999999999999999999999999999999999755421 1111111111 111111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 043278 671 SANEVMRCIHVGLLCVQDQAMDRPTMP-EVV 700 (752)
Q Consensus 671 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~-ev~ 700 (752)
....+.+++.+|++.||.+||++. ++.
T Consensus 219 ---~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 219 ---ITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred ---CCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 123466788999999999999984 665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=329.02 Aligned_cols=252 Identities=29% Similarity=0.400 Sum_probs=209.1
Q ss_pred CcCCeeecCCcccEEEEEe-cCCc----eeEEEEcccC-CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEe
Q 043278 433 STTNKLGEGGFGPVYKGKL-ADEQ----EVAIKRLSRS-SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYE 506 (752)
Q Consensus 433 ~~~~~LG~G~fg~Vy~~~~-~~~~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 506 (752)
...++||+|+||+||+|.+ +.|+ +||+|++... ..+...++.+|+-.|.+++|||+++|+|+|.... ..||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 3458999999999999975 4443 5899988765 3456778999999999999999999999998765 889999
Q ss_pred eCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccc
Q 043278 507 FMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586 (752)
Q Consensus 507 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~ 586 (752)
|||.|+|.+++... +..+-.+..+.|..|||+||.|||++. ++||||.++|||+.+-..+||.|||+++.+..+.
T Consensus 778 ~mP~G~LlDyvr~h--r~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREH--RDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred hcccchHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 99999999999763 455888999999999999999999988 9999999999999999999999999999987766
Q ss_pred cccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCC
Q 043278 587 SEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPS 665 (752)
Q Consensus 587 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 665 (752)
.+.......-.+.|||-|.+....++.++|||||||.+||++| |.+|++.....+ ....++.|...
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e-------I~dlle~geRL------ 919 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE-------IPDLLEKGERL------ 919 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH-------hhHHHhccccC------
Confidence 5555544445678999999999999999999999999999999 999988776433 22334444331
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 666 LEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 666 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
+.+......+..++.+||..|++.||+++++...+.+.
T Consensus 920 ---sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ 957 (1177)
T KOG1025|consen 920 ---SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM 957 (1177)
T ss_pred ---CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence 22333445577788999999999999999998876543
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=311.76 Aligned_cols=237 Identities=22% Similarity=0.291 Sum_probs=186.8
Q ss_pred CeeecCCcccEEEEEec-CCceeEEEEcccCC---cccHHHHHHHHH-HHHhcCCCCcceeeeeeeeCCeeEEEEeeCCC
Q 043278 436 NKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS---GQGIVEFKNEVR-LIAKLQHTNLVRLLGCSLHGEERLLVYEFMPN 510 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 510 (752)
+.||+|+||+||+++.. +++.||+|++.... .....++.+|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999875 68899999986532 122234445544 56779999999999999999999999999999
Q ss_pred CCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccccc
Q 043278 511 KSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEAN 590 (752)
Q Consensus 511 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~ 590 (752)
|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..... ...
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~ 152 (323)
T cd05575 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SKT 152 (323)
T ss_pred CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CCc
Confidence 999988854 335889999999999999999999988 999999999999999999999999998753221 122
Q ss_pred cccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCCC
Q 043278 591 TKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPC 670 (752)
Q Consensus 591 ~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 670 (752)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....... .+.. . +.+ .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~------~~~~~i~-~~~~-~-~~~----~- 218 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA------EMYDNIL-NKPL-R-LKP----N- 218 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH------HHHHHHH-cCCC-C-CCC----C-
Confidence 23457899999999999999999999999999999999999999754321 1111111 1111 0 111 1
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHH
Q 043278 671 SANEVMRCIHVGLLCVQDQAMDRPTMP 697 (752)
Q Consensus 671 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~ 697 (752)
....+.+++.+|++.||.+||++.
T Consensus 219 ---~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 219 ---ISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred ---CCHHHHHHHHHHhhcCHHhCCCCC
Confidence 134567889999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=303.18 Aligned_cols=252 Identities=28% Similarity=0.436 Sum_probs=202.4
Q ss_pred cCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCC
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMP 509 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 509 (752)
..|+..+.||+|+||.||++...+++.+|+|.+.... ....++.+|++++.+++|+|++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 3567778999999999999998778899999987543 345678999999999999999999999999999999999999
Q ss_pred CCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccccc
Q 043278 510 NKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEA 589 (752)
Q Consensus 510 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 589 (752)
+++|.+++... ...++++.+..++.|++.+|+|||+.+ ++|+||||+||+++.++.+||+|||+++........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~- 156 (256)
T cd05112 83 HGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT- 156 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCccc-
Confidence 99999988543 235789999999999999999999988 999999999999999999999999999865432211
Q ss_pred ccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCC
Q 043278 590 NTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQ 668 (752)
Q Consensus 590 ~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 668 (752)
......++.+|+|||.+.+..++.++||||||+++|||++ |+.|+...... ...+.+..+. ....+..
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~~~~~--~~~~~~~-- 225 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS-------EVVETINAGF--RLYKPRL-- 225 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH-------HHHHHHhCCC--CCCCCCC--
Confidence 1112234578999999998899999999999999999998 88888654321 1112222211 1111221
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 043278 669 PCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ 704 (752)
Q Consensus 669 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~ 704 (752)
....+.+++.+|++.+|++|||+.||+++|.
T Consensus 226 -----~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 226 -----ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred -----CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1246788999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=307.69 Aligned_cols=239 Identities=24% Similarity=0.371 Sum_probs=187.2
Q ss_pred eeecCCcccEEEEEecC-------------------------CceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCccee
Q 043278 437 KLGEGGFGPVYKGKLAD-------------------------EQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRL 491 (752)
Q Consensus 437 ~LG~G~fg~Vy~~~~~~-------------------------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l 491 (752)
.||+|+||.||+|.+.. ...|++|.+.........+|.+|+.++++++|+||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997521 13589999876554445678899999999999999999
Q ss_pred eeeeeeCCeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCC--
Q 043278 492 LGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKM-- 569 (752)
Q Consensus 492 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~-- 569 (752)
++++.++...++||||+++|+|+.++... ...+++..++.++.||++||+|||+.+ |+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 99999999999999999999999888542 345889999999999999999999987 99999999999997654
Q ss_pred -----CceecccccceeecccccccccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHH-hCCCCCCCCCCCCC
Q 043278 570 -----NPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIV-SGQKNHTRHHPDRP 642 (752)
Q Consensus 570 -----~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~ell-tG~~p~~~~~~~~~ 642 (752)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+........
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 3799999988643211 12346778999998875 56899999999999999995 68888865442211
Q ss_pred cchHHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 043278 643 LNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ 704 (752)
Q Consensus 643 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~ 704 (752)
. ....... . +..+ ....+.+++.+||+.+|.+|||+.+|++.|+
T Consensus 231 ---~----~~~~~~~--~-----~~~~----~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 ---E----RFYEKKH--R-----LPEP----SCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred ---H----HHHHhcc--C-----CCCC----CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 1 1111100 0 0011 1135778999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=314.66 Aligned_cols=241 Identities=26% Similarity=0.371 Sum_probs=190.7
Q ss_pred CeeecCCcccEEEEEec-CCceeEEEEcccCC---cccHHHHHHHHHHHHh-cCCCCcceeeeeeeeCCeeEEEEeeCCC
Q 043278 436 NKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS---GQGIVEFKNEVRLIAK-LQHTNLVRLLGCSLHGEERLLVYEFMPN 510 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~E~~~~ 510 (752)
+.||+|+||.||+|+.. +++.||||+++... ......+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999875 47889999987542 2234456677777776 4999999999999999999999999999
Q ss_pred CCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccccc
Q 043278 511 KSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEAN 590 (752)
Q Consensus 511 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~ 590 (752)
|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (316)
T cd05619 81 GDLMFHIQSC---HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AK 152 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cc
Confidence 9999988542 35889999999999999999999988 9999999999999999999999999987532211 12
Q ss_pred cccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCCC
Q 043278 591 TKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPC 670 (752)
Q Consensus 591 ~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 670 (752)
.....||..|+|||++.+..++.++|||||||++|||++|+.||...... ...+.+.... +....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-------~~~~~i~~~~------~~~~~-- 217 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE-------ELFQSIRMDN------PCYPR-- 217 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCC------CCCCc--
Confidence 23457899999999999999999999999999999999999999764421 1111121111 11111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 043278 671 SANEVMRCIHVGLLCVQDQAMDRPTMP-EVVC 701 (752)
Q Consensus 671 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~-ev~~ 701 (752)
.....+.+++.+|++.||.+||++. ++.+
T Consensus 218 --~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 218 --WLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred --cCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 1123467888999999999999997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=327.31 Aligned_cols=252 Identities=23% Similarity=0.326 Sum_probs=194.3
Q ss_pred CCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC---cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEe
Q 043278 431 NFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYE 506 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 506 (752)
+|++.+.||+|+||.||+++.. .++.||||.+.... ......+.+|+.++.+++|+||+++++.+.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 6888999999999999999864 57899999986532 2234567899999999999999999999999999999999
Q ss_pred eCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccc
Q 043278 507 FMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586 (752)
Q Consensus 507 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~ 586 (752)
|+++|+|.+++.. ...++...+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 82 YIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 9999999999854 345888999999999999999999988 9999999999999999999999999985331100
Q ss_pred c-----------------------------------------ccccccccccCCccChhhhccCCCCccchhHHHHHHHH
Q 043278 587 S-----------------------------------------EANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVL 625 (752)
Q Consensus 587 ~-----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ 625 (752)
. ........||+.|+|||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 0 00011347899999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCC---CHHHHHHH
Q 043278 626 EIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRP---TMPEVVCM 702 (752)
Q Consensus 626 elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP---t~~ev~~~ 702 (752)
||++|+.||........ ............ .+. ....+ ..+.+++.+|+ .+|.+|+ ++.|++++
T Consensus 236 ell~G~~Pf~~~~~~~~------~~~i~~~~~~~~--~~~-~~~~s----~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 236 EMLVGQPPFLADTPAET------QLKVINWETTLH--IPS-QAKLS----REASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred ehhhCCCCCCCCCHHHH------HHHHhccCcccc--CCC-CCCCC----HHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 99999999976543211 111111000000 010 01112 23445555655 4999999 88998876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=300.04 Aligned_cols=249 Identities=29% Similarity=0.396 Sum_probs=199.3
Q ss_pred CeeecCCcccEEEEEecC--C--ceeEEEEcccCCc-ccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCCC
Q 043278 436 NKLGEGGFGPVYKGKLAD--E--QEVAIKRLSRSSG-QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPN 510 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~~--~--~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 510 (752)
+.||+|++|.||+|.+.. + ..||+|.+..... ...+++.+|+.++.+++|+||+++++.+.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998643 3 3689999987655 556788999999999999999999999888 889999999999
Q ss_pred CCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccc-c
Q 043278 511 KSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE-A 589 (752)
Q Consensus 511 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~-~ 589 (752)
++|.+++..... ..+++.....++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+...... .
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999866432 46899999999999999999999988 999999999999999999999999999876542211 1
Q ss_pred ccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCC
Q 043278 590 NTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQ 668 (752)
Q Consensus 590 ~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 668 (752)
......++..|+|||.+.+..++.++||||||++++||++ |+.|+......+ .............
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~~~~-------- 221 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ------ILKKIDKEGERLE-------- 221 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHhcCCcCC--------
Confidence 1223456788999999999999999999999999999999 999986443211 1111111111110
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 043278 669 PCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ 704 (752)
Q Consensus 669 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~ 704 (752)
.+......+.+++.+|++.+|++|||+.|+++.|.
T Consensus 222 -~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 -RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 11122345778999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=303.96 Aligned_cols=240 Identities=23% Similarity=0.363 Sum_probs=188.6
Q ss_pred CeeecCCcccEEEEEecC-------------CceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeE
Q 043278 436 NKLGEGGFGPVYKGKLAD-------------EQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERL 502 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~~-------------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 502 (752)
+.||+|+||.||+|+... ...|++|.+..........|.+|+.++..++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998532 2258999887665555567889999999999999999999999999999
Q ss_pred EEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCC-------ceecc
Q 043278 503 LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMN-------PKISD 575 (752)
Q Consensus 503 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~-------~kl~D 575 (752)
+||||+++++|+.++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +|++|
T Consensus 81 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 999999999998887542 345899999999999999999999988 999999999999987664 89999
Q ss_pred cccceeecccccccccccccccCCccChhhhc-cCCCCccchhHHHHHHHHHHH-hCCCCCCCCCCCCCcchHHHHHHHh
Q 043278 576 FGMARIFEVNESEANTKRIVGTYGYMSPEYAM-SGIVSIKTDVFSFGVLVLEIV-SGQKNHTRHHPDRPLNLIGYAWQLL 653 (752)
Q Consensus 576 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~k~DV~S~G~vl~ell-tG~~p~~~~~~~~~~~l~~~~~~~~ 653 (752)
||++...... ....++..|+|||.+. +..++.++||||||+++|||+ .|+.|+....... .....
T Consensus 156 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-------~~~~~ 222 (262)
T cd05077 156 PGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE-------KERFY 222 (262)
T ss_pred CCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH-------HHHHH
Confidence 9998754311 1245678899999887 467899999999999999998 4777765432111 01111
Q ss_pred hCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 043278 654 SDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ 704 (752)
Q Consensus 654 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~ 704 (752)
.+.. ... . .....+.+|+.+||+.||.+||++.++++.|+
T Consensus 223 -~~~~-~~~-----~----~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 223 -EGQC-MLV-----T----PSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred -hcCc-cCC-----C----CChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 1110 111 1 11245678999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=310.39 Aligned_cols=263 Identities=25% Similarity=0.413 Sum_probs=205.0
Q ss_pred cCCCcCCeeecCCcccEEEEEec-----CCceeEEEEcccCCcc-cHHHHHHHHHHHHhcCCCCcceeeeeeee--CCee
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-----DEQEVAIKRLSRSSGQ-GIVEFKNEVRLIAKLQHTNLVRLLGCSLH--GEER 501 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-----~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 501 (752)
+.|...+.||+|+||.||+++.. .++.+|||.+...... ...+|.+|+++++.++|+||+++++++.. +...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45667789999999999999864 3678999999765443 46679999999999999999999999877 5578
Q ss_pred EEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceeccccccee
Q 043278 502 LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARI 581 (752)
Q Consensus 502 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~ 581 (752)
+++|||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 99999999999999986532 35899999999999999999999988 99999999999999999999999999987
Q ss_pred ecccccc-cccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCc--------chHHHHHHH
Q 043278 582 FEVNESE-ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPL--------NLIGYAWQL 652 (752)
Q Consensus 582 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~--------~l~~~~~~~ 652 (752)
....... .......++..|+|||.+.+..++.++||||||++++||++|+.|+......... .........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence 6532211 1111233456799999999889999999999999999999999887553322100 011111122
Q ss_pred hhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 653 LSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 653 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
+..+.. .+.+......+.+++.+|++.+|.+||||.||+++|+.+
T Consensus 239 ~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LKEGER---------LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHcCCc---------CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 221111 111112235678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=303.17 Aligned_cols=254 Identities=28% Similarity=0.433 Sum_probs=203.9
Q ss_pred hcCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeC
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFM 508 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 508 (752)
.++|.+.++||+|+||.||++...++..+|+|.+.... .....+.+|+.++++++|+||+++.+++.+ ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 36788889999999999999998788889999887543 345678999999999999999999999877 7789999999
Q ss_pred CCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccc
Q 043278 509 PNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE 588 (752)
Q Consensus 509 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 588 (752)
++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 83 AKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 999999998653 2345889999999999999999999987 999999999999999999999999999865432211
Q ss_pred cccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCC
Q 043278 589 ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLE 667 (752)
Q Consensus 589 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 667 (752)
......++..|+|||++....++.++|+||||++++|+++ |+.||...... .....+..+....
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-------~~~~~~~~~~~~~------- 223 (260)
T cd05073 159 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-------EVIRALERGYRMP------- 223 (260)
T ss_pred -cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHhCCCCCC-------
Confidence 1122345678999999999899999999999999999999 88888654321 1111222221111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 043278 668 QPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705 (752)
Q Consensus 668 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~ 705 (752)
........+.+++.+|++.+|++||++.++.+.|+.
T Consensus 224 --~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 224 --RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred --CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 111223457789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=306.30 Aligned_cols=251 Identities=31% Similarity=0.474 Sum_probs=197.6
Q ss_pred CeeecCCcccEEEEEecC-------CceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEee
Q 043278 436 NKLGEGGFGPVYKGKLAD-------EQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~~-------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
+.||+|+||.||+|+..+ ++.+|+|.+.... .....++.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999998643 2579999886543 23456789999999999999999999999999999999999
Q ss_pred CCCCCHhHHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCC-----Cceeccccc
Q 043278 508 MPNKSLDFFLFNSG----RKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKM-----NPKISDFGM 578 (752)
Q Consensus 508 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~-----~~kl~DFgl 578 (752)
+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.+. .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999986532 2235789999999999999999999987 99999999999999877 899999999
Q ss_pred ceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCC
Q 043278 579 ARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGK 657 (752)
Q Consensus 579 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 657 (752)
++...............++..|+|||++.++.++.++||||||+++|||++ |+.||...... .. ......+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~------~~-~~~~~~~~ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ------EV-LQHVTAGG 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH------HH-HHHHhcCC
Confidence 976543322222223345678999999999999999999999999999998 99888644311 11 11111111
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 043278 658 GLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705 (752)
Q Consensus 658 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~ 705 (752)
.. ..+......+.+++.+|++.+|.+||++.+|++.|++
T Consensus 231 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 RL---------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred cc---------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11 1111223457789999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=311.70 Aligned_cols=242 Identities=24% Similarity=0.332 Sum_probs=193.9
Q ss_pred CeeecCCcccEEEEEec-CCceeEEEEcccCC---cccHHHHHHHHHHHHhc-CCCCcceeeeeeeeCCeeEEEEeeCCC
Q 043278 436 NKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGEERLLVYEFMPN 510 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 510 (752)
+.||+|+||.||++... +++.||||+++... ......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999875 47889999987542 23345667888888887 799999999999999999999999999
Q ss_pred CCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccccc
Q 043278 511 KSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEAN 590 (752)
Q Consensus 511 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~ 590 (752)
++|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (318)
T cd05570 81 GDLMFHIQRS---GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VT 152 (318)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Cc
Confidence 9998888543 35899999999999999999999988 9999999999999999999999999987532111 12
Q ss_pred cccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCCC
Q 043278 591 TKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPC 670 (752)
Q Consensus 591 ~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 670 (752)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||...... ........... ..
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~-------~~~~~i~~~~~------~~---- 215 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED-------ELFQSILEDEV------RY---- 215 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH-------HHHHHHHcCCC------CC----
Confidence 23356899999999999999999999999999999999999999754421 11112211111 01
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHHH
Q 043278 671 SANEVMRCIHVGLLCVQDQAMDRPTM-----PEVVCM 702 (752)
Q Consensus 671 ~~~~~~~l~~l~~~Cl~~dp~~RPt~-----~ev~~~ 702 (752)
+......+.+++.+||+.||.+||++ .++++.
T Consensus 216 ~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 216 PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 11122456789999999999999999 888764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=312.96 Aligned_cols=246 Identities=24% Similarity=0.332 Sum_probs=194.4
Q ss_pred CCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC---cccHHHHHHHHHHHHhc-CCCCcceeeeeeeeCCeeEEEE
Q 043278 431 NFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 505 (752)
+|.+.+.||+|+||.||+++.. +++.||+|.+.... ......+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4677899999999999999875 46789999987542 22334567788888777 5889999999999999999999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccc
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVN 585 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~ 585 (752)
||+++|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQV---GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 999999998888543 34889999999999999999999988 999999999999999999999999999753221
Q ss_pred ccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCC
Q 043278 586 ESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPS 665 (752)
Q Consensus 586 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 665 (752)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... + ...+..... .
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~---~----~~~i~~~~~------~ 219 (323)
T cd05616 155 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---L----FQSIMEHNV------A 219 (323)
T ss_pred C--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH---H----HHHHHhCCC------C
Confidence 1 12234678999999999999999999999999999999999999997654211 1 111111111 0
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 043278 666 LEQPCSANEVMRCIHVGLLCVQDQAMDRPTM-----PEVVC 701 (752)
Q Consensus 666 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~-----~ev~~ 701 (752)
.+......+.+++.+|++.+|.+|++. .++.+
T Consensus 220 ----~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~ 256 (323)
T cd05616 220 ----YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 256 (323)
T ss_pred ----CCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence 111223456788999999999999984 56654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=329.38 Aligned_cols=261 Identities=20% Similarity=0.299 Sum_probs=192.1
Q ss_pred HhcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeC--------
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHG-------- 498 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------- 498 (752)
..++|.+.++||+|+||.||+|... .++.||||++.... ....+|+.++++++|+||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 4567999999999999999999874 57899999885432 2345799999999999999999876432
Q ss_pred CeeEEEEeeCCCCCHhHHHhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCC-Cceeccc
Q 043278 499 EERLLVYEFMPNKSLDFFLFN-SGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKM-NPKISDF 576 (752)
Q Consensus 499 ~~~~lv~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~-~~kl~DF 576 (752)
...++||||+++ +|..++.. ......+++..+..++.||+.||+|||+.+ |+||||||+||||+.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 245689999985 56555543 233456899999999999999999999998 99999999999998665 6999999
Q ss_pred ccceeecccccccccccccccCCccChhhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhC
Q 043278 577 GMARIFEVNESEANTKRIVGTYGYMSPEYAMSG-IVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSD 655 (752)
Q Consensus 577 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 655 (752)
|+++.+.... ......|++.|+|||++.+. .++.++|||||||++|||++|.+||......... ....+.+..
T Consensus 216 Gla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~---~~i~~~~~~ 289 (440)
T PTZ00036 216 GSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQL---VRIIQVLGT 289 (440)
T ss_pred ccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCC
Confidence 9998654322 12235678999999998764 6999999999999999999999999765432111 111111110
Q ss_pred C----------CcccccCCCC-----CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 656 G----------KGLELIDPSL-----EQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 656 ~----------~~~~~~d~~l-----~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
. ....+--+.. ....+......+.+|+.+||+.||.+|||+.|++++
T Consensus 290 p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 290 PTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred CCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 0 0000000100 000111123467889999999999999999999865
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=306.08 Aligned_cols=263 Identities=25% Similarity=0.396 Sum_probs=202.5
Q ss_pred cCCCcCCeeecCCcccEEEEEe-----cCCceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeC--Cee
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKL-----ADEQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHG--EER 501 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 501 (752)
+.|.+.+.||+|+||.||+++. .++..||+|.++... ......+.+|+.++++++|+|++++.+++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3567789999999999999974 346789999987553 33446789999999999999999999998775 568
Q ss_pred EEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceeccccccee
Q 043278 502 LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARI 581 (752)
Q Consensus 502 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~ 581 (752)
++||||+++++|..++... ...+++..++.++.||+.||+|||+.+ ++||||||+||++++++.+||+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 8999999999999998543 235899999999999999999999988 99999999999999999999999999986
Q ss_pred ecccccc-cccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCC--------CCCcchHHHHHHH
Q 043278 582 FEVNESE-ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHP--------DRPLNLIGYAWQL 652 (752)
Q Consensus 582 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~--------~~~~~l~~~~~~~ 652 (752)
....... .......++..|+|||++.+..++.++||||||+++|||++++.|...... .............
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 5433221 112234567789999999988999999999999999999998765432110 0001111111222
Q ss_pred hhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 653 LSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 653 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
+..+.... ........+.+++.+|++.+|.+|||+.++++.|+.+
T Consensus 239 ~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 239 LEEGKRLP---------RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHcCccCC---------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 22222111 1112235688899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=301.47 Aligned_cols=248 Identities=26% Similarity=0.377 Sum_probs=197.9
Q ss_pred cCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeee-eCCeeEEEEeeC
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSL-HGEERLLVYEFM 508 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~E~~ 508 (752)
++|.+.+.||+|+||.||++... +..+|+|.++... ..+.+.+|+.++++++|+|++++++++. +++..+++|||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 46788899999999999999874 6789999886542 3567899999999999999999999764 456789999999
Q ss_pred CCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccc
Q 043278 509 PNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE 588 (752)
Q Consensus 509 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 588 (752)
++++|.+++.... ...+++..++.++.||+.||+|||+++ ++||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 83 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 9999999986532 345889999999999999999999988 9999999999999999999999999987543221
Q ss_pred cccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCC
Q 043278 589 ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLE 667 (752)
Q Consensus 589 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 667 (752)
....++..|+|||++.+..++.++||||||+++|||++ |+.|+..... ... ...+..+.... .
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~------~~~-~~~~~~~~~~~-----~- 220 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL------KDV-VPRVEKGYKMD-----A- 220 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH------HHH-HHHHhcCCCCC-----C-
Confidence 12334568999999999899999999999999999998 8888764331 111 11121111111 1
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 043278 668 QPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705 (752)
Q Consensus 668 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~ 705 (752)
.......+.+++.+|++.+|++|||+.++++.|+.
T Consensus 221 ---~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 221 ---PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred ---CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 11223457788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=298.74 Aligned_cols=268 Identities=23% Similarity=0.343 Sum_probs=206.2
Q ss_pred HHhcCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHh--cCCCCcceeeeeeeeCC----e
Q 043278 427 AAANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAK--LQHTNLVRLLGCSLHGE----E 500 (752)
Q Consensus 427 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~ 500 (752)
...++..+.+.||+|.||+||+|++ .|+.||||++... ++..+.+|.++.+. |+|+||+.+++.-..++ .
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred hhhheeEEEEEecCccccceeeccc-cCCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 4567788899999999999999999 5677999999654 34567788888876 59999999999865544 6
Q ss_pred eEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCcEeecCCCCCcEEecCCCCceecc
Q 043278 501 RLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHK-----YSRLRVIHRDLKASNILLDDKMNPKISD 575 (752)
Q Consensus 501 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-----~~~~~iiH~Dikp~NIll~~~~~~kl~D 575 (752)
.+||++|.++|||.+||. +..++.+..++++..+|.||++||- +++|.|.|||||+.|||+..++.+.|+|
T Consensus 284 LwLvTdYHe~GSL~DyL~----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLN----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred EEEeeecccCCcHHHHHh----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 789999999999999994 4569999999999999999999995 5788999999999999999999999999
Q ss_pred cccceeecccc--cccccccccccCCccChhhhccCC----C--CccchhHHHHHHHHHHHh----C------CCCCCCC
Q 043278 576 FGMARIFEVNE--SEANTKRIVGTYGYMSPEYAMSGI----V--SIKTDVFSFGVLVLEIVS----G------QKNHTRH 637 (752)
Q Consensus 576 Fgla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~----~--t~k~DV~S~G~vl~ellt----G------~~p~~~~ 637 (752)
+|||....... -....+..+||.+|||||++...- + -..+||||||.|+||++- | +.||...
T Consensus 360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~ 439 (513)
T KOG2052|consen 360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV 439 (513)
T ss_pred ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence 99998654332 223345678999999999986532 1 236899999999999864 2 2344433
Q ss_pred CCCCCcchHHHHHHHhhCCCcccccCCCCC-CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCC
Q 043278 638 HPDRPLNLIGYAWQLLSDGKGLELIDPSLE-QPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETM 708 (752)
Q Consensus 638 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~~ 708 (752)
-+.++. .+...+.+- .+.+.|.+. .-.+.+.+..+.+++..||..+|..|-|+-.+-+.|.++..
T Consensus 440 Vp~DPs--~eeMrkVVC----v~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 440 VPSDPS--FEEMRKVVC----VQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCCCC--HHHHhccee----ecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 333222 111111111 122333332 22456788889999999999999999999999888877653
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=313.23 Aligned_cols=265 Identities=25% Similarity=0.370 Sum_probs=197.3
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCc-ccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEee
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSG-QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
++|.+.++||+|+||.||+|+.. +++.||+|.++.... .....+.+|+.++++++|+||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 46888899999999999999875 577899999875432 2334678899999999999999999999999999999999
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccc
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES 587 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~ 587 (752)
+++ +|..++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 985 777776543 345889999999999999999999988 99999999999999999999999999976432221
Q ss_pred ccccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHH--------HHHhhCC-C
Q 043278 588 EANTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYA--------WQLLSDG-K 657 (752)
Q Consensus 588 ~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~--------~~~~~~~-~ 657 (752)
......++..|+|||.+.+ ..++.++||||||++++||++|+.||......+....+... +..+... .
T Consensus 160 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 160 --TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred --ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence 1123457889999998865 56899999999999999999999999765432211111100 0000000 0
Q ss_pred cccccCCCCCC----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 658 GLELIDPSLEQ----PCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 658 ~~~~~d~~l~~----~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
....-.+.... .........+.+++.+|++.||.+|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 00000000000 0001112346789999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=307.64 Aligned_cols=252 Identities=27% Similarity=0.392 Sum_probs=204.6
Q ss_pred HhcCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEe
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYE 506 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 506 (752)
..++|.+.+.||+|+||.||++.. .+++.||+|.+..........+.+|+.+++.++|+||+++++++..++..++|||
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 346888899999999999999986 4689999999976655556678899999999999999999999999999999999
Q ss_pred eCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccc
Q 043278 507 FMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586 (752)
Q Consensus 507 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~ 586 (752)
|+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||||+|||++.++.++|+|||++.......
T Consensus 97 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 97 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred ccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 9999999998843 34789999999999999999999988 9999999999999999999999999987654322
Q ss_pred cccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCC
Q 043278 587 SEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666 (752)
Q Consensus 587 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 666 (752)
.. .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||....+...... ....+ .+.+
T Consensus 170 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~------~~~~~------~~~~ 235 (297)
T cd06656 170 SK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNG------TPEL 235 (297)
T ss_pred cC--cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee------eccCC------CCCC
Confidence 11 1234678899999999999999999999999999999999999976543221110 00000 0000
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 667 EQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 667 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
..+......+.+++.+|++.+|++||++.+++++
T Consensus 236 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 236 --QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred --CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111223446788899999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=304.22 Aligned_cols=247 Identities=25% Similarity=0.333 Sum_probs=192.6
Q ss_pred eecCCcccEEEEEec-CCceeEEEEcccCC---cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCCCCCH
Q 043278 438 LGEGGFGPVYKGKLA-DEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSL 513 (752)
Q Consensus 438 LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 513 (752)
||+|+||.||+++.. +|+.+|+|.+.... ......+..|++++.+++||||+++++++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999864 58999999986432 12234456799999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccccccccc
Q 043278 514 DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKR 593 (752)
Q Consensus 514 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~ 593 (752)
..++.... ...+++..+..++.||+.||+|||+.+ |+||||||+||++++++.++|+|||++....... ....
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~ 153 (277)
T cd05607 81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQ 153 (277)
T ss_pred HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeec
Confidence 88875432 345889999999999999999999988 9999999999999999999999999998654322 1123
Q ss_pred ccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCCCCHH
Q 043278 594 IVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSAN 673 (752)
Q Consensus 594 ~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 673 (752)
..|+..|+|||++.+..++.++|||||||++|||++|+.||......... ........ .... ... . ..
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~--~~~~~~~~-~~~~----~~~--~---~~ 221 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK--EELKRRTL-EDEV----KFE--H---QN 221 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH--HHHHHHhh-cccc----ccc--c---cc
Confidence 46889999999999989999999999999999999999998654322111 11111111 1110 000 0 01
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 043278 674 EVMRCIHVGLLCVQDQAMDRPTMPEVVCML 703 (752)
Q Consensus 674 ~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L 703 (752)
....+.+++..|++.||++||++.|+++.+
T Consensus 222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 222 FTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred CCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 233467899999999999999997766443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=308.95 Aligned_cols=261 Identities=21% Similarity=0.271 Sum_probs=199.1
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEee
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
++|++.++||+|+||.||++... ++..+|+|.+.... .....++.+|++++.+++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36888899999999999999865 57789999886542 23345688999999999999999999999999999999999
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccc
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES 587 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~ 587 (752)
+++++|..++... ..+++..+..++.||+.||.|||+.. +++|+||||+|||+++++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 153 (308)
T cd06615 81 MDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 153 (308)
T ss_pred cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc--
Confidence 9999999998543 45889999999999999999999842 2999999999999999999999999998754321
Q ss_pred ccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcc--------
Q 043278 588 EANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGL-------- 659 (752)
Q Consensus 588 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~-------- 659 (752)
......++..|+|||.+.+..++.++||||||++++||++|+.|+.........................
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 154 --MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred --ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCC
Confidence 1223567889999999988889999999999999999999999986443211110000000000000000
Q ss_pred ---------c----c---cCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 660 ---------E----L---IDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 660 ---------~----~---~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
+ + ..+.+.. ......+.+++.+|++.+|++|||+.||++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKLPS---GAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccCcC---cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0 0000000 0122357789999999999999999999886
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=301.29 Aligned_cols=248 Identities=31% Similarity=0.443 Sum_probs=196.5
Q ss_pred CeeecCCcccEEEEEecC----CceeEEEEcccCCc-ccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCCC
Q 043278 436 NKLGEGGFGPVYKGKLAD----EQEVAIKRLSRSSG-QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPN 510 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 510 (752)
++||+|+||.||+|+... +..+|+|.+..... ....++.+|+.+++++.|+||+++++++. ++..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999997532 26899999876543 24567899999999999999999999875 5578999999999
Q ss_pred CCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccccc
Q 043278 511 KSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEAN 590 (752)
Q Consensus 511 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~ 590 (752)
++|.+++.... .+++..+..++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 99999996533 5899999999999999999999988 99999999999999999999999999987643322111
Q ss_pred -cccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCC
Q 043278 591 -TKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQ 668 (752)
Q Consensus 591 -~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 668 (752)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .. ......+....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~----~~~~~~~~~~~-------- 218 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EV----IAMLESGERLP-------- 218 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HH----HHHHHcCCcCC--------
Confidence 111233567999999999999999999999999999998 99998654321 11 12222222111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 669 PCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 669 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
.+......+.+++.+|++.+|++||++.++++.|++.
T Consensus 219 -~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 219 -RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred -CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 1111224577899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=302.65 Aligned_cols=252 Identities=26% Similarity=0.381 Sum_probs=200.3
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCc-----ccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSG-----QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLL 503 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 503 (752)
++|...+.||+|++|.||++... +++++|+|.+..... .....+.+|++++.+++||||+++++++.+++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57888999999999999999864 588999998864321 123468899999999999999999999999999999
Q ss_pred EEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeec
Q 043278 504 VYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFE 583 (752)
Q Consensus 504 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~ 583 (752)
|+||+++++|.+++... ..++...+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY---GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 99999999999988543 35889999999999999999999988 9999999999999999999999999997654
Q ss_pred ccccccc-cccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCccccc
Q 043278 584 VNESEAN-TKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELI 662 (752)
Q Consensus 584 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 662 (752)
....... .....++..|+|||++.+..++.++||||||+++|||++|+.||...... ............
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~---- 225 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM------AAIFKIATQPTN---- 225 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH------HHHHHHhccCCC----
Confidence 3221111 12345778999999999988999999999999999999999998654211 111111111111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 663 DPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 663 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
+.+ +......+.+++.+|++.+|.+|||+.|++++
T Consensus 226 -~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 226 -PQL----PSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -CCC----CccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 111 11223356788899999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=322.13 Aligned_cols=260 Identities=22% Similarity=0.285 Sum_probs=201.3
Q ss_pred HHHHHHhcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccC---CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeC
Q 043278 423 QTIAAAANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRS---SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHG 498 (752)
Q Consensus 423 ~~i~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 498 (752)
.++....++|++.+.||+|+||.||+++.. +++.+|+|.+... .......+.+|+.++..++||||+++++.+.++
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 344455689999999999999999999875 5788999998642 122344578899999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceeccccc
Q 043278 499 EERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGM 578 (752)
Q Consensus 499 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgl 578 (752)
...++||||+++|+|..++.. ..++...+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 999999999999999998843 24788889999999999999999998 99999999999999999999999999
Q ss_pred ceeecccccccccccccccCCccChhhhccC----CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhh
Q 043278 579 ARIFEVNESEANTKRIVGTYGYMSPEYAMSG----IVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLS 654 (752)
Q Consensus 579 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 654 (752)
++....... .......||+.|+|||++... .++.++|||||||++|||++|+.||..... .......+.
T Consensus 189 a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~ 261 (371)
T cd05622 189 CMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIMN 261 (371)
T ss_pred eeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH------HHHHHHHHc
Confidence 987543221 122346799999999998753 388999999999999999999999976442 111222222
Q ss_pred CCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHHh
Q 043278 655 DGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMD--RPTMPEVVCML 703 (752)
Q Consensus 655 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~--RPt~~ev~~~L 703 (752)
......+.+ .......+.+++..|++.++.+ ||++.|++++.
T Consensus 262 ~~~~~~~~~-------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 262 HKNSLTFPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CCCcccCCC-------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 211111111 1122334667888899844433 78999998864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=299.85 Aligned_cols=254 Identities=21% Similarity=0.306 Sum_probs=189.8
Q ss_pred CeeecCCcccEEEEEecCCc---eeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCCCC
Q 043278 436 NKLGEGGFGPVYKGKLADEQ---EVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNK 511 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~~~~---~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 511 (752)
+.||+|+||.||++...++. .+++|.+.... ......+.+|+.++..++||||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 36999999999999764433 45677665433 234567899999999999999999999999999999999999999
Q ss_pred CHhHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccccc
Q 043278 512 SLDFFLFNSGR-KNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEAN 590 (752)
Q Consensus 512 sL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~ 590 (752)
+|..++..... ...+++.....++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||++...........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999865422 234667778899999999999999988 99999999999999999999999999864322211112
Q ss_pred cccccccCCccChhhhcc-------CCCCccchhHHHHHHHHHHHhC-CCCCCCCCCCCCcchHHHHHHHhhCCCccccc
Q 043278 591 TKRIVGTYGYMSPEYAMS-------GIVSIKTDVFSFGVLVLEIVSG-QKNHTRHHPDRPLNLIGYAWQLLSDGKGLELI 662 (752)
Q Consensus 591 ~~~~~gt~~y~aPE~~~~-------~~~t~k~DV~S~G~vl~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 662 (752)
.....++..|+|||++.. ..++.++||||||+++|||+++ ..|+..... .......+. +....+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~------~~~~~~~~~-~~~~~~~ 230 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD------REVLNHVIK-DQQVKLF 230 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHh-hcccccC
Confidence 223567889999998743 3467899999999999999975 556643321 111112222 2223344
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 043278 663 DPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ 704 (752)
Q Consensus 663 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~ 704 (752)
++.+....+ .++.+++..|+ .+|.+||+++||++.|.
T Consensus 231 ~~~~~~~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLELPYS----ERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCCCCc----HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 454433322 34556777899 57999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=299.73 Aligned_cols=249 Identities=25% Similarity=0.407 Sum_probs=202.9
Q ss_pred cCCCcCCeeecCCcccEEEEEecC-CceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeC
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLAD-EQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFM 508 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 508 (752)
++|+..++||+|+||.||++...+ ++.+++|.+..... ..++.+|++++++++|+||+++++++..+...++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578888999999999999999765 78999999875532 678999999999999999999999999999999999999
Q ss_pred CCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccc
Q 043278 509 PNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE 588 (752)
Q Consensus 509 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 588 (752)
++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 81 GAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 999999998543 346899999999999999999999988 99999999999999999999999999986543221
Q ss_pred cccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCC
Q 043278 589 ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQ 668 (752)
Q Consensus 589 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 668 (752)
......++..|+|||++.+..++.++||||||++++||++|+.|+....+..... ...... .+.+
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~-------~~~~~~-----~~~~-- 219 (256)
T cd06612 155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF-------MIPNKP-----PPTL-- 219 (256)
T ss_pred -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh-------hhccCC-----CCCC--
Confidence 1223457889999999999999999999999999999999999987654322110 000000 0111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 043278 669 PCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVC 701 (752)
Q Consensus 669 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~ 701 (752)
..+......+.+++.+|++.+|.+|||+.||++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 220 SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 111122345778899999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=310.48 Aligned_cols=255 Identities=30% Similarity=0.459 Sum_probs=199.6
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCc----eeEEEEcccCCc-ccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQ----EVAIKRLSRSSG-QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLL 503 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~----~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 503 (752)
++|+..+.||+|+||.||+|... ++. .+|+|.+..... ....++.+|+.++.+++|+||+++++++... ...+
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 56777899999999999999863 343 478898865432 2334688999999999999999999998754 5679
Q ss_pred EEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeec
Q 043278 504 VYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFE 583 (752)
Q Consensus 504 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~ 583 (752)
++||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||+++...
T Consensus 86 v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 86 VTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence 99999999999988543 235889999999999999999999988 9999999999999999999999999998664
Q ss_pred ccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCccccc
Q 043278 584 VNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELI 662 (752)
Q Consensus 584 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 662 (752)
............++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... .....+..+....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~-------~~~~~~~~~~~~~-- 231 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR-------EIPDLLEKGERLP-- 231 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHCCCCCC--
Confidence 3332222223345678999999999999999999999999999998 88888654311 1112222221111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 663 DPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 663 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
.+ ......+.+++..|+..+|++||+|.++++.|+.+
T Consensus 232 ~~-------~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 232 QP-------PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred CC-------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11 11123567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=313.06 Aligned_cols=194 Identities=24% Similarity=0.348 Sum_probs=165.1
Q ss_pred HHhcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEE
Q 043278 427 AAANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 427 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 505 (752)
....+|.+.+.||+|+||.||+|+.. .++.||+|..... ....|+.++.+++|+||+++++++.++...++|+
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 34568999999999999999999875 4678999975433 2356999999999999999999999999999999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccc
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVN 585 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~ 585 (752)
|++. ++|..++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 137 e~~~-~~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 137 PHYS-SDLYTYLTKR--SRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred EccC-CcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 9995 5777777542 345899999999999999999999988 999999999999999999999999999753221
Q ss_pred ccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 043278 586 ESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHT 635 (752)
Q Consensus 586 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~ 635 (752)
.......||..|+|||++.+..++.++|||||||++|||+++..++.
T Consensus 211 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 211 ---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred ---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 11223568999999999999999999999999999999999766553
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=302.31 Aligned_cols=256 Identities=23% Similarity=0.358 Sum_probs=199.2
Q ss_pred HhcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEe
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYE 506 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 506 (752)
+++.+.....||+|+||.||+|+.. ++..|++|.+..........+.+|+.++++++|+||+++++++..++..++|+|
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 85 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFME 85 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEe
Confidence 4556666679999999999999864 567899999887766666789999999999999999999999999999999999
Q ss_pred eCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecC-CCCceecccccceeeccc
Q 043278 507 FMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDD-KMNPKISDFGMARIFEVN 585 (752)
Q Consensus 507 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~-~~~~kl~DFgla~~~~~~ 585 (752)
|+++++|..++.........++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 162 (268)
T cd06624 86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI 162 (268)
T ss_pred cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecccC
Confidence 9999999999865322212278888899999999999999988 999999999999976 679999999998765322
Q ss_pred ccccccccccccCCccChhhhccCC--CCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccC
Q 043278 586 ESEANTKRIVGTYGYMSPEYAMSGI--VSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELID 663 (752)
Q Consensus 586 ~~~~~~~~~~gt~~y~aPE~~~~~~--~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 663 (752)
.. ......++..|+|||++.... ++.++||||||+++|||++|+.|+........ ..+...... ..
T Consensus 163 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~~~~~-------~~ 230 (268)
T cd06624 163 NP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKVGMFK-------IH 230 (268)
T ss_pred CC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhhhhhc-------cC
Confidence 21 122245788999999987643 78999999999999999999999865332110 000000000 01
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 664 PSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 664 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
+.+ +......+.+++.+|++.+|.+|||+.|+++.
T Consensus 231 ~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 231 PEI----PESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred CCC----CcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 111 12233457788999999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=305.04 Aligned_cols=255 Identities=29% Similarity=0.438 Sum_probs=201.9
Q ss_pred cCCCcCCeeecCCcccEEEEEecC-Cc----eeEEEEcccCCc-ccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLAD-EQ----EVAIKRLSRSSG-QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLL 503 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~----~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 503 (752)
.+|.+.+.||+|+||.||+|...+ ++ .+|+|.+..... ....++.+|+.++++++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 567778999999999999998643 33 589998876543 345678899999999999999999999887 78899
Q ss_pred EEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeec
Q 043278 504 VYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFE 583 (752)
Q Consensus 504 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~ 583 (752)
||||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ ++|+||||+||++++++.+||+|||+++...
T Consensus 86 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 99999999999998653 234899999999999999999999987 9999999999999999999999999998765
Q ss_pred ccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCccccc
Q 043278 584 VNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELI 662 (752)
Q Consensus 584 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 662 (752)
............++..|+|||.+....++.++||||||++++|+++ |+.|+......+ ....+..+....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~~-- 231 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE-------IPDLLEKGERLP-- 231 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH-------HHHHHhCCCCCC--
Confidence 3322211112223568999999998899999999999999999999 999986654211 112222221111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 663 DPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 663 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
.+ ......+.+++.+|+..+|++||++.++++.|+..
T Consensus 232 ~~-------~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 232 QP-------PICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred CC-------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 11 11223567888999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=305.41 Aligned_cols=253 Identities=29% Similarity=0.439 Sum_probs=198.9
Q ss_pred CCcCCeeecCCcccEEEEEecC-CceeEEEEcccCCcccHH--HHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeC
Q 043278 432 FSTTNKLGEGGFGPVYKGKLAD-EQEVAIKRLSRSSGQGIV--EFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFM 508 (752)
Q Consensus 432 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~--~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 508 (752)
|++.+.||+|+||+||+++... ++.+|+|.+......... ...+|+.++.+++|+||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 4567899999999999999765 568999999876543332 2356999999999999999999999999999999999
Q ss_pred CCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccc
Q 043278 509 PNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE 588 (752)
Q Consensus 509 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 588 (752)
++++|.+++. ....+++..+..++.||++||++||+.+ ++|+||||+||++++++.++|+|||++.... ...
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENN 152 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST--STT
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc--ccc
Confidence 9999999996 3345899999999999999999999998 9999999999999999999999999998641 112
Q ss_pred cccccccccCCccChhhhc-cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCC
Q 043278 589 ANTKRIVGTYGYMSPEYAM-SGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLE 667 (752)
Q Consensus 589 ~~~~~~~gt~~y~aPE~~~-~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 667 (752)
.......++..|+|||++. +...+.++||||+|+++++|++|+.|+.......... ........ ... ....
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~---~~~~~~~~-~~~---~~~~- 224 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLE---IIEKILKR-PLP---SSSQ- 224 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHH---HHHHHHHT-HHH---HHTT-
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhh---hhhhcccc-ccc---cccc-
Confidence 2233467788999999998 8899999999999999999999999987652111111 11111110 000 0000
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 668 QPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 668 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
........+.+++.+|++.||++||++.+++++
T Consensus 225 --~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 225 --QSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp --SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred --ccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000011578889999999999999999999863
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=308.35 Aligned_cols=237 Identities=22% Similarity=0.281 Sum_probs=186.1
Q ss_pred CeeecCCcccEEEEEec-CCceeEEEEcccCC---cccHHHHHHHH-HHHHhcCCCCcceeeeeeeeCCeeEEEEeeCCC
Q 043278 436 NKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS---GQGIVEFKNEV-RLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPN 510 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 510 (752)
+.||+|+||.||+++.. +++.||+|++.... ......+.+|. .+++.++|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999875 57889999986532 12233445554 467889999999999999999999999999999
Q ss_pred CCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccccc
Q 043278 511 KSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEAN 590 (752)
Q Consensus 511 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~ 590 (752)
++|..++.. ...++...+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~ 152 (321)
T cd05603 81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EET 152 (321)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CCc
Confidence 999888753 345888899999999999999999988 999999999999999999999999998753221 122
Q ss_pred cccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCCC
Q 043278 591 TKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPC 670 (752)
Q Consensus 591 ~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 670 (752)
.....|++.|+|||.+.+..++.++|||||||++|||++|+.||...... ... ..+..+. .. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~-~~i~~~~-~~---------~ 215 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS------QMY-DNILHKP-LQ---------L 215 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH------HHH-HHHhcCC-CC---------C
Confidence 23457899999999999999999999999999999999999999765311 111 1111111 00 1
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHH
Q 043278 671 SANEVMRCIHVGLLCVQDQAMDRPTMP 697 (752)
Q Consensus 671 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~ 697 (752)
+......+.+++.+|++.+|.+||++.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 216 PGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 112234577899999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=304.58 Aligned_cols=263 Identities=24% Similarity=0.324 Sum_probs=197.4
Q ss_pred CCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEee
Q 043278 431 NFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
+|++.+.||+|++|.||+|+.. +++.||+|++.... ......+.+|+.++.+++|+||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4677889999999999999875 58899999986542 22346788999999999999999999999999999999999
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccc
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES 587 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~ 587 (752)
++ ++|..++........+++..+..++.||+.||+|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 98 688888765444466899999999999999999999988 99999999999999999999999999976543211
Q ss_pred ccccccccccCCccChhhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhC-----------
Q 043278 588 EANTKRIVGTYGYMSPEYAMSG-IVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSD----------- 655 (752)
Q Consensus 588 ~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~----------- 655 (752)
......+++.|+|||.+.+. .++.++||||||++++||++|+.||........ +.... ..+..
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~ 231 (285)
T cd07861 157 --VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ--LFRIF-RILGTPTEDVWPGVTS 231 (285)
T ss_pred --cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHH-HHhCCCChhhhhcchh
Confidence 11223567899999988754 578999999999999999999999976542110 00000 00000
Q ss_pred -CCcccccCCCCC---CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 656 -GKGLELIDPSLE---QPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 656 -~~~~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.......+.... .........++.+++.+|++.||.+|||+.+|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 232 LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000000000 00000122456789999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=300.37 Aligned_cols=238 Identities=24% Similarity=0.390 Sum_probs=189.2
Q ss_pred CeeecCCcccEEEEEecCCc-----------eeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEE
Q 043278 436 NKLGEGGFGPVYKGKLADEQ-----------EVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLV 504 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~~~~-----------~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 504 (752)
+.||+|+||.||+|.+.+.. .+++|.+...... ...+.+|+.++++++|+||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 47999999999999876433 4788877654433 6788999999999999999999999988 778999
Q ss_pred EeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCC-------Cceecccc
Q 043278 505 YEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKM-------NPKISDFG 577 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~-------~~kl~DFg 577 (752)
|||+++|+|..++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 99999999999986533 25899999999999999999999988 99999999999999888 79999999
Q ss_pred cceeecccccccccccccccCCccChhhhccC--CCCccchhHHHHHHHHHHHhC-CCCCCCCCCCCCcchHHHHHHHhh
Q 043278 578 MARIFEVNESEANTKRIVGTYGYMSPEYAMSG--IVSIKTDVFSFGVLVLEIVSG-QKNHTRHHPDRPLNLIGYAWQLLS 654 (752)
Q Consensus 578 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~k~DV~S~G~vl~elltG-~~p~~~~~~~~~~~l~~~~~~~~~ 654 (752)
++..... .....++..|+|||++... .++.++||||||+++|||++| ..|+......... ....
T Consensus 154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~-------~~~~ 220 (259)
T cd05037 154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE-------RFYQ 220 (259)
T ss_pred ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHH-------HHHh
Confidence 9986443 1123456789999998876 789999999999999999994 6666554321110 0111
Q ss_pred CCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 043278 655 DGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ 704 (752)
Q Consensus 655 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~ 704 (752)
.... ... .....+.+++.+|++.+|.+|||+.||++.|+
T Consensus 221 ~~~~--~~~---------~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 DQHR--LPM---------PDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred cCCC--CCC---------CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 1110 000 01156778999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=294.18 Aligned_cols=249 Identities=24% Similarity=0.368 Sum_probs=211.4
Q ss_pred CCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCC
Q 043278 431 NFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMP 509 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 509 (752)
-|.+..+||+|+||.|||+.++ .|+.+|+|++.-. ....++.+|+.++++...+++|+++|.+......+||||||.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 3555689999999999999865 5899999998654 467788999999999999999999999999999999999999
Q ss_pred CCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccccc
Q 043278 510 NKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEA 589 (752)
Q Consensus 510 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 589 (752)
.|+..+.+.. +++.|++.++-.+++..++||+|||... -||||||+.||||+-+|.+||+|||.|..+......
T Consensus 112 AGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK- 185 (502)
T KOG0574|consen 112 AGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK- 185 (502)
T ss_pred CCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHHh-
Confidence 9999999865 4567999999999999999999999976 799999999999999999999999999866543322
Q ss_pred ccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCC
Q 043278 590 NTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQP 669 (752)
Q Consensus 590 ~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 669 (752)
.+.+.||+.|||||++..-.|+.++||||||+...||..|++|+...++-+...++. . .|.....
T Consensus 186 -RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIP------------T--~PPPTF~ 250 (502)
T KOG0574|consen 186 -RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIP------------T--KPPPTFK 250 (502)
T ss_pred -hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEecc------------C--CCCCCCC
Confidence 345899999999999999999999999999999999999999998877655443220 0 1111223
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 670 CSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 670 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.+......+-+++..|+-+.|++|-|+.+++++
T Consensus 251 KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 251 KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 355566778899999999999999999988876
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=309.81 Aligned_cols=239 Identities=22% Similarity=0.279 Sum_probs=187.4
Q ss_pred CeeecCCcccEEEEEec-CCceeEEEEcccCC---cccHHHHHHHHH-HHHhcCCCCcceeeeeeeeCCeeEEEEeeCCC
Q 043278 436 NKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS---GQGIVEFKNEVR-LIAKLQHTNLVRLLGCSLHGEERLLVYEFMPN 510 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 510 (752)
+.||+|+||.||+++.. +|+.+|+|++.... .....++..|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 47999999999999864 68899999986542 223344555554 46778999999999999999999999999999
Q ss_pred CCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccccc
Q 043278 511 KSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEAN 590 (752)
Q Consensus 511 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~ 590 (752)
|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..... ...
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~ 152 (325)
T cd05604 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDT 152 (325)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCC
Confidence 999888753 345899999999999999999999988 999999999999999999999999998743211 112
Q ss_pred cccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCCC
Q 043278 591 TKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPC 670 (752)
Q Consensus 591 ~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 670 (752)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||...... ....... .+.. .+.+ .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~------~~~~~~~-~~~~--~~~~----~- 218 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA------EMYDNIL-HKPL--VLRP----G- 218 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH------HHHHHHH-cCCc--cCCC----C-
Confidence 23467899999999999999999999999999999999999999765421 1111111 1111 0111 1
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 043278 671 SANEVMRCIHVGLLCVQDQAMDRPTMPEV 699 (752)
Q Consensus 671 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev 699 (752)
....+.+++.+|++.+|.+||++.+.
T Consensus 219 ---~~~~~~~ll~~ll~~~p~~R~~~~~~ 244 (325)
T cd05604 219 ---ASLTAWSILEELLEKDRQRRLGAKED 244 (325)
T ss_pred ---CCHHHHHHHHHHhccCHHhcCCCCCC
Confidence 22346678899999999999988643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=301.09 Aligned_cols=250 Identities=27% Similarity=0.376 Sum_probs=191.2
Q ss_pred CeeecCCcccEEEEEecC----CceeEEEEcccC-CcccHHHHHHHHHHHHhcCCCCcceeeeeee-eCCeeEEEEeeCC
Q 043278 436 NKLGEGGFGPVYKGKLAD----EQEVAIKRLSRS-SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSL-HGEERLLVYEFMP 509 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~E~~~ 509 (752)
+.||+|+||.||+|...+ ...+|+|++... .......+.+|+.+++.++||||+++++++. .+...++++||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998532 357999998643 2334567889999999999999999999775 4556789999999
Q ss_pred CCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccc-
Q 043278 510 NKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE- 588 (752)
Q Consensus 510 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~- 588 (752)
+++|..++... ...+++..++.++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 99999998643 234678888999999999999999987 999999999999999999999999999765332111
Q ss_pred -cccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCC-CCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCC
Q 043278 589 -ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ-KNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666 (752)
Q Consensus 589 -~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~-~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 666 (752)
.......++..|+|||.+....++.++||||||+++|||++|. +|+..... ..... .+..+.... .
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~------~~~~~-~~~~~~~~~-----~ 223 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS------FDITV-YLLQGRRLL-----Q 223 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHH-HHhcCCCCC-----C
Confidence 1112234567899999999889999999999999999999954 45543221 11111 111111110 0
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 667 EQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 667 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
+......+.+++..||+.+|++||++.||++.|+..
T Consensus 224 ----~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 224 ----PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred ----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 111123577899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=302.59 Aligned_cols=256 Identities=25% Similarity=0.393 Sum_probs=198.4
Q ss_pred CCcCCeeecCCcccEEEEEec----CCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCC------
Q 043278 432 FSTTNKLGEGGFGPVYKGKLA----DEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGE------ 499 (752)
Q Consensus 432 ~~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 499 (752)
|.+.+.||+|+||.||+|.+. .++.||||++.... ....+++.+|+.++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456789999999999999853 36789999987642 334567889999999999999999999886532
Q ss_pred eeEEEEeeCCCCCHhHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceeccc
Q 043278 500 ERLLVYEFMPNKSLDFFLFNSG---RKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDF 576 (752)
Q Consensus 500 ~~~lv~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DF 576 (752)
..++++||+++|+|..++.... ....+++.....++.||+.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2378899999999988875432 2235789999999999999999999988 999999999999999999999999
Q ss_pred ccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhC
Q 043278 577 GMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSD 655 (752)
Q Consensus 577 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 655 (752)
|+++...............++..|++||.+....++.++||||||+++|||++ |+.|+...... .. ......
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~~----~~~~~~ 230 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---EI----YNYLIK 230 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---HH----HHHHHc
Confidence 99986543322222222345678999999999999999999999999999999 88887654321 11 111111
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 656 GKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 656 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
+.... .+......+.+++.+|++.+|.+||++.|+++.|+++
T Consensus 231 ~~~~~---------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 GNRLK---------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11111 0112234688899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=297.02 Aligned_cols=254 Identities=24% Similarity=0.379 Sum_probs=199.9
Q ss_pred CCCcCCeeecCCcccEEEEEecC--CceeEEEEcccCC----------cccHHHHHHHHHHHHh-cCCCCcceeeeeeee
Q 043278 431 NFSTTNKLGEGGFGPVYKGKLAD--EQEVAIKRLSRSS----------GQGIVEFKNEVRLIAK-LQHTNLVRLLGCSLH 497 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~~~--~~~vavK~l~~~~----------~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~ 497 (752)
+|++.+.||+|+||.||++.... ++.+|+|.+.... .....++.+|+.++.+ ++|+||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 46778899999999999999765 6789999875321 2233456778888865 799999999999999
Q ss_pred CCeeEEEEeeCCCCCHhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCcEeecCCCCCcEEecCCCCceecc
Q 043278 498 GEERLLVYEFMPNKSLDFFLFNS-GRKNVLNWEKRFIIIEGISQGLLYLHK-YSRLRVIHRDLKASNILLDDKMNPKISD 575 (752)
Q Consensus 498 ~~~~~lv~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~Dikp~NIll~~~~~~kl~D 575 (752)
++..+++|||+++++|.+++... .....+++..++.++.|++.||.|||+ .+ ++|+||+|+||+++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999998887542 234568999999999999999999996 44 99999999999999999999999
Q ss_pred cccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhC
Q 043278 576 FGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSD 655 (752)
Q Consensus 576 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 655 (752)
||++....... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+...... .. ......
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~------~~-~~~~~~ 227 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML------SL-ATKIVE 227 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH------HH-HHHHhh
Confidence 99998654332 223456788999999999988999999999999999999999998644311 11 111111
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 043278 656 GKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705 (752)
Q Consensus 656 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~ 705 (752)
+..... . .......+.+++.+|++.||++||++.||.++|++
T Consensus 228 ~~~~~~----~----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 228 AVYEPL----P----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred ccCCcC----C----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 111111 0 00122457788899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=307.18 Aligned_cols=250 Identities=26% Similarity=0.385 Sum_probs=203.0
Q ss_pred cCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeC
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFM 508 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 508 (752)
.+|+..+.||.|++|.||++.. .+++.|++|.+..........+.+|+.+++.++|+|++++++++..++..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4688889999999999999985 568899999997665555677899999999999999999999999999999999999
Q ss_pred CCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccc
Q 043278 509 PNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE 588 (752)
Q Consensus 509 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 588 (752)
++++|..++.. ..+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 170 (296)
T cd06655 99 AGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS- 170 (296)
T ss_pred CCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc-
Confidence 99999998843 34899999999999999999999988 99999999999999999999999999876543221
Q ss_pred cccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCC
Q 043278 589 ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQ 668 (752)
Q Consensus 589 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 668 (752)
......++..|+|||.+.+..++.++|||||||++|||++|+.||....+.... .... ......+..
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~------~~~~-~~~~~~~~~----- 237 (296)
T cd06655 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------YLIA-TNGTPELQN----- 237 (296)
T ss_pred -cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHH-hcCCcccCC-----
Confidence 122346788999999999988999999999999999999999999765432111 1111 111111101
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 669 PCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 669 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
+......+.+++.+||+.+|.+|||+.+++..
T Consensus 238 --~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 238 --PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred --cccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 11122356678899999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=304.12 Aligned_cols=240 Identities=24% Similarity=0.374 Sum_probs=188.4
Q ss_pred CeeecCCcccEEEEEecC--------CceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEee
Q 043278 436 NKLGEGGFGPVYKGKLAD--------EQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
+.||+|+||.||+|.... ..++++|.+........+++.+|+.++..++|||++++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999997632 234888888665545556789999999999999999999999998999999999
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCC--------ceecccccc
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMN--------PKISDFGMA 579 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~--------~kl~DFgla 579 (752)
+++|+|..++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 99999999986532 35899999999999999999999988 999999999999987765 589999988
Q ss_pred eeecccccccccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCC-CCCCCCCCCCCcchHHHHHHHhhCCC
Q 043278 580 RIFEVNESEANTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQ-KNHTRHHPDRPLNLIGYAWQLLSDGK 657 (752)
Q Consensus 580 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~-~p~~~~~~~~~~~l~~~~~~~~~~~~ 657 (752)
..... .....++..|+|||++.+ ..++.++||||||+++|||++|. .|+....... . ......
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~------~-~~~~~~-- 220 (258)
T cd05078 156 ITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK------K-LQFYED-- 220 (258)
T ss_pred cccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH------H-HHHHHc--
Confidence 64332 123457788999999987 45899999999999999999995 4443322111 0 011111
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 043278 658 GLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ 704 (752)
Q Consensus 658 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~ 704 (752)
... + +......+.+++.+|++.+|++|||++++++.|+
T Consensus 221 ~~~-----~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 221 RHQ-----L----PAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ccc-----C----CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 001 1 1112245778999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=295.96 Aligned_cols=250 Identities=20% Similarity=0.288 Sum_probs=201.2
Q ss_pred CCCcCCeeecCCcccEEEEEec-CCceeEEEEcccC-CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeC
Q 043278 431 NFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRS-SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFM 508 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 508 (752)
+|++.+.||+|+||.||+++.. +++.+|+|.+... .....+.+.+|+.++++++|+||+++++.+..++..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4677899999999999999864 5888999988543 2334567889999999999999999999999999999999999
Q ss_pred CCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccc
Q 043278 509 PNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE 588 (752)
Q Consensus 509 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 588 (752)
++++|..++... ....++...+..++.||+.||.|||+.+ |+|+||||+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence 999998887543 2345789999999999999999999988 99999999999999999999999999986543221
Q ss_pred cccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCC
Q 043278 589 ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQ 668 (752)
Q Consensus 589 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 668 (752)
......++..|+|||++.+..++.++|+||||+++++|++|+.||...... .. ...+..+....+
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~------~~-~~~~~~~~~~~~------- 220 (255)
T cd08219 156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK------NL-ILKVCQGSYKPL------- 220 (255)
T ss_pred -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH------HH-HHHHhcCCCCCC-------
Confidence 122356788999999999989999999999999999999999999754321 11 111222221111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 669 PCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 669 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
+......+.+++.+||+.||.+|||+.|++..
T Consensus 221 --~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 --PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred --CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11122356788999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=301.82 Aligned_cols=249 Identities=27% Similarity=0.415 Sum_probs=202.2
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEee
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
++|+..+.||.|++|.||+|+.. +++.||+|.+.... ......+.+|+.+++.++|+|++++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36777899999999999999865 57899999987553 33456788999999999999999999999999999999999
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccc
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES 587 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~ 587 (752)
+++++|.+++... .+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++......
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 152 (274)
T cd06609 81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM- 152 (274)
T ss_pred eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence 9999999988532 6899999999999999999999988 9999999999999999999999999998765332
Q ss_pred ccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCC
Q 043278 588 EANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLE 667 (752)
Q Consensus 588 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 667 (752)
.......++..|+|||++.+..++.++||||||+++|||++|+.|+....+... ......+.. +.+.
T Consensus 153 -~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~-------~~~~~~~~~-----~~~~ 219 (274)
T cd06609 153 -SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV-------LFLIPKNNP-----PSLE 219 (274)
T ss_pred -cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH-------HHHhhhcCC-----CCCc
Confidence 112235678899999999998899999999999999999999999975542111 111111111 1111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 668 QPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 668 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.. .....+.+++.+|++.+|++|||+++++++
T Consensus 220 ~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 220 GN---KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred cc---ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 11 023356788899999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=302.16 Aligned_cols=252 Identities=24% Similarity=0.392 Sum_probs=201.0
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeC
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFM 508 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 508 (752)
+.|++.++||+|+||.||+|+.. +++.+++|.+..........+.+|+.++++++|+|++++++++..+...++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56888899999999999999875 47899999998776666778899999999999999999999999999999999999
Q ss_pred CCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccc
Q 043278 509 PNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE 588 (752)
Q Consensus 509 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 588 (752)
++++|..++.... ..+++..+..++.|++.+|+|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 92 ~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-- 164 (292)
T cd06644 92 PGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-- 164 (292)
T ss_pred CCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc--
Confidence 9999988875432 35899999999999999999999987 9999999999999999999999999987533221
Q ss_pred cccccccccCCccChhhhc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccC
Q 043278 589 ANTKRIVGTYGYMSPEYAM-----SGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELID 663 (752)
Q Consensus 589 ~~~~~~~gt~~y~aPE~~~-----~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 663 (752)
.......++..|+|||++. ...++.++||||||+++|||++|+.|+...... ....... ....
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~~~~-~~~~----- 232 (292)
T cd06644 165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIA-KSEP----- 232 (292)
T ss_pred cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH------HHHHHHh-cCCC-----
Confidence 1122346788999999884 345788999999999999999999998654321 1111111 1111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 664 PSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 664 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
+... .+......+.+++.+|++.+|++||++.|+++.
T Consensus 233 ~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 233 PTLS--QPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred ccCC--CCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 1110 111223356788999999999999999999874
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=302.66 Aligned_cols=256 Identities=27% Similarity=0.376 Sum_probs=202.5
Q ss_pred cCCCcCCeeecCCcccEEEEEec------CCceeEEEEcccCCcc-cHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA------DEQEVAIKRLSRSSGQ-GIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERL 502 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 502 (752)
++|+..+.||+|+||.||+|+.. +.+.|++|.+...... ...++.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56788899999999999999864 2467999988765433 4567899999999999999999999999989999
Q ss_pred EEEeeCCCCCHhHHHhhcCCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceeccc
Q 043278 503 LVYEFMPNKSLDFFLFNSGRK------NVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDF 576 (752)
Q Consensus 503 lv~E~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DF 576 (752)
+||||+++++|.+++...... ..+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998654322 25899999999999999999999988 999999999999999999999999
Q ss_pred ccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhC
Q 043278 577 GMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSD 655 (752)
Q Consensus 577 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 655 (752)
|++........ .......++..|+|||.+.+...+.++||||||++++||++ |..||....... .......
T Consensus 162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~-------~~~~~~~ 233 (275)
T cd05046 162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE-------VLNRLQA 233 (275)
T ss_pred ccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH-------HHHHHHc
Confidence 99875432211 11223456778999999998889999999999999999999 777775432111 1111222
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 043278 656 GKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ 704 (752)
Q Consensus 656 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~ 704 (752)
+..... .+......+.+++.+|++.+|.+|||+.|++.+|+
T Consensus 234 ~~~~~~--------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 234 GKLELP--------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCcCCC--------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 211110 01112246778999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=304.15 Aligned_cols=247 Identities=28% Similarity=0.440 Sum_probs=198.6
Q ss_pred CCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeC
Q 043278 431 NFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFM 508 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 508 (752)
.|+..+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++|+||+++++++..++..++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 3455678999999999999864 57789999887543 334457889999999999999999999999999999999999
Q ss_pred CCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccc
Q 043278 509 PNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE 588 (752)
Q Consensus 509 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 588 (752)
++++|.+++. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++..+.....
T Consensus 85 ~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06642 85 GGGSALDLLK----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch-
Confidence 9999998874 245889999999999999999999987 99999999999999999999999999976543221
Q ss_pred cccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCC
Q 043278 589 ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQ 668 (752)
Q Consensus 589 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 668 (752)
......++..|+|||++.+..++.++||||||++++||++|+.|+....+.... .....+. .+.+
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-------~~~~~~~-----~~~~-- 221 (277)
T cd06642 157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL-------FLIPKNS-----PPTL-- 221 (277)
T ss_pred -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH-------hhhhcCC-----CCCC--
Confidence 122345788999999999999999999999999999999999998654322111 0111111 1111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 669 PCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 669 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.......+.+++.+|++.+|.+||+|.||+++
T Consensus 222 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 222 --EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred --CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 11223457788999999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=302.16 Aligned_cols=253 Identities=27% Similarity=0.428 Sum_probs=198.8
Q ss_pred HHhcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCcccHHHHHHHHHHHHhc-CCCCcceeeeeeeeC------
Q 043278 427 AAANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHG------ 498 (752)
Q Consensus 427 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------ 498 (752)
.+++.|+..+.||+|+||.||+|... .++.||+|++.... .....+.+|+.++.++ +|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 45678888999999999999999865 57889999986543 4456788999999998 799999999998753
Q ss_pred CeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceeccccc
Q 043278 499 EERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGM 578 (752)
Q Consensus 499 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgl 578 (752)
...+++|||+++++|..++... ....+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 4678999999999999988653 2345889999999999999999999988 99999999999999999999999999
Q ss_pred ceeecccccccccccccccCCccChhhhc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHh
Q 043278 579 ARIFEVNESEANTKRIVGTYGYMSPEYAM-----SGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLL 653 (752)
Q Consensus 579 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 653 (752)
+....... .......|+..|+|||++. +..++.++|||||||++|||++|+.|+......... . ..
T Consensus 158 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~------~-~~ 228 (272)
T cd06637 158 SAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL------F-LI 228 (272)
T ss_pred ceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH------H-HH
Confidence 98653221 1223456889999999986 346888999999999999999999998654321111 1 11
Q ss_pred hCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 043278 654 SDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVC 701 (752)
Q Consensus 654 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~ 701 (752)
.........+ ......+.+++.+|++.+|.+|||+.|+++
T Consensus 229 ~~~~~~~~~~--------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 229 PRNPAPRLKS--------KKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred hcCCCCCCCC--------CCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 1111111111 112235678999999999999999999976
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=302.54 Aligned_cols=251 Identities=25% Similarity=0.331 Sum_probs=197.9
Q ss_pred CCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCc---ccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEee
Q 043278 432 FSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSG---QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 432 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
|+..+.||+|+||.||++... +++.+|+|.+..... .....+.+|+.++.+++|+|++++++.+.+++..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 566789999999999999865 578999999865422 2234577899999999999999999999999999999999
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccc
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES 587 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~ 587 (752)
+++++|..++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05630 82 MNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ- 156 (285)
T ss_pred cCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-
Confidence 99999998886433 235899999999999999999999987 9999999999999999999999999987643222
Q ss_pred ccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCC
Q 043278 588 EANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLE 667 (752)
Q Consensus 588 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 667 (752)
......|+..|+|||++.+..++.++||||||+++|||++|+.||......... .......... ....
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~---~~~~~~~~~~------~~~~- 224 (285)
T cd05630 157 --TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR---EEVERLVKEV------QEEY- 224 (285)
T ss_pred --cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH---HHHHhhhhhh------hhhc-
Confidence 112346899999999999999999999999999999999999999764322111 1111111100 0001
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 043278 668 QPCSANEVMRCIHVGLLCVQDQAMDRPT-----MPEVVCM 702 (752)
Q Consensus 668 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-----~~ev~~~ 702 (752)
+......+.+++..|++.||.+||| +.|++++
T Consensus 225 ---~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 225 ---SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred ---CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 1112234678889999999999999 7888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=301.30 Aligned_cols=255 Identities=24% Similarity=0.347 Sum_probs=201.3
Q ss_pred cCCCcCCeeecCCcccEEEEEecCC----ceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLADE----QEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLV 504 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~~----~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 504 (752)
++|.+.++||+|+||.||+|...+. ..|++|...... ....+.+.+|+.++++++|+||+++++++.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 4677889999999999999986432 468999887654 3445678999999999999999999998875 557899
Q ss_pred EeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecc
Q 043278 505 YEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~ 584 (752)
|||+++++|.+++... ...+++..++.++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||+++....
T Consensus 85 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 85 MELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence 9999999999998543 235899999999999999999999988 99999999999999999999999999986543
Q ss_pred cccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccccC
Q 043278 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELID 663 (752)
Q Consensus 585 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 663 (752)
..... .....++..|+|||.+....++.++||||||++++|+++ |+.||....... . ...+..+.....
T Consensus 160 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~------~-~~~~~~~~~~~~-- 229 (270)
T cd05056 160 ESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND------V-IGRIENGERLPM-- 229 (270)
T ss_pred cccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH------H-HHHHHcCCcCCC--
Confidence 32111 112334568999999988899999999999999999996 999986554221 1 111222211111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCC
Q 043278 664 PSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNET 707 (752)
Q Consensus 664 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~ 707 (752)
+......+.+++.+|+..+|.+|||+.++++.|+++.
T Consensus 230 -------~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 230 -------PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266 (270)
T ss_pred -------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1112245778899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=297.05 Aligned_cols=251 Identities=23% Similarity=0.332 Sum_probs=203.5
Q ss_pred CCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccC--CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEee
Q 043278 431 NFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRS--SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
+|+..+.||+|+||.||.++. .+++.+++|.+... ......++.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 577889999999999999985 45788999987654 234456788999999999999999999999999999999999
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccc
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES 587 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~ 587 (752)
+++++|.+++.... ...+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999886532 345899999999999999999999988 99999999999999999999999999986543332
Q ss_pred ccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCC
Q 043278 588 EANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLE 667 (752)
Q Consensus 588 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 667 (752)
......++..|+|||.+.+..++.++||||||++++||++|+.|+...... ...... ..+.....
T Consensus 157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~-~~~~~~~~------ 221 (256)
T cd08221 157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL------NLVVKI-VQGNYTPV------ 221 (256)
T ss_pred --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHH-HcCCCCCC------
Confidence 223356889999999999888999999999999999999999998654321 111111 12221111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 043278 668 QPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCML 703 (752)
Q Consensus 668 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L 703 (752)
.......+.+++.+|++.+|.+||++.|+++++
T Consensus 222 ---~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 222 ---VSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ---ccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 112234577888999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=307.12 Aligned_cols=262 Identities=23% Similarity=0.368 Sum_probs=197.1
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEee
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
++|...++||+|+||.||+|+.. +++.||+|.+.... ......+.+|+.++.+++|+||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 46888899999999999999875 57889999986443 23344678899999999999999999999999999999999
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccc
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES 587 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~ 587 (752)
++ ++|..++... ...+++..+..++.||++||+|||+.+ |+|+||||+|||+++++.+||+|||++........
T Consensus 86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 98 5888877543 335889999999999999999999988 99999999999999999999999999975432211
Q ss_pred ccccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhh------------
Q 043278 588 EANTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLS------------ 654 (752)
Q Consensus 588 ~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~------------ 654 (752)
......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||......+. .......+.
T Consensus 160 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 234 (301)
T cd07873 160 --TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ---LHFIFRILGTPTEETWPGILS 234 (301)
T ss_pred --cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCChhhchhhhc
Confidence 1122456889999998875 4588999999999999999999999976543211 111111110
Q ss_pred CCCcccccCCCCCCCC----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 655 DGKGLELIDPSLEQPC----SANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 655 ~~~~~~~~d~~l~~~~----~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.......-.+...... .......+.+++.+|++.||.+|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000000001100000 01112346789999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=307.63 Aligned_cols=240 Identities=24% Similarity=0.350 Sum_probs=190.4
Q ss_pred CCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC---cccHHHHHHHHHHHHhcC-CCCcceeeeeeeeCCeeEEEEe
Q 043278 432 FSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKLQ-HTNLVRLLGCSLHGEERLLVYE 506 (752)
Q Consensus 432 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E 506 (752)
|+..+.||+|+||.||++... +++.||+|++.... ......+..|..++..+. |++|+++.+++...+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 666789999999999999864 58899999987532 233455778888888885 5778889999999999999999
Q ss_pred eCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccc
Q 043278 507 FMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586 (752)
Q Consensus 507 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~ 586 (752)
|+++|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 y~~~g~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 82 YVNGGDLMYHIQQV---GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred CCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 99999999888543 35899999999999999999999988 9999999999999999999999999987532221
Q ss_pred cccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCC
Q 043278 587 SEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666 (752)
Q Consensus 587 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 666 (752)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ...... .... .+
T Consensus 156 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~------~~~~i~-~~~~------~~ 220 (323)
T cd05615 156 --VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE------LFQSIM-EHNV------SY 220 (323)
T ss_pred --ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH------HHHHHH-hCCC------CC
Confidence 12234568999999999999999999999999999999999999997654211 111111 1111 01
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 043278 667 EQPCSANEVMRCIHVGLLCVQDQAMDRPTM 696 (752)
Q Consensus 667 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~ 696 (752)
+......+.+++.+|++.+|.+|++.
T Consensus 221 ----p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 221 ----PKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ----CccCCHHHHHHHHHHcccCHhhCCCC
Confidence 11122356788899999999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=310.22 Aligned_cols=240 Identities=21% Similarity=0.287 Sum_probs=186.7
Q ss_pred CeeecCCcccEEEEEec-CCceeEEEEcccCC---cccHHHHHHHH-HHHHhcCCCCcceeeeeeeeCCeeEEEEeeCCC
Q 043278 436 NKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS---GQGIVEFKNEV-RLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPN 510 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 510 (752)
+.||+|+||.||+++.. +++.||+|++.... ......+..|. .++..++|+||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 47999999999999875 56789999986532 12223344444 456788999999999999999999999999999
Q ss_pred CCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccccc
Q 043278 511 KSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEAN 590 (752)
Q Consensus 511 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~ 590 (752)
++|..++... ..+....+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--~~~ 152 (325)
T cd05602 81 GELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NGT 152 (325)
T ss_pred CcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccC--CCC
Confidence 9999888542 34788888999999999999999988 999999999999999999999999999753221 112
Q ss_pred cccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCCC
Q 043278 591 TKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPC 670 (752)
Q Consensus 591 ~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 670 (752)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .. ........ . +.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~-~~i~~~~~-~-~~~------ 217 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE------MY-DNILNKPL-Q-LKP------ 217 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH------HH-HHHHhCCc-C-CCC------
Confidence 334678999999999999999999999999999999999999997544211 11 11111111 0 111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 043278 671 SANEVMRCIHVGLLCVQDQAMDRPTMPEVV 700 (752)
Q Consensus 671 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~ 700 (752)
.....+.+++.+|++.+|.+||++.+.+
T Consensus 218 --~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 218 --NITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred --CCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 1223466788899999999999987543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=303.28 Aligned_cols=251 Identities=24% Similarity=0.360 Sum_probs=198.9
Q ss_pred CCcCCeeecCCcccEEEEEecC-CceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCCC
Q 043278 432 FSTTNKLGEGGFGPVYKGKLAD-EQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPN 510 (752)
Q Consensus 432 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 510 (752)
|++.+.||+|+||.||++.... +..+++|.+..........+.+|++++..++|+|++++++++..++..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 4566889999999999998754 678899998766555667789999999999999999999999999999999999999
Q ss_pred CCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccccc
Q 043278 511 KSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEAN 590 (752)
Q Consensus 511 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~ 590 (752)
++|..++... ...+++..+..++.|++.||.|||+.+ ++|+||||+|||++.++.+||+|||++....... ..
T Consensus 87 ~~l~~~~~~~--~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~ 159 (282)
T cd06643 87 GAVDAVMLEL--ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QR 159 (282)
T ss_pred CcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--cc
Confidence 9998887542 345899999999999999999999988 9999999999999999999999999987543221 11
Q ss_pred cccccccCCccChhhhc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCC
Q 043278 591 TKRIVGTYGYMSPEYAM-----SGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPS 665 (752)
Q Consensus 591 ~~~~~gt~~y~aPE~~~-----~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 665 (752)
.....++..|+|||++. +..++.++|||||||++|||++|+.||......+ ....... .....+..
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~------~~~~~~~-~~~~~~~~-- 230 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR------VLLKIAK-SEPPTLAQ-- 230 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH------HHHHHhh-cCCCCCCC--
Confidence 22356788999999874 4567889999999999999999999986543211 1111111 11111111
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 043278 666 LEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCML 703 (752)
Q Consensus 666 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L 703 (752)
+......+.+++.+|++.+|.+||++.++++.-
T Consensus 231 -----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 231 -----PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred -----ccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 111224577899999999999999999997653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=319.31 Aligned_cols=203 Identities=24% Similarity=0.378 Sum_probs=174.1
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC---cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 505 (752)
++|+..+.||+|+||.||+++.. .++.||+|++.... ......+.+|+.++.+++|+||+++++.+.+++..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36788899999999999999875 58899999986432 233456788999999999999999999999999999999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccc
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVN 585 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~ 585 (752)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 99999999999854 345899999999999999999999988 999999999999999999999999998754221
Q ss_pred cc---------------------------------ccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCC
Q 043278 586 ES---------------------------------EANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQK 632 (752)
Q Consensus 586 ~~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~ 632 (752)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 10 000113478999999999999999999999999999999999999
Q ss_pred CCCCCC
Q 043278 633 NHTRHH 638 (752)
Q Consensus 633 p~~~~~ 638 (752)
||....
T Consensus 235 Pf~~~~ 240 (360)
T cd05627 235 PFCSET 240 (360)
T ss_pred CCCCCC
Confidence 997654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=301.12 Aligned_cols=253 Identities=25% Similarity=0.400 Sum_probs=200.1
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeC
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFM 508 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 508 (752)
++|...++||+|+||.||+++.. +++.||+|.++.........+.+|+.++..++||||+++++++..++..++|+||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 46777789999999999999864 58889999987665555567889999999999999999999999999999999999
Q ss_pred CCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccc
Q 043278 509 PNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE 588 (752)
Q Consensus 509 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 588 (752)
++++|.+++... ..+++.+...++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 89 ~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-- 160 (267)
T cd06645 89 GGGSLQDIYHVT---GPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI-- 160 (267)
T ss_pred CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc--
Confidence 999999988543 35899999999999999999999998 9999999999999999999999999987654221
Q ss_pred cccccccccCCccChhhhc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCC
Q 043278 589 ANTKRIVGTYGYMSPEYAM---SGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPS 665 (752)
Q Consensus 589 ~~~~~~~gt~~y~aPE~~~---~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 665 (752)
.......|+..|+|||++. ...++.++|||||||++|||++|+.|+....+.... .... .... ..+.
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~------~~~~-~~~~---~~~~ 230 (267)
T cd06645 161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL------FLMT-KSNF---QPPK 230 (267)
T ss_pred cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH------Hhhh-ccCC---CCCc
Confidence 1223456889999999874 456889999999999999999999998654422111 0011 1110 0111
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 666 LEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 666 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
... .......+.+++.+|++.+|++||++++|+++
T Consensus 231 ~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 231 LKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred ccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 111 00112346789999999999999999998864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=299.83 Aligned_cols=248 Identities=25% Similarity=0.408 Sum_probs=201.9
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEee
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
..|+..+.||+|+||.||+|... .++.||+|.+.... ......+.+|+.++.+++|+||+++++++.++...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 35667789999999999999875 57889999887543 33456788999999999999999999999999999999999
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccc
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES 587 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~ 587 (752)
+++++|.+++.. ..+++.....++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 84 LGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 999999998842 34888999999999999999999987 99999999999999999999999999976543221
Q ss_pred ccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCC
Q 043278 588 EANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLE 667 (752)
Q Consensus 588 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 667 (752)
......++..|+|||++.+..++.++||||||+++|||++|+.|+....+..... ....+. .
T Consensus 157 --~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-------~~~~~~-----~---- 218 (277)
T cd06640 157 --KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF-------LIPKNN-----P---- 218 (277)
T ss_pred --ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh-------hhhcCC-----C----
Confidence 1223457889999999999899999999999999999999999987554321110 111111 1
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 668 QPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 668 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
..........+.+++..|++.+|++||++.++++.
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 11223344567789999999999999999999876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=308.98 Aligned_cols=252 Identities=23% Similarity=0.281 Sum_probs=211.6
Q ss_pred HhcCCCcCCeeecCCcccEEEEEecC-CceeEEEEcccCCcc---cHHHHHHHHHHHHhcC-CCCcceeeeeeeeCCeeE
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGKLAD-EQEVAIKRLSRSSGQ---GIVEFKNEVRLIAKLQ-HTNLVRLLGCSLHGEERL 502 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 502 (752)
....|++.+.||.|.||.||+++.+. |+.+|+|.+.+.... ....+.+|+.+|+++. |||||.+.+.++.....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 34678888999999999999998765 999999999776433 3467899999999998 999999999999999999
Q ss_pred EEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecC----CCCceeccccc
Q 043278 503 LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDD----KMNPKISDFGM 578 (752)
Q Consensus 503 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~----~~~~kl~DFgl 578 (752)
+|||++.+|.|.+.+... .+++..+..++.||+.++.|||+.+ |+||||||+|+|+.. ++.+|++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999999998765 2999999999999999999999988 999999999999953 35799999999
Q ss_pred ceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCc
Q 043278 579 ARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKG 658 (752)
Q Consensus 579 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 658 (752)
+..... .......+||+.|+|||++....|+..+||||+|+++|.|++|.+||.......... .+..++.
T Consensus 186 a~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------~i~~~~~ 255 (382)
T KOG0032|consen 186 AKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------AILRGDF 255 (382)
T ss_pred ceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------HHHcCCC
Confidence 998665 233456899999999999999999999999999999999999999998877443221 2222222
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 659 LELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 659 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
....+........+.+++..++..||.+|+|+.+++++
T Consensus 256 ------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 ------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 22222233334566788899999999999999999995
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=292.71 Aligned_cols=251 Identities=34% Similarity=0.500 Sum_probs=200.4
Q ss_pred CCcCCeeecCCcccEEEEEecC-----CceeEEEEcccCCcc-cHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEE
Q 043278 432 FSTTNKLGEGGFGPVYKGKLAD-----EQEVAIKRLSRSSGQ-GIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 432 ~~~~~~LG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 505 (752)
|++.+.||.|+||.||+++..+ +..||+|.+...... ....+.+|+..+.+++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3456899999999999998754 378999999765433 5678899999999999999999999999999999999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccc
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVN 585 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~ 585 (752)
||+++++|.+++..... ..+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||+++.....
T Consensus 81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 99999999999865322 22899999999999999999999998 999999999999999999999999999876543
Q ss_pred ccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCC
Q 043278 586 ESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDP 664 (752)
Q Consensus 586 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 664 (752)
...... ...++..|+|||.+....++.++||||+|++++||++ |+.|+...... ...+....+.....
T Consensus 157 ~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~-------~~~~~~~~~~~~~~--- 225 (258)
T smart00219 157 DYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE-------EVLEYLKKGYRLPK--- 225 (258)
T ss_pred cccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHhcCCCCCC---
Confidence 222111 2336789999999988899999999999999999998 77777653211 11122222221111
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 043278 665 SLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCML 703 (752)
Q Consensus 665 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L 703 (752)
.......+.+++.+|+..+|.+|||+.|+++.|
T Consensus 226 ------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 226 ------PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ------CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 111234577899999999999999999999865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=306.56 Aligned_cols=198 Identities=26% Similarity=0.423 Sum_probs=161.1
Q ss_pred CCeeecCCcccEEEEEec---CCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeee--CCeeEEEEeeCC
Q 043278 435 TNKLGEGGFGPVYKGKLA---DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLH--GEERLLVYEFMP 509 (752)
Q Consensus 435 ~~~LG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~E~~~ 509 (752)
.++||+|+||.||+|+.. .++.+|+|.+.... ....+.+|+.++++++||||+++++++.. +...+++|||++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 368999999999999864 45789999986542 23457889999999999999999998854 456789999987
Q ss_pred CCCHhHHHhhc------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEe----cCCCCceecccccc
Q 043278 510 NKSLDFFLFNS------GRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILL----DDKMNPKISDFGMA 579 (752)
Q Consensus 510 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll----~~~~~~kl~DFgla 579 (752)
+ +|..++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5 676665422 12235889999999999999999999998 9999999999999 46678999999999
Q ss_pred eeeccccc-ccccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 043278 580 RIFEVNES-EANTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHH 638 (752)
Q Consensus 580 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~ 638 (752)
+....... ........+|+.|+|||++.+ ..++.++||||+||+++||++|++||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 87643321 122234678999999999987 468999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=298.76 Aligned_cols=249 Identities=28% Similarity=0.439 Sum_probs=198.2
Q ss_pred CCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCcc---------cHHHHHHHHHHHHhcCCCCcceeeeeeeeCCe
Q 043278 431 NFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQ---------GIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEE 500 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 500 (752)
+|.+.+.||+|++|.||+|... +++.+|+|.+...... ..+.+.+|+.++.+++|+||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3667789999999999999864 5788999988654322 12467899999999999999999999999999
Q ss_pred eEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccce
Q 043278 501 RLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR 580 (752)
Q Consensus 501 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~ 580 (752)
.+++|||+++++|..++... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY---GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 99999999999999998543 45888999999999999999999988 9999999999999999999999999998
Q ss_pred eecccccc----cccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCC
Q 043278 581 IFEVNESE----ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDG 656 (752)
Q Consensus 581 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 656 (752)
........ .......++..|+|||.+.+..++.++||||||++++||++|+.||...... .... .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~-~~~~~ 227 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL------QAIF-KIGEN 227 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH------HHHH-HHhcc
Confidence 66422111 1112345788999999999999999999999999999999999999754311 1111 11111
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 043278 657 KGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVC 701 (752)
Q Consensus 657 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~ 701 (752)
..+.+ +......+.+++.+||+.+|.+||++.|+++
T Consensus 228 -----~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 228 -----ASPEI----PSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred -----CCCcC----CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 11111 1122345678889999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=299.94 Aligned_cols=251 Identities=25% Similarity=0.381 Sum_probs=199.1
Q ss_pred CCCcCCeeecCCcccEEEEEecCCceeEEEEcccCCc------ccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEE
Q 043278 431 NFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSG------QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLV 504 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 504 (752)
+|...+.||+|+||+||+|...+++.+|+|.+..... .....+.+|++++++++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4677889999999999999988889999998864321 1234588999999999999999999999999999999
Q ss_pred EeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecc
Q 043278 505 YEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~ 584 (752)
+||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 9999999999998543 34789999999999999999999988 99999999999999999999999999876432
Q ss_pred cc----cccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCccc
Q 043278 585 NE----SEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLE 660 (752)
Q Consensus 585 ~~----~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 660 (752)
.. .........++..|+|||++.+..++.++||||||++++||++|+.||........ .........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~------~~~~~~~~~--- 225 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA------MFYIGAHRG--- 225 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH------HHHhhhccC---
Confidence 11 11112235678899999999998999999999999999999999999965432110 001110000
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 043278 661 LIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVC 701 (752)
Q Consensus 661 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~ 701 (752)
..+.+ +......+.+++.+|++.+|.+||++.|+++
T Consensus 226 -~~~~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 226 -LMPRL----PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -CCCCC----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 01111 1122345678899999999999999999876
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=302.23 Aligned_cols=251 Identities=26% Similarity=0.340 Sum_probs=197.0
Q ss_pred CCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC---cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEee
Q 043278 432 FSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 432 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
|+..+.||+|+||+||++... +++.+|+|.+.... ......+.+|++++.+++|+|++++.+++..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566789999999999999864 58899999986542 22334578899999999999999999999999999999999
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccc
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES 587 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~ 587 (752)
+++++|..++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05632 82 MNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE- 156 (285)
T ss_pred ccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence 99999998886432 335899999999999999999999988 9999999999999999999999999997643221
Q ss_pred ccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCC
Q 043278 588 EANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLE 667 (752)
Q Consensus 588 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 667 (752)
......|+..|+|||++.+..++.++|+||||++++||++|+.||......... ........... ...
T Consensus 157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~---~~~~~~~~~~~------~~~- 224 (285)
T cd05632 157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR---EEVDRRVLETE------EVY- 224 (285)
T ss_pred --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhhhccc------ccc-
Confidence 112356899999999999999999999999999999999999999754321111 11111111111 001
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 043278 668 QPCSANEVMRCIHVGLLCVQDQAMDRPT-----MPEVVCM 702 (752)
Q Consensus 668 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-----~~ev~~~ 702 (752)
.......+.+|+..|++.||++||+ +.+++..
T Consensus 225 ---~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 225 ---SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred ---CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 1112234567888999999999999 5566554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=315.13 Aligned_cols=250 Identities=27% Similarity=0.378 Sum_probs=205.7
Q ss_pred CcCCeeecCCcccEEEEEec--CCc--eeEEEEcccCCcc-cHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEee
Q 043278 433 STTNKLGEGGFGPVYKGKLA--DEQ--EVAIKRLSRSSGQ-GIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 433 ~~~~~LG~G~fg~Vy~~~~~--~~~--~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
...++||+|.||.|++|.+. .|+ .||||.+...... ....|.+|+.+|.+|+|+|+++|||...+ ...+||+|+
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 44578999999999999874 354 4899999876443 67789999999999999999999999887 778999999
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccc
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES 587 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~ 587 (752)
++.|+|.+.|.. ..+..|-......++.|||.||.||.++. +|||||..+|+||-..-.+||+||||.+-++..+.
T Consensus 192 aplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 192 APLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred cccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 999999999987 45567888899999999999999999988 99999999999999999999999999998875543
Q ss_pred c-cccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCC
Q 043278 588 E-ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPS 665 (752)
Q Consensus 588 ~-~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 665 (752)
. .......-...|.|||.+....++.++|||+|||.||||+| |+.||-+...... .+.+.++.
T Consensus 268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qI-------L~~iD~~e-------- 332 (1039)
T KOG0199|consen 268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQI-------LKNIDAGE-------- 332 (1039)
T ss_pred ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHH-------HHhccccc--------
Confidence 3 22333344678999999999999999999999999999999 7778866552211 12222221
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 043278 666 LEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCML 703 (752)
Q Consensus 666 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L 703 (752)
.-+.+....+++.+++..||..+|++|||+..+.+.+
T Consensus 333 -rLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 333 -RLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred -cCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 2233455667899999999999999999999997543
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=304.50 Aligned_cols=260 Identities=23% Similarity=0.316 Sum_probs=191.8
Q ss_pred CCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCc--ccHHHHHHHHHHHHhc---CCCCcceeeeeeee-----CC
Q 043278 431 NFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSG--QGIVEFKNEVRLIAKL---QHTNLVRLLGCSLH-----GE 499 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~~ 499 (752)
+|++.+.||+|+||.||++... +++.||+|.++.... .....+.+|+.++.++ +|+||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778899999999999999875 588999998875422 2223456677777665 79999999998764 34
Q ss_pred eeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccc
Q 043278 500 ERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMA 579 (752)
Q Consensus 500 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla 579 (752)
..+++|||+++ +|..++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 57899999984 7877775432 345899999999999999999999998 999999999999999999999999999
Q ss_pred eeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCC--
Q 043278 580 RIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGK-- 657 (752)
Q Consensus 580 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~-- 657 (752)
+...... ......++..|+|||++.+..++.++|||||||++|||++|++||......... ...........
T Consensus 156 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~---~~~~~~~~~~~~~ 229 (288)
T cd07863 156 RIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL---GKIFDLIGLPPED 229 (288)
T ss_pred ccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHH---HHHHHHhCCCChh
Confidence 8654221 122356788999999999999999999999999999999999998655422111 11111110000
Q ss_pred -cc-------cccCCCCC---CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 043278 658 -GL-------ELIDPSLE---QPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVC 701 (752)
Q Consensus 658 -~~-------~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~ 701 (752)
.. ....+... ..........+.+++.+|++.||++|||+.|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00 00000000 0001112345678999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=300.85 Aligned_cols=262 Identities=24% Similarity=0.351 Sum_probs=202.4
Q ss_pred HHHHHHHhcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCcccHHHHHHHHHHHHhc-CCCCcceeeeeee---
Q 043278 422 FQTIAAAANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKL-QHTNLVRLLGCSL--- 496 (752)
Q Consensus 422 ~~~i~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~--- 496 (752)
+..+..+.++|++.+.||+|+||.||++... .++.+|+|.+.... ....++.+|+.++.++ +|+||+++++++.
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 3455667889999999999999999999864 57889999876532 2345678899999999 6999999999874
Q ss_pred --eCCeeEEEEeeCCCCCHhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCcee
Q 043278 497 --HGEERLLVYEFMPNKSLDFFLFNS-GRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKI 573 (752)
Q Consensus 497 --~~~~~~lv~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl 573 (752)
.++..++||||+++++|.+++... .....+++..+..++.|+++||.|||+.+ ++||||||+||++++++.+||
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl 165 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKL 165 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEE
Confidence 345789999999999999887542 23346889999999999999999999987 999999999999999999999
Q ss_pred cccccceeecccccccccccccccCCccChhhhcc-----CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHH
Q 043278 574 SDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMS-----GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGY 648 (752)
Q Consensus 574 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~ 648 (752)
+|||+++....... ......|+..|+|||++.. ..++.++|||||||++|||++|+.|+.........
T Consensus 166 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~----- 238 (286)
T cd06638 166 VDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL----- 238 (286)
T ss_pred ccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH-----
Confidence 99999986543221 1223468899999998753 45789999999999999999999998755422110
Q ss_pred HHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 043278 649 AWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCML 703 (752)
Q Consensus 649 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L 703 (752)
. ...........++. .....+.+++.+|++.+|++|||+.|+++.+
T Consensus 239 -~-~~~~~~~~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 239 -F-KIPRNPPPTLHQPE-------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred -h-hccccCCCcccCCC-------CcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 0 01111111111111 1123577899999999999999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=301.15 Aligned_cols=266 Identities=23% Similarity=0.306 Sum_probs=200.8
Q ss_pred CCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCcc-----cHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEE
Q 043278 431 NFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQ-----GIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLV 504 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 504 (752)
+|...+.||+|++|.||+|... +++.||+|++...... ....+..|++++.+++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4677789999999999999865 5889999999765322 234567899999999999999999999999999999
Q ss_pred EeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecc
Q 043278 505 YEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~ 584 (752)
|||+ +++|..++.... ..+++..+..++.||++||.|||+.+ ++|+||||+||+++.++.+||+|||+++....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 899999885432 35899999999999999999999998 99999999999999999999999999987543
Q ss_pred cccccccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhC--------
Q 043278 585 NESEANTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSD-------- 655 (752)
Q Consensus 585 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~-------- 655 (752)
... ......++..|+|||.+.+ ..++.++||||||++++||++|.+++....... ...........
T Consensus 155 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 229 (298)
T cd07841 155 PNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID---QLGKIFEALGTPTEENWPG 229 (298)
T ss_pred CCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH---HHHHHHHHcCCCchhhhhh
Confidence 221 1122345778999998865 567899999999999999999987776544211 11111111000
Q ss_pred -CCcccccCCCCCCCCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hhcCC
Q 043278 656 -GKGLELIDPSLEQPCS-----ANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM--LQNET 707 (752)
Q Consensus 656 -~~~~~~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~--L~~~~ 707 (752)
...............+ ......+.+++.+|++.+|++|||+.|++++ +++.-
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~ 289 (298)
T cd07841 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP 289 (298)
T ss_pred cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence 0000000000001111 1223567889999999999999999999986 55543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=306.74 Aligned_cols=255 Identities=18% Similarity=0.252 Sum_probs=193.7
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccC---CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRS---SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 505 (752)
++|++.+.||+|+||.||+++.. +++.||+|.+.+. .......+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46888899999999999999865 5889999998642 2223456889999999999999999999999999999999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccc
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVN 585 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~ 585 (752)
||+++|+|..++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 999999999998542 335889999999999999999999998 999999999999999999999999998765432
Q ss_pred ccccccccccccCCccChhhhcc-----CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCccc
Q 043278 586 ESEANTKRIVGTYGYMSPEYAMS-----GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLE 660 (752)
Q Consensus 586 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 660 (752)
... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||...... ......+.......
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~------~~~~~i~~~~~~~~ 228 (331)
T cd05597 156 GTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHKEHFQ 228 (331)
T ss_pred CCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH------HHHHHHHcCCCccc
Confidence 211 1123468999999999863 45788999999999999999999999754321 11112221111111
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHcc--cCCCCCCCCHHHHHHH
Q 043278 661 LIDPSLEQPCSANEVMRCIHVGLLCV--QDQAMDRPTMPEVVCM 702 (752)
Q Consensus 661 ~~d~~l~~~~~~~~~~~l~~l~~~Cl--~~dp~~RPt~~ev~~~ 702 (752)
+. +. ... ....+.+++.+|+ ..++..||++.+++++
T Consensus 229 ~~-~~-~~~----~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 229 FP-PD-VTD----VSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CC-Cc-cCC----CCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 11 10 011 1223445555555 4455558899999887
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=302.68 Aligned_cols=265 Identities=26% Similarity=0.312 Sum_probs=200.1
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEe
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYE 506 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 506 (752)
++|+..+.||+|++|.||+++.. +++.||+|++.... ......+.+|+.++.+++|+|++++++++..+...++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46788899999999999999876 58899999886542 2234567899999999999999999999999999999999
Q ss_pred eCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccc
Q 043278 507 FMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586 (752)
Q Consensus 507 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~ 586 (752)
|+++++|..++.. ...+++..+..++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 9999988877643 234899999999999999999999988 9999999999999999999999999998754322
Q ss_pred cccccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHH--------HHhhCCC
Q 043278 587 SEANTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAW--------QLLSDGK 657 (752)
Q Consensus 587 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~--------~~~~~~~ 657 (752)
. ......++..|+|||++.+ ..++.++||||||++++||++|+.||......+....+.... .......
T Consensus 155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence 1 1223456789999999876 568899999999999999999999997655322111110000 0000000
Q ss_pred c-ccccCCCCCCCCCH-----HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 658 G-LELIDPSLEQPCSA-----NEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 658 ~-~~~~d~~l~~~~~~-----~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
. ..+..+......+. .....+.+++.+|++.+|++||++.|++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0 00011111111111 113457789999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=296.97 Aligned_cols=247 Identities=28% Similarity=0.447 Sum_probs=197.9
Q ss_pred cCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCC
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMP 509 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 509 (752)
++|.+.+.||+|+||.||++.. .++.+|+|.++... ....+.+|+.++.+++|+|++++++++..+ ..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4578889999999999999975 67789999986542 345789999999999999999999998654 5799999999
Q ss_pred CCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccccc
Q 043278 510 NKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEA 589 (752)
Q Consensus 510 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 589 (752)
+++|..++.... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 82 KGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 999999986542 345889999999999999999999987 9999999999999999999999999987543211
Q ss_pred ccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCC
Q 043278 590 NTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQ 668 (752)
Q Consensus 590 ~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 668 (752)
.....+..|+|||.+.+..++.++|+||||++++||++ |+.||....... .......+.... +
T Consensus 155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~~---~---- 218 (254)
T cd05083 155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE-------VKECVEKGYRME---P---- 218 (254)
T ss_pred --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH-------HHHHHhCCCCCC---C----
Confidence 12234568999999998999999999999999999998 888886544211 112222221111 1
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 043278 669 PCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705 (752)
Q Consensus 669 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~ 705 (752)
+......+.+++.+|++.+|++||+++++++.|++
T Consensus 219 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 219 --PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred --CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 11123456789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=301.49 Aligned_cols=256 Identities=25% Similarity=0.363 Sum_probs=202.5
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEee
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
++|++.++||+|+||+||++... +++.||+|++.... .....++.+|++++..++|+||+++++++...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 46677789999999999999864 58889999876543 33456789999999999999999999999999999999999
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccc
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES 587 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~ 587 (752)
+++++|..++.. ...+++..+..++.+++.+|.|||+.. +++|+||||+||++++++.++|+|||++......
T Consensus 85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-- 157 (284)
T cd06620 85 MDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-- 157 (284)
T ss_pred CCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh--
Confidence 999999988754 235899999999999999999999742 2999999999999999999999999998654221
Q ss_pred ccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCC-----cchHHHHHHHhhCCCccccc
Q 043278 588 EANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRP-----LNLIGYAWQLLSDGKGLELI 662 (752)
Q Consensus 588 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~-----~~l~~~~~~~~~~~~~~~~~ 662 (752)
......++..|+|||++.+..++.++|||||||+++||++|+.||........ ............. .
T Consensus 158 --~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~----- 229 (284)
T cd06620 158 --IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE-P----- 229 (284)
T ss_pred --ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc-c-----
Confidence 12235688999999999888999999999999999999999999986543211 1111111111111 0
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 043278 663 DPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCML 703 (752)
Q Consensus 663 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L 703 (752)
.+.+. .......+.+++.+|++.||.+|||+.|++++.
T Consensus 230 ~~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 230 PPRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred CCCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 01110 111334577899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=312.54 Aligned_cols=262 Identities=23% Similarity=0.254 Sum_probs=195.2
Q ss_pred HhcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccC--CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCC-----
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRS--SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGE----- 499 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 499 (752)
..++|++.+.||+|+||.||++... .++.||+|++... ......++.+|+.++..++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3578999999999999999999864 5889999998654 2234556789999999999999999999886543
Q ss_pred -eeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceeccccc
Q 043278 500 -ERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGM 578 (752)
Q Consensus 500 -~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgl 578 (752)
..++||||++++ |...+. ..++...+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~~-l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDAN-LCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCcC-HHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 468999999764 544442 23788899999999999999999998 99999999999999999999999999
Q ss_pred ceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcc------------hH
Q 043278 579 ARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLN------------LI 646 (752)
Q Consensus 579 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~------------l~ 646 (752)
++..... .......+|+.|+|||.+.+..++.++||||||+++|||++|+.||...+...... ..
T Consensus 170 a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 246 (359)
T cd07876 170 ARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM 246 (359)
T ss_pred ccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence 9754322 11223568899999999999999999999999999999999999997654211000 00
Q ss_pred H----HHHHHhhCC-Ccc-----cccCCCCC----CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 647 G----YAWQLLSDG-KGL-----ELIDPSLE----QPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 647 ~----~~~~~~~~~-~~~-----~~~d~~l~----~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
. ......... ... ++. +... ..........+.+++.+|++.||++|||+.|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 247 NRLQPTVRNYVENRPQYPGISFEELF-PDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHhhCCCCCCcchhhhc-cccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0 000000000 000 000 0000 00011112456789999999999999999999886
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=295.70 Aligned_cols=253 Identities=25% Similarity=0.406 Sum_probs=204.2
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeC
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFM 508 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 508 (752)
++|+..+.||+|+||.||++... +++.+++|.+..........+.+|+.++++++|+||+++++++..++..+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57888899999999999999874 57789999998766666778999999999999999999999999999999999999
Q ss_pred CCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccc
Q 043278 509 PNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE 588 (752)
Q Consensus 509 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 588 (752)
++++|.+++... ...++...+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 83 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 156 (262)
T cd06613 83 GGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA- 156 (262)
T ss_pred CCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh-
Confidence 999999988543 245899999999999999999999988 99999999999999999999999999876542211
Q ss_pred cccccccccCCccChhhhccC---CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCC
Q 043278 589 ANTKRIVGTYGYMSPEYAMSG---IVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPS 665 (752)
Q Consensus 589 ~~~~~~~gt~~y~aPE~~~~~---~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 665 (752)
......++..|+|||.+... .++.++||||||++++||++|+.|+......... . ...... +..+.
T Consensus 157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~------~-~~~~~~---~~~~~ 225 (262)
T cd06613 157 -KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL------F-LISKSN---FPPPK 225 (262)
T ss_pred -ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH------H-HHHhcc---CCCcc
Confidence 11235678899999998776 8899999999999999999999998654422110 1 111110 00111
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 043278 666 LEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVC 701 (752)
Q Consensus 666 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~ 701 (752)
+. ........+.+++.+|++.+|.+|||+++|+.
T Consensus 226 ~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 226 LK--DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred cc--chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 11 12233456788999999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=302.36 Aligned_cols=253 Identities=21% Similarity=0.330 Sum_probs=199.3
Q ss_pred CCCcCCeeecCCcccEEEEEec-CCceeEEEEcccC-CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeC
Q 043278 431 NFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRS-SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFM 508 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 508 (752)
+|++.+.||+|+||.||++... .++.||+|.+... ......++.+|+.++.+++|+||+++++++...+..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 5777899999999999999875 6889999988654 2233467889999999999999999999999999999999999
Q ss_pred CCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccc
Q 043278 509 PNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE 588 (752)
Q Consensus 509 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 588 (752)
++++|..++........+++..+..++.|++.||.|||+.. +|+|+||||+||+++.++.+||+|||++......
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--- 156 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--- 156 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC---
Confidence 99999988865433446899999999999999999999742 3999999999999999999999999998754322
Q ss_pred cccccccccCCccChhhhccC------CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCccccc
Q 043278 589 ANTKRIVGTYGYMSPEYAMSG------IVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELI 662 (752)
Q Consensus 589 ~~~~~~~gt~~y~aPE~~~~~------~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 662 (752)
......++..|+|||.+.+. .++.++|+|||||++|||++|+.||........ .. .......+...
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~-~~~~~~~~~~~--- 228 (286)
T cd06622 157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI---FA-QLSAIVDGDPP--- 228 (286)
T ss_pred -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH---HH-HHHHHhhcCCC---
Confidence 12234578899999988553 358899999999999999999999865432111 11 11111111111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 663 DPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 663 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
. .+......+.+++.+|++.+|.+||++.++++.
T Consensus 229 --~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 229 --T----LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred --C----CCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 1 112234456788999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=298.87 Aligned_cols=253 Identities=25% Similarity=0.364 Sum_probs=202.3
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEee
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
.++|++.+.||+|+||.||++... +++.+|+|.+..........+.+|++++++++|+||+++++.+..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 356888899999999999999874 5789999999776655667889999999999999999999999999999999999
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccc
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES 587 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~ 587 (752)
+++++|..++.... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 84 CDGGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred cCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 99999999885432 35899999999999999999999998 99999999999999999999999999875432211
Q ss_pred ccccccccccCCccChhhhc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCccccc
Q 043278 588 EANTKRIVGTYGYMSPEYAM-----SGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELI 662 (752)
Q Consensus 588 ~~~~~~~~gt~~y~aPE~~~-----~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 662 (752)
......++..|+|||.+. ...++.++||||||+++|||++|+.||....... .. ..+..+...
T Consensus 159 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~------~~-~~~~~~~~~--- 226 (280)
T cd06611 159 --KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR------VL-LKILKSEPP--- 226 (280)
T ss_pred --ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH------HH-HHHhcCCCC---
Confidence 122356788999999875 3457889999999999999999999987553211 11 111111111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 663 DPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 663 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.+.. +......+.+++..|++.+|.+||++.++++.
T Consensus 227 --~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 227 --TLDQ--PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred --CcCC--cccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 1111 11122356778899999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=292.39 Aligned_cols=250 Identities=22% Similarity=0.305 Sum_probs=199.7
Q ss_pred CCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeee-CCeeEEEEe
Q 043278 431 NFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLH-GEERLLVYE 506 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~E 506 (752)
+|++.+.||+|++|.||++... +++.+|+|++.... ....+.+.+|++++++++|+|++++++.+.. +...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4778899999999999999865 47889999986542 2344568899999999999999999998764 446789999
Q ss_pred eCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccc
Q 043278 507 FMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586 (752)
Q Consensus 507 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~ 586 (752)
|+++++|.+++... ....+++.+++.++.|++.||++||+.+ ++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999988653 2345899999999999999999999988 9999999999999999999999999998764322
Q ss_pred cccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCC
Q 043278 587 SEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666 (752)
Q Consensus 587 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 666 (752)
. ......+++.|+|||++.+..++.++||||||++++||++|+.||..... ...... ...+....
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~------~~~~~~-~~~~~~~~------ 221 (257)
T cd08223 157 D--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM------NSLVYR-IIEGKLPP------ 221 (257)
T ss_pred C--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHH-HHhcCCCC------
Confidence 1 22235678899999999999999999999999999999999999864431 111111 11222111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 667 EQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 667 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.+......+.+++.+|++.+|.+|||+.+++++
T Consensus 222 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 222 ---MPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ---CccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 112233467789999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=305.07 Aligned_cols=245 Identities=26% Similarity=0.361 Sum_probs=196.8
Q ss_pred CCeeecCCcccEEEEEec-CCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCCCCCH
Q 043278 435 TNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSL 513 (752)
Q Consensus 435 ~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 513 (752)
...||+|+||.||++... ++..||||.+..........+.+|+..+.+++|+||+++++.+..++..++||||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 367999999999999864 5789999998765555566789999999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccccccccc
Q 043278 514 DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKR 593 (752)
Q Consensus 514 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~ 593 (752)
.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++....... .....
T Consensus 107 ~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~ 177 (292)
T cd06658 107 TDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--PKRKS 177 (292)
T ss_pred HHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc--ccCce
Confidence 988732 34889999999999999999999988 9999999999999999999999999987543222 11223
Q ss_pred ccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCCCCHH
Q 043278 594 IVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSAN 673 (752)
Q Consensus 594 ~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 673 (752)
..++..|+|||.+.+..++.++||||||++++||++|+.|+....... .. ..... .+.+.+.. ...
T Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~~----~~~~~-----~~~~~~~~--~~~ 243 (292)
T cd06658 178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ---AM----RRIRD-----NLPPRVKD--SHK 243 (292)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HH----HHHHh-----cCCCcccc--ccc
Confidence 567889999999998899999999999999999999999987543211 11 11111 01111111 111
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 674 EVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 674 ~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
....+..++.+|++.+|.+|||++|+++.
T Consensus 244 ~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 244 VSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 22346678889999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=304.25 Aligned_cols=254 Identities=22% Similarity=0.281 Sum_probs=201.2
Q ss_pred cCCCcCCeeecCCcccEEEEEecC-CceeEEEEcccCCcc---cHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLAD-EQEVAIKRLSRSSGQ---GIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 505 (752)
++|+..+.||+|++|.||++...+ ++.+|+|.+...... ....+.+|++++..++|+||+++++.+.++...++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 367888999999999999998754 889999999765322 4456889999999999999999999999999999999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccc
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVN 585 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~ 585 (752)
||+.+++|.+++... ....+++..+..++.||+.||+|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 999999999988543 2356899999999999999999999988 999999999999999999999999998754321
Q ss_pred ccc---------------------------cccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 043278 586 ESE---------------------------ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHH 638 (752)
Q Consensus 586 ~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~ 638 (752)
... .......|+..|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 100 01123467889999999999899999999999999999999999987554
Q ss_pred CCCCcchHHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCC----HHHHHHH
Q 043278 639 PDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPT----MPEVVCM 702 (752)
Q Consensus 639 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt----~~ev~~~ 702 (752)
.... ..... .. ....+........+.+++.+|++.+|++||| +.|++..
T Consensus 237 ~~~~------~~~~~-~~--------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 237 RDET------FSNIL-KK--------EVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred hHHH------HHHHh-cC--------CccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 2211 11111 11 1111111113456788999999999999999 6666653
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=304.67 Aligned_cols=265 Identities=24% Similarity=0.319 Sum_probs=199.2
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCcc--cHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEe
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQ--GIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYE 506 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 506 (752)
++|+..++||+|+||.||++... .++.||+|++...... ....+.+|+++++.++|+||+++++++..+...++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46788899999999999999975 4889999998654322 34568899999999999999999999999999999999
Q ss_pred eCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccc
Q 043278 507 FMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586 (752)
Q Consensus 507 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~ 586 (752)
|+++++|..+... ...+++..+..++.||+.||+|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 9999999887643 234899999999999999999999988 9999999999999999999999999998654332
Q ss_pred cccccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHH--------HHhhCCC
Q 043278 587 SEANTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAW--------QLLSDGK 657 (752)
Q Consensus 587 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~--------~~~~~~~ 657 (752)
. ......++..|+|||++.+ ..++.++||||||++++||++|++|+...........+.... .......
T Consensus 155 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07846 155 E--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP 232 (286)
T ss_pred c--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccch
Confidence 1 1223457889999999875 457889999999999999999999886544211000000000 0000000
Q ss_pred -cccccCCCCCCCC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 658 -GLELIDPSLEQPC-----SANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 658 -~~~~~d~~l~~~~-----~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
......+...... .......+.+++.+||+.+|.+||++.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0000011110000 11223567889999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=294.88 Aligned_cols=258 Identities=28% Similarity=0.412 Sum_probs=205.7
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEee
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
++|++.+.||.|+||+||+|... ++..+++|++.... ......+.+|++.++.++|+|++++++.+..++..++++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888999999999999999864 57889999986543 23556789999999999999999999999999999999999
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccc
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES 587 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~ 587 (752)
+++++|.+++........+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999865444456899999999999999999999988 99999999999999999999999999876654322
Q ss_pred cc--ccccccccCCccChhhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCC
Q 043278 588 EA--NTKRIVGTYGYMSPEYAMSG-IVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDP 664 (752)
Q Consensus 588 ~~--~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 664 (752)
.. ......++..|+|||++... .++.++|+||||++++||++|+.|+......... ...... . .+
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~------~~~~~~-~-----~~ 225 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVL------MLTLQN-D-----PP 225 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhH------HHHhcC-C-----CC
Confidence 21 22335678899999998877 7899999999999999999999999765432211 111111 0 11
Q ss_pred CCCCCC-CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 665 SLEQPC-SANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 665 ~l~~~~-~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.+.... .......+.+++..|++.||++||++.|+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 111111 11233557789999999999999999999873
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=312.06 Aligned_cols=263 Identities=23% Similarity=0.247 Sum_probs=195.7
Q ss_pred HhcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeeeC------
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHG------ 498 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 498 (752)
..++|...+.||+|+||.||++... .++.||||++.... ......+.+|+.+++.++|+||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999864 57889999997542 22345678899999999999999999987643
Q ss_pred CeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceeccccc
Q 043278 499 EERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGM 578 (752)
Q Consensus 499 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgl 578 (752)
...++||||+++ +|...+. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 356899999976 4555552 23788999999999999999999988 99999999999999999999999999
Q ss_pred ceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchH------------
Q 043278 579 ARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLI------------ 646 (752)
Q Consensus 579 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~------------ 646 (752)
++..... .......+|..|+|||++.+..++.++|||||||++|||++|+.||............
T Consensus 166 ~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 166 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred cccCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 9864322 1123357899999999999999999999999999999999999999765421110000
Q ss_pred ----HHHHHHhhC-CCcccccCCCC--------CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 647 ----GYAWQLLSD-GKGLELIDPSL--------EQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 647 ----~~~~~~~~~-~~~~~~~d~~l--------~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
......... .....+..+.. ...........+.+++.+|++.||.+|||+.|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000000000 00000000000 000111123456789999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=294.59 Aligned_cols=255 Identities=25% Similarity=0.381 Sum_probs=198.1
Q ss_pred CCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCc---c-------cHHHHHHHHHHHHhcCCCCcceeeeeeeeCC
Q 043278 431 NFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSG---Q-------GIVEFKNEVRLIAKLQHTNLVRLLGCSLHGE 499 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 499 (752)
+|...+.||+|+||.||+|... +++.+|+|.++.... . ..+.+.+|+.++.+++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4667789999999999999864 688999998753211 0 1245788999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccc
Q 043278 500 ERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMA 579 (752)
Q Consensus 500 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla 579 (752)
..++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999998543 45899999999999999999999987 999999999999999999999999999
Q ss_pred eeecccccccccccccccCCccChhhhccCC--CCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCC
Q 043278 580 RIFEVNESEANTKRIVGTYGYMSPEYAMSGI--VSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGK 657 (752)
Q Consensus 580 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 657 (752)
+...............++..|+|||.+.... ++.++||||||++++|+++|+.|+...... ......... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~-~ 228 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI------AAMFKLGNK-R 228 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH------HHHHHhhcc-c
Confidence 8654322222223456788999999987654 899999999999999999999998543211 111111111 1
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 658 GLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 658 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
....+.... .......+.+++.+|++.+|.+|||+.+|+++
T Consensus 229 ~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 229 SAPPIPPDV----SMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred cCCcCCccc----cccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 111111111 11223567788899999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=326.23 Aligned_cols=266 Identities=20% Similarity=0.225 Sum_probs=192.5
Q ss_pred HHHHHhcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCcccHHHHHHHHHHHHhcCC------CCcceeeeeee
Q 043278 424 TIAAAANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQH------TNLVRLLGCSL 496 (752)
Q Consensus 424 ~i~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~~ 496 (752)
++...+++|.+.++||+|+||+||++... .++.||||+++... ....++..|+.++.+++| .+++++++++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34445688999999999999999999864 57889999986532 233455677777777755 45888888886
Q ss_pred eC-CeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEeecCCCCCcEEecCCC-----
Q 043278 497 HG-EERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY-SRLRVIHRDLKASNILLDDKM----- 569 (752)
Q Consensus 497 ~~-~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiH~Dikp~NIll~~~~----- 569 (752)
.+ .+.++|||++ +++|.+++... ..+++..+..++.||+.||+|||++ + ||||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKH---GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccc
Confidence 54 4788999988 56777777532 4589999999999999999999984 6 99999999999998765
Q ss_pred -----------CceecccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 043278 570 -----------NPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHH 638 (752)
Q Consensus 570 -----------~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~ 638 (752)
.+||+|||++.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred ccccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 49999999876422 11234678999999999999999999999999999999999999997655
Q ss_pred CCCCcchHHHHH-----------------HHhh-CCCcccccCCC----CCCC---CCHHHHHHHHHHHHHcccCCCCCC
Q 043278 639 PDRPLNLIGYAW-----------------QLLS-DGKGLELIDPS----LEQP---CSANEVMRCIHVGLLCVQDQAMDR 693 (752)
Q Consensus 639 ~~~~~~l~~~~~-----------------~~~~-~~~~~~~~d~~----l~~~---~~~~~~~~l~~l~~~Cl~~dp~~R 693 (752)
......++.... .... .+......++. +... ........+++|+.+||+.||++|
T Consensus 350 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R 429 (467)
T PTZ00284 350 NLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR 429 (467)
T ss_pred hHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence 322211111100 0000 00000000000 0000 000112456789999999999999
Q ss_pred CCHHHHHHH
Q 043278 694 PTMPEVVCM 702 (752)
Q Consensus 694 Pt~~ev~~~ 702 (752)
||++|++++
T Consensus 430 ~ta~e~L~H 438 (467)
T PTZ00284 430 LNARQMTTH 438 (467)
T ss_pred CCHHHHhcC
Confidence 999999874
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=292.23 Aligned_cols=248 Identities=27% Similarity=0.394 Sum_probs=199.4
Q ss_pred CCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC-----cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEE
Q 043278 431 NFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS-----GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLV 504 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 504 (752)
+|+..+.||+|++|.||+|... +++.|++|.+.... .+..+.+.+|+.++++++|+||+++++++..+...+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4667789999999999999876 78899999886543 22456789999999999999999999999999999999
Q ss_pred EeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecc
Q 043278 505 YEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~ 584 (752)
+||+++++|.+++... ..+++..+..++.||+.||+|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKKY---GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 9999999999998543 34889999999999999999999988 99999999999999999999999999886543
Q ss_pred cccccccccccccCCccChhhhccCC-CCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccC
Q 043278 585 NESEANTKRIVGTYGYMSPEYAMSGI-VSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELID 663 (752)
Q Consensus 585 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 663 (752)
.. ......++..|+|||.+.... ++.++|+||||++++||++|+.||...... .............. +
T Consensus 155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~~-~- 223 (258)
T cd06632 155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV------AAVFKIGRSKELPP-I- 223 (258)
T ss_pred cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH------HHHHHHHhcccCCC-c-
Confidence 22 123356788999999988776 899999999999999999999998654411 11111111111111 1
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 664 PSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 664 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
+......+.+++.+|++.+|.+||++.++++.
T Consensus 224 -------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 224 -------PDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred -------CCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 11123456778899999999999999999863
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=303.67 Aligned_cols=197 Identities=27% Similarity=0.435 Sum_probs=160.0
Q ss_pred CeeecCCcccEEEEEecC---CceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeee--CCeeEEEEeeCCC
Q 043278 436 NKLGEGGFGPVYKGKLAD---EQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLH--GEERLLVYEFMPN 510 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~~---~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~E~~~~ 510 (752)
.+||+|+||.||+|+..+ +..||+|.+.... ....+.+|+.++.+++||||+++++++.. +...++||||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 689999999999998653 4689999986543 23467899999999999999999998853 4577899999875
Q ss_pred CCHhHHHhhc------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEe----cCCCCceecccccce
Q 043278 511 KSLDFFLFNS------GRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILL----DDKMNPKISDFGMAR 580 (752)
Q Consensus 511 gsL~~~l~~~------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll----~~~~~~kl~DFgla~ 580 (752)
+|..++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 565555321 12235889999999999999999999988 9999999999999 567789999999998
Q ss_pred eecccccc-cccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 043278 581 IFEVNESE-ANTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHH 638 (752)
Q Consensus 581 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~ 638 (752)
........ .......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||....
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 76433211 12234578899999999876 458999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=303.57 Aligned_cols=258 Identities=19% Similarity=0.266 Sum_probs=192.7
Q ss_pred cCCeeecC--CcccEEEEEe-cCCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeC
Q 043278 434 TTNKLGEG--GFGPVYKGKL-ADEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFM 508 (752)
Q Consensus 434 ~~~~LG~G--~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 508 (752)
+.++||+| +|++||+++. .+|+.||+|++.... ......+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35789999 7899999986 468899999987542 223346778999999999999999999999999999999999
Q ss_pred CCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccc
Q 043278 509 PNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE 588 (752)
Q Consensus 509 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 588 (752)
++|+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++++||+...........
T Consensus 82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 9999999885432 234899999999999999999999988 999999999999999999999999875433211110
Q ss_pred -----cccccccccCCccChhhhcc--CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccc
Q 043278 589 -----ANTKRIVGTYGYMSPEYAMS--GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLEL 661 (752)
Q Consensus 589 -----~~~~~~~gt~~y~aPE~~~~--~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 661 (752)
.......++..|+|||++.+ ..++.++|||||||+++||++|+.||........ .. ... .+.....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~----~~~-~~~~~~~ 230 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LL----EKL-NGTVPCL 230 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HH----HHh-cCCcccc
Confidence 01112346678999999976 4689999999999999999999999975332110 00 000 0000000
Q ss_pred cC-------------------CCC-----------------CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 662 ID-------------------PSL-----------------EQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 662 ~d-------------------~~l-----------------~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
++ ... ..+........+.+++.+|++.||++|||++|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 231 LDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred ccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 00 000 001111223467789999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=302.96 Aligned_cols=255 Identities=18% Similarity=0.247 Sum_probs=193.6
Q ss_pred cCCCcCCeeecCCcccEEEEEecC-CceeEEEEcccC---CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLAD-EQEVAIKRLSRS---SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 505 (752)
++|++.++||+|+||.||+++... ++.+|+|.+.+. .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 468888999999999999998754 678999998642 1223345788999999999999999999999999999999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccc
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVN 585 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~ 585 (752)
||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 999999999999653 235889999999999999999999988 999999999999999999999999999754322
Q ss_pred ccccccccccccCCccChhhhc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCccc
Q 043278 586 ESEANTKRIVGTYGYMSPEYAM-----SGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLE 660 (752)
Q Consensus 586 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 660 (752)
.. .......||+.|+|||++. ...++.++|||||||++|||++|+.||...... ..............
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~------~~~~~i~~~~~~~~ 228 (332)
T cd05623 156 GT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHKERFQ 228 (332)
T ss_pred Cc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH------HHHHHHhCCCcccc
Confidence 21 1222357899999999986 346889999999999999999999999755421 11122222111111
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHcccC--CCCCCCCHHHHHHH
Q 043278 661 LIDPSLEQPCSANEVMRCIHVGLLCVQD--QAMDRPTMPEVVCM 702 (752)
Q Consensus 661 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~--dp~~RPt~~ev~~~ 702 (752)
+ +..... ....+.+++.+|+.. ++..||++.|++++
T Consensus 229 ~--p~~~~~----~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 229 F--PAQVTD----VSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred C--CCcccc----CCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 1 110011 123345566666644 44447899999877
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=307.62 Aligned_cols=260 Identities=23% Similarity=0.312 Sum_probs=194.4
Q ss_pred HHhcCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeeeC-----
Q 043278 427 AAANNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHG----- 498 (752)
Q Consensus 427 ~~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 498 (752)
...++|...+.||+|+||.||++.. .+++.||||++.... ......+.+|+.++++++|+||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 4567899999999999999999986 467889999987542 22345677899999999999999999987543
Q ss_pred -CeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccc
Q 043278 499 -EERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFG 577 (752)
Q Consensus 499 -~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg 577 (752)
...++++|++ +++|..++. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence 3568999987 678877763 235899999999999999999999998 9999999999999999999999999
Q ss_pred cceeecccccccccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCC
Q 043278 578 MARIFEVNESEANTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDG 656 (752)
Q Consensus 578 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 656 (752)
+++..... .....+++.|+|||++.+ ..++.++|||||||++|||++|+.||........ ...........
T Consensus 164 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~ 235 (343)
T cd07878 164 LARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ---LKRIMEVVGTP 235 (343)
T ss_pred cceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH---HHHHHHHhCCC
Confidence 99864321 223568899999999877 5789999999999999999999999965432111 00000000000
Q ss_pred -----------CcccccC--CCCCCCC----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 657 -----------KGLELID--PSLEQPC----SANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 657 -----------~~~~~~d--~~l~~~~----~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.....+. +...... .......+.+++.+|++.||.+|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 236 SPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred CHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000 0000000 00011246789999999999999999999875
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=291.61 Aligned_cols=254 Identities=21% Similarity=0.284 Sum_probs=206.3
Q ss_pred cCCCcCCeeecCCcccEEEEEecC-CceeEEEEcccCC---cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLAD-EQEVAIKRLSRSS---GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 505 (752)
++|+..+.||.|.-|+||++++.+ +..+|+|++.+.. .....+.+.|-++|+.++||.+..|++.++.++..+++|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 345566899999999999999876 5789999998763 334456778999999999999999999999999999999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecc-
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV- 584 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~- 584 (752)
|||++|+|...++.. ..+.+++..+.-++..|+-||+|||-.+ ||.|||||+||||.++|++-|+||.|+.....
T Consensus 157 eyCpGGdL~~LrqkQ-p~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQ-PGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred ecCCCccHHHHHhhC-CCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 999999998887654 3456999999999999999999999998 99999999999999999999999998753311
Q ss_pred --------------------------------ccc---------------------ccccccccccCCccChhhhccCCC
Q 043278 585 --------------------------------NES---------------------EANTKRIVGTYGYMSPEYAMSGIV 611 (752)
Q Consensus 585 --------------------------------~~~---------------------~~~~~~~~gt~~y~aPE~~~~~~~ 611 (752)
... ...+..++||..|+|||++.+..-
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 000 011234689999999999999999
Q ss_pred CccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCC
Q 043278 612 SIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAM 691 (752)
Q Consensus 612 t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~ 691 (752)
+.++|.|+|||+||||+.|..||.+....+.... ++-..+..+........+.+||...|.+||.
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~N---------------Iv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~ 377 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRN---------------IVGQPLKFPEEPEVSSAAKDLIRKLLVKDPS 377 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHH---------------HhcCCCcCCCCCcchhHHHHHHHHHhccChh
Confidence 9999999999999999999999998875543321 1122222233334556677899999999999
Q ss_pred CCCC----HHHHHHH
Q 043278 692 DRPT----MPEVVCM 702 (752)
Q Consensus 692 ~RPt----~~ev~~~ 702 (752)
+|-- +.||-++
T Consensus 378 kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 378 KRLGSKRGAAEIKRH 392 (459)
T ss_pred hhhccccchHHhhcC
Confidence 9997 7777654
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=303.54 Aligned_cols=255 Identities=18% Similarity=0.245 Sum_probs=195.2
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccC---CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRS---SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 505 (752)
++|.+.+.||+|+||.||+++.. +++.||+|.+.+. .......+.+|..++..++|+||+++++++.+++..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888899999999999999875 5788999998652 1223345788999999999999999999999999999999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccc
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVN 585 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~ 585 (752)
||+++|+|..++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999998653 235889999999999999999999988 999999999999999999999999999865432
Q ss_pred ccccccccccccCCccChhhhcc-----CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCccc
Q 043278 586 ESEANTKRIVGTYGYMSPEYAMS-----GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLE 660 (752)
Q Consensus 586 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 660 (752)
.. .......|++.|+|||++.+ +.++.++||||||++||||++|+.||...... ..............
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------~~~~~i~~~~~~~~ 228 (331)
T cd05624 156 GT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHEERFQ 228 (331)
T ss_pred Cc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH------HHHHHHHcCCCccc
Confidence 21 11223568999999999875 56889999999999999999999999754421 11111221111111
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 043278 661 LIDPSLEQPCSANEVMRCIHVGLLCVQDQAMD--RPTMPEVVCM 702 (752)
Q Consensus 661 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~--RPt~~ev~~~ 702 (752)
+ .+.. ......+.+++.+|++.++++ |+++++++++
T Consensus 229 ~-p~~~-----~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 229 F-PSHI-----TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred C-CCcc-----ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 1 1111 112245666777888765543 5688888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=309.52 Aligned_cols=263 Identities=23% Similarity=0.235 Sum_probs=195.7
Q ss_pred HhcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeeeC------
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHG------ 498 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 498 (752)
..++|...+.||+|+||.||++... .++.||||++.... ......+.+|+.+++.++|+||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3578999999999999999999864 57889999987542 23345678999999999999999999987543
Q ss_pred CeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceeccccc
Q 043278 499 EERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGM 578 (752)
Q Consensus 499 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgl 578 (752)
...++||||+++ +|...+. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 357999999975 5655552 23788999999999999999999988 99999999999999999999999999
Q ss_pred ceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHH-----------
Q 043278 579 ARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIG----------- 647 (752)
Q Consensus 579 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~----------- 647 (752)
++..... .......++..|+|||++.+..++.++|||||||++|||++|+.||...........+.
T Consensus 173 a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (364)
T cd07875 173 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 249 (364)
T ss_pred ccccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 9864322 12233568999999999999999999999999999999999999997654211100000
Q ss_pred -----HHHHHhhC-CCccc----ccCCCCCC----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 648 -----YAWQLLSD-GKGLE----LIDPSLEQ----PCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 648 -----~~~~~~~~-~~~~~----~~d~~l~~----~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
........ ..... .+.+.... .........+.+++.+|++.||.+|||+.|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000000 00000 00000000 0011122456789999999999999999999886
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=301.41 Aligned_cols=263 Identities=23% Similarity=0.336 Sum_probs=204.0
Q ss_pred ccHHHHHHHhcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCcccHHHHHHHHHHHHhc-CCCCcceeeeeeee
Q 043278 420 FDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLH 497 (752)
Q Consensus 420 ~~~~~i~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 497 (752)
+.+.++..+.++|.+.+.||+|+||.||++... +++.+|+|.+.... ....++.+|+.++.++ +|+|++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 445566667889999999999999999999874 57889999986542 2345678899999998 89999999999875
Q ss_pred C-----CeeEEEEeeCCCCCHhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCc
Q 043278 498 G-----EERLLVYEFMPNKSLDFFLFNS-GRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNP 571 (752)
Q Consensus 498 ~-----~~~~lv~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~ 571 (752)
. ...++||||+++++|.+++... .....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence 3 3589999999999999987542 22346899999999999999999999987 9999999999999999999
Q ss_pred eecccccceeecccccccccccccccCCccChhhhccC-----CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchH
Q 043278 572 KISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSG-----IVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLI 646 (752)
Q Consensus 572 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~ 646 (752)
||+|||++......... .....++..|+|||.+... .++.++||||||+++|||++|+.|+........
T Consensus 168 kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~---- 241 (291)
T cd06639 168 KLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT---- 241 (291)
T ss_pred EEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH----
Confidence 99999998765422211 1234678899999987643 368999999999999999999999875442111
Q ss_pred HHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 647 GYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 647 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
... +..+....+.+ +......+.+++.+|++.+|++||++.|++++
T Consensus 242 --~~~-~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 242 --LFK-IPRNPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred --HHH-HhcCCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 111 11111111111 11223457889999999999999999999874
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=303.20 Aligned_cols=245 Identities=28% Similarity=0.357 Sum_probs=197.3
Q ss_pred CCeeecCCcccEEEEEec-CCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCCCCCH
Q 043278 435 TNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSL 513 (752)
Q Consensus 435 ~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 513 (752)
..+||+|+||.||++... +++.||+|.+..........+.+|+.++..++||||+++++++..++..++++||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 457999999999999864 6889999998765555566788999999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccccccccc
Q 043278 514 DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKR 593 (752)
Q Consensus 514 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~ 593 (752)
..++.. ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++....... .....
T Consensus 106 ~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~ 176 (297)
T cd06659 106 TDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRKS 176 (297)
T ss_pred HHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc--ccccc
Confidence 987732 35899999999999999999999988 9999999999999999999999999987543221 11223
Q ss_pred ccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCCCCHH
Q 043278 594 IVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSAN 673 (752)
Q Consensus 594 ~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 673 (752)
..++..|+|||++.+..++.++||||||++++||++|+.||....... .. ..+....... ... ...
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------~~-~~~~~~~~~~-----~~~--~~~ 242 (297)
T cd06659 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ------AM-KRLRDSPPPK-----LKN--AHK 242 (297)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HH-HHHhccCCCC-----ccc--cCC
Confidence 568899999999999899999999999999999999999987543211 11 1111111000 000 011
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 674 EVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 674 ~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
....+.+++.+|++.+|.+||++.|++++
T Consensus 243 ~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 243 ISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 12346778889999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=294.74 Aligned_cols=250 Identities=25% Similarity=0.382 Sum_probs=192.5
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCc-----ccHHHHHHHHHHHHhcCCCCcceeeeeeee--CCee
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSG-----QGIVEFKNEVRLIAKLQHTNLVRLLGCSLH--GEER 501 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 501 (752)
.+|...+.||+|+||.||++... .+..|++|++..... .....+.+|+.++++++|+||+++++++.+ +...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46888899999999999999864 588999998864321 223467889999999999999999998865 3567
Q ss_pred EEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceeccccccee
Q 043278 502 LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARI 581 (752)
Q Consensus 502 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~ 581 (752)
++++||+++++|.+++... ..+++.....++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY---GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 8999999999999988543 34889999999999999999999987 99999999999999999999999999876
Q ss_pred eccccc-ccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCccc
Q 043278 582 FEVNES-EANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLE 660 (752)
Q Consensus 582 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 660 (752)
...... ........++..|+|||.+.+..++.++||||||+++|||++|+.||...... ..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~------~~~~~~~~~~---- 225 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM------AAIFKIATQP---- 225 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH------HHHHHHhcCC----
Confidence 532211 11112345788999999999989999999999999999999999998754311 1111111111
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 043278 661 LIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVC 701 (752)
Q Consensus 661 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~ 701 (752)
..+.+ +......+..++ .|+..+|++||+|+||++
T Consensus 226 -~~~~~----~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 226 -TNPQL----PSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred -CCCCC----chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 11111 111112233343 788899999999999976
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=324.89 Aligned_cols=255 Identities=23% Similarity=0.321 Sum_probs=196.7
Q ss_pred HhcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccC--CcccHHHHHHHHHHHHhcCCCCcceeeeeeee--CCeeE
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRS--SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLH--GEERL 502 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~ 502 (752)
..++|.+.++||+|+||+||+++.. .+..+|+|.+... .......+..|+.++.+++|||||++++++.. ....+
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 3468899999999999999999875 4678899988643 22345678899999999999999999998854 34689
Q ss_pred EEEeeCCCCCHhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCC----CcEeecCCCCCcEEecC----------
Q 043278 503 LVYEFMPNKSLDFFLFNSG-RKNVLNWEKRFIIIEGISQGLLYLHKYSR----LRVIHRDLKASNILLDD---------- 567 (752)
Q Consensus 503 lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~----~~iiH~Dikp~NIll~~---------- 567 (752)
|||||+++++|..+|.... ....+++..++.|+.||+.||.|||+.+. .+||||||||+||||+.
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 9999999999999886532 23469999999999999999999998542 24999999999999964
Q ss_pred -------CCCceecccccceeecccccccccccccccCCccChhhhcc--CCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 043278 568 -------KMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMS--GIVSIKTDVFSFGVLVLEIVSGQKNHTRHH 638 (752)
Q Consensus 568 -------~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~k~DV~S~G~vl~elltG~~p~~~~~ 638 (752)
...+||+|||++..+.... ......||+.|+|||++.+ ..++.++||||||||||||++|+.||....
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred cccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 3448999999998654322 1224578999999999864 458999999999999999999999996543
Q ss_pred CCCCcchHHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 043278 639 PDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVC 701 (752)
Q Consensus 639 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~ 701 (752)
.. ......+..+. .+... .....+.+|+..||+.+|.+||++.|++.
T Consensus 248 ~~------~qli~~lk~~p-------~lpi~---~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 248 NF------SQLISELKRGP-------DLPIK---GKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred cH------HHHHHHHhcCC-------CCCcC---CCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 21 11112222211 11000 11245778999999999999999999984
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=303.35 Aligned_cols=268 Identities=21% Similarity=0.276 Sum_probs=197.4
Q ss_pred CCCcCCeeecCCcccEEEEEec---CCceeEEEEcccCC---cccHHHHHHHHHHHHhcCCCCcceeeeeeeeC--CeeE
Q 043278 431 NFSTTNKLGEGGFGPVYKGKLA---DEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHG--EERL 502 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~~---~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 502 (752)
+|.+.++||+|+||.||+|... .++.||+|.+.... ......+.+|+.++.+++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4677889999999999999875 47899999998633 33345678899999999999999999999888 7899
Q ss_pred EEEeeCCCCCHhHHHhhc-CC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecC----CCCceeccc
Q 043278 503 LVYEFMPNKSLDFFLFNS-GR-KNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDD----KMNPKISDF 576 (752)
Q Consensus 503 lv~E~~~~gsL~~~l~~~-~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~----~~~~kl~DF 576 (752)
+||||+++ +|..++... .. ...++...+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999986 555555322 22 236889999999999999999999988 999999999999999 999999999
Q ss_pred ccceeeccccc-ccccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcc------hHHH
Q 043278 577 GMARIFEVNES-EANTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLN------LIGY 648 (752)
Q Consensus 577 gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~------l~~~ 648 (752)
|++........ ........++..|+|||.+.+ ..++.++||||||++++||++|+.||.......... ....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987643322 122234567889999998876 458999999999999999999999998665432100 0000
Q ss_pred HHHHhhCC------------CcccccCCCCCCCCC---H--------HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 649 AWQLLSDG------------KGLELIDPSLEQPCS---A--------NEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 649 ~~~~~~~~------------~~~~~~d~~l~~~~~---~--------~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
....+... ......+.......+ . ....++.+++.+|++.||++|||+.|++++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00111000 000000000000001 0 223457889999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=298.37 Aligned_cols=251 Identities=27% Similarity=0.396 Sum_probs=203.4
Q ss_pred hcCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEee
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
.++|...+.||+|+||.||++.. .+++.|++|.+........+.+.+|+.++++++|||++++++++..++..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 36788889999999999999985 46788999998755555566789999999999999999999999999999999999
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccc
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES 587 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~ 587 (752)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 999999998843 34789999999999999999999988 99999999999999999999999999876543221
Q ss_pred ccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCC
Q 043278 588 EANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLE 667 (752)
Q Consensus 588 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 667 (752)
......+++.|+|||.+....++.++||||||+++||+++|+.||........... ....+. +.
T Consensus 171 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~------~~~~~~------~~-- 234 (293)
T cd06647 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNGT------PE-- 234 (293)
T ss_pred --ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee------hhcCCC------CC--
Confidence 12234678899999999988899999999999999999999999976543221110 000000 00
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 668 QPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 668 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
..........+.+++.+|++.+|.+||++.+++.+
T Consensus 235 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 235 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111223456788999999999999999999887
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=292.98 Aligned_cols=253 Identities=24% Similarity=0.413 Sum_probs=200.0
Q ss_pred CCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCCc------ccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEE
Q 043278 431 NFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSSG------QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLL 503 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 503 (752)
+|+..+.||+|++|.||++.. .+++.+|+|.+..... .....+.+|+.++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 467778999999999999985 5688999999865331 124578899999999999999999999999999999
Q ss_pred EEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCC-Cceecccccceee
Q 043278 504 VYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKM-NPKISDFGMARIF 582 (752)
Q Consensus 504 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~-~~kl~DFgla~~~ 582 (752)
|+||+++++|.+++... ..+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++ .+||+|||++...
T Consensus 81 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY---GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 99999999999988543 35889999999999999999999998 99999999999998776 5999999999766
Q ss_pred cccccc--cccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCccc
Q 043278 583 EVNESE--ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLE 660 (752)
Q Consensus 583 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 660 (752)
...... .......++..|+|||.+.+..++.++||||+|++++||++|+.|+.......... ..........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~---~~~~~~~~~~--- 228 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLA---LIFKIASATT--- 228 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHH---HHHHHhccCC---
Confidence 433111 11223467889999999988889999999999999999999999986544322111 1111111100
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 043278 661 LIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVC 701 (752)
Q Consensus 661 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~ 701 (752)
. ...+......+.+++.+|++.+|.+||++.|+++
T Consensus 229 --~----~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 229 --A----PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred --C----CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0 1122233356778999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=300.83 Aligned_cols=266 Identities=24% Similarity=0.336 Sum_probs=201.1
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEe
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYE 506 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 506 (752)
++|++.+.||+|+||.||+|... +++.||+|+++... ......+.+|++++++++|+||+++++++..++..+++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36788899999999999999875 57889999886542 3345678999999999999999999999999999999999
Q ss_pred eCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccc
Q 043278 507 FMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586 (752)
Q Consensus 507 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~ 586 (752)
|++++.+..+... ...+++..+..++.||+.||.|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 9998877765532 344899999999999999999999988 9999999999999999999999999998765432
Q ss_pred cccccccccccCCccChhhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHH--------HHh-hCC
Q 043278 587 SEANTKRIVGTYGYMSPEYAMSG-IVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAW--------QLL-SDG 656 (752)
Q Consensus 587 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~--------~~~-~~~ 656 (752)
.. ......++..|+|||++.+. .++.++||||||+++|||++|+.|+...........+.... ..+ ...
T Consensus 155 ~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 155 AS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred cc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence 21 22235678899999999888 88999999999999999999999987543211110000000 000 000
Q ss_pred Ccc--cccCCCC----CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 657 KGL--ELIDPSL----EQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 657 ~~~--~~~d~~l----~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
... ++.+... ....+......+.+++.+|++.+|++|||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 000 0000000 000111124567899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=278.59 Aligned_cols=252 Identities=26% Similarity=0.352 Sum_probs=202.5
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC----cc----cHHHHHHHHHHHHhc-CCCCcceeeeeeeeC
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS----GQ----GIVEFKNEVRLIAKL-QHTNLVRLLGCSLHG 498 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~----~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 498 (752)
-+.|...+.||.|..++|-+...+ .|++.|+|++.... .+ -.++-.+|+.+|+++ .||+|+.+.+++..+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 456777889999999999988754 57889999885431 11 223456899999998 799999999999999
Q ss_pred CeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceeccccc
Q 043278 499 EERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGM 578 (752)
Q Consensus 499 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgl 578 (752)
...++|+|.|+.|.|.++|.. .-.++++...+|+.|+..|++|||... |+||||||+|||+|++.++||+|||+
T Consensus 96 sF~FlVFdl~prGELFDyLts---~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTS---KVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred chhhhhhhhcccchHHHHhhh---heeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccce
Confidence 999999999999999999953 345899999999999999999999998 99999999999999999999999999
Q ss_pred ceeecccccccccccccccCCccChhhhc------cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHH
Q 043278 579 ARIFEVNESEANTKRIVGTYGYMSPEYAM------SGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQL 652 (752)
Q Consensus 579 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~ 652 (752)
++.+..+.. ....+||++|+|||.+. ...|+..+|.|++||++|.|+.|.+||-... .-...+.
T Consensus 170 a~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk-------QmlMLR~ 239 (411)
T KOG0599|consen 170 ACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK-------QMLMLRM 239 (411)
T ss_pred eeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH-------HHHHHHH
Confidence 997765432 33579999999999874 2358889999999999999999999985432 1122344
Q ss_pred hhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 653 LSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 653 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
+.+|+.. +-. +.-.+......+|+.+|++.||.+|.|++|++++
T Consensus 240 ImeGkyq-F~s-----peWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 240 IMEGKYQ-FRS-----PEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred HHhcccc-cCC-----cchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 4455432 112 2223334456789999999999999999999875
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=293.84 Aligned_cols=261 Identities=24% Similarity=0.281 Sum_probs=201.8
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCc-ccHHHHHHHHHHHHhcCCCCcceeeeeeeeC--CeeEEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSG-QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHG--EERLLVY 505 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 505 (752)
++|...+.||.|++|.||++... .++.+|+|.+..... ....++.+|++++++++|+||+++++++.+. ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 35777899999999999999975 578899999875432 3456789999999999999999999988653 4689999
Q ss_pred eeCCCCCHhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecc
Q 043278 506 EFMPNKSLDFFLFNS-GRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584 (752)
Q Consensus 506 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~ 584 (752)
||+++++|.+++... .....++......++.||+.||+|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999887542 23445889999999999999999999988 99999999999999999999999999875432
Q ss_pred cccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCC
Q 043278 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDP 664 (752)
Q Consensus 585 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 664 (752)
.. .....++..|+|||.+.+..++.++||||||+++|||++|+.|+........ ...... ..........+ ..
T Consensus 158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~-~~~~~~~~~~~-~~ 230 (287)
T cd06621 158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPL-GPIELL-SYIVNMPNPEL-KD 230 (287)
T ss_pred cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCC-ChHHHH-HHHhcCCchhh-cc
Confidence 21 1134567899999999999999999999999999999999999986643111 111111 11111111111 11
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 665 SLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 665 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.. .........+.+++.+|++.+|.+|||+.|+++.
T Consensus 231 ~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 231 EP--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred CC--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 11 0011234567899999999999999999999884
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=290.23 Aligned_cols=250 Identities=20% Similarity=0.308 Sum_probs=201.0
Q ss_pred CCCcCCeeecCCcccEEEEEec-CCceeEEEEcccC--CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEee
Q 043278 431 NFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRS--SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
+|+..+.||+|+||.||++... +++.+|+|++... ......++.+|+.++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4778899999999999999864 6789999998643 233445789999999999999999999999999999999999
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccc
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES 587 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~ 587 (752)
+++++|.+++.... ...+++.+++.++.|++.||.|||+.+ ++|+||+|+|||++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 99999998885432 235789999999999999999999988 99999999999999999999999999986543221
Q ss_pred ccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCC
Q 043278 588 EANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLE 667 (752)
Q Consensus 588 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 667 (752)
......++..|+|||++.+...+.++|+||||++++||++|+.|+..... ........ .+....
T Consensus 157 --~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~~-~~~~~~------- 220 (256)
T cd08218 157 --LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM------KNLVLKII-RGSYPP------- 220 (256)
T ss_pred --hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH------HHHHHHHh-cCCCCC-------
Confidence 11234578899999999999999999999999999999999999864331 11111221 111111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 668 QPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 668 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.+......+.+++.+|++.+|.+||+|.||++.
T Consensus 221 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 221 --VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred --CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 112223457789999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=292.94 Aligned_cols=251 Identities=24% Similarity=0.347 Sum_probs=195.0
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC-----cccHHHHHHHHHHHHhcCCCCcceeeeeeeeC--Cee
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS-----GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHG--EER 501 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 501 (752)
++|++.+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++.+++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46888899999999999999864 58899999875321 12245678899999999999999999988764 467
Q ss_pred EEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceeccccccee
Q 043278 502 LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARI 581 (752)
Q Consensus 502 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~ 581 (752)
+++|||+++++|.+++... ..+++...+.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 8999999999999988543 34788999999999999999999988 99999999999999999999999999986
Q ss_pred eccccc-ccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCccc
Q 043278 582 FEVNES-EANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLE 660 (752)
Q Consensus 582 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 660 (752)
...... ........++..|+|||.+.+..++.++||||||+++|||++|+.||...... ....+......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~--- 226 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM------AAIFKIATQPT--- 226 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH------HHHHHHhcCCC---
Confidence 532211 11122346788999999999888999999999999999999999998654211 11111111110
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 661 LIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 661 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
. ...+......+.+++.+|+. +|++||+++||++.
T Consensus 227 --~----~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 227 --N----PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred --C----CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 1 11223334456677788885 89999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=295.39 Aligned_cols=262 Identities=22% Similarity=0.313 Sum_probs=200.4
Q ss_pred CCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEee
Q 043278 431 NFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
+|++.+.||+|++|.||+|+.. +++.||+|++.... ......+.+|+.++++++|+||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4777899999999999999874 68899999987653 23356789999999999999999999999999999999999
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccc
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES 587 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~ 587 (752)
+ +++|.+++.... ..+++.++..++.||++||+|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999999886533 45899999999999999999999988 99999999999999999999999999986643321
Q ss_pred ccccccccccCCccChhhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCC---------
Q 043278 588 EANTKRIVGTYGYMSPEYAMSG-IVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGK--------- 657 (752)
Q Consensus 588 ~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~--------- 657 (752)
.......++..|+|||.+.+. .++.++||||+|++++||++|++++...... .........+....
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI---EQLAIVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH---HHHHHHHHHcCCCChHHHhhccC
Confidence 112235678899999988654 5689999999999999999998777654321 11111111111000
Q ss_pred ---cccccCCCCCC----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 658 ---GLELIDPSLEQ----PCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 658 ---~~~~~d~~l~~----~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
...+..+.... ....+....+.+++.+|++.+|++|||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000 0001123677889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=293.45 Aligned_cols=254 Identities=25% Similarity=0.336 Sum_probs=200.6
Q ss_pred CCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeee--CCeeEEEE
Q 043278 431 NFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLH--GEERLLVY 505 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 505 (752)
+|++.+.||.|+||.||++.. .+++.+|+|.+.... .....++.+|+.++++++|+||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 467789999999999999986 467889999886542 3344568899999999999999999998754 45678999
Q ss_pred eeCCCCCHhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCcEeecCCCCCcEEecCCCCceecccccceee
Q 043278 506 EFMPNKSLDFFLFNS-GRKNVLNWEKRFIIIEGISQGLLYLHKYS--RLRVIHRDLKASNILLDDKMNPKISDFGMARIF 582 (752)
Q Consensus 506 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~ 582 (752)
||+++++|..++... .....+++..++.++.||+.||+|||..+ ..+++|+||||+||++++++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998653 22456899999999999999999999332 234999999999999999999999999999876
Q ss_pred cccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCccccc
Q 043278 583 EVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELI 662 (752)
Q Consensus 583 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 662 (752)
...... .....++..|+|||.+....++.++||||||+++++|++|+.|+...... ...+....+...
T Consensus 161 ~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~--- 228 (265)
T cd08217 161 GHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL-------QLASKIKEGKFR--- 228 (265)
T ss_pred cCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH-------HHHHHHhcCCCC---
Confidence 533221 22346789999999999989999999999999999999999998765411 111222222211
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 663 DPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 663 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
..+......+.+++.+|++.+|++||++.+|+++
T Consensus 229 ------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 229 ------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ------CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1122233567889999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=293.37 Aligned_cols=253 Identities=23% Similarity=0.327 Sum_probs=202.1
Q ss_pred CCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeC
Q 043278 431 NFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFM 508 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 508 (752)
+|+..+.||+|++|.||++... +++.+++|++.... .....++.+|++++++++|+||+++++.+..+...++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5677789999999999999876 58889999987653 344567899999999999999999999999999999999999
Q ss_pred CCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCcEeecCCCCCcEEecCCCCceecccccceeeccccc
Q 043278 509 PNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHK-YSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES 587 (752)
Q Consensus 509 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~ 587 (752)
++++|.+++.... ..++......++.|++.||+|||+ .+ ++|+||||+||++++++.+||+|||++........
T Consensus 82 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 82 DGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred CCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 9999999986532 568899999999999999999999 76 99999999999999999999999999875432211
Q ss_pred ccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCC
Q 043278 588 EANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLE 667 (752)
Q Consensus 588 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 667 (752)
....++..|+|||.+.+..++.++||||||+++++|++|+.|+........ .......... .+.. +.+.
T Consensus 157 ----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~-~~~~-----~~~~ 225 (265)
T cd06605 157 ----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELLQYIV-NEPP-----PRLP 225 (265)
T ss_pred ----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHHHHHHh-cCCC-----CCCC
Confidence 125678899999999999999999999999999999999999876542211 1112211111 1111 1110
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 668 QPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 668 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.. .....+.+++.+|++.+|.+|||+.|++.+
T Consensus 226 ~~---~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 226 SG---KFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred hh---hcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 10 133457788999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=290.60 Aligned_cols=252 Identities=27% Similarity=0.388 Sum_probs=205.7
Q ss_pred cCCCcCCeeecCCcccEEEEEecC-CceeEEEEcccCCc-ccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEee
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLAD-EQEVAIKRLSRSSG-QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
++|++.+.||+|++|.||+++... ++.|++|++..... ....++.+|+..+.+++|+|++++++++..++..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 367888999999999999998764 89999999876543 3457789999999999999999999999999999999999
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCcEeecCCCCCcEEecCCCCceecccccceeecccc
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHK-YSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~ 586 (752)
+++++|.+++... ..++...+..++.|+++||+|||+ .+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999998643 458999999999999999999999 87 9999999999999999999999999998664332
Q ss_pred cccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCC
Q 043278 587 SEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666 (752)
Q Consensus 587 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 666 (752)
.. .....++..|+|||.+....++.++||||||+++|||++|+.|+..........+. ........ +.+
T Consensus 155 ~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~----~~~~~~~~-----~~~ 223 (264)
T cd06623 155 DQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELM----QAICDGPP-----PSL 223 (264)
T ss_pred Cc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHH----HHHhcCCC-----CCC
Confidence 21 12346788999999999999999999999999999999999998766531111111 11111111 111
Q ss_pred CCCCCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 667 EQPCSAN-EVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 667 ~~~~~~~-~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
+.. ....+.+++.+|++.+|++||++.|++++
T Consensus 224 ----~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 224 ----PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred ----CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111 33567788999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=293.56 Aligned_cols=248 Identities=26% Similarity=0.447 Sum_probs=198.6
Q ss_pred CCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccC-CcccHHHHHHHHHHHHhcC---CCCcceeeeeeeeCCeeEEEE
Q 043278 431 NFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRS-SGQGIVEFKNEVRLIAKLQ---HTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~ 505 (752)
.|+..+.||+|+||.||+|.. .+++.+|+|.+... ......++.+|+.++++++ |+|++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 467778999999999999986 46889999998654 3344567889999999996 999999999999999999999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccc
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVN 585 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~ 585 (752)
||+++++|.+++.. ..+++..++.++.|++.||.|||+.+ |+|+||+|+||++++++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999988743 25899999999999999999999988 999999999999999999999999999876533
Q ss_pred ccccccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCC
Q 043278 586 ESEANTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDP 664 (752)
Q Consensus 586 ~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 664 (752)
.. ......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||......... ...... ..+
T Consensus 155 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~-------~~~~~~-----~~~ 220 (277)
T cd06917 155 SS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM-------MLIPKS-----KPP 220 (277)
T ss_pred cc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh-------hccccC-----CCC
Confidence 21 1223468889999998875 45789999999999999999999999755422111 011111 111
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 665 SLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 665 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.+... .....+.+++.+|++.||.+||++.|++++
T Consensus 221 ~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 221 RLEDN---GYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 11111 123457788899999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=299.00 Aligned_cols=262 Identities=23% Similarity=0.351 Sum_probs=195.6
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCc-ccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEee
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSG-QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
++|+..+.||+|++|.||+|... +++.||+|.+..... .....+.+|++++++++|+||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888899999999999999875 578999999865432 2234567899999999999999999999999999999999
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccc
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES 587 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~ 587 (752)
+++ +|..++.... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~~-~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 85 LDT-DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 985 8888875432 35889999999999999999999988 99999999999999999999999999875432111
Q ss_pred ccccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcc-------
Q 043278 588 EANTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGL------- 659 (752)
Q Consensus 588 ~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~------- 659 (752)
......++..|+|||++.+ ..++.++||||+|+++|||++|+.||...... ..........+......
T Consensus 159 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07844 159 --TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV--EDQLHKIFRVLGTPTEETWPGVSS 234 (291)
T ss_pred --cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHhcCCCChhhhhhhhh
Confidence 1112346788999998875 56899999999999999999999999654411 11111111111100000
Q ss_pred --cccC--------CCCCCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 043278 660 --ELID--------PSLEQP-CSANEVMRCIHVGLLCVQDQAMDRPTMPEVVC 701 (752)
Q Consensus 660 --~~~d--------~~l~~~-~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~ 701 (752)
+... ..+... ........+.+++.+|++.+|++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0000 000000 00111245678999999999999999999876
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=295.77 Aligned_cols=262 Identities=23% Similarity=0.314 Sum_probs=193.6
Q ss_pred CCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCc--ccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEee
Q 043278 431 NFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSG--QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
+|+..+.||+|+||.||+++.. +|+.+|+|++..... .....+.+|+.++++++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4677889999999999999875 588999999865422 2234678899999999999999999999999999999999
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccc
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES 587 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~ 587 (752)
+++ +|..++... ...+++..+..++.||++||.|||+.+ ++|+||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 81 CDQ-DLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 974 677766432 245899999999999999999999988 99999999999999999999999999986543221
Q ss_pred ccccccccccCCccChhhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCC------ccc
Q 043278 588 EANTKRIVGTYGYMSPEYAMSG-IVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGK------GLE 660 (752)
Q Consensus 588 ~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~------~~~ 660 (752)
......++..|+|||.+.+. .++.++||||||+++|||++|+.|+....... .............. ...
T Consensus 155 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07839 155 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEESWPGVSK 230 (284)
T ss_pred --CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH--HHHHHHHHHhCCCChHHhHHhhh
Confidence 11224568899999998764 47899999999999999999998864332111 01111000000000 000
Q ss_pred ccC----CCCCCC-----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 661 LID----PSLEQP-----CSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 661 ~~d----~~l~~~-----~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
..+ +..... ........+.+++.+|++.||.+|||++|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 000 000000 001123456789999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=294.46 Aligned_cols=255 Identities=27% Similarity=0.398 Sum_probs=200.5
Q ss_pred HhcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCcccHHHHHHHHHHHHhc-CCCCcceeeeeeeeCC------
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGE------ 499 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~------ 499 (752)
.+++|++.+.||+|++|.||+|... +++.+++|.+..... ...++.+|+.++.++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 5688999999999999999999975 577899999876543 346789999999999 7999999999987644
Q ss_pred eeEEEEeeCCCCCHhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceeccccc
Q 043278 500 ERLLVYEFMPNKSLDFFLFNSG-RKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGM 578 (752)
Q Consensus 500 ~~~lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgl 578 (752)
..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 4899999999999999886532 2456899999999999999999999988 99999999999999999999999999
Q ss_pred ceeecccccccccccccccCCccChhhhcc-----CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHh
Q 043278 579 ARIFEVNESEANTKRIVGTYGYMSPEYAMS-----GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLL 653 (752)
Q Consensus 579 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 653 (752)
+....... .......++..|+|||++.. ..++.++||||||++++||++|+.||....... ...+..
T Consensus 160 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~ 231 (275)
T cd06608 160 SAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR------ALFKIP 231 (275)
T ss_pred ceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH------HHHHhh
Confidence 87653222 11223567889999998753 357889999999999999999999996433211 111111
Q ss_pred hCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 654 SDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 654 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.+.. +.+ ..+......+.+++.+|++.||++|||+.|++++
T Consensus 232 -~~~~-----~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 232 -RNPP-----PTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred -ccCC-----CCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1111 111 1112234567789999999999999999999863
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=290.60 Aligned_cols=252 Identities=27% Similarity=0.455 Sum_probs=200.2
Q ss_pred CCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCcc--cHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEee
Q 043278 431 NFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQ--GIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
+|...+.||+|+||.||++... +++.|++|.++..... ....+.+|+.++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4777899999999999999864 6889999998766443 567889999999999999999999999999999999999
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccc
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES 587 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~ 587 (752)
+++++|.+++... ..+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhhc---CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 9999999988542 34789999999999999999999988 99999999999999999999999999987643322
Q ss_pred ccc--cccccccCCccChhhhccCC---CCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCccccc
Q 043278 588 EAN--TKRIVGTYGYMSPEYAMSGI---VSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELI 662 (752)
Q Consensus 588 ~~~--~~~~~gt~~y~aPE~~~~~~---~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 662 (752)
... .....++..|+|||++.... .+.++||||||++++||++|+.||....... ....... .+..
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-----~~~~~~~-~~~~---- 224 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-----QIMFHVG-AGHK---- 224 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-----HHHHHHh-cCCC----
Confidence 111 12346788999999998766 8999999999999999999999996543110 1111111 1111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 043278 663 DPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVC 701 (752)
Q Consensus 663 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~ 701 (752)
+.+ +........+.+++.+|++.+|.+|||+.|++.
T Consensus 225 -~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 225 -PPI--PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -CCC--CcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 111 111111344568889999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=297.43 Aligned_cols=257 Identities=19% Similarity=0.302 Sum_probs=200.4
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC---cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 505 (752)
++|+..+.||+|+||.||++... .++.|++|.+.... ......+.+|++++..++|+||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36788899999999999999875 47889999987543 223456789999999999999999999999999999999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccc
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVN 585 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~ 585 (752)
||+++++|..++... ..+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKNI---GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 999999999998543 35899999999999999999999987 999999999999999999999999998742111
Q ss_pred cc-------------ccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHH
Q 043278 586 ES-------------EANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQL 652 (752)
Q Consensus 586 ~~-------------~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~ 652 (752)
.. ........++..|+|||.+.+..++.++|+||||+++|||++|+.||....... . ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~------~-~~~ 227 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE------L-FGQ 227 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------H-HHH
Confidence 00 001112456889999999998899999999999999999999999986543211 1 111
Q ss_pred hhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 653 LSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 653 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
...+. ...+.... .....+.+++.+|++.+|++||++.++.+.|+..
T Consensus 228 ~~~~~---~~~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~ 274 (305)
T cd05609 228 VISDD---IEWPEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR 274 (305)
T ss_pred HHhcc---cCCCCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence 11111 11111111 1223467899999999999999987777777653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=293.61 Aligned_cols=247 Identities=27% Similarity=0.433 Sum_probs=198.5
Q ss_pred CCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeC
Q 043278 431 NFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFM 508 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 508 (752)
-|+..+.||+|+||.||+|... +++.+|+|.+.... ......+.+|+.++.+++|+||+++++++..++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 4666789999999999999864 67899999876443 233456889999999999999999999999999999999999
Q ss_pred CCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccc
Q 043278 509 PNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE 588 (752)
Q Consensus 509 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 588 (752)
++++|..++.. ..+++..+..++.|++.++.|||+.+ ++|+||||+||++++++.++|+|||++..+.....
T Consensus 85 ~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 85 GGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence 99999988842 35899999999999999999999988 99999999999999999999999999876543211
Q ss_pred cccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCC
Q 043278 589 ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQ 668 (752)
Q Consensus 589 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 668 (752)
......++..|+|||.+.+..++.++||||||++++||++|..|+....... .......+.. +.+.
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~~-----~~~~- 222 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK-------VLFLIPKNNP-----PTLE- 222 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH-------HHHHHhcCCC-----CCCC-
Confidence 1123467889999999998889999999999999999999999986543211 1111111111 1111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 669 PCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 669 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
......+.+++.+|++.+|.+||++.+++++
T Consensus 223 ---~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 223 ---GNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ---cccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1123446678999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=285.87 Aligned_cols=252 Identities=25% Similarity=0.380 Sum_probs=204.7
Q ss_pred CCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCc--ccHHHHHHHHHHHHhcCCCCcceeeeeeeeC--CeeEEEE
Q 043278 431 NFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSG--QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHG--EERLLVY 505 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 505 (752)
+|...+.||+|++|.||+|... +++.|++|++..... ...+.+.+|+..+++++|+||+++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3667789999999999999976 688999999876542 4567789999999999999999999999988 8899999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccc
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVN 585 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~ 585 (752)
||+++++|.+++.... .+++..+..++.|++++|+|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 9999999999986533 6899999999999999999999987 999999999999999999999999999876544
Q ss_pred ccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCC
Q 043278 586 ESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPS 665 (752)
Q Consensus 586 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 665 (752)
..........++..|+|||.+.....+.++||||||+++++|++|+.|+..... ...........+...
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~------ 223 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-----PMAALYKIGSSGEPP------ 223 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----hHHHHHhccccCCCc------
Confidence 321112335678899999999988899999999999999999999999876551 111111111111111
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 666 LEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 666 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
..+......+.+++.+|++.+|.+||++.|+++.
T Consensus 224 ---~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 224 ---EIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred ---CCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 1112224567889999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=278.39 Aligned_cols=252 Identities=23% Similarity=0.314 Sum_probs=200.7
Q ss_pred hcCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccC--CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEE
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRS--SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 505 (752)
++.|++.+.||+|.|+.|++... ..|+.+|+|++... ...+.+++.+|+++-+.|+||||+++.....+....+||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 35677778999999999999864 56888999987533 3446778899999999999999999999999999999999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEec---CCCCceecccccceee
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLD---DKMNPKISDFGMARIF 582 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~---~~~~~kl~DFgla~~~ 582 (752)
|+|.+++|-.-+-. +...++..+-..++||+.+|.|.|.++ |||||+||.|+||. ..--+||+|||+|..+
T Consensus 90 e~m~G~dl~~eIV~---R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 90 DLVTGGELFEDIVA---REFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred ecccchHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 99999999665533 355778888899999999999999998 99999999999994 3445899999999987
Q ss_pred cccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCccccc
Q 043278 583 EVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELI 662 (752)
Q Consensus 583 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 662 (752)
+.. .......||++|||||++...+|+..+|||+.|||||-|+.|..||..++..+ ..+.+..+...
T Consensus 164 ~~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r-------lye~I~~g~yd--- 230 (355)
T KOG0033|consen 164 NDG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-------LYEQIKAGAYD--- 230 (355)
T ss_pred CCc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH-------HHHHHhccccC---
Confidence 622 22334789999999999999999999999999999999999999998765322 12233333211
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 663 DPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 663 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
+..+.-....+...+|+.+|+..||.+|.|+.|.+.+
T Consensus 231 ---~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 231 ---YPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred ---CCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 1111112223445678889999999999999887654
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=309.88 Aligned_cols=241 Identities=22% Similarity=0.298 Sum_probs=185.4
Q ss_pred eecCCcccEEEEEec-CCceeEEEEcccCCc---ccHHHHHHHHHHHHhc---CCCCcceeeeeeeeCCeeEEEEeeCCC
Q 043278 438 LGEGGFGPVYKGKLA-DEQEVAIKRLSRSSG---QGIVEFKNEVRLIAKL---QHTNLVRLLGCSLHGEERLLVYEFMPN 510 (752)
Q Consensus 438 LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~E~~~~ 510 (752)
||+|+||+||+++.. +++.||||++..... .....+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999865 588999999864321 2223445566666655 699999999999999999999999999
Q ss_pred CCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccccc
Q 043278 511 KSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEAN 590 (752)
Q Consensus 511 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~ 590 (752)
|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~ 152 (330)
T cd05586 81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KT 152 (330)
T ss_pred ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CC
Confidence 999888854 345899999999999999999999988 9999999999999999999999999987532221 12
Q ss_pred cccccccCCccChhhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCC
Q 043278 591 TKRIVGTYGYMSPEYAMSG-IVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQP 669 (752)
Q Consensus 591 ~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 669 (752)
.....||..|+|||++.+. .++.++|||||||++|||++|+.||...... .....+..+.. .+.. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~-------~~~~~i~~~~~-~~~~-----~ 219 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ-------QMYRNIAFGKV-RFPK-----N 219 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH-------HHHHHHHcCCC-CCCC-----c
Confidence 2346789999999998764 5899999999999999999999999654321 11122222211 1110 0
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCC----CHHHHHHH
Q 043278 670 CSANEVMRCIHVGLLCVQDQAMDRP----TMPEVVCM 702 (752)
Q Consensus 670 ~~~~~~~~l~~l~~~Cl~~dp~~RP----t~~ev~~~ 702 (752)
.....+.+++.+|++.||.+|| ++.|++++
T Consensus 220 ---~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 220 ---VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred ---cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 1123456788999999999998 45666553
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=289.89 Aligned_cols=249 Identities=23% Similarity=0.379 Sum_probs=199.3
Q ss_pred CCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEee
Q 043278 431 NFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
+|+..+.||+|++|.||++... +++.+|+|.+.... ......+.+|++++++++|+|++++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4777899999999999999864 57889999986542 33456789999999999999999999999999999999999
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCC-CCceecccccceeecccc
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDK-MNPKISDFGMARIFEVNE 586 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~-~~~kl~DFgla~~~~~~~ 586 (752)
+++++|.+++.... ...+++..+..++.+++++|+|||+++ ++|+||+|+||+++++ +.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 99999999986532 345899999999999999999999988 9999999999999865 458999999998654322
Q ss_pred cccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCC
Q 043278 587 SEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666 (752)
Q Consensus 587 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 666 (752)
......++..|+|||.+.+..++.++||||||+++++|++|+.|+....... ...... .+....+
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~------~~~~~~-~~~~~~~----- 221 (256)
T cd08220 157 ---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA------LVLKIM-SGTFAPI----- 221 (256)
T ss_pred ---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH------HHHHHH-hcCCCCC-----
Confidence 1123467889999999999889999999999999999999999986544221 111111 1111111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 667 EQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 667 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
+......+.+++.+|++.+|.+|||+.|+++.
T Consensus 222 ----~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 222 ----SDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ----CCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 11123356788999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=304.40 Aligned_cols=251 Identities=23% Similarity=0.396 Sum_probs=205.5
Q ss_pred CCCcCCeeecCCcccEEEEEecCC-ceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCC
Q 043278 431 NFSTTNKLGEGGFGPVYKGKLADE-QEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMP 509 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~~~~-~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 509 (752)
.+.+...||.|+||.||++..++. -..|-|.+...+......|.-|+++|....||+||+|++.+..++..+|..|||+
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 445567899999999999987653 3467888888888888999999999999999999999999999999999999999
Q ss_pred CCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccccc
Q 043278 510 NKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEA 589 (752)
Q Consensus 510 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 589 (752)
+|-.+.++..-+ ..|+..++.-+++|++.||.|||++. |||||||+.|||++-+|.++|+|||.+.... ....
T Consensus 113 GGAVDaimlEL~--r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t~q 185 (1187)
T KOG0579|consen 113 GGAVDAIMLELG--RVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNK--STRQ 185 (1187)
T ss_pred CchHhHHHHHhc--cccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccch--hHHh
Confidence 999999887644 35999999999999999999999998 9999999999999999999999999986432 1223
Q ss_pred ccccccccCCccChhhh-----ccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCC
Q 043278 590 NTKRIVGTYGYMSPEYA-----MSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDP 664 (752)
Q Consensus 590 ~~~~~~gt~~y~aPE~~-----~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 664 (752)
....+.||+.|||||+. .+.+|+.++||||||+.|.||..+.+|.....+-+ .+ -.+.......++.
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR--Vl-----lKiaKSePPTLlq- 257 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--VL-----LKIAKSEPPTLLQ- 257 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH--HH-----HHHhhcCCCcccC-
Confidence 34468999999999976 46789999999999999999999999876554221 11 1111222222222
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 665 SLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 665 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
+......+-+++..|+..||..||++.+++++
T Consensus 258 ------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 258 ------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred ------cchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 33445567788999999999999999998875
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=283.49 Aligned_cols=249 Identities=29% Similarity=0.443 Sum_probs=203.1
Q ss_pred CCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCCC
Q 043278 432 FSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPN 510 (752)
Q Consensus 432 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 510 (752)
|...+.||+|++|.||++... +++.+++|++..........+.+|++.+++++|+|++++++++..++..++++||+++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 81 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG 81 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence 667789999999999999975 6889999999776555667889999999999999999999999999999999999999
Q ss_pred CCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccccc
Q 043278 511 KSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEAN 590 (752)
Q Consensus 511 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~ 590 (752)
++|.+++.... ..+++..+..++.|++.+|.+||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 82 ~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 153 (253)
T cd05122 82 GSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--- 153 (253)
T ss_pred CcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc---
Confidence 99999885432 46899999999999999999999987 99999999999999999999999999986543321
Q ss_pred cccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCCC
Q 043278 591 TKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPC 670 (752)
Q Consensus 591 ~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 670 (752)
.....++..|+|||.+.....+.++||||||+++++|++|+.|+......... ..........+..
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-------~~~~~~~~~~~~~------- 219 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKAL-------FKIATNGPPGLRN------- 219 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHH-------HHHHhcCCCCcCc-------
Confidence 23456788999999999888999999999999999999999998755421110 0111111111111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 671 SANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 671 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.......+.+++.+|++.||.+|||+.|++++
T Consensus 220 ~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 220 PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11113457788899999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=301.29 Aligned_cols=245 Identities=31% Similarity=0.429 Sum_probs=199.3
Q ss_pred CCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCCc---ccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEe
Q 043278 431 NFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSSG---QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYE 506 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 506 (752)
.|+..+.||.|+||.||-++. .+.+.||||++.-.-. +.+.++.+|+..|.+++|||++.+-||+..+...+||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 456668899999999999986 4678899999975433 345678999999999999999999999999999999999
Q ss_pred eCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccc
Q 043278 507 FMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586 (752)
Q Consensus 507 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~ 586 (752)
||- |+-.+++.-. +++|-+..+-.|+.+.+.||+|||+++ .||||||+.||||.+.|.+||+|||.|.....
T Consensus 107 YCl-GSAsDlleVh--kKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-- 178 (948)
T KOG0577|consen 107 YCL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP-- 178 (948)
T ss_pred HHh-ccHHHHHHHH--hccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc--
Confidence 994 5556665332 356888999999999999999999998 99999999999999999999999999976432
Q ss_pred cccccccccccCCccChhhhc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccC
Q 043278 587 SEANTKRIVGTYGYMSPEYAM---SGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELID 663 (752)
Q Consensus 587 ~~~~~~~~~gt~~y~aPE~~~---~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 663 (752)
...++||+.|||||++. .+.|+-|+||||||+...||...++|...... ..+...+..++ .
T Consensus 179 ----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA-------MSALYHIAQNe-----s 242 (948)
T KOG0577|consen 179 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYHIAQNE-----S 242 (948)
T ss_pred ----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH-------HHHHHHHHhcC-----C
Confidence 23589999999999985 58899999999999999999999988755431 11222222222 2
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 664 PSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 664 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
|.+. ..+....+.+++-.|+++-|.+|||..+++.+
T Consensus 243 PtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 243 PTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 2222 44566678889999999999999999888765
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=290.11 Aligned_cols=248 Identities=26% Similarity=0.350 Sum_probs=199.0
Q ss_pred CCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCCC
Q 043278 432 FSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPN 510 (752)
Q Consensus 432 ~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 510 (752)
|...+.||+|++|.||++.. .+++.+++|++..........+.+|+.++..++|+||+++++++..++..++++||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 44457999999999999986 46788999998765555566788999999999999999999999999999999999999
Q ss_pred CCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccccc
Q 043278 511 KSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEAN 590 (752)
Q Consensus 511 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~ 590 (752)
++|.+++.. ..+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++........ .
T Consensus 101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~ 171 (285)
T cd06648 101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--R 171 (285)
T ss_pred CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--c
Confidence 999998854 34889999999999999999999988 99999999999999999999999998875432211 1
Q ss_pred cccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCCC
Q 043278 591 TKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPC 670 (752)
Q Consensus 591 ~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 670 (752)
.....|+..|+|||.+.+..++.++||||||++++||++|+.||....+. ... ........ +.+..
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~------~~~-~~~~~~~~-----~~~~~-- 237 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL------QAM-KRIRDNLP-----PKLKN-- 237 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH------HHH-HHHHhcCC-----CCCcc--
Confidence 12346788999999999889999999999999999999999998654321 111 11111111 11111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 671 SANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 671 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.......+.+++.+|++.+|++|||+.++++.
T Consensus 238 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 238 LHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred cccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 11122467889999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=293.90 Aligned_cols=259 Identities=27% Similarity=0.423 Sum_probs=201.2
Q ss_pred cHHHHHHHhcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCcccHHHHHHHHHHHHhc-CCCCcceeeeeeee-
Q 043278 421 DFQTIAAAANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLH- 497 (752)
Q Consensus 421 ~~~~i~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~- 497 (752)
++.++....+.|++.+.||+|+||.||+|... .++.+|+|.+.... ....++..|+.++.++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 45556667789999999999999999999874 57889999886543 3345678899999998 79999999999853
Q ss_pred -----CCeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCce
Q 043278 498 -----GEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPK 572 (752)
Q Consensus 498 -----~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~k 572 (752)
.+..+++|||+++|+|..++.... ...+++..+..++.||+.||.|||+.+ |+|+||||+||++++++.++
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 457899999999999999886532 345788889999999999999999988 99999999999999999999
Q ss_pred ecccccceeecccccccccccccccCCccChhhhc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHH
Q 043278 573 ISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM-----SGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIG 647 (752)
Q Consensus 573 l~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~ 647 (752)
|+|||++....... .......++..|+|||.+. ...++.++||||||+++|||++|+.||....+.....
T Consensus 162 l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~--- 236 (282)
T cd06636 162 LVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF--- 236 (282)
T ss_pred EeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh---
Confidence 99999987543211 1122356888999999875 3568889999999999999999999986543221110
Q ss_pred HHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 043278 648 YAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVC 701 (752)
Q Consensus 648 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~ 701 (752)
... ... .+.+. .......+.+++.+||+.||.+||++.|+++
T Consensus 237 ---~~~-~~~-----~~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 237 ---LIP-RNP-----PPKLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ---hHh-hCC-----CCCCc---ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 000 000 11111 1112345778999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=293.00 Aligned_cols=253 Identities=27% Similarity=0.382 Sum_probs=204.1
Q ss_pred HhcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEe
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYE 506 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 506 (752)
.++.|+..+.||+|++|.||++... +++.+++|.+..... ....+.+|++++.+++|+|++++++++...+..++++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4567888899999999999999976 588899999976544 56678999999999999999999999999999999999
Q ss_pred eCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccc
Q 043278 507 FMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586 (752)
Q Consensus 507 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~ 586 (752)
|+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 999999999996543 36999999999999999999999987 9999999999999999999999999986543222
Q ss_pred cccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCC
Q 043278 587 SEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666 (752)
Q Consensus 587 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 666 (752)
. ......++..|+|||.+.+..++.++||||||+++|||++|+.|+....+.. .... ..........+
T Consensus 171 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~------~~~~-~~~~~~~~~~~--- 238 (286)
T cd06614 171 S--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR------ALFL-ITTKGIPPLKN--- 238 (286)
T ss_pred h--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH------HHHH-HHhcCCCCCcc---
Confidence 1 1123456789999999998899999999999999999999999986543221 1111 11111111111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 667 EQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 667 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.......+.+++.+|++.+|.+|||+.+++++
T Consensus 239 ----~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 239 ----PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred ----hhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11123457789999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=306.41 Aligned_cols=245 Identities=23% Similarity=0.352 Sum_probs=194.3
Q ss_pred cCCeeecCCcccEEEEEec-CCceeEEEEccc----CCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCe--eEEEEe
Q 043278 434 TTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSR----SSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEE--RLLVYE 506 (752)
Q Consensus 434 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~----~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv~E 506 (752)
...+||+|+|-+||||.+. .|-+||--.++. .......+|..|+.+|+.|+|+||++++.+..+... ..+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 3468999999999999874 466666443321 133455789999999999999999999999877665 778999
Q ss_pred eCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecC-CCCceecccccceeeccc
Q 043278 507 FMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDD-KMNPKISDFGMARIFEVN 585 (752)
Q Consensus 507 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~-~~~~kl~DFgla~~~~~~ 585 (752)
.|..|+|..|+.+. +.++.+....|++||++||.|||++. |||||||||-+||+|+. -|.+||+|+|||..+...
T Consensus 124 L~TSGtLr~Y~kk~---~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 124 LFTSGTLREYRKKH---RRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred cccCCcHHHHHHHh---ccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 99999999999654 34889999999999999999999975 78999999999999975 588999999999986543
Q ss_pred ccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCC
Q 043278 586 ESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPS 665 (752)
Q Consensus 586 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 665 (752)
. .+.+.|||.|||||+.. ..|++.+||||||++++||+|+.-|+..-.. .+...+.+..|....-+..
T Consensus 200 ~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n------~AQIYKKV~SGiKP~sl~k- 267 (632)
T KOG0584|consen 200 H----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN------PAQIYKKVTSGIKPAALSK- 267 (632)
T ss_pred c----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC------HHHHHHHHHcCCCHHHhhc-
Confidence 2 23489999999999887 7899999999999999999999999865431 2233444545443322221
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 666 LEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 666 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.... ++.+|+..||.. ..+|||+.|++..
T Consensus 268 ----V~dP---evr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 268 ----VKDP---EVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred ----cCCH---HHHHHHHHHhcC-chhccCHHHHhhC
Confidence 1112 355688899999 8999999999875
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=293.48 Aligned_cols=262 Identities=25% Similarity=0.377 Sum_probs=198.5
Q ss_pred CCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCcc-cHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeC
Q 043278 431 NFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQ-GIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFM 508 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 508 (752)
+|+..++||+|++|.||+|+.. +++.||+|.+...... ....+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4778899999999999999975 5889999998765332 3456788999999999999999999999999999999999
Q ss_pred CCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccc
Q 043278 509 PNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE 588 (752)
Q Consensus 509 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 588 (752)
++ +|.+++........+++..+..++.||+.||.|||+.+ ++|+||||+||++++++.++|+|||+++.......
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 78888765544456899999999999999999999988 99999999999999999999999999975532211
Q ss_pred cccccccccCCccChhhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHH--------HHHHhhCCCcc
Q 043278 589 ANTKRIVGTYGYMSPEYAMSG-IVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGY--------AWQLLSDGKGL 659 (752)
Q Consensus 589 ~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~--------~~~~~~~~~~~ 659 (752)
......++..|++||.+.+. .++.++||||||+++|||++|+.||......+....+.. .++.+... .
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 232 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQL--P 232 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcC--c
Confidence 11224567899999988664 578999999999999999999999876543211110000 00011100 0
Q ss_pred cccCCCCCC-------CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 043278 660 ELIDPSLEQ-------PCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVC 701 (752)
Q Consensus 660 ~~~d~~l~~-------~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~ 701 (752)
. ....... .........+.+++.+|++.||.+||++.|+++
T Consensus 233 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 233 E-YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred h-hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 0000000 000112345678999999999999999999986
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=296.52 Aligned_cols=255 Identities=25% Similarity=0.366 Sum_probs=202.9
Q ss_pred HHhcCCCcCCeeecCCcccEEEEEecCCceeEEEEccc--CCcccHHHHHHHHHHHHhc-CCCCcceeeeeeeeCCeeEE
Q 043278 427 AAANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSR--SSGQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGEERLL 503 (752)
Q Consensus 427 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 503 (752)
.....|++.++||+||.+.||++.-.+.+.+|+|++.. .+.+....|.+|+.+|.+| .|.+|++|++|-..+...+|
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 34567888999999999999999988888899987754 3556778899999999999 58999999999999999999
Q ss_pred EEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeec
Q 043278 504 VYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFE 583 (752)
Q Consensus 504 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~ 583 (752)
||||= .-+|..+|.+.. .....| .+..+..|++.++.++|+++ |||.||||.|+|+-. |.+||+|||+|..+.
T Consensus 438 vmE~G-d~DL~kiL~k~~-~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 438 VMECG-DIDLNKILKKKK-SIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQ 510 (677)
T ss_pred Eeecc-cccHHHHHHhcc-CCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccC
Confidence 99974 568888885532 223334 67778999999999999998 999999999999964 689999999999877
Q ss_pred ccccccccccccccCCccChhhhccCC-----------CCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHH
Q 043278 584 VNESEANTKRIVGTYGYMSPEYAMSGI-----------VSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQL 652 (752)
Q Consensus 584 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~ 652 (752)
.+.........+||+.||+||.+.... .++++||||+|||||+|+.|+.||.... +.+.
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-----n~~a----- 580 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-----NQIA----- 580 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-----HHHH-----
Confidence 666666666789999999999986432 5689999999999999999999996432 1111
Q ss_pred hhCCCcccccCCCCCCCCCH-HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 653 LSDGKGLELIDPSLEQPCSA-NEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 653 ~~~~~~~~~~d~~l~~~~~~-~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
++..+.+|....+++. ..-..+++++..||+.||++|||..|++++
T Consensus 581 ----Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 581 ----KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ----HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 1223445533222111 111128899999999999999999999885
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=292.43 Aligned_cols=245 Identities=25% Similarity=0.334 Sum_probs=199.1
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC---cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 505 (752)
++|++.+.||+|+||.||++... +++.+|+|.+.... ......+.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36788899999999999999875 57899999986542 223456889999999999999999999999999999999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccc
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVN 585 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~ 585 (752)
||+++++|.+++... ..++...+..++.||+.||.|||+.+ ++|+||+|+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 999999999998543 45899999999999999999999988 999999999999999999999999999865433
Q ss_pred ccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCC
Q 043278 586 ESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPS 665 (752)
Q Consensus 586 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 665 (752)
.....+++.|+|||.+.+...+.++||||||++++||++|+.||...... ...+....+.. .
T Consensus 155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~------~ 216 (290)
T cd05580 155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI-------QIYEKILEGKV------R 216 (290)
T ss_pred -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHhcCCc------c
Confidence 22346788999999999888999999999999999999999998654411 11111111111 1
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 043278 666 LEQPCSANEVMRCIHVGLLCVQDQAMDRP-----TMPEVVCM 702 (752)
Q Consensus 666 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~ev~~~ 702 (752)
+ +......+.+++.+|++.+|.+|| +++|+++.
T Consensus 217 ~----~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 217 F----PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred C----CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 1 111134567888999999999999 66777643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=295.58 Aligned_cols=265 Identities=22% Similarity=0.283 Sum_probs=196.7
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCc--ccHHHHHHHHHHHHhcCCCCcceeeeeeeeC--CeeEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSG--QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHG--EERLLV 504 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 504 (752)
++|+..+.||+|+||.||+|... +++.+++|.++.... .....+.+|+.++.+++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46788899999999999999975 578899999875432 2233567899999999999999999998877 789999
Q ss_pred EeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecc
Q 043278 505 YEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~ 584 (752)
|||+++ +|..++.... ..+++..+..++.||+.||+|||+.+ ++|+||||+||++++++.+||+|||+++....
T Consensus 85 ~e~~~~-~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVEH-DLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcCc-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 999984 8888775432 35899999999999999999999988 99999999999999999999999999986553
Q ss_pred cccccccccccccCCccChhhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHH--------HHHHHhhC
Q 043278 585 NESEANTKRIVGTYGYMSPEYAMSG-IVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIG--------YAWQLLSD 655 (752)
Q Consensus 585 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~--------~~~~~~~~ 655 (752)
... ......++..|+|||.+.+. .++.++|+||||++++||++|+.||...........+. ..+.....
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 159 PLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred Ccc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 321 11234567899999998764 47899999999999999999999987554221110000 00000000
Q ss_pred ------CCcccccCCCCCCCCCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 656 ------GKGLELIDPSLEQPCSAN-EVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 656 ------~~~~~~~d~~l~~~~~~~-~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
..........+....+.. ....+.+++..|++.+|++|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000000000111111111 23456788999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=293.92 Aligned_cols=252 Identities=23% Similarity=0.327 Sum_probs=192.4
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC-cccHHHHHHHHHH-HHhcCCCCcceeeeeeeeCCeeEEEEe
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS-GQGIVEFKNEVRL-IAKLQHTNLVRLLGCSLHGEERLLVYE 506 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~E 506 (752)
++|++.+.||+|+||.||+++.. +|+.||+|+++... .....++..|+.. ++.++|+||+++++++..++..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36788899999999999999875 58999999987543 2234455566665 566789999999999999999999999
Q ss_pred eCCCCCHhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEeecCCCCCcEEecCCCCceecccccceeecc
Q 043278 507 FMPNKSLDFFLFNS-GRKNVLNWEKRFIIIEGISQGLLYLHKY-SRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584 (752)
Q Consensus 507 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~ 584 (752)
|++ ++|..++... .....+++..+..++.||+.||+|||++ + ++||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 997 6787777542 2345689999999999999999999986 5 99999999999999999999999999986532
Q ss_pred cccccccccccccCCccChhhhcc----CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCccc
Q 043278 585 NESEANTKRIVGTYGYMSPEYAMS----GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLE 660 (752)
Q Consensus 585 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 660 (752)
.. ......++..|+|||.+.+ ..++.++|+||||+++|||++|+.|+...... . ....... .+....
T Consensus 157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~---~~~~~~~-~~~~~~ 227 (283)
T cd06617 157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP--F---QQLKQVV-EEPSPQ 227 (283)
T ss_pred cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC--H---HHHHHHH-hcCCCC
Confidence 21 1122457889999998865 45789999999999999999999998643211 1 1111111 111111
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 661 LIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 661 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
+.. ......+.+++.+|++.+|.+||++.++++.
T Consensus 228 ~~~--------~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 228 LPA--------EKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred CCc--------cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 110 0122457789999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=293.37 Aligned_cols=264 Identities=24% Similarity=0.325 Sum_probs=195.4
Q ss_pred HhcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCc-ccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEE
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSG-QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 505 (752)
++++|.+.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.+++.++|+||+++.+++..++..++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3578889999999999999999864 588999999865432 23346788999999999999999999999999999999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccc
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVN 585 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~ 585 (752)
||++ ++|..++... ...+.+..+..++.||+.||+|||+.+ |+|+||||+|||++.++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9996 6666665432 234788889999999999999999988 999999999999999999999999999754322
Q ss_pred ccccccccccccCCccChhhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCC--------
Q 043278 586 ESEANTKRIVGTYGYMSPEYAMSG-IVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDG-------- 656 (752)
Q Consensus 586 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~-------- 656 (752)
.. ......++..|+|||++.+. .++.++||||||++++||++|+.||...... ...+...+..+...
T Consensus 157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07870 157 SQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV--FEQLEKIWTVLGVPTEDTWPGV 232 (291)
T ss_pred CC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH--HHHHHHHHHHcCCCChhhhhhh
Confidence 11 11224568899999998764 5889999999999999999999999754421 11111111111000
Q ss_pred ----C-cccccCCCCCCC-----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 043278 657 ----K-GLELIDPSLEQP-----CSANEVMRCIHVGLLCVQDQAMDRPTMPEVVC 701 (752)
Q Consensus 657 ----~-~~~~~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~ 701 (752)
. ..+......... ........+.+++.+|++.||.+|||+.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0 000000000000 00011345668889999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=292.04 Aligned_cols=261 Identities=24% Similarity=0.313 Sum_probs=195.3
Q ss_pred CCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEee
Q 043278 431 NFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
+|+..+.||+|++|.||+|+.. +++.||||++.... ......+.+|++++.+++|+||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4778899999999999999875 58899999886542 22335688999999999999999999999999999999999
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccc
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES 587 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~ 587 (752)
++ ++|..++.... ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 96 68888875433 345899999999999999999999988 99999999999999999999999999876542211
Q ss_pred ccccccccccCCccChhhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCC---------
Q 043278 588 EANTKRIVGTYGYMSPEYAMSG-IVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGK--------- 657 (752)
Q Consensus 588 ~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~--------- 657 (752)
......++..|+|||.+.+. .++.++||||||+++|||++|+.||........ +. ...+......
T Consensus 156 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~--~~-~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07860 156 --TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LF-RIFRTLGTPDEVVWPGVTS 230 (284)
T ss_pred --ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HH-HHHHHhCCCChhhhhhhhH
Confidence 11223467889999988764 468899999999999999999999876542111 00 0000000000
Q ss_pred -------cccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 658 -------GLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 658 -------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
........+. .........+.+++.+|++.||.+|||++|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 231 LPDYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0000000000 0000112346689999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=303.91 Aligned_cols=267 Identities=22% Similarity=0.311 Sum_probs=197.6
Q ss_pred hcCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeC-----Cee
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHG-----EER 501 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 501 (752)
+++|++.++||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.++.+++|+||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46899999999999999999986 468899999986432 23445678899999999999999999986544 357
Q ss_pred EEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceeccccccee
Q 043278 502 LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARI 581 (752)
Q Consensus 502 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~ 581 (752)
++++||+++ +|..++. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~~-~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELMET-DLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhccc-CHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 999999975 7766663 245899999999999999999999988 99999999999999999999999999986
Q ss_pred eccccccc-ccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCc-
Q 043278 582 FEVNESEA-NTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKG- 658 (752)
Q Consensus 582 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~- 658 (752)
........ ......++..|+|||.+.+ ..++.++||||||++++||++|+.||...+... ........+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~~~~~~~~~~~ 232 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLILGVLGTPSQE 232 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCCHH
Confidence 54322111 1223567899999998765 568999999999999999999999996543211 11111111111000
Q ss_pred --ccccCCC---------CCCCCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hhcC
Q 043278 659 --LELIDPS---------LEQPCS-----ANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM--LQNE 706 (752)
Q Consensus 659 --~~~~d~~---------l~~~~~-----~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~--L~~~ 706 (752)
..+.+.. .....+ ......+.+++.+|++.+|++|||+.|++++ ++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 0000000 000000 0123457789999999999999999999987 5544
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=296.10 Aligned_cols=263 Identities=24% Similarity=0.318 Sum_probs=195.0
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCc--ccHHHHHHHHHHHHhcCCCCcceeeeeeeeC--CeeEE
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSG--QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHG--EERLL 503 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 503 (752)
.++|++.+.||+|+||.||+|... +++.||+|.++.... .....+.+|+.++.+++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 357888999999999999999875 588999999864422 2223467899999999999999999998754 46899
Q ss_pred EEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeec
Q 043278 504 VYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFE 583 (752)
Q Consensus 504 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~ 583 (752)
||||+.+ +|..++... ...+++..+..++.||++||+|||+.+ ++|+||||+||++++++.+||+|||++....
T Consensus 86 v~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 9999975 787777543 245899999999999999999999998 9999999999999999999999999998765
Q ss_pred ccccccccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCC--C---
Q 043278 584 VNESEANTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDG--K--- 657 (752)
Q Consensus 584 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~--~--- 657 (752)
.... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......... ......+... .
T Consensus 160 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~---~~~~~~~~~~~~~~~~ 234 (309)
T cd07845 160 LPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQL---DLIIQLLGTPNESIWP 234 (309)
T ss_pred CccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhcCCCChhhch
Confidence 3321 1122345778999999875 56899999999999999999999999755432211 1111111000 0
Q ss_pred ------ccccc--CC-CCCC--CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 658 ------GLELI--DP-SLEQ--PCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 658 ------~~~~~--d~-~l~~--~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
..... .. .... .........+.+++.+|++.||++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000 00 0000 0000113456679999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=291.40 Aligned_cols=249 Identities=22% Similarity=0.348 Sum_probs=210.2
Q ss_pred hcCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCCc--ccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEE
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSSG--QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 505 (752)
.+-|.+.+.||+|.|+.|-++++ -.|..||||++.+..- .....+.+|++.|+.++|||||++|.+.......+||+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 45677778999999999999974 4799999999976532 33456889999999999999999999999999999999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEe-cCCCCceecccccceeecc
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILL-DDKMNPKISDFGMARIFEV 584 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll-~~~~~~kl~DFgla~~~~~ 584 (752)
|.-++|+|.+|+..... .+++..+.+++.||+.|+.|.|+.+ +|||||||+||.+ ..-|-+||.|||++..+..
T Consensus 97 ELGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred EecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 99999999999976543 4899999999999999999999998 9999999999876 6678899999999987665
Q ss_pred cccccccccccccCCccChhhhccCCCC-ccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccC
Q 043278 585 NESEANTKRIVGTYGYMSPEYAMSGIVS-IKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELID 663 (752)
Q Consensus 585 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t-~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 663 (752)
.+. ....+|...|-|||++.+-.|+ +++||||||||||-|++|+.||+.....+.+.++ +|
T Consensus 172 G~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmI---------------mD 233 (864)
T KOG4717|consen 172 GKK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMI---------------MD 233 (864)
T ss_pred cch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhh---------------hc
Confidence 443 2347899999999999998876 6899999999999999999999987755544332 33
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 664 PSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 664 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
... ..+.....++.+|+..|++.||++|.+.+||+..
T Consensus 234 CKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 234 CKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred ccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 322 2355566788899999999999999999999865
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=294.89 Aligned_cols=264 Identities=24% Similarity=0.326 Sum_probs=194.4
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCc--ccHHHHHHHHHHHHhcC-CCCcceeeeeeeeCCe-----
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSG--QGIVEFKNEVRLIAKLQ-HTNLVRLLGCSLHGEE----- 500 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~----- 500 (752)
++|++.+.||+|+||.||+|... +++.||+|.+..... .....+.+|+.++..++ |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36888899999999999999875 588999998765432 23456788999999994 6999999999877665
Q ss_pred eEEEEeeCCCCCHhHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecC-CCCceecccc
Q 043278 501 RLLVYEFMPNKSLDFFLFNSGR--KNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDD-KMNPKISDFG 577 (752)
Q Consensus 501 ~~lv~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~-~~~~kl~DFg 577 (752)
.++||||+++ +|..++..... ...+++..++.++.||+.||.|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999985 78887754322 346899999999999999999999988 999999999999998 8999999999
Q ss_pred cceeecccccccccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCC
Q 043278 578 MARIFEVNESEANTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDG 656 (752)
Q Consensus 578 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 656 (752)
+++....... ......+++.|+|||++.+ ..++.++||||||+++|||++|+.||........ +. .....+...
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~--~~-~~~~~~~~~ 231 (295)
T cd07837 157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ--LL-HIFKLLGTP 231 (295)
T ss_pred cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH--HH-HHHHHhCCC
Confidence 9986532211 1112346788999998865 4679999999999999999999999875432110 00 011111000
Q ss_pred Ccc------cccC----CCCCC----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 657 KGL------ELID----PSLEQ----PCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 657 ~~~------~~~d----~~l~~----~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
... ...+ +.... .........+.+++.+|++.||.+||++.|++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000 0000 00000 0001123457789999999999999999999763
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=288.55 Aligned_cols=247 Identities=25% Similarity=0.295 Sum_probs=200.5
Q ss_pred CCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC---cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEe
Q 043278 431 NFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYE 506 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 506 (752)
+|++.+.||+|+||.||++... +++.+|+|.+.... ....+.+.+|++++++++||||+++++++.+++..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778899999999999999875 58899999987543 2345678999999999999999999999999999999999
Q ss_pred eCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccc
Q 043278 507 FMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586 (752)
Q Consensus 507 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~ 586 (752)
|+++++|..++... ..+++..+..++.||+.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999998543 46899999999999999999999988 9999999999999999999999999988654322
Q ss_pred cccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCC
Q 043278 587 SEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666 (752)
Q Consensus 587 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 666 (752)
......++..|+|||.+....++.++|+||||+++|+|++|+.|+....... .......... . ..
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~-~-~~------ 219 (258)
T cd05578 155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI----RDQIRAKQET-A-DV------ 219 (258)
T ss_pred ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH----HHHHHHHhcc-c-cc------
Confidence 1223567889999999998889999999999999999999999987665331 1111111111 0 00
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCH--HHHH
Q 043278 667 EQPCSANEVMRCIHVGLLCVQDQAMDRPTM--PEVV 700 (752)
Q Consensus 667 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~--~ev~ 700 (752)
..+......+.+++.+|++.||.+||++ +|++
T Consensus 220 --~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 220 --LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred --cCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 1111223567789999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=292.52 Aligned_cols=247 Identities=30% Similarity=0.423 Sum_probs=194.8
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCc---ccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSG---QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 505 (752)
+.|...++||+|+||.||+|+.. +++.||+|.+..... ....++.+|+++++.++||||+++.+++.+++..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45788899999999999999875 588999998864432 23356889999999999999999999999999999999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccc
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVN 585 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~ 585 (752)
||++ |+|.+++... ...+++..+..++.||+.||.|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 95 e~~~-g~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 95 EYCL-GSASDILEVH--KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HhhC-CCHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 9997 5666655432 235899999999999999999999988 999999999999999999999999998754322
Q ss_pred ccccccccccccCCccChhhhc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCccccc
Q 043278 586 ESEANTKRIVGTYGYMSPEYAM---SGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELI 662 (752)
Q Consensus 586 ~~~~~~~~~~gt~~y~aPE~~~---~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 662 (752)
....++..|+|||.+. ...++.++||||||+++|||++|+.|+....... ... .......
T Consensus 169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~------~~~-~~~~~~~---- 231 (307)
T cd06607 169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALY-HIAQNDS---- 231 (307)
T ss_pred ------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH------HHH-HHhcCCC----
Confidence 2345778999999874 4668899999999999999999999986543211 111 1111111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 043278 663 DPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCML 703 (752)
Q Consensus 663 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L 703 (752)
+.+. .......+.+++.+||+.+|.+||++.+|+.+.
T Consensus 232 -~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 232 -PTLS---SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred -CCCC---chhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 1110 112334678899999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=317.65 Aligned_cols=261 Identities=26% Similarity=0.395 Sum_probs=210.6
Q ss_pred HhcCCCcCCeeecCCcccEEEEEec----C----CceeEEEEcccCCc-ccHHHHHHHHHHHHhc-CCCCcceeeeeeee
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGKLA----D----EQEVAIKRLSRSSG-QGIVEFKNEVRLIAKL-QHTNLVRLLGCSLH 497 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~~~----~----~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 497 (752)
..++..+.+.||+|.||.|++|... . ...||||.++.... ...+.+..|+++|+.+ +|+||+.++|+|.+
T Consensus 294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~ 373 (609)
T KOG0200|consen 294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ 373 (609)
T ss_pred chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence 3345566679999999999999753 1 34699999986643 4566789999999998 69999999999999
Q ss_pred CCeeEEEEeeCCCCCHhHHHhhcC-----C------C--CCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEE
Q 043278 498 GEERLLVYEFMPNKSLDFFLFNSG-----R------K--NVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNIL 564 (752)
Q Consensus 498 ~~~~~lv~E~~~~gsL~~~l~~~~-----~------~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIl 564 (752)
+...++|.||+..|+|..++...+ . . ..++..+.+.++.|||.||+||++.. +|||||..+|||
T Consensus 374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVL 450 (609)
T KOG0200|consen 374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVL 450 (609)
T ss_pred CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEE
Confidence 999999999999999999997655 0 0 24899999999999999999999987 999999999999
Q ss_pred ecCCCCceecccccceeeccccccccc-ccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCC
Q 043278 565 LDDKMNPKISDFGMARIFEVNESEANT-KRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRP 642 (752)
Q Consensus 565 l~~~~~~kl~DFgla~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~ 642 (752)
+.++..+||+|||+|+........... ....-+..|||||.+....|+.|+||||||++||||+| |..|+.....
T Consensus 451 i~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~--- 527 (609)
T KOG0200|consen 451 ITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP--- 527 (609)
T ss_pred ecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc---
Confidence 999999999999999965544332211 11113567999999999999999999999999999999 7778765221
Q ss_pred cchHHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 643 LNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 643 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
.....+.+++|...+. +.....++.+++..||+.+|++||++.|+++.++..
T Consensus 528 ---~~~l~~~l~~G~r~~~---------P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 528 ---TEELLEFLKEGNRMEQ---------PEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred ---HHHHHHHHhcCCCCCC---------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 1122446677665443 222345677899999999999999999999999874
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=291.11 Aligned_cols=260 Identities=25% Similarity=0.319 Sum_probs=195.2
Q ss_pred CCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeC
Q 043278 432 FSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFM 508 (752)
Q Consensus 432 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 508 (752)
|+..++||.|++|.||+|... +|+.||+|++.... ......+.+|++++++++|+|++++++++.+++..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 566789999999999999864 68999999987543 223356789999999999999999999999999999999999
Q ss_pred CCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccc
Q 043278 509 PNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE 588 (752)
Q Consensus 509 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 588 (752)
+ ++|..++..... ..+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.++|+|||+++.......
T Consensus 81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~- 154 (283)
T cd07835 81 D-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR- 154 (283)
T ss_pred C-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence 5 688888854332 45899999999999999999999987 99999999999999999999999999975432211
Q ss_pred cccccccccCCccChhhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCC-----------
Q 043278 589 ANTKRIVGTYGYMSPEYAMSG-IVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDG----------- 656 (752)
Q Consensus 589 ~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~----------- 656 (752)
......++..|+|||++.+. .++.++||||||+++|||++|+.||........ +.. ..+.....
T Consensus 155 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07835 155 -TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ--LFR-IFRTLGTPDEDVWPGVTSL 230 (283)
T ss_pred -ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-HHHHhCCCChHHhhhhhhc
Confidence 11223567899999988664 578999999999999999999999876542111 000 00000000
Q ss_pred -C----cccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 657 -K----GLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 657 -~----~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
. ......+.. ..........+.+++.+|++.+|.+|||++|+++.
T Consensus 231 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 231 PDYKPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0 000000000 00011122467789999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=301.69 Aligned_cols=268 Identities=23% Similarity=0.316 Sum_probs=198.3
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccC--CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeC-----Ce
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRS--SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHG-----EE 500 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 500 (752)
.++|.+.+.||+|+||.||+++.. +++.||||.+... ......++.+|+.++..++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457888999999999999999864 5889999998753 233345678899999999999999999987654 35
Q ss_pred eEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccce
Q 043278 501 RLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR 580 (752)
Q Consensus 501 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~ 580 (752)
.++||||+. ++|..++.. ...+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||+++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999996 678777743 345899999999999999999999988 9999999999999999999999999998
Q ss_pred eecccccccccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHH--------H
Q 043278 581 IFEVNESEANTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAW--------Q 651 (752)
Q Consensus 581 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~--------~ 651 (752)
...... .......++..|+|||.+.. ..++.++||||||++++||++|+.||...........+.... .
T Consensus 157 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07858 157 TTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG 234 (337)
T ss_pred ccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence 654321 11223457889999998865 468999999999999999999999997653211111000000 0
Q ss_pred HhhCCCccc-------ccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hhcC
Q 043278 652 LLSDGKGLE-------LIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM--LQNE 706 (752)
Q Consensus 652 ~~~~~~~~~-------~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~--L~~~ 706 (752)
......... ..++... .........+.+++.+|++.+|++|||++|+++. ++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 235 FIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 000000000 0000000 0011223567889999999999999999999987 5543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=287.23 Aligned_cols=250 Identities=24% Similarity=0.337 Sum_probs=199.0
Q ss_pred CCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEee
Q 043278 431 NFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
+|+..+.||+|+||.||++... +|..+|+|.+.... ....+.+.+|+.++++++|+||+++++.+..+...++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4677899999999999999875 47889999986542 23445788999999999999999999999999999999999
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCC-ceecccccceeecccc
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMN-PKISDFGMARIFEVNE 586 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~-~kl~DFgla~~~~~~~ 586 (752)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++. +||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 99999999886532 235799999999999999999999988 999999999999998864 6999999998654322
Q ss_pred cccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCC
Q 043278 587 SEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666 (752)
Q Consensus 587 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 666 (752)
. ......|++.|+|||+..+..++.++||||||++++||++|+.|+..... ........ .+.....
T Consensus 157 ~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~-~~~~~~~----- 222 (257)
T cd08225 157 E--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL------HQLVLKIC-QGYFAPI----- 222 (257)
T ss_pred c--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHh-cccCCCC-----
Confidence 1 11234578899999999988999999999999999999999999864431 11122211 1111111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 667 EQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 667 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.......+.+++.+|++.+|++|||+.|+++.
T Consensus 223 ----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 223 ----SPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ----CCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11122357788899999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=291.72 Aligned_cols=261 Identities=22% Similarity=0.312 Sum_probs=196.7
Q ss_pred CCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeeeC--CeeEEEEe
Q 043278 432 FSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHG--EERLLVYE 506 (752)
Q Consensus 432 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~E 506 (752)
|++.+.||+|++|.||+|+.. +++.+|+|++.... ......+.+|+.++.+++|+|++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 556789999999999999875 47899999998663 33345688999999999999999999999887 78999999
Q ss_pred eCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccc
Q 043278 507 FMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586 (752)
Q Consensus 507 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~ 586 (752)
|+++ +|..++... ...+++..++.++.||+.||+|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9985 787777543 246899999999999999999999988 9999999999999999999999999998765432
Q ss_pred cccccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCC---Ccc---
Q 043278 587 SEANTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDG---KGL--- 659 (752)
Q Consensus 587 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~--- 659 (752)
.. ......++..|+|||.+.+ ..++.++||||||++++||++|+.|+........ ........... ...
T Consensus 155 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07840 155 SA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ---LEKIFELCGSPTDENWPGVS 230 (287)
T ss_pred cc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCchhhccccc
Confidence 21 1222456788999998765 4689999999999999999999999876543211 11111111000 000
Q ss_pred c-----ccCCCCC------CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 660 E-----LIDPSLE------QPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 660 ~-----~~d~~l~------~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
. ...+... ..........+.+++.+|++.+|.+||++.++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0 0000000 00000014567889999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=295.43 Aligned_cols=268 Identities=22% Similarity=0.318 Sum_probs=193.7
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCC------
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGE------ 499 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 499 (752)
-++|+..++||+|+||.||+++.. +++.||||.+.... ......+.+|+.++++++||||+++++++...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 357889999999999999999875 58899999886542 222345678999999999999999999986644
Q ss_pred --eeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccc
Q 043278 500 --ERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFG 577 (752)
Q Consensus 500 --~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg 577 (752)
..++||||+.+ +|...+... ...+++..+..++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNK--NVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence 45999999975 677766432 235899999999999999999999988 9999999999999999999999999
Q ss_pred cceeecccccc--cccccccccCCccChhhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhh
Q 043278 578 MARIFEVNESE--ANTKRIVGTYGYMSPEYAMSG-IVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLS 654 (752)
Q Consensus 578 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 654 (752)
++......... .......++..|+|||.+.+. .++.++||||||++++||++|+.|+...........+........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99865432211 112234567889999988764 478999999999999999999999876543211111111100000
Q ss_pred CC-----CcccccCC-CCCCC---------CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 655 DG-----KGLELIDP-SLEQP---------CSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 655 ~~-----~~~~~~d~-~l~~~---------~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.. ...+..+. .+... ........+.+++.+|++.||.+|||++|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 00 00000000 00000 000012356689999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=290.94 Aligned_cols=260 Identities=23% Similarity=0.310 Sum_probs=198.8
Q ss_pred CCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCcc--cHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeC
Q 043278 432 FSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQ--GIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFM 508 (752)
Q Consensus 432 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 508 (752)
|+..+.||+|++|.||++... +++.+++|++...... ....+.+|+.++++++|+||+++++++..++..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456789999999999999874 6888999998765332 4567889999999999999999999999999999999999
Q ss_pred CCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccc
Q 043278 509 PNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE 588 (752)
Q Consensus 509 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 588 (752)
++ +|..++.... ..+++..+..++.||+.||.|||+.+ |+|+||||+||++++++.+||+|||.+........
T Consensus 81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~- 153 (283)
T cd05118 81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR- 153 (283)
T ss_pred CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-
Confidence 85 7777775432 46899999999999999999999988 99999999999999999999999999987654331
Q ss_pred cccccccccCCccChhhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCC---cccccC-
Q 043278 589 ANTKRIVGTYGYMSPEYAMSG-IVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGK---GLELID- 663 (752)
Q Consensus 589 ~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~~~~d- 663 (752)
......++..|+|||.+.+. .++.++|+||||+++++|++|+.||......+. +......+.... ...+.+
T Consensus 154 -~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd05118 154 -PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ---LFKIFRTLGTPDPEVWPKFTSL 229 (283)
T ss_pred -cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCchHhcccchhh
Confidence 11224577889999998876 789999999999999999999999866543211 111111111000 000000
Q ss_pred --------CCCC----CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 664 --------PSLE----QPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 664 --------~~l~----~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
+... ..........+.+++..|++.||.+||++.+++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0000 00111234578899999999999999999999863
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=297.97 Aligned_cols=263 Identities=22% Similarity=0.253 Sum_probs=196.4
Q ss_pred HhcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccC--CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeC------
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRS--SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHG------ 498 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 498 (752)
..++|+..+.||+|+||.||+++.. +++.||+|.+... ......++.+|+.++.+++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3578999999999999999999864 6889999998653 223345677899999999999999999987643
Q ss_pred CeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceeccccc
Q 043278 499 EERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGM 578 (752)
Q Consensus 499 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgl 578 (752)
...++||||+++ +|...+.. .++...+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 356999999964 77776632 2888999999999999999999988 99999999999999999999999999
Q ss_pred ceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcc------------hH
Q 043278 579 ARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLN------------LI 646 (752)
Q Consensus 579 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~------------l~ 646 (752)
++....... .....++..|+|||.+.+..++.++||||||+++++|++|+.||...+...... ..
T Consensus 165 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 165 ARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred ceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 986543211 223457889999999999999999999999999999999999987554211000 00
Q ss_pred HH----HHHHhhCCC------cccccCCCC----CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 647 GY----AWQLLSDGK------GLELIDPSL----EQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 647 ~~----~~~~~~~~~------~~~~~d~~l----~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.. ......... ..++....+ ...........+.+++.+|++.||.+|||+.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 000000000 000110000 001111234456789999999999999999999875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=301.14 Aligned_cols=267 Identities=24% Similarity=0.318 Sum_probs=196.5
Q ss_pred HhcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccC--CcccHHHHHHHHHHHHhc-CCCCcceeeeeeeeC--Cee
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRS--SGQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHG--EER 501 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~ 501 (752)
..++|++.+.||+|+||.||+|... +++.+|+|++... .......+.+|+.++.++ +|+||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3467888899999999999999875 5788999988543 223445677899999999 999999999988643 468
Q ss_pred EEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceeccccccee
Q 043278 502 LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARI 581 (752)
Q Consensus 502 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~ 581 (752)
++||||++ ++|..++.. ..+++..+..++.||+.||+|||+.+ |+|+||||+||++++++.+||+|||+++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999997 588887743 26889999999999999999999988 99999999999999999999999999986
Q ss_pred ecccccc---cccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHH--------
Q 043278 582 FEVNESE---ANTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYA-------- 649 (752)
Q Consensus 582 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~-------- 649 (752)
....... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 5433221 12233568889999998765 56889999999999999999999998654322110000000
Q ss_pred HHHhhCCCcccccCC----CCC--CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 650 WQLLSDGKGLELIDP----SLE--QPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 650 ~~~~~~~~~~~~~d~----~l~--~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
...+.......+++. ... ..........+.+++.+|++.+|.+|||+.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000000001100 000 00000123467889999999999999999999976
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=291.32 Aligned_cols=254 Identities=24% Similarity=0.345 Sum_probs=193.0
Q ss_pred CCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC-cccHHHHHHHHHHHHhcC-CCCcceeeeeeeeCCeeEEEEee
Q 043278 431 NFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQ-HTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
+|...+.||+|+||.||++... +++.+|+|.+.... ......+.+|+.++.++. |+||+++++++..++..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 3445578999999999999864 57899999987543 234557889999999996 99999999999998899999999
Q ss_pred CCCCCHhHHHhh--cCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEeecCCCCCcEEecCCCCceecccccceeecc
Q 043278 508 MPNKSLDFFLFN--SGRKNVLNWEKRFIIIEGISQGLLYLHKY-SRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584 (752)
Q Consensus 508 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~ 584 (752)
++. ++..+... ......+++..+..++.|++.||+|||+. + ++||||||+||+++.++.+||+|||+++....
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 874 44443211 11235689999999999999999999975 5 99999999999999999999999999975432
Q ss_pred cccccccccccccCCccChhhhccC---CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccc
Q 043278 585 NESEANTKRIVGTYGYMSPEYAMSG---IVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLEL 661 (752)
Q Consensus 585 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 661 (752)
.. ......++..|+|||.+... .++.++||||||++++||++|+.||.... .......+.. .+.
T Consensus 161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~-~~~---- 227 (288)
T cd06616 161 SI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVV-KGD---- 227 (288)
T ss_pred CC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhc-CCC----
Confidence 21 11224578899999998876 68999999999999999999999986543 1111111111 111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 662 IDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 662 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.+.+...........+.+++.+|++.+|.+|||+.||++.
T Consensus 228 -~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 228 -PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred -CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111111112234567889999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=292.69 Aligned_cols=249 Identities=30% Similarity=0.418 Sum_probs=195.3
Q ss_pred CCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCc---ccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEe
Q 043278 431 NFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSG---QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYE 506 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 506 (752)
.|...+.||+|+||.||+++.. ++..+|+|++..... ....++.+|++++++++|+|++++++++.+++..++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 3666789999999999999864 578999999865422 233468899999999999999999999999999999999
Q ss_pred eCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccc
Q 043278 507 FMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586 (752)
Q Consensus 507 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~ 586 (752)
|+++ +|.+.+... ...+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.....
T Consensus 106 ~~~g-~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-- 177 (317)
T cd06635 106 YCLG-SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP-- 177 (317)
T ss_pred CCCC-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC--
Confidence 9974 676666432 345899999999999999999999988 99999999999999999999999999875332
Q ss_pred cccccccccccCCccChhhhc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccC
Q 043278 587 SEANTKRIVGTYGYMSPEYAM---SGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELID 663 (752)
Q Consensus 587 ~~~~~~~~~gt~~y~aPE~~~---~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 663 (752)
.....++..|+|||++. .+.++.++||||||++++||++|+.|+...... .........+.
T Consensus 178 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------~~~~~~~~~~~------ 241 (317)
T cd06635 178 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNES------ 241 (317)
T ss_pred ----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHHhccC------
Confidence 12346788999999874 467899999999999999999999998654211 11111111111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 664 PSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 664 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
+.. ........+.+++.+|++.+|.+||++.+|++.+--.
T Consensus 242 ~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 242 PTL---QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL 281 (317)
T ss_pred CCC---CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence 000 0112234577889999999999999999999876544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=287.33 Aligned_cols=244 Identities=26% Similarity=0.348 Sum_probs=195.6
Q ss_pred CeeecCCcccEEEEEec-CCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCCCCCHh
Q 043278 436 NKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLD 514 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~ 514 (752)
.+||+|+||.||++... +++.||+|++..........+.+|+.++..++|+|++++++++..++..+++|||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 57999999999999874 68899999986555555667899999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccccccccc
Q 043278 515 FFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594 (752)
Q Consensus 515 ~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~ 594 (752)
+++.. ..+++.....++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++....... ......
T Consensus 106 ~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~~ 176 (292)
T cd06657 106 DIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSL 176 (292)
T ss_pred HHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc--cccccc
Confidence 87732 34789999999999999999999988 9999999999999999999999999987554221 112235
Q ss_pred cccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCCCCHHH
Q 043278 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSANE 674 (752)
Q Consensus 595 ~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 674 (752)
.++..|+|||.+....++.++||||||++++||++|+.|+........ ......+. .+.+.. ....
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~-------~~~~~~~~-----~~~~~~--~~~~ 242 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA-------MKMIRDNL-----PPKLKN--LHKV 242 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhhC-----CcccCC--cccC
Confidence 678899999999888899999999999999999999999865432111 11111111 111100 0111
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 675 VMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 675 ~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
...+.+++.+|++.+|.+||++.+++++
T Consensus 243 ~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 243 SPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred CHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 2346678889999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=286.33 Aligned_cols=244 Identities=25% Similarity=0.327 Sum_probs=191.1
Q ss_pred eecCCcccEEEEEec-CCceeEEEEcccCC---cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCCCCCH
Q 043278 438 LGEGGFGPVYKGKLA-DEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSL 513 (752)
Q Consensus 438 LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 513 (752)
||+|+||+||++... +++.+|+|.+.... ......+.+|++++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999764 58899999986532 22344567899999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccccccccc
Q 043278 514 DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKR 593 (752)
Q Consensus 514 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~ 593 (752)
..++..... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++...... .....
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~ 153 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIKG 153 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC---Ccccc
Confidence 998865432 45899999999999999999999988 999999999999999999999999998764321 11123
Q ss_pred ccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCCCCHH
Q 043278 594 IVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSAN 673 (752)
Q Consensus 594 ~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 673 (752)
..++..|+|||++.+..++.++||||||+++++|++|+.||........... +....... .. ..+..
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-------~~~~~~~~--~~----~~~~~ 220 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEE-------LKRRTLEM--AV----EYPDK 220 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHH-------HHhccccc--cc----cCCcc
Confidence 4567899999999888899999999999999999999999976543211110 10100000 00 11111
Q ss_pred HHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 043278 674 EVMRCIHVGLLCVQDQAMDRP-----TMPEVVC 701 (752)
Q Consensus 674 ~~~~l~~l~~~Cl~~dp~~RP-----t~~ev~~ 701 (752)
....+.+++.+||+.+|.+|| ++.++++
T Consensus 221 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 234567889999999999999 5555654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=291.50 Aligned_cols=262 Identities=23% Similarity=0.308 Sum_probs=194.5
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCc--ccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEe
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSG--QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYE 506 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 506 (752)
++|+..+.||+|++|.||+|... +++.||+|++..... .....+.+|++++++++|+||+++++++..++..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888899999999999999875 688999999865432 234568899999999999999999999999999999999
Q ss_pred eCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecC-CCCceecccccceeeccc
Q 043278 507 FMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDD-KMNPKISDFGMARIFEVN 585 (752)
Q Consensus 507 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~-~~~~kl~DFgla~~~~~~ 585 (752)
|++ ++|..++.... ...+++..+..++.||+.||+|||+.+ ++|+||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 996 47777764332 233678888899999999999999987 999999999999985 557999999999765432
Q ss_pred ccccccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccc---
Q 043278 586 ESEANTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLEL--- 661 (752)
Q Consensus 586 ~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~--- 661 (752)
. .......++..|+|||++.+ ..++.++||||||+++|||++|+.||......+. ........... ....
T Consensus 157 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~---~~~~~~~~~~~-~~~~~~~ 230 (294)
T PLN00009 157 V--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE---LFKIFRILGTP-NEETWPG 230 (294)
T ss_pred c--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCC-Chhhccc
Confidence 1 11123456889999998876 4689999999999999999999999976542211 11111111000 0000
Q ss_pred ----cC-----CCCCCC----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 662 ----ID-----PSLEQP----CSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 662 ----~d-----~~l~~~----~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.+ +..... ........+.+++.+|++.+|++||++.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred cccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 000000 011123457789999999999999999999874
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=285.12 Aligned_cols=242 Identities=21% Similarity=0.282 Sum_probs=193.8
Q ss_pred eecCCcccEEEEEecC-CceeEEEEcccCCc---ccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCCCCCH
Q 043278 438 LGEGGFGPVYKGKLAD-EQEVAIKRLSRSSG---QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSL 513 (752)
Q Consensus 438 LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 513 (752)
||.|++|.||+++... ++.+|+|.+..... .....+.+|+.++++++|+||+++++.+.+++..++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 6999999999999754 88999999865432 3346789999999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccccccccc
Q 043278 514 DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKR 593 (752)
Q Consensus 514 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~ 593 (752)
.+++... ..++...+..++.||+.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~ 151 (262)
T cd05572 81 WTILRDR---GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT 151 (262)
T ss_pred HHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence 9998543 34899999999999999999999988 9999999999999999999999999998654332 1223
Q ss_pred ccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCCCCHH
Q 043278 594 IVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSAN 673 (752)
Q Consensus 594 ~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 673 (752)
..++..|+|||.+.+..++.++|+||||+++|||++|+.|+....... ............. ...+..
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~---------~~~~~~ 218 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP----MEIYNDILKGNGK---------LEFPNY 218 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH----HHHHHHHhccCCC---------CCCCcc
Confidence 467889999999988889999999999999999999999997665311 1111111110110 011111
Q ss_pred HHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 043278 674 EVMRCIHVGLLCVQDQAMDRPT-----MPEVVC 701 (752)
Q Consensus 674 ~~~~l~~l~~~Cl~~dp~~RPt-----~~ev~~ 701 (752)
....+.+++.+||+.+|.+||+ ++|+++
T Consensus 219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 2456788999999999999999 666655
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=289.06 Aligned_cols=256 Identities=18% Similarity=0.223 Sum_probs=182.8
Q ss_pred hcCCCcCCeeecCCcccEEEEEecCC----ceeEEEEcccCCcccHH-----------HHHHHHHHHHhcCCCCcceeee
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLADE----QEVAIKRLSRSSGQGIV-----------EFKNEVRLIAKLQHTNLVRLLG 493 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~~~----~~vavK~l~~~~~~~~~-----------~~~~E~~~l~~l~h~niv~l~~ 493 (752)
.++|.+.++||+|+||.||+|...++ ..+|+|........... ....+...+..++|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 46889999999999999999987543 45666654322211111 1122334455678999999999
Q ss_pred eeeeCC----eeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCC
Q 043278 494 CSLHGE----ERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKM 569 (752)
Q Consensus 494 ~~~~~~----~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~ 569 (752)
++.... ..++++|++.. ++...+... ...++..+..++.|++.||+|||+.+ |+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRI---KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHhh---ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence 765543 34677887643 454444321 23567888999999999999999988 99999999999999999
Q ss_pred Cceecccccceeeccccc-----ccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcc
Q 043278 570 NPKISDFGMARIFEVNES-----EANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLN 644 (752)
Q Consensus 570 ~~kl~DFgla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~ 644 (752)
.+||+|||+++.+..... ........||+.|+|||++.+..++.++|||||||+++||++|+.||........
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~-- 241 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN-- 241 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH--
Confidence 999999999987643221 1112235689999999999999999999999999999999999999976632211
Q ss_pred hHHH----HHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 043278 645 LIGY----AWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ 704 (752)
Q Consensus 645 l~~~----~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~ 704 (752)
++.. ....+..++. .... ....+.+++..|++.+|++||++.++++.|+
T Consensus 242 ~~~~~~~~~~~~~~~~~~--------~~~~---~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 242 LIHAAKCDFIKRLHEGKI--------KIKN---ANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHhHHHHHHHhhhhhh--------ccCC---CCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 1111 1111111111 1111 1245778888999999999999999998763
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=284.21 Aligned_cols=249 Identities=26% Similarity=0.365 Sum_probs=202.5
Q ss_pred CCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEee
Q 043278 431 NFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
+|++.++||+|++|.||+++.. +++.+++|.+.... .....++.+|+.++++++|+||+++.+++.++...++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4777899999999999999754 67889999987542 23345678999999999999999999999999999999999
Q ss_pred CCCCCHhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccc
Q 043278 508 MPNKSLDFFLFNSG-RKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586 (752)
Q Consensus 508 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~ 586 (752)
+++++|..++.... ....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 99999999886532 2356899999999999999999999988 999999999999999999999999999876543
Q ss_pred cccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCC
Q 043278 587 SEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666 (752)
Q Consensus 587 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 666 (752)
......++..|+|||...+..++.++|+||||++++||++|+.|+....... . ......+....
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~------~-~~~~~~~~~~~------ 220 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD------L-RYKVQRGKYPP------ 220 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------H-HHHHhcCCCCC------
Confidence 1223457889999999999999999999999999999999999986554211 1 11111111111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 667 EQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 667 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.+......+.+++.+|++.+|++||++.|+++.
T Consensus 221 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 221 ---IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred ---CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 122344567889999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=286.78 Aligned_cols=247 Identities=26% Similarity=0.363 Sum_probs=196.8
Q ss_pred eecCCcccEEEEEecC-CceeEEEEcccCCc---ccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCCCCCH
Q 043278 438 LGEGGFGPVYKGKLAD-EQEVAIKRLSRSSG---QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSL 513 (752)
Q Consensus 438 LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 513 (752)
||+|+||.||++.... ++.+++|.+..... .....+.+|++++.+++|+||+++++.+..+...+++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999864 89999999875533 3456788999999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccc------
Q 043278 514 DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES------ 587 (752)
Q Consensus 514 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~------ 587 (752)
.+++.... .+++..+..++.||+.||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 99986532 5899999999999999999999988 99999999999999999999999999875432211
Q ss_pred ccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCC
Q 043278 588 EANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLE 667 (752)
Q Consensus 588 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 667 (752)
........++..|+|||.......+.++||||||++++||++|+.||....... .. .....+...
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~-~~~~~~~~~-------- 219 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE------IF-QNILNGKIE-------- 219 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH------HH-HHHhcCCcC--------
Confidence 112223567889999999998889999999999999999999999986554211 11 111111110
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 043278 668 QPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705 (752)
Q Consensus 668 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~ 705 (752)
.+........+.+++.+|++.+|.+|||+.++.+.|+.
T Consensus 220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 220 WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 00011123556789999999999999999777776654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=312.69 Aligned_cols=268 Identities=21% Similarity=0.269 Sum_probs=185.9
Q ss_pred HhcCCCcCCeeecCCcccEEEEEecC--CceeEEE------------------EcccCCcccHHHHHHHHHHHHhcCCCC
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGKLAD--EQEVAIK------------------RLSRSSGQGIVEFKNEVRLIAKLQHTN 487 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~~~~--~~~vavK------------------~l~~~~~~~~~~~~~E~~~l~~l~h~n 487 (752)
..++|.+.++||+|+||+||++..+. +...++| .+. ........+.+|+.++.+++|+|
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 35789999999999999999987532 2222222 111 11223456789999999999999
Q ss_pred cceeeeeeeeCCeeEEEEeeCCCCCHhHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEe
Q 043278 488 LVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGR--KNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILL 565 (752)
Q Consensus 488 iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll 565 (752)
|+++++++...+..++|+|++. ++|..++..... ........+..++.||+.||+|||+.+ |+||||||+||||
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 9999999999999999999986 456566543211 222346677889999999999999988 9999999999999
Q ss_pred cCCCCceecccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcch
Q 043278 566 DDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNL 645 (752)
Q Consensus 566 ~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l 645 (752)
+.++.+||+|||+++.+..... .......||..|+|||++.+..++.++|||||||++|||++|+.++...........
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred CCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 9999999999999987643221 112235789999999999999999999999999999999998854433221111111
Q ss_pred HHHHHHHhhCCCcccccCC-----------CC--CCCCCH------HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 646 IGYAWQLLSDGKGLELIDP-----------SL--EQPCSA------NEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 646 ~~~~~~~~~~~~~~~~~d~-----------~l--~~~~~~------~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
+......+... ..++.++ .+ ...... .....+.+++.+|++.||++|||+.|++++
T Consensus 380 ~~~~~~~~~~~-~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 380 LLKIIDSLSVC-DEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHhcccC-hhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 11111100000 0000000 00 000000 011235567889999999999999999875
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=291.16 Aligned_cols=265 Identities=23% Similarity=0.319 Sum_probs=195.9
Q ss_pred HHhcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCC----
Q 043278 427 AAANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGE---- 499 (752)
Q Consensus 427 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 499 (752)
...++|++.+.||+|+||.||+|... +++.||+|+++... ......+.+|++++.+++|||++++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 35578999999999999999999975 57899999987543 223356788999999999999999999887654
Q ss_pred ------eeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCcee
Q 043278 500 ------ERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKI 573 (752)
Q Consensus 500 ------~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl 573 (752)
..++|+||+++ ++...+... ...+++..+..++.||+.||+|||+.+ |+|+||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 78999999986 565655432 345899999999999999999999988 999999999999999999999
Q ss_pred cccccceeecccccccccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHH
Q 043278 574 SDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQL 652 (752)
Q Consensus 574 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~ 652 (752)
+|||++......... ......++..|+|||.+.+ ..++.++||||||++++||++|+.||........ .....+.
T Consensus 158 ~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~---~~~~~~~ 233 (302)
T cd07864 158 ADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQ---LELISRL 233 (302)
T ss_pred CcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHH
Confidence 999999865433211 1112345778999998865 4578999999999999999999999875442211 1111111
Q ss_pred hhCCC---cccc--------cCC------CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 653 LSDGK---GLEL--------IDP------SLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 653 ~~~~~---~~~~--------~d~------~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
..... ...+ .++ ..... .......+.+++.+|++.+|.+||++.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred hCCCChhhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11000 0000 000 00000 00113457789999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-32 Score=279.02 Aligned_cols=251 Identities=21% Similarity=0.332 Sum_probs=203.9
Q ss_pred CCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCc--ccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEee
Q 043278 431 NFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSG--QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
+|...+.||.|+||.||++... +++.+++|++..... ....++.+|++++++++|+|++++.+.+..++..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4677889999999999999875 588999999876533 4556788999999999999999999999999999999999
Q ss_pred CCCCCHhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccc
Q 043278 508 MPNKSLDFFLFNSG-RKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586 (752)
Q Consensus 508 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~ 586 (752)
+++++|.+++.... ....+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999886532 2356899999999999999999999987 9999999999999999999999999998754432
Q ss_pred cccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCC
Q 043278 587 SEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666 (752)
Q Consensus 587 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 666 (752)
.......+++.|+|||...+..++.++||||+|+++++|++|+.|+...... ... ..........+
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~-~~~~~~~~~~~----- 223 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL------ELA-LKILKGQYPPI----- 223 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH------HHH-HHHhcCCCCCC-----
Confidence 1222346788999999999999999999999999999999999998654411 111 11112111111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 667 EQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 667 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
+......+.+++.+|+..+|.+|||+.|+++.
T Consensus 224 ----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 224 ----PSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred ----CCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11223456788999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=287.12 Aligned_cols=258 Identities=22% Similarity=0.270 Sum_probs=192.3
Q ss_pred CCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC-cccHHHHHHHHHHHHhcC-CCCcceeeeeeeeC--CeeEEEEe
Q 043278 432 FSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQ-HTNLVRLLGCSLHG--EERLLVYE 506 (752)
Q Consensus 432 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~E 506 (752)
|++.++||+|+||.||++... +++.+|+|+++... ........+|+..+.++. |+|++++++++.++ +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 456789999999999999864 58899999987642 222334467888888885 99999999999887 88999999
Q ss_pred eCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccc
Q 043278 507 FMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586 (752)
Q Consensus 507 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~ 586 (752)
|++ ++|.+++... ...+++..+..++.||+.||+|||+.+ ++|+||||+||+++. +.+||+|||+++......
T Consensus 81 ~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMD-MNLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCC-ccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 997 5777776442 246899999999999999999999988 999999999999999 999999999998654322
Q ss_pred cccccccccccCCccChhhhc-cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHH-----------Hhh
Q 043278 587 SEANTKRIVGTYGYMSPEYAM-SGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQ-----------LLS 654 (752)
Q Consensus 587 ~~~~~~~~~gt~~y~aPE~~~-~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~-----------~~~ 654 (752)
. .....++..|+|||.+. +..++.++|||||||++|||++|+.||......+ ....... ...
T Consensus 154 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07831 154 P---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVLKKFR 227 (282)
T ss_pred C---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHHHhhc
Confidence 1 12245788999999765 4567899999999999999999999997654321 1111111 111
Q ss_pred CCCcccccCCCCCC----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 655 DGKGLELIDPSLEQ----PCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 655 ~~~~~~~~d~~l~~----~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.........+.... .........+.+++.+|++.+|++||+++++++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 11111111110000 0011234678899999999999999999999863
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=286.25 Aligned_cols=242 Identities=24% Similarity=0.302 Sum_probs=185.9
Q ss_pred eeecCCcccEEEEEec-CCceeEEEEcccCCc---ccHHHHHHHHHHHH---hcCCCCcceeeeeeeeCCeeEEEEeeCC
Q 043278 437 KLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSG---QGIVEFKNEVRLIA---KLQHTNLVRLLGCSLHGEERLLVYEFMP 509 (752)
Q Consensus 437 ~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~---~l~h~niv~l~~~~~~~~~~~lv~E~~~ 509 (752)
.||+|+||.||++... +++.+|+|.+..... .....+.+|..++. ..+|+|++.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999874 588999998865421 12223444544433 3479999999999999999999999999
Q ss_pred CCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccccc
Q 043278 510 NKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEA 589 (752)
Q Consensus 510 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 589 (752)
+++|..++.. ...+++..+..++.|++.||+|||+.+ |+|+||||+|||+++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 9999988854 345899999999999999999999988 9999999999999999999999999987543221
Q ss_pred ccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCC
Q 043278 590 NTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQ 668 (752)
Q Consensus 590 ~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 668 (752)
.....|+..|+|||.+.. ..++.++||||||++++||++|+.||.......... ...... .....+
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~----~~~~~~------~~~~~~-- 218 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTL------TVNVEL-- 218 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH----HHHHhh------cCCcCC--
Confidence 123468899999999864 568999999999999999999999997654322111 111100 011111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 043278 669 PCSANEVMRCIHVGLLCVQDQAMDRP-----TMPEVVCM 702 (752)
Q Consensus 669 ~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~ev~~~ 702 (752)
+......+.+++.+|++.||.+|| |++|++++
T Consensus 219 --~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 219 --PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred --ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 112234567888999999999999 69999886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=278.92 Aligned_cols=266 Identities=24% Similarity=0.319 Sum_probs=220.5
Q ss_pred HHHHHHHhcCCCcCCeeecCCcccEEEEEec------CCceeEEEEcccC-CcccHHHHHHHHHHHHhcCCCCcceeeee
Q 043278 422 FQTIAAAANNFSTTNKLGEGGFGPVYKGKLA------DEQEVAIKRLSRS-SGQGIVEFKNEVRLIAKLQHTNLVRLLGC 494 (752)
Q Consensus 422 ~~~i~~~~~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 494 (752)
..++.....++.....+-+|.||.||.|.+. +.+.|.+|.++.. +.-....+..|..++..+.|||++.+.+.
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 3566667788999999999999999999654 3456888888765 33345678899999999999999999999
Q ss_pred eeeC-CeeEEEEeeCCCCCHhHHHh-----hcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCC
Q 043278 495 SLHG-EERLLVYEFMPNKSLDFFLF-----NSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDK 568 (752)
Q Consensus 495 ~~~~-~~~~lv~E~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~ 568 (752)
+.++ +..+++|.++.-|+|..||. +......++..+...++.|++.||+|||..+ +||.||.++|++||+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhh
Confidence 8654 57899999999999999998 4444556788888999999999999999998 9999999999999999
Q ss_pred CCceecccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHH
Q 043278 569 MNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIG 647 (752)
Q Consensus 569 ~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~ 647 (752)
.++||+|=.+++.+...+..........+..||+||.+....|+.++||||||++||||+| |+.|+...++.+.
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm----- 507 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM----- 507 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH-----
Confidence 9999999999998776665555555556789999999999999999999999999999999 8889887776543
Q ss_pred HHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 648 YAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 648 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
...+.+|.... .+...+.++..++.-||...|++||+.+|++.-|.+.
T Consensus 508 --~~ylkdGyRla---------QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 508 --EHYLKDGYRLA---------QPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred --HHHHhccceec---------CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 34455554322 2334556788999999999999999999999888653
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=295.01 Aligned_cols=268 Identities=21% Similarity=0.317 Sum_probs=198.3
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeee----CCee
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLH----GEER 501 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 501 (752)
.++|++.+.||+|+||.||++... +++.||+|++.... ......+.+|+.++.+++|+||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 468888999999999999999864 58899999987642 2345567889999999999999999998753 3467
Q ss_pred EEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceeccccccee
Q 043278 502 LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARI 581 (752)
Q Consensus 502 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~ 581 (752)
++||||+. ++|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 99999996 688887743 334899999999999999999999988 99999999999999999999999999976
Q ss_pred eccccccc--ccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHH--------H
Q 043278 582 FEVNESEA--NTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYA--------W 650 (752)
Q Consensus 582 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~--------~ 650 (752)
........ ......++..|+|||.+.. ..++.++||||||+++|||++|+.||...........+... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 54322111 1123467889999999866 56899999999999999999999999765432111100000 0
Q ss_pred HHhhCCCcccccCC-CCCCCCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 043278 651 QLLSDGKGLELIDP-SLEQPCS-----ANEVMRCIHVGLLCVQDQAMDRPTMPEVVCML 703 (752)
Q Consensus 651 ~~~~~~~~~~~~d~-~l~~~~~-----~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L 703 (752)
............+. ....... ......+.+++..|++.+|.+|||+.+++..-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 295 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence 00000000000000 0000011 11245678899999999999999999998863
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=291.96 Aligned_cols=257 Identities=21% Similarity=0.263 Sum_probs=192.3
Q ss_pred CeeecC--CcccEEEEEec-CCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCCC
Q 043278 436 NKLGEG--GFGPVYKGKLA-DEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPN 510 (752)
Q Consensus 436 ~~LG~G--~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 510 (752)
..||+| +||+||+++.. .++.||+|.+.... ....+.+.+|+.+++.++|+||+++++++..++..++|+||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 89999999864 68999999986532 22346788999999999999999999999999999999999999
Q ss_pred CCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccccc-
Q 043278 511 KSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEA- 589 (752)
Q Consensus 511 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~- 589 (752)
++|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+|++||+.+..........
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99999886542 235889999999999999999999988 9999999999999999999999998654322111000
Q ss_pred ----ccccccccCCccChhhhccC--CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhC--------
Q 043278 590 ----NTKRIVGTYGYMSPEYAMSG--IVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSD-------- 655 (752)
Q Consensus 590 ----~~~~~~gt~~y~aPE~~~~~--~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~-------- 655 (752)
......++..|+|||++.+. .++.++||||||++++||++|+.||........ ....+..
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~------~~~~~~~~~~~~~~~ 233 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM------LLQKLKGPPYSPLDI 233 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH------HHHHhcCCCCCCccc
Confidence 00112345679999998763 478999999999999999999999975432110 0000000
Q ss_pred ----------------------------CCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 656 ----------------------------GKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 656 ----------------------------~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
+......+..+..+........+.+++.+|++.||++|||+.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 234 TTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred cccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 00001111122222233455678899999999999999999999865
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-31 Score=279.15 Aligned_cols=248 Identities=21% Similarity=0.256 Sum_probs=189.7
Q ss_pred HHHHHhcCCCcCCee--ecCCcccEEEEEec-CCceeEEEEcccCCcccHHHHHHHHHHHHhc-CCCCcceeeeeeeeCC
Q 043278 424 TIAAAANNFSTTNKL--GEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGE 499 (752)
Q Consensus 424 ~i~~~~~~~~~~~~L--G~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 499 (752)
++....++|++.+.+ |+|+||.||++... ++..+|+|.+....... .|+.....+ +|+|++++++++...+
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCC
Confidence 334445677777776 99999999999864 57889999886542211 122222222 7999999999999999
Q ss_pred eeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCC-Cceeccccc
Q 043278 500 ERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKM-NPKISDFGM 578 (752)
Q Consensus 500 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~-~~kl~DFgl 578 (752)
..++||||+++++|.+++... ..+++..+..++.||++||.|||+.+ ++||||||+||+++.++ .++|+|||+
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~ 156 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGL 156 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCcc
Confidence 999999999999999998543 26899999999999999999999988 99999999999999998 999999999
Q ss_pred ceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCc
Q 043278 579 ARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKG 658 (752)
Q Consensus 579 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 658 (752)
++..... ....++..|+|||++.+..++.++||||||++++||++|+.||....... .....+. ... . ..
T Consensus 157 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~-~~~-~-~~ 226 (267)
T PHA03390 157 CKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLL-KRQ-Q-KK 226 (267)
T ss_pred ceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHH-Hhh-c-cc
Confidence 8765422 12457889999999999999999999999999999999999998543222 1111111 111 1 00
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 043278 659 LELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPT-MPEVVC 701 (752)
Q Consensus 659 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-~~ev~~ 701 (752)
... .......+.+++.+|++.+|.+||+ ++|+++
T Consensus 227 ~~~---------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 227 LPF---------IKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred CCc---------ccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 011 1123345778889999999999996 688875
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=286.75 Aligned_cols=260 Identities=20% Similarity=0.219 Sum_probs=191.1
Q ss_pred CeeecCCcccEEEEEecCCceeEEEEcccC--CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCCCCCH
Q 043278 436 NKLGEGGFGPVYKGKLADEQEVAIKRLSRS--SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSL 513 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 513 (752)
+.+|.|+++.||++.. +++.||||++... .......+.+|++++.+++|+||+++++++.+.+..+++|||+++++|
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 4455555555555554 6889999998754 344556789999999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccc-----c
Q 043278 514 DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES-----E 588 (752)
Q Consensus 514 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~-----~ 588 (752)
..++.... ...+++.....++.|+++||+|||+.+ |+|+||||+||+++.++.+||+|||.+........ .
T Consensus 87 ~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 87 EDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred HHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 99986532 235889999999999999999999988 99999999999999999999999999875532211 1
Q ss_pred cccccccccCCccChhhhcc--CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHH----hh-------C
Q 043278 589 ANTKRIVGTYGYMSPEYAMS--GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQL----LS-------D 655 (752)
Q Consensus 589 ~~~~~~~gt~~y~aPE~~~~--~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~----~~-------~ 655 (752)
.......++..|+|||++.. ..++.++||||||++++||++|+.||........ +....... +. .
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 240 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLDKSTYPLYE 240 (314)
T ss_pred cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCccccccCchhhhc
Confidence 11123456778999999876 3588999999999999999999999976432211 00000000 00 0
Q ss_pred CCccc----ccCCCC----CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 656 GKGLE----LIDPSL----EQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 656 ~~~~~----~~d~~l----~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
..... ..++.. ...........+.+++.+||+.||++|||++|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 00000 000100 011122333567889999999999999999999875
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-32 Score=286.00 Aligned_cols=251 Identities=24% Similarity=0.369 Sum_probs=191.6
Q ss_pred cCCCcCCeeecCCcccEEEEEecC-CceeEEEEcccCCc-ccHHHHHHHHHHHHhcC-CCCcceeeeeeeeCCeeEEEEe
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLAD-EQEVAIKRLSRSSG-QGIVEFKNEVRLIAKLQ-HTNLVRLLGCSLHGEERLLVYE 506 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E 506 (752)
++|.+.+.||+|+||.||+|...+ ++.||||.++.... ....++..|+.++.+.+ |+||+++++++.++...+++||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 567778999999999999999865 88999999975432 23445667777777765 9999999999999999999999
Q ss_pred eCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEeecCCCCCcEEecCCCCceecccccceeeccc
Q 043278 507 FMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY-SRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVN 585 (752)
Q Consensus 507 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~ 585 (752)
|+++ +|..++... ...+++..+..++.||++||+|||+. + |+||||+|+||++++++.+||+|||++..+...
T Consensus 95 ~~~~-~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 95 LMST-CLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred ccCc-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 9864 666665442 23689999999999999999999974 5 999999999999999999999999998765322
Q ss_pred ccccccccccccCCccChhhhccCC----CCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccc
Q 043278 586 ESEANTKRIVGTYGYMSPEYAMSGI----VSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLEL 661 (752)
Q Consensus 586 ~~~~~~~~~~gt~~y~aPE~~~~~~----~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 661 (752)
... ....++..|+|||.+.... ++.++||||||+++|||++|+.||...... .......+.. ....
T Consensus 169 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~-~~~~- 238 (296)
T cd06618 169 KAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLTKILQE-EPPS- 238 (296)
T ss_pred Ccc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHHHHhcC-CCCC-
Confidence 211 1234678999999987553 889999999999999999999998643211 1111111111 1111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 662 IDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 662 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
+.. ......++.+++.+|++.||.+||++.+++++
T Consensus 239 ----~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 239 ----LPP--NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred ----CCC--CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 100 01123457889999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=312.60 Aligned_cols=253 Identities=26% Similarity=0.382 Sum_probs=189.4
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccC-CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeC--------
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRS-SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHG-------- 498 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------- 498 (752)
.++|++.+.||+||||.|||++.+ ||+.+|||++.-. +........+|+.+|++|+|||||+++....+.
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 457788899999999999999864 8999999999765 333445678999999999999999997532110
Q ss_pred --------------------------------------------------------------------------------
Q 043278 499 -------------------------------------------------------------------------------- 498 (752)
Q Consensus 499 -------------------------------------------------------------------------------- 498 (752)
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence
Q ss_pred -------------------------------CeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 043278 499 -------------------------------EERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHK 547 (752)
Q Consensus 499 -------------------------------~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~ 547 (752)
...+|-||||+..+|+.++....-.. .....++++++|+.||+|+|+
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHHh
Confidence 01356788888888877775432211 367788999999999999999
Q ss_pred cCCCcEeecCCCCCcEEecCCCCceecccccceeecc----------------cccccccccccccCCccChhhhccC--
Q 043278 548 YSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV----------------NESEANTKRIVGTYGYMSPEYAMSG-- 609 (752)
Q Consensus 548 ~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~----------------~~~~~~~~~~~gt~~y~aPE~~~~~-- 609 (752)
.+ ||||||||.||+||++..+||+|||+|+.... .......+..+||.-|+|||.+.+.
T Consensus 716 ~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 716 QG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred Cc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 99 99999999999999999999999999987220 0111133457899999999998764
Q ss_pred -CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccC
Q 043278 610 -IVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQD 688 (752)
Q Consensus 610 -~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~ 688 (752)
.|+.|+|+||+|+||+||+. ||....+. ......++.+.+..- .....+....-.+++.|+++.
T Consensus 793 ~~Yn~KiDmYSLGIVlFEM~y---PF~TsMER------a~iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~h 857 (1351)
T KOG1035|consen 793 NKYNSKIDMYSLGIVLFEMLY---PFGTSMER------ASILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLLSH 857 (1351)
T ss_pred ccccchhhhHHHHHHHHHHhc---cCCchHHH------HHHHHhcccCCCCCC------cccccccchHHHHHHHHHhcC
Confidence 49999999999999999984 34443311 112233444433322 112233344456788999999
Q ss_pred CCCCCCCHHHHHH
Q 043278 689 QAMDRPTMPEVVC 701 (752)
Q Consensus 689 dp~~RPt~~ev~~ 701 (752)
||.+|||+.|++.
T Consensus 858 dP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 858 DPSKRPTATELLN 870 (1351)
T ss_pred CCccCCCHHHHhh
Confidence 9999999999876
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=279.72 Aligned_cols=247 Identities=27% Similarity=0.417 Sum_probs=200.7
Q ss_pred CCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCc--ccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEee
Q 043278 431 NFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSG--QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
+|+..+.||+|++|.||+++.. +++.+++|.+..... .....+.+|++++.+++|+|++++++++..++..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4677899999999999999865 578899999976643 3556789999999999999999999999999999999999
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccc
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES 587 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~ 587 (752)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 9999999988543 45899999999999999999999988 99999999999999999999999999987653322
Q ss_pred ccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCC
Q 043278 588 EANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLE 667 (752)
Q Consensus 588 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 667 (752)
. .....++..|+|||...+...+.++||||+|+++++|++|+.|+...... ...+... .... +.+
T Consensus 155 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~------~~~~~~~-~~~~-----~~~- 219 (254)
T cd06627 155 D--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM------AALFRIV-QDDH-----PPL- 219 (254)
T ss_pred c--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHh-ccCC-----CCC-
Confidence 1 22346788999999998888999999999999999999999998654311 1111111 1111 111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 043278 668 QPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVC 701 (752)
Q Consensus 668 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~ 701 (752)
+......+.+++.+|++.+|++|||+.|++.
T Consensus 220 ---~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 220 ---PEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred ---CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1112345678899999999999999999975
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=282.35 Aligned_cols=245 Identities=20% Similarity=0.246 Sum_probs=189.0
Q ss_pred CeeecCCcccEEEEEec-CCceeEEEEcccCCc---ccHHHHHHHHHH-HHhcCCCCcceeeeeeeeCCeeEEEEeeCCC
Q 043278 436 NKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSG---QGIVEFKNEVRL-IAKLQHTNLVRLLGCSLHGEERLLVYEFMPN 510 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 510 (752)
+.||+|+||.||+|... +++.||+|.+..... .....+..|..+ ....+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999864 578999999865432 122234445444 3455899999999999999999999999999
Q ss_pred CCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccccc
Q 043278 511 KSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEAN 590 (752)
Q Consensus 511 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~ 590 (752)
++|..++... ..+++..+..++.||+.||.|||+.+ ++|+||+|+||++++++.+||+|||+++....
T Consensus 82 ~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------ 149 (260)
T cd05611 82 GDCASLIKTL---GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------ 149 (260)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence 9999988543 35889999999999999999999988 99999999999999999999999999875432
Q ss_pred cccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCCC
Q 043278 591 TKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPC 670 (752)
Q Consensus 591 ~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 670 (752)
.....++..|+|||.+.+..++.++||||||++++||++|..|+....... .......+... ..+..
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~--~~~~~---- 216 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA-------VFDNILSRRIN--WPEEV---- 216 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhcccC--CCCcc----
Confidence 223457889999999998889999999999999999999999996543211 11111111110 00011
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 043278 671 SANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705 (752)
Q Consensus 671 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~ 705 (752)
.......+.+++.+|++.+|++||++.++.+.|+.
T Consensus 217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred cccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 11123457789999999999999988777666543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-32 Score=292.53 Aligned_cols=280 Identities=23% Similarity=0.296 Sum_probs=199.7
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeC----------
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHG---------- 498 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---------- 498 (752)
.+|...+.||.|+||.||+|... +++.||+|++........+.+.+|++++++++|+||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 67888999999999999999864 5889999998776666667789999999999999999999876543
Q ss_pred ----CeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEec-CCCCcee
Q 043278 499 ----EERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLD-DKMNPKI 573 (752)
Q Consensus 499 ----~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~-~~~~~kl 573 (752)
...++||||++ ++|..++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++ +++.+||
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEE
Confidence 35789999997 588777732 35889999999999999999999988 99999999999997 4567899
Q ss_pred cccccceeecccccc-cccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHH--
Q 043278 574 SDFGMARIFEVNESE-ANTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYA-- 649 (752)
Q Consensus 574 ~DFgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~-- 649 (752)
+|||+++.+...... .......++..|+|||.+.. ..++.++|||||||++|||++|+.||....+..........
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~ 236 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP 236 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 999999865422111 11122356889999998754 56889999999999999999999999755421110000000
Q ss_pred ------HHHhhCCCcccccCCCCCCCCCH-----HHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hhcCCCCCCCCCCC
Q 043278 650 ------WQLLSDGKGLELIDPSLEQPCSA-----NEVMRCIHVGLLCVQDQAMDRPTMPEVVCM--LQNETMPLPPPKQP 716 (752)
Q Consensus 650 ------~~~~~~~~~~~~~d~~l~~~~~~-----~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~--L~~~~~~~~~p~~~ 716 (752)
.....................+. ....++.+++.+|++.||.+|||+.|++.+ ++....+.+.|+.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~~~~~~~~ 316 (342)
T cd07854 237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCPFDEPVSL 316 (342)
T ss_pred CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCCccccCCC
Confidence 00000000000000000000011 122457789999999999999999999854 55443333444443
Q ss_pred c
Q 043278 717 A 717 (752)
Q Consensus 717 ~ 717 (752)
.
T Consensus 317 ~ 317 (342)
T cd07854 317 H 317 (342)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=285.12 Aligned_cols=263 Identities=24% Similarity=0.268 Sum_probs=195.6
Q ss_pred CCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCc-ccHHHHHHHHHHHHhcC-CCCcceeeeeeeeCCeeEEEEeeC
Q 043278 432 FSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSG-QGIVEFKNEVRLIAKLQ-HTNLVRLLGCSLHGEERLLVYEFM 508 (752)
Q Consensus 432 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~ 508 (752)
|.+.+.||+|++|+||+|+.. .++.|+||++..... .......+|+..+.+++ |+|++++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 566789999999999999985 478899999876532 22334567999999999 999999999999999999999999
Q ss_pred CCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccc
Q 043278 509 PNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE 588 (752)
Q Consensus 509 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 588 (752)
+++|.+++.... ...+++..+..++.|++.+|.|||+++ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP- 154 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence 788988875533 246899999999999999999999988 99999999999999999999999999986543221
Q ss_pred cccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchH----------HHHHHHhhCCC
Q 043278 589 ANTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLI----------GYAWQLLSDGK 657 (752)
Q Consensus 589 ~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~----------~~~~~~~~~~~ 657 (752)
.....++..|+|||++.. ..++.++|+||||++++||++|+.||............ .+.........
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 123457889999998754 56899999999999999999999998665422111000 00000000000
Q ss_pred cccccCCCCCC---CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 658 GLELIDPSLEQ---PCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 658 ~~~~~d~~l~~---~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
....+...... .........+.+++.+|++.+|++|||++|++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 00000000000 0000113568899999999999999999999764
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=297.96 Aligned_cols=203 Identities=28% Similarity=0.412 Sum_probs=175.8
Q ss_pred CCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCC------eeE
Q 043278 431 NFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGE------ERL 502 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~ 502 (752)
.+...+.||+|+||.||+|+. ..|+.||||.+.... ....+...+|+++|++++|+|||++++.-.+.. ..+
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 345568999999999999995 569999999997643 334566789999999999999999999865443 568
Q ss_pred EEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEec--CCC--Cceeccccc
Q 043278 503 LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLD--DKM--NPKISDFGM 578 (752)
Q Consensus 503 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~--~~~--~~kl~DFgl 578 (752)
+|||||.+|+|...+........|++.+.+.+..+++.||.|||+++ |+||||||.||++- ++| ..||+|||.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 99999999999999998888889999999999999999999999988 99999999999993 333 479999999
Q ss_pred ceeecccccccccccccccCCccChhhhc-cCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 043278 579 ARIFEVNESEANTKRIVGTYGYMSPEYAM-SGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHP 639 (752)
Q Consensus 579 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~ 639 (752)
|+-+..+. ......||..|++||.+. .+.|+..+|.|||||++||++||..||.....
T Consensus 171 Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~ 229 (732)
T KOG4250|consen 171 ARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG 229 (732)
T ss_pred cccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence 99766443 344689999999999999 48999999999999999999999999976543
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-32 Score=280.63 Aligned_cols=251 Identities=25% Similarity=0.343 Sum_probs=195.3
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccC-----CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeC--Cee
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRS-----SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHG--EER 501 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 501 (752)
.+|.+.+.||+|+||.||++... +++.||+|.+... ..+....+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46888899999999999999864 5889999987532 123345788999999999999999999998664 457
Q ss_pred EEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceeccccccee
Q 043278 502 LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARI 581 (752)
Q Consensus 502 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~ 581 (752)
++++||+++++|.+++... ..+++.....++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY---GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 8999999999999988542 34789999999999999999999988 99999999999999999999999999986
Q ss_pred eccccc-ccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCccc
Q 043278 582 FEVNES-EANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLE 660 (752)
Q Consensus 582 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 660 (752)
...... ........++..|+|||.+.+..++.++|+||||++++||++|+.||...... ....+....+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~-- 227 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM------AAIFKIATQPTK-- 227 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH------HHHHHHHcCCCC--
Confidence 532111 11112356788999999999888999999999999999999999998654211 111111111111
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 661 LIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 661 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
+ ..+......+.+++.+|++ +|..||+..+++.+
T Consensus 228 ---~----~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 228 ---P----MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred ---C----CCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 1 1122233457788889999 57999999988763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-32 Score=283.83 Aligned_cols=259 Identities=22% Similarity=0.316 Sum_probs=193.1
Q ss_pred CCcCCeeecCCcccEEEEEecC-CceeEEEEcccCCcc--cHHHHHHHHHHHHhc---CCCCcceeeeeeeeCCe-----
Q 043278 432 FSTTNKLGEGGFGPVYKGKLAD-EQEVAIKRLSRSSGQ--GIVEFKNEVRLIAKL---QHTNLVRLLGCSLHGEE----- 500 (752)
Q Consensus 432 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~----- 500 (752)
|++.+.||+|+||.||+|+... ++.+|+|++...... ....+.+|+.++.++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5567899999999999999864 889999999754222 234566787777666 69999999999988776
Q ss_pred eEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccce
Q 043278 501 RLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR 580 (752)
Q Consensus 501 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~ 580 (752)
.+++|||+++ +|.+++..... ..+++..+..++.||++||.|||+.+ ++|+||+|+||+++.++.+||+|||++.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 8999999974 78887754322 35899999999999999999999988 9999999999999999999999999998
Q ss_pred eecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCc--
Q 043278 581 IFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKG-- 658 (752)
Q Consensus 581 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~-- 658 (752)
....... .....++..|+|||++.+..++.++||||||++++||++|+.|+......+.. ............
T Consensus 156 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 229 (287)
T cd07838 156 IYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQL---DKIFDVIGLPSEEE 229 (287)
T ss_pred eccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHH---HHHHHHcCCCChHh
Confidence 7543321 12234688899999999999999999999999999999999988765432111 111110000000
Q ss_pred --------ccccCCCCC---CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 043278 659 --------LELIDPSLE---QPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVC 701 (752)
Q Consensus 659 --------~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~ 701 (752)
......... ..........+.+++.+|++.||.+||++.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000000000 0011123356778999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-32 Score=284.63 Aligned_cols=256 Identities=21% Similarity=0.304 Sum_probs=198.8
Q ss_pred CCCcCCeeecCCcccEEEEEe----cCCceeEEEEcccCC----cccHHHHHHHHHHHHhc-CCCCcceeeeeeeeCCee
Q 043278 431 NFSTTNKLGEGGFGPVYKGKL----ADEQEVAIKRLSRSS----GQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGEER 501 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 501 (752)
+|++.+.||+|++|.||+++. .+++.||||.++... ......+.+|+.++.++ +|+||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 366778999999999999874 356789999986532 22345678999999999 699999999999999999
Q ss_pred EEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceeccccccee
Q 043278 502 LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARI 581 (752)
Q Consensus 502 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~ 581 (752)
++||||+++++|..++... ..+++..+..++.|++++|.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR---EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhhc---CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 9999999999999988542 35889999999999999999999987 99999999999999999999999999876
Q ss_pred ecccccccccccccccCCccChhhhccCC--CCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcc
Q 043278 582 FEVNESEANTKRIVGTYGYMSPEYAMSGI--VSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGL 659 (752)
Q Consensus 582 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 659 (752)
+...... ......++..|+|||.+.+.. .+.++||||||++++||++|+.|+......... ..........
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--~~~~~~~~~~---- 227 (288)
T cd05583 155 FLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ--SEISRRILKS---- 227 (288)
T ss_pred ccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchH--HHHHHHHHcc----
Confidence 5433211 122346788999999987755 789999999999999999999998654322111 1111111111
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 660 ELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 660 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
.+.. +......+.+++.+|++.+|++|||+.++.+.|+..
T Consensus 228 ---~~~~----~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 228 ---KPPF----PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred ---CCCC----CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 0111 111223466788999999999999999998887653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-31 Score=289.62 Aligned_cols=262 Identities=23% Similarity=0.326 Sum_probs=194.0
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeeeC------C
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHG------E 499 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 499 (752)
.++|...+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++.+++|+||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 378988999999999999999864 68999999987542 22345678999999999999999999988654 2
Q ss_pred eeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccc
Q 043278 500 ERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMA 579 (752)
Q Consensus 500 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla 579 (752)
..++|+||+.. +|..++ ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 46899999974 666554 224889999999999999999999988 999999999999999999999999998
Q ss_pred eeecccccccccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHH------
Q 043278 580 RIFEVNESEANTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQL------ 652 (752)
Q Consensus 580 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~------ 652 (752)
+.... ......++..|+|||.+.+ ..++.++||||||++++||++|+.||....... ........
T Consensus 165 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~ 236 (342)
T cd07879 165 RHADA-----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQILKVTGVPGP 236 (342)
T ss_pred cCCCC-----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCCH
Confidence 75322 1123467889999999876 468999999999999999999999997654211 11100000
Q ss_pred -----hhCCCcccccC--CCC-CCCC---CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hhcCC
Q 043278 653 -----LSDGKGLELID--PSL-EQPC---SANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM--LQNET 707 (752)
Q Consensus 653 -----~~~~~~~~~~d--~~l-~~~~---~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~--L~~~~ 707 (752)
+........+. +.. .... .......+.+++.+|++.||.+||+++|++.+ ++...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 237 EFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred HHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 00000000000 000 0000 00122357789999999999999999999865 65543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-32 Score=292.27 Aligned_cols=263 Identities=24% Similarity=0.314 Sum_probs=195.1
Q ss_pred cCCC-cCCeeecCCcccEEEEEec-CCceeEEEEcccCCccc--------------HHHHHHHHHHHHhcCCCCcceeee
Q 043278 430 NNFS-TTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQG--------------IVEFKNEVRLIAKLQHTNLVRLLG 493 (752)
Q Consensus 430 ~~~~-~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~~ 493 (752)
++|. +.+.||+|+||.||++... .++.||||.+....... ...+.+|++++.+++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4554 3467999999999999865 68899999986543221 124678999999999999999999
Q ss_pred eeeeCCeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCcee
Q 043278 494 CSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKI 573 (752)
Q Consensus 494 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl 573 (752)
++..++..++||||++ ++|.+++.. ...+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence 9999999999999997 688888743 335899999999999999999999988 999999999999999999999
Q ss_pred cccccceeeccccc------------ccccccccccCCccChhhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCC
Q 043278 574 SDFGMARIFEVNES------------EANTKRIVGTYGYMSPEYAMSG-IVSIKTDVFSFGVLVLEIVSGQKNHTRHHPD 640 (752)
Q Consensus 574 ~DFgla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~G~vl~elltG~~p~~~~~~~ 640 (752)
+|||+++....... ........++..|+|||.+.+. .++.++||||||++++||++|+.||......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999986641110 1111123467889999998764 4789999999999999999999999766532
Q ss_pred CCcchHHHHHHHhhCCCcc---cc--------cCCCCCC---CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 641 RPLNLIGYAWQLLSDGKGL---EL--------IDPSLEQ---PCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 641 ~~~~l~~~~~~~~~~~~~~---~~--------~d~~l~~---~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
+ ........+...... .. ....... .........+.+++.+|++.+|.+|||+.|++.+
T Consensus 241 ~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 241 D---QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred H---HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 1 111111111111000 00 0000000 0001123457789999999999999999999875
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=283.43 Aligned_cols=252 Identities=23% Similarity=0.307 Sum_probs=194.7
Q ss_pred CCCcCCeeecCCcccEEEEEe----cCCceeEEEEcccCC----cccHHHHHHHHHHHHhc-CCCCcceeeeeeeeCCee
Q 043278 431 NFSTTNKLGEGGFGPVYKGKL----ADEQEVAIKRLSRSS----GQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGEER 501 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 501 (752)
+|++.+.||+|+||.||++.. .+|+.||+|++.... ....+.+.+|+.++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 467788999999999999986 368899999987532 12345678899999999 699999999999999999
Q ss_pred EEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceeccccccee
Q 043278 502 LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARI 581 (752)
Q Consensus 502 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~ 581 (752)
++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ ++||||+|+|||+++++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQR---ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 9999999999999998543 35889999999999999999999988 99999999999999999999999999986
Q ss_pred ecccccccccccccccCCccChhhhccC--CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcc
Q 043278 582 FEVNESEANTKRIVGTYGYMSPEYAMSG--IVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGL 659 (752)
Q Consensus 582 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 659 (752)
....... ......++..|+|||.+... .++.++||||||+++|||++|+.|+........ ............
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~~--- 228 (290)
T cd05613 155 FHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS--QAEISRRILKSE--- 228 (290)
T ss_pred ccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc--HHHHHHHhhccC---
Confidence 5432211 12235678899999998753 478899999999999999999999865432211 111111111111
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 043278 660 ELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRP-----TMPEVVCM 702 (752)
Q Consensus 660 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~ev~~~ 702 (752)
+. .+......+.+++.+|++.+|.+|| ++.+++.+
T Consensus 229 ----~~----~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 229 ----PP----YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred ----CC----CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 11 1111234566888999999999997 66666553
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=281.96 Aligned_cols=254 Identities=26% Similarity=0.341 Sum_probs=201.3
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccC---CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEE
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRS---SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLV 504 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 504 (752)
.+.|..-++||+|+||.||-++.. .|+.+|.|++.+. ..++.....+|-.+|.+++.+.||.+--.+...+..++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 355777789999999999999865 5899999988654 344566678999999999999999999889999999999
Q ss_pred EeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecc
Q 043278 505 YEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~ 584 (752)
+..|.+|+|..+|.+.+. ..++++.++-++.+|+.||++||... ||.||+||+|||||+.|+++|+|+|||..+..
T Consensus 264 LtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 999999999999987654 56999999999999999999999988 99999999999999999999999999997665
Q ss_pred cccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCC
Q 043278 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDP 664 (752)
Q Consensus 585 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 664 (752)
.+.. ...+||.+|||||++.+..|+...|.||+||+||||+.|+.||.......... ...+... -++
T Consensus 340 g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~e---Evdrr~~-------~~~ 406 (591)
T KOG0986|consen 340 GKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKRE---EVDRRTL-------EDP 406 (591)
T ss_pred CCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHH---HHHHHHh-------cch
Confidence 4432 23489999999999999999999999999999999999999997655322110 0011110 011
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 043278 665 SLEQPCSANEVMRCIHVGLLCVQDQAMDRP-----TMPEVVCM 702 (752)
Q Consensus 665 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~ev~~~ 702 (752)
...+....+++..|....|+.||.+|- .+++|-++
T Consensus 407 ---~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~H 446 (591)
T KOG0986|consen 407 ---EEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEH 446 (591)
T ss_pred ---hhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhC
Confidence 112222333444555567899999885 45555543
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-32 Score=284.88 Aligned_cols=249 Identities=26% Similarity=0.354 Sum_probs=200.8
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC---cccHHHHHHHHHHHHhcC-CCCcceeeeeeeeCCeeEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKLQ-HTNLVRLLGCSLHGEERLLV 504 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 504 (752)
++|...+.||+|+||.||+++.. +++.||+|.+.... ......+.+|+.++.+++ |+||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46788899999999999999875 68899999986532 233456889999999998 99999999999999999999
Q ss_pred EeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecc
Q 043278 505 YEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~ 584 (752)
|||+++++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRKY---GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 9999999999998543 35999999999999999999999988 99999999999999999999999999986543
Q ss_pred cccc------------------cccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchH
Q 043278 585 NESE------------------ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLI 646 (752)
Q Consensus 585 ~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~ 646 (752)
.... .......++..|+|||.......+.++||||||++++|+++|+.|+.......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----- 229 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL----- 229 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH-----
Confidence 3211 12223467889999999998889999999999999999999999987654211
Q ss_pred HHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCH----HHHHH
Q 043278 647 GYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTM----PEVVC 701 (752)
Q Consensus 647 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~----~ev~~ 701 (752)
...... ... ...+......+.+++.+|++.+|.+||++ +++++
T Consensus 230 -~~~~~~-~~~----------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 230 -TFQKIL-KLE----------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred -HHHHHH-hcC----------CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 011111 100 01111224457789999999999999999 77664
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-32 Score=294.38 Aligned_cols=269 Identities=25% Similarity=0.315 Sum_probs=201.2
Q ss_pred CCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCC-----eeE
Q 043278 431 NFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGE-----ERL 502 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 502 (752)
+|.+.+.||+|++|.||+++.. .++.+|+|++.... ......+.+|+.+++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999975 48899999987653 334567899999999999999999999988765 789
Q ss_pred EEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceee
Q 043278 503 LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIF 582 (752)
Q Consensus 503 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~ 582 (752)
++|||++ ++|..++... ..+++..+..++.||+.||+|||+.+ |+|+||||+|||++.++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~~---~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKSP---QPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999998 4787777432 36999999999999999999999988 999999999999999999999999999876
Q ss_pred cccccc-cccccccccCCccChhhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHH--------HHH
Q 043278 583 EVNESE-ANTKRIVGTYGYMSPEYAMSG-IVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYA--------WQL 652 (752)
Q Consensus 583 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~--------~~~ 652 (752)
...... .......++..|+|||++.+. .++.++|+||||+++++|++|+.||...........+... +..
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence 543210 112234578899999999887 8999999999999999999999999765532111000000 000
Q ss_pred hhCCCcccccCC-CCCCCC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hhcC
Q 043278 653 LSDGKGLELIDP-SLEQPC-----SANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM--LQNE 706 (752)
Q Consensus 653 ~~~~~~~~~~d~-~l~~~~-----~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~--L~~~ 706 (752)
.........+.. ...... .......+.+++.+||+.+|.+|||+.+++++ +++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 000000000000 000000 01123457789999999999999999999986 5443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=288.14 Aligned_cols=263 Identities=24% Similarity=0.344 Sum_probs=196.0
Q ss_pred HHhcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeee-CCeeE
Q 043278 427 AAANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLH-GEERL 502 (752)
Q Consensus 427 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~ 502 (752)
.++++|+..+.||.|+||.||++... +++.||+|++.... ......+.+|+.++.+++||||+++.+++.. ++..+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 46788999999999999999999854 68899999886432 2334667899999999999999999998865 56789
Q ss_pred EEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceee
Q 043278 503 LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIF 582 (752)
Q Consensus 503 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~ 582 (752)
+++||+. ++|..++. ...++......++.|++.||.|||+.+ |+|+||+|+|||+++++.+||+|||++...
T Consensus 87 lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~ 158 (328)
T cd07856 87 FVTELLG-TDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQ 158 (328)
T ss_pred EEeehhc-cCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccccc
Confidence 9999984 68887773 234788888999999999999999988 999999999999999999999999998753
Q ss_pred cccccccccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHH--------HHHHh
Q 043278 583 EVNESEANTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGY--------AWQLL 653 (752)
Q Consensus 583 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~--------~~~~~ 653 (752)
... .....++..|+|||.+.+ ..++.++||||||++++||++|+.||...........+.. ..+..
T Consensus 159 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 159 DPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred CCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 221 122456788999998766 5789999999999999999999999865542111100000 00000
Q ss_pred hCCCcccccCC-CCCCCCCH-----HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 654 SDGKGLELIDP-SLEQPCSA-----NEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 654 ~~~~~~~~~d~-~l~~~~~~-----~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
..+...+++.. ......+. .....+.+++.+|++.+|++|||+.+++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00110111000 00001111 112567789999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=280.62 Aligned_cols=242 Identities=25% Similarity=0.304 Sum_probs=186.3
Q ss_pred eeecCCcccEEEEEec-CCceeEEEEcccCCc---ccHHHHHHHHHH---HHhcCCCCcceeeeeeeeCCeeEEEEeeCC
Q 043278 437 KLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSG---QGIVEFKNEVRL---IAKLQHTNLVRLLGCSLHGEERLLVYEFMP 509 (752)
Q Consensus 437 ~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~---l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 509 (752)
.||+|+||.||++... .++.||+|.+..... .....+..|..+ +...+|+||+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 578999998865422 122233444433 444579999999999999999999999999
Q ss_pred CCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccccc
Q 043278 510 NKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEA 589 (752)
Q Consensus 510 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 589 (752)
+++|..++.. ...+++..+..++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||++..+...
T Consensus 81 g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~---- 150 (278)
T cd05606 81 GGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK---- 150 (278)
T ss_pred CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCcc----
Confidence 9999988853 345999999999999999999999988 999999999999999999999999998754322
Q ss_pred ccccccccCCccChhhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCC
Q 043278 590 NTKRIVGTYGYMSPEYAMSG-IVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQ 668 (752)
Q Consensus 590 ~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 668 (752)
......|+..|+|||.+.++ .++.++||||+|++++||++|+.||.......... ....... ..+.+..
T Consensus 151 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~~------~~~~~~~ 220 (278)
T cd05606 151 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTLT------MAVELPD 220 (278)
T ss_pred CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH----HHHHhhc------cCCCCCC
Confidence 11234688999999998754 68999999999999999999999997654322111 1111110 0111111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 043278 669 PCSANEVMRCIHVGLLCVQDQAMDRP-----TMPEVVCM 702 (752)
Q Consensus 669 ~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~ev~~~ 702 (752)
.....+.+++.+|++.+|.+|| ++.|++++
T Consensus 221 ----~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 221 ----SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred ----cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 1234577888899999999999 99999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-32 Score=290.06 Aligned_cols=264 Identities=22% Similarity=0.300 Sum_probs=192.8
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCcc--cHHHHHHHHHHHHhcCCCCcceeeeeeeeCC------
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQ--GIVEFKNEVRLIAKLQHTNLVRLLGCSLHGE------ 499 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 499 (752)
.++|++.++||+|+||.||+|... +++.+|+|++...... ....+.+|++++.+++|+||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468899999999999999999865 5789999988654322 2345688999999999999999999875433
Q ss_pred --eeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccc
Q 043278 500 --ERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFG 577 (752)
Q Consensus 500 --~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg 577 (752)
..++|+||+.. +|...+... ...+++..+..++.||++||+|||+.+ |+|+||||+||++++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP--SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 46899999975 565655432 345899999999999999999999988 9999999999999999999999999
Q ss_pred cceeeccccccc---------ccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHH
Q 043278 578 MARIFEVNESEA---------NTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIG 647 (752)
Q Consensus 578 la~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~ 647 (752)
+++......... ......+++.|+|||.+.+ ..++.++||||||++++||++|++||......... .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~---~ 237 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL---H 237 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHH---H
Confidence 998654322111 1123456788999998865 45899999999999999999999998754432111 1
Q ss_pred HHHHHhhCC---------Cccccc----CCCCCCC---CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 043278 648 YAWQLLSDG---------KGLELI----DPSLEQP---CSANEVMRCIHVGLLCVQDQAMDRPTMPEVVC 701 (752)
Q Consensus 648 ~~~~~~~~~---------~~~~~~----d~~l~~~---~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~ 701 (752)
......... ...... ....... ........+.+++.+|++.+|.+|||+.|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 238 LIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 111110000 000000 0000000 00111246778999999999999999999876
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-31 Score=282.49 Aligned_cols=248 Identities=31% Similarity=0.418 Sum_probs=193.3
Q ss_pred CCCcCCeeecCCcccEEEEEec-CCceeEEEEcccC---CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEe
Q 043278 431 NFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRS---SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYE 506 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 506 (752)
.|...+.||+|+||.||+|+.. +++.+|+|.+... ......++.+|+++++.++|+|++++++++...+..++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3556688999999999999864 5788999988643 22234567899999999999999999999999999999999
Q ss_pred eCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccc
Q 043278 507 FMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586 (752)
Q Consensus 507 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~ 586 (752)
|+. |+|...+... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 96 ~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 96 YCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (308)
T ss_pred ccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence 997 5776666432 234889999999999999999999988 999999999999999999999999998764321
Q ss_pred cccccccccccCCccChhhhc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccC
Q 043278 587 SEANTKRIVGTYGYMSPEYAM---SGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELID 663 (752)
Q Consensus 587 ~~~~~~~~~gt~~y~aPE~~~---~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 663 (752)
....++..|+|||.+. ...++.++||||||++++||++|+.|+....... .. .....+..
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~-~~~~~~~~----- 231 (308)
T cd06634 169 -----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------AL-YHIAQNES----- 231 (308)
T ss_pred -----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH------HH-HHHhhcCC-----
Confidence 2345788999999975 3568899999999999999999999986543111 11 11111111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 043278 664 PSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705 (752)
Q Consensus 664 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~ 705 (752)
+... .......+.+++.+||+.+|++||++.++++..-.
T Consensus 232 ~~~~---~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~ 270 (308)
T cd06634 232 PALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270 (308)
T ss_pred CCcC---cccccHHHHHHHHHHhhCCcccCCCHHHHhhCccc
Confidence 1110 11223446788899999999999999999987543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.6e-32 Score=278.74 Aligned_cols=250 Identities=24% Similarity=0.362 Sum_probs=194.0
Q ss_pred CCCcCCeeecCCcccEEEEEecC-CceeEEEEcccC-----CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEE
Q 043278 431 NFSTTNKLGEGGFGPVYKGKLAD-EQEVAIKRLSRS-----SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLV 504 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 504 (752)
+|.+.+.||+|+||.||++.... +..+++|.++.. ......++..|+.++.+++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47788999999999999998643 444555555432 122334567899999999999999999999999999999
Q ss_pred EeeCCCCCHhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeec
Q 043278 505 YEFMPNKSLDFFLFNS-GRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFE 583 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~ 583 (752)
|||+++++|..++... .....+++..++.++.|++.||.|||+.+ ++|+||+|+||++++ +.+||+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999888642 23456899999999999999999999988 999999999999975 569999999998654
Q ss_pred ccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccC
Q 043278 584 VNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELID 663 (752)
Q Consensus 584 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 663 (752)
.... ......++..|+|||.+.+..++.++|+||||+++++|++|+.|+.... ........ ..+. .
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~------~~~~~~~~-~~~~-----~ 222 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN------FLSVVLRI-VEGP-----T 222 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHH-HcCC-----C
Confidence 3221 1223557889999999988889999999999999999999999985432 11111111 1111 1
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 664 PSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 664 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
+.+ +......+.+++.+|++.+|.+||++.|+++.
T Consensus 223 ~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 223 PSL----PETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred CCC----cchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 111 22333467789999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-33 Score=319.22 Aligned_cols=255 Identities=25% Similarity=0.362 Sum_probs=201.1
Q ss_pred HhcCCCcCCeeecCCcccEEEEE-ecCCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEE
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLV 504 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~-~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 504 (752)
.+-++....+||.|.||.||-+. .++|...|+|-++... ........+|+.++..++|||+|+++|+-.+.+..+|.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 45566777899999999999997 4668889999876543 23445678999999999999999999999999999999
Q ss_pred EeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecc
Q 043278 505 YEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~ 584 (752)
||||++|+|.+.+...+ .+++....-+..|++.|++|||+++ ||||||||.||+|+.+|.+|++|||.|.....
T Consensus 1313 MEyC~~GsLa~ll~~gr---i~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGR---IEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHHhccCcHHHHHHhcc---hhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecC
Confidence 99999999999986542 2555666678899999999999999 99999999999999999999999999998765
Q ss_pred cc--cccccccccccCCccChhhhccCC---CCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcc
Q 043278 585 NE--SEANTKRIVGTYGYMSPEYAMSGI---VSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGL 659 (752)
Q Consensus 585 ~~--~~~~~~~~~gt~~y~aPE~~~~~~---~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 659 (752)
.. .........||+-|||||++.+.. -..++||||+|||.+||+||++||...+..- .|.+ ++..|...
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~---aIMy---~V~~gh~P 1460 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW---AIMY---HVAAGHKP 1460 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh---HHHh---HHhccCCC
Confidence 42 112223578999999999998743 4568999999999999999999998765321 1111 12222222
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 043278 660 ELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCML 703 (752)
Q Consensus 660 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L 703 (752)
. .+.....+-.+++-.|++.||++|-++.|++++-
T Consensus 1461 q---------~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1461 Q---------IPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred C---------CchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence 2 1222333445788899999999999998887754
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-32 Score=265.96 Aligned_cols=271 Identities=23% Similarity=0.328 Sum_probs=197.2
Q ss_pred cCCCcCCeeecCCcccEEEEEecC-----CceeEEEEcccCCcc-c-HHHHHHHHHHHHhcCCCCcceeeeeeee-CCee
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLAD-----EQEVAIKRLSRSSGQ-G-IVEFKNEVRLIAKLQHTNLVRLLGCSLH-GEER 501 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~~-~-~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 501 (752)
..|+...+||+|.||.|||+.-.+ .+.+|+|+++..... + .....+|+.++++++|+|++.+..++.. +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 467888999999999999995432 347999999866322 1 2345789999999999999999999877 7789
Q ss_pred EEEEeeCCCCCHhHHHh-h-cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCC----CCceecc
Q 043278 502 LLVYEFMPNKSLDFFLF-N-SGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDK----MNPKISD 575 (752)
Q Consensus 502 ~lv~E~~~~gsL~~~l~-~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~----~~~kl~D 575 (752)
+|++||.+.- |...+. + ..+...++...+..|+.||+.|+.|||++- |+||||||.|||+..+ |.+||+|
T Consensus 104 ~l~fdYAEhD-L~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEHD-LWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhhh-HHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence 9999999874 444443 2 223457899999999999999999999987 9999999999999877 9999999
Q ss_pred cccceeecccccc-cccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCC----Ccc--hHH
Q 043278 576 FGMARIFEVNESE-ANTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDR----PLN--LIG 647 (752)
Q Consensus 576 Fgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~----~~~--l~~ 647 (752)
||+++++...-.. .....++-|..|+|||.+.+ ..||.+.|||+.|||+.||++-++.|......- +.. ...
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 9999987654322 23445677999999999987 579999999999999999999999887654321 111 111
Q ss_pred HHHHHhhCCC---ccccc----------CC--CCCCCCCHHH--------HHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 043278 648 YAWQLLSDGK---GLELI----------DP--SLEQPCSANE--------VMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ 704 (752)
Q Consensus 648 ~~~~~~~~~~---~~~~~----------d~--~l~~~~~~~~--------~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~ 704 (752)
...+.+.... ...+. +- ......+... .....+|...+++.||.+|.|+++.++..-
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y 339 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY 339 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence 2222221110 00000 00 0000100100 012567888999999999999999887653
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=280.65 Aligned_cols=260 Identities=25% Similarity=0.338 Sum_probs=197.3
Q ss_pred CCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeC
Q 043278 432 FSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFM 508 (752)
Q Consensus 432 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 508 (752)
|+..++||+|++|.||+|+.. +++.+|+|.+.... ......+..|+.++++++|+|++++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 455688999999999999875 48899999987653 333456788999999999999999999999999999999999
Q ss_pred CCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccc
Q 043278 509 PNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE 588 (752)
Q Consensus 509 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 588 (752)
+ ++|.+++.... ..+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.+||+|||+++.......
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence 8 58999886532 35899999999999999999999988 99999999999999999999999999986543221
Q ss_pred cccccccccCCccChhhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCc------ccc
Q 043278 589 ANTKRIVGTYGYMSPEYAMSG-IVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKG------LEL 661 (752)
Q Consensus 589 ~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~------~~~ 661 (752)
......++..|+|||.+.+. .++.++||||||++++||++|+.||........ .......+..... ..+
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ---LFKIFQILGTPTEESWPGVTKL 229 (282)
T ss_pred -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH---HHHHHHHhCCCcHHHHHhhccc
Confidence 11223456789999998776 889999999999999999999999866542211 1111111100000 000
Q ss_pred --cC---CCCCC----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 662 --ID---PSLEQ----PCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 662 --~d---~~l~~----~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.+ +.... .........+.+++..|++.+|.+||++.+++..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 230 PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred ccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 00 00000 0000113467889999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.8e-31 Score=280.76 Aligned_cols=244 Identities=28% Similarity=0.403 Sum_probs=190.9
Q ss_pred CCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCc---ccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEee
Q 043278 432 FSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSG---QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 432 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
|...++||+|+||.||+|+.. +++.|++|++..... .....+.+|++++++++|+|++++++++.+++..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555678999999999999864 578899999865432 2334678899999999999999999999999999999999
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccc
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES 587 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~ 587 (752)
+. ++|..++... ...+++..+..++.||+.+|.|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 103 CL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 96 5666666432 345899999999999999999999988 99999999999999999999999999864221
Q ss_pred ccccccccccCCccChhhhc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCC
Q 043278 588 EANTKRIVGTYGYMSPEYAM---SGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDP 664 (752)
Q Consensus 588 ~~~~~~~~gt~~y~aPE~~~---~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 664 (752)
.....++..|+|||++. ...++.++||||||++++||++|+.|+....... ....... ........
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~------~~~~~~~-~~~~~~~~- 242 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQ-NDSPTLQS- 242 (313)
T ss_pred ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHHh-cCCCCCCc-
Confidence 12356788999999974 4668899999999999999999999986554211 1111111 11111111
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 665 SLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 665 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
......+.+++.+|++.+|.+||++.+++..
T Consensus 243 -------~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 243 -------NEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -------cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1112346778899999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-31 Score=286.25 Aligned_cols=268 Identities=23% Similarity=0.289 Sum_probs=197.6
Q ss_pred cHHHHHHHhcCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeee
Q 043278 421 DFQTIAAAANNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLH 497 (752)
Q Consensus 421 ~~~~i~~~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 497 (752)
...++...+++|.+.+.||+|+||.||++.. .+++.||+|++.... ......+.+|+.++.+++|+||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 3456677889999999999999999999985 468899999987542 2234567889999999999999999998764
Q ss_pred C------CeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCc
Q 043278 498 G------EERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNP 571 (752)
Q Consensus 498 ~------~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~ 571 (752)
. ...+++++++ +++|..++.. ..+++..+..++.||++||+|||+.+ |+||||||+||++++++.+
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~ 159 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCEL 159 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCE
Confidence 3 3467888876 6788777632 34899999999999999999999988 9999999999999999999
Q ss_pred eecccccceeecccccccccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHH--
Q 043278 572 KISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGY-- 648 (752)
Q Consensus 572 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~-- 648 (752)
||+|||+++.... ......++..|+|||.+.+ ..++.++||||||++++||++|+.||...........+..
T Consensus 160 kl~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 234 (345)
T cd07877 160 KILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 234 (345)
T ss_pred EEecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 9999999875432 1223467889999998876 5688999999999999999999999865432111100000
Q ss_pred ------HHHHhhCCCc-------ccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 649 ------AWQLLSDGKG-------LELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 649 ------~~~~~~~~~~-------~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
....+..... .......... ........+.+++.+|++.||.+||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 235 GTPGAELLKKISSESARNYIQSLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CCCCHHHHhhcccHhHHHHHHHhcccCCcchhh-hcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000000000 0000000000 000112356789999999999999999999876
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-31 Score=286.00 Aligned_cols=265 Identities=24% Similarity=0.322 Sum_probs=195.1
Q ss_pred HHHHhcCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCC--
Q 043278 425 IAAAANNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGE-- 499 (752)
Q Consensus 425 i~~~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-- 499 (752)
+....++|++.+.||+|+||.||++.. .+++.||||++.... ......+.+|+.++++++|+||+++++++..+.
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 334567899999999999999999985 468899999986432 223456789999999999999999999887553
Q ss_pred ----eeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecc
Q 043278 500 ----ERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISD 575 (752)
Q Consensus 500 ----~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~D 575 (752)
..++||||+ +++|..++. ...+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~d 161 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILD 161 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEee
Confidence 458999998 678887773 235899999999999999999999988 99999999999999999999999
Q ss_pred cccceeecccccccccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchH-H------
Q 043278 576 FGMARIFEVNESEANTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLI-G------ 647 (752)
Q Consensus 576 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~-~------ 647 (752)
||++...... .....+++.|+|||.+.+ ..++.++|+||||+++++|++|+.||...........+ .
T Consensus 162 fg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 236 (343)
T cd07880 162 FGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPS 236 (343)
T ss_pred cccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 9999754321 123456889999999876 45889999999999999999999998754321100000 0
Q ss_pred -HHHHHhhCCCcccccC--CCCCC----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 648 -YAWQLLSDGKGLELID--PSLEQ----PCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 648 -~~~~~~~~~~~~~~~d--~~l~~----~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.....+........+. +.... .........+.+++.+|++.||.+|||+.+++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 237 KEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred HHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000000000 00000 0001112346789999999999999999999854
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.3e-32 Score=288.67 Aligned_cols=248 Identities=23% Similarity=0.328 Sum_probs=203.4
Q ss_pred hcCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCCc--ccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEE
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSSG--QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 505 (752)
...|.+.++||+|.|++|.+++. ..+..||+|.+.+... .....+.+|+++|..++|||||+++.+.......++||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 46788899999999999999986 4588999999987632 23345889999999999999999999999999999999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccc
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVN 585 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~ 585 (752)
||+.+|.+.+++...+. +....+..+..|+.++++|||+++ |+|||||++||||+.+.++||+|||++.++...
T Consensus 135 eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred EeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeeccc
Confidence 99999999999976544 555888889999999999999998 999999999999999999999999999987633
Q ss_pred ccccccccccccCCccChhhhccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCC
Q 043278 586 ESEANTKRIVGTYGYMSPEYAMSGIV-SIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDP 664 (752)
Q Consensus 586 ~~~~~~~~~~gt~~y~aPE~~~~~~~-t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 664 (752)
......+|++.|+|||++.+..+ .+.+|+||+|++||-|+.|..||++..-..- ++..+ ..
T Consensus 209 ---~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L-----------r~rvl----~g 270 (596)
T KOG0586|consen 209 ---LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL-----------RPRVL----RG 270 (596)
T ss_pred ---ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccc-----------cchhe----ee
Confidence 23345789999999999998765 5899999999999999999999986552211 11111 11
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 665 SLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 665 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.+.. +......+-+++.+++-.+|.+|++++++.+.
T Consensus 271 k~rI--p~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 271 KYRI--PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred eecc--cceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 1111 11222346678889999999999999999775
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=268.44 Aligned_cols=249 Identities=23% Similarity=0.276 Sum_probs=198.7
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCccc---HHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEE
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQG---IVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLV 504 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 504 (752)
-++|...+.||+|.||+|-+++-+ .++.+|+|++++..... ...-..|-++|+..+||.+..+--.|...++.|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 467888899999999999999854 58899999998764333 33346788999999999999999899999999999
Q ss_pred EeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecc
Q 043278 505 YEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~ 584 (752)
|||..+|.|..+|.. ...+++....-+-..|..||.|||+++ ||.||||.+|.|||.+|++||+|||+++--
T Consensus 247 MeyanGGeLf~HLsr---er~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~-- 318 (516)
T KOG0690|consen 247 MEYANGGELFFHLSR---ERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEE-- 318 (516)
T ss_pred EEEccCceEeeehhh---hhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhc--
Confidence 999999999888843 445888888889999999999999988 999999999999999999999999999742
Q ss_pred cccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCC
Q 043278 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDP 664 (752)
Q Consensus 585 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 664 (752)
-.....++.++||+.|+|||++.+..|..++|.|.+|||+|||++|+.||...+......++-.. ++-
T Consensus 319 I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e----------d~k-- 386 (516)
T KOG0690|consen 319 IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME----------DLK-- 386 (516)
T ss_pred ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh----------hcc--
Confidence 22334456799999999999999999999999999999999999999999877644433332110 110
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 043278 665 SLEQPCSANEVMRCIHVGLLCVQDQAMDRP-----TMPEVVCM 702 (752)
Q Consensus 665 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~ev~~~ 702 (752)
++.....+...|..-.+..||++|. .+.||.++
T Consensus 387 -----FPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 387 -----FPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred -----CCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 1111122344556677889999995 45555443
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-32 Score=262.17 Aligned_cols=247 Identities=23% Similarity=0.356 Sum_probs=190.2
Q ss_pred CCeeecCCcccEEEEEec-CCceeEEEEcccCC-cccHHHHHHHHHHHHhcC-CCCcceeeeeeeeCCeeEEEEeeCCCC
Q 043278 435 TNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQ-HTNLVRLLGCSLHGEERLLVYEFMPNK 511 (752)
Q Consensus 435 ~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~~g 511 (752)
...||.|+.|.|++.+.. .|..+|||.+.+.. .+..+++...+.++.+-+ +|.||+.+|||..+...++.||.|. .
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs-~ 175 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS-T 175 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-H
Confidence 467999999999999875 48899999998763 445566777777776664 8999999999999999999999984 3
Q ss_pred CHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccccccc
Q 043278 512 SLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANT 591 (752)
Q Consensus 512 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~ 591 (752)
.++.++... ..++++.-+=++...+.+||.||.+++ +|||||+||+|||+|+.|++|++|||++-.+-... ..
T Consensus 176 C~ekLlkri--k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk---Ah 248 (391)
T KOG0983|consen 176 CAEKLLKRI--KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK---AH 248 (391)
T ss_pred HHHHHHHHh--cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc---cc
Confidence 445555432 345777777789999999999998866 59999999999999999999999999997654332 22
Q ss_pred ccccccCCccChhhhcc---CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCC
Q 043278 592 KRIVGTYGYMSPEYAMS---GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQ 668 (752)
Q Consensus 592 ~~~~gt~~y~aPE~~~~---~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 668 (752)
....|.+.|||||.+.- -.|+-++||||||+.|+||.||+.||.....+ .... -..+++. ...+++...
T Consensus 249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td--Fe~l---tkvln~e--PP~L~~~~g- 320 (391)
T KOG0983|consen 249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD--FEVL---TKVLNEE--PPLLPGHMG- 320 (391)
T ss_pred ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc--HHHH---HHHHhcC--CCCCCcccC-
Confidence 34578899999998864 46889999999999999999999999875422 1111 1122211 122222221
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 669 PCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 669 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
....+++++..|++.|+.+||...+++++
T Consensus 321 -----FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 321 -----FSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred -----cCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 34457788899999999999999999876
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=287.83 Aligned_cols=261 Identities=24% Similarity=0.303 Sum_probs=190.0
Q ss_pred CCCcCCeeecCCcccEEEEEec-C--CceeEEEEcccCC--cccHHHHHHHHHHHHhc-CCCCcceeeeeeeeC----Ce
Q 043278 431 NFSTTNKLGEGGFGPVYKGKLA-D--EQEVAIKRLSRSS--GQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHG----EE 500 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~~-~--~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~ 500 (752)
+|.+.+.||+|+||.||+++.. . ++.||+|++.... ......+.+|+.++.++ +|+||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4677889999999999999864 3 6789999986532 22345678899999999 599999999975432 45
Q ss_pred eEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccce
Q 043278 501 RLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR 580 (752)
Q Consensus 501 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~ 580 (752)
.++++||+. ++|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS---GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 678889886 578887743 345899999999999999999999988 9999999999999999999999999998
Q ss_pred eecccccc--cccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHH-----
Q 043278 581 IFEVNESE--ANTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQL----- 652 (752)
Q Consensus 581 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~----- 652 (752)
........ .......|+..|+|||++.+ ..++.++||||||+++++|++|+.||....... ........
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~ 230 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD---QLNQILQVLGTPD 230 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH---HHHHHHHHhCCCC
Confidence 65432211 11223568899999998766 468999999999999999999999987644211 01000000
Q ss_pred ------hhCCCcccc---c----CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 653 ------LSDGKGLEL---I----DPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 653 ------~~~~~~~~~---~----d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
+........ . ...+.. ........+.+++.+|++.||.+|||+.|++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 231 EETLSRIGSPKAQNYIRSLPNIPKKPFES-IFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHHHHhhhhhhHHHHHHhccccCCcchHh-hCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000 0 000000 000112457789999999999999999998754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=286.98 Aligned_cols=259 Identities=24% Similarity=0.313 Sum_probs=195.2
Q ss_pred HhcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCe----
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEE---- 500 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 500 (752)
..++|...+.||+|++|.||+|+.. +++.||+|++.... ......+.+|+.++++++|+|++++.+++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4678999999999999999999875 57889999986532 2234567789999999999999999998776554
Q ss_pred --eEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceeccccc
Q 043278 501 --RLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGM 578 (752)
Q Consensus 501 --~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgl 578 (752)
.++|+||+ +++|.+++.. ..+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence 89999998 5688888743 45899999999999999999999988 99999999999999999999999999
Q ss_pred ceeecccccccccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhh---
Q 043278 579 ARIFEVNESEANTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLS--- 654 (752)
Q Consensus 579 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~--- 654 (752)
+...... .....++..|+|||.+.+ ..++.++||||||++++||++|+.||......... ........
T Consensus 165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~---~~i~~~~~~~~ 236 (343)
T cd07851 165 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQL---KRIMNLVGTPD 236 (343)
T ss_pred ccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHhcCCCC
Confidence 9865322 223457888999998865 46889999999999999999999999754422110 00000000
Q ss_pred --------CCCcccccCC-CCCCCCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 655 --------DGKGLELIDP-SLEQPCS-----ANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 655 --------~~~~~~~~d~-~l~~~~~-----~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
......++.. ....... ......+.+++.+|++.+|.+|||+.||++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 237 EELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0000000000 0000000 0123567899999999999999999999774
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=260.47 Aligned_cols=254 Identities=23% Similarity=0.298 Sum_probs=199.5
Q ss_pred CeeecCCcccEEEEE-ecCCceeEEEEcccCCcccHHHHHHHHHHHHhc-CCCCcceeeeeeeeCCeeEEEEeeCCCCCH
Q 043278 436 NKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGEERLLVYEFMPNKSL 513 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 513 (752)
+.||+|+++.|--+. +..|.++|||++.+.......+..+|++++.+. .|+||+.++.+|+++...+||||-|.+|+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 689999999999886 678999999999998888888999999999998 499999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCC---ceecccccceeeccc--c--
Q 043278 514 DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMN---PKISDFGMARIFEVN--E-- 586 (752)
Q Consensus 514 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~---~kl~DFgla~~~~~~--~-- 586 (752)
-.++.+ +..+++.++.++..+|+.||.+||.++ |.|||+||+|||-..... +||+||.++.-.... -
T Consensus 164 LshI~~---~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 164 LSHIQK---RKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred HHHHHH---hhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 999864 456999999999999999999999999 999999999999965444 899999987543221 1
Q ss_pred -cccccccccccCCccChhhhc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCc--------chHHHHHHH
Q 043278 587 -SEANTKRIVGTYGYMSPEYAM-----SGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPL--------NLIGYAWQL 652 (752)
Q Consensus 587 -~~~~~~~~~gt~~y~aPE~~~-----~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~--------~l~~~~~~~ 652 (752)
+.+.....+|+..|||||+.. ...|+.+.|.||||||||-|++|-+||.+....+.. .-.....+.
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFes 317 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFES 317 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHH
Confidence 222233568888999999763 246889999999999999999999999876543221 111122333
Q ss_pred hhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 043278 653 LSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVC 701 (752)
Q Consensus 653 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~ 701 (752)
+.+|+. ++.|... .....+..+++...+..|+.+|-++.+++.
T Consensus 318 IQEGkY-eFPdkdW-----ahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 318 IQEGKY-EFPDKDW-----AHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HhccCC-cCChhhh-----HHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 344432 2222211 122234456677777899999999988877
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-32 Score=274.54 Aligned_cols=263 Identities=21% Similarity=0.232 Sum_probs=203.9
Q ss_pred hcCCCcCCeeecCCcccEEEEEecC-CceeEEEEcccCCcccHHHHHHHHHHHHhcCC--C----CcceeeeeeeeCCee
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLAD-EQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQH--T----NLVRLLGCSLHGEER 501 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h--~----niv~l~~~~~~~~~~ 501 (752)
+++|.+..++|+|.||.|-++.... +..||||+++.... ..+..+-|+++|+++.+ | -+|.+.++|...++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 6889999999999999999997643 67899999976543 34556789999999942 3 388888999999999
Q ss_pred EEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEec---------------
Q 043278 502 LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLD--------------- 566 (752)
Q Consensus 502 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~--------------- 566 (752)
|||+|.+ +-|+.+++..++ -.+++..++..++.|+++++++||+.. ++|-||||+|||+.
T Consensus 167 Civfell-G~S~~dFlk~N~-y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKENN-YIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred EEEEecc-ChhHHHHhccCC-ccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccc
Confidence 9999988 447888886543 346889999999999999999999998 99999999999983
Q ss_pred -----CCCCceecccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCC
Q 043278 567 -----DKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDR 641 (752)
Q Consensus 567 -----~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~ 641 (752)
.+..+||+|||.|++-.... ..++.|..|+|||++.+..++..+||||+||||.|+.+|...|+..+..+
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred eeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 24458999999998744332 45788999999999999999999999999999999999999999888554
Q ss_pred CcchHHHHH--------------HHhhCCCcc-----------cccCCC----CCCCCCHHHHHHHHHHHHHcccCCCCC
Q 043278 642 PLNLIGYAW--------------QLLSDGKGL-----------ELIDPS----LEQPCSANEVMRCIHVGLLCVQDQAMD 692 (752)
Q Consensus 642 ~~~l~~~~~--------------~~~~~~~~~-----------~~~d~~----l~~~~~~~~~~~l~~l~~~Cl~~dp~~ 692 (752)
.+.++.... +....+++. ...++. ........+...+++|+..++..||.+
T Consensus 317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~ 396 (415)
T KOG0671|consen 317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR 396 (415)
T ss_pred HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence 433333111 111111100 000000 011234456678999999999999999
Q ss_pred CCCHHHHHHH
Q 043278 693 RPTMPEVVCM 702 (752)
Q Consensus 693 RPt~~ev~~~ 702 (752)
|+|+.|++.+
T Consensus 397 RiTl~EAL~H 406 (415)
T KOG0671|consen 397 RITLREALSH 406 (415)
T ss_pred cccHHHHhcC
Confidence 9999999864
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-32 Score=263.14 Aligned_cols=252 Identities=23% Similarity=0.289 Sum_probs=193.1
Q ss_pred CCeeecCCcccEEEEEec-CCceeEEEEcccCCc-ccHHHHHHHHHHHHhc-CCCCcceeeeeeeeCCeeEEEEeeCCCC
Q 043278 435 TNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSG-QGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGEERLLVYEFMPNK 511 (752)
Q Consensus 435 ~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~g 511 (752)
...||.|+||+|+|-.++ .|+.+|||+++.... ....++..|.+...+- ++||||+++|.+..+...+|.||.|+ -
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~ 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-I 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-h
Confidence 467999999999999764 689999999987654 5566788888766554 79999999999988889999999996 4
Q ss_pred CHhHHHhh--cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccccc
Q 043278 512 SLDFFLFN--SGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEA 589 (752)
Q Consensus 512 sL~~~l~~--~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 589 (752)
||+.+... ..++..++++-.-.|..-..+||.||.... .|||||+||+|||||..|.+||+|||++-.+-.. .
T Consensus 148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S---i 222 (361)
T KOG1006|consen 148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS---I 222 (361)
T ss_pred hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH---H
Confidence 56554321 123445788877788888899999998754 5999999999999999999999999998754322 1
Q ss_pred ccccccccCCccChhhhcc--CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCC
Q 043278 590 NTKRIVGTYGYMSPEYAMS--GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLE 667 (752)
Q Consensus 590 ~~~~~~gt~~y~aPE~~~~--~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 667 (752)
..+.-.|...|||||.+.. ..|+.++||||||+.|+|+.||+.|+..-+. .. .....+..|+...++.+.
T Consensus 223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vf-eql~~Vv~gdpp~l~~~~-- 294 (361)
T KOG1006|consen 223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VF-EQLCQVVIGDPPILLFDK-- 294 (361)
T ss_pred HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HH-HHHHHHHcCCCCeecCcc--
Confidence 2223567889999998864 3589999999999999999999999876542 11 222334444443333222
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 668 QPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 668 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
...+....+++++..|+.+|..+||...++.++
T Consensus 295 --~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 295 --ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred --cccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 223345568889999999999999999988765
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=266.53 Aligned_cols=236 Identities=24% Similarity=0.304 Sum_probs=190.8
Q ss_pred eecCCcccEEEEEec-CCceeEEEEcccCCcc---cHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCCCCCH
Q 043278 438 LGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQ---GIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSL 513 (752)
Q Consensus 438 LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 513 (752)
||+|+||.||++... +++.+++|.+...... ....+.+|+.++++++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999875 4889999998765322 445788999999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccccccccc
Q 043278 514 DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKR 593 (752)
Q Consensus 514 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~ 593 (752)
.+++... ..+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~ 152 (250)
T cd05123 81 FSHLSKE---GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNT 152 (250)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccC
Confidence 9998543 25899999999999999999999987 9999999999999999999999999998654322 12234
Q ss_pred ccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCCCCHH
Q 043278 594 IVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSAN 673 (752)
Q Consensus 594 ~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 673 (752)
..++..|+|||...+...+.++|+||||++++||++|+.||...... .. ........ ..+ +..
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~------~~-~~~~~~~~------~~~----~~~ 215 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK------EI-YEKILKDP------LRF----PEF 215 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH------HH-HHHHhcCC------CCC----CCC
Confidence 56788999999999888999999999999999999999999655421 11 11111111 011 111
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHH
Q 043278 674 EVMRCIHVGLLCVQDQAMDRPTMPE 698 (752)
Q Consensus 674 ~~~~l~~l~~~Cl~~dp~~RPt~~e 698 (752)
....+.+++.+|+..||++||++.+
T Consensus 216 ~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 216 LSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCHHHHHHHHHHhcCCHhhCCCccc
Confidence 1345678999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=304.08 Aligned_cols=145 Identities=24% Similarity=0.410 Sum_probs=129.7
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC---cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 505 (752)
++|.+.++||+|+||.||+|... .++.||||+++... ......+.+|+.++..++|+||+++++++......+|||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57888899999999999999875 58899999987542 223456889999999999999999999999999999999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccce
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR 580 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~ 580 (752)
||+++++|..++... ..+++..++.++.||+.||+|||..+ |+||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~---~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIY---GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999988543 34888999999999999999999987 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=265.09 Aligned_cols=221 Identities=19% Similarity=0.122 Sum_probs=175.2
Q ss_pred CCcccEEEEEec-CCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCCCCCHhHHHhh
Q 043278 441 GGFGPVYKGKLA-DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFN 519 (752)
Q Consensus 441 G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~ 519 (752)
|.+|.||+++.. +++.+|+|++.... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999864 67899999997643 234555666667899999999999999999999999999999998854
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccccccccccccCC
Q 043278 520 SGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599 (752)
Q Consensus 520 ~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~ 599 (752)
. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++|||++..+.... ....++..
T Consensus 79 ~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~ 147 (237)
T cd05576 79 F---LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENM 147 (237)
T ss_pred h---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCcc
Confidence 3 34899999999999999999999988 9999999999999999999999999886543221 12345678
Q ss_pred ccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHH
Q 043278 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCI 679 (752)
Q Consensus 600 y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 679 (752)
|+|||.+....++.++||||+|++++||++|+.|+........ .. .. ..+ +......+.
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~------------~~--~~---~~~----~~~~~~~~~ 206 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN------------TH--TT---LNI----PEWVSEEAR 206 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc------------cc--cc---cCC----cccCCHHHH
Confidence 9999999888899999999999999999999987643321100 00 00 001 111224567
Q ss_pred HHHHHcccCCCCCCCCHHH
Q 043278 680 HVGLLCVQDQAMDRPTMPE 698 (752)
Q Consensus 680 ~l~~~Cl~~dp~~RPt~~e 698 (752)
+++.+|++.||.+||++.+
T Consensus 207 ~li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 207 SLLQQLLQFNPTERLGAGV 225 (237)
T ss_pred HHHHHHccCCHHHhcCCCc
Confidence 8899999999999999743
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=286.88 Aligned_cols=261 Identities=27% Similarity=0.422 Sum_probs=214.3
Q ss_pred cHHHHHHHhcCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCCcccHHHHHHHHHHHHhc-CCCCcceeeeeeee-
Q 043278 421 DFQTIAAAANNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLH- 497 (752)
Q Consensus 421 ~~~~i~~~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~- 497 (752)
+++.+...+..|++.+.||.|.+|.||+++. ++++.+|+|++..... ..++...|.++++.+ +|||++.++|++..
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 3444445677888899999999999999985 5688899998866543 445678888999887 79999999999864
Q ss_pred ----CCeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCcee
Q 043278 498 ----GEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKI 573 (752)
Q Consensus 498 ----~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl 573 (752)
++..+||||||.+|+..+++.... ...+.|+.+..|++.+++|+.+||.+. ++|||||-.||||+.++.+||
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEE
Confidence 468899999999999999997765 667999999999999999999999988 999999999999999999999
Q ss_pred cccccceeecccccccccccccccCCccChhhhcc-----CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHH
Q 043278 574 SDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMS-----GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGY 648 (752)
Q Consensus 574 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~ 648 (752)
.|||++..+.... .......||+.|||||++.- ..|+..+|+||||++..||.-|.+|+...++-..+-++
T Consensus 165 vDFGvSaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I-- 240 (953)
T KOG0587|consen 165 VDFGVSAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI-- 240 (953)
T ss_pred eeeeeeeeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC--
Confidence 9999998654332 33445789999999999853 35788999999999999999999999888865543221
Q ss_pred HHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 649 AWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 649 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.. .|...-..+.....++.+++..|+.+|-.+||++.+++++
T Consensus 241 ----------pR--NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 241 ----------PR--NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred ----------CC--CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 01 1222223356677889999999999999999999988765
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=279.27 Aligned_cols=240 Identities=22% Similarity=0.256 Sum_probs=193.3
Q ss_pred hcCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCCcccHHHHHHHHHHHHhc-CCCCcceeeeeeeeCCeeEEEEe
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGEERLLVYE 506 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E 506 (752)
+..|.....+|.|+|+.|-.+.. ..++..+||++.+...+ -.+|+.++... +|+||+++.+.+.++.+.++|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~----~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD----NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccccc----cccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 66788888999999999998875 46788999999876322 25566555554 79999999999999999999999
Q ss_pred eCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEe-cCCCCceecccccceeeccc
Q 043278 507 FMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILL-DDKMNPKISDFGMARIFEVN 585 (752)
Q Consensus 507 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll-~~~~~~kl~DFgla~~~~~~ 585 (752)
.+.++-+.+.+... .... ..+..|+.+|+.++.|||+++ ++||||||+|||+ ++.++++|+|||.++.....
T Consensus 397 ~l~g~ell~ri~~~---~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSK---PEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hccccHHHHHHHhc---chhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 99998887776432 2223 677789999999999999998 9999999999999 69999999999999876543
Q ss_pred ccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCC
Q 043278 586 ESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPS 665 (752)
Q Consensus 586 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 665 (752)
....+-|..|.|||+.....+++++|+||||++||+|++|+.||.....+ . .....+..++..
T Consensus 470 -----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~----ei~~~i~~~~~s------ 532 (612)
T KOG0603|consen 470 -----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--I----EIHTRIQMPKFS------ 532 (612)
T ss_pred -----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--H----HHHHhhcCCccc------
Confidence 22346688999999999999999999999999999999999999877644 1 112222222211
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 666 LEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 666 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
........+|+.+||+.||.+||+|.++...
T Consensus 533 ------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 533 ------ECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred ------cccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 2233456688899999999999999999765
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=270.14 Aligned_cols=257 Identities=26% Similarity=0.353 Sum_probs=194.8
Q ss_pred hcCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCC-------cccHHHHHHHHHHHHhcCCCCcceeeeeee-eCC
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSS-------GQGIVEFKNEVRLIAKLQHTNLVRLLGCSL-HGE 499 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~ 499 (752)
.++|-....||+|||+.|||+.. ...+.||||+-.-.. ....+...+|.++-+.|+||.||++++++. +.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 34566778999999999999974 456778998754321 112234678999999999999999999985 556
Q ss_pred eeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEec---CCCCceeccc
Q 043278 500 ERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLD---DKMNPKISDF 576 (752)
Q Consensus 500 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~---~~~~~kl~DF 576 (752)
.+|-|+|||++.+|+.+|.. .+.++++++..|+.||+.||.||.+.. +||||-||||.||||. ..|.+||.||
T Consensus 542 sFCTVLEYceGNDLDFYLKQ---hklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQ---HKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred cceeeeeecCCCchhHHHHh---hhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeec
Confidence 78999999999999999954 456999999999999999999999875 7899999999999994 4678999999
Q ss_pred ccceeecccccc-----cccccccccCCccChhhhccC----CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHH
Q 043278 577 GMARIFEVNESE-----ANTKRIVGTYGYMSPEYAMSG----IVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIG 647 (752)
Q Consensus 577 gla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~ 647 (752)
||++.+..+... ..+....||.+|++||.+.-+ .++.|+||||+|||+|..+.|++||...........
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILq-- 695 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQ-- 695 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHh--
Confidence 999998754332 234567899999999987543 588999999999999999999999987654322110
Q ss_pred HHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 043278 648 YAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVV 700 (752)
Q Consensus 648 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~ 700 (752)
....+....+. .+.......+...++.+|++..-++|....++.
T Consensus 696 -eNTIlkAtEVq--------FP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 696 -ENTILKATEVQ--------FPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred -hhchhcceecc--------CCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 01111111111 111112223455788899999999998665554
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=267.65 Aligned_cols=241 Identities=25% Similarity=0.345 Sum_probs=191.8
Q ss_pred hcCCCcCCeeecCCcccEEEEEecC-CceeEEEEcccCCc---ccHHHHHHHHHHHHhc-CCCCcceeeeeeeeCCeeEE
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLAD-EQEVAIKRLSRSSG---QGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGEERLL 503 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 503 (752)
..+|....+||+|+||.|.++.-++ .+.+|||++++... ...+--+.|-++|+.. +-|.++.+..+|..-+..++
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 3578888999999999999997654 56799999987632 2222235677777776 45789999999999999999
Q ss_pred EEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeec
Q 043278 504 VYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFE 583 (752)
Q Consensus 504 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~ 583 (752)
||||+.+|+|-.++.+.++ +.+..+.-+|..||-||-+||+++ ||.||||.+|||||.+|++||+|||+++-
T Consensus 428 VMEyvnGGDLMyhiQQ~Gk---FKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKE-- 499 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVGK---FKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE-- 499 (683)
T ss_pred EEEEecCchhhhHHHHhcc---cCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccc--
Confidence 9999999999888876544 677888899999999999999999 99999999999999999999999999973
Q ss_pred ccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccC
Q 043278 584 VNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELID 663 (752)
Q Consensus 584 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 663 (752)
.-....++..++||+.|+|||++...+|...+|.|||||+||||+.|++||+++++++....+ . +
T Consensus 500 ni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI-------~--------e 564 (683)
T KOG0696|consen 500 NIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAI-------M--------E 564 (683)
T ss_pred cccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-------H--------H
Confidence 222344566799999999999999999999999999999999999999999998855322111 1 1
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 043278 664 PSLEQPCSANEVMRCIHVGLLCVQDQAMDRP 694 (752)
Q Consensus 664 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP 694 (752)
.. ...+.....+...+...-+.++|.+|.
T Consensus 565 hn--vsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 565 HN--VSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred cc--CcCcccccHHHHHHHHHHhhcCCcccc
Confidence 11 112223333455566677888998884
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-29 Score=256.88 Aligned_cols=238 Identities=27% Similarity=0.335 Sum_probs=193.0
Q ss_pred CcccEEEEEecC-CceeEEEEcccCCccc-HHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCCCCCHhHHHhh
Q 043278 442 GFGPVYKGKLAD-EQEVAIKRLSRSSGQG-IVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFN 519 (752)
Q Consensus 442 ~fg~Vy~~~~~~-~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~ 519 (752)
+||.||+++..+ ++.+++|++....... ...+.+|++.+++++|+|++++++++......++++||+++++|..++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999864 8899999998765544 67899999999999999999999999999999999999999999998854
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccccccccccccCC
Q 043278 520 SGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599 (752)
Q Consensus 520 ~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~ 599 (752)
... +++..+..++.++++++.+||+.+ ++|+||+|+||++++++.++|+|||++....... ......++..
T Consensus 81 ~~~---~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~ 151 (244)
T smart00220 81 RGR---LSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE 151 (244)
T ss_pred ccC---CCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence 322 889999999999999999999987 9999999999999999999999999998765432 2234567889
Q ss_pred ccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHH
Q 043278 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCI 679 (752)
Q Consensus 600 y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 679 (752)
|++||......++.++||||||+++++|++|..|+...... ......+..+..... . ........+.
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~------~~~~~~~~~~~~~~~-~------~~~~~~~~~~ 218 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL------LELFKKIGKPKPPFP-P------PEWKISPEAK 218 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH------HHHHHHHhccCCCCc-c------ccccCCHHHH
Confidence 99999999888999999999999999999999998653211 111122222111100 0 0000234678
Q ss_pred HHHHHcccCCCCCCCCHHHHHH
Q 043278 680 HVGLLCVQDQAMDRPTMPEVVC 701 (752)
Q Consensus 680 ~l~~~Cl~~dp~~RPt~~ev~~ 701 (752)
+++.+|+..+|++||++.++++
T Consensus 219 ~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 219 DLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHccCCchhccCHHHHhh
Confidence 8999999999999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=292.42 Aligned_cols=259 Identities=22% Similarity=0.277 Sum_probs=203.5
Q ss_pred HHHHHHhcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccC---CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeC
Q 043278 423 QTIAAAANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRS---SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHG 498 (752)
Q Consensus 423 ~~i~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 498 (752)
.++....++|.+.+.||+|+||.|..++.+ .++.+|+|++.+- ......-|.+|-.+|..-+.+-|+.+.-.|.+.
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 445556788999999999999999999875 4788999999763 333455688899999988999999999999999
Q ss_pred CeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceeccccc
Q 043278 499 EERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGM 578 (752)
Q Consensus 499 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgl 578 (752)
.+.|+|||||+||+|-.++..- ..++...+.-++..|.-||.-||+.+ +|||||||+|||||..|++||+|||.
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~---~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGs 221 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKF---DRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGS 221 (1317)
T ss_pred cceEEEEecccCchHHHHHhhc---CCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchh
Confidence 9999999999999998888543 25899999999999999999999998 99999999999999999999999999
Q ss_pred ceeecccccccccccccccCCccChhhhcc-----CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHh
Q 043278 579 ARIFEVNESEANTKRIVGTYGYMSPEYAMS-----GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLL 653 (752)
Q Consensus 579 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 653 (752)
+..+..+.. ......+|||-|.+||++.. +.|.+.+|.||+||++|||+.|..||..+. +..-.-+.+
T Consensus 222 Clkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads------lveTY~KIm 294 (1317)
T KOG0612|consen 222 CLKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS------LVETYGKIM 294 (1317)
T ss_pred HHhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH------HHHHHHHHh
Confidence 987764433 23345789999999999852 578999999999999999999999997664 333333344
Q ss_pred hCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCC---HHHHHHH
Q 043278 654 SDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPT---MPEVVCM 702 (752)
Q Consensus 654 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt---~~ev~~~ 702 (752)
+......+.+. .+......+|+..-+ -+|..|-. ++++-.+
T Consensus 295 ~hk~~l~FP~~-------~~VSeeakdLI~~ll-~~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 295 NHKESLSFPDE-------TDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNH 338 (1317)
T ss_pred chhhhcCCCcc-------cccCHHHHHHHHHHh-cChhhhcccccHHHHHhC
Confidence 43333333311 112233344444433 36777776 8888765
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=272.21 Aligned_cols=245 Identities=26% Similarity=0.350 Sum_probs=193.9
Q ss_pred CCeeecCCcccEEEEEe-cCCceeEEEEcccC--CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCCCC
Q 043278 435 TNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRS--SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNK 511 (752)
Q Consensus 435 ~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 511 (752)
.+.||+|.||+||-|+. +.|+.||||++.+. ......++++|+.+|++++||.||.+.-.|+..+..++|||-+.+-
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 47999999999999986 46999999999754 4556678999999999999999999999999999999999999655
Q ss_pred CHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecC---CCCceecccccceeecccccc
Q 043278 512 SLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDD---KMNPKISDFGMARIFEVNESE 588 (752)
Q Consensus 512 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~---~~~~kl~DFgla~~~~~~~~~ 588 (752)
-|+-+| .. .+..|++....-++.||+.||.|||.++ |+|+||||+||||.. --++||+|||+|++.+.....
T Consensus 649 MLEMIL-Ss-EkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR 723 (888)
T KOG4236|consen 649 MLEMIL-SS-EKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR 723 (888)
T ss_pred HHHHHH-Hh-hcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence 554444 33 3445888888889999999999999998 999999999999954 456999999999998755432
Q ss_pred cccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCC
Q 043278 589 ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQ 668 (752)
Q Consensus 589 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 668 (752)
..++||+.|+|||++..+.|...-|+||+|||+|--++|..||..+..-.+ .+..+ .++-|.
T Consensus 724 ---rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdInd--QIQNA----------aFMyPp--- 785 (888)
T KOG4236|consen 724 ---RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIND--QIQNA----------AFMYPP--- 785 (888)
T ss_pred ---hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhH--Hhhcc----------ccccCC---
Confidence 357899999999999999999999999999999999999999976542211 11111 111111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 669 PCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 669 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
..-.+.....++++...+|..-.+|-|...-+.+
T Consensus 786 ~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 786 NPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred CchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 1112333456677778888888888887655443
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=287.21 Aligned_cols=260 Identities=21% Similarity=0.252 Sum_probs=167.2
Q ss_pred HhcCCCcCCeeecCCcccEEEEEecC-----CceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeee------ee
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGKLAD-----EQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGC------SL 496 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~ 496 (752)
..++|++.+.||+|+||.||+|++.+ +..||||++...... .....| .+....+.++..++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 45789999999999999999998754 688999988643211 111111 1122222223222221 24
Q ss_pred eCCeeEEEEeeCCCCCHhHHHhhcCCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCC
Q 043278 497 HGEERLLVYEFMPNKSLDFFLFNSGRK-----------------NVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLK 559 (752)
Q Consensus 497 ~~~~~~lv~E~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dik 559 (752)
.+...+|||||+++++|.+++...... .......+..++.||+.||+|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 566889999999999999888643210 01123345679999999999999988 9999999
Q ss_pred CCcEEecC-CCCceecccccceeecccccccccccccccCCccChhhhccC----------------------CCCccch
Q 043278 560 ASNILLDD-KMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSG----------------------IVSIKTD 616 (752)
Q Consensus 560 p~NIll~~-~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~t~k~D 616 (752)
|+|||++. ++.+||+|||+++.+..... .......+++.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999986 68999999999986543221 122346788999999965322 2445679
Q ss_pred hHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCc----ccccCCC----CCCCC--CHHHHHHHHHHHHHcc
Q 043278 617 VFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKG----LELIDPS----LEQPC--SANEVMRCIHVGLLCV 686 (752)
Q Consensus 617 V~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~----~~~~d~~----l~~~~--~~~~~~~l~~l~~~Cl 686 (752)
||||||+||||+++..+.... +..........+.. ...+.+. +.... .........+|+.+|+
T Consensus 362 VwSlGviL~el~~~~~~~~~~-------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSN-------LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchH-------HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence 999999999999876543221 11110000000000 0001111 00000 0001123457999999
Q ss_pred cCCCCCCCCHHHHHHH
Q 043278 687 QDQAMDRPTMPEVVCM 702 (752)
Q Consensus 687 ~~dp~~RPt~~ev~~~ 702 (752)
+.||++|||+.|++++
T Consensus 435 ~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 435 RFKGRQRISAKAALAH 450 (566)
T ss_pred cCCcccCCCHHHHhCC
Confidence 9999999999999986
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=276.58 Aligned_cols=262 Identities=19% Similarity=0.222 Sum_probs=178.8
Q ss_pred hcCCCcCCeeecCCcccEEEEEe-----------------cCCceeEEEEcccCCcccHHH--------------HHHHH
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKL-----------------ADEQEVAIKRLSRSSGQGIVE--------------FKNEV 477 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~-----------------~~~~~vavK~l~~~~~~~~~~--------------~~~E~ 477 (752)
.++|++.++||+|+||.||+|.+ ..++.||||++........++ +..|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 56899999999999999999964 234679999986543222222 33466
Q ss_pred HHHHhcCCCCc-----ceeeeeeee--------CCeeEEEEeeCCCCCHhHHHhhcCC---------------------C
Q 043278 478 RLIAKLQHTNL-----VRLLGCSLH--------GEERLLVYEFMPNKSLDFFLFNSGR---------------------K 523 (752)
Q Consensus 478 ~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~E~~~~gsL~~~l~~~~~---------------------~ 523 (752)
.++.+++|.++ ++++++|.. ....+|||||+++++|.++++.... .
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77777766554 677787753 3467999999999999998864211 1
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccccccccccccCCccCh
Q 043278 524 NVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSP 603 (752)
Q Consensus 524 ~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aP 603 (752)
..+++..+..++.|++.+|.|||+.+ |+||||||+|||++.++.+||+|||+++.+..... .......+++.|+||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSPP 379 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeCh
Confidence 23567888999999999999999988 99999999999999999999999999975433211 111122347899999
Q ss_pred hhhccCCC----------------------CccchhHHHHHHHHHHHhCCC-CCCCCCCCCC----cchHHHHHHHhhCC
Q 043278 604 EYAMSGIV----------------------SIKTDVFSFGVLVLEIVSGQK-NHTRHHPDRP----LNLIGYAWQLLSDG 656 (752)
Q Consensus 604 E~~~~~~~----------------------t~k~DV~S~G~vl~elltG~~-p~~~~~~~~~----~~l~~~~~~~~~~~ 656 (752)
|.+..... ..+.||||+||+++||++|.. |+........ .......|+.....
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 98754321 235799999999999999875 5543211110 00001111211111
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHHHcccCCC---CCCCCHHHHHHH
Q 043278 657 KGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQA---MDRPTMPEVVCM 702 (752)
Q Consensus 657 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp---~~RPt~~ev~~~ 702 (752)
.. +... .........+++.+++..+| .+|+|++|++++
T Consensus 460 ~~----~~~~----~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 460 KY----DFSL----LDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred CC----Cccc----ccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 11 1111 11123456678888888765 689999999874
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-30 Score=231.44 Aligned_cols=263 Identities=24% Similarity=0.295 Sum_probs=189.9
Q ss_pred CCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeC
Q 043278 432 FSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFM 508 (752)
Q Consensus 432 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 508 (752)
|...++||+|.||+||||+.. .++.||+|+++-.. +..-....+|+-++++++|.|||++++....++..-+|+|||
T Consensus 4 ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c 83 (292)
T KOG0662|consen 4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_pred hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh
Confidence 444579999999999999865 47889999886542 222345689999999999999999999998889999999999
Q ss_pred CCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccc
Q 043278 509 PNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE 588 (752)
Q Consensus 509 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 588 (752)
. .+|..+.... ...++.+.+..++.|+++||.+.|+++ +.|||+||+|.||+.+|..|++|||+++.++-.-.
T Consensus 84 d-qdlkkyfdsl--ng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr- 156 (292)
T KOG0662|consen 84 D-QDLKKYFDSL--NGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR- 156 (292)
T ss_pred h-HHHHHHHHhc--CCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE-
Confidence 5 4666665432 345899999999999999999999998 99999999999999999999999999997764321
Q ss_pred cccccccccCCccChhhhccC-CCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcc---cccC
Q 043278 589 ANTKRIVGTYGYMSPEYAMSG-IVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGL---ELID 663 (752)
Q Consensus 589 ~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~---~~~d 663 (752)
......-|..|++|+++.+. .|+...|+||-||++.|+.. |++.|.+.+..+....+-+......+.... .+.|
T Consensus 157 -cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpd 235 (292)
T KOG0662|consen 157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPD 235 (292)
T ss_pred -eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCC
Confidence 11123457899999998874 68999999999999999998 666676665443332222222222222211 1222
Q ss_pred CCCCCCC----CH-HHHHH----HHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 664 PSLEQPC----SA-NEVMR----CIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 664 ~~l~~~~----~~-~~~~~----l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
-...... +. ..+.+ =.++....+.-+|.+|.++++.++.
T Consensus 236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 1111111 11 11111 1235556666799999999887764
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-31 Score=250.94 Aligned_cols=267 Identities=22% Similarity=0.342 Sum_probs=194.9
Q ss_pred CCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCcc--cHHHHHHHHHHHHhcCCCCcceeeeeeeeC--------C
Q 043278 431 NFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQ--GIVEFKNEVRLIAKLQHTNLVRLLGCSLHG--------E 499 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------~ 499 (752)
.|....+||+|.||.||+++.. .|+.||+|++...... --....+|+.+|..+.|+|++.++..|... .
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 4555679999999999999865 4778899876542211 112347899999999999999999987532 3
Q ss_pred eeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccc
Q 043278 500 ERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMA 579 (752)
Q Consensus 500 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla 579 (752)
..++|+.+|+. +|.-+|.. ....++..++.+++.++..||.|+|... |+|||+||.|+||+.++.+||+|||++
T Consensus 98 t~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccc
Confidence 47899999975 56666643 2345889999999999999999999987 999999999999999999999999999
Q ss_pred eeecccccc--cccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCC
Q 043278 580 RIFEVNESE--ANTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDG 656 (752)
Q Consensus 580 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 656 (752)
+.+...... ..-...+-|..|++||.+.+ ..++++.|||.-|||+.||+++.+.++...+.....++..........
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 876533211 11223455899999999886 689999999999999999999999999888776665555322111111
Q ss_pred C--------ccccc--CCCCCCC--CCHHHH------HHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 043278 657 K--------GLELI--DPSLEQP--CSANEV------MRCIHVGLLCVQDQAMDRPTMPEVVCML 703 (752)
Q Consensus 657 ~--------~~~~~--d~~l~~~--~~~~~~------~~l~~l~~~Cl~~dp~~RPt~~ev~~~L 703 (752)
- +.+-+ .|-.... .-.+.+ ...++|+-.++..||.+|+.+++++.+-
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 0 00001 1000000 000111 2456788889999999999999987653
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=245.99 Aligned_cols=254 Identities=21% Similarity=0.235 Sum_probs=196.2
Q ss_pred HhcCCCcC-CeeecCCcccEEEEEec-CCceeEEEEcccCCcccHHHHHHHHHHHHhc-CCCCcceeeeeeee----CCe
Q 043278 428 AANNFSTT-NKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLH----GEE 500 (752)
Q Consensus 428 ~~~~~~~~-~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~ 500 (752)
.+++|++. ++||-|-.|.|..+..+ .++.+|+|++.... ..++|+++-... .|+|||.+++++.. ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~-----KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP-----KARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH-----HHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 34555543 68999999999999765 58889999996542 347788877665 69999999998753 346
Q ss_pred eEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEec---CCCCceecccc
Q 043278 501 RLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLD---DKMNPKISDFG 577 (752)
Q Consensus 501 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~---~~~~~kl~DFg 577 (752)
.++|||.|++|.|...+.+. ....+++.++-.|+.||+.|+.|||+.+ |.||||||+|+|.. .|-.+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 68999999999998888654 3456999999999999999999999988 99999999999995 35569999999
Q ss_pred cceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCC
Q 043278 578 MARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGK 657 (752)
Q Consensus 578 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 657 (752)
+|+.-.. .......+-|+.|.|||++-...|+...|+||+||++|-|++|-+||...+..... .-....++.|.
T Consensus 210 FAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ais---pgMk~rI~~gq 283 (400)
T KOG0604|consen 210 FAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---PGMKRRIRTGQ 283 (400)
T ss_pred cccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCC---hhHHhHhhccC
Confidence 9985332 23334568899999999999989999999999999999999999999876642211 11122233322
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 658 GLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 658 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
. ++.++ .-....+...+++...|..+|.+|-|+.|++..
T Consensus 284 y-~FP~p-----EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 284 Y-EFPEP-----EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred c-cCCCh-----hHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 1 12222 122334556678888899999999999999876
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.3e-30 Score=263.55 Aligned_cols=249 Identities=21% Similarity=0.293 Sum_probs=202.1
Q ss_pred cCCCcCCeeecCCcccEEEEEecCCc-eeEEEEcccCC---cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLADEQ-EVAIKRLSRSS---GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~~~-~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 505 (752)
.+++....||-|+||.|=+++..... .+|+|.+++.. ....+....|-.+|.+.+.+.||++|..|.+....++.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 34455678999999999999876544 48999887653 233445778999999999999999999999999999999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccc
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVN 585 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~ 585 (752)
|-|-+|.|-..|.+ +..++...+.-++..++.|++|||.++ ||.|||||+|.|||.+|-+||.|||+|+.++..
T Consensus 500 EaClGGElWTiLrd---Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 500 EACLGGELWTILRD---RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred HhhcCchhhhhhhh---cCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 99999999998854 455888888889999999999999998 999999999999999999999999999987644
Q ss_pred ccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCC
Q 043278 586 ESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPS 665 (752)
Q Consensus 586 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 665 (752)
. .+-.++||+.|.|||++.++.-+.++|.||||++++||++|++||...++-...+++-.....+
T Consensus 574 ~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i------------ 638 (732)
T KOG0614|consen 574 R---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI------------ 638 (732)
T ss_pred C---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh------------
Confidence 3 3456899999999999999999999999999999999999999999888655444432222111
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 043278 666 LEQPCSANEVMRCIHVGLLCVQDQAMDRPT-----MPEVVCM 702 (752)
Q Consensus 666 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-----~~ev~~~ 702 (752)
..+........+++......+|.+|-- +.|+-.+
T Consensus 639 ---~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 639 ---EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred ---hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 122233344566777777899999975 5566554
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-29 Score=262.85 Aligned_cols=236 Identities=22% Similarity=0.335 Sum_probs=189.4
Q ss_pred hcCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCC---cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEE
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLV 504 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 504 (752)
..-|..++.||-|+||+|.++.. +....+|+|.|.+.+ .......+.|-.+|.+-+.+-||+|+-.|.+++.+++|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 45688889999999999999964 445678999998764 23445578999999999999999999999999999999
Q ss_pred EeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecc
Q 043278 505 YEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~ 584 (752)
|+|+++|++-.+|.. .+.+.+..+.-++..+..|+++.|.-+ +|||||||+|||||.+|++||.||||+.-+.-
T Consensus 708 MdYIPGGDmMSLLIr---mgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW 781 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIR---MGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 781 (1034)
T ss_pred EeccCCccHHHHHHH---hccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeecccccccee
Confidence 999999999998865 345888888888999999999999988 99999999999999999999999999875421
Q ss_pred cc----------cc------------------------------cccccccccCCccChhhhccCCCCccchhHHHHHHH
Q 043278 585 NE----------SE------------------------------ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLV 624 (752)
Q Consensus 585 ~~----------~~------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl 624 (752)
.. .. ......+||+.|+|||++....++..+|.||.||||
T Consensus 782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil 861 (1034)
T KOG0608|consen 782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL 861 (1034)
T ss_pred ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence 00 00 001124799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCcch-HHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHH
Q 043278 625 LEIVSGQKNHTRHHPDRPLNL-IGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIH 680 (752)
Q Consensus 625 ~elltG~~p~~~~~~~~~~~l-~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 680 (752)
|||+.|+.||....+.+.... ++| ...++-......+.+.+..+.+
T Consensus 862 ~em~~g~~pf~~~tp~~tq~kv~nw----------~~~l~~~~~~~ls~e~~~li~k 908 (1034)
T KOG0608|consen 862 YEMLVGQPPFLADTPGETQYKVINW----------RNFLHIPYQGNLSKEALDLIQK 908 (1034)
T ss_pred HHHhhCCCCccCCCCCcceeeeeeh----------hhccccccccccCHHHHHHHHH
Confidence 999999999998877665432 222 1233444444555555554444
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=276.47 Aligned_cols=247 Identities=24% Similarity=0.348 Sum_probs=189.8
Q ss_pred CCcCCeeecCCccc-EEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhc-CCCCcceeeeeeeeCCeeEEEEeeCC
Q 043278 432 FSTTNKLGEGGFGP-VYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGEERLLVYEFMP 509 (752)
Q Consensus 432 ~~~~~~LG~G~fg~-Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~ 509 (752)
|...+.+|.|+-|+ ||+|.. +|++||||++... ...-..+|+..|+.- +|||||++++.-.+....+|..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 55567889999876 689988 6789999998653 233457899999887 69999999999999999999999995
Q ss_pred CCCHhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecC-----CCCceecccccceeec
Q 043278 510 NKSLDFFLFNS-GRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDD-----KMNPKISDFGMARIFE 583 (752)
Q Consensus 510 ~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~-----~~~~kl~DFgla~~~~ 583 (752)
.+|++++... .......-...+.+..|+++||++||+.+ ||||||||+||||+. ...++|+|||+++.+.
T Consensus 587 -~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 -CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred -hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 6899998653 11111111445778999999999999987 999999999999965 3569999999999887
Q ss_pred ccccc-cccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhC-CCCCCCCCCCCCcchHHHHHHHhhCCCcccc
Q 043278 584 VNESE-ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG-QKNHTRHHPDRPLNLIGYAWQLLSDGKGLEL 661 (752)
Q Consensus 584 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 661 (752)
.+... .......||.+|+|||++....-+.++|+||+|||+|+.++| .+||......+ ...+........
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--------~NIl~~~~~L~~ 734 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--------ANILTGNYTLVH 734 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--------hhhhcCccceee
Confidence 65433 334567899999999999998888899999999999999996 78887654221 122222222222
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 662 IDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 662 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
+.+.. +. ...+|+.+|+..+|..||++.+|+.+
T Consensus 735 L~~~~------d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 735 LEPLP------DC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred eccCc------hH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 22211 11 56788999999999999999999864
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-30 Score=246.98 Aligned_cols=263 Identities=21% Similarity=0.314 Sum_probs=196.1
Q ss_pred cCCeeecCCcccEEEEEe-cCCceeEEEEcccC--CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCC-----eeEEEE
Q 043278 434 TTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRS--SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGE-----ERLLVY 505 (752)
Q Consensus 434 ~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~ 505 (752)
-.+-||-|+||.||..+. ++|+.||+|++... .-...+.+.+|+++|.-++|.|++..++.-...+ +.++++
T Consensus 57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T 136 (449)
T KOG0664|consen 57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT 136 (449)
T ss_pred CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence 357899999999999986 57999999998754 2234567899999999999999999988755433 456788
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccc
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVN 585 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~ 585 (752)
|.|. .+|..++- ....|+...+.-+..||++||+|||+.+ |.||||||.|.|++.|...||+|||+++....+
T Consensus 137 ELmQ-SDLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 137 ELMQ-SDLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHHH-hhhhheec---cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchh
Confidence 8884 46666553 3456888889999999999999999998 999999999999999999999999999976655
Q ss_pred ccccccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHH--------HHHhhCC
Q 043278 586 ESEANTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYA--------WQLLSDG 656 (752)
Q Consensus 586 ~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~--------~~~~~~~ 656 (752)
+....+ ..+-|..|+|||++++ ..|+.+.||||+||++.||+..+..|+...+.+...++... .+..-+|
T Consensus 210 ~~~hMT-qEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG 288 (449)
T KOG0664|consen 210 DRLNMT-HEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG 288 (449)
T ss_pred hhhhhH-HHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence 444433 3455789999999987 57999999999999999999988888877766554444311 1111122
Q ss_pred CcccccCCCCCC---------CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 043278 657 KGLELIDPSLEQ---------PCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ 704 (752)
Q Consensus 657 ~~~~~~d~~l~~---------~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~ 704 (752)
...-++....+. ........+..++.+.++..||..|.+..+.+..+.
T Consensus 289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 211122111111 111122234456667889999999999998887763
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-30 Score=226.87 Aligned_cols=109 Identities=43% Similarity=0.705 Sum_probs=79.8
Q ss_pred CccEEeccCCCCCCCC--CceEEEecCCCcEEEEcCCCCcEEEe-eccCCc-cccceeEecCCCeEEEEecCCCccceeE
Q 043278 52 DEPIWIANRNTPILDQ--SGVLTIDSIDGNLKILHNGGNPIAVS-SVEGAS-NNTSATLLQSGNLVLREMDTDGTIKRVL 127 (752)
Q Consensus 52 ~t~vWvANr~~Pv~~~--~~~l~~~~~~g~L~l~~~~g~~~~~~-~~~~~~-~~~~a~lldsGNlVl~~~~~~~~~~~~l 127 (752)
+||||+|||+.|+.+. .++|.|.. ||||+|.|.+|+.+|++ .+.... ....|+|+|+|||||++.. +++|
T Consensus 2 ~tvvW~an~~~p~~~~s~~~~L~l~~-dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~-----~~~l 75 (114)
T PF01453_consen 2 RTVVWVANRNSPLTSSSGNYTLILQS-DGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSS-----GNVL 75 (114)
T ss_dssp --------TTEEEEECETTEEEEEET-TSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETT-----SEEE
T ss_pred cccccccccccccccccccccceECC-CCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEeec-----ceEE
Confidence 6999999999999543 37899998 99999999998889988 433222 4678999999999999854 6899
Q ss_pred eeeccCCCcccCCCCeeccccccCceeEEEEecCCCCCC
Q 043278 128 WQSFDYPTDTLLPGMKLGINLQTGHQWFLQSWLDYSSPA 166 (752)
Q Consensus 128 WQSFd~PTDTlLpg~kl~~~~~tg~~~~L~Sw~s~~dps 166 (752)
||||||||||+||+|+|+.+..+|.+..|+||++.+|||
T Consensus 76 W~Sf~~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 76 WQSFDYPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS 114 (114)
T ss_dssp EESTTSSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred EeecCCCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence 999999999999999999988888777799999999997
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=241.91 Aligned_cols=247 Identities=23% Similarity=0.344 Sum_probs=195.2
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccC---CcccHHHHHHHHHHHHhc-CCCCcceeeeeeeeCCeeEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRS---SGQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGEERLLV 504 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 504 (752)
++|.+.+.||+|+|++|..+++. ..+.+|+|++++. ..+..+-.+.|-.+..+- +||.+|.+..+|..+...++|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 56788899999999999999875 4678999998765 333444456677777665 799999999999999999999
Q ss_pred EeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecc
Q 043278 505 YEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~ 584 (752)
.||+++|+|-.++.+ +..|+++.+.-+...|+-||.|||+.+ ||.||||.+|+|||.+|++||.|+|+++---
T Consensus 330 ieyv~ggdlmfhmqr---qrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l- 402 (593)
T KOG0695|consen 330 IEYVNGGDLMFHMQR---QRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL- 402 (593)
T ss_pred EEEecCcceeeehhh---hhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC-
Confidence 999999999777644 445999999999999999999999999 9999999999999999999999999997422
Q ss_pred cccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCC-cchHHHHHHHhhCCCcccccC
Q 043278 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRP-LNLIGYAWQLLSDGKGLELID 663 (752)
Q Consensus 585 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~d 663 (752)
.....+..++||+.|.|||++.+..|...+|.|++||+++||+.|+.||.....+.+ .+...+..+.+-+.++
T Consensus 403 -~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi----- 476 (593)
T KOG0695|consen 403 -GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI----- 476 (593)
T ss_pred -CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc-----
Confidence 233445679999999999999999999999999999999999999999986543322 2333344444433221
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 043278 664 PSLEQPCSANEVMRCIHVGLLCVQDQAMDRP 694 (752)
Q Consensus 664 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP 694 (752)
.. +.....+...+..--+.+||.+|.
T Consensus 477 ---ri--prslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 477 ---RI--PRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ---cc--cceeehhhHHHHHHhhcCCcHHhc
Confidence 11 111222344566677888998884
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.8e-29 Score=229.10 Aligned_cols=204 Identities=25% Similarity=0.341 Sum_probs=165.4
Q ss_pred HhcCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccC-CcccHHHHHHHHHHHHhc-CCCCcceeeeeeeeCCeeEEE
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRS-SGQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGEERLLV 504 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 504 (752)
..+.......||+|++|.|-+.++ .+|+..|+|++... ..+..++..+|+.+..+- .+|.+|+++|........+|.
T Consensus 44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIc 123 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWIC 123 (282)
T ss_pred chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEe
Confidence 344555567899999999999886 57999999999755 445566677888777664 799999999988888899999
Q ss_pred EeeCCCCCHhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeec
Q 043278 505 YEFMPNKSLDFFLFNS-GRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFE 583 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~ 583 (752)
||.|+ .||+.+..+. .+...+++...=+|+..|.+||.|||++- .+||||+||+||||+.+|++||+|||.+-.+.
T Consensus 124 ME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~ 200 (282)
T KOG0984|consen 124 MELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLV 200 (282)
T ss_pred HHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeeh
Confidence 99995 5676665432 34456888888899999999999999964 59999999999999999999999999998765
Q ss_pred ccccccccccccccCCccChhhhcc----CCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 043278 584 VNESEANTKRIVGTYGYMSPEYAMS----GIVSIKTDVFSFGVLVLEIVSGQKNHTRH 637 (752)
Q Consensus 584 ~~~~~~~~~~~~gt~~y~aPE~~~~----~~~t~k~DV~S~G~vl~elltG~~p~~~~ 637 (752)
+.-. .+-..|...|||||.+.. ..|+.|+||||||+.+.||.+++.|++.-
T Consensus 201 dSiA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 201 DSIA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred hhhH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 3321 112357778999998753 46999999999999999999999988643
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-26 Score=231.22 Aligned_cols=211 Identities=35% Similarity=0.538 Sum_probs=183.1
Q ss_pred eecCCcccEEEEEecC-CceeEEEEcccCCcc-cHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCCCCCHhH
Q 043278 438 LGEGGFGPVYKGKLAD-EQEVAIKRLSRSSGQ-GIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDF 515 (752)
Q Consensus 438 LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~ 515 (752)
||+|.+|.||++...+ ++.+++|++...... ....+.+|+..+..++|++++++++++......++++|++++++|..
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999865 889999999765432 34678999999999999999999999999899999999999999999
Q ss_pred HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecC-CCCceecccccceeecccccccccccc
Q 043278 516 FLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDD-KMNPKISDFGMARIFEVNESEANTKRI 594 (752)
Q Consensus 516 ~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~-~~~~kl~DFgla~~~~~~~~~~~~~~~ 594 (752)
++.... ..+++..+..++.++++++.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 153 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI 153 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence 985432 35899999999999999999999997 999999999999999 89999999999986543321 12234
Q ss_pred cccCCccChhhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCCCCHH
Q 043278 595 VGTYGYMSPEYAMSG-IVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSAN 673 (752)
Q Consensus 595 ~gt~~y~aPE~~~~~-~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 673 (752)
.+...|++||..... ..+.+.|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 567889999999887 889999999999999999
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 043278 674 EVMRCIHVGLLCVQDQAMDRPTMPEVVCML 703 (752)
Q Consensus 674 ~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L 703 (752)
..+.+++..|++.+|.+||++.++++.|
T Consensus 188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 --PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred --HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 3567888999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.9e-28 Score=249.21 Aligned_cols=274 Identities=21% Similarity=0.220 Sum_probs=209.3
Q ss_pred ccHHHHHHHhcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCcccHHHHHHHHHHHHhcCC------CCcceee
Q 043278 420 FDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQH------TNLVRLL 492 (752)
Q Consensus 420 ~~~~~i~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~ 492 (752)
|.+..-+....+|.+....|+|-|++|..|... .|+.||||++.... ...+.=+.|+++|.+|+. -|+++++
T Consensus 422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~ 500 (752)
T KOG0670|consen 422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLF 500 (752)
T ss_pred EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence 344444556789999999999999999999864 48899999997652 223344789999999963 4899999
Q ss_pred eeeeeCCeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCC-CCc
Q 043278 493 GCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDK-MNP 571 (752)
Q Consensus 493 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~-~~~ 571 (752)
..|.+.+++|||+|-+. .+|.+.|..-+..-.|....+..++.|+.-||..|...+ |+|.||||.|||+++. ..+
T Consensus 501 r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iL 576 (752)
T KOG0670|consen 501 RHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNIL 576 (752)
T ss_pred HHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCccee
Confidence 99999999999999774 688999988888888999999999999999999999887 9999999999999875 458
Q ss_pred eecccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHH---
Q 043278 572 KISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGY--- 648 (752)
Q Consensus 572 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~--- 648 (752)
||||||.|.....+.-. ...-...|.|||++.+.+|+...|+||+||.||||.||+..|.+......+-+...
T Consensus 577 KLCDfGSA~~~~eneit----PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KG 652 (752)
T KOG0670|consen 577 KLCDFGSASFASENEIT----PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKG 652 (752)
T ss_pred eeccCcccccccccccc----HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcC
Confidence 99999999875543322 23345689999999999999999999999999999999999987765433322211
Q ss_pred --HHHHhhCCCc---------------------------ccccCCC------CC-----CCCCHHHHHHHHHHHHHcccC
Q 043278 649 --AWQLLSDGKG---------------------------LELIDPS------LE-----QPCSANEVMRCIHVGLLCVQD 688 (752)
Q Consensus 649 --~~~~~~~~~~---------------------------~~~~d~~------l~-----~~~~~~~~~~l~~l~~~Cl~~ 688 (752)
..++++.|.. +..+.|. +. .......+..+.+|+-.|+..
T Consensus 653 k~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~L 732 (752)
T KOG0670|consen 653 KFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLIL 732 (752)
T ss_pred CCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhcc
Confidence 1122222211 1111220 00 011233456677888999999
Q ss_pred CCCCCCCHHHHHHH
Q 043278 689 QAMDRPTMPEVVCM 702 (752)
Q Consensus 689 dp~~RPt~~ev~~~ 702 (752)
||++|.|..+.+.+
T Consensus 733 dP~KRit~nqAL~H 746 (752)
T KOG0670|consen 733 DPEKRITVNQALKH 746 (752)
T ss_pred ChhhcCCHHHHhcC
Confidence 99999999988763
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-25 Score=226.78 Aligned_cols=199 Identities=33% Similarity=0.485 Sum_probs=172.5
Q ss_pred CCcCCeeecCCcccEEEEEecC-CceeEEEEcccCCcc-cHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCC
Q 043278 432 FSTTNKLGEGGFGPVYKGKLAD-EQEVAIKRLSRSSGQ-GIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMP 509 (752)
Q Consensus 432 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 509 (752)
|...+.||+|++|.||++...+ ++.+++|.+...... ....+.+|++.+.+++|+|++++++++......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4556899999999999999865 889999999876544 56788999999999999999999999999899999999999
Q ss_pred CCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccccc
Q 043278 510 NKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEA 589 (752)
Q Consensus 510 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 589 (752)
+++|.+++..... .+++.....++.+++.++.+||+.+ ++|+||+|.||+++.++.++|+|||++........ .
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~ 154 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-A 154 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-c
Confidence 9999999864322 1789999999999999999999987 99999999999999999999999999987654321 1
Q ss_pred ccccccccCCccChhhh-ccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 043278 590 NTKRIVGTYGYMSPEYA-MSGIVSIKTDVFSFGVLVLEIVSGQKNHTR 636 (752)
Q Consensus 590 ~~~~~~gt~~y~aPE~~-~~~~~t~k~DV~S~G~vl~elltG~~p~~~ 636 (752)
......++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 22335677889999998 667788899999999999999999999955
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.8e-25 Score=228.96 Aligned_cols=132 Identities=27% Similarity=0.374 Sum_probs=107.2
Q ss_pred hcCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCCcccHHHHHHHHHHHHhcC-----C---CCcceeeeeeee--
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQ-----H---TNLVRLLGCSLH-- 497 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~~-- 497 (752)
.++|.+.++||-|.|++||++-. ...+.||+|+.+... ...+....|+++|++++ | .+||+|++.|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 36888999999999999999975 456789999986542 23345689999999983 3 369999999875
Q ss_pred --CCeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEe
Q 043278 498 --GEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILL 565 (752)
Q Consensus 498 --~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll 565 (752)
+.+.|||+|++....| .+|... ....++...+.+|++||+.||.|||..+ +|||-||||+||||
T Consensus 156 pNG~HVCMVfEvLGdnLL-klI~~s-~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 156 PNGQHVCMVFEVLGDNLL-KLIKYS-NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCCcEEEEEehhhhhHHH-HHHHHh-CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 5589999999965444 444433 3345999999999999999999999987 69999999999998
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-26 Score=243.99 Aligned_cols=196 Identities=25% Similarity=0.360 Sum_probs=165.0
Q ss_pred cCCCcCCeeecCCcccEEEEEecC-CceeEEEEcccCCcc--------cHHHHHHHHHHHHhcC---CCCcceeeeeeee
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLAD-EQEVAIKRLSRSSGQ--------GIVEFKNEVRLIAKLQ---HTNLVRLLGCSLH 497 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l~---h~niv~l~~~~~~ 497 (752)
..|+..+.+|+|+||.|+.+.++. ..+|+||.+.+...- ..-....|+.+|..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 358888999999999999998764 567999988764210 1112457999999997 9999999999999
Q ss_pred CCeeEEEEeeC-CCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceeccc
Q 043278 498 GEERLLVYEFM-PNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDF 576 (752)
Q Consensus 498 ~~~~~lv~E~~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DF 576 (752)
++.++|+||-. ++-+|.+++. .++.+++.++..|+.||+.|+++||+++ |||||||-+|+.++.+|-+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE---~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIE---FKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhh---ccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence 99999999986 5567777773 3456999999999999999999999999 999999999999999999999999
Q ss_pred ccceeecccccccccccccccCCccChhhhccCCCC-ccchhHHHHHHHHHHHhCCCCCC
Q 043278 577 GMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVS-IKTDVFSFGVLVLEIVSGQKNHT 635 (752)
Q Consensus 577 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t-~k~DV~S~G~vl~elltG~~p~~ 635 (752)
|.+.+..... ...++||..|+|||++.+..|- ..-|||++|++||.++.-+.|+.
T Consensus 715 gsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9997654333 2347899999999999987765 45899999999999998877763
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-26 Score=227.59 Aligned_cols=261 Identities=23% Similarity=0.245 Sum_probs=190.1
Q ss_pred hcCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccC--CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCC------
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRS--SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGE------ 499 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 499 (752)
..+|.-.+.+|.|.- .|-.+.. -.+++||+|++... .....++..+|..++..++|+|+++++.++....
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 346666778888887 4444432 35788999988654 3345567789999999999999999999987543
Q ss_pred eeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccc
Q 043278 500 ERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMA 579 (752)
Q Consensus 500 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla 579 (752)
+.++|||+|. .+|...+. ..++-+....|..|++.|+.|||+.+ |+||||||+||++..+..+||.|||+|
T Consensus 95 e~y~v~e~m~-~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 95 EVYLVMELMD-ANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred hHHHHHHhhh-hHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhh
Confidence 5689999996 46666664 23677788899999999999999998 999999999999999999999999999
Q ss_pred eeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHH------------
Q 043278 580 RIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIG------------ 647 (752)
Q Consensus 580 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~------------ 647 (752)
+..... ...+..+.|..|+|||++.+..+.+.+||||+||++.||++|+-.|.+.+.-+....+.
T Consensus 166 r~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~ 242 (369)
T KOG0665|consen 166 RTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMK 242 (369)
T ss_pred cccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHH
Confidence 854322 23345778899999999999889999999999999999999998887654221111111
Q ss_pred ----HHHHHhhC-CC-----ccccc-CCCCC--CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 648 ----YAWQLLSD-GK-----GLELI-DPSLE--QPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 648 ----~~~~~~~~-~~-----~~~~~-d~~l~--~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.+...... .+ ..+++ |.... .+.+.-....+.+++.+||-.+|++|-++++++++
T Consensus 243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 11111110 00 00111 11000 11122223345578889999999999999999987
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.5e-26 Score=213.52 Aligned_cols=257 Identities=19% Similarity=0.327 Sum_probs=190.0
Q ss_pred hcCCCcCCeeecCCcccEEEEE-ecCCceeEEEEcccCCcccHHHHHHHHHHHHhcC-CCCcceeeeeeeeCC--eeEEE
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQ-HTNLVRLLGCSLHGE--ERLLV 504 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~~lv 504 (752)
.++|++.+++|+|-++.||.|. ..+.+.++||+++... .+.+.+|+.+|..+. ||||+++++...+.. ...||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 5678888999999999999997 4567889999997643 356789999999997 999999999987654 56799
Q ss_pred EeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecC-CCCceecccccceeec
Q 043278 505 YEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDD-KMNPKISDFGMARIFE 583 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~-~~~~kl~DFgla~~~~ 583 (752)
+||+.+.+...+. ..|+..++...+.++++||.|+|+.+ |+|||+||.|+|||. .-.++|+|+|+|.+..
T Consensus 114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence 9999998876654 23777888999999999999999999 999999999999985 4569999999998876
Q ss_pred ccccccccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCC-CCCcchHHHHH------HHhhC
Q 043278 584 VNESEANTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHP-DRPLNLIGYAW------QLLSD 655 (752)
Q Consensus 584 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~~-~~~~~l~~~~~------~~~~~ 655 (752)
...... ..+.+..|--||.+.+ ..|+..-|+|||||+|.+|+..+.||-.-.. .+.+..++... ..+..
T Consensus 185 p~~eYn---VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~K 261 (338)
T KOG0668|consen 185 PGKEYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNK 261 (338)
T ss_pred CCceee---eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHH
Confidence 544322 2345667889998876 5688999999999999999999999764432 22221121110 01100
Q ss_pred CCcccccCCCCCC---------------CCCHHH-HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 656 GKGLELIDPSLEQ---------------PCSANE-VMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 656 ~~~~~~~d~~l~~---------------~~~~~~-~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
..--+||.+.. ...... ..+.++++-..+..|..+|||++|.+.+
T Consensus 262 --Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 262 --YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred --HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 00012222111 000000 1355667778889999999999998764
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.7e-27 Score=248.93 Aligned_cols=252 Identities=25% Similarity=0.381 Sum_probs=204.9
Q ss_pred hcCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEee
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
..+|+....+|+|++|.|||++. ..++..|+|.++-.......-.++|+.+++..+|+||+.++|.+...+..++.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 35788889999999999999986 46889999999887777777788999999999999999999999999999999999
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccc
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES 587 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~ 587 (752)
|.+|+|++.-+- ...+++.++-..++..++||+|||+.+ =+|||||-.|||++++|.+|++|||.+-.... .
T Consensus 94 cgggslQdiy~~---TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqita--t 165 (829)
T KOG0576|consen 94 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITA--T 165 (829)
T ss_pred cCCCcccceeee---cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhh--h
Confidence 999999887653 456888899999999999999999998 89999999999999999999999999865432 2
Q ss_pred ccccccccccCCccChhhhc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccC-
Q 043278 588 EANTKRIVGTYGYMSPEYAM---SGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELID- 663 (752)
Q Consensus 588 ~~~~~~~~gt~~y~aPE~~~---~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d- 663 (752)
-...+.+.||+.|||||+.. .+.|..++|||++|+...|+-.-++|....++.+...+ +.. ...+
T Consensus 166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~L-------mTk----S~~qp 234 (829)
T KOG0576|consen 166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFL-------MTK----SGFQP 234 (829)
T ss_pred hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHH-------hhc----cCCCC
Confidence 22345689999999999864 56799999999999999999988888766654432222 111 1111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 043278 664 PSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVC 701 (752)
Q Consensus 664 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~ 701 (752)
|.++. .......+-+++..|+.++|++|||++.+++
T Consensus 235 p~lkD--k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 235 PTLKD--KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CcccC--CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 22222 2233445677888999999999999977654
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-25 Score=216.08 Aligned_cols=253 Identities=21% Similarity=0.332 Sum_probs=187.3
Q ss_pred hcCCCcCCeeecCCcccEEEEEecC-CceeEEEEcccCCcccHHHHHHHHHHHHhc-CCCCcceeeee-eeeCCeeEEEE
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLAD-EQEVAIKRLSRSSGQGIVEFKNEVRLIAKL-QHTNLVRLLGC-SLHGEERLLVY 505 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-~~~~~~~~lv~ 505 (752)
.+.|.+.+.||+|.||.+.++.++. .+.+++|-+.+.. ...++|.+|...--.| .|.||+.-++. |...+.+++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 3568888999999999999999865 5679999887653 4567899998766666 58899988875 56667889999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEe-c-CCCCceecccccceeec
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILL-D-DKMNPKISDFGMARIFE 583 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll-~-~~~~~kl~DFgla~~~~ 583 (752)
||+|.|+|..-+. ...+-+.....++.|++.||.|||+.. +||||||.+|||| + +...+||+|||+.+..+
T Consensus 102 E~aP~gdL~snv~----~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 102 EFAPRGDLRSNVE----AAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred ccCccchhhhhcC----cccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence 9999999988773 345778888899999999999999998 9999999999999 3 34479999999988643
Q ss_pred ccccccccccccccCCccChhhhccC-----CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCc
Q 043278 584 VNESEANTKRIVGTYGYMSPEYAMSG-----IVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKG 658 (752)
Q Consensus 584 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 658 (752)
..- ....-+..|.+||..... ...+.+|||.||++++.+++|+.|++...... ... |.+..+..++.
T Consensus 175 ~tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d-~~Y--~~~~~w~~rk~ 246 (378)
T KOG1345|consen 175 TTV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD-KPY--WEWEQWLKRKN 246 (378)
T ss_pred cee-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC-chH--HHHHHHhcccC
Confidence 211 122335679999976542 35678999999999999999999999544322 222 33344444443
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 043278 659 LELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCML 703 (752)
Q Consensus 659 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L 703 (752)
..+ |..-... .+++.++..+-+..++++|-...++..+.
T Consensus 247 ~~~--P~~F~~f----s~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 247 PAL--PKKFNPF----SEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred ccC--chhhccc----CHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 322 1111122 23455566688899999997666666654
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=3e-25 Score=265.00 Aligned_cols=197 Identities=18% Similarity=0.253 Sum_probs=140.0
Q ss_pred hcCC-CCcceeeeee-------eeCCeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcE
Q 043278 482 KLQH-TNLVRLLGCS-------LHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRV 553 (752)
Q Consensus 482 ~l~h-~niv~l~~~~-------~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i 553 (752)
.++| .||++++++| .+.+..++++|++ .++|.+++... ...+++.+++.++.||++||+|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 3455 5888888887 2334567788987 56999998542 345899999999999999999999988 9
Q ss_pred eecCCCCCcEEecC-------------------CCCceecccccceeecccccc--------------cccccccccCCc
Q 043278 554 IHRDLKASNILLDD-------------------KMNPKISDFGMARIFEVNESE--------------ANTKRIVGTYGY 600 (752)
Q Consensus 554 iH~Dikp~NIll~~-------------------~~~~kl~DFgla~~~~~~~~~--------------~~~~~~~gt~~y 600 (752)
+||||||+||||+. ++.+||+|||+++........ .......||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 556777777777642210000 001113578899
Q ss_pred cChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHH
Q 043278 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIH 680 (752)
Q Consensus 601 ~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 680 (752)
||||++.+..++.++|||||||+||||++|..|+.... ... ..+... .+.+.. .........
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~~~----~~~~~~----~~~~~~-----~~~~~~~~~ 243 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----RTM----SSLRHR----VLPPQI-----LLNWPKEAS 243 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----HHH----HHHHHh----hcChhh-----hhcCHHHHH
Confidence 99999999999999999999999999999887754221 001 111100 111111 112234567
Q ss_pred HHHHcccCCCCCCCCHHHHHHH
Q 043278 681 VGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 681 l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
++.+||+.+|.+||+|.|++++
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHhCCCChhhCcChHHHhhc
Confidence 8889999999999999999874
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-24 Score=222.79 Aligned_cols=204 Identities=25% Similarity=0.440 Sum_probs=168.4
Q ss_pred HHHHhcCCCcCCeeecCCcccEEEEEec----CCceeEEEEcccCCcccHHHHHHHHHHHHhc-CCCCcceeeeeeeeCC
Q 043278 425 IAAAANNFSTTNKLGEGGFGPVYKGKLA----DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGE 499 (752)
Q Consensus 425 i~~~~~~~~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 499 (752)
+....+.|...++||+|.|++||++.+. ..+.||+|.+...+ .-.+..+|+++|..+ -+.||+++.+++..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 4445678889999999999999999764 35689999987654 334678999999999 5899999999999999
Q ss_pred eeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecC-CCCceeccccc
Q 043278 500 ERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDD-KMNPKISDFGM 578 (752)
Q Consensus 500 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~-~~~~kl~DFgl 578 (752)
..++|+||+++....++... ++...+..+++.+++||+++|.++ ||||||||+|+|.+. -+.-.|.|||+
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred eeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence 99999999999999888843 778899999999999999999999 999999999999975 45678999999
Q ss_pred ceeecccc-------------cc-----------------------------cccccccccCCccChhhhccC-CCCccc
Q 043278 579 ARIFEVNE-------------SE-----------------------------ANTKRIVGTYGYMSPEYAMSG-IVSIKT 615 (752)
Q Consensus 579 a~~~~~~~-------------~~-----------------------------~~~~~~~gt~~y~aPE~~~~~-~~t~k~ 615 (752)
|......+ .. .......||+||+|||++... ..++++
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 97211000 00 001124699999999998874 578999
Q ss_pred hhHHHHHHHHHHHhCCCCCCCCCC
Q 043278 616 DVFSFGVLVLEIVSGQKNHTRHHP 639 (752)
Q Consensus 616 DV~S~G~vl~elltG~~p~~~~~~ 639 (752)
||||.|+|++-+++++.||-....
T Consensus 260 Diws~GVI~Lslls~~~PFf~a~d 283 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFKAKD 283 (418)
T ss_pred ceeeccceeehhhccccccccCcc
Confidence 999999999999999999876543
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.8e-24 Score=188.77 Aligned_cols=108 Identities=40% Similarity=0.615 Sum_probs=91.7
Q ss_pred eEeeCCCeEEeeeeCCCCCCCCccEEEEecCCCCCCcCccccCCCCCCCCCccEEeccCCCCCCCCCceEEEecCCCcEE
Q 043278 2 LLVSAFGNFKLGFFSPASSTTTERYLGIWHDTAPDTLGWYFRPFLPRYQTDEPIWIANRNTPILDQSGVLTIDSIDGNLK 81 (752)
Q Consensus 2 ~lvS~~g~F~lGFf~~~~~~~~~~ylgIw~~~~~~~~~~~~~~~~~~~~~~t~vWvANr~~Pv~~~~~~l~~~~~~g~L~ 81 (752)
+|+|++|.|++|||.+... ...+++|||.+++ +++||.|||+.|. ...+.|.|.. ||+|+
T Consensus 9 ~l~s~~~~f~~G~~~~~~q--~~dgnlv~~~~~~----------------~~~vW~snt~~~~-~~~~~l~l~~-dGnLv 68 (116)
T cd00028 9 TLVSSGSLFELGFFKLIMQ--SRDYNLILYKGSS----------------RTVVWVANRDNPS-GSSCTLTLQS-DGNLV 68 (116)
T ss_pred EEEeCCCcEEEecccCCCC--CCeEEEEEEeCCC----------------CeEEEECCCCCCC-CCCEEEEEec-CCCeE
Confidence 6899999999999998654 1489999998764 4899999999994 4447899998 99999
Q ss_pred EEcCCCCcEEEeeccCCccccceeEecCCCeEEEEecCCCccceeEeeeccCC
Q 043278 82 ILHNGGNPIAVSSVEGASNNTSATLLQSGNLVLREMDTDGTIKRVLWQSFDYP 134 (752)
Q Consensus 82 l~~~~g~~~~~~~~~~~~~~~~a~lldsGNlVl~~~~~~~~~~~~lWQSFd~P 134 (752)
|.|.+|.++|++++.......+|+|+|+|||||++.+ +.++|||||||
T Consensus 69 l~~~~g~~vW~S~~~~~~~~~~~~L~ddGnlvl~~~~-----~~~~W~Sf~~P 116 (116)
T cd00028 69 IYDGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYDSD-----GNFLWQSFDYP 116 (116)
T ss_pred EEcCCCcEEEEecccCCCCceEEEEeCCCCEEEECCC-----CCEEEcCCCCC
Confidence 9999999999888754344567999999999999865 56999999999
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.8e-23 Score=200.88 Aligned_cols=167 Identities=17% Similarity=0.117 Sum_probs=125.0
Q ss_pred CCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccccc
Q 043278 511 KSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEAN 590 (752)
Q Consensus 511 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~ 590 (752)
|+|.+++... ...+++.+++.++.||+.||.|||+.+ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence 6888888543 345999999999999999999999875 999999999999999 99998754321
Q ss_pred cccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCCC
Q 043278 591 TKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPC 670 (752)
Q Consensus 591 ~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 670 (752)
..|++.|||||++.+..++.++|||||||++|||++|+.|+....... ............. ++.. ...
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~------~~~~-~~~ 131 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AILEILLNGMPAD------DPRD-RSN 131 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHHHHHHHhccC------Cccc-ccc
Confidence 257899999999999999999999999999999999999986543211 1111111111100 0000 011
Q ss_pred CHHHH--HHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 671 SANEV--MRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 671 ~~~~~--~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
..... ..+.+++.+|++.+|.+||++.|+++++...
T Consensus 132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 11122 2588999999999999999999999988643
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-22 Score=181.09 Aligned_cols=106 Identities=40% Similarity=0.655 Sum_probs=91.4
Q ss_pred eEeeCCCeEEeeeeCCCCCCCCccEEEEecCCCCCCcCccccCCCCCCCCCccEEeccCCCCCCCCCceEEEecCCCcEE
Q 043278 2 LLVSAFGNFKLGFFSPASSTTTERYLGIWHDTAPDTLGWYFRPFLPRYQTDEPIWIANRNTPILDQSGVLTIDSIDGNLK 81 (752)
Q Consensus 2 ~lvS~~g~F~lGFf~~~~~~~~~~ylgIw~~~~~~~~~~~~~~~~~~~~~~t~vWvANr~~Pv~~~~~~l~~~~~~g~L~ 81 (752)
.|+|++|.|++|||.+... ..+++|||++.+ +++||+|||+.|+.++ ..|.+.+ ||+|+
T Consensus 9 ~l~s~~~~f~~G~~~~~~q---~dgnlV~~~~~~----------------~~~vW~snt~~~~~~~-~~l~l~~-dGnLv 67 (114)
T smart00108 9 TLVSGNSLFELGFFTLIMQ---NDYNLILYKSSS----------------RTVVWVANRDNPVSDS-CTLTLQS-DGNLV 67 (114)
T ss_pred EEecCCCcEeeeccccCCC---CCEEEEEEECCC----------------CcEEEECCCCCCCCCC-EEEEEeC-CCCEE
Confidence 5899999999999998643 579999998764 4899999999998776 7899998 99999
Q ss_pred EEcCCCCcEEEeeccCCccccceeEecCCCeEEEEecCCCccceeEeeeccC
Q 043278 82 ILHNGGNPIAVSSVEGASNNTSATLLQSGNLVLREMDTDGTIKRVLWQSFDY 133 (752)
Q Consensus 82 l~~~~g~~~~~~~~~~~~~~~~a~lldsGNlVl~~~~~~~~~~~~lWQSFd~ 133 (752)
|.|.+|.++|++++........|+|+|+|||||++.+ +++|||||||
T Consensus 68 l~~~~g~~vW~S~t~~~~~~~~~~L~ddGnlvl~~~~-----~~~~W~Sf~~ 114 (114)
T smart00108 68 LYDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYDSD-----GNFLWQSFDY 114 (114)
T ss_pred EEeCCCCEEEEecccCCCCceEEEEeCCCCEEEECCC-----CCEEeCCCCC
Confidence 9999999999988753445567999999999999765 5699999997
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.6e-22 Score=213.38 Aligned_cols=166 Identities=19% Similarity=0.236 Sum_probs=129.2
Q ss_pred HHhcCCCcCCeeecCCcccEEEEEec--CCceeEEEEcccC-----CcccHHHHHHHHHHHHhcCCCCcce-eeeeeeeC
Q 043278 427 AAANNFSTTNKLGEGGFGPVYKGKLA--DEQEVAIKRLSRS-----SGQGIVEFKNEVRLIAKLQHTNLVR-LLGCSLHG 498 (752)
Q Consensus 427 ~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~ 498 (752)
...++|.+.+.||+|+||+||+|+.. +++.+|||++... .......|.+|+++|.+++|+|+++ ++++
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 34578999999999999999999864 5777899987533 1123456899999999999999985 4432
Q ss_pred CeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCC-CCCcEEecCCCCceecccc
Q 043278 499 EERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDL-KASNILLDDKMNPKISDFG 577 (752)
Q Consensus 499 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Di-kp~NIll~~~~~~kl~DFg 577 (752)
+..+|||||+++++|.... .. . ...++.+++++|.|||+.+ |+|||| ||+|||++.++.+||+|||
T Consensus 91 ~~~~LVmE~~~G~~L~~~~----~~---~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLAR----PH---G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CCcEEEEEccCCCCHHHhC----cc---c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECc
Confidence 4579999999999996321 11 1 1467889999999999988 999999 9999999999999999999
Q ss_pred cceeeccccccc------ccccccccCCccChhhhccC
Q 043278 578 MARIFEVNESEA------NTKRIVGTYGYMSPEYAMSG 609 (752)
Q Consensus 578 la~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~ 609 (752)
+++.+....... .-....+++.|+|||++...
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 999775432111 11246778899999988643
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.3e-21 Score=206.95 Aligned_cols=259 Identities=20% Similarity=0.238 Sum_probs=191.2
Q ss_pred CCCcCCeeecCCcccEEEEEecCC--ceeEEEEcccCCcccHHHHHHHHHHHHhcCC----CCcceeeeee-eeCCeeEE
Q 043278 431 NFSTTNKLGEGGFGPVYKGKLADE--QEVAIKRLSRSSGQGIVEFKNEVRLIAKLQH----TNLVRLLGCS-LHGEERLL 503 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~~~~--~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~l 503 (752)
+|.+.++||+|+||.||++..... ..+|+|............+..|..++..+.+ +++..+++.. ..+...+|
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 789999999999999999987554 4788887766533333367889999988873 5888999888 47778899
Q ss_pred EEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCC-----CCceeccccc
Q 043278 504 VYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDK-----MNPKISDFGM 578 (752)
Q Consensus 504 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~-----~~~kl~DFgl 578 (752)
||+.+ +.+|.++..... ...++..+.+.|+.|++.+|++||+.+ ++||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99987 678888765444 567999999999999999999999998 9999999999999754 4689999999
Q ss_pred ce--eeccccc------ccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHH
Q 043278 579 AR--IFEVNES------EANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAW 650 (752)
Q Consensus 579 a~--~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~ 650 (752)
++ ....... .......+||..|++++...+...+++.|+||++.++.|++.|..|+.............
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~--- 250 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE--- 250 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH---
Confidence 98 3211111 111234669999999999999999999999999999999999999986554332211111
Q ss_pred HHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 651 QLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 651 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
+.... ..... .......+ +.++...+-..+..++|....+...|+..
T Consensus 251 ~~~~~----~~~~~--~~~~~~~~---~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~ 297 (322)
T KOG1164|consen 251 KDPRK----LLTDR--FGDLKPEE---FAKILEYIDSLDYEDKPDYEKLAELLKDV 297 (322)
T ss_pred HHhhh----hcccc--ccCCChHH---HHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence 11110 01110 11122233 33344444457899999999998887665
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.8e-22 Score=194.29 Aligned_cols=247 Identities=18% Similarity=0.272 Sum_probs=186.2
Q ss_pred CCeeecCCcccEEEEEecCCceeEEEEcccC--CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCCCCC
Q 043278 435 TNKLGEGGFGPVYKGKLADEQEVAIKRLSRS--SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKS 512 (752)
Q Consensus 435 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gs 512 (752)
..+|.+...|+.|+|++... .+++|++.-. ...-.+.|.+|.-.|+.+.||||+.++|.|....+..++..||+.|+
T Consensus 195 ~tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 35788999999999999654 4556766432 22233568899999999999999999999999999999999999999
Q ss_pred HhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccccccc
Q 043278 513 LDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTK 592 (752)
Q Consensus 513 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~ 592 (752)
|...|++. ..-..+-.++.+++.++|+|++|||+..+ -|.---|++..++||++.+++|.- +=.++. ....
T Consensus 274 lynvlhe~-t~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarism-ad~kfs------fqe~ 344 (448)
T KOG0195|consen 274 LYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISM-ADTKFS------FQEV 344 (448)
T ss_pred HHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheec-ccceee------eecc
Confidence 99999764 33457788999999999999999999863 233446889999999999988742 111111 1111
Q ss_pred cccccCCccChhhhccCCCC---ccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCC
Q 043278 593 RIVGTYGYMSPEYAMSGIVS---IKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQP 669 (752)
Q Consensus 593 ~~~gt~~y~aPE~~~~~~~t---~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 669 (752)
.....+.||+||.++..+-+ +++|.|||+++||||.|.+-||....+-+..-.+ . -..++..
T Consensus 345 gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki------a---------leglrv~ 409 (448)
T KOG0195|consen 345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI------A---------LEGLRVH 409 (448)
T ss_pred ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh------h---------hcccccc
Confidence 22346789999999887644 5799999999999999999999876643322111 1 1122223
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 670 CSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 670 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
.+......+.+++.-|+.+||.+||.+..|+-.||..
T Consensus 410 ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 410 IPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred CCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 3444455677888899999999999999999999864
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.7e-20 Score=195.03 Aligned_cols=262 Identities=26% Similarity=0.395 Sum_probs=198.0
Q ss_pred CCcCCeeecCCcccEEEEEecCCceeEEEEcccCCcc---cHHHHHHHHHHHHhcCCC-CcceeeeeeeeCCeeEEEEee
Q 043278 432 FSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQ---GIVEFKNEVRLIAKLQHT-NLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 432 ~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~E~ 507 (752)
|...+.||.|+||.||++... ..+++|.+...... ....+.+|+.++..+.|+ +++++.+.+......++++|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 556789999999999999876 78899998766433 367789999999999988 799999999777778999999
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCC-Cceecccccceeecccc
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKM-NPKISDFGMARIFEVNE 586 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~-~~kl~DFgla~~~~~~~ 586 (752)
+.++++..++........+.......++.|++.++.|+|+.+ ++|||+||+||+++... .++++|||+++.+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999966643221125889999999999999999999998 99999999999999988 79999999998655433
Q ss_pred ccc----ccccccccCCccChhhhcc---CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcc
Q 043278 587 SEA----NTKRIVGTYGYMSPEYAMS---GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGL 659 (752)
Q Consensus 587 ~~~----~~~~~~gt~~y~aPE~~~~---~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 659 (752)
... ......++..|+|||.+.+ ...+...|+||+|++++++++|..|+...... .........+......
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~ 233 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTP 233 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCc
Confidence 221 2355789999999999988 68899999999999999999999996554421 0111122222211111
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 660 ELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 660 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.................+.+++..|+..+|..|.++.+....
T Consensus 234 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 -SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred -ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000011010002223456678889999999999999887664
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-20 Score=178.96 Aligned_cols=206 Identities=21% Similarity=0.326 Sum_probs=170.4
Q ss_pred HhcCCCcCCeeecCCcccEEEEE-ecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCC-CCcceeeeeeeeCCeeEEEE
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQH-TNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~ 505 (752)
..+.|.+.++||+|+||.+|.|. +.+|.+||||.-+..... -++..|..+...+++ ..|..+..+..+++.-.+||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 35789999999999999999997 578999999987654332 356789999999976 67888888899999999999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecC---CCCceecccccceee
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDD---KMNPKISDFGMARIF 582 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~---~~~~kl~DFgla~~~ 582 (752)
+.+ +-+|+++..-..+ .++.++.+-++.|++.-++|+|..+ +|||||||+|+|..- ...+.++|||+++.+
T Consensus 91 dLL-GPsLEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred ecc-CccHHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhh
Confidence 988 5677776643333 3788999999999999999999998 999999999999953 345889999999876
Q ss_pred cccccc-----cccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCC
Q 043278 583 EVNESE-----ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDR 641 (752)
Q Consensus 583 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~ 641 (752)
.+.... .......||..|++-....+...+.+.|.-|+|.||+.+.-|..||++.....
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~t 228 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAAT 228 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhh
Confidence 543322 12234679999999998888899999999999999999999999999876543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.4e-20 Score=181.96 Aligned_cols=204 Identities=25% Similarity=0.379 Sum_probs=171.5
Q ss_pred hcCCCcCCeeecCCcccEEEEE-ecCCceeEEEEcccCCcccHHHHHHHHHHHHhc-CCCCcceeeeeeeeCCeeEEEEe
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGEERLLVYE 506 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E 506 (752)
.-+|.+.++||+|.||..+.|+ +-+++.||||.-.+.+.. -++..|.+..+.| ..++|..++-+..++.+-.||+|
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A--PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA--PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccccCCc--chHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 4589999999999999999997 568899999987665432 3567888888888 56899999988888989999999
Q ss_pred eCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecC-----CCCceeccccccee
Q 043278 507 FMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDD-----KMNPKISDFGMARI 581 (752)
Q Consensus 507 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~-----~~~~kl~DFgla~~ 581 (752)
.+ +-+|+++..-.++ .++.+++.-+|.|++.-++|+|++. +|.|||||+|+||.. ...+.|+|||+|+.
T Consensus 105 LL-GPSLEDLFD~CgR--~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 105 LL-GPSLEDLFDLCGR--RFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hh-CcCHHHHHHHhcC--cccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 98 5678777654443 3899999999999999999999998 999999999999953 44589999999997
Q ss_pred eccccc-----ccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCC
Q 043278 582 FEVNES-----EANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPD 640 (752)
Q Consensus 582 ~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~ 640 (752)
..+... ....+...||.+||+-....+.+.+.+.|.-|+|-|+++.+-|..||++....
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~ 242 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD 242 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc
Confidence 654332 12234578999999999999999999999999999999999999999987643
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=5e-21 Score=216.97 Aligned_cols=255 Identities=20% Similarity=0.230 Sum_probs=186.2
Q ss_pred CcCCeeecCCcccEEEEEec-CCceeEEEEcccC--CcccHH----HHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEE
Q 043278 433 STTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRS--SGQGIV----EFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 433 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~----~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 505 (752)
...+.+|.|++|.|+..... ..+..+.|..... ...... .+..|+.+-..+.|+|++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 34578999999988877643 3333444432210 111111 2456777777789999998888877776666669
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccc
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVN 585 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~ 585 (752)
||+++ +|..++... ..+...++..++.|++.|++|||+.+ |.|||+|++|++++.++.+||+|||.+..+...
T Consensus 401 E~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 998888432 35888999999999999999999999 999999999999999999999999999887655
Q ss_pred ccc--cccccccccCCccChhhhccCCCCc-cchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCccccc
Q 043278 586 ESE--ANTKRIVGTYGYMSPEYAMSGIVSI-KTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELI 662 (752)
Q Consensus 586 ~~~--~~~~~~~gt~~y~aPE~~~~~~~t~-k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 662 (752)
... ......+|...|+|||.+.+..|.+ ..||||.|+++..|++|+.||......+... .......+.....
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-----~~~~~~~~~~~~~ 548 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-----KTNNYSDQRNIFE 548 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-----hhhcccccccccc
Confidence 443 4455688999999999999998886 5899999999999999999987665443321 0000000100000
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 663 DPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 663 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.+ .........+...++.++++.+|.+|-||++|++.
T Consensus 549 ~~---~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 549 GP---NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred Ch---HHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 00 11122334456678899999999999999999864
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.3e-20 Score=182.54 Aligned_cols=171 Identities=13% Similarity=0.123 Sum_probs=134.6
Q ss_pred HhcCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHH---------HHHHHHHHHhcCCCCcceeeeeeeeC
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVE---------FKNEVRLIAKLQHTNLVRLLGCSLHG 498 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~ 498 (752)
..++|...+.||.|+||.||+... ++..+|||.+.......... +.+|+..+.+++|++|..+.+++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 578999999999999999999766 56789999997654333222 67899999999999999999886533
Q ss_pred --------CeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCC
Q 043278 499 --------EERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMN 570 (752)
Q Consensus 499 --------~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~ 570 (752)
...+|+|||+++.+|.++.. ++. ....+++.+|..||+.+ ++|||+||+||+++.++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence 35789999999999977631 222 24568999999999998 99999999999999988
Q ss_pred ceecccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHH
Q 043278 571 PKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIV 628 (752)
Q Consensus 571 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ell 628 (752)
++|+|||.......... ...+.....+..++|+|+||+.+.-+.
T Consensus 173 i~liDfg~~~~~~e~~a--------------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKA--------------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhh--------------HHHHHHHhHhcccccccceeEeehHHH
Confidence 99999998864321110 111445556778999999999988665
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.1e-19 Score=177.83 Aligned_cols=139 Identities=20% Similarity=0.170 Sum_probs=108.1
Q ss_pred CCeeecCCcccEEEEEecCCceeEEEEcccCCcc--c-------HHH-----------------HHHHHHHHHhcCCCCc
Q 043278 435 TNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQ--G-------IVE-----------------FKNEVRLIAKLQHTNL 488 (752)
Q Consensus 435 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~--~-------~~~-----------------~~~E~~~l~~l~h~ni 488 (752)
...||+|+||.||+|...+|+.||||+++..... . ... ...|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999888999999999654211 1 112 2349999999988776
Q ss_pred ceeeeeeeeCCeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCcEeecCCCCCcEEecC
Q 043278 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYL-HKYSRLRVIHRDLKASNILLDD 567 (752)
Q Consensus 489 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~iiH~Dikp~NIll~~ 567 (752)
.....+.. ...+|||||++++++...... ...++......++.|++.+|.+| |+.+ |+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK---DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence 44333222 234899999999877654322 23588999999999999999999 6777 99999999999998
Q ss_pred CCCceecccccceee
Q 043278 568 KMNPKISDFGMARIF 582 (752)
Q Consensus 568 ~~~~kl~DFgla~~~ 582 (752)
++.++|+|||++...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 478999999999753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.8e-20 Score=210.93 Aligned_cols=252 Identities=19% Similarity=0.223 Sum_probs=179.9
Q ss_pred CCCcCCeeecCCcccEEEEEecCCceeEEEEcccCC-cccHHHHHHHHHHHH--hcCCCCcceeeeeeeeCCeeEEEEee
Q 043278 431 NFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSS-GQGIVEFKNEVRLIA--KLQHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~--~l~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
.+...+.||++.|=+|.+++.+.|. |+||++-+.. ....+.|.++++-++ .++|||.+++...-......+||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 4556689999999999999998887 8899886654 445566665555444 45899999998887777778899999
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccc
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES 587 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~ 587 (752)
..+ +|.+.+ ..+..|..-+..-|+.|++.||...|..+ |+|+|||.+||||+.-.-+.|+||..-+...-.+.
T Consensus 103 vkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 103 VKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred Hhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 865 455555 35666777888889999999999999998 99999999999999999999999987764432211
Q ss_pred ccc-----cccccccCCccChhhhcc----------CC-CCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHH
Q 043278 588 EAN-----TKRIVGTYGYMSPEYAMS----------GI-VSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAW 650 (752)
Q Consensus 588 ~~~-----~~~~~gt~~y~aPE~~~~----------~~-~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~ 650 (752)
.+. ...-..-..|+|||.+.. .. .+++-||||+|||++||++ |+++|.... +..+-.
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ------L~aYr~ 249 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ------LLAYRS 249 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH------HHhHhc
Confidence 111 111223347999998743 12 7789999999999999998 577764322 111100
Q ss_pred HHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 651 QLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 651 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
......+.+=..+.. ..+.++++.|++.||.+|-+++++++.-.+.
T Consensus 250 ---~~~~~~e~~Le~Ied-------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 250 ---GNADDPEQLLEKIED-------VSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred ---cCccCHHHHHHhCcC-------ccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 000000000000000 1355788999999999999999999986554
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.6e-19 Score=193.49 Aligned_cols=217 Identities=24% Similarity=0.370 Sum_probs=164.9
Q ss_pred HHhcCCCCcceeeeeeeeCCeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCC
Q 043278 480 IAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLK 559 (752)
Q Consensus 480 l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dik 559 (752)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+.. ....+++.-...++++|++||+|||... -..|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence 3567899999999999999999999999999999999976 3445899999999999999999999865 12999999
Q ss_pred CCcEEecCCCCceecccccceeecccccccccccccccCCccChhhhccC-------CCCccchhHHHHHHHHHHHhCCC
Q 043278 560 ASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSG-------IVSIKTDVFSFGVLVLEIVSGQK 632 (752)
Q Consensus 560 p~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~t~k~DV~S~G~vl~elltG~~ 632 (752)
++|+++|....+||+|||+.................-...|.|||.+... ..+.+.||||||++++|+++.+.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 99999999999999999998876431111111122335679999988663 25778999999999999999999
Q ss_pred CCCCCCCCCCc-chHHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCC
Q 043278 633 NHTRHHPDRPL-NLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNET 707 (752)
Q Consensus 633 p~~~~~~~~~~-~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~ 707 (752)
||......... .++.. +.. .....+.|.+.... +....+..++.+||..+|.+||++++|-..++...
T Consensus 157 ~~~~~~~~~~~~eii~~----~~~-~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~ 225 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILR----VKK-GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN 225 (484)
T ss_pred ccccccccCChHHHHHH----HHh-cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence 99875544332 12211 222 12223334332211 33336888999999999999999999998887653
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=1e-18 Score=171.62 Aligned_cols=140 Identities=21% Similarity=0.234 Sum_probs=110.8
Q ss_pred CCeeecCCcccEEEEEecCCceeEEEEcccCCcc---------------------c-----HHHHHHHHHHHHhcCCCCc
Q 043278 435 TNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQ---------------------G-----IVEFKNEVRLIAKLQHTNL 488 (752)
Q Consensus 435 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---------------------~-----~~~~~~E~~~l~~l~h~ni 488 (752)
...||+|++|.||+|...+|+.||||++...... . ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999878999999998764211 0 1123578999999999987
Q ss_pred ceeeeeeeeCCeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCcEeecCCCCCcEEecC
Q 043278 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHK-YSRLRVIHRDLKASNILLDD 567 (752)
Q Consensus 489 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~Dikp~NIll~~ 567 (752)
.....+... ..+|||||++++++...... ...++......++.|++.++.+||+ .+ |+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~---~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK---DVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh---hccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 544443322 34899999998865443222 2347788999999999999999999 87 99999999999999
Q ss_pred CCCceecccccceeec
Q 043278 568 KMNPKISDFGMARIFE 583 (752)
Q Consensus 568 ~~~~kl~DFgla~~~~ 583 (752)
++.++|+|||++....
T Consensus 153 ~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCCEEEEEcccceecC
Confidence 8899999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=6.8e-18 Score=163.19 Aligned_cols=187 Identities=19% Similarity=0.165 Sum_probs=140.1
Q ss_pred cCCeeecCCcccEEEEEecCCceeEEEEcccCCccc----HHHHHHHHHHHHhcC-CCCcceeeeeeeeCCeeEEEEeeC
Q 043278 434 TTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQG----IVEFKNEVRLIAKLQ-HTNLVRLLGCSLHGEERLLVYEFM 508 (752)
Q Consensus 434 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~----~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~ 508 (752)
....|++|+||+||.+.- ++.+++.+.+....... ...+.+|+++|.+++ |+++.+++++ +..+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 357899999999997765 67778877776553311 125789999999995 5789999886 4569999999
Q ss_pred CCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCC-CCCcEEecCCCCceecccccceeeccccc
Q 043278 509 PNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDL-KASNILLDDKMNPKISDFGMARIFEVNES 587 (752)
Q Consensus 509 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Di-kp~NIll~~~~~~kl~DFgla~~~~~~~~ 587 (752)
.+.+|...+.. ....++.|++++|.++|+++ |+|||| ||.|||++.++.++|+|||++........
T Consensus 81 ~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 81 AGAAMYQRPPR----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred cCccHHhhhhh----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 99998654311 12357789999999999998 999999 79999999999999999999986543221
Q ss_pred c----c--c-----cccccccCCccChhhhccC-CCC-ccchhHHHHHHHHHHHhCCCCCCCCC
Q 043278 588 E----A--N-----TKRIVGTYGYMSPEYAMSG-IVS-IKTDVFSFGVLVLEIVSGQKNHTRHH 638 (752)
Q Consensus 588 ~----~--~-----~~~~~gt~~y~aPE~~~~~-~~t-~k~DV~S~G~vl~elltG~~p~~~~~ 638 (752)
. . . ......++.|++|+...-. ..+ ...+.++-|.-+|.++|++.+.-.+.
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0 0 0 1112357888888854322 223 56789999999999999987765544
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=5e-18 Score=195.84 Aligned_cols=250 Identities=18% Similarity=0.245 Sum_probs=182.0
Q ss_pred HHHHhcCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcC---CCCcceeeeeeeeCCee
Q 043278 425 IAAAANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQ---HTNLVRLLGCSLHGEER 501 (752)
Q Consensus 425 i~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~ 501 (752)
++...+.|.+.+.||+|+||+||+|...+|+.||||.-+..... +|.--.+++.+|+ -+-|..+...+.-.+..
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 44566789999999999999999999888999999998765432 1222223333443 23455555556667788
Q ss_pred EEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEec-------CCCCceec
Q 043278 502 LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLD-------DKMNPKIS 574 (752)
Q Consensus 502 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~-------~~~~~kl~ 574 (752)
+||+||.+.|+|.+++. ..+.++|.....++.|+++.++.||..+ |||+||||+|.||. ++..++|+
T Consensus 770 ~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred eeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEE
Confidence 99999999999999985 5567999999999999999999999998 99999999999994 34558999
Q ss_pred ccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhh
Q 043278 575 DFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLS 654 (752)
Q Consensus 575 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 654 (752)
|||.+-.+..-.........++|-.+--+|+..+.++++++|.|.++.+++-|+.|+..- ..
T Consensus 844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q------------------~~ 905 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME------------------VK 905 (974)
T ss_pred ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH------------------hc
Confidence 999987654333333334567888999999999999999999999999999999986321 11
Q ss_pred CCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 043278 655 DGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705 (752)
Q Consensus 655 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~ 705 (752)
.|. ...++..+..-...+...+++++++. .|-..=|...++...|++
T Consensus 906 ~g~-~~~~~~~~~Ry~~~~~W~~~F~~lLN---~~~~~~p~l~~lr~~~~~ 952 (974)
T KOG1166|consen 906 NGS-SWMVKTNFPRYWKRDMWNKFFDLLLN---PDCDTLPNLQELRTELEE 952 (974)
T ss_pred CCc-ceeccccchhhhhHHHHHHHHHHHhC---cCcccchhHHHHHHHHHH
Confidence 111 11222223333344455555555444 455555666676666654
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.4e-17 Score=164.46 Aligned_cols=137 Identities=23% Similarity=0.319 Sum_probs=106.4
Q ss_pred CcCCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhc-----CCCCcceeeeeeeeCC---e-eEE
Q 043278 433 STTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKL-----QHTNLVRLLGCSLHGE---E-RLL 503 (752)
Q Consensus 433 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~-~~l 503 (752)
...+.||+|+||.||. ...++. .+||++........+++.+|+.++.++ +||||++++|++.++. . ..+
T Consensus 5 ~~~~~LG~G~~~~Vy~-hp~~~~-k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA-HPEDAQ-RCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE-CCCCcC-eEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 4457999999999996 333344 478988765445567899999999999 5799999999998764 3 347
Q ss_pred EEee--CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCcEeecCCCCCcEEecC----CCCceecc-
Q 043278 504 VYEF--MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGL-LYLHKYSRLRVIHRDLKASNILLDD----KMNPKISD- 575 (752)
Q Consensus 504 v~E~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l-~~LH~~~~~~iiH~Dikp~NIll~~----~~~~kl~D- 575 (752)
|+|| +++++|.+++.+. .+++. ..++.+++.++ +|||+++ |+||||||+|||++. +..++|+|
T Consensus 83 I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 8999 5689999999442 24444 35677888777 9999998 999999999999973 34799999
Q ss_pred cccce
Q 043278 576 FGMAR 580 (752)
Q Consensus 576 Fgla~ 580 (752)
||...
T Consensus 154 ~G~~~ 158 (210)
T PRK10345 154 IGEST 158 (210)
T ss_pred CCCcc
Confidence 45443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.7e-18 Score=183.40 Aligned_cols=233 Identities=22% Similarity=0.233 Sum_probs=174.1
Q ss_pred eeecCCcccEEEEE----ecCCceeEEEEcccCCccc--HHHHHHHHHHHHhcC-CCCcceeeeeeeeCCeeEEEEeeCC
Q 043278 437 KLGEGGFGPVYKGK----LADEQEVAIKRLSRSSGQG--IVEFKNEVRLIAKLQ-HTNLVRLLGCSLHGEERLLVYEFMP 509 (752)
Q Consensus 437 ~LG~G~fg~Vy~~~----~~~~~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~ 509 (752)
.+|+|.||.|++++ .+.|..+|+|.+++..... ......|..++...+ ||.+|++.-.+..+...+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999764 3457778999887653211 114467888888887 9999999999999999999999999
Q ss_pred CCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccccc
Q 043278 510 NKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEA 589 (752)
Q Consensus 510 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 589 (752)
+|.|...+.+ ....+..........++-+++++|+.+ |+|||+|++||+++.+|++|+.|||+++..-...
T Consensus 81 gg~lft~l~~---~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~--- 151 (612)
T KOG0603|consen 81 GGDLFTRLSK---EVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK--- 151 (612)
T ss_pred cchhhhcccc---CCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhh---
Confidence 9998777743 333566666677788999999999998 9999999999999999999999999998542211
Q ss_pred ccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCC
Q 043278 590 NTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQP 669 (752)
Q Consensus 590 ~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 669 (752)
..+||..|||||++. .....+|.||||++++||++|..||..+. ....+.. ...
T Consensus 152 ---~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~~----------~~~Il~~-----------~~~ 205 (612)
T KOG0603|consen 152 ---IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGDT----------MKRILKA-----------ELE 205 (612)
T ss_pred ---hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchHH----------HHHHhhh-----------ccC
Confidence 128899999999998 55778999999999999999999987711 1111110 011
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCH--HHHHHHhh
Q 043278 670 CSANEVMRCIHVGLLCVQDQAMDRPTM--PEVVCMLQ 704 (752)
Q Consensus 670 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~--~ev~~~L~ 704 (752)
.+.+....+-+++......+|..|--. ..+.++++
T Consensus 206 ~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~ 242 (612)
T KOG0603|consen 206 MPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQ 242 (612)
T ss_pred CchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhc
Confidence 233334444556667778888888644 34444443
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.6e-17 Score=164.80 Aligned_cols=231 Identities=18% Similarity=0.235 Sum_probs=149.1
Q ss_pred CcCCeeecCCcccEEEEEecC-CceeEEEEcccC---CcccHHHHHHHHHHHHhcCC----------CCcceeeee----
Q 043278 433 STTNKLGEGGFGPVYKGKLAD-EQEVAIKRLSRS---SGQGIVEFKNEVRLIAKLQH----------TNLVRLLGC---- 494 (752)
Q Consensus 433 ~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h----------~niv~l~~~---- 494 (752)
...+.||.|+++.||.++..+ ++++|||..... .....+++++|...+..+.+ -.++..++.
T Consensus 15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~ 94 (288)
T PF14531_consen 15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP 94 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence 345789999999999999854 889999987543 23345667777766655432 122222221
Q ss_pred -----eeeCC--------eeEEEEeeCCCCCHhHHHhh---cC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecC
Q 043278 495 -----SLHGE--------ERLLVYEFMPNKSLDFFLFN---SG-RKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRD 557 (752)
Q Consensus 495 -----~~~~~--------~~~lv~E~~~~gsL~~~l~~---~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~D 557 (752)
+.... ..+++|+-+ .++|..++.. .. ....+....++.+..|+++.+++||+.+ ++|+|
T Consensus 95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgd 170 (288)
T PF14531_consen 95 GKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGD 170 (288)
T ss_dssp TS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST
T ss_pred CCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEecc
Confidence 11111 236778877 5678776532 21 2233556677788899999999999999 99999
Q ss_pred CCCCcEEecCCCCceecccccceeecccccccccccccccCCccChhhhcc--------CCCCccchhHHHHHHHHHHHh
Q 043278 558 LKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMS--------GIVSIKTDVFSFGVLVLEIVS 629 (752)
Q Consensus 558 ikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~t~k~DV~S~G~vl~ellt 629 (752)
|+|+|++++.+|.++|+||+.....+..... ...+..|.+||.... ..++.+.|.|++|+++|.|++
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred cceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 9999999999999999999887754322111 233478999997644 357899999999999999999
Q ss_pred CCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCC
Q 043278 630 GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDR 693 (752)
Q Consensus 630 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~R 693 (752)
|+.||....+...... .+ ..+. +..+.+..|+..+++.+|++|
T Consensus 246 ~~lPf~~~~~~~~~~~-------------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADPEW-------------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTSGG-------------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCccccccc-------------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999987653322210 11 2233 556667788889999999987
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.6e-16 Score=157.64 Aligned_cols=134 Identities=19% Similarity=0.263 Sum_probs=113.2
Q ss_pred CeeecCCcccEEEEEecCCceeEEEEcccCCcc--------cHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEee
Q 043278 436 NKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQ--------GIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
+.||+|++|.||+|.. .|..+++|+....... ....+.+|+.++..++|+++.....++...+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 6678999986543211 123577899999999999988877777777888999999
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceeccccccee
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARI 581 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~ 581 (752)
+++++|.+.+... .. .+..++.+++.+|.+||+.+ ++|+|++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999888432 12 78899999999999999988 99999999999999 78899999999874
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.3e-16 Score=156.20 Aligned_cols=145 Identities=21% Similarity=0.204 Sum_probs=113.0
Q ss_pred HHHHHHhcCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCCc----------------------ccHHHHHHHHHHH
Q 043278 423 QTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSG----------------------QGIVEFKNEVRLI 480 (752)
Q Consensus 423 ~~i~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~----------------------~~~~~~~~E~~~l 480 (752)
.++......|.+.+.||+|+||.||++...+|+.||||++..... .....+..|..++
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 445555555888899999999999999988899999998654320 0112357788899
Q ss_pred HhcCCCC--cceeeeeeeeCCeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCC
Q 043278 481 AKLQHTN--LVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDL 558 (752)
Q Consensus 481 ~~l~h~n--iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Di 558 (752)
..+.|++ +...++. ...++||||+++++|..... ......++.+++.++.++|+.+ |+|+||
T Consensus 88 ~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl 151 (198)
T cd05144 88 KALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKHG---IIHGDL 151 (198)
T ss_pred HHHHHcCCCCCceeec----CCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHCC---CCcCCC
Confidence 9988774 4444442 35589999999999866541 1345678899999999999987 999999
Q ss_pred CCCcEEecCCCCceecccccceeec
Q 043278 559 KASNILLDDKMNPKISDFGMARIFE 583 (752)
Q Consensus 559 kp~NIll~~~~~~kl~DFgla~~~~ 583 (752)
||.||++++++.++|+|||++..+.
T Consensus 152 ~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 152 SEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CcccEEEcCCCcEEEEECCccccCC
Confidence 9999999999999999999997544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.9e-16 Score=159.07 Aligned_cols=146 Identities=18% Similarity=0.178 Sum_probs=112.3
Q ss_pred HhcCCCcCCeeecCCcccEEEEE--ecCCceeEEEEcccCCcc------------------------cHHHHHHHHHHHH
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGK--LADEQEVAIKRLSRSSGQ------------------------GIVEFKNEVRLIA 481 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~--~~~~~~vavK~l~~~~~~------------------------~~~~~~~E~~~l~ 481 (752)
....|.+.+.||+|++|.||+|. ..+|+.||+|++...... ....+..|+..+.
T Consensus 26 ~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~ 105 (237)
T smart00090 26 RGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQ 105 (237)
T ss_pred cCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHH
Confidence 34458888999999999999998 568999999998754210 0123568999999
Q ss_pred hcCCC--CcceeeeeeeeCCeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCC
Q 043278 482 KLQHT--NLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLK 559 (752)
Q Consensus 482 ~l~h~--niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dik 559 (752)
++.+. .+.+++++ ...++||||+++.+|...... ...+.......++.||+.++.+||+.+ .|+|||||
T Consensus 106 ~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dik 176 (237)
T smart00090 106 RLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLS 176 (237)
T ss_pred HHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCC
Confidence 99753 34444443 235899999999888665422 223556667889999999999999876 39999999
Q ss_pred CCcEEecCCCCceecccccceeec
Q 043278 560 ASNILLDDKMNPKISDFGMARIFE 583 (752)
Q Consensus 560 p~NIll~~~~~~kl~DFgla~~~~ 583 (752)
|+||+++ ++.++|+|||++....
T Consensus 177 p~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 177 EYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hhhEEEE-CCCEEEEEChhhhccC
Confidence 9999999 8899999999987543
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.66 E-value=5.2e-16 Score=153.95 Aligned_cols=130 Identities=21% Similarity=0.316 Sum_probs=106.4
Q ss_pred eeecCCcccEEEEEecCCceeEEEEcccCCcc--------cHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeC
Q 043278 437 KLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQ--------GIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFM 508 (752)
Q Consensus 437 ~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 508 (752)
.||+|+||.||+|.. ++..+++|........ ...++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 5678999986543211 1245678999999999887666555666677789999999
Q ss_pred CCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceeccccccee
Q 043278 509 PNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARI 581 (752)
Q Consensus 509 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~ 581 (752)
++++|.+.+.... . .++.+++.+|.+||+.+ ++|+|++|.||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~----~------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN----D------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH----H------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999988774311 0 78999999999999988 99999999999999 88999999999874
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.66 E-value=6e-17 Score=171.69 Aligned_cols=175 Identities=25% Similarity=0.323 Sum_probs=131.9
Q ss_pred eeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccc
Q 043278 500 ERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMA 579 (752)
Q Consensus 500 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla 579 (752)
+.+|.|++|...+|.++|.........++...+.++.|++.|++| ++ .+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 568999999999999999877777778899999999999999999 55 999999999999999999999999998
Q ss_pred eeecccc----cccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhh
Q 043278 580 RIFEVNE----SEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLS 654 (752)
Q Consensus 580 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~ 654 (752)
....... .........||..||+||.+.+..|+.|+||||||++|+|++. =...++.. .+..-++
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~----------~t~~d~r 473 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI----------ATLTDIR 473 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH----------Hhhhhhh
Confidence 7654333 1222345689999999999999999999999999999999997 11111111 1122233
Q ss_pred CCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 043278 655 DGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEV 699 (752)
Q Consensus 655 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev 699 (752)
++.+. |......+ .-..++.+++...|.+||++.++
T Consensus 474 ~g~ip----~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 474 DGIIP----PEFLQDYP-----EEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred cCCCC----hHHhhcCc-----HHHHHHHHhcCCCcccCchHHHH
Confidence 33222 11111111 22357779999999999955554
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.65 E-value=6.4e-16 Score=176.30 Aligned_cols=138 Identities=20% Similarity=0.306 Sum_probs=112.1
Q ss_pred hcCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCCc-------ccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCee
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSG-------QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEER 501 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 501 (752)
...|...+.||+|+||+||+|.+.+...++.+++.+... ....++.+|++++.+++|++++....++...+..
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 345566789999999999999875554333332322111 1234678999999999999999888888777788
Q ss_pred EEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceeccccccee
Q 043278 502 LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARI 581 (752)
Q Consensus 502 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~ 581 (752)
++||||+++++|.+++. ....++.+++++|.+||+.+ ++||||||+|||+ +++.++|+|||+++.
T Consensus 412 ~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999988873 45678999999999999988 9999999999999 678999999999975
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=5.1e-15 Score=150.51 Aligned_cols=197 Identities=23% Similarity=0.295 Sum_probs=133.6
Q ss_pred CCCCcceeeeeeeeC---------------------------CeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHH
Q 043278 484 QHTNLVRLLGCSLHG---------------------------EERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIE 536 (752)
Q Consensus 484 ~h~niv~l~~~~~~~---------------------------~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 536 (752)
+|||||++.+.|.+. ...++||.-.+ .+|..++... ..+...+.-++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~----~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR----HRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC----CCchHHHHHHHH
Confidence 599999998876532 35578887664 4788888542 356677777899
Q ss_pred HHHHHHHHHHhcCCCcEeecCCCCCcEEe--cCCC--Cceecccccceeeccc----ccccccccccccCCccChhhhcc
Q 043278 537 GISQGLLYLHKYSRLRVIHRDLKASNILL--DDKM--NPKISDFGMARIFEVN----ESEANTKRIVGTYGYMSPEYAMS 608 (752)
Q Consensus 537 ~i~~~l~~LH~~~~~~iiH~Dikp~NIll--~~~~--~~kl~DFgla~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~ 608 (752)
|+++|+.|||.++ |.|||+|++|||| |++. ...|+|||++---... ......-...|...-||||+...
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999999 9999999999999 3443 4689999987532211 01111123456778999998865
Q ss_pred CC------CCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHH
Q 043278 609 GI------VSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVG 682 (752)
Q Consensus 609 ~~------~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~ 682 (752)
.+ --.|+|.|+.|.+.||++.-..||.....- ....-.+ .+.++ |.+.. .....+.+++
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem-~L~~r~Y-----qe~qL-----Palp~----~vpp~~rqlV 490 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM-LLDTRTY-----QESQL-----PALPS----RVPPVARQLV 490 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh-eechhhh-----hhhhC-----CCCcc----cCChHHHHHH
Confidence 32 226899999999999999999999763211 1111111 11111 11211 2223455778
Q ss_pred HHcccCCCCCCCCHHHHHHHh
Q 043278 683 LLCVQDQAMDRPTMPEVVCML 703 (752)
Q Consensus 683 ~~Cl~~dp~~RPt~~ev~~~L 703 (752)
...++.||.+||+..-....|
T Consensus 491 ~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHhcCCccccCCccHHHhHH
Confidence 888999999999876555554
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.6e-14 Score=135.93 Aligned_cols=135 Identities=24% Similarity=0.247 Sum_probs=115.0
Q ss_pred cCCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCC--CCcceeeeeeeeCCeeEEEEeeCCCC
Q 043278 434 TTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQH--TNLVRLLGCSLHGEERLLVYEFMPNK 511 (752)
Q Consensus 434 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~E~~~~g 511 (752)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+..+..++| .++.+++++....+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35789999999999999855 7899999865543 5678999999999976 58999999888888899999999987
Q ss_pred CHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceeccccccee
Q 043278 512 SLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARI 581 (752)
Q Consensus 512 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~ 581 (752)
.+..+ +......++.+++++|++||.....+++|+|++|.||++++.+.++++|||.++.
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 76433 5567778899999999999987555699999999999999989999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.5e-14 Score=141.93 Aligned_cols=136 Identities=22% Similarity=0.232 Sum_probs=97.3
Q ss_pred CCeeecCCcccEEEEEecCCceeEEEEcccCCcc--cHHH----------------------HHHHHHHHHhcCCCC--c
Q 043278 435 TNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQ--GIVE----------------------FKNEVRLIAKLQHTN--L 488 (752)
Q Consensus 435 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~--~~~~----------------------~~~E~~~l~~l~h~n--i 488 (752)
.+.||+|+||.||++...+++.||||++...... .... ...|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4689999999999999888999999988653211 1111 134555565554432 4
Q ss_pred ceeeeeeeeCCeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCcEeecCCCCCcEEecC
Q 043278 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHK-YSRLRVIHRDLKASNILLDD 567 (752)
Q Consensus 489 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~Dikp~NIll~~ 567 (752)
.+.+++ ...++||||++++.+......... .. .....++.+++.++.++|. .+ |+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 444433 246899999999544221111100 11 5678899999999999999 76 99999999999999
Q ss_pred CCCceecccccceee
Q 043278 568 KMNPKISDFGMARIF 582 (752)
Q Consensus 568 ~~~~kl~DFgla~~~ 582 (752)
++.++|+|||.+...
T Consensus 150 ~~~~~liDfg~a~~~ 164 (187)
T cd05119 150 DGKVYIIDVPQAVEI 164 (187)
T ss_pred CCcEEEEECcccccc
Confidence 899999999999743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.54 E-value=5.5e-14 Score=142.75 Aligned_cols=134 Identities=24% Similarity=0.279 Sum_probs=104.7
Q ss_pred Ceee-cCCcccEEEEEecCCceeEEEEcccCC-------------cccHHHHHHHHHHHHhcCCCCc--ceeeeeeeeCC
Q 043278 436 NKLG-EGGFGPVYKGKLADEQEVAIKRLSRSS-------------GQGIVEFKNEVRLIAKLQHTNL--VRLLGCSLHGE 499 (752)
Q Consensus 436 ~~LG-~G~fg~Vy~~~~~~~~~vavK~l~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~~ 499 (752)
..|| .|+.|+||++... +..++||++.+.. ......+.+|++++.+++|+++ ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 5788 8999999999885 6678999885421 1223467889999999998774 67777654332
Q ss_pred ----eeEEEEeeCCC-CCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceec
Q 043278 500 ----ERLLVYEFMPN-KSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKIS 574 (752)
Q Consensus 500 ----~~~lv~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~ 574 (752)
..++|||++++ .+|.+++.. ..++.. .+.+|+.+|.+||+.+ |+|+||||.|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 23599999997 689888743 234433 3568999999999998 9999999999999998999999
Q ss_pred cccccee
Q 043278 575 DFGMARI 581 (752)
Q Consensus 575 DFgla~~ 581 (752)
|||.+..
T Consensus 185 Dfg~~~~ 191 (239)
T PRK01723 185 DFDRGEL 191 (239)
T ss_pred ECCCccc
Confidence 9999875
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.54 E-value=6.8e-15 Score=166.56 Aligned_cols=209 Identities=21% Similarity=0.332 Sum_probs=136.8
Q ss_pred hcCCCcCCeeecCCcccEEEEEecC-CceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEee
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLAD-EQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
..+|..++.|..|++|.||..+++. .+++|+| +.+...- .++ ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~li----lRn---ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI----LRN---ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccchh----hhc---cccccCCccee------------------
Confidence 4578888999999999999998764 5667774 3222110 000 11111222222
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccc-
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE- 586 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~- 586 (752)
|+=...+.. .+.++.. .+.+++|||+.+ |+|||+||+|.+|+.-|++|+.|||+.+......
T Consensus 136 ---gDc~tllk~---~g~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ---GDCATLLKN---IGPLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ---chhhhhccc---CCCCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 222222211 1223322 267899999988 9999999999999999999999999987532111
Q ss_pred ------------cccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhh
Q 043278 587 ------------SEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLS 654 (752)
Q Consensus 587 ------------~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 654 (752)
.+...+.++||+.|+|||++....|...+|.|++|+|+||.+-|+-||.++.+++.......-...+.
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wp 278 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP 278 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccc
Confidence 11123456999999999999999999999999999999999999999998865532211110000111
Q ss_pred CCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 043278 655 DGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRP 694 (752)
Q Consensus 655 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP 694 (752)
++ | +... .+..+++.+.++.+|.+|-
T Consensus 279 E~------d-----ea~p---~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 279 EE------D-----EALP---PEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred cc------C-----cCCC---HHHHHHHHHHHHhChHhhc
Confidence 10 1 1112 2344566678889999995
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.49 E-value=4.7e-15 Score=168.47 Aligned_cols=256 Identities=22% Similarity=0.276 Sum_probs=185.7
Q ss_pred cCCCcCCeeecCCcccEEEEEecC--CceeEEEEcccCC--cccHHHHHHHHHHHHhcC-CCCcceeeeeeeeCCeeEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLAD--EQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQ-HTNLVRLLGCSLHGEERLLV 504 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~--~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 504 (752)
..|...+.||+|+|+.|-...... ...+|+|.+.... .........|..+=..+. |+|++++++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 355666789999999998887533 4456777765543 222223344666666665 99999999999999999999
Q ss_pred EeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCcEeecCCCCCcEEecCCC-Cceecccccceee
Q 043278 505 YEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLH-KYSRLRVIHRDLKASNILLDDKM-NPKISDFGMARIF 582 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~iiH~Dikp~NIll~~~~-~~kl~DFgla~~~ 582 (752)
.||..++++...+.... ....+...+-....|+..++.|+| ..+ +.|+||||+|.+++..+ ..+++|||+|..+
T Consensus 100 ~~~s~g~~~f~~i~~~~-~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPD-STGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cCcccccccccccccCC-ccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence 99999999877773211 113556667778999999999999 776 99999999999999999 9999999999987
Q ss_pred cc-cccccccccccc-cCCccChhhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcc
Q 043278 583 EV-NESEANTKRIVG-TYGYMSPEYAMSG-IVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGL 659 (752)
Q Consensus 583 ~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 659 (752)
.. ..........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+.......... ..|. +.+..
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~-~~~~-----~~~~~ 249 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY-SSWK-----SNKGR 249 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc-eeec-----ccccc
Confidence 76 555555556778 9999999998884 56788999999999999999999987765443210 1110 00000
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 043278 660 ELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVC 701 (752)
Q Consensus 660 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~ 701 (752)
..............++...++..+|..|.+.+++-.
T Consensus 250 ------~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 250 ------FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ------cccCccccCChhhhhcccccccCCchhccccccccc
Confidence 000011111223455666788899999998887744
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.39 E-value=5.9e-13 Score=132.75 Aligned_cols=204 Identities=20% Similarity=0.231 Sum_probs=140.1
Q ss_pred HHHHhcCCCCcceeeeeeeeC-----CeeEEEEeeCCCCCHhHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 043278 478 RLIAKLQHTNLVRLLGCSLHG-----EERLLVYEFMPNKSLDFFLFNSGR-KNVLNWEKRFIIIEGISQGLLYLHKYSRL 551 (752)
Q Consensus 478 ~~l~~l~h~niv~l~~~~~~~-----~~~~lv~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ 551 (752)
.-|-++-|.|||++..|..+. .+..++.|||..|++..+|.+..+ ...+..+...+++.||+.||.|||+.. +
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-P 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-C
Confidence 344456799999999987543 356899999999999999987543 455788888899999999999999864 7
Q ss_pred cEeecCCCCCcEEecCCCCceecccccceeec--ccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh
Q 043278 552 RVIHRDLKASNILLDDKMNPKISDFGMARIFE--VNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629 (752)
Q Consensus 552 ~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~--~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt 629 (752)
+|+|+++.-+-|++..++-+||.--.-..... .......+....+-++|.+||+=.....+.++|||+||+..+||..
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 89999999999999999988884321111000 0001111223456789999998887888899999999999999988
Q ss_pred CCCCCC-CCCCCCCcchHHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 630 GQKNHT-RHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 630 G~~p~~-~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
+.--.. ..........+......+ ...+. ..++..|++..|+.||+|.+++.+
T Consensus 278 lEiq~tnseS~~~~ee~ia~~i~~l---------en~lq-----------r~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 278 LEIQSTNSESKVEVEENIANVIIGL---------ENGLQ-----------RGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred heeccCCCcceeehhhhhhhheeec---------cCccc-----------cCcCcccccCCCCCCcchhhhhcC
Confidence 764211 111111111111110011 11111 134567999999999999988766
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.9e-12 Score=142.95 Aligned_cols=140 Identities=21% Similarity=0.254 Sum_probs=99.1
Q ss_pred CeeecCCcccEEEEEecCCceeEEEEcccCCcccH----------------------------------------HHHHH
Q 043278 436 NKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGI----------------------------------------VEFKN 475 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~----------------------------------------~~~~~ 475 (752)
+.||+|++|.||+|++.+|+.||||+.+....... -.|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 67999999999999999999999999865421100 02444
Q ss_pred HHHHHHhc----CCCCcceeeeee-eeCCeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHH-HHHHHHhcC
Q 043278 476 EVRLIAKL----QHTNLVRLLGCS-LHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQ-GLLYLHKYS 549 (752)
Q Consensus 476 E~~~l~~l----~h~niv~l~~~~-~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~-~l~~LH~~~ 549 (752)
|...+.++ +|.+-+.+-..+ ......+|||||+++++|.+....... .. .+..++.++++ .+..+|..+
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhCC
Confidence 55555554 233323332322 223467999999999999887643211 12 23456666666 467889887
Q ss_pred CCcEeecCCCCCcEEecCCCCceecccccceeec
Q 043278 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFE 583 (752)
Q Consensus 550 ~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~ 583 (752)
++|+|+||.||++++++.++++|||++..+.
T Consensus 278 ---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 ---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999999999999999999997654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.9e-11 Score=117.66 Aligned_cols=130 Identities=21% Similarity=0.194 Sum_probs=97.4
Q ss_pred CeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcc-eeeeeeeeCCeeEEEEeeCCCCCHh
Q 043278 436 NKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLV-RLLGCSLHGEERLLVYEFMPNKSLD 514 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~E~~~~gsL~ 514 (752)
+.|+.|.++.||+++.. ++.+++|....... ....+..|+..+..+.+.+++ +++.+. ....++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 57899999999999875 67899998765432 223467899999988665544 444443 33468999999998875
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCcEeecCCCCCcEEecCCCCceeccccccee
Q 043278 515 FFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS--RLRVIHRDLKASNILLDDKMNPKISDFGMARI 581 (752)
Q Consensus 515 ~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~ 581 (752)
... . ....++.+++++|+.||..+ ...++|+|++|.||+++ ++.++++||+.+..
T Consensus 80 ~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 320 0 11245678999999999876 23469999999999999 66899999999864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.19 E-value=3.3e-11 Score=130.96 Aligned_cols=250 Identities=20% Similarity=0.250 Sum_probs=174.7
Q ss_pred cCCCcCCeeec--CCcccEEEEEe---cCCceeEEEEcccCCc--ccHHHHHHHHHHHHhc-CCCCcceeeeeeeeCCee
Q 043278 430 NNFSTTNKLGE--GGFGPVYKGKL---ADEQEVAIKRLSRSSG--QGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGEER 501 (752)
Q Consensus 430 ~~~~~~~~LG~--G~fg~Vy~~~~---~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 501 (752)
..|...+.+|. |.+|.||.+.. .++..+|+|+-+.... .....=.+|+....++ .|+|.++.......++..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 35566788999 99999999986 3577899998543322 2222224566666666 589999988888888999
Q ss_pred EEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCcEeecCCCCCcEEecCC-CCceeccc
Q 043278 502 LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQ----GLLYLHKYSRLRVIHRDLKASNILLDDK-MNPKISDF 576 (752)
Q Consensus 502 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~----~l~~LH~~~~~~iiH~Dikp~NIll~~~-~~~kl~DF 576 (752)
++-+|++. .+|..+.... ...++....+....+... ||..+|+.. ++|-|+||.||++..+ ...++.||
T Consensus 194 fiqtE~~~-~sl~~~~~~~--~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTP--CNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeeecccc-chhHHhhhcc--cccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence 99999886 6776666432 334666677777777777 999999988 9999999999999999 88999999
Q ss_pred ccceeecccccccc---cccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHh
Q 043278 577 GMARIFEVNESEAN---TKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLL 653 (752)
Q Consensus 577 gla~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 653 (752)
|+...++....... .....|...|++||.. .+.++.+.|+|++|.+++|..++..+...... ..|..+
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~--------~~W~~~ 338 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKN--------SSWSQL 338 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCC--------CCcccc
Confidence 99988765542211 1233577789999955 45678899999999999999998765433211 012222
Q ss_pred hCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 654 SDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 654 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
+.+.+. .++.... ..++...+..+++.+|..|++.+.+...
T Consensus 339 r~~~ip----~e~~~~~----s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 339 RQGYIP----LEFCEGG----SSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred ccccCc----hhhhcCc----chhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 222111 1111111 1123336778999999999988877543
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.17 E-value=4.5e-11 Score=133.43 Aligned_cols=144 Identities=16% Similarity=0.187 Sum_probs=92.4
Q ss_pred cCCCcCCeeecCCcccEEEEEecC-CceeEEEEcccCCccc----------------------------------HH---
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLAD-EQEVAIKRLSRSSGQG----------------------------------IV--- 471 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~----------------------------------~~--- 471 (752)
..|+. +-||+|++|.||+|++++ |+.||||+++...... .+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 34666 789999999999999987 9999999997542110 01
Q ss_pred ---HHHHHHHHHHhcC----CCCcceeeeeeee-CCeeEEEEeeCCCCCHhHHHhhcCC---CCCCCHHHHHHHHHHHHH
Q 043278 472 ---EFKNEVRLIAKLQ----HTNLVRLLGCSLH-GEERLLVYEFMPNKSLDFFLFNSGR---KNVLNWEKRFIIIEGISQ 540 (752)
Q Consensus 472 ---~~~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~E~~~~gsL~~~l~~~~~---~~~l~~~~~~~i~~~i~~ 540 (752)
+|.+|+..+.+++ +.+.+.+-..+.+ ....+|||||++++.+.++...... ...+.......++.|+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-- 276 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-- 276 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence 1334444444442 3333333333322 3467899999999999764311111 1112222223333333
Q ss_pred HHHHHHhcCCCcEeecCCCCCcEEecCCC----Cceecccccceeecc
Q 043278 541 GLLYLHKYSRLRVIHRDLKASNILLDDKM----NPKISDFGMARIFEV 584 (752)
Q Consensus 541 ~l~~LH~~~~~~iiH~Dikp~NIll~~~~----~~kl~DFgla~~~~~ 584 (752)
+..+ ++|+|+||.||+++.++ .++++|||+...+..
T Consensus 277 -----f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 -----FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -----HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3455 99999999999999888 999999999987653
|
|
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.3e-10 Score=102.65 Aligned_cols=84 Identities=30% Similarity=0.514 Sum_probs=67.8
Q ss_pred EecccccCCcccccccc----ceEEEEEecCceEEEEEEccCCceeeEEEEECCCCccc-------------------cC
Q 043278 193 WTSGLLLNGNFNFSRSW----NLSFSYTSNEQEKYFEYSLNEGVTSSVFLRIDPEGALS-------------------DS 249 (752)
Q Consensus 193 w~~g~~~~~~~~~~~~~----~~~~~~~~n~~e~~~~~~~~~~~~~~~~~~l~~~G~l~-------------------~~ 249 (752)
||+|+|+|..|...|.+ .+.+.|+.+++|.||+|.+.+.+... +++|+.+|+++ +.
T Consensus 1 wrsG~WnG~~f~g~p~~~~~~~~~~~fv~~~~e~~~t~~~~~~s~~~-r~~ld~~G~l~~~~w~~~~~~W~~~~~~p~d~ 79 (110)
T PF00954_consen 1 WRSGPWNGQRFSGIPEMSSNSLYNYSFVSNNEEVYYTYSLSNSSVLS-RLVLDSDGQLQRYIWNESTQSWSVFWSAPKDQ 79 (110)
T ss_pred CCccccCCeEECCcccccccceeEEEEEECCCeEEEEEecCCCceEE-EEEEeeeeEEEEEEEecCCCcEEEEEEecccC
Confidence 89999999999888754 48889999999999999998877665 68899999763 67
Q ss_pred CCCcccCCCCCccc--cCCcccccCCCCCC
Q 043278 250 RGSFAPCTYGGCWN--QLPRPICRKGTGPE 277 (752)
Q Consensus 250 cg~~~~C~~~~c~~--~~~~~~C~~~~~~~ 277 (752)
|+.|+.|+..|-|. ..|.|.|..||+|+
T Consensus 80 Cd~y~~CG~~g~C~~~~~~~C~Cl~GF~P~ 109 (110)
T PF00954_consen 80 CDVYGFCGPNGICNSNNSPKCSCLPGFEPK 109 (110)
T ss_pred CCCccccCCccEeCCCCCCceECCCCcCCC
Confidence 88888887766443 34568888888775
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.09 E-value=2.2e-09 Score=117.94 Aligned_cols=166 Identities=19% Similarity=0.236 Sum_probs=125.3
Q ss_pred ecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHH
Q 043278 451 LADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEK 530 (752)
Q Consensus 451 ~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~ 530 (752)
..++.+|.|...+...........+.++.|+.++||||++++...+.+...+||+|-+. .|..++.+ +....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~ 105 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEE 105 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHH
Confidence 44688899998887766445557888999999999999999999999999999999873 45555533 23445
Q ss_pred HHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccccccccccccCCccChhhhccCC
Q 043278 531 RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGI 610 (752)
Q Consensus 531 ~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 610 (752)
...-+.||+.||.|||+.+ .++|++|..+.|++++.|.-||++|.++........ .......-..|..|+.+....
T Consensus 106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc
Confidence 5567899999999999766 499999999999999999999999988764321111 111122223566676443322
Q ss_pred CCccchhHHHHHHHHHHHhC
Q 043278 611 VSIKTDVFSFGVLVLEIVSG 630 (752)
Q Consensus 611 ~t~k~DV~S~G~vl~elltG 630 (752)
-..|.|-||++++|++.|
T Consensus 182 --~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 --WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred --cchhhhhHHHHHHHHhCc
Confidence 346999999999999999
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.5e-09 Score=105.44 Aligned_cols=136 Identities=15% Similarity=0.119 Sum_probs=98.3
Q ss_pred CeeecCCcccEEEEEecC-------CceeEEEEcccCC----------------------cccHHHHH----HHHHHHHh
Q 043278 436 NKLGEGGFGPVYKGKLAD-------EQEVAIKRLSRSS----------------------GQGIVEFK----NEVRLIAK 482 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~~-------~~~vavK~l~~~~----------------------~~~~~~~~----~E~~~l~~ 482 (752)
..||.|--+.||.|...+ +..+|||+.+... ......+. +|++.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 579999999999997643 4789999874311 01122333 89999999
Q ss_pred cCC--CCcceeeeeeeeCCeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCcEeecCCC
Q 043278 483 LQH--TNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYL-HKYSRLRVIHRDLK 559 (752)
Q Consensus 483 l~h--~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~iiH~Dik 559 (752)
+.. -++.+++++ ...+|||||+.+..+..... +...++.++...+..+++.+|..| |..+ |||+||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L---kd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs 152 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL---KDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLS 152 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh---hccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 853 456666654 46789999998754422111 112345556677889999999999 7777 9999999
Q ss_pred CCcEEecCCCCceecccccceee
Q 043278 560 ASNILLDDKMNPKISDFGMARIF 582 (752)
Q Consensus 560 p~NIll~~~~~~kl~DFgla~~~ 582 (752)
+.|||++ ++.+.|+|||.+...
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeC
Confidence 9999997 467999999988754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.07 E-value=9e-10 Score=110.98 Aligned_cols=142 Identities=18% Similarity=0.243 Sum_probs=110.7
Q ss_pred CeeecCCcccEEEEEecCCceeEEEEcccCCc-ccHHHHHHHHHHHHhcCCC--CcceeeeeeeeCC---eeEEEEeeCC
Q 043278 436 NKLGEGGFGPVYKGKLADEQEVAIKRLSRSSG-QGIVEFKNEVRLIAKLQHT--NLVRLLGCSLHGE---ERLLVYEFMP 509 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~---~~~lv~E~~~ 509 (752)
+.|+.|..+.||++...+|+.+++|....... ....++..|++++..+++. ++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 57899999999999987778899998765432 1345678999999999763 4567777766532 5689999999
Q ss_pred CCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 043278 510 NKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS---------------------------------------- 549 (752)
Q Consensus 510 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---------------------------------------- 549 (752)
+.++...+.. ..++..+...++.+++++|..||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9888665421 34677888888999999999998521
Q ss_pred -------------CCcEeecCCCCCcEEecC--CCCceeccccccee
Q 043278 550 -------------RLRVIHRDLKASNILLDD--KMNPKISDFGMARI 581 (752)
Q Consensus 550 -------------~~~iiH~Dikp~NIll~~--~~~~kl~DFgla~~ 581 (752)
...++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 56689999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.7e-09 Score=100.49 Aligned_cols=143 Identities=24% Similarity=0.296 Sum_probs=106.0
Q ss_pred cCCeeecCCcccEEEEEecCCceeEEE-EcccCCc-------ccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEE
Q 043278 434 TTNKLGEGGFGPVYKGKLADEQEVAIK-RLSRSSG-------QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 434 ~~~~LG~G~fg~Vy~~~~~~~~~vavK-~l~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 505 (752)
....|-+|+-+.|+++.... +...|| ++.+... -...+.++|+++|.+++--.|.-..-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~~G-e~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSG-EAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccCC-ceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 35789999999999999854 444444 4443321 12345788999999987666655555677778889999
Q ss_pred eeCCC-CCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCC---ceeccccccee
Q 043278 506 EFMPN-KSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMN---PKISDFGMARI 581 (752)
Q Consensus 506 E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~---~kl~DFgla~~ 581 (752)
||+++ .++.+++...-..... .+....++.+|-+.+.-||.+. |||+||..+||+|..++. +.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~-d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESE-DEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCccc-chhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99987 5778887654333222 2233688999999999999998 999999999999965443 58999999874
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.5e-09 Score=101.39 Aligned_cols=131 Identities=21% Similarity=0.316 Sum_probs=101.1
Q ss_pred CeeecCCcccEEEEEecCCceeEEE-EcccCCcc-------cHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEee
Q 043278 436 NKLGEGGFGPVYKGKLADEQEVAIK-RLSRSSGQ-------GIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~~~~~vavK-~l~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
..+++|+-+.+|.+.+.+.. +++| ++++.... ...+..+|+++|.+++--.|.-.+=+..+.....|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~-av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLP-AVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccCcc-eEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 46889999999999774444 4555 44433211 123457899999998765555555566777888999999
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceeccccccee
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARI 581 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~ 581 (752)
+++..|.+.+... ...++..|-.-+.-||..+ |+|+||.++||++..+. +.++||||+..
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888543 3567888889999999998 99999999999998765 99999999974
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.98 E-value=7.4e-10 Score=120.60 Aligned_cols=246 Identities=20% Similarity=0.190 Sum_probs=171.4
Q ss_pred hcCCCcCCeeecCCcccEEEEEe--cCCceeEEEEcccCCcccHHHH--HHHHHHHHhc-CCCCcceeeeeeeeCCeeEE
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKL--ADEQEVAIKRLSRSSGQGIVEF--KNEVRLIAKL-QHTNLVRLLGCSLHGEERLL 503 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~--~~~~~vavK~l~~~~~~~~~~~--~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 503 (752)
..+|.....||.|.|+.|++... .++..+++|.+.+.......+. ..|+.+...+ .|.++++.+..+......++
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 46788889999999999999864 3578899998876643322221 3555555555 58888888877777777789
Q ss_pred EEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCC-CCceecccccceee
Q 043278 504 VYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDK-MNPKISDFGMARIF 582 (752)
Q Consensus 504 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~-~~~kl~DFgla~~~ 582 (752)
=-||+.++++...+ .....++...++++..|++.++.++|+.. ++|+|+||+||++..+ +..++.|||++.-+
T Consensus 344 p~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRL 417 (524)
T ss_pred chhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccccc
Confidence 99999999987766 22344777888999999999999999887 9999999999999876 88999999998632
Q ss_pred cccccccccccccccCCc-cChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccc
Q 043278 583 EVNESEANTKRIVGTYGY-MSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLEL 661 (752)
Q Consensus 583 ~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 661 (752)
..... .....+..| .+|+......+..+.|++|||.-+.|.+++......-.. +..+..+...
T Consensus 418 ~~~~~----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~----------~~~i~~~~~p-- 481 (524)
T KOG0601|consen 418 AFSSG----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ----------SLTIRSGDTP-- 481 (524)
T ss_pred ceecc----cccccccccccchhhccccccccccccccccccccccccCcccCccccc----------ceeeeccccc--
Confidence 21111 011122334 356666677889999999999999999998754332210 1111111111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 043278 662 IDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ 704 (752)
Q Consensus 662 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~ 704 (752)
. .+... ..+..+...++..++..||.+.+...+.+
T Consensus 482 ---~--~~~~~---~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 482 ---N--LPGLK---LQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred ---C--CCchH---HhhhhhhhhhcCCccccchhhhhhcccch
Confidence 1 11111 23334555678889999999888766544
|
|
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=98.88 E-value=7.7e-10 Score=87.52 Aligned_cols=62 Identities=19% Similarity=0.336 Sum_probs=42.8
Q ss_pred CCCccccccccccCCCcccccCCCCccchHHhhhhcCcccccccccccccccccccccccccccc
Q 043278 276 PENFQSKVGLISEHGFKFKESDNMSSTDCRANCFYNCSCIAFATGTSEYTDKQAYCEIWSEGTEF 340 (752)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~sl~~C~~~Cl~nCsC~Aya~~~~~~~~~~~~C~~~~~~~~~ 340 (752)
.+.|.+..+...+.........++++++|+..||+||||+||+|... . ++++|++|++.+.+
T Consensus 4 ~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~--~-~~~~C~lW~~~L~d 65 (66)
T PF08276_consen 4 GDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNL--S-GGGGCLLWYGDLVD 65 (66)
T ss_pred CCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeecc--C-CCCEEEEEcCEeec
Confidence 35566555444322222222256899999999999999999999542 1 56899999988764
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.5e-09 Score=88.69 Aligned_cols=59 Identities=15% Similarity=0.289 Sum_probs=48.1
Q ss_pred CcccccCCCCccchHHhhhh---cCcccccccccccccccccccccccccc-cccccccCCcchhhhh
Q 043278 291 FKFKESDNMSSTDCRANCFY---NCSCIAFATGTSEYTDKQAYCEIWSEGT-EFTEIASNNSREIFIL 354 (752)
Q Consensus 291 ~~~~~~~~~sl~~C~~~Cl~---nCsC~Aya~~~~~~~~~~~~C~~~~~~~-~~~~~~~~~~~~~~~~ 354 (752)
.+.++...++++||+++|++ ||||+||+|.. .+.+|.+|.+.+ .+.+...+.+.++|++
T Consensus 17 ~klpd~~~~s~~eC~~~Cl~~~~nCsC~Aya~~~-----~~~gC~~W~~~l~~d~~~~~~~g~~Ly~r 79 (80)
T cd00129 17 LKIKTTKANTADECANRCEKNGLPFSCKAFVFAK-----ARKQCLWFPFNSMSGVRKEFSHGFDLYEN 79 (80)
T ss_pred ccCCcccccCHHHHHHHHhcCCCCCCceeeeccC-----CCCCeEEecCcchhhHHhccCCCceeEeE
Confidence 44566666899999999999 99999999853 236899999999 8877777778888875
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.80 E-value=1.4e-07 Score=100.60 Aligned_cols=169 Identities=24% Similarity=0.327 Sum_probs=128.6
Q ss_pred cccEEEEEe-cCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeee----eCCeeEEEEeeCCC-CCHhHH
Q 043278 443 FGPVYKGKL-ADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSL----HGEERLLVYEFMPN-KSLDFF 516 (752)
Q Consensus 443 fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~lv~E~~~~-gsL~~~ 516 (752)
-.+.||+.. -||..+++|+++....+.......-++.++++.|+|+|++..++. .+...++||+|.|+ ++|.+.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 356788874 479999999996554444334466788999999999999999876 34578999999875 566666
Q ss_pred HhhcC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecc
Q 043278 517 LFNSG------------RKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584 (752)
Q Consensus 517 l~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~ 584 (752)
-+... .....++...+.++.|+..||.++|+.+ +.-+-|.|++||++.+.+++|+..|....+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 55421 1234678899999999999999999998 88899999999999999999988887765443
Q ss_pred cccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCC
Q 043278 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKN 633 (752)
Q Consensus 585 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p 633 (752)
+.. |-+.+ -.+-|.=-||.+++.|.+|...
T Consensus 446 d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPT----------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC----------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 321 11111 1356888999999999999754
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.77 E-value=1.3e-07 Score=97.20 Aligned_cols=141 Identities=15% Similarity=0.136 Sum_probs=100.6
Q ss_pred CeeecCCcccEEEEEecCCceeEEEEcccCCc-----------ccHHHHHHHHHHHHhcCCC--Ccceeeeeeee-----
Q 043278 436 NKLGEGGFGPVYKGKLADEQEVAIKRLSRSSG-----------QGIVEFKNEVRLIAKLQHT--NLVRLLGCSLH----- 497 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-----------~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~----- 497 (752)
+.+-.-....|.+..+ +|+.+.||+...... .....+.+|...+.++... ....++++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3444444455677666 667899997744321 1112477899999888433 34455555543
Q ss_pred CCeeEEEEeeCCCC-CHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecC-------CC
Q 043278 498 GEERLLVYEFMPNK-SLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDD-------KM 569 (752)
Q Consensus 498 ~~~~~lv~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~-------~~ 569 (752)
....+||+|++++. +|.+++.... ....+...+..++.+++..+.-||+.+ |+|+|++++|||++. +.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCc
Confidence 23568999999986 8888874321 123456677889999999999999999 999999999999975 56
Q ss_pred Cceeccccccee
Q 043278 570 NPKISDFGMARI 581 (752)
Q Consensus 570 ~~kl~DFgla~~ 581 (752)
.+.++||+.++.
T Consensus 183 ~~~LIDl~r~~~ 194 (268)
T PRK15123 183 KLSVIDLHRAQI 194 (268)
T ss_pred eEEEEECCcccc
Confidence 789999998864
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.73 E-value=6.1e-08 Score=93.89 Aligned_cols=125 Identities=27% Similarity=0.298 Sum_probs=82.0
Q ss_pred cEEEEEecCCceeEEEEcccCC--------------c--------c----cHHHHHHHHHHHHhcCCC--Ccceeeeeee
Q 043278 445 PVYKGKLADEQEVAIKRLSRSS--------------G--------Q----GIVEFKNEVRLIAKLQHT--NLVRLLGCSL 496 (752)
Q Consensus 445 ~Vy~~~~~~~~~vavK~l~~~~--------------~--------~----~~~~~~~E~~~l~~l~h~--niv~l~~~~~ 496 (752)
.||.|...+|..+|||..+... . . ......+|.+.|.++..- ++.+++++
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 4899999899999999864311 0 0 122467899999999765 45666644
Q ss_pred eCCeeEEEEeeCC--CCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCcEeecCCCCCcEEecCCCCcee
Q 043278 497 HGEERLLVYEFMP--NKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLY-LHKYSRLRVIHRDLKASNILLDDKMNPKI 573 (752)
Q Consensus 497 ~~~~~~lv~E~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~-LH~~~~~~iiH~Dikp~NIll~~~~~~kl 573 (752)
+..+|||||++ +..+..+.... ++.+....++.+++..+.. +|..+ |+|+||.+.|||++++ .+.|
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred --eCCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 24579999998 55554433211 1133455677778886665 46777 9999999999999988 9999
Q ss_pred cccccceee
Q 043278 574 SDFGMARIF 582 (752)
Q Consensus 574 ~DFgla~~~ 582 (752)
+|||.+...
T Consensus 148 IDf~qav~~ 156 (188)
T PF01163_consen 148 IDFGQAVDS 156 (188)
T ss_dssp --GTTEEET
T ss_pred EecCcceec
Confidence 999998753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.68 E-value=4e-09 Score=120.61 Aligned_cols=252 Identities=18% Similarity=0.190 Sum_probs=163.3
Q ss_pred HHHhcCCCcCCeeecCCcccEEEEEecC-CceeEEEEcccCC---cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCee
Q 043278 426 AAAANNFSTTNKLGEGGFGPVYKGKLAD-EQEVAIKRLSRSS---GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEER 501 (752)
Q Consensus 426 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 501 (752)
....+.+.+.+-+-+|.++.++.+.-.. |...+.|...... .........+-.++-..++|-+++..-.+......
T Consensus 800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~ 879 (1205)
T KOG0606|consen 800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL 879 (1205)
T ss_pred cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence 3456677778888999999998775432 3222333222111 11111122222222223445555555455566788
Q ss_pred EEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceeccccccee
Q 043278 502 LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARI 581 (752)
Q Consensus 502 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~ 581 (752)
.|+++|..+++|...++... .++.+.....+..+...++|||... +.|+|++|.|+|+..+++.++.|||....
T Consensus 880 ~L~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~ 953 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSK 953 (1205)
T ss_pred chhhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccc
Confidence 99999999999988886544 3555556667777889999999876 89999999999999999999999984332
Q ss_pred eccc-------------------------ccc----cccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCC
Q 043278 582 FEVN-------------------------ESE----ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQK 632 (752)
Q Consensus 582 ~~~~-------------------------~~~----~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~ 632 (752)
.+.. ... .......+|+.|.+||...+..-...+|.|++|++++|.++|..
T Consensus 954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen 954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence 2100 000 11223578999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 043278 633 NHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMP 697 (752)
Q Consensus 633 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ 697 (752)
||....+++.... +..++.. -+ ..+........+++..-+..+|.+|-.|.
T Consensus 1034 p~na~tpq~~f~n-------i~~~~~~---~p----~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1034 PFNAETPQQIFEN-------ILNRDIP---WP----EGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCcchhhhhhc-------cccCCCC---CC----CCccccChhhhhhhhhhhccCchhccCcc
Confidence 9987775543311 1111110 00 01112222334455566778888887665
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.62 E-value=2.2e-07 Score=92.35 Aligned_cols=136 Identities=18% Similarity=0.189 Sum_probs=98.2
Q ss_pred CCCcCCeeecCCcccEEEEEecCCceeEEEEcccCC----------------------cccHHHHHHHHHHHHhcCCC--
Q 043278 431 NFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSS----------------------GQGIVEFKNEVRLIAKLQHT-- 486 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~----------------------~~~~~~~~~E~~~l~~l~h~-- 486 (752)
-..+.++||-|--+.||.|..+.|.++|||.-+... .......++|.+.|.+|.-.
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 345568999999999999999999999999542110 01223467899999999655
Q ss_pred CcceeeeeeeeCCeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEec
Q 043278 487 NLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLD 566 (752)
Q Consensus 487 niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~ 566 (752)
.+.+.+++ +...+||||+++-.|...- ++.+..-.++..|+.-+.-+-..+ |||+|+++-||+++
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~ 236 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVT 236 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEe
Confidence 56666654 5678999999986663322 233344445555555555555556 99999999999999
Q ss_pred CCCCceeccccccee
Q 043278 567 DKMNPKISDFGMARI 581 (752)
Q Consensus 567 ~~~~~kl~DFgla~~ 581 (752)
++|.+.++||--+..
T Consensus 237 ~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 237 EDGDIVVIDWPQAVP 251 (304)
T ss_pred cCCCEEEEeCccccc
Confidence 999999999976653
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.56 E-value=3.6e-06 Score=87.83 Aligned_cols=260 Identities=14% Similarity=0.124 Sum_probs=151.7
Q ss_pred CcCCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhc-CCCCcceeeee------eeeCC-eeEEE
Q 043278 433 STTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKL-QHTNLVRLLGC------SLHGE-ERLLV 504 (752)
Q Consensus 433 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~------~~~~~-~~~lv 504 (752)
...+-||+|+-+.+|..- .-...+-|+.+....... .+.+..|... .||-+-.-+.+ .-++. ..-+.
T Consensus 14 ~~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~---aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQ---AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecc--hhhchhheeecCCCchHH---HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 345789999999999532 111124466655433222 2223333333 56544331221 11122 24567
Q ss_pred EeeCCCCCHhHHHhhc----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccce
Q 043278 505 YEFMPNKSLDFFLFNS----GRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR 580 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~ 580 (752)
|+.+++.-=-..+... ......+|.-.++.++.++.+.+.||..+ .+-+|++++|+|+.+++.+.|.|-..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence 7776654222222221 22345789999999999999999999998 8899999999999999999999865544
Q ss_pred eecccccccccccccccCCccChhhhc-----cCCCCccchhHHHHHHHHHHHhC-CCCCCCCCCCCCc----c-hHHHH
Q 043278 581 IFEVNESEANTKRIVGTYGYMSPEYAM-----SGIVSIKTDVFSFGVLVLEIVSG-QKNHTRHHPDRPL----N-LIGYA 649 (752)
Q Consensus 581 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~k~DV~S~G~vl~elltG-~~p~~~~~~~~~~----~-l~~~~ 649 (752)
....+ ....-.+|...|.+||.-. +..-+...|.|.+|+++++++.| ++||.+.....+. . -|...
T Consensus 166 i~~ng---~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g 242 (637)
T COG4248 166 INANG---TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG 242 (637)
T ss_pred eccCC---ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence 32111 1112356788999999643 44567889999999999999886 8998765432211 1 11100
Q ss_pred HHHhhCC-CcccccCCCCCCCCCHHHH-HHHHHHHHHcccC--CCCCCCCHHHHHHHhhcC
Q 043278 650 WQLLSDG-KGLELIDPSLEQPCSANEV-MRCIHVGLLCVQD--QAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 650 ~~~~~~~-~~~~~~d~~l~~~~~~~~~-~~l~~l~~~Cl~~--dp~~RPt~~ev~~~L~~~ 706 (752)
...... .......+.. ..+.+.+ ..+..+..+|+.. ++.-|||++-.+..|..+
T Consensus 243 -~f~ya~~~~~g~~p~P~--~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al 300 (637)
T COG4248 243 -RFAYASDQRRGLKPPPR--SIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL 300 (637)
T ss_pred -eeeechhccCCCCCCCC--CCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence 000000 0011111111 1111111 2333455678865 356899999888877543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.2e-06 Score=86.98 Aligned_cols=106 Identities=22% Similarity=0.264 Sum_probs=84.0
Q ss_pred HHHHHHHHHHHHhcCC--CCcceeeeeeeeCC----eeEEEEeeCCC-CCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHH
Q 043278 470 IVEFKNEVRLIAKLQH--TNLVRLLGCSLHGE----ERLLVYEFMPN-KSLDFFLFNSGRKNVLNWEKRFIIIEGISQGL 542 (752)
Q Consensus 470 ~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~----~~~lv~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l 542 (752)
.....+|...+..+.. -...+.+++..... ..+||+|++++ .+|.+++..... ++......++.+++..+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHH
Confidence 3457888888888743 34566667665532 45899999987 478888854222 56677888999999999
Q ss_pred HHHHhcCCCcEeecCCCCCcEEecCCC---Cceeccccccee
Q 043278 543 LYLHKYSRLRVIHRDLKASNILLDDKM---NPKISDFGMARI 581 (752)
Q Consensus 543 ~~LH~~~~~~iiH~Dikp~NIll~~~~---~~kl~DFgla~~ 581 (752)
.-||+.+ |+|+|+++.|||++.+. .+.++||+-++.
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999 99999999999998887 899999998875
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.45 E-value=3.3e-06 Score=82.24 Aligned_cols=139 Identities=16% Similarity=0.139 Sum_probs=102.7
Q ss_pred eeecCCcccEEEEEecCCceeEEEEcccCC------cccHHHHHHHHHHHHhcCC--CCcceeeeeee-eC----CeeEE
Q 043278 437 KLGEGGFGPVYKGKLADEQEVAIKRLSRSS------GQGIVEFKNEVRLIAKLQH--TNLVRLLGCSL-HG----EERLL 503 (752)
Q Consensus 437 ~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~-~~----~~~~l 503 (752)
--|.||-+.|+...+.+ +.+-+|+-.... ..+...|.+|...|.++.. -.+.+++ ++. .. -..+|
T Consensus 25 N~~rgG~SgV~r~~~~g-~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 25 NYRRNGMSGVQCVERNG-KKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred CcCCCCcceEEEEEeCC-cEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 34678999999987744 479999875221 3366789999999999853 2344444 332 11 24679
Q ss_pred EEeeCC-CCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCC--ceecccccce
Q 043278 504 VYEFMP-NKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMN--PKISDFGMAR 580 (752)
Q Consensus 504 v~E~~~-~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~--~kl~DFgla~ 580 (752)
|+|-++ ..+|.+++.+. .....+...+..+..+|++.+.-||+.+ +.|+|+.+.|||++.++. ++++||.-++
T Consensus 103 VTe~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 103 VTEDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEEeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 999665 46888777432 2234577778899999999999999998 999999999999986667 9999998765
Q ss_pred e
Q 043278 581 I 581 (752)
Q Consensus 581 ~ 581 (752)
.
T Consensus 179 ~ 179 (216)
T PRK09902 179 R 179 (216)
T ss_pred h
Confidence 3
|
|
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=98.44 E-value=9.5e-08 Score=80.09 Aligned_cols=52 Identities=25% Similarity=0.606 Sum_probs=39.8
Q ss_pred CCCCccchHHhhhhcCcccccccccccccccccccccccccccccccccCCcchhhh
Q 043278 297 DNMSSTDCRANCFYNCSCIAFATGTSEYTDKQAYCEIWSEGTEFTEIASNNSREIFI 353 (752)
Q Consensus 297 ~~~sl~~C~~~Cl~nCsC~Aya~~~~~~~~~~~~C~~~~~~~~~~~~~~~~~~~~~~ 353 (752)
.++++++|++.||+||+|+||++. .++++|.+|...+.........+..+|+
T Consensus 30 ~~~s~~~C~~~Cl~nCsC~a~~~~-----~~~~~C~~~~~~~~~~~~~~~~~~~~yi 81 (84)
T cd01098 30 TAISLEECREACLSNCSCTAYAYN-----NGSGGCLLWNGLLNNLRSLSSGGGTLYL 81 (84)
T ss_pred ccCCHHHHHHHHhcCCCcceeeec-----CCCCeEEEEeceecceEeecCCCcEEEE
Confidence 678899999999999999999984 3368999998877665554444444444
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.35 E-value=2.2e-06 Score=95.39 Aligned_cols=144 Identities=16% Similarity=0.223 Sum_probs=92.4
Q ss_pred CCCcCCeeecCCcccEEEEEecCCceeEEEEcccCCccc----------------------------------------H
Q 043278 431 NFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQG----------------------------------------I 470 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~----------------------------------------~ 470 (752)
.|+. +-|+.++-|.||+|++++|+.||||+.+..-.+. +
T Consensus 127 eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~E 205 (517)
T COG0661 127 EFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREE 205 (517)
T ss_pred HcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHH
Confidence 3443 6889999999999999999999999986532110 0
Q ss_pred HHHHHHHHHHHhcC----CCCcceeeeee-eeCCeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHH-HHH
Q 043278 471 VEFKNEVRLIAKLQ----HTNLVRLLGCS-LHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQG-LLY 544 (752)
Q Consensus 471 ~~~~~E~~~l~~l~----h~niv~l~~~~-~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~-l~~ 544 (752)
-.+.+|..-+.+++ +..-+++=..+ .-....+|+|||++|-.+.+...... ..++.+. ++..++++ +..
T Consensus 206 lDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~---ia~~~~~~f~~q 280 (517)
T COG0661 206 LDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRKE---LAELLVRAFLRQ 280 (517)
T ss_pred hCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHHH---HHHHHHHHHHHH
Confidence 11334444444442 11122222222 23457899999999999888753222 2244333 33333332 222
Q ss_pred HHhcCCCcEeecCCCCCcEEecCCCCceecccccceeec
Q 043278 545 LHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFE 583 (752)
Q Consensus 545 LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~ 583 (752)
+-..+ +.|.|.+|.||+++.++.+.+.|||+...+.
T Consensus 281 ~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 281 LLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred HHhcC---ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 22234 9999999999999999999999999987654
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.32 E-value=2.2e-07 Score=102.94 Aligned_cols=154 Identities=18% Similarity=0.253 Sum_probs=100.1
Q ss_pred HHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccc-------cccccccccCCccChhhh
Q 043278 534 IIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE-------ANTKRIVGTYGYMSPEYA 606 (752)
Q Consensus 534 i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~-------~~~~~~~gt~~y~aPE~~ 606 (752)
=+.+++.||.|+|... .+||++|.|++|.++.++..||+.|+++......... ....-......|.|||++
T Consensus 104 nl~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~ 181 (700)
T KOG2137|consen 104 NLGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYL 181 (700)
T ss_pred hhhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhh
Confidence 3445669999999855 5999999999999999999999999988654321100 001112235679999999
Q ss_pred ccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHc
Q 043278 607 MSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLC 685 (752)
Q Consensus 607 ~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C 685 (752)
.+...+.++|+||+|+++|.+.. |+..+....... ......... +. -....+.....++.+=+.+.
T Consensus 182 ~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~-----~~~~~~~~~-------~~-~~~~~s~~~p~el~~~l~k~ 248 (700)
T KOG2137|consen 182 LGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLL-----SYSFSRNLL-------NA-GAFGYSNNLPSELRESLKKL 248 (700)
T ss_pred ccccccccccceeeeeEEEEEecCCcchhhccCCcc-----hhhhhhccc-------cc-ccccccccCcHHHHHHHHHH
Confidence 99889999999999999999995 444443332111 111111000 00 00111222333444555577
Q ss_pred ccCCCCCCCCHHHHHHH
Q 043278 686 VQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 686 l~~dp~~RPt~~ev~~~ 702 (752)
+..++..||++.++...
T Consensus 249 l~~~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 249 LNGDSAVRPTLDLLLSI 265 (700)
T ss_pred hcCCcccCcchhhhhcc
Confidence 88999999988777554
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.32 E-value=8.4e-06 Score=82.08 Aligned_cols=133 Identities=17% Similarity=0.172 Sum_probs=86.1
Q ss_pred CeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCC--cceeeeeeeeCCeeEEEEeeCCCCC-
Q 043278 436 NKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTN--LVRLLGCSLHGEERLLVYEFMPNKS- 512 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~E~~~~gs- 512 (752)
..||+|..+.||+. .+..+++|...... ......+|.+++..+..-. +.+.+++....+...+|||++++..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57999999999984 24567788876533 3445688999999986443 4677888777777889999999863
Q ss_pred HhHHHhhcCCCCCCCHHHHHHHHHHHHHHH---------------------------------------HHHHhc-CCCc
Q 043278 513 LDFFLFNSGRKNVLNWEKRFIIIEGISQGL---------------------------------------LYLHKY-SRLR 552 (752)
Q Consensus 513 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l---------------------------------------~~LH~~-~~~~ 552 (752)
+...+. .+......++..+++.+ .+|... ..+.
T Consensus 82 ~~~~~~-------~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~ 154 (226)
T TIGR02172 82 FSRIIS-------DNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTST 154 (226)
T ss_pred hhhhhc-------CCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCc
Confidence 211110 00111111111111111 222211 1235
Q ss_pred EeecCCCCCcEEecCCCCceeccccccee
Q 043278 553 VIHRDLKASNILLDDKMNPKISDFGMARI 581 (752)
Q Consensus 553 iiH~Dikp~NIll~~~~~~kl~DFgla~~ 581 (752)
++|+|++|.||++++++ +.|+||+.+..
T Consensus 155 ~~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 155 CLHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred eEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 78999999999999888 99999998763
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.20 E-value=1.3e-05 Score=78.49 Aligned_cols=138 Identities=17% Similarity=0.153 Sum_probs=92.6
Q ss_pred HhcCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHH---------HHHHHHHHhcCC---CCcceeeeee
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEF---------KNEVRLIAKLQH---TNLVRLLGCS 495 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~---------~~E~~~l~~l~h---~niv~l~~~~ 495 (752)
..++|...+.+-......|.+-.. +|+.+++|.........++.| .+++..+.+++. .....++...
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 467888888888888787877776 557889998765543333222 233333444432 2333333222
Q ss_pred e-----eCCeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCC
Q 043278 496 L-----HGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMN 570 (752)
Q Consensus 496 ~-----~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~ 570 (752)
. .....+|+|||++|..|.++.. ++. .++..|..++.-||+.+ +.|+|.+|.|+++++++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~- 172 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG- 172 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-
Confidence 2 2245679999999988755431 221 24566778899999998 99999999999998655
Q ss_pred ceeccccccee
Q 043278 571 PKISDFGMARI 581 (752)
Q Consensus 571 ~kl~DFgla~~ 581 (752)
++++||+.-+.
T Consensus 173 i~iID~~~k~~ 183 (229)
T PF06176_consen 173 IRIIDTQGKRM 183 (229)
T ss_pred EEEEECccccc
Confidence 99999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.12 E-value=3.3e-05 Score=78.20 Aligned_cols=143 Identities=22% Similarity=0.203 Sum_probs=85.0
Q ss_pred CeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCC--Ccceeeeeeee---CCeeEEEEeeCCC
Q 043278 436 NKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHT--NLVRLLGCSLH---GEERLLVYEFMPN 510 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~---~~~~~lv~E~~~~ 510 (752)
+.|+.|..+.||+....+ ..+++|..... .....+.+|..++..+... .+.+++.+... ....+++|+++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 579999999999999877 58999987544 3456678898888888533 35566664433 2356899999999
Q ss_pred CCHhH----------------HH---hhc-CCCCCCCHHH---------HHHH------------HHHHHH-HHHHHHh-
Q 043278 511 KSLDF----------------FL---FNS-GRKNVLNWEK---------RFII------------IEGISQ-GLLYLHK- 547 (752)
Q Consensus 511 gsL~~----------------~l---~~~-~~~~~l~~~~---------~~~i------------~~~i~~-~l~~LH~- 547 (752)
..+.. .+ +.. .......... .... ...+.+ .+..+++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 98877 11 111 0111111110 0000 111222 2333332
Q ss_pred ---cCCCcEeecCCCCCcEEec-CCCCceeccccccee
Q 043278 548 ---YSRLRVIHRDLKASNILLD-DKMNPKISDFGMARI 581 (752)
Q Consensus 548 ---~~~~~iiH~Dikp~NIll~-~~~~~kl~DFgla~~ 581 (752)
.....++|+|+.|.|||++ +++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 2345699999999999999 566667999998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.04 E-value=1.5e-05 Score=77.57 Aligned_cols=104 Identities=23% Similarity=0.169 Sum_probs=82.9
Q ss_pred HHHHHHHHhcCC-CCcceeeeeeeeCCeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc
Q 043278 474 KNEVRLIAKLQH-TNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLR 552 (752)
Q Consensus 474 ~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ 552 (752)
.+|..+++.+++ +++.+++|+| ..+++.||.+.+++......-..--.-+|+.+.+||.++++.+.+|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 468889999977 6999999999 35789999987765321000001123689999999999999999999866556
Q ss_pred EeecCCCCCcEEecCCCCceeccccccee
Q 043278 553 VIHRDLKASNILLDDKMNPKISDFGMARI 581 (752)
Q Consensus 553 iiH~Dikp~NIll~~~~~~kl~DFgla~~ 581 (752)
+...|++++|+-+++++++|++|...+..
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 99999999999999999999999987654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.03 E-value=3.1e-05 Score=85.99 Aligned_cols=139 Identities=13% Similarity=0.192 Sum_probs=88.9
Q ss_pred CeeecCCcccEEEEEecCCceeEEEEcccCCccc-------------------------------------HHHHHHHHH
Q 043278 436 NKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQG-------------------------------------IVEFKNEVR 478 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~-------------------------------------~~~~~~E~~ 478 (752)
+-||.-+.|.||+|++++|+.||||+.+..-... +-.|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 6899999999999999999999999976532110 112444444
Q ss_pred HHHhc----CCCC------cceeeeeeeeCCeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 043278 479 LIAKL----QHTN------LVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548 (752)
Q Consensus 479 ~l~~l----~h~n------iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~ 548 (752)
-..+. .|-+ |.+++-. -...+.|+||||+|..+.+...-. ...++......-+.+...-+-+- .
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i~--~~gi~~~~i~~~l~~~~~~qIf~--~ 320 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAID--KRGISPHDILNKLVEAYLEQIFK--T 320 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHHH--HcCCCHHHHHHHHHHHHHHHHHh--c
Confidence 44333 3444 2222221 234789999999998887664322 22355444333333222222222 2
Q ss_pred CCCcEeecCCCCCcEEec----CCCCceecccccceeec
Q 043278 549 SRLRVIHRDLKASNILLD----DKMNPKISDFGMARIFE 583 (752)
Q Consensus 549 ~~~~iiH~Dikp~NIll~----~~~~~kl~DFgla~~~~ 583 (752)
+ ++|+|-+|.||+++ .++.+.+.|||+.....
T Consensus 321 G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 321 G---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred C---CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 3 99999999999998 36789999999987543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.01 E-value=5.1e-05 Score=77.68 Aligned_cols=140 Identities=15% Similarity=0.139 Sum_probs=85.0
Q ss_pred eeecCCc-ccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcC-CCCcceeeeeeeeCCeeEEEEeeCCCCCHh
Q 043278 437 KLGEGGF-GPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQ-HTNLVRLLGCSLHGEERLLVYEFMPNKSLD 514 (752)
Q Consensus 437 ~LG~G~f-g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~~gsL~ 514 (752)
.|-.|.. ..||+.... +..++||+..... ...+.+|++++..+. +--+.+++++...++..++|||++++.+|.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 3445555 888998764 4678888876543 334678888888873 344667777776666789999999998876
Q ss_pred HHHh-------------------hcCC-CCCCC--HHHHHHHHH--------------------HHHHHHHHHHh----c
Q 043278 515 FFLF-------------------NSGR-KNVLN--WEKRFIIIE--------------------GISQGLLYLHK----Y 548 (752)
Q Consensus 515 ~~l~-------------------~~~~-~~~l~--~~~~~~i~~--------------------~i~~~l~~LH~----~ 548 (752)
.... .... ..... ....+.... .+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 4321 0000 00010 001110000 01111112211 1
Q ss_pred CCCcEeecCCCCCcEEecCCCCceecccccce
Q 043278 549 SRLRVIHRDLKASNILLDDKMNPKISDFGMAR 580 (752)
Q Consensus 549 ~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~ 580 (752)
..+.++|+|+.|.|||++++..+.|+||+.+.
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 23458999999999999998778899999875
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=97.99 E-value=2.9e-05 Score=69.13 Aligned_cols=81 Identities=30% Similarity=0.452 Sum_probs=56.8
Q ss_pred CCcEEEEcCC-CCcEEEeeccCC-ccccceeEecCCCeEEEEecCCCccceeEeeeccCCCcccCCCCeeccccccCcee
Q 043278 77 DGNLKILHNG-GNPIAVSSVEGA-SNNTSATLLQSGNLVLREMDTDGTIKRVLWQSFDYPTDTLLPGMKLGINLQTGHQW 154 (752)
Q Consensus 77 ~g~L~l~~~~-g~~~~~~~~~~~-~~~~~a~lldsGNlVl~~~~~~~~~~~~lWQSFd~PTDTlLpg~kl~~~~~tg~~~ 154 (752)
||+||+.+.. +.++|.+++... .....+.|.++|||||++.+ +.++|+| +|-
T Consensus 29 dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~-----g~~vW~S-----~t~---------------- 82 (114)
T smart00108 29 DYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGD-----GRVVWSS-----NTT---------------- 82 (114)
T ss_pred CEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCC-----CCEEEEe-----ccc----------------
Confidence 8999998654 478888876433 22357899999999998765 4689987 110
Q ss_pred EEEEecCCCCCCCCCcEEeeecCCCceeEEEecCceEEEec
Q 043278 155 FLQSWLDYSSPAQGSFTLGIEPNATNQLIIRWRRETIYWTS 195 (752)
Q Consensus 155 ~L~Sw~s~~dps~G~f~l~~~~~g~~~~~~~~~~~~~yw~~ 195 (752)
...|.+.+.|+++|.. +++.....+.|.+
T Consensus 83 ----------~~~~~~~~~L~ddGnl--vl~~~~~~~~W~S 111 (114)
T smart00108 83 ----------GANGNYVLVLLDDGNL--VIYDSDGNFLWQS 111 (114)
T ss_pred ----------CCCCceEEEEeCCCCE--EEECCCCCEEeCC
Confidence 1235678999999954 4444456678875
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.98 E-value=7.7e-07 Score=97.39 Aligned_cols=183 Identities=17% Similarity=0.177 Sum_probs=132.1
Q ss_pred CeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCC-cceeeeeeeeCCeeEEEEeeCCCC-CH
Q 043278 436 NKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTN-LVRLLGCSLHGEERLLVYEFMPNK-SL 513 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~E~~~~g-sL 513 (752)
+-++++++++++|.+....+...++.+... ....-++++|.+.+||| .++.++-+..+...+++++++..+ +-
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~ 322 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSS 322 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccc
Confidence 467889999999988655555556655433 34567899999999999 777777777778889999999876 21
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccccccccc
Q 043278 514 DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKR 593 (752)
Q Consensus 514 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~ 593 (752)
..... .....+..-+...+...-++++++||+.. =+|+| ||+..+ +..|..||+....+.+.. ....
T Consensus 323 ~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t 389 (829)
T KOG0576|consen 323 ALEMT--VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRT 389 (829)
T ss_pred cccCC--hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc---cccc
Confidence 11110 00011222333445666678899999864 48888 777766 678999999987665443 2334
Q ss_pred ccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 043278 594 IVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTR 636 (752)
Q Consensus 594 ~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~ 636 (752)
..+++.++|||+.....+..+.|+|++|+-..++.-|-+|...
T Consensus 390 ~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 390 AIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred CCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 6789999999999999999999999999887788777776543
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.97 E-value=5.3e-05 Score=74.97 Aligned_cols=152 Identities=22% Similarity=0.247 Sum_probs=98.8
Q ss_pred ccHHHHHHHhcCCCcCCe---eecCCcccEEEEEecCCceeEEEEcccCCcc-------------------cHHH-----
Q 043278 420 FDFQTIAAAANNFSTTNK---LGEGGFGPVYKGKLADEQEVAIKRLSRSSGQ-------------------GIVE----- 472 (752)
Q Consensus 420 ~~~~~i~~~~~~~~~~~~---LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~-------------------~~~~----- 472 (752)
.+++.+....++..+... |..|--+.||+|.-.++..+|||+.+..... ...+
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 455566666666655554 4556677899998888999999998643211 1111
Q ss_pred HHHHHHHHHhcC--CCCcceeeeeeeeCCeeEEEEeeCCCCCH-hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-c
Q 043278 473 FKNEVRLIAKLQ--HTNLVRLLGCSLHGEERLLVYEFMPNKSL-DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHK-Y 548 (752)
Q Consensus 473 ~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~E~~~~gsL-~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~ 548 (752)
..+|+.-|.++. +-.+.+.+++. .-.|||||+....+ .-.| +.-.+..+....+..++++.+.-|-. .
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~~a 186 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYKEA 186 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHHhc
Confidence 245666666653 23333334332 45799999965421 1111 11123333577778888888888876 5
Q ss_pred CCCcEeecCCCCCcEEecCCCCceecccccceeec
Q 043278 549 SRLRVIHRDLKASNILLDDKMNPKISDFGMARIFE 583 (752)
Q Consensus 549 ~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~ 583 (752)
+ +||+||+.-|||+. ++.+.|+|||-|....
T Consensus 187 ~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 187 G---LVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred C---cccccchhhheEEE-CCeEEEEECccccccC
Confidence 5 99999999999999 8899999999887543
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=97.89 E-value=6.1e-05 Score=67.25 Aligned_cols=82 Identities=22% Similarity=0.352 Sum_probs=57.4
Q ss_pred CCcEEEEcCC-CCcEEEeeccCC-ccccceeEecCCCeEEEEecCCCccceeEeeeccCCCcccCCCCeeccccccCcee
Q 043278 77 DGNLKILHNG-GNPIAVSSVEGA-SNNTSATLLQSGNLVLREMDTDGTIKRVLWQSFDYPTDTLLPGMKLGINLQTGHQW 154 (752)
Q Consensus 77 ~g~L~l~~~~-g~~~~~~~~~~~-~~~~~a~lldsGNlVl~~~~~~~~~~~~lWQSFd~PTDTlLpg~kl~~~~~tg~~~ 154 (752)
||+|++.+.. +.++|++++... .....+.|.++|||||.+.+ +.++|||=-.
T Consensus 30 dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~-----g~~vW~S~~~--------------------- 83 (116)
T cd00028 30 DYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGS-----GTVVWSSNTT--------------------- 83 (116)
T ss_pred eEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcCC-----CcEEEEeccc---------------------
Confidence 7899998654 468888876542 34456899999999998765 4688986410
Q ss_pred EEEEecCCCCCCCCCcEEeeecCCCceeEEEecCceEEEecc
Q 043278 155 FLQSWLDYSSPAQGSFTLGIEPNATNQLIIRWRRETIYWTSG 196 (752)
Q Consensus 155 ~L~Sw~s~~dps~G~f~l~~~~~g~~~~~~~~~~~~~yw~~g 196 (752)
.+.+.+.+.|+++|. ++++.....+.|.+.
T Consensus 84 ----------~~~~~~~~~L~ddGn--lvl~~~~~~~~W~Sf 113 (116)
T cd00028 84 ----------RVNGNYVLVLLDDGN--LVLYDSDGNFLWQSF 113 (116)
T ss_pred ----------CCCCceEEEEeCCCC--EEEECCCCCEEEcCC
Confidence 024678899999995 444444567778764
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00019 Score=86.41 Aligned_cols=79 Identities=11% Similarity=0.296 Sum_probs=58.2
Q ss_pred CCeeecCCcccEEEEEecCC---ceeEEEEcccCC-cccHHHHHHHHHHHHhcC-CCCc--ceeeeeeeeC---CeeEEE
Q 043278 435 TNKLGEGGFGPVYKGKLADE---QEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQ-HTNL--VRLLGCSLHG---EERLLV 504 (752)
Q Consensus 435 ~~~LG~G~fg~Vy~~~~~~~---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~~~---~~~~lv 504 (752)
.+.|+.|.+..+|+....++ ..+++|+..... ......+.+|++++..+. |.++ .+++.+|.+. ...++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46789999999999887654 367788765432 223456889999999995 6654 7788887664 357899
Q ss_pred EeeCCCCCH
Q 043278 505 YEFMPNKSL 513 (752)
Q Consensus 505 ~E~~~~gsL 513 (752)
|||+++..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999987653
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00032 Score=68.64 Aligned_cols=129 Identities=19% Similarity=0.282 Sum_probs=89.8
Q ss_pred cCCeeecCCcccEEEEEecCCceeEEEEcccCC----------------cccHHHHHHHHHHHHhcC------CCCccee
Q 043278 434 TTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSS----------------GQGIVEFKNEVRLIAKLQ------HTNLVRL 491 (752)
Q Consensus 434 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~----------------~~~~~~~~~E~~~l~~l~------h~niv~l 491 (752)
....||+|+.-.||. +++.....||+..... ....++..+|+.....+. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 346899999999994 5566667888876554 223466777877777766 7899999
Q ss_pred eeeeeeCCeeEEEEeeCCC------CCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEe
Q 043278 492 LGCSLHGEERLLVYEFMPN------KSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILL 565 (752)
Q Consensus 492 ~~~~~~~~~~~lv~E~~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll 565 (752)
+|+...+...-+|+|.+.+ -+|.+++. ...++. ... ..+-+-..||-++. |+.+|++|.||++
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~----~~~~~~-~~~---~~L~~f~~~l~~~~---Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLK----EGGLTE-ELR---QALDEFKRYLLDHH---IVIRDLNPHNIVV 151 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHH----cCCccH-HHH---HHHHHHHHHHHHcC---CeecCCCcccEEE
Confidence 9999998889999998632 34666663 233444 333 33334455666666 9999999999999
Q ss_pred cCC--C--Cceecc
Q 043278 566 DDK--M--NPKISD 575 (752)
Q Consensus 566 ~~~--~--~~kl~D 575 (752)
... + .+.|+|
T Consensus 152 ~~~~~~~~~lvlID 165 (199)
T PF10707_consen 152 QRRDSGEFRLVLID 165 (199)
T ss_pred EecCCCceEEEEEe
Confidence 532 2 466666
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00081 Score=72.95 Aligned_cols=75 Identities=12% Similarity=0.155 Sum_probs=54.2
Q ss_pred CeeecCCcccEEEEEecCC-ceeEEEEcccCC-------cccHHHHHHHHHHHHhcC---CCCcceeeeeeeeCCeeEEE
Q 043278 436 NKLGEGGFGPVYKGKLADE-QEVAIKRLSRSS-------GQGIVEFKNEVRLIAKLQ---HTNLVRLLGCSLHGEERLLV 504 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~~~-~~vavK~l~~~~-------~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv 504 (752)
+.||.|.+..||++...+| +.++||.-.... ....+++..|.+.|..+. -.++.+++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5799999999999998877 489999854211 124556777888888763 2356677766 34567899
Q ss_pred EeeCCCCC
Q 043278 505 YEFMPNKS 512 (752)
Q Consensus 505 ~E~~~~gs 512 (752)
||++++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00027 Score=71.81 Aligned_cols=73 Identities=16% Similarity=0.277 Sum_probs=45.8
Q ss_pred CeeecCCcc-cEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCC---CcceeeeeeeeCC---eeEEEEeeC
Q 043278 436 NKLGEGGFG-PVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHT---NLVRLLGCSLHGE---ERLLVYEFM 508 (752)
Q Consensus 436 ~~LG~G~fg-~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~---~~~lv~E~~ 508 (752)
+.|+.|+.. .||+. +..+++|..+.. .....+.+|.+.+..+... -+.++++.....+ ..+++||++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 467777776 48875 235777765432 2345788999999887532 3444444433322 347899999
Q ss_pred CCCCHh
Q 043278 509 PNKSLD 514 (752)
Q Consensus 509 ~~gsL~ 514 (752)
++.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 987764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00049 Score=72.49 Aligned_cols=78 Identities=12% Similarity=0.067 Sum_probs=57.3
Q ss_pred CcCCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCC---CCcceeeeeeeeC---CeeEEEEe
Q 043278 433 STTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQH---TNLVRLLGCSLHG---EERLLVYE 506 (752)
Q Consensus 433 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~---~~~~lv~E 506 (752)
...+.||+|..+.||+....++ .+++|..+.. .....+..|.+.|+.+.. ..+.++++++..+ +..+||||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred heeeecCCccceeEEEEEcCCC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 3346899999999999876666 4666764331 123478899999988853 3678888877543 56899999
Q ss_pred eCCCCCH
Q 043278 507 FMPNKSL 513 (752)
Q Consensus 507 ~~~~gsL 513 (752)
++++.++
T Consensus 94 ~i~G~~~ 100 (297)
T PRK10593 94 RLRGVSV 100 (297)
T ss_pred ccCCEec
Confidence 9998764
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00042 Score=67.16 Aligned_cols=135 Identities=27% Similarity=0.407 Sum_probs=94.7
Q ss_pred cccccccHHHHHHHhcCCCcCCeeecCCc-ccEEEEEecCCceeEEEEcccC------------Cc---------ccHHH
Q 043278 415 HELKIFDFQTIAAAANNFSTTNKLGEGGF-GPVYKGKLADEQEVAIKRLSRS------------SG---------QGIVE 472 (752)
Q Consensus 415 ~~~~~~~~~~i~~~~~~~~~~~~LG~G~f-g~Vy~~~~~~~~~vavK~l~~~------------~~---------~~~~~ 472 (752)
..+..|+.. +..++..+.||.|.- |.||++++ +|+.+|+|.+..- .. .....
T Consensus 27 PKL~~F~~h-----~~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~P 100 (207)
T PF13095_consen 27 PKLEPFTHH-----GDDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADP 100 (207)
T ss_pred CCcCCcCCC-----CCcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcCh
Confidence 345556552 267888899999999 99999999 6679999993210 00 11235
Q ss_pred HHHHHHHHHhcC---CCCc--ceeeeeeeeC------------------CeeEEEEeeCCCCCHhHHHhhcCCCCCCCHH
Q 043278 473 FKNEVRLIAKLQ---HTNL--VRLLGCSLHG------------------EERLLVYEFMPNKSLDFFLFNSGRKNVLNWE 529 (752)
Q Consensus 473 ~~~E~~~l~~l~---h~ni--v~l~~~~~~~------------------~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~ 529 (752)
|..|.+...+|+ +.++ |+.+||..-. ....||.||++... .+
T Consensus 101 F~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~--- 165 (207)
T PF13095_consen 101 FNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PL--- 165 (207)
T ss_pred HHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------cc---
Confidence 788999988885 4456 8999986322 12357888876533 12
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccc
Q 043278 530 KRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMA 579 (752)
Q Consensus 530 ~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla 579 (752)
..+-+.+|.+-|..||..+ |+-+|+++.|.. .-||+|||.+
T Consensus 166 -~~~~~~~~~~dl~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 166 -QIRDIPQMLRDLKILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred -chhHHHHHHHHHHHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 2233556778888999988 999999999985 3589999864
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00034 Score=72.10 Aligned_cols=139 Identities=15% Similarity=0.108 Sum_probs=79.6
Q ss_pred eeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCc-ceeeeeeeeCCeeEEEEeeCCCCCHhH
Q 043278 437 KLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL-VRLLGCSLHGEERLLVYEFMPNKSLDF 515 (752)
Q Consensus 437 ~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~~~~gsL~~ 515 (752)
.+..|-...+|+... +++.+++|........-.....+|..++..+....+ .+++..+. ..+||||+++..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 456788889998874 566788887654322211235788888888864433 33444332 368999999876542
Q ss_pred H-----------------HhhcCC-CCCCCHHHHH-HHHHH---------HHHHHHHHHhc-----CCCcEeecCCCCCc
Q 043278 516 F-----------------LFNSGR-KNVLNWEKRF-IIIEG---------ISQGLLYLHKY-----SRLRVIHRDLKASN 562 (752)
Q Consensus 516 ~-----------------l~~~~~-~~~l~~~~~~-~i~~~---------i~~~l~~LH~~-----~~~~iiH~Dikp~N 562 (752)
. ++.... ...++....+ ....+ +.+.+..+... .+..++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 111110 1112222111 11111 11112222111 12358999999999
Q ss_pred EEecCCCCceeccccccee
Q 043278 563 ILLDDKMNPKISDFGMARI 581 (752)
Q Consensus 563 Ill~~~~~~kl~DFgla~~ 581 (752)
|++++++ +.|+||..+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999877 78999998864
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.00041 Score=70.50 Aligned_cols=141 Identities=20% Similarity=0.293 Sum_probs=82.2
Q ss_pred CeeecCCcccEEEEEecC--CceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCc-ceeeeeeeeCCeeEEEEeeCCCCC
Q 043278 436 NKLGEGGFGPVYKGKLAD--EQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL-VRLLGCSLHGEERLLVYEFMPNKS 512 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~~--~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~~~~gs 512 (752)
+.|..|-...+|+....+ ++.+++|+....... .....+|+.++..+...++ .++++.+. ..++|||+++.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 567888889999998764 677888977543221 1233578888888854333 44444332 248999999877
Q ss_pred HhHH-------H----------hhcCCC--------CCCC-HHHHHHHHH----------------------HHHHHHHH
Q 043278 513 LDFF-------L----------FNSGRK--------NVLN-WEKRFIIIE----------------------GISQGLLY 544 (752)
Q Consensus 513 L~~~-------l----------~~~~~~--------~~l~-~~~~~~i~~----------------------~i~~~l~~ 544 (752)
+... + +..... .... ++....+.. .+.+.+..
T Consensus 79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 158 (235)
T cd05157 79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW 158 (235)
T ss_pred CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence 6321 0 111111 1111 222112111 11111111
Q ss_pred H----Hhc-CCCcEeecCCCCCcEEecC-CCCceeccccccee
Q 043278 545 L----HKY-SRLRVIHRDLKASNILLDD-KMNPKISDFGMARI 581 (752)
Q Consensus 545 L----H~~-~~~~iiH~Dikp~NIll~~-~~~~kl~DFgla~~ 581 (752)
| ... ....++|+|+++.|||+++ +..+.|+||..|..
T Consensus 159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 1 111 2345999999999999998 57899999988763
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.00082 Score=70.90 Aligned_cols=143 Identities=17% Similarity=0.138 Sum_probs=86.2
Q ss_pred CCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCC--cceeeee------eeeCCeeEEEEe
Q 043278 435 TNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTN--LVRLLGC------SLHGEERLLVYE 506 (752)
Q Consensus 435 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~------~~~~~~~~lv~E 506 (752)
.+.|..|....+|+....++ .+++|+... ....+...|++++..+.+.+ +.+++.. ...++..+++++
T Consensus 19 i~~i~~G~~n~~y~v~~~~~-~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSG-RYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCCC-cEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 45778888899999876554 688888764 23445677888888875332 4444432 123345689999
Q ss_pred eCCCCCHhH----HH----------hhcCC--------CCCCCHHHHH----------HHHHHHHHHHHHHHh----cCC
Q 043278 507 FMPNKSLDF----FL----------FNSGR--------KNVLNWEKRF----------IIIEGISQGLLYLHK----YSR 550 (752)
Q Consensus 507 ~~~~gsL~~----~l----------~~~~~--------~~~l~~~~~~----------~i~~~i~~~l~~LH~----~~~ 550 (752)
|+++..+.. .. +.... .....|.... .....+...+.++.. ..+
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999877532 11 11000 0111222111 011223334445443 122
Q ss_pred CcEeecCCCCCcEEecCCCCceeccccccee
Q 043278 551 LRVIHRDLKASNILLDDKMNPKISDFGMARI 581 (752)
Q Consensus 551 ~~iiH~Dikp~NIll~~~~~~kl~DFgla~~ 581 (752)
..++|+|++|.|||++++..+.|+||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 3599999999999999987788999998763
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.00094 Score=78.77 Aligned_cols=196 Identities=21% Similarity=0.236 Sum_probs=133.5
Q ss_pred HHHHHHHHHhcCCCCcceeeeeeeeCCeeE----EEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 043278 473 FKNEVRLIAKLQHTNLVRLLGCSLHGEERL----LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548 (752)
Q Consensus 473 ~~~E~~~l~~l~h~niv~l~~~~~~~~~~~----lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~ 548 (752)
..-|...+.++.|+|++.++.|..+....- +..|++..-++...+... ..++....+.+..++..||+|+|+.
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v---~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV---GSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc---cccCHHHHHHHHHHHhhhHHHHHHh
Confidence 345777788889999999999977655443 344677777776666443 3478888999999999999999998
Q ss_pred CCCcEeecCCCCC---cEEecCCCCceec--ccccceeecccccccccccccccCCccChhhhccCCCCc--cchhHHHH
Q 043278 549 SRLRVIHRDLKAS---NILLDDKMNPKIS--DFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSI--KTDVFSFG 621 (752)
Q Consensus 549 ~~~~iiH~Dikp~---NIll~~~~~~kl~--DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~--k~DV~S~G 621 (752)
. ..|.-+..+ +--.+.++...+. ||+..+.+....... ....+..+.+||......++. +.|+|.+|
T Consensus 306 ~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg 379 (1351)
T KOG1035|consen 306 S---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLWCLG 379 (1351)
T ss_pred c---cceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHHHHH
Confidence 5 555555554 4555667777777 888887655432211 123345678888777665554 47999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 043278 622 VLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVC 701 (752)
Q Consensus 622 ~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~ 701 (752)
..+..+..|..+....... ..+++.. ... .+......|+..++++|+++.+++.
T Consensus 380 ll~~~~~~~~~i~~~~~~~------------------~~~l~~~-----~~~---~~~d~~~~~~~~~~~~Rl~~~~ll~ 433 (1351)
T KOG1035|consen 380 LLLLQLSQGEDISEKSAVP------------------VSLLDVL-----STS---ELLDALPKCLDEDSEERLSALELLT 433 (1351)
T ss_pred HHHhhhhhcCcccccccch------------------hhhhccc-----cch---hhhhhhhhhcchhhhhccchhhhhh
Confidence 9999999886543322100 0111110 110 2445667899999999999999988
Q ss_pred Hh
Q 043278 702 ML 703 (752)
Q Consensus 702 ~L 703 (752)
+.
T Consensus 434 ~~ 435 (1351)
T KOG1035|consen 434 HP 435 (1351)
T ss_pred ch
Confidence 65
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.0016 Score=61.07 Aligned_cols=127 Identities=19% Similarity=0.275 Sum_probs=84.2
Q ss_pred CCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcce-eeeeeeeCCeeEEEEeeCCCCCH
Q 043278 435 TNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVR-LLGCSLHGEERLLVYEFMPNKSL 513 (752)
Q Consensus 435 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~~~~lv~E~~~~gsL 513 (752)
.+.|++|++|.||++.+.+ ..+|+|+-...+ ....+..|+++|..++-.++-+ ++.|- ..++.|||+.+-.|
T Consensus 27 ~~~L~KG~~s~Vyl~~~~~-~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~L 99 (201)
T COG2112 27 EKELAKGTTSVVYLGEWRG-GEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRPL 99 (201)
T ss_pred hhhhhcccccEEEEeeccC-ceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcch
Confidence 4789999999999999854 478888765543 4567889999999987666544 33332 23455999998888
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCC-CCcEEecCCCCceeccccccee
Q 043278 514 DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLK-ASNILLDDKMNPKISDFGMARI 581 (752)
Q Consensus 514 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dik-p~NIll~~~~~~kl~DFgla~~ 581 (752)
...-... +-++.+. ++..---|...+ |-|+.|. |..++|.++..+.|+||..|+.
T Consensus 100 ~~~~~~~------~rk~l~~----vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 100 GKLEIGG------DRKHLLR----VLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhcc------cHHHHHH----HHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 6654211 2233333 333322233334 8888875 4555555555999999999874
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.0015 Score=69.05 Aligned_cols=141 Identities=25% Similarity=0.312 Sum_probs=83.7
Q ss_pred CeeecCCcccEEEEEecC-------CceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCc-ceeeeeeeeCCeeEEEEee
Q 043278 436 NKLGEGGFGPVYKGKLAD-------EQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL-VRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~~-------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~ 507 (752)
+.|..|-...+|+....+ ++.+++|+..... .......+|.+++..+....+ .++++++.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 456777778999988765 4778889865543 222345788888888754333 345555432 358999
Q ss_pred CCCCCHhHHH-----------------hhcCCCC------CCC--HHHHHH--------------------------HHH
Q 043278 508 MPNKSLDFFL-----------------FNSGRKN------VLN--WEKRFI--------------------------IIE 536 (752)
Q Consensus 508 ~~~gsL~~~l-----------------~~~~~~~------~l~--~~~~~~--------------------------i~~ 536 (752)
+++..+.... +...... ..+ +..... +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 9887764311 1111110 011 111101 111
Q ss_pred HHHHHHHHHHh------cCCCcEeecCCCCCcEEecCC----CCceeccccccee
Q 043278 537 GISQGLLYLHK------YSRLRVIHRDLKASNILLDDK----MNPKISDFGMARI 581 (752)
Q Consensus 537 ~i~~~l~~LH~------~~~~~iiH~Dikp~NIll~~~----~~~kl~DFgla~~ 581 (752)
.+.+-+..|.. .....++|+|+.|.|||++++ +.++++||..+..
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 22223334432 134568999999999999985 8899999998863
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.00066 Score=69.46 Aligned_cols=145 Identities=17% Similarity=0.233 Sum_probs=98.3
Q ss_pred ccHHHHHHHhc---CCCcCCeeecCCcccEEEEEecCCceeEEEEcccC------------------Ccc----cHHHHH
Q 043278 420 FDFQTIAAAAN---NFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRS------------------SGQ----GIVEFK 474 (752)
Q Consensus 420 ~~~~~i~~~~~---~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~------------------~~~----~~~~~~ 474 (752)
+++-.|....+ -++..++||-|--+.||.+...+|++.++|.-.-. ... +.-...
T Consensus 79 yDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~ 158 (465)
T KOG2268|consen 79 YDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAAT 158 (465)
T ss_pred chHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHH
Confidence 56655555433 46788999999999999999999999988843110 000 122356
Q ss_pred HHHHHHHhcCC-C-CcceeeeeeeeCCeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc
Q 043278 475 NEVRLIAKLQH-T-NLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLR 552 (752)
Q Consensus 475 ~E~~~l~~l~h-~-niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ 552 (752)
+|...|+.+.. . -+.+.+++ +..++|||++.+-.|...- ...+..++. ..+..-+.-|..++
T Consensus 159 kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~------~v~d~~~ly---~~lm~~Iv~la~~G--- 222 (465)
T KOG2268|consen 159 KEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVR------HVEDPPTLY---DDLMGLIVRLANHG--- 222 (465)
T ss_pred HHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeee------ecCChHHHH---HHHHHHHHHHHHcC---
Confidence 78888888743 2 23444443 4678999999887774432 123333333 33444455566666
Q ss_pred EeecCCCCCcEEecCCCCceecccccce
Q 043278 553 VIHRDLKASNILLDDKMNPKISDFGMAR 580 (752)
Q Consensus 553 iiH~Dikp~NIll~~~~~~kl~DFgla~ 580 (752)
+||+|.+--||+++++..++++||--..
T Consensus 223 lIHgDFNEFNimv~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 223 LIHGDFNEFNIMVKDDDKIVVIDFPQMV 250 (465)
T ss_pred ceecccchheeEEecCCCEEEeechHhh
Confidence 9999999999999999999999996543
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0057 Score=65.28 Aligned_cols=142 Identities=17% Similarity=0.171 Sum_probs=77.6
Q ss_pred CeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCC--Ccceeeee------eeeCCeeEEEEee
Q 043278 436 NKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHT--NLVRLLGC------SLHGEERLLVYEF 507 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~------~~~~~~~~lv~E~ 507 (752)
+.|+.|....+|+....+| .+++|+.... .......|+.++..|... .+.+.+.. ....+..++++||
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~---~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFERL---TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEeccC---ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 5677788889999887665 6888987522 223334455555555321 23333321 2234567899999
Q ss_pred CCCCCHhH-----H---------HhhcCC--------CCCCCH-HHHHH------------HH-HHHHHHHHHHHhc---
Q 043278 508 MPNKSLDF-----F---------LFNSGR--------KNVLNW-EKRFI------------II-EGISQGLLYLHKY--- 548 (752)
Q Consensus 508 ~~~gsL~~-----~---------l~~~~~--------~~~l~~-~~~~~------------i~-~~i~~~l~~LH~~--- 548 (752)
+++..+.. . ++.... ...+.| ..... .. ..+...++.+...
T Consensus 104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 183 (319)
T PRK05231 104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP 183 (319)
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence 99875421 1 111110 001112 11111 11 1111122233211
Q ss_pred -CCCcEeecCCCCCcEEecCCCCceeccccccee
Q 043278 549 -SRLRVIHRDLKASNILLDDKMNPKISDFGMARI 581 (752)
Q Consensus 549 -~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~ 581 (752)
-+..+||+|++|.|||++++...-|+||+.+..
T Consensus 184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 234699999999999999766568999998863
|
|
| >PF11883 DUF3403: Domain of unknown function (DUF3403); InterPro: IPR021820 This functionally uncharacterised domain of around 50 amino acids is found in the C terminus of eukaryotic S-locus receptor kinase proteins | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.001 Score=48.23 Aligned_cols=45 Identities=36% Similarity=0.575 Sum_probs=34.7
Q ss_pred CCCCCCCCCceecccCCCCCCCCCCCCcccccccCceeeeeeccC
Q 043278 708 MPLPPPKQPAFFINANADDQVPEVPDNEVAKFSTNDVTMTTMEAR 752 (752)
Q Consensus 708 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~ 752 (752)
..+|.|++|+|++.+...+..++.....-...|.|++|.|.|+||
T Consensus 4 ~~LP~PKqPgF~~~r~~~e~~sSss~~~~~~~SvNevTiT~l~~R 48 (48)
T PF11883_consen 4 ATLPQPKQPGFFTGRSPSETDSSSSKQRDESCSVNEVTITMLEAR 48 (48)
T ss_pred ccCCCCCCCCEEeEcCCCCcCCCcccccCCCCCeeeEEEEeEecC
Confidence 458999999999999876554443221125799999999999999
|
; GO: 0004674 protein serine/threonine kinase activity |
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.00055 Score=56.01 Aligned_cols=39 Identities=28% Similarity=0.649 Sum_probs=31.2
Q ss_pred CCCCccchHHhhhh-cCccccccccccccccccccccccc-ccccc
Q 043278 297 DNMSSTDCRANCFY-NCSCIAFATGTSEYTDKQAYCEIWS-EGTEF 340 (752)
Q Consensus 297 ~~~sl~~C~~~Cl~-nCsC~Aya~~~~~~~~~~~~C~~~~-~~~~~ 340 (752)
...++++|++.|+. +|+|.||+|.. ....|.+|. ..+..
T Consensus 23 ~~~s~~~C~~~C~~~~~~C~s~~y~~-----~~~~C~l~~~~~~~~ 63 (78)
T smart00473 23 SVASLEECASKCLNSNCSCRSFTYNN-----GTKGCLLWSESSLGD 63 (78)
T ss_pred cCCCHHHHHHHhCCCCCceEEEEEcC-----CCCEEEEeeCCcccc
Confidence 45688999999999 99999999842 457999998 44333
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.023 Score=60.25 Aligned_cols=143 Identities=19% Similarity=0.180 Sum_probs=82.6
Q ss_pred CCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCC--Ccceeeeee------eeCCeeEEEEe
Q 043278 435 TNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHT--NLVRLLGCS------LHGEERLLVYE 506 (752)
Q Consensus 435 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~------~~~~~~~lv~E 506 (752)
.+.++.|....+|+....++ .+++|+..... ...+...|.+++..|... .+.+++... ..++..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 35677777789999876555 57788765421 233455677777776422 234444321 22345689999
Q ss_pred eCCCCCHhH----H----------HhhcCCC------C---CCCHHHHH------------HHHHHHHHHHHHHHh----
Q 043278 507 FMPNKSLDF----F----------LFNSGRK------N---VLNWEKRF------------IIIEGISQGLLYLHK---- 547 (752)
Q Consensus 507 ~~~~gsL~~----~----------l~~~~~~------~---~l~~~~~~------------~i~~~i~~~l~~LH~---- 547 (752)
|+++..+.. . ++..... . .-.|.... .....+.+.++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 998855421 0 1110000 0 01121110 011223345555543
Q ss_pred cCCCcEeecCCCCCcEEecCCCCceecccccce
Q 043278 548 YSRLRVIHRDLKASNILLDDKMNPKISDFGMAR 580 (752)
Q Consensus 548 ~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~ 580 (752)
..+..++|+|+++.||++++++...|+||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 223569999999999999988777899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.01 Score=62.22 Aligned_cols=119 Identities=18% Similarity=0.226 Sum_probs=75.0
Q ss_pred CceeEEEEccc--CCcccHHHHHHHHHHHHhcCC--CCcceeeeeeeeCC--eeEEEEeeCCCCCHhHHHhhcCCCCCCC
Q 043278 454 EQEVAIKRLSR--SSGQGIVEFKNEVRLIAKLQH--TNLVRLLGCSLHGE--ERLLVYEFMPNKSLDFFLFNSGRKNVLN 527 (752)
Q Consensus 454 ~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~--~~~lv~E~~~~gsL~~~l~~~~~~~~l~ 527 (752)
+++++|. ... ..........+|+.+|+.+.- .-+.+.+++|.++. ..+.||+|+++..+...+.. .+
T Consensus 48 ~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~------~~ 120 (321)
T COG3173 48 GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPP------ES 120 (321)
T ss_pred CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCc------cc
Confidence 6777777 332 223344556788888888743 23455677777766 66999999988543222211 00
Q ss_pred HHHHHHHH-HHHHHHHHHHHh--------------------------------------------------c-----CCC
Q 043278 528 WEKRFIII-EGISQGLLYLHK--------------------------------------------------Y-----SRL 551 (752)
Q Consensus 528 ~~~~~~i~-~~i~~~l~~LH~--------------------------------------------------~-----~~~ 551 (752)
.. .+++ ..+++.|+-||+ + +.+
T Consensus 121 ~~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~ 198 (321)
T COG3173 121 LG--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPP 198 (321)
T ss_pred ch--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCc
Confidence 00 1111 244444444442 2 234
Q ss_pred cEeecCCCCCcEEecCCCCceeccccccee
Q 043278 552 RVIHRDLKASNILLDDKMNPKISDFGMARI 581 (752)
Q Consensus 552 ~iiH~Dikp~NIll~~~~~~kl~DFgla~~ 581 (752)
.++|+|+++.||+++.+.-+-|.||+++.+
T Consensus 199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred eeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 699999999999999988899999999875
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.0095 Score=64.15 Aligned_cols=141 Identities=21% Similarity=0.282 Sum_probs=82.2
Q ss_pred CeeecCCcccEEEEEecC-----CceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcc-eeeeeeeeCCeeEEEEeeCC
Q 043278 436 NKLGEGGFGPVYKGKLAD-----EQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLV-RLLGCSLHGEERLLVYEFMP 509 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~E~~~ 509 (752)
+.|-.|-.-.+|+....+ ++.+++|+......... ...+|..++..+...++. ++++.+..+ .|+||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 455567778899887533 35788888765443222 237788888888544443 455655332 5899998
Q ss_pred CCCHhHH-----------------HhhcC---CCCCCCHHHHHHHHHH-----------------HHHHHHHHH----h-
Q 043278 510 NKSLDFF-----------------LFNSG---RKNVLNWEKRFIIIEG-----------------ISQGLLYLH----K- 547 (752)
Q Consensus 510 ~gsL~~~-----------------l~~~~---~~~~l~~~~~~~i~~~-----------------i~~~l~~LH----~- 547 (752)
+.+|... ++... ......+.+...+..+ +...+..|. .
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 7776422 11111 0111123333233211 111222222 1
Q ss_pred cCCCcEeecCCCCCcEEecC-CCCceeccccccee
Q 043278 548 YSRLRVIHRDLKASNILLDD-KMNPKISDFGMARI 581 (752)
Q Consensus 548 ~~~~~iiH~Dikp~NIll~~-~~~~kl~DFgla~~ 581 (752)
.....++|+|+++.|||+++ ++.+.++||..+..
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 22346899999999999986 46899999998864
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.69 E-value=0.012 Score=61.22 Aligned_cols=74 Identities=16% Similarity=0.262 Sum_probs=48.5
Q ss_pred cCCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcC---CCCcceeeeeeeeCCeeEEEEeeCCC
Q 043278 434 TTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQ---HTNLVRLLGCSLHGEERLLVYEFMPN 510 (752)
Q Consensus 434 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~E~~~~ 510 (752)
..+.|+.|....+|+.. .+++.+.||.-.. .....|..|.+-|+.|. -..+.+++++....+..+||+||++.
T Consensus 21 ~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~ 96 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM 96 (288)
T ss_dssp EEEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred eeEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence 34678989999999887 5778899998762 23346788888888883 44677888888777778999999987
Q ss_pred C
Q 043278 511 K 511 (752)
Q Consensus 511 g 511 (752)
+
T Consensus 97 ~ 97 (288)
T PF03881_consen 97 G 97 (288)
T ss_dssp -
T ss_pred C
Confidence 7
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.012 Score=61.23 Aligned_cols=31 Identities=26% Similarity=0.533 Sum_probs=25.9
Q ss_pred CcEeecCCCCCcEEecCCCC-ceeccccccee
Q 043278 551 LRVIHRDLKASNILLDDKMN-PKISDFGMARI 581 (752)
Q Consensus 551 ~~iiH~Dikp~NIll~~~~~-~kl~DFgla~~ 581 (752)
+.++|+|++|.|||+++++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 35899999999999997555 46999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.43 E-value=0.038 Score=59.89 Aligned_cols=80 Identities=13% Similarity=0.050 Sum_probs=53.0
Q ss_pred CCeeecCCcccEEEEEecCCceeEEEEcccCCc-------ccHHHHHHHHHHHHhcC---CCCcceeeeeeeeCCeeEEE
Q 043278 435 TNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSG-------QGIVEFKNEVRLIAKLQ---HTNLVRLLGCSLHGEERLLV 504 (752)
Q Consensus 435 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-------~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv 504 (752)
.+.||.|....||+.... +..++||+-..... ....+-..|.+.|..+. ..++.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 368899999999998864 45699998652111 12333445566666553 247778888876 457889
Q ss_pred EeeCCC--CCHhHHH
Q 043278 505 YEFMPN--KSLDFFL 517 (752)
Q Consensus 505 ~E~~~~--gsL~~~l 517 (752)
||+++. ..+..-+
T Consensus 114 ME~L~~~~~ilr~~L 128 (418)
T PLN02756 114 MRYLEPPHIILRKGL 128 (418)
T ss_pred EeecCCcceehhhhh
Confidence 999976 3444443
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.012 Score=52.06 Aligned_cols=74 Identities=24% Similarity=0.322 Sum_probs=46.8
Q ss_pred CccEEec-cCCCCCCCCCceEEEecCCCcEEEEcCCCCcEEEeeccCCccccceeEec--CCCeEEEEecCCCccceeEe
Q 043278 52 DEPIWIA-NRNTPILDQSGVLTIDSIDGNLKILHNGGNPIAVSSVEGASNNTSATLLQ--SGNLVLREMDTDGTIKRVLW 128 (752)
Q Consensus 52 ~t~vWvA-Nr~~Pv~~~~~~l~~~~~~g~L~l~~~~g~~~~~~~~~~~~~~~~a~lld--sGNlVl~~~~~~~~~~~~lW 128 (752)
.+++|.. +....-. ....+.|.. +|||||.|..+.++|.+. .....+.....+ .||++ .... ..+.|
T Consensus 38 ~~~iWss~~t~~~~~-~~~~~~L~~-~GNlvl~d~~~~~lW~Sf--~~ptdt~L~~q~l~~~~~~-~~~~-----~~~sw 107 (114)
T PF01453_consen 38 GSVIWSSNNTSGRGN-SGCYLVLQD-DGNLVLYDSSGNVLWQSF--DYPTDTLLPGQKLGDGNVT-GKND-----SLTSW 107 (114)
T ss_dssp TEEEEE--S-TTSS--SSEEEEEET-TSEEEEEETTSEEEEEST--TSSS-EEEEEET--TSEEE-EEST-----SSEEE
T ss_pred CCEEEEecccCCccc-cCeEEEEeC-CCCEEEEeecceEEEeec--CCCccEEEeccCcccCCCc-cccc-----eEEeE
Confidence 3679999 4343332 336799988 999999999888888873 233455566666 88888 5432 35788
Q ss_pred eeccCCC
Q 043278 129 QSFDYPT 135 (752)
Q Consensus 129 QSFd~PT 135 (752)
.|=+.|+
T Consensus 108 ~s~~dps 114 (114)
T PF01453_consen 108 SSNTDPS 114 (114)
T ss_dssp ESS----
T ss_pred CCCCCCC
Confidence 8876663
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.39 E-value=0.057 Score=57.55 Aligned_cols=79 Identities=14% Similarity=0.096 Sum_probs=50.0
Q ss_pred eeecCCcccEEEEEecCC-ceeEEEEcccC-------CcccHHHHHHHHHHHHhcC--CC-CcceeeeeeeeCCeeEEEE
Q 043278 437 KLGEGGFGPVYKGKLADE-QEVAIKRLSRS-------SGQGIVEFKNEVRLIAKLQ--HT-NLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 437 ~LG~G~fg~Vy~~~~~~~-~~vavK~l~~~-------~~~~~~~~~~E~~~l~~l~--h~-niv~l~~~~~~~~~~~lv~ 505 (752)
.||.|...-||++..++| +.|+||.-... -.-...+..-|.+.|.... .| .+.+++.+ +.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 579999999999998655 57999975421 1223445556777776652 34 34445433 455677999
Q ss_pred eeCCC-CCHhHHH
Q 043278 506 EFMPN-KSLDFFL 517 (752)
Q Consensus 506 E~~~~-gsL~~~l 517 (752)
|+++. ..|...|
T Consensus 80 EdL~~~~ilR~~L 92 (370)
T TIGR01767 80 EDLSHHKIARKGL 92 (370)
T ss_pred hhCccchHHHHHH
Confidence 99854 3344444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.84 E-value=0.018 Score=57.44 Aligned_cols=30 Identities=33% Similarity=0.473 Sum_probs=21.8
Q ss_pred cEeecCCCCCcEEe-cCCCCceeccccccee
Q 043278 552 RVIHRDLKASNILL-DDKMNPKISDFGMARI 581 (752)
Q Consensus 552 ~iiH~Dikp~NIll-~~~~~~kl~DFgla~~ 581 (752)
.++|+|+.|.|||+ +.++.++++||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 48899999999999 8899999999998875
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.81 E-value=0.042 Score=57.61 Aligned_cols=140 Identities=21% Similarity=0.182 Sum_probs=94.9
Q ss_pred CcCCeeecCCcccEEEEEecCCceeEEEEcccCC---------ccc-------------HHH----HHHHHHHHHhcCCC
Q 043278 433 STTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSS---------GQG-------------IVE----FKNEVRLIAKLQHT 486 (752)
Q Consensus 433 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~---------~~~-------------~~~----~~~E~~~l~~l~h~ 486 (752)
.+...|..|--+.||.+.-.+|..+|||+.+... ..+ .+. ..+|++-|.+++..
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 4456889999999999999999999999875421 001 111 24577777777544
Q ss_pred CcceeeeeeeeCCeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEec
Q 043278 487 NLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLD 566 (752)
Q Consensus 487 niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~ 566 (752)
.|.-.--... ...+|||+|+.......-. -+.-.++...+..+-.++++-|.-|-+.+ .+||.||.--|+|+-
T Consensus 227 GIP~PePIlL--k~hVLVM~FlGrdgw~aPk---LKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh 299 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFLGRDGWAAPK---LKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH 299 (520)
T ss_pred CCCCCCceee--ecceEeeeeccCCCCcCcc---cccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE
Confidence 3221111111 2357999998643321111 12334777788888899999999998877 499999999999985
Q ss_pred CCCCceecccccce
Q 043278 567 DKMNPKISDFGMAR 580 (752)
Q Consensus 567 ~~~~~kl~DFgla~ 580 (752)
+|.+.|+|.+-+.
T Consensus 300 -dG~lyiIDVSQSV 312 (520)
T KOG2270|consen 300 -DGKLYIIDVSQSV 312 (520)
T ss_pred -CCEEEEEEccccc
Confidence 4578888987664
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.79 E-value=0.35 Score=51.61 Aligned_cols=96 Identities=15% Similarity=0.069 Sum_probs=56.6
Q ss_pred cccccHHHHHHHhcCCCcC---C-eeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCC--Ccce
Q 043278 417 LKIFDFQTIAAAANNFSTT---N-KLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHT--NLVR 490 (752)
Q Consensus 417 ~~~~~~~~i~~~~~~~~~~---~-~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~--niv~ 490 (752)
...++...+..+...+.+. + ..=.+.-..||+...++++.+++|..... .....+...|++.+..+... .++.
T Consensus 8 ~~~l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~ 86 (325)
T PRK11768 8 FQTLTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVA 86 (325)
T ss_pred CCCCChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCC
Confidence 3445555565555554331 1 22234557899998888888999987532 23455677788888777321 2222
Q ss_pred ee---e--eeeeCCeeEEEEeeCCCCCH
Q 043278 491 LL---G--CSLHGEERLLVYEFMPNKSL 513 (752)
Q Consensus 491 l~---~--~~~~~~~~~lv~E~~~~gsL 513 (752)
.. | ....++..+.+++++++...
T Consensus 87 p~~~~G~~~~~~~g~~~~l~~~~~G~~~ 114 (325)
T PRK11768 87 PLAFNGQTLHEHQGFRFALFPRRGGRAP 114 (325)
T ss_pred CccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence 22 2 12234567889999987653
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.75 E-value=0.053 Score=58.07 Aligned_cols=141 Identities=18% Similarity=0.313 Sum_probs=80.1
Q ss_pred CeeecCCcccEEEEEecC----CceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcc-eeeeeeeeCCeeEEEEeeCCC
Q 043278 436 NKLGEGGFGPVYKGKLAD----EQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLV-RLLGCSLHGEERLLVYEFMPN 510 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~E~~~~ 510 (752)
+.|..|-...+|+....+ +..|++|+....... .-...+|..++..+...++- ++++++..+ +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcC
Confidence 456667777888886543 237888877554332 22346788888888655543 456555322 58999877
Q ss_pred CCHhHH-------H----------hhcC---CCCCCCHHHHHHHHHH----------------------HHHHHHHHHh-
Q 043278 511 KSLDFF-------L----------FNSG---RKNVLNWEKRFIIIEG----------------------ISQGLLYLHK- 547 (752)
Q Consensus 511 gsL~~~-------l----------~~~~---~~~~l~~~~~~~i~~~----------------------i~~~l~~LH~- 547 (752)
..|... + +... ....-.|....++..+ +..-+..+..
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 665321 1 1111 0111123322222211 1111222211
Q ss_pred ----cCCCcEeecCCCCCcEEecC-CCCceeccccccee
Q 043278 548 ----YSRLRVIHRDLKASNILLDD-KMNPKISDFGMARI 581 (752)
Q Consensus 548 ----~~~~~iiH~Dikp~NIll~~-~~~~kl~DFgla~~ 581 (752)
..+..++|+|+.+.|||+++ ++.++++||..|..
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 12234799999999999975 57899999998864
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 752 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-53 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-52 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-38 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-38 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-38 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 6e-38 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-37 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-36 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-23 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-23 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-23 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-23 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-23 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-23 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-23 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-23 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-23 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-23 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-23 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-22 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-22 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-22 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-22 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-22 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-22 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 6e-22 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-21 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-21 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-20 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-20 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-20 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-20 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-20 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-20 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-20 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-20 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-20 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-20 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-20 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-20 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-20 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-20 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-20 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-20 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-20 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-20 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 6e-20 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 9e-20 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-19 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-19 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-19 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-19 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-19 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-19 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-19 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-19 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-19 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-19 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-19 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-19 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-19 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-19 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-19 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-19 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-19 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-19 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-19 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-19 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-19 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-19 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-19 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-19 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-19 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-19 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-19 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-19 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-19 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-19 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-19 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-19 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-19 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-19 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-19 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-19 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 7e-19 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 7e-19 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-19 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 7e-19 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 7e-19 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 8e-19 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 8e-19 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 8e-19 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 9e-19 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-18 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-18 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-18 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-18 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-18 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-18 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-18 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-18 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-18 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-18 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-18 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-18 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-18 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-18 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-18 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-18 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-18 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 6e-18 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 7e-18 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-18 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 8e-18 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-18 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-18 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 8e-18 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-17 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-17 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-17 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-17 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-17 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-17 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-17 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-17 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-17 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-17 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-17 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-17 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-17 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-17 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-17 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-17 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-17 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-17 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-17 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 7e-17 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 8e-17 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-17 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-16 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-16 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-16 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-16 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-16 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-16 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-16 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-16 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-16 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-16 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-16 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-16 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-16 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-16 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-16 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-16 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-16 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-16 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-16 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-16 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-16 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-16 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-16 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-16 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-16 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-16 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-16 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-16 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-16 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-16 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-16 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-16 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-16 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-16 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 5e-16 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-16 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-16 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 6e-16 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-16 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 6e-16 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 7e-16 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 7e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 7e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 7e-16 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-16 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 7e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-16 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 7e-16 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 7e-16 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 7e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 7e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-16 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 7e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 7e-16 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-16 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 8e-16 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 8e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 8e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 8e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 8e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 8e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 9e-16 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 9e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 9e-16 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 9e-16 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 9e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-15 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-15 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-15 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-15 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-15 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-15 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-15 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-15 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-15 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-15 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-15 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-15 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-15 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-15 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-15 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-15 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-15 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-15 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-15 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-15 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-15 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-15 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-15 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-15 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-15 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-15 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-15 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-15 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-15 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-15 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-15 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-15 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-15 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-15 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-15 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-15 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-15 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-15 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-15 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-15 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-15 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-15 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-15 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-15 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-15 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-15 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-15 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-15 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-15 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-15 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-15 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-15 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-15 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-15 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-15 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-15 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-15 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-15 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-15 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 6e-15 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 7e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 8e-15 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 9e-15 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 9e-15 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-14 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-14 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-14 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-14 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-14 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-14 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-14 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-14 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-14 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-14 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-14 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-14 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-14 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-14 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-14 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-14 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-14 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 6e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-14 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 6e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 6e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 6e-14 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 7e-14 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-14 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 7e-14 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-14 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 7e-14 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 7e-14 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 9e-14 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-13 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-13 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-13 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-13 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-13 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-13 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-13 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-13 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-13 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-13 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-13 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-13 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-13 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-13 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-13 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-13 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-13 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-13 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-13 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-13 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-13 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-13 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-13 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-13 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-13 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-13 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-13 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-13 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-13 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 5e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-13 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-13 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 6e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 7e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 7e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 8e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 8e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 9e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 9e-13 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-12 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-12 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-12 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-12 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-12 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-12 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-12 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-12 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-12 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-12 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-12 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-12 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-12 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-12 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-12 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-12 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-12 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-12 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-12 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-12 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-12 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-12 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-12 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-12 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-12 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-12 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-12 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-12 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-12 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-12 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-12 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-12 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-12 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-12 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-12 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-12 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-12 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-12 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-12 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-12 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-12 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-12 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-12 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-12 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-12 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-12 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-12 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-12 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-12 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-12 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-12 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-12 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-12 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-12 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-12 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 6e-12 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-12 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-12 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-12 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 7e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 7e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-12 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 7e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 7e-12 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 7e-12 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 8e-12 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 8e-12 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 8e-12 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 8e-12 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 8e-12 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 8e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 8e-12 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 9e-12 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 9e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 9e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 9e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 9e-12 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-11 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-11 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-11 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-11 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-11 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-11 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-11 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-11 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-11 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-11 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-11 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-11 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-11 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-11 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-11 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 8e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 8e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-11 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 9e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 9e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-10 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-10 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-10 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-10 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 6e-10 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 6e-10 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 6e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-10 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 6e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 7e-10 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-10 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 7e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 7e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 8e-10 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 8e-10 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 8e-10 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 8e-10 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 9e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 9e-10 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-09 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-09 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-09 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 5e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 5e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-09 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 6e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 6e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 6e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 6e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 6e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 7e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 7e-09 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 7e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 7e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 7e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 7e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 8e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 8e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 8e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 8e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 8e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 8e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 8e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 8e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 8e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 8e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 8e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 8e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 8e-09 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 8e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 9e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 9e-09 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 9e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 9e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 9e-09 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-09 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-08 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-08 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-08 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-08 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-08 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-08 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-08 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-08 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-08 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 5e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-08 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 5e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 6e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 6e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 6e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 6e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 7e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 7e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 7e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 7e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 7e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 8e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 8e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 8e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 8e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 8e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 8e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 8e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 8e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 9e-08 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 9e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 9e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 9e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 6e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 6e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 6e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 6e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 7e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 7e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 7e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 7e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 7e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 7e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 8e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-06 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 4e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 4e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 4e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 4e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 5e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 5e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 5e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 5e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 6e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 7e-06 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 7e-06 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 8e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 9e-06 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 9e-06 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-05 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-05 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-05 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-05 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-05 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 6e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 7e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 424 bits (1093), Expect = e-144
Identities = 107/312 (34%), Positives = 163/312 (52%), Gaps = 19/312 (6%)
Query: 408 EKDQSISHELKIFDFQTIAAAANNFS------TTNKLGEGGFGPVYKGKLADEQEVAIKR 461
+ + F F + NNF NK+GEGGFG VYKG + + VA+K+
Sbjct: 3 KSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKK 61
Query: 462 LS----RSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFL 517
L+ ++ + +F E++++AK QH NLV LLG S G++ LVY +MPN SL L
Sbjct: 62 LAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL 121
Query: 518 FNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFG 577
L+W R I +G + G+ +LH+ IHRD+K++NILLD+ KISDFG
Sbjct: 122 SCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFG 178
Query: 578 MARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRH 637
+AR E T RIVGT YM+PE + G ++ K+D++SFGV++LEI++G H
Sbjct: 179 LARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEH 237
Query: 638 HPDRPLNLIGYAWQLLSDGKGLE-LIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTM 696
+ L+ ++ + K +E ID + + V V C+ ++ RP +
Sbjct: 238 REPQ--LLLDIKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRPDI 294
Query: 697 PEVVCMLQNETM 708
+V +LQ T
Sbjct: 295 KKVQQLLQEMTA 306
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 415 bits (1069), Expect = e-140
Identities = 120/297 (40%), Positives = 176/297 (59%), Gaps = 5/297 (1%)
Query: 417 LKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGI-VEFKN 475
LK F + + A++NFS N LG GGFG VYKG+LAD VA+KRL QG ++F+
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76
Query: 476 EVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLF-NSGRKNVLNWEKRFII 534
EV +I+ H NL+RL G + ERLLVY +M N S+ L + L+W KR I
Sbjct: 77 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 535 IEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594
G ++GL YLH + ++IHRD+KA+NILLD++ + DFG+A++ + ++ T +
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AV 195
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKN--HTRHHPDRPLNLIGYAWQL 652
GT G+++PEY +G S KTDVF +GV++LE+++GQ+ R D + L+ + L
Sbjct: 196 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255
Query: 653 LSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETMP 709
L + K L+D L+ EV + I V LLC Q M+RP M EVV ML+ + +
Sbjct: 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA 312
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 369 bits (949), Expect = e-123
Identities = 99/308 (32%), Positives = 170/308 (55%), Gaps = 6/308 (1%)
Query: 399 PTYGKRKSPEKDQSISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEVA 458
T + + E + A NNF +G G FG VYKG L D +VA
Sbjct: 8 ATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVA 67
Query: 459 IKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLF 518
+KR + S QGI EF+ E+ ++ +H +LV L+G E +L+Y++M N +L L+
Sbjct: 68 LKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLY 127
Query: 519 NSGR-KNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFG 577
S ++WE+R I G ++GL YLH + +IHRD+K+ NILLD+ PKI+DFG
Sbjct: 128 GSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFG 184
Query: 578 MARIF-EVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTR 636
+++ E++++ +T + GT GY+ PEY + G ++ K+DV+SFGV++ E++ + +
Sbjct: 185 ISKKGTELDQTHLST-VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQ 243
Query: 637 HHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTM 696
P +NL +A + ++G+ +++DP+L + + + C+ + DRP+M
Sbjct: 244 SLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSM 303
Query: 697 PEVVCMLQ 704
+V+ L+
Sbjct: 304 GDVLWKLE 311
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 285 bits (732), Expect = 2e-90
Identities = 71/320 (22%), Positives = 125/320 (39%), Gaps = 29/320 (9%)
Query: 408 EKDQSISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSG 467
S + + + + G FG V+K +L + VA+K
Sbjct: 3 HHHHHHSSGVD-LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDK 60
Query: 468 QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGE----ERLLVYEFMPNKSLDFFLFNSGRK 523
Q + + EV + ++H N+++ +G G + L+ F SL FL +
Sbjct: 61 QS-WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KA 115
Query: 524 NVLNWEKRFIIIEGISQGLLYLH-------KYSRLRVIHRDLKASNILLDDKMNPKISDF 576
NV++W + I E +++GL YLH + + HRD+K+ N+LL + + I+DF
Sbjct: 116 NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175
Query: 577 GMARIFEVNESEANTKRIVGTYGYMSPEYAMSGI-----VSIKTDVFSFGVLVLEIVSGQ 631
G+A FE +S +T VGT YM+PE I ++ D+++ G+++ E+ S
Sbjct: 176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRC 235
Query: 632 KNHTRHHPDRPLNLIGYAWQLLS-----DGKGLELIDPSLEQPCSANEVMRCI-HVGLLC 685
+ L Q S + + P L + M + C
Sbjct: 236 TAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEEC 295
Query: 686 VQDQAMDRPTMPEVVCMLQN 705
A R + V +
Sbjct: 296 WDHDAEARLSAGCVGERITQ 315
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 245 bits (626), Expect = 7e-75
Identities = 69/340 (20%), Positives = 124/340 (36%), Gaps = 45/340 (13%)
Query: 420 FDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNE--V 477
+ +N +G G +G VYKG L DE+ VA+K S ++ Q F NE +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNI 58
Query: 478 RLIAKLQHTNLVRLLGCSLHGE-----ERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRF 532
+ ++H N+ R + E LLV E+ PN SL +L + +W
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVSSC 114
Query: 533 IIIEGISQGLLYLH------KYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIF---- 582
+ +++GL YLH + + + HRDL + N+L+ + ISDFG++
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 583 --EVNESEANTKRIVGTYGYMSPEYAMSGI-------VSIKTDVFSFGVLVLEIVSGQKN 633
E + VGT YM+PE + + D+++ G++ EI +
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 634 HTRHHPDRPLNLIGYAWQLLSDGKGLELID--------PSLEQPCSANEVMRCIHVGLL- 684
+ + ++ + ++ P + N + +
Sbjct: 235 LFPGESVPEYQMA-FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293
Query: 685 -CVQDQAMDRPTMPEVVCMLQNETMPLPPPKQPAFFINAN 723
C A R T + M K + + +
Sbjct: 294 DCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAHHH 333
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 3e-60
Identities = 74/289 (25%), Positives = 136/289 (47%), Gaps = 28/289 (9%)
Query: 436 NKLGEGGFGPVYKGKLADEQEVAIKRLSRS--SGQGIVEFKNEVRLIAKLQHTNLVRLLG 493
K+G G FG V++ + +VA+K L + + EF EV ++ +L+H N+V +G
Sbjct: 43 EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 494 CSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRV 553
+V E++ SL L SG + L+ +R + +++G+ YLH +
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPI 160
Query: 554 IHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSI 613
+HR+LK+ N+L+D K K+ DFG++R+ + ++K GT +M+PE +
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDEPSNE 218
Query: 614 KTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLEL---IDPSLEQPC 670
K+DV+SFGV++ E+ T P LN + K LE+ ++P +
Sbjct: 219 KSDVYSFGVILWELA------TLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAA-- 270
Query: 671 SANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN-ETMPLPPPKQPAF 718
++ C ++ RP+ ++ +L+ +PPP +
Sbjct: 271 ----IIE------GCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRSDL 309
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 1e-55
Identities = 74/285 (25%), Positives = 122/285 (42%), Gaps = 42/285 (14%)
Query: 436 NKLGEGGFGPVYKGKLADEQEVAIKRL----SRSSGQGIVEFKNEVRLIAKLQHTNLVRL 491
+G GGFG VY+ EVA+K Q I + E +L A L+H N++ L
Sbjct: 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 492 LGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRL 551
G L LV EF L+ L + + I++G+ YLH + +
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 552 RVIHRDLKASNILLDDKMNP--------KISDFGMARIFEVNESEANTKRIVGTYGYMSP 603
+IHRDLK+SNIL+ K+ KI+DFG+AR + + G Y +M+P
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA----GAYAWMAP 183
Query: 604 EYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLEL-- 661
E + + S +DV+S+GVL+ E+++G+ P R ++ + A+ + + L +
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGEV------PFRGIDGLAVAYGVAMNKLALPIPS 237
Query: 662 -IDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
+ +M C RP+ ++ L
Sbjct: 238 TCPEPFAK------LME------DCWNPDPHSRPSFTNILDQLTT 270
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 2e-55
Identities = 66/301 (21%), Positives = 121/301 (40%), Gaps = 42/301 (13%)
Query: 436 NKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGC 494
LG+G FG K + + +K L R + F EV+++ L+H N+++ +G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 495 SLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVI 554
+ + E++ +L + + + W +R + I+ G+ YLH + +I
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIASGMAYLH---SMNII 130
Query: 555 HRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKR------------IVGTYGYMS 602
HRDL + N L+ + N ++DFG+AR+ +++ R +VG +M+
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 603 PEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELI 662
PE K DVFSFG+++ EI+ D + L G L+
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVN------ADPDYLPRTMDFGLNVRG-FLDRY 243
Query: 663 DPSLEQPCSAN--EVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN------ETMPLPPPK 714
P C + + + C RP+ ++ L+ +PL P
Sbjct: 244 CP---PNCPPSFFPIT------VRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQL 294
Query: 715 Q 715
+
Sbjct: 295 E 295
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 8e-55
Identities = 79/289 (27%), Positives = 119/289 (41%), Gaps = 39/289 (13%)
Query: 436 NKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCS 495
+G G FG V K K ++VAIK++ S F E+R ++++ H N+V+L G
Sbjct: 14 EVVGRGAFGVVCKAKWRA-KDVAIKQIE--SESERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 496 LHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIH 555
L LV E+ SL L + SQG+ YLH +IH
Sbjct: 71 L--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128
Query: 556 RDLKASNILLDDKMN-PKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIK 614
RDLK N+LL KI DFG A + + + G+ +M+PE S K
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSEK 183
Query: 615 TDVFSFGVLVLEIVSGQKNHTRHHP----DRPLNLIGYAWQLLSDGKGLELID---PSLE 667
DVFS+G+++ E++ TR P P I +A + +G LI +E
Sbjct: 184 CDVFSWGIILWEVI------TRRKPFDEIGGPAFRIMWA---VHNGTRPPLIKNLPKPIE 234
Query: 668 QPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETMPLPPPKQP 716
+M C RP+M E+V ++ + P +P
Sbjct: 235 ------SLMTR------CWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 8e-54
Identities = 70/285 (24%), Positives = 126/285 (44%), Gaps = 38/285 (13%)
Query: 436 NKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQG-------IVEFKNEVRLIAKLQHTN 487
++G+GGFG V+KG+ + D+ VAIK L +G EF+ EV +++ L H N
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 488 LVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHK 547
+V+L G +V EF+P L L + + + + W + ++ I+ G+ Y+
Sbjct: 85 IVKLYGLMH--NPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQN 140
Query: 548 YSRLRVIHRDLKASNILLDDK-----MNPKISDFGMARIFEVNESEANTKRIVGTYGYMS 602
++HRDL++ NI L + K++DFG+++ +S + ++G + +M+
Sbjct: 141 -QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQWMA 194
Query: 603 PE--YAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLE 660
PE A + K D +SF +++ I+ T P + + + +GL
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILYTIL------TGEGPFDEYSYGKIKFINMIREEGLR 248
Query: 661 LIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
P + P V+ LC RP +V L
Sbjct: 249 PTIPE-DCPPRLRNVIE------LCWSGDPKKRPHFSYIVKELSE 286
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 3e-53
Identities = 72/279 (25%), Positives = 129/279 (46%), Gaps = 32/279 (11%)
Query: 436 NKLGEGGFGPVYKGKLADEQEVAIKRLSRS--SGQGIVEFKNEVRLIAKLQHTNLVRLLG 493
++G G FG VYKGK +VA+K L+ + + Q + FKNEV ++ K +H N++ +G
Sbjct: 30 QRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 494 CSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLR 552
S +L +V ++ SL L + +K I ++G+ YLH
Sbjct: 88 YST--APQLAIVTQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLH---AKS 140
Query: 553 VIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPE---YAMSG 609
+IHRDLK++NI L + KI DFG+A +++ G+ +M+PE S
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 610 IVSIKTDVFSFGVLVLEIVSGQ---KNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666
S ++DV++FG+++ E+++GQ N + I + +L
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNIN------NRDQI--IEMVGRGSLSPDLSKVRS 252
Query: 667 EQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
P +M C++ + +RP+ P ++ ++
Sbjct: 253 NCPKRMKRLMA------ECLKKKRDERPSFPRILAEIEE 285
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 3e-53
Identities = 54/280 (19%), Positives = 112/280 (40%), Gaps = 38/280 (13%)
Query: 436 NKLGEGGFGPVYKGKLADEQEVAIKRLSRS--SGQGIVEFKNEVRLIAKLQHTNLVRLLG 493
KL E G ++KG+ ++ +K L S + +F E + H N++ +LG
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 494 CSLHGEERLL--VYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRL 551
+ +MP SL L + G V++ + +++G+ +LH L
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVL-HEGTNFVVDQSQAVKFALDMARGMAFLHTLEPL 133
Query: 552 RVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPE---YAMS 608
+ L + ++++D+ M +IS + F+ + + +++PE
Sbjct: 134 -IPRHALNSRSVMIDEDMTARISMADVKFSFQ-------SPGRMYAPAWVAPEALQKKPE 185
Query: 609 GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLEL---IDPS 665
D++SF VL+ E+V TR P L+ + ++ +G + I P
Sbjct: 186 DTNRRSADMWSFAVLLWELV------TREVPFADLSNMEIGMKVALEGLRPTIPPGISPH 239
Query: 666 LEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
+ + +M+ +C+ + RP +V +L+
Sbjct: 240 VSK------LMK------ICMNEDPAKRPKFDMIVPILEK 267
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 2e-52
Identities = 70/326 (21%), Positives = 133/326 (40%), Gaps = 45/326 (13%)
Query: 394 NVSLLPTYGKRKSPEKDQSISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLAD 453
N+SLL + + E I F+ + +G+G FG VY G+
Sbjct: 5 NLSLLSARSFPRKASQTSIFLQEWDI-PFEQL-------EIGELIGKGRFGQVYHGRW-- 54
Query: 454 EQEVAIKRL--SRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNK 511
EVAI+ + R + + FK EV + +H N+V +G + ++ +
Sbjct: 55 HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGR 114
Query: 512 SLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNP 571
+L + + K VL+ K I + I +G+ YLH ++H+DLK+ N+ D+
Sbjct: 115 TLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYDNG-KV 168
Query: 572 KISDFGMARIFEVNESEANTKRI---VGTYGYMSPE---------YAMSGIVSIKTDVFS 619
I+DFG+ I V ++ ++ G +++PE S +DVF+
Sbjct: 169 VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFA 228
Query: 620 FGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCI 679
G + E+ + + P + WQ+ G G++ + ++++
Sbjct: 229 LGTIWYELHAREW------PFKTQPAEAIIWQM---GTGMKPNLSQIGMGKEISDILL-- 277
Query: 680 HVGLLCVQDQAMDRPTMPEVVCMLQN 705
C + +RPT +++ ML+
Sbjct: 278 ----FCWAFEQEERPTFTKLMDMLEK 299
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 1e-47
Identities = 62/295 (21%), Positives = 117/295 (39%), Gaps = 34/295 (11%)
Query: 436 NKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNE--VRLIAKLQHTNLVRLLG 493
++G+G +G V+ GK ++VA+K + E + ++H N++ +
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIA 98
Query: 494 CSLHGEER----LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLH--- 546
+ G L+ ++ N SL +L + L+ + + GL +LH
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 547 --KYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI--VGTYGYMS 602
+ + HRDLK+ NIL+ I+D G+A F + +E + VGT YM
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 603 PE------YAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRP----LNLIGYAWQL 652
PE I D++SFG+++ E+ + + L +++
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYED 274
Query: 653 LSDGKGLELIDPSLEQPCSANEVMRCIHVGLL--CVQDQAMDRPTMPEVVCMLQN 705
+ + ++ + PS S++E +R + L+ C R T V L
Sbjct: 275 MREIVCIKKLRPSFPNRWSSDECLRQM-GKLMTECWAHNPASRLTALRVKKTLAK 328
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 1e-47
Identities = 54/295 (18%), Positives = 116/295 (39%), Gaps = 34/295 (11%)
Query: 436 NKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNE--VRLIAKLQHTNLVRLLG 493
+G+G +G V++G + VA+K S + + E + L+H N++ +
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 494 CSLHGE----ERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLH--- 546
+ + L+ + SL +L + L+ I+ I+ GL +LH
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 547 --KYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI--VGTYGYMS 602
+ + HRDLK+ NIL+ I+D G+A + + ++ + VGT YM+
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 603 PE------YAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRP----LNLIGYAWQL 652
PE + D+++FG+++ E+ ++ +P + +++
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFED 245
Query: 653 LSDGKGLELIDPSLEQPCSANEVMRCIHVGLL--CVQDQAMDRPTMPEVVCMLQN 705
+ ++ P++ ++ + + L+ C R T + L
Sbjct: 246 MRKVVCVDQQRPNIPNRWFSDPTLTSL-AKLMKECWYQNPSARLTALRIKKTLTK 299
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 2e-47
Identities = 73/290 (25%), Positives = 112/290 (38%), Gaps = 46/290 (15%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRL-SRSSGQGIVEFKNEVRLIAKLQHTN 487
+ ++G G FG V+ G+L AD VA+K +F E R++ + H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 488 LVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHK 547
+VRL+G + +V E + FL G + L + ++ + G+ YL
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR--LRVKTLLQMVGDAAAGMEYLES 231
Query: 548 YSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM 607
IHRDL A N L+ +K KISDFGM+R A+ + +PE
Sbjct: 232 ---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALN 288
Query: 608 SGIVSIKTDVFSFGVLVLEIVS-------GQKNH-TRHHPDRPLNLIGYAWQLLSDGKGL 659
G S ++DV+SFG+L+ E S N TR ++ G
Sbjct: 289 YGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEK-----GG----------- 332
Query: 660 ELIDPSLEQP--CSAN--EVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
L P C +M C + RP+ + LQ+
Sbjct: 333 -----RLPCPELCPDAVFRLM------EQCWAYEPGQRPSFSTIYQELQS 371
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 2e-44
Identities = 78/301 (25%), Positives = 132/301 (43%), Gaps = 61/301 (20%)
Query: 436 NKLGEGGFGPVYKGKL------ADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLV 489
+LGEG FG V+ + D+ VA+K L + +F+ E L+ LQH ++V
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFI-------------IIE 536
+ G G+ ++V+E+M + L+ FL G ++ + + I
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVG 596
I+ G++YL + +HRDL N L+ + KI DFGM+R +V ++ G
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR--DVYSTDYYRV---G 192
Query: 597 TYG-----YMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAW 650
+ +M PE M + ++DV+SFGV++ EI + G+ +P W
Sbjct: 193 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK---------QP-------W 236
Query: 651 QLLSDGKGLELIDP--SLEQP--CSAN--EVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ 704
LS+ + +E I LE+P C +VM C Q + R + E+ +L
Sbjct: 237 FQLSNTEVIECITQGRVLERPRVCPKEVYDVML------GCWQREPQQRLNIKEIYKILH 290
Query: 705 N 705
Sbjct: 291 A 291
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 3e-44
Identities = 60/296 (20%), Positives = 111/296 (37%), Gaps = 36/296 (12%)
Query: 436 NKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNE--VRLIAKLQHTNLVRLLG 493
+G+G FG V++GK +EVA+K S + + E + L+H N++ +
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIA 103
Query: 494 CSLHGE----ERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLH--- 546
+ LV ++ + SL +L + + E + + GL +LH
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEI 159
Query: 547 --KYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI--VGTYGYMS 602
+ + HRDLK+ NIL+ I+D G+A + + VGT YM+
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219
Query: 603 PE------YAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDG 656
PE + D+++ G++ EI + H D L S
Sbjct: 220 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARR-CSIGGIHEDYQLPYYDLVPSDPSVE 278
Query: 657 KGLELID-----PSLEQPCSANEVMRCIHVGLL--CVQDQAMDRPTMPEVVCMLQN 705
+ +++ P++ + E +R + ++ C R T + L
Sbjct: 279 EMRKVVCEQKLRPNIPNRWQSCEALRVM-AKIMRECWYANGAARLTALRIKKTLSQ 333
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 1e-43
Identities = 77/290 (26%), Positives = 127/290 (43%), Gaps = 39/290 (13%)
Query: 436 NKLGEGGFGPVYKGKLADEQE-----VAIKRLSRSSG-QGIVEFKNEVRLIAKLQHTNLV 489
LGEG FG V + VA+K L +G Q +K E+ ++ L H +++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 490 RLLGCSLHGEER--LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHK 547
+ GC LV E++P SL +L ++ + + + + I +G+ YLH
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLH- 151
Query: 548 YSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG-----YMS 602
IHRDL A N+LLD+ KI DFG+A+ V G + +
Sbjct: 152 --AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR----VREDGDSPVFWYA 205
Query: 603 PEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLEL 661
PE +DV+SFGV + E+++ + + P + L LIG A ++ + EL
Sbjct: 206 PECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSP--PTKFLELIGIAQGQMTVLRLTEL 263
Query: 662 IDPS--LEQP--CSAN--EVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
++ L +P C A +M C + +A RPT ++ +L+
Sbjct: 264 LERGERLPRPDKCPAEVYHLM------KNCWETEASFRPTFENLIPILKT 307
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-43
Identities = 68/288 (23%), Positives = 124/288 (43%), Gaps = 33/288 (11%)
Query: 436 NKLGEGGFGPVYKGKLADEQE-----VAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVR 490
+LG+G FG V + Q+ VA+K+L S+ + + +F+ E+ ++ LQH N+V+
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 491 LLGCSLHGEER--LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
G R L+ E++P SL +L K ++ K I +G+ YL
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 130
Query: 549 SRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG-----YMSP 603
R IHRDL NIL++++ KI DFG+ ++ ++ K G + +P
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVK----EPGESPIFWYAP 186
Query: 604 EYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELID 663
E S+ +DV+SFGV++ E+ + + + + + +EL+
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 246
Query: 664 PS--LEQP--CSAN--EVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
+ L +P C +M C + RP+ ++ +
Sbjct: 247 NNGRLPRPDGCPDEIYMIM------TECWNNNVNQRPSFRDLALRVDQ 288
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 2e-43
Identities = 67/288 (23%), Positives = 124/288 (43%), Gaps = 33/288 (11%)
Query: 436 NKLGEGGFGPVYKGKLADEQE-----VAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVR 490
+LG+G FG V + Q+ VA+K+L S+ + + +F+ E+ ++ LQH N+V+
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 491 LLGCSLHGEER--LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
G R L+ E++P SL +L + ++ K I +G+ YL
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL--- 161
Query: 549 SRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG-----YMSP 603
R IHRDL NIL++++ KI DFG+ ++ ++ V G + +P
Sbjct: 162 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYY----KVKEPGESPIFWYAP 217
Query: 604 EYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELID 663
E S+ +DV+SFGV++ E+ + + + + + +EL+
Sbjct: 218 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 277
Query: 664 PS--LEQP--CSAN--EVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
+ L +P C +M C + RP+ ++ +
Sbjct: 278 NNGRLPRPDGCPDEIYMIM------TECWNNNVNQRPSFRDLALRVDQ 319
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 2e-43
Identities = 79/300 (26%), Positives = 132/300 (44%), Gaps = 60/300 (20%)
Query: 436 NKLGEGGFGPVYKGKL------ADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLV 489
+LGEG FG V+ + D+ VA+K L +S +F+ E L+ LQH ++V
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFI------------IIEG 537
R G G L+V+E+M + L+ FL + G L + +
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 538 ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT 597
++ G++YL + L +HRDL N L+ + KI DFGM+R ++ ++ G
Sbjct: 167 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR--DIYSTDYYRV---GG 218
Query: 598 YG-----YMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQ 651
+M PE + + ++DV+SFGV++ EI + G+ +P W
Sbjct: 219 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGK---------QP-------WY 262
Query: 652 LLSDGKGLELIDP--SLEQP--CSAN--EVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
LS+ + ++ I LE+P C +MR C Q + R ++ +V LQ
Sbjct: 263 QLSNTEAIDCITQGRELERPRACPPEVYAIMR------GCWQREPQQRHSIKDVHARLQA 316
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 6e-43
Identities = 82/302 (27%), Positives = 129/302 (42%), Gaps = 62/302 (20%)
Query: 436 NKLGEGGFGPVYKGKLAD------EQEVAIKRL-SRSSGQGIVEFKNEVRLIAKLQHTNL 488
+LGE FG VYKG L Q VAIK L ++ G EF++E L A+LQH N+
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFI-------------II 535
V LLG + +++ + + L FL + + ++
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 536 EGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIV 595
I+ G+ YL S V+H+DL N+L+ DK+N KISD G+ R EV ++
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR--EVYAADYYKL--- 186
Query: 596 GTYG-----YMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYA 649
+M+PE M G SI +D++S+GV++ E+ S G +P
Sbjct: 187 LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGL---------QP------- 230
Query: 650 WQLLSDGKGLELIDP--SLEQP--CSAN--EVMRCIHVGLLCVQDQAMDRPTMPEVVCML 703
+ S+ +E+I L P C A +M + C + RP ++ L
Sbjct: 231 YCGYSNQDVVEMIRNRQVLPCPDDCPAWVYALM------IECWNEFPSRRPRFKDIHSRL 284
Query: 704 QN 705
+
Sbjct: 285 RA 286
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 1e-42
Identities = 75/292 (25%), Positives = 126/292 (43%), Gaps = 59/292 (20%)
Query: 436 NKLGEGGFGPVYKGKLADEQE-----VAIKRL-SRSSGQGIVEFKNEVRLIAKLQHTNLV 489
LG G FG VYKG E E VAIK L +S + E +E ++A + + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRK----NVLNWEKRFIIIEGISQGLLYL 545
RLLG L L+ + MP L ++ +LNW I++G+ YL
Sbjct: 81 RLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 133
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG-----Y 600
R++HRDL A N+L+ + KI+DFG+A++ E E + + G +
Sbjct: 134 ---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIKW 185
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGL 659
M+ E + I + ++DV+S+GV V E+++ G +P + + +
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGS---------KP-------YDGIPASEIS 229
Query: 660 ELIDPS--LEQP--CSAN--EVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
+++ L QP C+ + +M C A RP E++
Sbjct: 230 SILEKGERLPQPPICTIDVYMIM------RKCWMIDADSRPKFRELIIEFSK 275
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 2e-42
Identities = 76/305 (24%), Positives = 135/305 (44%), Gaps = 39/305 (12%)
Query: 436 NKLGEGGFGPVYKGKL-----ADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVR 490
++LG+G FG V + VA+K+L S +F+ E++++ L +V+
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 491 LLGCSLHGEER--LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
G S + LV E++P+ L FL + L+ + + I +G+ YL
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR--LDASRLLLYSSQICKGMEYL--- 143
Query: 549 SRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG-----YMSP 603
R +HRDL A NIL++ + + KI+DFG+A++ +++ +V G + +P
Sbjct: 144 GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY----VVREPGQSPIFWYAP 199
Query: 604 EYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELI 662
E I S ++DV+SFGV++ E+ + K+ + L ++G + + + LEL+
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSP--SAEFLRMMGCERDVPALSRLLELL 257
Query: 663 DPS--LEQP--CSAN--EVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN---ETMPLPPP 713
+ L P C A E+M LC DRP+ + L +
Sbjct: 258 EEGQRLPAPPACPAEVHELM------KLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETH 311
Query: 714 KQPAF 718
A
Sbjct: 312 AFTAH 316
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 2e-42
Identities = 84/328 (25%), Positives = 138/328 (42%), Gaps = 66/328 (20%)
Query: 436 NKLGEGGFGPVYKGKLAD------EQEVAIKRL-SRSSGQGIVEFKNEVRLIAKLQHTNL 488
+LG+G FG VY+G E VAIK + +S + +EF NE ++ + ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFI-------IIEGISQG 541
VRLLG G+ L++ E M L +L + N + I+ G
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 542 LLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGY- 600
+ YL + + +HRDL A N ++ + KI DFGM R ++ E++ K G G
Sbjct: 151 MAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRK---GGKGLL 202
Query: 601 ----MSPEYAMSGIVSIKTDVFSFGVLVLEIVS-------GQKNHTRHHPDRPLNLIGYA 649
MSPE G+ + +DV+SFGV++ EI + G N
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-------------V 249
Query: 650 WQLLSDGKGLELIDPSLEQP--CSAN--EVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
+ + +G L++P C E+MR +C Q RP+ E++ ++
Sbjct: 250 LRFVMEGG-------LLDKPDNCPDMLFELMR------MCWQYNPKMRPSFLEIISSIKE 296
Query: 706 ETMPLPPPKQPAFFINANADDQVPEVPD 733
E P ++ +F+ + PE D
Sbjct: 297 EME--PGFREVSFYYSEENKLPEPEELD 322
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 4e-42
Identities = 78/319 (24%), Positives = 128/319 (40%), Gaps = 57/319 (17%)
Query: 406 SPEKDQSISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLAD----EQEVAIKR 461
+PE Q++ H + + +G G FG VY G L D + A+K
Sbjct: 8 NPELVQAVQHVVIGPSSLIV-------HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS 60
Query: 462 LSR-SSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEE-RLLVYEFMPNKSLDFFLFN 519
L+R + + +F E ++ H N++ LLG L E L+V +M + L F+ N
Sbjct: 61 LNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN 120
Query: 520 SGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMA 579
+ +++G+ YL + + +HRDL A N +LD+K K++DFG+A
Sbjct: 121 ETHN--PTVKDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLA 175
Query: 580 RIFEVNESEANTKRIVGTY--GYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-------G 630
R E + + +M+ E + + K+DV+SFGVL+ E+++
Sbjct: 176 RDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 235
Query: 631 QKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQP--CSAN--EVMRCIHVGLLCV 686
L G+ L QP C EVM L C
Sbjct: 236 VNTFD-------------ITVYLLQGR-------RLLQPEYCPDPLYEVM------LKCW 269
Query: 687 QDQAMDRPTMPEVVCMLQN 705
+A RP+ E+V +
Sbjct: 270 HPKAEMRPSFSELVSRISA 288
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 5e-42
Identities = 76/287 (26%), Positives = 112/287 (39%), Gaps = 50/287 (17%)
Query: 437 KLGEGGFGPVYKGKL----ADEQEVAIKRL---SRSSGQGIVEFKNEVRLIAKLQHTNLV 489
KLG+G FG V +G+ VA+K L S + + +F EV + L H NL+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 490 RLLG-CSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
RL G +V E P SL L +++G+ YL
Sbjct: 85 RLYGVVL--TPPMKMVTELAPLGSLLDRLRKHQGH--FLLGTLSRYAVQVAEGMGYL--- 137
Query: 549 SRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT---YGYMSPEY 605
R IHRDL A N+LL + KI DFG+ R N+ + + + +PE
Sbjct: 138 ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAWCAPES 195
Query: 606 AMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDP 664
+ S +D + FGV + E+ + GQ+ P W L+ + L ID
Sbjct: 196 LKTRTFSHASDTWMFGVTLWEMFTYGQE------P----------WIGLNGSQILHKIDK 239
Query: 665 S---LEQP--CSAN--EVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ 704
L +P C + VM + C + DRPT + L
Sbjct: 240 EGERLPRPEDCPQDIYNVM------VQCWAHKPEDRPTFVALRDFLL 280
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 7e-42
Identities = 71/292 (24%), Positives = 126/292 (43%), Gaps = 43/292 (14%)
Query: 436 NKLGEGGFGPVYKGKLADEQE-----VAIKRL-SRSSGQGIVEFKNEVRLIAKLQHTNLV 489
LGEG FG V + E + VA+K L S G I + K E+ ++ L H N+V
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 490 RLLG-CSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHK 547
+ G C+ G + L+ EF+P+ SL +L + K +N +++ I +G+ YL
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK--INLKQQLKYAVQICKGMDYL-- 142
Query: 548 YSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG-----YMS 602
+ +HRDL A N+L++ + KI DFG+ + E ++ K + +
Sbjct: 143 -GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVK----DDRDSPVFWYA 197
Query: 603 PEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLEL 661
PE M I +DV+SFGV + E+++ + + + + Q+ L
Sbjct: 198 PECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTH-GQM----TVTRL 252
Query: 662 IDP-----SLEQP--CSAN--EVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ 704
++ L P C ++M C + Q +R + ++ +
Sbjct: 253 VNTLKEGKRLPCPPNCPDEVYQLM------RKCWEFQPSNRTSFQNLIEGFE 298
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 7e-42
Identities = 72/290 (24%), Positives = 120/290 (41%), Gaps = 52/290 (17%)
Query: 436 NKLGEGGFGPVYKGKLAD----EQEVAIKRLSR-SSGQGIVEFKNEVRLIAKLQHTNLVR 490
+G+G FG VY G+ D + AIK LSR + Q + F E L+ L H N++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 491 LLGCSLHGEERLL-VYEFMPNKSLDFFLFNSGRKNVLNWEKRFI-IIEGISQGLLYLHKY 548
L+G L E + +M + L F+ + R + K I +++G+ YL
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV---KDLISFGLQVARGMEYL--- 140
Query: 549 SRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTY--GYMSPEYA 606
+ + +HRDL A N +LD+ K++DFG+AR E + + + + E
Sbjct: 141 AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESL 200
Query: 607 MSGIVSIKTDVFSFGVLVLEIVS-------GQKNHTRHHPDRPLNLIGYAWQLLSDGKGL 659
+ + K+DV+SFGVL+ E+++ L+ G+
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD-------------LTHFLAQGR-- 245
Query: 660 ELIDPSLEQP--CSAN--EVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
L QP C + +VM C + RPT +V ++
Sbjct: 246 -----RLPQPEYCPDSLYQVM------QQCWEADPAVRPTFRVLVGEVEQ 284
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 8e-42
Identities = 79/286 (27%), Positives = 128/286 (44%), Gaps = 42/286 (14%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLV 489
+ + ++G G FG V+ G ++ +VAIK + R +F E ++ KL H LV
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 66
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
+L G L LV EFM + L +L ++ + E + + +G+ YL
Sbjct: 67 QLYGVCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYL---E 121
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT---YGYMSPEYA 606
VIHRDL A N L+ + K+SDFGM R ++ ++T GT + SPE
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVF 177
Query: 607 MSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPS 665
S K+DV+SFGVL+ E+ S G+ P ++ S+ + +E I
Sbjct: 178 SFSRYSSKSDVWSFGVLMWEVFSEGK---------IP-------YENRSNSEVVEDISTG 221
Query: 666 --LEQP--CSAN--EVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
L +P S + ++M C +++ DRP ++ L
Sbjct: 222 FRLYKPRLASTHVYQIM------NHCWRERPEDRPAFSRLLRQLAE 261
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 8e-42
Identities = 69/287 (24%), Positives = 118/287 (41%), Gaps = 52/287 (18%)
Query: 437 KLGEGGFGPVYKGKL---ADEQEVAIKRL-SRSSGQGIVEFKNEVRLIAKLQHTNLVRLL 492
+LG G FG V +G + +VAIK L + E E +++ +L + +VRL+
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 493 G-CSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRL 551
G C E +LV E L FL + + ++ +S G+ YL
Sbjct: 77 GVCQ--AEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYL---EEK 129
Query: 552 RVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG------YMSPEY 605
+HRDL A N+LL ++ KISDFG+++ ++S + + +PE
Sbjct: 130 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS-----AGKWPLKWYAPEC 184
Query: 606 AMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDP 664
S ++DV+S+GV + E +S GQ +P ++ + + + I+
Sbjct: 185 INFRKFSSRSDVWSYGVTMWEALSYGQ---------KP-------YKKMKGPEVMAFIEQ 228
Query: 665 S--LEQP--CSAN--EVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
+E P C +M C + DRP V ++
Sbjct: 229 GKRMECPPECPPELYALM------SDCWIYKWEDRPDFLTVEQRMRA 269
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-41
Identities = 79/354 (22%), Positives = 138/354 (38%), Gaps = 56/354 (15%)
Query: 374 GIPLLCYLCYVTWRKLKAKDNVSLLPTYGKRKSPEKDQSISHELKIFDFQTIAAAANNFS 433
G+ +C + ++ K + +L + ++ I ++
Sbjct: 33 GLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIVH 92
Query: 434 TTNKLGEGGFGPVYKGKLAD----EQEVAIKRLSR-SSGQGIVEFKNEVRLIAKLQHTNL 488
+G G FG VY G L D + A+K L+R + + +F E ++ H N+
Sbjct: 93 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 152
Query: 489 VRLLGCSLHGEE-RLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHK 547
+ LLG L E L+V +M + L F+ N + +++G+ +L
Sbjct: 153 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKFL-- 208
Query: 548 YSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG-----YMS 602
+ + +HRDL A N +LD+K K++DFG+AR E ++ + T +M+
Sbjct: 209 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK---TGAKLPVKWMA 264
Query: 603 PEYAMSGIVSIKTDVFSFGVLVLEIVS-------GQKNHTRHHPDRPLNLIGYAWQLLSD 655
E + + K+DV+SFGVL+ E+++ L
Sbjct: 265 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-------------ITVYLLQ 311
Query: 656 GKGLELIDPSLEQP--CSAN--EVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
G+ L QP C EVM L C +A RP+ E+V +
Sbjct: 312 GR-------RLLQPEYCPDPLYEVM------LKCWHPKAEMRPSFSELVSRISA 352
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-41
Identities = 83/292 (28%), Positives = 135/292 (46%), Gaps = 44/292 (15%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGKL----ADEQEVAIKRL-SRSSGQGIVEFKNEVRLIAKL 483
A N S +G G FG V G+L E VAIK L + + +F E ++ +
Sbjct: 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 103
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLL 543
H N++RL G + ++V E+M N SLD FL + + ++ GI+ G+
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ--FTVIQLVGMLRGIASGMK 161
Query: 544 YLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT---YGY 600
YL S + +HRDL A NIL++ + K+SDFG+ R+ E + A T R G +
Sbjct: 162 YL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR--GGKIPIRW 216
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGL 659
SPE + +DV+S+G+++ E++S G+ RP + +S+ +
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE---------RP-------YWEMSNQDVI 260
Query: 660 ELIDPS--LEQP--CSAN--EVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
+ +D L P C A ++M L C Q +RP ++V +L
Sbjct: 261 KAVDEGYRLPPPMDCPAALYQLM------LDCWQKDRNNRPKFEQIVSILDK 306
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-41
Identities = 89/314 (28%), Positives = 125/314 (39%), Gaps = 63/314 (20%)
Query: 436 NKLGEGGFGPVYKGKL------ADEQEVAIKRL-SRSSGQGIVEFKNEVRLIAKLQHTNL 488
LG G FG VY+G++ +VA+K L S Q ++F E +I+K H N+
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNS----GRKNVLNWEKRFIIIEGISQGLLY 544
VR +G SL R ++ E M L FL + + + L + I+ G Y
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 545 LHKYSRLRVIHRDLKASNILLD---DKMNPKISDFGMARIFEVNESEANTKRIVGTYGY- 600
L IHRD+ A N LL KI DFGMAR ++ + K G
Sbjct: 156 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRASYYRK---GGCAML 207
Query: 601 ----MSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSD 655
M PE M GI + KTD +SFGVL+ EI S G P + S+
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGY---------MP-------YPSKSN 251
Query: 656 GKGLELIDP--SLEQP--CSAN--EVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNET-- 707
+ LE + ++ P C +M C Q Q DRP ++ ++ T
Sbjct: 252 QEVLEFVTSGGRMDPPKNCPGPVYRIMT------QCWQHQPEDRPNFAIILERIEYCTQD 305
Query: 708 -----MPLPPPKQP 716
LP P
Sbjct: 306 PDVINTALPIEYGP 319
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-41
Identities = 75/288 (26%), Positives = 128/288 (44%), Gaps = 50/288 (17%)
Query: 436 NKLGEGGFGPVYKGKL----ADEQEVAIKRL-SRSSGQGIVEFKNEVRLIAKLQHTNLVR 490
+G G G V G+L + VAIK L + + + +F +E ++ + H N++R
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 491 LLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSR 550
L G G ++V E+M N SLD FL + + ++ G+ G+ YL S
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ--FTIMQLVGMLRGVGAGMRYL---SD 169
Query: 551 LRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG------YMSPE 604
L +HRDL A N+L+D + K+SDFG++R+ E + A T G + +PE
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT-----GGKIPIRWTAPE 224
Query: 605 YAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELID 663
S +DV+SFGV++ E+++ G+ RP + +++ + ++
Sbjct: 225 AIAFRTFSSASDVWSFGVVMWEVLAYGE---------RP-------YWNMTNRDVISSVE 268
Query: 664 PS--LEQP--CSAN--EVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
L P C ++M L C RP ++V +L
Sbjct: 269 EGYRLPAPMGCPHALHQLM------LDCWHKDRAQRPRFSQIVSVLDA 310
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-41
Identities = 76/295 (25%), Positives = 138/295 (46%), Gaps = 51/295 (17%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKL-----ADEQEVAIKRL-SRSSGQGIVEFKNEVRLIAKL 483
+ + +G G FG VYKG L E VAIK L + + + V+F E ++ +
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLL 543
H N++RL G + +++ E+M N +LD FL + + + ++ GI+ G+
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE--FSVLQLVGMLRGIAAGMK 161
Query: 544 YLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG---- 599
YL + + +HRDL A NIL++ + K+SDFG++R+ E + T G
Sbjct: 162 YL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS-----GGKIP 213
Query: 600 --YMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDG 656
+ +PE + +DV+SFG+++ E+++ G+ RP + LS+
Sbjct: 214 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGE---------RP-------YWELSNH 257
Query: 657 KGLELIDPS--LEQP--CSAN--EVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
+ ++ I+ L P C + ++M + C Q + RP ++V +L
Sbjct: 258 EVMKAINDGFRLPTPMDCPSAIYQLM------MQCWQQERARRPKFADIVSILDK 306
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-41
Identities = 75/307 (24%), Positives = 123/307 (40%), Gaps = 66/307 (21%)
Query: 436 NKLGEGGFGPVYKGKLAD----EQEVAIKRLSR--SSGQGIVEFKNEVRLIAKLQHTNLV 489
LGEG FG V +G L +VA+K + SS + I EF +E + H N++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 490 RLLGCSLHGE-----ERLLVYEFMPNKSLDFFLFNS---GRKNVLNWEKRFIIIEGISQG 541
RLLG + + +++ FM L +L S + + + I+ G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 542 LLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR-IFEVNESEANTK-----RIV 595
+ YL S +HRDL A N +L D M ++DFG+++ I+ + +
Sbjct: 160 MEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK-- 214
Query: 596 GTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-------GQKNHTRHHPDRPLNLIGY 648
+++ E + + K+DV++FGV + EI + G +NH
Sbjct: 215 ----WIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE------------- 257
Query: 649 AWQLLSDGKGLELIDPSLEQP--CSAN--EVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ 704
+ L G L+QP C E+M C + +DRPT + L+
Sbjct: 258 MYDYLLHGH-------RLKQPEDCLDELYEIMYS------CWRTDPLDRPTFSVLRLQLE 304
Query: 705 NETMPLP 711
LP
Sbjct: 305 KLLESLP 311
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 151 bits (385), Expect = 2e-41
Identities = 72/285 (25%), Positives = 126/285 (44%), Gaps = 40/285 (14%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLV 489
+ + +LG G FG V GK + +VAIK + + EF E +++ L H LV
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLV 82
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
+L G ++ E+M N L +L + ++ + + + + + YL
Sbjct: 83 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYL---E 137
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE--SEANTKRIVGTYGYMSPEYAM 607
+ +HRDL A N L++D+ K+SDFG++R +E S +K V + PE M
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV---RWSPPEVLM 194
Query: 608 SGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPS- 665
S K+D+++FGVL+ EI S G+ P ++ ++ + E I
Sbjct: 195 YSKFSSKSDIWAFGVLMWEIYSLGK---------MP-------YERFTNSETAEHIAQGL 238
Query: 666 -LEQP--CSAN--EVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
L +P S +M C ++A +RPT ++ + +
Sbjct: 239 RLYRPHLASEKVYTIM------YSCWHEKADERPTFKILLSNILD 277
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-41
Identities = 74/315 (23%), Positives = 122/315 (38%), Gaps = 80/315 (25%)
Query: 436 NKLGEGGFGPVYKGKLAD------EQEVAIKRL-SRSSGQGIVEFKNEVRLIAKLQHTNL 488
LGEG FG V K VA+K L +S + + +E ++ ++ H ++
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEG----------- 537
++L G LL+ E+ SL FL S +
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 538 ----------ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR-IFEVNE 586
ISQG+ YL + ++++HRDL A NIL+ + KISDFG++R ++E +
Sbjct: 149 MGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205
Query: 587 SEANTK-----RIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-------GQKNH 634
++ + +M+ E I + ++DV+SFGVL+ EIV+ G
Sbjct: 206 YVKRSQGRIPVK------WMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE 259
Query: 635 TRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQP--CSAN--EVMRCIHVGLLCVQDQA 690
L LL G +E+P CS +M C + +
Sbjct: 260 ---------RLF----NLLKTGH-------RMERPDNCSEEMYRLMLQ------CWKQEP 293
Query: 691 MDRPTMPEVVCMLQN 705
RP ++ L+
Sbjct: 294 DKRPVFADISKDLEK 308
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 3e-41
Identities = 71/285 (24%), Positives = 123/285 (43%), Gaps = 40/285 (14%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLV 489
+ +LG G FG V GK + +VA+K + + EF E + + KL H LV
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLV 66
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
+ G +V E++ N L +L + G+ L + + + +G+ +L
Sbjct: 67 KFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKG--LEPSQLLEMCYDVCEGMAFL---E 121
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE--SEANTKRIVGTYGYMSPEYAM 607
+ IHRDL A N L+D + K+SDFGM R ++ S TK V + +PE
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPV---KWSAPEVFH 178
Query: 608 SGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPS- 665
S K+DV++FG+L+ E+ S G+ P + L ++ + + +
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFSLGK---------MP-------YDLYTNSEVVLKVSQGH 222
Query: 666 -LEQP--CSAN--EVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
L +P S ++M C + RPT +++ ++
Sbjct: 223 RLYRPHLASDTIYQIM------YSCWHELPEKRPTFQQLLSSIEP 261
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 4e-41
Identities = 80/332 (24%), Positives = 140/332 (42%), Gaps = 65/332 (19%)
Query: 436 NKLGEGGFGPVYKGKLADEQE-----VAIKRL-SRSSGQGIVEFKNEVRLIAKLQHTNLV 489
LG G FG VYKG E E VAIK L +S + E +E ++A + + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
RLLG L L+ + MP L ++ + + I++G+ YL
Sbjct: 81 RLLGICL-TSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNYL---E 134
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG-----YMSPE 604
R++HRDL A N+L+ + KI+DFG+A++ E E + + G +M+ E
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIKWMALE 189
Query: 605 YAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELID 663
+ I + ++DV+S+GV V E+++ G +P + + + +++
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGS---------KP-------YDGIPASEISSILE 233
Query: 664 PS--LEQP--CSAN--EVMRCIHVGLLCVQDQAMDRPTMPEVVCML-------------- 703
L QP C+ + +M + C A RP E++
Sbjct: 234 KGERLPQPPICTIDVYMIM------VKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQ 287
Query: 704 QNETMPLPPPKQPAFFINANADDQVPEVPDNE 735
+E M LP P F+ ++ + +V D +
Sbjct: 288 GDERMHLPSPTDSNFYRALMDEEDMDDVVDAD 319
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 4e-41
Identities = 89/315 (28%), Positives = 125/315 (39%), Gaps = 63/315 (20%)
Query: 436 NKLGEGGFGPVYKGKL------ADEQEVAIKRL-SRSSGQGIVEFKNEVRLIAKLQHTNL 488
LG G FG VY+G++ +VA+K L S Q ++F E +I+K H N+
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNS----GRKNVLNWEKRFIIIEGISQGLLY 544
VR +G SL R ++ E M L FL + + + L + I+ G Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 545 LHKYSRLRVIHRDLKASNILLD---DKMNPKISDFGMARIFEVNESEANTKRIVGTYGY- 600
L IHRD+ A N LL KI DFGMAR ++ + K G
Sbjct: 197 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRAGYYRK---GGCAML 248
Query: 601 ----MSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSD 655
M PE M GI + KTD +SFGVL+ EI S G P + S+
Sbjct: 249 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGY---------MP-------YPSKSN 292
Query: 656 GKGLELIDP--SLEQP--CSAN--EVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNET-- 707
+ LE + ++ P C +M C Q Q DRP ++ ++ T
Sbjct: 293 QEVLEFVTSGGRMDPPKNCPGPVYRIMT------QCWQHQPEDRPNFAIILERIEYCTQD 346
Query: 708 -----MPLPPPKQPA 717
LP P
Sbjct: 347 PDVINTALPIEYGPL 361
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 4e-41
Identities = 71/314 (22%), Positives = 120/314 (38%), Gaps = 78/314 (24%)
Query: 436 NKLGEGGFGPVYKGKLAD------EQEVAIKRL-SRSSGQGIVEFKNEVRLIAKLQHTNL 488
+GEG FG V++ + VA+K L +S +F+ E L+A+ + N+
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEG----------- 537
V+LLG G+ L++E+M L+ FL + V + +
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 538 ----------ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES 587
++ G+ YL S + +HRDL N L+ + M KI+DFG++R + +
Sbjct: 173 CAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR--NIYSA 227
Query: 588 EANTKRIVGTYGY-----MSPEYAMSGIVSIKTDVFSFGVLVLEIVS-------GQKNHT 635
+ M PE + ++DV+++GV++ EI S G +
Sbjct: 228 DYYKA---DGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE- 283
Query: 636 RHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQP--CSAN--EVMRCIHVGLLCVQDQAM 691
+I + DG L P C +MR LC
Sbjct: 284 --------EVI----YYVRDGN-------ILACPENCPLELYNLMR------LCWSKLPA 318
Query: 692 DRPTMPEVVCMLQN 705
DRP+ + +LQ
Sbjct: 319 DRPSFCSIHRILQR 332
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 7e-41
Identities = 77/302 (25%), Positives = 126/302 (41%), Gaps = 67/302 (22%)
Query: 436 NKLGEGGFGPVYKGKL---ADEQEVAIKRL-SRSSGQGIVEFKNEVRLIAKL-QHTNLVR 490
+ +GEG FG V K ++ + AIKR+ +S +F E+ ++ KL H N++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 491 LLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEG------------- 537
LLG H L E+ P+ +L FL S
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 538 ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTK---RI 594
+++G+ YL S+ + IHRDL A NIL+ + KI+DFG++R EV + + R
Sbjct: 151 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR- 206
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-------GQKNHTRHHPDRPLNLIG 647
+M+ E + + +DV+S+GVL+ EIVS G L
Sbjct: 207 -----WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---------ELY- 251
Query: 648 YAWQLLSDGKGLELIDPSLEQP--CSAN--EVMRCIHVGLLCVQDQAMDRPTMPEVVCML 703
+ L G LE+P C ++MR C +++ +RP+ +++ L
Sbjct: 252 ---EKLPQGY-------RLEKPLNCDDEVYDLMR------QCWREKPYERPSFAQILVSL 295
Query: 704 QN 705
Sbjct: 296 NR 297
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 8e-41
Identities = 72/283 (25%), Positives = 120/283 (42%), Gaps = 46/283 (16%)
Query: 436 NKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGC 494
+KLG G +G VY+G VA+K L + + EF E ++ +++H NLV+LLG
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 495 SLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVI 554
++ EFM +L +L + ++ + IS + YL + I
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYL---EKKNFI 133
Query: 555 HRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTK-----RIVGTYGYMSPEYAMSG 609
HRDL A N L+ + K++DFG++R+ + A+ + + +PE
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK------WTAPESLAYN 187
Query: 610 IVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLI--GYAWQLLSDGKGLELIDPSL 666
SIK+DV++FGVL+ EI + G + + L+ Y +
Sbjct: 188 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY----------------RM 231
Query: 667 EQP--CSAN--EVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
E+P C E+M C Q DRP+ E+ +
Sbjct: 232 ERPEGCPEKVYELM------RACWQWNPSDRPSFAEIHQAFET 268
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 9e-41
Identities = 71/322 (22%), Positives = 124/322 (38%), Gaps = 69/322 (21%)
Query: 436 NKLGEGGFGPVYKGKLAD----EQEVAIKRL--SRSSGQGIVEFKNEVRLIAKLQHTNLV 489
LG+G FG V + +L +VA+K L + I EF E + + H ++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 490 RLLGCSLHGEER------LLVYEFMPNKSLDFFLFNS---GRKNVLNWEKRFIIIEGISQ 540
+L+G SL + +++ FM + L FL S L + + I+
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR-IFEVNESEANTK-----RI 594
G+ YL S IHRDL A N +L + M ++DFG++R I+ + +
Sbjct: 149 GMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK- 204
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-------GQKNHTRHHPDRPLNLIG 647
+++ E + ++ +DV++FGV + EI++ G +N
Sbjct: 205 -----WLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE------------ 247
Query: 648 YAWQLLSDGKGLELIDPSLEQP--CSAN--EVMRCIHVGLLCVQDQAMDRPTMPEVVCML 703
+ L G L+QP C ++M C RP+ + L
Sbjct: 248 -IYNYLIGGN-------RLKQPPECMEEVYDLMYQ------CWSADPKQRPSFTCLRMEL 293
Query: 704 QN--ETMPLPPPKQPAFFINAN 723
+N + + Q +IN
Sbjct: 294 ENILGHLSVLSTSQDPLYINIE 315
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-40
Identities = 70/288 (24%), Positives = 118/288 (40%), Gaps = 54/288 (18%)
Query: 437 KLGEGGFGPVYKGKL---ADEQEVAIKRL--SRSSGQGIVEFKNEVRLIAKLQHTNLVRL 491
+LG G FG V KG + VA+K L + E E ++ +L + +VR+
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 492 LG-CSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSR 550
+G C E +LV E L+ +L + + + ++ +S G+ YL
Sbjct: 84 IGICE--AESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYL---EE 135
Query: 551 LRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG------YMSPE 604
+HRDL A N+LL + KISDFG+++ +E+ + + +PE
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT-----HGKWPVKWYAPE 190
Query: 605 YAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELID 663
S K+DV+SFGVL+ E S GQ +P ++ + + +++
Sbjct: 191 CINYYKFSSKSDVWSFGVLMWEAFSYGQ---------KP-------YRGMKGSEVTAMLE 234
Query: 664 PS--LEQP--CSAN--EVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
+ P C ++M LC +RP V L+N
Sbjct: 235 KGERMGCPAGCPREMYDLM------NLCWTYDVENRPGFAAVELRLRN 276
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-40
Identities = 80/335 (23%), Positives = 131/335 (39%), Gaps = 61/335 (18%)
Query: 436 NKLGEGGFGPVYKGKLADEQE-----VAIKRLSRSSG-QGIVEFKNEVRLIAKLQHTNLV 489
LG G FG V+KG E E V IK + SG Q + + I L H ++V
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGR----KNVLNWEKRFIIIEGISQGLLYL 545
RLLG G LV +++P SL + + +LNW I++G+ YL
Sbjct: 79 RLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW------GVQIAKGMYYL 131
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG-----Y 600
++HR+L A N+LL +++DFG+A + ++ + +
Sbjct: 132 ---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE-----AKTPIKW 183
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGL 659
M+ E G + ++DV+S+GV V E+++ G + + L + LL G+
Sbjct: 184 MALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP----YAGLRLAEV---PDLLEKGE-- 234
Query: 660 ELIDPSLEQP--CSAN--EVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETMPLPPPKQ 715
L QP C+ + VM + C RPT E+ M PP+
Sbjct: 235 -----RLAQPQICTIDVYMVM------VKCWMIDENIRPTFKELANEF--TRMARDPPRY 281
Query: 716 PAFFINANADDQVPEVPDNEVAKFSTNDVTMTTME 750
+ + P E + + +E
Sbjct: 282 ----LVIKRESGPGIAPGPEPHGLTNKKLEEVELE 312
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 1e-40
Identities = 68/310 (21%), Positives = 123/310 (39%), Gaps = 75/310 (24%)
Query: 436 NKLGEGGFGPVYKGKLAD--------EQEVAIKRL-SRSSGQGIVEFKNEVRLIAKL-QH 485
LGEG FG V + VA+K L ++ + + + +E+ ++ + +H
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 486 TNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEG-------- 537
N++ LLG ++ E+ +L +L + + E
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 538 -----ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR-IFEVNESEANT 591
+++G+ YL + + IHRDL A N+L+ + KI+DFG+AR I ++ + T
Sbjct: 207 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 263
Query: 592 K-----RIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-------GQKNHTRHHP 639
+ +M+PE + + ++DV+SFGVL+ EI + G
Sbjct: 264 NGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE----- 312
Query: 640 DRPLNLIGYAWQLLSDGKGLELIDPSLEQP--CSAN--EVMRCIHVGLLCVQDQAMDRPT 695
L +LL +G +++P C+ +MR C RPT
Sbjct: 313 ----ELF----KLLKEGH-------RMDKPANCTNELYMMMRD------CWHAVPSQRPT 351
Query: 696 MPEVVCMLQN 705
++V L
Sbjct: 352 FKQLVEDLDR 361
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-40
Identities = 66/287 (22%), Positives = 115/287 (40%), Gaps = 53/287 (18%)
Query: 437 KLGEGGFGPVYKGKL----ADEQEVAIKRLSR-SSGQGIVEFKNEVRLIAKLQHTNLVRL 491
LGEG FG VY+G ++ VA+K + + +F +E ++ L H ++V+L
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 492 LG-CSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSR 550
+G E ++ E P L +L + L + I + + YL
Sbjct: 79 IGIIE--EEPTWIIMELYPYGELGHYLERNKNS--LKVLTLVLYSLQICKAMAYL---ES 131
Query: 551 LRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTK-----RIVGTYGYMSPEY 605
+ +HRD+ NIL+ K+ DFG++R E + + + +MSPE
Sbjct: 132 INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK------WMSPES 185
Query: 606 AMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDP 664
+ +DV+ F V + EI+S G+ +P + L + + +++
Sbjct: 186 INFRRFTTASDVWMFAVCMWEILSFGK---------QP-------FFWLENKDVIGVLEK 229
Query: 665 S--LEQP--CSAN--EVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
L +P C +M C DRP E+VC L +
Sbjct: 230 GDRLPKPDLCPPVLYTLM------TRCWDYDPSDRPRFTELVCSLSD 270
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-40
Identities = 66/298 (22%), Positives = 120/298 (40%), Gaps = 55/298 (18%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKL--------ADEQEVAIKRLSRSSGQGIVEFKNEVRLIA 481
+ LG+G F ++KG E EV +K L ++ F +++
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 482 KLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQG 541
KL H +LV G + G+E +LV EF+ SLD +L + +N + + + ++
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC--INILWKLEVAKQLAAA 125
Query: 542 LLYLHKYSRLRVIHRDLKASNILLDDKMNP--------KISDFGMARIFEVNESEANTKR 593
+ +L +IH ++ A NILL + + K+SD G++ V + +R
Sbjct: 126 MHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI--TVLPKDILQER 180
Query: 594 IVGTYGYMSPE-YAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQ 651
I ++ PE +++ TD +SFG + EI S G K P
Sbjct: 181 I----PWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDK------P----------LS 220
Query: 652 LLSDGKGLELIDPS--LEQPCSAN--EVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
L + L+ + L P +A ++ C+ + RP+ ++ L +
Sbjct: 221 ALDSQRKLQFYEDRHQLPAPKAAELANLI------NNCMDYEPDHRPSFRAIIRDLNS 272
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-40
Identities = 68/316 (21%), Positives = 125/316 (39%), Gaps = 75/316 (23%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLAD--------EQEVAIKRL-SRSSGQGIVEFKNEVRLI 480
+ + LGEG FG V + VA+K L ++ + + + +E+ ++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 481 AKL-QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEG-- 537
+ +H N++ LLG ++ E+ +L +L + + E
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 538 -----------ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR-IFEVN 585
+++G+ YL + + IHRDL A N+L+ + KI+DFG+AR I ++
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 586 ESEANTK-----RIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-------GQKN 633
+ T + +M+PE + + ++DV+SFGVL+ EI + G
Sbjct: 212 YYKKTTNGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 265
Query: 634 HTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQP--CSAN--EVMRCIHVGLLCVQDQ 689
L +LL +G +++P C+ +MR C
Sbjct: 266 E---------ELF----KLLKEGH-------RMDKPANCTNELYMMMR------DCWHAV 299
Query: 690 AMDRPTMPEVVCMLQN 705
RPT ++V L
Sbjct: 300 PSQRPTFKQLVEDLDR 315
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 5e-40
Identities = 71/277 (25%), Positives = 122/277 (44%), Gaps = 34/277 (12%)
Query: 436 NKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGC 494
+KLG G +G VY+G VA+K L + + EF E ++ +++H NLV+LLG
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 495 SLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVI 554
++ EFM +L +L + ++ + IS + YL + I
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYL---EKKNFI 340
Query: 555 HRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIK 614
HR+L A N L+ + K++DFG++R+ + A+ + +PE SIK
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIK 399
Query: 615 TDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPS--LEQP--C 670
+DV++FGVL+ EI + + P + + + EL++ +E+P C
Sbjct: 400 SDVWAFGVLLWEIAT--------YGMSP-------YPGIDLSQVYELLEKDYRMERPEGC 444
Query: 671 SAN--EVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
E+M C Q DRP+ E+ +
Sbjct: 445 PEKVYELM------RACWQWNPSDRPSFAEIHQAFET 475
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 6e-40
Identities = 73/305 (23%), Positives = 126/305 (41%), Gaps = 65/305 (21%)
Query: 436 NKLGEGGFGPVYKGKLAD------EQEVAIKRL-SRSSGQGIVEFKNEVRLIAKL-QHTN 487
LG G FG V + + VA+K L ++ +E++++ + H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 488 LVRLLG-CSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEG--------- 537
+V LLG C+ G +++ EF +L +L + + V + +
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 538 ----ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR-IFEVNESEANTK 592
+++G+ +L + + IHRDL A NILL +K KI DFG+AR I++ +
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209
Query: 593 -----RIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLN-- 644
+ +M+PE + +I++DV+SFGVL+ EI S G +P ++
Sbjct: 210 ARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS----PYPGVKIDEE 259
Query: 645 LIGYAWQLLSDGKGLELIDPSLEQP--CSAN--EVMRCIHVGLLCVQDQAMDRPTMPEVV 700
+ L +G + P + + M C + RPT E+V
Sbjct: 260 FC----RRLKEGT-------RMRAPDYTTPEMYQTML------DCWHGEPSQRPTFSELV 302
Query: 701 CMLQN 705
L N
Sbjct: 303 EHLGN 307
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 7e-40
Identities = 68/307 (22%), Positives = 123/307 (40%), Gaps = 56/307 (18%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLAD------EQEVAIKRL-SRSSGQGIVEFKNEVRLIAK 482
N S LG G FG V + VA+K L + +E+++++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 483 L-QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEG---- 537
L H N+V LLG G L++ E+ L FL + + I+ +
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 538 -----------ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR-IFEVN 585
+++G+ +L + IHRDL A NILL KI DFG+AR I +
Sbjct: 143 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 586 ESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLN 644
+ +M+PE + + + ++DV+S+G+ + E+ S G +P P++
Sbjct: 200 NYVVKGNARL-PVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS----SPYPGMPVD 254
Query: 645 --LIGYAWQLLSDGKGLELIDPSLEQP--CSAN--EVMRCIHVGLLCVQDQAMDRPTMPE 698
+++ +G + P A ++M+ C + RPT +
Sbjct: 255 SKFY----KMIKEGF-------RMLSPEHAPAEMYDIMK------TCWDADPLKRPTFKQ 297
Query: 699 VVCMLQN 705
+V +++
Sbjct: 298 IVQLIEK 304
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 8e-40
Identities = 75/339 (22%), Positives = 138/339 (40%), Gaps = 76/339 (22%)
Query: 436 NKLGEGGFGPVYKGKLAD--------EQEVAIKRL-SRSSGQGIVEFKNEVRLIAKL-QH 485
LGEG FG V + +VA+K L S ++ + + + +E+ ++ + +H
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 486 TNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEG-------- 537
N++ LLG ++ E+ +L +L + E
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 538 -----ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTK 592
+++G+ YL + + IHRDL A N+L+ + KI+DFG+AR +++ + K
Sbjct: 195 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR--DIHHIDYYKK 249
Query: 593 RIVGTYG-----YMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-------GQKNHTRHHPD 640
T G +M+PE I + ++DV+SFGVL+ EI + G
Sbjct: 250 T---TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE------ 300
Query: 641 RPLNLIGYAWQLLSDGKGLELIDPSLEQP--CSAN--EVMRCIHVGLLCVQDQAMDRPTM 696
L +LL +G +++P C+ +MR C RPT
Sbjct: 301 ---ELF----KLLKEGH-------RMDKPSNCTNELYMMMR------DCWHAVPSQRPTF 340
Query: 697 PEVVCMLQNETMPLPPPKQPAFFINANADDQVPEVPDNE 735
++V L + L ++ ++ + + D ++P E
Sbjct: 341 KQLVEDLDRI-VALTSNQEMGYYHHHHHHD--YDIPTTE 376
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-39
Identities = 71/283 (25%), Positives = 116/283 (40%), Gaps = 52/283 (18%)
Query: 436 NKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLG-C 494
+G+G FG V G +VA+K + + F E ++ +L+H+NLV+LLG
Sbjct: 199 QTIGKGEFGDVMLGDYRG-NKVAVKCIKNDATAQ--AFLAEASVMTQLRHSNLVQLLGVI 255
Query: 495 SLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVI 554
+V E+M SL +L + GR VL + + + + YL +
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYL---EGNNFV 311
Query: 555 HRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIK 614
HRDL A N+L+ + K+SDFG+ + E + ++ K V + +PE S K
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLPV---KWTAPEALREKKFSTK 366
Query: 615 TDVFSFGVLVLEIVS-------GQKNH-TRHHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666
+DV+SFG+L+ EI S ++ GY +
Sbjct: 367 SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-----GY----------------KM 405
Query: 667 EQP--CSAN--EVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
+ P C +VM C A RPT ++ L++
Sbjct: 406 DAPDGCPPAVYDVM------KNCWHLDAATRPTFLQLREQLEH 442
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 1e-39
Identities = 84/286 (29%), Positives = 131/286 (45%), Gaps = 54/286 (18%)
Query: 436 NKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLG-C 494
+LG G FG V+ G +VA+K L + F E L+ +LQH LVRL
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 495 SLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVI 554
+ E ++ E+M N SL FL + L K + I++G+ ++ I
Sbjct: 78 T--QEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFI---EERNYI 131
Query: 555 HRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT---YGYMSPEYAMSGIV 611
HRDL+A+NIL+ D ++ KI+DFG+AR+ E NE A G + +PE G
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE----GAKFPIKWTAPEAINYGTF 187
Query: 612 SIKTDVFSFGVLVLEIVS-------GQKNH-TRHHPDRPLNLIGYAWQLLSDGKGLELID 663
+IK+DV+SFG+L+ EIV+ G N + +R GY
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-----GY--------------- 227
Query: 664 PSLEQP--CSAN--EVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
+ +P C ++M LC +++ DRPT + +L++
Sbjct: 228 -RMVRPDNCPEELYQLM------RLCWKERPEDRPTFDYLRSVLED 266
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 2e-39
Identities = 80/302 (26%), Positives = 135/302 (44%), Gaps = 48/302 (15%)
Query: 436 NKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLG-C 494
KLG+G FG V+ G VAIK L + F E +++ KL+H LV+L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 495 SLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVI 554
S E +V E+M SL FL K L + + I+ G+ Y+ R+ +
Sbjct: 249 S--EEPIYIVTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYV---ERMNYV 302
Query: 555 HRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIK 614
HRDL+A+NIL+ + + K++DFG+AR+ E NE A + +PE A+ G +IK
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 361
Query: 615 TDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPS--LEQP--C 670
+DV+SFG+L+ E+ + P + + + + L+ ++ + P C
Sbjct: 362 SDVWSFGILLTELTT--------KGRVP-------YPGMVNREVLDQVERGYRMPCPPEC 406
Query: 671 SAN--EVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETMPLPPPKQPAFFINANADDQV 728
+ ++M C + + +RPT + L++ +F + Q
Sbjct: 407 PESLHDLM------CQCWRKEPEERPTFEYLQAFLED------------YFTSTEPQYQP 448
Query: 729 PE 730
E
Sbjct: 449 GE 450
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-39
Identities = 72/278 (25%), Positives = 120/278 (43%), Gaps = 42/278 (15%)
Query: 436 NKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLG-C 494
+G+G FG V G +VA+K + + F E ++ +L+H+NLV+LLG
Sbjct: 27 QTIGKGEFGDVMLGDYRG-NKVAVKCIKNDATAQ--AFLAEASVMTQLRHSNLVQLLGVI 83
Query: 495 SLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVI 554
+V E+M SL +L S ++VL + + + + YL +
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFV 139
Query: 555 HRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIK 614
HRDL A N+L+ + K+SDFG+ + E + ++ K V + +PE S K
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLPV---KWTAPEALREKKFSTK 194
Query: 615 TDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLI--GYAWQLLSDGKGLELIDPSLEQP-- 669
+DV+SFG+L+ EI S G+ + R + + GY ++ P
Sbjct: 195 SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY----------------KMDAPDG 238
Query: 670 CSAN--EVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
C EVM C A RP+ ++ L++
Sbjct: 239 CPPAVYEVM------KNCWHLDAAMRPSFLQLREQLEH 270
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-39
Identities = 64/294 (21%), Positives = 107/294 (36%), Gaps = 53/294 (18%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLAD----EQEVAIKRL-SRSSGQGIVEFKNEVRLIAKLQ 484
+GEG FG V++G VAIK + +S +F E + +
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 485 HTNLVRLLG-CSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLL 543
H ++V+L+G + ++ E L FL L+ + +S L
Sbjct: 75 HPHIVKLIGVIT--ENPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALA 130
Query: 544 YLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTK-----RIVGTY 598
YL R +HRD+ A N+L+ K+ DFG++R E + +K +
Sbjct: 131 YL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK----- 182
Query: 599 GYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGK 657
+M+PE + +DV+ FGV + EI+ G +P +Q + +
Sbjct: 183 -WMAPESINFRRFTSASDVWMFGVCMWEILMHGV---------KP-------FQGVKNND 225
Query: 658 GLELIDPS--LEQP--CSAN--EVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
+ I+ L P C +M C RP E+ L
Sbjct: 226 VIGRIENGERLPMPPNCPPTLYSLM------TKCWAYDPSRRPRFTELKAQLST 273
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 6e-39
Identities = 72/301 (23%), Positives = 121/301 (40%), Gaps = 60/301 (19%)
Query: 436 NKLGEGGFGPVYKGKLAD------EQEVAIKRL-SRSSGQGIVEFKNEVRLIAKL-QHTN 487
LG G FG V + +VA+K L S + +E+++++ L QH N
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 488 LVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIE----------- 536
+V LLG HG L++ E+ L FL R +
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR-IFEVNESEANTKRIV 595
++QG+ +L + IHRD+ A N+LL + KI DFG+AR I + +
Sbjct: 172 QVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228
Query: 596 GTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-------GQKNHTRHHPDRPLNLIGY 648
+M+PE + ++++DV+S+G+L+ EI S G +++
Sbjct: 229 -PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK------------ 275
Query: 649 AWQLLSDGKGLELIDPSLEQP--CSAN--EVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ 704
++L+ DG + QP N +M+ C + RPT ++ LQ
Sbjct: 276 FYKLVKDGY-------QMAQPAFAPKNIYSIMQ------ACWALEPTHRPTFQQICSFLQ 322
Query: 705 N 705
Sbjct: 323 E 323
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 6e-39
Identities = 80/302 (26%), Positives = 135/302 (44%), Gaps = 48/302 (15%)
Query: 436 NKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLG-C 494
KLG+G FG V+ G VAIK L + F E +++ KL+H LV+L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 495 SLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVI 554
S E +V E+M SL FL K L + + I+ G+ Y+ R+ +
Sbjct: 332 S--EEPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYV---ERMNYV 385
Query: 555 HRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIK 614
HRDL+A+NIL+ + + K++DFG+AR+ E NE A + +PE A+ G +IK
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 444
Query: 615 TDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPS--LEQP--C 670
+DV+SFG+L+ E+ + P + + + + L+ ++ + P C
Sbjct: 445 SDVWSFGILLTELTT--------KGRVP-------YPGMVNREVLDQVERGYRMPCPPEC 489
Query: 671 SAN--EVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETMPLPPPKQPAFFINANADDQV 728
+ ++M C + + +RPT + L++ +F + Q
Sbjct: 490 PESLHDLM------CQCWRKEPEERPTFEYLQAFLED------------YFTSTEPQYQP 531
Query: 729 PE 730
E
Sbjct: 532 GE 533
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 7e-39
Identities = 77/285 (27%), Positives = 123/285 (43%), Gaps = 52/285 (18%)
Query: 436 NKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCS 495
KLG G FG V+ +VA+K + + + F E ++ LQH LV+L
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 496 LHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIH 555
E ++ EFM SL FL + K I++G+ ++ + IH
Sbjct: 253 T-KEPIYIITEFMAKGSLLDFLKSDEGSK-QPLPKLIDFSAQIAEGMAFI---EQRNYIH 307
Query: 556 RDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT---YGYMSPEYAMSGIVS 612
RDL+A+NIL+ + KI+DFG+AR+ E NE A G + +PE G +
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDNEYTARE----GAKFPIKWTAPEAINFGSFT 363
Query: 613 IKTDVFSFGVLVLEIVS-------GQKNH-TRHHPDRPLNLIGYAWQLLSDGKGLELIDP 664
IK+DV+SFG+L++EIV+ G N +R GY
Sbjct: 364 IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER-----GY---------------- 402
Query: 665 SLEQP--CSAN--EVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
+ +P C +M + C +++ +RPT + +L +
Sbjct: 403 RMPRPENCPEELYNIM------MRCWKNRPEERPTFEYIQSVLDD 441
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 4e-38
Identities = 68/310 (21%), Positives = 119/310 (38%), Gaps = 69/310 (22%)
Query: 436 NKLGEGGFGPVYKGKLAD------EQEVAIKRL-SRSSGQGIVEFKNEVRLIAKL-QHTN 487
LG G FG V +VA+K L ++ +E++++ +L H N
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 488 LVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEG---------- 537
+V LLG L++E+ L +L + K + +
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 538 ----------ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES 587
+++G+ +L +HRDL A N+L+ KI DFG+AR ++
Sbjct: 171 FEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR--DIMSD 225
Query: 588 EANTKRIVGTYG-----YMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDR 641
R +M+PE GI +IK+DV+S+G+L+ EI S G +P
Sbjct: 226 SNYVVR---GNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV----NPYPGI 278
Query: 642 PLN--LIGYAWQLLSDGKGLELIDPSLEQP--CSAN--EVMRCIHVGLLCVQDQAMDRPT 695
P++ +L+ +G ++QP + +M+ C + RP+
Sbjct: 279 PVDANFY----KLIQNGF-------KMDQPFYATEEIYIIMQ------SCWAFDSRKRPS 321
Query: 696 MPEVVCMLQN 705
P + L
Sbjct: 322 FPNLTSFLGC 331
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 7e-38
Identities = 69/296 (23%), Positives = 120/296 (40%), Gaps = 46/296 (15%)
Query: 437 KLGEGGFGPVYKGKLADEQE---VAIKRL-SRSSGQGIVEFKNEVRLIAKLQHTNLVRLL 492
+LG G FG V +G ++ VAIK L + E E +++ +L + +VRL+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 493 G-CSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRL 551
G C E +LV E L FL + + ++ +S G+ YL
Sbjct: 403 GVCQ--AEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYL---EEK 455
Query: 552 RVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT---YGYMSPEYAMS 608
+HR+L A N+LL ++ KISDFG+++ ++S + + +PE
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR--SAGKWPLKWYAPECINF 513
Query: 609 GIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPS-- 665
S ++DV+S+GV + E +S GQ +P ++ + + + I+
Sbjct: 514 RKFSSRSDVWSYGVTMWEALSYGQ---------KP-------YKKMKGPEVMAFIEQGKR 557
Query: 666 LEQP--CSAN--EVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETMPLPPPKQPA 717
+E P C +M C + DRP V ++ L +
Sbjct: 558 MECPPECPPELYALM------SDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGG 607
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 5e-37
Identities = 54/208 (25%), Positives = 97/208 (46%), Gaps = 12/208 (5%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRL---SRSSGQGIVEFKNEVRLIAKLQH 485
NF K+G G F VY+ L D VA+K++ + + E+ L+ +L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 486 TNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEK--RFIIIEGISQGLL 543
N+++ + E +V E L + + ++ L E+ ++ + L
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQ-LCSALE 150
Query: 544 YLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSP 603
++H RV+HRD+K +N+ + K+ D G+ R F + A++ +VGT YMSP
Sbjct: 151 HMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSP 205
Query: 604 EYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
E + K+D++S G L+ E+ + Q
Sbjct: 206 ERIHENGYNFKSDIWSLGCLLYEMAALQ 233
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 28/221 (12%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTN 487
+F +G GGFG V+K K D + IKR+ ++ + + EV+ +AKL H N
Sbjct: 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVN 65
Query: 488 LVRLLGC-------------SLHGEERLLVY---EFMPNKSLDFFLFNSGRKNVLNWEKR 531
+V GC + + ++ EF +L+ ++ R L+
Sbjct: 66 IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLA 124
Query: 532 FIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANT 591
+ E I++G+ Y+H ++I+RDLK SNI L D KI DFG+ + N+ +
Sbjct: 125 LELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLK-NDGKRTR 180
Query: 592 KRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQK 632
GT YMSPE S + D+++ G+++ E++
Sbjct: 181 --SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 3e-36
Identities = 66/282 (23%), Positives = 109/282 (38%), Gaps = 43/282 (15%)
Query: 437 KLGEGGFGPVYKGKLAD----EQEVAIKRL-SRSSGQGIVEFKNEVRLIAKLQHTNLVRL 491
+GEG FG V++G VAIK + +S +F E + + H ++V+L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 492 LG-CSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSR 550
+G + ++ E L FL RK L+ + +S L YL
Sbjct: 457 IGVIT--ENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYL---ES 509
Query: 551 LRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGI 610
R +HRD+ A N+L+ K+ DFG++R E + +K + +M+PE
Sbjct: 510 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESINFRR 568
Query: 611 VSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDP--SLE 667
+ +DV+ FGV + EI+ G +P +Q + + + I+ L
Sbjct: 569 FTSASDVWMFGVCMWEILMHGV---------KP-------FQGVKNNDVIGRIENGERLP 612
Query: 668 QP--CSAN--EVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
P C +M C RP E+ L
Sbjct: 613 MPPNCPPTLYSLM------TKCWAYDPSRRPRFTELKAQLST 648
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 4e-36
Identities = 60/224 (26%), Positives = 96/224 (42%), Gaps = 31/224 (13%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRS-SGQGIVEFKNEVRLIAKLQHTN 487
+F LG GGFG V++ K D+ AIKR+ + EV+ +AKL+H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 488 LVRLLGC---------SLHGEERLLVY---EFMPNKSLDFFLFNSGRKNVLNWEKRFI-- 533
+VR ++ +Y + ++L ++ +GR + E+
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM--NGRCTIEERERSVCLH 122
Query: 534 IIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKR 593
I I++ + +LH ++HRDLK SNI K+ DFG+ + +E E
Sbjct: 123 IFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 594 ----------IVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEI 627
VGT YMSPE S K D+FS G+++ E+
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL 223
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 8e-36
Identities = 52/206 (25%), Positives = 96/206 (46%), Gaps = 11/206 (5%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK-LADEQEVAIK--RLSRSSGQGIVEFKNEVRLIAKLQHT 486
+ K+GEG FG K D ++ IK +SR S + E + EV ++A ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 487 NLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKR-FIIIEGISQGLLYL 545
N+V+ +V ++ L + + +K VL E + I L ++
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRI--NAQKGVLFQEDQILDWFVQICLALKHV 141
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEY 605
H +++HRD+K+ NI L ++ DFG+AR+ A +GT Y+SPE
Sbjct: 142 H---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPEI 196
Query: 606 AMSGIVSIKTDVFSFGVLVLEIVSGQ 631
+ + K+D+++ G ++ E+ + +
Sbjct: 197 CENKPYNNKSDIWALGCVLYELCTLK 222
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 69/252 (27%), Positives = 118/252 (46%), Gaps = 19/252 (7%)
Query: 402 GKRKSPEKDQSISHELKIFDFQTIAAAAN---NFSTTNKLGEGGFGPVYKGK-LADEQEV 457
G + ++HE + + + + K+GEG G V + ++V
Sbjct: 14 GTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQV 73
Query: 458 AIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFL 517
A+K + Q NEV ++ QH N+V + L GEE ++ EF+ +L +
Sbjct: 74 AVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIV 133
Query: 518 FNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFG 577
+ LN E+ + E + Q L YLH VIHRD+K+ +ILL K+SDFG
Sbjct: 134 ----SQVRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTLDGRVKLSDFG 186
Query: 578 M-ARIFEVNESEANTKR--IVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNH 634
A+I S+ KR +VGT +M+PE + + + D++S G++V+E+V G+ +
Sbjct: 187 FCAQI-----SKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPY 241
Query: 635 TRHHPDRPLNLI 646
P + + +
Sbjct: 242 FSDSPVQAMKRL 253
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 60/227 (26%), Positives = 99/227 (43%), Gaps = 29/227 (12%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTN 487
A++F LG+G FG V K + D + AIK++ + + + +EV L+A L H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 488 LVRLLGCSLHGEERLLVYEFMPNKSLDFF---------LFNSGRKNVLNWEKRFI--IIE 536
+VR L + + KS F L++ LN ++ +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFE------------V 584
I + L Y+H +IHRDLK NI +D+ N KI DFG+A+ +
Sbjct: 124 QILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 585 NESEANTKRIVGTYGYMSPE-YAMSGIVSIKTDVFSFGVLVLEIVSG 630
S N +GT Y++ E +G + K D++S G++ E++
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 4e-35
Identities = 69/316 (21%), Positives = 118/316 (37%), Gaps = 47/316 (14%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKNEVRLIA 481
+ ++ KLGEGGF V + L D A+KR+ Q E + E +
Sbjct: 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHR 81
Query: 482 KLQHTNLVRLLGCSL----HGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKR-FIIIE 536
H N++RL+ L E L+ F +L + K E + ++
Sbjct: 82 LFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLL 141
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIV- 595
GI +GL +H HRDLK +NILL D+ P + D G ++ + +
Sbjct: 142 GICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQ 198
Query: 596 ------GTYGYMSPE------YAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPL 643
T Y +PE + + + +TDV+S G ++ ++ G+ P +
Sbjct: 199 DWAAQRCTISYRAPELFSVQSHCV---IDERTDVWSLGCVLYAMMFGE------GPYDMV 249
Query: 644 NLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEV---V 700
G + L + S+ Q + + + ++ V RP +P + +
Sbjct: 250 FQKGDSVALAVQNQ------LSIPQSPRHSSALWQLLNSMMTV--DPHQRPHIPLLLSQL 301
Query: 701 CMLQNETMPLPPPKQP 716
LQ P P Q
Sbjct: 302 EALQP-----PAPGQH 312
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 7e-35
Identities = 56/211 (26%), Positives = 94/211 (44%), Gaps = 12/211 (5%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK-LADEQEVAIK--RLSRSSGQGIVEFKNEVRLIAKLQHT 486
++ +G G +G K + +D + + K + +EV L+ +L+H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 487 NLVRLLGCSLHGEERLL--VYEFMPNKSLDFFLFNSGRKNVLNWEKR--FIIIEGISQGL 542
N+VR + L V E+ L + ++ E+ ++ + ++ L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ-LTLAL 124
Query: 543 LYLH--KYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGY 600
H V+HRDLK +N+ LD K N K+ DFG+ARI + S A T VGT Y
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYY 182
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
MSPE + K+D++S G L+ E+ +
Sbjct: 183 MSPEQMNRMSYNEKSDIWSLGCLLYELCALM 213
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 8e-35
Identities = 53/226 (23%), Positives = 102/226 (45%), Gaps = 25/226 (11%)
Query: 422 FQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRS--SGQGIVEFKNEVRL 479
FQ+++ +S ++G GG V++ +Q AIK ++ Q + ++NE+
Sbjct: 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 79
Query: 480 IAKLQHTNL--VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLN-WEKRFIIIE 536
+ KLQ + +RL + + +V E N L+ +L ++ WE++
Sbjct: 80 LNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKS---IDPWERKSYWKN 135
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVG 596
+ + + +H++ ++H DLK +N L+ D K+ DFG+A + + + VG
Sbjct: 136 -MLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVG 190
Query: 597 TYGYMSPE-----------YAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
T YM PE +S K+DV+S G ++ + G+
Sbjct: 191 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 61/216 (28%), Positives = 110/216 (50%), Gaps = 10/216 (4%)
Query: 432 FSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVR 490
++ K+G+G G VY +A QEVAI++++ NE+ ++ + ++ N+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 491 LLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSR 550
L L G+E +V E++ SL + + ++ + + Q L +LH
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHS--- 134
Query: 551 LRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGI 610
+VIHRD+K+ NILL + K++DFG +S+ +T +VGT +M+PE
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKA 192
Query: 611 VSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLI 646
K D++S G++ +E++ G+ + +P R L LI
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI 228
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 6e-34
Identities = 54/203 (26%), Positives = 95/203 (46%), Gaps = 17/203 (8%)
Query: 437 KLGEGGFGPVYKGKLADE-QEVAIK--RLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLG 493
++G G F VYKG + EVA + + + FK E ++ LQH N+VR
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 494 C---SLHGEERLLVY-EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
++ G++ +++ E M + +L +L + + I +GL +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV---MKIKVLRSWCRQILKGLQFLHT-R 148
Query: 550 RLRVIHRDLKASNILLDDKM-NPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMS 608
+IHRDLK NI + + KI D G+A + + + K ++GT +M+PE
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEFMAPEMYEE 204
Query: 609 GIVSIKTDVFSFGVLVLEIVSGQ 631
DV++FG+ +LE+ + +
Sbjct: 205 K-YDESVDVYAFGMCMLEMATSE 226
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 9e-34
Identities = 50/217 (23%), Positives = 96/217 (44%), Gaps = 23/217 (10%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRS--SGQGIVEFKNEVRLIAKLQHTN 487
+S ++G GG V++ +Q AIK ++ Q + ++NE+ + KLQ +
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 488 L--VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYL 545
+RL + + +V E N L+ +L ++ +R + + + + +
Sbjct: 69 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTI 124
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPE- 604
H++ ++H DLK +N L+ D K+ DFG+A + + + VGT YM PE
Sbjct: 125 HQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180
Query: 605 ----------YAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
+S K+DV+S G ++ + G+
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-33
Identities = 53/242 (21%), Positives = 103/242 (42%), Gaps = 25/242 (10%)
Query: 406 SPEKDQSISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRS 465
SP+ + + I+ +S ++G GG V++ +Q AIK ++
Sbjct: 32 SPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLE 91
Query: 466 --SGQGIVEFKNEVRLIAKLQHTNL--VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSG 521
Q + ++NE+ + KLQ + +RL + + +V E N L+ +L
Sbjct: 92 EADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK 150
Query: 522 RKNVLN-WEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR 580
++ WE++ + + + +H++ ++H DLK +N L+ D K+ DFG+A
Sbjct: 151 S---IDPWERKSYWKN-MLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIAN 202
Query: 581 IFEVNESEANTKRIVGTYGYMSPE-----------YAMSGIVSIKTDVFSFGVLVLEIVS 629
+ + + VG YM PE +S K+DV+S G ++ +
Sbjct: 203 QMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 262
Query: 630 GQ 631
G+
Sbjct: 263 GK 264
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 56/198 (28%), Positives = 89/198 (44%), Gaps = 9/198 (4%)
Query: 438 LGEGGFGPVYKGKLADEQE-VAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSL 496
LG+G +G VY G+ Q +AIK + + E+ L L+H N+V+ LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 497 HGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHR 556
+ E +P SL L + N + + I +GL YLH +++HR
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHR 146
Query: 557 DLKASNILLDDKM-NPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIV--SI 613
D+K N+L++ KISDFG ++ T GT YM+PE G
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKGPRGYGK 204
Query: 614 KTDVFSFGVLVLEIVSGQ 631
D++S G ++E+ +G+
Sbjct: 205 AADIWSLGCTIIEMATGK 222
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-33
Identities = 62/217 (28%), Positives = 108/217 (49%), Gaps = 11/217 (5%)
Query: 432 FSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQG-IVEFKNEVRLIAKLQHTNLV 489
F+ K+G+G FG V+KG ++ VAIK + + I + + E+ ++++ +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
+ G L + ++ E++ S L L+ + I+ I +GL YLH
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHS-- 137
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSG 609
+ IHRD+KA+N+LL + K++DFG+A + + NT VGT +M+PE
Sbjct: 138 -EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQS 194
Query: 610 IVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLI 646
K D++S G+ +E+ G+ H+ HP + L LI
Sbjct: 195 AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLI 231
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 8e-33
Identities = 57/221 (25%), Positives = 107/221 (48%), Gaps = 13/221 (5%)
Query: 432 FSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVR 490
+ +LG+G FG VYK K A K + S + + ++ E+ ++A H +V+
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 491 LLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSR 550
LLG H + ++ EF P ++D + L + ++ + + L +LH
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDAIM--LELDRGLTEPQIQVVCRQMLEALNFLHS--- 135
Query: 551 LRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGI 610
R+IHRDLKA N+L+ + + +++DFG++ + ++ +GT +M+PE M
Sbjct: 136 KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVMCET 193
Query: 611 VS-----IKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLI 646
+ K D++S G+ ++E+ + H +P R L I
Sbjct: 194 MKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI 234
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 62/277 (22%), Positives = 91/277 (32%), Gaps = 40/277 (14%)
Query: 431 NFSTTNKLGEGGFGPVYKG-KLADEQEVAIK--RLSRSSGQGIVEFKNEVRLIAKL-QHT 486
+F ++LG G +G V+K D + A+K + EV K+ QH
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 487 NLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEK--RFIIIEGISQGLLY 544
VRL G L E SL G L E + + L +
Sbjct: 118 CCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGAS--LP-EAQVWGYLRD-TLLALAH 172
Query: 545 LHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPE 604
LH ++H D+K +NI L + K+ DFG+ G YM+PE
Sbjct: 173 LHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG-TAGAGEV--QEGDPRYMAPE 226
Query: 605 YAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDP 664
DVFS G+ +LE+ P G WQ L G + P
Sbjct: 227 LLQGSY-GTAADVFSLGLTILEVACN-----MELPHG-----GEGWQQLRQGY----LPP 271
Query: 665 SLEQPCS--ANEVMRCIHVGLLCVQDQAMDRPTMPEV 699
S V+ + ++ R T +
Sbjct: 272 EFTAGLSSELRSVLV------MMLEPDPKLRATAEAL 302
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 59/229 (25%), Positives = 105/229 (45%), Gaps = 14/229 (6%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLS-RSSGQGIVEFKNEVRLIAKLQHT 486
+++ +G G V +++VAIKR++ + E E++ +++ H
Sbjct: 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHP 73
Query: 487 NLVRLLGCSLHGEERLLVYEFMPNKSL-----DFFLFNSGRKNVLNWEKRFIIIEGISQG 541
N+V + +E LV + + S+ + VL+ I+ + +G
Sbjct: 74 NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133
Query: 542 LLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGM-ARIFEVNESEANTKR--IVGTY 598
L YLHK IHRD+KA NILL + + +I+DFG+ A + + N R VGT
Sbjct: 134 LEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 599 GYMSPEYAMSGIV-SIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLI 646
+M+PE K D++SFG+ +E+ +G + ++ P + L L
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT 239
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 3e-32
Identities = 63/235 (26%), Positives = 109/235 (46%), Gaps = 16/235 (6%)
Query: 403 KRKSPEKDQSISHELKIFDFQ---TIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEV-A 458
K + E D+ L+ F Q ++F ++LG G G V+K V A
Sbjct: 3 KLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMA 62
Query: 459 IKRLSRSSGQGIVEF-KNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFL 517
K + I E++++ + +V G E + E M SLD L
Sbjct: 63 RKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL 122
Query: 518 FNSGRKNVLNWEKRF-IIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDF 576
+GR E+ + + +GL YL + +++HRD+K SNIL++ + K+ DF
Sbjct: 123 KKAGRIP----EQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDF 176
Query: 577 GMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
G++ ++ +S AN+ VGT YMSPE S+++D++S G+ ++E+ G+
Sbjct: 177 GVSG--QLIDSMANS--FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 7e-32
Identities = 62/217 (28%), Positives = 107/217 (49%), Gaps = 10/217 (4%)
Query: 431 NFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLV 489
F KLGEG +G VYK Q VAIK++ + E E+ ++ + ++V
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVV 87
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
+ G + +V E+ S+ + R L ++ I++ +GL YLH
Sbjct: 88 KYYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIATILQSTLKGLEYLHF-- 143
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSG 609
+R IHRD+KA NILL+ + + K++DFG+A ++ NT ++GT +M+PE
Sbjct: 144 -MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGTPFWMAPEVIQEI 200
Query: 610 IVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLI 646
+ D++S G+ +E+ G+ + HP R + +I
Sbjct: 201 GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMI 237
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 73/252 (28%), Positives = 113/252 (44%), Gaps = 25/252 (9%)
Query: 402 GKRKSPEKDQSISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGK-LADEQEVAIK 460
G R KD ++ D + + FS ++G G FG VY + + + + VAIK
Sbjct: 32 GGRAGSLKDPDVAELFFKDDPEKL------FSDLREIGHGSFGAVYFARDVRNSEVVAIK 85
Query: 461 RLS---RSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFL 517
++S + S + + EVR + KL+H N ++ GC L LV E+ + D
Sbjct: 86 KMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLE 145
Query: 518 FNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFG 577
+ L + + G QGL YLH +IHRD+KA NILL + K+ DFG
Sbjct: 146 VHKK---PLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFG 199
Query: 578 MARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVS---IKTDVFSFGVLVLEIVSGQKNH 634
A I + AN+ VGT +M+PE ++ K DV+S G+ +E+ +
Sbjct: 200 SASIM----APANS--FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 253
Query: 635 TRHHPDRPLNLI 646
+ L I
Sbjct: 254 FNMNAMSALYHI 265
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 52/218 (23%), Positives = 87/218 (39%), Gaps = 18/218 (8%)
Query: 436 NKLGEGGFGPVYKGKLADEQE-VAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGC 494
++G G FG V++ K A+K++ + E+ A L +V L G
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGA 118
Query: 495 SLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRF-IIIEGISQGLLYLHKYSRLRV 553
G + E + SL + G E R + +GL YLH R+
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQMGCLP----EDRALYYLGQALEGLEYLH---TRRI 171
Query: 554 IHRDLKASNILLDDKMNP-KISDFGMA-RIFEVNESEANTKR--IVGTYGYMSPEYAMSG 609
+H D+KA N+LL + + DFG A + ++ I GT +M+PE M
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 231
Query: 610 IVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIG 647
K D++S ++L +++G T++ I
Sbjct: 232 PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIA 269
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 21/204 (10%)
Query: 437 KLGEGGFGPVYKGKLADEQ---EVAIK--RLSRSSGQGIVE-FKNEVRLIAKLQHTNLVR 490
KLG GG VY + D +VAIK + + ++ F+ EV ++L H N+V
Sbjct: 18 KLGGGGMSTVYLAE--DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 491 LLGCSLHGEERLLVY---EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHK 547
++ EE Y E++ +L ++ + G L+ + I G+ + H
Sbjct: 76 MID---VDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAH- 128
Query: 548 YSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM 607
+R++HRD+K NIL+D KI DFG+A+ S T ++GT Y SPE A
Sbjct: 129 --DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPEQAK 185
Query: 608 SGIVSIKTDVFSFGVLVLEIVSGQ 631
TD++S G+++ E++ G+
Sbjct: 186 GEATDECTDIYSIGIVLYEMLVGE 209
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 8e-31
Identities = 51/240 (21%), Positives = 96/240 (40%), Gaps = 27/240 (11%)
Query: 402 GKRKSPEKDQSISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKR 461
G S E+D + +F + LG G G + + D ++VA+KR
Sbjct: 2 GSSPSLEQDDGDEET------SVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKR 55
Query: 462 LSRSSGQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNS 520
+ EV+L+ + +H N++R + + + E ++
Sbjct: 56 ILPECFSFA---DREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVE--- 109
Query: 521 GRKNVLNWEKR-FIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDK-----MNPKIS 574
+K+ + +++ + GL +LH L ++HRDLK NIL+ + IS
Sbjct: 110 -QKDFAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMIS 165
Query: 575 DFGMARIFEVNESE-ANTKRIVGTYGYMSPEY---AMSGIVSIKTDVFSFGVLVLEIVSG 630
DFG+ + V + + GT G+++PE + D+FS G + ++S
Sbjct: 166 DFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 9e-31
Identities = 61/198 (30%), Positives = 101/198 (51%), Gaps = 13/198 (6%)
Query: 438 LGEGGFGPVYKGK-LADEQEVAIKRLSRSS--GQGIVE-FKNEVRLIAKLQHTNLVRLLG 493
LG+G F VY+ + + EVAIK + + + G+V+ +NEV++ +L+H +++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 494 CSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLR 552
+ LV E N + + K E R + + I G+LYLH
Sbjct: 79 Y-FEDSNYVYLVLEMCHNGEM-NRYLKNRVKPFSENEARHFMHQ-IITGMLYLH---SHG 132
Query: 553 VIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVS 612
++HRDL SN+LL MN KI+DFG+A ++ + T + GT Y+SPE A
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPEIATRSAHG 190
Query: 613 IKTDVFSFGVLVLEIVSG 630
+++DV+S G + ++ G
Sbjct: 191 LESDVWSLGCMFYTLLIG 208
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 72/249 (28%), Positives = 108/249 (43%), Gaps = 22/249 (8%)
Query: 412 SISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGI 470
S + L D + A F +G G +G VYKG+ + Q AIK + +G
Sbjct: 6 SPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTGDEE 64
Query: 471 VEFKNEVRLIAKL-QHTNLVRLLGCSLHGEERL------LVYEFMPNKSL-DFFLFNSGR 522
E K E+ ++ K H N+ G + LV EF S+ D L + +
Sbjct: 65 EEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD--LIKNTK 122
Query: 523 KNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIF 582
N L E I I +GL +LH+ +VIHRD+K N+LL + K+ DFG++
Sbjct: 123 GNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179
Query: 583 EVNESEANTKRIVGTYGYMSPEYAMSGIVS-----IKTDVFSFGVLVLEIVSGQKNHTRH 637
+ NT +GT +M+PE K+D++S G+ +E+ G
Sbjct: 180 DRTVGRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 237
Query: 638 HPDRPLNLI 646
HP R L LI
Sbjct: 238 HPMRALFLI 246
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 50/218 (22%), Positives = 94/218 (43%), Gaps = 22/218 (10%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAKLQHTN 487
+ + ++ LG+G V++G+ AIK + S V+ E ++ KL H N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 488 LVRLLGC--SLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYL 545
+V+L ++L+ EF P SL L L + I++ + G+ +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 546 HKYSRLRVIHRDLKASNILL----DDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYM 601
+ ++HR++K NI+ D + K++DFG AR E ++ + + + GT Y+
Sbjct: 129 RE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVS--LYGTEEYL 182
Query: 602 SPEYAMSGIVSI--------KTDVFSFGVLVLEIVSGQ 631
P+ ++ D++S GV +G
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 55/198 (27%), Positives = 91/198 (45%), Gaps = 14/198 (7%)
Query: 438 LGEGGFGPVYKGK-LADEQEVAIKRLSRSS--GQGIVE-FKNEVRLIAKLQHTNLVRLLG 493
LG+GGF ++ ++ A K + +S E E+ + L H ++V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 494 CSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLR 552
+ + +V E +SL + RK + E R+ + + + G YLH R R
Sbjct: 83 F-FEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARYYLRQIVL-GCQYLH---RNR 135
Query: 553 VIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVS 612
VIHRDLK N+ L++ + KI DFG+A E + + GT Y++PE S
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGHS 193
Query: 613 IKTDVFSFGVLVLEIVSG 630
+ DV+S G ++ ++ G
Sbjct: 194 FEVDVWSIGCIMYTLLVG 211
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-30
Identities = 55/198 (27%), Positives = 91/198 (45%), Gaps = 14/198 (7%)
Query: 438 LGEGGFGPVYKGK-LADEQEVAIKRLSRSS--GQGIVE-FKNEVRLIAKLQHTNLVRLLG 493
LG+GGF ++ ++ A K + +S E E+ + L H ++V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 494 CSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLR 552
+ + +V E +SL + RK + E R+ + + + G YLH R R
Sbjct: 109 F-FEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARYYLRQIVL-GCQYLH---RNR 161
Query: 553 VIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVS 612
VIHRDLK N+ L++ + KI DFG+A E + + GT Y++PE S
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGHS 219
Query: 613 IKTDVFSFGVLVLEIVSG 630
+ DV+S G ++ ++ G
Sbjct: 220 FEVDVWSIGCIMYTLLVG 237
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 60/206 (29%), Positives = 94/206 (45%), Gaps = 16/206 (7%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRS--SGQGIVE-FKNEVRLIAKLQH 485
+F LG+G FG VY + + +A+K L ++ G+ + EV + + L+H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 486 TNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLY 544
N++RL G H R+ L+ E+ P ++ L + + I E ++ L Y
Sbjct: 69 PNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFD--EQRTATYITE-LANALSY 124
Query: 545 LHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPE 604
H RVIHRD+K N+LL KI+DFG + S + GT Y+ PE
Sbjct: 125 CHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV--HAPSSRRTD--LCGTLDYLPPE 177
Query: 605 YAMSGIVSIKTDVFSFGVLVLEIVSG 630
+ K D++S GVL E + G
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVG 203
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-29
Identities = 51/218 (23%), Positives = 92/218 (42%), Gaps = 22/218 (10%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAKLQHTN 487
+ + ++ LG+G V++G+ AIK + S V+ E ++ KL H N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 488 LVRLLGC--SLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYL 545
+V+L ++L+ EF P SL L L + I++ + G+ +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 546 HKYSRLRVIHRDLKASNILL----DDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYM 601
+ ++HR++K NI+ D + K++DFG AR E +E + GT Y+
Sbjct: 129 RE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGTEEYL 182
Query: 602 SPEYAMSGIVSI--------KTDVFSFGVLVLEIVSGQ 631
P+ ++ D++S GV +G
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 56/206 (27%), Positives = 98/206 (47%), Gaps = 19/206 (9%)
Query: 437 KLGEGGFGPVYKGKLADEQ---EVAIK--RLSRSSGQGIVE-FKNEVRLIAKLQHTNLVR 490
LG GG V+ + D + +VA+K R + F+ E + A L H +V
Sbjct: 19 ILGFGGMSEVHLAR--DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 491 LL--GCSLHGEERL--LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLH 546
+ G + L +V E++ +L + G + ++ +I Q L + H
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSH 133
Query: 547 KYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR-IFEVNESEANTKRIVGTYGYMSPEY 605
+ +IHRD+K +NI++ K+ DFG+AR I + S T ++GT Y+SPE
Sbjct: 134 ---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 606 AMSGIVSIKTDVFSFGVLVLEIVSGQ 631
A V ++DV+S G ++ E+++G+
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-29
Identities = 47/249 (18%), Positives = 92/249 (36%), Gaps = 21/249 (8%)
Query: 414 SHELKIFDFQTIAAA---ANNFSTTNKLGEG--GFGPVYKGK-LADEQEVAIKR--LSRS 465
H ++ FQ +++ + +G+G V + + V ++R L
Sbjct: 6 HHHMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC 65
Query: 466 SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSL-DFFLFNSGRKN 524
S + + + E+ + H N+V + E +V FM S D L + +
Sbjct: 66 SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKD--LICTHFMD 123
Query: 525 VLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
+N I++G+ + L Y+H + +HR +KAS+IL+ +S
Sbjct: 124 GMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180
Query: 585 NESEANT-----KRIVGTYGYMSPEYAMSGIV--SIKTDVFSFGVLVLEIVSGQKNHTRH 637
+ K V ++SPE + K+D++S G+ E+ +G
Sbjct: 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 240
Query: 638 HPDRPLNLI 646
+ L
Sbjct: 241 PATQMLLEK 249
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-29
Identities = 49/234 (20%), Positives = 95/234 (40%), Gaps = 49/234 (20%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADE--QEVAIKRLSRSSGQGIVEF-------------- 473
N++ L +G F + L ++ + A+K+ +S + +F
Sbjct: 31 NDYRIIRTLNQGKFNKII---LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87
Query: 474 ---KNEVRLIAKLQHTNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGR------K 523
KNE+++I +++ + G + + + ++YE+M N S+ F
Sbjct: 88 DDFKNELQIITDIKNEYCLTCEG-IITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTC 146
Query: 524 NVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFE 583
+ + II ++ Y+H + + HRD+K SNIL+D K+SDFG +
Sbjct: 147 FIPIQVIKCIIKSVLN-SFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV 203
Query: 584 VNESEANTKRIVGTYGYMSPEYAMSGIVSIKT-------DVFSFGVLVLEIVSG 630
+ K GTY +M PE S ++ D++S G+ + +
Sbjct: 204 ----DKKIKGSRGTYEFMPPE-----FFSNESSYNGAKVDIWSLGICLYVMFYN 248
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 4e-29
Identities = 55/237 (23%), Positives = 104/237 (43%), Gaps = 25/237 (10%)
Query: 424 TIAAAANNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVE-FKNEVR-LI 480
++ A++ +LG G +G V K + + Q +A+KR+ + + ++ +
Sbjct: 1 SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM 60
Query: 481 AKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRF------II 534
+ V G + + E M + SLD F K V++ + I
Sbjct: 61 RTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFY-----KQVIDKGQTIPEDILGKI 114
Query: 535 IEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRI 594
I + L +LH S+L VIHRD+K SN+L++ K+ DFG++ V++ +
Sbjct: 115 AVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDID-- 169
Query: 595 VGTYGYMSPE----YAMSGIVSIKTDVFSFGVLVLEIVSGQK-NHTRHHPDRPLNLI 646
G YM+PE S+K+D++S G+ ++E+ + + P + L +
Sbjct: 170 AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV 226
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-29
Identities = 52/231 (22%), Positives = 92/231 (39%), Gaps = 23/231 (9%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKNEVRLIA 481
QT+ L EGGF VY+ + + +E A+KRL + + EV +
Sbjct: 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMK 80
Query: 482 KLQ-HTNLVRLLGCSLHGEER-------LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFI 533
KL H N+V+ + G+E L+ + L FL + L+ +
Sbjct: 81 KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK 140
Query: 534 IIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKR 593
I + + ++H + +IHRDLK N+LL ++ K+ DFG A + + +
Sbjct: 141 IFYQTCRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQ 199
Query: 594 I----------VGTYGYMSPE---YAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
T Y +PE + + K D+++ G ++ + Q
Sbjct: 200 RRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-29
Identities = 61/232 (26%), Positives = 104/232 (44%), Gaps = 25/232 (10%)
Query: 414 SHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVE 472
S +LKI Q A + ++G G +G V K Q +A+KR+ + + +
Sbjct: 6 SGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQK 65
Query: 473 -FKNEVRLIAKL-QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEK 530
++ ++ + +V+ G + + E M + S D F K V +
Sbjct: 66 QLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFY-----KYVYSVLD 119
Query: 531 RFI-------IIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFE 583
I I + L +L L++IHRD+K SNILLD N K+ DFG++ +
Sbjct: 120 DVIPEEILGKITLATVKALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGISG--Q 175
Query: 584 VNESEANTKRIVGTYGYMSPE----YAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
+ +S A T R G YM+PE A +++DV+S G+ + E+ +G+
Sbjct: 176 LVDSIAKT-RDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 8e-29
Identities = 58/212 (27%), Positives = 90/212 (42%), Gaps = 17/212 (8%)
Query: 431 NFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAKLQHTNL 488
+ +LG GGFG V + ++VAIK+ + E + E++++ KL H N+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 489 VRLL------GCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGL 542
V + LL E+ L +L L ++ IS L
Sbjct: 75 VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 134
Query: 543 LYLHKYSRLRVIHRDLKASNILLD---DKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
YLH+ R+IHRDLK NI+L ++ KI D G A+ + VGT
Sbjct: 135 RYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTE--FVGTLQ 188
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
Y++PE ++ D +SFG L E ++G
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 9e-29
Identities = 60/295 (20%), Positives = 103/295 (34%), Gaps = 59/295 (20%)
Query: 429 ANNFSTTNKLGEGGFGPVYKG-KLADEQEVAIKR--LSRSSGQGIVEFKNEVRLIAKL-Q 484
F K+G G FG V+K K D AIKR + EV A L Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 485 HTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEK--RFIIIEGISQGL 542
H+++VR + L+ E+ SL + + R E + ++++ + +GL
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQ-VGRGL 128
Query: 543 LYLHKYSRLRVIHRDLKASNILLDDKMNP-------------------KISDFGMARIFE 583
Y+H + ++H D+K SNI + P KI D G
Sbjct: 129 RYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT--- 182
Query: 584 VNESEANTKRIVGTYGYMSPEYAMSGIV-SIKTDVFSFGVLVLEIVSGQKNHTRHHPDRP 642
++ + G +++ E K D+F+ + V+ P
Sbjct: 183 ---RISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGA----------EP 229
Query: 643 LNLIGYAWQLLSDGKGLELIDPSLEQPCS--ANEVMRCIHVGLLCVQDQAMDRPT 695
L G W + G+ P + Q S E+++ + + RP+
Sbjct: 230 LPRNGDQWHEIRQGR-----LPRIPQVLSQEFTELLK------VMIHPDPERRPS 273
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 51/207 (24%), Positives = 81/207 (39%), Gaps = 27/207 (13%)
Query: 437 KLGEGGFGPVYKGKLADEQ---EVAIKRLSR--SSGQGIVE-FKNEVRLIAKLQHTNLVR 490
+G GG G VY+ + D VA+K +S SS + E R +LQ ++V
Sbjct: 41 LVGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVV- 97
Query: 491 LLGCSLH--GEERLLVY---EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYL 545
+H GE +Y + L L G L + I+ I L
Sbjct: 98 ----PIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAA 150
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEA-NTKRIVGTYGYMSPE 604
H HRD+K NIL+ + DFG+A + + VGT YM+PE
Sbjct: 151 H---AAGATHRDVKPENILVSADDFAYLVDFGIAS--ATTDEKLTQLGNTVGTLYYMAPE 205
Query: 605 YAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
+ + D+++ ++ E ++G
Sbjct: 206 RFSESHATYRADIYALTCVLYECLTGS 232
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-28
Identities = 43/221 (19%), Positives = 86/221 (38%), Gaps = 28/221 (12%)
Query: 437 KLGEGGFGPVYKGK--LADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAKLQHTNLVRLLG 493
+ GG G +Y + + V +K L S E + +A++ H ++V++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 494 CSLHGEERL-----LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
H + +V E++ +SL + L + + I L YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSL-----KRSKGQKLPVAEAIAYLLEILPALSYLH-- 199
Query: 549 SRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMS 608
+ +++ DLK NI+L ++ K+ D G + + GT G+ +PE +
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVS------RINSFGYLYGTPGFQAPEIVRT 251
Query: 609 GIVSIKTDVFSFGVLVLEIVSGQK----NHTRHHPDRPLNL 645
G ++ TD+++ G + + + P+ L
Sbjct: 252 G-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVL 291
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 16/206 (7%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRS--SGQGIVE-FKNEVRLIAKLQH 485
++F LG+G FG VY + ++ +A+K L +S +G+ + E+ + + L+H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 486 TNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLY 544
N++R+ H +R+ L+ EF P L L GR + + E ++ L Y
Sbjct: 74 PNILRMYN-YFHDRKRIYLMLEFAPRGELYKELQKHGRFD--EQRSATFMEE-LADALHY 129
Query: 545 LHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPE 604
H +VIHRD+K N+L+ K KI+DFG + V+ + + GT Y+ PE
Sbjct: 130 CH---ERKVIHRDIKPENLLMGYKGELKIADFG----WSVHAPSLRRRTMCGTLDYLPPE 182
Query: 605 YAMSGIVSIKTDVFSFGVLVLEIVSG 630
K D++ GVL E + G
Sbjct: 183 MIEGKTHDEKVDLWCAGVLCYEFLVG 208
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-27
Identities = 59/266 (22%), Positives = 97/266 (36%), Gaps = 72/266 (27%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAKLQHTN 487
+F +G GGFG V++ K D+ AIKR+ + + E EV+ +AKL+H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 488 LVRLLGC----SLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKR------------ 531
+VR + + ++ ++S D+ L + + + + R
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 532 -----------FIIIEGISQGLL------------------------------YLHKYSR 550
+I ++ + L +LH
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH---S 182
Query: 551 LRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTK----------RIVGTYGY 600
++HRDLK SNI K+ DFG+ + +E E VGT Y
Sbjct: 183 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLE 626
MSPE S K D+FS G+++ E
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFE 268
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-27
Identities = 56/234 (23%), Positives = 100/234 (42%), Gaps = 19/234 (8%)
Query: 423 QTIAAAANNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVE-FKNEVRLI 480
Q A N+ ++G G G V+K + +A+K++ RS + + ++ ++
Sbjct: 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVV 77
Query: 481 AKL-QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRF-IIIEGI 538
K +V+ G + + + E M + G E+ + I
Sbjct: 78 LKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIP----ERILGKMTVAI 133
Query: 539 SQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTY 598
+ L YL + VIHRD+K SNILLD++ K+ DFG++ + + +A R G
Sbjct: 134 VKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFGISG--RLVDDKAKD-RSAGCA 188
Query: 599 GYMSPE-----YAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPD-RPLNLI 646
YM+PE I+ DV+S G+ ++E+ +GQ + D L +
Sbjct: 189 AYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKV 242
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 9e-27
Identities = 66/260 (25%), Positives = 116/260 (44%), Gaps = 46/260 (17%)
Query: 394 NVSLLPTYGKRKSPEKDQSISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLAD 453
+S P G + +P D + ++ D +T ++ +G G FG V++ KL +
Sbjct: 4 TMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVE 63
Query: 454 EQEVAIKRLSRSSGQGIVEFKN-EVRLIAKLQHTNLVRLLGC-----SLHGEERL-LVYE 506
EVAIK++ + FKN E++++ ++H N+V L E L LV E
Sbjct: 64 SDEVAIKKVLQDK-----RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLE 118
Query: 507 FMP---NKSLDFFLFNSGRKNVLNWE--KRFI--IIEGISQGLLYLHKYSRLRVIHRDLK 559
++P ++ + + K + K ++ ++ + L Y+H + + HRD+K
Sbjct: 119 YVPETVYRASRHY---AKLKQTMPMLLIKLYMYQLL----RSLAYIHS---IGICHRDIK 168
Query: 560 ASNILLDDKMNP-KISDFGMARIFEVNESEANTKRIVGTYGYMSPE-------YAMSGIV 611
N+LLD K+ DFG A+I E N I Y Y +PE Y
Sbjct: 169 PQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVSYICSRY-YRAPELIFGATNY------ 219
Query: 612 SIKTDVFSFGVLVLEIVSGQ 631
+ D++S G ++ E++ GQ
Sbjct: 220 TTNIDIWSTGCVMAELMQGQ 239
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 33/223 (14%), Positives = 65/223 (29%), Gaps = 26/223 (11%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADE------QEVAIKRLSRSSGQGIVEFKNEVRLIAKL 483
+ LGEG F VY+ D Q+ +K ++ + +
Sbjct: 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPS 124
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGR----KNVLNWEKRFIIIEGIS 539
++ L +LV E +L N + K + + +
Sbjct: 125 MQHMFMKFYSAHLFQNGSVLVGELYSYGTL-LNAINLYKNTPEKVMPQGLVISFAMR-ML 182
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNP-----------KISDFGMARIFEVNESE 588
+ +H +IH D+K N +L + + D G + ++
Sbjct: 183 YMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG 239
Query: 589 ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
T G+ E + + + D F V ++ G
Sbjct: 240 TIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-25
Identities = 49/227 (21%), Positives = 79/227 (34%), Gaps = 32/227 (14%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKL-QHTNL 488
N + LG G G V + VA+KR+ E++L+ + H N+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIA---LMEIKLLTESDDHPNV 71
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFL---FNSGRKNVLNWEKRFIIIEGISQGLLYL 545
+R + E D + + ++ I+ G+ +L
Sbjct: 72 IRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNP-------------KISDFGMARIFEVNES--EAN 590
H L++IHRDLK NIL+ ISDFG+ + + +S N
Sbjct: 132 HS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188
Query: 591 TKRIVGTYGYMSPEYAMSGIVSI-------KTDVFSFGVLVLEIVSG 630
GT G+ +PE D+FS G + I+S
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 53/179 (29%), Positives = 83/179 (46%), Gaps = 13/179 (7%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKN--EVRLIAKLQHT 486
+ K+GEG +G V+K + Q VAIK+ S +++ E+R++ +L+H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 487 NLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYL 545
NLV LL + RL LV+E+ + ++ L R + K Q + +
Sbjct: 63 NLVNLLEV-FRRKRRLHLVFEYC-DHTVLHELDRYQRGVPEHLVKSITW--QTLQAVNFC 118
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPE 604
HK+ IHRD+K NIL+ K+ DFG AR+ S+ + T Y SPE
Sbjct: 119 HKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTG-PSDYYDDEVA-TRWYRSPE 172
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 55/188 (29%), Positives = 95/188 (50%), Gaps = 21/188 (11%)
Query: 427 AAANNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKN-----EVRLI 480
++++ F KLG G + VYKG VA+K + S +G E+ L+
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT----PSTAIREISLM 57
Query: 481 AKLQHTNLVRLLGCSLHGEERL-LVYEFMPN---KSLDFFLFNSGRKNVLNWEKRFIIIE 536
+L+H N+VRL +H E +L LV+EFM N K +D + + + ++ +
Sbjct: 58 KELKHENIVRLYDV-IHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVG 596
+ QGL + H+ +++HRDLK N+L++ + K+ DFG+AR F + + +V
Sbjct: 117 -LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGI-PVNTFSSEVV- 170
Query: 597 TYGYMSPE 604
T Y +P+
Sbjct: 171 TLWYRAPD 178
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 107 bits (267), Expect = 4e-25
Identities = 19/229 (8%), Positives = 48/229 (20%), Gaps = 43/229 (18%)
Query: 438 LGEGGFGPVYKGK-LADEQEVAIKRLSRS---SGQGIVEFKNEVRLIAKLQHTNLVRLLG 493
L G V+ + + ++ A+K + S + A+L +
Sbjct: 70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129
Query: 494 C--------------------------SLHGEERLLVYEFMP---NKSLDFFLFNSGRKN 524
LL+ F +
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRG 189
Query: 525 VLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
I+ + + L ++H N+ + + D
Sbjct: 190 DEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALW---- 242
Query: 585 NESEANTKRIVGTYGYMSPEYAMSG--IVSIKTDVFSFGVLVLEIVSGQ 631
+ Y E+ + + + + G+ + +
Sbjct: 243 -KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 56/184 (30%), Positives = 95/184 (51%), Gaps = 20/184 (10%)
Query: 428 AANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLS-RSSGQGIVEFKN-----EVRLIA 481
+ K+GEG +G VYK K + + VA+KR+ + +GI E+ L+
Sbjct: 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGI----PSTAIREISLLK 74
Query: 482 KLQHTNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQ 540
+L H N+V L+ +H E L LV+EFM K L L + + K ++ + +
Sbjct: 75 ELHHPNIVSLIDV-IHSERCLTLVFEFME-KDLKKVLDENKTGLQDSQIKIYLY--QLLR 130
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGY 600
G+ + H++ R++HRDLK N+L++ K++DFG+AR F + + T +V T Y
Sbjct: 131 GVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGI-PVRSYTHEVV-TLWY 185
Query: 601 MSPE 604
+P+
Sbjct: 186 RAPD 189
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 6e-25
Identities = 54/227 (23%), Positives = 95/227 (41%), Gaps = 15/227 (6%)
Query: 405 KSPEKDQSISHELKIFDFQTIAAAANNFSTT----NKLGEGGFGPVYKGK-LADEQEVAI 459
S D + K + Q + ++ +LG G FG V++ A A
Sbjct: 128 VSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAA 187
Query: 460 KRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFN 519
K + + E++ ++ L+H LV L E +++YEFM L F
Sbjct: 188 KFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL--FEKV 245
Query: 520 SGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNP--KISDFG 577
+ N ++ ++ + + +GL ++H+ +H DLK NI+ K + K+ DFG
Sbjct: 246 ADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFG 302
Query: 578 MARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLV 624
+ + + + K GT + +PE A V TD++S GVL
Sbjct: 303 LTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 6e-25
Identities = 52/241 (21%), Positives = 91/241 (37%), Gaps = 33/241 (13%)
Query: 399 PTYGKRKSPEKDQSISHELKIFDFQTIAAAANNFSTT----NKLGEGGFGPVYKGK-LAD 453
Y K + D+ K + Q + + +LG G FG V++ A
Sbjct: 16 GKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKAT 75
Query: 454 EQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSL 513
+ K ++ KNE+ ++ +L H L+ L E +L+ EF+
Sbjct: 76 GRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL----- 130
Query: 514 DFFLFNSG---------RKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNIL 564
SG ++ + + +GL ++H+ ++H D+K NI+
Sbjct: 131 ------SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIM 181
Query: 565 LDDKMNP--KISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGV 622
+ K KI DFG+A +E K T + +PE V TD+++ GV
Sbjct: 182 CETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGV 238
Query: 623 L 623
L
Sbjct: 239 L 239
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 8e-25
Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 30/215 (13%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKN--EVRLIAKLQHT 486
+ +GEG +G V K + + VAIK+ S +V+ E++L+ +L+H
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE 84
Query: 487 NLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFI--IIEGISQGLL 543
NLV LL ++R LV+EF+ + ++ L ++++ II GI
Sbjct: 85 NLVNLLEV-CKKKKRWYLVFEFV-DHTILDDLELFPNGLDYQVVQKYLFQIINGIG---- 138
Query: 544 YLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSP 603
+ H + +IHRD+K NIL+ K+ DFG AR E + T Y +P
Sbjct: 139 FCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYDDEVA-TRWYRAP 193
Query: 604 E-------YAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
E Y + DV++ G LV E+ G+
Sbjct: 194 ELLVGDVKYGKA------VDVWAIGCLVTEMFMGE 222
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 52/183 (28%), Positives = 89/183 (48%), Gaps = 21/183 (11%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLS-RSSGQGIVEFKN-----EVRLIAK 482
+ K+GEG +G V+K K + VA+KR+ +G+ E+ L+ +
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV----PSSALREICLLKE 57
Query: 483 LQHTNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQG 541
L+H N+VRL LH +++L LV+EF + L + + K F+ + +G
Sbjct: 58 LKHKNIVRLHDV-LHSDKKLTLVFEFCD-QDLKKYFDSCNGDLDPEIVKSFLF--QLLKG 113
Query: 542 LLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYM 601
L + H V+HRDLK N+L++ K+++FG+AR F + + +V T Y
Sbjct: 114 LGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGI-PVRCYSAEVV-TLWYR 168
Query: 602 SPE 604
P+
Sbjct: 169 PPD 171
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 60/234 (25%), Positives = 99/234 (42%), Gaps = 18/234 (7%)
Query: 406 SPEKDQSISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEV-AIKRLSR 464
+ + + S + Q +F LGEG F V + AIK L +
Sbjct: 6 AEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEK 65
Query: 465 SSGQGIVEFK------NEVRLIAKLQHTNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFL 517
I++ E ++++L H V+L + +E+L + N L ++
Sbjct: 66 RH---IIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI 121
Query: 518 FNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFG 577
G RF E I L YLH +IHRDLK NILL++ M+ +I+DFG
Sbjct: 122 RKIGS--FDETCTRFYTAE-IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFG 175
Query: 578 MARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
A++ +A VGT Y+SPE +D+++ G ++ ++V+G
Sbjct: 176 TAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 54/182 (29%), Positives = 91/182 (50%), Gaps = 20/182 (10%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLS-RSSGQGIVEFKN-----EVRLIAKL 483
+ K+GEG +G VYK + + A+K++ +GI E+ ++ +L
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGI----PSTTIREISILKEL 57
Query: 484 QHTNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGL 542
+H+N+V+L +H ++RL LV+E + + L L K F++ + G+
Sbjct: 58 KHSNIVKLYDV-IHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLL--QLLNGI 113
Query: 543 LYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMS 602
Y H RV+HRDLK N+L++ + KI+DFG+AR F + T IV T Y +
Sbjct: 114 AYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEIV-TLWYRA 168
Query: 603 PE 604
P+
Sbjct: 169 PD 170
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-24
Identities = 76/322 (23%), Positives = 126/322 (39%), Gaps = 35/322 (10%)
Query: 328 QAYCEIWSEGTEFTEIASNNSREIFILAIKEEKWWRSLTIAIGVVLGIPLLCYLCYVTWR 387
E+ E+ ++ R+ + + + I V L C
Sbjct: 78 SRCVAFLDGVAEY-EVTPDDKRKACGRNLTQNFLSHTGPDLIPEVP--RQLVTNCTQRLE 134
Query: 388 KLKAKDNVSLL----PTYGKRKSPEKDQSISHELKIFDFQTI---AAAANNFSTTNKLGE 440
+ KD L Y + + ++ + N F LG+
Sbjct: 135 QGPCKDLFQELTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGK 194
Query: 441 GGFGPVYKGKLADEQEV-AIKRLSRS---SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSL 496
GGFG V ++ ++ A K+L + +G NE +++ K+ +V L +
Sbjct: 195 GGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-AYAY 253
Query: 497 HGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIH 555
++ L LV M L F +++ G+ F E I GL LH+ R+++
Sbjct: 254 ETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLEDLHR---ERIVY 309
Query: 556 RDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPE------YAMSG 609
RDLK NILLDD + +ISD G+A ++ K VGT GYM+PE Y S
Sbjct: 310 RDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFS- 365
Query: 610 IVSIKTDVFSFGVLVLEIVSGQ 631
D ++ G L+ E+++GQ
Sbjct: 366 -----PDWWALGCLLYEMIAGQ 382
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 57/186 (30%), Positives = 97/186 (52%), Gaps = 22/186 (11%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKN--------EVRL 479
A + + LGEG F VYK + Q VAIK++ E K+ E++L
Sbjct: 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRS---EAKDGINRTALREIKL 65
Query: 480 IAKLQHTNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGI 538
+ +L H N++ LL + + LV++FM L+ + ++ + K ++++
Sbjct: 66 LQELSHPNIIGLLDA-FGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLM--T 121
Query: 539 SQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTY 598
QGL YLH++ ++HRDLK +N+LLD+ K++DFG+A+ F + A T ++V T
Sbjct: 122 LQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGS-PNRAYTHQVV-TR 176
Query: 599 GYMSPE 604
Y +PE
Sbjct: 177 WYRAPE 182
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 31/238 (13%), Positives = 66/238 (27%), Gaps = 53/238 (22%)
Query: 438 LGEGGFGPVYKGK-LADEQEVAIKRLS---RSSGQGIVEFKNEVRLIAKLQ--------- 484
LG+ + + + R I + K EV + L+
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 485 -------------HTNLVRLLGCSLHGE-----ERLLVYEFMPNKSLDFF--LFNSGRKN 524
+++ L R +Y M + F L + +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 525 -VLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFE 583
L R + + + L LH ++H L+ +I+LD + ++ F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV--- 259
Query: 584 VNESEANTKRIVGTYGYMSPEY----------AMSGIVSIKTDVFSFGVLVLEIVSGQ 631
+ + G+ PE +++ D ++ G+ + I
Sbjct: 260 ---RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-24
Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 26/215 (12%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEV-AIKRLSRS---SGQGIVEFKNEVRLIAKLQH 485
+ F LG GGFG V+ ++ ++ A K+L++ +G E +++AK+
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 486 TNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKR--FIIIEGISQGL 542
+V L + + L LV M + + ++N N E R F + I GL
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ-IVSGL 302
Query: 543 LYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMS 602
+LH+ +I+RDLK N+LLDD N +ISD G+A E+ + TK GT G+M+
Sbjct: 303 EHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAV--ELKAGQTKTKGYAGTPGFMA 357
Query: 603 PE------YAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
PE Y S D F+ GV + E+++ +
Sbjct: 358 PELLLGEEYDFS------VDYFALGVTLYEMIAAR 386
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 56/178 (31%), Positives = 95/178 (53%), Gaps = 12/178 (6%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGI-VEFKNEVRLIAKLQHTN 487
+ +KLGEG + VYKGK + VA+K + +G EV L+ L+H N
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 488 LVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLH 546
+V L +H E+ L LV+E++ +K L +L + G ++ K F+ + +GL Y H
Sbjct: 62 IVTLHDI-IHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLF--QLLRGLAYCH 117
Query: 547 KYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPE 604
+ +V+HRDLK N+L++++ K++DFG+AR + ++ +V T Y P+
Sbjct: 118 RQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSI-PTKTYDNEVV-TLWYRPPD 170
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-24
Identities = 62/243 (25%), Positives = 104/243 (42%), Gaps = 36/243 (14%)
Query: 399 PTYGKRKSPEKDQSISHELKIFDFQTIAAAANNFS------TTNKLGEGGFGPVYKGK-L 451
P KR S + FD + + A + T LG G FG V+K +
Sbjct: 53 PVKSKRTSALAVDIPAPP-APFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEET 111
Query: 452 ADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNK 511
A ++A K + + E KNE+ ++ +L H NL++L + +LV E++
Sbjct: 112 ATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYV--- 168
Query: 512 SLDFFLFNSG---------RKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASN 562
G L + ++ I +G+ ++H+ + ++H DLK N
Sbjct: 169 --------DGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPEN 217
Query: 563 ILLDDKMNP--KISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSF 620
IL ++ KI DFG+AR ++ E K GT +++PE VS TD++S
Sbjct: 218 ILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSV 274
Query: 621 GVL 623
GV+
Sbjct: 275 GVI 277
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 6e-24
Identities = 59/183 (32%), Positives = 97/183 (53%), Gaps = 20/183 (10%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLS-RSSGQGIVEFKN-----EVRLIAK 482
NF K+GEG +G VYK + + VA+K++ + +G+ E+ L+ +
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGV----PSTAIREISLLKE 58
Query: 483 LQHTNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQG 541
L H N+V+LL +H E +L LV+EF+ + L F+ S + + + + + QG
Sbjct: 59 LNHPNIVKLLDV-IHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQ-LLQG 115
Query: 542 LLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYM 601
L + H + RV+HRDLK N+L++ + K++DFG+AR F V T +V T Y
Sbjct: 116 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYR 170
Query: 602 SPE 604
+PE
Sbjct: 171 APE 173
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 7e-24
Identities = 30/238 (12%), Positives = 67/238 (28%), Gaps = 54/238 (22%)
Query: 438 LGEGGFGPVYKGK-LADEQEVAIKRLSRS---SGQGIVEFKNEVRLIAKLQ--------- 484
LG+ + + + + I + K EV + L+
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 485 ----------------HTNLVRLLGCSLHGE--ERLLVYEFMPNKSLDFF--LFNSGRKN 524
++R+ R +Y M + F L + +
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 525 -VLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFE 583
L R + + + L LH ++H L+ +I+LD + ++ F
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV--- 254
Query: 584 VNESEANTKRIVGTYGYMSPEYAMS-----------GIVSIKTDVFSFGVLVLEIVSG 630
+ + G+ PE +++ D ++ G+++ I
Sbjct: 255 ---RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 56/236 (23%), Positives = 96/236 (40%), Gaps = 38/236 (16%)
Query: 398 LPTYGKRKSPEKDQSISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGK-LADEQE 456
R++ +I F KLG G FG V+ + + E
Sbjct: 5 HHHSSGRENLYFQGTIDD---------------LFIFKRKLGSGAFGDVHLVEERSSGLE 49
Query: 457 VAIKRLSRSSGQGIVE-FKNEVRLIAKLQHTNLVRLLGC-----SLHGEERLLVYEFMPN 510
IK +++ Q +E + E+ ++ L H N++++ +++ +V E
Sbjct: 50 RVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMY-----IVMETCEG 104
Query: 511 KSL-DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDK- 568
L + + R L+ +++ + L Y H V+H+DLK NIL D
Sbjct: 105 GELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTS 161
Query: 569 --MNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGV 622
KI DFG+A +F+ +E + GT YM+PE V+ K D++S GV
Sbjct: 162 PHSPIKIIDFGLAELFKSDEH---STNAAGTALYMAPE-VFKRDVTFKCDIWSAGV 213
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 1e-23
Identities = 63/244 (25%), Positives = 106/244 (43%), Gaps = 32/244 (13%)
Query: 403 KRKSPEKDQSISHELKIFDFQTIAAAANNFSTT----NKLGEGGFGPVYKGK-LADEQEV 457
S ++ +L+ I + + S KLG G +G V + E
Sbjct: 6 HHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVER 65
Query: 458 AIKRLSRS--SGQGIVEFKNEVRLIAKLQHTNLVRLLGC-----SLHGEERLLVYEFMPN 510
AIK + ++ S + EV ++ L H N+++L + + LV E
Sbjct: 66 AIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYY-----LVMECYKG 120
Query: 511 KSL-DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKM 569
L D + + N +II+ + G+ YLHK ++HRDLK N+LL+ K
Sbjct: 121 GELFDEII----HRMKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKE 173
Query: 570 ---NPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLE 626
KI DFG++ +FE + K +GT Y++PE + K DV+S GV++
Sbjct: 174 KDALIKIVDFGLSAVFENQKK---MKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFI 229
Query: 627 IVSG 630
+++G
Sbjct: 230 LLAG 233
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 3e-23
Identities = 53/218 (24%), Positives = 91/218 (41%), Gaps = 53/218 (24%)
Query: 438 LGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAKLQHTNLVRLLGCS 495
LGEG +G V E+ VA+K + E K E+ + L H N+V+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF---- 70
Query: 496 LHGEERLLVYEFMPNKSLDFF---------LFN----SGRKNVLN-WEKRFI---IIEGI 538
Y ++ + LF+ + + + ++ G+
Sbjct: 71 ---------YGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGV 118
Query: 539 SQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTY 598
YLH + + HRD+K N+LLD++ N KISDFG+A +F N E ++ GT
Sbjct: 119 V----YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 599 GYMSPE------YAMSGIVSIKTDVFSFGVLVLEIVSG 630
Y++PE + DV+S G+++ +++G
Sbjct: 172 PYVAPELLKRREFHAE-----PVDVWSCGIVLTAMLAG 204
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 4e-23
Identities = 61/220 (27%), Positives = 102/220 (46%), Gaps = 39/220 (17%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADEQE-VAIKRLSRSSGQGIVEFKN-EVRLIAKLQHTNL 488
+++ T +G G FG VY+ KL D E VAIK++ + FKN E++++ KL H N+
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNI 109
Query: 489 VRLLGCSLHGEERL------LVYEFMP---NKSLDFFLFNSGRKNVLNWEKRFIIIEGIS 539
VRL E+ LV +++P + + + ++ + + + + +
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY--SRAKQTLPVIYVKLYMYQ-LF 166
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNP-KISDFGMARIFEVNESEANTKRIVGTY 598
+ L Y+H + HRD+K N+LLD K+ DFG A+ E N I Y
Sbjct: 167 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRY 221
Query: 599 GYMSPE-------YAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
Y +PE Y + DV+S G ++ E++ GQ
Sbjct: 222 -YRAPELIFGATDY------TSSIDVWSAGCVLAELLLGQ 254
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 7e-23
Identities = 61/208 (29%), Positives = 97/208 (46%), Gaps = 29/208 (13%)
Query: 436 NKLGEGGFGPVYKGK-LADEQEVAIKRLSRS---SGQGIVEFKNEVRLIAKLQHTNLVRL 491
LG+G FG V K QE A+K +S+ EV+L+ +L H N+++L
Sbjct: 32 RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91
Query: 492 LGC-----SLHGEERLLVYEFMPNKSL-DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYL 545
+ LV E L D + + + II + G+ Y+
Sbjct: 92 YEFFEDKGYFY-----LVGEVYTGGELFDEII----SRKRFSEVDAARIIRQVLSGITYM 142
Query: 546 HKYSRLRVIHRDLKASNILLDDKM---NPKISDFGMARIFEVNESEANTKRIVGTYGYMS 602
HK +++HRDLK N+LL+ K N +I DFG++ FE ++ K +GT Y++
Sbjct: 143 HK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK---MKDKIGTAYYIA 196
Query: 603 PEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
PE + G K DV+S GV++ ++SG
Sbjct: 197 PE-VLHGTYDEKCDVWSTGVILYILLSG 223
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 8e-23
Identities = 52/210 (24%), Positives = 85/210 (40%), Gaps = 53/210 (25%)
Query: 438 LGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAKLQHTNLVRLLGCS 495
LGEG +G V E+ VA+K + E K E+ + L H N+V+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF---- 70
Query: 496 LHGEERLLVYEFMPNKSLDFF---------LFN----SGRKNVLN-WEKRFI---IIEGI 538
Y ++ + LF+ + + + ++ G+
Sbjct: 71 ---------YGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGV 118
Query: 539 SQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTY 598
YLH + + HRD+K N+LLD++ N KISDFG+A +F N E ++ GT
Sbjct: 119 V----YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 599 GYMSPE------YAMSGIVSIKTDVFSFGV 622
Y++PE + DV+S G+
Sbjct: 172 PYVAPELLKRREFHAE-----PVDVWSCGI 196
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 9e-23
Identities = 46/199 (23%), Positives = 83/199 (41%), Gaps = 30/199 (15%)
Query: 437 KLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCS 495
LG G FG V++ + ++ K + G V K E+ ++ +H N++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 496 LHGEERLLVYEFMPNKSLDFFLFNSG---------RKNVLNWEKRFIIIEGISQGLLYLH 546
EE ++++EF+ SG LN + + + + L +LH
Sbjct: 71 ESMEELVMIFEFI-----------SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH 119
Query: 547 KYSRLRVIHRDLKASNILLDDKMNP--KISDFGMARIFEVNESEANTKRIVGTYGYMSPE 604
+ H D++ NI+ + + KI +FG AR + + N + + Y +PE
Sbjct: 120 S---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPE 173
Query: 605 YAMSGIVSIKTDVFSFGVL 623
+VS TD++S G L
Sbjct: 174 VHQHDVVSTATDMWSLGTL 192
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-22
Identities = 61/215 (28%), Positives = 102/215 (47%), Gaps = 28/215 (13%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEV-AIKRLSRSSGQGIVEFKNEVR---------- 478
N+FS +G GGFG VY + AD ++ A+K L + I K
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKR---IKM-KQGETLALNERIMLS 244
Query: 479 LIAKLQHTNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEG 537
L++ +V + + H ++L + + M L + L G + RF E
Sbjct: 245 LVSTGDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGV--FSEADMRFYAAE- 300
Query: 538 ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT 597
I GL ++H V++RDLK +NILLD+ + +ISD G+A + ++ + + VGT
Sbjct: 301 IILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLAC--DFSKKKPHA--SVGT 353
Query: 598 YGYMSPEYAMSGIVSIKT-DVFSFGVLVLEIVSGQ 631
+GYM+PE G+ + D FS G ++ +++ G
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 52/202 (25%), Positives = 81/202 (40%), Gaps = 25/202 (12%)
Query: 437 KLGEGGFGPVYKGK-LADEQEVAIK-----RLSRSSGQGIVEFKNEVRLIAKLQHTNLVR 490
+G+G F V + Q+ A+K + + S G + K E + L+H ++V
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 491 LLGC-----SLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKR-FIIIEGISQGLLY 544
LL L+ +V+EFM L F + + E + I + L Y
Sbjct: 91 LLETYSSDGMLY-----MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 545 LHKYSRLRVIHRDLKASNILLDDKMNP---KISDFGMARIFEVNESEANTKRIVGTYGYM 601
H +IHRD+K +LL K N K+ FG+A + A VGT +M
Sbjct: 146 CHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--RVGTPHFM 200
Query: 602 SPEYAMSGIVSIKTDVFSFGVL 623
+PE DV+ GV+
Sbjct: 201 APEVVKREPYGKPVDVWGCGVI 222
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 50/207 (24%), Positives = 90/207 (43%), Gaps = 24/207 (11%)
Query: 438 LGEGGFGPVYKGK-LADEQEVAIKRLSRSS----GQGIVEFKNEVRLIAKLQHTNLVRLL 492
LGEG +G V + A+K L + G K E++L+ +L+H N+++L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 493 GCSLHGEERL---LVYEFMPNKSLDFFLFNSGRKNVLN-WEKRFI---IIEGISQGLLYL 545
L+ EE+ +V E+ + + +S + + +I+G+ YL
Sbjct: 73 DV-LYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLE----YL 125
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEY 605
H ++H+D+K N+LL KIS G+A ++ + G+ + PE
Sbjct: 126 H---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEI 182
Query: 606 AMS--GIVSIKTDVFSFGVLVLEIVSG 630
A K D++S GV + I +G
Sbjct: 183 ANGLDTFSGFKVDIWSAGVTLYNITTG 209
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 99.9 bits (249), Expect = 2e-22
Identities = 49/183 (26%), Positives = 92/183 (50%), Gaps = 20/183 (10%)
Query: 437 KLGEGGFGPVYKGKLADEQ---EVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLG 493
K+G G +G VYK K D + + A+K++ +G + + E+ L+ +L+H N++ L
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQI-EGTGISMSACR-EIALLRELKHPNVISLQK 85
Query: 494 -CSLHGEERL-LVYEFMPN---KSLDFFLFNSGRKNVLNWEKRFI--IIEGISQGLLYLH 546
H + ++ L++++ + + F + K + + + ++ I G+ YLH
Sbjct: 86 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 547 KYSRLRVIHRDLKASNILLDDKMNP----KISDFGMARIFEV-NESEANTKRIVGTYGYM 601
V+HRDLK +NIL+ + KI+D G AR+F + A+ +V T+ Y
Sbjct: 146 AN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 202
Query: 602 SPE 604
+PE
Sbjct: 203 APE 205
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-22
Identities = 44/230 (19%), Positives = 84/230 (36%), Gaps = 58/230 (25%)
Query: 431 NFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRS--SGQGIVEFKN------EVRLIA 481
+ST + LG G FG V+ +EV +K + + +E E+ +++
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 482 KLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFF----------LFN--SGRKNVLNWE 529
+++H N++++ + N+ LF +
Sbjct: 85 RVEHANIIKV-------------LDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPL 131
Query: 530 KRFI---IIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586
+I ++ + YL +IHRD+K NI++ + K+ DFG A E +
Sbjct: 132 ASYIFRQLVSAVG----YLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK 184
Query: 587 SEANTKRIVGTYGYMSPE------YAMSGIVSIKTDVFSFGVLVLEIVSG 630
GT Y +PE Y + +++S GV + +V
Sbjct: 185 ---LFYTFCGTIEYCAPEVLMGNPYRGP-----ELEMWSLGVTLYTLVFE 226
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 3e-22
Identities = 63/213 (29%), Positives = 103/213 (48%), Gaps = 28/213 (13%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRS--SGQGIVEFKNEVRLIAKLQHT 486
++ LG+G FG V K K +QE A+K ++++ + EV L+ KL H
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 487 NLVRLLGC-----SLHGEERLLVYEFMPNKSLDFFLFNS-GRKNVLNWEKRFIIIEGISQ 540
N+++L S + +V E L F+ ++ + II+ +
Sbjct: 82 NIMKLFEILEDSSSFY-----IVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFS 132
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDK---MNPKISDFGMARIFEVNESEANTKRIVGT 597
G+ Y+HK ++HRDLK NILL+ K + KI DFG++ F+ N K +GT
Sbjct: 133 GITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGT 186
Query: 598 YGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
Y++PE + G K DV+S GV++ ++SG
Sbjct: 187 AYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 5e-22
Identities = 51/272 (18%), Positives = 89/272 (32%), Gaps = 52/272 (19%)
Query: 408 EKDQSISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGK-LADEQEVAIK-----R 461
S E F ++ + +G+G +G V AIK +
Sbjct: 4 HHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNK 63
Query: 462 LSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGC-----SLH--------GE--------- 499
+ + + + + K EVRL+ KL H N+ RL + G
Sbjct: 64 IRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFI 123
Query: 500 ---------ERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRF------IIIEGISQGLLY 544
+ + + + + S + + I+ I L Y
Sbjct: 124 DDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183
Query: 545 LHKYSRLRVIHRDLKASNILLDDK--MNPKISDFGMARIFEVNESEANT--KRIVGTYGY 600
LH + HRD+K N L K+ DFG+++ F + GT +
Sbjct: 184 LHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYF 240
Query: 601 MSPE--YAMSGIVSIKTDVFSFGVLVLEIVSG 630
++PE + K D +S GVL+ ++ G
Sbjct: 241 VAPEVLNTTNESYGPKCDAWSAGVLLHLLLMG 272
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 6e-22
Identities = 56/199 (28%), Positives = 91/199 (45%), Gaps = 22/199 (11%)
Query: 437 KLGEGGFGPVYKGK-LADEQEVAIK------RLSRSSGQGIVEFKNEVRLIAKLQHTNLV 489
+LG G F V K + + E A K + G E + EV ++ ++ H N++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 490 RLLGCSLHGEERLLVYEFMPNKSL-DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
L + + +L+ E + L DF +K L+ E+ I+ I G+ YLH
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLHT- 133
Query: 549 SRLRVIHRDLKASNILLDDKMNP----KISDFGMARIFEVNESEANTKRIVGTYGYMSPE 604
++ H DLK NI+L DK P K+ DFG+A E K I GT +++PE
Sbjct: 134 --KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPE 188
Query: 605 YAMSGIVSIKTDVFSFGVL 623
+ ++ D++S GV+
Sbjct: 189 IVNYEPLGLEADMWSIGVI 207
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 7e-22
Identities = 56/199 (28%), Positives = 92/199 (46%), Gaps = 22/199 (11%)
Query: 437 KLGEGGFGPVYKGK-LADEQEVAIKRLSRS------SGQGIVEFKNEVRLIAKLQHTNLV 489
+LG G F V K + + E A K + + G E + EV ++ ++ H N++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 490 RLLGCSLHGEERLLVYEFMPNKSL-DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
L + + +L+ E + L DF +K L+ E+ I+ I G+ YLH
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLHT- 133
Query: 549 SRLRVIHRDLKASNILLDDKMNP----KISDFGMARIFEVNESEANTKRIVGTYGYMSPE 604
++ H DLK NI+L DK P K+ DFG+A E K I GT +++PE
Sbjct: 134 --KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPE 188
Query: 605 YAMSGIVSIKTDVFSFGVL 623
+ ++ D++S GV+
Sbjct: 189 IVNYEPLGLEADMWSIGVI 207
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 56/231 (24%), Positives = 97/231 (41%), Gaps = 69/231 (29%)
Query: 438 LGEGGFGPVYKGK-LADEQEVAIKRLSRS-------------------------SGQGIV 471
+G+G +G V D A+K LS+ +G +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 472 EF-KNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFM--PNKSLDFF---------LFN 519
E E+ ++ KL H N+V+L E + PN+ + +
Sbjct: 81 EQVYQEIAILKKLDHPNVVKL-------------VEVLDDPNEDHLYMVFELVNQGPVME 127
Query: 520 SGRKNVLN-WEKRFI---IIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISD 575
L+ + RF +I+GI YLH ++IHRD+K SN+L+ + + KI+D
Sbjct: 128 VPTLKPLSEDQARFYFQDLIKGIE----YLH---YQKIIHRDIKPSNLLVGEDGHIKIAD 180
Query: 576 FGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSI----KTDVFSFGV 622
FG++ F+ +++ + VGT +M+PE ++S I DV++ GV
Sbjct: 181 FGVSNEFKGSDALLSNT--VGTPAFMAPE-SLSETRKIFSGKALDVWAMGV 228
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-21
Identities = 54/226 (23%), Positives = 95/226 (42%), Gaps = 41/226 (18%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGKLADEQE-VAIKRLSRSSGQGIVEFKN----EVRLIAKL 483
+ F G+G FG V GK VAIK++ + F+N ++ +A L
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-----PRFRNRELQIMQDLAVL 76
Query: 484 QHTNLVRLLGCSLHGEER-------LLVYEFMP---NKSLDFFLFNSGRKNVLNWEKRFI 533
H N+V+L ER +V E++P ++ + + +
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRN--YYRRQVAPPPILIKVF 134
Query: 534 IIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNP-KISDFGMARIFEVNESEANTK 592
+ + + + + LH S + V HRD+K N+L+++ K+ DFG A+ + SE N
Sbjct: 135 LFQ-LIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL--SPSEPNVA 190
Query: 593 RIVGTYGYMSPE-------YAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
I Y Y +PE Y + D++S G + E++ G+
Sbjct: 191 YICSRY-YRAPELIFGNQHY------TTAVDIWSVGCIFAEMMLGE 229
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-21
Identities = 56/191 (29%), Positives = 85/191 (44%), Gaps = 33/191 (17%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLS-RSSGQGIVEFKN-----EVRLIAK 482
+ + KLGEG +G VYK + VAIKR+ +G+ EV L+ +
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGV----PGTAIREVSLLKE 89
Query: 483 LQHTNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGR---KNVLNWEKRFIIIEGI 538
LQH N++ L +H RL L++E+ L ++ + + + K F+ +
Sbjct: 90 LQHRNIIELKSV-IHHNHRLHLIFEYA-ENDLKKYMDKNPDVSMRVI----KSFLY--QL 141
Query: 539 SQGLLYLHKYSRLRVIHRDLKASNILLDDKMNP-----KISDFGMARIFEVNESEANTKR 593
G+ + H R +HRDLK N+LL KI DFG+AR F + T
Sbjct: 142 INGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI-PIRQFTHE 197
Query: 594 IVGTYGYMSPE 604
I+ T Y PE
Sbjct: 198 II-TLWYRPPE 207
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-21
Identities = 63/251 (25%), Positives = 105/251 (41%), Gaps = 39/251 (15%)
Query: 403 KRKSPEKDQSISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKR 461
+ Q I+ ++ + ++ KLG G +G V K E AIK
Sbjct: 9 SGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKV 68
Query: 462 LSRSSGQGIV-------------EFKNEVRLIAKLQHTNLVRLLGC-----SLHGEERLL 503
+ +S E NE+ L+ L H N+++L + L
Sbjct: 69 IKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFY-----L 123
Query: 504 VYEFMPNKSLDFFLFNS-GRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASN 562
V EF L F ++ + I++ I G+ YLHK ++HRD+K N
Sbjct: 124 VTEFYEGGEL----FEQIINRHKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPEN 176
Query: 563 ILLDDK---MNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFS 619
ILL++K +N KI DFG++ F + + +GT Y++PE + + K DV+S
Sbjct: 177 ILLENKNSLLNIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPE-VLKKKYNEKCDVWS 232
Query: 620 FGVLVLEIVSG 630
GV++ ++ G
Sbjct: 233 CGVIMYILLCG 243
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 2e-21
Identities = 52/191 (27%), Positives = 92/191 (48%), Gaps = 22/191 (11%)
Query: 428 AANNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRL---SRSSGQGIVEFKN--EVRLIA 481
A + + ++G G +G VYK + VA+K + + G G + EV L+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 482 KLQ---HTNLVRLL----GCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFI 533
+L+ H N+VRL+ E ++ LV+E + ++ L +L + + + +
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDL 125
Query: 534 IIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKR 593
+ + +GL +LH ++HRDLK NIL+ K++DFG+ARI+ + T
Sbjct: 126 MRQ-FLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA--LTPV 179
Query: 594 IVGTYGYMSPE 604
+V T Y +PE
Sbjct: 180 VV-TLWYRAPE 189
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 2e-21
Identities = 57/206 (27%), Positives = 91/206 (44%), Gaps = 36/206 (17%)
Query: 437 KLGEGGFGPVYKGK-LADEQEVAIK-----RLSRSSGQGIVE-FKNEVRLIAKLQHTNLV 489
+LG G F V K + +E A K RLS S E + EV ++ +++H N++
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSG--------RKNVLNWEKRFIIIEGISQG 541
L + + +L+ E + SG K L ++ ++ I G
Sbjct: 72 TLHDIFENKTDVVLILELV-----------SGGELFDFLAEKESLTEDEATQFLKQILDG 120
Query: 542 LLYLHKYSRLRVIHRDLKASNILLDDKMNP----KISDFGMARIFEVNESEANTKRIVGT 597
+ YLH R+ H DLK NI+L DK P K+ DFG+A E K I GT
Sbjct: 121 VHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNIFGT 174
Query: 598 YGYMSPEYAMSGIVSIKTDVFSFGVL 623
+++PE + ++ D++S GV+
Sbjct: 175 PEFVAPEIVNYEPLGLEADMWSIGVI 200
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 3e-21
Identities = 53/206 (25%), Positives = 91/206 (44%), Gaps = 36/206 (17%)
Query: 437 KLGEGGFGPVYKGK-LADEQEVAIKRL------SRSSGQGIVEFKNEVRLIAKLQHTNLV 489
+LG G F V K + + + A K + S G + + EV ++ ++QH N++
Sbjct: 18 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSG--------RKNVLNWEKRFIIIEGISQG 541
L + + +L+ E + +G K L E+ ++ I G
Sbjct: 78 TLHEVYENKTDVILILELV-----------AGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 542 LLYLHKYSRLRVIHRDLKASNILLDDKMNP----KISDFGMARIFEVNESEANTKRIVGT 597
+ YLH L++ H DLK NI+L D+ P KI DFG+A + K I GT
Sbjct: 127 VYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGT 180
Query: 598 YGYMSPEYAMSGIVSIKTDVFSFGVL 623
+++PE + ++ D++S GV+
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVI 206
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 4e-21
Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 51/205 (24%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKN-----------E 476
+ + K+G+G FG V+K + Q+VA+K+ V +N E
Sbjct: 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKK---------VLMENEKEGFPITALRE 66
Query: 477 VRLIAKLQHTNLVRLLGCSLHGEERL---------LVYEFMPN--KSLDFFLFNSGRKNV 525
++++ L+H N+V L+ + LV++F + L L N K
Sbjct: 67 IKILQLLKHENVVNLIEI-CRTKASPYNRCKGSIYLVFDFCEHDLAGL---LSNVLVKFT 122
Query: 526 LNWEKRFIIIEGISQ---GLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIF 582
L+ KR + GL Y+H+ +++HRD+KA+N+L+ K++DFG+AR F
Sbjct: 123 LSEIKRVMQ-----MLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAF 174
Query: 583 EVNESEAN---TKRIVGTYGYMSPE 604
+ ++ T R+V T Y PE
Sbjct: 175 SLAKNSQPNRYTNRVV-TLWYRPPE 198
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 4e-21
Identities = 63/209 (30%), Positives = 96/209 (45%), Gaps = 37/209 (17%)
Query: 438 LGEGGFGPVYKGKLAD----EQEVAIKRLSRS--SGQGIVEFKNEVRLIAKLQHTNLVRL 491
+G+G F V KLA +EVAIK + ++ + + + EVR++ L H N+V+L
Sbjct: 23 IGKGNFAKV---KLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL 79
Query: 492 LGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLN-WEKRFI---IIEGISQGLLYLHK 547
+ L+ E+ + +L GR + E R I+ + Y H
Sbjct: 80 FEVIETEKTLYLIMEYASGGEVFDYLVAHGR---MKEKEARSKFRQIVSAVQ----YCH- 131
Query: 548 YSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPE--- 604
+ R++HRDLKA N+LLD MN KI+DFG + F V G Y +PE
Sbjct: 132 --QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG---KLDAFCGAPPYAAPELFQ 186
Query: 605 ---YAMSGIVSIKTDVFSFGVLVLEIVSG 630
Y + DV+S GV++ +VSG
Sbjct: 187 GKKYD-----GPEVDVWSLGVILYTLVSG 210
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 5e-21
Identities = 65/215 (30%), Positives = 97/215 (45%), Gaps = 48/215 (22%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRS--SGQGIVEFKNEVRLIAKLQHT 486
++ LG+G FG V K K +QE A+K ++++ + EV L+ KL H
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 487 NLVRLLGC-----SLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRF------III 535
N+++L S + +V E L F+ K KRF II
Sbjct: 82 NIMKLFEILEDSSSFY-----IVGELYTGGEL----FDEIIK-----RKRFSEHDAARII 127
Query: 536 EGISQGLLYLHKYSRLRVIHRDLKASNILLDDK---MNPKISDFGMARIFEVNESEANTK 592
+ + G+ Y+HK ++HRDLK NILL+ K + KI DFG++ F+ N K
Sbjct: 128 KQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MK 181
Query: 593 RIVGTYGYMSPE-----YAMSGIVSIKTDVFSFGV 622
+GT Y++PE Y K DV+S GV
Sbjct: 182 DRIGTAYYIAPEVLRGTY------DEKCDVWSAGV 210
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 7e-21
Identities = 52/198 (26%), Positives = 84/198 (42%), Gaps = 27/198 (13%)
Query: 437 KLGEGGFGPVYKG-KLADEQEVAIKRLSRS--SGQGIVEFKNEVRLIAKLQHTNLVRLLG 493
+LG+G F V + E A K ++ S + + + E R+ KLQH N+VRL
Sbjct: 13 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 72
Query: 494 C-----SLHGEERLLVYEFMPNKSLDFFLFNS-GRKNVLNWEKRFIIIEGISQGLLYLHK 547
+ LV++ + L F + + I+ I + + Y H
Sbjct: 73 SIQEESFHY-----LVFDLVTGGEL----FEDIVAREFYSEADASHCIQQILESIAYCHS 123
Query: 548 YSRLRVIHRDLKASNILLDDKMNP---KISDFGMARIFEVNESEANTKRIVGTYGYMSPE 604
++HR+LK N+LL K K++DFG+A +E+ GT GY+SPE
Sbjct: 124 ---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPE 177
Query: 605 YAMSGIVSIKTDVFSFGV 622
S D+++ GV
Sbjct: 178 VLKKDPYSKPVDIWACGV 195
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 8e-21
Identities = 50/197 (25%), Positives = 79/197 (40%), Gaps = 28/197 (14%)
Query: 437 KLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCS 495
+G G +G V A K++ + + + FK E+ ++ L H N++RL
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYE-- 73
Query: 496 LHGEERLLVYEFMPNKSLDFFLFNSG-------RKNVLNWEKRFIIIEGISQGLLYLHKY 548
+E + L L G K V I++ + + Y HK
Sbjct: 74 --------TFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHK- 124
Query: 549 SRLRVIHRDLKASNILLDDK---MNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEY 605
L V HRDLK N L K+ DFG+A F+ + + VGT Y+SP+
Sbjct: 125 --LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK---MMRTKVGTPYYVSPQ- 178
Query: 606 AMSGIVSIKTDVFSFGV 622
+ G+ + D +S GV
Sbjct: 179 VLEGLYGPECDEWSAGV 195
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 58/212 (27%), Positives = 89/212 (41%), Gaps = 36/212 (16%)
Query: 438 LGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKN------EVRLIAKLQHT--NL 488
LG GGFG VY G ++D VAIK + + E N EV L+ K+ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFI---IIEGISQGLLYL 545
+RLL + +L+ E P D F F + R + R ++E + +
Sbjct: 111 IRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEAVR----HC 165
Query: 546 HKYSRLRVIHRDLKASNILLD-DKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPE 604
H V+HRD+K NIL+D ++ K+ DFG + + + GT Y PE
Sbjct: 166 H---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPE 218
Query: 605 ------YAMSGIVSIKTDVFSFGVLVLEIVSG 630
Y V+S G+L+ ++V G
Sbjct: 219 WIRYHRYHGR-----SAAVWSLGILLYDMVCG 245
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 3e-20
Identities = 49/178 (27%), Positives = 82/178 (46%), Gaps = 35/178 (19%)
Query: 428 AANNFSTTNKLGEGGFGPVYKGK--LADEQEVAIKRLSRSSGQGIVEFKNE--------V 477
A + ++GEG +G V+K + + VA+KR V + +
Sbjct: 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKR---------VRVQTGEEGMPLSTI 59
Query: 478 RLIAKLQ------HTNLVRLL----GCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVL 526
R +A L+ H N+VRL E +L LV+E + ++ L +L V
Sbjct: 60 REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVP 118
Query: 527 NWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584
+ ++ + + +GL +LH + RV+HRDLK NIL+ K++DFG+ARI+
Sbjct: 119 TETIKDMMFQ-LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF 172
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-20
Identities = 52/199 (26%), Positives = 81/199 (40%), Gaps = 29/199 (14%)
Query: 437 KLGEGGFGPVYKG-KLADEQEVAIKRLSRS--SGQGIVEFKNEVRLIAKLQHTNLVRLLG 493
+LG+G F V + E A K ++ S + + + E R+ KLQH N+VRL
Sbjct: 36 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95
Query: 494 CSLHGEERLLVYEFMPNKSLDFFLFNSG-------RKNVLNWEKRFIIIEGISQGLLYLH 546
+ L F L G + + I+ I + + Y H
Sbjct: 96 ----------SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH 145
Query: 547 KYSRLRVIHRDLKASNILLDDKMNP---KISDFGMARIFEVNESEANTKRIVGTYGYMSP 603
++HR+LK N+LL K K++DFG+A +E+ GT GY+SP
Sbjct: 146 S---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSP 199
Query: 604 EYAMSGIVSIKTDVFSFGV 622
E S D+++ GV
Sbjct: 200 EVLKKDPYSKPVDIWACGV 218
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 7e-20
Identities = 48/204 (23%), Positives = 85/204 (41%), Gaps = 34/204 (16%)
Query: 437 KLGEGGFGPVYKGK-LADEQEVAIK--RLSRSSGQGIVEFKNEVRLIAKLQHT-NLVRLL 492
+LG G F V + + QE A K + R E +E+ ++ + ++ L
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 493 GCSLHGEERLLVYEFMP---------NKSLDFFLFNSGRKNVLNWEKRFI-IIEGISQGL 542
+ E +L+ E+ + + E I +I+ I +G+
Sbjct: 96 EVYENTSEIILILEYAAGGEIFSLCLPELAEMVS-----------ENDVIRLIKQILEGV 144
Query: 543 LYLHKYSRLRVIHRDLKASNILLDDK---MNPKISDFGMARIFEVNESEANTKRIVGTYG 599
YLH+ ++H DLK NILL + KI DFGM+R + I+GT
Sbjct: 145 YYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE---LREIMGTPE 198
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVL 623
Y++PE ++ TD+++ G++
Sbjct: 199 YLAPEILNYDPITTATDMWNIGII 222
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 8e-20
Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 38/209 (18%)
Query: 437 KLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVE---------FKNEVRLIAKL-QH 485
LG G V + +E A+K + + G EV ++ K+ H
Sbjct: 24 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 486 TNLVRLLGC-----SLHGEERLLVYEFMPNKSL-DFFLFNSGRKNVLNWEKRFIIIEGIS 539
N+++L LV++ M L D+ K L+ ++ I+ +
Sbjct: 84 PNIIQLKDTYETNTFFF-----LVFDLMKKGELFDYLT----EKVTLSEKETRKIMRALL 134
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
+ + LHK L ++HRDLK NILLDD MN K++DFG + + E + + GT
Sbjct: 135 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPS 188
Query: 600 YMSPEYAMSGIVSIKT------DVFSFGV 622
Y++PE + D++S GV
Sbjct: 189 YLAPEIIECSMNDNHPGYGKEVDMWSTGV 217
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 9e-20
Identities = 54/256 (21%), Positives = 98/256 (38%), Gaps = 49/256 (19%)
Query: 402 GKRKSPEKDQSIS---HELKIFDFQTIAAAANNFSTTN---------KLGEGGFGPVYKG 449
GKR+ + I+ K+F F + + LG G G V
Sbjct: 95 GKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLA 154
Query: 450 K-LADEQEVAIKRLSRS--------SGQGIVEFKNEVRLIAKLQHTNLVRLLGC----SL 496
++VAI+ +S+ + + E+ ++ KL H ++++
Sbjct: 155 FERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY 214
Query: 497 HGEERLLVYEFMPNKSLDFFLFN--SGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVI 554
+ +V E M L F+ G K + + + + + YLH+ +I
Sbjct: 215 Y-----IVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQ-MLLAVQYLHE---NGII 261
Query: 555 HRDLKASNILLDDKMNP---KISDFGMARIFEVNESEANTKRIVGTYGYMSPE---YAMS 608
HRDLK N+LL + KI+DFG ++I + + GT Y++PE +
Sbjct: 262 HRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGT 318
Query: 609 GIVSIKTDVFSFGVLV 624
+ D +S GV++
Sbjct: 319 AGYNRAVDCWSLGVIL 334
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 1e-19
Identities = 61/243 (25%), Positives = 107/243 (44%), Gaps = 46/243 (18%)
Query: 405 KSPEKDQSISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEV-AIKRLS 463
P D++ ++ F+ + A +G+G FG V + D +++ A+K ++
Sbjct: 2 MPPVFDEN--EDVNFDHFEILRA----------IGKGSFGKVCIVQKNDTKKMYAMKYMN 49
Query: 464 RSSGQGIVEFK------NEVRLIAKLQHTNLVRLLGCSLHGEERL-LVYEFMPNKSLDFF 516
+ VE E++++ L+H LV L S EE + +V + + L +
Sbjct: 50 KQK---CVERNEVRNVFKELQIMQGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYH 105
Query: 517 LFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDF 576
L + + I E + L YL R+IHRD+K NILLD+ + I+DF
Sbjct: 106 LQQNVH--FKEETVKLFICE-LVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDF 159
Query: 577 GMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKT--------DVFSFGVLVLEIV 628
+A + E++ T + GT YM+PE + S + D +S GV E++
Sbjct: 160 NIAAMLP-RETQITT--MAGTKPYMAPE-----MFSSRKGAGYSFAVDWWSLGVTAYELL 211
Query: 629 SGQ 631
G+
Sbjct: 212 RGR 214
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 1e-19
Identities = 52/220 (23%), Positives = 93/220 (42%), Gaps = 35/220 (15%)
Query: 403 KRKSPEKDQSISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKR 461
K QS+ E ++ D+ + + +G G V + A E A+K
Sbjct: 67 KGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKI 126
Query: 462 LSRSSGQGIVE--------FKNEVRLIAKL-QHTNLVRLLGC-----SLHGEERLLVYEF 507
+ ++ + E + E ++ ++ H +++ L+ + LV++
Sbjct: 127 MEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMF-----LVFDL 181
Query: 508 MPNKSLDF-FLFNSGRKNVLNWEK--RFIIIEGISQGLLYLHKYSRLRVIHRDLKASNIL 564
M L F +L + EK R I+ + + + +LH ++HRDLK NIL
Sbjct: 182 MRKGEL-FDYLTEKVALS----EKETRSIMRS-LLEAVSFLHA---NNIVHRDLKPENIL 232
Query: 565 LDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPE 604
LDD M ++SDFG + E E + + GT GY++PE
Sbjct: 233 LDDNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPE 269
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 48/212 (22%), Positives = 79/212 (37%), Gaps = 58/212 (27%)
Query: 437 KLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCS 495
LG G F V+ K + A+K + +S +NE+ ++ K++H N+V L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 496 LHGEERLLVY---------EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEG--------- 537
E Y E LF+ I+ G
Sbjct: 76 ---ESTTHYYLVMQLVSGGE----------LFD------------RILERGVYTEKDASL 110
Query: 538 ----ISQGLLYLHKYSRLRVIHRDLKASNILL---DDKMNPKISDFGMARIFEVNESEAN 590
+ + YLH+ ++HRDLK N+L ++ I+DFG++++ +
Sbjct: 111 VIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ----NGI 163
Query: 591 TKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGV 622
GT GY++PE S D +S GV
Sbjct: 164 MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGV 195
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 49/207 (23%), Positives = 82/207 (39%), Gaps = 33/207 (15%)
Query: 438 LGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQ-HTNLVRLLGCS 495
LGEG V L QE A+K + + G EV ++ + Q H N++ L+
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 496 LHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRF------IIIEGISQGLLYLHKYS 549
+ LV+E M S+ + K + F ++++ ++ L +LH
Sbjct: 81 EEEDRFYLVFEKMRGGSI----LSHIHK-----RRHFNELEASVVVQDVASALDFLHN-- 129
Query: 550 RLRVIHRDLKASNILLDDKMNP---KISDFGMARIFEVNESEANTKR-----IVGTYGYM 601
+ HRDLK NIL + KI DF + ++N + G+ YM
Sbjct: 130 -KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188
Query: 602 SPEYAMSGIVSIKT-----DVFSFGVL 623
+PE + D++S GV+
Sbjct: 189 APEVVEAFSEEASIYDKRCDLWSLGVI 215
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 58/209 (27%), Positives = 93/209 (44%), Gaps = 28/209 (13%)
Query: 438 LGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKN------EVRLIAKL----QHT 486
LG+GGFG V+ G L D +VAIK + R+ G + EV L+ K+ H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 487 NLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFI---IIEGISQGLL 543
++RLL E +LV E P + D F + + + + R ++ I
Sbjct: 99 GVIRLLDWFETQEGFMLVLER-PLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQ---- 153
Query: 544 YLHKYSRLRVIHRDLKASNILLDDKMNP-KISDFGMARIFEVNESEANTKRIVGTYGYMS 602
+ H V+HRD+K NIL+D + K+ DFG + + GT Y
Sbjct: 154 HCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH----DEPYTDFDGTRVYSP 206
Query: 603 PEY-AMSGIVSIKTDVFSFGVLVLEIVSG 630
PE+ + ++ V+S G+L+ ++V G
Sbjct: 207 PEWISRHQYHALPATVWSLGILLYDMVCG 235
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 3e-19
Identities = 58/221 (26%), Positives = 93/221 (42%), Gaps = 60/221 (27%)
Query: 438 LGEGGFGPVYKGK-LADEQEVAIKRLSRSS--GQGIVE-FKNEVRLIAKLQHTNLVRLLG 493
LG G FG V G+ +VA+K L+R +V K E++ + +H ++++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL-- 76
Query: 494 CSLHGEERLLVYEFMPNKSLDFF---------LFN----SGRKNVLNWEK---RFI--II 535
Y+ + + F LF+ GR E R I+
Sbjct: 77 -----------YQVISTPTDFFMVMEYVSGGELFDYICKHGRVE----EMEARRLFQQIL 121
Query: 536 EGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIV 595
+ Y H R V+HRDLK N+LLD MN KI+DFG++ + E +
Sbjct: 122 SAVD----YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---FLRTSC 171
Query: 596 GTYGYMSPE------YAMSGIVSIKTDVFSFGVLVLEIVSG 630
G+ Y +PE YA + D++S GV++ ++ G
Sbjct: 172 GSPNYAAPEVISGRLYAGP-----EVDIWSCGVILYALLCG 207
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 4e-19
Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 33/215 (15%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEV-AIKRLSRSSGQGIVEFK------NEVRLIAK 482
+ F LG G FG V K + A+K L + +V+ K NE R++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK---VVKLKQIEHTLNEKRILQA 97
Query: 483 LQHTNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQG 541
+ LV+L S L +V E++ + L GR + RF + I
Sbjct: 98 VNFPFLVKLE-FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARFYAAQ-IVLT 153
Query: 542 LLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYM 601
YLH +I+RDLK N+L+D + +++DFG A+ + T + GT +
Sbjct: 154 FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEAL 205
Query: 602 SPEYAMSGIVSIK-----TDVFSFGVLVLEIVSGQ 631
+PE I+ K D ++ GVL+ E+ +G
Sbjct: 206 APE-----IILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 6e-19
Identities = 58/216 (26%), Positives = 94/216 (43%), Gaps = 51/216 (23%)
Query: 438 LGEGGFGPVYKGK-LADEQEVAIKRLSRS--SGQGIVE-FKNEVRLIAKLQHTNLVRLLG 493
LGEG FG V +Q+VA+K +SR + + E+ + L+H ++++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL-- 74
Query: 494 CSLHGEERLLVYEFMPNKSLDFF--------LFN--SGRKNVLNWEKRFI---IIEGISQ 540
Y+ + + LF+ +K + E R II I
Sbjct: 75 -----------YDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIE- 122
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGY 600
Y H R +++HRDLK N+LLDD +N KI+DFG++ I K G+ Y
Sbjct: 123 ---YCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN---FLKTSCGSPNY 173
Query: 601 MSPE------YAMSGIVSIKTDVFSFGVLVLEIVSG 630
+PE YA + DV+S G+++ ++ G
Sbjct: 174 AAPEVINGKLYAGP-----EVDVWSCGIVLYVMLVG 204
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 48/207 (23%), Positives = 81/207 (39%), Gaps = 37/207 (17%)
Query: 437 KLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVE--------FKNEVRLIAKLQHTN 487
LG G G V ++VAIK +S+ + E+ ++ KL H
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 488 LVRLLGC----SLHGEERLLVYEFMPNKSLDFFLFN--SGRKNVLNWEKRFIIIEGISQG 541
++++ + +V E M L F+ G K + + + +
Sbjct: 77 IIKIKNFFDAEDYY-----IVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQ-MLLA 126
Query: 542 LLYLHKYSRLRVIHRDLKASNILLDDK---MNPKISDFGMARIFEVNESEANTKRIVGTY 598
+ YLH +IHRDLK N+LL + KI+DFG ++I + + GT
Sbjct: 127 VQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCGTP 180
Query: 599 GYMSPE---YAMSGIVSIKTDVFSFGV 622
Y++PE + + D +S GV
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGV 207
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 2e-18
Identities = 46/180 (25%), Positives = 80/180 (44%), Gaps = 26/180 (14%)
Query: 437 KLGEGGFGPVYKGK-LADEQEVAIKRLSRS--SGQGIVEFKNEVRLIAKLQHTNLVRLLG 493
+LG+G F V + + QE A ++ S + + + E R+ L+H N+VRL
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 494 C-----SLHGEERLLVYEFMPNKSLDFFLFNS-GRKNVLNWEKRFIIIEGISQGLLYLHK 547
+ L+++ + L F + + I+ I + +L+ H+
Sbjct: 78 SISEEGHHY-----LIFDLVTGGEL----FEDIVAREYYSEADASHCIQQILEAVLHCHQ 128
Query: 548 YSRLRVIHRDLKASNILLDDKMNP---KISDFGMARIFEVNESEANTKRIVGTYGYMSPE 604
+ V+HR+LK N+LL K+ K++DFG+A E + GT GY+SPE
Sbjct: 129 ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FAGTPGYLSPE 183
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 3e-18
Identities = 52/242 (21%), Positives = 97/242 (40%), Gaps = 33/242 (13%)
Query: 403 KRKSPEKDQSISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEV-AIKR 461
+ P + L DF+ + +G G FG V KL + +V A+K
Sbjct: 57 EWAKPFTSKVKQMRLHREDFEILKV----------IGRGAFGEVAVVKLKNADKVFAMKI 106
Query: 462 LSRSSGQGIVE------FKNEVRLIAKLQHTNLVRLLGCSLHGEERL-LVYEFMPNKSLD 514
L++ +++ F+ E ++ + L + + L LV ++ L
Sbjct: 107 LNKWE---MLKRAETACFREERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDL- 161
Query: 515 FFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKIS 574
L + + RF + E + + +H+ L +HRD+K NIL+D + +++
Sbjct: 162 LTLLSKFEDRLPEEMARFYLAE-MVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLA 217
Query: 575 DFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKT-----DVFSFGVLVLEIVS 629
DFG + + + VGT Y+SPE + D +S GV + E++
Sbjct: 218 DFGSCLKL-MEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLY 276
Query: 630 GQ 631
G+
Sbjct: 277 GE 278
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 4e-18
Identities = 56/244 (22%), Positives = 97/244 (39%), Gaps = 35/244 (14%)
Query: 403 KRKSPEKDQSISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEV-AIKR 461
+ P + L+ DF+ + +G G F V K+ +V A+K
Sbjct: 44 QWAEPIVVRLKEVRLQRDDFEILKV----------IGRGAFSEVAVVKMKQTGQVYAMKI 93
Query: 462 LSRSSGQGIVE------FKNEVRLIAKLQHTNLVRLLGCSLHGEERL-LVYEFMPNKSLD 514
+++ +++ F+ E ++ + +L + E L LV E+ L
Sbjct: 94 MNKWD---MLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLL 149
Query: 515 FFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKIS 574
L G + RF + E I + +H+ L +HRD+K NILLD + +++
Sbjct: 150 TLLSKFGERIPAEM-ARFYLAE-IVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLA 204
Query: 575 DFGMARIFEVNESEANTKRIVGTYGYMSPE--YAMSGIVSIKT-----DVFSFGVLVLEI 627
DFG + + VGT Y+SPE A+ G + D ++ GV E+
Sbjct: 205 DFGSCLKLRADG-TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEM 263
Query: 628 VSGQ 631
GQ
Sbjct: 264 FYGQ 267
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 5e-18
Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 60/221 (27%)
Query: 438 LGEGGFGPVYKGK-LADEQEVAIKRLSRS---SGQGIVEFKNEVRLIAKLQHTNLVRLLG 493
LG G FG V GK +VA+K L+R S + + + E++ + +H ++++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL-- 81
Query: 494 CSLHGEERLLVYEFMPNKSLDFF---------LFN----SGRKNVLNWEK---RFI--II 535
Y+ + S F LF+ +GR + EK R I+
Sbjct: 82 -----------YQVISTPSDIFMVMEYVSGGELFDYICKNGRLD----EKESRRLFQQIL 126
Query: 536 EGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIV 595
G+ Y H R V+HRDLK N+LLD MN KI+DFG++ + E +
Sbjct: 127 SGVD----YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---FLRTSC 176
Query: 596 GTYGYMSPE------YAMSGIVSIKTDVFSFGVLVLEIVSG 630
G+ Y +PE YA + D++S GV++ ++ G
Sbjct: 177 GSPNYAAPEVISGRLYA-----GPEVDIWSSGVILYALLCG 212
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 83.7 bits (208), Expect = 1e-17
Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 33/215 (15%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEV-AIKRLSRSSGQGIVEFK------NEVRLIAK 482
+F LG G FG V+ + A+K L + +V K +E +++
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEI---VVRLKQVEHTNDERLMLSI 62
Query: 483 LQHTNLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQG 541
+ H ++R+ + +++ ++ +++ L L S R N +F E +
Sbjct: 63 VTHPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQR--FPNPVAKFYAAE-VCLA 118
Query: 542 LLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYM 601
L YLH +I+RDLK NILLD + KI+DFG A+ T + GT Y+
Sbjct: 119 LEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYI 170
Query: 602 SPEYAMSGIVSIK-----TDVFSFGVLVLEIVSGQ 631
+PE +VS K D +SFG+L+ E+++G
Sbjct: 171 APE-----VVSTKPYNKSIDWWSFGILIYEMLAGY 200
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 1e-17
Identities = 64/263 (24%), Positives = 104/263 (39%), Gaps = 40/263 (15%)
Query: 381 LCYVTWRKLKAKDNVSLLPTYGKRKSPEKDQSISHELKIFDFQTIAAAANNFSTTNKLGE 440
L + RK K DN + R ++ +K D++ + +G
Sbjct: 36 LDFPALRKNKNIDN------FLSRYKDTINKIRDLRMKAEDYEVVKV----------IGR 79
Query: 441 GGFGPVYKGKLADEQEV-AIKRLSRSSGQGIVE------FKNEVRLIAKLQHTNLVRLLG 493
G FG V + ++V A+K LS+ +++ F E ++A +V+L
Sbjct: 80 GAFGEVQLVRHKSTRKVYAMKLLSKFE---MIKRSDSAFFWEERDIMAFANSPWVVQLF- 135
Query: 494 CSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLR 552
+ + L +V E+MP L L ++ V RF E + L +H +
Sbjct: 136 YAFQDDRYLYMVMEYMPGGDL-VNLMSNYD--VPEKWARFYTAE-VVLALDAIHS---MG 188
Query: 553 VIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVS 612
IHRD+K N+LLD + K++DFG VGT Y+SPE S
Sbjct: 189 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGD 247
Query: 613 IK----TDVFSFGVLVLEIVSGQ 631
D +S GV + E++ G
Sbjct: 248 GYYGRECDWWSVGVFLYEMLVGD 270
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 84.2 bits (208), Expect = 1e-17
Identities = 48/175 (27%), Positives = 80/175 (45%), Gaps = 31/175 (17%)
Query: 538 ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT 597
+++G+ +L + + IHRDL A NILL +K KI DFG+AR ++ + ++
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR--DIYKDPDYVRKGDAR 256
Query: 598 --YGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLS 654
+M+PE + +I++DV+SFGVL+ EI S G +P ++ + L
Sbjct: 257 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA----SPYPGVKIDEEFC--RRLK 310
Query: 655 DGKGLELIDPSLEQP--CSAN--EVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
+G + P + + M C + RPT E+V L N
Sbjct: 311 EGT-------RMRAPDYTTPEMYQTML------DCWHGEPSQRPTFSELVEHLGN 352
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 35/168 (20%), Positives = 61/168 (36%), Gaps = 19/168 (11%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKL------ADEQEVAIKRLSRSSGQG-IVEFKNEVRLIAK 482
+ LG G FG V + A + VA+K L + +E++++
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 483 L-QHTNLVRLLG-CSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQ 540
+ H N+V LLG C+ G +++ EF +L +L KR + ++
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTK 131
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE 588
G + + I DLK + + S F + E E
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 1e-17
Identities = 49/248 (19%), Positives = 100/248 (40%), Gaps = 59/248 (23%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGKLADEQE-VAIKRLSRSSGQGIVEFKN-EVRLIAKLQHT 486
+ +S LG G FG V + + + A+K++ + +KN E+ ++ L H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-----RYKNRELDIMKVLDHV 60
Query: 487 NLVRLLGC-------------------------------------SLHGEERL-LVYEFM 508
N+++L+ + + L ++ E++
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 509 P---NKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILL 565
P +K L F +++ I + + + + ++H L + HRD+K N+L+
Sbjct: 121 PDTLHKVLKSF--IRSGRSIPMNLISIYIYQ-LFRAVGFIHS---LGICHRDIKPQNLLV 174
Query: 566 DDKMNP-KISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIV-SIKTDVFSFGVL 623
+ K N K+ DFG A+ SE + I + Y +PE + + D++S G +
Sbjct: 175 NSKDNTLKLCDFGSAKKL--IPSEPSVAYICSRF-YRAPELMLGATEYTPSIDLWSIGCV 231
Query: 624 VLEIVSGQ 631
E++ G+
Sbjct: 232 FGELILGK 239
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 43/181 (23%), Positives = 73/181 (40%), Gaps = 30/181 (16%)
Query: 436 NKLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKL-QHTNLVRLLG 493
+G G + + A E A+K + +S + E+ ++ + QH N++ L
Sbjct: 28 EDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK----RDPTEEIEILLRYGQHPNIITLKD 83
Query: 494 CSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRF------IIIEGISQGLLYLHK 547
G+ +V E M L + + +K F ++ I++ + YLH
Sbjct: 84 VYDDGKYVYVVTELMKGGEL----LDKILR-----QKFFSEREASAVLFTITKTVEYLHA 134
Query: 548 YSRLRVIHRDLKASNILLDDKMNP----KISDFGMARIFEVNESEANTKRIVGTYGYMSP 603
V+HRDLK SNIL D+ +I DFG A+ T T +++P
Sbjct: 135 ---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT--PCYTANFVAP 189
Query: 604 E 604
E
Sbjct: 190 E 190
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 4e-17
Identities = 50/197 (25%), Positives = 87/197 (44%), Gaps = 29/197 (14%)
Query: 437 KLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCS 495
+LG G VY+ K ++ A+K L ++ + IV + E+ ++ +L H N+++L
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIV--RTEIGVLLRLSHPNIIKLKE-- 115
Query: 496 LHGEERLLVYEFMPNKSLDFFLFNSG-------RKNVLNWEKRFIIIEGISQGLLYLHKY 548
++E SL L G K + ++ I + + YLH+
Sbjct: 116 --------IFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHE- 166
Query: 549 SRLRVIHRDLKASNILLDDKMNP---KISDFGMARIFEVNESEANTKRIVGTYGYMSPEY 605
++HRDLK N+L KI+DFG+++I E K + GT GY +PE
Sbjct: 167 --NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGTPGYCAPEI 221
Query: 606 AMSGIVSIKTDVFSFGV 622
+ D++S G+
Sbjct: 222 LRGCAYGPEVDMWSVGI 238
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 6e-17
Identities = 56/211 (26%), Positives = 84/211 (39%), Gaps = 58/211 (27%)
Query: 438 LGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAKLQHTNLVRLLGCS 495
+G G FG + ++ VA+K + R G I E + E+ L+H N+VR
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDENVQREIINHRSLRHPNIVRF---- 81
Query: 496 LHGEERLLVYEFMPNKSLDFF---------LF----NSGRKNVLNWEKRFI---IIEGIS 539
E + + L+ N+GR + E RF ++ G+S
Sbjct: 82 ---------KEVILTPTHLAIIMEYASGGELYERICNAGRFSED--EARFFFQQLLSGVS 130
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDK--MNPKISDFGMARIFEVNESEANTKRIVGT 597
Y H +++ HRDLK N LLD KI DFG ++ ++ K VGT
Sbjct: 131 ----YCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGT 180
Query: 598 YGYMSPE------YAMSGIVSIKTDVFSFGV 622
Y++PE Y DV+S GV
Sbjct: 181 PAYIAPEVLLRQEYD-----GKIADVWSCGV 206
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 7e-17
Identities = 62/267 (23%), Positives = 103/267 (38%), Gaps = 43/267 (16%)
Query: 401 YGKRKSPEKDQSISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGK-LADEQEVAI 459
Y KS +Q S E+ + + +G G G V ++ VAI
Sbjct: 37 YNMSKSKVDNQFYSVEV----GDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAI 92
Query: 460 KRLSRSSGQGIVEFKN---------EVRLIAKLQHTNLVRLLGCSLHGEERL------LV 504
K+LSR F+N E+ L+ + H N++ LL + LV
Sbjct: 93 KKLSRP-------FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLV 145
Query: 505 YEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNIL 564
E M L + + + +++ + + G+ +LH +IHRDLK SNI+
Sbjct: 146 MELMDAN-----LCQVIQMELDHERMSYLLYQ-MLCGIKHLHS---AGIIHRDLKPSNIV 196
Query: 565 LDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLV 624
+ KI DFG+AR S T V T Y +PE + D++S G ++
Sbjct: 197 VKSDCTLKILDFGLARTAG--TSFMMTPY-VVTRYYRAPEVILGMGYKENVDIWSVGCIM 253
Query: 625 LEIVSGQK----NHTRHHPDRPLNLIG 647
E+V + ++ + +G
Sbjct: 254 GEMVRHKILFPGRDYIDQWNKVIEQLG 280
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 9e-17
Identities = 47/202 (23%), Positives = 78/202 (38%), Gaps = 34/202 (16%)
Query: 437 KLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQ-HTNLVRLLGC 494
LG G G V + Q+ A+K L S + + EV + ++V +L
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYDSP-----KARQEVDHHWQASGGPHIVCILDV 90
Query: 495 ---SLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRF------IIIEGISQGLLY 544
HG+ L ++ E M L F+ + ++ F I+ I + +
Sbjct: 91 YENMHHGKRCLLIIMECMEGGEL----FS---RIQERGDQAFTEREAAEIMRDIGTAIQF 143
Query: 545 LHKYSRLRVIHRDLKASNILLDDK---MNPKISDFGMARIFEVNESEANTKRIVGTYGYM 601
LH + HRD+K N+L K K++DFG A+ N + T Y+
Sbjct: 144 LHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA----LQTPCYTPYYV 196
Query: 602 SPEYAMSGIVSIKTDVFSFGVL 623
+PE D++S GV+
Sbjct: 197 APEVLGPEKYDKSCDMWSLGVI 218
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 1e-16
Identities = 61/262 (23%), Positives = 105/262 (40%), Gaps = 41/262 (15%)
Query: 406 SPEKDQSISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSR 464
S K + + ++I D + + +G G G V E+ VAIK+LSR
Sbjct: 3 SRSKRDNNFYSVEIGD--STFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR 60
Query: 465 SSGQGIVEFKN---------EVRLIAKLQHTNLVRLL------GCSLHGEERLLVYEFMP 509
F+N E+ L+ + H N++ LL ++ +V E M
Sbjct: 61 P-------FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM- 112
Query: 510 NKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKM 569
D L + + + +++ + + G+ +LH +IHRDLK SNI++
Sbjct: 113 ----DANLCQVIQMELDHERMSYLLYQ-MLCGIKHLHSAG---IIHRDLKPSNIVVKSDC 164
Query: 570 NPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS 629
KI DFG+AR S T V T Y +PE + D++S G ++ E++
Sbjct: 165 TLKILDFGLARTAG--TSFMMTPY-VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIK 221
Query: 630 GQK----NHTRHHPDRPLNLIG 647
G ++ + +G
Sbjct: 222 GGVLFPGTDHIDQWNKVIEQLG 243
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 1e-16
Identities = 66/241 (27%), Positives = 100/241 (41%), Gaps = 35/241 (14%)
Query: 402 GKRKSPEKDQSISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEV-AIK 460
G + H + + +F+ + LG+G FG V K A+K
Sbjct: 130 GAEEMEVSLAKPKHRVTMNEFEYLKL----------LGKGTFGKVILVKEKATGRYYAMK 179
Query: 461 RLSRSSGQGIVEFKNEV-------RLIAKLQHTNLVRLLGCSLHGEERL-LVYEFMPNKS 512
L + IV K+EV R++ +H L L S +RL V E+
Sbjct: 180 ILKKEV---IVA-KDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGE 234
Query: 513 LDFFLFNSGRKNVLNWEKR--FIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMN 570
L F L + E R F E +S L YLH S V++RDLK N++LD +
Sbjct: 235 LFFHLSRERVFS----EDRARFYGAEIVS-ALDYLH--SEKNVVYRDLKLENLMLDKDGH 287
Query: 571 PKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG 630
KI+DFG+ + E + A K GT Y++PE D + GV++ E++ G
Sbjct: 288 IKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 345
Query: 631 Q 631
+
Sbjct: 346 R 346
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 50/198 (25%), Positives = 78/198 (39%), Gaps = 28/198 (14%)
Query: 437 KLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQ-HTNLVRLLGC 494
LGEG F K Q A+K +S+ + E+ + + H N+V+L
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANT---QKEITALKLCEGHPNIVKLHEV 74
Query: 495 SLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRF------IIIEGISQGLLYLHKY 548
LV E + L F +K +K F I+ + + ++H
Sbjct: 75 FHDQLHTFLVMELLNGGEL----FERIKK-----KKHFSETEASYIMRKLVSAVSHMHD- 124
Query: 549 SRLRVIHRDLKASNILLDDKMNP---KISDFGMARIFEVNESEANTKRIVGTYGYMSPEY 605
+ V+HRDLK N+L D+ + KI DFG AR+ + T T Y +PE
Sbjct: 125 --VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTLHYAAPEL 180
Query: 606 AMSGIVSIKTDVFSFGVL 623
D++S GV+
Sbjct: 181 LNQNGYDESCDLWSLGVI 198
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 2e-16
Identities = 45/225 (20%), Positives = 93/225 (41%), Gaps = 41/225 (18%)
Query: 403 KRKSPEKDQSISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKR 461
+++ + S D+Q + + + +G G +G V + +++ VAIK+
Sbjct: 30 RKQHHSSKPTASMPRPHSDWQI----PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKK 85
Query: 462 LSRSSGQGIVEFKN---------EVRLIAKLQHTNLVRLL----GCSLHGEERL-LVYEF 507
+ R F++ E+ ++ +L H ++V++L + + L +V E
Sbjct: 86 ILR-------VFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEI 138
Query: 508 MP---NKSLDFFLFNSGRKNVLNWE-KRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNI 563
K LF + L + ++ + G+ Y+H S ++HRDLK +N
Sbjct: 139 ADSDFKK-----LFRTPVY--LTELHIKTLLYN-LLVGVKYVH--SA-GILHRDLKPANC 187
Query: 564 LLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMS 608
L++ + K+ DFG+AR + E+ + I M+
Sbjct: 188 LVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPH 232
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 5e-16
Identities = 47/203 (23%), Positives = 83/203 (40%), Gaps = 35/203 (17%)
Query: 437 KLGEGGFGPVYKG-KLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQ-HTNLVRLLGC 494
LG G G V + +++ A+K L + + EV L + ++VR++
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKMLQDCP-----KARREVELHWRASQCPHIVRIVDV 123
Query: 495 ---SLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRF------IIIEGISQGLLY 544
G + L +V E + L F+ + ++ F I++ I + + Y
Sbjct: 124 YENLYAGRKCLLIVMECLDGGEL----FS---RIQDRGDQAFTEREASEIMKSIGEAIQY 176
Query: 545 LHKYSRLRVIHRDLKASNILLDDKMNP----KISDFGMARIFEVNESEANTKRIVGTYGY 600
LH + + HRD+K N+L K P K++DFG A+ + S T Y
Sbjct: 177 LHS---INIAHRDVKPENLLYTSK-RPNAILKLTDFGFAKETTSHNS---LTTPCYTPYY 229
Query: 601 MSPEYAMSGIVSIKTDVFSFGVL 623
++PE D++S GV+
Sbjct: 230 VAPEVLGPEKYDKSCDMWSLGVI 252
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 5e-16
Identities = 56/240 (23%), Positives = 98/240 (40%), Gaps = 32/240 (13%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVE--FKN---------EVR 478
+ ++ + G +G V G ++ VAIKR+ + G + E+R
Sbjct: 22 SPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIR 81
Query: 479 LIAKLQHTNLVRLLGCSLHGEERL-----LVYEFMPNKSLDFF-LFNSGRKNVLNWEKRF 532
L+ H N++ L +H EE LV E M D + + R + ++
Sbjct: 82 LLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT---DLAQVIHDQRIVISPQHIQY 138
Query: 533 IIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTK 592
+ I GL LH+ V+HRDL NILL D + I DF +AR + N
Sbjct: 139 FMYH-ILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADA---NKT 191
Query: 593 RIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQK----NHTRHHPDRPLNLIG 647
V Y +PE M + D++S G ++ E+ + + + + ++ + ++G
Sbjct: 192 HYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVG 251
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 6e-16
Identities = 59/211 (27%), Positives = 90/211 (42%), Gaps = 38/211 (18%)
Query: 438 LGEGGFGPVYKGKLADEQEV-AIKRLSRSSGQGIVEFKNEV-------RLIAKLQHTNLV 489
LG+G FG V + A+K L + I+ K+EV R++ +H L
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEV---IIA-KDEVAHTVTESRVLQNTRHPFLT 68
Query: 490 RLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKR--FIIIEGISQGLLYLH 546
L + +RL V E+ L F L E+R F E I L YLH
Sbjct: 69 ALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFT----EERARFYGAE-IVSALEYLH 122
Query: 547 KYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPE-- 604
V++RD+K N++LD + KI+DFG+ + E A K GT Y++PE
Sbjct: 123 S---RDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVL 177
Query: 605 ----YAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
Y + D + GV++ E++ G+
Sbjct: 178 EDNDYGRA------VDWWGLGVVMYEMMCGR 202
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 22/213 (10%), Positives = 53/213 (24%), Gaps = 45/213 (21%)
Query: 437 KLGEGGFGPVYKGKLADEQ---EVAIKRLSRSSG---QGIVEFKNEVRLIAKLQHTNLVR 490
G ++ D +VA+ + + E + ++++ + R
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 491 LLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSR 550
+L L+V E++ SL + ++ ++ H R
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAADAAH---R 147
Query: 551 LRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGI 610
V S + +S G + M
Sbjct: 148 AGVALSIDHPSRVR--------VSIDGDVV--------------LAYPATMPD------- 178
Query: 611 VSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPL 643
+ + D+ G + ++ + L
Sbjct: 179 ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL 211
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 67/251 (26%), Positives = 108/251 (43%), Gaps = 49/251 (19%)
Query: 399 PTYGKRKSPEKDQSISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEV- 457
P ++ + S+ L I +F+ I LG+G FG V ++ + ++
Sbjct: 2 PKESSKEGNGIGVNSSNRLGIDNFEFIRV----------LGKGSFGKVMLARVKETGDLY 51
Query: 458 AIKRLSRSSGQGIVEFKNEVR--------LIAKLQHTNLVRLLGCSLHGEERL-LVYEFM 508
A+K L + I++ ++V L H L +L C +RL V EF+
Sbjct: 52 AVKVLKKDV---ILQ-DDDVECTMTEKRILSLARNHPFLTQLF-CCFQTPDRLFFVMEFV 106
Query: 509 PNKSLDFFLFNSGRKNVLNWEKR--FIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLD 566
L F + S R + E R F E I L++LH +I+RDLK N+LLD
Sbjct: 107 NGGDLMFHIQKSRRFD----EARARFYAAE-IISALMFLHD---KGIIYRDLKLDNVLLD 158
Query: 567 DKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPE------YAMSGIVSIKTDVFSF 620
+ + K++DFGM + N T GT Y++PE Y + D ++
Sbjct: 159 HEGHCKLADFGMCKEGICNGVTTAT--FCGTPDYIAPEILQEMLYGPA------VDWWAM 210
Query: 621 GVLVLEIVSGQ 631
GVL+ E++ G
Sbjct: 211 GVLLYEMLCGH 221
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 1e-15
Identities = 59/213 (27%), Positives = 109/213 (51%), Gaps = 40/213 (18%)
Query: 438 LGEGGFGPVY---KGKLADEQEV-AIKRLSRSSGQGIVEFKNEV------RLIAKLQHTN 487
LG+G FG V+ K +D +++ A+K L +++ + ++ V ++ ++ H
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKAT---LKV-RDRVRTKMERDILVEVNHPF 87
Query: 488 LVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEK--RFIIIEGISQGLLY 544
+V+L + E +L L+ +F+ L L E+ +F + E ++ L +
Sbjct: 88 IVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFT----EEDVKFYLAE-LALALDH 141
Query: 545 LHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPE 604
LH L +I+RDLK NILLD++ + K++DFG+++ +E +A + GT YM+PE
Sbjct: 142 LHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPE 196
Query: 605 ------YAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
+ S D +SFGVL+ E+++G
Sbjct: 197 VVNRRGHTQS------ADWWSFGVLMFEMLTGT 223
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 56/239 (23%), Positives = 100/239 (41%), Gaps = 42/239 (17%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKN---------EVRL 479
+ + +G G +G V ++VAIK+LSR F++ E+ L
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP-------FQSEIFAKRAYRELLL 76
Query: 480 IAKLQHTNLVRLLGCSLHGEERL------LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFI 533
+ +QH N++ LL LV FM D L + +++
Sbjct: 77 LKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT---D--LQKIMGLKFSEEKIQYL 131
Query: 534 IIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKR 593
+ + + +GL Y+H V+HRDLK N+ +++ KI DFG+AR + +
Sbjct: 132 VYQ-MLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG----- 182
Query: 594 IVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQK----NHTRHHPDRPLNLIG 647
V T Y +PE +S + D++S G ++ E+++G+ + L + G
Sbjct: 183 YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG 241
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 2e-15
Identities = 54/214 (25%), Positives = 101/214 (47%), Gaps = 40/214 (18%)
Query: 438 LGEGGFGPVY---KGKLADEQEV-AIKRLSRSSGQGIVEFKNEV-------RLIAKLQHT 486
LG+GG+G V+ K A+ ++ A+K L ++ IV + ++ +++H
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAM---IVRNAKDTAHTKAERNILEEVKHP 81
Query: 487 NLVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEK--RFIIIEGISQGLL 543
+V L+ + +L L+ E++ L L G E F + E IS L
Sbjct: 82 FIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFM----EDTACFYLAE-ISMALG 135
Query: 544 YLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSP 603
+LH+ +I+RDLK NI+L+ + + K++DFG+ + + + +T GT YM+P
Sbjct: 136 HLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGTIEYMAP 190
Query: 604 E------YAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
E + + D +S G L+ ++++G
Sbjct: 191 EILMRSGHNRA------VDWWSLGALMYDMLTGA 218
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 4e-15
Identities = 61/246 (24%), Positives = 106/246 (43%), Gaps = 39/246 (15%)
Query: 404 RKSPEKDQSISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEV-AIKRL 462
+P + S ++ + A ++F +G+G FG V + E+ A+K L
Sbjct: 12 NANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVL 71
Query: 463 SRSSGQGIVEFKNEVR--------LIAKLQHTNLVRLLGCSLHGEERL-LVYEFMPNKSL 513
+ + I++ K E + L+ ++H LV L S ++L V +++ L
Sbjct: 72 QKKA---ILK-KKEEKHIMSERNVLLKNVKHPFLVGLH-FSFQTADKLYFVLDYINGGEL 126
Query: 514 DFFLFNSGRKNVLNWEKR--FIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNP 571
+ L E R F E I+ L YLH L +++RDLK NILLD + +
Sbjct: 127 FYHLQRERCFL----EPRARFYAAE-IASALGYLHS---LNIVYRDLKPENILLDSQGHI 178
Query: 572 KISDFGMARIFEVNESEANTKRIVGTYGYMSPE------YAMSGIVSIKTDVFSFGVLVL 625
++DFG+ + E E + T GT Y++PE Y + D + G ++
Sbjct: 179 VLTDFGLCK--ENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRT------VDWWCLGAVLY 230
Query: 626 EIVSGQ 631
E++ G
Sbjct: 231 EMLYGL 236
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 5e-15
Identities = 44/215 (20%), Positives = 92/215 (42%), Gaps = 37/215 (17%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQ-HTN 487
+++ KLG G + V++ + + ++V +K L + + K E++++ L+ N
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPN 92
Query: 488 LVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVL----NWEKRFIIIEGISQGLL 543
++ L R F + DF K + +++ RF + E I + L
Sbjct: 93 IITLADIVKDPVSRTPALVFEHVNNTDF-------KQLYQTLTDYDIRFYMYE-ILKALD 144
Query: 544 YLHKYSRLRVIHRDLKASNILLD-DKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMS 602
Y H S ++HRD+K N+++D + ++ D+G+A + + R+ Y +
Sbjct: 145 YCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH--PGQEYNVRVASRY-FKG 198
Query: 603 PE-------YAMSGIVSIKTDVFSFGVLVLEIVSG 630
PE Y S D++S G ++ ++
Sbjct: 199 PELLVDYQMYDYS------LDMWSLGCMLASMIFR 227
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 5e-15
Identities = 59/264 (22%), Positives = 108/264 (40%), Gaps = 45/264 (17%)
Query: 406 SPEKDQSISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSR 464
SP +S + ++ T + +G G +G V +VAIK+L R
Sbjct: 3 SPPPARSGFYRQEVTK--TAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR 60
Query: 465 SSGQGIVEFKN---------EVRLIAKLQHTNLVRLLGCSLHGEERL------LVYEFMP 509
F++ E+RL+ ++H N++ LL E LV FM
Sbjct: 61 P-------FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM- 112
Query: 510 NKSLDFFLFNSGRKNVLNWE-KRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDK 568
L + L + +F++ + + +GL Y+H +IHRDLK N+ +++
Sbjct: 113 ----GTDLGKLMKHEKLGEDRIQFLVYQ-MLKGLRYIHAAG---IIHRDLKPGNLAVNED 164
Query: 569 MNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEI 627
KI DFG+AR + + V T Y +PE ++ + D++S G ++ E+
Sbjct: 165 CELKILDFGLARQADSEMTGY-----VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEM 219
Query: 628 VSGQK----NHTRHHPDRPLNLIG 647
++G+ + + + G
Sbjct: 220 ITGKTLFKGSDHLDQLKEIMKVTG 243
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 6e-15
Identities = 66/245 (26%), Positives = 108/245 (44%), Gaps = 42/245 (17%)
Query: 399 PTYGKRKSPEKDQSISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEV- 457
P K + + + LKI DF LG+G FG V+ + +
Sbjct: 1 PELNKERPSLQIK-----LKIEDFILHKM----------LGKGSFGKVFLAEFKKTNQFF 45
Query: 458 AIKRLSRSSGQGIVEFKNEVR--------LIAKLQHTNLVRLLGCSLHGEERL-LVYEFM 508
AIK L + ++ ++V L +H L + C+ +E L V E++
Sbjct: 46 AIKALKKDV---VLM-DDDVECTMVEKRVLSLAWEHPFLTHMF-CTFQTKENLFFVMEYL 100
Query: 509 PNKSLDFFLFNSGRKNVLNWEKR--FIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLD 566
L + + + + + R F E I GL +LH +++RDLK NILLD
Sbjct: 101 NGGDLMYHIQSCHKFD----LSRATFYAAE-IILGLQFLHS---KGIVYRDLKLDNILLD 152
Query: 567 DKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLE 626
+ KI+DFGM + + +++ NT GT Y++PE + + D +SFGVL+ E
Sbjct: 153 KDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYE 210
Query: 627 IVSGQ 631
++ GQ
Sbjct: 211 MLIGQ 215
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 54/212 (25%), Positives = 90/212 (42%), Gaps = 39/212 (18%)
Query: 438 LGEGGFGPVYKGKLADEQEV-AIKRLSRSSGQGIVEFKNEVR--------LIAKLQHTNL 488
+G G + V +L + A+K + + + + ++ H L
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKEL---VND-DEDIDWVQTEKHVFEQASNHPFL 72
Query: 489 VRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEK--RFIIIEGISQGLLYL 545
V L E RL V E++ L F + + E+ RF E IS L YL
Sbjct: 73 VGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP----EEHARFYSAE-ISLALNYL 126
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPE- 604
H+ +I+RDLK N+LLD + + K++D+GM + +T GT Y++PE
Sbjct: 127 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNYIAPEI 181
Query: 605 -----YAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
Y S D ++ GVL+ E+++G+
Sbjct: 182 LRGEDYGFS------VDWWALGVLMFEMMAGR 207
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 58/252 (23%), Positives = 107/252 (42%), Gaps = 52/252 (20%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKN---------EVR 478
+ + LG GG G V+ ++ VAIK++ + E++
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVKHALREIK 60
Query: 479 LIAKLQHTNLVRLL----------GCSLHGEERL----LVYEFMPNKSLDFFLFNSGRKN 524
+I +L H N+V++ + L +V E+M + L N +
Sbjct: 61 IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVLEQG 115
Query: 525 VLNWE-KRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDK-MNPKISDFGMARIF 582
L E R + + + +GL Y+H + V+HRDLK +N+ ++ + + KI DFG+ARI
Sbjct: 116 PLLEEHARLFMYQ-LLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIM 171
Query: 583 EVNESEAN--TKRIVGTYGYMSPEYAMSGIV-SIKTDVFSFGVLVLEIVSGQK----NHT 635
+ + S ++ +V T Y SP +S + D+++ G + E+++G+ H
Sbjct: 172 DPHYSHKGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE 230
Query: 636 RHHPDRPLNLIG 647
L I
Sbjct: 231 LEQMQLILESIP 242
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-14
Identities = 55/241 (22%), Positives = 110/241 (45%), Gaps = 41/241 (17%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKN---------EVRL 479
++ + +GEG +G V ++ VAIK++S F++ E+++
Sbjct: 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLREIKI 78
Query: 480 IAKLQHTNLVRLLGCSLHGEERL-----LVYEFMPNKSLDFFLFNSGRKNVLNWE-KRFI 533
+ + +H N++ + +V + M + L+ + L+ + +
Sbjct: 79 LLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICYF 133
Query: 534 IIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEAN--T 591
+ + I +GL Y+H S V+HRDLK SN+LL+ + KI DFG+AR+ + + T
Sbjct: 134 LYQ-ILRGLKYIH--SA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189
Query: 592 KRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQK----NHTRHHPDRPLNLI 646
+ V T Y +PE ++ + D++S G ++ E++S + H + L ++
Sbjct: 190 EY-VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 248
Query: 647 G 647
G
Sbjct: 249 G 249
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 76.2 bits (187), Expect = 2e-14
Identities = 61/212 (28%), Positives = 96/212 (45%), Gaps = 39/212 (18%)
Query: 438 LGEGGFGPVYKGKLADEQEV-AIKRLSRSSGQGIVEFKNEVR--------LIAKLQHTNL 488
LG+G FG V + E+ A+K L + +++ ++V L + L
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDV---VIQ-DDDVECTMVEKRVLALPGKPPFL 404
Query: 489 VRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKR--FIIIEGISQGLLYL 545
+L C +RL V E++ L + + GR E F E I+ GL +L
Sbjct: 405 TQLHSCF-QTMDRLYFVMEYVNGGDLMYHIQQVGRFK----EPHAVFYAAE-IAIGLFFL 458
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPE- 604
+I+RDLK N++LD + + KI+DFGM + E TK GT Y++PE
Sbjct: 459 QS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKTFCGTPDYIAPEI 513
Query: 605 -----YAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
Y S D ++FGVL+ E+++GQ
Sbjct: 514 IAYQPYGKS------VDWWAFGVLLYEMLAGQ 539
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 58/212 (27%), Positives = 94/212 (44%), Gaps = 39/212 (18%)
Query: 438 LGEGGFGPVYKGKLADEQEV-AIKRLSRSSGQGIVEFKNEVR--------LIAKLQHTNL 488
LG+G FG V + E+ A+K L + +++ ++V L + L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDV---VIQ-DDDVECTMVEKRVLALPGKPPFL 83
Query: 489 VRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKR--FIIIEGISQGLLYL 545
+L +RL V E++ L + + GR E F E I+ GL +L
Sbjct: 84 TQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK----EPHAVFYAAE-IAIGLFFL 137
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPE- 604
+I+RDLK N++LD + + KI+DFGM + + T GT Y++PE
Sbjct: 138 QS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGTPDYIAPEI 192
Query: 605 -----YAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
Y S D ++FGVL+ E+++GQ
Sbjct: 193 IAYQPYGKS------VDWWAFGVLLYEMLAGQ 218
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 3e-14
Identities = 53/212 (25%), Positives = 90/212 (42%), Gaps = 39/212 (18%)
Query: 438 LGEGGFGPVYKGKLADEQEV-AIKRLSRSSGQGIVEFKNEVR--------LIAKLQHTNL 488
+G G + V +L + A++ + + + + ++ H L
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKEL---VND-DEDIDWVQTEKHVFEQASNHPFL 115
Query: 489 VRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEK--RFIIIEGISQGLLYL 545
V L E RL V E++ L F + + E+ RF E IS L YL
Sbjct: 116 VGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP----EEHARFYSAE-ISLALNYL 169
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPE- 604
H+ +I+RDLK N+LLD + + K++D+GM + +T GT Y++PE
Sbjct: 170 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNYIAPEI 224
Query: 605 -----YAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
Y S D ++ GVL+ E+++G+
Sbjct: 225 LRGEDYGFS------VDWWALGVLMFEMMAGR 250
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 3e-14
Identities = 47/222 (21%), Positives = 82/222 (36%), Gaps = 37/222 (16%)
Query: 407 PEKDQSISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRS 465
S E F +N+ + +G G +G VY E+ VAIK+++R
Sbjct: 3 HHHHHSSGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM 62
Query: 466 SGQGIVEFKN---------EVRLIAKLQHTNLVRLL-----GCSLHGEERLLVYEFMP-- 509
F++ E+ ++ +L+ ++RL L +E +V E
Sbjct: 63 -------FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSD 115
Query: 510 -NKSLDFFLFNSGRKNVLNWE-KRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDD 567
K LF + L E + I+ + G ++H +IHRDLK +N LL+
Sbjct: 116 LKK-----LFKTP--IFLTEEHIKTILYN-LLLGENFIH--ES-GIIHRDLKPANCLLNQ 164
Query: 568 KMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSG 609
+ K+ DFG+AR + + +
Sbjct: 165 DCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKK 206
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 4e-14
Identities = 60/218 (27%), Positives = 97/218 (44%), Gaps = 44/218 (20%)
Query: 438 LGEGGFGPVY---KGKLADEQEV-AIKRLSRSSGQGIVEFKNEV------RLIAKLQHTN 487
LG G +G V+ K D ++ A+K L +++ IV+ R + L+H
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKAT---IVQKAKTTEHTRTERQV--LEHIR 116
Query: 488 ----LVRLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEK--RFIIIEGISQ 540
LV L + E +L L+ +++ L L R E + + E I
Sbjct: 117 QSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFT----EHEVQIYVGE-IVL 170
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGY 600
L +LHK L +I+RD+K NILLD + ++DFG+++ F V + GT Y
Sbjct: 171 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF-VADETERAYDFCGTIEY 226
Query: 601 MSPEYAMSGIVSIKT-------DVFSFGVLVLEIVSGQ 631
M+P+ IV D +S GVL+ E+++G
Sbjct: 227 MAPD-----IVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 4e-14
Identities = 55/248 (22%), Positives = 103/248 (41%), Gaps = 46/248 (18%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKN---------EVR 478
+++F + LGEG +G V + VAIK++ F E++
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIK 61
Query: 479 LIAKLQHTNLVRLL-----GCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWE-KRF 532
++ +H N++ + + E ++ E M L +L+ + ++
Sbjct: 62 ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-----QTDLHRVISTQMLSDDHIQY 116
Query: 533 IIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTK 592
I + + + LH + VIHRDLK SN+L++ + K+ DFG+ARI + + ++ +
Sbjct: 117 FIYQ-TLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEP 172
Query: 593 RI--------VGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQK----NHTRHHP 639
V T Y +PE ++ S DV+S G ++ E+ + RH
Sbjct: 173 TGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQL 232
Query: 640 DRPLNLIG 647
+IG
Sbjct: 233 LLIFGIIG 240
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 8e-14
Identities = 44/207 (21%), Positives = 78/207 (37%), Gaps = 44/207 (21%)
Query: 429 ANNFSTTNKLGEGGFGPVYKG------KLADEQEVAIKRLSRSSGQGIVEFKNEVRL--- 479
A + +G+GGFG +Y + + +K +G E K R
Sbjct: 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKP 93
Query: 480 --------IAKLQHTNLVRLLGCSLHGEE----RLLVYEFMPNKSL-DFFLFNSGR---K 523
KL++ + + G LH + R ++ + L + N+ R K
Sbjct: 94 EQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRK 152
Query: 524 NVLNWEKRFI-IIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKI--SDFGMAR 580
VL R + I+E Y+H++ +H D+KASN+LL+ K ++ D+G+A
Sbjct: 153 TVLQLSLRILDILE-------YIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
Query: 581 IFEVNES-----EANTKRIVGTYGYMS 602
+ + GT + S
Sbjct: 203 RYCPEGVHKAYAADPKRCHDGTIEFTS 229
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 71.5 bits (174), Expect = 2e-13
Identities = 42/268 (15%), Positives = 75/268 (27%), Gaps = 60/268 (22%)
Query: 412 SISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSS----- 466
+ F K+GEG FG V++ AD VAIK ++
Sbjct: 3 GECSQKGPVPFSHCLPT-EKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVN 60
Query: 467 ---GQGIVEFKNEVRLIAKLQ---------HTNLVRLLGCSL----HGEERLLVYEFM-- 508
+ E E+ + +L + L + L ++
Sbjct: 61 GSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNS 120
Query: 509 ----PNKSLDFF----------------LFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
N DFF R + + I+ ++ L
Sbjct: 121 TKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA- 179
Query: 549 SRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGY--MSPEYA 606
LR HRDL N+LL K+ + + + G +Y
Sbjct: 180 -SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSST-----------IPSCGLQVSIIDYT 227
Query: 607 MSGIVSIKTDVFSFGVLVLEIVSGQKNH 634
+S + VF + ++ +G ++
Sbjct: 228 LSRLERDGIVVFCDVSMDEDLFTGDGDY 255
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 34/207 (16%), Positives = 67/207 (32%), Gaps = 46/207 (22%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK---------LADEQEVAIKRLSRSSGQGIVEFKNEVRLI 480
+ + G +Y+ +Q+ ++K L G+ E R
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAA 100
Query: 481 AKLQHTNLVRLLGCSLHG------------EERLLVYEFMPNKSL-DFFLFNSGR----K 523
LQ +L L + R LV + +SL + +
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSER 159
Query: 524 NVLNWEKRFI-IIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKI--SDFGMAR 580
+VL R + +E +LH+ +H ++ A NI +D + ++ + +G A
Sbjct: 160 SVLQVACRLLDALE-------FLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
Query: 581 IF-----EVNESEANTKRIVGTYGYMS 602
+ V E + G ++S
Sbjct: 210 RYCPSGKHVAYVEGSRSPHEGDLEFIS 236
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 62/240 (25%), Positives = 104/240 (43%), Gaps = 43/240 (17%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKN---------EVRL 479
+ + +G G +G V VA+K+LSR F++ E+RL
Sbjct: 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-------FQSIIHAKRTYRELRL 81
Query: 480 IAKLQHTNLVRLL-----GCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWE-KRF 532
+ ++H N++ LL SL + LV M D L N + L + +F
Sbjct: 82 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA---D--LNNIVKCQKLTDDHVQF 136
Query: 533 IIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTK 592
+I + I +GL Y+H +IHRDLK SN+ +++ KI DFG+AR +
Sbjct: 137 LIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY--- 189
Query: 593 RIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQK----NHTRHHPDRPLNLIG 647
V T Y +PE ++ + D++S G ++ E+++G+ L L+G
Sbjct: 190 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 247
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 3e-13
Identities = 50/188 (26%), Positives = 80/188 (42%), Gaps = 26/188 (13%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTN 487
N + K+G G FG +Y G +A +EVAIK + + E ++ +Q
Sbjct: 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI--ESKIYKMMQGGV 65
Query: 488 LV-RLLGCSLHGEERLLVYEFMPNKSL-DFFLFNSGR---KNVLNWEKRFIIIEGISQGL 542
+ + C G+ ++V E + SL D F F S + K VL + + IS+ +
Sbjct: 66 GIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLL-----LADQMISR-I 118
Query: 543 LYLHKYSRLRVIHRDLKASNILLDDKMNPK---ISDFGMARIFEVNESEA-----NTKRI 594
Y+H + IHRD+K N L+ I DFG+A+ + + K +
Sbjct: 119 EYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL 175
Query: 595 VGTYGYMS 602
GT Y S
Sbjct: 176 TGTARYAS 183
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 6e-13
Identities = 52/217 (23%), Positives = 92/217 (42%), Gaps = 32/217 (14%)
Query: 437 KLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHT--------- 486
KLG G F V+ K + + VA+K + R ++E++L+ ++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 487 --NLVRLLGC-SLHGEERL---LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQ 540
++++LL + G + +V+E + L R L + K+ +
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK--QLLL 142
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDKMNP------KISDFGMARIFEVNESEANTKRI 594
GL Y+H+ R +IH D+K N+L++ +P KI+D G A E T I
Sbjct: 143 GLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW----YDEHYTNSI 196
Query: 595 VGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
T Y SPE + D++S L+ E+++G
Sbjct: 197 Q-TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 70.4 bits (172), Expect = 9e-13
Identities = 48/188 (25%), Positives = 81/188 (43%), Gaps = 26/188 (13%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTN 487
N F K+G G FG +Y G + +EVAIK + + + + E ++ LQ
Sbjct: 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY--ESKIYRILQGGT 63
Query: 488 LV-RLLGCSLHGEERLLVYEFMPNKSL-DFFLFNSGR---KNVLNWEKRFIIIEGISQGL 542
+ + + G+ +LV + + SL D F F S + K VL + + I++ +
Sbjct: 64 GIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLM-----LADQMINR-V 116
Query: 543 LYLHKYSRLRVIHRDLKASNILLDDKMNPK---ISDFGMARIFEVNESEA-----NTKRI 594
++H S +HRD+K N L+ I DFG+A+ + + K +
Sbjct: 117 EFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNL 173
Query: 595 VGTYGYMS 602
GT Y S
Sbjct: 174 TGTARYAS 181
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 9e-13
Identities = 52/190 (27%), Positives = 79/190 (41%), Gaps = 28/190 (14%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTN 487
NF K+G G FG + GK L + VAIK S + E R +L +
Sbjct: 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHL--EYRFYKQLGSGD 65
Query: 488 LV-RLLGCSLHGEERLLVYEFMPNKSL-DFFLFNSGR---KNVLNWEKRFIIIEGISQGL 542
+ ++ G+ +V E + SL D F K VL I I+ IS+ +
Sbjct: 66 GIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLM-----IAIQLISR-M 118
Query: 543 LYLHKYSRLRVIHRDLKASNILLDDKMNPK-----ISDFGMARIFEVNESEA-----NTK 592
Y+H + +I+RD+K N L+ N I DF +A+ + E++ K
Sbjct: 119 EYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHK 175
Query: 593 RIVGTYGYMS 602
+ GT YMS
Sbjct: 176 SLTGTARYMS 185
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 47/187 (25%), Positives = 90/187 (48%), Gaps = 30/187 (16%)
Query: 432 FSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKN---------EVRLIA 481
+ KLG+G +G V+K + VA+K++ + F+N E+ ++
Sbjct: 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-------FQNSTDAQRTFREIMILT 63
Query: 482 KLQ-HTNLVRLLGCSL--HGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWE-KRFIIIEG 537
+L H N+V LL + + LV+++M + L R N+L K++++ +
Sbjct: 64 ELSGHENIVNLLNVLRADNDRDVYLVFDYM-----ETDLHAVIRANILEPVHKQYVVYQ- 117
Query: 538 ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT 597
+ + + YLH S ++HRD+K SNILL+ + + K++DFG++R F N +
Sbjct: 118 LIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSIN 174
Query: 598 YGYMSPE 604
+ +
Sbjct: 175 ENTENFD 181
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 43/191 (22%), Positives = 77/191 (40%), Gaps = 30/191 (15%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTN 487
++ ++GEG FG +++G L + Q+VAIK R S + E R L
Sbjct: 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRD--EYRTYKLLAGCT 66
Query: 488 LV-RLLGCSLHGEERLLVYEFMPNKSL-DFFLFNSGR---KNVLNWEKRFI-IIEGISQG 541
+ + G +LV + + SL D + K V K+ + ++
Sbjct: 67 GIPNVYYFGQEGLHNVLVIDLLG-PSLEDLLDLCGRKFSVKTVAMAAKQMLARVQ----- 120
Query: 542 LLYLHKYSRLRVIHRDLKASNILLDDKMNPK-----ISDFGMARIFEVNESEA-----NT 591
+H+ S +++RD+K N L+ + + DFGM + + ++
Sbjct: 121 --SIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 175
Query: 592 KRIVGTYGYMS 602
K + GT YMS
Sbjct: 176 KNLSGTARYMS 186
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 38/169 (22%), Positives = 66/169 (39%), Gaps = 44/169 (26%)
Query: 437 KLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKL-QHTNLVRLLGC 494
LG G G V + +++ A+K L + + EV L + Q ++VR++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQDCP-----KARREVELHWRASQCPHIVRIVD- 78
Query: 495 SLHGEERLLVYEFMPNKSLDFF----------LFNSGRKNVLNWEKRF------IIIEGI 538
VYE + LF+ + ++ F I++ I
Sbjct: 79 ---------VYENLYAGRKCLLIVMECLDGGELFS---RIQDRGDQAFTEREASEIMKSI 126
Query: 539 SQGLLYLHKYSRLRVIHRDLKASNILLDDK---MNPKISDFGMARIFEV 584
+ + YLH + + HRD+K N+L K K++DFG A+ E
Sbjct: 127 GEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ET 170
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 44/204 (21%), Positives = 77/204 (37%), Gaps = 41/204 (20%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGK-LADEQEVA---IKRLSRSSGQGIVEFKNEVRL----- 479
N + K+G GGFG +Y ++ A +K + +G E K R+
Sbjct: 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDC 95
Query: 480 ------IAKLQHTNLVRLLGCSLH----GEERLLVYEFMPNKSLDFFLFNSGR---KNVL 526
+L + + G L R +V E + L +G VL
Sbjct: 96 IKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVL 154
Query: 527 NWEKRFI-IIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKI--SDFGMARIFE 583
R + ++E Y+H+ +H D+KA+N+LL K ++ +D+G++ +
Sbjct: 155 QLGIRMLDVLE-------YIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYC 204
Query: 584 VNES-----EANTKRIVGTYGYMS 602
N + E K GT + S
Sbjct: 205 PNGNHKQYQENPRKGHNGTIEFTS 228
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 54/216 (25%), Positives = 92/216 (42%), Gaps = 26/216 (12%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGK-LADEQEVAIK---RLSRSSGQGIVEFKNEVRLIAKLQ 484
+ + + +G+G FG V K +++ VAIK Q + EVRL+ +
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA----QIEVRLLELMN 108
Query: 485 HT------NLVRLLGCSLHGEERLLVYEFMPNKSL-DFFLFNSGRKNVLNWEKRFIIIEG 537
+V L + LV+E + + +L D + R LN ++F
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQ--Q 165
Query: 538 ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNP--KISDFGMARIFEVNESEANTKRIV 595
+ LL+L L +IH DLK NILL + KI DFG + + + I
Sbjct: 166 MCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ----LGQRIYQYIQ 220
Query: 596 GTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
+ Y SPE + + D++S G +++E+ +G+
Sbjct: 221 SRF-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 52/207 (25%), Positives = 88/207 (42%), Gaps = 28/207 (13%)
Query: 438 LGEGGFGPVYKGK-LADEQEVAIKRL---SRSSGQGIVEFKNEVRLIAKLQH------TN 487
+G+G FG V K Q VA+K + R Q E +R++ L+ N
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEE----IRILEHLRKQDKDNTMN 160
Query: 488 LVRLLGCSLHGEERLLVYEFMPNKSL-DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLH 546
++ +L + +E + + +L + N + L ++F I Q L LH
Sbjct: 161 VIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAH--SILQCLDALH 217
Query: 547 KYSRLRVIHRDLKASNILLDDKMNP--KISDFGMARIFEVNESEANTKRIVGTYGYMSPE 604
K R+IH DLK NILL + K+ DFG + E + I + Y +PE
Sbjct: 218 K---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY----EHQRVYTYIQSRF-YRAPE 269
Query: 605 YAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
+ + D++S G ++ E+++G
Sbjct: 270 VILGARYGMPIDMWSLGCILAELLTGY 296
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 53/257 (20%), Positives = 100/257 (38%), Gaps = 72/257 (28%)
Query: 437 KLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTN-------- 487
KLG G F V+ + ++ VA+K + +S+ +E+RL+ +++++
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVRNSDPNDPNREM 102
Query: 488 LVRLLGC----SLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLL 543
+V+LL ++G +V+E + L ++ S + + + II + + QGL
Sbjct: 103 VVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQ-VLQGLD 160
Query: 544 YLHKYSRLRVIHRDLKASNILL-------------------------------------- 565
YLH ++ R+IH D+K NILL
Sbjct: 161 YLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218
Query: 566 -----------DDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIK 614
+K+ KI+D G A + +E + T Y S E + +
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTE-----DIQTRQYRSLEVLIGSGYNTP 273
Query: 615 TDVFSFGVLVLEIVSGQ 631
D++S + E+ +G
Sbjct: 274 ADIWSTACMAFELATGD 290
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.0 bits (134), Expect = 4e-08
Identities = 65/589 (11%), Positives = 164/589 (27%), Gaps = 147/589 (24%)
Query: 113 VLREMDTDGTIKRVLWQSFDYPTDTLLPGMKLGINLQTGHQWFLQSW-LDYSSPA--QGS 169
++ D R+ W + + + L+ +++ + + P+
Sbjct: 54 IIMSKDAVSGTLRLFWTLLSKQEEMV--QKFVEEVLRINYKFLMSPIKTEQRQPSMMTRM 111
Query: 170 FTLGIEP-NATNQLIIR---WRRETIYW----------TSGLLLNGNFNFSRSWNLSFSY 215
+ + NQ+ + R + +L++G ++W
Sbjct: 112 YIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVC 171
Query: 216 TSNEQEKYFEYS---LNEGVTSSVFLRIDPEGALSDSRGSFAPCTYGGC-WNQLPRPICR 271
S + + ++ LN +S ++ L W
Sbjct: 172 LSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKL---------LYQIDPNWTSRSDHSSN 222
Query: 272 KGTGPENFQSKV-GLISEHGFKFKES----DNMSSTDCRANCFYNCSC-IAFATGTSEYT 325
+ Q+++ L+ ++ N+ + N F N SC I T + T
Sbjct: 223 IKLRIHSIQAELRRLLKSK--PYENCLLVLLNVQNAKA-WNAF-NLSCKILLTTRFKQVT 278
Query: 326 DK---QAYCEIWSEGTE--FTEIASNNSREIFILAIKEEKWWRSLTIAIG-----VVLGI 375
D I + T + + + + K+ L V+
Sbjct: 279 DFLSAATTTHISLDHHSMTLTP---DEVKSLLL------KY---LDCRPQDLPREVLTTN 326
Query: 376 PLLCYLCYVTWRKLKAKDNVSLLPTYGKRKSPEKDQSISHELKIFD-------FQTIAAA 428
P + ++ D ++ + + I L + + F ++
Sbjct: 327 PRRLSII---AESIR--DGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSV- 380
Query: 429 ANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL 488
F + + ++ + + V + +L + S L+ K +
Sbjct: 381 ---FPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYS------------LVEKQPKEST 425
Query: 489 VRLLGC------------SLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIE 536
+ + +LH R +V + K+ D + + ++
Sbjct: 426 ISIPSIYLELKVKLENEYALH---RSIVDHYNIPKTFD------------SDDLIPPYLD 470
Query: 537 GISQGLLYLHKY-----SRLRVIHRDLKASNILLDDK-MNPKISDFGMA----------- 579
Y + + + R + LD + + KI A
Sbjct: 471 Q------YFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTL 524
Query: 580 ---RIFE--VNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVL 623
+ ++ + +++ +R+V P+ + I S TD+ ++
Sbjct: 525 QQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIALM 573
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 45.2 bits (106), Expect = 7e-05
Identities = 64/444 (14%), Positives = 122/444 (27%), Gaps = 113/444 (25%)
Query: 327 KQAYCEIWSEGTE-------FTEIASNNSR--EIFILAIKEEKW-WRSLTIAIGVVLGIP 376
K+ I F + S + F+ + + + L I P
Sbjct: 48 KEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKF--LMSPIKTEQRQP 105
Query: 377 LLCYLCYVTWRKLKAKDNVSLLPTYGKRKSPEKDQSISHELKIFDFQTIAAAANNFSTTN 436
+ Y+ R DN R P + + A
Sbjct: 106 SMMTRMYIEQRDRLYNDNQVFAKYNVSRLQP--------------YLKLRQALLELRPAK 151
Query: 437 KL---GEGGFGPVYKGKLADEQEVAIKRLSRSSGQGI--VEFKNEVR---LIAKLQHTNL 488
+ G G G K +A + ++ K + I + KN ++ LQ L
Sbjct: 152 NVLIDGVLGSG---KTWVALDVCLSYKVQCKMDF-KIFWLNLKNCNSPETVLEMLQ--KL 205
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
+ + + + N L ++ + + + LL Y
Sbjct: 206 LYQIDPNWTSRS-----DHSSNIKLR-----------IHSIQAEL------RRLLKSKPY 243
Query: 549 SRLRVIHRDLKASNILLDDKMNPKISD-FGMA-------RIFEVNE--SEANTKRI--VG 596
L ++L + N K + F ++ R +V + S A T I
Sbjct: 244 EN------CL----LVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDH 293
Query: 597 TYGYMSPEYAM---SGIVSIKTD-----VFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGY 648
++P+ + + V + L I++ R N
Sbjct: 294 HSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESI---RDGLATWDN---- 346
Query: 649 AWQLLSDGKGLELIDPSLEQPCSANEVMRC------------IHVGLLCVQDQAMDRPTM 696
W+ ++ K +I+ SL E + I LL + + + +
Sbjct: 347 -WKHVNCDKLTTIIESSLNV-LEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDV 404
Query: 697 PEVVCMLQNETMPLPPPKQPAFFI 720
VV L ++ PK+ I
Sbjct: 405 MVVVNKLHKYSLVEKQPKESTISI 428
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 2e-05
Identities = 16/85 (18%), Positives = 28/85 (32%), Gaps = 10/85 (11%)
Query: 49 YQTDEPIWIANRNTPILDQSGVLTIDSIDGNLKILHNGGNPIAVSSVEGASNNTSATLLQ 108
Y +W +N + G + DGN + G + S + N L +
Sbjct: 34 YDHSTSVWASNTGIL--GKKGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQE 91
Query: 109 SGNLVLREMDTDGTIKRVLWQSFDY 133
GN+V+ +W + Y
Sbjct: 92 DGNVVIY--------GSDIWSTGTY 108
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 41/182 (22%), Positives = 72/182 (39%), Gaps = 34/182 (18%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGK-LADEQEVAIK---RLSRSSGQGIVEFKNEVRLIAKLQ 484
N F K+G+G FG V + + +++ A+K + + + +E ++ K+Q
Sbjct: 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIE----ADILKKIQ 89
Query: 485 H-----TNLVRLLGCSLHGE------ERLL--VYEFMPNKSLDFFLFNSGRKNVLNWEKR 531
+ N+V+ G ++ + E L +YE + ++ F+ + K
Sbjct: 90 NDDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEII--TRNNYNGFH------IEDIKL 141
Query: 532 FIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANT 591
+ I I + L YL K + + H DLK NILLDD K T
Sbjct: 142 YCI--EILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRT 196
Query: 592 KR 593
K
Sbjct: 197 KS 198
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 48/240 (20%), Positives = 85/240 (35%), Gaps = 58/240 (24%)
Query: 429 ANNFSTTNKLGEGGFGPVYKG--KLADEQEVAIK---RLSRSSGQGIVEFKNEVRLIAKL 483
+ LGEG FG V + + +VA+K + + +E + ++ K+
Sbjct: 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLE----INVLKKI 73
Query: 484 QHT------NLVRLLGCSLHGEERLLVYEFMPNKSL-DFFLFNSGRKNVLNWEKRFIIIE 536
+ V + + +E + K+ +F N+ + L +
Sbjct: 74 KEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAY-- 130
Query: 537 GISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNP-------------------KISDFG 577
+ L +LH+ ++ H DLK NIL + +++DFG
Sbjct: 131 QLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG 187
Query: 578 MARIFEVNESEANTKRIVGTYGYMSPE------YAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
A F + E +T IV T Y PE +A DV+S G ++ E G
Sbjct: 188 SA-TF---DHEHHT-TIVATRHYRPPEVILELGWAQP------CDVWSIGCILFEYYRGF 236
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 7e-05
Identities = 18/82 (21%), Positives = 34/82 (41%), Gaps = 9/82 (10%)
Query: 49 YQTDEPIWIANRNTPILDQSGVLTIDSIDGNLKILHNGGNPIAVSSVEGASNNTSATLLQ 108
Y + +W + T VL + + DGNL ++++G I S+ + N L +
Sbjct: 34 YDNNRAVWASG--TNGKASGCVLKMQN-DGNL-VIYSGSRAIWASNTNRQNGNYYLILQR 89
Query: 109 SGNLVLREMDTDGTIKRVLWQS 130
N+V+ D +W +
Sbjct: 90 DRNVVIY--DNSN---NAIWAT 106
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 1e-04
Identities = 52/242 (21%), Positives = 92/242 (38%), Gaps = 62/242 (25%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGK--LADEQEVAIK------RLSRSSGQGIVEFKNEVRLI 480
+ + + LGEG FG V + A + VA+K R ++ ++E++++
Sbjct: 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA-------RSEIQVL 65
Query: 481 AKLQH------TNLVRLLGCSLHGEERLLVYEFMPNKSL-DFFLFNSGRKNVLNWEKRFI 533
L V++L H +V+E + S DF N L+ ++
Sbjct: 66 EHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMA 124
Query: 534 IIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNP-------------------KIS 574
I + + +LH ++ H DLK NIL K+
Sbjct: 125 Y--QICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVV 179
Query: 575 DFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIV-----SIKTDVFSFGVLVLEIVS 629
DFG A ++ +E + +V T Y +PE ++ S DV+S G +++E
Sbjct: 180 DFGSA-TYD-DEHHST---LVSTRHYRAPE-----VILALGWSQPCDVWSIGCILIEYYL 229
Query: 630 GQ 631
G
Sbjct: 230 GF 231
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 39.9 bits (93), Expect = 4e-04
Identities = 23/82 (28%), Positives = 32/82 (39%), Gaps = 11/82 (13%)
Query: 49 YQTDEPIWIANRNTPILDQSGVLTIDSIDGNLKILHNGGNPIAVSSVEGASNNTSATLLQ 108
YQ IW +N T LT+ S DGNL I + N + S+ G + + L +
Sbjct: 35 YQNGRQIWASN--TDRRGSGCRLTLLS-DGNLVIYDHNNNDVWGSACWGDNGKYALVLQK 91
Query: 109 SGNLVLREMDTDGTIKRVLWQS 130
G V+ VLW
Sbjct: 92 DGRFVIY--------GPVLWSL 105
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 752 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.86 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.74 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.65 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.63 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.63 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.62 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.62 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.56 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.56 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.52 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.5 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.46 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.41 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.25 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.2 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.18 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.11 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.08 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.07 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.03 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.93 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.89 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.84 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 98.83 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.82 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 98.78 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 98.78 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.54 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.43 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.36 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 98.35 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 98.31 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.29 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.18 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.11 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.91 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.89 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.88 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.7 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.57 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.24 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.18 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.18 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.17 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.17 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.15 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.01 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.62 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.59 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.14 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.09 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.4 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.87 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 82.04 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-53 Score=443.86 Aligned_cols=259 Identities=27% Similarity=0.440 Sum_probs=215.8
Q ss_pred cCCCcCCeeecCCcccEEEEEec------CCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA------DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLL 503 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 503 (752)
++|.+.++||+|+||+||+|++. ++..||||+++.......++|.+|+++|++++|||||+++|+|.+++..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 46777899999999999999864 467899999988777777889999999999999999999999999999999
Q ss_pred EEeeCCCCCHhHHHhhcC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCcee
Q 043278 504 VYEFMPNKSLDFFLFNSG----------RKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKI 573 (752)
Q Consensus 504 v~E~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl 573 (752)
|||||++|+|.++|.... ....++|.+++.++.|||+||+|||+++ ||||||||+||||++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 999999999999997532 3456999999999999999999999988 999999999999999999999
Q ss_pred cccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHH
Q 043278 574 SDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQL 652 (752)
Q Consensus 574 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 652 (752)
+|||+|+...............||+.|||||++.+..++.|+|||||||+||||+| |+.||...... .....
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~-------~~~~~ 242 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN-------EVIEC 242 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-------HHHHH
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHH
Confidence 99999987654444334445679999999999999999999999999999999999 89999765421 12223
Q ss_pred hhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCC
Q 043278 653 LSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNET 707 (752)
Q Consensus 653 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~ 707 (752)
+..+..... +......+.+|+.+||+.||++||||+||++.|+++.
T Consensus 243 i~~~~~~~~---------p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~ 288 (299)
T 4asz_A 243 ITQGRVLQR---------PRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA 288 (299)
T ss_dssp HHHTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHcCCCCCC---------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 333332221 1122345778999999999999999999999998764
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-53 Score=446.68 Aligned_cols=260 Identities=27% Similarity=0.431 Sum_probs=208.5
Q ss_pred cCCCcCCeeecCCcccEEEEEec------CCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA------DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLL 503 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 503 (752)
++|.+.++||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45667789999999999999864 467899999988777777889999999999999999999999999999999
Q ss_pred EEeeCCCCCHhHHHhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCc
Q 043278 504 VYEFMPNKSLDFFLFNSGR------------KNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNP 571 (752)
Q Consensus 504 v~E~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~ 571 (752)
|||||++|+|.+++..... ...++|.+++.|+.|||+||+|||+.+ ||||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 9999999999999975422 346999999999999999999999988 9999999999999999999
Q ss_pred eecccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHH
Q 043278 572 KISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAW 650 (752)
Q Consensus 572 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~ 650 (752)
||+|||+++...............||+.|||||++.+..++.++|||||||+||||+| |+.||...... ...
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~-------~~~ 270 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT-------EAI 270 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH-------HHH
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH-------HHH
Confidence 9999999997655444444455789999999999999999999999999999999999 89999765421 122
Q ss_pred HHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCC
Q 043278 651 QLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETM 708 (752)
Q Consensus 651 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~~ 708 (752)
..+..+..... +......+.+|+.+||+.||++||||+||+++|+.+..
T Consensus 271 ~~i~~g~~~~~---------p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 271 DCITQGRELER---------PRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp HHHHHTCCCCC---------CTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHcCCCCCC---------cccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 22333322211 11123457789999999999999999999999998754
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=441.66 Aligned_cols=257 Identities=28% Similarity=0.411 Sum_probs=212.8
Q ss_pred CCCcCCeeecCCcccEEEEEec------CCceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEE
Q 043278 431 NFSTTNKLGEGGFGPVYKGKLA------DEQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLL 503 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 503 (752)
.+++.++||+|+||+||+|++. +++.||||+++... ....++|.+|+.++++++|||||+++|+|.+++..+|
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 3445689999999999999863 46789999997553 3456789999999999999999999999999999999
Q ss_pred EEeeCCCCCHhHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCC
Q 043278 504 VYEFMPNKSLDFFLFNSGR-------------KNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMN 570 (752)
Q Consensus 504 v~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~ 570 (752)
|||||++|+|.++|..... ...++|.+++.|+.|||+||+|||+++ ||||||||+||||+++++
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCC
Confidence 9999999999999965321 245999999999999999999999988 999999999999999999
Q ss_pred ceecccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHH
Q 043278 571 PKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYA 649 (752)
Q Consensus 571 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~ 649 (752)
+||+|||+++...............||+.|||||++.++.++.|+|||||||+||||+| |+.||..... ...
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~-------~~~ 256 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-------QDV 256 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH-------HHH
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH-------HHH
Confidence 99999999987655444444455789999999999999999999999999999999999 8999976542 112
Q ss_pred HHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 650 WQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 650 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
...+..+..... +......+.+|+.+||+.||++||||+||+++|+..
T Consensus 257 ~~~i~~~~~~~~---------p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 257 VEMIRNRQVLPC---------PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHcCCCCCC---------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 233344433221 122334577899999999999999999999999864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-52 Score=433.44 Aligned_cols=263 Identities=25% Similarity=0.438 Sum_probs=205.4
Q ss_pred cCCCcCCeeecCCcccEEEEEecCCceeEEEEcccC--CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEee
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRS--SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
+++.+.++||+|+||+||+|++.+ .||||+++.. ..+..++|.+|+.++++++|||||+++|++.+ +..+|||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 567788999999999999998754 5999998754 33445789999999999999999999999865 568999999
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccc
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES 587 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~ 587 (752)
|++|+|.++|... ...+++.+++.|+.|||+||+|||+++ ||||||||+||||++++++||+|||+|+.......
T Consensus 113 ~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 113 CEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp CSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred CCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence 9999999999653 345999999999999999999999988 99999999999999999999999999987654443
Q ss_pred ccccccccccCCccChhhhcc---CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCC
Q 043278 588 EANTKRIVGTYGYMSPEYAMS---GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDP 664 (752)
Q Consensus 588 ~~~~~~~~gt~~y~aPE~~~~---~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 664 (752)
........||+.|||||++.+ ..|+.|+|||||||+||||+||+.||...... ......+..+.. .|
T Consensus 188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~------~~~~~~~~~~~~----~p 257 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR------DQIIFMVGRGYA----SP 257 (307)
T ss_dssp ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH------HHHHHHHHTTCC----CC
T ss_pred ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH------HHHHHHHhcCCC----CC
Confidence 334455789999999999864 46999999999999999999999999754421 111222222211 11
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCCCCC
Q 043278 665 SLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETMPLP 711 (752)
Q Consensus 665 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~~~~~ 711 (752)
.+. ..+......+.+|+.+||+.||++||||.||+++|+.+..++|
T Consensus 258 ~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 258 DLS-KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP 303 (307)
T ss_dssp CST-TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred Ccc-cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence 111 1112223457789999999999999999999999987765444
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-50 Score=423.62 Aligned_cols=251 Identities=20% Similarity=0.303 Sum_probs=202.4
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEe
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYE 506 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 506 (752)
++|++.++||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..+||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 57999999999999999999864 68999999997542 3345678999999999999999999999999999999999
Q ss_pred eCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccc
Q 043278 507 FMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586 (752)
Q Consensus 507 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~ 586 (752)
||++|+|.+++... +...+++.+++.++.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+.+....
T Consensus 104 y~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp CCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred CCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 99999999999653 3345789999999999999999999998 9999999999999999999999999998754321
Q ss_pred cccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCC
Q 043278 587 SEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666 (752)
Q Consensus 587 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 666 (752)
......+||+.|||||++.+..|+.++|||||||+||||++|+.||..... .....+... +.... +
T Consensus 180 --~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~------~~~~~~i~~-~~~~~-----~ 245 (350)
T 4b9d_A 180 --ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM------KNLVLKIIS-GSFPP-----V 245 (350)
T ss_dssp --HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHH-TCCCC-----C
T ss_pred --ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHHHHHHc-CCCCC-----C
Confidence 123346899999999999999999999999999999999999999976542 222222222 22111 1
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 667 EQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 667 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.. .....+.+|+.+||+.||++|||+.|++++
T Consensus 246 ~~----~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 246 SL----HYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp CT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred Cc----cCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11 122357789999999999999999999864
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=422.41 Aligned_cols=250 Identities=26% Similarity=0.336 Sum_probs=208.6
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeC
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFM 508 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 508 (752)
+.|+..++||+|+||+||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..+||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56888899999999999999875 68999999997665556667899999999999999999999999999999999999
Q ss_pred CCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccc
Q 043278 509 PNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE 588 (752)
Q Consensus 509 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 588 (752)
++|+|.+++.. ..+++.++..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.+....
T Consensus 154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-- 224 (346)
T 4fih_A 154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-- 224 (346)
T ss_dssp TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--
T ss_pred CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC--
Confidence 99999998854 34899999999999999999999998 9999999999999999999999999998765332
Q ss_pred cccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCC
Q 043278 589 ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQ 668 (752)
Q Consensus 589 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 668 (752)
......+||+.|||||++.+..|+.++|||||||+||||++|+.||...... . ....+..+. .+.+.
T Consensus 225 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~------~-~~~~i~~~~-----~~~~~- 291 (346)
T 4fih_A 225 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL------K-AMKMIRDNL-----PPRLK- 291 (346)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------H-HHHHHHHSS-----CCCCS-
T ss_pred CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------H-HHHHHHcCC-----CCCCC-
Confidence 2234578999999999999999999999999999999999999999765421 1 112222211 11111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 669 PCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 669 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
........+.+|+.+||+.||++|||+.|++++
T Consensus 292 -~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 292 -NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp -CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111223457789999999999999999999874
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-50 Score=430.50 Aligned_cols=269 Identities=27% Similarity=0.377 Sum_probs=218.6
Q ss_pred ccHHHHHHHhcCCCcCCeeecCCcccEEEEEecC------CceeEEEEcccCCc-ccHHHHHHHHHHHHhcCC-CCccee
Q 043278 420 FDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLAD------EQEVAIKRLSRSSG-QGIVEFKNEVRLIAKLQH-TNLVRL 491 (752)
Q Consensus 420 ~~~~~i~~~~~~~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h-~niv~l 491 (752)
++..+.+...++|++.++||+|+||+||+|++.. ++.||||++..... ...++|.+|+++|.+++| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 4445555556889999999999999999998643 35799999976543 345679999999999965 899999
Q ss_pred eeeeeeC-CeeEEEEeeCCCCCHhHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecC
Q 043278 492 LGCSLHG-EERLLVYEFMPNKSLDFFLFNSG-------------RKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRD 557 (752)
Q Consensus 492 ~~~~~~~-~~~~lv~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~D 557 (752)
+|+|.+. +..+||||||++|+|.++|.... ....+++.+++.++.|||+||+|||+++ |||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCc
Confidence 9999764 56899999999999999997532 1345899999999999999999999998 99999
Q ss_pred CCCCcEEecCCCCceecccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 043278 558 LKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTR 636 (752)
Q Consensus 558 ikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~ 636 (752)
|||+||||++++.+||+|||+|+.+........+....||+.|||||++.+..|+.|+|||||||+||||+| |+.||..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999997665544444456789999999999999999999999999999999998 8999976
Q ss_pred CCCCCCcchHHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 637 HHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 637 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
..... .....+..+...... .....++.+++.+||+.||++||||.||+++|+.+
T Consensus 291 ~~~~~------~~~~~i~~g~~~~~p---------~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 291 VKIDE------EFCRRLKEGTRMRAP---------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp CCCSH------HHHHHHHHTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCHHH------HHHHHHHcCCCCCCC---------ccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 54221 122333333322211 11224577899999999999999999999999765
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-49 Score=414.98 Aligned_cols=267 Identities=21% Similarity=0.265 Sum_probs=202.1
Q ss_pred cCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCC----eeEEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGE----ERLLVY 505 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~ 505 (752)
++|.+.++||+|+||+||+|++ .|+.||||++..... ....+..|+..+.+++|||||+++++|.+++ ..+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4567789999999999999998 688999999965422 1222345666667889999999999998654 579999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCcEeecCCCCCcEEecCCCCceecccccce
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY-----SRLRVIHRDLKASNILLDDKMNPKISDFGMAR 580 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~ 580 (752)
|||++|+|.+++.. ..++|+.+++++.|+++||+|||++ ..++||||||||+||||++++++||+|||+++
T Consensus 81 Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999999999964 3489999999999999999999986 23459999999999999999999999999998
Q ss_pred eecccccc--cccccccccCCccChhhhccC------CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCC--------cc
Q 043278 581 IFEVNESE--ANTKRIVGTYGYMSPEYAMSG------IVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRP--------LN 644 (752)
Q Consensus 581 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~--------~~ 644 (752)
........ .......||+.|||||++.+. .++.|+|||||||+||||+||++|+........ ..
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 76543322 222346899999999999764 478899999999999999999887754332211 00
Q ss_pred hHHHHHHHhhCCCcccccCCCCCC-CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 645 LIGYAWQLLSDGKGLELIDPSLEQ-PCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 645 l~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
...........+ .++|.+.. ..+.+....+.+|+.+||+.||++||||.||+++|+.+
T Consensus 237 ~~~~~~~~~~~~----~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l 295 (303)
T 3hmm_A 237 SVEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CHHHHHHHHTTS----CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred hHHHHHHHHhcc----cCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 111222222221 12232221 12345667788999999999999999999999999865
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-49 Score=416.25 Aligned_cols=252 Identities=20% Similarity=0.252 Sum_probs=203.8
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeC
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFM 508 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 508 (752)
+.|...++||+|+||+||+|+.. +|+.||||+++.... ..+|+.++++++|||||++++++.+++..+||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 45777889999999999999874 589999999976432 257999999999999999999999999999999999
Q ss_pred CCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCC-Cceecccccceeeccccc
Q 043278 509 PNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKM-NPKISDFGMARIFEVNES 587 (752)
Q Consensus 509 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~-~~kl~DFgla~~~~~~~~ 587 (752)
++|+|.+++... ..+++..+..++.||+.||+|||+++ ||||||||+||||+.++ .+||+|||+|+.+.....
T Consensus 133 ~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 133 EGGSLGQLIKQM---GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp TTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred CCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 999999999653 35999999999999999999999998 99999999999999987 699999999997654322
Q ss_pred c---cccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCC
Q 043278 588 E---ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDP 664 (752)
Q Consensus 588 ~---~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 664 (752)
. ......+||+.|||||++.+..++.++|||||||+||||++|+.||.......... ..........-
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~------~i~~~~~~~~~--- 277 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL------KIASEPPPIRE--- 277 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHH------HHHHSCCGGGG---
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH------HHHcCCCCchh---
Confidence 1 12234689999999999999999999999999999999999999998765443221 11222111111
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 665 SLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 665 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
+ +......+.+++.+||+.||.+|||+.|+++.|...
T Consensus 278 -~----~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 278 -I----PPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp -S----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -c----CccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 1 111234567889999999999999999999887543
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-49 Score=409.50 Aligned_cols=248 Identities=23% Similarity=0.311 Sum_probs=208.4
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccC---CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRS---SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 505 (752)
++|++.+.||+|+||+||+|+.. +++.||||++.+. .......+.+|+++|++++|||||++++++.+++..+|||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 46899999999999999999864 6899999999753 2345677899999999999999999999999999999999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccc
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVN 585 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~ 585 (752)
||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+...
T Consensus 112 Ey~~gG~L~~~i~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 999999999999653 35999999999999999999999998 999999999999999999999999999987654
Q ss_pred ccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCC
Q 043278 586 ESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPS 665 (752)
Q Consensus 586 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 665 (752)
.........+||+.|||||++.+..|+.++||||+||+||||++|+.||..... ........ .+.. .
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~------~~~~~~i~-~~~~------~ 252 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE------GLIFAKII-KLEY------D 252 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHH-HTCC------C
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHH-cCCC------C
Confidence 444445567999999999999999999999999999999999999999976442 11112222 2211 1
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 043278 666 LEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVV 700 (752)
Q Consensus 666 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~ 700 (752)
+.... ...+.+|+.+||+.||++|||++|++
T Consensus 253 ~p~~~----s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 253 FPEKF----FPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp CCTTC----CHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred CCccc----CHHHHHHHHHHccCCHhHCcChHHHc
Confidence 11112 23567899999999999999999863
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-48 Score=419.80 Aligned_cols=250 Identities=26% Similarity=0.339 Sum_probs=208.8
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeC
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFM 508 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 508 (752)
+.|+..++||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..+||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56888999999999999999875 58999999998766666677899999999999999999999999999999999999
Q ss_pred CCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccc
Q 043278 509 PNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE 588 (752)
Q Consensus 509 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 588 (752)
++|+|.+++.. ..+++.++..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.+....
T Consensus 231 ~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-- 301 (423)
T 4fie_A 231 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-- 301 (423)
T ss_dssp TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC--
T ss_pred CCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC--
Confidence 99999998853 34899999999999999999999998 9999999999999999999999999998765332
Q ss_pred cccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCC
Q 043278 589 ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQ 668 (752)
Q Consensus 589 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 668 (752)
......+||+.|||||++.+..|+.++|||||||+||||++|+.||...... . ....+..+. .+.+..
T Consensus 302 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~------~-~~~~i~~~~-----~~~~~~ 369 (423)
T 4fie_A 302 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL------K-AMKMIRDNL-----PPRLKN 369 (423)
T ss_dssp CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------H-HHHHHHHSC-----CCCCSC
T ss_pred ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------H-HHHHHHcCC-----CCCCcc
Confidence 2234578999999999999999999999999999999999999999765421 1 112222211 111111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 669 PCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 669 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.......+.+|+.+||+.||++|||+.|++++
T Consensus 370 --~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 370 --LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp --TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11112356788999999999999999999874
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-48 Score=399.83 Aligned_cols=247 Identities=25% Similarity=0.363 Sum_probs=197.0
Q ss_pred CcCCeeecCCcccEEEEEec-CCceeEEEEcccC--CcccHHHHHHHHHHHHhcCCCCcceeeeeeee----CCeeEEEE
Q 043278 433 STTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRS--SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLH----GEERLLVY 505 (752)
Q Consensus 433 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 505 (752)
...++||+|+||+||+|... .+..||+|++... .......|.+|++++++++|||||++++++.. ++..+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 45578999999999999875 5789999998654 33345679999999999999999999999865 34679999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecC-CCCceecccccceeecc
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDD-KMNPKISDFGMARIFEV 584 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~-~~~~kl~DFgla~~~~~ 584 (752)
|||++|+|.+++... ..+++..+..++.||+.||+|||+++ ++||||||||+||||+. ++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 999999999999653 45999999999999999999999875 35999999999999984 79999999999985332
Q ss_pred cccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCC
Q 043278 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDP 664 (752)
Q Consensus 585 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 664 (752)
......+||+.|||||++.+ .|+.++|||||||+||||++|+.||..... .......+..+.....++
T Consensus 185 ----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~------~~~~~~~i~~~~~~~~~~- 252 (290)
T 3fpq_A 185 ----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN------AAQIYRRVTSGVKPASFD- 252 (290)
T ss_dssp ----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS------HHHHHHHHTTTCCCGGGG-
T ss_pred ----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc------HHHHHHHHHcCCCCCCCC-
Confidence 22345789999999998865 699999999999999999999999965431 111222333322111111
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 665 SLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 665 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
...+ ..+.+|+.+||+.||++|||++|++++
T Consensus 253 ---~~~~----~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 253 ---KVAI----PEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp ---GCCC----HHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ---ccCC----HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1112 246788999999999999999999874
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=393.45 Aligned_cols=246 Identities=22% Similarity=0.348 Sum_probs=190.4
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC---cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 505 (752)
++|++.+.||+|+||+||+|+.. +++.||||++.+.. ......+.+|+.++++++|||||++++++.+.+..+|||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 58999999999999999999864 68999999997542 334567899999999999999999999999999999999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccc
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVN 585 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~ 585 (752)
||+ +|+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+||||++++++||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR---DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHHHS---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 57898888653 45999999999999999999999998 999999999999999999999999999865432
Q ss_pred ccccccccccccCCccChhhhccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCC
Q 043278 586 ESEANTKRIVGTYGYMSPEYAMSGIV-SIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDP 664 (752)
Q Consensus 586 ~~~~~~~~~~gt~~y~aPE~~~~~~~-t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 664 (752)
. .....+||+.|||||++.+..+ +.++||||+||++|||++|+.||..... .. ..+.+..+..
T Consensus 166 ~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~------~~-~~~~i~~~~~------ 229 (275)
T 3hyh_A 166 N---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI------PV-LFKNISNGVY------ 229 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HH-HHHHHHHTCC------
T ss_pred C---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH------HH-HHHHHHcCCC------
Confidence 2 2234689999999999998876 5899999999999999999999975431 11 1122222221
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 665 SLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 665 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.+.... ...+.+|+.+||+.||++|||++|++++
T Consensus 230 ~~p~~~----s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 230 TLPKFL----SPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp CCCTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred CCCCCC----CHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 111111 2356788999999999999999999874
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=401.06 Aligned_cols=248 Identities=24% Similarity=0.297 Sum_probs=195.8
Q ss_pred cCCCcCCeeecCCcccEEEEEec----CCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA----DEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLL 503 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 503 (752)
++|++.+.||+|+||+||+|+.. .++.||||++++.. .....++.+|++++++++|||||++++++.+++..+|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57889999999999999999852 46789999997542 2233467899999999999999999999999999999
Q ss_pred EEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeec
Q 043278 504 VYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFE 583 (752)
Q Consensus 504 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~ 583 (752)
|||||++|+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 99999999999999653 35999999999999999999999998 9999999999999999999999999998654
Q ss_pred ccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccC
Q 043278 584 VNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELID 663 (752)
Q Consensus 584 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 663 (752)
... ......+||+.|||||++.+..++.++|||||||+||||++|+.||...... ........ +..
T Consensus 178 ~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~------~~~~~i~~-~~~----- 243 (304)
T 3ubd_A 178 DHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK------ETMTMILK-AKL----- 243 (304)
T ss_dssp -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHH-CCC-----
T ss_pred CCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH------HHHHHHHc-CCC-----
Confidence 322 2233478999999999999999999999999999999999999999765421 11112222 111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHHH
Q 043278 664 PSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTM-----PEVVCM 702 (752)
Q Consensus 664 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~-----~ev~~~ 702 (752)
.+... ....+.+|+.+||+.||++|||+ +|++++
T Consensus 244 -~~p~~----~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 244 -GMPQF----LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp -CCCTT----SCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred -CCCCc----CCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 11111 22356789999999999999984 677653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=391.45 Aligned_cols=256 Identities=24% Similarity=0.332 Sum_probs=192.4
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCc-ccHHHHHHHHHHHHhcCCCCcceeeeeeeeCC--------
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSG-QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGE-------- 499 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------- 499 (752)
++|++.+.||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|+.+|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 35888899999999999999864 688999999975543 34467899999999999999999999987544
Q ss_pred ----eeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecc
Q 043278 500 ----ERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISD 575 (752)
Q Consensus 500 ----~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~D 575 (752)
..+||||||++|+|.+++..........+..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 36899999999999999976555555677889999999999999999998 99999999999999999999999
Q ss_pred cccceeeccccccc----------ccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcch
Q 043278 576 FGMARIFEVNESEA----------NTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNL 645 (752)
Q Consensus 576 Fgla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l 645 (752)
||+|+.+....... .....+||+.|||||++.+..|+.++|||||||+||||++ ||.... ..
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~-----~~ 233 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM-----ER 233 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH-----HH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc-----HH
Confidence 99998765432211 1234579999999999999999999999999999999996 553211 11
Q ss_pred HHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hhcC
Q 043278 646 IGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM--LQNE 706 (752)
Q Consensus 646 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~--L~~~ 706 (752)
. ............. ........+.+|+.+||+.||++|||+.|++++ ++++
T Consensus 234 ~-~~~~~~~~~~~p~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~ 286 (299)
T 4g31_A 234 V-RTLTDVRNLKFPP---------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL 286 (299)
T ss_dssp H-HHHHHHHTTCCCH---------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred H-HHHHHHhcCCCCC---------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence 1 1111222221111 111223345678999999999999999999873 4443
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-45 Score=387.35 Aligned_cols=282 Identities=34% Similarity=0.597 Sum_probs=248.3
Q ss_pred HHHHHHHhcCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCee
Q 043278 422 FQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEER 501 (752)
Q Consensus 422 ~~~i~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 501 (752)
+.++...+++|...+.||+|+||.||+|+..+++.||||++.........++.+|+.++.+++||||+++++++.+++..
T Consensus 31 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 110 (321)
T 2qkw_B 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM 110 (321)
T ss_dssp CSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred HHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence 33445567899999999999999999999888999999999877666778899999999999999999999999999999
Q ss_pred EEEEeeCCCCCHhHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccce
Q 043278 502 LLVYEFMPNKSLDFFLFNSGR-KNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR 580 (752)
Q Consensus 502 ~lv~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~ 580 (752)
++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 187 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISK 187 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccccc
Confidence 999999999999999865432 335899999999999999999999988 9999999999999999999999999998
Q ss_pred eecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCccc
Q 043278 581 IFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLE 660 (752)
Q Consensus 581 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 660 (752)
...............||+.|+|||++.+..++.++||||||+++|||++|+.||....+........+.......+....
T Consensus 188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (321)
T 2qkw_B 188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ 267 (321)
T ss_dssp ECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCS
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHH
Confidence 75433333333445689999999999999999999999999999999999999988877777777777766777777778
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 661 LIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 661 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
.+++.+......+....+.+++.+|++.||++|||+.||+++|+..
T Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp SSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 8888887778888899999999999999999999999999999865
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=381.46 Aligned_cols=293 Identities=40% Similarity=0.669 Sum_probs=248.1
Q ss_pred ccccccccHHHHHHHhcCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCCc-ccHHHHHHHHHHHHhcCCCCcceee
Q 043278 414 SHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSG-QGIVEFKNEVRLIAKLQHTNLVRLL 492 (752)
Q Consensus 414 ~~~~~~~~~~~i~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~ 492 (752)
....+.|++.++....++|+..+.||+|+||.||+|+..+++.||||++..... .....+.+|+.++.+++||||++++
T Consensus 14 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 93 (326)
T 3uim_A 14 LGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 93 (326)
T ss_dssp -CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCC
T ss_pred cCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceE
Confidence 345677899999999999999999999999999999988899999999976532 2233689999999999999999999
Q ss_pred eeeeeCCeeEEEEeeCCCCCHhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCc
Q 043278 493 GCSLHGEERLLVYEFMPNKSLDFFLFNSG-RKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNP 571 (752)
Q Consensus 493 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~ 571 (752)
+++...+..++||||+++|+|.+++.... ....+++..+..++.||+.||+|||+...++|+||||||+|||++.++.+
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~ 173 (326)
T 3uim_A 94 GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 173 (326)
T ss_dssp EEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCE
T ss_pred EEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCE
Confidence 99999999999999999999999997643 34459999999999999999999999833339999999999999999999
Q ss_pred eecccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCC--CCCCcchHHHH
Q 043278 572 KISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHH--PDRPLNLIGYA 649 (752)
Q Consensus 572 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~--~~~~~~l~~~~ 649 (752)
||+|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.... .........+.
T Consensus 174 kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 252 (326)
T 3uim_A 174 VVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252 (326)
T ss_dssp EECCCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHH
T ss_pred EeccCccccccCccccc-ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHH
Confidence 99999999876533222 2234568999999999999999999999999999999999999996321 22333455566
Q ss_pred HHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCC
Q 043278 650 WQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNET 707 (752)
Q Consensus 650 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~ 707 (752)
...........+.+..+......+....+.+++.+|++.||.+|||+.||+++|++..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp TTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred HHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 5666666777788888888888999999999999999999999999999999998754
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=384.43 Aligned_cols=264 Identities=21% Similarity=0.301 Sum_probs=200.9
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeee------CC
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLH------GE 499 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~ 499 (752)
.++|++.+.||+|+||+||+|+.. +|+.||||+++... ......+.+|+++|++++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 357999999999999999999874 68999999997543 2334568899999999999999999998753 35
Q ss_pred eeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccc
Q 043278 500 ERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMA 579 (752)
Q Consensus 500 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla 579 (752)
..+||||||+ |+|..++.. ...+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~---~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHS---SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTS---SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence 7899999996 678888853 456999999999999999999999998 999999999999999999999999999
Q ss_pred eeecccc--cccccccccccCCccChhhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCC
Q 043278 580 RIFEVNE--SEANTKRIVGTYGYMSPEYAMSG-IVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDG 656 (752)
Q Consensus 580 ~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 656 (752)
+.+.... ........+||+.|||||++.+. .++.++||||+||++|||++|+.||........... ........
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~---I~~~~g~p 282 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQL---IMMVLGTP 282 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHH---HHHHHCCC
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHH---HHHhcCCC
Confidence 8764332 12233457899999999998875 579999999999999999999999987653221111 11111110
Q ss_pred Cccc-----------ccCC-CCCCCCCHH-----HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 657 KGLE-----------LIDP-SLEQPCSAN-----EVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 657 ~~~~-----------~~d~-~l~~~~~~~-----~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.... .+.. ....+.+.+ ....+.+|+.+||+.||.+|||+.|++++
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 283 SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp CGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000 0000 000011111 12356789999999999999999999875
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=377.06 Aligned_cols=201 Identities=23% Similarity=0.386 Sum_probs=172.1
Q ss_pred HHhcCCCcCCeeecCCcccEEEEEec----CCceeEEEEcccCCcccHHHHHHHHHHHHhc-CCCCcceeeeeeeeCCee
Q 043278 427 AAANNFSTTNKLGEGGFGPVYKGKLA----DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGEER 501 (752)
Q Consensus 427 ~~~~~~~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 501 (752)
...++|++.++||+|+||+||+|+.+ .++.||||++.... ...++.+|+++|..+ +|||||++++++.+.++.
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 35688999999999999999999753 46789999986543 345678999999998 699999999999999999
Q ss_pred EEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCC-CCceecccccce
Q 043278 502 LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDK-MNPKISDFGMAR 580 (752)
Q Consensus 502 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~-~~~kl~DFgla~ 580 (752)
+|||||+++|+|.+++. .+++.++..++.||+.||+|||+++ |+||||||+||||+.+ +.+||+|||+|+
T Consensus 96 ~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp EEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 99999999999999882 3899999999999999999999998 9999999999999876 799999999998
Q ss_pred eecccccc--------------------------cccccccccCCccChhhhccC-CCCccchhHHHHHHHHHHHhCCCC
Q 043278 581 IFEVNESE--------------------------ANTKRIVGTYGYMSPEYAMSG-IVSIKTDVFSFGVLVLEIVSGQKN 633 (752)
Q Consensus 581 ~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~G~vl~elltG~~p 633 (752)
........ ......+||+.|||||++.+. .++.++||||+||++|||++|+.|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 65432110 112235799999999999875 589999999999999999999999
Q ss_pred CCCCC
Q 043278 634 HTRHH 638 (752)
Q Consensus 634 ~~~~~ 638 (752)
|....
T Consensus 247 f~~~~ 251 (361)
T 4f9c_A 247 FYKAS 251 (361)
T ss_dssp SSCCS
T ss_pred CCCCC
Confidence 96543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=400.03 Aligned_cols=252 Identities=22% Similarity=0.287 Sum_probs=208.2
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeC
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFM 508 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 508 (752)
++|++.+.||+|+||.||+++.. +|+.||+|++..........+.+|+.+|++++|||||++++++.+.+..+||||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 57889999999999999999874 68999999998776666678899999999999999999999999999999999999
Q ss_pred CCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCC--CCceecccccceeecccc
Q 043278 509 PNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDK--MNPKISDFGMARIFEVNE 586 (752)
Q Consensus 509 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~--~~~kl~DFgla~~~~~~~ 586 (752)
++|+|.+++.. ....+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+++.+....
T Consensus 237 ~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 237 SGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp CCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred CCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 99999998853 3346999999999999999999999998 9999999999999854 899999999999765332
Q ss_pred cccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCC
Q 043278 587 SEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666 (752)
Q Consensus 587 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 666 (752)
.....+||+.|||||++.+..|+.++|||||||+||||++|+.||...... . ....+...... + .+..
T Consensus 312 ---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~------~-~~~~i~~~~~~-~-~~~~ 379 (573)
T 3uto_A 312 ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD------E-TLRNVKSCDWN-M-DDSA 379 (573)
T ss_dssp ---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------H-HHHHHHTTCCC-C-CSGG
T ss_pred ---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------H-HHHHHHhCCCC-C-Cccc
Confidence 223468999999999999999999999999999999999999999765421 1 11222222110 0 1111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 667 EQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 667 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
... ....+.+|+.+||+.||.+|||+.|++++
T Consensus 380 ~~~----~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 380 FSG----ISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp GTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ccC----CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 011 12356788999999999999999999885
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=358.55 Aligned_cols=285 Identities=36% Similarity=0.571 Sum_probs=234.1
Q ss_pred cccccccHHHHHHHhcCCCcC------CeeecCCcccEEEEEecCCceeEEEEcccCC----cccHHHHHHHHHHHHhcC
Q 043278 415 HELKIFDFQTIAAAANNFSTT------NKLGEGGFGPVYKGKLADEQEVAIKRLSRSS----GQGIVEFKNEVRLIAKLQ 484 (752)
Q Consensus 415 ~~~~~~~~~~i~~~~~~~~~~------~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~ 484 (752)
.....|++.++..++++|... +.||+|+||.||+|.. +++.||||++.... ......+.+|+.++.+++
T Consensus 10 ~~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 88 (307)
T 2nru_A 10 TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ 88 (307)
T ss_dssp -CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC
T ss_pred CCCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC
Confidence 345779999999999999888 8999999999999987 67899999986532 234567899999999999
Q ss_pred CCCcceeeeeeeeCCeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEE
Q 043278 485 HTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNIL 564 (752)
Q Consensus 485 h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIl 564 (752)
||||+++++++.+.+..++||||+++++|.+++........+++..++.++.||+.||+|||+.+ |+||||||+|||
T Consensus 89 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil 165 (307)
T 2nru_A 89 HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANIL 165 (307)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred CCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEE
Confidence 99999999999999999999999999999999976555567999999999999999999999998 999999999999
Q ss_pred ecCCCCceecccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcc
Q 043278 565 LDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLN 644 (752)
Q Consensus 565 l~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~ 644 (752)
+++++.+||+|||+++...............|++.|+|||.+.+ .++.++||||||+++|||++|+.||..........
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~ 244 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL 244 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTT
T ss_pred EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHH
Confidence 99999999999999987654333333344678999999998765 58999999999999999999999998765433222
Q ss_pred hHHHHHHHhh-CCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCC
Q 043278 645 LIGYAWQLLS-DGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNET 707 (752)
Q Consensus 645 l~~~~~~~~~-~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~ 707 (752)
. ....... .....+.+++.+ ...+......+.+++.+|++.||.+|||+.||+++|+.+.
T Consensus 245 ~--~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 245 D--IKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp H--HHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred H--HHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 1 1111111 122233444443 3346677788999999999999999999999999998754
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=392.04 Aligned_cols=249 Identities=25% Similarity=0.312 Sum_probs=199.0
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC---cccHHHHHH---HHHHHHhcCCCCcceeeeeeeeCCeeE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS---GQGIVEFKN---EVRLIAKLQHTNLVRLLGCSLHGEERL 502 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~---E~~~l~~l~h~niv~l~~~~~~~~~~~ 502 (752)
++|++.++||+|+||+||+++.. +|+.||||++.+.. ......+.+ ++.++..++|||||++++++.+.+..+
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 57899999999999999999875 58999999996431 222333333 456667789999999999999999999
Q ss_pred EEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceee
Q 043278 503 LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIF 582 (752)
Q Consensus 503 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~ 582 (752)
||||||++|+|..+|... ..+++..+..++.||+.||+|||+++ ||||||||+||||+.+|++||+|||+|+.+
T Consensus 269 lVmEy~~GGdL~~~l~~~---~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEECCCCSCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeec
Confidence 999999999999999653 35999999999999999999999998 999999999999999999999999999876
Q ss_pred cccccccccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccc
Q 043278 583 EVNESEANTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLEL 661 (752)
Q Consensus 583 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 661 (752)
.... ....+||+.|||||++.. ..|+.++|+|||||+||||++|+.||..........+ ....... .
T Consensus 343 ~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i---~~~i~~~-~---- 410 (689)
T 3v5w_A 343 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI---DRMTLTM-A---- 410 (689)
T ss_dssp SSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHH---HHHHHHC-C----
T ss_pred CCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHhhcCC-C----
Confidence 4332 334789999999999975 5799999999999999999999999976543322111 1111111 1
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 043278 662 IDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPT-----MPEVVCM 702 (752)
Q Consensus 662 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-----~~ev~~~ 702 (752)
..+ +......+.+|+.+||+.||.+|++ ++||.++
T Consensus 411 --~~~----p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 411 --VEL----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp --CCC----CTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred --CCC----CccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 011 1112235678999999999999998 6787764
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=368.74 Aligned_cols=258 Identities=25% Similarity=0.398 Sum_probs=211.4
Q ss_pred cCCCcCCeeecCCcccEEEEEec--------CCceeEEEEcccCC-cccHHHHHHHHHHHHhc-CCCCcceeeeeeeeCC
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA--------DEQEVAIKRLSRSS-GQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGE 499 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 499 (752)
++|.+.+.||+|+||.||+|+.. ++..||||+++... .....++.+|+.++.++ +||||+++++++.+.+
T Consensus 81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 160 (370)
T 2psq_A 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 160 (370)
T ss_dssp GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence 67888899999999999999852 34579999997653 23456789999999999 8999999999999999
Q ss_pred eeEEEEeeCCCCCHhHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEec
Q 043278 500 ERLLVYEFMPNKSLDFFLFNSGR-------------KNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLD 566 (752)
Q Consensus 500 ~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~ 566 (752)
..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+++ |+||||||+||||+
T Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~ 237 (370)
T 2psq_A 161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVT 237 (370)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEC
T ss_pred CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEEC
Confidence 99999999999999999976432 235899999999999999999999998 99999999999999
Q ss_pred CCCCceecccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcch
Q 043278 567 DKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNL 645 (752)
Q Consensus 567 ~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l 645 (752)
.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||....... +
T Consensus 238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~---~ 314 (370)
T 2psq_A 238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---L 314 (370)
T ss_dssp TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---H
T ss_pred CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---H
Confidence 999999999999987654433333344567889999999999999999999999999999999 999987654221 1
Q ss_pred HHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 646 IGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 646 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
...+..+..... +......+.+++.+||+.||.+|||+.|+++.|+.+
T Consensus 315 ----~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 315 ----FKLLKEGHRMDK---------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp ----HHHHHTTCCCCC---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----HHHHhcCCCCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 122222221111 112234577899999999999999999999999875
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=357.73 Aligned_cols=262 Identities=26% Similarity=0.434 Sum_probs=204.2
Q ss_pred HhcCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEE
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 505 (752)
..++|++.+.||+|+||+||+|+. .++.||||++.... .....++.+|+.++.+++||||+++++++.+.+..++||
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 356888899999999999999987 67889999987653 334467899999999999999999999999999999999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccc
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVN 585 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~ 585 (752)
||+++|+|.+++........+++..++.++.||+.||+|||+.+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 192 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST 192 (309)
T ss_dssp ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccccc
Confidence 99999999999975443445999999999999999999999875 34999999999999999999999999999854322
Q ss_pred ccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCC
Q 043278 586 ESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPS 665 (752)
Q Consensus 586 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 665 (752)
. .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ..............
T Consensus 193 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~------~~~~~~~~~~~~~~----- 259 (309)
T 3p86_A 193 F--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA------QVVAAVGFKCKRLE----- 259 (309)
T ss_dssp -----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH------HHHHHHHHSCCCCC-----
T ss_pred c--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhcCCCCC-----
Confidence 1 1223467899999999999999999999999999999999999999755421 11111111111111
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCC
Q 043278 666 LEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETM 708 (752)
Q Consensus 666 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~~ 708 (752)
+ +......+.+++.+||+.||.+|||+.|+++.|+.+..
T Consensus 260 ~----~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 260 I----PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp C----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred C----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1 11122357789999999999999999999999988754
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=364.38 Aligned_cols=268 Identities=25% Similarity=0.354 Sum_probs=209.4
Q ss_pred hcCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCC----eeEEE
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGE----ERLLV 504 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv 504 (752)
.++|++.++||+|+||.||+|+.. ++.||||++.... .....+..|+.++.+++||||+++++++.+.. ..++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 367888999999999999999875 7899999996543 23445667899999999999999999998754 46999
Q ss_pred EeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-------CCCcEeecCCCCCcEEecCCCCceecccc
Q 043278 505 YEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY-------SRLRVIHRDLKASNILLDDKMNPKISDFG 577 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-------~~~~iiH~Dikp~NIll~~~~~~kl~DFg 577 (752)
|||+++|+|.+++.. ..+++..+..++.||+.||+|||+. ...+|+||||||+|||++.++.+||+|||
T Consensus 101 ~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg 176 (322)
T 3soc_A 101 TAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176 (322)
T ss_dssp EECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred EecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence 999999999999954 3489999999999999999999987 01139999999999999999999999999
Q ss_pred cceeecccccccccccccccCCccChhhhcc-----CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHH-----
Q 043278 578 MARIFEVNESEANTKRIVGTYGYMSPEYAMS-----GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIG----- 647 (752)
Q Consensus 578 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~----- 647 (752)
+++...............||+.|+|||++.+ ..++.++||||||+++|||++|+.||.............
T Consensus 177 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 256 (322)
T 3soc_A 177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH 256 (322)
T ss_dssp TCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSS
T ss_pred cccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccC
Confidence 9987765444333445679999999999987 356678999999999999999999998765433221111
Q ss_pred ----HHHHHhhCCCcccccCCCCCC-CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 648 ----YAWQLLSDGKGLELIDPSLEQ-PCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 648 ----~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
........... .+.+.. .........+.+++.+||+.||++|||+.||++.|+.+
T Consensus 257 ~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 257 PSLEDMQEVVVHKKK----RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp CCHHHHHHHHTTSCC----CCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CchhhhhhhhhcccC----CCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11111111111 111111 11234556788999999999999999999999999864
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=356.03 Aligned_cols=258 Identities=23% Similarity=0.392 Sum_probs=210.4
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeC
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFM 508 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 508 (752)
++|.+.+.||+|+||+||++... +++.||+|++..........+.+|++++.+++||||+++++++.+++..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 57888899999999999999875 58899999997777777788999999999999999999999999999999999999
Q ss_pred CCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccc
Q 043278 509 PNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE 588 (752)
Q Consensus 509 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 588 (752)
++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 90 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 90 KGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp TTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred CCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 999999999653 345899999999999999999999998 999999999999999999999999999876433221
Q ss_pred c------------ccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCC
Q 043278 589 A------------NTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDG 656 (752)
Q Consensus 589 ~------------~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 656 (752)
. ......||+.|+|||.+.+..++.++||||||+++|||++|..|+.............. ......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~-~~~~~~- 242 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV-RGFLDR- 242 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCH-HHHHHH-
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhh-hccccc-
Confidence 1 11145789999999999999999999999999999999999999876543322111000 000000
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 657 KGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 657 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
...+ . ....+.+++.+|++.||++|||+.|+++.|+.+
T Consensus 243 ----~~~~----~----~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l 280 (310)
T 3s95_A 243 ----YCPP----N----CPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL 280 (310)
T ss_dssp ----TCCT----T----CCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----cCCC----C----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0001 1 112467899999999999999999999999876
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=352.83 Aligned_cols=251 Identities=25% Similarity=0.371 Sum_probs=208.6
Q ss_pred hcCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEee
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
.++|.+.+.||+|+||+||+|.. .+++.||||++..........+.+|+.++.+++||||+++++++..++..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46899999999999999999986 56889999999776666677889999999999999999999999999999999999
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccc
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES 587 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~ 587 (752)
+++++|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 99 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp CTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 9999999998542 4899999999999999999999998 99999999999999999999999999987653322
Q ss_pred ccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCC
Q 043278 588 EANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLE 667 (752)
Q Consensus 588 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 667 (752)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .........+. ..+
T Consensus 172 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~~~~~~~-~~~------ 236 (297)
T 3fxz_A 172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNGT-PEL------ 236 (297)
T ss_dssp --CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHHCS-CCC------
T ss_pred --ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCC-CCC------
Confidence 223467899999999999999999999999999999999999999765421 11111111111 011
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 668 QPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 668 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
..+......+.+++.+||+.||.+|||+.|++++
T Consensus 237 -~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 237 -QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp -SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -CCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0111223457789999999999999999999874
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=351.05 Aligned_cols=262 Identities=28% Similarity=0.364 Sum_probs=215.5
Q ss_pred ccccHHHHHHHhcC----------CCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCcccHHHHHHHHHHHHhcCCC
Q 043278 418 KIFDFQTIAAAANN----------FSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHT 486 (752)
Q Consensus 418 ~~~~~~~i~~~~~~----------~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ 486 (752)
..++++++..+++. |...+.||+|+||.||+|+.. +|+.||||++..........+.+|+.++.+++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 45788888887765 666789999999999999976 6899999999877767778899999999999999
Q ss_pred CcceeeeeeeeCCeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEec
Q 043278 487 NLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLD 566 (752)
Q Consensus 487 niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~ 566 (752)
||+++++++..++..++||||+++++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~ 175 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLT 175 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEC
Confidence 999999999999999999999999999998842 35899999999999999999999988 99999999999999
Q ss_pred CCCCceecccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchH
Q 043278 567 DKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLI 646 (752)
Q Consensus 567 ~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~ 646 (752)
.++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~------ 247 (321)
T 2c30_A 176 LDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV------ 247 (321)
T ss_dssp TTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------
T ss_pred CCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------
Confidence 999999999999987653321 223467899999999999999999999999999999999999999754321
Q ss_pred HHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 647 GYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 647 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
. ....+..... +.+.. .......+.+++.+||+.||++|||+.|+++.
T Consensus 248 ~-~~~~~~~~~~-----~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 248 Q-AMKRLRDSPP-----PKLKN--SHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp H-HHHHHHHSSC-----CCCTT--GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred H-HHHHHhcCCC-----CCcCc--cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1 1112222111 11111 11122356788899999999999999999885
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=360.00 Aligned_cols=259 Identities=27% Similarity=0.433 Sum_probs=207.7
Q ss_pred hcCCCcCCeeecCCcccEEEEEec----CCceeEEEEcccC-CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEE
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA----DEQEVAIKRLSRS-SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLL 503 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 503 (752)
.++|.+.+.||+|+||.||+|... .+..||||+++.. .......+.+|+.++.+++||||+++++++.+++..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 357888899999999999999874 3445999999765 33445678999999999999999999999999999999
Q ss_pred EEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeec
Q 043278 504 VYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFE 583 (752)
Q Consensus 504 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~ 583 (752)
||||+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 128 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 99999999999998543 345999999999999999999999998 9999999999999999999999999998765
Q ss_pred cccccc-ccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccc
Q 043278 584 VNESEA-NTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLEL 661 (752)
Q Consensus 584 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 661 (752)
...... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... .....+..+...
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-------~~~~~~~~~~~~-- 273 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR-------DVISSVEEGYRL-- 273 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-------HHHHHHHTTCCC--
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH-------HHHHHHHcCCCC--
Confidence 432211 1223455778999999999999999999999999999999 99998654321 112222222111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCC
Q 043278 662 IDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETM 708 (752)
Q Consensus 662 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~~ 708 (752)
+.+......+.+++.+||+.||.+|||+.||+++|+.+..
T Consensus 274 -------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~ 313 (325)
T 3kul_A 274 -------PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313 (325)
T ss_dssp -------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1112223467789999999999999999999999988643
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=365.36 Aligned_cols=257 Identities=28% Similarity=0.452 Sum_probs=198.0
Q ss_pred hcCCCcCCeeecCCcccEEEEEec----CCceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEE
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA----DEQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLL 503 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 503 (752)
.++|++.+.||+|+||.||+|+.. .+..||||+++... .....+|.+|+.++.+++||||+++++++.+++..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357899999999999999999865 56789999997653 3345679999999999999999999999999999999
Q ss_pred EEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeec
Q 043278 504 VYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFE 583 (752)
Q Consensus 504 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~ 583 (752)
||||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 124 v~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 99999999999999643 345899999999999999999999998 9999999999999999999999999998765
Q ss_pred cccccc-ccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccc
Q 043278 584 VNESEA-NTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLEL 661 (752)
Q Consensus 584 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 661 (752)
...... ......++..|+|||++.+..++.++||||||+++|||++ |+.||...... .....+..+..
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~-------~~~~~i~~~~~--- 268 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ-------DVIKAVDEGYR--- 268 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH-------HHHHHHHTTEE---
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCCC---
Confidence 432211 1222345778999999999999999999999999999998 99998654311 11122222211
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 662 IDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 662 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
.+.+......+.+++.+||+.||.+||++.||+++|+.+
T Consensus 269 ------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 269 ------LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp ------CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 111222335678899999999999999999999999875
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=369.00 Aligned_cols=257 Identities=26% Similarity=0.356 Sum_probs=208.6
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCc-ccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEe
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSG-QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYE 506 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 506 (752)
.++|.+.+.||+|+||.||+|+.. +++.||||.++.... ....+|.+|++++.+++||||+++++++.+++..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 357788899999999999999986 688999999875432 233468899999999999999999999999999999999
Q ss_pred eCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccc
Q 043278 507 FMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586 (752)
Q Consensus 507 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~ 586 (752)
|+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 193 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 193 LVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267 (377)
T ss_dssp CCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred cCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence 99999999998653 234899999999999999999999998 9999999999999999999999999998654332
Q ss_pred cccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCC
Q 043278 587 SEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPS 665 (752)
Q Consensus 587 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 665 (752)
.........++..|+|||.+....++.++||||||+++|||++ |+.||...... .....+..+.....
T Consensus 268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~-------~~~~~~~~~~~~~~---- 336 (377)
T 3cbl_A 268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ-------QTREFVEKGGRLPC---- 336 (377)
T ss_dssp EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH-------HHHHHHHTTCCCCC----
T ss_pred eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCCCCCC----
Confidence 2222222345778999999999999999999999999999998 99998765421 12222323221111
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 666 LEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 666 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
+......+.+++.+||+.||++|||+.++++.|+.+
T Consensus 337 -----~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 337 -----PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp -----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 111224577899999999999999999999999864
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=359.28 Aligned_cols=255 Identities=27% Similarity=0.420 Sum_probs=200.1
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCce----eEEEEcccC-CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQE----VAIKRLSRS-SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLL 503 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~----vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 503 (752)
++|+..++||+|+||+||+|+.. +++. ||+|.+... ......++.+|+.++.+++||||+++++++.++. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 57888899999999999999864 3443 588888644 3356678999999999999999999999998754 789
Q ss_pred EEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeec
Q 043278 504 VYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFE 583 (752)
Q Consensus 504 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~ 583 (752)
|+||+++|+|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 94 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 999999999999997643 45899999999999999999999998 9999999999999999999999999998765
Q ss_pred ccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCccccc
Q 043278 584 VNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELI 662 (752)
Q Consensus 584 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 662 (752)
............+|..|+|||.+.+..++.++||||||+++|||++ |+.||....... + ...+..+...
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~----~~~~~~~~~~--- 238 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---I----SSILEKGERL--- 238 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---H----HHHHHTTCCC---
T ss_pred CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---H----HHHHHcCCCC---
Confidence 4443333334566889999999999999999999999999999999 999997654221 1 1222222111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 663 DPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 663 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
..+......+.+++.+||+.||.+|||+.|++++|+.+
T Consensus 239 ------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 239 ------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp ------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred ------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 11122234577899999999999999999999999764
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=363.74 Aligned_cols=258 Identities=31% Similarity=0.435 Sum_probs=209.3
Q ss_pred cCCCcCCeeecCCcccEEEEEec------CCceeEEEEcccC-CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA------DEQEVAIKRLSRS-SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERL 502 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 502 (752)
++|.+.++||+|+||.||+|+.. .++.||||++... ......++.+|+.++.+++||||+++++++.++...+
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 57888899999999999999853 4568999999754 3344567889999999999999999999999999999
Q ss_pred EEEeeCCCCCHhHHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCC---Cceecc
Q 043278 503 LVYEFMPNKSLDFFLFNSG----RKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKM---NPKISD 575 (752)
Q Consensus 503 lv~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~---~~kl~D 575 (752)
+||||+++|+|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+||||+.++ .+||+|
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEECC
Confidence 9999999999999997643 2245899999999999999999999998 99999999999999555 599999
Q ss_pred cccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhh
Q 043278 576 FGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLS 654 (752)
Q Consensus 576 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~ 654 (752)
||+++...............+|+.|+|||.+.+..++.++|||||||++|||++ |+.||...... .....+.
T Consensus 228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~-------~~~~~i~ 300 (367)
T 3l9p_A 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ-------EVLEFVT 300 (367)
T ss_dssp CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-------HHHHHHH
T ss_pred CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHH
Confidence 999986543333333344667899999999999999999999999999999998 99998765421 1122222
Q ss_pred CCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 655 DGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 655 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
.+..... +......+.+|+.+||+.||.+|||+.||++.|+..
T Consensus 301 ~~~~~~~---------~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 301 SGGRMDP---------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp TTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCCC---------CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 2221111 111223577899999999999999999999999765
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=351.06 Aligned_cols=247 Identities=24% Similarity=0.365 Sum_probs=204.3
Q ss_pred cCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccC--CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEe
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRS--SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYE 506 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 506 (752)
++|.+.+.||+|+||.||+|+. .+|+.||||++... .......+.+|++++++++||||+++++++...+..++|||
T Consensus 15 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 94 (328)
T 3fe3_A 15 GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIME 94 (328)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEE
Confidence 5788899999999999999987 57899999998654 33345678899999999999999999999999999999999
Q ss_pred eCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccc
Q 043278 507 FMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586 (752)
Q Consensus 507 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~ 586 (752)
|+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 95 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 168 (328)
T 3fe3_A 95 YASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG 168 (328)
T ss_dssp CCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred CCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence 99999999998654 34899999999999999999999998 9999999999999999999999999997654322
Q ss_pred cccccccccccCCccChhhhccCCCC-ccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCC
Q 043278 587 SEANTKRIVGTYGYMSPEYAMSGIVS-IKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPS 665 (752)
Q Consensus 587 ~~~~~~~~~gt~~y~aPE~~~~~~~t-~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 665 (752)
......||+.|+|||++.+..++ .++|||||||++|||++|+.||..... ... ...+..+...
T Consensus 169 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~-~~~i~~~~~~------ 232 (328)
T 3fe3_A 169 ---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL------KEL-RERVLRGKYR------ 232 (328)
T ss_dssp ---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHH-HHHHHHCCCC------
T ss_pred ---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH------HHH-HHHHHhCCCC------
Confidence 22346799999999999988765 899999999999999999999976541 111 1222222110
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 666 LEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 666 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
+ +......+.+++.+|++.||.+|||++|++++
T Consensus 233 ~----p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 233 I----PFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp C----CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred C----CCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1 11122356788999999999999999999875
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=344.80 Aligned_cols=254 Identities=28% Similarity=0.416 Sum_probs=209.3
Q ss_pred cCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCC
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMP 509 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 509 (752)
++|.+.+.||+|+||.||++...+++.||+|++.... ...+++.+|+.++.+++||||+++++++.+++..++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 5688889999999999999999888999999997653 345679999999999999999999999999999999999999
Q ss_pred CCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccccc
Q 043278 510 NKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEA 589 (752)
Q Consensus 510 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 589 (752)
+++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 89 ~~~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 162 (269)
T 4hcu_A 89 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-T 162 (269)
T ss_dssp TCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-H
T ss_pred CCcHHHHHHhc--CcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccc-c
Confidence 99999998543 345899999999999999999999998 99999999999999999999999999986543321 1
Q ss_pred ccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCC
Q 043278 590 NTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQ 668 (752)
Q Consensus 590 ~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 668 (752)
......+++.|+|||.+.+..++.++||||||++++||++ |+.||...... .....+..+.. ...+
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~-------~~~~~~~~~~~--~~~~---- 229 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-------EVVEDISTGFR--LYKP---- 229 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHHHHHTTCC--CCCC----
T ss_pred cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH-------HHHHHHhcCcc--CCCC----
Confidence 2223456778999999999999999999999999999999 89998754421 11122222211 1111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 669 PCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 669 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
......+.+++.+|++.||.+|||+.|++++|+.+
T Consensus 230 ---~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 230 ---RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp ---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 11124577889999999999999999999999865
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=365.03 Aligned_cols=269 Identities=27% Similarity=0.391 Sum_probs=214.9
Q ss_pred ccHHHHHHHhcCCCcCCeeecCCcccEEEEEe------cCCceeEEEEcccCC-cccHHHHHHHHHHHHhc-CCCCccee
Q 043278 420 FDFQTIAAAANNFSTTNKLGEGGFGPVYKGKL------ADEQEVAIKRLSRSS-GQGIVEFKNEVRLIAKL-QHTNLVRL 491 (752)
Q Consensus 420 ~~~~~i~~~~~~~~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l 491 (752)
++..+.....++|.+.+.||+|+||.||+|+. .+++.||||++.... ......+.+|++++.++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 44555556678999999999999999999974 245789999997653 23446789999999999 88999999
Q ss_pred eeeeeeCC-eeEEEEeeCCCCCHhHHHhhcCC------------------------------------------------
Q 043278 492 LGCSLHGE-ERLLVYEFMPNKSLDFFLFNSGR------------------------------------------------ 522 (752)
Q Consensus 492 ~~~~~~~~-~~~lv~E~~~~gsL~~~l~~~~~------------------------------------------------ 522 (752)
++++.+.+ ..++||||+++|+|.+++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 99988755 48999999999999999976432
Q ss_pred ---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccc
Q 043278 523 ---------------KNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES 587 (752)
Q Consensus 523 ---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~ 587 (752)
...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 222899999999999999999999998 99999999999999999999999999987654433
Q ss_pred ccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCC
Q 043278 588 EANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666 (752)
Q Consensus 588 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 666 (752)
........||+.|+|||++.+..++.++||||||+++|||++ |+.||....... .....+..+.....
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~~~~~~~~~~~~----- 317 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEGTRMRA----- 317 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH------HHHHHHHHTCCCCC-----
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH------HHHHHHHcCCCCCC-----
Confidence 333445678899999999999999999999999999999998 999997654321 11222222221111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 667 EQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 667 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
+......+.+++..|++.||.+|||+.||+++|+.+
T Consensus 318 ----~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 318 ----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 111223577889999999999999999999999864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=353.46 Aligned_cols=263 Identities=26% Similarity=0.402 Sum_probs=213.9
Q ss_pred HHhcCCCcCCeeecCCcccEEEEEec------CCceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCC
Q 043278 427 AAANNFSTTNKLGEGGFGPVYKGKLA------DEQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGE 499 (752)
Q Consensus 427 ~~~~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 499 (752)
...++|.+.+.||+|+||.||+|+.. +++.||||+++... ......+.+|+.++.+++||||+++++++.+++
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 123 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence 34678999999999999999999874 34789999997653 334567899999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHhHHHhhcCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCC
Q 043278 500 ERLLVYEFMPNKSLDFFLFNSGR---------------------KNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDL 558 (752)
Q Consensus 500 ~~~lv~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Di 558 (752)
..++||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dl 200 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDL 200 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 99999999999999999976421 256899999999999999999999998 999999
Q ss_pred CCCcEEecCCCCceecccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCC
Q 043278 559 KASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRH 637 (752)
Q Consensus 559 kp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~ 637 (752)
||+|||++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 280 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 280 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence 99999999999999999999986644333233334567889999999999999999999999999999999 99998754
Q ss_pred CCCCCcchHHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCC
Q 043278 638 HPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETM 708 (752)
Q Consensus 638 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~~ 708 (752)
.. ......+..+..... +......+.+++.+||+.||.+|||+.||+++|+.+..
T Consensus 281 ~~-------~~~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 281 AH-------EEVIYYVRDGNILAC---------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp CH-------HHHHHHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred Ch-------HHHHHHHhCCCcCCC---------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 31 112223333332211 11122457789999999999999999999999998754
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=345.35 Aligned_cols=271 Identities=20% Similarity=0.255 Sum_probs=215.8
Q ss_pred cCCCcCCeeecCCcccEEEEEecC-CceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCC--eeEEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLAD-EQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGE--ERLLVY 505 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~ 505 (752)
++|.+.++||+|+||.||+|+... ++.||||++.... ......+.+|++++.+++||||+++++++.... ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 578889999999999999998754 8899999997543 345677889999999999999999999987765 779999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEe----cCCCCceeccccccee
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILL----DDKMNPKISDFGMARI 581 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll----~~~~~~kl~DFgla~~ 581 (752)
||+++++|.+++........+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 99999999999976555555999999999999999999999998 9999999999999 8888899999999987
Q ss_pred ecccccccccccccccCCccChhhhc--------cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHh
Q 043278 582 FEVNESEANTKRIVGTYGYMSPEYAM--------SGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLL 653 (752)
Q Consensus 582 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 653 (752)
...... .....||+.|+|||++. +..++.++||||||+++|||++|+.||......... .......+
T Consensus 166 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~ 240 (319)
T 4euu_A 166 LEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKII 240 (319)
T ss_dssp CCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC--HHHHHHHH
T ss_pred cCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh--HHHHHHHh
Confidence 653321 22356899999999986 578999999999999999999999999754432221 11112222
Q ss_pred hCC---Cccccc-----------CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCC
Q 043278 654 SDG---KGLELI-----------DPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETM 708 (752)
Q Consensus 654 ~~~---~~~~~~-----------d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~~ 708 (752)
... ....+. +.......+......+.+++.+||+.||++|||++|+++..++...
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~ 309 (319)
T 4euu_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (319)
T ss_dssp HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence 111 100000 0011123456677788899999999999999999999999987644
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=364.04 Aligned_cols=261 Identities=25% Similarity=0.364 Sum_probs=213.6
Q ss_pred hcCCCcCCeeecCCcccEEEEEec--------CCceeEEEEcccCC-cccHHHHHHHHHHHHhc-CCCCcceeeeeeeeC
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA--------DEQEVAIKRLSRSS-GQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHG 498 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 498 (752)
.++|.+.+.||+|+||.||+|+.. .+..||||++.... .....++.+|++++.++ +||||+++++++.++
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 467888999999999999999852 23579999997653 33456789999999999 999999999999999
Q ss_pred CeeEEEEeeCCCCCHhHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEe
Q 043278 499 EERLLVYEFMPNKSLDFFLFNSGR-------------KNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILL 565 (752)
Q Consensus 499 ~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll 565 (752)
+..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+.+ |+||||||+||||
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEE
Confidence 999999999999999999976432 245999999999999999999999998 9999999999999
Q ss_pred cCCCCceecccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcc
Q 043278 566 DDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLN 644 (752)
Q Consensus 566 ~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~ 644 (752)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||++++||++ |+.||.....
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~----- 299 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV----- 299 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH-----
Confidence 9999999999999987654433333444567889999999999999999999999999999999 9999865541
Q ss_pred hHHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCC
Q 043278 645 LIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETM 708 (752)
Q Consensus 645 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~~ 708 (752)
......+..+..... +......+.+++.+||+.||.+|||+.||++.|+.+..
T Consensus 300 --~~~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 352 (382)
T 3tt0_A 300 --EELFKLLKEGHRMDK---------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 352 (382)
T ss_dssp --HHHHHHHHTTCCCCC---------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --HHHHHHHHcCCCCCC---------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 122233333322111 11122457789999999999999999999999988743
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=342.70 Aligned_cols=257 Identities=25% Similarity=0.344 Sum_probs=211.1
Q ss_pred hcCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeC
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFM 508 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 508 (752)
.++|++.+.||+|+||.||+++..++..||+|++.... ....++.+|+.++.+++||||+++++++.+++..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 36788889999999999999999888899999997654 34567899999999999999999999999999999999999
Q ss_pred CCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccc
Q 043278 509 PNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE 588 (752)
Q Consensus 509 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 588 (752)
++++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.........
T Consensus 86 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 86 SNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp TTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred CCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 999999998653 235899999999999999999999998 999999999999999999999999999876543222
Q ss_pred cccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCC
Q 043278 589 ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLE 667 (752)
Q Consensus 589 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 667 (752)
. .....+++.|+|||.+.+..++.++||||||++++||++ |+.||...... ........+.. ...+.
T Consensus 161 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~~~~~~~--~~~~~-- 228 (268)
T 3sxs_A 161 S-SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS-------EVVLKVSQGHR--LYRPH-- 228 (268)
T ss_dssp E-CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH-------HHHHHHHTTCC--CCCCT--
T ss_pred c-ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH-------HHHHHHHcCCC--CCCCC--
Confidence 1 223456778999999999999999999999999999999 99998654421 11112222211 11111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCC
Q 043278 668 QPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETM 708 (752)
Q Consensus 668 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~~ 708 (752)
.....+.+++.+|++.||.+|||+.|+++.|+.+..
T Consensus 229 -----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 229 -----LASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp -----TSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred -----cChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 112357789999999999999999999999998743
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=351.43 Aligned_cols=259 Identities=29% Similarity=0.434 Sum_probs=212.2
Q ss_pred hcCCCcCCeeecCCcccEEEEEe------cCCceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCee
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKL------ADEQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEER 501 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 501 (752)
.++|.+.+.||+|+||.||++.. .+++.||||++.... .....++.+|+.++.+++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 46788889999999999999985 235789999997643 33456789999999999999999999999999999
Q ss_pred EEEEeeCCCCCHhHHHhhcCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCC
Q 043278 502 LLVYEFMPNKSLDFFLFNSGR---------------------KNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKA 560 (752)
Q Consensus 502 ~lv~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp 560 (752)
++||||+++++|.+++..... ...+++..++.++.||+.||+|||+++ |+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccch
Confidence 999999999999999976432 234899999999999999999999998 99999999
Q ss_pred CcEEecCCCCceecccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCC
Q 043278 561 SNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHP 639 (752)
Q Consensus 561 ~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~ 639 (752)
+|||++.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987654443333344567889999999999999999999999999999999 9999976543
Q ss_pred CCCcchHHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 640 DRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 640 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
.. + ...+..+..... +......+.+++.+|++.||.+|||+.|+++.|+.+
T Consensus 259 ~~---~----~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 259 ER---L----FNLLKTGHRMER---------PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp GG---H----HHHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HH---H----HHHhhcCCcCCC---------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 21 1 122222221111 112234577899999999999999999999999865
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=351.13 Aligned_cols=253 Identities=23% Similarity=0.351 Sum_probs=203.6
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCc-ccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEee
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSG-QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
++|++.+.||+|+||.||+++.. +++.||||++..... ...+.+.+|+.++.+++||||+++++++.+++..++||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 57888999999999999999875 688999999865432 2345688999999999999999999999999999999999
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccc
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES 587 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~ 587 (752)
+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 87 ~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 87 CSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp CTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred CCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence 999999998843 345999999999999999999999998 99999999999999999999999999987654443
Q ss_pred ccccccccccCCccChhhhccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCC
Q 043278 588 EANTKRIVGTYGYMSPEYAMSGIV-SIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666 (752)
Q Consensus 588 ~~~~~~~~gt~~y~aPE~~~~~~~-t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 666 (752)
........||+.|+|||++.+..+ +.++||||||+++|||++|+.||......... ...+..... ...+
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~------~~~~~~~~~--~~~~-- 230 (323)
T 3tki_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE------YSDWKEKKT--YLNP-- 230 (323)
T ss_dssp ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH------HHHHHTTCT--TSTT--
T ss_pred ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH------HHHHhcccc--cCCc--
Confidence 333445789999999999988775 78999999999999999999999765432111 111111110 0010
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 667 EQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 667 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.......+.+++.+||+.||.+|||+.|+++.
T Consensus 231 ----~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 231 ----WKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp ----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ----cccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 11122456788999999999999999999876
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=343.99 Aligned_cols=261 Identities=22% Similarity=0.327 Sum_probs=203.8
Q ss_pred hcCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHh--cCCCCcceeeeeeee----CCeeE
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAK--LQHTNLVRLLGCSLH----GEERL 502 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~----~~~~~ 502 (752)
.++|.+.+.||+|+||+||+|+. +++.||||++... ....+..|.+++.. ++||||+++++++.. ....+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46888999999999999999988 6889999998653 34556677777776 799999999998654 34578
Q ss_pred EEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCcEeecCCCCCcEEecCCCCceec
Q 043278 503 LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLH--------KYSRLRVIHRDLKASNILLDDKMNPKIS 574 (752)
Q Consensus 503 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~~~~iiH~Dikp~NIll~~~~~~kl~ 574 (752)
+||||+++|+|.+++. ...+++..++.++.||+.||+||| +.+ |+||||||+|||++.++.+||+
T Consensus 83 lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred EehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence 9999999999999993 345999999999999999999999 655 9999999999999999999999
Q ss_pred ccccceeecccccc--cccccccccCCccChhhhccC------CCCccchhHHHHHHHHHHHhC----------CCCCCC
Q 043278 575 DFGMARIFEVNESE--ANTKRIVGTYGYMSPEYAMSG------IVSIKTDVFSFGVLVLEIVSG----------QKNHTR 636 (752)
Q Consensus 575 DFgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~t~k~DV~S~G~vl~elltG----------~~p~~~ 636 (752)
|||+++........ .......||+.|+|||.+.+. .++.++||||||+++|||++| +.||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 99999876543222 112335789999999999876 456799999999999999999 777765
Q ss_pred CCCCCCcchHHHHHHHhhCCCcccccCCCCC-CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 637 HHPDRPLNLIGYAWQLLSDGKGLELIDPSLE-QPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 637 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
........ ............ .+.+. ...+......+.+++.+||+.||++|||+.||++.|+.+
T Consensus 236 ~~~~~~~~--~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 236 VVPNDPSF--EDMRKVVCVDQQ----RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TSCSSCCH--HHHHHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCcch--hhhhHHHhccCC----CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 54333221 111222211111 11111 112334667888999999999999999999999999864
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=369.72 Aligned_cols=263 Identities=28% Similarity=0.431 Sum_probs=207.8
Q ss_pred cCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCC
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMP 509 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 509 (752)
++|.+.++||+|+||.||+|...++..||||+++... ...++|.+|+.++.+++||||+++++++.+ +..++||||++
T Consensus 184 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~ 261 (452)
T 1fmk_A 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 261 (452)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred hHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhc
Confidence 5677789999999999999999888889999997654 346789999999999999999999999876 67899999999
Q ss_pred CCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccccc
Q 043278 510 NKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEA 589 (752)
Q Consensus 510 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 589 (752)
+|+|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++....... .
T Consensus 262 ~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-~ 336 (452)
T 1fmk_A 262 KGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-T 336 (452)
T ss_dssp TCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCce-e
Confidence 99999999542 1235899999999999999999999998 99999999999999999999999999987643221 1
Q ss_pred ccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCC
Q 043278 590 NTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQ 668 (752)
Q Consensus 590 ~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 668 (752)
......++..|+|||.+....++.++||||||+++|||++ |+.||...... .....+..+....
T Consensus 337 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~-------~~~~~i~~~~~~~-------- 401 (452)
T 1fmk_A 337 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-------EVLDQVERGYRMP-------- 401 (452)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------HHHHHHHTTCCCC--------
T ss_pred cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCCCCC--------
Confidence 1223456788999999999999999999999999999999 89998754321 1122222222111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCCCCCCCCC
Q 043278 669 PCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETMPLPPPKQ 715 (752)
Q Consensus 669 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~~~~~~p~~ 715 (752)
.+......+.+++.+||+.||++|||++++++.|+......+++.+
T Consensus 402 -~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~~~ 447 (452)
T 1fmk_A 402 -CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQ 447 (452)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCC
T ss_pred -CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCcccc
Confidence 1122234577899999999999999999999999987654444433
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=357.58 Aligned_cols=264 Identities=23% Similarity=0.382 Sum_probs=205.5
Q ss_pred hcCCCcCCeeecCCcccEEEEEe-----cCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeC--Cee
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKL-----ADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHG--EER 501 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 501 (752)
.++|++.++||+|+||+||++++ .+++.||||++..........+.+|+.++.+++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 36788889999999999999984 35789999999877666677899999999999999999999998653 458
Q ss_pred EEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceeccccccee
Q 043278 502 LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARI 581 (752)
Q Consensus 502 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~ 581 (752)
++||||+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 9999999999999999654 234899999999999999999999988 99999999999999999999999999987
Q ss_pred ecccccc-cccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCC---------CCCcchHHHHHH
Q 043278 582 FEVNESE-ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHP---------DRPLNLIGYAWQ 651 (752)
Q Consensus 582 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~---------~~~~~l~~~~~~ 651 (752)
....... .......++..|+|||.+.+..++.++||||||+++|||++|..|+..... ............
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence 6543221 122234567789999999999999999999999999999999988754321 000111111122
Q ss_pred HhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 652 LLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 652 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
.+..+... +.+......+.+++.+||+.||++|||+.|+++.|+.+
T Consensus 244 ~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l 289 (295)
T 3ugc_A 244 LLKNNGRL---------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289 (295)
T ss_dssp HHHTTCCC---------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhccCcC---------CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 22222111 11222234677899999999999999999999999875
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=370.81 Aligned_cols=257 Identities=28% Similarity=0.416 Sum_probs=209.5
Q ss_pred hcCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeC
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFM 508 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 508 (752)
.++|.+.+.||+|+||.||+|...++..||||+++... ...++|.+|+.++.+++||||+++++++. .+..++||||+
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~ 264 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFM 264 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeec
Confidence 35677889999999999999999888999999997654 45778999999999999999999999986 56789999999
Q ss_pred CCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccc
Q 043278 509 PNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE 588 (752)
Q Consensus 509 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 588 (752)
++|+|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++........
T Consensus 265 ~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 340 (454)
T 1qcf_A 265 AKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 340 (454)
T ss_dssp TTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHH
T ss_pred CCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCcee
Confidence 9999999996432 234789999999999999999999998 999999999999999999999999999865432211
Q ss_pred cccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCC
Q 043278 589 ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLE 667 (752)
Q Consensus 589 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 667 (752)
......++..|+|||++....++.++||||||++||||++ |+.||...... .....+..+....
T Consensus 341 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~-------~~~~~i~~~~~~~------- 405 (454)
T 1qcf_A 341 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-------EVIRALERGYRMP------- 405 (454)
T ss_dssp -TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-------HHHHHHHHTCCCC-------
T ss_pred -ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCCCCC-------
Confidence 1223446788999999999999999999999999999999 99999754321 1112222221111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCC
Q 043278 668 QPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETM 708 (752)
Q Consensus 668 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~~ 708 (752)
.+......+.+++.+||+.||++|||+.+|++.|+....
T Consensus 406 --~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 406 --RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred --CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 111223457789999999999999999999999998754
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=371.14 Aligned_cols=256 Identities=26% Similarity=0.399 Sum_probs=211.4
Q ss_pred cCCCcCCeeecCCcccEEEEEecC-CceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeC
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLAD-EQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFM 508 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 508 (752)
++|.+.++||+|+||.||+|+... +..||||+++... ...++|.+|+.++.+++||||++++++|.+.+..+|||||+
T Consensus 220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~ 298 (495)
T 1opk_A 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 298 (495)
T ss_dssp GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEcc
Confidence 567788999999999999999865 7889999997653 35678999999999999999999999999999999999999
Q ss_pred CCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccc
Q 043278 509 PNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE 588 (752)
Q Consensus 509 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 588 (752)
++|+|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.......
T Consensus 299 ~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~- 373 (495)
T 1opk_A 299 TYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY- 373 (495)
T ss_dssp TTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE-
T ss_pred CCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCce-
Confidence 9999999997543 345899999999999999999999998 99999999999999999999999999987643321
Q ss_pred cccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCC
Q 043278 589 ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLE 667 (752)
Q Consensus 589 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 667 (752)
.......++..|+|||.+....++.++||||||++||||++ |+.||....... . .+.+..+...
T Consensus 374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~---~----~~~~~~~~~~-------- 438 (495)
T 1opk_A 374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---V----YELLEKDYRM-------- 438 (495)
T ss_dssp ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---H----HHHHHTTCCC--------
T ss_pred eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH---H----HHHHHcCCCC--------
Confidence 11223456788999999999999999999999999999999 999987654221 1 1222222111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCC
Q 043278 668 QPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNET 707 (752)
Q Consensus 668 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~ 707 (752)
..+......+.+|+.+||+.||.+|||+.||++.|+.+.
T Consensus 439 -~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 439 -ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred -CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 111222345778999999999999999999999999864
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=353.39 Aligned_cols=261 Identities=25% Similarity=0.408 Sum_probs=194.4
Q ss_pred HhcCCCcCCeeecCCcccEEEEEecCCc----eeEEEEcccC--CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCee
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGKLADEQ----EVAIKRLSRS--SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEER 501 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~----~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 501 (752)
..++|++.+.||+|+||.||+|+..... .||||++... .....+++.+|+.++++++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 3468999999999999999999875432 7999999765 334567899999999999999999999999877655
Q ss_pred ------EEEEeeCCCCCHhHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCce
Q 043278 502 ------LLVYEFMPNKSLDFFLFNSG---RKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPK 572 (752)
Q Consensus 502 ------~lv~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~k 572 (752)
++||||+++|+|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEE
Confidence 99999999999999986532 2225899999999999999999999998 99999999999999999999
Q ss_pred ecccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHH
Q 043278 573 ISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQ 651 (752)
Q Consensus 573 l~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~ 651 (752)
|+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... . ..
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~----~~ 250 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE---I----YN 250 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---H----HH
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH---H----HH
Confidence 999999987654433333334556788999999999999999999999999999999 899987654321 1 11
Q ss_pred HhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCC
Q 043278 652 LLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNET 707 (752)
Q Consensus 652 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~ 707 (752)
.+..+.... .+......+.+++.+|++.||.+|||+.|+++.|+.+.
T Consensus 251 ~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l 297 (323)
T 3qup_A 251 YLIGGNRLK---------QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENIL 297 (323)
T ss_dssp HHHTTCCCC---------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhcCCCCC---------CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 122221111 11122245778999999999999999999999998763
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=346.00 Aligned_cols=260 Identities=20% Similarity=0.232 Sum_probs=208.1
Q ss_pred hcCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCCcccHHHHHHHHHHHHhc-CCCCcceeeeeeeeCCeeEEEEe
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGEERLLVYE 506 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E 506 (752)
.++|.+.+.||+|+||.||+|+. .+++.||||++..... ..++.+|+.++.++ +|+||+++++++..++..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 36788899999999999999986 5688999999875432 23578999999999 99999999999999999999999
Q ss_pred eCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCC-----ceeccccccee
Q 043278 507 FMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMN-----PKISDFGMARI 581 (752)
Q Consensus 507 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~-----~kl~DFgla~~ 581 (752)
|+ +++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+++.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 99999998654 346999999999999999999999998 999999999999998887 99999999987
Q ss_pred eccccccc-----ccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCC
Q 043278 582 FEVNESEA-----NTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDG 656 (752)
Q Consensus 582 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 656 (752)
........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||......................
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~ 239 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT 239 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence 64432211 1235689999999999999999999999999999999999999998765433222221111111000
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 657 KGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 657 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
. .+. +... ...+.+++..|++.||.+||++.+|++.|+.+
T Consensus 240 ~-~~~----~~~~-----~p~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 240 P-IEV----LCEN-----FPEMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp C-HHH----HTTT-----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred C-HHH----Hhcc-----ChHHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 0 000 0000 11678899999999999999999999998754
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=346.24 Aligned_cols=263 Identities=24% Similarity=0.317 Sum_probs=202.5
Q ss_pred hcCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCCc--ccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEe
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSG--QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYE 506 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 506 (752)
.++|.+.++||+|+||+||+++..+++.||+|++..... .....+.+|+.++++++||||+++++++.+++..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 367888999999999999999998899999999875432 234678899999999999999999999999999999999
Q ss_pred eCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccc
Q 043278 507 FMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586 (752)
Q Consensus 507 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~ 586 (752)
|+++ +|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 100 FMEK-DLKKVLDEN--KTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp CCSE-EHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred CCCC-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 9985 777777543 345899999999999999999999998 9999999999999999999999999998754322
Q ss_pred cccccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCccc---cc
Q 043278 587 SEANTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLE---LI 662 (752)
Q Consensus 587 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~---~~ 662 (752)
. ......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||......... ......+....... ..
T Consensus 174 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~~~ 248 (311)
T 3niz_A 174 R--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQL---PKIFSILGTPNPREWPQVQ 248 (311)
T ss_dssp C-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHH---HHHHHHHCCCCTTTSGGGT
T ss_pred c--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHHCCCChHHhhhhh
Confidence 1 1223568999999999876 56899999999999999999999999876544322 22222221111000 00
Q ss_pred ------CCC--CCCCCCH-----HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 663 ------DPS--LEQPCSA-----NEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 663 ------d~~--l~~~~~~-----~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
+.. .....+. .....+.+++.+|++.||++|||++|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 000 0000011 112457789999999999999999999874
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=354.02 Aligned_cols=256 Identities=25% Similarity=0.370 Sum_probs=202.5
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCce----eEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQE----VAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLL 503 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~----vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 503 (752)
++|.+.+.||+|+||.||+|+.. +++. ||+|.+.... ......+.+|+.++.+++||||+++++++. ++..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 57788899999999999999864 4444 7888775442 233456788999999999999999999986 566889
Q ss_pred EEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeec
Q 043278 504 VYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFE 583 (752)
Q Consensus 504 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~ 583 (752)
||||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 92 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence 99999999999998643 346899999999999999999999998 9999999999999999999999999998765
Q ss_pred ccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCccccc
Q 043278 584 VNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELI 662 (752)
Q Consensus 584 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 662 (752)
............++..|+|||.+.+..++.++||||||+++|||++ |+.||....... ....+..+.....
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~~~- 238 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE-------VPDLLEKGERLAQ- 238 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH-------HHHHHHTTCBCCC-
T ss_pred cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH-------HHHHHHcCCCCCC-
Confidence 4443333445677889999999999999999999999999999999 999997654321 1122222221111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCC
Q 043278 663 DPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNET 707 (752)
Q Consensus 663 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~ 707 (752)
+.. ....+.+++.+||+.||.+|||+.|++++|+.+.
T Consensus 239 -~~~-------~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 239 -PQI-------CTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp -CTT-------BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred -CCc-------CcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 110 1123567889999999999999999999998764
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=355.10 Aligned_cols=263 Identities=26% Similarity=0.401 Sum_probs=210.9
Q ss_pred HhcCCCcCCeeecCCcccEEEEEe------cCCceeEEEEcccCC-cccHHHHHHHHHHHHhc-CCCCcceeeeeeeeCC
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGKL------ADEQEVAIKRLSRSS-GQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGE 499 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 499 (752)
..++|.+.+.||+|+||.||+|+. ..+..||||++.... ......+.+|+.++.++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 357889999999999999999986 235679999997542 33456789999999999 8999999999999999
Q ss_pred eeEEEEeeCCCCCHhHHHhhcCCC--------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCC
Q 043278 500 ERLLVYEFMPNKSLDFFLFNSGRK--------------------NVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLK 559 (752)
Q Consensus 500 ~~~lv~E~~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dik 559 (752)
..++||||+++|+|.+++...... ..+++..++.++.||+.||+|||+.+ |+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 999999999999999999754321 34899999999999999999999998 9999999
Q ss_pred CCcEEecCCCCceecccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 043278 560 ASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHH 638 (752)
Q Consensus 560 p~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~ 638 (752)
|+|||++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999987654433333344567889999999999999999999999999999998 999997654
Q ss_pred CCCCcchHHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCC
Q 043278 639 PDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETM 708 (752)
Q Consensus 639 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~~ 708 (752)
... .....+..+.... .+......+.+++.+||+.||.+|||+.|++++|+....
T Consensus 280 ~~~------~~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 280 VDA------NFYKLIQNGFKMD---------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp CSH------HHHHHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred cHH------HHHHHHhcCCCCC---------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 321 1122222221111 111123457789999999999999999999999988654
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=340.46 Aligned_cols=253 Identities=28% Similarity=0.415 Sum_probs=196.0
Q ss_pred cCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCCc----ccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSG----QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 505 (752)
++|+..+.||+|+||.||+|... ++.||||++..... ...+.+.+|++++.+++||||+++++++.+++..++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 57888899999999999999974 78899999875432 33567899999999999999999999999999999999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecC--------CCCceecccc
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDD--------KMNPKISDFG 577 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~--------~~~~kl~DFg 577 (752)
||+++++|.+++. ...+++..+..++.|++.||+|||+++..+|+||||||+|||++. ++.+||+|||
T Consensus 86 e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 86 EFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp ECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 9999999999883 346899999999999999999999987666999999999999986 7789999999
Q ss_pred cceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCC
Q 043278 578 MARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGK 657 (752)
Q Consensus 578 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 657 (752)
+++...... .....|++.|+|||.+.+..++.++||||||++++||++|+.||...... ...........
T Consensus 162 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~ 231 (271)
T 3dtc_A 162 LAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL------AVAYGVAMNKL 231 (271)
T ss_dssp C-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH------HHHHHHHTSCC
T ss_pred ccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHhhhcCCC
Confidence 998654322 12356899999999999999999999999999999999999999754311 11111111111
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 658 GLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 658 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
.. . .+......+.+++.+|++.||.+|||+.|++++|+.+
T Consensus 232 ~~-----~----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 232 AL-----P----IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp CC-----C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CC-----C----CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 11 1 1112234577899999999999999999999999853
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=343.75 Aligned_cols=255 Identities=26% Similarity=0.404 Sum_probs=206.7
Q ss_pred hcCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeC
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFM 508 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 508 (752)
.++|.+.+.||+|+||.||+++..++..||+|++.... ....++.+|++++.+++|+||+++++++.+++..++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 46788889999999999999999888899999997653 34577899999999999999999999999999999999999
Q ss_pred CCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccc
Q 043278 509 PNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE 588 (752)
Q Consensus 509 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 588 (752)
++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 102 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~- 175 (283)
T 3gen_A 102 ANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY- 175 (283)
T ss_dssp TTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH-
T ss_pred CCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccccc-
Confidence 999999999653 345999999999999999999999998 99999999999999999999999999986543221
Q ss_pred cccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCC
Q 043278 589 ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLE 667 (752)
Q Consensus 589 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 667 (752)
.......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... .....+..+... ..+
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~-------~~~~~~~~~~~~--~~~--- 243 (283)
T 3gen_A 176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-------ETAEHIAQGLRL--YRP--- 243 (283)
T ss_dssp HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-------HHHHHHHTTCCC--CCC---
T ss_pred ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh-------HHHHHHhcccCC--CCC---
Confidence 11223456788999999999999999999999999999998 99998765421 111222222111 111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 668 QPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 668 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
......+.+++.+||+.||.+|||+.|+++.|+.+
T Consensus 244 ----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 244 ----HLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp ----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 11124577899999999999999999999999764
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=340.64 Aligned_cols=262 Identities=27% Similarity=0.388 Sum_probs=201.9
Q ss_pred cCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCC
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMP 509 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 509 (752)
++|++.+.||+|+||.||+++.. ++.||||++... .....+.+|++++.+++||||+++++++.+ ..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence 56778899999999999999874 688999999653 345678999999999999999999998873 4799999999
Q ss_pred CCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCC-ceecccccceeecccccc
Q 043278 510 NKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMN-PKISDFGMARIFEVNESE 588 (752)
Q Consensus 510 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~-~kl~DFgla~~~~~~~~~ 588 (752)
+++|.+++........+++..++.++.||++||+|||+.+..+|+||||||+|||++.++. +||+|||++......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 9999999976554456889999999999999999999943334999999999999998887 799999999754322
Q ss_pred cccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCC
Q 043278 589 ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQ 668 (752)
Q Consensus 589 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 668 (752)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .....+. ...+..... ..
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~~-~~~~~~~~~-----~~ 227 (307)
T 2eva_A 160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP----AFRIMWA-VHNGTRPPL-----IK 227 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS----HHHHHHH-HHTTCCCCC-----BT
T ss_pred --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc----HHHHHHH-HhcCCCCCc-----cc
Confidence 12346899999999999999999999999999999999999999754321 1111111 122221111 11
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCCCCCCCCC
Q 043278 669 PCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETMPLPPPKQ 715 (752)
Q Consensus 669 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~~~~~~p~~ 715 (752)
.. ...+.+++.+|++.||.+|||+.|++++|+.+....+.+..
T Consensus 228 ~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~ 270 (307)
T 2eva_A 228 NL----PKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADE 270 (307)
T ss_dssp TC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTS
T ss_pred cc----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCC
Confidence 12 23567899999999999999999999999876443443333
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=342.80 Aligned_cols=261 Identities=24% Similarity=0.377 Sum_probs=205.9
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCc---ccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEE
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSG---QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLV 504 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 504 (752)
.++|++.+.||+|+||.||+++.. .++.||+|++..... .....+.+|+.++.+++||||+++++++.+++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 357888999999999999999864 588999999865432 3346789999999999999999999999999999999
Q ss_pred EeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecc
Q 043278 505 YEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~ 584 (752)
|||+++++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 90 ~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 9999999999998653 35899999999999999999999998 99999999999999999999999999986543
Q ss_pred cccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCC
Q 043278 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDP 664 (752)
Q Consensus 585 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 664 (752)
... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ............ ... ..
T Consensus 164 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~~~~-~~~-~~ 234 (294)
T 4eqm_A 164 TSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA------VSIAIKHIQDSV-PNV-TT 234 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH------HHHHHHHHSSCC-CCH-HH
T ss_pred ccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhhccC-CCc-ch
Confidence 221 223346789999999999999999999999999999999999999976541 111222222211 110 00
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHhhcCCC
Q 043278 665 SLEQPCSANEVMRCIHVGLLCVQDQAMDRP-TMPEVVCMLQNETM 708 (752)
Q Consensus 665 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-t~~ev~~~L~~~~~ 708 (752)
.. .......+.+++.+|++.||.+|| +++++.+.|+....
T Consensus 235 ~~----~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 235 DV----RKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp HS----CTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred hc----ccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 01 111234577899999999999999 99999999987643
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=345.06 Aligned_cols=248 Identities=23% Similarity=0.270 Sum_probs=204.4
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccC---CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRS---SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 505 (752)
++|++.+.||+|+||.||+++.. +++.||+|++++. .......+.+|+.++.+++||||+++++++...+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 57888999999999999999875 5889999999754 2345667899999999999999999999999999999999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccc
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVN 585 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~ 585 (752)
||+++|+|..++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 85 E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 85 EYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 999999999988643 35899999999999999999999998 999999999999999999999999999853322
Q ss_pred ccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCC
Q 043278 586 ESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPS 665 (752)
Q Consensus 586 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 665 (752)
. .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ........ +.. .
T Consensus 159 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~~i~~-~~~------~ 223 (337)
T 1o6l_A 159 G--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------RLFELILM-EEI------R 223 (337)
T ss_dssp T--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHH-CCC------C
T ss_pred C--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH------HHHHHHHc-CCC------C
Confidence 1 2233568999999999999999999999999999999999999999754311 11111221 111 1
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 043278 666 LEQPCSANEVMRCIHVGLLCVQDQAMDRP-----TMPEVVCM 702 (752)
Q Consensus 666 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~ev~~~ 702 (752)
+ +......+.+++.+||+.||.+|| +++|++++
T Consensus 224 ~----p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 224 F----PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp C----CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred C----CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 1 111223567889999999999999 89999875
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=361.92 Aligned_cols=249 Identities=26% Similarity=0.382 Sum_probs=204.6
Q ss_pred cCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCC-eeEEEEeeC
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGE-ERLLVYEFM 508 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~E~~ 508 (752)
++|.+.+.||+|+||.||+|... ++.||||+++... ...+|.+|+.++.+++||||+++++++.+.+ ..++||||+
T Consensus 193 ~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~ 269 (450)
T 1k9a_A 193 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269 (450)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred HHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence 56778899999999999999985 6799999997653 4567999999999999999999999987765 789999999
Q ss_pred CCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccc
Q 043278 509 PNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE 588 (752)
Q Consensus 509 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 588 (752)
++|+|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 270 ~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--- 342 (450)
T 1k9a_A 270 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 342 (450)
T ss_dssp TTCBHHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc---
Confidence 9999999997643 345799999999999999999999998 999999999999999999999999999854321
Q ss_pred cccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCC
Q 043278 589 ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLE 667 (752)
Q Consensus 589 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 667 (752)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||....... . ...+..+....
T Consensus 343 --~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~----~~~i~~~~~~~------- 406 (450)
T 1k9a_A 343 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---V----VPRVEKGYKMD------- 406 (450)
T ss_dssp ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---H----HHHHHTTCCCC-------
T ss_pred --ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---H----HHHHHcCCCCC-------
Confidence 112356789999999999999999999999999999999 999997655332 1 12222222111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 668 QPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 668 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
.+......+.+++.+||+.||.+|||+.|+++.|+.+
T Consensus 407 --~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i 443 (450)
T 1k9a_A 407 --APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443 (450)
T ss_dssp --CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1112234577899999999999999999999999864
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=347.98 Aligned_cols=260 Identities=25% Similarity=0.401 Sum_probs=211.4
Q ss_pred hcCCCcCCeeecCCcccEEEEEe------cCCceeEEEEcccCCc-ccHHHHHHHHHHHHhc-CCCCcceeeeeeeeCCe
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKL------ADEQEVAIKRLSRSSG-QGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGEE 500 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 500 (752)
.++|.+.+.||+|+||.||+|+. .+++.||||++..... .....+.+|+.++.++ +||||+++++++.+++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 36788899999999999999985 3467899999976533 3456789999999999 99999999999999999
Q ss_pred eEEEEeeCCCCCHhHHHhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEe
Q 043278 501 RLLVYEFMPNKSLDFFLFNSGR---------------KNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILL 565 (752)
Q Consensus 501 ~~lv~E~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll 565 (752)
.++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+.+ |+||||||+|||+
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence 9999999999999999976432 224899999999999999999999998 9999999999999
Q ss_pred cCCCCceecccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcc
Q 043278 566 DDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLN 644 (752)
Q Consensus 566 ~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~ 644 (752)
+.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||++++||++ |+.||.......
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--- 255 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS--- 255 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH---
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh---
Confidence 9999999999999987654433333344567889999999999999999999999999999999 999987654321
Q ss_pred hHHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 645 LIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 645 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
........+... . .+......+.+++.+|++.||.+|||+.|++++|+..
T Consensus 256 ---~~~~~~~~~~~~-----~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 305 (313)
T 1t46_A 256 ---KFYKMIKEGFRM-----L----SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (313)
T ss_dssp ---HHHHHHHHTCCC-----C----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHHhccCCCC-----C----CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 111122211110 0 0111224577899999999999999999999999865
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=348.25 Aligned_cols=264 Identities=26% Similarity=0.417 Sum_probs=213.1
Q ss_pred HHHhcCCCcCCeeecCCcccEEEEEec------CCceeEEEEcccCCc-ccHHHHHHHHHHHHhcCCCCcceeeeeeeeC
Q 043278 426 AAAANNFSTTNKLGEGGFGPVYKGKLA------DEQEVAIKRLSRSSG-QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHG 498 (752)
Q Consensus 426 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 498 (752)
....++|.+.+.||+|+||.||+|+.. .++.||||.+..... ....++.+|+.++.+++|+||+++++++.++
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 100 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 100 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence 345678999999999999999999764 367899999976532 3445688999999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHhHHHhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCc
Q 043278 499 EERLLVYEFMPNKSLDFFLFNSG-------RKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNP 571 (752)
Q Consensus 499 ~~~~lv~E~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~ 571 (752)
+..++||||+++++|.+++.... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCE
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeE
Confidence 99999999999999999986532 1245789999999999999999999998 9999999999999999999
Q ss_pred eecccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHH
Q 043278 572 KISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAW 650 (752)
Q Consensus 572 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~ 650 (752)
||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ....
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------~~~~ 250 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-------EQVL 250 (322)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-------HHHH
T ss_pred EECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH-------HHHH
Confidence 9999999986554333333334567889999999999999999999999999999999 8888865431 1112
Q ss_pred HHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCC
Q 043278 651 QLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETM 708 (752)
Q Consensus 651 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~~ 708 (752)
..+..+..... +......+.+++.+|++.||.+|||+.|+++.|+....
T Consensus 251 ~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 251 RFVMEGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHHcCCcCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 22222222111 11122457789999999999999999999999988643
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=343.57 Aligned_cols=253 Identities=24% Similarity=0.314 Sum_probs=200.8
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCC-------
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGE------- 499 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------- 499 (752)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++.+++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 357888999999999999999976 68999999997543 334567899999999999999999999986543
Q ss_pred --------------------------------------------------eeEEEEeeCCCCCHhHHHhhcCCCCCCCHH
Q 043278 500 --------------------------------------------------ERLLVYEFMPNKSLDFFLFNSGRKNVLNWE 529 (752)
Q Consensus 500 --------------------------------------------------~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~ 529 (752)
..++||||+++++|.+++..........+.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 378999999999999999876666667888
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccc----------cccccccccCC
Q 043278 530 KRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE----------ANTKRIVGTYG 599 (752)
Q Consensus 530 ~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~----------~~~~~~~gt~~ 599 (752)
.++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++........ .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 89999999999999999998 999999999999999999999999999876543211 12234578999
Q ss_pred ccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHH
Q 043278 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCI 679 (752)
Q Consensus 600 y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 679 (752)
|+|||.+.+..++.++||||||+++|||++|..|+.. ............... ........+.
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~---------~~~~~~~~~~~~~~~---------~~~~~~~~~~ 303 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME---------RVRIITDVRNLKFPL---------LFTQKYPQEH 303 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH---------HHHHHHHHHTTCCCH---------HHHHHCHHHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH---------HHHHHHHhhccCCCc---------ccccCChhHH
Confidence 9999999999999999999999999999998654311 111111122211110 1122334567
Q ss_pred HHHHHcccCCCCCCCCHHHHHHH
Q 043278 680 HVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 680 ~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
+++.+||+.||.+|||+.|++++
T Consensus 304 ~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 304 MMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHccCCCCcCCCHHHHhhc
Confidence 89999999999999999999874
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=350.18 Aligned_cols=252 Identities=24% Similarity=0.294 Sum_probs=204.9
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCc------ccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCee
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSG------QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEER 501 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 501 (752)
.++|.+.+.||+|+||.||+++.. +|+.||+|.+..... .....+.+|+.++.+++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 467889999999999999999875 588999999976532 2357889999999999999999999999999999
Q ss_pred EEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCC----Cceecccc
Q 043278 502 LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKM----NPKISDFG 577 (752)
Q Consensus 502 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~----~~kl~DFg 577 (752)
++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 999999999999999853 346999999999999999999999998 99999999999998877 79999999
Q ss_pred cceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCC
Q 043278 578 MARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGK 657 (752)
Q Consensus 578 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 657 (752)
+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .. ...+..+.
T Consensus 165 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~------~~-~~~i~~~~ 234 (361)
T 2yab_A 165 LAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ET-LANITAVS 234 (361)
T ss_dssp SCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------HH-HHHHHTTC
T ss_pred CceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH------HH-HHHHHhcC
Confidence 998765322 223467999999999999999999999999999999999999999765321 11 11121211
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 658 GLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 658 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.. .++.... .....+.+++.+||+.||.+|||+.|++++
T Consensus 235 ~~--~~~~~~~----~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 235 YD--FDEEFFS----QTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp CC--CCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CC--CCchhcc----CCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 10 0000000 112356789999999999999999999864
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=344.51 Aligned_cols=259 Identities=24% Similarity=0.388 Sum_probs=209.7
Q ss_pred hcCCCcCCeeecCCcccEEEEEec--------CCceeEEEEcccCC-cccHHHHHHHHHHHHhc-CCCCcceeeeeeeeC
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA--------DEQEVAIKRLSRSS-GQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHG 498 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 498 (752)
.++|.+.+.||+|+||.||+|+.. ++..||||++.... .....++.+|+.++.++ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 468888999999999999999863 46789999997653 33456789999999999 899999999999999
Q ss_pred CeeEEEEeeCCCCCHhHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEe
Q 043278 499 EERLLVYEFMPNKSLDFFLFNSGR-------------KNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILL 565 (752)
Q Consensus 499 ~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll 565 (752)
+..++||||+++++|.+++..... ...+++..++.++.||+.||+|||+.+ |+||||||+|||+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence 999999999999999999975432 234899999999999999999999998 9999999999999
Q ss_pred cCCCCceecccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcc
Q 043278 566 DDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLN 644 (752)
Q Consensus 566 ~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~ 644 (752)
+.++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |+.||......
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---- 266 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---- 266 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH----
Confidence 9999999999999987654433333334567889999999999999999999999999999999 99998654311
Q ss_pred hHHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 645 LIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 645 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
.....+..+.... . +......+.+++.+|++.||.+|||+.|+++.|+.+
T Consensus 267 ---~~~~~~~~~~~~~-----~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l 316 (334)
T 2pvf_A 267 ---ELFKLLKEGHRMD-----K----PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316 (334)
T ss_dssp ---HHHHHHHHTCCCC-----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHHHhcCCCCC-----C----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1122222222111 1 111224577889999999999999999999999876
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=348.74 Aligned_cols=265 Identities=25% Similarity=0.388 Sum_probs=211.0
Q ss_pred cCCCcCCeeecCCcccEEEEEe-----cCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeee--eCCeeE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKL-----ADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSL--HGEERL 502 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~ 502 (752)
++|++.+.||+|+||.||++++ ..++.||||++........+.+.+|++++.+++|+||+++++++. +....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5788889999999999999984 357889999998776666778999999999999999999999886 455789
Q ss_pred EEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceee
Q 043278 503 LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIF 582 (752)
Q Consensus 503 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~ 582 (752)
+||||+++++|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 103 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEeecCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceec
Confidence 9999999999999986532 34899999999999999999999988 999999999999999999999999999876
Q ss_pred cccccc-cccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCC--------CCcchHHHHHHHh
Q 043278 583 EVNESE-ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPD--------RPLNLIGYAWQLL 653 (752)
Q Consensus 583 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~--------~~~~l~~~~~~~~ 653 (752)
...... .......++..|+|||.+.+..++.++||||||++++||++|+.|+...... .............
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH
T ss_pred ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh
Confidence 543221 2223356788899999999999999999999999999999999987543210 0111111222222
Q ss_pred hCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCC
Q 043278 654 SDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETM 708 (752)
Q Consensus 654 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~~ 708 (752)
..+.. ...+......+.+++.+|++.||.+|||+.|++++|+.+..
T Consensus 258 ~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 258 EEGQR---------LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp HTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred hcccC---------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 22211 11122233457789999999999999999999999998743
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=336.62 Aligned_cols=261 Identities=18% Similarity=0.219 Sum_probs=209.8
Q ss_pred hcCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCCcccHHHHHHHHHHHHhc-CCCCcceeeeeeeeCCeeEEEEe
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGEERLLVYE 506 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E 506 (752)
.++|.+.+.||+|+||.||+|+. .+++.||||++..... ...+.+|+.++.++ +|+|++++++++.++...++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 46788999999999999999986 5688999999865432 23578899999999 89999999999999999999999
Q ss_pred eCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCC-----ceeccccccee
Q 043278 507 FMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMN-----PKISDFGMARI 581 (752)
Q Consensus 507 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~-----~kl~DFgla~~ 581 (752)
|+ +++|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+++.
T Consensus 87 ~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 87 LL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 99 999999996542 35899999999999999999999988 999999999999987776 99999999987
Q ss_pred ecccccc-----cccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCC
Q 043278 582 FEVNESE-----ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDG 656 (752)
Q Consensus 582 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 656 (752)
....... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......................
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 240 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence 6543221 12334678999999999999999999999999999999999999998765443322222211111111
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 657 KGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 657 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
....+ ... ....+.+++.+|++.||.+|||+++|++.|+.+
T Consensus 241 ~~~~~-----~~~----~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~ 281 (298)
T 1csn_A 241 PLREL-----CAG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 281 (298)
T ss_dssp CHHHH-----TTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred cHHHH-----Hhh----CcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence 11111 011 124577899999999999999999999999875
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=350.43 Aligned_cols=261 Identities=26% Similarity=0.414 Sum_probs=209.8
Q ss_pred HhcCCCcCCeeecCCcccEEEEEecC-C-----ceeEEEEcccCC-cccHHHHHHHHHHHHhc-CCCCcceeeeeeeeCC
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGKLAD-E-----QEVAIKRLSRSS-GQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGE 499 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~~~~-~-----~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 499 (752)
..++|.+.+.||+|+||.||+|.... + ..||+|.+.... ......+.+|+.++.++ +||||+++++++.+++
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 34788999999999999999998643 2 479999997653 23456789999999999 8999999999999999
Q ss_pred eeEEEEeeCCCCCHhHHHhhcC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCC
Q 043278 500 ERLLVYEFMPNKSLDFFLFNSG-----------RKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDK 568 (752)
Q Consensus 500 ~~~lv~E~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~ 568 (752)
..++||||+++|+|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNG 200 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGG
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCC
Confidence 9999999999999999986532 1345899999999999999999999998 9999999999999999
Q ss_pred CCceecccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHH
Q 043278 569 MNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIG 647 (752)
Q Consensus 569 ~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~ 647 (752)
+.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..||.......
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~------ 274 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS------ 274 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH------
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH------
Confidence 9999999999987654433333334567889999999999999999999999999999999 888987654221
Q ss_pred HHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 648 YAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 648 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
........+.... .+ ......+.+++.+||+.||.+|||+.||+++|+..
T Consensus 275 ~~~~~~~~~~~~~--~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 275 KFYKLVKDGYQMA--QP-------AFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp HHHHHHHHTCCCC--CC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHhcCCCCC--CC-------CCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 1112222221110 11 11124577899999999999999999999999764
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=345.57 Aligned_cols=252 Identities=23% Similarity=0.317 Sum_probs=204.2
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCc------ccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCee
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSG------QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEER 501 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 501 (752)
.++|.+.+.||+|+||.||+++.. +++.||+|.+..... .....+.+|+.++.+++||||+++++++.+.+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 357888999999999999999875 588999999875432 2467899999999999999999999999999999
Q ss_pred EEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCC----Cceecccc
Q 043278 502 LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKM----NPKISDFG 577 (752)
Q Consensus 502 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~----~~kl~DFg 577 (752)
++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 999999999999999853 345899999999999999999999998 99999999999998887 79999999
Q ss_pred cceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCC
Q 043278 578 MARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGK 657 (752)
Q Consensus 578 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 657 (752)
+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .... .+....
T Consensus 164 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~-~~~~~~ 233 (326)
T 2y0a_A 164 LAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLA-NVSAVN 233 (326)
T ss_dssp TCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHH-HHHHTC
T ss_pred CCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH------HHHH-HHHhcC
Confidence 998764322 123457899999999999999999999999999999999999999754321 1111 111111
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 658 GLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 658 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
. .. .+.... .....+.+++.+||+.||.+|||+.|++++
T Consensus 234 ~-~~-~~~~~~----~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 234 Y-EF-EDEYFS----NTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp C-CC-CHHHHT----TSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred C-Cc-Cccccc----cCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 00 000000 112356788999999999999999999985
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=358.16 Aligned_cols=264 Identities=18% Similarity=0.227 Sum_probs=207.9
Q ss_pred cHHHHHHHhcCCCcCCeeecCCcccEEEEEecC-CceeEEEEcccCC---cccHHHHHHHHHHHHhcCCCCcceeeeeee
Q 043278 421 DFQTIAAAANNFSTTNKLGEGGFGPVYKGKLAD-EQEVAIKRLSRSS---GQGIVEFKNEVRLIAKLQHTNLVRLLGCSL 496 (752)
Q Consensus 421 ~~~~i~~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 496 (752)
.+.++....++|++.++||+|+||+||+++... ++.||+|++.+.. ......+.+|..++..++||||+++++++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 445555667899999999999999999999765 7889999986531 112234789999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceeccc
Q 043278 497 HGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDF 576 (752)
Q Consensus 497 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DF 576 (752)
+++..+|||||+++|+|..++... ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+||
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcch
Confidence 999999999999999999999652 345999999999999999999999998 999999999999999999999999
Q ss_pred ccceeecccccccccccccccCCccChhhhc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHH
Q 043278 577 GMARIFEVNESEANTKRIVGTYGYMSPEYAM-----SGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQ 651 (752)
Q Consensus 577 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~ 651 (752)
|+++........ ......||+.|+|||++. ...++.++|||||||++|||++|+.||......+ ....
T Consensus 220 Gla~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~------~~~~ 292 (437)
T 4aw2_A 220 GSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGK 292 (437)
T ss_dssp TTCEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHH
T ss_pred hhhhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH------HHHh
Confidence 999865433221 223468999999999987 5679999999999999999999999997654221 1111
Q ss_pred HhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 043278 652 LLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMD--RPTMPEVVCM 702 (752)
Q Consensus 652 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~--RPt~~ev~~~ 702 (752)
.+.... .+.-|...... ...+.+|+.+|++.+|++ ||+++|++++
T Consensus 293 i~~~~~--~~~~p~~~~~~----s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 293 IMNHKE--RFQFPTQVTDV----SENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp HHTHHH--HCCCCSSCCCS----CHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred hhhccc--cccCCcccccC----CHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 111100 00011110111 234667888999888887 9999999886
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=337.05 Aligned_cols=251 Identities=24% Similarity=0.361 Sum_probs=202.9
Q ss_pred cCCCcCCeeecCCcccEEEEEecC-C-------ceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCee
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLAD-E-------QEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEER 501 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~-~-------~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 501 (752)
++|.+.+.||+|+||.||+|+... + ..||+|++........+.+.+|+.++.+++||||+++++++.+++..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 578888999999999999998643 3 46999999877667778899999999999999999999999999999
Q ss_pred EEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCC--------cee
Q 043278 502 LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMN--------PKI 573 (752)
Q Consensus 502 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~--------~kl 573 (752)
++||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. +||
T Consensus 88 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp EEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred EEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeee
Confidence 9999999999999999653 334899999999999999999999998 999999999999998887 999
Q ss_pred cccccceeecccccccccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHH
Q 043278 574 SDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQL 652 (752)
Q Consensus 574 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~ 652 (752)
+|||++..... .....+++.|+|||.+.+ ..++.++||||||+++|||++|..|+..... ... ....
T Consensus 163 ~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~-----~~~-~~~~ 230 (289)
T 4fvq_A 163 SDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD-----SQR-KLQF 230 (289)
T ss_dssp CCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-----HHH-HHHH
T ss_pred ccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc-----hHH-HHHH
Confidence 99999864322 123457889999999987 7799999999999999999996554433221 111 1111
Q ss_pred hhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCC
Q 043278 653 LSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETM 708 (752)
Q Consensus 653 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~~ 708 (752)
..... .+ .+ .. ...+.+++.+||+.||.+|||+.|+++.|+.+..
T Consensus 231 ~~~~~--~~-~~----~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 231 YEDRH--QL-PA----PK----AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp HHTTC--CC-CC----CS----SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred hhccC--CC-CC----CC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 11111 00 01 11 1236688899999999999999999999998755
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=335.81 Aligned_cols=249 Identities=23% Similarity=0.330 Sum_probs=194.8
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCc--------------------------ccHHHHHHHHHHHHh
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSG--------------------------QGIVEFKNEVRLIAK 482 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--------------------------~~~~~~~~E~~~l~~ 482 (752)
++|.+.+.||+|+||.||+|+.. +++.||||++..... ...+++.+|+.++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 57888999999999999999864 578999999865431 123468899999999
Q ss_pred cCCCCcceeeeeeee--CCeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCC
Q 043278 483 LQHTNLVRLLGCSLH--GEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKA 560 (752)
Q Consensus 483 l~h~niv~l~~~~~~--~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp 560 (752)
++||||+++++++.+ ++..++||||+++++|.+++ ....+++..+..++.||+.||+|||+.+ |+||||||
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp 165 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKP 165 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCG
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCH
Confidence 999999999999986 56889999999999997765 3346999999999999999999999998 99999999
Q ss_pred CcEEecCCCCceecccccceeecccccccccccccccCCccChhhhccCC---CCccchhHHHHHHHHHHHhCCCCCCCC
Q 043278 561 SNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGI---VSIKTDVFSFGVLVLEIVSGQKNHTRH 637 (752)
Q Consensus 561 ~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~t~k~DV~S~G~vl~elltG~~p~~~~ 637 (752)
+|||++.++.+||+|||+++....... ......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||...
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 999999999999999999987643321 123457899999999987755 478999999999999999999999654
Q ss_pred CCCCCcchHHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 638 HPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 638 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.. .... ..+..... ...+ .......+.+++.+||+.||++|||+.|++++
T Consensus 244 ~~------~~~~-~~~~~~~~-~~~~-------~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 244 RI------MCLH-SKIKSQAL-EFPD-------QPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp SH------HHHH-HHHHHCCC-CCCS-------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred cH------HHHH-HHHhcccC-CCCC-------ccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 31 1111 11111111 1000 01122357789999999999999999999753
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=345.21 Aligned_cols=256 Identities=27% Similarity=0.409 Sum_probs=199.2
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCce----eEEEEcccC-CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQE----VAIKRLSRS-SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLL 503 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~----vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 503 (752)
++|++.+.||+|+||.||+|+.. +++. ||+|.+... ......++.+|+.++.+++||||+++++++..+. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 67888999999999999999864 4544 577777543 3456778999999999999999999999998754 789
Q ss_pred EEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeec
Q 043278 504 VYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFE 583 (752)
Q Consensus 504 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~ 583 (752)
|+||+++|+|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 94 v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred EEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 99999999999998654 345899999999999999999999998 9999999999999999999999999998765
Q ss_pred ccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCccccc
Q 043278 584 VNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELI 662 (752)
Q Consensus 584 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 662 (752)
............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... + ...+..+....
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~----~~~~~~~~~~~-- 239 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---I----SSILEKGERLP-- 239 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---H----HHHHHTTCCCC--
T ss_pred CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---H----HHHHHcCCCCC--
Confidence 4433333334556788999999999999999999999999999999 999997654321 1 11222221111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCC
Q 043278 663 DPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNET 707 (752)
Q Consensus 663 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~ 707 (752)
.+......+.+++.+||+.||.+|||+.|+++.|+.+.
T Consensus 240 -------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 240 -------QPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp -------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11112335778999999999999999999999998764
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=349.46 Aligned_cols=255 Identities=22% Similarity=0.316 Sum_probs=201.2
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC---cccHHHHHHHHHHHHhc-CCCCcceeeeeeeeCCeeEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGEERLLV 504 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 504 (752)
++|++.++||+|+||+||+++.. +++.||||++++.. ......+.+|..++.++ +||||+++++++.+.+..++|
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV 131 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 131 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence 57888999999999999999975 47889999997642 22234578899999887 899999999999999999999
Q ss_pred EeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecc
Q 043278 505 YEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~ 584 (752)
|||+++|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++....
T Consensus 132 ~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 132 IEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEcCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 9999999999988653 35899999999999999999999998 99999999999999999999999999985322
Q ss_pred cccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCC--cchHHHHHHHhhCCCccccc
Q 043278 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRP--LNLIGYAWQLLSDGKGLELI 662 (752)
Q Consensus 585 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~--~~l~~~~~~~~~~~~~~~~~ 662 (752)
. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||........ ........+....+..
T Consensus 206 ~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~---- 279 (396)
T 4dc2_A 206 P--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---- 279 (396)
T ss_dssp T--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC----
T ss_pred C--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc----
Confidence 2 1223457899999999999999999999999999999999999999975432211 1111222222222211
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCH------HHHHHH
Q 043278 663 DPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTM------PEVVCM 702 (752)
Q Consensus 663 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~------~ev~~~ 702 (752)
.+ +......+.+|+.+||+.||.+||++ .|++++
T Consensus 280 --~~----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 280 --RI----PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp --CC----CTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred --CC----CCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 11 11122356789999999999999996 566554
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=335.55 Aligned_cols=254 Identities=28% Similarity=0.403 Sum_probs=208.9
Q ss_pred cCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCC
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMP 509 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 509 (752)
++|.+.+.||+|+||.||++...+++.||+|++..... ..+++.+|+.++.+++||||+++++++.+.+..++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 57788899999999999999998888999999976543 45688999999999999999999999999999999999999
Q ss_pred CCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccccc
Q 043278 510 NKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEA 589 (752)
Q Consensus 510 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 589 (752)
+++|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++....... .
T Consensus 87 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~ 160 (267)
T 3t9t_A 87 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-T 160 (267)
T ss_dssp TCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-H
T ss_pred CCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccc-c
Confidence 99999999653 345899999999999999999999998 99999999999999999999999999986543221 1
Q ss_pred ccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCC
Q 043278 590 NTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQ 668 (752)
Q Consensus 590 ~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 668 (752)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .....+..+... ..+
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~i~~~~~~--~~~---- 227 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-------EVVEDISTGFRL--YKP---- 227 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHHHHHTTCCC--CCC----
T ss_pred ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH-------HHHHHHhcCCcC--CCC----
Confidence 1223456788999999999999999999999999999999 89888754311 111222222111 111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 669 PCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 669 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
......+.+++.+|++.||.+|||+.|++++|+.+
T Consensus 228 ---~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 228 ---RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp ---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---ccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11224577899999999999999999999999865
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=371.58 Aligned_cols=261 Identities=28% Similarity=0.433 Sum_probs=211.6
Q ss_pred hcCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeC
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFM 508 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 508 (752)
.++|.+.++||+|+||.||+|.+.++..||||+++... ...++|.+|+++|.+++|+||+++++++.+ +..+|||||+
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~ 343 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 343 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence 46788889999999999999999888889999997654 346789999999999999999999999876 6789999999
Q ss_pred CCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccc
Q 043278 509 PNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE 588 (752)
Q Consensus 509 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 588 (752)
++|+|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+||||++++.+||+|||+++.......
T Consensus 344 ~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~- 418 (535)
T 2h8h_A 344 SKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY- 418 (535)
T ss_dssp TTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH-
T ss_pred cCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCce-
Confidence 999999999542 1235899999999999999999999998 99999999999999999999999999986543221
Q ss_pred cccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCC
Q 043278 589 ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLE 667 (752)
Q Consensus 589 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 667 (752)
.......++..|+|||.+....++.++||||||++||||++ |+.||...... .....+..+....
T Consensus 419 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~-------~~~~~i~~~~~~~------- 484 (535)
T 2h8h_A 419 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-------EVLDQVERGYRMP------- 484 (535)
T ss_dssp HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH-------HHHHHHHTTCCCC-------
T ss_pred ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCCCCC-------
Confidence 11223456788999999999999999999999999999999 89998754321 1122233322111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCCCCCC
Q 043278 668 QPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETMPLPP 712 (752)
Q Consensus 668 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~~~~~~ 712 (752)
.+......+.+|+.+||+.||++|||+.+|+++|+.+.....+
T Consensus 485 --~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~ 527 (535)
T 2h8h_A 485 --CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 527 (535)
T ss_dssp --CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSC
T ss_pred --CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCc
Confidence 1112234577899999999999999999999999987554433
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=344.97 Aligned_cols=252 Identities=20% Similarity=0.275 Sum_probs=204.5
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEee
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
.++|.+.+.||+|+||.||+++.. +++.+|+|.+.... .....+.+|+.++..++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 367888999999999999999875 57889999987543 3455688999999999999999999999999999999999
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecC--CCCceecccccceeeccc
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDD--KMNPKISDFGMARIFEVN 585 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~--~~~~kl~DFgla~~~~~~ 585 (752)
+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 83 ~~g~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 9999999998542 335899999999999999999999998 999999999999987 889999999999876433
Q ss_pred ccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCC
Q 043278 586 ESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPS 665 (752)
Q Consensus 586 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 665 (752)
. ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ........ +... .++.
T Consensus 158 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i~~-~~~~--~~~~ 225 (321)
T 1tki_A 158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ------QIIENIMN-AEYT--FDEE 225 (321)
T ss_dssp C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHH-TCCC--CCHH
T ss_pred C---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH------HHHHHHHc-CCCC--CChh
Confidence 2 123457899999999999988999999999999999999999999765421 11111111 1110 0000
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 666 LEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 666 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
... .....+.+++.+|++.||.+|||+.|++++
T Consensus 226 ~~~----~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 226 AFK----EISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hhc----cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 000 112457789999999999999999999986
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=349.18 Aligned_cols=252 Identities=23% Similarity=0.342 Sum_probs=196.9
Q ss_pred hcCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCC--cccHHHHHHHHHHHHhcCC--CCcceeeeeeeeCCeeEEE
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQH--TNLVRLLGCSLHGEERLLV 504 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv 504 (752)
.++|++.+.||+|+||.||++...+++.||||++.... ......+.+|+.++.+++| +||+++++++.+++..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 45788899999999999999999889999999986543 3345678999999999976 9999999999999999999
Q ss_pred EeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecc
Q 043278 505 YEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~ 584 (752)
|| +.+++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||+++....
T Consensus 88 ~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EC-CCSEEHHHHHHHS---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred Ee-CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 99 5688999998653 45899999999999999999999998 99999999999997 57899999999987654
Q ss_pred cccccccccccccCCccChhhhcc-----------CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHh
Q 043278 585 NESEANTKRIVGTYGYMSPEYAMS-----------GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLL 653 (752)
Q Consensus 585 ~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 653 (752)
...........||+.|+|||++.+ ..++.++||||||+++|||++|+.||.... ..........
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~~~~~~~ 234 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-----NQISKLHAII 234 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC-----SHHHHHHHHH
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh-----hHHHHHHHHh
Confidence 433333345679999999999865 678999999999999999999999996533 1122222222
Q ss_pred hCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 654 SDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 654 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.... ....+......+.+++.+||+.||.+|||+.|++++
T Consensus 235 ~~~~---------~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 235 DPNH---------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp CTTS---------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cCCc---------ccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 1111 111111112356788999999999999999999876
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=347.75 Aligned_cols=249 Identities=23% Similarity=0.328 Sum_probs=199.7
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccC---CcccHHHHHHHHHHHHhc-CCCCcceeeeeeeeCCeeEE
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRS---SGQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGEERLL 503 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 503 (752)
.++|++.+.||+|+||.||+++.. +++.||||++++. .......+.+|..++..+ +||||+++++++.+.+..++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 478999999999999999999875 5889999999754 233456678999999988 79999999999999999999
Q ss_pred EEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeec
Q 043278 504 VYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFE 583 (752)
Q Consensus 504 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~ 583 (752)
||||+++|+|..++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 102 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 99999999999998654 34899999999999999999999998 9999999999999999999999999998532
Q ss_pred ccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccC
Q 043278 584 VNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELID 663 (752)
Q Consensus 584 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 663 (752)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........ +...
T Consensus 176 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~~i~~-~~~~---- 242 (353)
T 3txo_A 176 CN--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED------DLFEAILN-DEVV---- 242 (353)
T ss_dssp C-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHH-CCCC----
T ss_pred cC--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH------HHHHHHHc-CCCC----
Confidence 22 12233468999999999999999999999999999999999999999765421 11112222 1110
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCH------HHHHHH
Q 043278 664 PSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTM------PEVVCM 702 (752)
Q Consensus 664 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~------~ev~~~ 702 (752)
. +......+.+++.+|++.||.+||++ .|++++
T Consensus 243 --~----p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 243 --Y----PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp --C----CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred --C----CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 0 11122346788999999999999998 777664
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=337.64 Aligned_cols=255 Identities=24% Similarity=0.330 Sum_probs=194.8
Q ss_pred hcCCCcCCeeecCCcccEEEEEecC----CceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEE
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLAD----EQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLL 503 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 503 (752)
.++|.+.+.||+|+||.||+|.... +..||+|++.... ......+.+|+.++.+++||||+++++++. ++..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 3678888999999999999998743 4569999987643 334567899999999999999999999984 467889
Q ss_pred EEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeec
Q 043278 504 VYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFE 583 (752)
Q Consensus 504 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~ 583 (752)
||||+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 93 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccC
Confidence 99999999999999653 335899999999999999999999998 9999999999999999999999999998764
Q ss_pred ccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCccccc
Q 043278 584 VNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELI 662 (752)
Q Consensus 584 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 662 (752)
..... ......+++.|+|||.+....++.++||||||+++|||++ |+.||....... .. ..+..+....
T Consensus 168 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~---~~----~~i~~~~~~~-- 237 (281)
T 1mp8_A 168 DSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VI----GRIENGERLP-- 237 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HH----HHHHTTCCCC--
T ss_pred ccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH---HH----HHHHcCCCCC--
Confidence 33211 1223456788999999999999999999999999999997 999987654221 11 1222222111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 663 DPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 663 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
+ +......+.+++.+|++.||.+|||+.|+++.|+.+
T Consensus 238 ---~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 238 ---M----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp ---C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---C----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1 111234577899999999999999999999999864
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=347.19 Aligned_cols=249 Identities=21% Similarity=0.328 Sum_probs=202.9
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccC---CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRS---SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 505 (752)
++|.+.+.||+|+||.||+++.. +++.||+|++... .......+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 57888899999999999999875 4788999998653 2345567889999999999999999999999999999999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccc
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVN 585 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~ 585 (752)
||+++|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.....
T Consensus 95 e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp CCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 99999999999864 345999999999999999999999998 999999999999999999999999999875432
Q ss_pred ccccccccccccCCccChhhhcc---CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCccccc
Q 043278 586 ESEANTKRIVGTYGYMSPEYAMS---GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELI 662 (752)
Q Consensus 586 ~~~~~~~~~~gt~~y~aPE~~~~---~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 662 (752)
.......||+.|+|||++.. ..++.++|||||||++|||++|+.||............ ........
T Consensus 169 ---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~----~~~~~~~~---- 237 (384)
T 4fr4_A 169 ---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV----HTFETTVV---- 237 (384)
T ss_dssp ---CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHH----HHHHHCCC----
T ss_pred ---CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHH----HHHhhccc----
Confidence 22334689999999999874 45899999999999999999999999765543222111 11111110
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 043278 663 DPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPT-MPEVVC 701 (752)
Q Consensus 663 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-~~ev~~ 701 (752)
. .+......+.+|+.+||+.||.+||+ +++|.+
T Consensus 238 --~----~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 238 --T----YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp --C----CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred --C----CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 0 11112345778999999999999998 777765
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=350.56 Aligned_cols=253 Identities=20% Similarity=0.231 Sum_probs=206.2
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEee
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
.++|.+.+.||+|+||.||+|... +++.||+|.+..........+.+|+.++.+++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 357889999999999999999875 5889999999876555566789999999999999999999999999999999999
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecC--CCCceecccccceeeccc
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDD--KMNPKISDFGMARIFEVN 585 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~--~~~~kl~DFgla~~~~~~ 585 (752)
+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 130 ~~gg~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 9999999988542 335899999999999999999999998 999999999999974 577999999999876433
Q ss_pred ccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCC
Q 043278 586 ESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPS 665 (752)
Q Consensus 586 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 665 (752)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....... ..... .++.
T Consensus 205 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~------~~~~~i~-~~~~~--~~~~ 272 (387)
T 1kob_A 205 E---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL------ETLQNVK-RCDWE--FDED 272 (387)
T ss_dssp S---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHH-HCCCC--CCSS
T ss_pred c---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH------HHHHHHH-hCCCC--CCcc
Confidence 2 122357899999999999999999999999999999999999999765321 1111111 11110 1111
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 666 LEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 666 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
. .......+.+++.+||+.||.+|||+.|+++.
T Consensus 273 ~----~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 273 A----FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp T----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred c----cccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 1 11122457789999999999999999999986
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=335.15 Aligned_cols=260 Identities=27% Similarity=0.464 Sum_probs=195.7
Q ss_pred hcCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEe
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYE 506 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 506 (752)
.++|.+.++||+|+||.||+|+... .||||+++... ......+.+|+.++++++|+||+++++++ .....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 4678899999999999999998643 59999987543 33456789999999999999999999965 4556899999
Q ss_pred eCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccc
Q 043278 507 FMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586 (752)
Q Consensus 507 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~ 586 (752)
|+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 174 (289)
T 3og7_A 100 WCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174 (289)
T ss_dssp CCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred ecCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccccc
Confidence 99999999998543 345899999999999999999999998 9999999999999999999999999998655333
Q ss_pred cccccccccccCCccChhhhc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccC
Q 043278 587 SEANTKRIVGTYGYMSPEYAM---SGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELID 663 (752)
Q Consensus 587 ~~~~~~~~~gt~~y~aPE~~~---~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 663 (752)
.........||+.|+|||.+. ...++.++||||||+++|||++|+.||...... .........+.....+.
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~ 248 (289)
T 3og7_A 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR------DQIIEMVGRGSLSPDLS 248 (289)
T ss_dssp ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH------HHHHHHHHHTSCCCCTT
T ss_pred ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH------HHHHHHhcccccCcchh
Confidence 333334467899999999986 667899999999999999999999999764421 11122222222211111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCC
Q 043278 664 PSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNET 707 (752)
Q Consensus 664 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~ 707 (752)
.+ .......+.+++.+|++.||.+|||+.|++++|+.+.
T Consensus 249 -~~----~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 249 -KV----RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp -SS----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred -hc----cccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 11 1122346778999999999999999999999998864
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=345.58 Aligned_cols=269 Identities=27% Similarity=0.391 Sum_probs=214.5
Q ss_pred ccHHHHHHHhcCCCcCCeeecCCcccEEEEEe------cCCceeEEEEcccCCc-ccHHHHHHHHHHHHhc-CCCCccee
Q 043278 420 FDFQTIAAAANNFSTTNKLGEGGFGPVYKGKL------ADEQEVAIKRLSRSSG-QGIVEFKNEVRLIAKL-QHTNLVRL 491 (752)
Q Consensus 420 ~~~~~i~~~~~~~~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l 491 (752)
++..+.....++|.+.+.||+|+||.||+|+. .+++.||||++..... .....+.+|+.++.++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 34445555678999999999999999999974 3467899999976533 3445789999999999 79999999
Q ss_pred eeeeeeCC-eeEEEEeeCCCCCHhHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecC
Q 043278 492 LGCSLHGE-ERLLVYEFMPNKSLDFFLFNSGR-------------KNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRD 557 (752)
Q Consensus 492 ~~~~~~~~-~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~D 557 (752)
++++...+ ..++||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ |+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 99987654 58999999999999999975432 223899999999999999999999998 99999
Q ss_pred CCCCcEEecCCCCceecccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 043278 558 LKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTR 636 (752)
Q Consensus 558 ikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~ 636 (752)
|||+|||++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999987654433333344567889999999999999999999999999999998 9999876
Q ss_pred CCCCCCcchHHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 637 HHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 637 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
..... .....+..+..... +......+.+++.+||+.||.+|||+.|++++|+.+
T Consensus 254 ~~~~~------~~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 254 VKIDE------EFCRRLKEGTRMRA---------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp CCCSH------HHHHHHHHTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cchhH------HHHHHhccCccCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 54221 11122222221111 111223577889999999999999999999999865
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=337.99 Aligned_cols=263 Identities=26% Similarity=0.413 Sum_probs=206.1
Q ss_pred cCCCcCCeeecCCcccEEEEEe-----cCCceeEEEEcccC-CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeC--Cee
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKL-----ADEQEVAIKRLSRS-SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHG--EER 501 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 501 (752)
+.|++.+.||+|+||.||++++ .+++.||||++... .......+.+|+.++.+++||||+++++++.+. +..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4578889999999999999984 46789999999754 334567889999999999999999999999876 568
Q ss_pred EEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceeccccccee
Q 043278 502 LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARI 581 (752)
Q Consensus 502 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~ 581 (752)
++||||+++++|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence 99999999999999986533 34899999999999999999999998 99999999999999999999999999987
Q ss_pred ecccccc-cccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCC--------CCCCcchHHHHHHH
Q 043278 582 FEVNESE-ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHH--------PDRPLNLIGYAWQL 652 (752)
Q Consensus 582 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~--------~~~~~~l~~~~~~~ 652 (752)
....... .......+|..|+|||.+.+..++.++||||||+++|||++|+.|+.... +.............
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence 6543321 22334567888999999999999999999999999999999998753221 11111111122222
Q ss_pred hhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 653 LSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 653 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
+..+... +.+......+.+++.+||+.||.+|||+.|+++.|+.+
T Consensus 256 ~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 256 LKEGKRL---------PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HHTTCCC---------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhccCCC---------CCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 2222211 11222234677899999999999999999999999864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=336.82 Aligned_cols=263 Identities=22% Similarity=0.284 Sum_probs=199.0
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEe
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYE 506 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 506 (752)
++|++.++||+|+||+||+|+.. +++.||||++.... ......+.+|+.++.+++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 46888899999999999999875 58899999997543 2334678899999999999999999999999999999999
Q ss_pred eCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccc
Q 043278 507 FMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586 (752)
Q Consensus 507 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~ 586 (752)
|++++ |...+... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~-l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQD-LKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEE-HHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCCC-HHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 99864 44444332 345999999999999999999999998 9999999999999999999999999998764322
Q ss_pred cccccccccccCCccChhhhccCC-CCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcc------
Q 043278 587 SEANTKRIVGTYGYMSPEYAMSGI-VSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGL------ 659 (752)
Q Consensus 587 ~~~~~~~~~gt~~y~aPE~~~~~~-~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~------ 659 (752)
.......||+.|+|||++.+.. ++.++||||||++++||++|+.|+...... ........+........
T Consensus 156 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~--~~~~~~i~~~~~~~~~~~~~~~~ 231 (292)
T 3o0g_A 156 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp --SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH--HHHHHHHHHHHCCCCTTTCTTGG
T ss_pred --ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCH--HHHHHHHHHHhCCCChhhhhhhc
Confidence 2223457899999999998765 899999999999999999998886433211 11111222211111000
Q ss_pred cccCC---------CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 660 ELIDP---------SLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 660 ~~~d~---------~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
...+. .............+.+++.+|++.||++|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00000 00001111223456789999999999999999999874
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=333.82 Aligned_cols=254 Identities=27% Similarity=0.498 Sum_probs=201.8
Q ss_pred cCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCCccc-------HHHHHHHHHHHHhcCCCCcceeeeeeeeCCee
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSSGQG-------IVEFKNEVRLIAKLQHTNLVRLLGCSLHGEER 501 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 501 (752)
++|.+.+.||+|+||.||+|+. .+++.||+|++....... ..++.+|+.++.+++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 6788889999999999999987 468899999986543221 167899999999999999999999987654
Q ss_pred EEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCC-----ceeccc
Q 043278 502 LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMN-----PKISDF 576 (752)
Q Consensus 502 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~-----~kl~DF 576 (752)
++||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ .+|+||||||+|||++.++. +||+||
T Consensus 97 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp EEEEECCTTCBHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred eEEEEecCCCCHHHHHhcc--cCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 6999999999998888643 346999999999999999999999875 34999999999999988776 999999
Q ss_pred ccceeecccccccccccccccCCccChhhh--ccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhh
Q 043278 577 GMARIFEVNESEANTKRIVGTYGYMSPEYA--MSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLS 654 (752)
Q Consensus 577 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 654 (752)
|+++.... ......||+.|+|||.+ ....++.++||||||+++|||++|+.||....... .........
T Consensus 174 g~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~~~~~~~ 244 (287)
T 4f0f_A 174 GLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK----IKFINMIRE 244 (287)
T ss_dssp TTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH----HHHHHHHHH
T ss_pred Cccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH----HHHHHHHhc
Confidence 99974332 22346789999999998 45568899999999999999999999997654321 111111111
Q ss_pred CCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 655 DGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 655 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
.+. .+.+ +......+.+++.+||+.||.+|||+.|+++.|+.+
T Consensus 245 ~~~-----~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 245 EGL-----RPTI----PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp SCC-----CCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred cCC-----CCCC----CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 111 1111 112234577899999999999999999999999863
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=338.39 Aligned_cols=262 Identities=22% Similarity=0.315 Sum_probs=199.3
Q ss_pred cCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEee
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
++|.+.+.||+|+||.||+|+...++.||+|++.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 4688889999999999999999889999999986543 22346788999999999999999999999999999999999
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccc
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES 587 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~ 587 (752)
+++ +|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV- 154 (288)
T ss_dssp CSE-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc-
Confidence 985 888887543 245899999999999999999999998 9999999999999999999999999998654221
Q ss_pred ccccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcc-------
Q 043278 588 EANTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGL------- 659 (752)
Q Consensus 588 ~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~------- 659 (752)
.......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||...... ................
T Consensus 155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T 1ob3_A 155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA---DQLMRIFRILGTPNSKNWPNVTE 230 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTTTSTTGGG
T ss_pred -cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHHCCCChhhchhhhc
Confidence 11223568999999999876 45899999999999999999999999765421 1111111111111000
Q ss_pred -cccCCCCCC-------CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 660 -ELIDPSLEQ-------PCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 660 -~~~d~~l~~-------~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
...++.... .........+.+++.+|++.||++|||++|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 001111100 0001123456789999999999999999999864
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=336.29 Aligned_cols=245 Identities=22% Similarity=0.291 Sum_probs=203.6
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC---cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 505 (752)
++|++.+.||+|+||.||+++.. +|+.||+|++.... ......+.+|..++..++||||+++++++.+.+..++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 57888899999999999999875 68899999987542 234567889999999999999999999999999999999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccc
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVN 585 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~ 585 (752)
||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 86 e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~- 158 (318)
T 1fot_A 86 DYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD- 158 (318)
T ss_dssp CCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS-
T ss_pred eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC-
Confidence 999999999999653 35899999999999999999999988 99999999999999999999999999986532
Q ss_pred ccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCC
Q 043278 586 ESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPS 665 (752)
Q Consensus 586 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 665 (752)
......||+.|+|||++.+..++.++||||||+++|||++|+.||..... .......... .. .
T Consensus 159 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~i~~~-~~------~ 221 (318)
T 1fot_A 159 ----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MKTYEKILNA-EL------R 221 (318)
T ss_dssp ----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHC-CC------C
T ss_pred ----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHhC-CC------C
Confidence 12346799999999999999999999999999999999999999975431 1112222221 11 0
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 043278 666 LEQPCSANEVMRCIHVGLLCVQDQAMDRP-----TMPEVVCM 702 (752)
Q Consensus 666 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~ev~~~ 702 (752)
+ +......+.+++.+|++.||.+|| +++|++++
T Consensus 222 ~----p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 222 F----PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp C----CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred C----CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 1 111123567888999999999999 89999865
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=348.88 Aligned_cols=263 Identities=19% Similarity=0.251 Sum_probs=204.7
Q ss_pred hcCCCcCCeeecC--CcccEEEEEec-CCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEE
Q 043278 429 ANNFSTTNKLGEG--GFGPVYKGKLA-DEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLL 503 (752)
Q Consensus 429 ~~~~~~~~~LG~G--~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 503 (752)
.++|++.++||+| +||.||+++.. +++.||||++.... ......+.+|+.++++++||||+++++++.+++..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4678899999999 99999999976 68999999997543 3344668889999999999999999999999999999
Q ss_pred EEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeec
Q 043278 504 VYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFE 583 (752)
Q Consensus 504 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~ 583 (752)
||||+++|+|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++....
T Consensus 104 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 999999999999986542 345899999999999999999999998 9999999999999999999999999987653
Q ss_pred cccc-----ccccccccccCCccChhhhcc--CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCC
Q 043278 584 VNES-----EANTKRIVGTYGYMSPEYAMS--GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDG 656 (752)
Q Consensus 584 ~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 656 (752)
.... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......... . .+ .+
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~----~~-~~ 252 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL--E----KL-NG 252 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHH--H----C----
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHH--H----Hh-cC
Confidence 2211 111223478899999999987 679999999999999999999999997654332110 0 00 00
Q ss_pred CcccccCC------------------------------C------CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 043278 657 KGLELIDP------------------------------S------LEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVV 700 (752)
Q Consensus 657 ~~~~~~d~------------------------------~------l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~ 700 (752)
....+++. . ...+........+.+|+.+||+.||++|||+.|++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell 332 (389)
T 3gni_B 253 TVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLL 332 (389)
T ss_dssp -----------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred CCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHh
Confidence 00000000 0 00011122234678899999999999999999998
Q ss_pred HH
Q 043278 701 CM 702 (752)
Q Consensus 701 ~~ 702 (752)
++
T Consensus 333 ~h 334 (389)
T 3gni_B 333 NH 334 (389)
T ss_dssp TS
T ss_pred cC
Confidence 76
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=344.90 Aligned_cols=253 Identities=23% Similarity=0.315 Sum_probs=194.4
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEee
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
.++|.+.+.||+|+||.||+++.. +++.||||++..... ....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 367889999999999999999975 688999999976543 335688999999999999999999999999999999999
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCC--ceecccccceeeccc
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMN--PKISDFGMARIFEVN 585 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~--~kl~DFgla~~~~~~ 585 (752)
+++|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+++.....
T Consensus 98 ~~~~~L~~~l~~~---~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 98 ASGGELYERICNA---GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp CCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 9999999998653 34899999999999999999999998 999999999999987765 999999999743221
Q ss_pred ccccccccccccCCccChhhhccCCCCcc-chhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCC
Q 043278 586 ESEANTKRIVGTYGYMSPEYAMSGIVSIK-TDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDP 664 (752)
Q Consensus 586 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k-~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 664 (752)
.......||+.|+|||++.+..++.+ +||||||+++|||++|+.||......... .......... ..
T Consensus 172 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~--~~~~~~~~~~-~~------ 239 (361)
T 3uc3_A 172 ---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY--RKTIQRILSV-KY------ 239 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH--HHHHHHHHTT-CC------
T ss_pred ---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH--HHHHHHHhcC-CC------
Confidence 12234578999999999988887665 89999999999999999999865543322 1111222211 11
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 665 SLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 665 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
..+........+.+|+.+||+.||.+|||+.|++++
T Consensus 240 --~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 240 --SIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp --CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred --CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 001111112456789999999999999999999886
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=342.91 Aligned_cols=261 Identities=24% Similarity=0.396 Sum_probs=197.8
Q ss_pred HhcCCCcCCeeecCCcccEEEEEecC----CceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCC--
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGKLAD----EQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGE-- 499 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-- 499 (752)
..++|.+.+.||+|+||.||+|.... ++.||+|++.... ......+.+|+.++.+++||||+++++++.+.+
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 45788899999999999999997642 4579999987543 334567899999999999999999999987755
Q ss_pred ---eeEEEEeeCCCCCHhHHHhhc---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCcee
Q 043278 500 ---ERLLVYEFMPNKSLDFFLFNS---GRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKI 573 (752)
Q Consensus 500 ---~~~lv~E~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl 573 (752)
..++||||+++++|..++... .....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEE
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEE
Confidence 349999999999999998543 23456999999999999999999999988 999999999999999999999
Q ss_pred cccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHH
Q 043278 574 SDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQL 652 (752)
Q Consensus 574 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 652 (752)
+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... .. ..
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~----~~ 261 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE---MY----DY 261 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HH----HH
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH---HH----HH
Confidence 99999987654332233334567889999999999999999999999999999999 888886654221 11 11
Q ss_pred hhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCC
Q 043278 653 LSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNET 707 (752)
Q Consensus 653 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~ 707 (752)
...+..... +......+.+++.+|++.||.+|||+.+++++|+.+.
T Consensus 262 ~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 262 LLHGHRLKQ---------PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp HHTTCCCCC---------BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHcCCCCCC---------CccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 222211111 1112245778999999999999999999999998764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=355.17 Aligned_cols=254 Identities=21% Similarity=0.273 Sum_probs=204.3
Q ss_pred HhcCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEE
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLV 504 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 504 (752)
..++|.+.+.||+|+||.||++.. .+++.+|+|++.... ......+.+|+.++++++||||+++++++.+++..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 457899999999999999999986 468899999987653 23345688999999999999999999999999999999
Q ss_pred EeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEec---CCCCceeccccccee
Q 043278 505 YEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLD---DKMNPKISDFGMARI 581 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~---~~~~~kl~DFgla~~ 581 (752)
|||+++|+|.+.+... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++ .++.+||+|||+++.
T Consensus 89 ~E~~~gg~L~~~i~~~---~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 89 FDLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp ECCCBCCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EEeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 9999999999988653 45899999999999999999999998 99999999999998 567899999999986
Q ss_pred ecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccc
Q 043278 582 FEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLEL 661 (752)
Q Consensus 582 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 661 (752)
...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+..+.. ..
T Consensus 163 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~-------~~~~~i~~~~~-~~ 232 (444)
T 3soa_A 163 VEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH-------RLYQQIKAGAY-DF 232 (444)
T ss_dssp CCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHTCC-CC
T ss_pred ecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH-------HHHHHHHhCCC-CC
Confidence 543321 223467999999999999999999999999999999999999999654411 11222222221 11
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 662 IDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 662 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
..+.. ......+.+++.+||+.||.+|||+.|++++
T Consensus 233 ~~~~~-----~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 233 PSPEW-----DTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp CTTTT-----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred Ccccc-----ccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 11111 1122456788999999999999999999985
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=347.61 Aligned_cols=266 Identities=17% Similarity=0.197 Sum_probs=202.3
Q ss_pred hcCCCcCCeeecCCcccEEEEEecC------CceeEEEEcccCCcccH-----------HHHHHHHHHHHhcCCCCccee
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLAD------EQEVAIKRLSRSSGQGI-----------VEFKNEVRLIAKLQHTNLVRL 491 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~l 491 (752)
.++|.+.+.||+|+||.||+|.+.. ++.||||++........ ..+..|+..+..++|+||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4688899999999999999998765 47899999876542111 123345556677789999999
Q ss_pred eeeeeeC----CeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEec-
Q 043278 492 LGCSLHG----EERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLD- 566 (752)
Q Consensus 492 ~~~~~~~----~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~- 566 (752)
++++... ...+|||||+ +++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+||||+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNY 187 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEES
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEec
Confidence 9998764 4589999999 99999998653 345999999999999999999999998 99999999999999
Q ss_pred -CCCCceecccccceeeccccccc-----ccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCC
Q 043278 567 -DKMNPKISDFGMARIFEVNESEA-----NTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPD 640 (752)
Q Consensus 567 -~~~~~kl~DFgla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~ 640 (752)
.++.+||+|||+++.+....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 89999999999998765432211 112356999999999999999999999999999999999999999864322
Q ss_pred CCcchHHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 641 RPLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 641 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
. ........... ....+++++.+.... ....+.+++..|++.+|.+||++.+|++.|+..
T Consensus 268 ~--~~~~~~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~ 327 (364)
T 3op5_A 268 P--KYVRDSKIRYR-ENIASLMDKCFPAAN---APGEIAKYMETVKLLDYTEKPLYENLRDILLQG 327 (364)
T ss_dssp H--HHHHHHHHHHH-HCHHHHHHHHSCTTC---CCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred H--HHHHHHHHHhh-hhHHHHHHHhccccc---CHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence 1 11111111111 122223332221111 123567888899999999999999999998765
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=340.18 Aligned_cols=266 Identities=23% Similarity=0.293 Sum_probs=207.3
Q ss_pred hcCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeee----CCeeEE
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLH----GEERLL 503 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~l 503 (752)
.++|.+.+.||+|+||.||+++. .+++.||||++..........+.+|+.++.+++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 46889999999999999999987 5689999999977666667789999999999999999999999873 347889
Q ss_pred EEeeCCCCCHhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceee
Q 043278 504 VYEFMPNKSLDFFLFNS-GRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIF 582 (752)
Q Consensus 504 v~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~ 582 (752)
||||+++++|.+++... .....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 99999999999988653 23456999999999999999999999998 999999999999999999999999998765
Q ss_pred cccccc-------cccccccccCCccChhhhccCC---CCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHH
Q 043278 583 EVNESE-------ANTKRIVGTYGYMSPEYAMSGI---VSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQL 652 (752)
Q Consensus 583 ~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~---~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~ 652 (752)
...... .......||+.|+|||.+.... ++.++||||||+++|||++|+.||......... .. ..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~----~~ 259 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS-VA----LA 259 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC-HH----HH
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch-hh----HH
Confidence 321111 0112345789999999987654 789999999999999999999998542211111 11 11
Q ss_pred hhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCCCCC
Q 043278 653 LSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETMPLP 711 (752)
Q Consensus 653 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~~~~~ 711 (752)
..... . .+........+.+++.+||+.||.+|||+.|+++.|+.+..+.|
T Consensus 260 ~~~~~--~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 309 (317)
T 2buj_A 260 VQNQL--S-------IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP 309 (317)
T ss_dssp HHCC-----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCC
T ss_pred hhccC--C-------CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCC
Confidence 11100 0 01111123457789999999999999999999999998765333
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=336.77 Aligned_cols=255 Identities=31% Similarity=0.451 Sum_probs=206.9
Q ss_pred hcCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeC
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFM 508 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 508 (752)
.++|.+.+.||+|+||.||+|...+++.||||.+.... ...+.+.+|++++.+++||||+++++++.+ +..++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecC
Confidence 35788889999999999999999888899999997643 356789999999999999999999999864 5689999999
Q ss_pred CCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccc
Q 043278 509 PNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE 588 (752)
Q Consensus 509 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 588 (752)
++++|.+++.... ...+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 90 ~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T 1qpc_A 90 ENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (279)
T ss_dssp TTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence 9999999985321 125899999999999999999999998 999999999999999999999999999876533221
Q ss_pred cccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCC
Q 043278 589 ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLE 667 (752)
Q Consensus 589 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 667 (752)
......++..|+|||.+.+..++.++||||||++++||++ |+.||...... .....+..+.... .
T Consensus 166 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-------~~~~~~~~~~~~~-----~- 231 (279)
T 1qpc_A 166 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-------EVIQNLERGYRMV-----R- 231 (279)
T ss_dssp -CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------HHHHHHHTTCCCC-----C-
T ss_pred -cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH-------HHHHHHhcccCCC-----C-
Confidence 1223456788999999998999999999999999999999 89888654311 1112222221111 1
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 668 QPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 668 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
+......+.+++.+|++.||++|||+.++++.|+..
T Consensus 232 ---~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 267 (279)
T 1qpc_A 232 ---PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (279)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 111224577899999999999999999999999875
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=356.57 Aligned_cols=259 Identities=22% Similarity=0.276 Sum_probs=206.1
Q ss_pred HHHHHHhcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC---cccHHHHHHHHHHHHhcCCCCcceeeeeeeeC
Q 043278 423 QTIAAAANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHG 498 (752)
Q Consensus 423 ~~i~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 498 (752)
.++....++|.+.++||+|+||+||+++.. +++.||+|++.+.. ......+.+|+.++..++||||+++++++.++
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 344456788999999999999999999975 47889999986521 12233578999999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceeccccc
Q 043278 499 EERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGM 578 (752)
Q Consensus 499 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgl 578 (752)
+..++||||+++|+|..++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccce
Confidence 999999999999999998854 24899999999999999999999998 99999999999999999999999999
Q ss_pred ceeecccccccccccccccCCccChhhhccCC----CCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhh
Q 043278 579 ARIFEVNESEANTKRIVGTYGYMSPEYAMSGI----VSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLS 654 (752)
Q Consensus 579 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 654 (752)
++....... ......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...... ......+.
T Consensus 215 a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~ 287 (410)
T 3v8s_A 215 CMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMN 287 (410)
T ss_dssp CEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHT
T ss_pred eEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh------hHHHHHHh
Confidence 987653322 1223468999999999998765 889999999999999999999999765421 11111111
Q ss_pred CCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 043278 655 DGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMD--RPTMPEVVCM 702 (752)
Q Consensus 655 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~--RPt~~ev~~~ 702 (752)
......+ |. .......+.+|+.+|++.+|.+ ||+++||+++
T Consensus 288 ~~~~~~~--p~-----~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 288 HKNSLTF--PD-----DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp HHHHCCC--CT-----TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ccccccC--CC-----cccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 1000011 10 0011235678888999999988 9999999986
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=336.94 Aligned_cols=256 Identities=26% Similarity=0.404 Sum_probs=210.1
Q ss_pred hcCCCcCCeeecCCcccEEEEEecC-CceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEee
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLAD-EQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
.++|++.+.||+|+||.||+|.... +..||+|.+.... ....++.+|+.++++++||||+++++++.+++..++||||
T Consensus 12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 90 (288)
T 3kfa_A 12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 90 (288)
T ss_dssp GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence 4678888999999999999999764 7889999997543 3467789999999999999999999999999999999999
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccc
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES 587 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~ 587 (752)
+++++|.+++.... ...+++..++.++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||++........
T Consensus 91 ~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 166 (288)
T 3kfa_A 91 MTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 166 (288)
T ss_dssp CTTEEHHHHHHHCC-TTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS
T ss_pred CCCCcHHHHHHhcc-cCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCcc
Confidence 99999999996543 355899999999999999999999998 99999999999999999999999999986543322
Q ss_pred ccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCC
Q 043278 588 EANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666 (752)
Q Consensus 588 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 666 (752)
.......+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... . ...+......
T Consensus 167 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~---~----~~~~~~~~~~------- 231 (288)
T 3kfa_A 167 -TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---V----YELLEKDYRM------- 231 (288)
T ss_dssp -EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---H----HHHHHTTCCC-------
T ss_pred -ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---H----HHHHhccCCC-------
Confidence 12223456789999999999999999999999999999999 999987654221 1 1112111111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 667 EQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 667 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
..+......+.+++.+|++.||.+|||+.|+++.|+.+
T Consensus 232 --~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 232 --ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 11112234577899999999999999999999999764
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=347.38 Aligned_cols=253 Identities=22% Similarity=0.302 Sum_probs=204.5
Q ss_pred HhcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEE
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLV 504 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 504 (752)
..++|.+.+.||+|+||.||++... +++.||+|++.... ......+.+|+.++.+++||||+++++++.+++..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3568999999999999999999875 58899999997543 23446788999999999999999999999999999999
Q ss_pred EeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCC---CCceeccccccee
Q 043278 505 YEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDK---MNPKISDFGMARI 581 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~---~~~kl~DFgla~~ 581 (752)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.+ +.+||+|||++..
T Consensus 107 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 107 FDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp ECCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 999999999988853 345899999999999999999999998 9999999999999765 4599999999986
Q ss_pred ecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccc
Q 043278 582 FEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLEL 661 (752)
Q Consensus 582 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 661 (752)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+..+... .
T Consensus 181 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-------~~~~~i~~~~~~-~ 249 (362)
T 2bdw_A 181 VNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-------RLYAQIKAGAYD-Y 249 (362)
T ss_dssp CTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHTCCC-C
T ss_pred ecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHhCCCC-C
Confidence 54322 123467899999999999999999999999999999999999999764321 111222222111 0
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 662 IDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 662 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
..+. .......+.+++.+||+.||.+|||+.|++++
T Consensus 250 ~~~~-----~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 250 PSPE-----WDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp CTTG-----GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred Cccc-----ccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0110 01122456789999999999999999999875
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=342.02 Aligned_cols=267 Identities=18% Similarity=0.204 Sum_probs=199.7
Q ss_pred hcCCCcCCeeecCCcccEEEEEec----CCceeEEEEcccCCcc-----------cHHHHHHHHHHHHhcCCCCcceeee
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA----DEQEVAIKRLSRSSGQ-----------GIVEFKNEVRLIAKLQHTNLVRLLG 493 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~~ 493 (752)
.++|.+.+.||+|+||.||+|... .+..+|||++...... ....+.+|+..+..++|+||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 367888999999999999999975 5678999998765322 1123567888899999999999999
Q ss_pred eeee----CCeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCC
Q 043278 494 CSLH----GEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKM 569 (752)
Q Consensus 494 ~~~~----~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~ 569 (752)
++.. ....++||||+ +++|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 9987 67899999999 999999985432 6999999999999999999999998 99999999999998887
Q ss_pred --Cceecccccceeecccccc-----cccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCC
Q 043278 570 --NPKISDFGMARIFEVNESE-----ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRP 642 (752)
Q Consensus 570 --~~kl~DFgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~ 642 (752)
.+||+|||+++.+...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||........
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 9999999999876533211 111345789999999999999999999999999999999999999965332211
Q ss_pred cchHHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCC
Q 043278 643 LNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETM 708 (752)
Q Consensus 643 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~~ 708 (752)
............ ....+..... .......+.+++..||+.||++|||+.+|++.|+....
T Consensus 269 --~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 269 --AVQTAKTNLLDE-LPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp --HHHHHHHHHHHT-TTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred --HHHHHHHhhccc-ccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 111111111111 0000000000 00122357788999999999999999999999998765
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=352.30 Aligned_cols=252 Identities=21% Similarity=0.325 Sum_probs=197.7
Q ss_pred hcCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCC--cccHHHHHHHHHHHHhcC--CCCcceeeeeeeeCCeeEEE
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQ--HTNLVRLLGCSLHGEERLLV 504 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv 504 (752)
.++|.+.+.||+|+||.||++....++.||||++.... ......+.+|+.++.+++ |+||+++++++..++..+||
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 35688999999999999999998889999999986542 344567899999999996 59999999999999999999
Q ss_pred EeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecc
Q 043278 505 YEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~ 584 (752)
|| +.+++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||+++.+..
T Consensus 135 ~E-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EE-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred Ee-cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 99 6788999998653 35889999999999999999999988 99999999999995 58999999999987654
Q ss_pred cccccccccccccCCccChhhhcc-----------CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHh
Q 043278 585 NESEANTKRIVGTYGYMSPEYAMS-----------GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLL 653 (752)
Q Consensus 585 ~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 653 (752)
...........||+.|+|||++.+ ..++.++|||||||+||||++|+.||..... ........+
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-----~~~~~~~~~ 281 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAII 281 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----HHHHHHHHH
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-----HHHHHHHHh
Confidence 433333345679999999999875 4689999999999999999999999965431 112222222
Q ss_pred hCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 654 SDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 654 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
..... ...+......+.+|+.+||+.||.+|||+.|++++
T Consensus 282 ~~~~~---------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 282 DPNHE---------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp CTTSC---------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred Ccccc---------CCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 21111 11111112356788999999999999999999876
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=340.53 Aligned_cols=255 Identities=22% Similarity=0.317 Sum_probs=202.1
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC---cccHHHHHHHHHHHHhc-CCCCcceeeeeeeeCCeeEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGEERLLV 504 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 504 (752)
++|++.+.||+|+||.||+++.. +++.||+|++.... ......+.+|..++.++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 56888899999999999999975 57899999997653 23345678999999988 899999999999999999999
Q ss_pred EeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecc
Q 043278 505 YEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~ 584 (752)
|||+++|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 89 ~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 9999999999998653 35899999999999999999999998 99999999999999999999999999985322
Q ss_pred cccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCC--cchHHHHHHHhhCCCccccc
Q 043278 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRP--LNLIGYAWQLLSDGKGLELI 662 (752)
Q Consensus 585 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~--~~l~~~~~~~~~~~~~~~~~ 662 (752)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ........+.+..+..
T Consensus 163 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~---- 236 (345)
T 3a8x_A 163 PG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---- 236 (345)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC----
T ss_pred CC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC----
Confidence 21 223346899999999999999999999999999999999999999975322111 0111122222222211
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCH------HHHHHH
Q 043278 663 DPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTM------PEVVCM 702 (752)
Q Consensus 663 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~------~ev~~~ 702 (752)
.+ +......+.+++.+||+.||.+||++ .|++++
T Consensus 237 --~~----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 237 --RI----PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp --CC----CTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred --CC----CCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 11 11122356788999999999999996 566654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=343.61 Aligned_cols=255 Identities=22% Similarity=0.274 Sum_probs=203.9
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccC-----CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeE
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRS-----SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERL 502 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 502 (752)
.++|++.+.||+|+||.||++... +++.||||++... .....+.+.+|+.++.+++||||+++++++.+++..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 357889999999999999999864 5899999998532 2234678999999999999999999999999999999
Q ss_pred EEEeeCCCCCHhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCC---ceeccccc
Q 043278 503 LVYEFMPNKSLDFFLFNSG-RKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMN---PKISDFGM 578 (752)
Q Consensus 503 lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~---~kl~DFgl 578 (752)
+||||+++++|.+++.... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999988775432 3345899999999999999999999998 999999999999986655 99999999
Q ss_pred ceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCc
Q 043278 579 ARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKG 658 (752)
Q Consensus 579 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 658 (752)
++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .....+..+..
T Consensus 180 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~i~~~~~ 249 (351)
T 3c0i_A 180 AIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE--------RLFEGIIKGKY 249 (351)
T ss_dssp CEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH--------HHHHHHHHTCC
T ss_pred eeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH--------HHHHHHHcCCC
Confidence 987654321 22345799999999999999999999999999999999999999975321 11111111111
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 659 LELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 659 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
. ..+.... .....+.+++.+||+.||++|||+.|++++
T Consensus 250 ~--~~~~~~~----~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 250 K--MNPRQWS----HISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp C--CCHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred C--CCccccc----cCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 0000000 112457789999999999999999999874
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=343.81 Aligned_cols=246 Identities=22% Similarity=0.324 Sum_probs=200.7
Q ss_pred cCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCC---cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 505 (752)
++|.+.+.||+|+||.||+|.. .+++.||||++.... ......+.+|+.+++.++||||+++++++...+..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5788899999999999999996 568899999986431 223457899999999999999999999999999999999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccc
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVN 585 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~ 585 (752)
||+ +|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||++......
T Consensus 89 E~~-~g~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 89 EYA-GGELFDYIVEK---KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp CCC-CEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred ECC-CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 999 67888887653 34899999999999999999999998 999999999999999999999999999865432
Q ss_pred ccccccccccccCCccChhhhccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCC
Q 043278 586 ESEANTKRIVGTYGYMSPEYAMSGIV-SIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDP 664 (752)
Q Consensus 586 ~~~~~~~~~~gt~~y~aPE~~~~~~~-t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 664 (752)
. ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||........... +...
T Consensus 162 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~---------------i~~~ 223 (336)
T 3h4j_B 162 N---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK---------------VNSC 223 (336)
T ss_dssp B---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC---------------CCSS
T ss_pred c---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH---------------HHcC
Confidence 2 2234578999999999988776 7899999999999999999999976543221110 0000
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 665 SLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 665 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
. ...+......+.+++.+|++.||.+|||++|+++.
T Consensus 224 ~--~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 224 V--YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp C--CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred C--CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 0 00111122456788999999999999999999875
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=340.50 Aligned_cols=245 Identities=22% Similarity=0.280 Sum_probs=204.1
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC---cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 505 (752)
++|.+.+.||+|+||.||+++.. +++.||||++.... ......+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57888899999999999999875 58899999986532 234567889999999999999999999999999999999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccc
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVN 585 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~ 585 (752)
||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC
Confidence 999999999999654 34899999999999999999999998 999999999999999999999999999865422
Q ss_pred ccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCC
Q 043278 586 ESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPS 665 (752)
Q Consensus 586 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 665 (752)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||..... ... ...+..+.. .
T Consensus 195 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~-~~~i~~~~~------~ 256 (350)
T 1rdq_E 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP------IQI-YEKIVSGKV------R 256 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHH-HHHHHHCCC------C
T ss_pred -----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH------HHH-HHHHHcCCC------C
Confidence 2346799999999999999999999999999999999999999975431 111 122222211 1
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 043278 666 LEQPCSANEVMRCIHVGLLCVQDQAMDRPT-----MPEVVCM 702 (752)
Q Consensus 666 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-----~~ev~~~ 702 (752)
+ +......+.+++.+||+.||.+||+ ++|++++
T Consensus 257 ~----p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 257 F----PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp C----CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred C----CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 1 1112245778899999999999998 8888765
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=341.35 Aligned_cols=246 Identities=24% Similarity=0.275 Sum_probs=193.4
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCc--ccHHHHHHHHHHHHhc-CCCCcceeeeeeeeCCeeEEE
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSG--QGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGEERLLV 504 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 504 (752)
.++|++.++||+|+||+||+|+.. +++.||||++..... ....++..|+..+.++ +|+||+++++++.+++..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 367999999999999999999976 689999999865432 2333455566666555 999999999999999999999
Q ss_pred EeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecc
Q 043278 505 YEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~ 584 (752)
|||+ +++|..++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 136 ~e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp EECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred Eecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 9999 678888876543 45999999999999999999999988 99999999999999999999999999986543
Q ss_pred cccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCC
Q 043278 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDP 664 (752)
Q Consensus 585 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 664 (752)
.. ......||+.|+|||++.+ .++.++||||||+++|||++|..++.... .+..+..+.....+.
T Consensus 210 ~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~----------~~~~~~~~~~~~~~~- 274 (311)
T 3p1a_A 210 AG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE----------GWQQLRQGYLPPEFT- 274 (311)
T ss_dssp --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH----------HHHHHTTTCCCHHHH-
T ss_pred CC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc----------HHHHHhccCCCcccc-
Confidence 22 2234568999999998876 79999999999999999999977654321 122222222111111
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 665 SLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 665 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
. .....+.+++.+|++.||++|||+.|++++
T Consensus 275 ---~----~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 275 ---A----GLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp ---T----TSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ---c----CCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 1 112457789999999999999999999874
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=340.98 Aligned_cols=258 Identities=23% Similarity=0.352 Sum_probs=195.5
Q ss_pred hcCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCCc---ccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCe----
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSSG---QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEE---- 500 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 500 (752)
.++|++.+.||+|+||.||+++. .+++.||||++..... .....+.+|+.++.+++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 36788999999999999999986 5688999999976532 234568899999999999999999999876543
Q ss_pred eEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccce
Q 043278 501 RLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR 580 (752)
Q Consensus 501 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~ 580 (752)
.++||||+++++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 39999999999999998653 35899999999999999999999998 9999999999999999999999999998
Q ss_pred eeccccc-ccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcc
Q 043278 581 IFEVNES-EANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGL 659 (752)
Q Consensus 581 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 659 (752)
....... ........||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ..............
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~~~~~~ 238 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDPIP 238 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCCCC
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhcCCCCC
Confidence 7654322 1223346789999999999999999999999999999999999999976542 12222222222111
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH-HHhhc
Q 043278 660 ELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVV-CMLQN 705 (752)
Q Consensus 660 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~-~~L~~ 705 (752)
.. .... .....+.+++.+||+.||.+||++.+++ ..|..
T Consensus 239 ~~---~~~~----~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 278 (311)
T 3ork_A 239 PS---ARHE----GLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 278 (311)
T ss_dssp HH---HHST----TCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred cc---cccC----CCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence 00 0000 1123567889999999999999766654 44544
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=343.27 Aligned_cols=250 Identities=23% Similarity=0.349 Sum_probs=203.1
Q ss_pred HHhcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC---cccHHHHHHHHHHHHhc-CCCCcceeeeeeeeCCee
Q 043278 427 AAANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGEER 501 (752)
Q Consensus 427 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 501 (752)
...++|.+.+.||+|+||.||+++.. +++.||||+++... ......+..|..++..+ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34578999999999999999999975 58899999997542 33456678899999887 999999999999999999
Q ss_pred EEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceeccccccee
Q 043278 502 LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARI 581 (752)
Q Consensus 502 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~ 581 (752)
++||||+++|+|..++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 94 ~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 9999999999999998653 34899999999999999999999998 99999999999999999999999999985
Q ss_pred ecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccc
Q 043278 582 FEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLEL 661 (752)
Q Consensus 582 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 661 (752)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... . ....+..+.
T Consensus 168 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~-~~~~i~~~~---- 234 (345)
T 1xjd_A 168 NMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE------E-LFHSIRMDN---- 234 (345)
T ss_dssp CCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHHCC----
T ss_pred cccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH------H-HHHHHHhCC----
Confidence 43221 2234568999999999999999999999999999999999999999765421 1 111221111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 043278 662 IDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMP-EVVC 701 (752)
Q Consensus 662 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~-ev~~ 701 (752)
+.+... ....+.+++.+|++.||.+||++. |+++
T Consensus 235 --~~~p~~----~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 235 --PFYPRW----LEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp --CCCCTT----SCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred --CCCCcc----cCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 111111 223567889999999999999997 7654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=339.62 Aligned_cols=265 Identities=23% Similarity=0.329 Sum_probs=190.1
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEe
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYE 506 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 506 (752)
.++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++.+++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 467889999999999999999864 58899999987543 2334678899999999999999999999999999999999
Q ss_pred eCCCCCHhHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeec
Q 043278 507 FMPNKSLDFFLFNSG---RKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFE 583 (752)
Q Consensus 507 ~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~ 583 (752)
|++ ++|.+++.... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 58988886432 2345899999999999999999999998 9999999999999999999999999998754
Q ss_pred ccccccccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCC---cc
Q 043278 584 VNESEANTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGK---GL 659 (752)
Q Consensus 584 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~ 659 (752)
.... ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ............. ..
T Consensus 160 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~ 234 (317)
T 2pmi_A 160 IPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE---QLKLIFDIMGTPNESLWP 234 (317)
T ss_dssp SCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCCTTTCG
T ss_pred CCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCChhHhh
Confidence 3221 1223578999999999976 468999999999999999999999997654221 1111111111100 00
Q ss_pred c-----ccCCCCCC------------CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 660 E-----LIDPSLEQ------------PCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 660 ~-----~~d~~l~~------------~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
. ...+.+.. .........+.+++.+||+.||++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0 00000000 0000112357789999999999999999999874
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=354.29 Aligned_cols=263 Identities=19% Similarity=0.232 Sum_probs=206.5
Q ss_pred cHHHHHHHhcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC---cccHHHHHHHHHHHHhcCCCCcceeeeeee
Q 043278 421 DFQTIAAAANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKLQHTNLVRLLGCSL 496 (752)
Q Consensus 421 ~~~~i~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 496 (752)
.++++....++|++.+.||+|+||+||+++.. +++.||||++.+.. ......+.+|..++.+++|+||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 44555556789999999999999999999975 68999999996532 122334789999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceeccc
Q 043278 497 HGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDF 576 (752)
Q Consensus 497 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DF 576 (752)
+.+..+|||||+++|+|..++.... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++++||+||
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeec
Confidence 9999999999999999999996532 35899999999999999999999998 999999999999999999999999
Q ss_pred ccceeecccccccccccccccCCccChhhhc-------cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHH
Q 043278 577 GMARIFEVNESEANTKRIVGTYGYMSPEYAM-------SGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYA 649 (752)
Q Consensus 577 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~ 649 (752)
|+++....... ......+||+.|+|||++. ...++.++|||||||++|||++|+.||....... ..
T Consensus 207 Gla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~ 279 (412)
T 2vd5_A 207 GSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE------TY 279 (412)
T ss_dssp TTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HH
T ss_pred hhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH------HH
Confidence 99987643322 1223468999999999987 4578999999999999999999999997654211 11
Q ss_pred HHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCC---CCHHHHHHH
Q 043278 650 WQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDR---PTMPEVVCM 702 (752)
Q Consensus 650 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~R---Pt~~ev~~~ 702 (752)
...+.... .+.-|..... ....+.+++.+||+ +|.+| |+++|++++
T Consensus 280 ~~i~~~~~--~~~~p~~~~~----~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 280 GKIVHYKE--HLSLPLVDEG----VPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHHHTHHH--HCCCC----C----CCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred HHHHhccc--CcCCCccccC----CCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 11111000 0001111111 12356788899999 99998 699999876
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=342.25 Aligned_cols=257 Identities=27% Similarity=0.444 Sum_probs=200.5
Q ss_pred cCCCcCCeeecCCcccEEEEEecC-----CceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLAD-----EQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLL 503 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 503 (752)
++|...+.||+|+||.||+|.... +..||||++.... .....++.+|+.++.+++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 466777999999999999998643 2359999997653 2345578999999999999999999999999999999
Q ss_pred EEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeec
Q 043278 504 VYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFE 583 (752)
Q Consensus 504 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~ 583 (752)
||||+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 124 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 124 ITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp EEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 99999999999998653 345899999999999999999999998 9999999999999999999999999998765
Q ss_pred cccccc-ccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccc
Q 043278 584 VNESEA-NTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLEL 661 (752)
Q Consensus 584 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 661 (752)
...... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+..+....
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-------~~~~~~~~~~~~~~- 270 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-------HEVMKAINDGFRLP- 270 (333)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHTTCCCC-
T ss_pred cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH-------HHHHHHHHCCCcCC-
Confidence 332211 1222345778999999999999999999999999999999 9999865431 11122222221111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCC
Q 043278 662 IDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNET 707 (752)
Q Consensus 662 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~ 707 (752)
.+......+.+++.+||+.||.+||++.|++++|+.+.
T Consensus 271 --------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 271 --------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp --------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred --------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11122345778999999999999999999999998753
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=349.40 Aligned_cols=259 Identities=25% Similarity=0.365 Sum_probs=204.2
Q ss_pred CCcCCeeecCCcccEEEEEec-----CCceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeC--CeeEE
Q 043278 432 FSTTNKLGEGGFGPVYKGKLA-----DEQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHG--EERLL 503 (752)
Q Consensus 432 ~~~~~~LG~G~fg~Vy~~~~~-----~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 503 (752)
|++.++||+|+||.||++... +++.||||++.... ......+.+|++++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 478899999999999998643 57889999997653 23456789999999999999999999999874 57899
Q ss_pred EEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeec
Q 043278 504 VYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFE 583 (752)
Q Consensus 504 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~ 583 (752)
||||+++++|.+++.. ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 113 v~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 9999999999999854 24899999999999999999999998 9999999999999999999999999998765
Q ss_pred ccccc-cccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCC--------CCcchHHHHHHHhh
Q 043278 584 VNESE-ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPD--------RPLNLIGYAWQLLS 654 (752)
Q Consensus 584 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~--------~~~~l~~~~~~~~~ 654 (752)
..... .......++..|+|||.+.+..++.++||||||++++||++|+.|+...... ............+.
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh
Confidence 43221 2223456788899999999999999999999999999999999988643210 00000001111222
Q ss_pred CCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 655 DGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 655 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
.+.. ...+......+.+++.+||+.||.+|||+.|+++.|+.+
T Consensus 266 ~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 308 (318)
T 3lxp_A 266 RGER---------LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308 (318)
T ss_dssp TTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cccC---------CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 2111 111222335678899999999999999999999999876
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=334.51 Aligned_cols=255 Identities=26% Similarity=0.393 Sum_probs=205.7
Q ss_pred cCCCcCC-eeecCCcccEEEEEec---CCceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEE
Q 043278 430 NNFSTTN-KLGEGGFGPVYKGKLA---DEQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLV 504 (752)
Q Consensus 430 ~~~~~~~-~LG~G~fg~Vy~~~~~---~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 504 (752)
++|.+.+ .||+|+||.||+|... .+..||||+++... .....++.+|+.++.+++||||+++++++ +.+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 3455555 8999999999999853 57789999997653 33456789999999999999999999999 55678999
Q ss_pred EeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecc
Q 043278 505 YEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~ 584 (752)
|||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 88 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 88 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 999999999999854 3445999999999999999999999998 99999999999999999999999999987654
Q ss_pred cccc-cccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCccccc
Q 043278 585 NESE-ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELI 662 (752)
Q Consensus 585 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 662 (752)
.... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... .....+..+.....
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-------~~~~~i~~~~~~~~- 234 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-------EVMAFIEQGKRMEC- 234 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-------HHHHHHHTTCCCCC-
T ss_pred CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH-------HHHHHHhcCCcCCC-
Confidence 3322 12223456889999999998899999999999999999999 99999765421 11122222221111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 663 DPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 663 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
+......+.+++.+|++.||.+||++.|+++.|+.+
T Consensus 235 --------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 235 --------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp --------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 112234677899999999999999999999999876
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=336.04 Aligned_cols=269 Identities=23% Similarity=0.337 Sum_probs=203.7
Q ss_pred HHHHhcCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhc--CCCCcceeeeeeeeC----
Q 043278 425 IAAAANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKL--QHTNLVRLLGCSLHG---- 498 (752)
Q Consensus 425 i~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~---- 498 (752)
-....++|.+.+.||+|+||.||+|+.. ++.||||++... ....+..|.+++..+ +|+||+++++++...
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred ccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 3345678999999999999999999885 889999998643 234455566666554 999999999999887
Q ss_pred CeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCcEeecCCCCCcEEecCCCCcee
Q 043278 499 EERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS-----RLRVIHRDLKASNILLDDKMNPKI 573 (752)
Q Consensus 499 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~iiH~Dikp~NIll~~~~~~kl 573 (752)
...++||||+++|+|.+++.. ..+++..++.++.|++.||+|||+.. ..+|+||||||+|||++.++.+||
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred CceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence 688999999999999999954 24899999999999999999999871 113999999999999999999999
Q ss_pred cccccceeeccccccc--ccccccccCCccChhhhccCCCCcc------chhHHHHHHHHHHHhC----------CCCCC
Q 043278 574 SDFGMARIFEVNESEA--NTKRIVGTYGYMSPEYAMSGIVSIK------TDVFSFGVLVLEIVSG----------QKNHT 635 (752)
Q Consensus 574 ~DFgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~k------~DV~S~G~vl~elltG----------~~p~~ 635 (752)
+|||+++......... ......||+.|+|||++.+...+.+ +||||||+++|||++| +.|+.
T Consensus 184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~ 263 (337)
T 3mdy_A 184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263 (337)
T ss_dssp CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence 9999998764332221 1224578999999999988766665 9999999999999999 55555
Q ss_pred CCCCCCCcchHHHHHHHhhCCCcccccCCCCCC-CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCC
Q 043278 636 RHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQ-PCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNET 707 (752)
Q Consensus 636 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~ 707 (752)
........ ............ ..+.+.. .........+.+++.+||+.||.+|||+.||+++|+.+.
T Consensus 264 ~~~~~~~~--~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 330 (337)
T 3mdy_A 264 DLVPSDPS--YEDMREIVCIKK----LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS 330 (337)
T ss_dssp TTSCSSCC--HHHHHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhcCCCCc--hhhhHHHHhhhc----cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHH
Confidence 44333222 111112221111 1111111 112256677889999999999999999999999998764
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=346.64 Aligned_cols=269 Identities=20% Similarity=0.266 Sum_probs=213.3
Q ss_pred cCCCcCCeeecCCcccEEEEEecC-CceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCC--eeEEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLAD-EQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGE--ERLLVY 505 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~ 505 (752)
++|.+.++||+|+||.||+|+... ++.||||++.... ......+.+|++++.+++||||+++++++.+.+ ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 578889999999999999998754 8899999997543 344677889999999999999999999988755 679999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEe----cCCCCceeccccccee
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILL----DDKMNPKISDFGMARI 581 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll----~~~~~~kl~DFgla~~ 581 (752)
||+++|+|.+++........+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 99999999999976544445999999999999999999999998 9999999999999 7888899999999987
Q ss_pred ecccccccccccccccCCccChhhhcc--------CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHh
Q 043278 582 FEVNESEANTKRIVGTYGYMSPEYAMS--------GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLL 653 (752)
Q Consensus 582 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 653 (752)
..... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......... .......+
T Consensus 166 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~--~~~~~~~~ 240 (396)
T 4eut_A 166 LEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKII 240 (396)
T ss_dssp CCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC--HHHHHHHH
T ss_pred ccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch--HHHHHHHh
Confidence 64332 1223578999999999875 56788999999999999999999999765432222 11222222
Q ss_pred hCCCc---cccc-----------CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 654 SDGKG---LELI-----------DPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 654 ~~~~~---~~~~-----------d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
..... ..+. +.......+......+.+++.+||+.||++||++.|+++.|+.+
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i 307 (396)
T 4eut_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (396)
T ss_dssp HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence 21110 0000 00111234466777888999999999999999999999988764
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=329.48 Aligned_cols=262 Identities=19% Similarity=0.243 Sum_probs=204.5
Q ss_pred HhcCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeee-eeCCeeEEEE
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCS-LHGEERLLVY 505 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~ 505 (752)
..++|.+.+.||+|+||.||+|+. .+++.||||++...... .++.+|+.++.+++|++++..+..+ .+++..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999986 56889999987554322 3578899999999988877777665 6677889999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEe---cCCCCceecccccceee
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILL---DDKMNPKISDFGMARIF 582 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll---~~~~~~kl~DFgla~~~ 582 (752)
||+ +++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++..
T Consensus 85 e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 99999998643 235999999999999999999999998 9999999999999 89999999999999876
Q ss_pred cccccc-----cccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCC
Q 043278 583 EVNESE-----ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGK 657 (752)
Q Consensus 583 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 657 (752)
...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......................
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence 543321 122346789999999999999999999999999999999999999987665544433332222111111
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 658 GLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 658 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
.. .+. ... ...+.+++.+|++.||++|||+.||++.|+.+
T Consensus 239 ~~-~~~----~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 278 (296)
T 4hgt_A 239 IE-VLC----KGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp HH-HHT----TTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred hh-hhh----ccC----CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence 00 000 111 23577899999999999999999999999875
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=339.27 Aligned_cols=251 Identities=22% Similarity=0.238 Sum_probs=181.5
Q ss_pred CCeeecCCcccEEEEEec-CCceeEEEEcccCCcccHHHHHHHHHHHHhcC-CCCcceeeeeeeeCCeeEEEEeeCCCCC
Q 043278 435 TNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQ-HTNLVRLLGCSLHGEERLLVYEFMPNKS 512 (752)
Q Consensus 435 ~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~~gs 512 (752)
.+.||+|+||.||++... +++.||||++... ....+.+|+.++.+++ ||||+++++++.++...++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 378999999999999875 5889999999653 4567789999999997 9999999999999999999999999999
Q ss_pred HhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCC---Cceecccccceeeccccccc
Q 043278 513 LDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKM---NPKISDFGMARIFEVNESEA 589 (752)
Q Consensus 513 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~---~~kl~DFgla~~~~~~~~~~ 589 (752)
|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+++.......
T Consensus 93 L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-- 164 (325)
T 3kn6_A 93 LFERIKKK---KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-- 164 (325)
T ss_dssp HHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--
Confidence 99999653 45999999999999999999999998 99999999999997665 799999999986543221
Q ss_pred ccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCC
Q 043278 590 NTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQP 669 (752)
Q Consensus 590 ~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 669 (752)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||..................+..+... ....
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~------~~~~ 238 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS------FEGE 238 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC------CCSH
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC------CCcc
Confidence 2234568999999999999999999999999999999999999998765432222222233333332211 0000
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 670 CSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 670 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
........+.+++.+|++.||.+|||+.|++++
T Consensus 239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred cccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 001123457789999999999999999999764
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=339.96 Aligned_cols=251 Identities=22% Similarity=0.321 Sum_probs=189.3
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEee
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
.++|.+.+.||+|+||.||+|+.. +++.||||++.... ..+.+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 467889999999999999999986 47889999997643 345678999999999999999999999999999999999
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecC---CCCceecccccceeecc
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDD---KMNPKISDFGMARIFEV 584 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~---~~~~kl~DFgla~~~~~ 584 (752)
+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++....
T Consensus 130 ~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 130 VTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp CCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 999999998854 345899999999999999999999998 999999999999975 89999999999986543
Q ss_pred cccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCC
Q 043278 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDP 664 (752)
Q Consensus 585 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 664 (752)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......+...... ...+
T Consensus 204 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~~i~~~~~~-~~~~ 273 (349)
T 2w4o_A 204 QV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD------QFMFRRILNCEYY-FISP 273 (349)
T ss_dssp ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH------HHHHHHHHTTCCC-CCTT
T ss_pred cc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc------HHHHHHHHhCCCc-cCCc
Confidence 21 223467899999999999999999999999999999999999999654421 1111222222111 1111
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 665 SLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 665 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
........+.+++.+|++.||++|||+.|+++.
T Consensus 274 -----~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 274 -----WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp -----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -----hhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111223457789999999999999999999884
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=337.48 Aligned_cols=249 Identities=23% Similarity=0.324 Sum_probs=194.1
Q ss_pred hcCCCcCCeeecCCcccEEEEEe----cCCceeEEEEcccCC----cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCe
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKL----ADEQEVAIKRLSRSS----GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEE 500 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 500 (752)
.++|++.+.||+|+||.||+++. .+++.||+|+++... ......+.+|+.++.+++||||+++++++.+++.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 36788899999999999999987 468899999997642 2334567899999999999999999999999999
Q ss_pred eEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccce
Q 043278 501 RLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR 580 (752)
Q Consensus 501 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~ 580 (752)
.++||||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE---GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 99999999999999998653 35889999999999999999999998 9999999999999999999999999997
Q ss_pred eecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCccc
Q 043278 581 IFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLE 660 (752)
Q Consensus 581 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 660 (752)
...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ........ ...
T Consensus 170 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~-~~~-- 238 (327)
T 3a62_A 170 ESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK------KTIDKILK-CKL-- 238 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHH-TCC--
T ss_pred ccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHh-CCC--
Confidence 543222 1223467899999999999999999999999999999999999999765421 11112221 111
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 043278 661 LIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRP-----TMPEVVCM 702 (752)
Q Consensus 661 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~ev~~~ 702 (752)
.+ +......+.+++.+||+.||.+|| ++.|++++
T Consensus 239 ----~~----p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 239 ----NL----PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp ----CC----CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred ----CC----CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 11 111224567889999999999999 77788765
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=347.19 Aligned_cols=247 Identities=26% Similarity=0.315 Sum_probs=196.6
Q ss_pred CCeeecCCcccEEEEEec-CCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCCCCCH
Q 043278 435 TNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSL 513 (752)
Q Consensus 435 ~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 513 (752)
.+.||+|+||.||+|... +++.||+|++.........++.+|+.++.+++||||+++++++.+.+..+|||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 468999999999999864 6889999999876656677899999999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEe--cCCCCceecccccceeeccccccccc
Q 043278 514 DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILL--DDKMNPKISDFGMARIFEVNESEANT 591 (752)
Q Consensus 514 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll--~~~~~~kl~DFgla~~~~~~~~~~~~ 591 (752)
.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++....... .
T Consensus 174 ~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~ 245 (373)
T 2x4f_A 174 FDRIIDE--SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---L 245 (373)
T ss_dssp HHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---C
T ss_pred HHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---c
Confidence 9888643 345899999999999999999999998 9999999999999 5678899999999987643322 2
Q ss_pred ccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCCCC
Q 043278 592 KRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCS 671 (752)
Q Consensus 592 ~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 671 (752)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........... .+..+. ..
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~~~~~i~~~~~--~~~~~~-~~--- 313 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA------ETLNNILACRW--DLEDEE-FQ--- 313 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTCC--CSCSGG-GT---
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhccC--CCChhh-hc---
Confidence 2356899999999999999999999999999999999999999765421 11112221111 000000 01
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 672 ANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 672 ~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.....+.+++.+||+.||.+|||+.|+++.
T Consensus 314 -~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 314 -DISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp -TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -cCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 112457789999999999999999999884
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=341.76 Aligned_cols=259 Identities=31% Similarity=0.431 Sum_probs=204.5
Q ss_pred hcCCCcCCeeecCCcccEEEEEe------cCCceeEEEEcccC-CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCee
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKL------ADEQEVAIKRLSRS-SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEER 501 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 501 (752)
.++|.+.+.||+|+||.||+|+. .+++.||||++... ......++.+|+.++.+++||||+++++++.+.+..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 46889999999999999999984 24678999999754 334556789999999999999999999999999999
Q ss_pred EEEEeeCCCCCHhHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecC---CCCceec
Q 043278 502 LLVYEFMPNKSLDFFLFNSGR----KNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDD---KMNPKIS 574 (752)
Q Consensus 502 ~lv~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~---~~~~kl~ 574 (752)
++||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999976432 245899999999999999999999998 999999999999984 4569999
Q ss_pred ccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHh
Q 043278 575 DFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLL 653 (752)
Q Consensus 575 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 653 (752)
|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... .....+
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-------~~~~~~ 258 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ-------EVLEFV 258 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-------HHHHHH
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH-------HHHHHH
Confidence 9999986543333233334567889999999999999999999999999999998 88888654311 112222
Q ss_pred hCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 654 SDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 654 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
..+.... . +......+.+++.+||+.||.+|||+.|++++|+..
T Consensus 259 ~~~~~~~-----~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 259 TSGGRMD-----P----PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp HTTCCCC-----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hcCCCCC-----C----CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 2222111 1 111224577899999999999999999999999865
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=328.07 Aligned_cols=261 Identities=19% Similarity=0.241 Sum_probs=207.3
Q ss_pred hcCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeee-eeCCeeEEEEe
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCS-LHGEERLLVYE 506 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~E 506 (752)
.++|.+.+.||+|+||.||+|+. .+++.||||++...... .++.+|+.++.+++|++++..+..+ .+++..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46889999999999999999986 57899999998655432 3688999999999998877666655 56778899999
Q ss_pred eCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEe---cCCCCceecccccceeec
Q 043278 507 FMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILL---DDKMNPKISDFGMARIFE 583 (752)
Q Consensus 507 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll---~~~~~~kl~DFgla~~~~ 583 (752)
|+ +++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++...
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 86 LL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred ec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99 89999998643 235999999999999999999999998 9999999999999 588999999999998765
Q ss_pred cccccc-----ccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCc
Q 043278 584 VNESEA-----NTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKG 658 (752)
Q Consensus 584 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 658 (752)
...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........................
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence 433211 123467899999999999999999999999999999999999999876544433333222221111110
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 659 LELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 659 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
.. +.... ...+.+++.+|++.||.+|||+.||++.|+.+
T Consensus 240 ~~-----~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 278 (296)
T 3uzp_A 240 EV-----LCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp HH-----HTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred HH-----HHhhC----CHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence 00 00111 24577899999999999999999999999875
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=367.81 Aligned_cols=248 Identities=26% Similarity=0.381 Sum_probs=198.9
Q ss_pred eeecCCcccEEEEEec---CCceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCCCCC
Q 043278 437 KLGEGGFGPVYKGKLA---DEQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKS 512 (752)
Q Consensus 437 ~LG~G~fg~Vy~~~~~---~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gs 512 (752)
.||+|+||.||+|.+. ++..||||+++... ....++|.+|++++.+++|||||++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999864 45679999998653 3456789999999999999999999999976 56899999999999
Q ss_pred HhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccccc-cc
Q 043278 513 LDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEA-NT 591 (752)
Q Consensus 513 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~-~~ 591 (752)
|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+||||++++.+||+|||+++......... ..
T Consensus 422 L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 496 (613)
T 2ozo_A 422 LHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 496 (613)
T ss_dssp HHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC---------
T ss_pred HHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeec
Confidence 99998543 456999999999999999999999998 9999999999999999999999999998764332211 11
Q ss_pred ccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCCC
Q 043278 592 KRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPC 670 (752)
Q Consensus 592 ~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 670 (752)
....+++.|+|||++.+..++.++|||||||+||||++ |+.||......+ ....+..+.....
T Consensus 497 ~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-------~~~~i~~~~~~~~--------- 560 (613)
T 2ozo_A 497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQGKRMEC--------- 560 (613)
T ss_dssp -----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH-------HHHHHHTTCCCCC---------
T ss_pred cCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHcCCCCCC---------
Confidence 22345689999999999999999999999999999998 999997654221 1223333322211
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 671 SANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 671 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
+......+.+|+.+||+.||++||++.+|++.|+..
T Consensus 561 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 561 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 112234677899999999999999999999999864
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=344.80 Aligned_cols=258 Identities=24% Similarity=0.278 Sum_probs=189.3
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCcccHHHHHHHHHHHHhcC-CCCcceeeeeee--------eC
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQ-HTNLVRLLGCSL--------HG 498 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~--------~~ 498 (752)
..+|.+.++||+|+||.||+++.. +++.||||++..........+.+|+.++.++. ||||+++++++. ..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 457888999999999999999964 68899999997766666778899999999996 999999999984 34
Q ss_pred CeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceeccccc
Q 043278 499 EERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGM 578 (752)
Q Consensus 499 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgl 578 (752)
...++||||++ |+|.+++........+++..++.++.||+.||+|||+.+ ++|+||||||+|||++.++.+||+|||+
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCcc
Confidence 45789999996 789888866444556999999999999999999999875 3599999999999999999999999999
Q ss_pred ceeeccccccc----------ccccccccCCccChhhh---ccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcch
Q 043278 579 ARIFEVNESEA----------NTKRIVGTYGYMSPEYA---MSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNL 645 (752)
Q Consensus 579 a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l 645 (752)
++......... ......||+.|+|||++ .+..++.++||||||+++|||++|+.||........
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--- 261 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI--- 261 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh---
Confidence 98765332111 11134689999999998 567789999999999999999999999965432110
Q ss_pred HHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCC
Q 043278 646 IGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNET 707 (752)
Q Consensus 646 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~ 707 (752)
. .+... ..........+.+++.+||+.||.+|||+.|+++.|+.+.
T Consensus 262 -------~-~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~ 307 (337)
T 3ll6_A 262 -------V-NGKYS--------IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA 307 (337)
T ss_dssp ------------CC--------CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------h-cCccc--------CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0 00000 0000111123667889999999999999999999998763
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=344.43 Aligned_cols=212 Identities=27% Similarity=0.365 Sum_probs=182.1
Q ss_pred ccccccHHHHHHHhcCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCCcccHHHHHHHHHHHHhcC-----CCCcc
Q 043278 416 ELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQ-----HTNLV 489 (752)
Q Consensus 416 ~~~~~~~~~i~~~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----h~niv 489 (752)
+...|++.+.....++|.+.++||+|+||.||+|+. .+++.||||++... ......+..|+.++.+++ |+||+
T Consensus 21 ~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv 99 (360)
T 3llt_A 21 EIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIV 99 (360)
T ss_dssp GGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred cceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence 344455555555678999999999999999999987 46889999999643 334456788999999996 99999
Q ss_pred eeeeeeeeCCeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecC--
Q 043278 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDD-- 567 (752)
Q Consensus 490 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~-- 567 (752)
++++++...+..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~ 174 (360)
T 3llt_A 100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPY 174 (360)
T ss_dssp CEEEEEEETTEEEEEECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTT
T ss_pred cccceeeECCeeEEEEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccc
Confidence 9999999999999999999 899999986543 235899999999999999999999998 999999999999975
Q ss_pred -----------------------CCCceecccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHH
Q 043278 568 -----------------------KMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLV 624 (752)
Q Consensus 568 -----------------------~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl 624 (752)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 249 (360)
T 3llt_A 175 FEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVL 249 (360)
T ss_dssp CCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHH
T ss_pred ccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHH
Confidence 889999999999864322 2346789999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCC
Q 043278 625 LEIVSGQKNHTRHH 638 (752)
Q Consensus 625 ~elltG~~p~~~~~ 638 (752)
|||++|+.||....
T Consensus 250 ~ell~g~~pf~~~~ 263 (360)
T 3llt_A 250 AELYTGSLLFRTHE 263 (360)
T ss_dssp HHHHHSSCSCCCSS
T ss_pred HHHHHCCCCCCCCc
Confidence 99999999997654
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=332.51 Aligned_cols=255 Identities=25% Similarity=0.382 Sum_probs=201.6
Q ss_pred hcCCCcCCeeecCCcccEEEEEecC----CceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEE
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLAD----EQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLL 503 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 503 (752)
.++|.+.+.||+|+||.||+|+... +..||+|.+.... ......+.+|+.++.+++||||+++++++.+ +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 4678888999999999999998643 2359999997653 3345678999999999999999999999865 45689
Q ss_pred EEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeec
Q 043278 504 VYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFE 583 (752)
Q Consensus 504 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~ 583 (752)
||||+++++|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 90 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp EEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred EEecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 999999999999996532 35899999999999999999999998 9999999999999999999999999998654
Q ss_pred ccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCccccc
Q 043278 584 VNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELI 662 (752)
Q Consensus 584 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 662 (752)
..... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... .. ..+..+.....
T Consensus 165 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---~~----~~~~~~~~~~~- 235 (281)
T 3cc6_A 165 DEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---VI----GVLEKGDRLPK- 235 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---HH----HHHHHTCCCCC-
T ss_pred ccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---HH----HHHhcCCCCCC-
Confidence 33211 1223456789999999999999999999999999999998 999997544221 11 11111111110
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 663 DPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 663 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
+......+.+++.+|++.||.+|||+.|+++.|+.+
T Consensus 236 --------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 236 --------PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp --------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 111224577899999999999999999999999864
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=335.87 Aligned_cols=265 Identities=23% Similarity=0.319 Sum_probs=209.3
Q ss_pred HHHHhcCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHh--cCCCCcceeeeeeeeCC---
Q 043278 425 IAAAANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAK--LQHTNLVRLLGCSLHGE--- 499 (752)
Q Consensus 425 i~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~--- 499 (752)
-....++|.+.+.||+|+||.||+|+. .++.||||++... ....+.+|.+++.. ++||||+++++++....
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred cccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 345668999999999999999999998 5889999998643 34567889998887 79999999999998776
Q ss_pred -eeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCcEeecCCCCCcEEecCCCC
Q 043278 500 -ERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLH--------KYSRLRVIHRDLKASNILLDDKMN 570 (752)
Q Consensus 500 -~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~~~~iiH~Dikp~NIll~~~~~ 570 (752)
..++||||+++|+|.+++.. ..+++..++.++.||+.||+||| +.+ |+||||||+|||++.++.
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~ 185 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGT 185 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSC
T ss_pred ceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCC
Confidence 78999999999999999954 34899999999999999999999 555 999999999999999999
Q ss_pred ceecccccceeeccccccc--ccccccccCCccChhhhccC------CCCccchhHHHHHHHHHHHhC----------CC
Q 043278 571 PKISDFGMARIFEVNESEA--NTKRIVGTYGYMSPEYAMSG------IVSIKTDVFSFGVLVLEIVSG----------QK 632 (752)
Q Consensus 571 ~kl~DFgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~t~k~DV~S~G~vl~elltG----------~~ 632 (752)
+||+|||+++......... ......||+.|+|||.+.+. .++.++||||||+++|||++| +.
T Consensus 186 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~ 265 (342)
T 1b6c_B 186 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 265 (342)
T ss_dssp EEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccccc
Confidence 9999999998765433211 22345789999999998875 344789999999999999999 66
Q ss_pred CCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCC-CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 633 NHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQ-PCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 633 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
||......... .......+.... ..+.+.. ....+....+.+++.+||+.||.+|||+.||+++|+.+
T Consensus 266 p~~~~~~~~~~--~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 266 PYYDLVPSDPS--VEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp TTTTTSCSSCC--HHHHHHHHTTSC----CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CccccCcCccc--HHHHHHHHHHHH----hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 77654433221 111222222211 1121111 12345667888999999999999999999999999875
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=346.96 Aligned_cols=256 Identities=27% Similarity=0.393 Sum_probs=193.0
Q ss_pred CCCcCCeeecCCcccEEEEEec--CC--ceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeee-CCeeEEE
Q 043278 431 NFSTTNKLGEGGFGPVYKGKLA--DE--QEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLH-GEERLLV 504 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~~--~~--~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv 504 (752)
.|...+.||+|+||.||+|+.. ++ ..||||.+.... .....+|.+|+.++.+++||||+++++++.+ ++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4566789999999999999863 22 358999987543 3445779999999999999999999998754 4578999
Q ss_pred EeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecc
Q 043278 505 YEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~ 584 (752)
|||+++|+|.+++... ...+++..++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 170 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp EECCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EECCCCCCHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccc
Confidence 9999999999999543 345889999999999999999999998 99999999999999999999999999986543
Q ss_pred cccc--cccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccc
Q 043278 585 NESE--ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLEL 661 (752)
Q Consensus 585 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 661 (752)
.... .......+++.|+|||.+.+..++.++||||||+++|||++ |.+||....... .. ..+..+...
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~----~~~~~~~~~-- 315 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---IT----VYLLQGRRL-- 315 (373)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HH----HHHHTTCCC--
T ss_pred cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HH----HHHHcCCCC--
Confidence 3211 11223456788999999999999999999999999999999 666776544322 11 112222211
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCC
Q 043278 662 IDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNET 707 (752)
Q Consensus 662 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~ 707 (752)
..+ ......+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus 316 ~~p-------~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~ 354 (373)
T 3c1x_A 316 LQP-------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 354 (373)
T ss_dssp CCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCC-------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111 112235778999999999999999999999998763
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=334.28 Aligned_cols=261 Identities=21% Similarity=0.341 Sum_probs=198.7
Q ss_pred cCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCC---cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 505 (752)
++|.+.+.||+|+||.||+|.. .+++.||||++.... .....++.+|+.++.+++|+||+++++++.+++..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 5788899999999999999986 468899999987532 334567889999999999999999999999999999999
Q ss_pred eeCCCCCHhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecc
Q 043278 506 EFMPNKSLDFFLFNS-GRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584 (752)
Q Consensus 506 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~ 584 (752)
||+++++|.+++... .....+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++.....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 999999999988642 23456899999999999999999999998 99999999999999999999999999986543
Q ss_pred cccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCC
Q 043278 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDP 664 (752)
Q Consensus 585 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 664 (752)
... ......+++.|+|||.+.+..++.++||||||+++|||++|+.||...... .... ...+..........
T Consensus 189 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~-~~~~~~~~~~~~~~- 260 (310)
T 2wqm_A 189 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSL-CKKIEQCDYPPLPS- 260 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----HHHH-HHHHHTTCSCCCCT-
T ss_pred CCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----HHHH-HHHhhcccCCCCcc-
Confidence 221 122356899999999999999999999999999999999999998654321 1111 12222222211111
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCC
Q 043278 665 SLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETM 708 (752)
Q Consensus 665 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~~ 708 (752)
......+.+++.+||+.||.+|||+.||++.|+.+..
T Consensus 261 -------~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~ 297 (310)
T 2wqm_A 261 -------DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA 297 (310)
T ss_dssp -------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------cccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 1122357788999999999999999999999988743
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=328.79 Aligned_cols=254 Identities=23% Similarity=0.345 Sum_probs=205.3
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEe
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYE 506 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 506 (752)
.++|++.+.||+|+||.||+++.. +++.||||++.... ......+.+|+.++.+++||||+++++++.+++..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 367888999999999999999875 68899999986543 2345678999999999999999999999999999999999
Q ss_pred eCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccc
Q 043278 507 FMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586 (752)
Q Consensus 507 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~ 586 (752)
|+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 86 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 86 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ecCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 9999999988843 345899999999999999999999998 9999999999999999999999999998765433
Q ss_pred cccccccccccCCccChhhhccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCC
Q 043278 587 SEANTKRIVGTYGYMSPEYAMSGIV-SIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPS 665 (752)
Q Consensus 587 ~~~~~~~~~gt~~y~aPE~~~~~~~-t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 665 (752)
.........|++.|+|||.+.+..+ +.++||||||++++||++|+.||........ . ...+...... ..+
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~----~~~~~~~~~~--~~~- 230 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--E----YSDWKEKKTY--LNP- 230 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH--H----HHHHHTTCTT--STT-
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH--H----HHHhhhcccc--cCc-
Confidence 3333345678999999999987765 7899999999999999999999976543211 1 1111111100 000
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 666 LEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 666 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.......+.+++.+|++.||.+|||+.|+++.
T Consensus 231 -----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 231 -----WKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp -----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -----hhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 11122356789999999999999999999874
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=339.48 Aligned_cols=249 Identities=22% Similarity=0.304 Sum_probs=203.1
Q ss_pred hcCCCcCCeeecCCcccEEEEEecC-CceeEEEEcccC---CcccHHHHHHHHHHHHhc-CCCCcceeeeeeeeCCeeEE
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLAD-EQEVAIKRLSRS---SGQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGEERLL 503 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 503 (752)
.++|.+.+.||+|+||.||+++... ++.||||+++.. .......+..|..++..+ +||||+++++++.+.+..++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 4688999999999999999999764 788999999754 223456788999999988 89999999999999999999
Q ss_pred EEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeec
Q 043278 504 VYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFE 583 (752)
Q Consensus 504 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~ 583 (752)
||||+++|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 99 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 99999999999998653 34899999999999999999999998 9999999999999999999999999998532
Q ss_pred ccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccC
Q 043278 584 VNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELID 663 (752)
Q Consensus 584 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 663 (752)
... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ........ +..
T Consensus 173 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~~i~~-~~~----- 238 (353)
T 2i0e_A 173 WDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------ELFQSIME-HNV----- 238 (353)
T ss_dssp CTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHH-CCC-----
T ss_pred cCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH------HHHHHHHh-CCC-----
Confidence 221 2234568999999999999999999999999999999999999999764321 11112222 111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 043278 664 PSLEQPCSANEVMRCIHVGLLCVQDQAMDRPT-----MPEVVCM 702 (752)
Q Consensus 664 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-----~~ev~~~ 702 (752)
.+ +......+.+++.+||+.||.+||+ +.|++++
T Consensus 239 -~~----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 239 -AY----PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp -CC----CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred -CC----CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 01 1112245778899999999999995 5777654
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=339.04 Aligned_cols=262 Identities=21% Similarity=0.214 Sum_probs=202.4
Q ss_pred HHHHhcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccC-----CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeC
Q 043278 425 IAAAANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRS-----SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHG 498 (752)
Q Consensus 425 i~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 498 (752)
+....++|.+.+.||+|+||.||+|... +++.||+|++... .......+.+|+.++.+++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 4456788999999999999999999874 5788999998643 234567889999999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHhHHHhhcC-------------------------------------CCCCCCHHHHHHHHHHHHHH
Q 043278 499 EERLLVYEFMPNKSLDFFLFNSG-------------------------------------RKNVLNWEKRFIIIEGISQG 541 (752)
Q Consensus 499 ~~~~lv~E~~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~i~~~ 541 (752)
+..++||||+++|+|.+++.... ....+++..+..++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 99999999999999999884210 01224577788999999999
Q ss_pred HHHHHhcCCCcEeecCCCCCcEEecCCC--Cceecccccceeecccccc--cccccccccCCccChhhhcc--CCCCccc
Q 043278 542 LLYLHKYSRLRVIHRDLKASNILLDDKM--NPKISDFGMARIFEVNESE--ANTKRIVGTYGYMSPEYAMS--GIVSIKT 615 (752)
Q Consensus 542 l~~LH~~~~~~iiH~Dikp~NIll~~~~--~~kl~DFgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~t~k~ 615 (752)
|+|||+.+ |+||||||+|||++.++ .+||+|||+++.+...... .......||+.|+|||.+.+ ..++.++
T Consensus 181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999998 99999999999998766 8999999999876432211 12234678999999999975 6789999
Q ss_pred hhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCC
Q 043278 616 DVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPT 695 (752)
Q Consensus 616 DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt 695 (752)
||||||+++|||++|+.||...... ............ ...+. .......+.+++.+|++.||.+|||
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~------~~~~~~~~~~~~--~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps 324 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDA------DTISQVLNKKLC--FENPN-----YNVLSPLARDLLSNLLNRNVDERFD 324 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCC--TTSGG-----GGGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChH------HHHHHHHhcccc--cCCcc-----cccCCHHHHHHHHHHcCCChhHCCC
Confidence 9999999999999999999655421 112222222111 00111 1112245778999999999999999
Q ss_pred HHHHHHH
Q 043278 696 MPEVVCM 702 (752)
Q Consensus 696 ~~ev~~~ 702 (752)
+.|+++.
T Consensus 325 ~~~~l~h 331 (345)
T 3hko_A 325 AMRALQH 331 (345)
T ss_dssp HHHHHHS
T ss_pred HHHHhcC
Confidence 9999885
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=327.63 Aligned_cols=251 Identities=27% Similarity=0.382 Sum_probs=204.3
Q ss_pred HhcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeee---------
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLH--------- 497 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------- 497 (752)
..++|++.+.||+|+||.||+++.. +++.||+|++.... ..+.+|++++.+++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 3467889999999999999999975 68999999997653 346789999999999999999998754
Q ss_pred -------CCeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCC
Q 043278 498 -------GEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMN 570 (752)
Q Consensus 498 -------~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~ 570 (752)
....++||||+++++|.+++.... ...+++..++.++.||+.||.|||+.+ |+|+||||+|||+++++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence 445799999999999999996532 346899999999999999999999998 999999999999999999
Q ss_pred ceecccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHH
Q 043278 571 PKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAW 650 (752)
Q Consensus 571 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~ 650 (752)
+||+|||++....... ......+++.|+|||.+.+..++.++||||||+++|||++|..|+... ....
T Consensus 161 ~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---------~~~~ 228 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET---------SKFF 228 (284)
T ss_dssp EEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH---------HHHH
T ss_pred EEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH---------HHHH
Confidence 9999999998765332 122356899999999999999999999999999999999998775321 1112
Q ss_pred HHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCCCC
Q 043278 651 QLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETMPL 710 (752)
Q Consensus 651 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~~~~ 710 (752)
..+..+... ...+ ..+.+++.+|++.||.+|||+.|++++|+.....+
T Consensus 229 ~~~~~~~~~--------~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 229 TDLRDGIIS--------DIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276 (284)
T ss_dssp HHHHTTCCC--------TTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred HHhhccccc--------ccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence 222222211 1112 34668889999999999999999999998875533
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=335.14 Aligned_cols=264 Identities=23% Similarity=0.329 Sum_probs=198.5
Q ss_pred HhcCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCC-----cccHHHHHHHHHHHHhcC---CCCcceeeeeeeeC
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSS-----GQGIVEFKNEVRLIAKLQ---HTNLVRLLGCSLHG 498 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~ 498 (752)
..++|++.++||+|+||+||+|+. .+++.||||++.... ......+.+|+.++.+++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467899999999999999999996 468899999986432 112345677777777764 99999999999775
Q ss_pred C-----eeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCcee
Q 043278 499 E-----ERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKI 573 (752)
Q Consensus 499 ~-----~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl 573 (752)
. ..++||||++ ++|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 5 5789999997 59988886543 334999999999999999999999998 999999999999999999999
Q ss_pred cccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHh
Q 043278 574 SDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLL 653 (752)
Q Consensus 574 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 653 (752)
+|||+++..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||....... .........
T Consensus 162 ~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~ 235 (308)
T 3g33_A 162 ADFGLARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD---QLGKIFDLI 235 (308)
T ss_dssp CSCSCTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH---HHHHHHHHH
T ss_pred eeCccccccCCC---cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHh
Confidence 999999865422 22234678999999999999999999999999999999999999997654221 111111111
Q ss_pred hCCCcccc------cCCCC--CCCCCH-----HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 654 SDGKGLEL------IDPSL--EQPCSA-----NEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 654 ~~~~~~~~------~d~~l--~~~~~~-----~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
........ ....+ ....+. +....+.+++.+|++.||++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 236 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 11100000 00000 000011 122467789999999999999999999874
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=331.68 Aligned_cols=253 Identities=18% Similarity=0.313 Sum_probs=203.5
Q ss_pred cCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeeeC--CeeEEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHG--EERLLVY 505 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 505 (752)
++|.+.+.||+|+||.||+|+.. ++.||||++.... ....+++.+|+.++.+++||||+++++++.+. ...++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 57888899999999999999984 7889999997653 33456789999999999999999999999877 7789999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccc
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVN 585 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~ 585 (752)
||+++|+|.+++... ....+++..++.++.||+.||+|||+.+ .+|+||||||+|||++.++.++|+|||++....
T Consensus 89 e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~-- 164 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-- 164 (271)
T ss_dssp ECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS--
T ss_pred cccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec--
Confidence 999999999999653 2335899999999999999999999864 359999999999999999999999998875322
Q ss_pred ccccccccccccCCccChhhhccCCCCc---cchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCccccc
Q 043278 586 ESEANTKRIVGTYGYMSPEYAMSGIVSI---KTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELI 662 (752)
Q Consensus 586 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~---k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 662 (752)
.....+|+.|+|||.+.+...+. ++||||||+++|||++|+.||..... ..........+...
T Consensus 165 -----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~~~--- 230 (271)
T 3kmu_A 165 -----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN------MEIGMKVALEGLRP--- 230 (271)
T ss_dssp -----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH------HHHHHHHHHSCCCC---
T ss_pred -----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh------HHHHHHHHhcCCCC---
Confidence 12356789999999998765544 89999999999999999999975431 11112222222111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCC
Q 043278 663 DPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNET 707 (752)
Q Consensus 663 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~ 707 (752)
.+.. .....+.+++..|++.||++|||+.|+++.|+.+.
T Consensus 231 --~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 231 --TIPP----GISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp --CCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred --CCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 1111 12345778899999999999999999999998753
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=342.55 Aligned_cols=252 Identities=15% Similarity=0.151 Sum_probs=203.9
Q ss_pred HhcCCCcCCeeecCCcccEEEEE------ecCCceeEEEEcccCCcccHHHHHHHHHHHHhcC---CCCcceeeeeeeeC
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGK------LADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQ---HTNLVRLLGCSLHG 498 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~------~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~ 498 (752)
..++|.+.++||+|+||.||+|. ...++.||||++... ...++..|+.++.+++ |+||+++++++...
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 34678889999999999999994 456889999999754 3457788888888886 89999999999999
Q ss_pred CeeEEEEeeCCCCCHhHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecC---------
Q 043278 499 EERLLVYEFMPNKSLDFFLFNSG--RKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDD--------- 567 (752)
Q Consensus 499 ~~~~lv~E~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~--------- 567 (752)
+..+|||||+++|+|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+||||+.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccc
Confidence 99999999999999999996532 3456999999999999999999999988 999999999999998
Q ss_pred --CCCceecccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcch
Q 043278 568 --KMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNL 645 (752)
Q Consensus 568 --~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l 645 (752)
++.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---- 292 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE---- 292 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE----
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc----
Confidence 89999999999987653333333345679999999999999999999999999999999999999985443211
Q ss_pred HHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCC-CCHHHHHHHhhcC
Q 043278 646 IGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDR-PTMPEVVCMLQNE 706 (752)
Q Consensus 646 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~R-Pt~~ev~~~L~~~ 706 (752)
..+...+..... ...+.+++..|++.+|.+| |+++++.+.|+..
T Consensus 293 --------------~~~~~~~~~~~~---~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~ 337 (365)
T 3e7e_A 293 --------------CKPEGLFRRLPH---LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV 337 (365)
T ss_dssp --------------EEECSCCTTCSS---HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred --------------eeechhccccCc---HHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence 001111111112 2345567789999999998 6888888888764
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=324.17 Aligned_cols=252 Identities=21% Similarity=0.261 Sum_probs=204.9
Q ss_pred HhcCCCcCCeeecCCcccEEEEEecC-CceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEe
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGKLAD-EQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYE 506 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 506 (752)
..++|.+.+.||+|+||.||+|.... +..||+|++..........+.+|++++.+++||||+++++++.+++..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 34678999999999999999998754 67899999987766677889999999999999999999999999999999999
Q ss_pred eCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEe---cCCCCceecccccceeec
Q 043278 507 FMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILL---DDKMNPKISDFGMARIFE 583 (752)
Q Consensus 507 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll---~~~~~~kl~DFgla~~~~ 583 (752)
|+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||++....
T Consensus 87 ~~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 87 LCTGGELFERVVHK---RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ccCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 99999999988653 34899999999999999999999998 9999999999999 888999999999998754
Q ss_pred ccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccC
Q 043278 584 VNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELID 663 (752)
Q Consensus 584 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 663 (752)
... ......||+.|+|||.+.+. ++.++||||||++++||++|+.||...... .....+..+.... ..
T Consensus 161 ~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~-~~ 228 (277)
T 3f3z_A 161 PGK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS-------EVMLKIREGTFTF-PE 228 (277)
T ss_dssp TTS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCCCC-CH
T ss_pred Ccc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHhCCCCC-Cc
Confidence 332 22345789999999988654 899999999999999999999999764321 1111222211100 00
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 664 PSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 664 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.. .. .....+.+++.+|++.||.+|||+.|+++.
T Consensus 229 ~~-~~----~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 229 KD-WL----NVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp HH-HT----TSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred hh-hh----cCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 00 112457789999999999999999999864
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=337.62 Aligned_cols=263 Identities=25% Similarity=0.305 Sum_probs=198.8
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCc--ccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEe
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSG--QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYE 506 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 506 (752)
++|.+.++||+|+||.||+|+.. +++.||||++..... .....+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57888999999999999999975 488999999865532 234567899999999999999999999999999999999
Q ss_pred eCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccc
Q 043278 507 FMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586 (752)
Q Consensus 507 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~ 586 (752)
|+++++|..++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 83 YCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp CCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred eCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 9999999888753 345899999999999999999999998 9999999999999999999999999998754322
Q ss_pred cccccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHH--------HHHhhCCC
Q 043278 587 SEANTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYA--------WQLLSDGK 657 (752)
Q Consensus 587 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~--------~~~~~~~~ 657 (752)
. ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...........+... ........
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
T 4agu_A 157 D--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ 234 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred c--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence 1 1223578999999999876 67899999999999999999999999765432211111000 00011110
Q ss_pred c---ccccCCCCCCCCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 658 G---LELIDPSLEQPCS-----ANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 658 ~---~~~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
. ..+.++. ...+ ......+.+++.+|++.||.+|||++|++++
T Consensus 235 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 235 YFSGVKIPDPE--DMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GGTTCCCCCCS--SCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccccCcCCCcc--ccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0 0011110 0001 1122357789999999999999999999875
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=337.92 Aligned_cols=261 Identities=21% Similarity=0.272 Sum_probs=199.7
Q ss_pred cCCCcC-CeeecCCcccEEEEEe-cCCceeEEEEcccCCcccHHHHHHHHHHHHhc-CCCCcceeeeeeeeCCeeEEEEe
Q 043278 430 NNFSTT-NKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGEERLLVYE 506 (752)
Q Consensus 430 ~~~~~~-~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E 506 (752)
+.|.+. +.||+|+||.||+++. .+++.||||++..........+.+|+.++.++ +||||+++++++.+++..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 466664 7899999999999985 46889999999877666778899999999985 79999999999999999999999
Q ss_pred eCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCC---ceecccccceeec
Q 043278 507 FMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMN---PKISDFGMARIFE 583 (752)
Q Consensus 507 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~---~kl~DFgla~~~~ 583 (752)
|+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||++....
T Consensus 92 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 92 KMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp CCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred cCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 99999999998653 35899999999999999999999998 999999999999988776 9999999998654
Q ss_pred cccc-----ccccccccccCCccChhhhcc-----CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcch--------
Q 043278 584 VNES-----EANTKRIVGTYGYMSPEYAMS-----GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNL-------- 645 (752)
Q Consensus 584 ~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l-------- 645 (752)
.... ........||+.|+|||++.. ..++.++||||||+++|||++|+.||...........
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 245 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence 2211 111223568999999999875 5688999999999999999999999987654321110
Q ss_pred HHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 646 IGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 646 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.......+..+... +..... . .....+.+++.+|++.||.+|||+.|++++
T Consensus 246 ~~~~~~~i~~~~~~-~~~~~~-~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 246 QNMLFESIQEGKYE-FPDKDW-A----HISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHHCCCC-CCHHHH-T----TSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHhccCcc-cCchhc-c----cCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 01111222222110 000000 0 112457789999999999999999999985
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=339.73 Aligned_cols=264 Identities=26% Similarity=0.347 Sum_probs=196.0
Q ss_pred cCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHH--HHhcCCCCcceeeeeee-----eCCeeE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRL--IAKLQHTNLVRLLGCSL-----HGEERL 502 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~-----~~~~~~ 502 (752)
++|++.+.||+|+||.||+|+. +++.||||++.... ...+..|.++ +..++|+||+++++.+. .....+
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred HHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence 5788899999999999999987 67899999986542 3344445444 44589999999998543 233678
Q ss_pred EEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc---------CCCcEeecCCCCCcEEecCCCCcee
Q 043278 503 LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY---------SRLRVIHRDLKASNILLDDKMNPKI 573 (752)
Q Consensus 503 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---------~~~~iiH~Dikp~NIll~~~~~~kl 573 (752)
+||||+++|+|.+++... ..++..+..++.||++||+|||+. + |+||||||+|||++.++.+||
T Consensus 89 lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL 161 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVI 161 (336)
T ss_dssp EEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEE
T ss_pred EEEecCCCCcHHHHHhhc----ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEE
Confidence 999999999999999542 358999999999999999999998 6 999999999999999999999
Q ss_pred cccccceeeccccc------ccccccccccCCccChhhhcc-------CCCCccchhHHHHHHHHHHHhCCCCCCCCCCC
Q 043278 574 SDFGMARIFEVNES------EANTKRIVGTYGYMSPEYAMS-------GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPD 640 (752)
Q Consensus 574 ~DFgla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~ 640 (752)
+|||+++.+..... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.|+......
T Consensus 162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 241 (336)
T 3g2f_A 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241 (336)
T ss_dssp CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence 99999987653321 111224578999999999987 45678999999999999999997776443322
Q ss_pred CCcc-hH----------HHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 641 RPLN-LI----------GYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 641 ~~~~-l~----------~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
.... .. ...............+... ..........+.+++.+||+.||++|||++|+++.|+.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l 316 (336)
T 3g2f_A 242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEA--WKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL 316 (336)
T ss_dssp CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTT--CCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred hHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcc--cccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence 2111 00 0111111111111111111 112334556788999999999999999999999999876
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=332.87 Aligned_cols=257 Identities=27% Similarity=0.381 Sum_probs=199.9
Q ss_pred hcCCCcCCeeecCCcccEEEEEecCC----ceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeee-eCCeeE
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLADE----QEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSL-HGEERL 502 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~~~----~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~ 502 (752)
..+|.+.+.||+|+||.||+|+..+. ..+|+|.+.... .....++.+|+.++++++||||+++++++. .++..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 35677889999999999999986432 258999987643 334567899999999999999999999865 456789
Q ss_pred EEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceee
Q 043278 503 LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIF 582 (752)
Q Consensus 503 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~ 582 (752)
+||||+++++|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 104 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence 99999999999999964 3345899999999999999999999998 999999999999999999999999999876
Q ss_pred cccccc--cccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhC-CCCCCCCCCCCCcchHHHHHHHhhCCCcc
Q 043278 583 EVNESE--ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG-QKNHTRHHPDRPLNLIGYAWQLLSDGKGL 659 (752)
Q Consensus 583 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 659 (752)
...... .......+|+.|+|||.+.+..++.++||||||++++||++| .+|+....... .. .....+...
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~~----~~~~~~~~~ 251 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---IT----VYLLQGRRL 251 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT---HH----HHHHTTCCC
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH---HH----HHHhcCCCC
Confidence 433221 122335677899999999999999999999999999999995 45554433221 11 111111111
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 660 ELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 660 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
..+ ......+.+++.+|++.||.+|||+.|+++.|+.+
T Consensus 252 --~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 289 (298)
T 3f66_A 252 --LQP-------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289 (298)
T ss_dssp --CCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCC-------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111 11123577899999999999999999999999875
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=349.37 Aligned_cols=247 Identities=25% Similarity=0.395 Sum_probs=204.0
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC---cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 505 (752)
++|.+.+.||+|+||.||+|+.. +|+.||||++.... ......+.+|+.+++.++||||+++++++...+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 57888899999999999999875 68999999996542 234567899999999999999999999999999999999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccc
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVN 585 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~ 585 (752)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 96 E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 96 EYVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp ECCSSEEHHHHTTS---SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 99999999999853 345999999999999999999999998 999999999999999999999999999876432
Q ss_pred ccccccccccccCCccChhhhccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCC
Q 043278 586 ESEANTKRIVGTYGYMSPEYAMSGIV-SIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDP 664 (752)
Q Consensus 586 ~~~~~~~~~~gt~~y~aPE~~~~~~~-t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 664 (752)
. ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||...... . ....+..+... .+
T Consensus 170 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~------~-~~~~i~~~~~~---~p 236 (476)
T 2y94_A 170 E---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP------T-LFKKICDGIFY---TP 236 (476)
T ss_dssp C---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH------H-HHHHHHTTCCC---CC
T ss_pred c---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH------H-HHHHHhcCCcC---CC
Confidence 2 2234579999999999988765 78999999999999999999999754421 1 11222222110 01
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 665 SLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 665 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.. ....+.+++.+||+.||.+|||+.|++++
T Consensus 237 ---~~----~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 237 ---QY----LNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp ---TT----CCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ---cc----CCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 11 12356788999999999999999999874
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=335.32 Aligned_cols=255 Identities=27% Similarity=0.368 Sum_probs=202.5
Q ss_pred hcCCCcCC-eeecCCcccEEEEEe---cCCceeEEEEcccCCc--ccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeE
Q 043278 429 ANNFSTTN-KLGEGGFGPVYKGKL---ADEQEVAIKRLSRSSG--QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERL 502 (752)
Q Consensus 429 ~~~~~~~~-~LG~G~fg~Vy~~~~---~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 502 (752)
.++|.+.+ .||+|+||.||+|.. ..++.||||++..... ...+++.+|+.++.+++||||+++++++ +.+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 35666667 999999999999964 2467899999976532 2356789999999999999999999999 567789
Q ss_pred EEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceee
Q 043278 503 LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIF 582 (752)
Q Consensus 503 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~ 582 (752)
+||||+++++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 94 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EEEECCTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEeCCCCCHHHHHHhC---cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 999999999999999653 34899999999999999999999998 999999999999999999999999999876
Q ss_pred ccccccc-ccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCccc
Q 043278 583 EVNESEA-NTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLE 660 (752)
Q Consensus 583 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 660 (752)
....... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... .....+..+....
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~~~~~~~~~ 240 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-------EVTAMLEKGERMG 240 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------HHHHHHHTTCCCC
T ss_pred ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHHcCCCCC
Confidence 5433221 1222346788999999999899999999999999999999 99998765421 1222233322211
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 661 LIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 661 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
. +......+.+++.+|++.||.+|||+.|+++.|+.+
T Consensus 241 ~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 241 C---------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp C---------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred C---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1 112234577899999999999999999999999875
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=332.14 Aligned_cols=256 Identities=27% Similarity=0.368 Sum_probs=201.5
Q ss_pred CCCcCCeeecCCcccEEEEEecC-C---ceeEEEEcccCCc-ccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCee-EEE
Q 043278 431 NFSTTNKLGEGGFGPVYKGKLAD-E---QEVAIKRLSRSSG-QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEER-LLV 504 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~~~-~---~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lv 504 (752)
.|...++||+|+||.||+|...+ + ..+|+|.+..... ...+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 34556899999999999998643 2 3699999876433 3456789999999999999999999999876655 999
Q ss_pred EeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecc
Q 043278 505 YEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~ 584 (752)
|||+.+++|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 102 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 999999999999965 2345899999999999999999999998 99999999999999999999999999986543
Q ss_pred cc--cccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCccccc
Q 043278 585 NE--SEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELI 662 (752)
Q Consensus 585 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 662 (752)
.. .........+++.|+|||.+.+..++.++||||||+++|||++|..|+...... .... .....+....
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~--~~~~----~~~~~~~~~~-- 248 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP--FDLT----HFLAQGRRLP-- 248 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG--GGHH----HHHHTTCCCC--
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH--HHHH----HHhhcCCCCC--
Confidence 32 112223456788999999999999999999999999999999966654433211 1111 1122221111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 663 DPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 663 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
.+......+.+++.+|++.||.+|||+.|+++.|+.+
T Consensus 249 -------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~ 285 (298)
T 3pls_A 249 -------QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285 (298)
T ss_dssp -------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0111224577899999999999999999999999875
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=328.52 Aligned_cols=250 Identities=26% Similarity=0.414 Sum_probs=183.5
Q ss_pred hcCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCC---cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEE
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLV 504 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 504 (752)
.++|.+.+.||+|+||.||+|+. .+++.||||++.... ......+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 35788889999999999999987 468899999986432 23356789999999999999999999999999999999
Q ss_pred EeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecc
Q 043278 505 YEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~ 584 (752)
|||+++++|.+++... ...+++..+..++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 9999999999998643 346899999999999999999999998 99999999999999999999999999987543
Q ss_pred cccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCC
Q 043278 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDP 664 (752)
Q Consensus 585 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 664 (752)
... ......|++.|+|||.+.+..++.++||||||++++||++|+.||.......... ..... +.
T Consensus 165 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-------~~~~~------~~ 229 (278)
T 3cok_A 165 PHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN-------KVVLA------DY 229 (278)
T ss_dssp -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------CCSS------CC
T ss_pred CCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH-------HHhhc------cc
Confidence 221 1223568999999999999999999999999999999999999997654332110 00000 11
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 665 SLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 665 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.. +......+.+++.+|++.||++|||+.|+++.
T Consensus 230 ~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 230 EM----PSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp CC----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CC----ccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 11 11122356789999999999999999999873
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=338.08 Aligned_cols=248 Identities=30% Similarity=0.409 Sum_probs=199.7
Q ss_pred hcCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCCc---ccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEE
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSSG---QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLV 504 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 504 (752)
.+.|+..+.||+|+||.||+|+. .+++.||||++..... ....++.+|++++.+++||||+++++++.+++..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 35688889999999999999986 5688999999975432 2345688999999999999999999999999999999
Q ss_pred EeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecc
Q 043278 505 YEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~ 584 (752)
|||++ |+|.+++... ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 133 ~e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 99998 6777777543 245899999999999999999999998 99999999999999999999999999986432
Q ss_pred cccccccccccccCCccChhhhc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccc
Q 043278 585 NESEANTKRIVGTYGYMSPEYAM---SGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLEL 661 (752)
Q Consensus 585 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 661 (752)
. ....||+.|+|||++. ...++.++||||||+++|||++|+.||..... ........... ....
T Consensus 207 ~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~------~~~~~~~~~~~-~~~~ 273 (348)
T 1u5q_A 207 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNE-SPAL 273 (348)
T ss_dssp B------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSC-CCCC
T ss_pred C------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHhcC-CCCC
Confidence 1 2357899999999985 57899999999999999999999999865431 11122222221 1111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 043278 662 IDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCML 703 (752)
Q Consensus 662 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L 703 (752)
.. .. ....+.+++.+||+.||++|||+.|+++..
T Consensus 274 ~~----~~----~~~~l~~li~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 274 QS----GH----WSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp CC----TT----SCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred CC----CC----CCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 11 11 123467888999999999999999998753
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=328.04 Aligned_cols=252 Identities=22% Similarity=0.307 Sum_probs=203.4
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEE
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 505 (752)
.++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++.+++||||+++++++.+++..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 468889999999999999999875 58899999986542 334567889999999999999999999999999999999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCC---ceecccccceee
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMN---PKISDFGMARIF 582 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~---~kl~DFgla~~~ 582 (752)
||+++++|.+.+... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||++...
T Consensus 85 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 999999998888653 35899999999999999999999998 999999999999986655 999999999865
Q ss_pred cccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCccccc
Q 043278 583 EVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELI 662 (752)
Q Consensus 583 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 662 (752)
..... .....|++.|+|||.+.+..++.++||||||++++||++|+.||...... . .......+... ..
T Consensus 159 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------~-~~~~~~~~~~~-~~ 227 (284)
T 3kk8_A 159 NDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH------R-LYAQIKAGAYD-YP 227 (284)
T ss_dssp CSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHHTCCC-CC
T ss_pred ccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh------H-HHHHHHhcccc-CC
Confidence 43221 22357899999999999999999999999999999999999999654321 1 11112111111 11
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 663 DPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 663 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.+. .......+.+++.+|++.||.+|||+.|++++
T Consensus 228 ~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 228 SPE-----WDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp TTT-----TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred chh-----hcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 111 01122356788999999999999999999874
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=325.41 Aligned_cols=253 Identities=23% Similarity=0.331 Sum_probs=198.1
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEe
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYE 506 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 506 (752)
.++|.+.++||+|+||.||+++.. ++..+|+|++.... ......+.+|++++.+++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 367888999999999999999874 58899999987653 3456789999999999999999999999999999999999
Q ss_pred eCCCCCHhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEe---cCCCCceecccccceee
Q 043278 507 FMPNKSLDFFLFNS-GRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILL---DDKMNPKISDFGMARIF 582 (752)
Q Consensus 507 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll---~~~~~~kl~DFgla~~~ 582 (752)
|+++++|.+++... .....+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++..
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999988643 22356999999999999999999999998 9999999999999 45688999999999865
Q ss_pred cccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCccccc
Q 043278 583 EVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELI 662 (752)
Q Consensus 583 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 662 (752)
.... ......|++.|+|||.+. ..++.++||||||++++||++|+.||...... ...............
T Consensus 178 ~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~------~~~~~~~~~~~~~~~- 246 (285)
T 3is5_A 178 KSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE------EVQQKATYKEPNYAV- 246 (285)
T ss_dssp ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCCCCC-
T ss_pred CCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH------HHHhhhccCCccccc-
Confidence 4322 123457899999999875 57899999999999999999999999764411 111111111110000
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 663 DPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 663 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
. ... ....+.+++.+|++.||.+|||+.|+++.
T Consensus 247 ~---~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 247 E---CRP----LTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp -----CC----CCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred c---cCc----CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 011 12356688999999999999999999863
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=353.08 Aligned_cols=249 Identities=22% Similarity=0.262 Sum_probs=194.2
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccC---CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEE
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRS---SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLV 504 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 504 (752)
.++|++.+.||+|+||.||+++.. +++.||||++... .......+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 367889999999999999999864 5889999998753 233445678899999999999999999999999999999
Q ss_pred EeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCcEeecCCCCCcEEecCCCCceecccccceeec
Q 043278 505 YEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHK-YSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFE 583 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~ 583 (752)
|||+++|+|..++... ..+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++.+||+|||+++...
T Consensus 227 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 9999999999988653 358999999999999999999998 77 9999999999999999999999999997533
Q ss_pred ccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccC
Q 043278 584 VNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELID 663 (752)
Q Consensus 584 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 663 (752)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......... ..
T Consensus 301 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~~i~~~-~~----- 366 (446)
T 4ejn_A 301 KDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELILME-EI----- 366 (446)
T ss_dssp C-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHC-CC-----
T ss_pred CCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH------HHHHHHHhC-CC-----
Confidence 221 2233468999999999999999999999999999999999999999665421 111111111 11
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 043278 664 PSLEQPCSANEVMRCIHVGLLCVQDQAMDRP-----TMPEVVCM 702 (752)
Q Consensus 664 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~ev~~~ 702 (752)
.+ +......+.+++.+||+.||.+|| +++|++++
T Consensus 367 -~~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 367 -RF----PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp -CC----CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -CC----CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 01 111224577899999999999999 99999875
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=326.30 Aligned_cols=247 Identities=24% Similarity=0.358 Sum_probs=199.8
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC---cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEE
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLV 504 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 504 (752)
.++|.+.+.||+|+||.||++... +++.||||++.... ......+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 367888899999999999999875 46789999986432 23456789999999999999999999999999999999
Q ss_pred EeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecc
Q 043278 505 YEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~ 584 (752)
|||+++++|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 9999999999998654 34899999999999999999999988 99999999999999999999999999865332
Q ss_pred cccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCC
Q 043278 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDP 664 (752)
Q Consensus 585 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 664 (752)
. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... . ......... .
T Consensus 162 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~-~~~~~~~~~------~ 224 (279)
T 3fdn_A 162 S----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ------E-TYKRISRVE------F 224 (279)
T ss_dssp ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------H-HHHHHHHTC------C
T ss_pred c----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH------H-HHHHHHhCC------C
Confidence 2 123357899999999999999999999999999999999999999754311 1 111111111 0
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 665 SLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 665 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.. +......+.+++.+|++.||.+|||+.|++++
T Consensus 225 ~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 225 TF----PDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp CC----CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred CC----CCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 11 11122356788999999999999999999986
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=327.72 Aligned_cols=258 Identities=19% Similarity=0.234 Sum_probs=199.5
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCcc---cHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEE
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQ---GIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLV 504 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 504 (752)
-++|.+.+.||+|+||.||+++.. +++.||+|++...... ....+.+|+.++.+++||||+++++++..++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 478999999999999999999875 6889999999765322 346789999999999999999999999999999999
Q ss_pred EeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecc
Q 043278 505 YEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~ 584 (752)
|||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 113 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 9999999999998653 35899999999999999999999998 99999999999999999999999999986543
Q ss_pred cccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCC-cccccC
Q 043278 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGK-GLELID 663 (752)
Q Consensus 585 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~-~~~~~d 663 (752)
... .......|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ......+.... ......
T Consensus 187 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~~~~~~~~~~~~~ 258 (309)
T 2h34_A 187 EKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL-------SVMGAHINQAIPRPSTVR 258 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH-------HHHHHHHHSCCCCGGGTS
T ss_pred ccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH-------HHHHHHhccCCCCccccC
Confidence 321 112245689999999999999999999999999999999999999975431 11112222211 111111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHhhcCCC
Q 043278 664 PSLEQPCSANEVMRCIHVGLLCVQDQAMDRP-TMPEVVCMLQNETM 708 (752)
Q Consensus 664 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-t~~ev~~~L~~~~~ 708 (752)
+ .....+.+++.+||+.||++|| +++++++.|+....
T Consensus 259 ~--------~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 259 P--------GIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA 296 (309)
T ss_dssp T--------TCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred C--------CCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence 1 1123467889999999999999 99999999988754
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=334.73 Aligned_cols=264 Identities=23% Similarity=0.375 Sum_probs=207.9
Q ss_pred hcCCCcCCeeecCCcccEEEEEe-----cCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCC--ee
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKL-----ADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGE--ER 501 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~ 501 (752)
.++|++.+.||+|+||.||+++. .+++.||||++..........+.+|+.++.+++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 35688889999999999999984 357899999998776666778999999999999999999999987644 68
Q ss_pred EEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceeccccccee
Q 043278 502 LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARI 581 (752)
Q Consensus 502 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~ 581 (752)
++||||+++++|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 99999999999999996542 35899999999999999999999988 99999999999999999999999999987
Q ss_pred ecccccc-cccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCC---------CCCCcchHHHHHH
Q 043278 582 FEVNESE-ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHH---------PDRPLNLIGYAWQ 651 (752)
Q Consensus 582 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~---------~~~~~~l~~~~~~ 651 (752)
....... .......++..|+|||.+.+..++.++||||||++++||++|+.|+.... .............
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence 6543221 11223456778999999999999999999999999999999998875321 0000011111112
Q ss_pred HhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 652 LLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 652 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
.+..+... +.+......+.+++.+||+.||.+|||+.||++.|+.+
T Consensus 275 ~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 275 LLKNNGRL---------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp HHHTTCCC---------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HhhcCCCC---------CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 22222111 11112234577899999999999999999999999864
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=335.30 Aligned_cols=252 Identities=24% Similarity=0.294 Sum_probs=204.7
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCc------ccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCee
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSG------QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEER 501 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 501 (752)
.++|.+.+.||+|+||.||+++.. +++.||+|.+..... ....++.+|+.++.+++||||+++++++.+++..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 467889999999999999999875 588999999876432 1467899999999999999999999999999999
Q ss_pred EEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCC----Cceecccc
Q 043278 502 LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKM----NPKISDFG 577 (752)
Q Consensus 502 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~----~~kl~DFg 577 (752)
++||||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 999999999999999854 345899999999999999999999998 99999999999999888 79999999
Q ss_pred cceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCC
Q 043278 578 MARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGK 657 (752)
Q Consensus 578 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 657 (752)
+++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .. ...+....
T Consensus 165 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~-~~~i~~~~ 234 (321)
T 2a2a_A 165 LAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ET-LANITSVS 234 (321)
T ss_dssp TCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------HH-HHHHHTTC
T ss_pred cceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH------HH-HHHHHhcc
Confidence 998755322 123456899999999999999999999999999999999999999654311 11 11111111
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 658 GLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 658 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.. .++..... ....+.+++.+|++.||.+|||+.|++++
T Consensus 235 ~~--~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 235 YD--FDEEFFSH----TSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp CC--CCHHHHTT----CCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred cc--cChhhhcc----cCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 00000011 12356789999999999999999999884
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=354.81 Aligned_cols=254 Identities=25% Similarity=0.344 Sum_probs=207.2
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccC---CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEE
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRS---SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLV 504 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 504 (752)
.++|...+.||+|+||.||+++.. +|+.||||++... .......+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467888899999999999999875 6899999998653 233456788999999999999999999999999999999
Q ss_pred EeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecc
Q 043278 505 YEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~ 584 (752)
|||+++|+|..++.... ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 263 mEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 99999999999986543 345899999999999999999999998 99999999999999999999999999987643
Q ss_pred cccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCC
Q 043278 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDP 664 (752)
Q Consensus 585 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 664 (752)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+ ........ .
T Consensus 339 ~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i---~~~i~~~~------~ 406 (576)
T 2acx_A 339 GQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV---ERLVKEVP------E 406 (576)
T ss_dssp TC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHH---HHHHHHCC------C
T ss_pred Cc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHH---HHHhhccc------c
Confidence 32 123357999999999999999999999999999999999999999876533222111 11111111 0
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 043278 665 SLEQPCSANEVMRCIHVGLLCVQDQAMDRP-----TMPEVVCM 702 (752)
Q Consensus 665 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~ev~~~ 702 (752)
.+ +......+.+|+.+||+.||.+|| ++.||+++
T Consensus 407 ~~----p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 407 EY----SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp CC----CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred cC----CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 11 111224577889999999999999 78888765
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=346.51 Aligned_cols=261 Identities=20% Similarity=0.269 Sum_probs=206.0
Q ss_pred hcCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCCcccHHHHHHHHHHHHhcCC-CCcceeeeeeeeCCeeEEEEe
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQH-TNLVRLLGCSLHGEERLLVYE 506 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~E 506 (752)
.++|.+.++||+|+||.||+|+. .+++.||||++...... .++.+|++++..++| +++..+..++.+++..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 46899999999999999999986 56889999987654332 357899999999987 556666667778889999999
Q ss_pred eCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEe---cCCCCceecccccceeec
Q 043278 507 FMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILL---DDKMNPKISDFGMARIFE 583 (752)
Q Consensus 507 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll---~~~~~~kl~DFgla~~~~ 583 (752)
|+ +++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||| +.++.+||+|||+++...
T Consensus 84 ~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 99999998643 235999999999999999999999998 9999999999999 689999999999998765
Q ss_pred ccccc-----cccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCc
Q 043278 584 VNESE-----ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKG 658 (752)
Q Consensus 584 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 658 (752)
..... .......||..|+|||.+.+..++.++|||||||+||||++|+.||...........+............
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI 237 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence 43321 1123567999999999999999999999999999999999999999876543322222221111111111
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 659 LELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 659 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
..+. ... ...+.+++..||+.+|++||++.+|+++|+.+
T Consensus 238 ~~l~-----~~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 238 EALC-----RGY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HHHH-----TTS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HHHh-----cCC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 1110 111 24578899999999999999999999998764
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=337.29 Aligned_cols=255 Identities=29% Similarity=0.435 Sum_probs=202.6
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCce--eEEEEcccC-CcccHHHHHHHHHHHHhc-CCCCcceeeeeeeeCCeeEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQE--VAIKRLSRS-SGQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGEERLLV 504 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~--vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 504 (752)
++|.+.+.||+|+||.||+++.. ++.. +|+|.+... .......+.+|++++.++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 57888899999999999999864 4554 499988754 233455789999999999 999999999999999999999
Q ss_pred EeeCCCCCHhHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCc
Q 043278 505 YEFMPNKSLDFFLFNSG-------------RKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNP 571 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~ 571 (752)
|||+++++|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999986542 2346899999999999999999999998 9999999999999999999
Q ss_pred eecccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHH
Q 043278 572 KISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAW 650 (752)
Q Consensus 572 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~ 650 (752)
||+|||+++..... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ....
T Consensus 182 kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-------~~~~ 251 (327)
T 1fvr_A 182 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-------AELY 251 (327)
T ss_dssp EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHH
T ss_pred EEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH-------HHHH
Confidence 99999999743211 11223456789999999999999999999999999999998 9999965541 1112
Q ss_pred HHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 651 QLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 651 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
..+..+.... .+......+.+++.+|++.||.+|||+.|+++.|+.+
T Consensus 252 ~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 298 (327)
T 1fvr_A 252 EKLPQGYRLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 298 (327)
T ss_dssp HHGGGTCCCC---------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhhcCCCCC---------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 2222221111 1112234577899999999999999999999999875
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=341.47 Aligned_cols=264 Identities=21% Similarity=0.316 Sum_probs=191.6
Q ss_pred HhcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccC--CcccHHHHHHHHHHHHhcC-CCCcceeeeeeeeCC--ee
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRS--SGQGIVEFKNEVRLIAKLQ-HTNLVRLLGCSLHGE--ER 501 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~ 501 (752)
..++|.+.+.||+|+||.||+|... +++.||||++... .......+.+|+.++.++. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 4578999999999999999999864 6889999998654 2334556789999999997 999999999997544 68
Q ss_pred EEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceeccccccee
Q 043278 502 LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARI 581 (752)
Q Consensus 502 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~ 581 (752)
++|||||+ ++|..++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 87 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 99999998 688888854 35899999999999999999999998 99999999999999999999999999986
Q ss_pred ecccc-------------------cccccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCC
Q 043278 582 FEVNE-------------------SEANTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDR 641 (752)
Q Consensus 582 ~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~ 641 (752)
+.... .........||+.|+|||++.+ ..++.++|||||||+++||++|+.||.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 238 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 53211 0111234579999999999986 679999999999999999999999997654221
Q ss_pred CcchHHHHHHHhhCCCcccc--c-------------------CCCCCCCC------------CHHHHHHHHHHHHHcccC
Q 043278 642 PLNLIGYAWQLLSDGKGLEL--I-------------------DPSLEQPC------------SANEVMRCIHVGLLCVQD 688 (752)
Q Consensus 642 ~~~l~~~~~~~~~~~~~~~~--~-------------------d~~l~~~~------------~~~~~~~l~~l~~~Cl~~ 688 (752)
. .......+.......+ + ........ .......+.+|+.+||+.
T Consensus 239 ~---~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~ 315 (388)
T 3oz6_A 239 Q---LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF 315 (388)
T ss_dssp H---HHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred H---HHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence 1 1111111110000000 0 00000000 001123577899999999
Q ss_pred CCCCCCCHHHHHHH
Q 043278 689 QAMDRPTMPEVVCM 702 (752)
Q Consensus 689 dp~~RPt~~ev~~~ 702 (752)
||.+|||+.|++++
T Consensus 316 dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 316 NPNKRISANDALKH 329 (388)
T ss_dssp SGGGSCCHHHHTTS
T ss_pred CcccCCCHHHHhCC
Confidence 99999999999886
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=340.37 Aligned_cols=254 Identities=22% Similarity=0.308 Sum_probs=202.8
Q ss_pred cCCCcCCeeecCCcccEEEEEe----cCCceeEEEEcccCC----cccHHHHHHHHHHHHhc-CCCCcceeeeeeeeCCe
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKL----ADEQEVAIKRLSRSS----GQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGEE 500 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 500 (752)
++|.+.+.||+|+||.||+++. .+++.||||+++... ......+.+|+.++.++ +|+||+++++++..++.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5788899999999999999987 368899999987532 22345577899999999 69999999999999999
Q ss_pred eEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccce
Q 043278 501 RLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR 580 (752)
Q Consensus 501 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~ 580 (752)
.++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 99999999999999998653 35899999999999999999999998 9999999999999999999999999998
Q ss_pred eecccccccccccccccCCccChhhhcc--CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCc
Q 043278 581 IFEVNESEANTKRIVGTYGYMSPEYAMS--GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKG 658 (752)
Q Consensus 581 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 658 (752)
........ ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......... ...........
T Consensus 208 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~~~-- 282 (355)
T 1vzo_A 208 EFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AEISRRILKSE-- 282 (355)
T ss_dssp ECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HHHHHHHHHCC--
T ss_pred ecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH--HHHHHHHhccC--
Confidence 75433222 2234679999999999986 45789999999999999999999999765533322 11111222111
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHh
Q 043278 659 LELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRP-----TMPEVVCML 703 (752)
Q Consensus 659 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~ev~~~L 703 (752)
+.. +......+.+|+.+||+.||.+|| |+.|++++.
T Consensus 283 -----~~~----~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 283 -----PPY----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp -----CCC----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred -----CCC----CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 111 112224567899999999999999 999998875
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=366.96 Aligned_cols=248 Identities=28% Similarity=0.371 Sum_probs=198.2
Q ss_pred CeeecCCcccEEEEEec---CCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCCC
Q 043278 436 NKLGEGGFGPVYKGKLA---DEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPN 510 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~---~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 510 (752)
++||+|+||.||+|.+. .++.||||+++... ....+++.+|++++.+++|||||++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 57999999999999653 45789999997643 3346789999999999999999999999864 568899999999
Q ss_pred CCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccc-c
Q 043278 511 KSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE-A 589 (752)
Q Consensus 511 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~-~ 589 (752)
|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+...... .
T Consensus 454 g~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 9999999643 35899999999999999999999998 999999999999999999999999999876533221 1
Q ss_pred ccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCC
Q 043278 590 NTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQ 668 (752)
Q Consensus 590 ~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 668 (752)
......+|+.|+|||++.+..++.++||||||++||||++ |+.||...... .....+..+.....
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-------~~~~~i~~~~~~~~------- 593 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-------EVTAMLEKGERMGC------- 593 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------HHHHHHHTTCCCCC-------
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCCCCCC-------
Confidence 2223456788999999999999999999999999999998 99999765421 12233333322211
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 669 PCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 669 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
+......+.+|+.+||+.||++|||+.+|+++|+..
T Consensus 594 --p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 594 --PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp --CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred --CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 112234677899999999999999999999999864
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=336.31 Aligned_cols=253 Identities=21% Similarity=0.270 Sum_probs=200.4
Q ss_pred HhcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCcccHHHHHHHHHHHHhc-CCCCcceeeeeeeeCCeeEEEE
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 505 (752)
..++|++.+.||+|+||.||++... +++.||||++...... ..+|++++.++ +||||+++++++.+++..++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 3567999999999999999999875 5889999999765432 35688888887 7999999999999999999999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCC-C---Cceeccccccee
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDK-M---NPKISDFGMARI 581 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~-~---~~kl~DFgla~~ 581 (752)
||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+.++ + .+||+|||+++.
T Consensus 96 E~~~gg~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 96 ELMKGGELLDKILRQ---KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCCSCBHHHHHHTC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred eCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 999999999988643 45899999999999999999999998 9999999999998443 3 499999999987
Q ss_pred ecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccc
Q 043278 582 FEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLEL 661 (752)
Q Consensus 582 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 661 (752)
...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......... .....+..+... +
T Consensus 170 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~----~~~~~i~~~~~~-~ 242 (342)
T 2qr7_A 170 LRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPE----EILARIGSGKFS-L 242 (342)
T ss_dssp CBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHH----HHHHHHHHCCCC-C
T ss_pred CcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHH----HHHHHHccCCcc-c
Confidence 543322 223467899999999999888999999999999999999999999764322211 112222222211 0
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 662 IDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 662 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
. ..........+.+++.+|++.||++|||+.|++++
T Consensus 243 -~----~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 243 -S----GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp -C----STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred -C----ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 11111123456788999999999999999999875
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=326.58 Aligned_cols=253 Identities=23% Similarity=0.349 Sum_probs=200.1
Q ss_pred CCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCC
Q 043278 431 NFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMP 509 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 509 (752)
.|.....||+|+||.||+|.. .+++.||||.+..........+.+|+.++.+++||||+++++++.+.+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 445556999999999999986 4578999999987766667789999999999999999999999999999999999999
Q ss_pred CCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecC-CCCceecccccceeecccccc
Q 043278 510 NKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDD-KMNPKISDFGMARIFEVNESE 588 (752)
Q Consensus 510 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~-~~~~kl~DFgla~~~~~~~~~ 588 (752)
+++|.+++........+++..+..++.||+.||+|||+.+ |+|+||||+|||++. ++.+||+|||+++......
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-- 177 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-- 177 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC--
Confidence 9999999976555556789999999999999999999998 999999999999987 8999999999998654322
Q ss_pred cccccccccCCccChhhhccCC--CCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCC
Q 043278 589 ANTKRIVGTYGYMSPEYAMSGI--VSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666 (752)
Q Consensus 589 ~~~~~~~gt~~y~aPE~~~~~~--~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 666 (752)
.......|++.|+|||.+.+.. ++.++||||||+++|||++|+.||....... .. ........ ..+.+
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~-~~~~~~~~-----~~~~~ 247 (295)
T 2clq_A 178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ----AA-MFKVGMFK-----VHPEI 247 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH----HH-HHHHHHHC-----CCCCC
T ss_pred CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh----HH-HHhhcccc-----ccccc
Confidence 1123457899999999987654 8899999999999999999999986433110 01 11110000 11111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 667 EQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 667 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.. .....+.+++.+||+.||++|||+.|+++.
T Consensus 248 ~~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 248 PE----SMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp CT----TSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred cc----cCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11 122456788999999999999999999864
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=336.43 Aligned_cols=243 Identities=21% Similarity=0.291 Sum_probs=200.6
Q ss_pred HhcCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCCc--------ccHHHHHHHHHHHHhcCCCCcceeeeeeeeC
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSSG--------QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHG 498 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 498 (752)
..++|.+.+.||+|+||.||+|+. .+++.||||++..... .....+.+|+.++.+++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 457899999999999999999986 4688999999876531 1233567899999999999999999999999
Q ss_pred CeeEEEEeeCCCC-CHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccc
Q 043278 499 EERLLVYEFMPNK-SLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFG 577 (752)
Q Consensus 499 ~~~~lv~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg 577 (752)
+..++||||+..| +|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRH---PRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTC---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999777 998888543 35999999999999999999999998 9999999999999999999999999
Q ss_pred cceeecccccccccccccccCCccChhhhccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCC
Q 043278 578 MARIFEVNESEANTKRIVGTYGYMSPEYAMSGIV-SIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDG 656 (752)
Q Consensus 578 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 656 (752)
+++...... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||......
T Consensus 176 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------------- 236 (335)
T 3dls_A 176 SAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET---------------- 236 (335)
T ss_dssp TCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG----------------
T ss_pred cceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH----------------
Confidence 998765332 1224578999999999998876 88999999999999999999999642210
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 657 KGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 657 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
....... +......+.+++.+||+.||.+|||+.|+++.
T Consensus 237 -----~~~~~~~--~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 -----VEAAIHP--PYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -----TTTCCCC--SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -----HhhccCC--CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000 00112357788999999999999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=324.25 Aligned_cols=252 Identities=19% Similarity=0.266 Sum_probs=198.9
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC----cccHHHHHHHHHHHHhcCCCCcceeeeeee--eCCee
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS----GQGIVEFKNEVRLIAKLQHTNLVRLLGCSL--HGEER 501 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~ 501 (752)
.++|.+.+.||+|+||.||++... +++.||+|++.... ......+.+|+.++.+++|+||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999874 57899999987542 234567899999999999999999999984 45578
Q ss_pred EEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceeccccccee
Q 043278 502 LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARI 581 (752)
Q Consensus 502 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~ 581 (752)
++||||++++ |.+++... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999987 66666543 2346899999999999999999999998 99999999999999999999999999987
Q ss_pred ecccccccccccccccCCccChhhhccCC--CCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcc
Q 043278 582 FEVNESEANTKRIVGTYGYMSPEYAMSGI--VSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGL 659 (752)
Q Consensus 582 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 659 (752)
..............|++.|+|||.+.+.. .+.++||||||+++|||++|+.||..... . .....+..+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~-~~~~~i~~~~~- 230 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI------Y-KLFENIGKGSY- 230 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH------H-HHHHHHHHCCC-
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH------H-HHHHHHhcCCC-
Confidence 65333333333457899999999987644 47899999999999999999999975431 1 11222222211
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 660 ELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 660 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.+... ....+.+++.+|++.||.+|||+.|++++
T Consensus 231 -----~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 231 -----AIPGD----CGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp -----CCCSS----SCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -----CCCCc----cCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11111 22356788999999999999999999976
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=324.51 Aligned_cols=249 Identities=23% Similarity=0.322 Sum_probs=204.0
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC---cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEE
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLV 504 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 504 (752)
.++|.+.+.||+|+||.||+++.. +++.+|+|++.... ....+.+.+|+.++++++|+||+++++++.+++..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 367888899999999999999976 47889999986542 23456788999999999999999999999999999999
Q ss_pred EeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecc
Q 043278 505 YEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~ 584 (752)
|||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 94 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 9999999999988543 35899999999999999999999998 99999999999999999999999999987543
Q ss_pred cccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCC
Q 043278 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDP 664 (752)
Q Consensus 585 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 664 (752)
... ......|++.|+|||.+.+..++.++||||||++++||++|+.||...... . .......+..
T Consensus 168 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~-~~~~~~~~~~------ 232 (294)
T 2rku_A 168 DGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------E-TYLRIKKNEY------ 232 (294)
T ss_dssp TTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------H-HHHHHHTTCC------
T ss_pred Ccc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------H-HHHHHhhccC------
Confidence 221 123357899999999999999999999999999999999999999654311 1 1112222111
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 665 SLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 665 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.+.. .....+.+++.+|++.||++|||+.|+++.
T Consensus 233 ~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 233 SIPK----HINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp CCCT----TSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred CCcc----ccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0111 112356788999999999999999999875
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=329.33 Aligned_cols=250 Identities=26% Similarity=0.369 Sum_probs=196.5
Q ss_pred hcCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeC-CeeEEEEee
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHG-EERLLVYEF 507 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~E~ 507 (752)
.++|.+.+.||+|+||.||+++. .++.||||++.... ..+.+.+|+.++.+++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 36788889999999999999987 47899999997543 456789999999999999999999987654 478999999
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccc
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES 587 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~ 587 (752)
+++++|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 97 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 171 (278)
T 1byg_A 97 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 171 (278)
T ss_dssp CTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccccc-
Confidence 99999999986432 223789999999999999999999998 9999999999999999999999999997543221
Q ss_pred ccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCC
Q 043278 588 EANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666 (752)
Q Consensus 588 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 666 (752)
....++..|+|||.+.+..++.++||||||++++||++ |+.||....... . ...+..+... ..
T Consensus 172 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~----~~~~~~~~~~-----~~ 235 (278)
T 1byg_A 172 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---V----VPRVEKGYKM-----DA 235 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---H----HHHHTTTCCC-----CC
T ss_pred ----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---H----HHHHhcCCCC-----CC
Confidence 12356889999999999999999999999999999998 999987654211 1 1122222111 11
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 667 EQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 667 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
+......+.+++.+|++.||.+|||+.|+++.|+.+
T Consensus 236 ----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 236 ----PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 112234577889999999999999999999999864
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=328.21 Aligned_cols=259 Identities=25% Similarity=0.320 Sum_probs=204.0
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeee--CCeeEE
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLH--GEERLL 503 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 503 (752)
.++|++.+.||+|+||.||+++.. +++.||+|++.... ......+.+|+.++.+++||||+++++++.+ +...++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 367888999999999999999875 68899999997543 3345678999999999999999999998754 568899
Q ss_pred EEeeCCCCCHhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCcEeecCCCCCcEEecCCCCceecccccce
Q 043278 504 VYEFMPNKSLDFFLFNSG-RKNVLNWEKRFIIIEGISQGLLYLHKYS--RLRVIHRDLKASNILLDDKMNPKISDFGMAR 580 (752)
Q Consensus 504 v~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~iiH~Dikp~NIll~~~~~~kl~DFgla~ 580 (752)
||||+++++|.+++.... ....+++..++.++.||+.||+|||+.+ ..+|+||||||+|||++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999986532 3445899999999999999999999976 2349999999999999999999999999998
Q ss_pred eecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCccc
Q 043278 581 IFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLE 660 (752)
Q Consensus 581 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 660 (752)
....... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ......+..+....
T Consensus 165 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~i~~~~~~~ 235 (279)
T 2w5a_A 165 ILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-------KELAGKIREGKFRR 235 (279)
T ss_dssp HC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTCCCC
T ss_pred eeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH-------HHHHHHHhhccccc
Confidence 6543221 12235689999999999999999999999999999999999999876531 11122222332211
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 043278 661 LIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705 (752)
Q Consensus 661 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~ 705 (752)
+ .. .....+.+++.+||+.||.+|||+.||++.+..
T Consensus 236 ~-----~~----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 236 I-----PY----RYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp C-----CT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred C-----Cc----ccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 1 11 122457789999999999999999999997754
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=331.54 Aligned_cols=249 Identities=23% Similarity=0.317 Sum_probs=203.9
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC---cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEE
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLV 504 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 504 (752)
.++|.+.+.||+|+||.||+++.. +++.||+|++.... ......+.+|+.++.+++|+||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 367888999999999999999875 47889999986542 23456788999999999999999999999999999999
Q ss_pred EeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecc
Q 043278 505 YEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~ 584 (752)
|||+++++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 120 ~e~~~~~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 120 LELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp ECCCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 9999999999988643 35899999999999999999999998 99999999999999999999999999987643
Q ss_pred cccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCC
Q 043278 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDP 664 (752)
Q Consensus 585 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 664 (752)
... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||...... .. ...+..+..
T Consensus 194 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~-~~~~~~~~~------ 258 (335)
T 2owb_A 194 DGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------ET-YLRIKKNEY------ 258 (335)
T ss_dssp TTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HH-HHHHHHTCC------
T ss_pred Ccc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH------HH-HHHHhcCCC------
Confidence 221 223457899999999999999999999999999999999999999654311 11 111111111
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 665 SLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 665 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.+.... ...+.+++.+||+.||++|||+.|+++.
T Consensus 259 ~~~~~~----~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 259 SIPKHI----NPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp CCCTTS----CHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred CCCccC----CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111111 2346788999999999999999999874
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=349.90 Aligned_cols=255 Identities=23% Similarity=0.319 Sum_probs=206.4
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC---cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEE
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLV 504 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 504 (752)
.++|...+.||+|+||.||+++.. +|+.||+|++.... ......+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 367888899999999999999975 58999999996542 23456788999999999999999999999999999999
Q ss_pred EeeCCCCCHhHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeec
Q 043278 505 YEFMPNKSLDFFLFNSGR-KNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFE 583 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~ 583 (752)
|||+++|+|..++..... ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999875432 446999999999999999999999998 9999999999999999999999999998754
Q ss_pred ccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccC
Q 043278 584 VNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELID 663 (752)
Q Consensus 584 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 663 (752)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ......... ...
T Consensus 341 ~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~--~~~~~~i~~-~~~----- 410 (543)
T 3c4z_A 341 AGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KELKQRVLE-QAV----- 410 (543)
T ss_dssp TTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH--HHHHHHHHH-CCC-----
T ss_pred CCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH--HHHHHHHhh-ccc-----
Confidence 3321 223458999999999999999999999999999999999999999876432221 111112221 111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 043278 664 PSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTM-----PEVVC 701 (752)
Q Consensus 664 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~-----~ev~~ 701 (752)
.. +......+.+++.+||+.||.+||++ .|+++
T Consensus 411 -~~----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 411 -TY----PDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp -CC----CTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred -CC----CcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 01 11122456788899999999999975 56664
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=327.73 Aligned_cols=252 Identities=21% Similarity=0.312 Sum_probs=202.7
Q ss_pred HhcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEe
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYE 506 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 506 (752)
..++|.+.+.||+|+||.||+++.. +++.||+|.+..........+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 3467888999999999999999875 688999999987655555678999999999999999999999999999999999
Q ss_pred eCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEe---cCCCCceecccccceeec
Q 043278 507 FMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILL---DDKMNPKISDFGMARIFE 583 (752)
Q Consensus 507 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll---~~~~~~kl~DFgla~~~~ 583 (752)
|+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||+ ++++.+||+|||++....
T Consensus 87 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 87 LVSGGELFDRILER---GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred cCCCccHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 99999999988653 34899999999999999999999998 9999999999999 788999999999997543
Q ss_pred ccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccC
Q 043278 584 VNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELID 663 (752)
Q Consensus 584 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 663 (752)
.. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... .....+..+... . .
T Consensus 161 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~i~~~~~~-~-~ 227 (304)
T 2jam_A 161 NG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES-------KLFEKIKEGYYE-F-E 227 (304)
T ss_dssp CB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHCCCC-C-C
T ss_pred CC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHcCCCC-C-C
Confidence 22 122356899999999999999999999999999999999999999754311 111222222111 0 1
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 664 PSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 664 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
. +........+.+++.+|++.||.+|||+.|+++.
T Consensus 228 ~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 228 S----PFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp T----TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred c----cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1 1111223457789999999999999999999874
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=339.45 Aligned_cols=252 Identities=21% Similarity=0.245 Sum_probs=191.5
Q ss_pred cCCCcC-CeeecCCcccEEEEEec-CCceeEEEEcccCCcccHHHHHHHHHHHHh-cCCCCcceeeeeeee----CCeeE
Q 043278 430 NNFSTT-NKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQGIVEFKNEVRLIAK-LQHTNLVRLLGCSLH----GEERL 502 (752)
Q Consensus 430 ~~~~~~-~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~~~~ 502 (752)
++|.+. +.||+|+||+||++... +++.||||++... ..+.+|+.++.+ .+||||+++++++.. ....+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 455554 68999999999999875 5889999998642 356788888754 589999999998865 56789
Q ss_pred EEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecC---CCCceecccccc
Q 043278 503 LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDD---KMNPKISDFGMA 579 (752)
Q Consensus 503 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~---~~~~kl~DFgla 579 (752)
|||||+++|+|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 136 lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccc
Confidence 9999999999999996532 345899999999999999999999988 999999999999987 789999999999
Q ss_pred eeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcc
Q 043278 580 RIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGL 659 (752)
Q Consensus 580 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 659 (752)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||............ ...+..+..
T Consensus 212 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~---~~~i~~~~~- 284 (400)
T 1nxk_A 212 KETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---KTRIRMGQY- 284 (400)
T ss_dssp EECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSH---HHHHHHTCC-
T ss_pred cccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHH---HHHHHcCcc-
Confidence 8654221 223467899999999999999999999999999999999999999876543322111 111111111
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 660 ELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 660 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.+..+. .......+.+|+.+||+.||.+|||+.|++++
T Consensus 285 ~~~~~~-----~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 285 EFPNPE-----WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp CCCTTT-----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cCCCcc-----cccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 111110 01122457789999999999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=329.65 Aligned_cols=250 Identities=27% Similarity=0.419 Sum_probs=205.6
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEe
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYE 506 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 506 (752)
.+.|...+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++.+++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 356888899999999999999864 68899999987553 3456789999999999999999999999999999999999
Q ss_pred eCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccc
Q 043278 507 FMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586 (752)
Q Consensus 507 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~ 586 (752)
|+++++|.+++. ...+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 101 ~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 101 YLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CCTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred eCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 999999999984 345899999999999999999999998 9999999999999999999999999998765332
Q ss_pred cccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCC
Q 043278 587 SEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666 (752)
Q Consensus 587 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 666 (752)
. ......|++.|+|||.+.+..++.++||||||++++||++|+.||...... .. ......+.. +.+
T Consensus 174 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~-~~~~~~~~~-----~~~ 239 (303)
T 3a7i_A 174 I--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM------KV-LFLIPKNNP-----PTL 239 (303)
T ss_dssp C--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HH-HHHHHHSCC-----CCC
T ss_pred c--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH------HH-HHHhhcCCC-----CCC
Confidence 1 223457899999999999999999999999999999999999998654311 11 111111111 111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 043278 667 EQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCML 703 (752)
Q Consensus 667 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L 703 (752)
....+ ..+.+++..|++.||.+|||+.|+++..
T Consensus 240 ~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 240 EGNYS----KPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp CSSCC----HHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred ccccC----HHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 12222 3477889999999999999999998753
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=339.01 Aligned_cols=262 Identities=23% Similarity=0.386 Sum_probs=194.1
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCccc-HHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEee
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQG-IVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
++|.+.++||+|+||.||+|+.. +++.||||++....... ...+.+|+.++.+++||||+++++++..++..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 46888899999999999999875 68899999986543221 12345799999999999999999999999999999999
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccc
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES 587 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~ 587 (752)
++ ++|..++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT- 154 (324)
T ss_dssp CS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc-
Confidence 98 5888887653 345899999999999999999999998 9999999999999999999999999998644222
Q ss_pred ccccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCc---ccccC
Q 043278 588 EANTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKG---LELID 663 (752)
Q Consensus 588 ~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~---~~~~d 663 (752)
.......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||....... ........+..... .....
T Consensus 155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~ 230 (324)
T 3mtl_A 155 -KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE---QLHFIFRILGTPTEETWPGILS 230 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGG
T ss_pred -cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChHhchhhhc
Confidence 11223567999999999876 678999999999999999999999997654221 11112221111100 00000
Q ss_pred ---------CCCCCC----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 664 ---------PSLEQP----CSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 664 ---------~~l~~~----~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
+..... ........+.+|+.+|++.||.+|||+.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp CHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred chhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000000 000112456789999999999999999999884
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=350.55 Aligned_cols=259 Identities=23% Similarity=0.241 Sum_probs=194.4
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccC--CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeC------C
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRS--SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHG------E 499 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 499 (752)
.++|++.++||+|+||.||+|... +++.||||++... ......++.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 468899999999999999999864 5889999999754 333456788999999999999999999998654 3
Q ss_pred eeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccc
Q 043278 500 ERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMA 579 (752)
Q Consensus 500 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla 579 (752)
..+|||||++++ |...+. ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence 579999999865 545552 23899999999999999999999998 999999999999999999999999999
Q ss_pred eeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCC---
Q 043278 580 RIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDG--- 656 (752)
Q Consensus 580 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~--- 656 (752)
+..... .......||+.|+|||++.+..++.++|||||||+++||++|+.||........ .....+.+...
T Consensus 212 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~---~~~i~~~lg~p~~~ 285 (464)
T 3ttj_A 212 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ---WNKVIEQLGTPCPE 285 (464)
T ss_dssp -----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCSCCHH
T ss_pred eecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCCHH
Confidence 865432 123346889999999999999999999999999999999999999976542111 11111111000
Q ss_pred -----------------Ccc-----cccCCCCCCC---CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 657 -----------------KGL-----ELIDPSLEQP---CSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 657 -----------------~~~-----~~~d~~l~~~---~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
... ..+...+... ........+.+|+.+||+.||++|||++|++++
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 286 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 0000000000 011124567899999999999999999999986
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=327.21 Aligned_cols=252 Identities=23% Similarity=0.303 Sum_probs=201.5
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCc------ccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCee
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSG------QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEER 501 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 501 (752)
.++|.+.+.||+|+||.||+++.. +++.||+|.+..... .....+.+|+.++.+++||||+++++++.+.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 357888999999999999999976 588999999875421 2467899999999999999999999999999999
Q ss_pred EEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCC----Cceecccc
Q 043278 502 LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKM----NPKISDFG 577 (752)
Q Consensus 502 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~----~~kl~DFg 577 (752)
++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++ .+||+|||
T Consensus 84 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEK---ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 9999999999999998643 35899999999999999999999998 99999999999998877 89999999
Q ss_pred cceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCC
Q 043278 578 MARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGK 657 (752)
Q Consensus 578 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 657 (752)
++....... ......+++.|+|||.+.+..++.++||||||++++||++|+.||...... .....+....
T Consensus 158 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~ 227 (283)
T 3bhy_A 158 IAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ-------ETLTNISAVN 227 (283)
T ss_dssp TCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHTTC
T ss_pred cceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH-------HHHHHhHhcc
Confidence 998654322 122356899999999999999999999999999999999999999764321 1111111111
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 658 GLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 658 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.. ..+.... .....+.+++.+|++.||.+|||+.|++++
T Consensus 228 ~~--~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 228 YD--FDEEYFS----NTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp CC--CCHHHHT----TCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred cC--Ccchhcc----cCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 00 0000000 112357789999999999999999999874
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=338.71 Aligned_cols=262 Identities=18% Similarity=0.184 Sum_probs=204.1
Q ss_pred hcCCCcCCeeecCCcccEEEEEecC---------CceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcce---------
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLAD---------EQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVR--------- 490 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~~---------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~--------- 490 (752)
.++|.+.+.||+|+||.||+|+... ++.||||.+... ..+.+|+.++.+++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3678889999999999999998764 789999998754 35789999999999999988
Q ss_pred ------eeeeeee-CCeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcE
Q 043278 491 ------LLGCSLH-GEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNI 563 (752)
Q Consensus 491 ------l~~~~~~-~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NI 563 (752)
+++++.. +...++||||+ +++|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 5667765 67889999999 999999997532 356999999999999999999999998 99999999999
Q ss_pred EecCCC--Cceecccccceeecccccc-----cccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 043278 564 LLDDKM--NPKISDFGMARIFEVNESE-----ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTR 636 (752)
Q Consensus 564 ll~~~~--~~kl~DFgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~ 636 (752)
|++.++ .+||+|||+++.+...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 9999999999876533221 112335789999999999999999999999999999999999999976
Q ss_pred CCCCCCcchHHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 637 HHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 637 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
...... .+......... ....+.+...... .....+.+++.+|++.||.+|||++||++.|+.+
T Consensus 271 ~~~~~~--~~~~~~~~~~~-~~~~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 334 (352)
T 2jii_A 271 CLPNTE--DIMKQKQKFVD-KPGPFVGPCGHWI---RPSETLQKYLKVVMALTYEEKPPYAMLRNNLEAL 334 (352)
T ss_dssp GTTCHH--HHHHHHHHHHH-SCCCEECTTSCEE---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred CCcCHH--HHHHHHHhccC-ChhhhhhhccccC---CCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHH
Confidence 542211 11111111111 1112222111110 1124577888999999999999999999999875
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=339.40 Aligned_cols=244 Identities=20% Similarity=0.273 Sum_probs=190.3
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCc---ccHHHHHHHHHH-HHhcCCCCcceeeeeeeeCCeeEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSG---QGIVEFKNEVRL-IAKLQHTNLVRLLGCSLHGEERLLV 504 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv 504 (752)
++|++.+.||+|+||.||+++.. +++.||||++.+... .....+.+|..+ ++.++||||+++++++.+.+..++|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 57888999999999999999975 478899999976532 233445666665 4678999999999999999999999
Q ss_pred EeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecc
Q 043278 505 YEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~ 584 (752)
|||+++|+|..++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++++||+|||+++....
T Consensus 118 ~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 118 LDYINGGELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred EeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 9999999999998653 35889999999999999999999998 99999999999999999999999999975322
Q ss_pred cccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCC
Q 043278 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDP 664 (752)
Q Consensus 585 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 664 (752)
. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .......+.. ..
T Consensus 192 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~~-~~------ 256 (373)
T 2r5t_A 192 H--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT------AEMYDNILNK-PL------ 256 (373)
T ss_dssp C--CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH------HHHHHHHHHS-CC------
T ss_pred C--CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHhc-cc------
Confidence 2 1223456899999999999999999999999999999999999999975432 1111222221 11
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 043278 665 SLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPE 698 (752)
Q Consensus 665 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~e 698 (752)
.+... ....+.+++.+||+.||.+||++.+
T Consensus 257 ~~~~~----~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 257 QLKPN----ITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp CCCSS----SCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred CCCCC----CCHHHHHHHHHHcccCHHhCCCCCC
Confidence 01111 1235678899999999999999854
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=349.26 Aligned_cols=243 Identities=15% Similarity=0.156 Sum_probs=188.3
Q ss_pred hcCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccC---CcccHHHHHHHH---HHHHhcCCCCcceee-------ee
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRS---SGQGIVEFKNEV---RLIAKLQHTNLVRLL-------GC 494 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~---~~l~~l~h~niv~l~-------~~ 494 (752)
.++|.+.+.||+|+||.||+|+. .+++.||||++... .....+.+.+|+ +++++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 36788889999999999999996 56899999999743 333457788999 555566899999998 55
Q ss_pred eeeCC-----------------eeEEEEeeCCCCCHhHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcE
Q 043278 495 SLHGE-----------------ERLLVYEFMPNKSLDFFLFNSGR----KNVLNWEKRFIIIEGISQGLLYLHKYSRLRV 553 (752)
Q Consensus 495 ~~~~~-----------------~~~lv~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i 553 (752)
+...+ ..+|||||+ +|+|.+++..... ...+++..++.++.||+.||+|||+.+ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 44432 278999999 6899999875321 223556888999999999999999998 9
Q ss_pred eecCCCCCcEEecCCCCceecccccceeecccccccccccccccCCccChhhhccC-----------CCCccchhHHHHH
Q 043278 554 IHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSG-----------IVSIKTDVFSFGV 622 (752)
Q Consensus 554 iH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~t~k~DV~S~G~ 622 (752)
+||||||+||||+.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999985322 2223567 999999999887 8999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 623 LVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 623 vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
++|||++|+.||........... +.. .. ... ...+.+++.+||+.||.+|||+.|++++
T Consensus 302 il~elltg~~Pf~~~~~~~~~~~---------------~~~-~~-~~~----~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGSEW---------------IFR-SC-KNI----PQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HHHHHHHSSCCC------CCSGG---------------GGS-SC-CCC----CHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred HHHHHHHCCCCCcccccccchhh---------------hhh-hc-cCC----CHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 99999999999976553322211 001 00 111 2357788999999999999999999863
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=333.00 Aligned_cols=265 Identities=25% Similarity=0.325 Sum_probs=199.5
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCcc--cHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEe
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQ--GIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYE 506 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 506 (752)
++|.+.+.||+|+||.||+++.. +++.||||++...... ....+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 57888899999999999999875 4889999998655332 34557899999999999999999999999999999999
Q ss_pred eCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccc
Q 043278 507 FMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586 (752)
Q Consensus 507 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~ 586 (752)
|+++++|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 105 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 105 FVDHTILDDLELFP---NGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp CCSEEHHHHHHHST---TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred cCCcchHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 99999998876432 34899999999999999999999998 9999999999999999999999999998654322
Q ss_pred cccccccccccCCccChhhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHH--------HHHHHhhCC-
Q 043278 587 SEANTKRIVGTYGYMSPEYAMSG-IVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIG--------YAWQLLSDG- 656 (752)
Q Consensus 587 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~--------~~~~~~~~~- 656 (752)
. ......|++.|+|||.+.+. .++.++||||||+++|||++|+.||...........+. .........
T Consensus 179 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (331)
T 4aaa_A 179 E--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP 256 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred c--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcc
Confidence 1 12235689999999999875 78999999999999999999999997654221110000 000001100
Q ss_pred CcccccCCCCCCCCCH-----HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 657 KGLELIDPSLEQPCSA-----NEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 657 ~~~~~~d~~l~~~~~~-----~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.......+.+....+. .....+.+++.+||+.||.+|||+.|++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0111111111111111 123567889999999999999999999874
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=336.54 Aligned_cols=264 Identities=20% Similarity=0.290 Sum_probs=199.1
Q ss_pred cCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCCc--ccHHHHHHHHHHHHhcCCCCcceeeeeeee--------C
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSSG--QGIVEFKNEVRLIAKLQHTNLVRLLGCSLH--------G 498 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~ 498 (752)
++|.+.++||+|+||.||+|+. .+++.||||++..... .....+.+|+.++.+++||||+++++++.. +
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 5788899999999999999987 4688999999865432 234567899999999999999999999877 4
Q ss_pred CeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceeccccc
Q 043278 499 EERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGM 578 (752)
Q Consensus 499 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgl 578 (752)
+..++||||+++ +|...+... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCC-CHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchh
Confidence 468999999985 666666432 345999999999999999999999998 99999999999999999999999999
Q ss_pred ceeeccccc--ccccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhC
Q 043278 579 ARIFEVNES--EANTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSD 655 (752)
Q Consensus 579 a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 655 (752)
++.+..... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||........ ..........
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~i~~~~~~ 247 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ---LALISQLCGS 247 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCC
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCC
Confidence 987653221 122234578999999999876 5689999999999999999999999976542211 1111111111
Q ss_pred CC---cccc--------cCCCCCCCCCH-HH------HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 656 GK---GLEL--------IDPSLEQPCSA-NE------VMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 656 ~~---~~~~--------~d~~l~~~~~~-~~------~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.. .... +.......... +. ...+.+|+.+||+.||++|||+.|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 248 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp CCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 00 0000 00000000111 11 1346789999999999999999999885
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=331.42 Aligned_cols=266 Identities=23% Similarity=0.339 Sum_probs=199.4
Q ss_pred hcCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEe
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYE 506 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 506 (752)
.++|.+.+.||+|+||.||+|+..+ .+|+|++.... ......+.+|+.++.+++|+||+++++++.+.+..++|||
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 109 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS 109 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence 4688899999999999999998754 59999987542 2334567889999999999999999999999999999999
Q ss_pred eCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccc
Q 043278 507 FMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586 (752)
Q Consensus 507 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~ 586 (752)
|+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||+++......
T Consensus 110 ~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~ 183 (319)
T 2y4i_B 110 LCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ 183 (319)
T ss_dssp CCCSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred cccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence 99999999998543 345899999999999999999999998 99999999999998 6799999999987653221
Q ss_pred ---cccccccccccCCccChhhhcc---------CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhh
Q 043278 587 ---SEANTKRIVGTYGYMSPEYAMS---------GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLS 654 (752)
Q Consensus 587 ---~~~~~~~~~gt~~y~aPE~~~~---------~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 654 (752)
.........|++.|+|||.+.. ..++.++||||||+++|||++|+.||...... .......
T Consensus 184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~ 256 (319)
T 2y4i_B 184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE-------AIIWQMG 256 (319)
T ss_dssp ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH-------HHHHHHH
T ss_pred ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHhc
Confidence 1122233568999999999874 45889999999999999999999999754421 1112222
Q ss_pred CCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCCCCCCCCCCc
Q 043278 655 DGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETMPLPPPKQPA 717 (752)
Q Consensus 655 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~~~~~~p~~~~ 717 (752)
.+......... . ...+.+++.+||+.||.+|||+.|++++|+.+.........|+
T Consensus 257 ~~~~~~~~~~~----~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~ 311 (319)
T 2y4i_B 257 TGMKPNLSQIG----M----GKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPG 311 (319)
T ss_dssp TTCCCCCCCSS----C----CTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----------
T ss_pred cCCCCCCCcCC----C----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCc
Confidence 22222111111 1 1246788999999999999999999999998765444434333
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=326.40 Aligned_cols=253 Identities=22% Similarity=0.380 Sum_probs=199.6
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEee
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
.++|++.+.||+|+||.||+|+.. +++.||+|++..........+.+|+.++.+++||||+++++++..++..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 468889999999999999999975 4889999999877777788899999999999999999999999999999999999
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccc
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES 587 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~ 587 (752)
+++++|..++.... ..+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||++.......
T Consensus 98 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 171 (302)
T 2j7t_A 98 CPGGAVDAIMLELD--RGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL- 171 (302)
T ss_dssp CTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-
T ss_pred CCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc-
Confidence 99999999886532 34899999999999999999999998 9999999999999999999999999976432111
Q ss_pred ccccccccccCCccChhhh-----ccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCccccc
Q 043278 588 EANTKRIVGTYGYMSPEYA-----MSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELI 662 (752)
Q Consensus 588 ~~~~~~~~gt~~y~aPE~~-----~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 662 (752)
.......|++.|+|||.+ ....++.++||||||+++|||++|+.|+..... .......... ......
T Consensus 172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~-~~~~~~ 243 (302)
T 2j7t_A 172 -QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKS-DPPTLL 243 (302)
T ss_dssp -HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHS-CCCCCS
T ss_pred -cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH------HHHHHHHhcc-CCcccC
Confidence 112235689999999998 367789999999999999999999999875442 1111122211 111111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 663 DPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 663 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
. +......+.+++.+|++.||.+|||+.|++++
T Consensus 244 ~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 244 T-------PSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp S-------GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred C-------ccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 1 11122457789999999999999999999764
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=325.85 Aligned_cols=246 Identities=22% Similarity=0.289 Sum_probs=199.5
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC--cccHHHHHHHHHHHHhc-CCCCcceeeeeeeeCCeeEEE
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGEERLLV 504 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 504 (752)
.++|.+.+.||+|+||.||+++.. +++.||||++.... .....++.+|+..+.++ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 467889999999999999999875 68999999987642 33456788999999999 999999999999999999999
Q ss_pred EeeCCCCCHhHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecC----------------
Q 043278 505 YEFMPNKSLDFFLFNSGR-KNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDD---------------- 567 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~---------------- 567 (752)
|||+++++|.+++..... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999999865322 245899999999999999999999998 999999999999984
Q ss_pred ---CCCceecccccceeecccccccccccccccCCccChhhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCc
Q 043278 568 ---KMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSG-IVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPL 643 (752)
Q Consensus 568 ---~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~ 643 (752)
...+||+|||++....... ...||+.|+|||.+.+. .++.++||||||++++||++|++++....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----- 235 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD----- 235 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH-----
T ss_pred cCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh-----
Confidence 4479999999998654322 24589999999999876 67789999999999999999987753321
Q ss_pred chHHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 644 NLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 644 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
....+..+....+ .... ...+.+++.+|++.||.+|||+.|++++
T Consensus 236 -----~~~~~~~~~~~~~-----~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 236 -----QWHEIRQGRLPRI-----PQVL----SQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp -----HHHHHHTTCCCCC-----SSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -----HHHHHHcCCCCCC-----Cccc----CHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 1222333322211 1111 2356788999999999999999999874
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=335.50 Aligned_cols=266 Identities=23% Similarity=0.294 Sum_probs=197.1
Q ss_pred HHhcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCccc-----HHHHHHHHHHHHhcCCCCcceeeeeeeeCCe
Q 043278 427 AAANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQG-----IVEFKNEVRLIAKLQHTNLVRLLGCSLHGEE 500 (752)
Q Consensus 427 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 500 (752)
...++|.+.+.||+|+||.||+++.. +++.||||++....... ...+.+|+.++.+++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999975 58899999997542211 2367899999999999999999999999999
Q ss_pred eEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccce
Q 043278 501 RLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR 580 (752)
Q Consensus 501 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~ 580 (752)
.++||||+++ +|..++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CEEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred eEEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccce
Confidence 9999999986 78777754 2345889999999999999999999998 9999999999999999999999999998
Q ss_pred eecccccccccccccccCCccChhhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcc
Q 043278 581 IFEVNESEANTKRIVGTYGYMSPEYAMSG-IVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGL 659 (752)
Q Consensus 581 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 659 (752)
...... .......+|+.|+|||.+.+. .++.++||||||+++|||++|.+||...... ................
T Consensus 161 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~---~~~~~i~~~~~~~~~~ 235 (346)
T 1ua2_A 161 SFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL---DQLTRIFETLGTPTEE 235 (346)
T ss_dssp TTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCTT
T ss_pred eccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH---HHHHHHHHHcCCCChh
Confidence 654322 122345789999999998764 5899999999999999999999998765421 1111111111111000
Q ss_pred ---c------ccCCCCCCCCCH-----HHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 043278 660 ---E------LIDPSLEQPCSA-----NEVMRCIHVGLLCVQDQAMDRPTMPEVVCML 703 (752)
Q Consensus 660 ---~------~~d~~l~~~~~~-----~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L 703 (752)
. .+........+. .....+.+++.+|++.||.+|||+.|++++-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred hhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 0 000000001111 1125678899999999999999999999864
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=336.65 Aligned_cols=262 Identities=21% Similarity=0.281 Sum_probs=193.3
Q ss_pred HhcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCc--ccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEE
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSG--QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLV 504 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 504 (752)
..++|.+.++||+|+||+||+++.. +++.||||++..... .....+.+|+.++.+++||||+++++++.+++..++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 4568999999999999999999864 688999999975532 2245678999999999999999999999999999999
Q ss_pred EeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEec-----CCCCceecccccc
Q 043278 505 YEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLD-----DKMNPKISDFGMA 579 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~-----~~~~~kl~DFgla 579 (752)
|||++ ++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++ +++.+||+|||++
T Consensus 112 ~e~~~-~~L~~~~~~~---~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 112 FEYAE-NDLKKYMDKN---PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp EECCS-EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred EecCC-CCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 99998 5898888653 34899999999999999999999998 99999999999994 5556999999999
Q ss_pred eeecccccccccccccccCCccChhhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCc
Q 043278 580 RIFEVNESEANTKRIVGTYGYMSPEYAMSG-IVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKG 658 (752)
Q Consensus 580 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 658 (752)
+...... .......+|+.|+|||++.+. .++.++|||||||++|||++|+.||....... ..............
T Consensus 185 ~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~~~~~~~~~~~ 259 (329)
T 3gbz_A 185 RAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID---QLFKIFEVLGLPDD 259 (329)
T ss_dssp HHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCT
T ss_pred cccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH---HHHHHHHHhCCCch
Confidence 8654322 122335679999999999874 58999999999999999999999997654221 11111111111000
Q ss_pred cc------c-----cCCCCCCCCCHH------HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 659 LE------L-----IDPSLEQPCSAN------EVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 659 ~~------~-----~d~~l~~~~~~~------~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.. . ..+.... .... ....+.+|+.+||+.||.+|||+.|++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 260 TTWPGVTALPDWKQSFPKFRG-KTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp TTSTTGGGSTTCCTTCCCCCC-CCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhhhhhhhcc-ccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 00 0 0000000 0011 12456789999999999999999999873
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=320.80 Aligned_cols=246 Identities=22% Similarity=0.309 Sum_probs=202.6
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC---cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 505 (752)
++|.+.+.||+|+||.||+++.. +++.||+|++.... ......+.+|+.++.+++||||+++++++.+++..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57888899999999999999875 57789999986431 234567899999999999999999999999999999999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccc
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVN 585 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~ 585 (752)
||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 94 EFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 999999999998654 34899999999999999999999988 999999999999999999999999999764422
Q ss_pred ccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCC
Q 043278 586 ESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPS 665 (752)
Q Consensus 586 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 665 (752)
. .....|++.|+|||.+.+..++.++||||||++++||++|+.||..... ... ...+.... ..
T Consensus 168 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~-~~~~~~~~------~~ 230 (284)
T 2vgo_A 168 R----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH------TET-HRRIVNVD------LK 230 (284)
T ss_dssp C----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHH-HHHHHTTC------CC
T ss_pred c----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH------hHH-HHHHhccc------cC
Confidence 1 2345789999999999999999999999999999999999999965431 111 11121111 11
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 666 LEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 666 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
+.. .....+.+++.+|++.||.+|||+.|++++
T Consensus 231 ~~~----~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 231 FPP----FLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp CCT----TSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred CCC----cCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 111 122356789999999999999999999874
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=344.10 Aligned_cols=253 Identities=23% Similarity=0.328 Sum_probs=191.9
Q ss_pred HhcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC--------cccHHHHHHHHHHHHhcCCCCcceeeeeeeeC
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS--------GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHG 498 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 498 (752)
..++|.+.++||+|+||.||+|... +++.||||++.... ......+.+|+.++.+++||||+++++++. .
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~ 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 4678999999999999999999864 57899999986532 112234789999999999999999999975 4
Q ss_pred CeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCC---CCceecc
Q 043278 499 EERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDK---MNPKISD 575 (752)
Q Consensus 499 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~---~~~kl~D 575 (752)
+..++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.+ ..+||+|
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred CceEEEEEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEee
Confidence 567999999999999888753 345899999999999999999999998 9999999999999654 4599999
Q ss_pred cccceeecccccccccccccccCCccChhhhcc---CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHH
Q 043278 576 FGMARIFEVNESEANTKRIVGTYGYMSPEYAMS---GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQL 652 (752)
Q Consensus 576 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~ 652 (752)
||+++..... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||........ +. ..
T Consensus 286 FG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~----~~ 356 (419)
T 3i6u_A 286 FGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LK----DQ 356 (419)
T ss_dssp SSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HH----HH
T ss_pred cccceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HH----HH
Confidence 9999875432 12234678999999999863 6788999999999999999999999976543221 11 11
Q ss_pred hhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 653 LSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 653 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
+..+..... +... ......+.+++.+||+.||.+|||+.|++++
T Consensus 357 i~~~~~~~~--~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 357 ITSGKYNFI--PEVW----AEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HHTTCCCCC--HHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HhcCCCCCC--chhh----cccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 222211100 0000 0113457789999999999999999999874
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=330.06 Aligned_cols=258 Identities=26% Similarity=0.368 Sum_probs=197.1
Q ss_pred hcCCCcCCeeecCCcccEEEEEec--CCc--eeEEEEcccC---CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCee
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA--DEQ--EVAIKRLSRS---SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEER 501 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~--~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 501 (752)
.++|++.+.||+|+||.||+|+.. +++ .||||+++.. .....+++.+|+.++.+++||||+++++++...+ .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 357888999999999999999853 233 5899998754 2334567899999999999999999999998765 8
Q ss_pred EEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceeccccccee
Q 043278 502 LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARI 581 (752)
Q Consensus 502 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~ 581 (752)
++||||+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++..
T Consensus 96 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence 8999999999999998653 245899999999999999999999998 99999999999999999999999999987
Q ss_pred ecccccc-cccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcc
Q 043278 582 FEVNESE-ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGL 659 (752)
Q Consensus 582 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 659 (752)
....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .........+...
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~~~~~~ 244 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------QILHKIDKEGERL 244 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTSCCCC
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH------HHHHHHHccCCCC
Confidence 6543221 12233567788999999999899999999999999999999 99998755421 1111222221111
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCC
Q 043278 660 ELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNET 707 (752)
Q Consensus 660 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~ 707 (752)
. .+......+.+++.+|++.||.+|||+.++++.|+...
T Consensus 245 ~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 245 P---------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp C---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred C---------CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 1 11122345778999999999999999999999998764
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=331.12 Aligned_cols=262 Identities=25% Similarity=0.379 Sum_probs=186.7
Q ss_pred HhcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEE
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 505 (752)
..++|.+.+.||+|+||.||++... +++.||||++.... .....++.+|+.++.+++||||+++++++...+..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 3478999999999999999999864 68899999986543 334567889999999999999999999999999999999
Q ss_pred eeCCCCCHhHHHhhc-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccce
Q 043278 506 EFMPNKSLDFFLFNS-----GRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR 580 (752)
Q Consensus 506 E~~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~ 580 (752)
||+++++|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 999999999988641 12456899999999999999999999998 9999999999999999999999999997
Q ss_pred eeccccc---ccccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCC
Q 043278 581 IFEVNES---EANTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDG 656 (752)
Q Consensus 581 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 656 (752)
....... ........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||....... .. .......
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~---~~~~~~~ 243 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK---VL---MLTLQND 243 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HH---HHHHTSS
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh---HH---HHHhccC
Confidence 6543221 111234578999999999876 578999999999999999999999997654221 11 1111111
Q ss_pred C--c-ccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 657 K--G-LELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 657 ~--~-~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
. . ....++...... ...+.+++.+||+.||.+|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 244 PPSLETGVQDKEMLKKY----GKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp CCCTTC-----CCCCCC----CHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCccccccccchhhhhh----hHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0 0 011111111122 2356788999999999999999999874
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=334.69 Aligned_cols=200 Identities=25% Similarity=0.342 Sum_probs=175.2
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEe
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYE 506 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 506 (752)
.++|.+.+.||+|+||.||++... +++.||+|++.... ......+.+|+.++.+++||||+++++++.+++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 467888999999999999999875 58899999987653 3345678999999999999999999999999999999999
Q ss_pred eCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEeecCCCCCcEEecCCCCceecccccceeeccc
Q 043278 507 FMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY-SRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVN 585 (752)
Q Consensus 507 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~ 585 (752)
|+++++|.+++... ..+++..+..++.|++.||+|||+. + |+||||||+|||++.++.+||+|||++......
T Consensus 112 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred CCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 99999999999654 3489999999999999999999985 6 999999999999999999999999999754321
Q ss_pred ccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 043278 586 ESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHH 638 (752)
Q Consensus 586 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~ 638 (752)
......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 186 ----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 234 (360)
T 3eqc_A 186 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 234 (360)
T ss_dssp ----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCC
T ss_pred ----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 2234578999999999999999999999999999999999999997643
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=345.20 Aligned_cols=195 Identities=23% Similarity=0.375 Sum_probs=153.6
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeeeC-----Ce
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHG-----EE 500 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 500 (752)
.++|.+.+.||+|+||.||+|+.. +++.||||++.... ....+++.+|+.++.+++|+||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 368999999999999999999865 68899999986542 33456788999999999999999999998543 56
Q ss_pred eEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccce
Q 043278 501 RLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR 580 (752)
Q Consensus 501 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~ 580 (752)
.++||||+. ++|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 132 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeccc-cchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence 899999985 788888753 345999999999999999999999998 9999999999999999999999999998
Q ss_pred eecccccc-------------------------cccccccccCCccChhhh-ccCCCCccchhHHHHHHHHHHHhC
Q 043278 581 IFEVNESE-------------------------ANTKRIVGTYGYMSPEYA-MSGIVSIKTDVFSFGVLVLEIVSG 630 (752)
Q Consensus 581 ~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~t~k~DV~S~G~vl~elltG 630 (752)
........ .......||+.|+|||++ ....++.++|||||||+||||++|
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 75422110 112345789999999986 456799999999999999999993
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=340.52 Aligned_cols=254 Identities=10% Similarity=0.018 Sum_probs=180.7
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCc---ccHHHHHHHHHHHHhc--CCCCcceee-------eeee
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSG---QGIVEFKNEVRLIAKL--QHTNLVRLL-------GCSL 496 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l--~h~niv~l~-------~~~~ 496 (752)
..|...+.||+|+||.||+|+.. +++.||||++..... .....+.+|+.++..+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 45778899999999999999965 688999999987543 2345577885544444 699988755 3332
Q ss_pred eC-----------------CeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHH------HHHHHHHHHHHHHHHhcCCCcE
Q 043278 497 HG-----------------EERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKR------FIIIEGISQGLLYLHKYSRLRV 553 (752)
Q Consensus 497 ~~-----------------~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~i~~~l~~LH~~~~~~i 553 (752)
.. ...+|||||++ |+|.+++..... .+.+..+ +.++.||+.||+|||+++ |
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---i 215 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSKG---L 215 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---C
Confidence 22 34799999999 899999975422 2455555 788899999999999998 9
Q ss_pred eecCCCCCcEEecCCCCceecccccceeecccccccccccccccCCccChhhhcc--CCCCccchhHHHHHHHHHHHhCC
Q 043278 554 IHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMS--GIVSIKTDVFSFGVLVLEIVSGQ 631 (752)
Q Consensus 554 iH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~k~DV~S~G~vl~elltG~ 631 (752)
+||||||+||||+.++.+||+|||+++...... ....+|+.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp EETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred ccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 999999999999999999999999998654221 13456799999999987 78999999999999999999999
Q ss_pred CCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 632 KNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 632 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.||....+...... ............+..+........+.+++.+||+.||++|||+.|++++
T Consensus 291 ~Pf~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 291 LPFGLVTPGIKGSW--------KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp CSTTBCCTTCTTCC--------CBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred CCCCCcCcccccch--------hhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 99987653321100 0000000011111111111223467789999999999999999999753
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=331.12 Aligned_cols=258 Identities=20% Similarity=0.270 Sum_probs=202.7
Q ss_pred HHHHhcCCCcC-CeeecCCcccEEEEEec-CCceeEEEEcccC--CcccHHHHHHHHHHHHhc-CCCCcceeeeeeeeCC
Q 043278 425 IAAAANNFSTT-NKLGEGGFGPVYKGKLA-DEQEVAIKRLSRS--SGQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGE 499 (752)
Q Consensus 425 i~~~~~~~~~~-~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 499 (752)
.....+.|.+. +.||+|+||.||++... +++.||+|++... ......++.+|+.++.++ +||||+++++++.+.+
T Consensus 23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~ 102 (327)
T 3lm5_A 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS 102 (327)
T ss_dssp HHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred HHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC
Confidence 34455677776 88999999999999875 5889999998754 334567889999999999 5699999999999999
Q ss_pred eeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecC---CCCceeccc
Q 043278 500 ERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDD---KMNPKISDF 576 (752)
Q Consensus 500 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~---~~~~kl~DF 576 (752)
..++||||+++|+|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+||
T Consensus 103 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Df 178 (327)
T 3lm5_A 103 EIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDF 178 (327)
T ss_dssp EEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred eEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeC
Confidence 999999999999999988542 2356999999999999999999999998 999999999999987 789999999
Q ss_pred ccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCC
Q 043278 577 GMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDG 656 (752)
Q Consensus 577 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 656 (752)
|+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ....... ..
T Consensus 179 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i~-~~ 248 (327)
T 3lm5_A 179 GMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ------ETYLNIS-QV 248 (327)
T ss_dssp GGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHH-HT
T ss_pred ccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch------HHHHHHH-hc
Confidence 9998764322 123357899999999999999999999999999999999999999665421 1111111 11
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 657 KGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 657 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.. . ............+.+++.+||+.||.+|||++|+++.
T Consensus 249 ~~-~-----~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 249 NV-D-----YSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp CC-C-----CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred cc-c-----cCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 10 0 0011111223457788999999999999999999875
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=327.99 Aligned_cols=258 Identities=20% Similarity=0.309 Sum_probs=205.4
Q ss_pred HHHHHHhcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCcc--------cHHHHHHHHHHHHhc-CCCCcceee
Q 043278 423 QTIAAAANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQ--------GIVEFKNEVRLIAKL-QHTNLVRLL 492 (752)
Q Consensus 423 ~~i~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l-~h~niv~l~ 492 (752)
.......++|.+.+.||+|+||.||+|+.. +|+.||||++...... ....+.+|+.++.++ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 344555678999999999999999999985 6899999998654321 134678999999999 899999999
Q ss_pred eeeeeCCeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCce
Q 043278 493 GCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPK 572 (752)
Q Consensus 493 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~k 572 (752)
+++......++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+|
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ik 240 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIR 240 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEE
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEE
Confidence 9999999999999999999999998643 35899999999999999999999998 99999999999999999999
Q ss_pred ecccccceeecccccccccccccccCCccChhhhcc------CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchH
Q 043278 573 ISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMS------GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLI 646 (752)
Q Consensus 573 l~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~ 646 (752)
|+|||++..+.... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......
T Consensus 241 l~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~------ 311 (365)
T 2y7j_A 241 LSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI------ 311 (365)
T ss_dssp ECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------
T ss_pred EEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH------
Confidence 99999998765332 2234678999999999863 36889999999999999999999999654311
Q ss_pred HHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 647 GYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 647 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
. ....+..+.... ..+.. . .....+.+++.+|++.||++|||+.|+++.
T Consensus 312 ~-~~~~i~~~~~~~-~~~~~-~----~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 312 L-MLRMIMEGQYQF-SSPEW-D----DRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp H-HHHHHHHTCCCC-CHHHH-S----SSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred H-HHHHHHhCCCCC-CCccc-c----cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1 111121111100 00000 0 112357789999999999999999999874
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=337.09 Aligned_cols=270 Identities=21% Similarity=0.261 Sum_probs=199.8
Q ss_pred cHHHHHHHhcCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCCcc-----------cHHHHHHHHHHHHhcCCCCcc
Q 043278 421 DFQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQ-----------GIVEFKNEVRLIAKLQHTNLV 489 (752)
Q Consensus 421 ~~~~i~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~-----------~~~~~~~E~~~l~~l~h~niv 489 (752)
...++....++|.+.+.||+|+||.||+|...+++.||||++...... ....+.+|+.++.+++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 456778889999999999999999999999888999999998653221 136789999999999999999
Q ss_pred eeeeeeee-----CCeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEE
Q 043278 490 RLLGCSLH-----GEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNIL 564 (752)
Q Consensus 490 ~l~~~~~~-----~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIl 564 (752)
++++++.. ....++||||++ |+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 166 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNIL 166 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEE
Confidence 99999854 336799999998 677777753 3346999999999999999999999998 999999999999
Q ss_pred ecCCCCceecccccceeecccccccccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCc
Q 043278 565 LDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPL 643 (752)
Q Consensus 565 l~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~ 643 (752)
++.++.+||+|||+++...... ......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||.......
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-- 241 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN-- 241 (362)
T ss_dssp ECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--
T ss_pred EcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH--
Confidence 9999999999999997543222 2234578899999999887 679999999999999999999999997654211
Q ss_pred chHHHHHHHhhCCCcc-----------cccCCCCCC-------CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 644 NLIGYAWQLLSDGKGL-----------ELIDPSLEQ-------PCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 644 ~l~~~~~~~~~~~~~~-----------~~~d~~l~~-------~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
............... ..+...+.. .........+.+++.+|++.||.+|||+.|++++
T Consensus 242 -~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 242 -QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp -HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 111111111110000 000000000 0001112457789999999999999999999875
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=322.03 Aligned_cols=252 Identities=24% Similarity=0.356 Sum_probs=199.9
Q ss_pred HhcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEe
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYE 506 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 506 (752)
..++|.+.+.||+|+||.||+|... +++.||||.+.... ...++.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4578999999999999999999875 48899999997643 34678999999999999999999999999999999999
Q ss_pred eCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccc
Q 043278 507 FMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586 (752)
Q Consensus 507 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~ 586 (752)
|+++++|.+++... ...+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 105 ~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 105 YCGAGSVSDIIRLR--NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp CCTTEEHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred cCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 99999999998642 345899999999999999999999998 9999999999999999999999999998754332
Q ss_pred cccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCC
Q 043278 587 SEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666 (752)
Q Consensus 587 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 666 (752)
. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... ....... ......+..
T Consensus 180 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~-~~~~~~~~~--- 247 (314)
T 3com_A 180 A--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM------RAIFMIP-TNPPPTFRK--- 247 (314)
T ss_dssp S--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHH-HSCCCCCSS---
T ss_pred c--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHh-cCCCcccCC---
Confidence 1 223357899999999999999999999999999999999999999754311 1111111 111111111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 667 EQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 667 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
+......+.+++.+|++.||.+|||+.|+++.
T Consensus 248 ----~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 248 ----PELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp ----GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ----cccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11122457789999999999999999999874
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=319.35 Aligned_cols=247 Identities=22% Similarity=0.355 Sum_probs=195.1
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC---cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 505 (752)
++|.+.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 57888999999999999999975 68899999986532 234567899999999999999999999999999999999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccc
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVN 585 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~ 585 (752)
||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++......
T Consensus 91 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 91 EYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp ECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred eccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 999999999998654 34899999999999999999999998 999999999999999999999999999865432
Q ss_pred ccccccccccccCCccChhhhccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCC
Q 043278 586 ESEANTKRIVGTYGYMSPEYAMSGIV-SIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDP 664 (752)
Q Consensus 586 ~~~~~~~~~~gt~~y~aPE~~~~~~~-t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 664 (752)
. ......+++.|+|||.+.+..+ +.++||||||++++||++|+.||..... ......+..+..
T Consensus 165 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~~~~~~------ 228 (276)
T 2h6d_A 165 E---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV-------PTLFKKIRGGVF------ 228 (276)
T ss_dssp ---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCC------
T ss_pred c---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH-------HHHHHHhhcCcc------
Confidence 2 1223568899999999988765 6899999999999999999999865431 111122222111
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 665 SLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 665 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.+... ....+.+++.+|++.||.+|||+.|++++
T Consensus 229 ~~~~~----~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 229 YIPEY----LNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp CCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred cCchh----cCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 01011 12356788999999999999999999985
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=340.62 Aligned_cols=260 Identities=22% Similarity=0.306 Sum_probs=196.0
Q ss_pred cCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCC------eeEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGE------ERLL 503 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~l 503 (752)
.+|...+.||+|+||.||+|+...+..+|+|++...... ..+|+.+++.++||||+++++++.... ..++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 468889999999999999999877777999988654322 247999999999999999999986543 3789
Q ss_pred EEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEec-CCCCceecccccceee
Q 043278 504 VYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLD-DKMNPKISDFGMARIF 582 (752)
Q Consensus 504 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~-~~~~~kl~DFgla~~~ 582 (752)
||||++++.+............+++..+..++.||++||+|||+.+ |+||||||+||||+ .++.+||+|||+++..
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 9999998766554433334556999999999999999999999998 99999999999999 7999999999999876
Q ss_pred cccccccccccccccCCccChhhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCC-----
Q 043278 583 EVNESEANTKRIVGTYGYMSPEYAMSG-IVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDG----- 656 (752)
Q Consensus 583 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~----- 656 (752)
..... .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||......... ....+.+...
T Consensus 193 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l---~~i~~~~g~p~~~~~ 266 (394)
T 4e7w_A 193 IAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQL---VEIIKVLGTPSREQI 266 (394)
T ss_dssp CTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHHHCCCCHHHH
T ss_pred cCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCCCHHHH
Confidence 43322 2245789999999998765 5999999999999999999999999775422111 1111111000
Q ss_pred -----CcccccCCCCCC-----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 657 -----KGLELIDPSLEQ-----PCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 657 -----~~~~~~d~~l~~-----~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
...+..-+.... .........+.+|+.+||+.||.+|||+.|++++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 000000011100 0111123467889999999999999999999986
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=338.35 Aligned_cols=261 Identities=23% Similarity=0.299 Sum_probs=195.7
Q ss_pred hcCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCC------
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGE------ 499 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 499 (752)
.++|...+.||+|+||.||+|.. .+|+.||||++.... .....++.+|+.++++++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46788999999999999999987 468999999996542 233457889999999999999999999987653
Q ss_pred eeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccc
Q 043278 500 ERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMA 579 (752)
Q Consensus 500 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla 579 (752)
..++||||+ +++|..++.. ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 459999999 7899998854 35899999999999999999999998 999999999999999999999999999
Q ss_pred eeecccccccccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCC-
Q 043278 580 RIFEVNESEANTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGK- 657 (752)
Q Consensus 580 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~- 657 (752)
+..... .....+|+.|+|||++.+ ..++.++||||+||+++||++|+.||....... .............
T Consensus 176 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~l~~i~~~~g~~~~ 247 (367)
T 1cm8_A 176 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD---QLKEIMKVTGTPPA 247 (367)
T ss_dssp EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCH
T ss_pred cccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCCH
Confidence 865422 234578999999999887 789999999999999999999999997654221 1111111100000
Q ss_pred -----------------cccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hhcC
Q 043278 658 -----------------GLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM--LQNE 706 (752)
Q Consensus 658 -----------------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~--L~~~ 706 (752)
........+. .........+.+|+.+|++.||.+|||+.|++++ ++..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~ 314 (367)
T 1cm8_A 248 EFVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314 (367)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHHHHhhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence 0000000000 0011123457788999999999999999999985 5544
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=317.91 Aligned_cols=250 Identities=24% Similarity=0.359 Sum_probs=197.4
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccC--CcccHHHHHHHHHHHHhcCCCCcceeeeeeee----CCeeE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRS--SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLH----GEERL 502 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~ 502 (752)
+.|.+.+.||+|+||.||+|... ++..||+|.+... .......+.+|+.++.+++||||+++++++.. +...+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 34677789999999999999874 5778999998654 23345678999999999999999999998865 45689
Q ss_pred EEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEec-CCCCceeccccccee
Q 043278 503 LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLD-DKMNPKISDFGMARI 581 (752)
Q Consensus 503 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~-~~~~~kl~DFgla~~ 581 (752)
+||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ .+|+|+||||+|||++ .++.+||+|||++..
T Consensus 106 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 999999999999999653 45899999999999999999999875 3599999999999997 889999999999975
Q ss_pred ecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccc
Q 043278 582 FEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLEL 661 (752)
Q Consensus 582 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 661 (752)
.... ......|++.|+|||.+. ..++.++||||||+++|||++|+.||...... .........+.....
T Consensus 182 ~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~~~ 250 (290)
T 1t4h_A 182 KRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRRVTSGVKPAS 250 (290)
T ss_dssp CCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHHHHHTTTCCCGG
T ss_pred cccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH------HHHHHHHhccCCccc
Confidence 4322 223356899999999876 45899999999999999999999999654321 111222222211111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 662 IDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 662 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.+. . ....+.+++..||+.||.+|||+.|++++
T Consensus 251 ~~~----~----~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 251 FDK----V----AIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp GGG----C----CCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cCC----C----CCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 111 1 12357789999999999999999999874
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=356.31 Aligned_cols=250 Identities=22% Similarity=0.312 Sum_probs=204.2
Q ss_pred HhcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccC---CcccHHHHHHHHHHHHhc-CCCCcceeeeeeeeCCeeE
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRS---SGQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGEERL 502 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 502 (752)
..++|++.+.||+|+||.||+++.. +++.||||+++.. .......+..|..++..+ +|++|+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3567999999999999999999875 5788999998753 223455678899999987 7999999999999999999
Q ss_pred EEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceee
Q 043278 503 LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIF 582 (752)
Q Consensus 503 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~ 582 (752)
|||||+++|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++++||+|||+++..
T Consensus 419 lV~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 999999999999999754 34899999999999999999999998 999999999999999999999999999854
Q ss_pred cccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCccccc
Q 043278 583 EVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELI 662 (752)
Q Consensus 583 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 662 (752)
.... .......||+.|+|||++.+..++.++||||||++||||++|+.||...... .. .+.+..+..
T Consensus 493 ~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~------~~-~~~i~~~~~---- 559 (674)
T 3pfq_A 493 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------EL-FQSIMEHNV---- 559 (674)
T ss_dssp CCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HH-HHHHHSSCC----
T ss_pred ccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH------HH-HHHHHhCCC----
Confidence 3222 2234578999999999999999999999999999999999999999765421 11 122222211
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHHH
Q 043278 663 DPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTM-----PEVVCM 702 (752)
Q Consensus 663 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~-----~ev~~~ 702 (752)
. .+......+.+|+..||+.||.+||++ +||+++
T Consensus 560 --~----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 560 --A----YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp --C----CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred --C----CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 0 111223457789999999999999998 777653
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=332.88 Aligned_cols=263 Identities=24% Similarity=0.260 Sum_probs=202.4
Q ss_pred hcCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCCcccHHHHHHHHHHHHhcC--------CCCcceeeeeee---
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQ--------HTNLVRLLGCSL--- 496 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~--- 496 (752)
.++|.+.++||+|+||.||+|+. .+++.||||++... ......+.+|+.++.+++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 36899999999999999999986 45789999999754 334567889999999985 788999999987
Q ss_pred -eCCeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEeecCCCCCcEEecCCC-----
Q 043278 497 -HGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY-SRLRVIHRDLKASNILLDDKM----- 569 (752)
Q Consensus 497 -~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiH~Dikp~NIll~~~~----- 569 (752)
.+...++||||+. ++|...+... ....+++..+..++.||+.||+|||++ + |+||||||+||||+.++
T Consensus 115 ~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 115 VNGTHICMVFEVLG-HHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TTEEEEEEEECCCC-CBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred CCCceEEEEEeccC-ccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence 5568899999995 5555555433 234599999999999999999999998 7 99999999999998775
Q ss_pred --------------------------------------------CceecccccceeecccccccccccccccCCccChhh
Q 043278 570 --------------------------------------------NPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEY 605 (752)
Q Consensus 570 --------------------------------------------~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~ 605 (752)
.+||+|||+++..... .....||+.|+|||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChh
Confidence 8999999999875432 223578999999999
Q ss_pred hccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHH---HHHhhC--------CCc-ccccCCC-----C--
Q 043278 606 AMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYA---WQLLSD--------GKG-LELIDPS-----L-- 666 (752)
Q Consensus 606 ~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~---~~~~~~--------~~~-~~~~d~~-----l-- 666 (752)
+.+..++.++|||||||+||||++|+.||............... ...+.. +.. ....... +
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 99999999999999999999999999999876544322111111 111110 000 0000000 0
Q ss_pred ------------CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 667 ------------EQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 667 ------------~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
....+......+.+|+.+||+.||++|||+.|++++
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 012345667788999999999999999999999864
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=328.65 Aligned_cols=261 Identities=25% Similarity=0.393 Sum_probs=199.4
Q ss_pred ccHHHHHHHhcCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCCcccHHHHHHHHHHHHhc-CCCCcceeeeeeee
Q 043278 420 FDFQTIAAAANNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLH 497 (752)
Q Consensus 420 ~~~~~i~~~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 497 (752)
+++.++....++|.+.+.||+|+||.||+|+. .+++.||||++.... .....+.+|+.++.++ +||||+++++++..
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 34444445678899999999999999999987 468899999986543 3456789999999999 89999999999976
Q ss_pred ------CCeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCc
Q 043278 498 ------GEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNP 571 (752)
Q Consensus 498 ------~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~ 571 (752)
.+..++||||+++++|.+++.... ...+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~ 168 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEV 168 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCE
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCE
Confidence 467899999999999999986542 346899999999999999999999998 9999999999999999999
Q ss_pred eecccccceeecccccccccccccccCCccChhhhc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchH
Q 043278 572 KISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM-----SGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLI 646 (752)
Q Consensus 572 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~ 646 (752)
||+|||++........ ......|++.|+|||.+. +..++.++||||||+++|||++|+.||......
T Consensus 169 kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------ 240 (326)
T 2x7f_A 169 KLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM------ 240 (326)
T ss_dssp EECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------
T ss_pred EEeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH------
Confidence 9999999986543211 122357899999999987 567899999999999999999999998654311
Q ss_pred HHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 647 GYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 647 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
......... ........ . ....+.+++.+||+.||.+|||+.|++++
T Consensus 241 ~~~~~~~~~-~~~~~~~~----~----~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 241 RALFLIPRN-PAPRLKSK----K----WSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp HHHHHHHHS-CCCCCSCS----C----SCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHHhhcC-ccccCCcc----c----cCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 111111111 11111111 1 12356788899999999999999999874
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=343.75 Aligned_cols=252 Identities=26% Similarity=0.321 Sum_probs=202.2
Q ss_pred HhcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccC--CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEE
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRS--SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLV 504 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 504 (752)
..++|.+.++||+|+||+||+++.. +++.||||++... .......+.+|+.++.+++||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3467999999999999999999875 6889999998643 234567889999999999999999999999999999999
Q ss_pred EeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEec---CCCCceeccccccee
Q 043278 505 YEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLD---DKMNPKISDFGMARI 581 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~---~~~~~kl~DFgla~~ 581 (752)
|||+++++|.+.+... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+++.
T Consensus 100 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 100 GELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 9999999998888654 35899999999999999999999998 99999999999995 566799999999986
Q ss_pred ecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccc
Q 043278 582 FEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLEL 661 (752)
Q Consensus 582 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 661 (752)
..... ......||+.|+|||++.+ .++.++|||||||++|||++|+.||...... . ....+..+.....
T Consensus 174 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~-~~~~i~~~~~~~~ 242 (486)
T 3mwu_A 174 FQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY------D-ILKRVETGKYAFD 242 (486)
T ss_dssp BCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHHTCCCSC
T ss_pred CCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------H-HHHHHHhCCCCCC
Confidence 54322 2234578999999998875 5999999999999999999999999765421 1 1112222211100
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 662 IDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 662 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.+ ........+.+++.+||+.||.+|||+.|++++
T Consensus 243 -~~-----~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 243 -LP-----QWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp -SG-----GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred -Cc-----ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 011122457789999999999999999999986
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=347.36 Aligned_cols=251 Identities=25% Similarity=0.341 Sum_probs=198.1
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEE
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 505 (752)
.++|.+.++||+|+||+||+++.. ++..||+|++.... ......+.+|+.++.+++||||+++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 457889999999999999999975 57889999987643 334567899999999999999999999999999999999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecC---CCCceecccccceee
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDD---KMNPKISDFGMARIF 582 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~---~~~~kl~DFgla~~~ 582 (752)
||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++..
T Consensus 116 e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 116 ECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 999999998888654 34899999999999999999999998 999999999999976 455999999999876
Q ss_pred cccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCccccc
Q 043278 583 EVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELI 662 (752)
Q Consensus 583 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 662 (752)
.... ......||+.|+|||++. ..++.++|||||||++|||++|+.||...... .....+..+... ..
T Consensus 190 ~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~~i~~~~~~-~~ 257 (494)
T 3lij_A 190 ENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ-------EILRKVEKGKYT-FD 257 (494)
T ss_dssp BTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHTCCC-CC
T ss_pred CCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCCC-CC
Confidence 5332 223457999999999876 56999999999999999999999999765421 111222222111 11
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 663 DPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 663 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.+.. . .....+.+++.+||+.||.+|||+.|++++
T Consensus 258 ~~~~-~----~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 258 SPEW-K----NVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp SGGG-T----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred chhc-c----cCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 1111 1 112356788999999999999999999865
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=327.39 Aligned_cols=253 Identities=23% Similarity=0.297 Sum_probs=185.9
Q ss_pred hcCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCCc-cc-HHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEE
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSSG-QG-IVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 505 (752)
.++|++.+.||+|+||.||+++. .+++.||||++..... .. ...+.++...+..++||||+++++++.+++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 46788899999999999999987 4688999999976522 22 233445555678889999999999999999999999
Q ss_pred eeCCCCCHhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEeecCCCCCcEEecCCCCceecccccceeec
Q 043278 506 EFMPNKSLDFFLFNS-GRKNVLNWEKRFIIIEGISQGLLYLHKY-SRLRVIHRDLKASNILLDDKMNPKISDFGMARIFE 583 (752)
Q Consensus 506 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~ 583 (752)
||++ |+|.+++... .....+++..+..++.||+.||+|||++ + |+||||||+|||++.++.+||+|||+++...
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9998 5887776542 2345699999999999999999999998 7 9999999999999999999999999998654
Q ss_pred ccccccccccccccCCccChhhh----ccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcc
Q 043278 584 VNESEANTKRIVGTYGYMSPEYA----MSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGL 659 (752)
Q Consensus 584 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 659 (752)
.... .....||+.|+|||.+ .+..++.++||||||++++||++|+.||..... ............. .
T Consensus 162 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~-~ 232 (290)
T 3fme_A 162 DDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT-----PFQQLKQVVEEPS-P 232 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC-----HHHHHHHHHHSCC-C
T ss_pred cccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc-----hHHHHHHHhccCC-C
Confidence 3221 2234689999999996 566789999999999999999999999965321 1111122222211 1
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 660 ELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 660 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.... ......+.+++.+|++.||++|||+.|++++
T Consensus 233 ~~~~--------~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 233 QLPA--------DKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp CCCT--------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred Cccc--------ccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 1111 1122357788999999999999999999873
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-37 Score=327.14 Aligned_cols=257 Identities=16% Similarity=0.257 Sum_probs=198.8
Q ss_pred hcCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCCcccHHHHHHHHHHHHhcC-CCCcceeeeeeee--CCeeEEE
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQ-HTNLVRLLGCSLH--GEERLLV 504 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv 504 (752)
.++|++.++||+|+||.||+|+. .+++.||||++... ....+.+|+.++.+++ |+||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 36788999999999999999986 56889999998743 3567899999999997 9999999999987 6678999
Q ss_pred EeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCC-Cceecccccceeec
Q 043278 505 YEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKM-NPKISDFGMARIFE 583 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~-~~kl~DFgla~~~~ 583 (752)
|||+++++|..++. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+++...
T Consensus 112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 99999999998873 3889999999999999999999998 99999999999999776 89999999998754
Q ss_pred ccccccccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHH---------Hh
Q 043278 584 VNESEANTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQ---------LL 653 (752)
Q Consensus 584 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~---------~~ 653 (752)
.... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ........ .+
T Consensus 183 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~--~~l~~~~~~~~~~~~~~~~ 257 (330)
T 3nsz_A 183 PGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY--DQLVRIAKVLGTEDLYDYI 257 (330)
T ss_dssp TTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH--HHHHHHHHHHCHHHHHHHH
T ss_pred CCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchH--HHHHHHHHhcCCchhhhHH
Confidence 3322 233578899999999987 679999999999999999999999985443211 00100000 00
Q ss_pred hCCCc--------------ccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 654 SDGKG--------------LELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 654 ~~~~~--------------~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
..... ...................+.+++.+||+.||.+|||++|++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00000 00000000011111123567889999999999999999999874
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=321.32 Aligned_cols=201 Identities=18% Similarity=0.241 Sum_probs=154.4
Q ss_pred eEeeCCCeEEeeeeCCCCCCCCccEEEEecCCCCCCcCccccCCCCCCCCCccEEeccCCCCCCCC----CceEEEecCC
Q 043278 2 LLVSAFGNFKLGFFSPASSTTTERYLGIWHDTAPDTLGWYFRPFLPRYQTDEPIWIANRNTPILDQ----SGVLTIDSID 77 (752)
Q Consensus 2 ~lvS~~g~F~lGFf~~~~~~~~~~ylgIw~~~~~~~~~~~~~~~~~~~~~~t~vWvANr~~Pv~~~----~~~l~~~~~~ 77 (752)
.|||++|+|+||||.++ ++|| |+ | .+ +||+||||+||.++ +++|+|+. |
T Consensus 28 ~l~S~~g~F~lgf~~~~-----~~~l---y~--~---------------~~-vvW~Anr~~p~~~~~~~~~~~l~l~~-~ 80 (276)
T 3m7h_A 28 YLLSPNQRFKLLLQGDG-----NLVI---QD--N---------------GA-TVWVANEQQPFSSTIPLRNKKAPLAF-Y 80 (276)
T ss_dssp EEECTTSSEEEEECTTS-----CEEE---EE--T---------------TE-EEEECSTTSTTEEEEECCCTTCCSEE-E
T ss_pred EEEcCCCcEEEEEECCC-----CeEE---EC--C---------------CC-eEEECCCCCCcCCcccccceEEEEeC-C
Confidence 69999999999999432 5788 76 4 36 99999999999884 68999998 9
Q ss_pred CcEEE--EcCCCCcEEEeeccCC-----ccccceeEecCCCeEEEEecCCCccceeEeeeccCCCcccCCCCeecccccc
Q 043278 78 GNLKI--LHNGGNPIAVSSVEGA-----SNNTSATLLQSGNLVLREMDTDGTIKRVLWQSFDYPTDTLLPGMKLGINLQT 150 (752)
Q Consensus 78 g~L~l--~~~~g~~~~~~~~~~~-----~~~~~a~lldsGNlVl~~~~~~~~~~~~lWQSFd~PTDTlLpg~kl~~~~~t 150 (752)
|+|+| .|++|.+||+++++.. ..++.|+|+|+|||||++ +.+|||| |||||||||||||.+.++
T Consensus 81 G~Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~-------~~~lWqS--~ptdtlLpg~~~~~~l~~ 151 (276)
T 3m7h_A 81 VQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD-------SLALWNG--TPAIPLVPGAIDSLLLAP 151 (276)
T ss_dssp ESSSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE-------EEEEEES--CTTSCCCCSCTTCEEECS
T ss_pred CcEEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC-------CceeeCc--cccccccccccccccccc
Confidence 99999 8888899998876432 345689999999999997 2599999 999999999999999999
Q ss_pred CceeEEEEecCCCCCCCCCcEEeeecCCCceeEEEecCceEEEecccccCCccccccccceEEEEEecCc-eEEEEEEcc
Q 043278 151 GHQWFLQSWLDYSSPAQGSFTLGIEPNATNQLIIRWRRETIYWTSGLLLNGNFNFSRSWNLSFSYTSNEQ-EKYFEYSLN 229 (752)
Q Consensus 151 g~~~~L~Sw~s~~dps~G~f~l~~~~~g~~~~~~~~~~~~~yw~~g~~~~~~~~~~~~~~~~~~~~~n~~-e~~~~~~~~ 229 (752)
|+. | ++.+||++|.|+++|+++| +++++++...+||++|.|+.+.....-.....+.+.++.+ ++.++++.
T Consensus 152 g~~--L---~S~~dps~G~fsl~l~~dG--nlvLy~~~~~~yW~Sgt~~~~~~~l~l~~dGnLvl~d~~~~~vWsS~t~- 223 (276)
T 3m7h_A 152 GSE--L---VQGVVYGAGASKLVFQGDG--NLVAYGPNGAATWNAGTQGKGAVRAVFQGDGNLVVYGAGNAVLWHSHTG- 223 (276)
T ss_dssp SEE--E---CTTCEEEETTEEEEECTTS--CEEEECTTSSEEEECCCTTTTCCEEEECTTSCEEEECTTSCEEEECSCT-
T ss_pred Ccc--c---ccCCCCCCceEEEeecCCc--eEEEEeCCCeEEEECCCCCCccEEEEEcCCCeEEEEeCCCcEEEEecCC-
Confidence 977 6 6789999999999999998 4666665679999999987653211111122233334333 44443332
Q ss_pred CCceeeEEEEECCCCcccc
Q 043278 230 EGVTSSVFLRIDPEGALSD 248 (752)
Q Consensus 230 ~~~~~~~~~~l~~~G~l~~ 248 (752)
+.. .++++|+.||+|+-
T Consensus 224 -~~~-~~rl~Ld~dGnLvl 240 (276)
T 3m7h_A 224 -GHA-SAVLRLQANGSIAI 240 (276)
T ss_dssp -TCT-TCEEEECTTSCEEE
T ss_pred -CCC-CEEEEEcCCccEEE
Confidence 222 24799999999864
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=337.50 Aligned_cols=200 Identities=25% Similarity=0.391 Sum_probs=166.6
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeeeC-----Ce
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHG-----EE 500 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 500 (752)
.++|.+.+.||+|+||.||+|+.. +++.||||++.... .....++.+|+.++.+++|+||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 468999999999999999999875 57889999997642 33456789999999999999999999998776 57
Q ss_pred eEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccce
Q 043278 501 RLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR 580 (752)
Q Consensus 501 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~ 580 (752)
.++||||++ ++|..++.. ...+++..+..++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 899999987 599888853 345999999999999999999999998 9999999999999999999999999998
Q ss_pred eecccccc--------------------cccccccccCCccChhhh-ccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 043278 581 IFEVNESE--------------------ANTKRIVGTYGYMSPEYA-MSGIVSIKTDVFSFGVLVLEIVSGQKNHT 635 (752)
Q Consensus 581 ~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~t~k~DV~S~G~vl~elltG~~p~~ 635 (752)
........ .......||+.|+|||++ ....++.++|||||||++|||++|..|+.
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 76533211 112456889999999986 45679999999999999999998655543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=345.87 Aligned_cols=251 Identities=25% Similarity=0.293 Sum_probs=204.0
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC---cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEE
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLV 504 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 504 (752)
.++|.+.+.||+|+||.||+++.. +++.||||++.... ......+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 467888999999999999999875 68899999986542 34567899999999999999999999999999999999
Q ss_pred EeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEe---cCCCCceeccccccee
Q 043278 505 YEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILL---DDKMNPKISDFGMARI 581 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll---~~~~~~kl~DFgla~~ 581 (752)
|||+.+++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 105 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 105 GEVYTGGELFDEIISR---KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp ECCCCSCBHHHHHHTC---SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 9999999999888643 45899999999999999999999998 9999999999999 5678999999999986
Q ss_pred ecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccc
Q 043278 582 FEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLEL 661 (752)
Q Consensus 582 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 661 (752)
..... ......||+.|+|||++.+ .++.++|||||||++|||++|+.||...... .....+..+.....
T Consensus 179 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~~i~~~~~~~~ 247 (484)
T 3nyv_A 179 FEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY-------DILKKVEKGKYTFE 247 (484)
T ss_dssp BCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCCCCC
T ss_pred ccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHcCCCCCC
Confidence 54322 2234578999999998876 6999999999999999999999999765421 11122222221100
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 662 IDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 662 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.+ ........+.+++.+||+.||.+|||+.|++++
T Consensus 248 -~~-----~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 248 -LP-----QWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp -SG-----GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -Cc-----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 00 011123457789999999999999999999875
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=336.96 Aligned_cols=199 Identities=23% Similarity=0.297 Sum_probs=172.0
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCcccHHHHHHHHHHHHhc------CCCCcceeeeeeeeCCee
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKL------QHTNLVRLLGCSLHGEER 501 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~~ 501 (752)
..+|++.++||+|+||.||+|... +++.||||++... .....++.+|+.++..+ +|+||+++++++...+..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 457889999999999999999865 5789999999754 23345678888888887 567999999999999999
Q ss_pred EEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCC--ceecccccc
Q 043278 502 LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMN--PKISDFGMA 579 (752)
Q Consensus 502 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~--~kl~DFgla 579 (752)
++||||++ ++|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++. +||+|||++
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEeccC-CCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence 99999997 68888886543 335899999999999999999999998 999999999999999887 999999999
Q ss_pred eeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 043278 580 RIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHH 638 (752)
Q Consensus 580 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~ 638 (752)
+..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 250 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 250 CYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp EETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 764321 223578999999999999999999999999999999999999997665
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=328.08 Aligned_cols=253 Identities=23% Similarity=0.343 Sum_probs=196.4
Q ss_pred HhcCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCC--cccHHHHHHHHHHHHhcC--CCCcceeeeeeeeCCeeEE
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQ--HTNLVRLLGCSLHGEERLL 503 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~l 503 (752)
..++|.+.+.||+|+||.||++...+++.||||++.... ......+.+|+.++.+++ |+||+++++++.+++..++
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 105 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence 457899999999999999999998889999999986542 334567899999999997 5999999999999999999
Q ss_pred EEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeec
Q 043278 504 VYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFE 583 (752)
Q Consensus 504 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~ 583 (752)
||| +.+++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||+++ +.+||+|||+++...
T Consensus 106 v~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 106 VME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQMQ 177 (313)
T ss_dssp EEC-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC--
T ss_pred EEe-cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeecccccccc
Confidence 999 6788999998653 35899999999999999999999998 999999999999965 889999999998765
Q ss_pred ccccccccccccccCCccChhhhcc-----------CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHH
Q 043278 584 VNESEANTKRIVGTYGYMSPEYAMS-----------GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQL 652 (752)
Q Consensus 584 ~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~ 652 (752)
............|++.|+|||.+.+ ..++.++||||||+++|||++|+.||..... ........
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~~~~~~~~ 252 (313)
T 3cek_A 178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAI 252 (313)
T ss_dssp ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHHH
T ss_pred CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH-----HHHHHHHH
Confidence 4333223334578999999999875 4788999999999999999999999965431 11122222
Q ss_pred hhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 653 LSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 653 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
........ .+......+.+++.+||+.||.+|||+.|+++.
T Consensus 253 ~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 253 IDPNHEIE---------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HCTTSCCC---------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HhcccccC---------CcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 22111111 111112457788899999999999999999875
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-37 Score=329.28 Aligned_cols=258 Identities=22% Similarity=0.298 Sum_probs=203.9
Q ss_pred cCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCCccc-----------------HHHHHHHHHHHHhcCCCCcceee
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQG-----------------IVEFKNEVRLIAKLQHTNLVRLL 492 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~-----------------~~~~~~E~~~l~~l~h~niv~l~ 492 (752)
++|.+.+.||+|+||.||+++. +++.||||++....... ...+.+|+.++.+++||||++++
T Consensus 31 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 109 (348)
T 2pml_X 31 NDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE 109 (348)
T ss_dssp TTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred CceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence 6888999999999999999999 89999999986542111 17899999999999999999999
Q ss_pred eeeeeCCeeEEEEeeCCCCCHhHH------HhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCcEeecCCCCCcEEe
Q 043278 493 GCSLHGEERLLVYEFMPNKSLDFF------LFNSGRKNVLNWEKRFIIIEGISQGLLYLHK-YSRLRVIHRDLKASNILL 565 (752)
Q Consensus 493 ~~~~~~~~~~lv~E~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~Dikp~NIll 565 (752)
+++.+.+..++||||+++++|.++ +.. .....+++..+..++.||+.||.|||+ .+ |+|+||||+|||+
T Consensus 110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~ 185 (348)
T 2pml_X 110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILM 185 (348)
T ss_dssp EEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEE
T ss_pred EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEE
Confidence 999999999999999999999988 432 124569999999999999999999999 77 9999999999999
Q ss_pred cCCCCceecccccceeecccccccccccccccCCccChhhhccC-CCCc-cchhHHHHHHHHHHHhCCCCCCCCCCCCCc
Q 043278 566 DDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSG-IVSI-KTDVFSFGVLVLEIVSGQKNHTRHHPDRPL 643 (752)
Q Consensus 566 ~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~-k~DV~S~G~vl~elltG~~p~~~~~~~~~~ 643 (752)
+.++.+||+|||++...... ......|+..|+|||.+.+. .++. ++||||||++++||++|+.||......
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--- 258 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL--- 258 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS---
T ss_pred cCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH---
Confidence 99999999999999875433 22345789999999999887 6766 999999999999999999999765431
Q ss_pred chHHHHHHHhhCCCcccccC------CCCC---CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 644 NLIGYAWQLLSDGKGLELID------PSLE---QPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 644 ~l~~~~~~~~~~~~~~~~~d------~~l~---~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
......+..+......+ +... ..........+.+++.+||+.||.+|||+.|++++
T Consensus 259 ---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 259 ---VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp ---HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ---HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11122222221110000 0000 00001223467789999999999999999999874
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=328.75 Aligned_cols=263 Identities=21% Similarity=0.309 Sum_probs=201.0
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeC-----Cee
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHG-----EER 501 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 501 (752)
.++|.+.+.||+|+||.||++... +++.||||++.... ......+.+|++++.+++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 468999999999999999999865 57889999997543 23346788999999999999999999998654 368
Q ss_pred EEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceeccccccee
Q 043278 502 LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARI 581 (752)
Q Consensus 502 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~ 581 (752)
++||||++ ++|..++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 106 ~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 99999998 588888853 34899999999999999999999998 99999999999999999999999999987
Q ss_pred eccccccc-ccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcc
Q 043278 582 FEVNESEA-NTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGL 659 (752)
Q Consensus 582 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 659 (752)
........ ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||........ .......+......
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~i~~~~~~~~~~ 254 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ---LNHILGILGSPSQE 254 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH---HHHHHHHHCSCCHH
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH---HHHHHHHhCCCCHH
Confidence 65432221 1234678999999998764 5589999999999999999999999976653321 11111111110000
Q ss_pred cc-----------c-CCCCCCCCCH-----HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 660 EL-----------I-DPSLEQPCSA-----NEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 660 ~~-----------~-d~~l~~~~~~-----~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.+ . ........+. .....+.+|+.+||+.||.+|||+.|++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 0 0000000011 112457789999999999999999999885
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=340.58 Aligned_cols=252 Identities=27% Similarity=0.331 Sum_probs=200.5
Q ss_pred HhcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCc-------------ccHHHHHHHHHHHHhcCCCCcceeee
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSG-------------QGIVEFKNEVRLIAKLQHTNLVRLLG 493 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~~ 493 (752)
..++|.+.++||+|+||+||+|+.. +++.||||++..... ....++.+|+.++.+++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3578999999999999999999875 578899999875421 33567899999999999999999999
Q ss_pred eeeeCCeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCC---C
Q 043278 494 CSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKM---N 570 (752)
Q Consensus 494 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~---~ 570 (752)
++.++...++||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR---HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence 999999999999999999999888653 34899999999999999999999998 99999999999998776 6
Q ss_pred ceecccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHH
Q 043278 571 PKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAW 650 (752)
Q Consensus 571 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~ 650 (752)
+||+|||+++...... ......||+.|+|||++. ..++.++||||+|+++|+|++|+.||...... ...
T Consensus 188 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~ 256 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ-------DII 256 (504)
T ss_dssp EEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHH
T ss_pred EEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH-------HHH
Confidence 9999999998765332 223457899999999876 56999999999999999999999999765421 111
Q ss_pred HHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 651 QLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 651 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
..+..+.... +..... .....+.+++.+|++.||.+|||+.|++++
T Consensus 257 ~~i~~~~~~~--~~~~~~----~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 257 KKVEKGKYYF--DFNDWK----NISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HHHHHCCCCC--CHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHcCCCCC--CccccC----CCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 2222221110 000000 112457789999999999999999999875
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-37 Score=337.88 Aligned_cols=259 Identities=24% Similarity=0.307 Sum_probs=192.5
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeC------CeeE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHG------EERL 502 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~ 502 (752)
.+|...+.||+|+||.||+|+.. +++.||||++..... .+.+|++++++++|+||+++++++... ...+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 35778899999999999999985 589999999865432 234799999999999999999988542 2367
Q ss_pred EEEeeCCCCCHhHHHhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCC-CCceecccccce
Q 043278 503 LVYEFMPNKSLDFFLFN-SGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDK-MNPKISDFGMAR 580 (752)
Q Consensus 503 lv~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~-~~~kl~DFgla~ 580 (752)
+||||+++ +|...+.. ......+++..+..++.||++||+|||+.+ |+||||||+||||+.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999986 45444432 223456999999999999999999999988 9999999999999965 568999999998
Q ss_pred eecccccccccccccccCCccChhhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhh-----
Q 043278 581 IFEVNESEANTKRIVGTYGYMSPEYAMSG-IVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLS----- 654 (752)
Q Consensus 581 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~----- 654 (752)
.+..... .....+|+.|+|||++.+. .++.++|||||||+||||++|+.||....... .+....+.+.
T Consensus 206 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~---~l~~i~~~lg~p~~~ 279 (420)
T 1j1b_A 206 QLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD---QLVEIIKVLGTPTRE 279 (420)
T ss_dssp ECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCSCCHH
T ss_pred hcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHH
Confidence 7543321 2235789999999999765 79999999999999999999999997654221 1111111111
Q ss_pred -----CCCcccccCCCCCCC-----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 655 -----DGKGLELIDPSLEQP-----CSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 655 -----~~~~~~~~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.....+..-+.+... ........+.+|+.+||+.||.+|||+.|++++
T Consensus 280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 011111111111110 011123567889999999999999999999875
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=320.74 Aligned_cols=251 Identities=24% Similarity=0.313 Sum_probs=201.9
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCc---------ccHHHHHHHHHHHHhcC-CCCcceeeeeeee
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSG---------QGIVEFKNEVRLIAKLQ-HTNLVRLLGCSLH 497 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~ 497 (752)
.++|.+.+.||+|+||.||++... +++.||||++..... .....+.+|+.++.+++ ||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 468889999999999999999875 578999999865431 22456789999999995 9999999999999
Q ss_pred CCeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccc
Q 043278 498 GEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFG 577 (752)
Q Consensus 498 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFg 577 (752)
++..++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred CCeEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEeccc
Confidence 99999999999999999998653 35899999999999999999999998 9999999999999999999999999
Q ss_pred cceeecccccccccccccccCCccChhhhc------cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHH
Q 043278 578 MARIFEVNESEANTKRIVGTYGYMSPEYAM------SGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQ 651 (752)
Q Consensus 578 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~ 651 (752)
++....... ......+++.|+|||.+. ...++.++||||||++++||++|+.||..... ... ..
T Consensus 170 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~-~~ 239 (298)
T 1phk_A 170 FSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ------MLM-LR 239 (298)
T ss_dssp TCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHH-HH
T ss_pred chhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH------HHH-HH
Confidence 998754322 123356899999999885 45789999999999999999999999865431 111 11
Q ss_pred HhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 043278 652 LLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVC 701 (752)
Q Consensus 652 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~ 701 (752)
.+..+... ...+ ........+.+++.+|++.||.+|||+.|+++
T Consensus 240 ~~~~~~~~-~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 240 MIMSGNYQ-FGSP-----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHTCCC-CCTT-----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHhcCCcc-cCcc-----cccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 22221111 0011 11122345778999999999999999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=337.91 Aligned_cols=263 Identities=18% Similarity=0.254 Sum_probs=195.4
Q ss_pred HHHhcCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeee-------
Q 043278 426 AAAANNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLH------- 497 (752)
Q Consensus 426 ~~~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------- 497 (752)
....++|.+.+.||+|+||.||+|+. .+++.||||++...... ..+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 34567899999999999999999986 56899999998654322 2479999999999999999999844
Q ss_pred -------------------------------CCeeEEEEeeCCCCCHhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHH
Q 043278 498 -------------------------------GEERLLVYEFMPNKSLDFFLFNS-GRKNVLNWEKRFIIIEGISQGLLYL 545 (752)
Q Consensus 498 -------------------------------~~~~~lv~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~L 545 (752)
....++||||++ ++|...+... .....+++..+..++.||++||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 234789999998 5777766531 2345699999999999999999999
Q ss_pred HhcCCCcEeecCCCCCcEEec-CCCCceecccccceeecccccccccccccccCCccChhhhccC-CCCccchhHHHHHH
Q 043278 546 HKYSRLRVIHRDLKASNILLD-DKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSG-IVSIKTDVFSFGVL 623 (752)
Q Consensus 546 H~~~~~~iiH~Dikp~NIll~-~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~G~v 623 (752)
|+.+ |+||||||+|||++ .++.+||+|||+++...... ......+|+.|+|||.+.+. .++.++||||+||+
T Consensus 158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 9988 99999999999998 68899999999998754332 12235679999999998875 59999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCC----------CcccccCCCCCCC-----CCHHHHHHHHHHHHHcccC
Q 043278 624 VLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDG----------KGLELIDPSLEQP-----CSANEVMRCIHVGLLCVQD 688 (752)
Q Consensus 624 l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~----------~~~~~~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~ 688 (752)
+|||++|+.||......+. .....+.+... ...+..-+.+... .+......+.+|+.+||+.
T Consensus 232 l~ell~g~~pf~~~~~~~~---~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 308 (383)
T 3eb0_A 232 FGELILGKPLFSGETSIDQ---LVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY 308 (383)
T ss_dssp HHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred HHHHHhCCCCCCCCChHHH---HHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence 9999999999976542211 11111111100 0001111111100 1111234577899999999
Q ss_pred CCCCCCCHHHHHHH
Q 043278 689 QAMDRPTMPEVVCM 702 (752)
Q Consensus 689 dp~~RPt~~ev~~~ 702 (752)
||.+|||+.|++++
T Consensus 309 dP~~R~t~~e~l~h 322 (383)
T 3eb0_A 309 EPDLRINPYEAMAH 322 (383)
T ss_dssp SGGGSCCHHHHHTS
T ss_pred ChhhCCCHHHHhcC
Confidence 99999999999865
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=322.97 Aligned_cols=267 Identities=23% Similarity=0.315 Sum_probs=195.3
Q ss_pred hcCCCcCCeeecCCcccEEEEEecC-CceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeee-----------
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLAD-EQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSL----------- 496 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----------- 496 (752)
.++|.+.+.||+|+||.||+|.... ++.||||++........+++.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 3678889999999999999999764 8899999998776666778999999999999999999998873
Q ss_pred ---eCCeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEec-CCCCce
Q 043278 497 ---HGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLD-DKMNPK 572 (752)
Q Consensus 497 ---~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~-~~~~~k 572 (752)
+....++||||++ |+|.+++. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++ +++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 4467899999998 69998884 345899999999999999999999998 99999999999997 567999
Q ss_pred ecccccceeeccccc-ccccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHH
Q 043278 573 ISDFGMARIFEVNES-EANTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAW 650 (752)
Q Consensus 573 l~DFgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~ 650 (752)
|+|||+++....... ........++..|+|||.+.. ..++.++||||||+++|||++|+.||....... ......
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~~~~ 238 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE---QMQLIL 238 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH---HHHHHH
Confidence 999999987543221 112233567899999998875 789999999999999999999999997654211 111100
Q ss_pred HHhhC----------CCcccccCCCCC-CCCCH-----HHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hhcC
Q 043278 651 QLLSD----------GKGLELIDPSLE-QPCSA-----NEVMRCIHVGLLCVQDQAMDRPTMPEVVCM--LQNE 706 (752)
Q Consensus 651 ~~~~~----------~~~~~~~d~~l~-~~~~~-----~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~--L~~~ 706 (752)
..... ......+..... ...+. .....+.+++.+|++.||.+|||+.|++++ ++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (320)
T 2i6l_A 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY 312 (320)
T ss_dssp HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTT
T ss_pred HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccc
Confidence 00000 000000000000 00000 123457789999999999999999999875 4443
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=324.85 Aligned_cols=253 Identities=22% Similarity=0.302 Sum_probs=196.2
Q ss_pred HhcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCc--------ccHHHHHHHHHHHHhcCCCCcceeeeeeeeC
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSG--------QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHG 498 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 498 (752)
..++|.+.+.||+|+||.||+|... +++.||||++..... .....+.+|+.++.+++||||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3468999999999999999999875 578999999865321 2234578999999999999999999998765
Q ss_pred CeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCC---ceecc
Q 043278 499 EERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMN---PKISD 575 (752)
Q Consensus 499 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~---~kl~D 575 (752)
+ .++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+|
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp S-EEEEEECCTTEETHHHHST---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred c-eEEEEecCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence 4 8999999999999998853 345899999999999999999999998 999999999999987654 99999
Q ss_pred cccceeecccccccccccccccCCccChhhhc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHH
Q 043278 576 FGMARIFEVNESEANTKRIVGTYGYMSPEYAM---SGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQL 652 (752)
Q Consensus 576 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~ 652 (752)
||+++...... ......||+.|+|||++. ...++.++||||||+++|||++|+.||........ +.. .
T Consensus 161 fg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~----~ 231 (322)
T 2ycf_A 161 FGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKD----Q 231 (322)
T ss_dssp CTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHH----H
T ss_pred Cccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHH----H
Confidence 99998754321 122356899999999874 56789999999999999999999999976543321 111 1
Q ss_pred hhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 653 LSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 653 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
+..+.... .+.... .....+.+++.+|++.||.+|||+.|++++
T Consensus 232 ~~~~~~~~--~~~~~~----~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 232 ITSGKYNF--IPEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp HHHTCCCC--CHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHhCcccc--Cchhhh----hcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 11111110 000000 112457789999999999999999999864
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=330.68 Aligned_cols=257 Identities=23% Similarity=0.308 Sum_probs=183.1
Q ss_pred hcCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeeeC------C
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHG------E 499 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 499 (752)
.++|.+.+.||+|+||.||+|.. .+|+.||||++.... ......+.+|+.++++++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 46899999999999999999986 468899999997542 23456788999999999999999999998654 5
Q ss_pred eeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccc
Q 043278 500 ERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMA 579 (752)
Q Consensus 500 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla 579 (752)
..++|+|++ +++|..++.. ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence 679999999 6888888743 45999999999999999999999998 999999999999999999999999999
Q ss_pred eeecccccccccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCc
Q 043278 580 RIFEVNESEANTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKG 658 (752)
Q Consensus 580 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 658 (752)
+..... .....||+.|+|||++.+ ..++.++|||||||+++||++|+.||....... ......+.+....
T Consensus 180 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~l~~i~~~~g~p~- 250 (367)
T 2fst_X 180 RHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID---QLKLILRLVGTPG- 250 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCC-
T ss_pred cccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCC-
Confidence 864321 234578999999999887 689999999999999999999999997654221 1111111111100
Q ss_pred ccccCC-----------CC--CCCCCHH-----HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 659 LELIDP-----------SL--EQPCSAN-----EVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 659 ~~~~d~-----------~l--~~~~~~~-----~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.+.+.. .+ ....... ....+.+|+.+||+.||.+|||+.|++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 251 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 000000 00 0001111 12457789999999999999999999886
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=329.40 Aligned_cols=261 Identities=24% Similarity=0.258 Sum_probs=190.8
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCC------e
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGE------E 500 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~ 500 (752)
++|.+.+.||+|+||.||+|... +++.||||++.... ......+.+|+.+++.++||||+++++++...+ .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 67889999999999999999864 58899999997542 234456889999999999999999999987654 7
Q ss_pred eEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccce
Q 043278 501 RLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR 580 (752)
Q Consensus 501 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~ 580 (752)
.++||||+++ +|.+.+. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 105 ~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 105 VYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 175 (371)
T ss_dssp EEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred eEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeeccc
Confidence 8999999985 6777763 23899999999999999999999998 9999999999999999999999999998
Q ss_pred eecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchH--------------
Q 043278 581 IFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLI-------------- 646 (752)
Q Consensus 581 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~-------------- 646 (752)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+
T Consensus 176 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 252 (371)
T 2xrw_A 176 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 252 (371)
T ss_dssp -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTT
T ss_pred cccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 654221 223457899999999999999999999999999999999999999765421100000
Q ss_pred --HHHHHHhhCC-Ccc----cccCCCCCCCC----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 647 --GYAWQLLSDG-KGL----ELIDPSLEQPC----SANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 647 --~~~~~~~~~~-~~~----~~~d~~l~~~~----~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.......... ... +.+-+....+. .......+.+|+.+||+.||.+|||++|++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp SCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 0000000000 000 00000000000 11224578899999999999999999999886
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=329.36 Aligned_cols=269 Identities=20% Similarity=0.236 Sum_probs=190.9
Q ss_pred HHHHHhcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCe--
Q 043278 424 TIAAAANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEE-- 500 (752)
Q Consensus 424 ~i~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-- 500 (752)
+.....++|.+.+.||+|+||.||+|+.. +++.||||++..... ....+.+|++.+..++||||+++++++.....
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 44566789999999999999999999974 588999999865432 23456788888999999999999999865433
Q ss_pred -----eEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCcEeecCCCCCcEEecC-CCCce
Q 043278 501 -----RLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLH--KYSRLRVIHRDLKASNILLDD-KMNPK 572 (752)
Q Consensus 501 -----~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--~~~~~~iiH~Dikp~NIll~~-~~~~k 572 (752)
.++||||++++.+..+.........+++..+..++.||+.||.||| +.+ |+||||||+|||++. ++.+|
T Consensus 96 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~k 172 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLK 172 (360)
T ss_dssp TTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEE
T ss_pred ccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEE
Confidence 7899999987544333332344566899999999999999999999 777 999999999999996 89999
Q ss_pred ecccccceeecccccccccccccccCCccChhhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHH
Q 043278 573 ISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSG-IVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQ 651 (752)
Q Consensus 573 l~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~ 651 (752)
|+|||+++....... .....||+.|+|||++.+. .++.++||||||+++|||++|+.||........ .....+
T Consensus 173 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~---~~~~~~ 246 (360)
T 3e3p_A 173 LCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ---LHEIVR 246 (360)
T ss_dssp ECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHH
T ss_pred EeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH---HHHHHH
Confidence 999999986553321 2235689999999998765 489999999999999999999999976542211 111111
Q ss_pred HhhC-----------C-CcccccCCC------CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 652 LLSD-----------G-KGLELIDPS------LEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 652 ~~~~-----------~-~~~~~~d~~------l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.... . ......+.. ............+.+|+.+||+.||.+|||+.|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 247 VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 1100 0 000000000 0011112234578899999999999999999999875
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=331.90 Aligned_cols=267 Identities=22% Similarity=0.346 Sum_probs=182.9
Q ss_pred cCCCc-CCeeecCCcccEEEEEec---CCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeee--CCeeEE
Q 043278 430 NNFST-TNKLGEGGFGPVYKGKLA---DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLH--GEERLL 503 (752)
Q Consensus 430 ~~~~~-~~~LG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 503 (752)
+.|.+ .++||+|+||.||+|+.. +++.||||++..... ...+.+|+.++.+++||||+++++++.. +...++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 34554 468999999999999965 478899999975432 3467899999999999999999999954 678899
Q ss_pred EEeeCCCCCHhHHHhhc------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEe----cCCCCcee
Q 043278 504 VYEFMPNKSLDFFLFNS------GRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILL----DDKMNPKI 573 (752)
Q Consensus 504 v~E~~~~gsL~~~l~~~------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll----~~~~~~kl 573 (752)
||||+++ +|..++... .....+++..+..++.||+.||+|||+.+ |+||||||+|||| +.++.+||
T Consensus 98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence 9999975 666666421 12234899999999999999999999998 9999999999999 77899999
Q ss_pred cccccceeeccccc-ccccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCC----C--cch
Q 043278 574 SDFGMARIFEVNES-EANTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDR----P--LNL 645 (752)
Q Consensus 574 ~DFgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~----~--~~l 645 (752)
+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... . ...
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 253 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence 99999987653321 122334678999999999987 459999999999999999999999997654321 0 111
Q ss_pred HHHHHHHhhCCCc---ccc------------cCCCCCCCCCHH---------HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 043278 646 IGYAWQLLSDGKG---LEL------------IDPSLEQPCSAN---------EVMRCIHVGLLCVQDQAMDRPTMPEVVC 701 (752)
Q Consensus 646 ~~~~~~~~~~~~~---~~~------------~d~~l~~~~~~~---------~~~~l~~l~~~Cl~~dp~~RPt~~ev~~ 701 (752)
+......+..... ..+ +........... ....+.+|+.+||+.||.+|||++|+++
T Consensus 254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1111111111000 000 000000000000 0235678999999999999999999998
Q ss_pred H
Q 043278 702 M 702 (752)
Q Consensus 702 ~ 702 (752)
+
T Consensus 334 h 334 (405)
T 3rgf_A 334 D 334 (405)
T ss_dssp S
T ss_pred C
Confidence 6
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=351.68 Aligned_cols=256 Identities=23% Similarity=0.314 Sum_probs=202.3
Q ss_pred HhcCCCcCCeeecCCcccEEEEEecC----CceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeE
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGKLAD----EQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERL 502 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 502 (752)
..++|.+.+.||+|+||.||+|.... +..||||++.... ......+.+|+.++.+++||||+++++++. ++..+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 34678888999999999999998743 4569999987643 334467899999999999999999999985 45689
Q ss_pred EEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceee
Q 043278 503 LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIF 582 (752)
Q Consensus 503 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~ 582 (752)
+||||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 467 lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp EEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred EEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 999999999999999653 335899999999999999999999998 999999999999999999999999999876
Q ss_pred cccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccc
Q 043278 583 EVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLEL 661 (752)
Q Consensus 583 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 661 (752)
...... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... .....+..+....+
T Consensus 542 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~-------~~~~~i~~~~~~~~ 613 (656)
T 2j0j_A 542 EDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-------DVIGRIENGERLPM 613 (656)
T ss_dssp CC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHHHHHHTCCCCC
T ss_pred CCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH-------HHHHHHHcCCCCCC
Confidence 433221 1223456789999999999999999999999999999997 99998765421 11122222221111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 662 IDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 662 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
+......+.+++.+||+.||.+|||+.|+++.|+.+
T Consensus 614 ---------~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 614 ---------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp ---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------CccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 111234577899999999999999999999999764
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=325.78 Aligned_cols=260 Identities=22% Similarity=0.275 Sum_probs=202.1
Q ss_pred hcCCCcCCeeecCCcccEEEEEe--cCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCC------CcceeeeeeeeCCe
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKL--ADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHT------NLVRLLGCSLHGEE 500 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~--~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~------niv~l~~~~~~~~~ 500 (752)
.++|.+.+.||+|+||.||++.. .+++.||||+++.. ......+.+|+.++.+++|+ +++++++++.+.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 35788999999999999999986 36789999999654 33456788999999998765 49999999999999
Q ss_pred eEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecC-------------
Q 043278 501 RLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDD------------- 567 (752)
Q Consensus 501 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~------------- 567 (752)
.++||||+ +++|.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence 99999999 889988886543 245899999999999999999999998 999999999999987
Q ss_pred ------CCCceecccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCC
Q 043278 568 ------KMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDR 641 (752)
Q Consensus 568 ------~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~ 641 (752)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred ccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 678999999999864322 234578999999999999999999999999999999999999997654221
Q ss_pred CcchHHHHHHHhhC--------CCccccc-CCCC---------------------CCCCCHHHHHHHHHHHHHcccCCCC
Q 043278 642 PLNLIGYAWQLLSD--------GKGLELI-DPSL---------------------EQPCSANEVMRCIHVGLLCVQDQAM 691 (752)
Q Consensus 642 ~~~l~~~~~~~~~~--------~~~~~~~-d~~l---------------------~~~~~~~~~~~l~~l~~~Cl~~dp~ 691 (752)
.. ......... ....... .... ...........+.+++.+||+.||.
T Consensus 242 ~~---~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 318 (339)
T 1z57_A 242 HL---AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPA 318 (339)
T ss_dssp HH---HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred HH---HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcc
Confidence 11 111111100 0000000 0000 0112334556788999999999999
Q ss_pred CCCCHHHHHHH
Q 043278 692 DRPTMPEVVCM 702 (752)
Q Consensus 692 ~RPt~~ev~~~ 702 (752)
+|||+.|++++
T Consensus 319 ~Rpt~~ell~h 329 (339)
T 1z57_A 319 KRITLREALKH 329 (339)
T ss_dssp TSCCHHHHTTS
T ss_pred cccCHHHHhcC
Confidence 99999999864
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=325.18 Aligned_cols=264 Identities=22% Similarity=0.319 Sum_probs=199.2
Q ss_pred HhcCCCcCCeeecCCcccEEEEEe--cCCceeEEEEcccCCc--ccHHHHHHHHHHHHhc---CCCCcceeeeeee----
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGKL--ADEQEVAIKRLSRSSG--QGIVEFKNEVRLIAKL---QHTNLVRLLGCSL---- 496 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~~--~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~---- 496 (752)
..++|.+.+.||+|+||.||+++. .+++.||+|++..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999997 4678899999864321 1223456777777666 8999999999987
Q ss_pred -eCCeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecc
Q 043278 497 -HGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISD 575 (752)
Q Consensus 497 -~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~D 575 (752)
.....++||||++ |+|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 5567899999998 69999886543 335899999999999999999999998 99999999999999999999999
Q ss_pred cccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhC
Q 043278 576 FGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSD 655 (752)
Q Consensus 576 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 655 (752)
||+++...... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||...... ............
T Consensus 164 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~ 237 (326)
T 1blx_A 164 FGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV---DQLGKILDVIGL 237 (326)
T ss_dssp CCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCC
T ss_pred CcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHHHcCC
Confidence 99998654322 223457899999999999999999999999999999999999999765421 111111111111
Q ss_pred CCcccc----------cCC---CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 656 GKGLEL----------IDP---SLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 656 ~~~~~~----------~d~---~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
...... ... .............+.+++.+||+.||.+|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000000 000 00000111123456789999999999999999999864
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-37 Score=330.37 Aligned_cols=263 Identities=21% Similarity=0.302 Sum_probs=197.9
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeC-----Cee
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHG-----EER 501 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 501 (752)
.++|.+.+.||+|+||.||+|+.. +++.||||++.... .....++.+|+.++.+++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 467888999999999999999875 58899999996543 23345678999999999999999999987654 678
Q ss_pred EEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceeccccccee
Q 043278 502 LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARI 581 (752)
Q Consensus 502 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~ 581 (752)
++||||++ ++|..++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 90 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 99999997 689888854 35899999999999999999999998 99999999999999999999999999987
Q ss_pred eccccccc--------ccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHH
Q 043278 582 FEVNESEA--------NTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQL 652 (752)
Q Consensus 582 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~ 652 (752)
........ ......||+.|+|||++.. ..++.++||||||+++|||++|+.||........ .......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~ 238 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ---LLLIFGI 238 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHH
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHHH
Confidence 65322111 1123578999999998765 7899999999999999999999999976542110 1111111
Q ss_pred hhCCCccc---c---------cCC-CCCCCCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 653 LSDGKGLE---L---------IDP-SLEQPCS-----ANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 653 ~~~~~~~~---~---------~d~-~l~~~~~-----~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
........ . +.. ....... ......+.+++.+||+.||.+|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 11000000 0 000 0000000 0122456789999999999999999999885
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=325.08 Aligned_cols=201 Identities=25% Similarity=0.349 Sum_probs=170.0
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCcccHHHHHHHHHHHHhcC-CC-----CcceeeeeeeeCCee
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQ-HT-----NLVRLLGCSLHGEER 501 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~~~ 501 (752)
.++|.+.+.||+|+||+||+|... +++.||||++... .....++..|+.++..++ |+ +|+++++++...+..
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 131 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL 131 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence 468999999999999999999865 5788999999753 234556788999988885 44 499999999999999
Q ss_pred EEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEec--CCCCceecccccc
Q 043278 502 LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLD--DKMNPKISDFGMA 579 (752)
Q Consensus 502 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~--~~~~~kl~DFgla 579 (752)
++||||++ ++|.+++.... ...+++..+..++.||+.||.|||.+. .+|+||||||+||||+ .++.+||+|||++
T Consensus 132 ~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a 208 (382)
T 2vx3_A 132 CLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208 (382)
T ss_dssp EEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence 99999996 59988886543 245899999999999999999999521 2399999999999994 5788999999999
Q ss_pred eeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 043278 580 RIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHH 638 (752)
Q Consensus 580 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~ 638 (752)
+..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 209 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 209 CQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp EETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 875422 224578999999999999999999999999999999999999998654
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=321.27 Aligned_cols=262 Identities=21% Similarity=0.267 Sum_probs=198.9
Q ss_pred cCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCCcccHHHHHHHHHHHHhcC-----------CCCcceeeeeeee
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQ-----------HTNLVRLLGCSLH 497 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~ 497 (752)
++|.+.+.||+|+||.||+|+. .+++.||||++... ......+.+|+.++.+++ |+||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 5788899999999999999986 46889999999743 234566889999999886 8899999999876
Q ss_pred CC----eeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEeecCCCCCcEEec------
Q 043278 498 GE----ERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY-SRLRVIHRDLKASNILLD------ 566 (752)
Q Consensus 498 ~~----~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiH~Dikp~NIll~------ 566 (752)
.+ ..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||++ + |+||||||+|||++
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTT
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCc
Confidence 54 789999999 899999886543 34589999999999999999999998 7 99999999999994
Q ss_pred CCCCceecccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchH
Q 043278 567 DKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLI 646 (752)
Q Consensus 567 ~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~ 646 (752)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||............
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred CcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 4457999999999865422 22357899999999999999999999999999999999999999866533221111
Q ss_pred HHH---HHHhhC--------C----------CcccccCC-C---------CCCCCCHHHHHHHHHHHHHcccCCCCCCCC
Q 043278 647 GYA---WQLLSD--------G----------KGLELIDP-S---------LEQPCSANEVMRCIHVGLLCVQDQAMDRPT 695 (752)
Q Consensus 647 ~~~---~~~~~~--------~----------~~~~~~d~-~---------l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt 695 (752)
... ...+.. + .....+.. . -....+......+.+|+.+||+.||.+|||
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 111 111100 0 00000000 0 011234566778889999999999999999
Q ss_pred HHHHHHH
Q 043278 696 MPEVVCM 702 (752)
Q Consensus 696 ~~ev~~~ 702 (752)
+.|++++
T Consensus 328 ~~ell~h 334 (373)
T 1q8y_A 328 AGGLVNH 334 (373)
T ss_dssp HHHHHTC
T ss_pred HHHHhhC
Confidence 9999885
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=322.48 Aligned_cols=255 Identities=23% Similarity=0.326 Sum_probs=177.5
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCc-ccHHHHHHHHH-HHHhcCCCCcceeeeeeeeCCeeEEEEe
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSG-QGIVEFKNEVR-LIAKLQHTNLVRLLGCSLHGEERLLVYE 506 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~E 506 (752)
++|...+.||+|+||.||++... +++.||||++..... ....++..|+. +++.++||||+++++++.+.+..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 67888899999999999999975 688999999976532 23345556665 6777899999999999999999999999
Q ss_pred eCCCCCHhHHHhh--cCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEeecCCCCCcEEecCCCCceecccccceeec
Q 043278 507 FMPNKSLDFFLFN--SGRKNVLNWEKRFIIIEGISQGLLYLHKY-SRLRVIHRDLKASNILLDDKMNPKISDFGMARIFE 583 (752)
Q Consensus 507 ~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~ 583 (752)
|+++ +|.+++.. ......+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+++...
T Consensus 102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 9985 77776643 12245689999999999999999999998 7 9999999999999999999999999998654
Q ss_pred ccccccccccccccCCccChhhh----ccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcc
Q 043278 584 VNESEANTKRIVGTYGYMSPEYA----MSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGL 659 (752)
Q Consensus 584 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 659 (752)
... ......|++.|+|||.+ .+..++.++||||||+++|||++|+.||......... ......+..
T Consensus 178 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~~~~~~~~- 247 (327)
T 3aln_A 178 DSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ------LTQVVKGDP- 247 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CCCCCSCC-
T ss_pred ccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH------HHHHhcCCC-
Confidence 322 12234689999999998 4567899999999999999999999999754321100 000011111
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 660 ELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 660 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
+.+...........+.+++.+||+.||.+|||+.|+++.
T Consensus 248 ----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 248 ----PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp ----CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred ----CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 111111111223457789999999999999999999764
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=325.99 Aligned_cols=256 Identities=23% Similarity=0.300 Sum_probs=194.6
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCee----
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEER---- 501 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---- 501 (752)
.++|...+.||+|+||.||+|... +++.||||++.... .....++.+|+.++++++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 368888999999999999999864 58899999997643 23356788999999999999999999999877654
Q ss_pred --EEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccc
Q 043278 502 --LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMA 579 (752)
Q Consensus 502 --~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla 579 (752)
++||||++ ++|..++. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred eEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 99999998 67877762 23899999999999999999999998 999999999999999999999999999
Q ss_pred eeecccccccccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCc
Q 043278 580 RIFEVNESEANTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKG 658 (752)
Q Consensus 580 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 658 (752)
+..... .....||+.|+|||.+.+ ..++.++||||||++++||++|+.||....... ............ .
T Consensus 192 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~-~ 262 (371)
T 4exu_A 192 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQILKVTGVP-G 262 (371)
T ss_dssp -------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCC-C
T ss_pred cccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCC-c
Confidence 864322 223578999999999987 789999999999999999999999997654211 111111110000 0
Q ss_pred cccc---------------CCCCCCC---CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 659 LELI---------------DPSLEQP---CSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 659 ~~~~---------------d~~l~~~---~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.+.. ....... ........+.+|+.+||+.||.+|||+.|++++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 263 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0000 0000000 000113467789999999999999999999876
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-36 Score=315.35 Aligned_cols=253 Identities=24% Similarity=0.357 Sum_probs=192.1
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeee----------
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLH---------- 497 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------- 497 (752)
.++|++.+.||+|+||.||+|+.. +++.||||++... ......+.+|+.++.+++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 467889999999999999999874 6889999999643 3345678999999999999999999998765
Q ss_pred ---CCeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceec
Q 043278 498 ---GEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKIS 574 (752)
Q Consensus 498 ---~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~ 574 (752)
.+..++||||+++++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence 35678999999999999999653 345788999999999999999999998 9999999999999999999999
Q ss_pred ccccceeeccccc------------ccccccccccCCccChhhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCC
Q 043278 575 DFGMARIFEVNES------------EANTKRIVGTYGYMSPEYAMSG-IVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDR 641 (752)
Q Consensus 575 DFgla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~ 641 (752)
|||+++....... ........|++.|+|||.+.+. .++.++||||||+++|||++ |+....
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~--- 232 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM--- 232 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH---
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch---
Confidence 9999986542210 1122345689999999999864 78999999999999999998 332110
Q ss_pred CcchHHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 642 PLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 642 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
. .......+.... ..+....+......+.+++.+|++.||.+|||+.|++++
T Consensus 233 --~-~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 233 --E-RVNILKKLRSVS------IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp --H-HHHHHHHHHSTT------CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred --h-HHHHHHhccccc------cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 1 111112222211 111111222333456789999999999999999999884
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-36 Score=312.47 Aligned_cols=253 Identities=26% Similarity=0.339 Sum_probs=202.3
Q ss_pred HHhcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEE
Q 043278 427 AAANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLL 503 (752)
Q Consensus 427 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 503 (752)
...++|.+.+.||+|+||.||+++.. +++.||||++.... ......+.+|+.++.+++||||+++++++.+.+..++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34578999999999999999999875 68899999986542 3456788999999999999999999999999999999
Q ss_pred EEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCC---CCceecccccce
Q 043278 504 VYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDK---MNPKISDFGMAR 580 (752)
Q Consensus 504 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~---~~~kl~DFgla~ 580 (752)
||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+|+||||+||+++.+ +.+||+|||++.
T Consensus 99 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 99 VGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEEccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 99999999998888653 34899999999999999999999998 9999999999999754 469999999998
Q ss_pred eecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCccc
Q 043278 581 IFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLE 660 (752)
Q Consensus 581 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 660 (752)
...... ......+++.|+|||.+.+ .++.++||||||++++||++|+.||...... . ....+..+....
T Consensus 173 ~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~-~~~~~~~~~~~~ 241 (287)
T 2wei_A 173 CFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY------D-ILKRVETGKYAF 241 (287)
T ss_dssp TBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHHCCCCC
T ss_pred eecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH------H-HHHHHHcCCCCC
Confidence 654322 1223468899999998875 4899999999999999999999998764311 1 112222222110
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 661 LIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 661 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.. +. .......+.+++.+|++.||.+|||+.|+++.
T Consensus 242 ~~-~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 242 DL-PQ-----WRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp CS-GG-----GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred Cc-hh-----hhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 00 00 01112357789999999999999999999874
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=333.72 Aligned_cols=253 Identities=21% Similarity=0.269 Sum_probs=188.1
Q ss_pred CCCcCCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhc-CCCCcceeeeeeeeCCeeEEEEeeCC
Q 043278 431 NFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGEERLLVYEFMP 509 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~ 509 (752)
.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+.++.++ +||||+++++++.+++..+|||||++
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 44556889999999998777678999999998653 345678999999886 89999999999999999999999996
Q ss_pred CCCHhHHHhhcCCCC----CCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCC-------------CCce
Q 043278 510 NKSLDFFLFNSGRKN----VLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDK-------------MNPK 572 (752)
Q Consensus 510 ~gsL~~~l~~~~~~~----~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~-------------~~~k 572 (752)
|+|.+++....... ...+..++.++.||+.||+|||+.+ |+||||||+||||+.+ +.+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 69999986543211 1133346789999999999999998 9999999999999654 4799
Q ss_pred ecccccceeeccccccc--ccccccccCCccChhhhcc-------CCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCC
Q 043278 573 ISDFGMARIFEVNESEA--NTKRIVGTYGYMSPEYAMS-------GIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRP 642 (752)
Q Consensus 573 l~DFgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~ 642 (752)
|+|||+++......... ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.......
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~- 247 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE- 247 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-
Confidence 99999999765433221 2234679999999999976 678999999999999999999 899986543210
Q ss_pred cchHHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 643 LNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 643 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
...+..... .+.+...........+.+++.+|++.||.+|||+.||+++
T Consensus 248 -------~~i~~~~~~----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 248 -------SNIIRGIFS----LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp -------HHHHHTCCC----CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -------HHHhcCCCC----cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 111111100 0111122344556778899999999999999999999863
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-36 Score=320.83 Aligned_cols=253 Identities=19% Similarity=0.200 Sum_probs=172.6
Q ss_pred hcCCCcCC-eeecCCcccEEEEEec-CCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeee----CCeeE
Q 043278 429 ANNFSTTN-KLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLH----GEERL 502 (752)
Q Consensus 429 ~~~~~~~~-~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~ 502 (752)
.++|.+.+ .||+|+||.||+++.. +++.||||++... .....+....+..++|+||+++++++.. +...+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 46788754 6999999999999876 6899999998653 2222333445667799999999999876 44589
Q ss_pred EEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecC---CCCceecccccc
Q 043278 503 LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDD---KMNPKISDFGMA 579 (752)
Q Consensus 503 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~---~~~~kl~DFgla 579 (752)
+||||+++|+|.+++.... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 103 lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 9999999999999996542 346999999999999999999999998 999999999999976 455999999999
Q ss_pred eeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcc
Q 043278 580 RIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGL 659 (752)
Q Consensus 580 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 659 (752)
+...... .....+|+.|+|||++.+..++.++||||||+++|||++|+.||............ ......+. .
T Consensus 179 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~~-~ 250 (336)
T 3fhr_A 179 KETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM---KRRIRLGQ-Y 250 (336)
T ss_dssp EEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred eeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH---HHhhhccc-c
Confidence 8654221 22356799999999999889999999999999999999999999765433211000 00010000 0
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 660 ELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 660 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
... .+........+.+++.+|++.||.+|||+.|++++
T Consensus 251 ~~~-----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 251 GFP-----NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp CCC-----TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ccC-----chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000 01111223457789999999999999999999984
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=324.95 Aligned_cols=255 Identities=22% Similarity=0.271 Sum_probs=194.1
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCe------
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEE------ 500 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------ 500 (752)
++|...+.||+|+||.||+|... +|+.||||++.... .....++.+|+.++.+++||||+++++++...+.
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 57888899999999999999874 58899999997643 2234678899999999999999999999987654
Q ss_pred eEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccce
Q 043278 501 RLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR 580 (752)
Q Consensus 501 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~ 580 (752)
.++||||++ ++|..++. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp CEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred EEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeeccccc
Confidence 499999998 58877662 24899999999999999999999998 9999999999999999999999999997
Q ss_pred eecccccccccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCC---
Q 043278 581 IFEVNESEANTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDG--- 656 (752)
Q Consensus 581 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~--- 656 (752)
..... .....+|+.|+|||.+.+ ..++.++||||||++++||++|+.||....... ............
T Consensus 175 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~ 246 (353)
T 3coi_A 175 HADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQILKVTGVPGTE 246 (353)
T ss_dssp C-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH---HHHHHHHHHCBCCHH
T ss_pred CCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHH
Confidence 64322 223578999999999887 688999999999999999999999997654211 111111110000
Q ss_pred ---------------CcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 657 ---------------KGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 657 ---------------~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.......+.+. .........+.+++.+|++.||.+|||+.|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 247 FVQKLNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHTTCSCHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHhhHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00000000110 1111223467789999999999999999999875
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=315.50 Aligned_cols=244 Identities=26% Similarity=0.404 Sum_probs=190.4
Q ss_pred HHHhcCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCCcc------cHHHHHHHHHHHHhc----CCCCcceeeee
Q 043278 426 AAAANNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSSGQ------GIVEFKNEVRLIAKL----QHTNLVRLLGC 494 (752)
Q Consensus 426 ~~~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l----~h~niv~l~~~ 494 (752)
....++|.+.+.||+|+||.||+|+. .+++.||||++...... ....+.+|+.++.++ +|+||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 34567899999999999999999986 46889999999765322 223456799999998 89999999999
Q ss_pred eeeCCeeEEEEee-CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEec-CCCCce
Q 043278 495 SLHGEERLLVYEF-MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLD-DKMNPK 572 (752)
Q Consensus 495 ~~~~~~~~lv~E~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~-~~~~~k 572 (752)
+...+..++|+|+ +++++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++ +++.+|
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEK---GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEE
Confidence 9999999999999 7999999998653 34899999999999999999999998 99999999999999 889999
Q ss_pred ecccccceeecccccccccccccccCCccChhhhccCCCC-ccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHH
Q 043278 573 ISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVS-IKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQ 651 (752)
Q Consensus 573 l~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t-~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~ 651 (752)
|+|||+++...... .....|+..|+|||++.+..+. .++||||||+++|||++|+.||.... .
T Consensus 181 l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------------~ 244 (312)
T 2iwi_A 181 LIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------------E 244 (312)
T ss_dssp ECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------H
T ss_pred EEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------------H
Confidence 99999998765322 2235689999999999877664 59999999999999999999986421 0
Q ss_pred HhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 652 LLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 652 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.... .. .+ +......+.+++.+|++.||++|||+.|++++
T Consensus 245 ~~~~-~~------~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 245 ILEA-EL------HF----PAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp HHHT-CC------CC----CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred Hhhh-cc------CC----cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111 00 01 11122356789999999999999999999985
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=327.52 Aligned_cols=251 Identities=22% Similarity=0.333 Sum_probs=187.3
Q ss_pred hcCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhc-CCCCcceeeeeeeeCCeeEEEEee
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
..+|...+.||+|+||+|+.....+++.||||++...... .+.+|+.++.++ +||||+++++++.+....+|||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 3568888999999999977665668899999999754332 346899999999 899999999999999999999999
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecC-----CCCceecccccceee
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDD-----KMNPKISDFGMARIF 582 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~-----~~~~kl~DFgla~~~ 582 (752)
++ |+|.+++.... ..+....++.++.||+.||+|||+.+ |+||||||+||||+. ...+||+|||+++..
T Consensus 100 ~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 100 CA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp CS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred CC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 97 69999886543 22444566789999999999999998 999999999999943 345789999999876
Q ss_pred ccccc-ccccccccccCCccChhhhc---cCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCC
Q 043278 583 EVNES-EANTKRIVGTYGYMSPEYAM---SGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGK 657 (752)
Q Consensus 583 ~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 657 (752)
..... ........||+.|+|||++. ...++.++|||||||++|||++ |+.||...... .. .......
T Consensus 174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~-------~~-~~~~~~~ 245 (432)
T 3p23_A 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR-------QA-NILLGAC 245 (432)
T ss_dssp ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH-------HH-HHHTTCC
T ss_pred cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH-------HH-HHHhccC
Confidence 53321 12233467999999999997 4677889999999999999999 88888543311 11 1111111
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 658 GLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 658 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
...... ........+.+|+.+||+.||.+|||+.||+++
T Consensus 246 ~~~~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 246 SLDCLH------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp CCTTSC------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CccccC------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 111111 122334456789999999999999999999853
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=317.06 Aligned_cols=259 Identities=20% Similarity=0.240 Sum_probs=198.1
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CC-ceeEEEEcccCCcccHHHHHHHHHHHHhcCCCC------cceeeeeeeeCCee
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DE-QEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTN------LVRLLGCSLHGEER 501 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~-~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~~ 501 (752)
++|.+.+.||+|+||.||++... .+ +.||||+++.. ......+.+|+.++.+++|++ ++.+++++...+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 68889999999999999999874 34 68999999653 334567889999999997665 89999999999999
Q ss_pred EEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEe----------------
Q 043278 502 LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILL---------------- 565 (752)
Q Consensus 502 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll---------------- 565 (752)
++||||+ +++|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||+
T Consensus 98 ~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 98 CIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp EEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred EEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccccc
Confidence 9999999 55665666543 2245899999999999999999999988 9999999999999
Q ss_pred ---cCCCCceecccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCC
Q 043278 566 ---DDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRP 642 (752)
Q Consensus 566 ---~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~ 642 (752)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||........
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH 247 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 67889999999999864322 2245789999999999999999999999999999999999999976542211
Q ss_pred cchHHHHHHHhhC--------CCccc-ccCCCC---------------------CCCCCHHHHHHHHHHHHHcccCCCCC
Q 043278 643 LNLIGYAWQLLSD--------GKGLE-LIDPSL---------------------EQPCSANEVMRCIHVGLLCVQDQAMD 692 (752)
Q Consensus 643 ~~l~~~~~~~~~~--------~~~~~-~~d~~l---------------------~~~~~~~~~~~l~~l~~~Cl~~dp~~ 692 (752)
.......... ..... ...... ...........+.+|+.+||+.||.+
T Consensus 248 ---~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 324 (355)
T 2eu9_A 248 ---LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ 324 (355)
T ss_dssp ---HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred ---HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence 1111111100 00000 000000 01112334557889999999999999
Q ss_pred CCCHHHHHHH
Q 043278 693 RPTMPEVVCM 702 (752)
Q Consensus 693 RPt~~ev~~~ 702 (752)
|||+.|++++
T Consensus 325 Rpt~~e~l~h 334 (355)
T 2eu9_A 325 RITLAEALLH 334 (355)
T ss_dssp SCCHHHHTTS
T ss_pred CcCHHHHhcC
Confidence 9999999864
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=311.04 Aligned_cols=251 Identities=22% Similarity=0.311 Sum_probs=178.6
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCcc-c-HHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEe
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQ-G-IVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYE 506 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~-~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 506 (752)
++|+..+.||+|+||.||+++.. +++.||||++...... . ...+.++..++..++||||+++++++.+++..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e 104 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME 104 (318)
T ss_dssp GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence 57888899999999999999975 6889999999765322 2 2334455567888899999999999999999999999
Q ss_pred eCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEeecCCCCCcEEecCCCCceecccccceeeccc
Q 043278 507 FMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY-SRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVN 585 (752)
Q Consensus 507 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~ 585 (752)
|+ ++.+..+.... ...+++..+..++.||+.||.|||+. + |+|+||||+|||++.++.+||+|||++......
T Consensus 105 ~~-~~~~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 105 LM-GTCAEKLKKRM--QGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp CC-SEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred cc-CCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 99 45555544322 34589999999999999999999985 7 999999999999999999999999999765432
Q ss_pred ccccccccccccCCccChhhhc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCccc
Q 043278 586 ESEANTKRIVGTYGYMSPEYAM-----SGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLE 660 (752)
Q Consensus 586 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 660 (752)
. ......+++.|+|||.+. ...++.++||||||+++|||++|+.||...... ........... ...
T Consensus 179 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~-~~~ 249 (318)
T 2dyl_A 179 K---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-----FEVLTKVLQEE-PPL 249 (318)
T ss_dssp -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHHHHSC-CCC
T ss_pred c---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-----HHHHHHHhccC-CCC
Confidence 2 122356899999999984 567899999999999999999999999753311 11112222221 111
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 661 LIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 661 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
+.. .......+.+++.+||+.||.+|||+.|++++
T Consensus 250 ~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 250 LPG-------HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp CCS-------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CCc-------cCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 100 00112356788999999999999999999874
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=316.03 Aligned_cols=242 Identities=25% Similarity=0.381 Sum_probs=197.3
Q ss_pred HhcCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCCcc------cHHHHHHHHHHHHhcC--CCCcceeeeeeeeC
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSSGQ------GIVEFKNEVRLIAKLQ--HTNLVRLLGCSLHG 498 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~ 498 (752)
..++|.+.+.||+|+||.||+|+. .+++.||||++...... ....+.+|+.++.+++ |+||+++++++.+.
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 457899999999999999999986 46889999998654321 2235678999999996 59999999999999
Q ss_pred CeeEEEEeeCCC-CCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEec-CCCCceeccc
Q 043278 499 EERLLVYEFMPN-KSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLD-DKMNPKISDF 576 (752)
Q Consensus 499 ~~~~lv~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~-~~~~~kl~DF 576 (752)
+..++|+|++.. ++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++ +++.+||+||
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Df 194 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDF 194 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCC
T ss_pred CcEEEEEEcCCCCccHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeC
Confidence 999999999976 8999998653 35899999999999999999999998 99999999999999 7899999999
Q ss_pred ccceeecccccccccccccccCCccChhhhccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhC
Q 043278 577 GMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIV-SIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSD 655 (752)
Q Consensus 577 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 655 (752)
|+++...... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||.... .....
T Consensus 195 g~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------------~~~~~ 258 (320)
T 3a99_A 195 GSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EIIRG 258 (320)
T ss_dssp TTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHHC
T ss_pred cccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------------hhhcc
Confidence 9998764322 223568999999999987765 788999999999999999999985431 11111
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 656 GKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 656 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.. ... ... ...+.+++.+||+.||++|||+.|+++.
T Consensus 259 -~~--~~~----~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 259 -QV--FFR----QRV----SSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp -CC--CCS----SCC----CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -cc--ccc----ccC----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 10 011 111 2357789999999999999999999884
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=337.58 Aligned_cols=264 Identities=24% Similarity=0.289 Sum_probs=197.8
Q ss_pred hcCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccC-CcccHHHHHHHHHHHHhcCCCCcceeeeeeee------CCe
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRS-SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLH------GEE 500 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 500 (752)
.++|.+.+.||+|+||.||+|.. .+++.||||++... .......+.+|+.++.+++||||+++++++.. ++.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 37899999999999999999987 45889999998764 33445678999999999999999999998765 667
Q ss_pred eEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCC---ceecccc
Q 043278 501 RLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMN---PKISDFG 577 (752)
Q Consensus 501 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~---~kl~DFg 577 (752)
.++||||+++|+|.+++........+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 8999999999999999977555556999999999999999999999988 999999999999997665 8999999
Q ss_pred cceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCc--ch-HHHHHHHhh
Q 043278 578 MARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPL--NL-IGYAWQLLS 654 (752)
Q Consensus 578 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~--~l-~~~~~~~~~ 654 (752)
++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......... .. .........
T Consensus 170 ~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~ 246 (676)
T 3qa8_A 170 YAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV 246 (676)
T ss_dssp CCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCS
T ss_pred ccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhh
Confidence 998654332 223467899999999999999999999999999999999999999653210000 00 000000000
Q ss_pred CCCcccc--cCCCC--CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 043278 655 DGKGLEL--IDPSL--EQPCSANEVMRCIHVGLLCVQDQAMDRPTMPE 698 (752)
Q Consensus 655 ~~~~~~~--~d~~l--~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~e 698 (752)
....... ....+ ...........+.+++.+|++.||.+|||+.|
T Consensus 247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 0000000 00000 11233445677889999999999999999976
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=300.15 Aligned_cols=230 Identities=11% Similarity=0.061 Sum_probs=182.3
Q ss_pred hcCCCcCCeeecCCcccEEEEEecC-CceeEEEEcccCCcc---cHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEE
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLAD-EQEVAIKRLSRSSGQ---GIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLV 504 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 504 (752)
.++|.+.+.||+|+||.||+|.... ++.||||++...... ....+.+|+..+.+++|+||+++++++.+++..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 3679999999999999999999754 889999999765332 346789999999999999999999999999999999
Q ss_pred EeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecc
Q 043278 505 YEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~ 584 (752)
|||+++++|.+++.. . ....++..++.||+.||+|||+++ |+||||||+|||++.++.+||++++
T Consensus 110 ~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp EECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-------
Confidence 999999999999832 1 356678899999999999999998 9999999999999999999997543
Q ss_pred cccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCC
Q 043278 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDP 664 (752)
Q Consensus 585 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 664 (752)
|++| ++.++||||||+++|||++|+.||............ .... .+. ...+
T Consensus 175 ---------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~---~~~~-~~~---~~~~ 225 (286)
T 3uqc_A 175 ---------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA---ERDT-AGQ---PIEP 225 (286)
T ss_dssp ---------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC---CBCT-TSC---BCCH
T ss_pred ---------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH---HHHh-ccC---CCCh
Confidence 3443 689999999999999999999999876543321000 0000 000 0000
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 665 SLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 665 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
. .........+.+++.+||+.||.+| |+.|+++.|+..
T Consensus 226 ~---~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~ 263 (286)
T 3uqc_A 226 A---DIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQA 263 (286)
T ss_dssp H---HHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHH
T ss_pred h---hcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHH
Confidence 0 0001122457789999999999999 999999999875
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=340.28 Aligned_cols=237 Identities=20% Similarity=0.279 Sum_probs=190.7
Q ss_pred cCCCcCCeeecCCcccEEEEEec--CCceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCe-----e
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA--DEQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEE-----R 501 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----~ 501 (752)
++|.+.+.||+|+||.||++... +++.||||++.... ......+.+|+.++.+++||||+++++++.+.+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 67889999999999999999875 58899999986543 3345578899999999999999999999987665 6
Q ss_pred EEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceeccccccee
Q 043278 502 LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARI 581 (752)
Q Consensus 502 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~ 581 (752)
+|||||+++++|.+++.. .+++..++.++.||+.||.|||+++ |+||||||+|||++.+ .+||+|||+++.
T Consensus 160 ~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchh
Confidence 999999999999887632 5999999999999999999999998 9999999999999986 899999999986
Q ss_pred ecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccc
Q 043278 582 FEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLEL 661 (752)
Q Consensus 582 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 661 (752)
.... ....||+.|+|||++.+.. +.++||||||++++||++|..|+.........
T Consensus 231 ~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~------------------ 285 (681)
T 2pzi_A 231 INSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLP------------------ 285 (681)
T ss_dssp TTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSCC------------------
T ss_pred cccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccccc------------------
Confidence 5432 3457899999999987765 89999999999999999998887643211100
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCC-HHHHHHHhhc
Q 043278 662 IDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPT-MPEVVCMLQN 705 (752)
Q Consensus 662 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-~~ev~~~L~~ 705 (752)
...........+.+++.+|++.||.+||+ ++++...|..
T Consensus 286 -----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 286 -----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp -----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred -----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 00001122346778999999999999995 5556665543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-35 Score=320.32 Aligned_cols=241 Identities=15% Similarity=0.142 Sum_probs=179.4
Q ss_pred cCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCCc---ccHHHHHHHHHHHHhcCC-CCcceeeee----------
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSSG---QGIVEFKNEVRLIAKLQH-TNLVRLLGC---------- 494 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h-~niv~l~~~---------- 494 (752)
..|...+.||+|+||.||+|+. .+|+.||||++..... ...+.+.+|+.++..++| +|...+..+
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 4566678999999999999995 5689999999874322 235678999999999987 322111111
Q ss_pred -----------eee-----CCeeEEEEeeCCCCCHhHHHhh----cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEe
Q 043278 495 -----------SLH-----GEERLLVYEFMPNKSLDFFLFN----SGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVI 554 (752)
Q Consensus 495 -----------~~~-----~~~~~lv~E~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ii 554 (752)
+.. ....+++|+++ .++|.+++.. ......+++..++.++.||++||+|||+.+ |+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 111 12346677754 6889888742 223455888999999999999999999998 99
Q ss_pred ecCCCCCcEEecCCCCceecccccceeecccccccccccccccCCccChhhh----------ccCCCCccchhHHHHHHH
Q 043278 555 HRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYA----------MSGIVSIKTDVFSFGVLV 624 (752)
Q Consensus 555 H~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~t~k~DV~S~G~vl 624 (752)
||||||+||||+.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||++
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 9999999999999999999999999864422 233567 999999999 555688999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 043278 625 LEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVC 701 (752)
Q Consensus 625 ~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~ 701 (752)
|||++|+.||.......... .++... ...+ ..+.+|+.+||+.||++|||+.|+++
T Consensus 308 ~elltg~~Pf~~~~~~~~~~---------------~~~~~~--~~~~----~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 308 YWIWCADLPNTDDAALGGSE---------------WIFRSC--KNIP----QPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHSSCCCCTTGGGSCSG---------------GGGSSC--CCCC----HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHCCCCCCCcchhhhHH---------------HHHhhc--ccCC----HHHHHHHHHHccCChhhCcCHHHHHh
Confidence 99999999997654322111 111100 1112 45778999999999999999877654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=295.85 Aligned_cols=227 Identities=20% Similarity=0.251 Sum_probs=177.0
Q ss_pred cCCCcC-CeeecCCcccEEEEEe-cCCceeEEEEcccCCcccHHHHHHHHHHH-HhcCCCCcceeeeeeee----CCeeE
Q 043278 430 NNFSTT-NKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSSGQGIVEFKNEVRLI-AKLQHTNLVRLLGCSLH----GEERL 502 (752)
Q Consensus 430 ~~~~~~-~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~~ 502 (752)
++|.+. +.||+|+||.||++.. .+++.||+|++... ..+.+|+.++ ...+||||+++++++.. +...+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 456665 7799999999999987 46889999998642 3567888888 55699999999999876 67789
Q ss_pred EEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecC---CCCceecccccc
Q 043278 503 LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDD---KMNPKISDFGMA 579 (752)
Q Consensus 503 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~---~~~~kl~DFgla 579 (752)
+||||+++++|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 92 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEECCCCSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 9999999999999997643 345899999999999999999999998 999999999999998 789999999998
Q ss_pred eeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcc
Q 043278 580 RIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGL 659 (752)
Q Consensus 580 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 659 (752)
.... +..++.++||||||+++|||++|+.||......... .....
T Consensus 168 ~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-----------~~~~~ 212 (299)
T 3m2w_A 168 KETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----------PGMKT 212 (299)
T ss_dssp EECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSCC
T ss_pred cccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-----------HHHHH
Confidence 7532 234678999999999999999999999765422110 00000
Q ss_pred cccCCCCCCCCCH----HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 660 ELIDPSLEQPCSA----NEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 660 ~~~d~~l~~~~~~----~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.+..... ..+. .....+.+++.+|++.||.+|||+.|++++
T Consensus 213 ~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 213 RIRMGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp SSCTTCC--SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhhccc--cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0000000 1111 123467789999999999999999999885
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-34 Score=305.83 Aligned_cols=243 Identities=15% Similarity=0.125 Sum_probs=181.9
Q ss_pred hcCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCC--------cccHHHHHHHHHHHHhcC---------CCCccee
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSS--------GQGIVEFKNEVRLIAKLQ---------HTNLVRL 491 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv~l 491 (752)
.++|.+.+.||+|+||+||+|+. +++.||||++.... ......+.+|+.++++++ |+||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 35688889999999999999998 77999999997652 233477899999999886 5555555
Q ss_pred eee-----------------eee-------------CCeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHH
Q 043278 492 LGC-----------------SLH-------------GEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQG 541 (752)
Q Consensus 492 ~~~-----------------~~~-------------~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~ 541 (752)
.+. +.+ .+..+|||||+++|++.+.+.. ..+++..+..++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence 554 433 6789999999999976665522 458999999999999999
Q ss_pred HHHHH-hcCCCcEeecCCCCCcEEecCCC--------------------CceecccccceeecccccccccccccccCCc
Q 043278 542 LLYLH-KYSRLRVIHRDLKASNILLDDKM--------------------NPKISDFGMARIFEVNESEANTKRIVGTYGY 600 (752)
Q Consensus 542 l~~LH-~~~~~~iiH~Dikp~NIll~~~~--------------------~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y 600 (752)
|+||| +.+ |+||||||+||||+.++ .+||+|||+++..... ...||+.|
T Consensus 174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y 243 (336)
T 2vuw_A 174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVS 243 (336)
T ss_dssp HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCT
T ss_pred HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecc
Confidence 99999 888 99999999999999887 8999999999875432 35789999
Q ss_pred cChhhhccCCCCccchhHHHHHH-HHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHH
Q 043278 601 MSPEYAMSGIVSIKTDVFSFGVL-VLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCI 679 (752)
Q Consensus 601 ~aPE~~~~~~~t~k~DV~S~G~v-l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 679 (752)
+|||++.+.. +.++||||++++ .+++++|..||.... .+............. ...............+.
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~-----~~~~~~~~~~~~~~~----~~~~~~~~~~~~s~~~~ 313 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL-----WLHYLTDKMLKQMTF----KTKCNTPAMKQIKRKIQ 313 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH-----HHHHHHHHHHHTCCC----SSCCCSHHHHHHHHHHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh-----hhhHHHHhhhhhhcc----CcccchhhhhhcCHHHH
Confidence 9999998766 899999998777 777888888773210 000001111111110 01111111234566788
Q ss_pred HHHHHcccCCCCCCCCHHHHH-H
Q 043278 680 HVGLLCVQDQAMDRPTMPEVV-C 701 (752)
Q Consensus 680 ~l~~~Cl~~dp~~RPt~~ev~-~ 701 (752)
+|+.+||+.| |+.|++ +
T Consensus 314 dli~~~L~~d-----sa~e~l~~ 331 (336)
T 2vuw_A 314 EFHRTMLNFS-----SATDLLCQ 331 (336)
T ss_dssp HHHHHGGGSS-----SHHHHHHH
T ss_pred HHHHHHhccC-----CHHHHHhc
Confidence 9999999966 999988 5
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=99.97 E-value=7.9e-31 Score=264.90 Aligned_cols=194 Identities=16% Similarity=0.209 Sum_probs=142.0
Q ss_pred CCCeEEeeeeCCCCCCCCccEEEEecCCCCCCcCccccCCCCCCCCCccEEeccCCCCCCCCCceEEEecCCCcEEEEcC
Q 043278 6 AFGNFKLGFFSPASSTTTERYLGIWHDTAPDTLGWYFRPFLPRYQTDEPIWIANRNTPILDQSGVLTIDSIDGNLKILHN 85 (752)
Q Consensus 6 ~~g~F~lGFf~~~~~~~~~~ylgIw~~~~~~~~~~~~~~~~~~~~~~t~vWvANr~~Pv~~~~~~l~~~~~~g~L~l~~~ 85 (752)
++|.|+|||+.+++ +. +|.. +|+||+|||+.| ..++|+|.. ||||||.|.
T Consensus 24 ~~g~f~l~f~~~gn-------l~-ly~~------------------~~~vW~an~~~~---~~~~l~l~~-dGnLvl~d~ 73 (236)
T 1dlp_A 24 ELSSFRFTMQSDCN-------LV-LFDS------------------DVRVWASNTAGA---TGCRAVLQS-DGLLVILTA 73 (236)
T ss_dssp CSTTEEEEECTTSC-------EE-EEES------------------SSEEECCCCCSC---SCCBCCBCS-SSCBCCBCT
T ss_pred EcCCEEEEECCCCc-------EE-EEEC------------------CEEEEECCCCCC---CCeEEEEcC-CCcEEEEcC
Confidence 48999999986542 22 3431 499999999998 447899998 999999999
Q ss_pred CCCcEEEeeccCCccccceeEecCCCeEEEEecCCCccceeEeeeccCCCccc-CCCCeecccc-ccCc-----eeEEEE
Q 043278 86 GGNPIAVSSVEGASNNTSATLLQSGNLVLREMDTDGTIKRVLWQSFDYPTDTL-LPGMKLGINL-QTGH-----QWFLQS 158 (752)
Q Consensus 86 ~g~~~~~~~~~~~~~~~~a~lldsGNlVl~~~~~~~~~~~~lWQSFd~PTDTl-Lpg~kl~~~~-~tg~-----~~~L~S 158 (752)
+|+++|++++........|+|+|+|||||++ .++||||||||||+ ||+| |.|. .+|+ +++|+|
T Consensus 74 ~~~~vW~s~~~~~~~~~~~~l~d~Gnlvl~~--------~~~W~S~~~p~~t~~lp~~--g~d~L~~gq~~~~~~~~L~s 143 (236)
T 1dlp_A 74 QNTIRWSSGTKGSIGNYVLVLQPDRTVTIYG--------PGLWDSGTSNKGSVVVANN--GNSILYSTQGNDNHPQTLHA 143 (236)
T ss_dssp TTCCSCCCCCCCCSSCCEEEECSSSCEEEEC--------SEEEECSCCCSSCCCCSSC--CCEECCCC--CCCCCCEECS
T ss_pred CCcEEEeCCccccCCcEEEEEeCCCCEEEec--------CCEEECCCCCCcccccCCc--cceEEecCCcCCCccceEEc
Confidence 9999998876433344579999999999983 28999999999888 7776 6666 6666 567874
Q ss_pred ecCCCCCCCCCcEEeeecCCCceeEEEecCceEEEecccccCCccccccc---cceEEEEEecCceEEEEEEccCCceee
Q 043278 159 WLDYSSPAQGSFTLGIEPNATNQLIIRWRRETIYWTSGLLLNGNFNFSRS---WNLSFSYTSNEQEKYFEYSLNEGVTSS 235 (752)
Q Consensus 159 w~s~~dps~G~f~l~~~~~g~~~~~~~~~~~~~yw~~g~~~~~~~~~~~~---~~~~~~~~~n~~e~~~~~~~~~~~~~~ 235 (752)
.+||++|.|+|+++++| +++++. +..+||++++|++. +...+. ....+.|..++++.+++|...... .
T Consensus 144 ---~~d~s~G~~~l~l~~dG--~LvL~~-~~~~~W~s~~~~~~-~~~~~~L~~~Gnl~ly~~~~~~vw~s~~~~~~~--~ 214 (236)
T 1dlp_A 144 ---TQSLQLSPYRLSMETDC--NLVLFD-RDDRVWSTNTAGKG-TGCRAVLQPNGRMDVLTNQNIAVWTSGNSRSAG--R 214 (236)
T ss_dssp ---SCCCBCSSCEEEEETTT--EEEEEB-TTBCCSCCCCCSSC-SSCEEEEETTTEEEEEETTTEEEEECCCCCSSS--C
T ss_pred ---CcEeecCcEEEEECCCC--cEEEEc-CCEeEEeCCCcCCC-CceEEEECCCCcEEEEeCCCcEEEEeCCCCCCC--C
Confidence 78999999999999999 677754 55789999998653 222111 111233444556666666544322 2
Q ss_pred EEEEECCCCcccc
Q 043278 236 VFLRIDPEGALSD 248 (752)
Q Consensus 236 ~~~~l~~~G~l~~ 248 (752)
.+++|+.+|.++.
T Consensus 215 ~rl~Ld~dG~l~l 227 (236)
T 1dlp_A 215 YVFVLQPDRNLAI 227 (236)
T ss_dssp CEEEECSSSCEEE
T ss_pred EEEEEcCCCcEEE
Confidence 4689999998763
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7.6e-28 Score=274.62 Aligned_cols=183 Identities=16% Similarity=0.145 Sum_probs=129.0
Q ss_pred eeecCCcccEEEEE-ecCCceeEEEEcccCC----------cccHHHHHHHHHHHHhc-CCCCcceeeeeeeeCCeeEEE
Q 043278 437 KLGEGGFGPVYKGK-LADEQEVAIKRLSRSS----------GQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGEERLLV 504 (752)
Q Consensus 437 ~LG~G~fg~Vy~~~-~~~~~~vavK~l~~~~----------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 504 (752)
.++.|+.|.+..++ .--|+.+++|.+.... ....++|.+|+++|+++ .|+||+++++++.+++..+||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 45667777666654 3458889999986542 12345699999999999 799999999999999999999
Q ss_pred EeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecc
Q 043278 505 YEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~ 584 (752)
|||++|++|.+.|... ..++.. +|+.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+....
T Consensus 321 MEyv~G~~L~d~i~~~---~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAG---EEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EECCCSEEHHHHHHTT---CCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EecCCCCcHHHHHHhC---CCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 9999999999999643 345543 58899999999999999 99999999999999999999999999986543
Q ss_pred cccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCC
Q 043278 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631 (752)
Q Consensus 585 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~ 631 (752)
.. ......+||+.|||||++.+ .+..++|+||+|++++++.++.
T Consensus 392 ~~--~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 392 DC--SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp ----CCSHHHHHHHHHHHHHHC------------------CCCCTTH
T ss_pred CC--ccccCceechhhccHHHhCC-CCCCcccccccccchhhhcccc
Confidence 32 22334789999999998875 4677899999999998886653
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.7e-25 Score=252.13 Aligned_cols=184 Identities=18% Similarity=0.196 Sum_probs=146.4
Q ss_pred cCCeeecCCcccEEEEEecCCceeEEEEcccCCcc--------cHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEE
Q 043278 434 TTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQ--------GIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 434 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 505 (752)
..+.||+|+||.||++.. .++.+++|+....... ..+++.+|++++.+++||||+++..++...+..+|||
T Consensus 340 ~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp --------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 357899999999999954 5678888876443211 1345799999999999999997777777788889999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccc
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVN 585 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~ 585 (752)
||+++++|.+++.. ++.++.||++||+|||+++ |+||||||+|||+++ .+||+|||+++.....
T Consensus 419 E~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 419 SYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp ECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred ECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 99999999999843 5689999999999999998 999999999999999 9999999999987543
Q ss_pred cccc-----ccccccccCCccChhhhcc--CCCCccchhHHHHHHHHHHHhCCCCC
Q 043278 586 ESEA-----NTKRIVGTYGYMSPEYAMS--GIVSIKTDVFSFGVLVLEIVSGQKNH 634 (752)
Q Consensus 586 ~~~~-----~~~~~~gt~~y~aPE~~~~--~~~t~k~DV~S~G~vl~elltG~~p~ 634 (752)
.... ......||+.|||||++.. ..|+.++|+||..+-.++.+.++.++
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 2211 1235689999999999987 56888999999999999988877665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=2.3e-22 Score=209.13 Aligned_cols=154 Identities=18% Similarity=0.142 Sum_probs=123.3
Q ss_pred HHHHHHHhcCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCCc------------------ccHHHHHHHHHHHHhc
Q 043278 422 FQTIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSG------------------QGIVEFKNEVRLIAKL 483 (752)
Q Consensus 422 ~~~i~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~------------------~~~~~~~~E~~~l~~l 483 (752)
+..+......|.+.+.||+|+||.||+|...+|+.||||.++.... .....+.+|+.++.++
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 3444555666777799999999999999997799999999864321 1245689999999999
Q ss_pred CCCCcceeeeeeeeCCeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcE
Q 043278 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNI 563 (752)
Q Consensus 484 ~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NI 563 (752)
+ | +++.+++.. +..++||||+++++|.+ +.. .....++.||+.||.|||+.+ |+||||||+||
T Consensus 162 ~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NI 224 (282)
T 1zar_A 162 Q--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNV 224 (282)
T ss_dssp T--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSE
T ss_pred c--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHE
Confidence 9 5 677775543 56799999999999987 411 234579999999999999998 99999999999
Q ss_pred EecCCCCceecccccceeecccccccccccccccCCccChhhhcc
Q 043278 564 LLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMS 608 (752)
Q Consensus 564 ll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 608 (752)
|++ ++.+||+|||+++. +..++|||++..
T Consensus 225 Ll~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~r 253 (282)
T 1zar_A 225 LVS-EEGIWIIDFPQSVE---------------VGEEGWREILER 253 (282)
T ss_dssp EEE-TTEEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred EEE-CCcEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence 999 99999999999973 335789998753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=2.6e-18 Score=176.33 Aligned_cols=136 Identities=17% Similarity=0.177 Sum_probs=106.1
Q ss_pred CCcCCeeecCCcccEEEEEe-cCCce--eEEEEcccCCcc------------------------cHHHHHHHHHHHHhcC
Q 043278 432 FSTTNKLGEGGFGPVYKGKL-ADEQE--VAIKRLSRSSGQ------------------------GIVEFKNEVRLIAKLQ 484 (752)
Q Consensus 432 ~~~~~~LG~G~fg~Vy~~~~-~~~~~--vavK~l~~~~~~------------------------~~~~~~~E~~~l~~l~ 484 (752)
|.+.+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|+..+.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56778999999999999997 68888 999987543111 1135789999999998
Q ss_pred CCCc--ceeeeeeeeCCeeEEEEeeCCC-C----CHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCcEeec
Q 043278 485 HTNL--VRLLGCSLHGEERLLVYEFMPN-K----SLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLH-KYSRLRVIHR 556 (752)
Q Consensus 485 h~ni--v~l~~~~~~~~~~~lv~E~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~iiH~ 556 (752)
|+++ ..++.+ +..+|||||+.. | +|.+.... .++..+..++.||+.+|.||| +.+ |+||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivHr 195 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVHA 195 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EECS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEeC
Confidence 8764 334432 357899999942 4 66665422 234467789999999999999 887 9999
Q ss_pred CCCCCcEEecCCCCceecccccceee
Q 043278 557 DLKASNILLDDKMNPKISDFGMARIF 582 (752)
Q Consensus 557 Dikp~NIll~~~~~~kl~DFgla~~~ 582 (752)
||||+|||++. .++|+|||++...
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999998 9999999999753
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.65 E-value=5.9e-16 Score=134.05 Aligned_cols=90 Identities=18% Similarity=0.307 Sum_probs=72.8
Q ss_pred EeeCCCeEEeeeeCCCCCCCCccEEEEecCCCCCCcCccccCCCCCCCCCccEEeccCCCCCCCCCceEEEecCCCcEEE
Q 043278 3 LVSAFGNFKLGFFSPASSTTTERYLGIWHDTAPDTLGWYFRPFLPRYQTDEPIWIANRNTPILDQSGVLTIDSIDGNLKI 82 (752)
Q Consensus 3 lvS~~g~F~lGFf~~~~~~~~~~ylgIw~~~~~~~~~~~~~~~~~~~~~~t~vWvANr~~Pv~~~~~~l~~~~~~g~L~l 82 (752)
|+| |.|.|.|...+ .|.++.. .++||+|||++|..++ +.|.|.. ||||||
T Consensus 16 L~s--g~y~l~~q~Dg-------NLvly~~-------------------~~~vW~ant~~~~~~~-~~L~l~~-dGnLvL 65 (105)
T 4h3o_A 16 LDV--EPYHFIMQDDC-------NLVLYDH-------------------STSTWASNTEIGGKSG-CSAVLQS-DGNFVV 65 (105)
T ss_dssp EEE--TTEEEEECTTS-------CEEEEET-------------------TEEEEECCCCCTTCCS-CEEEECT-TSCEEE
T ss_pred EEE--CCEEEEECCCC-------eEEEEEC-------------------CEEEEEecCCCCCCcc-EEEEEeC-CccEEE
Confidence 455 78999887443 3666543 4889999999998776 6899998 999999
Q ss_pred EcCCCCcEEEeeccCCccccceeEecCCCeEEEEecCCCccceeEeee
Q 043278 83 LHNGGNPIAVSSVEGASNNTSATLLQSGNLVLREMDTDGTIKRVLWQS 130 (752)
Q Consensus 83 ~~~~g~~~~~~~~~~~~~~~~a~lldsGNlVl~~~~~~~~~~~~lWQS 130 (752)
.|.+|+++|+++++.......|+|+|+|||||++ ..+|||
T Consensus 66 ~d~~~~~vWss~t~~~~~~~~l~L~ddGNlVly~--------~~~W~S 105 (105)
T 4h3o_A 66 YDSSGRSLWASHSTRGSGNYILILQDDGNVIIYG--------SDIWST 105 (105)
T ss_dssp ECTTCCEEEECCCCCCSSCEEEEECTTSCEEEEE--------SEEEEC
T ss_pred ECCCcEEEEEecCCCCCCCEEEEEeCCCeEEEEC--------CcEecC
Confidence 9999999999887555556679999999999984 269998
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.63 E-value=9.6e-16 Score=136.01 Aligned_cols=92 Identities=20% Similarity=0.321 Sum_probs=75.0
Q ss_pred eEe--eCCCeEEeeeeCCCCCCCCccEEEEecCCCCCCcCccccCCCCCCCCCccEEeccCCCCCCCCCceEEEecCCCc
Q 043278 2 LLV--SAFGNFKLGFFSPASSTTTERYLGIWHDTAPDTLGWYFRPFLPRYQTDEPIWIANRNTPILDQSGVLTIDSIDGN 79 (752)
Q Consensus 2 ~lv--S~~g~F~lGFf~~~~~~~~~~ylgIw~~~~~~~~~~~~~~~~~~~~~~t~vWvANr~~Pv~~~~~~l~~~~~~g~ 79 (752)
.|+ |++|.|+|+|+.+++ . +||++ .++||+|||+.| +.++.|.|.. |||
T Consensus 22 ~l~~~S~~g~~~L~~~~dgn-----l---vly~~------------------~~~vW~sn~~~~--~~~~~l~l~~-dGN 72 (119)
T 1b2p_A 22 SLEILFGTHVYRFIMQTDCN-----L---VLYDN------------------NNPIWATNTGGL--GNGCRAVLQP-DGV 72 (119)
T ss_dssp EEEEEETTEEEEEEECTTSC-----E---EEEET------------------TEEEEECCCTTS--CSSCEEEECT-TSC
T ss_pred EEEEeCCCCCEEEEEecCCC-----E---EEEEC------------------CEEEEeCCCccC--CCceEEEEcc-CCE
Confidence 477 999999999998653 2 57863 489999999977 3346899987 999
Q ss_pred EEEEcCCCCcEEEeeccCCccccceeEecCCCeEEEEecCCCccceeEeee
Q 043278 80 LKILHNGGNPIAVSSVEGASNNTSATLLQSGNLVLREMDTDGTIKRVLWQS 130 (752)
Q Consensus 80 L~l~~~~g~~~~~~~~~~~~~~~~a~lldsGNlVl~~~~~~~~~~~~lWQS 130 (752)
|||.|.+|.++|.+.+....+...++|+|+|||||++ .++|||
T Consensus 73 LVl~d~~~~~lW~S~~~~~~g~~~l~l~~~Gnlvl~~--------~~~W~S 115 (119)
T 1b2p_A 73 LVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG--------DALWAT 115 (119)
T ss_dssp EEEECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEE--------SEEEEC
T ss_pred EEEEeCCCcEEEcCCCCCCCCCEEEEEECCCcEEEEC--------ccEeCC
Confidence 9999999999998876544445679999999999985 279998
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.63 E-value=1e-15 Score=134.80 Aligned_cols=99 Identities=18% Similarity=0.364 Sum_probs=79.4
Q ss_pred CCCCCCCCceEEEecCCCcEEEEcCCCCcEEEeeccCCccccceeEecCCCeEEEEecCCCccceeEeeeccCCCcccCC
Q 043278 61 NTPILDQSGVLTIDSIDGNLKILHNGGNPIAVSSVEGASNNTSATLLQSGNLVLREMDTDGTIKRVLWQSFDYPTDTLLP 140 (752)
Q Consensus 61 ~~Pv~~~~~~l~~~~~~g~L~l~~~~g~~~~~~~~~~~~~~~~a~lldsGNlVl~~~~~~~~~~~~lWQSFd~PTDTlLp 140 (752)
+.|+.+...+|.|.. ||||+|.+. +.++|++++........|+|+|+|||||++ + +.++||||+
T Consensus 13 g~~L~~~~~~L~~~~-dgnlvl~~~-~~~vW~sn~~~~~~~~~l~l~~~GNLvl~d-~-----~~~~W~S~~-------- 76 (112)
T 1xd5_A 13 GGSLAEGGYLFIIQN-DCNLVLYDN-NRAVWASGTNGKASGCVLKMQNDGNLVIYS-G-----SRAIWASNT-------- 76 (112)
T ss_dssp TCEEEETTEEEEECT-TSCEEEEET-TEEEEECCCTTSCSSEEEEECTTSCEEEEE-T-----TEEEEECCC--------
T ss_pred CCEEeCCCEEEEEcC-CCcEEEEEC-CEEEEeCCCcCCCCCEEEEEeCCCCEEEEc-C-----CEEEEECCc--------
Confidence 345555567899988 999999987 788898886533334679999999999997 4 469999993
Q ss_pred CCeeccccccCceeEEEEecCCCCCCCCCcEEeeecCCCceeEEEecCceEEEecccccC
Q 043278 141 GMKLGINLQTGHQWFLQSWLDYSSPAQGSFTLGIEPNATNQLIIRWRRETIYWTSGLLLN 200 (752)
Q Consensus 141 g~kl~~~~~tg~~~~L~Sw~s~~dps~G~f~l~~~~~g~~~~~~~~~~~~~yw~~g~~~~ 200 (752)
+|++|.|++.++++|. ++++.....+||++++|.+
T Consensus 77 -----------------------~~~~g~~~l~l~~dGn--lvl~~~~~~~~W~S~~~~g 111 (112)
T 1xd5_A 77 -----------------------NRQNGNYYLILQRDRN--VVIYDNSNNAIWATHTNVG 111 (112)
T ss_dssp -----------------------CCSCCCCEEEECTTSC--EEEECTTSCEEEECCCCCC
T ss_pred -----------------------cCCCCCEEEEEeCCCc--EEEECCCCceEEECCCccC
Confidence 4567899999999995 6666666789999999876
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.62 E-value=1.8e-16 Score=169.07 Aligned_cols=139 Identities=14% Similarity=0.131 Sum_probs=98.8
Q ss_pred hcCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCCc--------------ccHHHH--------HHHHHHHHhcCCC
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSG--------------QGIVEF--------KNEVRLIAKLQHT 486 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~--------------~~~~~~--------~~E~~~l~~l~h~ 486 (752)
..-|++.+.||+|++|.||+|...+|+.||||+++.... ...... .+|...|.++.+.
T Consensus 94 g~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~ 173 (397)
T 4gyi_A 94 KDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE 173 (397)
T ss_dssp TSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence 334899999999999999999998999999998753210 011111 3455555555443
Q ss_pred CcceeeeeeeeCCeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEec
Q 043278 487 NLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLD 566 (752)
Q Consensus 487 niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~ 566 (752)
++.-..-+. ....+|||||+++++|..+.. .+....++.||+.+|.+||+.+ ||||||||.||||+
T Consensus 174 gv~vp~p~~--~~~~~LVME~i~G~~L~~l~~---------~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~ 239 (397)
T 4gyi_A 174 GFPVPEPIA--QSRHTIVMSLVDALPMRQVSS---------VPDPASLYADLIALILRLAKHG---LIHGDFNEFNILIR 239 (397)
T ss_dssp TCSCCCEEE--EETTEEEEECCSCEEGGGCCC---------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE
T ss_pred CCCCCeeee--ccCceEEEEecCCccHhhhcc---------cHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEe
Confidence 322111111 123479999999988855431 1234568899999999999988 99999999999998
Q ss_pred CCCC----------ceeccccccee
Q 043278 567 DKMN----------PKISDFGMARI 581 (752)
Q Consensus 567 ~~~~----------~kl~DFgla~~ 581 (752)
+++. +.|+||+-+..
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCCCcccccccccceEEEEeCCccc
Confidence 8774 78999997764
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=1.5e-15 Score=132.99 Aligned_cols=96 Identities=22% Similarity=0.323 Sum_probs=76.6
Q ss_pred eEeeCCCeEEeeeeCCCCCCCCccEEEEecCCCCCCcCccccCCCCCCCCCccEEeccCCCCCCCCCceEEEecCCCcEE
Q 043278 2 LLVSAFGNFKLGFFSPASSTTTERYLGIWHDTAPDTLGWYFRPFLPRYQTDEPIWIANRNTPILDQSGVLTIDSIDGNLK 81 (752)
Q Consensus 2 ~lvS~~g~F~lGFf~~~~~~~~~~ylgIw~~~~~~~~~~~~~~~~~~~~~~t~vWvANr~~Pv~~~~~~l~~~~~~g~L~ 81 (752)
.|+ ++|.|+|+|+..++ . |||+. .++||.||++.|- ..+.|.|.. |||||
T Consensus 15 ~l~-~~~~~~l~~~~dGn-----l---vl~~~------------------~~~vW~sn~~~~~--~~~~l~l~~-dGNLV 64 (110)
T 3a0c_A 15 SLE-VGPSYRLIMQGDCN-----F---VLYDS------------------GKPVWASNTGGLG--SGCRLTLHN-NGNLV 64 (110)
T ss_dssp EEE-ETTTEEEEECTTSC-----E---EEEET------------------TEEEEECCCTTSC--SSCEEEECT-TSCEE
T ss_pred EEE-ECCCEEEEEcCCCc-----E---EEEEC------------------CEEEEECCCCCCC--CcEEEEEeC-CCCEE
Confidence 467 89999999986653 2 66762 4899999999773 336899987 99999
Q ss_pred EEcCCCCcEEEeeccCCccccceeEecCCCeEEEEecCCCccceeEeeeccCCC
Q 043278 82 ILHNGGNPIAVSSVEGASNNTSATLLQSGNLVLREMDTDGTIKRVLWQSFDYPT 135 (752)
Q Consensus 82 l~~~~g~~~~~~~~~~~~~~~~a~lldsGNlVl~~~~~~~~~~~~lWQSFd~PT 135 (752)
|.|.+|.++|.+.+....+...++|+|+|||||++. .+||||+||.
T Consensus 65 l~~~~~~~~W~S~t~~~~g~~~l~l~~dGnlvl~~~--------~~W~S~~~~~ 110 (110)
T 3a0c_A 65 IYDQSNRVIWQTKTNGKEDHYVLVLQQDRNVVIYGP--------VVWATGSGPA 110 (110)
T ss_dssp EECTTCCEEEECCCCCSSSCCEEEECTTSCEEEECS--------EEEECSCCC-
T ss_pred EECCCCcEEEecCCCCCCCCEEEEEeCCccEEEECC--------CEecCCCcCC
Confidence 999989999988775444455799999999999741 6999999983
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.56 E-value=9.1e-15 Score=129.28 Aligned_cols=93 Identities=24% Similarity=0.297 Sum_probs=73.3
Q ss_pred CCeEEeeeeCCCCCCCCccEEEEecCCCCCCcCccccCCCCCCCCCccEEeccCCCCCCCCCceEEEecCCCcEEEEcCC
Q 043278 7 FGNFKLGFFSPASSTTTERYLGIWHDTAPDTLGWYFRPFLPRYQTDEPIWIANRNTPILDQSGVLTIDSIDGNLKILHNG 86 (752)
Q Consensus 7 ~g~F~lGFf~~~~~~~~~~ylgIw~~~~~~~~~~~~~~~~~~~~~~t~vWvANr~~Pv~~~~~~l~~~~~~g~L~l~~~~ 86 (752)
+|.|+|+|+..++ .. +|+. .++||+|||+.|. .+++|.|.. +|||||.|.+
T Consensus 19 ~g~~~L~~~~dgn-----lv---ly~~------------------~~~vW~sn~~~~~--~~~~l~l~~-~GnLvl~d~~ 69 (115)
T 2dpf_A 19 AGAYTLTIQNKCN-----LV---KYQN------------------GRQIWASNTDRRG--SGCRLTLLS-DGNLVIYDHN 69 (115)
T ss_dssp ETTEEEEECTTSC-----EE---EEET------------------TEEEEECSCTTSC--SSCEEEECT-TSCEEEECTT
T ss_pred CCCEEEEEcCCCc-----EE---EEeC------------------CEEEEeCCCCCCC--CceEEEECC-CCcEEEECCC
Confidence 7999999986642 32 3541 4899999999883 346899988 9999999988
Q ss_pred CCcEEEeeccCCccccceeEecCCCeEEEEecCCCccceeEeeeccCCCc
Q 043278 87 GNPIAVSSVEGASNNTSATLLQSGNLVLREMDTDGTIKRVLWQSFDYPTD 136 (752)
Q Consensus 87 g~~~~~~~~~~~~~~~~a~lldsGNlVl~~~~~~~~~~~~lWQSFd~PTD 136 (752)
+.++|.+.+....+...++|+|+|||||++ . ++||||.+++.
T Consensus 70 ~~~vW~S~~~~~~g~~~l~l~~dGnlvl~~-------~-~~W~S~~~~~~ 111 (115)
T 2dpf_A 70 NNDVWGSACWGDNGKYALVLQKDGRFVIYG-------P-VLWSLGPNGCR 111 (115)
T ss_dssp CCEEEECCCCCSSSCCEEEECTTSCEEEEC-------S-EEECSSTTCBC
T ss_pred ceEEEEcCCCCCCCCEEEEEeCCCeEEEEC-------C-CEEECCCCCCc
Confidence 889998776434445579999999999973 1 79999998765
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.56 E-value=6.4e-15 Score=129.00 Aligned_cols=101 Identities=22% Similarity=0.436 Sum_probs=76.0
Q ss_pred ccEEeccCCCCCCCCCceEEEecCCCcEEEEcCCCCcEEEeeccCCccccceeEecCCCeEEEEecCCCccceeEeeecc
Q 043278 53 EPIWIANRNTPILDQSGVLTIDSIDGNLKILHNGGNPIAVSSVEGASNNTSATLLQSGNLVLREMDTDGTIKRVLWQSFD 132 (752)
Q Consensus 53 t~vWvANr~~Pv~~~~~~l~~~~~~g~L~l~~~~g~~~~~~~~~~~~~~~~a~lldsGNlVl~~~~~~~~~~~~lWQSFd 132 (752)
..+|..+.-. .+...+|.|.. ||||||.+ .++++|++++........++|+|+|||||++.+ +.++||||
T Consensus 8 ~~L~~g~~l~--~~~~~~l~~~~-dGnlvl~~-~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~~~~-----~~~~W~S~- 77 (110)
T 3a0c_A 8 NSLFTGHSLE--VGPSYRLIMQG-DCNFVLYD-SGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQS-----NRVIWQTK- 77 (110)
T ss_dssp CEECTTCEEE--ETTTEEEEECT-TSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTT-----CCEEEECC-
T ss_pred CEECCCCEEE--ECCCEEEEEcC-CCcEEEEE-CCEEEEECCCCCCCCcEEEEEeCCCCEEEECCC-----CcEEEecC-
Confidence 3455544433 13347899987 99999998 578899888754333467999999999999754 46999999
Q ss_pred CCCcccCCCCeeccccccCceeEEEEecCCCCCCCCCcEEeeecCCCceeEEEecCceEEEecccc
Q 043278 133 YPTDTLLPGMKLGINLQTGHQWFLQSWLDYSSPAQGSFTLGIEPNATNQLIIRWRRETIYWTSGLL 198 (752)
Q Consensus 133 ~PTDTlLpg~kl~~~~~tg~~~~L~Sw~s~~dps~G~f~l~~~~~g~~~~~~~~~~~~~yw~~g~~ 198 (752)
+++++|.|++.++++|. ++++. . +||+++.+
T Consensus 78 ------------------------------t~~~~g~~~l~l~~dGn--lvl~~-~--~~W~S~~~ 108 (110)
T 3a0c_A 78 ------------------------------TNGKEDHYVLVLQQDRN--VVIYG-P--VVWATGSG 108 (110)
T ss_dssp ------------------------------CCCSSSCCEEEECTTSC--EEEEC-S--EEEECSCC
T ss_pred ------------------------------CCCCCCCEEEEEeCCcc--EEEEC-C--CEecCCCc
Confidence 35678999999999995 56644 2 79998764
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.52 E-value=1.9e-14 Score=126.65 Aligned_cols=94 Identities=21% Similarity=0.372 Sum_probs=73.4
Q ss_pred CCCeEEeeeeCCCCCCCCccEEEEecCCCCCCcCccccCCCCCCCCCccEEeccCCCCCCCCCceEEEecCCCcEEEEcC
Q 043278 6 AFGNFKLGFFSPASSTTTERYLGIWHDTAPDTLGWYFRPFLPRYQTDEPIWIANRNTPILDQSGVLTIDSIDGNLKILHN 85 (752)
Q Consensus 6 ~~g~F~lGFf~~~~~~~~~~ylgIw~~~~~~~~~~~~~~~~~~~~~~t~vWvANr~~Pv~~~~~~l~~~~~~g~L~l~~~ 85 (752)
++|.|+|+|+.+++- +||++ .++||+||++.+ +.+++|.|.. +|||||.|
T Consensus 17 ~~~~~~L~~~~dgnl--------vl~~~------------------~~~vW~sn~~~~--~~~~~l~l~~-~GNLvl~d- 66 (112)
T 1xd5_A 17 AEGGYLFIIQNDCNL--------VLYDN------------------NRAVWASGTNGK--ASGCVLKMQN-DGNLVIYS- 66 (112)
T ss_dssp EETTEEEEECTTSCE--------EEEET------------------TEEEEECCCTTS--CSSEEEEECT-TSCEEEEE-
T ss_pred eCCCEEEEEcCCCcE--------EEEEC------------------CEEEEeCCCcCC--CCCEEEEEeC-CCCEEEEc-
Confidence 478999999987632 35653 389999999864 3346899987 99999999
Q ss_pred CCCcEEEeeccCCccccceeEecCCCeEEEEecCCCccceeEeeeccCC
Q 043278 86 GGNPIAVSSVEGASNNTSATLLQSGNLVLREMDTDGTIKRVLWQSFDYP 134 (752)
Q Consensus 86 ~g~~~~~~~~~~~~~~~~a~lldsGNlVl~~~~~~~~~~~~lWQSFd~P 134 (752)
++.++|.+.+....+...++|+++|||||++.+ +.++||||+|.
T Consensus 67 ~~~~~W~S~~~~~~g~~~l~l~~dGnlvl~~~~-----~~~~W~S~~~~ 110 (112)
T 1xd5_A 67 GSRAIWASNTNRQNGNYYLILQRDRNVVIYDNS-----NNAIWATHTNV 110 (112)
T ss_dssp TTEEEEECCCCCSCCCCEEEECTTSCEEEECTT-----SCEEEECCCCC
T ss_pred CCEEEEECCccCCCCCEEEEEeCCCcEEEECCC-----CceEEECCCcc
Confidence 788888877644444557999999999998643 46999999984
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.50 E-value=6.5e-14 Score=124.18 Aligned_cols=86 Identities=26% Similarity=0.437 Sum_probs=69.4
Q ss_pred ceEEEecCCCcEEEEcCCCCcEEEeeccCCccccceeEecCCCeEEEEecCCCccceeEeeeccCCCcccCCCCeecccc
Q 043278 69 GVLTIDSIDGNLKILHNGGNPIAVSSVEGASNNTSATLLQSGNLVLREMDTDGTIKRVLWQSFDYPTDTLLPGMKLGINL 148 (752)
Q Consensus 69 ~~l~~~~~~g~L~l~~~~g~~~~~~~~~~~~~~~~a~lldsGNlVl~~~~~~~~~~~~lWQSFd~PTDTlLpg~kl~~~~ 148 (752)
.+|.|.. ||||+|.+. +++||++++........++|+|+|||||++.+ ++++||||
T Consensus 32 ~~L~~~~-dgnlvly~~-~~~vW~sn~~~~~~~~~l~l~~dGNLVl~d~~-----~~~lW~S~----------------- 87 (119)
T 1b2p_A 32 YRFIMQT-DCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNE-----NVTVWQSP----------------- 87 (119)
T ss_dssp EEEEECT-TSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTT-----CCEEEECS-----------------
T ss_pred EEEEEec-CCCEEEEEC-CEEEEeCCCccCCCceEEEEccCCEEEEEeCC-----CcEEEcCC-----------------
Confidence 4688887 999999986 78889888754333467999999999999754 56999999
Q ss_pred ccCceeEEEEecCCCCCCCCCcEEeeecCCCceeEEEecCceEEEeccc
Q 043278 149 QTGHQWFLQSWLDYSSPAQGSFTLGIEPNATNQLIIRWRRETIYWTSGL 197 (752)
Q Consensus 149 ~tg~~~~L~Sw~s~~dps~G~f~l~~~~~g~~~~~~~~~~~~~yw~~g~ 197 (752)
+||++|.|++.++++|. ++++. .+||++|+
T Consensus 88 --------------~~~~~g~~~l~l~~~Gn--lvl~~---~~~W~Sg~ 117 (119)
T 1b2p_A 88 --------------VAGKAGHYVLVLQPDRN--VVIYG---DALWATQT 117 (119)
T ss_dssp --------------CCCCSSCEEEEECTTSC--EEEEE---SEEEECCC
T ss_pred --------------CCCCCCCEEEEEECCCc--EEEEC---ccEeCCCC
Confidence 45678999999999996 56644 38999875
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=1.8e-13 Score=120.86 Aligned_cols=92 Identities=24% Similarity=0.378 Sum_probs=72.9
Q ss_pred CceEEEecCCCcEEEEcCCCCcEEEeeccCCccccceeEecCCCeEEEEecCCCccceeEeeeccCCCcccCCCCeeccc
Q 043278 68 SGVLTIDSIDGNLKILHNGGNPIAVSSVEGASNNTSATLLQSGNLVLREMDTDGTIKRVLWQSFDYPTDTLLPGMKLGIN 147 (752)
Q Consensus 68 ~~~l~~~~~~g~L~l~~~~g~~~~~~~~~~~~~~~~a~lldsGNlVl~~~~~~~~~~~~lWQSFd~PTDTlLpg~kl~~~ 147 (752)
...|.|.. ||||+|.+ .++++|++++........++|+++|||||++.+ +.++|||||+
T Consensus 21 ~~~L~~~~-dgnlvly~-~~~~vW~sn~~~~~~~~~l~l~~~GnLvl~d~~-----~~~vW~S~~~-------------- 79 (115)
T 2dpf_A 21 AYTLTIQN-KCNLVKYQ-NGRQIWASNTDRRGSGCRLTLLSDGNLVIYDHN-----NNDVWGSACW-------------- 79 (115)
T ss_dssp TEEEEECT-TSCEEEEE-TTEEEEECSCTTSCSSCEEEECTTSCEEEECTT-----CCEEEECCCC--------------
T ss_pred CEEEEEcC-CCcEEEEe-CCEEEEeCCCCCCCCceEEEECCCCcEEEECCC-----ceEEEEcCCC--------------
Confidence 46899987 99999997 577889887644333467999999999999753 4699999997
Q ss_pred cccCceeEEEEecCCCCCCCCCcEEeeecCCCceeEEEecCceEEEecccccCCc
Q 043278 148 LQTGHQWFLQSWLDYSSPAQGSFTLGIEPNATNQLIIRWRRETIYWTSGLLLNGN 202 (752)
Q Consensus 148 ~~tg~~~~L~Sw~s~~dps~G~f~l~~~~~g~~~~~~~~~~~~~yw~~g~~~~~~ 202 (752)
+++|.|++.++++|. ++++. . +||++++|....
T Consensus 80 -----------------~~~g~~~l~l~~dGn--lvl~~-~--~~W~S~~~~~~~ 112 (115)
T 2dpf_A 80 -----------------GDNGKYALVLQKDGR--FVIYG-P--VLWSLGPNGCRR 112 (115)
T ss_dssp -----------------CSSSCCEEEECTTSC--EEEEC-S--EEECSSTTCBCC
T ss_pred -----------------CCCCCEEEEEeCCCe--EEEEC-C--CEEECCCCCCcC
Confidence 356889999999995 56643 2 899999997653
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.41 E-value=5.4e-13 Score=116.55 Aligned_cols=87 Identities=29% Similarity=0.463 Sum_probs=68.0
Q ss_pred CCeEEeeeeCCCCCCCCccEEEEecCCCCCCcCccccCCCCCCCCCccEEeccCCCCCCCCCceEEEecCCCcEEEEcCC
Q 043278 7 FGNFKLGFFSPASSTTTERYLGIWHDTAPDTLGWYFRPFLPRYQTDEPIWIANRNTPILDQSGVLTIDSIDGNLKILHNG 86 (752)
Q Consensus 7 ~g~F~lGFf~~~~~~~~~~ylgIw~~~~~~~~~~~~~~~~~~~~~~t~vWvANr~~Pv~~~~~~l~~~~~~g~L~l~~~~ 86 (752)
+|.|+|+|+..+ +.+| |+. .++||+||++.+ +..+.|.|.. ||||||.|.+
T Consensus 18 ~g~~~L~~q~dG-----nLvl---y~~------------------~~~vW~snt~~~--~~~~~l~l~~-dGNLvl~~~~ 68 (109)
T 3dzw_A 18 NGRYVFIMQEDC-----NLVL---YDV------------------DKPIWATNTGGL--DRRCHLSMQS-DGNLVVYSPR 68 (109)
T ss_dssp ETTEEEEECTTS-----CEEE---EET------------------TEEEEECCCTTS--SSSCEEEECT-TSCEEEECTT
T ss_pred CCCEEEEEcCCC-----cEEE---EeC------------------CEEEEECCcccC--CCCEEEEEeC-CCCEEEECCC
Confidence 799999998665 2333 542 388999999976 3346899987 9999999988
Q ss_pred CCcEEEeeccCCccccceeEecCCCeEEEEecCCCccceeEeee
Q 043278 87 GNPIAVSSVEGASNNTSATLLQSGNLVLREMDTDGTIKRVLWQS 130 (752)
Q Consensus 87 g~~~~~~~~~~~~~~~~a~lldsGNlVl~~~~~~~~~~~~lWQS 130 (752)
+.++|.+++........|+|+|+|||||++. .+|||
T Consensus 69 ~~~~W~S~t~~~~~~~~~~L~ddGNlvly~~--------~~W~s 104 (109)
T 3dzw_A 69 NNPIWASNTGGENGNYVCVLQKDRNVVIYGT--------ARWAT 104 (109)
T ss_dssp SCEEEECCCCCSSSCEEEEECTTSCEEEEES--------CCCCC
T ss_pred CCEEEECCCCCCCCCEEEEEeCCCEEEEECC--------CEEeC
Confidence 8899988764433345799999999999852 68998
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.25 E-value=1.7e-11 Score=125.64 Aligned_cols=146 Identities=16% Similarity=0.092 Sum_probs=113.9
Q ss_pred HHhcCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcC-CCCcceeeeeeeeCCeeEEEE
Q 043278 427 AAANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQ-HTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 427 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 505 (752)
..-..|.....++.|+.+.||+.... ++.+++|+...........+.+|+.+++.+. +..+.++++++.+.+..++||
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 89 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence 34457877788888999999999854 6789999986532222345789999999884 677888999998888999999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS------------------------------------ 549 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------------------ 549 (752)
||+++.+|...+. +......++.+++++|..||+..
T Consensus 90 e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 90 SEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp ECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred EecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 9999999876531 11223478889999999999821
Q ss_pred --------------------CCcEeecCCCCCcEEecCCCCceeccccccee
Q 043278 550 --------------------RLRVIHRDLKASNILLDDKMNPKISDFGMARI 581 (752)
Q Consensus 550 --------------------~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~ 581 (752)
...++|+|++|.|||++++..+.|+||+.+..
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 14589999999999998766667999998764
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.20 E-value=6.3e-11 Score=103.37 Aligned_cols=67 Identities=16% Similarity=0.206 Sum_probs=53.7
Q ss_pred ccEEeccCCCCCCCCCceEEEecCCCcEEEEcCCCCcEEEeeccCCccccceeEecCCCeEEEEecCCCccceeEeee
Q 043278 53 EPIWIANRNTPILDQSGVLTIDSIDGNLKILHNGGNPIAVSSVEGASNNTSATLLQSGNLVLREMDTDGTIKRVLWQS 130 (752)
Q Consensus 53 t~vWvANr~~Pv~~~~~~l~~~~~~g~L~l~~~~g~~~~~~~~~~~~~~~~a~lldsGNlVl~~~~~~~~~~~~lWQS 130 (752)
++||.+|++.. +....|.|.. ||||||.|.+|.++|.+++........|+|+|+|||||++ ..+|+|
T Consensus 42 ~~vW~snt~~~--~~~~~l~l~~-dGNLvl~d~~~~~iW~S~t~~~~~~~~~~L~~dGNlvly~--------~~~W~t 108 (110)
T 3r0e_B 42 KYGWQSNTHGN--GEHCFLRLNH-KGELIIKDDDFKTIWSSRSSSKQGEYVLILQDDGFGVIYG--------PAIFET 108 (110)
T ss_dssp SSCEECCCTTS--SSSCEEEECT-TSCEEEECTTCCEEEECCCCCSSSCCEEEECTTSCEEEEC--------SEEEES
T ss_pred eEEEECCCcCC--CcCEEEEEeC-CCcEEEEeCCCCEEEEcCCcCCCCCEEEEEcCCccEEEec--------CCEecC
Confidence 47999999863 3336899987 9999999998999998876443344679999999999985 268987
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.18 E-value=8.4e-11 Score=103.17 Aligned_cols=68 Identities=19% Similarity=0.333 Sum_probs=55.3
Q ss_pred CccEEeccCCCCCCCCCceEEEecCCCcEEEEcCCCCcEEEeeccCCccccceeEecCCCeEEEEecCCCccceeEeee
Q 043278 52 DEPIWIANRNTPILDQSGVLTIDSIDGNLKILHNGGNPIAVSSVEGASNNTSATLLQSGNLVLREMDTDGTIKRVLWQS 130 (752)
Q Consensus 52 ~t~vWvANr~~Pv~~~~~~l~~~~~~g~L~l~~~~g~~~~~~~~~~~~~~~~a~lldsGNlVl~~~~~~~~~~~~lWQS 130 (752)
.++||.+|+..+- ....|.|.. ||||||.|.++.++|.+++....+...|+|+|+|||||++ ..+|+|
T Consensus 44 ~~~vWssnt~~~~--~~~~l~l~~-dGNLVl~d~~~~~iW~S~t~~~~~~~~~~L~~dGnlvly~--------~~~W~s 111 (113)
T 3mez_B 44 TNIVWESGTSGRG--QHCFMRLGH-SGELDITDDRLNTVFVSNTVGQEGDYVLILQINGQAVVYG--------PAVWST 111 (113)
T ss_dssp TEEEEECCCTTSC--SSCEEEECT-TSCEEEECTTSCEEEECSCCCSSSCCEEEECTTSCEEEEC--------SEEEES
T ss_pred CEEEEECCcccCC--cCEEEEEeC-CCcEEEECCCCCEEEECCCcCCCCCEEEEEcCCceEEEec--------CCEecC
Confidence 4899999998762 336899987 9999999998888988876443344679999999999984 379997
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.11 E-value=2.1e-10 Score=100.57 Aligned_cols=96 Identities=19% Similarity=0.271 Sum_probs=71.0
Q ss_pred CCCCCCCCCceEEEecCCCcEEEEcC-CCCcEEEeeccCCccccceeEecCCCeEEEEecCCCccceeEeeeccCCCccc
Q 043278 60 RNTPILDQSGVLTIDSIDGNLKILHN-GGNPIAVSSVEGASNNTSATLLQSGNLVLREMDTDGTIKRVLWQSFDYPTDTL 138 (752)
Q Consensus 60 r~~Pv~~~~~~l~~~~~~g~L~l~~~-~g~~~~~~~~~~~~~~~~a~lldsGNlVl~~~~~~~~~~~~lWQSFd~PTDTl 138 (752)
.+.|+.+...+|.+.. ||||||.+. .+.++|++++........++|+++|||||++.+ +.++|||=.+
T Consensus 17 ~g~~L~~g~~~L~~q~-dGNLvL~~~~~~~~vWssnt~~~~~~~~l~l~~dGNLVl~d~~-----~~~iW~S~t~----- 85 (113)
T 3mez_B 17 DNAQLATRDYSLVMRD-DCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDR-----LNTVFVSNTV----- 85 (113)
T ss_dssp TTCEEEETTEEEEECT-TSCEEEEETTTTEEEEECCCTTSCSSCEEEECTTSCEEEECTT-----SCEEEECSCC-----
T ss_pred CCCEeEcCCEEEEEcC-CCEEEEEECCCCEEEEECCcccCCcCEEEEEeCCCcEEEECCC-----CCEEEECCCc-----
Confidence 4677777778999987 999999987 478899887753333457999999999999754 4589997321
Q ss_pred CCCCeeccccccCceeEEEEecCCCCCCCCCcEEeeecCCCceeEEEecCceEEEeccc
Q 043278 139 LPGMKLGINLQTGHQWFLQSWLDYSSPAQGSFTLGIEPNATNQLIIRWRRETIYWTSGL 197 (752)
Q Consensus 139 Lpg~kl~~~~~tg~~~~L~Sw~s~~dps~G~f~l~~~~~g~~~~~~~~~~~~~yw~~g~ 197 (752)
+ ..|.|.+.++++|. ++++. .+.|.+|+
T Consensus 86 --~------------------------~~~~~~~~L~~dGn--lvly~---~~~W~s~~ 113 (113)
T 3mez_B 86 --G------------------------QEGDYVLILQINGQ--AVVYG---PAVWSTAA 113 (113)
T ss_dssp --C------------------------SSSCCEEEECTTSC--EEEEC---SEEEESCC
T ss_pred --C------------------------CCCCEEEEEcCCce--EEEec---CCEecCCC
Confidence 0 12458999999994 44533 57898764
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.08 E-value=3.2e-10 Score=98.99 Aligned_cols=96 Identities=16% Similarity=0.320 Sum_probs=68.7
Q ss_pred CCCCCCCCceEEEecCCCcEEEEcCCCCcEEEeeccCCccccceeEecCCCeEEEEecCCCccceeEeeeccCCCcccCC
Q 043278 61 NTPILDQSGVLTIDSIDGNLKILHNGGNPIAVSSVEGASNNTSATLLQSGNLVLREMDTDGTIKRVLWQSFDYPTDTLLP 140 (752)
Q Consensus 61 ~~Pv~~~~~~l~~~~~~g~L~l~~~~g~~~~~~~~~~~~~~~~a~lldsGNlVl~~~~~~~~~~~~lWQSFd~PTDTlLp 140 (752)
+.++.....+|.+.. ||||||.+.++ +|++++........++|+++|||||++.++ +.++|||.-+
T Consensus 14 g~~L~~g~~~L~~q~-dGnLvl~~~~~--vW~snt~~~~~~~~l~l~~dGNLVl~~~~~----~~~vW~S~t~------- 79 (111)
T 3mez_A 14 DNQLSYESAAFVMQG-DCNLVLYNEAG--GFQSNTHGRGVDCTLRLNNRGQLEIHSANS----NTPVWVYPRS------- 79 (111)
T ss_dssp TCEEEETTEEEEECT-TSCEEEECSSC--CEECCCTTSCSSCEEEECTTSCEEEECSSC----SSCSEEESSS-------
T ss_pred CCEEecCCEEEEEcc-CCeEEEECCCC--EEECCcccCCcCEEEEEcCCCcEEEEeCCC----CEEEEEeccc-------
Confidence 445555557899987 99999998776 898876433334679999999999997641 2359999721
Q ss_pred CCeeccccccCceeEEEEecCCCCCCCCCcEEeeecCCCceeEEEecCceEEEeccc
Q 043278 141 GMKLGINLQTGHQWFLQSWLDYSSPAQGSFTLGIEPNATNQLIIRWRRETIYWTSGL 197 (752)
Q Consensus 141 g~kl~~~~~tg~~~~L~Sw~s~~dps~G~f~l~~~~~g~~~~~~~~~~~~~yw~~g~ 197 (752)
.....|.|.+.++++|. ++++. .++|.++.
T Consensus 80 ----------------------~~~~~~~~~l~Lq~dGN--lvly~---~~~W~s~t 109 (111)
T 3mez_A 80 ----------------------VNTVRGNYAATLGPDQH--VTIYG---PAIWSTPA 109 (111)
T ss_dssp ----------------------CCCCSSCCEEEECTTSC--EEEEC---SEEEECCC
T ss_pred ----------------------cCCCCcCEEEEECCCCe--EEEec---cCEEccCC
Confidence 01134789999999994 45543 67898763
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.07 E-value=1.6e-10 Score=118.02 Aligned_cols=129 Identities=16% Similarity=0.161 Sum_probs=98.4
Q ss_pred ecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCC--cceeeeeeeeCCeeEEEEeeCCCCCHhHH
Q 043278 439 GEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTN--LVRLLGCSLHGEERLLVYEFMPNKSLDFF 516 (752)
Q Consensus 439 G~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~E~~~~gsL~~~ 516 (752)
+.|..+.||+....+|+.+++|..... ....+.+|+.+++.+.+.+ +.+++++...++..++||||+++.+|.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-- 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-- 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence 456669999998877888999997654 2235678999999886544 556888888777889999999998884
Q ss_pred HhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------------------
Q 043278 517 LFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS----------------------------------------------- 549 (752)
Q Consensus 517 l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~----------------------------------------------- 549 (752)
. .. .. ...++.++++.|..||+..
T Consensus 104 ~-~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 174 (264)
T 1nd4_A 104 S-SH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL 174 (264)
T ss_dssp T-SC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred c-Cc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHH
Confidence 2 11 11 2357778888888888743
Q ss_pred --------CCcEeecCCCCCcEEecCCCCceeccccccee
Q 043278 550 --------RLRVIHRDLKASNILLDDKMNPKISDFGMARI 581 (752)
Q Consensus 550 --------~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~ 581 (752)
+..++|+|++|.|||++++..+.|+||+.+..
T Consensus 175 ~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 175 KARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998876677999999864
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.03 E-value=6.8e-10 Score=96.58 Aligned_cols=71 Identities=23% Similarity=0.356 Sum_probs=55.3
Q ss_pred EEeccCCCCCCCCCceEEEecCCCcEEEEcCCCCcEEEeeccCCccccceeEecCCCeEEEEecCCCccceeEeeeccCC
Q 043278 55 IWIANRNTPILDQSGVLTIDSIDGNLKILHNGGNPIAVSSVEGASNNTSATLLQSGNLVLREMDTDGTIKRVLWQSFDYP 134 (752)
Q Consensus 55 vWvANr~~Pv~~~~~~l~~~~~~g~L~l~~~~g~~~~~~~~~~~~~~~~a~lldsGNlVl~~~~~~~~~~~~lWQSFd~P 134 (752)
+|.+|+..+ .....|.|.. ||||||.|.++.++|.+++........|+|+|+|||||++ ..+|+|
T Consensus 39 ~Wssnt~~~--~~~~~l~l~~-dGnLvl~d~~~~~vWss~t~~~~~~~~~~L~~dGNlvly~--------~~~W~s---- 103 (109)
T 3r0e_A 39 NWQSNTANN--GRDCKLTLTD-YGELVIKNGDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFG--------PSVFKI---- 103 (109)
T ss_dssp TEECCCTTS--CSSCEEEECT-TSCEEEECTTSCEEEECCCCCSSSCCEEEEETTTEEEEEC--------SEEEEE----
T ss_pred eEEcCCCCC--CCcEEEEEcC-CCeEEEEeCCCCEEEcCCCcCCCcCEEEEEcCCCeEEEEe--------cCEECC----
Confidence 699998865 2346899988 9999999998889997766443334579999999999984 379998
Q ss_pred CcccCCC
Q 043278 135 TDTLLPG 141 (752)
Q Consensus 135 TDTlLpg 141 (752)
+|.+||
T Consensus 104 -~t~~~~ 109 (109)
T 3r0e_A 104 -DPWVRG 109 (109)
T ss_dssp -CTTSCC
T ss_pred -CCccCC
Confidence 555554
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.93 E-value=3.7e-09 Score=113.51 Aligned_cols=142 Identities=13% Similarity=0.216 Sum_probs=107.1
Q ss_pred cCCeeecCCcccEEEEEecCCceeEEEEcc--cCC-cccHHHHHHHHHHHHhcC--CCCcceeeeeeeeC---CeeEEEE
Q 043278 434 TTNKLGEGGFGPVYKGKLADEQEVAIKRLS--RSS-GQGIVEFKNEVRLIAKLQ--HTNLVRLLGCSLHG---EERLLVY 505 (752)
Q Consensus 434 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~ 505 (752)
..+.|+.|.++.||+....+ ..+++|+.. ... ......+.+|+.+++.+. +..+.+++.++.+. ...++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 34689999999999998754 578888876 322 123346788999999997 45678888888776 3479999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS------------------------------------ 549 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------------------ 549 (752)
||+++..+.+.. ...++..++..++.++++.|+.||...
T Consensus 121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999998774321 123678888999999999999999731
Q ss_pred -------------------CCcEeecCCCCCcEEecCCCC--ceeccccccee
Q 043278 550 -------------------RLRVIHRDLKASNILLDDKMN--PKISDFGMARI 581 (752)
Q Consensus 550 -------------------~~~iiH~Dikp~NIll~~~~~--~kl~DFgla~~ 581 (752)
...++|+|++|.|||++.++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 256999999999999987753 68999999875
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.89 E-value=5.4e-09 Score=91.05 Aligned_cols=91 Identities=18% Similarity=0.269 Sum_probs=64.8
Q ss_pred CCCCCCCceEEEecCCCcEEEEcCCCCcEEEeeccCCccccceeEecCCCeEEEEecCCCccceeEeeeccCCCcccCCC
Q 043278 62 TPILDQSGVLTIDSIDGNLKILHNGGNPIAVSSVEGASNNTSATLLQSGNLVLREMDTDGTIKRVLWQSFDYPTDTLLPG 141 (752)
Q Consensus 62 ~Pv~~~~~~l~~~~~~g~L~l~~~~g~~~~~~~~~~~~~~~~a~lldsGNlVl~~~~~~~~~~~~lWQSFd~PTDTlLpg 141 (752)
.++.....+|.+.. ||||||.+. .++|++++........++|+|+|||||++.+ +.++|||-.+-
T Consensus 19 ~~L~sg~~~L~~q~-dGnLvl~~~--~~vW~snt~~~~~~~~l~l~~dGNLvl~d~~-----~~~iW~S~t~~------- 83 (110)
T 3r0e_B 19 GRLTAKNHQLVMQG-DCNLVLYGG--KYGWQSNTHGNGEHCFLRLNHKGELIIKDDD-----FKTIWSSRSSS------- 83 (110)
T ss_dssp EEEECSSCEEEECT-TSCEEEECS--SSCEECCCTTSSSSCEEEECTTSCEEEECTT-----CCEEEECCCCC-------
T ss_pred CEEEeCCEEEEEcC-CCeEEEECC--eEEEECCCcCCCcCEEEEEeCCCcEEEEeCC-----CCEEEEcCCcC-------
Confidence 34444457899987 999999875 5889887654333357999999999999754 46899985210
Q ss_pred CeeccccccCceeEEEEecCCCCCCCCCcEEeeecCCCceeEEEecCceEEEecc
Q 043278 142 MKLGINLQTGHQWFLQSWLDYSSPAQGSFTLGIEPNATNQLIIRWRRETIYWTSG 196 (752)
Q Consensus 142 ~kl~~~~~tg~~~~L~Sw~s~~dps~G~f~l~~~~~g~~~~~~~~~~~~~yw~~g 196 (752)
..|.|.+.++++|. ++++. .+.|.+|
T Consensus 84 ------------------------~~~~~~~~L~~dGN--lvly~---~~~W~t~ 109 (110)
T 3r0e_B 84 ------------------------KQGEYVLILQDDGF--GVIYG---PAIFETS 109 (110)
T ss_dssp ------------------------SSSCCEEEECTTSC--EEEEC---SEEEESC
T ss_pred ------------------------CCCCEEEEEcCCcc--EEEec---CCEecCC
Confidence 12458899999994 44433 3678876
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.84 E-value=3.8e-09 Score=110.56 Aligned_cols=186 Identities=20% Similarity=0.245 Sum_probs=122.6
Q ss_pred CCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcC-CCC--cceeeeeeeeCC---eeEEEEeeC
Q 043278 435 TNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQ-HTN--LVRLLGCSLHGE---ERLLVYEFM 508 (752)
Q Consensus 435 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~E~~ 508 (752)
.+.++.|....||+.. ..+++|+.... .....+.+|.+++..+. +.. +.+++.....++ ..++|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 3578999999999753 56888886432 34567889999998883 332 344555443333 347899999
Q ss_pred CCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 043278 509 PNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS--------------------------------------- 549 (752)
Q Consensus 509 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--------------------------------------- 549 (752)
++..|..... ..++..++..++.++++.|+.||+..
T Consensus 99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9998865442 23677888889999999999999611
Q ss_pred ----------------CCcEeecCCCCCcEEecC--CCCceecccccceeecccccccccc------------cccccCC
Q 043278 550 ----------------RLRVIHRDLKASNILLDD--KMNPKISDFGMARIFEVNESEANTK------------RIVGTYG 599 (752)
Q Consensus 550 ----------------~~~iiH~Dikp~NIll~~--~~~~kl~DFgla~~~~~~~~~~~~~------------~~~gt~~ 599 (752)
.+.++|+|++|.||++++ ...+.|+||+.+..-.......... ......+
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence 235899999999999998 5567899999987532211000000 0000111
Q ss_pred ccC-hhhhccCCCCccchhHHHHHHHHHHHhCCCC
Q 043278 600 YMS-PEYAMSGIVSIKTDVFSFGVLVLEIVSGQKN 633 (752)
Q Consensus 600 y~a-PE~~~~~~~t~k~DV~S~G~vl~elltG~~p 633 (752)
... |+..... ....+.|+++.+++++.+|..+
T Consensus 254 ~~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~ 286 (304)
T 3sg8_A 254 HKDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMD 286 (304)
T ss_dssp CSCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHH
T ss_pred CCCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHH
Confidence 122 2222111 1236899999999999999754
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=98.83 E-value=8.3e-09 Score=89.83 Aligned_cols=86 Identities=21% Similarity=0.381 Sum_probs=62.0
Q ss_pred CceEEEecCCCcEEEEcCCCCcEEEeeccCCccccceeEecCCCeEEEEecCCCccceeEeeeccCCCcccCCCCeeccc
Q 043278 68 SGVLTIDSIDGNLKILHNGGNPIAVSSVEGASNNTSATLLQSGNLVLREMDTDGTIKRVLWQSFDYPTDTLLPGMKLGIN 147 (752)
Q Consensus 68 ~~~l~~~~~~g~L~l~~~~g~~~~~~~~~~~~~~~~a~lldsGNlVl~~~~~~~~~~~~lWQSFd~PTDTlLpg~kl~~~ 147 (752)
..+|.+.. ||||||.+. +.++|++++........++|+++|||||++.+ +.++|||....
T Consensus 20 ~~~L~~q~-dGnLvly~~-~~~vW~snt~~~~~~~~l~l~~dGNLvl~~~~-----~~~~W~S~t~~------------- 79 (109)
T 3dzw_A 20 RYVFIMQE-DCNLVLYDV-DKPIWATNTGGLDRRCHLSMQSDGNLVVYSPR-----NNPIWASNTGG------------- 79 (109)
T ss_dssp TEEEEECT-TSCEEEEET-TEEEEECCCTTSSSSCEEEECTTSCEEEECTT-----SCEEEECCCCC-------------
T ss_pred CEEEEEcC-CCcEEEEeC-CEEEEECCcccCCCCEEEEEeCCCCEEEECCC-----CCEEEECCCCC-------------
Confidence 36799987 999999986 67889887644333457899999999999754 46899986311
Q ss_pred cccCceeEEEEecCCCCCCCCCcEEeeecCCCceeEEEecCceEEEecc
Q 043278 148 LQTGHQWFLQSWLDYSSPAQGSFTLGIEPNATNQLIIRWRRETIYWTSG 196 (752)
Q Consensus 148 ~~tg~~~~L~Sw~s~~dps~G~f~l~~~~~g~~~~~~~~~~~~~yw~~g 196 (752)
..+.|.+.++++|. ++++. .+.|.+|
T Consensus 80 ------------------~~~~~~~~L~ddGN--lvly~---~~~W~s~ 105 (109)
T 3dzw_A 80 ------------------ENGNYVCVLQKDRN--VVIYG---TARWATG 105 (109)
T ss_dssp ------------------SSSCEEEEECTTSC--EEEEE---SCCCCCC
T ss_pred ------------------CCCCEEEEEeCCCE--EEEEC---CCEEeCC
Confidence 12467899999984 44433 2567665
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.82 E-value=1.1e-08 Score=88.87 Aligned_cols=95 Identities=17% Similarity=0.284 Sum_probs=67.8
Q ss_pred cCCCCCCCCCceEEEecCCCcEEEEcCCCCcEEEeeccCCccccceeEecCCCeEEEEecCCCccceeEeeeccCCCccc
Q 043278 59 NRNTPILDQSGVLTIDSIDGNLKILHNGGNPIAVSSVEGASNNTSATLLQSGNLVLREMDTDGTIKRVLWQSFDYPTDTL 138 (752)
Q Consensus 59 Nr~~Pv~~~~~~l~~~~~~g~L~l~~~~g~~~~~~~~~~~~~~~~a~lldsGNlVl~~~~~~~~~~~~lWQSFd~PTDTl 138 (752)
..+.|+.+....|.+.. ||||||.++ +|++++........++|.++|||||++.+ +.++|+|- |
T Consensus 13 ~~g~~L~~g~~~L~~q~-dGNLvl~~~----~Wssnt~~~~~~~~l~l~~dGnLvl~d~~-----~~~vWss~-----t- 76 (109)
T 3r0e_A 13 DTEGHLKNGDFDLVMQD-DCNLVLYNG----NWQSNTANNGRDCKLTLTDYGELVIKNGD-----GSTVWKSG-----A- 76 (109)
T ss_dssp CTTCEEEETTEEEEECT-TSCEEEETT----TEECCCTTSCSSCEEEECTTSCEEEECTT-----SCEEEECC-----C-
T ss_pred CCCCEeECCCEEEEEec-CCeEEEEeC----eEEcCCCCCCCcEEEEEcCCCeEEEEeCC-----CCEEEcCC-----C-
Confidence 34556666667899987 999999973 68887654333457899999999998754 46899752 1
Q ss_pred CCCCeeccccccCceeEEEEecCCCCCCCCCcEEeeecCCCceeEEEecCceEEEeccccc
Q 043278 139 LPGMKLGINLQTGHQWFLQSWLDYSSPAQGSFTLGIEPNATNQLIIRWRRETIYWTSGLLL 199 (752)
Q Consensus 139 Lpg~kl~~~~~tg~~~~L~Sw~s~~dps~G~f~l~~~~~g~~~~~~~~~~~~~yw~~g~~~ 199 (752)
....+.|.+.++++| .++++. .+.|.+++|-
T Consensus 77 -------------------------~~~~~~~~~~L~~dG--Nlvly~---~~~W~s~t~~ 107 (109)
T 3r0e_A 77 -------------------------QSVKGNYAAVVHPDG--RLVVFG---PSVFKIDPWV 107 (109)
T ss_dssp -------------------------CCSSSCCEEEEETTT--EEEEEC---SEEEEECTTS
T ss_pred -------------------------cCCCcCEEEEEcCCC--eEEEEe---cCEECCCCcc
Confidence 002356899999999 455533 5789998764
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=98.78 E-value=1.6e-08 Score=103.36 Aligned_cols=69 Identities=19% Similarity=0.362 Sum_probs=57.1
Q ss_pred ccEEeccCCCCCCCCCceEEEecCCCcEEEEcCCCCcEEEeeccCCccccceeEecCCCeEEEEecCCCccceeEeeecc
Q 043278 53 EPIWIANRNTPILDQSGVLTIDSIDGNLKILHNGGNPIAVSSVEGASNNTSATLLQSGNLVLREMDTDGTIKRVLWQSFD 132 (752)
Q Consensus 53 t~vWvANr~~Pv~~~~~~l~~~~~~g~L~l~~~~g~~~~~~~~~~~~~~~~a~lldsGNlVl~~~~~~~~~~~~lWQSFd 132 (752)
+++|.+++.++- . ..|.+.. +|+|++.|.++..+|.+.+.. .....|+|+++|||||++. +.+|||||
T Consensus 184 ~~yW~Sgt~~~~--~-~~l~l~~-dGnLvl~d~~~~~vWsS~t~~-~~~~rl~Ld~dGnLvly~~-------~~~Wqsf~ 251 (276)
T 3m7h_A 184 AATWNAGTQGKG--A-VRAVFQG-DGNLVVYGAGNAVLWHSHTGG-HASAVLRLQANGSIAILDE-------KPVWARFG 251 (276)
T ss_dssp SEEEECCCTTTT--C-CEEEECT-TSCEEEECTTSCEEEECSCTT-CTTCEEEECTTSCEEEEEE-------EEEEESSS
T ss_pred eEEEECCCCCCc--c-EEEEEcC-CCeEEEEeCCCcEEEEecCCC-CCCEEEEEcCCccEEEEcC-------CCeEEccC
Confidence 789999998862 2 6789987 999999998888888877643 3346899999999999864 37999999
Q ss_pred C
Q 043278 133 Y 133 (752)
Q Consensus 133 ~ 133 (752)
|
T Consensus 252 ~ 252 (276)
T 3m7h_A 252 F 252 (276)
T ss_dssp C
T ss_pred c
Confidence 7
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=98.78 E-value=2e-08 Score=87.63 Aligned_cols=65 Identities=20% Similarity=0.278 Sum_probs=50.7
Q ss_pred EEeccCCCCCCCCCceEEEecCCCcEEEEcCCCC-cEEEeeccC--CccccceeEecCCCeEEEEecCCCccceeEeee
Q 043278 55 IWIANRNTPILDQSGVLTIDSIDGNLKILHNGGN-PIAVSSVEG--ASNNTSATLLQSGNLVLREMDTDGTIKRVLWQS 130 (752)
Q Consensus 55 vWvANr~~Pv~~~~~~l~~~~~~g~L~l~~~~g~-~~~~~~~~~--~~~~~~a~lldsGNlVl~~~~~~~~~~~~lWQS 130 (752)
||.+|+..+- ....|.+.. ||||||.|.++. ++|.+++.. ......++|+|+|||||++ ..+|+|
T Consensus 40 vW~snt~~~~--~~~~l~l~~-dGNLVl~~~~~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~--------~~~W~s 107 (111)
T 3mez_A 40 GFQSNTHGRG--VDCTLRLNN-RGQLEIHSANSNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYG--------PAIWST 107 (111)
T ss_dssp CEECCCTTSC--SSCEEEECT-TSCEEEECSSCSSCSEEESSSCCCCSSCCEEEECTTSCEEEEC--------SEEEEC
T ss_pred EEECCcccCC--cCEEEEEcC-CCcEEEEeCCCCEEEEEeccccCCCCcCEEEEECCCCeEEEec--------cCEEcc
Confidence 9999998762 235899987 999999998876 489877532 2234579999999999984 378987
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=3.7e-06 Score=87.73 Aligned_cols=135 Identities=21% Similarity=0.189 Sum_probs=97.0
Q ss_pred CeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCC---Ccceeeeeee-eCCeeEEEEeeCCCC
Q 043278 436 NKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHT---NLVRLLGCSL-HGEERLLVYEFMPNK 511 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~E~~~~g 511 (752)
+.++.|....||+. +..+++|+-.. ......+.+|..+|..+.+. .+.+++.++. ..+..++|||++++.
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 56888888899987 56788887432 23346788999999999653 3556666664 345678999999999
Q ss_pred CHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-------------------------------------------
Q 043278 512 SLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY------------------------------------------- 548 (752)
Q Consensus 512 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~------------------------------------------- 548 (752)
.+...... .++..++..++.++++.|+.||+.
T Consensus 99 ~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 99 ILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp ECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred ECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 88764321 245556666666777776666653
Q ss_pred --------------CCCcEeecCCCCCcEEecC---CCCc-eeccccccee
Q 043278 549 --------------SRLRVIHRDLKASNILLDD---KMNP-KISDFGMARI 581 (752)
Q Consensus 549 --------------~~~~iiH~Dikp~NIll~~---~~~~-kl~DFgla~~ 581 (752)
..+.++|+|++|.|||++. ++.+ .|+||+.+..
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2235799999999999987 4554 8999998875
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=98.35 E-value=2.1e-06 Score=73.83 Aligned_cols=55 Identities=27% Similarity=0.373 Sum_probs=42.9
Q ss_pred ceEEEecCCCcEEEEcCCCCcEEEeeccCC-ccccceeEecCCCeEEEEecCCCccceeEeee
Q 043278 69 GVLTIDSIDGNLKILHNGGNPIAVSSVEGA-SNNTSATLLQSGNLVLREMDTDGTIKRVLWQS 130 (752)
Q Consensus 69 ~~l~~~~~~g~L~l~~~~g~~~~~~~~~~~-~~~~~a~lldsGNlVl~~~~~~~~~~~~lWQS 130 (752)
-+|.+-. ||||||.+. +.++|.+++... .....++|.++|||||.+.+ ++++|.|
T Consensus 21 y~l~~q~-DgNLvly~~-~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~~-----~~~vWss 76 (105)
T 4h3o_A 21 YHFIMQD-DCNLVLYDH-STSTWASNTEIGGKSGCSAVLQSDGNFVVYDSS-----GRSLWAS 76 (105)
T ss_dssp EEEEECT-TSCEEEEET-TEEEEECCCCCTTCCSCEEEECTTSCEEEECTT-----CCEEEEC
T ss_pred EEEEECC-CCeEEEEEC-CEEEEEecCCCCCCccEEEEEeCCccEEEECCC-----cEEEEEe
Confidence 4688877 999999974 578898887433 23457899999999999765 5689986
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=98.31 E-value=1.1e-06 Score=87.95 Aligned_cols=93 Identities=17% Similarity=0.344 Sum_probs=64.4
Q ss_pred CCCCCCCCCceEEEecCCCcEEEEcCCCCcEEEeeccCCccccceeEecCCCeEEEEecCCCccceeEeeeccCCCcccC
Q 043278 60 RNTPILDQSGVLTIDSIDGNLKILHNGGNPIAVSSVEGASNNTSATLLQSGNLVLREMDTDGTIKRVLWQSFDYPTDTLL 139 (752)
Q Consensus 60 r~~Pv~~~~~~l~~~~~~g~L~l~~~~g~~~~~~~~~~~~~~~~a~lldsGNlVl~~~~~~~~~~~~lWQSFd~PTDTlL 139 (752)
.++|.++. -+|.+.. +|+|+|.+.+ .++|.+++........++|.++||||+++.+ +..+||||.+
T Consensus 144 ~~d~s~G~-~~l~l~~-dG~LvL~~~~-~~~W~s~~~~~~~~~~~~L~~~Gnl~ly~~~-----~~~vw~s~~~------ 209 (236)
T 1dlp_A 144 TQSLQLSP-YRLSMET-DCNLVLFDRD-DRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQ-----NIAVWTSGNS------ 209 (236)
T ss_dssp SCCCBCSS-CEEEEET-TTEEEEEBTT-BCCSCCCCCSSCSSCEEEEETTTEEEEEETT-----TEEEEECCCC------
T ss_pred CcEeecCc-EEEEECC-CCcEEEEcCC-EeEEeCCCcCCCCceEEEECCCCcEEEEeCC-----CcEEEEeCCC------
Confidence 34454333 5799987 8999998754 5777665532222356899999999999743 4689999943
Q ss_pred CCCeeccccccCceeEEEEecCCCCCCCCCcEEeeecCCCceeEEEecCceEEEecc
Q 043278 140 PGMKLGINLQTGHQWFLQSWLDYSSPAQGSFTLGIEPNATNQLIIRWRRETIYWTSG 196 (752)
Q Consensus 140 pg~kl~~~~~tg~~~~L~Sw~s~~dps~G~f~l~~~~~g~~~~~~~~~~~~~yw~~g 196 (752)
| ++|.|++.+|++|..+++ . ..||.+|
T Consensus 210 -------------------~------~~~~~rl~Ld~dG~l~ly--~---~~~W~sg 236 (236)
T 1dlp_A 210 -------------------R------SAGRYVFVLQPDRNLAIY--G---GALWTTG 236 (236)
T ss_dssp -------------------C------SSSCCEEEECSSSCEEEE--C---CCCCBC-
T ss_pred -------------------C------CCCCEEEEEcCCCcEEEe--C---CCCccCC
Confidence 1 236789999999965544 2 2688765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.29 E-value=3.5e-06 Score=86.18 Aligned_cols=136 Identities=18% Similarity=0.152 Sum_probs=99.5
Q ss_pred CeeecCCcc-cEEEEEec-CCceeEEEEcccCCcccHHHHHHHHHHHHhcC-CCCcceeeeeeeeCCeeEEEEeeCCCCC
Q 043278 436 NKLGEGGFG-PVYKGKLA-DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQ-HTNLVRLLGCSLHGEERLLVYEFMPNKS 512 (752)
Q Consensus 436 ~~LG~G~fg-~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~~gs 512 (752)
+.+..|..+ .||+.... ++..++||+-... ...++.+|...|..+. +--+.++++++.+++..++|||++++.+
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 456666665 58987764 4567899986533 3456788999998884 3346778899998899999999999988
Q ss_pred HhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc--------------------------------------------
Q 043278 513 LDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY-------------------------------------------- 548 (752)
Q Consensus 513 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-------------------------------------------- 548 (752)
+....... ......++.+++..|..||..
T Consensus 107 ~~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 107 AFQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred ccccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 87654321 123345667777777777742
Q ss_pred -----------CCCcEeecCCCCCcEEecCCCCceeccccccee
Q 043278 549 -----------SRLRVIHRDLKASNILLDDKMNPKISDFGMARI 581 (752)
Q Consensus 549 -----------~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~ 581 (752)
..+.++|+|+++.|||+++++.+-|+||+.+..
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 112389999999999999887778999998864
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.18 E-value=2.5e-06 Score=91.08 Aligned_cols=79 Identities=6% Similarity=0.040 Sum_probs=54.9
Q ss_pred Cee-ecCCcccEEEEEec-------CCceeEEEEcccCC---cccHHHHHHHHHHHHhcCC---CCcceeeeeeeeC---
Q 043278 436 NKL-GEGGFGPVYKGKLA-------DEQEVAIKRLSRSS---GQGIVEFKNEVRLIAKLQH---TNLVRLLGCSLHG--- 498 (752)
Q Consensus 436 ~~L-G~G~fg~Vy~~~~~-------~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~--- 498 (752)
+.| +.|....+|+.... +++.+++|+..... ......+.+|+.++..+.. ..+.+++.++.++
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 567 88889999998764 26678888765432 1012356788888888742 3567788877655
Q ss_pred CeeEEEEeeCCCCCHh
Q 043278 499 EERLLVYEFMPNKSLD 514 (752)
Q Consensus 499 ~~~~lv~E~~~~gsL~ 514 (752)
...++||||+++..+.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3568999999987654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.91 E-value=5.9e-05 Score=79.67 Aligned_cols=141 Identities=17% Similarity=0.203 Sum_probs=81.1
Q ss_pred CeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcC--CCCcceeee------eeeeCCeeEEEEee
Q 043278 436 NKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQ--HTNLVRLLG------CSLHGEERLLVYEF 507 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~------~~~~~~~~~lv~E~ 507 (752)
+.|+.|..+.||+....+| .+++|+.... ..++..|..++..+. .-.+.+++. +...++..+++|||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 3466677899999987655 4889988652 233444555555542 112333443 12345678999999
Q ss_pred CCCCCHh--------------HHHhhc-C-C--C-------CCCCHHHHH------------------------------
Q 043278 508 MPNKSLD--------------FFLFNS-G-R--K-------NVLNWEKRF------------------------------ 532 (752)
Q Consensus 508 ~~~gsL~--------------~~l~~~-~-~--~-------~~l~~~~~~------------------------------ 532 (752)
+++..+. ..++.. . . . ..-.|...+
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 011111 0 0 0 011232210
Q ss_pred -HHHHHHHHHHHHHHh----------cCCCcEeecCCCCCcEEecCCCCceeccccccee
Q 043278 533 -IIIEGISQGLLYLHK----------YSRLRVIHRDLKASNILLDDKMNPKISDFGMARI 581 (752)
Q Consensus 533 -~i~~~i~~~l~~LH~----------~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~ 581 (752)
.+...+.+++.+|+. ..+..++|+|+++.|||++.++.+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 111224446667763 1235699999999999998888999999998763
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.89 E-value=5e-05 Score=78.32 Aligned_cols=80 Identities=18% Similarity=0.218 Sum_probs=59.5
Q ss_pred cCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCC---CcceeeeeeeeCCeeEEEEe
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHT---NLVRLLGCSLHGEERLLVYE 506 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~~~~lv~E 506 (752)
......+.+|.|..+.||+.++.+|+.++||+...........|..|...|+.+... -+.++++.. ..++|||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e 90 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAME 90 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEE
Confidence 345556789999999999999999999999987665544455688999999888432 244455432 3478999
Q ss_pred eCCCCCH
Q 043278 507 FMPNKSL 513 (752)
Q Consensus 507 ~~~~gsL 513 (752)
|++.+..
T Consensus 91 ~l~~~~~ 97 (288)
T 3f7w_A 91 WVDERPP 97 (288)
T ss_dssp CCCCCCC
T ss_pred eecccCC
Confidence 9987654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.88 E-value=5.4e-05 Score=82.02 Aligned_cols=75 Identities=15% Similarity=0.174 Sum_probs=49.5
Q ss_pred CCeeecCCcccEEEEEec-CCceeEEEEcccCCc-------ccHHHHHHHHHHHHhcCC--CC-cceeeeeeeeCCeeEE
Q 043278 435 TNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSG-------QGIVEFKNEVRLIAKLQH--TN-LVRLLGCSLHGEERLL 503 (752)
Q Consensus 435 ~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~~E~~~l~~l~h--~n-iv~l~~~~~~~~~~~l 503 (752)
.+.||.|..+.||++... +++.++||....... ....++..|.+++..+.. +. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 368999999999999764 467899997643211 123456788888887742 33 3345543 3455789
Q ss_pred EEeeCCCC
Q 043278 504 VYEFMPNK 511 (752)
Q Consensus 504 v~E~~~~g 511 (752)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999763
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.70 E-value=0.00026 Score=73.65 Aligned_cols=138 Identities=21% Similarity=0.172 Sum_probs=92.6
Q ss_pred CCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcC---CCCcceeeeeeeeCCeeEEEEeeCCCC
Q 043278 435 TNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQ---HTNLVRLLGCSLHGEERLLVYEFMPNK 511 (752)
Q Consensus 435 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~E~~~~g 511 (752)
.+.|+.|....+|+... ++..++||+.... ....+..|...|+.+. ...+.++++++...+..++||||+++.
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 46789999999999886 4677889987543 3567889999888884 356888888888778899999999987
Q ss_pred CHhH-----------HHhhcCCCC-------------------CCCHHHHHH---HH----------------HHHHHH-
Q 043278 512 SLDF-----------FLFNSGRKN-------------------VLNWEKRFI---II----------------EGISQG- 541 (752)
Q Consensus 512 sL~~-----------~l~~~~~~~-------------------~l~~~~~~~---i~----------------~~i~~~- 541 (752)
.+.. .++...... .-+|..... +. ..++..
T Consensus 117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l 196 (312)
T 3jr1_A 117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV 196 (312)
T ss_dssp CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence 6521 122221100 124543321 11 111111
Q ss_pred HHHHHh-cCCCcEeecCCCCCcEEecCCCCceecccc
Q 043278 542 LLYLHK-YSRLRVIHRDLKASNILLDDKMNPKISDFG 577 (752)
Q Consensus 542 l~~LH~-~~~~~iiH~Dikp~NIll~~~~~~kl~DFg 577 (752)
...|.. ...+.++|+|+.+.|++++.++ +.|+|+.
T Consensus 197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 223322 2346799999999999999887 8899984
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.57 E-value=0.00044 Score=75.41 Aligned_cols=77 Identities=9% Similarity=0.100 Sum_probs=46.9
Q ss_pred CCcEeecCCCCCcEEecCCCCceecccccceeecccccccccccccc--cCCccChhhhccC---CCCccchhHHHHHHH
Q 043278 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVG--TYGYMSPEYAMSG---IVSIKTDVFSFGVLV 624 (752)
Q Consensus 550 ~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~t~k~DV~S~G~vl 624 (752)
...++|+|++|.|||++.++ ++|+||+.+..-....... .... ...|.+|+..... .-....++......+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla---~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIG---AYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHH---HHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHH---HHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 45699999999999998876 9999999987532111100 0010 1345566544311 111234556777777
Q ss_pred HHHHhC
Q 043278 625 LEIVSG 630 (752)
Q Consensus 625 ~elltG 630 (752)
|+.+.+
T Consensus 307 ~~~y~~ 312 (420)
T 2pyw_A 307 WNLFNK 312 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 777665
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.24 E-value=0.00071 Score=70.70 Aligned_cols=158 Identities=15% Similarity=0.116 Sum_probs=87.6
Q ss_pred cHHHHHHHhcCCCc-----CCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCC--cceeee
Q 043278 421 DFQTIAAAANNFST-----TNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTN--LVRLLG 493 (752)
Q Consensus 421 ~~~~i~~~~~~~~~-----~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~ 493 (752)
+.+++...-.+|.. .+.|+.|....+|+....+| .+++|...... ...++..|+.++..+...+ +.+++.
T Consensus 8 ~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~ 84 (322)
T 2ppq_A 8 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP 84 (322)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccC
Confidence 44555555555654 24566788889999987665 68889886521 1124556777777663212 233332
Q ss_pred e------eeeCCeeEEEEeeCCCCCHhH--------------HHhhcCC----C--CC---CCHHHHHH-----------
Q 043278 494 C------SLHGEERLLVYEFMPNKSLDF--------------FLFNSGR----K--NV---LNWEKRFI----------- 533 (752)
Q Consensus 494 ~------~~~~~~~~lv~E~~~~gsL~~--------------~l~~~~~----~--~~---l~~~~~~~----------- 533 (752)
. ....+..+++++|+++..+.. .++.... . .. ..|...+.
T Consensus 85 ~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 164 (322)
T 2ppq_A 85 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 164 (322)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred CCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhh
Confidence 1 122356789999999865421 0111100 0 00 11322111
Q ss_pred -HHHHHHHHHHHHHhc----CCCcEeecCCCCCcEEecCCCCceeccccccee
Q 043278 534 -IIEGISQGLLYLHKY----SRLRVIHRDLKASNILLDDKMNPKISDFGMARI 581 (752)
Q Consensus 534 -i~~~i~~~l~~LH~~----~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~ 581 (752)
+...+...++.|+.. .+..++|+|+++.|||++++..+.|+||+.+..
T Consensus 165 ~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 165 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 011244455566532 234699999999999999876668999998764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.18 E-value=0.0015 Score=67.60 Aligned_cols=128 Identities=14% Similarity=0.135 Sum_probs=75.8
Q ss_pred CCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCc-ceeeeeeeeCCeeEEEEeeC-CCCC
Q 043278 435 TNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL-VRLLGCSLHGEERLLVYEFM-PNKS 512 (752)
Q Consensus 435 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~~-~~gs 512 (752)
.+.|+.|....+|+. +.+++|+........ ....+|+..+..+...++ .++++.+ .+.-++++||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence 478999999999998 568888875432111 123567777777643333 3555543 33457899999 6655
Q ss_pred HhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------------
Q 043278 513 LDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHK--------------------------------------------- 547 (752)
Q Consensus 513 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~--------------------------------------------- 547 (752)
+....... +..++.++++.|+-||+
T Consensus 95 l~~~~~~~----------~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~ 164 (301)
T 3dxq_A 95 MSPEKFKT----------RPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRS 164 (301)
T ss_dssp CCHHHHHH----------STTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHH
T ss_pred CCHhhHhh----------hHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHH
Confidence 43210000 00012222222222221
Q ss_pred -----cCCCcEeecCCCCCcEEecCCCCceeccccccee
Q 043278 548 -----YSRLRVIHRDLKASNILLDDKMNPKISDFGMARI 581 (752)
Q Consensus 548 -----~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~ 581 (752)
.....++|+|+.+.||+ ..++.+.|+||..+..
T Consensus 165 ~l~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 165 ALAAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp HHHSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHhcCCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 12345899999999999 5667789999998875
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.18 E-value=0.0016 Score=69.49 Aligned_cols=141 Identities=19% Similarity=0.219 Sum_probs=83.5
Q ss_pred CeeecCCcccEEEEEecC--------CceeEEEEcccCCcccHHHHHHHHHHHHhcCCCC-cceeeeeeeeCCeeEEEEe
Q 043278 436 NKLGEGGFGPVYKGKLAD--------EQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTN-LVRLLGCSLHGEERLLVYE 506 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~E 506 (752)
+.|..|-...+|+....+ ++.+++|+... .......+.+|.++++.+...+ ..++++++.++ +|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEE
Confidence 577788889999988742 46788888633 2234566678999998884322 35666665432 9999
Q ss_pred eCCCCCHhHH-----------------HhhcCC--CCCC--CHHHHHHHHHHHHH-------------------HHHHHH
Q 043278 507 FMPNKSLDFF-----------------LFNSGR--KNVL--NWEKRFIIIEGISQ-------------------GLLYLH 546 (752)
Q Consensus 507 ~~~~gsL~~~-----------------l~~~~~--~~~l--~~~~~~~i~~~i~~-------------------~l~~LH 546 (752)
|+++..|..- ++.... .+.. -|.+..++..++.. .+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998665311 111110 1111 23444444443321 233332
Q ss_pred h----c-CCCcEeecCCCCCcEEecCC----CCceeccccccee
Q 043278 547 K----Y-SRLRVIHRDLKASNILLDDK----MNPKISDFGMARI 581 (752)
Q Consensus 547 ~----~-~~~~iiH~Dikp~NIll~~~----~~~kl~DFgla~~ 581 (752)
+ . ....++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2 1 23468999999999999876 7899999998875
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.17 E-value=0.0073 Score=63.02 Aligned_cols=142 Identities=13% Similarity=0.144 Sum_probs=82.9
Q ss_pred CeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCC--Ccceeeee-----eeeCCeeEEEEeeC
Q 043278 436 NKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHT--NLVRLLGC-----SLHGEERLLVYEFM 508 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~-----~~~~~~~~lv~E~~ 508 (752)
..|+ |....||+....+|+.+++|...... .....+..|..++..+... .+.+++.. ...++..+++||++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 3566 88889999887778789999986331 2345667788888777422 23444443 12244567899999
Q ss_pred CCCCHh-----HH---------Hhhc--C----CCCCCCHHHH----HHH---------------HHHHHHHHHHHHhc-
Q 043278 509 PNKSLD-----FF---------LFNS--G----RKNVLNWEKR----FII---------------IEGISQGLLYLHKY- 548 (752)
Q Consensus 509 ~~gsL~-----~~---------l~~~--~----~~~~l~~~~~----~~i---------------~~~i~~~l~~LH~~- 548 (752)
++..+. .. ++.. . ....+++... ..+ ...+.+.++.+...
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 875532 10 1110 0 1112232211 001 11111223333221
Q ss_pred ---CCCcEeecCCCCCcEEecCCCCceeccccccee
Q 043278 549 ---SRLRVIHRDLKASNILLDDKMNPKISDFGMARI 581 (752)
Q Consensus 549 ---~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~ 581 (752)
.+..++|+|+++.|||++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 234589999999999999 4 899999988764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.17 E-value=0.00075 Score=73.63 Aligned_cols=72 Identities=15% Similarity=0.253 Sum_probs=49.4
Q ss_pred CeeecCCcccEEEEEecC--------CceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCc-ceeeeeeeeCCeeEEEEe
Q 043278 436 NKLGEGGFGPVYKGKLAD--------EQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL-VRLLGCSLHGEERLLVYE 506 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E 506 (752)
+.|+.|....||+....+ ++.+++|+.... .....+..|..++..+...++ .++++.+.+ .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 578888889999998753 467888887432 122455679888888853333 566666543 28999
Q ss_pred eCCCCCH
Q 043278 507 FMPNKSL 513 (752)
Q Consensus 507 ~~~~gsL 513 (752)
|+++..|
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9986444
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.15 E-value=0.0029 Score=66.41 Aligned_cols=142 Identities=15% Similarity=0.095 Sum_probs=72.7
Q ss_pred CeeecCCccc-EEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCC--CCcceeeeeeeeCCeeEEEEeeCCCCC
Q 043278 436 NKLGEGGFGP-VYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQH--TNLVRLLGCSLHGEERLLVYEFMPNKS 512 (752)
Q Consensus 436 ~~LG~G~fg~-Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~E~~~~gs 512 (752)
+.|+.|.... +|+....+++.+++|....... .++..|+.++..+.. -.+.+++.+..+. -+++||++++..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcc
Confidence 4565554444 6677654467777876544321 223456666666532 2355666654333 278999998766
Q ss_pred HhHHHhhc---------------------CC--CCCCCHHHHH-------H-------------HHHHHHHHHHHHH---
Q 043278 513 LDFFLFNS---------------------GR--KNVLNWEKRF-------I-------------IIEGISQGLLYLH--- 546 (752)
Q Consensus 513 L~~~l~~~---------------------~~--~~~l~~~~~~-------~-------------i~~~i~~~l~~LH--- 546 (752)
+...+... .. ...++..... . ....+...++.|.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 64333210 00 0111111100 0 0011112222221
Q ss_pred hcCCCcEeecCCCCCcEEecCC----CCceecccccceee
Q 043278 547 KYSRLRVIHRDLKASNILLDDK----MNPKISDFGMARIF 582 (752)
Q Consensus 547 ~~~~~~iiH~Dikp~NIll~~~----~~~kl~DFgla~~~ 582 (752)
......++|+|+++.|||++.+ ..+.|+||+.+..-
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 1223569999999999999874 67899999988753
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.01 E-value=0.0028 Score=69.50 Aligned_cols=73 Identities=16% Similarity=0.161 Sum_probs=47.6
Q ss_pred CeeecCCcccEEEEEecC-CceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCc-ceeeeeeeeCCeeEEEEeeCCCCCH
Q 043278 436 NKLGEGGFGPVYKGKLAD-EQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL-VRLLGCSLHGEERLLVYEFMPNKSL 513 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~~~~gsL 513 (752)
+.|+.|-...+|+....+ +..+++|+....... ......|..++..+...++ .++++.+. + .+||||+++..|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 578888889999998765 467888876433211 1122578888888865554 46676663 2 259999987554
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.62 E-value=0.0038 Score=66.59 Aligned_cols=73 Identities=11% Similarity=0.160 Sum_probs=43.7
Q ss_pred CeeecCCcccEEEEEecC---------CceeEEEEcccCCcccHHHHHHHHHHHHhcCCCC-cceeeeeeeeCCeeEEEE
Q 043278 436 NKLGEGGFGPVYKGKLAD---------EQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTN-LVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~~---------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~ 505 (752)
+.|+.|....+|+....+ ++.+++|+....... ......|..++..+...+ ..++++.. . -.+||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 467888889999988754 267888876543221 112367888888774333 34566543 2 36899
Q ss_pred eeCCCCCH
Q 043278 506 EFMPNKSL 513 (752)
Q Consensus 506 E~~~~gsL 513 (752)
||+++..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.59 E-value=0.022 Score=59.87 Aligned_cols=32 Identities=22% Similarity=0.402 Sum_probs=28.3
Q ss_pred CCcEeecCCCCCcEEecCCCCceeccccccee
Q 043278 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARI 581 (752)
Q Consensus 550 ~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~ 581 (752)
...++|+|+.+.||++++++.+.|+||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 34699999999999999888899999988775
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.14 E-value=0.022 Score=54.78 Aligned_cols=102 Identities=13% Similarity=0.058 Sum_probs=65.2
Q ss_pred CCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccccc
Q 043278 510 NKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEA 589 (752)
Q Consensus 510 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 589 (752)
.-+|.++|... ..++++++++.++.|.+.+|.-+-.... + ..+=+-|..|+|..+|.+.+.+ ..+.
T Consensus 32 ~vSL~eIL~~~--~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 32 ALSLEEILRLY--NQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred cccHHHHHHHc--CCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc---------
Confidence 34688888653 4569999999999999999877622110 1 1233457899999999887753 1110
Q ss_pred ccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCC
Q 043278 590 NTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631 (752)
Q Consensus 590 ~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~ 631 (752)
.....+.|||... ...+.+.-|||+|+++|.-+--.
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDyg 133 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYG 133 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcC
Confidence 1122456887653 45578899999999999998643
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.40 E-value=0.19 Score=54.13 Aligned_cols=140 Identities=16% Similarity=0.240 Sum_probs=83.5
Q ss_pred CeeecCCcccEEEEEecC--------CceeEEEEcccCCcccHHHHHHHHHHHHhcCCCC-cceeeeeeeeCCeeEEEEe
Q 043278 436 NKLGEGGFGPVYKGKLAD--------EQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTN-LVRLLGCSLHGEERLLVYE 506 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~E 506 (752)
+.|..|-...+|+....+ ++.+++++....... .....+|..+++.+...+ ..++++.+. -++|||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence 577788889999998753 577888886543221 122367888888774323 344554332 378999
Q ss_pred eCCCCCHhH-------H----------Hhh--c-----C---CCCCCCHHHHHHHHHHH-------------------HH
Q 043278 507 FMPNKSLDF-------F----------LFN--S-----G---RKNVLNWEKRFIIIEGI-------------------SQ 540 (752)
Q Consensus 507 ~~~~gsL~~-------~----------l~~--~-----~---~~~~l~~~~~~~i~~~i-------------------~~ 540 (752)
|+++..|.. . ++. . . .+.+..|.+...+..++ ..
T Consensus 151 fI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~ 230 (424)
T 3mes_A 151 FIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILE 230 (424)
T ss_dssp CCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHH
T ss_pred EeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHH
Confidence 999866421 0 010 0 0 11111243333333222 22
Q ss_pred HHHHHHh---------------------cCCCcEeecCCCCCcEEecCCCCceeccccccee
Q 043278 541 GLLYLHK---------------------YSRLRVIHRDLKASNILLDDKMNPKISDFGMARI 581 (752)
Q Consensus 541 ~l~~LH~---------------------~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~ 581 (752)
.+..|.+ .....++|+|+.+.||+ +.++.+.|+||..+..
T Consensus 231 e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 231 EIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 2333321 12345899999999999 8888999999999875
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.87 E-value=0.39 Score=51.40 Aligned_cols=30 Identities=30% Similarity=0.430 Sum_probs=25.8
Q ss_pred cEeecCCCCCcEEe------cCCCCceeccccccee
Q 043278 552 RVIHRDLKASNILL------DDKMNPKISDFGMARI 581 (752)
Q Consensus 552 ~iiH~Dikp~NIll------~~~~~~kl~DFgla~~ 581 (752)
.++|+|+.+.|||+ +++..++++||.+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36799999999999 4567799999999875
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=82.04 E-value=2.9 Score=40.18 Aligned_cols=83 Identities=7% Similarity=-0.000 Sum_probs=58.8
Q ss_pred CCCCcceeeeeeeeCCeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHH-HHHhcCCCcEeecCCCCCc
Q 043278 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLL-YLHKYSRLRVIHRDLKASN 562 (752)
Q Consensus 484 ~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~-~LH~~~~~~iiH~Dikp~N 562 (752)
.||++ -...-.+++...+.|+.-+++.=...+ ..++...+++++.+|+.... +++. -+|--|+|+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~N 114 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPEN 114 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCce
Confidence 57777 334446667777777765333222223 23788899999998888766 5544 5788899999
Q ss_pred EEecCCCCceecccccc
Q 043278 563 ILLDDKMNPKISDFGMA 579 (752)
Q Consensus 563 Ill~~~~~~kl~DFgla 579 (752)
|++|.++.++|.-.|+-
T Consensus 115 L~f~~~~~p~i~hRGi~ 131 (219)
T 4ano_A 115 LMFNRALEPFFLHVGVK 131 (219)
T ss_dssp EEECTTCCEEESCCEET
T ss_pred EEEeCCCcEEEEEcCCc
Confidence 99999999999866653
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 752 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-69 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-64 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-64 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-63 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-61 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-61 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-61 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-61 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-60 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-59 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-59 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 7e-59 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-58 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-58 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 8e-58 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-57 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-57 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-57 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-56 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-56 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 6e-56 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-55 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-55 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-55 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-54 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-54 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-53 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-53 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-51 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-49 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-48 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-48 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-48 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-46 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-43 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-43 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-43 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 9e-43 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-42 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-42 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-42 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-42 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-41 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-41 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-40 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-40 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-40 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-39 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-38 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-38 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 7e-38 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-37 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-37 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-37 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-35 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-34 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-32 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-30 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-30 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 8e-30 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-27 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-25 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 1e-12 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 3e-09 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 0.002 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 2e-07 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 9e-06 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 3e-04 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (578), Expect = 2e-69
Identities = 72/285 (25%), Positives = 131/285 (45%), Gaps = 20/285 (7%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLV 489
+ ++G G FG VYKGK + V + ++ + Q + FKNEV ++ K +H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
+G S + +V ++ SL L K K I +QG+ YLH
Sbjct: 68 LFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLH--- 121
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM-- 607
+IHRDLK++NI L + + KI DFG+A + +++ G+ +M+PE
Sbjct: 122 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 608 -SGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666
S ++DV++FG+++ E+++GQ P +N ++ G + P L
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQ------LPYSNINNRDQIIFMVGRGY----LSPDL 231
Query: 667 EQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETMPLP 711
+N + C++ + +RP P+++ ++ LP
Sbjct: 232 S-KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 2e-64
Identities = 77/276 (27%), Positives = 125/276 (45%), Gaps = 22/276 (7%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLV 489
+LG G FG V+ G +VA+K L + S F E L+ +LQH LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 71
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
RL E ++ E+M N SL FL L K + I++G+ ++ +
Sbjct: 72 RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEE-- 127
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSG 609
IHRDL+A+NIL+ D ++ KI+DFG+AR+ E NE A + +PE G
Sbjct: 128 -RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFPIKWTAPEAINYG 185
Query: 610 IVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQP 669
+IK+DV+SFG+L+ EIV+ + + + ++ ++
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV---------------IQNLERGYRMV 230
Query: 670 CSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
N + LC +++ DRPT + +L++
Sbjct: 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 2e-64
Identities = 76/288 (26%), Positives = 128/288 (44%), Gaps = 22/288 (7%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLV 489
+ KLG+G FG V+ G VAIK L + F E +++ KL+H LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 75
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
+L + E +V E+M SL FL K + + + I+ G+ Y+ +
Sbjct: 76 QLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVERM- 132
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSG 609
+HRDL+A+NIL+ + + K++DFG+AR+ E NE A + +PE A+ G
Sbjct: 133 --NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ-GAKFPIKWTAPEAALYG 189
Query: 610 IVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQP 669
+IK+DV+SFG+L+ E+ + + +R + L+ ++ P
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV---------------LDQVERGYRMP 234
Query: 670 CSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETMPLPPPKQPA 717
C + C + + +RPT + L++ P QP
Sbjct: 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 282
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 6e-63
Identities = 72/276 (26%), Positives = 117/276 (42%), Gaps = 24/276 (8%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLV 489
+ + ++G G FG V+ G ++ +VAIK + + +F E ++ KL H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLV 63
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
+L G L LV+EFM + L +L ++ + E + + +G+ YL +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEE-- 119
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSG 609
VIHRDL A N L+ + K+SDFGM R ++ ++ + SPE
Sbjct: 120 -ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFS 177
Query: 610 IVSIKTDVFSFGVLVLEIVSGQK-NHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQ 668
S K+DV+SFGVL+ E+ S K + + I G L P L
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI---------STGFRLYKPRLAS 228
Query: 669 PCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ 704
+ C +++ DRP ++ L
Sbjct: 229 T-------HVYQIMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (529), Expect = 1e-61
Identities = 72/301 (23%), Positives = 124/301 (41%), Gaps = 30/301 (9%)
Query: 428 AANNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAKLQH 485
++F ++LG G G V+K +A K + I E++++ +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 486 TNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYL 545
+V G E + E M SLD L +GR + + + + +GL YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYL 120
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEY 605
+ +++HRD+K SNIL++ + K+ DFG++ ++ VGT YMSPE
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPER 174
Query: 606 AMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPS 665
S+++D++S G+ ++E+ G+ +P P D K LEL+
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGR------YPIPP-----------PDAKELELMFGC 217
Query: 666 LEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETMPLPPPKQPAFFINANAD 725
+ +A R G RP M + L + + PPPK P+ +
Sbjct: 218 QVEGDAAETPPRPRTPGRPLSSYGMDSRPPMA--IFELLDYIVNEPPPKLPSGVFSLEFQ 275
Query: 726 D 726
D
Sbjct: 276 D 276
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 1e-61
Identities = 65/276 (23%), Positives = 120/276 (43%), Gaps = 22/276 (7%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLV 489
+ + +LG G FG V GK + +VAIK + S EF E +++ L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
+L G ++ E+M N L +L ++ ++ + + + + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLE--- 117
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSG 609
+ +HRDL A N L++D+ K+SDFG++R ++ ++ + PE M
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYS 176
Query: 610 IVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQP 669
S K+D+++FGVL+ EI S K ++ ++ + E I L
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGK---------------MPYERFTNSETAEHIAQGLRLY 221
Query: 670 CSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
+ + C ++A +RPT ++ + +
Sbjct: 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 205 bits (523), Expect = 4e-61
Identities = 67/304 (22%), Positives = 123/304 (40%), Gaps = 46/304 (15%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKL------ADEQEVAIKRLSRSSGQGIV-EFKNEVRLIAK 482
NN +GEG FG V++ + VA+K L + + +F+ E L+A+
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 483 LQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNV----------------- 525
+ N+V+LLG G+ L++E+M L+ FL + V
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 526 ----LNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARI 581
L+ ++ I ++ G+ YL + + +HRDL N L+ + M KI+DFG++R
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 582 FEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDR 641
+ +M PE + ++DV+++GV++ EI S P
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL-----QP-- 242
Query: 642 PLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVC 701
+ ++ + + + C N + ++ LC DRP+ +
Sbjct: 243 --------YYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294
Query: 702 MLQN 705
+LQ
Sbjct: 295 ILQR 298
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 5e-61
Identities = 60/291 (20%), Positives = 111/291 (38%), Gaps = 28/291 (9%)
Query: 437 KLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGC-- 494
+G+G FG V++GK +EVA+K S + + E+ L+H N++ +
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSW-FREAEIYQTVMLRHENILGFIAADN 67
Query: 495 --SLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHK----- 547
+ + LV ++ + SL +L + + E + + GL +LH
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 548 YSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES--EANTKRIVGTYGYMSPEY 605
+ + HRDLK+ NIL+ I+D G+A + + VGT YM+PE
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183
Query: 606 AMSGI------VSIKTDVFSFGVLVLEIVSGQKNHTRH----HPDRPLNLIGYAWQLLSD 655
I + D+++ G++ EI H P L + + +
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243
Query: 656 GKGLELIDPSLEQPCSANEVMRCIH-VGLLCVQDQAMDRPTMPEVVCMLQN 705
+ + P++ + E +R + + C R T + L
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 203 bits (517), Expect = 2e-60
Identities = 73/302 (24%), Positives = 127/302 (42%), Gaps = 37/302 (12%)
Query: 420 FDFQTIAAAANNFSTT---------NKLGEGGFGPVYKGKLA----DEQEVAIKRLSRS- 465
F F+ A F+ +G G FG V G L E VAIK L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 466 SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNV 525
+ + +F +E ++ + H N++ L G +++ EFM N SLD FL + +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 526 LNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVN 585
+ ++ GI+ G+ YL +HRDL A NIL++ + K+SDFG++R E +
Sbjct: 126 -TVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 586 ESEANTKRIVG---TYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRP 642
S+ +G + +PE + +DV+S+G+++ E++S + RP
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE--------RP 233
Query: 643 LNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702
+ +++ + I+ P + + L C Q RP ++V
Sbjct: 234 -------YWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286
Query: 703 LQ 704
L
Sbjct: 287 LD 288
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 200 bits (510), Expect = 2e-59
Identities = 69/277 (24%), Positives = 120/277 (43%), Gaps = 22/277 (7%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLAD-EQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL 488
+ + +KLG G +G VY+G VA+K L + + + EF E ++ +++H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 75
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
V+LLG ++ EFM +L +L R+ ++ + IS + YL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLE-- 132
Query: 549 SRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMS 608
+ IHRDL A N L+ + K++DFG++R+ + A+ + +PE
Sbjct: 133 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA-GAKFPIKWTAPESLAY 190
Query: 609 GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQ 668
SIK+DV++FGVL+ EI + +P L+ + EL++
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGM---SPYPGIDLSQV------------YELLEKDYRM 235
Query: 669 PCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
+ + C Q DRP+ E+ +
Sbjct: 236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 272
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 6e-59
Identities = 64/282 (22%), Positives = 121/282 (42%), Gaps = 27/282 (9%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLAD-----EQEVAIKRLSRSSGQG-IVEFKNEVRLIAKL 483
+ + +G G FG VYKG L E VAIK L + V+F E ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 484 QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLL 543
H N++RL G + +++ E+M N + F + + + ++ GI+ G+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGA--LDKFLREKDGEFSVLQLVGMLRGIAAGMK 124
Query: 544 YLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANT-KRIVGTYGYMS 602
YL + +HRDL A NIL++ + K+SDFG++R+ E + T + +
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 603 PEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELI 662
PE + +DV+SFG+++ E+++ + + + ++ I
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV---------------MKAI 226
Query: 663 DPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ 704
+ P + + + C Q + RP ++V +L
Sbjct: 227 NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILD 268
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (508), Expect = 7e-59
Identities = 75/282 (26%), Positives = 121/282 (42%), Gaps = 30/282 (10%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLAD----EQEVAIKRLSRSSGQGIVE-FKNEVRLIAKLQH 485
+F+ +G G FG VY G L D + A+K L+R + G V F E ++ H
Sbjct: 30 HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 486 TNLVRLLGCSLHGEER-LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLY 544
N++ LLG L E L+V +M + L F+ N + F +
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK-----G 142
Query: 545 LHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKR--IVGTYGYMS 602
+ + + +HRDL A N +LD+K K++DFG+AR E ++ + +M+
Sbjct: 143 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 202
Query: 603 PEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELI 662
E + + K+DV+SFGVL+ E+++ P +N LL +G L+
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMTR-----GAPPYPDVNTFDITVYLL---QGRRLL 254
Query: 663 DPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ 704
P C V L C +A RP+ E+V +
Sbjct: 255 QPEY---CPD----PLYEVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 3e-58
Identities = 66/276 (23%), Positives = 113/276 (40%), Gaps = 28/276 (10%)
Query: 436 NKLGEGGFGPVYKGKLADE---QEVAIKRLSRSSGQGIV--EFKNEVRLIAKLQHTNLVR 490
+LG G FG V KG + + VA+K L + + E E ++ +L + +VR
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 491 LLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSR 550
++G E +LV E L+ +L + + + ++ +S G+ YL
Sbjct: 73 MIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLE---E 125
Query: 551 LRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTK-RIVGTYGYMSPEYAMSG 609
+HRDL A N+LL + KISDFG+++ +E+ + + +PE
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 610 IVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQP 669
S K+DV+SFGVL+ E S P ++ + + +++
Sbjct: 186 KFSSKSDVWSFGVLMWEAFS-----YGQKP----------YRGMKGSEVTAMLEKGERMG 230
Query: 670 CSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
C A + LC +RP V L+N
Sbjct: 231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 5e-58
Identities = 75/327 (22%), Positives = 135/327 (41%), Gaps = 41/327 (12%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGKLADEQE-----VAIKRLSRS-SGQGIVEFKNEVRLIAK 482
F LG G FG VYKG E E VAIK L + S + E +E ++A
Sbjct: 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 67
Query: 483 LQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGL 542
+ + ++ RLLG L +L + + MP L ++ K+ + + I++G+
Sbjct: 68 VDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGM 124
Query: 543 LYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMS 602
YL R++HRDL A N+L+ + KI+DFG+A++ E E + + +M+
Sbjct: 125 NYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181
Query: 603 PEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELI 662
E + I + ++DV+S+GV V E+++ + + + ++
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFGS---------------KPYDGIPASEISSIL 226
Query: 663 DPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ--------------NETM 708
+ P + + + C A RP E++ +E M
Sbjct: 227 EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERM 286
Query: 709 PLPPPKQPAFFINANADDQVPEVPDNE 735
LP P F+ ++ + +V D +
Sbjct: 287 HLPSPTDSNFYRALMDEEDMDDVVDAD 313
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 8e-58
Identities = 68/277 (24%), Positives = 113/277 (40%), Gaps = 28/277 (10%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLV 489
+G+G FG V G +VA+K + + F E ++ +L+H+NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQ--AFLAEASVMTQLRHSNLV 63
Query: 490 RLLGCSLHGEERL-LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
+LLG + + L +V E+M SL +L + GR VL + + + + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLE-- 120
Query: 549 SRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMS 608
+HRDL A N+L+ + K+SDFG+ + E+ + + +PE
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALRE 174
Query: 609 GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQ 668
S K+DV+SFG+L+ EI S P + L ++ K
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSF-----GRVPYPRIPLKDVVPRVEKGYK------MDAPD 223
Query: 669 PCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
C V C A RP+ ++ L++
Sbjct: 224 GCPP----AVYEVMKNCWHLDAAMRPSFLQLREQLEH 256
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 1e-57
Identities = 67/300 (22%), Positives = 115/300 (38%), Gaps = 40/300 (13%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLA------DEQEVAIKRLSRSSGQGIVE-FKNEVRLIAK 482
N S LG G FG V + VA+K L S+ E +E+++++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 483 L-QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNV---------------L 526
L H N+V LLG G L++ E+ L FL + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 527 NWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586
+ E +++G+ +L IHRDL A NILL KI DFG+AR + +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 587 SEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLI 646
+ +M+PE + + + ++DV+S+G+ + E+ S + P
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV------ 253
Query: 647 GYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706
D K ++I + + C + RPT ++V +++ +
Sbjct: 254 --------DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 3e-57
Identities = 65/281 (23%), Positives = 117/281 (41%), Gaps = 27/281 (9%)
Query: 430 NNFSTTN-KLGEGGFGPVYKGKLA---DEQEVAIKRLSRSSGQGIVE-FKNEVRLIAKLQ 484
+N + +LG G FG V +G + +VAIK L + + + E E +++ +L
Sbjct: 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD 67
Query: 485 HTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLY 544
+ +VRL+G E +LV E L FL G++ + ++ +S G+ Y
Sbjct: 68 NPYIVRLIGV-CQAEALMLVMEMAGGGPLHKFLV--GKREEIPVSNVAELLHQVSMGMKY 124
Query: 545 LHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKR-IVGTYGYMSP 603
L +HRDL A N+LL ++ KISDFG+++ ++S + + +P
Sbjct: 125 LE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 181
Query: 604 EYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELID 663
E S ++DV+S+GV + E +S P ++ + + + I+
Sbjct: 182 ECINFRKFSSRSDVWSYGVTMWEALS-----YGQKP----------YKKMKGPEVMAFIE 226
Query: 664 PSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ 704
C + C + DRP V ++
Sbjct: 227 QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 195 bits (496), Expect = 3e-57
Identities = 76/276 (27%), Positives = 119/276 (43%), Gaps = 34/276 (12%)
Query: 432 FSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQG---IVEFKNEVRLIAKLQHTN 487
FS ++G G FG VY + + + + VAIK++S S Q + EVR + KL+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 488 LVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHK 547
++ GC L LV E+ + D + L + + G QGL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGALQGLAYLH- 132
Query: 548 YSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM 607
+IHRD+KA NILL + K+ DFG A I VGT +M+PE +
Sbjct: 133 --SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------PANSFVGTPYWMAPEVIL 184
Query: 608 S---GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDP 664
+ G K DV+S G+ +E+ + P +N + + + + P
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERK------PPLFNMNAMSALYHIAQNE------SP 232
Query: 665 SLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVV 700
+L+ + + C+Q DRPT ++
Sbjct: 233 ALQSGHWSEYFRNFV---DSCLQKIPQDRPTSEVLL 265
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 2e-56
Identities = 59/273 (21%), Positives = 110/273 (40%), Gaps = 23/273 (8%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAKLQHTN 487
++ LGEG +G V E+ VA+K + E K E+ + L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 488 LVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHK 547
+V+ G G + L E+ L + + + G++YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLH- 120
Query: 548 YSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM 607
+ + HRD+K N+LLD++ N KISDFG+A +F N E ++ GT Y++PE
Sbjct: 121 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 608 SG-IVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666
+ DV+S G+++ +++G+ + + ++P
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW--------KEKKTYLNPWK 230
Query: 667 EQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEV 699
+ + ++ + + R T+P++
Sbjct: 231 KIDSAPLALLHK------ILVENPSARITIPDI 257
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 2e-56
Identities = 69/305 (22%), Positives = 117/305 (38%), Gaps = 45/305 (14%)
Query: 430 NNFSTTNKLGEGGFGPVYKG------KLADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAK 482
N LG G FG V K +VA+K L + E +E++++ +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 483 L-QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRK------------------ 523
L H N+V LLG L++E+ L +L + K
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 524 --NVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARI 581
NVL +E +++G+ +L +HRDL A N+L+ KI DFG+AR
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 582 FEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDR 641
+ + +M+PE GI +IK+DV+S+G+L+ EI S +P
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV-----NPYP 268
Query: 642 PLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVC 701
+ + ++L+ +G + + C + RP+ P +
Sbjct: 269 GIPVDANFYKLIQNGFKM---------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
Query: 702 MLQNE 706
L +
Sbjct: 320 FLGCQ 324
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 6e-56
Identities = 73/306 (23%), Positives = 131/306 (42%), Gaps = 34/306 (11%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKL------ADEQEVAIKRLSRS-SGQGIVEFKNEVRLIAK 482
+ + +LG+G FG VY+G E VAIK ++ + S + +EF NE ++ +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 483 LQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRK-------NVLNWEKRFIII 535
++VRLLG G+ L++ E M L +L + + K +
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 536 EGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIV 595
I+ G+ YL+ + +HRDL A N ++ + KI DFGM R + + +
Sbjct: 140 GEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 596 GTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSD 655
+MSPE G+ + +DV+SFGV++ EI + + +Q LS+
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE---------------QPYQGLSN 241
Query: 656 GKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETMPLPPPKQ 715
+ L + N + +C Q RP+ E++ ++ E P ++
Sbjct: 242 EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME--PGFRE 299
Query: 716 PAFFIN 721
+F+ +
Sbjct: 300 VSFYYS 305
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 2e-55
Identities = 67/280 (23%), Positives = 112/280 (40%), Gaps = 26/280 (9%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQH 485
A ++ +G G +G K + +D + + K L S +EV L+ +L+H
Sbjct: 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 62
Query: 486 TNLVRLLGCSLHGEERLL--VYEFMPNKSLDFFLFNSGR-KNVLNWEKRFIIIEGISQGL 542
N+VR + L V E+ L + + + L+ E ++ ++ L
Sbjct: 63 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122
Query: 543 LYLHKYSR--LRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGY 600
H+ S V+HRDLK +N+ LD K N K+ DFG+ARI + S A VGT Y
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA--FVGTPYY 180
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLE 660
MSPE + K+D++S G L+ E+ + T I E
Sbjct: 181 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI------------RE 228
Query: 661 LIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVV 700
+ S + + + RP++ E++
Sbjct: 229 GKFRRIPYRYSDE----LNEIITRMLNLKDYHRPSVEEIL 264
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 2e-55
Identities = 65/275 (23%), Positives = 114/275 (41%), Gaps = 27/275 (9%)
Query: 431 NFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLV 489
+ +LG+G FG VYK + A K + S + + ++ E+ ++A H N+V
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIV 72
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
+LL + ++ EF ++D + R L + ++ + L YLH
Sbjct: 73 KLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLH--- 127
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMS- 608
++IHRDLKA NIL + K++DFG++ ++ +GT +M+PE M
Sbjct: 128 DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCE 185
Query: 609 ----GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDP 664
K DV+S G+ ++E+ + H +P R L I + P
Sbjct: 186 TSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI------------AKSEPP 233
Query: 665 SLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEV 699
+L QP + + L R T ++
Sbjct: 234 TLAQPSRWSSNFKDFLKKCLEK--NVDARWTTSQL 266
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 6e-55
Identities = 68/293 (23%), Positives = 123/293 (41%), Gaps = 39/293 (13%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLAD---EQEVAIKRLSR-SSGQGIVEFKNEVRLIAKL-Q 484
N+ + +GEG FG V K ++ + AIKR+ +S +F E+ ++ KL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 485 HTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFN-------------SGRKNVLNWEKR 531
H N++ LLG H L E+ P+ +L FL + + L+ ++
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 532 FIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANT 591
+++G+ YL + + IHRDL A NIL+ + KI+DFG++R EV
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK---K 183
Query: 592 KRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQ 651
+M+ E + + +DV+S+GVL+ EIVS +
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT---------------PYC 228
Query: 652 LLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ 704
++ + E + N + C +++ +RP+ +++ L
Sbjct: 229 GMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 281
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 1e-54
Identities = 73/283 (25%), Positives = 116/283 (40%), Gaps = 28/283 (9%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKL----ADEQEVAIKRLSR---SSGQGIVEFKNEVRLIAK 482
+ KLG+G FG V +G+ VA+K L S + + +F EV +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 483 LQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGL 542
L H NL+RL G L ++ V E P SL L +L R+ + +++G+
Sbjct: 68 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGM 124
Query: 543 LYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE-ANTKRIVGTYGYM 601
YL R IHRDL A N+LL + KI DFG+ R N+ + + +
Sbjct: 125 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 602 SPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLEL 661
+PE + S +D + FGV + E+ + + P LN ++ +G+ L
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQ-----EPWIGLNGSQILHKIDKEGERL-- 234
Query: 662 IDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ 704
P + +V + C + DRPT + L
Sbjct: 235 -------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 2e-54
Identities = 67/273 (24%), Positives = 115/273 (42%), Gaps = 31/273 (11%)
Query: 436 NKLGEGGFGPVYKGKLADE-QEVAIKRLSRS--SGQGIVEFKNEVRLIAKLQHTNLVRLL 492
++G G F VYKG + EVA L + FK E ++ LQH N+VR
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 493 GC----SLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
+ +LV E M + +L +L R V+ + I +GL +LH
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTR 131
Query: 549 SRLRVIHRDLKASNILLDDK-MNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM 607
+ +IHRDLK NI + + KI D G+A + + K ++GT +M+PE
Sbjct: 132 TP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEM-Y 185
Query: 608 SGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLE 667
DV++FG+ +LE+ + + P + A Q+ + + P+
Sbjct: 186 EEKYDESVDVYAFGMCMLEMATSE---------YPYSECQNAAQIYR--RVTSGVKPASF 234
Query: 668 QPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVV 700
+ EV I C++ +R ++ +++
Sbjct: 235 DKVAIPEVKEII---EGCIRQNKDERYSIKDLL 264
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 3e-53
Identities = 63/275 (22%), Positives = 108/275 (39%), Gaps = 31/275 (11%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRS---SGQGIVEFKNEVRLIAKLQH 485
+F LG+G FG VY + + +A+K L ++ + + EV + + L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 486 TNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYL 545
N++RL G L+ E+ P ++ L + + ++ I ++ L Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYC 122
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEY 605
H RVIHRD+K N+LL KI+DFG + + + GT Y+ PE
Sbjct: 123 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPPEM 175
Query: 606 AMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPS 665
+ K D++S GVL E + G+ + I +E P
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI----------SRVEFTFPD 225
Query: 666 LEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVV 700
+ + + R + RP + EV+
Sbjct: 226 FVTEGARDLISRLLKH-------NPSQRPMLREVL 253
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 3e-53
Identities = 71/291 (24%), Positives = 130/291 (44%), Gaps = 26/291 (8%)
Query: 410 DQSISHELKIFDFQTIAAAANNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQ 468
D+ I +L+ ++ ++ K+G+G G VY +A QEVAI++++
Sbjct: 2 DEEILEKLR--SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP 59
Query: 469 GIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNW 528
NE+ ++ + ++ N+V L L G+E +V E++ SL + + +
Sbjct: 60 KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DE 115
Query: 529 EKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE 588
+ + Q L +LH +VIHRD+K+ NILL + K++DFG +S+
Sbjct: 116 GQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172
Query: 589 ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGY 648
+T +VGT +M+PE K D++S G++ +E++ G+ + +P R L LI
Sbjct: 173 RST--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI-- 228
Query: 649 AWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEV 699
P L+ P + + R L + R + E+
Sbjct: 229 ----------ATNGTPELQNPEKLSAIFRDFLNRCLDM--DVEKRGSAKEL 267
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 2e-51
Identities = 72/298 (24%), Positives = 117/298 (39%), Gaps = 39/298 (13%)
Query: 430 NNFSTTNKLGEGGFGPVYKG------KLADEQEVAIKRLSRSSGQG-IVEFKNEVRLIAK 482
+ LG G FG V + K A + VA+K L + +E++++
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 483 LQHTNLVRLLG--CSLHGEERLLVYEFMPNKSLDFFLFNSGR-------------KNVLN 527
+ H V L C+ G +++ EF +L +L + K+ L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 528 WEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES 587
E +++G+ +L + IHRDL A NILL +K KI DFG+AR +
Sbjct: 133 LEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 588 EANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIG 647
+M+PE + +I++DV+SFGVL+ EI S P + +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG-----ASPYPGVKIDE 244
Query: 648 YAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
+ L +G + D + + L C + RPT E+V L N
Sbjct: 245 EFCRRLKEGTRMRAPDYTTPE---------MYQTMLDCWHGEPSQRPTFSELVEHLGN 293
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 7e-49
Identities = 57/281 (20%), Positives = 100/281 (35%), Gaps = 27/281 (9%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQE----VAIKRLSRSSGQGIVE-FKNEVRLIAKLQ 484
+GEG FG V++G + VAIK + + E F E + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 485 HTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLY 544
H ++V+L+G ++ E L FL L+ + +S L Y
Sbjct: 67 HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAY 123
Query: 545 LHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPE 604
L R +HRD+ A N+L+ K+ DFG++R E + + + +M+PE
Sbjct: 124 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPE 179
Query: 605 YAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDP 664
+ +DV+ FGV + EI+ P + + ++ + +
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGV-----KPFQGVKNNDVIGRIENGER------L 228
Query: 665 SLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
+ C + C RP E+ L
Sbjct: 229 PMPPNCPP----TLYSLMTKCWAYDPSRRPRFTELKAQLST 265
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 173 bits (439), Expect = 1e-48
Identities = 63/301 (20%), Positives = 114/301 (37%), Gaps = 26/301 (8%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL 488
+++ +LG G FG V++ A A K + + E++ ++ L+H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
V L E +++YEFM L + + N ++ ++ + + +GL ++H+
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHE- 142
Query: 549 SRLRVIHRDLKASNILLDDKMNP--KISDFGMARIFEVNESEANTKRIVGTYGYMSPEYA 606
+H DLK NI+ K + K+ DFG+ + +S K GT + +PE A
Sbjct: 143 --NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS---VKVTTGTAEFAAPEVA 197
Query: 607 MSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666
V TD++S GVL ++SG + D L + +D S
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV---------KSCDWNMDDSA 248
Query: 667 EQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM--LQNETMPLPPPKQPAFFINANA 724
S + + R T+ + + L P + P+
Sbjct: 249 FSGISED----GKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIR 304
Query: 725 D 725
D
Sbjct: 305 D 305
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (433), Expect = 2e-48
Identities = 55/220 (25%), Positives = 92/220 (41%), Gaps = 10/220 (4%)
Query: 431 NFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRS---SGQGIVEFKNEVRLIAKLQHT 486
+F LGEG F V + LA +E AIK L + + E ++++L H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 487 NLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLH 546
V+L E+ + N L ++ G + RF + + L
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE--TCTRFYTA----EIVSALE 122
Query: 547 KYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYA 606
+IHRDLK NILL++ M+ +I+DFG A++ +A VGT Y+SPE
Sbjct: 123 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182
Query: 607 MSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLI 646
+D+++ G ++ ++V+G + I
Sbjct: 183 TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI 222
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 2e-48
Identities = 65/299 (21%), Positives = 120/299 (40%), Gaps = 41/299 (13%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKL--------ADEQEVAIKRLSR-SSGQGIVEFKNEVRLI 480
+ LGEG FG V + +VA+K L ++ + + + +E+ ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 481 AKL-QHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNV-------------L 526
+ +H N++ LLG ++ E+ +L +L + L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 527 NWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586
+ + +++G+ YL + IHRDL A N+L+ + KI+DFG+AR +
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 587 SEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLI 646
T +M+PE I + ++DV+SFGVL+ EI + +P P+ +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG---SPYPGVPVEEL 246
Query: 647 GYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
++LL +G ++ N + C RPT ++V L
Sbjct: 247 ---FKLLKEGHRMDKPS---------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 167 bits (423), Expect = 2e-46
Identities = 55/273 (20%), Positives = 99/273 (36%), Gaps = 24/273 (8%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL 488
+ + +LG G FG V++ A + K ++ KNE+ ++ +L H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 489 VRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY 548
+ L E +L+ EF+ L + K ++ + + +GL ++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK--MSEAEVINYMRQACEGLKHMH-- 144
Query: 549 SRLRVIHRDLKASNILLDDKMNP--KISDFGMARIFEVNESEANTKRIVGTYGYMSPEYA 606
++H D+K NI+ + K KI DFG+A +E K T + +PE
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIV 200
Query: 607 MSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666
V TD+++ GVL ++SG L + + D
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV---------KRCDWEFDEDA 251
Query: 667 EQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEV 699
S +Q + R T+ +
Sbjct: 252 FSSVSPE----AKDFIKNLLQKEPRKRLTVHDA 280
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 1e-43
Identities = 52/222 (23%), Positives = 100/222 (45%), Gaps = 7/222 (3%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAKLQHT 486
++ + +GEG +G V ++ VAIK++S Q + E++++ + +H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 487 NLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLH 546
N++ + + ++ + L+ + L+ + + I +GL Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 547 KYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANT-KRIVGTYGYMSPEY 605
V+HRDLK SN+LL+ + KI DFG+AR+ + + V T Y +PE
Sbjct: 127 S---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 606 AMSGIVSI-KTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLI 646
++ D++S G ++ E++S + H LN I
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 225
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 156 bits (394), Expect = 4e-43
Identities = 55/287 (19%), Positives = 104/287 (36%), Gaps = 27/287 (9%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTN 487
N + K+G G FG +Y G +A +EVAIK + + E ++ +Q
Sbjct: 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP--QLHIESKIYKMMQGGV 63
Query: 488 LVRLLG-CSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLH 546
+ + C G+ ++V E + D F F S + + + ++ + + + Y+H
Sbjct: 64 GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK---FSLKTVLLLADQMISRIEYIH 120
Query: 547 KYSRLRVIHRDLKASNIL---LDDKMNPKISDFGMARIFEVNESEAN-----TKRIVGTY 598
IHRD+K N L I DFG+A+ + + + K + GT
Sbjct: 121 ---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177
Query: 599 GYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKG 658
Y S + S + D+ S G +++ G + K
Sbjct: 178 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE-----KK 232
Query: 659 LELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
+ L + +E ++ C + D+P + + +N
Sbjct: 233 MSTPIEVLCKGYP-SEFATYLN---FCRSLRFDDKPDYSYLRQLFRN 275
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 154 bits (391), Expect = 5e-43
Identities = 55/227 (24%), Positives = 102/227 (44%), Gaps = 15/227 (6%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQG---IVEFKNEVRLIAKLQ 484
++ + LG GG V+ + L ++VA+K L + + F+ E + A L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 485 HTNLVRLLGC----SLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQ 540
H +V + + G +V E++ +L + G + ++ +I Q
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE-ANTKRIVGTYG 599
L + H + +IHRD+K +NI++ K+ DFG+AR + + T ++GT
Sbjct: 123 ALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLI 646
Y+SPE A V ++DV+S G ++ E+++G+ T P
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH 226
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 156 bits (396), Expect = 9e-43
Identities = 60/225 (26%), Positives = 98/225 (43%), Gaps = 18/225 (8%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLAD-EQEVAIKRLSRS---SGQGIVEFKNEVRLIAKLQ- 484
N+FS +G GGFG VY + AD + A+K L + QG NE +++ +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 485 --HTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGL 542
+V + ++ + + M L + L G + I GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS---EADMRFYAAEIILGL 120
Query: 543 LYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMS 602
++H V++RDLK +NILLD+ + +ISD G+A F S+ VGT+GYM+
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDF----SKKKPHASVGTHGYMA 173
Query: 603 PEYAMSGI-VSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLI 646
PE G+ D FS G ++ +++ G +H +
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 218
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 155 bits (392), Expect = 1e-42
Identities = 50/221 (22%), Positives = 94/221 (42%), Gaps = 15/221 (6%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRS---SGQGIVEFKNEVRLIAKLQH 485
+F LG G FG V+ + + + A+K L + + + +E +++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 486 TNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYL 545
++R+ G ++ ++ +++ L L S R + + L L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------CLAL 117
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEY 605
+I+RDLK NILLD + KI+DFG A+ T + GT Y++PE
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV-----PDVTYTLCGTPDYIAPEV 172
Query: 606 AMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLI 646
+ + D +SFG+L+ E+++G + + I
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI 213
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 1e-42
Identities = 54/266 (20%), Positives = 103/266 (38%), Gaps = 25/266 (9%)
Query: 437 KLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCS 495
LG G FG V++ + ++ K + + G V K E+ ++ +H N++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 496 LHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIH 555
EE ++++EF+ + + S + LN + + + + L +LH + H
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFE--LNEREIVSYVHQVCEALQFLH---SHNIGH 125
Query: 556 RDLKASNILLDDKMNP--KISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSI 613
D++ NI+ + + KI +FG AR + + N + + Y +PE +VS
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVST 182
Query: 614 KTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSAN 673
TD++S G LV ++SG + + I D + S
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFLAETNQQIIENI---------MNAEYTFDEEAFKEISIE 233
Query: 674 EVMRCIHVGLLCVQDQAMDRPTMPEV 699
+ + + R T E
Sbjct: 234 ----AMDFVDRLLVKERKSRMTASEA 255
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 153 bits (388), Expect = 3e-42
Identities = 57/275 (20%), Positives = 108/275 (39%), Gaps = 27/275 (9%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVE-FKNEVRLIAKLQHTN 487
+ + + LG G F V + ++ VAIK +++ + +G +NE+ ++ K++H N
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPN 68
Query: 488 LVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHK 547
+V L G L+ + + L + G +I + + YLH
Sbjct: 69 IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF---YTERDASRLIFQVLDAVKYLHD 125
Query: 548 YSRLRVIHRDLKASNILL---DDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPE 604
++HRDLK N+L D+ ISDFG++++ + GT GY++PE
Sbjct: 126 L---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAPE 179
Query: 605 YAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDP 664
S D +S GV+ ++ G + + I L ++ +
Sbjct: 180 VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQI-----LKAEYEFDSPYWD 234
Query: 665 SLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEV 699
+ SA + +R ++ R T +
Sbjct: 235 DI--SDSAKDFIRH------LMEKDPEKRFTCEQA 261
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 7e-42
Identities = 68/301 (22%), Positives = 110/301 (36%), Gaps = 28/301 (9%)
Query: 436 NKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVE-----FKNEVRLIAKLQHTNLV 489
+ LGEG F VYK + Q VAIK++ + E++L+ +L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 490 RLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYS 549
LL H LV++FM NS L + QGL YLH++
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLV---LTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 550 RLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMS- 608
++HRDLK +N+LLD+ K++DFG+A+ F V T Y +PE
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSF--GSPNRAYTHQVVTRWYRAPELLFGA 175
Query: 609 GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLI-----------GYAWQLLSDGK 657
+ + D+++ G ++ E++ L I L D
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235
Query: 658 GLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM--LQNETMPLPPPKQ 715
+ + + + R T + + M N P P +
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQL 295
Query: 716 P 716
P
Sbjct: 296 P 296
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 150 bits (381), Expect = 1e-41
Identities = 60/286 (20%), Positives = 107/286 (37%), Gaps = 39/286 (13%)
Query: 431 NFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVE---------FKNEVRLI 480
N+ LG G V + +E A+K + + G EV ++
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 481 AKLQ-HTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGIS 539
K+ H N+++L LV++ M L +L L+ ++ I+ +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRALL 120
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
+ + LH +L ++HRDLK NILLDD MN K++DFG + + E + + GT
Sbjct: 121 EVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPS 174
Query: 600 YMSPEYAMSGIV------SIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLL 653
Y++PE + + D++S GV++ +++G L +I
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG---- 230
Query: 654 SDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEV 699
+ P + + + Q R T E
Sbjct: 231 ---------NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 149 bits (378), Expect = 5e-41
Identities = 47/288 (16%), Positives = 99/288 (34%), Gaps = 27/288 (9%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTN 487
++ ++GEG FG +++G L + Q+VAIK R S + ++E R L
Sbjct: 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP--QLRDEYRTYKLLAGCT 61
Query: 488 LVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHK 547
+ + ++ + SL+ L GRK + + + + + + +H
Sbjct: 62 GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK--FSVKTVAMAAKQMLARVQSIH- 118
Query: 548 YSRLRVIHRDLKASNILLDDKMNP-----KISDFGMARIFEVNESEAN-----TKRIVGT 597
+++RD+K N L+ + + DFGM + + ++ + K + GT
Sbjct: 119 --EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176
Query: 598 YGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGK 657
YMS + S + D+ + G + + + G ++ +
Sbjct: 177 ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY---ERIGEKKQ 233
Query: 658 GLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705
L + P + M P + +
Sbjct: 234 STPLRELCAGFPEEFYKYMHY------ARNLAFDATPDYDYLQGLFSK 275
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 148 bits (373), Expect = 2e-40
Identities = 62/285 (21%), Positives = 108/285 (37%), Gaps = 23/285 (8%)
Query: 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIK--RLSRSSGQGIVEFKNEVRLIAKLQHTN 487
+ K+GEG +G VYK + + A+K RL + E+ ++ +L+H+N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 488 LVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHK 547
+V+L + +LV+E + G L + + G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG---LESVTAKSFLLQLLNGIAYCHD 118
Query: 548 YSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAM 607
RV+HRDLK N+L++ + KI+DFG+AR F + + + T Y +P+ M
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH--EIVTLWYRAPDVLM 173
Query: 608 -SGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666
S S D++S G + E+V+G L I + + +
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233
Query: 667 EQPCSANEVMRCIHVGLLCVQDQAMD------------RPTMPEV 699
P L + + +D R T +
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 4e-40
Identities = 64/265 (24%), Positives = 110/265 (41%), Gaps = 29/265 (10%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSG---QGIVEFKNEVRLIAK-LQ 484
+F LG+G FG V+ + Q AIK L + + E R+++ +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 485 HTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLY 544
H L + E V E++ L + + + + + + I GL +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQF 118
Query: 545 LHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPE 604
LH +++RDLK NILLD + KI+DFGM + + +++ NT GT Y++PE
Sbjct: 119 LHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPE 173
Query: 605 YAMSGIVSIKTDVFSFGVLVLEIVSGQ------------KNHTRHHPDRPLNLIGYAWQL 652
+ + D +SFGVL+ E++ GQ + +P P L A L
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDL 233
Query: 653 LSDGKGLELIDPSLEQPCSANEVMR 677
L K +P ++ ++ +
Sbjct: 234 LV--KLFV-REPE-KRLGVRGDIRQ 254
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 6e-40
Identities = 69/299 (23%), Positives = 113/299 (37%), Gaps = 25/299 (8%)
Query: 431 NFSTTNKLGEGGFGPVYKGK-LADEQEVAIK--RLSRSSGQGIVEFKNEVRLIAKLQHTN 487
NF K+GEG +G VYK + + VA+K RL + E+ L+ +L H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 488 LVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHK 547
+V+LL + LV+EF+ F ++ L K ++ Q L L
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF-----QLLQGLAF 117
Query: 548 YSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPE-YA 606
RV+HRDLK N+L++ + K++DFG+AR F V V T Y +PE
Sbjct: 118 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH--EVVTLWYRAPEILL 175
Query: 607 MSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666
S D++S G + E+V+ + L I + +
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235
Query: 667 EQPCSANEVMRCIHVGLLCVQDQAMD------------RPTMPEVVCM--LQNETMPLP 711
+P + + + + R + + Q+ T P+P
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 294
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 4e-39
Identities = 59/224 (26%), Positives = 94/224 (41%), Gaps = 17/224 (7%)
Query: 431 NFSTTNKLGEGGFGPVYKGKLADE-QEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLV 489
+++ T +G G FG VY+ KL D + VAIK++ + E++++ KL H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIV 76
Query: 490 RLLGCSLHGEER------LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLL 543
RL E+ LV +++P S K L + + + + L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 544 YLHKYSRLRVIHRDLKASNILLD-DKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMS 602
Y+H + HRD+K N+LLD D K+ DFG A+ E N I Y
Sbjct: 137 YIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRYYRAP 191
Query: 603 PEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLI 646
+ + DV+S G ++ E++ GQ L I
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 235
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 1e-38
Identities = 61/294 (20%), Positives = 113/294 (38%), Gaps = 34/294 (11%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK--LADEQEVAIKRLSRSSGQG--IVEFKNEVRLIAKL-- 483
+ ++GEG +G V+K + + VA+KR+ +G+ + EV ++ L
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66
Query: 484 -QHTNLVRLLGCSLHGEER-----LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEG 537
+H N+VRL LV+E + + + E ++
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--VPTETIKDMMFQ 124
Query: 538 ISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGT 597
+ +GL +LH RV+HRDLK NIL+ K++DFG+ARI+ + +V T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA---LTSVVVT 178
Query: 598 YGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGK 657
Y +PE + + D++S G + E+ + L I + G+
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV--IGLPGE 236
Query: 658 GLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMD------------RPTMPEV 699
D +L + ++ + I + + + D R +
Sbjct: 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 2e-38
Identities = 58/281 (20%), Positives = 108/281 (38%), Gaps = 33/281 (11%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSS------GQGIVEFKNEVRLIAK 482
+ + T +LG G F V K + + + A K + + G + + EV ++ +
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 483 LQHTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGL 542
+QH N++ L + + +L+ E + L FL L E+ ++ I L
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI---L 123
Query: 543 LYLHKYSRLRVIHRDLKASNILLDDKMNP----KISDFGMARIFEVNESEANTKRIVGTY 598
++ L++ H DLK NI+L D+ P KI DFG+A + K I GT
Sbjct: 124 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTP 180
Query: 599 GYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKG 658
+++PE + ++ D++S GV+ ++SG L +
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------------ 228
Query: 659 LELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEV 699
++ E +N + R T+ +
Sbjct: 229 -SAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 268
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 7e-38
Identities = 53/221 (23%), Positives = 90/221 (40%), Gaps = 12/221 (5%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRS---SGQGIVEFKNEVRLIAKLQH 485
N+F LG+G FG V + A + A+K L + + + E R++ +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 486 TNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYL 545
L L + V E+ L F L + + E+R ++ + L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFY--GAEIVSAL 118
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEY 605
V++RD+K N++LD + KI+DFG+ + E A K GT Y++PE
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEV 176
Query: 606 AMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLI 646
D + GV++ E++ G+ +R LI
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 1e-37
Identities = 63/282 (22%), Positives = 104/282 (36%), Gaps = 43/282 (15%)
Query: 429 ANNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVE------FKNEVRLIA 481
+ + LG GGFG VY G ++D VAIK + + E EV L+
Sbjct: 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 62
Query: 482 KLQ--HTNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGIS 539
K+ + ++RLL + +L+ E F + L E +
Sbjct: 63 KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT--ERGALQEELARSFFWQVL 120
Query: 540 QGLLYLHKYSRLRVIHRDLKASNILLD-DKMNPKISDFGMARIFEVNESEANTKRIVGTY 598
+ + + H V+HRD+K NIL+D ++ K+ DFG + + + GT
Sbjct: 121 EAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTR 173
Query: 599 GYMSPEYAMSG-IVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGK 657
Y PE+ V+S G+L+ ++V G H + +
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD--IPFEHDEEIIRG------------ 219
Query: 658 GLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEV 699
Q S+ C H+ C+ + DRPT E+
Sbjct: 220 -----QVFFRQRVSSE----CQHLIRWCLALRPSDRPTFEEI 252
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (352), Expect = 2e-37
Identities = 54/299 (18%), Positives = 114/299 (38%), Gaps = 35/299 (11%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQG--IVEFKNEVRLIAKLQHT 486
+ + K+G+G FG V+K + Q+VA+K++ + + + E++++ L+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 487 NLVRLLGCSLHGEER--------LLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGI 538
N+V L+ LV++F + + + + KR +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTL-SEIKRVMQ---- 124
Query: 539 SQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKR--IVG 596
L L+ R +++HRD+KA+N+L+ K++DFG+AR F + ++ + V
Sbjct: 125 -MLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 597 TYGYMSPEYAMSGI-VSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLI--------G 647
T Y PE + D++ G ++ E+ + + L LI
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243
Query: 648 YAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLL-------CVQDQAMDRPTMPEV 699
W + + + E ++ Q + ++ + R +
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 6e-37
Identities = 58/300 (19%), Positives = 120/300 (40%), Gaps = 34/300 (11%)
Query: 430 NNFSTTNK-LGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKL-QHT 486
+++ T++ LG G G V + +++ A+K L + + EV L + Q
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-----KARREVELHWRASQCP 65
Query: 487 NLVRLLGC----SLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGL 542
++VR++ + L+V E + L + + G + + I++ I + +
Sbjct: 66 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-AFTEREASEIMKSIGEAI 124
Query: 543 LYLHKYSRLRVIHRDLKASNILLDDKMNP---KISDFGMARIFEVNESEANTKRIVGTYG 599
YLH + + HRD+K N+L K K++DFG A+ + S T
Sbjct: 125 QYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPY 178
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGL 659
Y++PE D++S GV++ + + P + + + + + +
Sbjct: 179 YVAPEVLGPEKYDKSCDMWSLGVIMYIL------LCGYPPFYSNHGLAISPGMKTRIRMG 232
Query: 660 ELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVC---MLQNETMPLPPPKQP 716
+ P+ E + EV I ++ + R T+ E + ++Q+ +P P
Sbjct: 233 QYEFPNPEWSEVSEEVKMLIR---NLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 289
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 3e-35
Identities = 51/206 (24%), Positives = 88/206 (42%), Gaps = 10/206 (4%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK-LADEQEVAIK--RLSRSSGQGIVEFKNEVRLIAKLQHT 486
+ K+GEG +G V+K K + VA+K RL E+ L+ +L+H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 487 NLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLH 546
N+VRL ++ LV+EF +F +G I+ + Q L L
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNG------DLDPEIVKSFLFQLLKGLG 115
Query: 547 KYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYA 606
V+HRDLK N+L++ K+++FG+AR F + +V +
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFG-IPVRCYSAEVVTLWYRPPDVLF 174
Query: 607 MSGIVSIKTDVFSFGVLVLEIVSGQK 632
+ + S D++S G + E+ + +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 131 bits (331), Expect = 4e-34
Identities = 54/221 (24%), Positives = 88/221 (39%), Gaps = 15/221 (6%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRS---SGQGIVEFKNEVRLIAKLQH 485
+ F LG G FG V K A+K L + + I NE R++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 486 TNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYL 545
LV+L +V E++ + L GR + I YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYL 157
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEY 605
H L +I+RDLK N+L+D + +++DFG A+ + T + GT ++PE
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWTLCGTPEALAPEI 209
Query: 606 AMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLI 646
+S + D ++ GVL+ E+ +G P + I
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 2e-32
Identities = 71/340 (20%), Positives = 125/340 (36%), Gaps = 43/340 (12%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRS--SGQGIVEFKNEVRLIAKLQHT 486
+ +G G +G V +VAIK+L R S E+RL+ ++H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 487 NLVRLLGCSLHGE------ERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQ 540
N++ LL E + LV FM + L ++ ++ + +
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM-----KHEKLGEDRIQFLVYQMLK 132
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGY 600
GL Y+H +IHRDLK N+ +++ KI DFG+AR ++++ V T Y
Sbjct: 133 GLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVTRWY 184
Query: 601 MSPEYAMSGI-VSIKTDVFSFGVLVLEIVSGQ------------KNHTRHHPDRPLNLIG 647
+PE ++ + + D++S G ++ E+++G+ K + P +
Sbjct: 185 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244
Query: 648 YAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLL--CVQDQAMDRPTMPEVVC---- 701
+ L + + S + V LL + A R T E +
Sbjct: 245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 304
Query: 702 --MLQNETMPLPPPKQPAFFINANADDQVPEVPDNEVAKF 739
+ E P +F D+ V EV F
Sbjct: 305 ESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVTYKEVLSF 344
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 2e-30
Identities = 52/226 (23%), Positives = 86/226 (38%), Gaps = 21/226 (9%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRS--SGQGIVEFKNEVRLIAKLQHT 486
+ +G G G V ++ VAIK+LSR + E+ L+ + H
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 487 NLVRLLGCSLH------GEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQ 540
N++ LL ++ LV E M + E+ ++ +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------DHERMSYLLYQMLC 130
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGY 600
G+ +LH +IHRDLK SNI++ KI DFG+AR + V T Y
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYY 184
Query: 601 MSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLI 646
+PE + D++S G ++ E+V + N +
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 230
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 3e-30
Identities = 54/248 (21%), Positives = 101/248 (40%), Gaps = 20/248 (8%)
Query: 412 SISHELKIFDF--QTIAAAANNFSTTNKLGEGGFGPVYKGKLA----DEQEVAIKRLSRS 465
++ HEL+ + NF LG G +G V+ + + A+K L ++
Sbjct: 4 TVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKA 63
Query: 466 S----GQGIVEFKNEVRLIAKLQHT-NLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNS 520
+ + + E +++ ++ + LV L + L+ +++ L L
Sbjct: 64 TIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR 123
Query: 521 GRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR 580
R + + +L L +L +I+RD+K NILLD + ++DFG+++
Sbjct: 124 ERFTEHEVQIYV------GEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK 177
Query: 581 IFEVNESEANTKRIVGTYGYMSPEYAMSGIVSI--KTDVFSFGVLVLEIVSGQKNHTRHH 638
F +E+E GT YM+P+ G D +S GVL+ E+++G T
Sbjct: 178 EFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG 236
Query: 639 PDRPLNLI 646
I
Sbjct: 237 EKNSQAEI 244
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 118 bits (297), Expect = 8e-30
Identities = 40/208 (19%), Positives = 94/208 (45%), Gaps = 21/208 (10%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQ-HTN 487
+++ KLG G + V++ + + ++V +K L + + K E++++ L+ N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPN 91
Query: 488 LVRLLGCSLHGEERL--LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYL 545
++ L R LV+E + N + + +++ RF + E I + L Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYE-ILKALDYC 145
Query: 546 HKYSRLRVIHRDLKASNILLD-DKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPE 604
H + ++HRD+K N+++D + ++ D+G+A + + V + + PE
Sbjct: 146 HS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPE 199
Query: 605 YAMS-GIVSIKTDVFSFGVLVLEIVSGQ 631
+ + D++S G ++ ++ +
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRK 227
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 1e-27
Identities = 66/341 (19%), Positives = 121/341 (35%), Gaps = 45/341 (13%)
Query: 430 NNFSTTNKLGEGGFGPVYKGK-LADEQEVAIKRLSRS--SGQGIVEFKNEVRLIAKLQHT 486
+ + +G G +G V VA+K+LSR S E+RL+ ++H
Sbjct: 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 487 NLVRLLGC-----SLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQG 541
N++ LL SL + + + L+ + L + +I I +G
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI----VKCQKLTDDHVQFLIYQILRG 133
Query: 542 LLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYM 601
L Y+H +IHRDLK SN+ +++ KI DFG+AR + T + +
Sbjct: 134 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRA 186
Query: 602 SPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLI--------GYAWQLL 653
+ D++S G ++ E+++G+ L LI + +
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246
Query: 654 SDGKGLELIDPSLEQP-CSANEVMRCIHVGLL-----CVQDQAMDRPTMPEVVCMLQN-- 705
S I + P + V + + + + R T + L +
Sbjct: 247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA---LAHAY 303
Query: 706 -------ETMPLPPPKQPAFFINANADDQVPEVPDNEVAKF 739
+ P+ P +F D+ + +EV F
Sbjct: 304 FAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISF 344
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 108 bits (271), Expect = 3e-26
Identities = 42/212 (19%), Positives = 84/212 (39%), Gaps = 22/212 (10%)
Query: 437 KLGEGGFGPVYKGK-LADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCS 495
KLG G F V+ K + + VA+K + ++E++L+ ++ + +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE-AAEDEIKLLQRVNDADNTKEDSMG 78
Query: 496 LHGEERLLVY---------------EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQ 540
+ +LL + E + L R L + K+ I + +
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ--ISKQLLL 136
Query: 541 GLLYLHKYSRLRVIHRDLKASNILLD-DKMNPKISDFGMARIFEVNESEANTKRIVGTYG 599
GL Y+H+ R +IH D+K N+L++ + +A + + + + T
Sbjct: 137 GLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194
Query: 600 YMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ 631
Y SPE + D++S L+ E+++G
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 100 bits (249), Expect = 7e-25
Identities = 33/202 (16%), Positives = 70/202 (34%), Gaps = 27/202 (13%)
Query: 436 NKLGEGGFGPVYKGKLADEQEVAIK--RLSRSSGQ--------GIVEFKNEVRLIAKLQH 485
+GEG V+ E +K ++ +S + G + F A+ +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 486 TNLVRLLGCSLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYL 545
L +L G ++ Y + N ++ L ++ + E +++ I + +
Sbjct: 66 RALQKLQGLAVPKV-----YAWEGN-AVLMELIDAKELYRVRVENPDEVLDMILEEVAKF 119
Query: 546 HKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEANTKR-IVGTYGYMSPE 604
+ ++H DL N+L+ + I DF + +R + Y S
Sbjct: 120 YHR---GIVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSRT 175
Query: 605 YAMSGIVSIKTDVFSFGVLVLE 626
Y + D+ S +L+
Sbjct: 176 Y------RTEKDINSAIDRILQ 191
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 62.7 bits (152), Expect = 1e-12
Identities = 20/106 (18%), Positives = 31/106 (29%), Gaps = 10/106 (9%)
Query: 28 GIWHDTAPDTLGWYFRPFLPRYQTDEPIWIANRNTPILDQSGVLTIDSIDGNLKILHNGG 87
G D P L Y +W +N + S DGN + G
Sbjct: 13 GQSLDVEPYHFIMQEDCNLVLYDHSTSVWASNTGILGKKGCK-AVLQS-DGNFVVYDAEG 70
Query: 88 NPIAVSSVEGASNNTSATLLQSGNLVLREMDTDGTIKRVLWQSFDY 133
+ S + N L + GN+V+ +W + Y
Sbjct: 71 RSLWASHSVRGNGNYVLVLQEDGNVVIYG--------SDIWSTGTY 108
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 53.4 bits (128), Expect = 3e-09
Identities = 12/92 (13%), Positives = 30/92 (32%), Gaps = 9/92 (9%)
Query: 50 QTDEPIWIANRNTPILDQSGVLTIDSIDGNLKILHNGGNPIAVSSVEGASNNTSATLLQS 109
D + + L++++ D NL +L + + + ++ G A L +
Sbjct: 18 GNDNHPQTLHATQSLQLSPYRLSMET-DCNL-VLFDRDDRVWSTNTAGKGTGCRAVLQPN 75
Query: 110 GNLVLREMDTDGTIKRVLWQSFD--YPTDTLL 139
G + + +W S + +
Sbjct: 76 GRMDVLTNQ-----NIAVWTSGNSRSAGRYVF 102
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 36.8 bits (85), Expect = 0.002
Identities = 11/66 (16%), Positives = 23/66 (34%), Gaps = 3/66 (4%)
Query: 49 YQTDEPIWIANRNTPILDQSGVLTIDSIDGNLKILHNGGNPIAVSSVEGASNNTSATLLQ 108
+ D+ +W + NT + +G + +L N + S ++ L
Sbjct: 50 FDRDDRVW--STNTAGKGTGCRAVLQP-NGRMDVLTNQNIAVWTSGNSRSAGRYVFVLQP 106
Query: 109 SGNLVL 114
NL +
Sbjct: 107 DRNLAI 112
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 48.1 bits (114), Expect = 2e-07
Identities = 19/85 (22%), Positives = 33/85 (38%), Gaps = 11/85 (12%)
Query: 49 YQTDEPIWIANRNTPILDQSGVLTIDSIDGNLKILHNGGNPIAVSSVEGASNNTSATLLQ 108
Y D+PIW N +S L++ + NL + + PI S+ G + N L +
Sbjct: 34 YDVDKPIWATNTGGL--SRSCFLSMQTDG-NLVVYNPSNKPIWASNTGGQNGNYVCILQK 90
Query: 109 SGNLVLREMDTDGTIKRVLWQSFDY 133
N+V+ W + +
Sbjct: 91 DRNVVIYG--------TDRWATGTH 107
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 43.5 bits (102), Expect = 9e-06
Identities = 19/85 (22%), Positives = 28/85 (32%), Gaps = 11/85 (12%)
Query: 49 YQTDEPIWIANRNTPILDQSGVLTIDSIDGNLKILHNGGNPIAVSSVEGASNNTSATLLQ 108
Y + PIW N VL D G L ++ N + S V G + + L
Sbjct: 45 YDNNNPIWATNTGGLGNGCRAVLQPD---GVLVVITNENVTVWQSPVAGKAGHYVLVLQP 101
Query: 109 SGNLVLREMDTDGTIKRVLWQSFDY 133
N+V+ LW +
Sbjct: 102 DRNVVIYG--------DALWATQTV 118
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 38.6 bits (89), Expect = 3e-04
Identities = 16/129 (12%), Positives = 32/129 (24%), Gaps = 35/129 (27%)
Query: 8 GNFKLGFFSPASSTTTERYLGIWHDTAPDTLGWYFRPFLPRYQTDEPIWIANRNTPILDQ 67
G + + + Y + +W + N
Sbjct: 19 GGYLFIIQNDCNLVL--------------------------YDNNRAVWASGTNGKASGC 52
Query: 68 SGVLTIDSIDGNLKILHNGGNPIAVSSVEGASNNTSATLLQSGNLVLREMDTDGTIKRVL 127
+ DGNL I A ++ + N L + N+V+ D +
Sbjct: 53 VLKMQ---NDGNLVIYSGSRAIWASNTNRQ-NGNYYLILQRDRNVVIY--DNSN---NAI 103
Query: 128 WQSFDYPTD 136
W + +
Sbjct: 104 WATHTNVGN 112
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 752 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.66 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.61 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.59 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.58 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.52 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.24 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 98.78 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 98.71 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 98.61 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 98.54 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 98.53 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.51 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.45 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.93 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.63 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.81 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.52 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.72 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=410.53 Aligned_cols=262 Identities=27% Similarity=0.452 Sum_probs=204.0
Q ss_pred cCCCcCCeeecCCcccEEEEEecCCceeEEEEcccC--CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEee
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRS--SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
++|++.++||+|+||+||+|+.++ .||||+++.. .....++|.+|+.++.+++|||||++++++.+ +..+|||||
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey 84 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQW 84 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred ccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEec
Confidence 678889999999999999998643 5999998654 34456789999999999999999999998765 568999999
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccc
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES 587 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~ 587 (752)
+++|+|.+++... ...+++..++.++.||++||+|||+++ ||||||||+||||+.++.+||+|||+|+.......
T Consensus 85 ~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 85 CEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp CCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred CCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence 9999999999653 345999999999999999999999988 99999999999999999999999999987654444
Q ss_pred ccccccccccCCccChhhhcc---CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCC
Q 043278 588 EANTKRIVGTYGYMSPEYAMS---GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDP 664 (752)
Q Consensus 588 ~~~~~~~~gt~~y~aPE~~~~---~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 664 (752)
........||+.|||||++.. ..++.++|||||||+||||+||+.||....... .....+..+... |
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~------~~~~~~~~~~~~----p 229 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD------QIIFMVGRGYLS----P 229 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHHHHTSCC----C
T ss_pred cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH------HHHHHHhcCCCC----C
Confidence 444455789999999999864 458999999999999999999999997654221 111222222111 1
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCCCC
Q 043278 665 SLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETMPL 710 (752)
Q Consensus 665 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~~~~ 710 (752)
.+. ..+......+.+|+.+||+.||++||||+||+++|+.+....
T Consensus 230 ~~~-~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 230 DLS-KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp CGG-GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred cch-hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 110 011122345778999999999999999999999998765433
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=408.90 Aligned_cols=255 Identities=28% Similarity=0.400 Sum_probs=199.5
Q ss_pred cCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCC
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMP 509 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 509 (752)
++|++.++||+|+||+||+|++.+++.||||++... ....++|.+|++++++++|||||+++|+|.+++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 467788999999999999999988889999999764 3456789999999999999999999999999999999999999
Q ss_pred CCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccccc
Q 043278 510 NKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEA 589 (752)
Q Consensus 510 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 589 (752)
+|+|.+++... ...+++..++.++.|||+||+|||+.+ |+||||||+||||++++.+||+|||+++........
T Consensus 84 ~g~L~~~l~~~--~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~- 157 (263)
T d1sm2a_ 84 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT- 157 (263)
T ss_dssp TCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCce-
Confidence 99999988643 346899999999999999999999988 999999999999999999999999999876533222
Q ss_pred ccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCC
Q 043278 590 NTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQP 669 (752)
Q Consensus 590 ~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 669 (752)
......||+.|+|||++.+..++.|+|||||||++|||+|+..|+..... .. ...+.+..+... ..|.
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~-----~~-~~~~~i~~~~~~--~~p~---- 225 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-----NS-EVVEDISTGFRL--YKPR---- 225 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC-----HH-HHHHHHHHTCCC--CCCT----
T ss_pred eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC-----HH-HHHHHHHhcCCC--CCcc----
Confidence 22235789999999999999999999999999999999996554432221 11 111222222211 1111
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 670 CSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 670 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
....++.+++.+||+.||++||||+||+++|+++
T Consensus 226 ---~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 226 ---LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp ---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---ccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 1224577899999999999999999999999864
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.4e-49 Score=410.24 Aligned_cols=257 Identities=26% Similarity=0.399 Sum_probs=197.4
Q ss_pred cCCCcCCeeecCCcccEEEEEecC-Cc---eeEEEEcccC-CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLAD-EQ---EVAIKRLSRS-SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLV 504 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~---~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 504 (752)
++|++.+.||+|+||+||+|++.. ++ .||||++... .....++|.+|+++|++++|||||+++|++.+++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 445667899999999999998753 32 5899988754 334456799999999999999999999999999999999
Q ss_pred EeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecc
Q 043278 505 YEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~ 584 (752)
||||++|+|..++... ...+++.+++.++.||++||+|||+.+ |+||||||+||||+.++++||+|||+++.+..
T Consensus 106 ~Ey~~~g~L~~~~~~~--~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEecCCCcceeeeccc--cCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence 9999999999988643 345999999999999999999999988 99999999999999999999999999987654
Q ss_pred cccccc---cccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCccc
Q 043278 585 NESEAN---TKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLE 660 (752)
Q Consensus 585 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 660 (752)
...... .....||+.|||||.+.+..++.++|||||||+||||+| |+.||...... .....+..+...
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~-------~~~~~i~~~~~~- 252 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ-------DVINAIEQDYRL- 252 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHHHHHTTCCC-
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCCCC-
Confidence 332221 122457899999999999999999999999999999998 89998765421 112222222211
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCC
Q 043278 661 LIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNET 707 (752)
Q Consensus 661 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~ 707 (752)
+.+......+.+|+.+||+.||++||||.||++.|+.+.
T Consensus 253 --------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l 291 (299)
T d1jpaa_ 253 --------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 291 (299)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred --------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 112223345778999999999999999999999998753
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=402.30 Aligned_cols=252 Identities=23% Similarity=0.338 Sum_probs=203.7
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEee
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
++|++.++||+|+||+||+|+.. +|+.||||++.... .+..+++.+|+.++++++|||||++++++.+++..+|||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 46888899999999999999874 68999999987543 23445689999999999999999999999999999999999
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccc
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES 587 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~ 587 (752)
+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.+.....
T Consensus 85 ~~gg~L~~~l~~---~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 85 CSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCcHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 999999998843 346999999999999999999999998 99999999999999999999999999998765544
Q ss_pred ccccccccccCCccChhhhccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCC
Q 043278 588 EANTKRIVGTYGYMSPEYAMSGIV-SIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666 (752)
Q Consensus 588 ~~~~~~~~gt~~y~aPE~~~~~~~-t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 666 (752)
........||+.|||||++.+..+ +.++|||||||+||||++|+.||........ .. .......... .+
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~--~~----~~~~~~~~~~--~~-- 228 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EY----SDWKEKKTYL--NP-- 228 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH--HH----HHHHTTCTTS--TT--
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH--HH----HHHhcCCCCC--Cc--
Confidence 444456789999999999988876 6789999999999999999999976543211 11 1111111110 00
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 043278 667 EQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVC 701 (752)
Q Consensus 667 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~ 701 (752)
.......+.+|+.+||+.||++|||++|+++
T Consensus 229 ----~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 229 ----WKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp ----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111235668889999999999999999865
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-49 Score=405.46 Aligned_cols=254 Identities=31% Similarity=0.459 Sum_probs=206.5
Q ss_pred cCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCC
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMP 509 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 509 (752)
++|++.++||+|+||+||+|++++++.||||+++... ...++|.+|+.++.+++|||||+++|++.+ +..++||||++
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~ 90 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME 90 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence 5677889999999999999999888899999997643 456789999999999999999999998865 56789999999
Q ss_pred CCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccccc
Q 043278 510 NKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEA 589 (752)
Q Consensus 510 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 589 (752)
+|+|.+++.... ...+++..++.++.||++||.|||+.+ |+||||||+||||++++.+||+|||+|+.+......
T Consensus 91 ~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~- 165 (272)
T d1qpca_ 91 NGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT- 165 (272)
T ss_dssp TCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE-
T ss_pred CCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCccc-
Confidence 999998875432 234899999999999999999999988 999999999999999999999999999987543322
Q ss_pred ccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCC
Q 043278 590 NTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQP 669 (752)
Q Consensus 590 ~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 669 (752)
......||+.|||||++.+..++.|+|||||||++|||+||+.|+...... ......+..+..... |
T Consensus 166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~------~~~~~~i~~~~~~~~--p----- 232 (272)
T d1qpca_ 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN------PEVIQNLERGYRMVR--P----- 232 (272)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HHHHHHHHTTCCCCC--C-----
T ss_pred cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH------HHHHHHHHhcCCCCC--c-----
Confidence 223457899999999999999999999999999999999976655433211 112223333321111 1
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 043278 670 CSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705 (752)
Q Consensus 670 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~ 705 (752)
......+.+|+.+||+.||++||||+||+++|+.
T Consensus 233 --~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 233 --DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp --TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 1122457789999999999999999999999985
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-48 Score=395.92 Aligned_cols=253 Identities=26% Similarity=0.406 Sum_probs=212.4
Q ss_pred cCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCC
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMP 509 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 509 (752)
++|+..++||+|+||+||+|+.++++.||||+++... ...++|.+|+.++++++||||++++|+|.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 5788999999999999999999888899999997653 356789999999999999999999999999999999999999
Q ss_pred CCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccccc
Q 043278 510 NKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEA 589 (752)
Q Consensus 510 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 589 (752)
+|+|..++... ...+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 83 ~g~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~- 156 (258)
T d1k2pa_ 83 NGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT- 156 (258)
T ss_dssp TEEHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-
T ss_pred CCcHHHhhhcc--ccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce-
Confidence 99999987543 345899999999999999999999988 999999999999999999999999999876543322
Q ss_pred ccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCC
Q 043278 590 NTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQ 668 (752)
Q Consensus 590 ~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 668 (752)
......+|+.|+|||.+.+..++.|+|||||||++|||+| |+.||...... .....+..+.... .|.
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~-------~~~~~i~~~~~~~--~p~--- 224 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-------ETAEHIAQGLRLY--RPH--- 224 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-------HHHHHHHTTCCCC--CCT---
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH-------HHHHHHHhCCCCC--Ccc---
Confidence 2234678999999999999999999999999999999998 88888765421 1222333332211 121
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 043278 669 PCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705 (752)
Q Consensus 669 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~ 705 (752)
.....+.+++.+||+.||++|||++|++++|.+
T Consensus 225 ----~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 225 ----LASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp ----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred ----cccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 122457789999999999999999999999965
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.1e-48 Score=404.37 Aligned_cols=258 Identities=26% Similarity=0.381 Sum_probs=212.1
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEee
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
.++|++.++||+|+||+||+|++. +++.||||+++... ...++|.+|+.++++++|||||+++++|.+++..+|||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 357888899999999999999975 47889999997643 4567899999999999999999999999999999999999
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccc
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES 587 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~ 587 (752)
+++|+|..++... ....+++..++.++.||++||+|||+++ |+||||||+||||++++.+||+|||+++.......
T Consensus 95 ~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 95 MTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp CTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred ccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence 9999999998654 3356999999999999999999999988 99999999999999999999999999987654322
Q ss_pred ccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCC
Q 043278 588 EANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLE 667 (752)
Q Consensus 588 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 667 (752)
. ......|++.|+|||++.+..++.|+|||||||++|||++|+.|+..... .....+.+..+.....
T Consensus 171 ~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~------~~~~~~~i~~~~~~~~------ 237 (287)
T d1opja_ 171 T-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID------LSQVYELLEKDYRMER------ 237 (287)
T ss_dssp E-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC------HHHHHHHHHTTCCCCC------
T ss_pred e-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch------HHHHHHHHhcCCCCCC------
Confidence 2 22235688999999999999999999999999999999998776643321 1122233333321111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCC
Q 043278 668 QPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNET 707 (752)
Q Consensus 668 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~ 707 (752)
+......+.+|+.+||+.||++||||+||++.|+.+.
T Consensus 238 ---~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 238 ---PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ---CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1122345788999999999999999999999998764
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-48 Score=399.93 Aligned_cols=250 Identities=24% Similarity=0.370 Sum_probs=208.4
Q ss_pred cCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeC
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFM 508 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 508 (752)
++|++.++||+|+||+||+|+. .+|+.||||++........+.+.+|+.++++++|||||++++++.+++..+|||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4799999999999999999986 468999999998766666778999999999999999999999999999999999999
Q ss_pred CCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccc
Q 043278 509 PNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE 588 (752)
Q Consensus 509 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 588 (752)
++|+|..++.. ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++.+....
T Consensus 100 ~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-- 170 (293)
T d1yhwa1 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-- 170 (293)
T ss_dssp TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--
T ss_pred CCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc--
Confidence 99999988754 35899999999999999999999998 9999999999999999999999999998764332
Q ss_pred cccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCC
Q 043278 589 ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQ 668 (752)
Q Consensus 589 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 668 (752)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .........+.. .+
T Consensus 171 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~~~~~~~~-~~------- 236 (293)
T d1yhwa1 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNGTP-EL------- 236 (293)
T ss_dssp CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHHCSC-CC-------
T ss_pred ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH------HHHHHHHhCCCC-CC-------
Confidence 2233467999999999999999999999999999999999999999654421 111222222111 11
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 669 PCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 669 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
..+......+.+++.+||+.||++|||+.|++++
T Consensus 237 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0111223457789999999999999999999763
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-48 Score=400.85 Aligned_cols=265 Identities=27% Similarity=0.407 Sum_probs=207.7
Q ss_pred cCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCC
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMP 509 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 509 (752)
++|++.+.||+|+||+||+|++++++.||||+++.. ....++|.+|+.++++++|+|||+++|++.+ +..++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence 578889999999999999999988889999999654 4456789999999999999999999999865 56789999999
Q ss_pred CCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccccc
Q 043278 510 NKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESEA 589 (752)
Q Consensus 510 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 589 (752)
+|+|..++.... ...++|.+++.++.||+.||+|||+.+ |+||||||+||||+.++++||+|||+++........
T Consensus 95 ~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~- 169 (285)
T d1fmka3 95 KGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT- 169 (285)
T ss_dssp TCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCce-
Confidence 999998886532 235999999999999999999999998 999999999999999999999999999876433322
Q ss_pred ccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCCC
Q 043278 590 NTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQP 669 (752)
Q Consensus 590 ~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 669 (752)
......||+.|+|||++....++.++||||||+++|||++|+.|+...... ......+..+.... .
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~------~~~~~~i~~~~~~~-----~--- 235 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN------REVLDQVERGYRMP-----C--- 235 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HHHHHHHHTTCCCC-----C---
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH------HHHHHHHHhcCCCC-----C---
Confidence 223357899999999999999999999999999999999977665443311 11122222222111 1
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCCCCCCCCCC
Q 043278 670 CSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETMPLPPPKQP 716 (752)
Q Consensus 670 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~~~~~~p~~~ 716 (752)
+.....++.+++.+||+.||++||||++|+++|+......+++.+|
T Consensus 236 -~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~p 281 (285)
T d1fmka3 236 -PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 281 (285)
T ss_dssp -CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCC
T ss_pred -CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCCCC
Confidence 1122345778999999999999999999999999875544444444
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=391.24 Aligned_cols=245 Identities=24% Similarity=0.360 Sum_probs=204.6
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccC---CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRS---SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 505 (752)
++|++.+.||+|+||+||+|+.. +++.||+|++.+. .......+.+|+.++++++|||||++++++.+++..+|||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46888899999999999999975 5889999998643 2345667899999999999999999999999999999999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccc
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVN 585 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~ 585 (752)
||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 86 Ey~~~g~L~~~l~~~---~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 999999999998653 35999999999999999999999998 999999999999999999999999999865432
Q ss_pred ccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCC
Q 043278 586 ESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPS 665 (752)
Q Consensus 586 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 665 (752)
......||+.|||||++.+..++.++|||||||+||||++|+.||...... .....+..+.. .
T Consensus 160 ----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-------~~~~~i~~~~~------~ 222 (263)
T d2j4za1 160 ----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ-------ETYKRISRVEF------T 222 (263)
T ss_dssp ----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHTTCC------C
T ss_pred ----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH-------HHHHHHHcCCC------C
Confidence 223467999999999999999999999999999999999999999754321 11222222221 1
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 043278 666 LEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVC 701 (752)
Q Consensus 666 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~ 701 (752)
+.. .....+.+++.+||+.||++|||++|+++
T Consensus 223 ~p~----~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 223 FPD----FVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp CCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCc----cCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 111 12235678899999999999999999986
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-48 Score=409.68 Aligned_cols=257 Identities=26% Similarity=0.406 Sum_probs=207.3
Q ss_pred cCCCcCCeeecCCcccEEEEEecC-C-----ceeEEEEcccC-CcccHHHHHHHHHHHHhc-CCCCcceeeeeeeeCCee
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLAD-E-----QEVAIKRLSRS-SGQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGEER 501 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~-~-----~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 501 (752)
++|++.++||+|+||+||+|+... + ..||+|++... .......+.+|+.++.++ +|||||++++++.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 578888999999999999998643 2 36999998654 333456789999999998 899999999999999999
Q ss_pred EEEEeeCCCCCHhHHHhhcCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCC
Q 043278 502 LLVYEFMPNKSLDFFLFNSGR--------------------KNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKAS 561 (752)
Q Consensus 502 ~lv~E~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~ 561 (752)
+|||||+++|+|.+++..... ...+++..++.++.||++||+|||+++ ||||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchh
Confidence 999999999999999975432 235899999999999999999999988 999999999
Q ss_pred cEEecCCCCceecccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCC
Q 043278 562 NILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPD 640 (752)
Q Consensus 562 NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~ 640 (752)
|||++.++.+||+|||+|+...............||+.|||||++.+..++.++|||||||+||||+| |+.||......
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999987655443333345678999999999999999999999999999999998 89999765432
Q ss_pred CCcchHHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 043278 641 RPLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQ 704 (752)
Q Consensus 641 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~ 704 (752)
. ...+.+..+...+ .+......+.+|+.+||+.||++||||+||+++|.
T Consensus 274 ~------~~~~~~~~~~~~~---------~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 274 A------NFYKLIQNGFKMD---------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp H------HHHHHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred H------HHHHHHhcCCCCC---------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 1 1122333322111 11112345778999999999999999999999985
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-48 Score=401.80 Aligned_cols=259 Identities=26% Similarity=0.419 Sum_probs=201.7
Q ss_pred cCCCcCCeeecCCcccEEEEEecCC-----ceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLADE-----QEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLL 503 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~~-----~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 503 (752)
..|+..+.||+|+||+||+|.++.. ..||||++.... .....+|.+|+.++.+++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4577789999999999999987542 369999997553 3345578999999999999999999999999999999
Q ss_pred EEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeec
Q 043278 504 VYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFE 583 (752)
Q Consensus 504 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~ 583 (752)
||||+.++++..++... ...+++.+++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 87 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 87 ITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEecccCcchhhhhcc--cccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence 99999999998887653 345999999999999999999999988 9999999999999999999999999998765
Q ss_pred ccccc-cccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCccccc
Q 043278 584 VNESE-ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELI 662 (752)
Q Consensus 584 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 662 (752)
..... .......||+.|||||++.+..++.++|||||||++|||++|+.|+...... ......+..+....
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~------~~~~~~i~~~~~~~-- 233 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN------HEVMKAINDGFRLP-- 233 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTTCCCC--
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH------HHHHHHHhccCCCC--
Confidence 43222 2223456899999999999999999999999999999999976665443211 11223333332211
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCC
Q 043278 663 DPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETM 708 (752)
Q Consensus 663 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~~ 708 (752)
.+......+.+|+.+||+.||++||||.||+++|+.+..
T Consensus 234 -------~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 234 -------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp -------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -------CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 122233567889999999999999999999999987643
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-48 Score=398.89 Aligned_cols=255 Identities=26% Similarity=0.387 Sum_probs=206.5
Q ss_pred cCCCcCC-eeecCCcccEEEEEec---CCceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEE
Q 043278 430 NNFSTTN-KLGEGGFGPVYKGKLA---DEQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLV 504 (752)
Q Consensus 430 ~~~~~~~-~LG~G~fg~Vy~~~~~---~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 504 (752)
++|.+.+ +||+|+||+||+|.+. ++..||||+++... ....++|.+|+++|.+++|||||+++|++.. +..+||
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 3455556 4999999999999764 34579999997653 3345779999999999999999999999865 568899
Q ss_pred EeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecc
Q 043278 505 YEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~ 584 (752)
|||+++|+|.+++.. .+..+++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 87 mE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence 999999999998754 3346999999999999999999999988 99999999999999999999999999998764
Q ss_pred cccc-cccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCccccc
Q 043278 585 NESE-ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELI 662 (752)
Q Consensus 585 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 662 (752)
.... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||...... .....+..+...++
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~-------~~~~~i~~~~~~~~- 233 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-------EVMAFIEQGKRMEC- 233 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-------HHHHHHHTTCCCCC-
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCCCCCC-
Confidence 4322 22334578999999999999999999999999999999998 89999765421 12233344433222
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 663 DPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 663 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
+......+.+|+.+||+.||++||||.+|++.|+..
T Consensus 234 --------p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 234 --------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp --------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 111224577899999999999999999999998753
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=396.44 Aligned_cols=247 Identities=28% Similarity=0.376 Sum_probs=198.9
Q ss_pred CeeecCCcccEEEEEecC---CceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeCCC
Q 043278 436 NKLGEGGFGPVYKGKLAD---EQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFMPN 510 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~~---~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 510 (752)
++||+|+||+||+|.+.+ ++.||||+++... ....++|.+|++++++++|||||+++|+|.. +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999998643 4679999997543 2335679999999999999999999999864 567899999999
Q ss_pred CCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccc-c
Q 043278 511 KSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE-A 589 (752)
Q Consensus 511 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~-~ 589 (752)
|+|.+++... ..+++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++.+...... .
T Consensus 92 g~L~~~l~~~---~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhhc---cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 9999998653 35999999999999999999999988 999999999999999999999999999876544322 2
Q ss_pred ccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCCC
Q 043278 590 NTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLEQ 668 (752)
Q Consensus 590 ~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 668 (752)
......||+.|||||.+.+..++.++|||||||++|||++ |+.||..... ......+..+.....
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~-------~~~~~~i~~~~~~~~------- 231 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-------SEVTAMLEKGERMGC------- 231 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHHHHTTCCCCC-------
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH-------HHHHHHHHcCCCCCC-------
Confidence 2334678999999999999999999999999999999998 8999976442 112233334332221
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 043278 669 PCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705 (752)
Q Consensus 669 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~ 705 (752)
+......+.+|+.+||+.||++||||+||+++|+.
T Consensus 232 --p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 232 --PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp --CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred --CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 11122457789999999999999999999998875
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=397.45 Aligned_cols=252 Identities=23% Similarity=0.364 Sum_probs=206.8
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeC
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFM 508 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 508 (752)
+.|++.+.||+|+||+||+|+.. +++.||||++........+.+.+|++++++++|||||++++++.+.+..+|||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46788899999999999999874 58899999998776666778999999999999999999999999999999999999
Q ss_pred CCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccc
Q 043278 509 PNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE 588 (752)
Q Consensus 509 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 588 (752)
++|+|..++.+.. ..+++.++..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+......
T Consensus 92 ~~g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-- 164 (288)
T d2jfla1 92 AGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-- 164 (288)
T ss_dssp TTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--
T ss_pred CCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc--
Confidence 9999999876532 35999999999999999999999998 9999999999999999999999999998654322
Q ss_pred cccccccccCCccChhhhc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccC
Q 043278 589 ANTKRIVGTYGYMSPEYAM-----SGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELID 663 (752)
Q Consensus 589 ~~~~~~~gt~~y~aPE~~~-----~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 663 (752)
.......||+.|||||++. +..++.|+|||||||++|||++|+.||......+ .. ...... ....+..
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~---~~---~~i~~~-~~~~~~~ 237 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR---VL---LKIAKS-EPPTLAQ 237 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HH---HHHHHS-CCCCCSS
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH---HH---HHHHcC-CCCCCCc
Confidence 1223467999999999984 4568999999999999999999999997654322 11 112221 1111111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 664 PSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 664 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
+......+.+|+.+||+.||++|||++|++++
T Consensus 238 -------~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 238 -------PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp -------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred -------cccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11223457788999999999999999999763
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=394.87 Aligned_cols=254 Identities=25% Similarity=0.337 Sum_probs=194.6
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeee--CCeeEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLH--GEERLLV 504 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv 504 (752)
++|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++.+++|||||++++++.+ ++..+||
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57888999999999999999864 68899999987653 3345568999999999999999999999865 4467899
Q ss_pred EeeCCCCCHhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCC--CcEeecCCCCCcEEecCCCCceeccccccee
Q 043278 505 YEFMPNKSLDFFLFNSG-RKNVLNWEKRFIIIEGISQGLLYLHKYSR--LRVIHRDLKASNILLDDKMNPKISDFGMARI 581 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~--~~iiH~Dikp~NIll~~~~~~kl~DFgla~~ 581 (752)
|||+++|+|.+++.... ....+++..++.++.||+.||+|||+.+. .+|+||||||+||||+.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999986432 34569999999999999999999998652 3599999999999999999999999999987
Q ss_pred ecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccc
Q 043278 582 FEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLEL 661 (752)
Q Consensus 582 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 661 (752)
+.... .......||+.|||||++.+..++.++|||||||++|||++|+.||...... .....+..+....+
T Consensus 164 ~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~-------~~~~~i~~~~~~~~ 234 (269)
T d2java1 164 LNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK-------ELAGKIREGKFRRI 234 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHTCCCCC
T ss_pred cccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH-------HHHHHHHcCCCCCC
Confidence 65332 2233468999999999999999999999999999999999999999754321 11222333332221
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 043278 662 IDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVC 701 (752)
Q Consensus 662 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~ 701 (752)
.... ...+.+|+.+||+.||++|||++|+++
T Consensus 235 -----~~~~----s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 235 -----PYRY----SDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp -----CTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----Cccc----CHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1112 235778899999999999999999976
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-47 Score=393.67 Aligned_cols=248 Identities=23% Similarity=0.319 Sum_probs=202.2
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccC---CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRS---SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 505 (752)
++|++.+.||+|+||+||+|+.. +++.||||++.+. .......+.+|++++++++||||+++++++.+++..+|||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 46888999999999999999874 6889999998643 2345567899999999999999999999999999999999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccc
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVN 585 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~ 585 (752)
||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||++++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhcc---CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 999999999988653 35999999999999999999999998 999999999999999999999999999987644
Q ss_pred ccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCC
Q 043278 586 ESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPS 665 (752)
Q Consensus 586 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 665 (752)
..........||+.|||||++.+..++.++|||||||+||||++|+.||...... .. ...+..+.. .
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------~~-~~~i~~~~~------~ 228 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY------LI-FQKIIKLEY------D 228 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HH-HHHHHTTCC------C
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH------HH-HHHHHcCCC------C
Confidence 4444444568999999999999999999999999999999999999999764311 11 122222211 1
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 043278 666 LEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVV 700 (752)
Q Consensus 666 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~ 700 (752)
+.... ...+.+|+.+||+.||++|||++|++
T Consensus 229 ~p~~~----s~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 229 FPEKF----FPKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp CCTTC----CHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred CCccC----CHHHHHHHHHHccCCHhHCcCHHHHc
Confidence 11112 23567899999999999999999864
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5e-47 Score=397.57 Aligned_cols=260 Identities=26% Similarity=0.404 Sum_probs=211.9
Q ss_pred HhcCCCcCCeeecCCcccEEEEEec------CCceeEEEEcccCCc-ccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCe
Q 043278 428 AANNFSTTNKLGEGGFGPVYKGKLA------DEQEVAIKRLSRSSG-QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEE 500 (752)
Q Consensus 428 ~~~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 500 (752)
..++|++.+.||+|+||+||+|+.. +++.||||+++.... +..++|.+|+.++++++||||++++++|.+.+.
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 4578999999999999999999864 357899999976533 345679999999999999999999999999999
Q ss_pred eEEEEeeCCCCCHhHHHhhcC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCC
Q 043278 501 RLLVYEFMPNKSLDFFLFNSG---------------------RKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLK 559 (752)
Q Consensus 501 ~~lv~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dik 559 (752)
.+++|||+++|+|.+++.... ....+++..++.++.||+.||+|||+.+ |||||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlK 167 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA 167 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEc
Confidence 999999999999999996432 1234899999999999999999999988 9999999
Q ss_pred CCcEEecCCCCceecccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCC-CCCCCCC
Q 043278 560 ASNILLDDKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ-KNHTRHH 638 (752)
Q Consensus 560 p~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~-~p~~~~~ 638 (752)
|+||||+.++++||+|||+++.+.............+++.|+|||.+.+..++.|+|||||||++|||++|. +||....
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence 999999999999999999998765444444444567889999999999999999999999999999999986 4565443
Q ss_pred CCCCcchHHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 639 PDRPLNLIGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 639 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
.. .....+.++..... +.....++.+|+.+||+.+|++||||.||+++|+.+
T Consensus 248 ~~-------e~~~~v~~~~~~~~---------p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 248 HE-------EVIYYVRDGNILAC---------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp HH-------HHHHHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred HH-------HHHHHHHcCCCCCC---------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 21 12233444443222 111224577899999999999999999999999875
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-47 Score=400.33 Aligned_cols=200 Identities=25% Similarity=0.343 Sum_probs=177.0
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCc-ccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEe
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSG-QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYE 506 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 506 (752)
.++|++.++||+|+||+||+|+.. +|+.||+|+++.... ....++.+|+.+|++++|||||+++++|.+.++.+||||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 467899999999999999999864 688999999976533 335678999999999999999999999999999999999
Q ss_pred eCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEeecCCCCCcEEecCCCCceecccccceeeccc
Q 043278 507 FMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY-SRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVN 585 (752)
Q Consensus 507 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~ 585 (752)
|+++|+|.+++.+. ..+++..+..++.||+.||.|||+. + |+||||||+||||+.++++||+|||+|+.....
T Consensus 85 y~~gg~L~~~l~~~---~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp CCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred cCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 99999999999654 3489999999999999999999974 6 999999999999999999999999999865422
Q ss_pred ccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 043278 586 ESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHH 638 (752)
Q Consensus 586 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~ 638 (752)
......||+.|||||++.+..++.++||||+||++|||++|+.||....
T Consensus 159 ----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~ 207 (322)
T d1s9ja_ 159 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207 (322)
T ss_dssp ----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred ----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 2234689999999999999999999999999999999999999997654
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.3e-46 Score=397.82 Aligned_cols=252 Identities=21% Similarity=0.281 Sum_probs=207.6
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeC
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFM 508 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 508 (752)
++|.+.+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..+||||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 57889999999999999999874 68999999998776666778899999999999999999999999999999999999
Q ss_pred CCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEec--CCCCceecccccceeecccc
Q 043278 509 PNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLD--DKMNPKISDFGMARIFEVNE 586 (752)
Q Consensus 509 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~--~~~~~kl~DFgla~~~~~~~ 586 (752)
++|+|.+++... ...+++..+..++.||+.||+|||+++ ||||||||+||||+ .++.+||+|||+++.+....
T Consensus 106 ~gg~L~~~l~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 106 SGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CSCBHHHHHTCT--TSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred CCCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 999999988542 345999999999999999999999998 99999999999995 46889999999998765332
Q ss_pred cccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCC
Q 043278 587 SEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666 (752)
Q Consensus 587 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 666 (752)
......||+.|||||++.+..++.++|||||||++|||++|+.||...... ....... .+... .++..
T Consensus 181 ---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~-~~~~~--~~~~~ 248 (350)
T d1koaa2 181 ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD------ETLRNVK-SCDWN--MDDSA 248 (350)
T ss_dssp ---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHH-HTCCC--SCCGG
T ss_pred ---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH------HHHHHHH-hCCCC--CCccc
Confidence 223467899999999999999999999999999999999999999755321 1111111 11110 01110
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 667 EQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 667 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.......+.+|+.+||+.||++|||++|++++
T Consensus 249 ----~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 249 ----FSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp ----GGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred ----ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11112356788999999999999999999986
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-46 Score=380.33 Aligned_cols=247 Identities=25% Similarity=0.369 Sum_probs=195.9
Q ss_pred CcCCeeecCCcccEEEEEec-CCceeEEEEcccC--CcccHHHHHHHHHHHHhcCCCCcceeeeeeee----CCeeEEEE
Q 043278 433 STTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRS--SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLH----GEERLLVY 505 (752)
Q Consensus 433 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 505 (752)
+..++||+|+||+||+|+.. +++.||+|++... .....+.|.+|++++++++|||||++++++.+ +...+|||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 44568999999999999875 5789999998654 33345678999999999999999999999864 34678999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEec-CCCCceecccccceeecc
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLD-DKMNPKISDFGMARIFEV 584 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~-~~~~~kl~DFgla~~~~~ 584 (752)
||+++|+|.+++... ..+++..+..++.||++||+|||+++ .+|+||||||+||||+ +++.+||+|||+++....
T Consensus 92 E~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCcHHHHHhcc---ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 999999999998653 35899999999999999999999875 4599999999999996 578999999999985432
Q ss_pred cccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCC
Q 043278 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDP 664 (752)
Q Consensus 585 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 664 (752)
. ......||+.|||||++.+ .++.++|||||||++|||++|+.||...... ....+.+..+.....++
T Consensus 168 ~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~------~~~~~~i~~~~~~~~~~- 235 (270)
T d1t4ha_ 168 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRRVTSGVKPASFD- 235 (270)
T ss_dssp T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHHHHHTTTCCCGGGG-
T ss_pred C----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH------HHHHHHHHcCCCCcccC-
Confidence 2 2234689999999998865 5999999999999999999999999654311 11222333322111111
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 665 SLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 665 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
... ...+.+|+.+||+.||++|||++|++++
T Consensus 236 ---~~~----~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 236 ---KVA----IPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp ---GCC----CHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ---ccC----CHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 111 2346788999999999999999999863
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.5e-46 Score=388.01 Aligned_cols=246 Identities=29% Similarity=0.432 Sum_probs=200.7
Q ss_pred cCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCCc---ccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSSG---QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 505 (752)
+.|+..++||+|+||+||+|+. .+++.||||++..... ...+.+.+|+.++++++|||||++++++.+++..+|||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 4588889999999999999986 4688899999876532 23456889999999999999999999999999999999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccc
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVN 585 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~ 585 (752)
|||++|+|..++... ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 95 E~~~~g~l~~~~~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp ECCSEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EecCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence 999999997766432 45999999999999999999999998 99999999999999999999999999986432
Q ss_pred ccccccccccccCCccChhhhcc---CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCccccc
Q 043278 586 ESEANTKRIVGTYGYMSPEYAMS---GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELI 662 (752)
Q Consensus 586 ~~~~~~~~~~gt~~y~aPE~~~~---~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 662 (752)
.....||+.|||||++.+ ..++.++|||||||++|||++|+.||..... ......... +....+.
T Consensus 168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~------~~~~~~i~~-~~~~~~~ 235 (309)
T d1u5ra_ 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQ-NESPALQ 235 (309)
T ss_dssp -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHH-SCCCCCS
T ss_pred -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHh-CCCCCCC
Confidence 234679999999999864 5689999999999999999999999975431 111122222 2111111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 663 DPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 663 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.. .. ...+.+|+.+||+.||.+|||++|++++
T Consensus 236 ~~----~~----s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 236 SG----HW----SEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp CT----TS----CHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CC----CC----CHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 11 11 2357788999999999999999999873
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-45 Score=387.09 Aligned_cols=252 Identities=21% Similarity=0.278 Sum_probs=190.2
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCc-ccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEe
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSG-QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYE 506 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 506 (752)
.+.|++.+.||+|+||+||+|+.. +++.||||++..... .....+.+|+.++++++|||||++++++.+++..+||||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 356888999999999999999875 588999999976532 334567899999999999999999999999999999999
Q ss_pred eCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEec---CCCCceecccccceeec
Q 043278 507 FMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLD---DKMNPKISDFGMARIFE 583 (752)
Q Consensus 507 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~---~~~~~kl~DFgla~~~~ 583 (752)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+. +++.+||+|||+++...
T Consensus 88 ~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 88 LVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred ccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 9999999999964 345999999999999999999999998 99999999999994 57899999999998654
Q ss_pred ccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccC
Q 043278 584 VNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELID 663 (752)
Q Consensus 584 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 663 (752)
... ......||+.|||||++.+..++.++|||||||+||||++|+.||...... .. ......+... ..
T Consensus 162 ~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------~~-~~~i~~~~~~--~~ 229 (307)
T d1a06a_ 162 PGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA------KL-FEQILKAEYE--FD 229 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HH-HHHHHTTCCC--CC
T ss_pred CCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH------HH-HHHHhccCCC--CC
Confidence 322 223467999999999999999999999999999999999999999754311 11 1222222111 01
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 664 PSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 664 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.+........+.+|+.+||+.||++|||++|++++
T Consensus 230 ----~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 230 ----SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp ----TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ----CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 11111222457789999999999999999999885
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-46 Score=393.81 Aligned_cols=255 Identities=27% Similarity=0.412 Sum_probs=201.5
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCc----eeEEEEcccC-CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQ----EVAIKRLSRS-SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLL 503 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 503 (752)
++|++.++||+|+||+||+|+.. +|+ +||+|+++.. ..+..++|.+|+.++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 35888899999999999999864 343 5899988654 445677899999999999999999999999865 5678
Q ss_pred EEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeec
Q 043278 504 VYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFE 583 (752)
Q Consensus 504 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~ 583 (752)
++||+.+|+|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 88 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHHT--SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCccccccccc--ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 88999999998887653 456999999999999999999999988 9999999999999999999999999999776
Q ss_pred ccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCccccc
Q 043278 584 VNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELI 662 (752)
Q Consensus 584 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 662 (752)
............||+.|+|||++.++.++.++|||||||+||||+| |+.||....... + ...+..+....
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~----~~~i~~~~~~~-- 233 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---I----SSILEKGERLP-- 233 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---H----HHHHHHTCCCC--
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---H----HHHHHcCCCCC--
Confidence 5544444445678999999999999999999999999999999999 788886654221 1 12222222111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 663 DPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 663 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
.+......+.+|+.+||+.||.+|||+.||++.|+..
T Consensus 234 -------~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 234 -------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp -------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 1112234577899999999999999999999998764
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.3e-45 Score=393.52 Aligned_cols=256 Identities=21% Similarity=0.250 Sum_probs=209.3
Q ss_pred cCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeC
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFM 508 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 508 (752)
++|++.+.||+|+||.||+|+. .+|+.||||++..........+.+|+.+|++++|||||++++++.+++..+||||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 4788999999999999999986 468999999998766556677899999999999999999999999999999999999
Q ss_pred CCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEec--CCCCceecccccceeecccc
Q 043278 509 PNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLD--DKMNPKISDFGMARIFEVNE 586 (752)
Q Consensus 509 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~--~~~~~kl~DFgla~~~~~~~ 586 (752)
++|+|.+++.. ....+++.++..++.||+.||+|||+++ |+||||||+||||+ .++.+||+|||+|+.+....
T Consensus 109 ~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 109 SGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp CCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 99999887743 2345999999999999999999999998 99999999999997 67899999999998765432
Q ss_pred cccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCC
Q 043278 587 SEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666 (752)
Q Consensus 587 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 666 (752)
......||+.|||||++.+..++.++|||||||+||||++|+.||...... ..... +..+... ..+..
T Consensus 184 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~-i~~~~~~--~~~~~ 251 (352)
T d1koba_ 184 ---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL------ETLQN-VKRCDWE--FDEDA 251 (352)
T ss_dssp ---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHH-HHHCCCC--CCSST
T ss_pred ---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH------HHHHH-HHhCCCC--CCccc
Confidence 223467899999999999999999999999999999999999999755421 11111 2111110 01111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hhcC
Q 043278 667 EQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM--LQNE 706 (752)
Q Consensus 667 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~--L~~~ 706 (752)
.......+.+|+.+||+.||.+|||+.|++++ +++.
T Consensus 252 ----~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 252 ----FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp ----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred ----ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 11122456789999999999999999999885 5543
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-46 Score=381.98 Aligned_cols=249 Identities=25% Similarity=0.371 Sum_probs=196.4
Q ss_pred cCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeC-CeeEEEEeeC
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHG-EERLLVYEFM 508 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~E~~ 508 (752)
++|++.++||+|+||.||+|++ .|+.||||+++.. ...++|.+|++++++++||||++++|+|.++ +..++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 4567778999999999999998 4678999999754 3456799999999999999999999998654 5679999999
Q ss_pred CCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccc
Q 043278 509 PNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE 588 (752)
Q Consensus 509 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 588 (752)
++|+|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--- 156 (262)
T d1byga_ 84 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 156 (262)
T ss_dssp TTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC---
Confidence 999999999653 2235899999999999999999999988 999999999999999999999999999864322
Q ss_pred cccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCCC
Q 043278 589 ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSLE 667 (752)
Q Consensus 589 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 667 (752)
.....++..|+|||++.+..++.++||||||+++|||+| |+.|+...... ... ..+..+...++
T Consensus 157 --~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~---~~~----~~i~~~~~~~~------ 221 (262)
T d1byga_ 157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVV----PRVEKGYKMDA------ 221 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHH----HHHTTTCCCCC------
T ss_pred --CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH---HHH----HHHHcCCCCCC------
Confidence 223467889999999999999999999999999999998 67776554322 111 22233322222
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 668 QPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 668 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
+.....++.+|+.+||+.||++||||.||+++|+.+
T Consensus 222 ---~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 222 ---PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 112224577899999999999999999999999864
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-46 Score=387.70 Aligned_cols=260 Identities=27% Similarity=0.373 Sum_probs=199.8
Q ss_pred hcCCCcCCeeecCCcccEEEEEec------CCceeEEEEcccCC-cccHHHHHHHHHHHHhc-CCCCcceeeeeeeeC-C
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA------DEQEVAIKRLSRSS-GQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHG-E 499 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~ 499 (752)
.++|++.++||+|+||.||+|+.. +++.||||+++... ....+++.+|...+.++ +|+||+.+++++.+. +
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 467889999999999999999863 24679999997543 33455678888888777 689999999988664 4
Q ss_pred eeEEEEeeCCCCCHhHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEec
Q 043278 500 ERLLVYEFMPNKSLDFFLFNSG-------------RKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLD 566 (752)
Q Consensus 500 ~~~lv~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~ 566 (752)
..++|||||++|+|.+++.... ....+++.+++.++.||++||+|||+++ |+||||||+||||+
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeEC
Confidence 6899999999999999996532 1345899999999999999999999988 99999999999999
Q ss_pred CCCCceecccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCC-CCCCCCCCCCCcch
Q 043278 567 DKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ-KNHTRHHPDRPLNL 645 (752)
Q Consensus 567 ~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~-~p~~~~~~~~~~~l 645 (752)
+++.+||+|||+|+...............||+.|||||++.+..++.++|||||||++|||++|. .||.......
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~---- 244 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---- 244 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH----
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH----
Confidence 99999999999998765554444455678999999999999999999999999999999999975 4665443221
Q ss_pred HHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 646 IGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 646 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
.....+..+...... . ....++.+++.+||+.||++||||+||+++|+++
T Consensus 245 --~~~~~~~~~~~~~~~-----~----~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 245 --EFCRRLKEGTRMRAP-----D----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp --HHHHHHHHTCCCCCC-----T----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HHHHHHhcCCCCCCC-----c----cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 122333333322211 1 1223577899999999999999999999999864
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=381.81 Aligned_cols=254 Identities=24% Similarity=0.333 Sum_probs=195.7
Q ss_pred cCCCcCCeeecCCcccEEEEEecC----CceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLAD----EQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLV 504 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 504 (752)
++|++.+.||+|+||.||+|+... +..||||.++... ......|.+|+.++++++|||||++++++.+ +..++|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEEE
Confidence 578888999999999999998643 3468999986543 3345679999999999999999999999864 678999
Q ss_pred EeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecc
Q 043278 505 YEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~ 584 (752)
|||+++|+|..++... ...+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 86 ~E~~~~g~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp EECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEeccCCcHHhhhhcc--CCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccC
Confidence 9999999999987543 345899999999999999999999998 99999999999999999999999999987653
Q ss_pred cccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCcccccC
Q 043278 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELID 663 (752)
Q Consensus 585 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 663 (752)
.... ......||+.|+|||++.+..++.++|||||||++|||++ |++|+......+ +. ..+..+....+
T Consensus 161 ~~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~~----~~i~~~~~~~~-- 230 (273)
T d1mp8a_ 161 STYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VI----GRIENGERLPM-- 230 (273)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HH----HHHHTTCCCCC--
T ss_pred Ccce-eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---HH----HHHHcCCCCCC--
Confidence 3222 2334678999999999999999999999999999999998 888887655321 11 22233322211
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 664 PSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 664 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
+......+.+|+.+||+.||++|||+.||++.|+.+
T Consensus 231 -------~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 231 -------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp -------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 111234577899999999999999999999998754
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-45 Score=383.80 Aligned_cols=258 Identities=25% Similarity=0.370 Sum_probs=208.7
Q ss_pred cCCCcCCeeecCCcccEEEEEecC--------CceeEEEEcccCCc-ccHHHHHHHHHHHHhc-CCCCcceeeeeeeeCC
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLAD--------EQEVAIKRLSRSSG-QGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGE 499 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 499 (752)
++|.+.+.||+|+||.||+|+... +..||||+++.... ....++.+|...+.++ +|||||+++++|.+++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 578888999999999999998532 24799999976543 3456788999999888 8999999999999999
Q ss_pred eeEEEEeeCCCCCHhHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEec
Q 043278 500 ERLLVYEFMPNKSLDFFLFNSGR-------------KNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLD 566 (752)
Q Consensus 500 ~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~ 566 (752)
..++||||+++|+|.+++..... ...+++.+++.++.||+.||+|||+.+ ||||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceeec
Confidence 99999999999999999965431 245899999999999999999999998 99999999999999
Q ss_pred CCCCceecccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcch
Q 043278 567 DKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNL 645 (752)
Q Consensus 567 ~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l 645 (752)
.++.+||+|||+++...............+++.|+|||.+.++.++.|+||||||+++|||++ |+.||.....
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~------ 243 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV------ 243 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH------
Confidence 999999999999998765555555556788999999999999999999999999999999998 6777765442
Q ss_pred HHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 646 IGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 646 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
......+..+..... +.....++.+|+.+||+.||.+||||.||+++|+++
T Consensus 244 -~~~~~~i~~~~~~~~---------p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 244 -EELFKLLKEGHRMDK---------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp -HHHHHHHHTTCCCCC---------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HHHHHHHHcCCCCCC---------CccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 122334444432221 111224578899999999999999999999999875
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-45 Score=383.86 Aligned_cols=260 Identities=26% Similarity=0.404 Sum_probs=213.2
Q ss_pred cCCCcCCeeecCCcccEEEEEec------CCceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA------DEQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERL 502 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 502 (752)
++|.+.++||+|+||+||+|.+. +++.||||+++... ......|.+|+.++++++|||||+++++|..++..+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 57788899999999999999863 35789999997543 334456899999999999999999999999999999
Q ss_pred EEEeeCCCCCHhHHHhhc-------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecc
Q 043278 503 LVYEFMPNKSLDFFLFNS-------GRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISD 575 (752)
Q Consensus 503 lv~E~~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~D 575 (752)
+||||+++|+|..++... .....+++..++.++.|+++||.|||+++ |+||||||+||||++++++||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEee
Confidence 999999999999988642 22345799999999999999999999987 99999999999999999999999
Q ss_pred cccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCC-CCCCCCCCCCCcchHHHHHHHhh
Q 043278 576 FGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQ-KNHTRHHPDRPLNLIGYAWQLLS 654 (752)
Q Consensus 576 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~-~p~~~~~~~~~~~l~~~~~~~~~ 654 (752)
||+++.+.............+|+.|+|||.+.+..++.++||||||+++|||+||. .|+..... ......+.
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~-------~~~~~~i~ 249 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-------EQVLRFVM 249 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-------HHHHHHHH
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHH
Confidence 99998776554444445567899999999999999999999999999999999985 55644321 11223333
Q ss_pred CCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCCC
Q 043278 655 DGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNETM 708 (752)
Q Consensus 655 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~~ 708 (752)
++...... . .....+.+++.+||+.+|.+||||+||+++|+....
T Consensus 250 ~~~~~~~p-----~----~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 250 EGGLLDKP-----D----NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp TTCCCCCC-----T----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred hCCCCCCc-----c----cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 43332211 1 122458889999999999999999999999988644
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-45 Score=383.68 Aligned_cols=251 Identities=23% Similarity=0.318 Sum_probs=204.5
Q ss_pred cCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCC------cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSS------GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERL 502 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 502 (752)
++|++.+.||+|+||+||+|+. .+|+.||||++.+.. ....+.+.+|+.+|++++|||||++++++.+.+..+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 6789999999999999999997 468999999986432 224678999999999999999999999999999999
Q ss_pred EEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCC----Cceeccccc
Q 043278 503 LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKM----NPKISDFGM 578 (752)
Q Consensus 503 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~----~~kl~DFgl 578 (752)
||||||++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+
T Consensus 90 iv~E~~~gg~L~~~i~~~---~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEcCCCccccchhccc---cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhh
Confidence 999999999999998653 35999999999999999999999998 99999999999998776 499999999
Q ss_pred ceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCc
Q 043278 579 ARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKG 658 (752)
Q Consensus 579 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 658 (752)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .. ...+..+..
T Consensus 164 a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------~~-~~~i~~~~~ 233 (293)
T d1jksa_ 164 AHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ET-LANVSAVNY 233 (293)
T ss_dssp CEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HH-HHHHHTTCC
T ss_pred hhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH------HH-HHHHHhcCC
Confidence 98764332 223457899999999999999999999999999999999999999765421 11 112222111
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 659 LELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 659 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.. .+.. .......+.+|+.+||+.||.+|||++|++++
T Consensus 234 ~~--~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 234 EF--EDEY----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp CC--CHHH----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CC--Cchh----cCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 0000 00112356789999999999999999999874
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=381.21 Aligned_cols=255 Identities=26% Similarity=0.365 Sum_probs=196.8
Q ss_pred cCCCcCCeeecCCcccEEEEEecC--C--ceeEEEEcccC---CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLAD--E--QEVAIKRLSRS---SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERL 502 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~--~--~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 502 (752)
++|++.+.||+|+||.||+|++.. + ..||||++... ..+..++|.+|+.++++++|||||+++|+|.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 568888999999999999998642 2 36899998754 23445689999999999999999999999976 4678
Q ss_pred EEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceee
Q 043278 503 LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIF 582 (752)
Q Consensus 503 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~ 582 (752)
+||||+++|++.+++... ...+++..++.++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 87 lv~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence 999999999999887653 345999999999999999999999988 999999999999999999999999999987
Q ss_pred cccccc-cccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhCCCccc
Q 043278 583 EVNESE-ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVS-GQKNHTRHHPDRPLNLIGYAWQLLSDGKGLE 660 (752)
Q Consensus 583 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 660 (752)
...... .......|+..|+|||.+.+..++.++||||||+++|||+| |+.||..... ..........+...+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~------~~~~~~i~~~~~~~~ 235 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG------SQILHKIDKEGERLP 235 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTSCCCCC
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH------HHHHHHHHhCCCCCC
Confidence 544322 22334567889999999999999999999999999999998 8999875442 122223333332211
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 043278 661 LIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQN 705 (752)
Q Consensus 661 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~ 705 (752)
. +......+.+|+.+||+.||++||||.||++.|++
T Consensus 236 ~---------~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 236 R---------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp C---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred C---------cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 1 11122457789999999999999999999999975
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-45 Score=387.34 Aligned_cols=259 Identities=25% Similarity=0.386 Sum_probs=210.4
Q ss_pred cCCCcCCeeecCCcccEEEEEe------cCCceeEEEEcccCC-cccHHHHHHHHHHHHhc-CCCCcceeeeeeeeCCee
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKL------ADEQEVAIKRLSRSS-GQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGEER 501 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 501 (752)
++|++.++||+|+||.||+|++ ..++.||||+++... .....+|.+|+.++.++ +|||||+++++|.+++..
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 5788889999999999999985 245689999997653 33455789999999999 799999999999999999
Q ss_pred EEEEeeCCCCCHhHHHhhcC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEec
Q 043278 502 LLVYEFMPNKSLDFFLFNSG---------------RKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLD 566 (752)
Q Consensus 502 ~lv~E~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~ 566 (752)
+||||||++|+|..++.... ....+++..++.++.||++||+|||+++ ++||||||+|||++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccccccccc
Confidence 99999999999999997543 2335899999999999999999999998 99999999999999
Q ss_pred CCCCceecccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhC-CCCCCCCCCCCCcch
Q 043278 567 DKMNPKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSG-QKNHTRHHPDRPLNL 645 (752)
Q Consensus 567 ~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG-~~p~~~~~~~~~~~l 645 (752)
.++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||+++ ++|+......
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~----- 254 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD----- 254 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS-----
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH-----
Confidence 9999999999999977654444444567899999999999999999999999999999999995 4445443322
Q ss_pred HHHHHHHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 646 IGYAWQLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 646 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
....+.+..+.... .+......+.+|+.+||+.||++||||.||+++|++.
T Consensus 255 -~~~~~~i~~~~~~~---------~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 255 -SKFYKMIKEGFRML---------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp -HHHHHHHHHTCCCC---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HHHHHHHhcCCCCC---------CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 11122232222111 1111234578899999999999999999999999863
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=379.85 Aligned_cols=252 Identities=27% Similarity=0.385 Sum_probs=201.5
Q ss_pred CCeeecCCcccEEEEEecCC----ceeEEEEcccC-CcccHHHHHHHHHHHHhcCCCCcceeeeeeee-CCeeEEEEeeC
Q 043278 435 TNKLGEGGFGPVYKGKLADE----QEVAIKRLSRS-SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLH-GEERLLVYEFM 508 (752)
Q Consensus 435 ~~~LG~G~fg~Vy~~~~~~~----~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~E~~ 508 (752)
.++||+|+||+||+|++.++ ..||||+++.. ......+|.+|++++++++||||++++|++.+ +...++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 36899999999999987542 25899999754 44455789999999999999999999999876 45889999999
Q ss_pred CCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccc
Q 043278 509 PNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE 588 (752)
Q Consensus 509 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 588 (752)
++|+|.+++.. ....+++..++.++.|+++||.|||+.+ |+||||||+||||++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 99999998864 3445788999999999999999999988 999999999999999999999999999876543322
Q ss_pred --cccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCC
Q 043278 589 --ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666 (752)
Q Consensus 589 --~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 666 (752)
.......||+.|+|||.+....++.++||||||+++|||++|+.|+........ . ...+..+.... .|.
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~--~----~~~i~~g~~~~--~p~- 257 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--I----TVYLLQGRRLL--QPE- 257 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------C----HHHHHTTCCCC--CCT-
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH--H----HHHHHcCCCCC--Ccc-
Confidence 222345789999999999999999999999999999999998888765442211 1 12223333221 111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 667 EQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 667 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
.....+.+|+.+||+.||++||||.||+++|+.+
T Consensus 258 ------~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i 291 (311)
T d1r0pa_ 258 ------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291 (311)
T ss_dssp ------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------cCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1224577899999999999999999999999876
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-44 Score=380.99 Aligned_cols=248 Identities=23% Similarity=0.288 Sum_probs=205.7
Q ss_pred cCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccC---CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRS---SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 505 (752)
++|++.+.||+|+||.||+|+. .+++.||||++.+. .......+.+|+.+|++++||||+++++++.+.+..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 5688899999999999999986 46899999999754 2345677899999999999999999999999999999999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccc
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVN 585 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~ 585 (752)
|||++|+|..++... ..+++..+..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+.....
T Consensus 85 ey~~gg~L~~~~~~~---~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 85 EYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eccCCCchhhhhhcc---cCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 999999999998653 35899999999999999999999998 999999999999999999999999999865432
Q ss_pred ccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCC
Q 043278 586 ESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPS 665 (752)
Q Consensus 586 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 665 (752)
. ......+||+.|||||++.+..++.++||||+||++|||++|+.||...... .. .+....+.. .
T Consensus 159 ~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~------~~-~~~i~~~~~------~ 223 (337)
T d1o6la_ 159 G--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------RL-FELILMEEI------R 223 (337)
T ss_dssp T--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HH-HHHHHHCCC------C
T ss_pred C--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH------HH-HHHHhcCCC------C
Confidence 2 2233578999999999999999999999999999999999999999775521 11 122222211 1
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 043278 666 LEQPCSANEVMRCIHVGLLCVQDQAMDRPT-----MPEVVCM 702 (752)
Q Consensus 666 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-----~~ev~~~ 702 (752)
+.... ...+.+|+.+||+.||.+||+ ++|++++
T Consensus 224 ~p~~~----s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 224 FPRTL----SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp CCTTS----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCccC----CHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 11112 234678999999999999995 7888774
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-45 Score=383.40 Aligned_cols=265 Identities=22% Similarity=0.300 Sum_probs=200.9
Q ss_pred cCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHH--HHHHHHhcCCCCcceeeeeeeeCC----eeEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKN--EVRLIAKLQHTNLVRLLGCSLHGE----ERLL 503 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~--E~~~l~~l~h~niv~l~~~~~~~~----~~~l 503 (752)
++|.+.+.||+|+||.||+|++ +|+.||||+++... ..++.. |+..+.+++|||||+++++|.+.+ ..++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 4567778999999999999997 67899999986542 233444 455556789999999999997654 5789
Q ss_pred EEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCcEeecCCCCCcEEecCCCCceeccccc
Q 043278 504 VYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY-----SRLRVIHRDLKASNILLDDKMNPKISDFGM 578 (752)
Q Consensus 504 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~iiH~Dikp~NIll~~~~~~kl~DFgl 578 (752)
|||||++|+|..++.. ..++|..++.++.|++.||+|||+. ...+|+||||||+||||+.++.+||+|||+
T Consensus 79 v~Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 9999999999999964 3489999999999999999999974 124599999999999999999999999999
Q ss_pred ceeecccccc--cccccccccCCccChhhhccCC------CCccchhHHHHHHHHHHHhCCCCCCCCCCCCCc-------
Q 043278 579 ARIFEVNESE--ANTKRIVGTYGYMSPEYAMSGI------VSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPL------- 643 (752)
Q Consensus 579 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~------- 643 (752)
++........ .......||+.|+|||++.+.. ++.|+|||||||+||||+||..|+.........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence 9987544322 2234568999999999987643 678999999999999999998887543322110
Q ss_pred -chHHHHHHHhhCCCcccccCCCCCCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 644 -NLIGYAWQLLSDGKGLELIDPSLEQP-CSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 644 -~l~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
............+. ++|.+... .+.+....+.+|+.+||+.||++||||.||+++|+.+
T Consensus 235 ~~~~~~~~~~~~~~~----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 235 DPSVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp SCCHHHHHHHHTTSC----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred cchHHHHHHHHhccc----cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 11112222222211 22222111 2334566788999999999999999999999999765
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.7e-44 Score=376.98 Aligned_cols=245 Identities=22% Similarity=0.290 Sum_probs=203.5
Q ss_pred cCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccC---CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRS---SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 505 (752)
++|++.+.||+|+||+||+|+. .+|+.||||++++. .....+.+.+|+.++++++|||||++++++.+++..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 4688899999999999999997 45899999998643 2345677899999999999999999999999999999999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccc
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVN 585 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~ 585 (752)
||+++|+|..++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCcccccccccc---ccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 999999998888643 34788999999999999999999998 999999999999999999999999999875432
Q ss_pred ccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCC
Q 043278 586 ESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPS 665 (752)
Q Consensus 586 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 665 (752)
.....||+.|||||++.+..++.++|||||||+||||++|+.||...... ....... .+.. .
T Consensus 158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~i~-~~~~------~ 219 (316)
T d1fota_ 158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM------KTYEKIL-NAEL------R 219 (316)
T ss_dssp -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHH-HCCC------C
T ss_pred -----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH------HHHHHHH-cCCC------C
Confidence 23468999999999999999999999999999999999999999764421 1111222 2211 1
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 043278 666 LEQPCSANEVMRCIHVGLLCVQDQAMDRP-----TMPEVVCM 702 (752)
Q Consensus 666 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~ev~~~ 702 (752)
+.... ...+.+++.+||+.||.+|| |++|++++
T Consensus 220 ~p~~~----s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 220 FPPFF----NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp CCTTS----CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCCC----CHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 11111 23467888999999999996 89999875
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-45 Score=382.97 Aligned_cols=256 Identities=28% Similarity=0.415 Sum_probs=203.4
Q ss_pred cCCCcCCeeecCCcccEEEEEecC-Cc--eeEEEEcccC-CcccHHHHHHHHHHHHhc-CCCCcceeeeeeeeCCeeEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLAD-EQ--EVAIKRLSRS-SGQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLHGEERLLV 504 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 504 (752)
++|++.++||+|+||+||+|++.+ +. .||||++... .....++|.+|+++|.++ +|||||+++++|.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 567788999999999999998754 33 4788888654 334556799999999998 799999999999999999999
Q ss_pred EeeCCCCCHhHHHhhc-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCc
Q 043278 505 YEFMPNKSLDFFLFNS-------------GRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNP 571 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~ 571 (752)
|||+++|+|.+++... .....+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999998653 23456999999999999999999999988 9999999999999999999
Q ss_pred eecccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCC-CCCCCCCCCCcchHHHHH
Q 043278 572 KISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQK-NHTRHHPDRPLNLIGYAW 650 (752)
Q Consensus 572 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~-p~~~~~~~~~~~l~~~~~ 650 (752)
||+|||+++...... ......||..|+|||.+.+..++.++|||||||++|||++|.. ||.... .....
T Consensus 167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~-------~~~~~ 236 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-------CAELY 236 (309)
T ss_dssp EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-------HHHHH
T ss_pred EEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC-------HHHHH
Confidence 999999998643221 2234568999999999999999999999999999999999765 554432 11122
Q ss_pred HHhhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCC
Q 043278 651 QLLSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNET 707 (752)
Q Consensus 651 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~~ 707 (752)
..+..+.... .+......+.+|+.+||+.||++||||+||++.|+.+.
T Consensus 237 ~~i~~~~~~~---------~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 237 EKLPQGYRLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp HHGGGTCCCC---------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhcCCCC---------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 2333332211 11122346788999999999999999999999998763
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=9e-44 Score=368.32 Aligned_cols=258 Identities=24% Similarity=0.345 Sum_probs=200.9
Q ss_pred hcCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCCc---ccHHHHHHHHHHHHhcCCCCcceeeeeeeeCC----e
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSSG---QGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGE----E 500 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~ 500 (752)
.++|++.+.||+|+||+||+|+. .+++.||||+++.... .....|.+|++++++++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 36789999999999999999986 4689999999976532 23456899999999999999999999987644 3
Q ss_pred eEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccce
Q 043278 501 RLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR 580 (752)
Q Consensus 501 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~ 580 (752)
.+|||||+++++|..++... ..+++.+++.++.||+.||+|||+++ |+||||||+||||+.++..+|+|||.+.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhccc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 78999999999999888654 35899999999999999999999998 9999999999999999999999999987
Q ss_pred eecccc-cccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcc
Q 043278 581 IFEVNE-SEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGL 659 (752)
Q Consensus 581 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 659 (752)
...... .........||+.|||||++.+..++.++|||||||++|||++|+.||..... .......+..+...
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~~~~~~~~~ 233 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDPIP 233 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCCCC
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH------HHHHHHHHhcCCCC
Confidence 654332 22233456899999999999999999999999999999999999999975432 22223333332221
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHhhc
Q 043278 660 ELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRP-TMPEVVCMLQN 705 (752)
Q Consensus 660 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-t~~ev~~~L~~ 705 (752)
.. ..... ....+.+++.+|++.||.+|| |++++++.|..
T Consensus 234 ~~---~~~~~----~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 234 PS---ARHEG----LSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp GG---GTSSS----CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred Cc---hhccC----CCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 10 01111 124577889999999999999 89999888865
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=8.8e-44 Score=366.91 Aligned_cols=251 Identities=24% Similarity=0.303 Sum_probs=203.4
Q ss_pred cCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCCcc---------cHHHHHHHHHHHHhcC-CCCcceeeeeeeeC
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSSGQ---------GIVEFKNEVRLIAKLQ-HTNLVRLLGCSLHG 498 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~---------~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 498 (752)
++|++.+.||+|+||+||+|+. .+++.||||++...... ..+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 5788999999999999999986 46889999998765321 1235789999999997 99999999999999
Q ss_pred CeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceeccccc
Q 043278 499 EERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGM 578 (752)
Q Consensus 499 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgl 578 (752)
+..+|||||+++|+|.+++... ..+++.++..++.||++||+|||+++ |+||||||+||||+.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEcCCCchHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence 9999999999999999999653 35999999999999999999999998 99999999999999999999999999
Q ss_pred ceeecccccccccccccccCCccChhhhcc------CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHH
Q 043278 579 ARIFEVNESEANTKRIVGTYGYMSPEYAMS------GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQL 652 (752)
Q Consensus 579 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~ 652 (752)
++....... .....||+.|+|||++.+ ..++.++||||+||+||||++|+.||...... . ....
T Consensus 157 a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~------~-~~~~ 226 (277)
T d1phka_ 157 SCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM------L-MLRM 226 (277)
T ss_dssp CEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHH
T ss_pred eeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH------H-HHHH
Confidence 987654322 234679999999999853 45789999999999999999999999765421 1 1122
Q ss_pred hhCCCcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 653 LSDGKGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 653 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
+..+... .. .+........+.+++.+||+.||.+|||+.||+++
T Consensus 227 i~~~~~~-~~-----~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 227 IMSGNYQ-FG-----SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHHTCCC-CC-----TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHhCCCC-CC-----CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 2222211 10 11111222457789999999999999999999764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-44 Score=376.63 Aligned_cols=261 Identities=24% Similarity=0.265 Sum_probs=196.5
Q ss_pred CCeeecCCcccEEEEEec-CCceeEEEEcccCCccc-----HHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeC
Q 043278 435 TNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQG-----IVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFM 508 (752)
Q Consensus 435 ~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 508 (752)
.++||+|+||+||+|+.. +|+.||||+++...... ...+.+|+.++++++|||||++++++.++++.+|||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 478999999999999974 58999999996543221 245889999999999999999999999999999999999
Q ss_pred CCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccccc
Q 043278 509 PNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNESE 588 (752)
Q Consensus 509 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~~ 588 (752)
+++++..+.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~- 155 (299)
T d1ua2a_ 83 ETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR- 155 (299)
T ss_dssp SEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-
T ss_pred cchHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc-
Confidence 9887765552 3455889999999999999999999998 99999999999999999999999999986543322
Q ss_pred cccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccC----
Q 043278 589 ANTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELID---- 663 (752)
Q Consensus 589 ~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d---- 663 (752)
......||+.|+|||++.. ..++.++|||||||++|||++|+.||......+ ......+.+.........+
T Consensus 156 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~---~l~~i~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ua2a_ 156 -AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD---QLTRIFETLGTPTEEQWPDMCSL 231 (299)
T ss_dssp -CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCTTTSSSTTSS
T ss_pred -cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH---HHHHHHHhcCCCChhhccchhcc
Confidence 2234578999999999875 468999999999999999999999997654221 1111112111110000000
Q ss_pred -----CCCCCCCCHH-----HHHHHHHHHHHcccCCCCCCCCHHHHHHH--hhcC
Q 043278 664 -----PSLEQPCSAN-----EVMRCIHVGLLCVQDQAMDRPTMPEVVCM--LQNE 706 (752)
Q Consensus 664 -----~~l~~~~~~~-----~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~--L~~~ 706 (752)
.......+.. ....+.+|+.+||+.||++|||++|++++ +++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred chhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence 0000011111 12467889999999999999999999874 5543
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-43 Score=376.89 Aligned_cols=245 Identities=22% Similarity=0.272 Sum_probs=203.9
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccC---CcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRS---SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVY 505 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 505 (752)
++|++.+.||+|+||.||+|+.. +|+.||||++.+. .......+.+|+.+|++++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 47888999999999999999874 6899999998643 2344567899999999999999999999999999999999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccc
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVN 585 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~ 585 (752)
||+.+|+|..++... ..+++..+..++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.+...
T Consensus 121 e~~~~g~l~~~l~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 999999999998654 35899999999999999999999998 999999999999999999999999999876422
Q ss_pred ccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCC
Q 043278 586 ESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPS 665 (752)
Q Consensus 586 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 665 (752)
.....||+.|||||++.+..++.++|||||||+||||++|+.||..... .... ..+..+.. .
T Consensus 195 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~-~~i~~~~~------~ 256 (350)
T d1rdqe_ 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP------IQIY-EKIVSGKV------R 256 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHH-HHHHHCCC------C
T ss_pred -----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH------HHHH-HHHhcCCC------C
Confidence 2346799999999999999999999999999999999999999975431 1111 11212211 0
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCC-----CCHHHHHHH
Q 043278 666 LEQPCSANEVMRCIHVGLLCVQDQAMDR-----PTMPEVVCM 702 (752)
Q Consensus 666 l~~~~~~~~~~~l~~l~~~Cl~~dp~~R-----Pt~~ev~~~ 702 (752)
... .....+.+++.+||+.||.+| ||++|++++
T Consensus 257 ~p~----~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 257 FPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp CCT----TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCc----cCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 111 122356788999999999999 499999874
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-43 Score=368.57 Aligned_cols=270 Identities=24% Similarity=0.311 Sum_probs=203.0
Q ss_pred cCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEe
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYE 506 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 506 (752)
++|++.++||+|+||+||+|+. .+++.||||+++... .....++.+|++++++++|||||++++++.++++.++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 4788899999999999999986 568999999996543 2345678999999999999999999999999999999999
Q ss_pred eCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccc
Q 043278 507 FMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586 (752)
Q Consensus 507 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~ 586 (752)
|+.++.+...... ....+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEEHHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCchhhhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence 9986655443322 3445999999999999999999999998 9999999999999999999999999998654322
Q ss_pred cccccccccccCCccChhhhccCC-CCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCC------cc
Q 043278 587 SEANTKRIVGTYGYMSPEYAMSGI-VSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGK------GL 659 (752)
Q Consensus 587 ~~~~~~~~~gt~~y~aPE~~~~~~-~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~------~~ 659 (752)
.......||+.|+|||.+.... ++.++||||+||++|||++|+.||....... ............. ..
T Consensus 157 --~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~ 231 (298)
T d1gz8a_ 157 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID---QLFRIFRTLGTPDEVVWPGVT 231 (298)
T ss_dssp --BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGG
T ss_pred --ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH---HHHHHHHhcCCCchhhccccc
Confidence 2233457899999999887765 5889999999999999999999997654211 1111111111100 00
Q ss_pred cccC--CCCC--CCCCH-----HHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hhcCCCC
Q 043278 660 ELID--PSLE--QPCSA-----NEVMRCIHVGLLCVQDQAMDRPTMPEVVCM--LQNETMP 709 (752)
Q Consensus 660 ~~~d--~~l~--~~~~~-----~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~--L~~~~~~ 709 (752)
...+ +... ..... .....+.+|+.+|++.||++|||++|++++ ++++..+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred cccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence 0000 0000 00000 112457789999999999999999999996 7766543
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.7e-43 Score=379.07 Aligned_cols=249 Identities=25% Similarity=0.308 Sum_probs=198.0
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC---cccHHHHHHH---HHHHHhcCCCCcceeeeeeeeCCeeE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS---GQGIVEFKNE---VRLIAKLQHTNLVRLLGCSLHGEERL 502 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E---~~~l~~l~h~niv~l~~~~~~~~~~~ 502 (752)
++|++.+.||+|+||.||+|+.. +|+.||||++.+.. ......+.+| +.+++.++|||||++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57888999999999999999875 58999999986431 2233334444 66677778999999999999999999
Q ss_pred EEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceee
Q 043278 503 LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIF 582 (752)
Q Consensus 503 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~ 582 (752)
|||||+++|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+.+
T Consensus 84 ivmE~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHhc---ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 999999999999998653 35889999999999999999999998 999999999999999999999999999876
Q ss_pred cccccccccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccc
Q 043278 583 EVNESEANTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLEL 661 (752)
Q Consensus 583 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 661 (752)
.... .....||+.|+|||++.. ..++.++|||||||+||||++|+.||......... . .........
T Consensus 158 ~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~---~-~~~~~~~~~---- 225 (364)
T d1omwa3 158 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---E-IDRMTLTMA---- 225 (364)
T ss_dssp SSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH---H-HHHHSSSCC----
T ss_pred CCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH---H-HHHhcccCC----
Confidence 5332 234679999999999975 56899999999999999999999999765533211 1 111111110
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 043278 662 IDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPT-----MPEVVCM 702 (752)
Q Consensus 662 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-----~~ev~~~ 702 (752)
+.+.... ...+.+|+.+||+.||++||| ++|++++
T Consensus 226 --~~~~~~~----s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 226 --VELPDSF----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp --CCCCSSS----CHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred --CCCCCCC----CHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 1111112 235678999999999999999 6888764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=373.39 Aligned_cols=247 Identities=23% Similarity=0.358 Sum_probs=201.0
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccC---CcccHHHHHHHHHHHH-hcCCCCcceeeeeeeeCCeeEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRS---SGQGIVEFKNEVRLIA-KLQHTNLVRLLGCSLHGEERLLV 504 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv 504 (752)
++|.+.+.||+|+||+||+|+.. +++.||||++++. .......+..|..++. .++|||||++++++.+++..+||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 47888999999999999999875 5889999999653 2334556677777665 68999999999999999999999
Q ss_pred EeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecc
Q 043278 505 YEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEV 584 (752)
Q Consensus 505 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~ 584 (752)
|||+++|+|..++... ..+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~~---~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 9999999999998653 34899999999999999999999998 99999999999999999999999999986543
Q ss_pred cccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCC
Q 043278 585 NESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDP 664 (752)
Q Consensus 585 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 664 (752)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........+. +
T Consensus 156 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~-------~~~~~i~~~~------~ 220 (320)
T d1xjda_ 156 GD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-------ELFHSIRMDN------P 220 (320)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCC------C
T ss_pred cc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH-------HHHHHHHcCC------C
Confidence 32 2233467999999999999999999999999999999999999999765421 1122222221 1
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 043278 665 SLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMP-EVVC 701 (752)
Q Consensus 665 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~-ev~~ 701 (752)
.+.... ...+.+|+.+||+.||.+|||+. |+++
T Consensus 221 ~~p~~~----s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 FYPRWL----EKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CCCTTS----CHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CCCccC----CHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 111111 23477899999999999999995 7754
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-43 Score=372.72 Aligned_cols=252 Identities=20% Similarity=0.230 Sum_probs=197.2
Q ss_pred cCCCcCC-eeecCCcccEEEEEe-cCCceeEEEEcccCCcccHHHHHHHHHHHHhc-CCCCcceeeeeeee----CCeeE
Q 043278 430 NNFSTTN-KLGEGGFGPVYKGKL-ADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKL-QHTNLVRLLGCSLH----GEERL 502 (752)
Q Consensus 430 ~~~~~~~-~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~~ 502 (752)
++|.+.+ .||+|+||+||+|+. .+++.||||+++.. ..+.+|+.++.++ +|||||++++++.+ +...+
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 5787764 599999999999986 56899999998643 4567899887654 89999999999865 45789
Q ss_pred EEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecC---CCCceecccccc
Q 043278 503 LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDD---KMNPKISDFGMA 579 (752)
Q Consensus 503 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~---~~~~kl~DFgla 579 (752)
||||||++|+|.+++... ....+++.++..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 86 ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccccccee
Confidence 999999999999999653 2346999999999999999999999998 999999999999975 567999999999
Q ss_pred eeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcc
Q 043278 580 RIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGL 659 (752)
Q Consensus 580 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 659 (752)
+...... ......||+.|||||++.+..++.++|||||||+||||++|+.||...........+ ......+.
T Consensus 162 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~---~~~i~~~~-- 233 (335)
T d2ozaa1 162 KETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---KTRIRMGQ-- 233 (335)
T ss_dssp EECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCS--
T ss_pred eeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH---HHHHhcCC--
Confidence 8765432 223467999999999999999999999999999999999999999766533221100 00111100
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 660 ELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 660 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
..+..+........+.+|+.+||+.||++|||+.|++++
T Consensus 234 ----~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 234 ----YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp ----SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ----CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 001011111223567889999999999999999999884
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=373.83 Aligned_cols=251 Identities=20% Similarity=0.275 Sum_probs=203.2
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEeeC
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEFM 508 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 508 (752)
++|++.+.||+|+||+||+|... +++.||||.++.... ....+.+|+.+|.+++|||||++++++.+++..+||||||
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 57889999999999999999875 588999999976543 3456889999999999999999999999999999999999
Q ss_pred CCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecC--CCCceecccccceeecccc
Q 043278 509 PNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDD--KMNPKISDFGMARIFEVNE 586 (752)
Q Consensus 509 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~--~~~~kl~DFgla~~~~~~~ 586 (752)
++|+|.+++... ...+++.++..++.||+.||+|||+.+ |+||||||+|||++. ...+||+|||+++......
T Consensus 84 ~gg~L~~~i~~~--~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~ 158 (321)
T d1tkia_ 84 SGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred CCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence 999999998542 235899999999999999999999998 999999999999985 4579999999998754322
Q ss_pred cccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCcccccCCCC
Q 043278 587 SEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLELIDPSL 666 (752)
Q Consensus 587 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 666 (752)
......+++.|+|||.+.+..++.++||||+||++|||++|+.||...... ........ +... ++...
T Consensus 159 ---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~------~~~~~i~~-~~~~--~~~~~ 226 (321)
T d1tkia_ 159 ---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ------QIIENIMN-AEYT--FDEEA 226 (321)
T ss_dssp ---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHH-TCCC--CCHHH
T ss_pred ---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH------HHHHHHHh-CCCC--CChhh
Confidence 123457899999999999999999999999999999999999999765421 11112221 1110 00000
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 667 EQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 667 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
... ....+.+|+.+||+.||.+|||+.|++++
T Consensus 227 ~~~----~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 227 FKE----ISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ccC----CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 001 12346789999999999999999999884
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.5e-43 Score=365.79 Aligned_cols=261 Identities=22% Similarity=0.325 Sum_probs=199.6
Q ss_pred cCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEee
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYEF 507 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 507 (752)
++|.+.++||+|+||+||+|+..+|+.||||++.... .....++.+|+.+|++++||||+++++++...+..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5788899999999999999999999999999996643 33356889999999999999999999999999999999999
Q ss_pred CCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeeccccc
Q 043278 508 MPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNES 587 (752)
Q Consensus 508 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~~ 587 (752)
+.++.+..+.. ....+++..+..++.||+.||+|||+.+ ||||||||+||||+.++.+||+|||++........
T Consensus 82 ~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 99887766653 3356999999999999999999999988 99999999999999999999999999986543221
Q ss_pred ccccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCc------cc
Q 043278 588 EANTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKG------LE 660 (752)
Q Consensus 588 ~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~------~~ 660 (752)
......+++.|+|||.+.+ ..++.++|||||||+++||++|+.||......+ ........+..... ..
T Consensus 156 --~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~ 230 (286)
T d1ob3a_ 156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD---QLMRIFRILGTPNSKNWPNVTE 230 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGG
T ss_pred --ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH---HHHHHHHhhCCCChhhccchhh
Confidence 2233568899999999876 457999999999999999999999997544211 11111111111000 00
Q ss_pred c--cCCCCC-------CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 043278 661 L--IDPSLE-------QPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVC 701 (752)
Q Consensus 661 ~--~d~~l~-------~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~ 701 (752)
. ...... ..........+.+++.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 000000 0001112245778999999999999999999985
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-43 Score=359.35 Aligned_cols=240 Identities=26% Similarity=0.390 Sum_probs=193.9
Q ss_pred cCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCCc------ccHHHHHHHHHHHHhcC--CCCcceeeeeeeeCCe
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSSG------QGIVEFKNEVRLIAKLQ--HTNLVRLLGCSLHGEE 500 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~ 500 (752)
++|++.+.||+|+||+||+|+. .+|+.||||++..... ....++.+|+.++++++ |||||++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 5788999999999999999986 4689999999865321 11234678999999986 8999999999999999
Q ss_pred eEEEEeeCCC-CCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecC-CCCceeccccc
Q 043278 501 RLLVYEFMPN-KSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDD-KMNPKISDFGM 578 (752)
Q Consensus 501 ~~lv~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~-~~~~kl~DFgl 578 (752)
.++||||+.+ +++.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~---~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEeccCcchHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcccc
Confidence 9999999976 6777776543 45899999999999999999999998 999999999999985 57899999999
Q ss_pred ceeecccccccccccccccCCccChhhhccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCC
Q 043278 579 ARIFEVNESEANTKRIVGTYGYMSPEYAMSGIV-SIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGK 657 (752)
Q Consensus 579 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 657 (752)
++..... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... .... +.
T Consensus 158 a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------------~i~~-~~ 220 (273)
T d1xwsa_ 158 GALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EIIR-GQ 220 (273)
T ss_dssp CEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHH-CC
T ss_pred ceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------------HHhh-cc
Confidence 9865432 2234679999999999987765 677999999999999999999996431 1111 11
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 658 GLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 658 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
. .+. ...+ ..+.+++.+||+.||++|||++|++++
T Consensus 221 ~--~~~----~~~s----~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 221 V--FFR----QRVS----SECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp C--CCS----SCCC----HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred c--CCC----CCCC----HHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0 111 1122 356788999999999999999999874
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-42 Score=364.04 Aligned_cols=263 Identities=21% Similarity=0.287 Sum_probs=195.9
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-C-CceeEEEEcccCC--cccHHHHHHHHHHHHhc---CCCCcceeeeeeee----
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-D-EQEVAIKRLSRSS--GQGIVEFKNEVRLIAKL---QHTNLVRLLGCSLH---- 497 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~-~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~---- 497 (752)
.++|++.++||+|+||+||+|+.. + ++.||||+++... ......+.+|+.+++.+ +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999863 4 5679999986432 12223456777776665 89999999999853
Q ss_pred -CCeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceeccc
Q 043278 498 -GEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDF 576 (752)
Q Consensus 498 -~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DF 576 (752)
....+++|||++++++...... ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 3467899999998877655432 3456899999999999999999999998 999999999999999999999999
Q ss_pred ccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCC
Q 043278 577 GMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDG 656 (752)
Q Consensus 577 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 656 (752)
|+++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||....... ......+.....
T Consensus 161 g~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~~~ 234 (305)
T d1blxa_ 161 GLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLP 234 (305)
T ss_dssp CSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCC
T ss_pred hhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH---HHHHHHHhhCCC
Confidence 9998644322 2335689999999999999999999999999999999999999997654221 111111111110
Q ss_pred Cccc----------ccCCCC---CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 657 KGLE----------LIDPSL---EQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 657 ~~~~----------~~d~~l---~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.... ...... ...........+.+|+.+||+.||++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred chhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000 000000 000111122356788999999999999999999875
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-41 Score=358.30 Aligned_cols=264 Identities=20% Similarity=0.293 Sum_probs=196.5
Q ss_pred cCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccC--CcccHHHHHHHHHHHHhcCCCCcceeeeeeee--------C
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRS--SGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLH--------G 498 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~ 498 (752)
++|++.++||+|+||+||+|+. .+|+.||||++... ......++.+|+.+|++++|+||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 6888999999999999999997 47899999998644 33345678899999999999999999998755 3
Q ss_pred CeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceeccccc
Q 043278 499 EERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGM 578 (752)
Q Consensus 499 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgl 578 (752)
.+.++||||++++.+..+.. ....++...+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~---~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTC---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCCCccchhhh---cccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecce
Confidence 45789999999887765542 3345889999999999999999999998 99999999999999999999999999
Q ss_pred ceeecccccc--cccccccccCCccChhhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhC
Q 043278 579 ARIFEVNESE--ANTKRIVGTYGYMSPEYAMSG-IVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSD 655 (752)
Q Consensus 579 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 655 (752)
++........ .......||+.|+|||.+.+. .++.|+|||||||++|||++|+.||...........+ .+....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i---~~~~~~ 240 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI---SQLCGS 240 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCC
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHH---HHhcCC
Confidence 9876543222 122335789999999998765 6899999999999999999999999765422211111 111110
Q ss_pred C--Ccc-cc--------cCCCCCCCCCHHH-------HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 656 G--KGL-EL--------IDPSLEQPCSANE-------VMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 656 ~--~~~-~~--------~d~~l~~~~~~~~-------~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
. ... .. +............ ...+.+|+.+||+.||++|||++|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp CCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 0 000 00 0000000111111 2345679999999999999999999986
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-41 Score=361.32 Aligned_cols=261 Identities=24% Similarity=0.300 Sum_probs=193.8
Q ss_pred CCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCcceeeeeeeeC------CeeEE
Q 043278 431 NFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHG------EERLL 503 (752)
Q Consensus 431 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l 503 (752)
.|+..++||+|+||+||+|+.. +|+.||||++...... +.+|+++|++++|+||+++++++... .+.+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 4667789999999999999975 5899999999765322 25799999999999999999998542 24689
Q ss_pred EEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCC-Cceecccccceee
Q 043278 504 VYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKM-NPKISDFGMARIF 582 (752)
Q Consensus 504 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~-~~kl~DFgla~~~ 582 (752)
||||++++.+..+.........+++.++..++.||+.||+|||+++ |+||||||+||||+.++ .+||+|||+++.+
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999997765555443344557999999999999999999999988 99999999999999775 8999999999876
Q ss_pred cccccccccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHH--------HHHHHh
Q 043278 583 EVNESEANTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIG--------YAWQLL 653 (752)
Q Consensus 583 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~--------~~~~~~ 653 (752)
..... .....|+..|+|||.+.+ ..++.++||||+||++|||++|+.||...........+. ..+...
T Consensus 174 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 174 VRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp CTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred cCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence 53322 223578999999998875 578999999999999999999999997654221111000 000111
Q ss_pred hCCCcccccCCCCC-----CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 654 SDGKGLELIDPSLE-----QPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 654 ~~~~~~~~~d~~l~-----~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
... .....-+... ..........+.+|+.+||+.||++|||+.|++++
T Consensus 251 ~~~-~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 251 NPN-YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp CC----CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccc-hhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 100 0000000000 00111123357788999999999999999999974
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-40 Score=349.32 Aligned_cols=261 Identities=20% Similarity=0.242 Sum_probs=196.9
Q ss_pred hcCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCccee-eeeeeeCCeeEEEEe
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNLVRL-LGCSLHGEERLLVYE 506 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l-~~~~~~~~~~~lv~E 506 (752)
.++|++.+.||+|+||.||+|+. .+++.||||++..... ..++..|++++++++|+|++.. .++..+++..++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 35799999999999999999986 4688999998875433 2357899999999987765555 555677888999999
Q ss_pred eCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEec---CCCCceecccccceeec
Q 043278 507 FMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLD---DKMNPKISDFGMARIFE 583 (752)
Q Consensus 507 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~---~~~~~kl~DFgla~~~~ 583 (752)
|++ ++|...+... ...+++..++.++.|++.||+|||+++ |+||||||+|||++ .+..+||+|||+|+.+.
T Consensus 84 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 84 LLG-PSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp CCC-CBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred EcC-Cchhhhhhhc--cCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 995 4555555432 345899999999999999999999998 99999999999975 46679999999999875
Q ss_pred ccccc-----cccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCc
Q 043278 584 VNESE-----ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKG 658 (752)
Q Consensus 584 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 658 (752)
..... .......||+.|||||.+.+..++.++|||||||++|||++|+.||........................
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh
Confidence 43221 2234568999999999999999999999999999999999999999876654433222211111111010
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 659 LELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 659 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
.. +....+ .++.+++..|++.+|.+||+++++.+.|+..
T Consensus 238 ~~-----~~~~~p----~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 238 EV-----LCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp HH-----HTTTSC----HHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred hH-----hccCCC----HHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 01 111112 3577888999999999999999998888753
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-40 Score=355.70 Aligned_cols=267 Identities=21% Similarity=0.296 Sum_probs=198.5
Q ss_pred hcCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCC-cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCC----eeE
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSS-GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGE----ERL 502 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~ 502 (752)
+.+|++.++||+|+||+||+|+. .+|+.||||++.... ....+++++|+.+|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 35788999999999999999986 578999999997543 334567899999999999999999999986543 335
Q ss_pred EEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceee
Q 043278 503 LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIF 582 (752)
Q Consensus 503 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~ 582 (752)
++++|+.+|+|.+++.. ..+++..+..++.||+.||+|||+++ ||||||||+||||++++.+||+|||+++..
T Consensus 87 ~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 55667789999999853 24899999999999999999999998 999999999999999999999999999876
Q ss_pred cccccc-cccccccccCCccChhhhc-cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCccc
Q 043278 583 EVNESE-ANTKRIVGTYGYMSPEYAM-SGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKGLE 660 (752)
Q Consensus 583 ~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 660 (752)
...... .......||+.|+|||.+. ...++.++||||+||+++||++|+.||......... ..............
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~ 236 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL---NHILGILGSPSQED 236 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCSCCHHH
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHH---HHHhhhccCCChhh
Confidence 544322 2234567899999999985 456789999999999999999999999765422111 11111110000000
Q ss_pred -------------ccCCCCCCCCCHH-----HHHHHHHHHHHcccCCCCCCCCHHHHHHH--hhcC
Q 043278 661 -------------LIDPSLEQPCSAN-----EVMRCIHVGLLCVQDQAMDRPTMPEVVCM--LQNE 706 (752)
Q Consensus 661 -------------~~d~~l~~~~~~~-----~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~--L~~~ 706 (752)
...+.. ...+.. ...++.+|+.+||+.||.+|||++|++++ |+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 237 LNCIINLKARNYLLSLPHK-NKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp HHTCCCHHHHHHHHTSCCC-CCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhhhhcccccCCcc-CCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 000000 011111 11357789999999999999999999986 5433
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.8e-40 Score=344.36 Aligned_cols=261 Identities=18% Similarity=0.223 Sum_probs=205.1
Q ss_pred hcCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCCcccHHHHHHHHHHHHhcCC-CCcceeeeeeeeCCeeEEEEe
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQH-TNLVRLLGCSLHGEERLLVYE 506 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~E 506 (752)
.++|++.++||+|+||+||+|+.. +|+.||||++..... ...+.+|++.+..++| +|++.+++++.++...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 468999999999999999999964 688999998865432 2346789999999965 899999999999999999999
Q ss_pred eCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecC-----CCCceeccccccee
Q 043278 507 FMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDD-----KMNPKISDFGMARI 581 (752)
Q Consensus 507 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~-----~~~~kl~DFgla~~ 581 (752)
|+ +++|..++.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||+|+.
T Consensus 82 ~~-~~~l~~~~~~~~--~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHhhc--cchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 98 688888876533 35899999999999999999999998 999999999999964 57899999999998
Q ss_pred ecccccc-----cccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCC
Q 043278 582 FEVNESE-----ANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDG 656 (752)
Q Consensus 582 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 656 (752)
+...... .......||+.|||||.+.+..++.++||||||+++|||++|+.||......................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence 6533211 12334689999999999999999999999999999999999999998765443322221111111111
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 043278 657 KGLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCMLQNE 706 (752)
Q Consensus 657 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~L~~~ 706 (752)
...++ ....+ .++.+++..|++.+|++||+++.+.+.|++.
T Consensus 236 ~~~~l-----~~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 236 PLREL-----CAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp CHHHH-----TTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred ChHHh-----cCCCC----HHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 11111 11122 3467788899999999999999988887654
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-40 Score=355.11 Aligned_cols=264 Identities=23% Similarity=0.302 Sum_probs=193.1
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCC------e
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGE------E 500 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~ 500 (752)
++|++.++||+|+||+||+|... +|+.||||+++... ....+.+.+|+.+|++++|||||+++++|...+ +
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~ 97 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 97 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence 58889999999999999999864 58999999997542 233457889999999999999999999987654 5
Q ss_pred eEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccce
Q 043278 501 RLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR 580 (752)
Q Consensus 501 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~ 580 (752)
.++||||+ +.+|..+... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 98 ~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 98 FYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 169 (346)
T ss_dssp CEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecc-cccHHHHHHh----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhccccccccccccccee
Confidence 69999999 4567666632 35999999999999999999999998 9999999999999999999999999998
Q ss_pred eecccccccccccccccCCccChhhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHH-----HHhh
Q 043278 581 IFEVNESEANTKRIVGTYGYMSPEYAMS-GIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAW-----QLLS 654 (752)
Q Consensus 581 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~-----~~~~ 654 (752)
..... .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||................ ..+.
T Consensus 170 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (346)
T d1cm8a_ 170 QADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244 (346)
T ss_dssp ECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred ccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHh
Confidence 65422 234678999999999876 467899999999999999999999997654211110000000 0000
Q ss_pred CCC----------cccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hhcCC
Q 043278 655 DGK----------GLELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM--LQNET 707 (752)
Q Consensus 655 ~~~----------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~--L~~~~ 707 (752)
... ..+.....+. .........+.+|+.+||+.||.+|||++|++++ ++.+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 245 RLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hhcchhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 000 0000000000 0001112346788999999999999999999986 66553
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-40 Score=343.02 Aligned_cols=263 Identities=22% Similarity=0.282 Sum_probs=201.4
Q ss_pred cCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeeeCCeeEEEEe
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHGEERLLVYE 506 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 506 (752)
++|++.++||+|+||+||+|+. .+++.||||+++... .....++.+|+.++++++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 4788999999999999999996 468889999986543 2345788999999999999999999999999999999999
Q ss_pred eCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccceeecccc
Q 043278 507 FMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMARIFEVNE 586 (752)
Q Consensus 507 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~~~~~~ 586 (752)
++.+++|..++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.++......
T Consensus 82 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred ecccccccccccc---ccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 9999998877753 345889999999999999999999998 9999999999999999999999999998765332
Q ss_pred cccccccccccCCccChhhhccCC-CCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCC---c---c
Q 043278 587 SEANTKRIVGTYGYMSPEYAMSGI-VSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGK---G---L 659 (752)
Q Consensus 587 ~~~~~~~~~gt~~y~aPE~~~~~~-~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~---~ 659 (752)
. ......++..|+|||.+.... ++.++|||||||+++||++|+.||...... ............... . .
T Consensus 156 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 231 (292)
T d1unla_ 156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp S--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH--HHHHHHHHHHHCCCCTTTCTTGG
T ss_pred c--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCH--HHHHHHHHhhcCCCChhhhhhhh
Confidence 2 222345678999999987654 699999999999999999999997543211 111111111111100 0 0
Q ss_pred cccC--------C-CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 660 ELID--------P-SLEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 660 ~~~d--------~-~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
...+ . .............+.+|+.+|++.||++|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000 0 00001111222456788999999999999999999874
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-40 Score=347.26 Aligned_cols=253 Identities=23% Similarity=0.313 Sum_probs=201.6
Q ss_pred cCCCcCCeeecCCcccEEEEEec----CCceeEEEEcccCC----cccHHHHHHHHHHHHhcCC-CCcceeeeeeeeCCe
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA----DEQEVAIKRLSRSS----GQGIVEFKNEVRLIAKLQH-TNLVRLLGCSLHGEE 500 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~ 500 (752)
++|++.++||+|+||+||+|+.. +|+.||||++.+.. ....+.+.+|++++.+++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 56888999999999999999752 47899999986532 2334567899999999966 899999999999999
Q ss_pred eEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccce
Q 043278 501 RLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR 580 (752)
Q Consensus 501 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~ 580 (752)
.+++|||+.+|+|..++.... .+....+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 999999999999999986543 3678899999999999999999998 9999999999999999999999999998
Q ss_pred eecccccccccccccccCCccChhhhccC--CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCc
Q 043278 581 IFEVNESEANTKRIVGTYGYMSPEYAMSG--IVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKG 658 (752)
Q Consensus 581 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 658 (752)
.+....... .....|++.|+|||.+.+. .++.++|||||||+||||++|+.||...........+.. ..... .
T Consensus 178 ~~~~~~~~~-~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~--~~~~~-~- 252 (322)
T d1vzoa_ 178 EFVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR--RILKS-E- 252 (322)
T ss_dssp ECCGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH--HHHHC-C-
T ss_pred hhccccccc-ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH--hcccC-C-
Confidence 765433222 2346789999999999764 478899999999999999999999987765543322211 11111 1
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 043278 659 LELIDPSLEQPCSANEVMRCIHVGLLCVQDQAMDRP-----TMPEVVCM 702 (752)
Q Consensus 659 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~ev~~~ 702 (752)
+.+ +.....++.+++.+||+.||++|| |++|++++
T Consensus 253 -----~~~----~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 253 -----PPY----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp -----CCC----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred -----CCC----cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 111 112234577889999999999999 47888863
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.3e-39 Score=345.71 Aligned_cols=258 Identities=16% Similarity=0.281 Sum_probs=195.3
Q ss_pred cCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCCcccHHHHHHHHHHHHhcC-CCCcceeeeeeee--CCeeEEEE
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQ-HTNLVRLLGCSLH--GEERLLVY 505 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~ 505 (752)
++|++.++||+|+||+||+|+. .+++.||||+++.. ..+++.+|+.+|.+++ ||||+++++++.. ....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5799999999999999999987 46889999998754 3567899999999995 9999999999874 34689999
Q ss_pred eeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCC-Cceecccccceeecc
Q 043278 506 EFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKM-NPKISDFGMARIFEV 584 (752)
Q Consensus 506 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~-~~kl~DFgla~~~~~ 584 (752)
||+++++|..+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++....
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999987653 34899999999999999999999998 99999999999998655 589999999987653
Q ss_pred cccccccccccccCCccChhhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcc-hHHH------HHHHhhC-
Q 043278 585 NESEANTKRIVGTYGYMSPEYAMSG-IVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLN-LIGY------AWQLLSD- 655 (752)
Q Consensus 585 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~-l~~~------~~~~~~~- 655 (752)
.. ......+|+.|+|||.+.+. .++.++||||+||+++||++|+.||.......... .+.. .......
T Consensus 183 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 259 (328)
T d3bqca1 183 GQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259 (328)
T ss_dssp TC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred CC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence 32 22345789999999998865 57999999999999999999999997654321100 0000 0000000
Q ss_pred --CCc---ccccCCC--------CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 656 --GKG---LELIDPS--------LEQPCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 656 --~~~---~~~~d~~--------l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
... ....... ............+.+|+.+||+.||++|||++|++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 0000000 0000111122457789999999999999999999873
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-39 Score=343.25 Aligned_cols=263 Identities=22% Similarity=0.285 Sum_probs=195.3
Q ss_pred hcCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeeeC-----Ce
Q 043278 429 ANNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLHG-----EE 500 (752)
Q Consensus 429 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 500 (752)
.++|++.++||+|+||+||+|+. .+|+.||||++.... ....+++.+|+.+|++++|+|+|++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 46899999999999999999986 568999999997653 23445688999999999999999999998643 34
Q ss_pred eEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccce
Q 043278 501 RLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR 580 (752)
Q Consensus 501 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~ 580 (752)
.+++++|+.+|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence 5777888899999998842 35999999999999999999999998 9999999999999999999999999997
Q ss_pred eecccccccccccccccCCccChhhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhCCCc-
Q 043278 581 IFEVNESEANTKRIVGTYGYMSPEYAMSG-IVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGYAWQLLSDGKG- 658 (752)
Q Consensus 581 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~- 658 (752)
.... ......|++.|+|||.+.+. .++.++|||||||++|||++|+.||...+.......+ .........
T Consensus 170 ~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i---~~~~~~~~~~ 241 (348)
T d2gfsa1 170 HTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI---LRLVGTPGAE 241 (348)
T ss_dssp CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCCCCHH
T ss_pred ccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHH---HHhcCCCChH
Confidence 5432 22345788999999987765 5689999999999999999999999765422111111 000000000
Q ss_pred ----------ccccCCCC-CCCCCH-----HHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hhcC
Q 043278 659 ----------LELIDPSL-EQPCSA-----NEVMRCIHVGLLCVQDQAMDRPTMPEVVCM--LQNE 706 (752)
Q Consensus 659 ----------~~~~d~~l-~~~~~~-----~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~--L~~~ 706 (752)
........ ...... .....+.+|+.+||+.||++|||++|++++ ++..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 242 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp HHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 00000000 000000 112356789999999999999999999984 5544
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-39 Score=342.92 Aligned_cols=261 Identities=22% Similarity=0.223 Sum_probs=189.9
Q ss_pred cCCCcCCeeecCCcccEEEEEec-CCceeEEEEcccCC--cccHHHHHHHHHHHHhcCCCCcceeeeeeee------CCe
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKLA-DEQEVAIKRLSRSS--GQGIVEFKNEVRLIAKLQHTNLVRLLGCSLH------GEE 500 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 500 (752)
++|++.++||+|+||+||+|... +|+.||||++.... .....++.+|+.++++++||||+++++++.. ..+
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57889999999999999999875 58999999997653 2334568899999999999999999999863 367
Q ss_pred eEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceecccccce
Q 043278 501 RLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKISDFGMAR 580 (752)
Q Consensus 501 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~ 580 (752)
.++||||+.++.+.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence 89999999876554432 34899999999999999999999998 9999999999999999999999999988
Q ss_pred eecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHH-------------
Q 043278 581 IFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIG------------- 647 (752)
Q Consensus 581 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~------------- 647 (752)
...... ......+|+.|+|||++.+..+++++||||+||+++||++|+.||...........+.
T Consensus 168 ~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 168 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred cccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence 654322 2234578999999999999999999999999999999999999997654211100000
Q ss_pred ---HHHHHhhCCC-c-----ccccCCCCCC---CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 043278 648 ---YAWQLLSDGK-G-----LELIDPSLEQ---PCSANEVMRCIHVGLLCVQDQAMDRPTMPEVVCM 702 (752)
Q Consensus 648 ---~~~~~~~~~~-~-----~~~~d~~l~~---~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ev~~~ 702 (752)
.......... . .......... .........+.+|+.+|++.||++|||++|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000001000 0 0000001101 1122334567889999999999999999999876
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.4e-35 Score=315.17 Aligned_cols=267 Identities=21% Similarity=0.233 Sum_probs=195.0
Q ss_pred cCCCcCCeeecCCcccEEEEEe-cCCceeEEEEcccCCcccHHHHHHHHHHHHhcC-----------CCCcceeeeeeee
Q 043278 430 NNFSTTNKLGEGGFGPVYKGKL-ADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQ-----------HTNLVRLLGCSLH 497 (752)
Q Consensus 430 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~ 497 (752)
++|++.++||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+.++++++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 3588999999999999999986 468999999997543 23456788999988875 4789999988764
Q ss_pred C--CeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCcEeecCCCCCcEEecCCCC----
Q 043278 498 G--EERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHK-YSRLRVIHRDLKASNILLDDKMN---- 570 (752)
Q Consensus 498 ~--~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~Dikp~NIll~~~~~---- 570 (752)
. ...+++++++..+..............+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 3 4567777777666554444445556678999999999999999999998 65 999999999999986654
Q ss_pred --ceecccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCcchHHH
Q 043278 571 --PKISDFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVLEIVSGQKNHTRHHPDRPLNLIGY 648 (752)
Q Consensus 571 --~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~elltG~~p~~~~~~~~~~~l~~~ 648 (752)
+|++|||.+...... .....||+.|+|||++....++.++||||+||+++||++|+.||..............
T Consensus 169 ~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp EEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred ceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 899999999864322 2346789999999999999999999999999999999999999976543322211111
Q ss_pred HH---HHhhC--------CC----------cccccCCC----------CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 043278 649 AW---QLLSD--------GK----------GLELIDPS----------LEQPCSANEVMRCIHVGLLCVQDQAMDRPTMP 697 (752)
Q Consensus 649 ~~---~~~~~--------~~----------~~~~~d~~----------l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ 697 (752)
.. ..+.. +. ....+... ............+.+|+.+|++.||.+|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 11 11100 00 00000000 01123455667889999999999999999999
Q ss_pred HHHHH--hhc
Q 043278 698 EVVCM--LQN 705 (752)
Q Consensus 698 ev~~~--L~~ 705 (752)
|++++ +++
T Consensus 324 e~L~Hp~f~~ 333 (362)
T d1q8ya_ 324 GLVNHPWLKD 333 (362)
T ss_dssp HHHTCGGGTT
T ss_pred HHhcCcccCC
Confidence 99986 553
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=2e-22 Score=194.82 Aligned_cols=170 Identities=19% Similarity=0.160 Sum_probs=120.9
Q ss_pred CcCCeeecCCcccEEEEEecCCceeEEEEcccCCc------------------ccHHHHHHHHHHHHhcCCCCcceeeee
Q 043278 433 STTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSG------------------QGIVEFKNEVRLIAKLQHTNLVRLLGC 494 (752)
Q Consensus 433 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~l~~~ 494 (752)
.+.++||+|+||+||+|+..+|+.||||+++.... .......+|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 35689999999999999998999999998753210 011234578889999999999988765
Q ss_pred eeeCCeeEEEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEeecCCCCCcEEecCCCCceec
Q 043278 495 SLHGEERLLVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKYSRLRVIHRDLKASNILLDDKMNPKIS 574 (752)
Q Consensus 495 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~ 574 (752)
. ..+++|||+++..+.. ++......++.|++++|+|||+.+ |+||||||+|||+++++ ++|+
T Consensus 83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~~li 144 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-IWII 144 (191)
T ss_dssp E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-EEEC
T ss_pred c----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCCC-EEEE
Confidence 3 2479999998866532 334456679999999999999998 99999999999999764 8999
Q ss_pred ccccceeecccccccccccccccCCccChhhhccCCCCccchhHHHHHHHH
Q 043278 575 DFGMARIFEVNESEANTKRIVGTYGYMSPEYAMSGIVSIKTDVFSFGVLVL 625 (752)
Q Consensus 575 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DV~S~G~vl~ 625 (752)
|||+|...............+. .-.|.+ .+.|..++|+||..--++
T Consensus 145 DFG~a~~~~~~~~~~~l~rd~~----~~~~~f-~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 145 DFPQSVEVGEEGWREILERDVR----NIITYF-SRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp CCTTCEETTSTTHHHHHHHHHH----HHHHHH-HHHHCCCCCHHHHHHHHH
T ss_pred ECCCcccCCCCCcHHHHHHHHH----HHHHHH-cCCCCCcccHHHHHHHHh
Confidence 9999976442221110000000 001111 356788999999865443
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.66 E-value=9.6e-17 Score=140.05 Aligned_cols=99 Identities=16% Similarity=0.261 Sum_probs=81.3
Q ss_pred EecCCCCCCcCccccCCCCCCCCCccEEeccCCCCCCCCCceEEEecCCCcEEEEcCCCCcEEEeeccCCccccceeEec
Q 043278 29 IWHDTAPDTLGWYFRPFLPRYQTDEPIWIANRNTPILDQSGVLTIDSIDGNLKILHNGGNPIAVSSVEGASNNTSATLLQ 108 (752)
Q Consensus 29 Iw~~~~~~~~~~~~~~~~~~~~~~t~vWvANr~~Pv~~~~~~l~~~~~~g~L~l~~~~g~~~~~~~~~~~~~~~~a~lld 108 (752)
|||.+++ +++++|++|++.|+....-+|.+.. ||||+|.+. +.++|++++........|+|++
T Consensus 12 il~~~~~---------------~~~~~~~l~~~q~l~~g~y~L~~q~-DGNLvL~~~-~~~vW~s~t~~~~~~~~~~l~~ 74 (120)
T d1dlpa2 12 ILYSTQG---------------NDNHPQTLHATQSLQLSPYRLSMET-DCNLVLFDR-DDRVWSTNTAGKGTGCRAVLQP 74 (120)
T ss_dssp ECCCC-----------------CCCCCCEECSSCCCBCSSCEEEEET-TTEEEEEBT-TBCCSCCCCCSSCSSCEEEEET
T ss_pred EEEcCCC---------------CCCcccEEcCCCeeEcCCEEEEEcC-CCcEEEecC-CcEEEEEccccCCCcEEEEEeC
Confidence 7887776 5799999999999998877899998 999999985 6678888775555556899999
Q ss_pred CCCeEEEEecCCCccceeEeeeccCCCcccCCCCeeccccccCceeEEEEecCCCCCCCCCcEEeeecCCCc
Q 043278 109 SGNLVLREMDTDGTIKRVLWQSFDYPTDTLLPGMKLGINLQTGHQWFLQSWLDYSSPAQGSFTLGIEPNATN 180 (752)
Q Consensus 109 sGNlVl~~~~~~~~~~~~lWQSFd~PTDTlLpg~kl~~~~~tg~~~~L~Sw~s~~dps~G~f~l~~~~~g~~ 180 (752)
+|||||++.+ ++++||||. +.++|.|.+.|++||..
T Consensus 75 ~GnLvl~d~~-----~~~lW~S~t-------------------------------~~~~~~~~l~Lq~DGnl 110 (120)
T d1dlpa2 75 NGRMDVLTNQ-----NIAVWTSGN-------------------------------SRSAGRYVFVLQPDRNL 110 (120)
T ss_dssp TTEEEEEETT-----TEEEEECCC-------------------------------CCSSSCCEEEECSSSCE
T ss_pred CeeEEEEcCC-----CCEEEEeCC-------------------------------CCCCCcEEEEECCCCcE
Confidence 9999999865 579999982 34678899999999943
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.61 E-value=1.1e-15 Score=132.44 Aligned_cols=95 Identities=19% Similarity=0.355 Sum_probs=75.6
Q ss_pred CCeEEeeeeCCCCCCCCccEEEEecCCCCCCcCccccCCCCCCCCCccEEeccCCCCCCCCCceEEEecCCCcEEEEcCC
Q 043278 7 FGNFKLGFFSPASSTTTERYLGIWHDTAPDTLGWYFRPFLPRYQTDEPIWIANRNTPILDQSGVLTIDSIDGNLKILHNG 86 (752)
Q Consensus 7 ~g~F~lGFf~~~~~~~~~~ylgIw~~~~~~~~~~~~~~~~~~~~~~t~vWvANr~~Pv~~~~~~l~~~~~~g~L~l~~~~ 86 (752)
+|.|+|+|...++ |.|++. .++||.||++.|... ..|.|.. ||+|+|.|.
T Consensus 18 ~g~~~l~~q~DGN-------Lvly~~-------------------~~~vW~s~~~~~~~~--~~l~l~~-dGnLvl~~~- 67 (112)
T d1xd5a_ 18 EGGYLFIIQNDCN-------LVLYDN-------------------NRAVWASGTNGKASG--CVLKMQN-DGNLVIYSG- 67 (112)
T ss_dssp ETTEEEEECTTSC-------EEEEET-------------------TEEEEECCCTTSCSS--EEEEECT-TSCEEEEET-
T ss_pred ECCEEEEEcCCCC-------EEEEcC-------------------CcEEEEccCccCCCC--cEEEEec-cccEEEEec-
Confidence 5899999986542 555553 378999999988544 5799988 999999986
Q ss_pred CCcEEEeeccCCccccceeEecCCCeEEEEecCCCccceeEeeeccCCCc
Q 043278 87 GNPIAVSSVEGASNNTSATLLQSGNLVLREMDTDGTIKRVLWQSFDYPTD 136 (752)
Q Consensus 87 g~~~~~~~~~~~~~~~~a~lldsGNlVl~~~~~~~~~~~~lWQSFd~PTD 136 (752)
+..+|+++++...+...|+|+|+|||||++.+ +.++|||+.+|+|
T Consensus 68 ~~~~w~s~t~~~~~~~~l~L~ddGNlvly~~~-----~~~~W~S~t~~~n 112 (112)
T d1xd5a_ 68 SRAIWASNTNRQNGNYYLILQRDRNVVIYDNS-----NNAIWATHTNVGN 112 (112)
T ss_dssp TEEEEECCCCCSCCCCEEEECTTSCEEEECTT-----SCEEEECCCCCCC
T ss_pred CCeEEEEeeccCCCceEEEEcCCCCEEEECCC-----CcEEecCCCccCC
Confidence 56778877655555668999999999999754 4689999999986
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.59 E-value=2.2e-15 Score=129.13 Aligned_cols=91 Identities=18% Similarity=0.308 Sum_probs=73.6
Q ss_pred CCeEEeeeeCCCCCCCCccEEEEecCCCCCCcCccccCCCCCCCCCccEEeccCCCCCCCCCceEEEecCCCcEEEEcCC
Q 043278 7 FGNFKLGFFSPASSTTTERYLGIWHDTAPDTLGWYFRPFLPRYQTDEPIWIANRNTPILDQSGVLTIDSIDGNLKILHNG 86 (752)
Q Consensus 7 ~g~F~lGFf~~~~~~~~~~ylgIw~~~~~~~~~~~~~~~~~~~~~~t~vWvANr~~Pv~~~~~~l~~~~~~g~L~l~~~~ 86 (752)
+|.|.|+|...+ .|.++.. .++||+||++.|...+ +.|.|.+ ||+|||.|.+
T Consensus 18 ~g~~~l~~q~dg-------nLvl~~~-------------------~~~vW~ant~~~~~~~-~~l~l~~-dGnLvl~~~~ 69 (109)
T d1kj1a_ 18 VEPYHFIMQEDC-------NLVLYDH-------------------STSVWASNTGILGKKG-CKAVLQS-DGNFVVYDAE 69 (109)
T ss_dssp ETTEEEEECTTS-------CEEEEET-------------------TEEEEECCCCCTTCCC-CEEEECT-TSCEEEECSS
T ss_pred eCCEEEEecCCC-------eEEEEeC-------------------CEEEEEeCCCCCCcee-EEEEEcC-CceEEEEeCC
Confidence 588999997543 2555542 4789999999998776 6799998 9999999999
Q ss_pred CCcEEEeeccCCccccceeEecCCCeEEEEecCCCccceeEeeeccC
Q 043278 87 GNPIAVSSVEGASNNTSATLLQSGNLVLREMDTDGTIKRVLWQSFDY 133 (752)
Q Consensus 87 g~~~~~~~~~~~~~~~~a~lldsGNlVl~~~~~~~~~~~~lWQSFd~ 133 (752)
|.++|.+.++...+...|+|+|+|||||++ ..+|||+-|
T Consensus 70 g~~vW~s~t~~~~~~~~l~L~ddGNlvly~--------~~~W~S~t~ 108 (109)
T d1kj1a_ 70 GRSLWASHSVRGNGNYVLVLQEDGNVVIYG--------SDIWSTGTY 108 (109)
T ss_dssp SCEEEECCCCCCSSCCEEEECTTSCEEEEC--------CEEEECCCC
T ss_pred CcEEEEEeeECCCCCEEEEEeCCCcEEEEC--------CCEecCCCc
Confidence 999999887555556679999999999984 259999854
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.58 E-value=1.6e-15 Score=129.92 Aligned_cols=90 Identities=24% Similarity=0.414 Sum_probs=72.9
Q ss_pred CCeEEeeeeCCCCCCCCccEEEEecCCCCCCcCccccCCCCCCCCCccEEeccCCCCCCCCCceEEEecCCCcEEEEcCC
Q 043278 7 FGNFKLGFFSPASSTTTERYLGIWHDTAPDTLGWYFRPFLPRYQTDEPIWIANRNTPILDQSGVLTIDSIDGNLKILHNG 86 (752)
Q Consensus 7 ~g~F~lGFf~~~~~~~~~~ylgIw~~~~~~~~~~~~~~~~~~~~~~t~vWvANr~~Pv~~~~~~l~~~~~~g~L~l~~~~ 86 (752)
+|.|.|+|...+ .|.|+.. .++||.||++.|-.. ..|.+.. +|+|+|.|++
T Consensus 18 ng~~~l~~q~DG-------NLvly~~-------------------~~~vW~s~~~~~~~~--~~l~l~~-~Gnlvl~~~~ 68 (108)
T d1jpca_ 18 YGSFVFIMQEDC-------NLVLYDV-------------------DKPIWATNTGGLSRS--CFLSMQT-DGNLVVYNPS 68 (108)
T ss_dssp ETTEEEEECTTS-------CEEEEET-------------------TEEEEECCCTTSCSS--CEEEECT-TSCEEEECTT
T ss_pred cCCEEEEECCCC-------eEEEEeC-------------------CceeeEeCCCCCCCc--cEEEEec-cceEEEECCC
Confidence 689999998765 2666653 478999999988433 5799987 9999999999
Q ss_pred CCcEEEeeccCCccccceeEecCCCeEEEEecCCCccceeEeeeccC
Q 043278 87 GNPIAVSSVEGASNNTSATLLQSGNLVLREMDTDGTIKRVLWQSFDY 133 (752)
Q Consensus 87 g~~~~~~~~~~~~~~~~a~lldsGNlVl~~~~~~~~~~~~lWQSFd~ 133 (752)
|.++|++++........|+|+|+|||||++. .+||||+|
T Consensus 69 g~~vWsS~t~~~~~~~~l~L~ddGNlVly~~--------~~W~S~t~ 107 (108)
T d1jpca_ 69 NKPIWASNTGGQNGNYVCILQKDRNVVIYGT--------DRWATGTH 107 (108)
T ss_dssp CCEEEECCCCCSCSCEEEEECTTSCEEEEEC--------CCCCCCCC
T ss_pred ccceEEccccCCCCcEEEEEcCCCCEEEeCC--------CcccCCCC
Confidence 9999998765554555789999999999842 48999987
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.52 E-value=6.5e-15 Score=126.84 Aligned_cols=110 Identities=20% Similarity=0.256 Sum_probs=87.0
Q ss_pred CCCCCCCCCccEEeccCCCCCCCCCceEEEecCCCcEEEEcCCCCcEEEeeccCCccccceeEecCCCeEEEEecCCCcc
Q 043278 44 PFLPRYQTDEPIWIANRNTPILDQSGVLTIDSIDGNLKILHNGGNPIAVSSVEGASNNTSATLLQSGNLVLREMDTDGTI 123 (752)
Q Consensus 44 ~~~~~~~~~t~vWvANr~~Pv~~~~~~l~~~~~~g~L~l~~~~g~~~~~~~~~~~~~~~~a~lldsGNlVl~~~~~~~~~ 123 (752)
|+|....+.+..|..+.+.++.....+|.+.. ||||||.+ ++.++|.+++. +..+..+.|+|+|||||++.+
T Consensus 3 ~~~~~~~~~~~~~tl~~~~~l~~g~~~l~~q~-DGNLvL~~-~~~~vW~s~t~-~~~~~~l~l~~dGNLvl~d~~----- 74 (115)
T d1dlpa1 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQS-DCNLVLFD-SDVRVWASNTA-GATGCRAVLQSDGLLVILTAQ----- 74 (115)
T ss_dssp CCBCSSSSSCSCSCCCTTCEECSTTEEEEECT-TSCEEEEE-SSSEEECCCCC-SCSCCBCCBCSSSCBCCBCTT-----
T ss_pred EEEecCCCCCCcceecCCCcEEcCCEEEEECC-CCeEEEEc-CCeeEEEcccC-CCCceEEEEeccCCEEEEccC-----
Confidence 34444456788899999999998878899998 99999987 46778887763 455678999999999998755
Q ss_pred ceeEeeeccCCCcccCCCCeeccccccCceeEEEEecCCCCCCCCCcEEeeecCCCceeEEEecCceEEEeccc
Q 043278 124 KRVLWQSFDYPTDTLLPGMKLGINLQTGHQWFLQSWLDYSSPAQGSFTLGIEPNATNQLIIRWRRETIYWTSGL 197 (752)
Q Consensus 124 ~~~lWQSFd~PTDTlLpg~kl~~~~~tg~~~~L~Sw~s~~dps~G~f~l~~~~~g~~~~~~~~~~~~~yw~~g~ 197 (752)
++++|||+- +.+.|.|.|.|+++|. ++++ ..+||.+|.
T Consensus 75 ~~~vWsS~t-------------------------------~~~~g~y~l~Lq~DGN--lvlY---~~~~Wssgt 112 (115)
T d1dlpa1 75 NTIRWSSGT-------------------------------KGSIGNYVLVLQPDRT--VTIY---GPGLWDSGT 112 (115)
T ss_dssp TCCSCCCCC-------------------------------CCCSSCCEEEECSSSC--EEEE---CSEEEECSC
T ss_pred CCEEEEcCC-------------------------------CCCCCCEEEEECCCCc--EEEe---CCCeecCCC
Confidence 568999862 3467999999999995 4554 347898874
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.24 E-value=1.3e-11 Score=106.69 Aligned_cols=93 Identities=19% Similarity=0.306 Sum_probs=71.9
Q ss_pred EeeCCCeEEeeeeCCCCCCCCccEEEEecCCCCCCcCccccCCCCCCCCCccEEeccCCCCCCCCCceEEEecCCCcEEE
Q 043278 3 LVSAFGNFKLGFFSPASSTTTERYLGIWHDTAPDTLGWYFRPFLPRYQTDEPIWIANRNTPILDQSGVLTIDSIDGNLKI 82 (752)
Q Consensus 3 lvS~~g~F~lGFf~~~~~~~~~~ylgIw~~~~~~~~~~~~~~~~~~~~~~t~vWvANr~~Pv~~~~~~l~~~~~~g~L~l 82 (752)
+++..|.|.|.|...|+ |.+ |. ..++||.||+..|..+ ..|.|.. ||+|+|
T Consensus 25 ~~~~~~~y~l~mQ~DGN-------LVL-y~------------------~~~~vWssnt~~~~~~--~~l~l~~-dGnLvL 75 (119)
T d1b2pa_ 25 ILFGTHVYRFIMQTDCN-------LVL-YD------------------NNNPIWATNTGGLGNG--CRAVLQP-DGVLVV 75 (119)
T ss_dssp EEETTEEEEEEECTTSC-------EEE-EE------------------TTEEEEECCCTTSCSS--CEEEECT-TSCEEE
T ss_pred EecCCceEEEEECCCCc-------EEE-EE------------------CCeEEEEecCCCCCcc--eEEEEEe-CCCEEE
Confidence 35568999999886652 333 33 1478999999877543 5799998 999999
Q ss_pred EcCCCCcEEEeeccCCccccceeEecCCCeEEEEecCCCccceeEeeecc
Q 043278 83 LHNGGNPIAVSSVEGASNNTSATLLQSGNLVLREMDTDGTIKRVLWQSFD 132 (752)
Q Consensus 83 ~~~~g~~~~~~~~~~~~~~~~a~lldsGNlVl~~~~~~~~~~~~lWQSFd 132 (752)
.|.+|.++|++++........++|+|+|||||++ ..+|||-.
T Consensus 76 ~d~~g~~vWsS~t~~~~~~~~l~Lq~DGNlvlYg--------~~~W~S~T 117 (119)
T d1b2pa_ 76 ITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG--------DALWATQT 117 (119)
T ss_dssp ECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEE--------SEEEECCC
T ss_pred ECCCCcEEEECCCcCCCCceEEEEcCCCCEEEEC--------CCEeccCC
Confidence 9999999998876544445579999999999983 36999964
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.78 E-value=2.6e-09 Score=91.19 Aligned_cols=88 Identities=22% Similarity=0.309 Sum_probs=67.9
Q ss_pred CCCeEEeeeeCCCCCCCCccEEEEecCCCCCCcCccccCCCCCCCCCccEEeccCCCCCCCCCceEEEecCCCcEEEEcC
Q 043278 6 AFGNFKLGFFSPASSTTTERYLGIWHDTAPDTLGWYFRPFLPRYQTDEPIWIANRNTPILDQSGVLTIDSIDGNLKILHN 85 (752)
Q Consensus 6 ~~g~F~lGFf~~~~~~~~~~ylgIw~~~~~~~~~~~~~~~~~~~~~~t~vWvANr~~Pv~~~~~~l~~~~~~g~L~l~~~ 85 (752)
.+|.|.|.|...|+ |.|+.. .++||.+|...+ ....+.+.+ +|||||.|.
T Consensus 24 ~~g~~~l~~q~DGN-------LvL~~~-------------------~~~vW~s~t~~~---~~~~l~l~~-dGNLvl~d~ 73 (115)
T d1dlpa1 24 ELSSFRFTMQSDCN-------LVLFDS-------------------DVRVWASNTAGA---TGCRAVLQS-DGLLVILTA 73 (115)
T ss_dssp CSTTEEEEECTTSC-------EEEEES-------------------SSEEECCCCCSC---SCCBCCBCS-SSCBCCBCT
T ss_pred EcCCEEEEECCCCe-------EEEEcC-------------------CeeEEEcccCCC---CceEEEEec-cCCEEEEcc
Confidence 47889998886652 556542 367999997642 235788887 999999999
Q ss_pred CCCcEEEeeccCCccccceeEecCCCeEEEEecCCCccceeEeeec
Q 043278 86 GGNPIAVSSVEGASNNTSATLLQSGNLVLREMDTDGTIKRVLWQSF 131 (752)
Q Consensus 86 ~g~~~~~~~~~~~~~~~~a~lldsGNlVl~~~~~~~~~~~~lWQSF 131 (752)
++.++|.+.+....+...++|.++|||||++ ..+|+|-
T Consensus 74 ~~~~vWsS~t~~~~g~y~l~Lq~DGNlvlY~--------~~~Wssg 111 (115)
T d1dlpa1 74 QNTIRWSSGTKGSIGNYVLVLQPDRTVTIYG--------PGLWDSG 111 (115)
T ss_dssp TTCCSCCCCCCCCSSCCEEEECSSSCEEEEC--------SEEEECS
T ss_pred CCCEEEEcCCCCCCCCEEEEECCCCcEEEeC--------CCeecCC
Confidence 9999998877655555679999999999983 3689985
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.71 E-value=3e-08 Score=85.05 Aligned_cols=85 Identities=26% Similarity=0.458 Sum_probs=62.1
Q ss_pred eEEEecCCCcEEEEcCCCCcEEEeeccCCccccceeEecCCCeEEEEecCCCccceeEeeeccCCCcccCCCCeeccccc
Q 043278 70 VLTIDSIDGNLKILHNGGNPIAVSSVEGASNNTSATLLQSGNLVLREMDTDGTIKRVLWQSFDYPTDTLLPGMKLGINLQ 149 (752)
Q Consensus 70 ~l~~~~~~g~L~l~~~~g~~~~~~~~~~~~~~~~a~lldsGNlVl~~~~~~~~~~~~lWQSFd~PTDTlLpg~kl~~~~~ 149 (752)
.|.+-. ||||||.++ +.++|++++........+.|.++|||||.+.+ +.++|+|.
T Consensus 33 ~l~mQ~-DGNLVLy~~-~~~vWssnt~~~~~~~~l~l~~dGnLvL~d~~-----g~~vWsS~------------------ 87 (119)
T d1b2pa_ 33 RFIMQT-DCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNE-----NVTVWQSP------------------ 87 (119)
T ss_dssp EEEECT-TSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTT-----CCEEEECS------------------
T ss_pred EEEECC-CCcEEEEEC-CeEEEEecCCCCCcceEEEEEeCCCEEEECCC-----CcEEEECC------------------
Confidence 466666 999999875 56789888755444568999999999998765 56899753
Q ss_pred cCceeEEEEecCCCCCCCCCcEEeeecCCCceeEEEecCceEEEeccc
Q 043278 150 TGHQWFLQSWLDYSSPAQGSFTLGIEPNATNQLIIRWRRETIYWTSGL 197 (752)
Q Consensus 150 tg~~~~L~Sw~s~~dps~G~f~l~~~~~g~~~~~~~~~~~~~yw~~g~ 197 (752)
+.-+.|.|.+.|+++|. ++++. .+.|.++.
T Consensus 88 -------------t~~~~~~~~l~Lq~DGN--lvlYg---~~~W~S~T 117 (119)
T d1b2pa_ 88 -------------VAGKAGHYVLVLQPDRN--VVIYG---DALWATQT 117 (119)
T ss_dssp -------------CCCCSSCEEEEECTTSC--EEEEE---SEEEECCC
T ss_pred -------------CcCCCCceEEEEcCCCC--EEEEC---CCEeccCC
Confidence 11245778999999994 45542 46888764
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=98.61 E-value=4.8e-08 Score=82.56 Aligned_cols=85 Identities=22% Similarity=0.403 Sum_probs=61.4
Q ss_pred ceEEEecCCCcEEEEcCCCCcEEEeeccCCccccceeEecCCCeEEEEecCCCccceeEeeeccCCCcccCCCCeecccc
Q 043278 69 GVLTIDSIDGNLKILHNGGNPIAVSSVEGASNNTSATLLQSGNLVLREMDTDGTIKRVLWQSFDYPTDTLLPGMKLGINL 148 (752)
Q Consensus 69 ~~l~~~~~~g~L~l~~~~g~~~~~~~~~~~~~~~~a~lldsGNlVl~~~~~~~~~~~~lWQSFd~PTDTlLpg~kl~~~~ 148 (752)
-+|.+-. ||||||.+ .+.+||++++........++|.++|||||.+.+ +.++|+|
T Consensus 21 ~~l~~q~-DGNLvly~-~~~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~~~-----g~~vWsS------------------ 75 (108)
T d1jpca_ 21 FVFIMQE-DCNLVLYD-VDKPIWATNTGGLSRSCFLSMQTDGNLVVYNPS-----NKPIWAS------------------ 75 (108)
T ss_dssp EEEEECT-TSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTT-----CCEEEEC------------------
T ss_pred EEEEECC-CCeEEEEe-CCceeeEeCCCCCCCccEEEEeccceEEEECCC-----ccceEEc------------------
Confidence 5688877 99999987 467889887754444557999999999998765 5689986
Q ss_pred ccCceeEEEEecCCCCCCCCCcEEeeecCCCceeEEEecCceEEEecc
Q 043278 149 QTGHQWFLQSWLDYSSPAQGSFTLGIEPNATNQLIIRWRRETIYWTSG 196 (752)
Q Consensus 149 ~tg~~~~L~Sw~s~~dps~G~f~l~~~~~g~~~~~~~~~~~~~yw~~g 196 (752)
.+..+.+.|.+.|+++|. ++++. .+.|.++
T Consensus 76 -------------~t~~~~~~~~l~L~ddGN--lVly~---~~~W~S~ 105 (108)
T d1jpca_ 76 -------------NTGGQNGNYVCILQKDRN--VVIYG---TDRWATG 105 (108)
T ss_dssp -------------CCCCSCSCEEEEECTTSC--EEEEE---CCCCCCC
T ss_pred -------------cccCCCCcEEEEEcCCCC--EEEeC---CCcccCC
Confidence 112245678899999994 45543 2356654
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=98.54 E-value=2e-07 Score=78.65 Aligned_cols=86 Identities=22% Similarity=0.394 Sum_probs=61.6
Q ss_pred ceEEEecCCCcEEEEcCCCCcEEEeeccCC-ccccceeEecCCCeEEEEecCCCccceeEeeeccCCCcccCCCCeeccc
Q 043278 69 GVLTIDSIDGNLKILHNGGNPIAVSSVEGA-SNNTSATLLQSGNLVLREMDTDGTIKRVLWQSFDYPTDTLLPGMKLGIN 147 (752)
Q Consensus 69 ~~l~~~~~~g~L~l~~~~g~~~~~~~~~~~-~~~~~a~lldsGNlVl~~~~~~~~~~~~lWQSFd~PTDTlLpg~kl~~~ 147 (752)
-.|.+-. ||||||.. .+.++|++++... .....+.|.++|||||++.+ ++++|+|=
T Consensus 21 ~~l~~q~-dgnLvl~~-~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~~-----g~~vW~s~---------------- 77 (109)
T d1kj1a_ 21 YHFIMQE-DCNLVLYD-HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAE-----GRSLWASH---------------- 77 (109)
T ss_dssp EEEEECT-TSCEEEEE-TTEEEEECCCCCTTCCCCEEEECTTSCEEEECSS-----SCEEEECC----------------
T ss_pred EEEEecC-CCeEEEEe-CCEEEEEeCCCCCCceeEEEEEcCCceEEEEeCC-----CcEEEEEe----------------
Confidence 5688877 99999986 5678898876432 23456899999999998765 56899871
Q ss_pred cccCceeEEEEecCCCCCCCCCcEEeeecCCCceeEEEecCceEEEeccc
Q 043278 148 LQTGHQWFLQSWLDYSSPAQGSFTLGIEPNATNQLIIRWRRETIYWTSGL 197 (752)
Q Consensus 148 ~~tg~~~~L~Sw~s~~dps~G~f~l~~~~~g~~~~~~~~~~~~~yw~~g~ 197 (752)
+..+.|.|.+.|+++|. ++++. .+.|.++.
T Consensus 78 ---------------t~~~~~~~~l~L~ddGN--lvly~---~~~W~S~t 107 (109)
T d1kj1a_ 78 ---------------SVRGNGNYVLVLQEDGN--VVIYG---SDIWSTGT 107 (109)
T ss_dssp ---------------CCCCSSCCEEEECTTSC--EEEEC---CEEEECCC
T ss_pred ---------------eECCCCCEEEEEeCCCc--EEEEC---CCEecCCC
Confidence 11135678999999994 45542 35787654
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.53 E-value=1.1e-07 Score=81.70 Aligned_cols=67 Identities=16% Similarity=0.297 Sum_probs=52.2
Q ss_pred ccEEeccCCCCCCCCCceEEEecCCCcEEEEcCCCCcEEEeeccCCccccceeEecCCCeEEEEecCCCccceeEeee
Q 043278 53 EPIWIANRNTPILDQSGVLTIDSIDGNLKILHNGGNPIAVSSVEGASNNTSATLLQSGNLVLREMDTDGTIKRVLWQS 130 (752)
Q Consensus 53 t~vWvANr~~Pv~~~~~~l~~~~~~g~L~l~~~~g~~~~~~~~~~~~~~~~a~lldsGNlVl~~~~~~~~~~~~lWQS 130 (752)
.+||.+|-. ..+....+.|.. +|||||.|.+++++|.+.+........++|.++|||||++ ..+|.|
T Consensus 54 ~~vW~s~t~--~~~~~~~~~l~~-~GnLvl~d~~~~~lW~S~t~~~~~~~~l~Lq~DGnlvlY~--------~~~W~t 120 (120)
T d1dlpa2 54 DRVWSTNTA--GKGTGCRAVLQP-NGRMDVLTNQNIAVWTSGNSRSAGRYVFVLQPDRNLAIYG--------GALWTT 120 (120)
T ss_dssp BCCSCCCCC--SSCSSCEEEEET-TTEEEEEETTTEEEEECCCCCSSSCCEEEECSSSCEEEEC--------CCCCBC
T ss_pred cEEEEEccc--cCCCcEEEEEeC-CeeEEEEcCCCCEEEEeCCCCCCCcEEEEECCCCcEEEeC--------CCcccC
Confidence 668988743 333345789987 9999999999999999887555555678999999999983 257875
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.51 E-value=1.7e-07 Score=93.01 Aligned_cols=149 Identities=15% Similarity=0.110 Sum_probs=103.3
Q ss_pred HHHHHhcCCCcCCeeecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcC-CCCcceeeeeeeeCCeeE
Q 043278 424 TIAAAANNFSTTNKLGEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQ-HTNLVRLLGCSLHGEERL 502 (752)
Q Consensus 424 ~i~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 502 (752)
++...-+.|...+..+.++.+.||+... +++.++||+...........+.+|...+..+. +--+.+++.+..+++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 4555556776655555555578998864 55667888876654444445678888887774 334667788888888899
Q ss_pred EEEeeCCCCCHhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc----------------------------------
Q 043278 503 LVYEFMPNKSLDFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHKY---------------------------------- 548 (752)
Q Consensus 503 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---------------------------------- 548 (752)
+||+++++..+....... .....++.++++.+..||+.
T Consensus 87 lv~~~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEECCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEeccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 999999998886544211 11233556666667777642
Q ss_pred ----------------------CCCcEeecCCCCCcEEecCCCCceeccccccee
Q 043278 549 ----------------------SRLRVIHRDLKASNILLDDKMNPKISDFGMARI 581 (752)
Q Consensus 549 ----------------------~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~ 581 (752)
....++|+|+.|.|||++++..+-|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 112379999999999999877677999998864
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.45 E-value=4.9e-07 Score=76.83 Aligned_cols=88 Identities=19% Similarity=0.387 Sum_probs=64.8
Q ss_pred ceEEEecCCCcEEEEcCCCCcEEEeeccCCccccceeEecCCCeEEEEecCCCccceeEeeeccCCCcccCCCCeecccc
Q 043278 69 GVLTIDSIDGNLKILHNGGNPIAVSSVEGASNNTSATLLQSGNLVLREMDTDGTIKRVLWQSFDYPTDTLLPGMKLGINL 148 (752)
Q Consensus 69 ~~l~~~~~~g~L~l~~~~g~~~~~~~~~~~~~~~~a~lldsGNlVl~~~~~~~~~~~~lWQSFd~PTDTlLpg~kl~~~~ 148 (752)
-.|.+-. ||||||.+ .+.+||++++......+.++|..+|||||++.+ +.+|-|
T Consensus 21 ~~l~~q~-DGNLvly~-~~~~vW~s~~~~~~~~~~l~l~~dGnLvl~~~~------~~~w~s------------------ 74 (112)
T d1xd5a_ 21 YLFIIQN-DCNLVLYD-NNRAVWASGTNGKASGCVLKMQNDGNLVIYSGS------RAIWAS------------------ 74 (112)
T ss_dssp EEEEECT-TSCEEEEE-TTEEEEECCCTTSCSSEEEEECTTSCEEEEETT------EEEEEC------------------
T ss_pred EEEEEcC-CCCEEEEc-CCcEEEEccCccCCCCcEEEEeccccEEEEecC------CeEEEE------------------
Confidence 5788877 99999986 467889887655455568999999999998742 456644
Q ss_pred ccCceeEEEEecCCCCCCCCCcEEeeecCCCceeEEEecCceEEEeccc
Q 043278 149 QTGHQWFLQSWLDYSSPAQGSFTLGIEPNATNQLIIRWRRETIYWTSGL 197 (752)
Q Consensus 149 ~tg~~~~L~Sw~s~~dps~G~f~l~~~~~g~~~~~~~~~~~~~yw~~g~ 197 (752)
.+.-..|.|.+.|+++| .++++.....+.|.++.
T Consensus 75 -------------~t~~~~~~~~l~L~ddG--Nlvly~~~~~~~W~S~t 108 (112)
T d1xd5a_ 75 -------------NTNRQNGNYYLILQRDR--NVVIYDNSNNAIWATHT 108 (112)
T ss_dssp -------------CCCCSCCCCEEEECTTS--CEEEECTTSCEEEECCC
T ss_pred -------------eeccCCCceEEEEcCCC--CEEEECCCCcEEecCCC
Confidence 12224467899999999 45666666778898864
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.93 E-value=2.1e-05 Score=76.93 Aligned_cols=131 Identities=16% Similarity=0.132 Sum_probs=87.4
Q ss_pred eeecCCc-ccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCC--CCcceeeeeeeeCCeeEEEEeeCCCCCH
Q 043278 437 KLGEGGF-GPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQH--TNLVRLLGCSLHGEERLLVYEFMPNKSL 513 (752)
Q Consensus 437 ~LG~G~f-g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~E~~~~gsL 513 (752)
.+..|.. +.||+...+++..+++|........ .+..|...++.+.. ..+.+++.+..+++..++|||++++.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~---~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN---ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTS---CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCHh---HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 4445543 6789999888888999986554332 35677777776643 3466778888888889999999988665
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------------
Q 043278 514 DFFLFNSGRKNVLNWEKRFIIIEGISQGLLYLHK---------------------------------------------- 547 (752)
Q Consensus 514 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---------------------------------------------- 547 (752)
.... +.. ..++.++++.|.-||+
T Consensus 94 ~~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cccc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 3211 111 1122333344444442
Q ss_pred -----c----CCCcEeecCCCCCcEEecCCCCceeccccccee
Q 043278 548 -----Y----SRLRVIHRDLKASNILLDDKMNPKISDFGMARI 581 (752)
Q Consensus 548 -----~----~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~ 581 (752)
. ....++|+|+.|.|||++++..+-|+||+.+..
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 1 122489999999999999877778999998764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.63 E-value=0.0002 Score=74.75 Aligned_cols=75 Identities=16% Similarity=0.182 Sum_probs=47.7
Q ss_pred CeeecCCcccEEEEEecC-CceeEEEEcccC---C----cccHHHHHHHHHHHHhcC-C-C-CcceeeeeeeeCCeeEEE
Q 043278 436 NKLGEGGFGPVYKGKLAD-EQEVAIKRLSRS---S----GQGIVEFKNEVRLIAKLQ-H-T-NLVRLLGCSLHGEERLLV 504 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~----~~~~~~~~~E~~~l~~l~-h-~-niv~l~~~~~~~~~~~lv 504 (752)
+.||.|....||+....+ ++.++||.-... . .....+...|.+.|..+. + | .+.+++.+ +.+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 578999999999998754 678999964321 1 112334456887777662 2 2 34555544 45567899
Q ss_pred EeeCCCCC
Q 043278 505 YEFMPNKS 512 (752)
Q Consensus 505 ~E~~~~gs 512 (752)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.81 E-value=0.0031 Score=63.41 Aligned_cols=136 Identities=14% Similarity=0.138 Sum_probs=79.6
Q ss_pred cccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCc--ceeee-----eeeeCCeeEEEEeeCCCCCHhH
Q 043278 443 FGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL--VRLLG-----CSLHGEERLLVYEFMPNKSLDF 515 (752)
Q Consensus 443 fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~-----~~~~~~~~~lv~E~~~~gsL~~ 515 (752)
--.||+++.++|+.+++|+.... ....+++..|...+..|....+ +..+. .+..+...+.+++++++..+..
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 36899999999999999987543 3356778889988888743221 11111 2344567788999987644321
Q ss_pred ----HH----------hh------cCCCCCCCHHH-------------------HHHHHHHHHHHHHHHHh----cCCCc
Q 043278 516 ----FL----------FN------SGRKNVLNWEK-------------------RFIIIEGISQGLLYLHK----YSRLR 552 (752)
Q Consensus 516 ----~l----------~~------~~~~~~l~~~~-------------------~~~i~~~i~~~l~~LH~----~~~~~ 552 (752)
.+ +. ...+..+++.. +-.+...+.+.++.+.. ..+..
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 11 10 00111222211 11122222233333322 22346
Q ss_pred EeecCCCCCcEEecCCCCceeccccccee
Q 043278 553 VIHRDLKASNILLDDKMNPKISDFGMARI 581 (752)
Q Consensus 553 iiH~Dikp~NIll~~~~~~kl~DFgla~~ 581 (752)
+||+|+++.|||++++ ..++||+-+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 8999999999999754 45899998874
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.52 E-value=0.0028 Score=65.73 Aligned_cols=72 Identities=15% Similarity=0.240 Sum_probs=48.8
Q ss_pred CeeecCCcccEEEEEecCC--------ceeEEEEcccCCcccHHHHHHHHHHHHhcCCCCc-ceeeeeeeeCCeeEEEEe
Q 043278 436 NKLGEGGFGPVYKGKLADE--------QEVAIKRLSRSSGQGIVEFKNEVRLIAKLQHTNL-VRLLGCSLHGEERLLVYE 506 (752)
Q Consensus 436 ~~LG~G~fg~Vy~~~~~~~--------~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E 506 (752)
+.|+.|-.-.+|+....++ +.|.+++.- . ........+|..+++.+.-.++ .++++++.. .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 5788899999999987543 345555543 2 2334456789988888853344 467777643 68899
Q ss_pred eCCCCCH
Q 043278 507 FMPNKSL 513 (752)
Q Consensus 507 ~~~~gsL 513 (752)
|+++..+
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987554
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.72 E-value=0.059 Score=53.17 Aligned_cols=158 Identities=13% Similarity=0.016 Sum_probs=81.3
Q ss_pred cHHHHHHHhcCCCcCCee-----ecCCcccEEEEEecCCceeEEEEcccCCcccHHHHHHHHHHHHhcCC-----CCcce
Q 043278 421 DFQTIAAAANNFSTTNKL-----GEGGFGPVYKGKLADEQEVAIKRLSRSSGQGIVEFKNEVRLIAKLQH-----TNLVR 490 (752)
Q Consensus 421 ~~~~i~~~~~~~~~~~~L-----G~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h-----~niv~ 490 (752)
+.+++...-.+|.+.+.. ..|---+.|+.+.++| .+++|+...... ..+...|++++..+.. |..+.
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi~ 80 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPLP 80 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCCC--HHHHHHHHHHHHhhhhccccccccce
Confidence 456777777788775444 3555577899887665 489998764322 2234556666666632 22222
Q ss_pred eee---eeeeCCeeEEEEeeCCCCCHhHH--------------HhhcC------CCCCCCH------------------H
Q 043278 491 LLG---CSLHGEERLLVYEFMPNKSLDFF--------------LFNSG------RKNVLNW------------------E 529 (752)
Q Consensus 491 l~~---~~~~~~~~~lv~E~~~~gsL~~~--------------l~~~~------~~~~l~~------------------~ 529 (752)
..+ +.........++.++.+...... ++... ....... .
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (316)
T d2ppqa1 81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 160 (316)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence 111 12223455666666655333110 00000 0000000 0
Q ss_pred HHHHHHHHHHHHHHHHHh-cCCCcEeecCCCCCcEEecCCCCceeccccccee
Q 043278 530 KRFIIIEGISQGLLYLHK-YSRLRVIHRDLKASNILLDDKMNPKISDFGMARI 581 (752)
Q Consensus 530 ~~~~i~~~i~~~l~~LH~-~~~~~iiH~Dikp~NIll~~~~~~kl~DFgla~~ 581 (752)
.....+..+...+.-.+. .-+.++||+|+.+.||+++.+...-|+||+.+..
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 111112222222222222 1234699999999999999888778999998864
|